Citrus Sinensis ID: 043568

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450---
Protein Sequence
MKCFHFSNGERERRDGGDDGGVVSRTSKVSWARSLSVASSSVDTRRSEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW
Secondary Structure (PSIPRED)
ccEEcccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHccccccccccHHHHHHHHcccccccccccccccEEEEEEEEcccccccccccccccEEEEEEcccccccHHHHHHHHHHHHHcccccccccEEEEEccccccccEEEEEEEEcccccHHHHccccccccccHHHHHHHHHHHHHHHHHcccccccccEEcccccccEEccccccccccccccccccccccccccccccccccccccHHHHcccccccccccccHHHHHHHHHHcccccccccccccccHHHcccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHcccccccccccccccccccccccHHHHHHHHHHccccHHHcccccHHHHHcccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEcHHHHHHHHccccHHHccccccccEEEEEEEccccccccccccccccEEEEEEEccccccccHHHHHHHHHHHHHccccHEEEEEEEcccccccccEEEEEEEcccccHHHHHcccccccccHHHHHHHHHHHHHHHHHHHHccccccccccccHHHEEEcccccEEEccccccccccHHHccccHHEEEccHHHccHHHHHHccccHHHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHccccHHHHcccHHcccccHHHHHHHHHHHHHHHcccHcccccHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccHHcccccccccccEEEEccccccEEcc
Coil and Loop (DISEMBL)
mkcfhfsngererrdggddggvvsRTSKVSWARSLSVASssvdtrrsefdsdsrdwsdSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGeggfgcvyrgvvrvssddhqtsghdsKLDVAIKQLNRQGFQGHKEWINEVNFlgvvkhpnlvKLVGycaedderGMQRLLVYELMHNKSLEdhllsrvptPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDfktsnilldedykaklsdfglarqgppeglghvstsvvgtvgyaapeyvqtgrltaksdVWSFGVVLYELITGRravernlprnEQKLLEWVrpyvsdskkfhliidprlegnycIKSAQKLAALASKcltkqpksrpkmSEVVDILGNIISeissqdevtlqpvaeiedvkeepeAEAVVESAKQGNSYLKKVFDIRDLVNLRnksigkldwrnwtpglvrsw
Flexible Loop (DISEMBL)
mkcfhfsngererrdggddggvvsrtskvswarslsvasssvdtrrsefdsdsrdwsdSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSddhqtsghdskLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTgrltaksdvwsFGVVLYELItgrravernlprneqkllewvrpyvsdskKFHLIIDPRLEGNYCIKSAQKLAALASkcltkqpksrpkmsEVVDILGNIIseissqdevtlQPVAEIEDVKEEPEAEAVVesakqgnsylkkvfdirdlvnlrnksigkldwrnwtpglvrsw
Low Complexity Region (SEG)
MKCFHFSNgererrdggddggVVSRTSKvswarslsvasssvDTRRSEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHvstsvvgtvgYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIksaqklaalaskCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPvaeiedvkeepeaeavvesaKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW
Disordered region (IsUnstruct)
**********************************************************SLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRV*************LDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCL************VVDILGNIISEI**********************************SYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLV***
Disordered Region (DISOPRED)
MKCF***********************************************************************VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN********************************************************************PGL**S*
Disordered Region (DISEMBL)
*********************VVSRTSK**************************DWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVS**********SKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCL**********SEVVDILGNIISEISSQDEVTLQPVAEIEDV*************KQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW
Disordered Region (DISPRO)
***********************************************************************NDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQT****SKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS********************************************************GKLDWRNWTPGLVRSW
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MKCFHFSNGERERRDGGDDGGVVSRTSKVSWARSLSVASSSVDTRRSEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	453	2.2.26 [Sep-21-2011]
Q9LTC0	410	Probable receptor-like pr	no	no	0.821	0.907	0.508	1e-102
Q9LFP7	493	Probable receptor-like pr	no	no	0.713	0.655	0.541	6e-99
Q9SRH7	490	Receptor-like serine/thre	no	no	0.713	0.659	0.538	7e-98
Q8GXZ3	410	Serine/threonine-protein	no	no	0.640	0.707	0.553	2e-91
Q8H186	389	Probable receptor-like pr	no	no	0.668	0.778	0.531	1e-89
P43293	389	Probable serine/threonine	no	no	0.728	0.848	0.475	1e-89
O49839	426	Protein kinase 2A, chloro	no	no	0.668	0.711	0.549	5e-89
Q06548	410	Protein kinase APK1A, chl	no	no	0.666	0.736	0.540	7e-88
P46573	412	Protein kinase APK1B, chl	no	no	0.655	0.720	0.532	8e-88
O48814	395	Serine/threonine-protein	no	no	0.668	0.767	0.507	3e-87

>sp|Q9LTC0|Y5707_ARATH Probable receptor-like protein kinase At5g47070 OS=Arabidopsis thaliana GN=At5g47070 PE=1 SV=1

 Score =  370 bits (951), Expect = e-102,   Method: Compositional matrix adjust.
 Identities = 199/391 (50%), Positives = 250/391 (63%), Gaps = 19/391 (4%)

Query: 1   MKCFHFSNGERERRDGGDDGGVVSRTSKVSWARSLSVASSSVDTRRSEFDS----DSRDW 56
           M C      ++ R+   D+     +       + L   S+   T RSE  S      R  
Sbjct: 1   MNCLFLFKSKKPRKQQKDNNKNKRK------GKELLQNSAPELTNRSETSSFNLQTPRSL 54

Query: 57  SDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQ 116
               +  +L ++R  N LRVFS+ EL  AT  FSR L+IGEGGFG VY+G +  + D   
Sbjct: 55  PSPRSIKDLYTEREQN-LRVFSYEELSKATYVFSRKLVIGEGGFGIVYKGKILSNGD--- 110

Query: 117 TSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLL 176
               D  L VAIK+LNRQG QGHK+W+ EV FLGVV HPN+VKL+GYC+ED E G++RLL
Sbjct: 111 --SSDPPLVVAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVKLIGYCSEDGETGIERLL 168

Query: 177 VYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL 236
           VYE M N+SLEDHL  R    L W  RL+I   AA GL YLH   D ++I+RDFK+SN+L
Sbjct: 169 VYEYMSNRSLEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLH---DLKVIYRDFKSSNVL 225

Query: 237 LDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL 296
           LD+ +  KLSDFGLAR+GP     HV+T+ VGT GYAAPEYVQTG L  KSDV+SFGVVL
Sbjct: 226 LDDQFCPKLSDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQTGHLRLKSDVYSFGVVL 285

Query: 297 YELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALAS 356
           YE+ITGRR +ERN P  E++LL+WV+ Y +DS++F +I+DPRL  NY    A+ LA LA 
Sbjct: 286 YEIITGRRTIERNKPVAERRLLDWVKEYPADSQRFSMIVDPRLRNNYPAAGARSLAKLAD 345

Query: 357 KCLTKQPKSRPKMSEVVDILGNIISEISSQD 387
            CL K  K RP M  VV+ L  II E  S+D
Sbjct: 346 LCLKKNDKERPTMEIVVERLKKIIEESDSED 376

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9LFP7|Y5158_ARATH Probable receptor-like protein kinase At5g15080 OS=Arabidopsis thaliana GN=At5g15080 PE=1 SV=1

 Score =  361 bits (927), Expect = 6e-99,   Method: Compositional matrix adjust.
 Identities = 183/338 (54%), Positives = 236/338 (69%), Gaps = 15/338 (4%)

Query: 39  SSSVDTRRSEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEG 98
           SS+  T  +E  S +   S+ L          ++ LR F+F +LK +TR F    L+GEG
Sbjct: 100 SSTTTTSNAESSSSTPVISEELNI--------SSHLRKFTFNDLKLSTRNFRPESLLGEG 151

Query: 99  GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLV 158
           GFGCV++G +  +       G  + L VA+K LN  G QGHKEW+ E+NFLG + HPNLV
Sbjct: 152 GFGCVFKGWIEENGTAPVKPG--TGLTVAVKTLNPDGLQGHKEWLAEINFLGNLLHPNLV 209

Query: 159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLH 218
           KLVGYC EDD    QRLLVYE M   SLE+HL  R   PL W  R+KIA  AA+GL++LH
Sbjct: 210 KLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLH 264

Query: 219 EEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV 278
           EE    +I+RDFKTSNILLD DY AKLSDFGLA+  P EG  HVST V+GT GYAAPEYV
Sbjct: 265 EEALKPVIYRDFKTSNILLDADYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYV 324

Query: 279 QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPR 338
            TG LT+KSDV+SFGVVL E++TGRR++++N P  E  L+EW RP++ D ++F+ ++DPR
Sbjct: 325 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPR 384

Query: 339 LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
           LEG++ IK AQK+  LA++CL++ PK RPKMS+VV+ L
Sbjct: 385 LEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMSDVVEAL 422

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SRH7|Y3130_ARATH Receptor-like serine/threonine-protein kinase At3g01300 OS=Arabidopsis thaliana GN=At3g01300 PE=2 SV=1

 Score =  358 bits (918), Expect = 7e-98,   Method: Compositional matrix adjust.
 Identities = 182/338 (53%), Positives = 235/338 (69%), Gaps = 15/338 (4%)

Query: 39  SSSVDTRRSEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEG 98
           SS+  T  +E    +   S+ L  Y        + L+ FSF +LK ATR F    L+GEG
Sbjct: 94  SSTTTTSNAESSLSTPIISEELNIY--------SHLKKFSFIDLKLATRNFRPESLLGEG 145

Query: 99  GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLV 158
           GFGCV++G V  +       G  + L VA+K LN  G QGHKEW+ E+N+LG + HPNLV
Sbjct: 146 GFGCVFKGWVEENGTAPVKPG--TGLTVAVKTLNPDGLQGHKEWLAEINYLGNLLHPNLV 203

Query: 159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLH 218
           KLVGYC EDD    QRLLVYE M   SLE+HL  R   PL W  R+KIA  AA+GL++LH
Sbjct: 204 KLVGYCIEDD----QRLLVYEFMPRGSLENHLFRRS-LPLPWSIRMKIALGAAKGLSFLH 258

Query: 219 EEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV 278
           EE    +I+RDFKTSNILLD +Y AKLSDFGLA+  P EG  HVST V+GT GYAAPEYV
Sbjct: 259 EEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKDAPDEGKTHVSTRVMGTYGYAAPEYV 318

Query: 279 QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPR 338
            TG LT+KSDV+SFGVVL E++TGRR++++N P  E  L+EW RP++ D ++F+ ++DPR
Sbjct: 319 MTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNGEHNLVEWARPHLLDKRRFYRLLDPR 378

Query: 339 LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
           LEG++ +K AQK+  LA++CL++  K RPKMSEVV++L
Sbjct: 379 LEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVVEVL 416

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8GXZ3|Y5102_ARATH Serine/threonine-protein kinase At5g01020 OS=Arabidopsis thaliana GN=At5g01020 PE=1 SV=1

 Score =  336 bits (862), Expect = 2e-91,   Method: Compositional matrix adjust.
 Identities = 166/300 (55%), Positives = 216/300 (72%), Gaps = 10/300 (3%)

Query: 77  FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF 136
           F+  EL++ T+ F    ++GEGGFG VY+G +    DD+   G  S L VA+K LN++G 
Sbjct: 57  FTLFELETITKSFRPDYILGEGGFGTVYKGYI----DDNLRVGLKS-LPVAVKVLNKEGL 111

Query: 137 QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT 196
           QGH+EW+ EVNFLG ++HPNLVKL+GYC EDD     RLLVYE M   SLE+HL  +   
Sbjct: 112 QGHREWLTEVNFLGQLRHPNLVKLIGYCCEDD----HRLLVYEFMLRGSLENHLFRKTTA 167

Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
           PL+W  R+ IA  AA+GLA+LH   +  +I+RDFKTSNILLD DY AKLSDFGLA+ GP 
Sbjct: 168 PLSWSRRMMIALGAAKGLAFLHNA-ERPVIYRDFKTSNILLDSDYTAKLSDFGLAKAGPQ 226

Query: 257 EGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
               HVST V+GT GYAAPEYV TG LTA+SDV+SFGVVL E++TGR++V++  P  EQ 
Sbjct: 227 GDETHVSTRVMGTYGYAAPEYVMTGHLTARSDVYSFGVVLLEMLTGRKSVDKTRPSKEQN 286

Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
           L++W RP ++D +K   IIDPRLE  Y +++AQK  +LA  CL++ PK+RP MS+VV+ L
Sbjct: 287 LVDWARPKLNDKRKLLQIIDPRLENQYSVRAAQKACSLAYYCLSQNPKARPLMSDVVETL 346

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8H186|Y3545_ARATH Probable receptor-like protein kinase At3g55450 OS=Arabidopsis thaliana GN=At3g55450 PE=1 SV=1

 Score =  330 bits (847), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 168/316 (53%), Positives = 223/316 (70%), Gaps = 13/316 (4%)

Query: 64  ELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSK 123
           E+LS   +  ++ FSF ELK ATR F    ++GEGGFGCV+RG +  ++     S   S 
Sbjct: 39  EILS---STTVKSFSFNELKLATRNFRSDSVVGEGGFGCVFRGWLDETTLTPTKS--SSG 93

Query: 124 LDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN 183
           L +A+K+LN  GFQGH+EW+ E+N+LG + HPNLVKL+GYC ED+    QRLLVYE MH 
Sbjct: 94  LVIAVKRLNPDGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDE----QRLLVYEFMHK 149

Query: 184 KSLEDHLLS---RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED 240
            SLE+HL +   +   PL+WI R+K+A DAA+GLA+LH +   ++I+RD K SNILLD D
Sbjct: 150 GSLENHLFANGNKDFKPLSWILRIKVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDSD 208

Query: 241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
           + AKLSDFGLAR GP     +VST V+GT GYAAPEYV TG L A+SDV+SFGVVL EL+
Sbjct: 209 FNAKLSDFGLARDGPMGEQSYVSTRVMGTFGYAAPEYVSTGHLNARSDVYSFGVVLLELL 268

Query: 301 TGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLT 360
            GR+A++ N P  EQ L++W RPY++  +K  LI+D RL   Y  + A +LA++A +CL+
Sbjct: 269 CGRQALDHNRPAKEQNLVDWARPYLTSRRKVLLIVDTRLNSQYKPEGAVRLASIAVQCLS 328

Query: 361 KQPKSRPKMSEVVDIL 376
            +PKSRP M +VV  L
Sbjct: 329 FEPKSRPTMDQVVRAL 344

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P43293|NAK_ARATH Probable serine/threonine-protein kinase NAK OS=Arabidopsis thaliana GN=NAK PE=2 SV=2

 Score =  330 bits (847), Expect = 1e-89,   Method: Compositional matrix adjust.
 Identities = 166/349 (47%), Positives = 233/349 (66%), Gaps = 19/349 (5%)

Query: 73  DLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN 132
           +L+ FS +ELKSATR F    ++GEGGFGCV++G +  SS      G  + + +A+K+LN
Sbjct: 52  NLKNFSLSELKSATRNFRPDSVVGEGGFGCVFKGWIDESSLAPSKPG--TGIVIAVKRLN 109

Query: 133 RQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS 192
           ++GFQGH+EW+ E+N+LG + HPNLVKL+GYC E++     RLLVYE M   SLE+HL  
Sbjct: 110 QEGFQGHREWLAEINYLGQLDHPNLVKLIGYCLEEE----HRLLVYEFMTRGSLENHLFR 165

Query: 193 R--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R     PL+W  R+++A  AARGLA+LH     Q+I+RDFK SNILLD +Y AKLSDFGL
Sbjct: 166 RGTFYQPLSWNTRVRMALGAARGLAFLHNAQP-QVIYRDFKASNILLDSNYNAKLSDFGL 224

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL 310
           AR GP     HVST V+GT GYAAPEY+ TG L+ KSDV+SFGVVL EL++GRRA+++N 
Sbjct: 225 ARDGPMGDNSHVSTRVMGTQGYAAPEYLATGHLSVKSDVYSFGVVLLELLSGRRAIDKNQ 284

Query: 311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
           P  E  L++W RPY+++ ++   ++DPRL+G Y +  A K+A LA  C++   KSRP M+
Sbjct: 285 PVGEHNLVDWARPYLTNKRRLLRVMDPRLQGQYSLTRALKIAVLALDCISIDAKSRPTMN 344

Query: 371 EVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQGNSY 419
           E+V  +          +E+ +Q  A  E    +   + ++  + Q  +Y
Sbjct: 345 EIVKTM----------EELHIQKEASKEQQNPQISIDNIINKSPQAVNY 383

May play a role in the regulation of plant growth and development.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O49839|APK2A_ARATH Protein kinase 2A, chloroplastic OS=Arabidopsis thaliana GN=APK2A PE=2 SV=1

 Score =  328 bits (841), Expect = 5e-89,   Method: Compositional matrix adjust.
 Identities = 172/313 (54%), Positives = 215/313 (68%), Gaps = 10/313 (3%)

Query: 64  ELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSK 123
           E+LS   + +L+ F+F ELK+AT+ F +  L+GEGGFGCV++G +  +S      G  S 
Sbjct: 64  EILS---SPNLKAFTFNELKNATKNFRQDNLLGEGGFGCVFKGWIDQTSLTASRPG--SG 118

Query: 124 LDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN 183
           + VA+KQL  +GFQGHKEW+ EVN+LG + HPNLV LVGYCAE    G  RLLVYE M  
Sbjct: 119 IVVAVKQLKPEGFQGHKEWLTEVNYLGQLSHPNLVLLVGYCAE----GENRLLVYEFMPK 174

Query: 184 KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA 243
            SLE+HL  R   PL W  R+K+A  AA+GL +LHE    Q+I+RDFK +NILLD D+ A
Sbjct: 175 GSLENHLFRRGAQPLTWAIRMKVAVGAAKGLTFLHEAKS-QVIYRDFKAANILLDADFNA 233

Query: 244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           KLSDFGLA+ GP     HVST V+GT GYAAPEYV TGRLTAKSDV+SFGVVL ELI+GR
Sbjct: 234 KLSDFGLAKAGPTGDNTHVSTKVIGTHGYAAPEYVATGRLTAKSDVYSFGVVLLELISGR 293

Query: 304 RAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQP 363
           RA++ +   NE  L++W  PY+ D +K   I+D +L G Y  K A   A LA +CL    
Sbjct: 294 RAMDNSNGGNEYSLVDWATPYLGDKRKLFRIMDTKLGGQYPQKGAFTAANLALQCLNPDA 353

Query: 364 KSRPKMSEVVDIL 376
           K RPKMSEV+  L
Sbjct: 354 KLRPKMSEVLVTL 366

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q06548|APK1A_ARATH Protein kinase APK1A, chloroplastic OS=Arabidopsis thaliana GN=APK1A PE=2 SV=1

 Score =  324 bits (831), Expect = 7e-88,   Method: Compositional matrix adjust.
 Identities = 168/311 (54%), Positives = 220/311 (70%), Gaps = 9/311 (2%)

Query: 73  DLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN 132
           +L+ FSFAELKSATR F    ++GEGGFGCV++G +   S      G  + L +A+K+LN
Sbjct: 52  NLKSFSFAELKSATRNFRPDSVLGEGGFGCVFKGWIDEKSLTASRPG--TGLVIAVKKLN 109

Query: 133 RQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS 192
           + G+QGH+EW+ EVN+LG   H +LVKL+GYC ED+     RLLVYE M   SLE+HL  
Sbjct: 110 QDGWQGHQEWLAEVNYLGQFSHRHLVKLIGYCLEDE----HRLLVYEFMPRGSLENHLFR 165

Query: 193 R--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R     PL+W  RLK+A  AA+GLA+LH   + ++I+RDFKTSNILLD +Y AKLSDFGL
Sbjct: 166 RGLYFQPLSWKLRLKVALGAAKGLAFLHSS-ETRVIYRDFKTSNILLDSEYNAKLSDFGL 224

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL 310
           A+ GP     HVST V+GT GYAAPEY+ TG LT KSDV+SFGVVL EL++GRRAV++N 
Sbjct: 225 AKDGPIGDKSHVSTRVMGTHGYAAPEYLATGHLTTKSDVYSFGVVLLELLSGRRAVDKNR 284

Query: 311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
           P  E+ L+EW +PY+ + +K   +ID RL+  Y ++ A K+A L+ +CLT + K RP MS
Sbjct: 285 PSGERNLVEWAKPYLVNKRKIFRVIDNRLQDQYSMEEACKVATLSLRCLTTEIKLRPNMS 344

Query: 371 EVVDILGNIIS 381
           EVV  L +I S
Sbjct: 345 EVVSHLEHIQS 355

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P46573|APK1B_ARATH Protein kinase APK1B, chloroplastic OS=Arabidopsis thaliana GN=APK1B PE=2 SV=2

 Score =  324 bits (831), Expect = 8e-88,   Method: Compositional matrix adjust.
 Identities = 166/312 (53%), Positives = 221/312 (70%), Gaps = 15/312 (4%)

Query: 73  DLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQT---SGHDSKLDVAIK 129
           +L+ F+FAELK+ATR F    ++GEGGFG V++G +     D QT   S   + + +A+K
Sbjct: 53  NLKSFTFAELKAATRNFRPDSVLGEGGFGSVFKGWI-----DEQTLTASKPGTGVVIAVK 107

Query: 130 QLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH 189
           +LN+ G+QGH+EW+ EVN+LG   HPNLVKL+GYC ED+     RLLVYE M   SLE+H
Sbjct: 108 KLNQDGWQGHQEWLAEVNYLGQFSHPNLVKLIGYCLEDE----HRLLVYEFMPRGSLENH 163

Query: 190 LLSRVP--TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
           L  R     PL+W  RLK+A  AA+GLA+LH   +  +I+RDFKTSNILLD +Y AKLSD
Sbjct: 164 LFRRGSYFQPLSWTLRLKVALGAAKGLAFLHNA-ETSVIYRDFKTSNILLDSEYNAKLSD 222

Query: 248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
           FGLA+ GP     HVST ++GT GYAAPEY+ TG LT KSDV+S+GVVL E+++GRRAV+
Sbjct: 223 FGLAKDGPTGDKSHVSTRIMGTYGYAAPEYLATGHLTTKSDVYSYGVVLLEVLSGRRAVD 282

Query: 308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           +N P  EQKL+EW RP +++ +K   +ID RL+  Y ++ A K+A LA +CLT + K RP
Sbjct: 283 KNRPPGEQKLVEWARPLLANKRKLFRVIDNRLQDQYSMEEACKVATLALRCLTFEIKLRP 342

Query: 368 KMSEVVDILGNI 379
            M+EVV  L +I
Sbjct: 343 NMNEVVSHLEHI 354

Possible bi-functional kinase. In vitro, it exhibits serine/threonine activity. In vivo, can phosphorylate tyrosine residues of limited substrates.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O48814|BIK1_ARATH Serine/threonine-protein kinase BIK1 OS=Arabidopsis thaliana GN=BIK1 PE=1 SV=1

 Score =  322 bits (826), Expect = 3e-87,   Method: Compositional matrix adjust.
 Identities = 160/315 (50%), Positives = 222/315 (70%), Gaps = 12/315 (3%)

Query: 64  ELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSK 123
           E+LS   +  ++ F+F ELK ATR F    +IGEGGFGCV++G +  S+      G  + 
Sbjct: 45  EILS---STPVKSFTFNELKLATRNFRPDSVIGEGGFGCVFKGWLDESTLTPTKPG--TG 99

Query: 124 LDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN 183
           L +A+K+LN++GFQGH+EW+ E+N+LG + HPNLVKL+GYC ED+     RLLVYE M  
Sbjct: 100 LVIAVKKLNQEGFQGHREWLTEINYLGQLSHPNLVKLIGYCLEDE----HRLLVYEFMQK 155

Query: 184 KSLEDHLLSRVP--TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY 241
            SLE+HL  R     PL W  R+ +A DAA+GLA+LH +   ++I+RD K SNILLD DY
Sbjct: 156 GSLENHLFRRGAYFKPLPWFLRVNVALDAAKGLAFLHSD-PVKVIYRDIKASNILLDADY 214

Query: 242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            AKLSDFGLAR GP   L +VST V+GT GYAAPEY+ +G L A+SDV+SFGV+L E+++
Sbjct: 215 NAKLSDFGLARDGPMGDLSYVSTRVMGTYGYAAPEYMSSGHLNARSDVYSFGVLLLEILS 274

Query: 302 GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTK 361
           G+RA++ N P  E+ L++W RPY++  +K  LI+D RL+  Y  + A ++A++A +CL+ 
Sbjct: 275 GKRALDHNRPAKEENLVDWARPYLTSKRKVLLIVDNRLDTQYLPEEAVRMASVAVQCLSF 334

Query: 362 QPKSRPKMSEVVDIL 376
           +PKSRP M +VV  L
Sbjct: 335 EPKSRPTMDQVVRAL 349

Required to activate the resistance responses to necrotrophic pathogens. Phosphorylates FLS2 and BAK1.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
225434931	443	PREDICTED: probable receptor-like protei	0.977	1.0	0.812	0.0
255581254	490	Protein kinase APK1B, chloroplast precur	0.984	0.910	0.803	0.0
449450738	448	PREDICTED: probable receptor-like protei	0.982	0.993	0.785	0.0
449517533	448	PREDICTED: LOW QUALITY PROTEIN: probable	0.982	0.993	0.782	0.0
351722833	446	protein kinase [Glycine max] gi|22345244	0.953	0.968	0.708	0.0
42570965	462	protein kinase family protein [Arabidops	0.980	0.961	0.721	0.0
297826281	461	kinase family protein [Arabidopsis lyrat	0.982	0.965	0.710	1e-180
356542435	448	PREDICTED: probable receptor-like protei	0.964	0.975	0.681	1e-178
297746067	358	unnamed protein product [Vitis vinifera]	0.781	0.988	0.810	1e-170
224104437	318	predicted protein [Populus trichocarpa]	0.699	0.996	0.842	1e-156

>gi|225434931|ref|XP_002283598.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Vitis vinifera]

 Score =  754 bits (1948), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 368/453 (81%), Positives = 410/453 (90%), Gaps = 10/453 (2%)

Query: 1   MKCFHFSNGERERRDGGDDGGVVSRTSKVSWARSLSVASSSVDTRRSEFDSDSRDWSDSL 60
           MKCFHF+NGER      ++ GV+SR SKVSWARSLSVASSS D RRSEFD DSRD SDS+
Sbjct: 1   MKCFHFNNGERRE----EEDGVLSRASKVSWARSLSVASSSADVRRSEFDFDSRDLSDSV 56

Query: 61  AFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGH 120
           +F+E L+QRRANDLRVF+F+ELKSATRGFSRAL+IGEGGFGCVYRGVVRV +D+      
Sbjct: 57  SFHEFLAQRRANDLRVFTFSELKSATRGFSRALMIGEGGFGCVYRGVVRVHADE----AP 112

Query: 121 DSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYEL 180
           DSK+DVA+KQLNR GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG+QRLLVYEL
Sbjct: 113 DSKMDVAVKQLNRNGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGIQRLLVYEL 172

Query: 181 MHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED 240
           M NKSLEDHLL+RVP+ L W+ RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN+LLDED
Sbjct: 173 MCNKSLEDHLLARVPSSLPWMTRLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNVLLDED 232

Query: 241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
           + AKLSDFGLARQGP +G+ HVSTSVVGTVGYAAPEYV TGRLTAKSDVWSFGVVLYELI
Sbjct: 233 FNAKLSDFGLARQGPSQGVSHVSTSVVGTVGYAAPEYVHTGRLTAKSDVWSFGVVLYELI 292

Query: 301 TGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLT 360
           TGRRAVERNLPR+EQKLLEWVRPYVSDSKKFHLI+DPRLEG YCIKSAQKLA+LA+KCL+
Sbjct: 293 TGRRAVERNLPRSEQKLLEWVRPYVSDSKKFHLIVDPRLEGEYCIKSAQKLASLANKCLS 352

Query: 361 KQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQGNSYL 420
           KQPKSRPKMSEVV+ILGNIISEI+ Q+EV  QP+ E ++VKE  EAE   E  KQGN+YL
Sbjct: 353 KQPKSRPKMSEVVEILGNIISEIAPQEEVAPQPINETDNVKE--EAEEETEPIKQGNNYL 410

Query: 421 KKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
           +KVFD++D+VNLR KS+GKLDWRNWTPG+VR+W
Sbjct: 411 RKVFDLKDMVNLRTKSVGKLDWRNWTPGMVRTW 443

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255581254|ref|XP_002531439.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis] gi|223528958|gb|EEF30951.1| Protein kinase APK1B, chloroplast precursor, putative [Ricinus communis]

 Score =  727 bits (1877), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 373/464 (80%), Positives = 401/464 (86%), Gaps = 18/464 (3%)

Query: 1   MKCFHFSNGERERRDGGD---DGGVVSRTSKVSWARSLSVASSSVDT--RRSEFDSD--- 52
           MKCFHF+NGER   D G    +  V    S+VSWARSLSVASSSVDT  RRSEFDS+   
Sbjct: 1   MKCFHFTNGERREDDDGGGGGNDVVSRVVSRVSWARSLSVASSSVDTTTRRSEFDSECCN 60

Query: 53  -SRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVS 111
            SRD SDS+ F+E LSQRRAND++VF F+ELKSATRGFSRALLIGEGGFGCVYRGVVRV 
Sbjct: 61  SSRDLSDSVGFFEFLSQRRANDIKVFKFSELKSATRGFSRALLIGEGGFGCVYRGVVRVL 120

Query: 112 SDDHQTSGHDSKLDVAIKQLNRQGF-------QGHKEWINEVNFLGVVKHPNLVKLVGYC 164
             D + +G DSK+DVA+KQLNR GF       QGHKEWINEVNFLGVVKHPNLVKLVGYC
Sbjct: 121 --DEENNGLDSKMDVAVKQLNRHGFSVCISSIQGHKEWINEVNFLGVVKHPNLVKLVGYC 178

Query: 165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ 224
           AEDDERGMQRLLVYELM NKSLEDHLL+RVP PL W+ RLKIAQDAARGLAYLHEEMDFQ
Sbjct: 179 AEDDERGMQRLLVYELMRNKSLEDHLLARVPMPLPWMTRLKIAQDAARGLAYLHEEMDFQ 238

Query: 225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT 284
           LIFRDFK SN+LLDED+ AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT
Sbjct: 239 LIFRDFKASNVLLDEDFNAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT 298

Query: 285 AKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYC 344
           AKSDVWSFGVVLYELITGRRA+ERNLPR EQKLLEWVRPYVSDSKKFHLI+DPRLEG YC
Sbjct: 299 AKSDVWSFGVVLYELITGRRALERNLPRAEQKLLEWVRPYVSDSKKFHLILDPRLEGEYC 358

Query: 345 IKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEP 404
           IKSAQKLAALA+KCL KQPKSRPKMS+VV+ LGNII+E SSQDEV  +PV E E+VKEE 
Sbjct: 359 IKSAQKLAALANKCLAKQPKSRPKMSDVVETLGNIINETSSQDEVACEPVPETEEVKEET 418

Query: 405 EAEAVVESAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPG 448
             E   ES KQGN   KKVFDIR++VNLRN+SIGKLDWRNWTPG
Sbjct: 419 SVETEPESTKQGNGCRKKVFDIREIVNLRNRSIGKLDWRNWTPG 462

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449450738|ref|XP_004143119.1| PREDICTED: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  716 bits (1847), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 358/456 (78%), Positives = 397/456 (87%), Gaps = 11/456 (2%)

Query: 1   MKCFHFSNGERERRDGGDDGGVVSRTSKVSWARSLSVASSSVDTRRSEFDSD-SRDWSDS 59
           MKCFHF+NGER  RD  D+ GV SRTSKVSWARSLS+ASS+ DTRRSEFDSD SRD+SDS
Sbjct: 1   MKCFHFTNGER--RD--DEDGVASRTSKVSWARSLSMASSTFDTRRSEFDSDYSRDFSDS 56

Query: 60  LAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSG 119
           + FYE L+ RRANDLRVFSF+EL+SATRGFSRALLIGEGGFGCV++GVV   S+    S 
Sbjct: 57  IGFYEFLTHRRANDLRVFSFSELRSATRGFSRALLIGEGGFGCVFKGVVNGDSN----SK 112

Query: 120 HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE 179
            D K++VA+KQLNR GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE
Sbjct: 113 SDLKMEVAVKQLNRNGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE 172

Query: 180 LMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE 239
           LM N+SLEDHLL RV  PL+W+ARLKIAQDAARGLAYLHEEMDFQLIFRD K SNILLDE
Sbjct: 173 LMRNRSLEDHLLVRVSPPLSWLARLKIAQDAARGLAYLHEEMDFQLIFRDLKASNILLDE 232

Query: 240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           ++ AKLSDFGLARQGPPEG+ HVSTSVVGT+GYAAPEYVQTGRLTAKSDVWSFGVVLYEL
Sbjct: 233 EFNAKLSDFGLARQGPPEGISHVSTSVVGTIGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 292

Query: 300 ITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCL 359
           ITGRRAVERNLPRNEQKLLEW++PY+SD KKFHLI+DPRLEG   IKSAQKLA+LA+KCL
Sbjct: 293 ITGRRAVERNLPRNEQKLLEWIKPYISDPKKFHLIVDPRLEGECNIKSAQKLASLANKCL 352

Query: 360 TKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESA--KQGN 417
            KQPK+RPKMSEVV+ LGNIISE     E  +QPV    + KEE   EA VE A  +  N
Sbjct: 353 MKQPKNRPKMSEVVEFLGNIISESCQDIETAVQPVDRTVETKEESVEEAEVEPATTRHRN 412

Query: 418 SYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
           S+LKKVFD +D+V+LRN+S GKLDWRNWTPGLVR+W
Sbjct: 413 SHLKKVFDFKDMVSLRNRSFGKLDWRNWTPGLVRTW 448

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449517533|ref|XP_004165800.1| PREDICTED: LOW QUALITY PROTEIN: probable receptor-like protein kinase At5g47070-like [Cucumis sativus]

 Score =  714 bits (1843), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 357/456 (78%), Positives = 396/456 (86%), Gaps = 11/456 (2%)

Query: 1   MKCFHFSNGERERRDGGDDGGVVSRTSKVSWARSLSVASSSVDTRRSEFDSD-SRDWSDS 59
           MKCFHF+NGER  RD  D+ GV SRTSKVSWARSLS+ASS+ DTRRSEFDSD SRD+SDS
Sbjct: 1   MKCFHFTNGER--RD--DEDGVASRTSKVSWARSLSMASSTFDTRRSEFDSDYSRDFSDS 56

Query: 60  LAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSG 119
           + FYE L+ RRANDLRVF F+EL+SATRGFSRALLIGEGGFGCV++GVV   S+    S 
Sbjct: 57  IGFYEFLTHRRANDLRVFXFSELRSATRGFSRALLIGEGGFGCVFKGVVNGDSN----SK 112

Query: 120 HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE 179
            D K++VA+KQLNR GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE
Sbjct: 113 SDLKMEVAVKQLNRNGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE 172

Query: 180 LMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE 239
           LM N+SLEDHLL RV  PL+W+ARLKIAQDAARGLAYLHEEMDFQLIFRD K SNILLDE
Sbjct: 173 LMRNRSLEDHLLVRVSPPLSWLARLKIAQDAARGLAYLHEEMDFQLIFRDLKASNILLDE 232

Query: 240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           ++ AKLSDFGLARQGPPEG+ HVSTSVVGT+GYAAPEYVQTGRLTAKSDVWSFGVVLYEL
Sbjct: 233 EFNAKLSDFGLARQGPPEGISHVSTSVVGTIGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 292

Query: 300 ITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCL 359
           ITGRRAVERNLPRNEQKLLEW++PY+SD KKFHLI+DPRLEG   IKSAQKLA+LA+KCL
Sbjct: 293 ITGRRAVERNLPRNEQKLLEWIKPYISDPKKFHLIVDPRLEGECNIKSAQKLASLANKCL 352

Query: 360 TKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESA--KQGN 417
            KQPK+RPKMSEVV+ LGNIISE     E  +QPV    + KEE   EA VE A  +  N
Sbjct: 353 MKQPKNRPKMSEVVEFLGNIISESCQDIETAVQPVDRTVETKEESVEEAEVEPATTRHRN 412

Query: 418 SYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
           S+LKKVFD +D+V+LRN+S GKLDWRNWTPGLVR+W
Sbjct: 413 SHLKKVFDFKDMVSLRNRSFGKLDWRNWTPGLVRTW 448

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|351722833|ref|NP_001235210.1| protein kinase [Glycine max] gi|223452446|gb|ACM89550.1| protein kinase [Glycine max]

 Score =  651 bits (1679), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/467 (70%), Positives = 380/467 (81%), Gaps = 35/467 (7%)

Query: 1   MKCFHFSNGERERRDGGDDGGVVSR----TSKVSWARSLSVASSSVDTR---RSEFDSDS 53
           MKCF+FSNGE E   GG  G   S     TS+VSWARSLS+    +DTR   RS FDS+S
Sbjct: 1   MKCFYFSNGEDEDSVGG--GAAASSRGGSTSRVSWARSLSL----MDTRSSSRSHFDSES 54

Query: 54  RDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSD 113
            ++SD++ F+  L+QRRANDLR+FSF++LKSATR FSRALL+GEGGFG VYRG +     
Sbjct: 55  TEFSDTVDFHHFLAQRRANDLRLFSFSDLKSATRAFSRALLVGEGGFGSVYRGFL----- 109

Query: 114 DHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQ 173
                    + DVAIKQLNR G QGHKEWINEVN LGV+KHPNLVKLVGYCAEDDERG+Q
Sbjct: 110 --------DQNDVAIKQLNRNGHQGHKEWINEVNLLGVMKHPNLVKLVGYCAEDDERGIQ 161

Query: 174 RLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT 232
           RLLVYE M NKSLEDHLL+RVP T + W  RL+IAQDAARGLAYLHEEMDFQLIFRDFKT
Sbjct: 162 RLLVYEFMPNKSLEDHLLARVPSTIIPWGTRLRIAQDAARGLAYLHEEMDFQLIFRDFKT 221

Query: 233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSF 292
           SNILLDE++ AKLSDFGLARQGP EG G+VST+VVGT+GYAAPEYVQTG+LTAKSDVWSF
Sbjct: 222 SNILLDENFNAKLSDFGLARQGPSEGSGYVSTAVVGTIGYAAPEYVQTGKLTAKSDVWSF 281

Query: 293 GVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLA 352
           GVVLYELITGRRAVERNLP+NEQKLLEWVRPYVSD +KF+ I+DPRLEG YCIKSA KLA
Sbjct: 282 GVVLYELITGRRAVERNLPKNEQKLLEWVRPYVSDPRKFYRIVDPRLEGQYCIKSAHKLA 341

Query: 353 ALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVE- 411
            LA+KC+ KQPKSRPKMSEVV+ LG+II+EI  QDE    P A +  + EE E +  VE 
Sbjct: 342 ILANKCIMKQPKSRPKMSEVVESLGSIINEIVPQDEQI--PQAAVVAIGEEKEEKLSVEN 399

Query: 412 -----SAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
                SAKQGN YLKKVF+++D+V+LRNKSIG+LDW++W PGLVR+W
Sbjct: 400 TKPEPSAKQGNYYLKKVFELKDIVSLRNKSIGRLDWKSWAPGLVRTW 446

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|42570965|ref|NP_973556.1| protein kinase family protein [Arabidopsis thaliana] gi|3461836|gb|AAC33222.1| putative protein kinase [Arabidopsis thaliana] gi|20197438|gb|AAM15076.1| putative protein kinase [Arabidopsis thaliana] gi|134031928|gb|ABO45701.1| At2g28940 [Arabidopsis thaliana] gi|330253099|gb|AEC08193.1| protein kinase family protein [Arabidopsis thaliana]

 Score =  648 bits (1671), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 340/471 (72%), Positives = 381/471 (80%), Gaps = 27/471 (5%)

Query: 1   MKCFHFSNGER------ERRDGGDDGGVVSRTSKVSWARSLSVASSSVD--TRRSEFDSD 52
           MKCFHF+NG++      E   GG D  VVSR S++SWARSLSVASS+    TRRSEFDSD
Sbjct: 1   MKCFHFTNGDKRTTTTIEEGVGGGDS-VVSRASRLSWARSLSVASSTTSDPTRRSEFDSD 59

Query: 53  SRDWSDSLAFYELLSQR------RANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRG 106
                + L F + LSQR        NDL+VF+F ELK AT+GF+R LLIGEGGFGCVYRG
Sbjct: 60  WSFSPERLTFPKPLSQRWIGGLVPENDLKVFTFKELKIATKGFNRGLLIGEGGFGCVYRG 119

Query: 107 VVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE 166
           VV VS     ++G DSK++VA+KQLNRQG QGHKEWINEVNFLGVV HPNLVKLVGYCA+
Sbjct: 120 VVDVS----DSNGFDSKINVAVKQLNRQGLQGHKEWINEVNFLGVVNHPNLVKLVGYCAD 175

Query: 167 DDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQL 225
           DDERGMQRLLVYELM NKSLEDHL+ RV    L W+ RLKIAQDAA+GLAYLHEEMDFQL
Sbjct: 176 DDERGMQRLLVYELMCNKSLEDHLVGRVVSVSLPWMMRLKIAQDAAQGLAYLHEEMDFQL 235

Query: 226 IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTA 285
           IFRDFK+SNILLDE + AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG+LTA
Sbjct: 236 IFRDFKSSNILLDERFGAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTA 295

Query: 286 KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGN-YC 344
           KSDVWSFGVVLYELITGRRAV+RN PR EQKLLEWV+PYVSDSKKFHLI+DPRLEG  YC
Sbjct: 296 KSDVWSFGVVLYELITGRRAVDRNRPRGEQKLLEWVKPYVSDSKKFHLIVDPRLEGQYYC 355

Query: 345 IKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAE--IEDVKE 402
           +KS Q++AALA+KCL KQPKSRPKMSEVV +LG II E   + E    PVA+   E +K 
Sbjct: 356 MKSVQRVAALANKCLMKQPKSRPKMSEVVSLLGRIIDE---EAENVPPPVADETEEIIKA 412

Query: 403 EPEAEAVVESAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
           E   E+  E  KQG+SY KKV D+RD +NL NKS+ KLDWRNWTPGLVR+W
Sbjct: 413 ELNGESEPELKKQGSSYRKKVLDLRDKMNL-NKSLSKLDWRNWTPGLVRTW 462

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297826281|ref|XP_002881023.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297326862|gb|EFH57282.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  638 bits (1646), Expect = e-180,   Method: Compositional matrix adjust.
 Identities = 333/469 (71%), Positives = 378/469 (80%), Gaps = 24/469 (5%)

Query: 1   MKCFHFSNGERERR--DGGDDGG--VVSRTSKVSWARSLSVASSSVD--TRRSEFDSDSR 54
           MKCFHF+NG++     D G  GG  V+SR S++SWARSLSVASS+    TRRSEFDSD  
Sbjct: 1   MKCFHFTNGDKRGTTIDEGGGGGDSVISRASRLSWARSLSVASSTTSDPTRRSEFDSDWS 60

Query: 55  DWSDSLAFYELLSQR------RANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVV 108
              + L+F + LSQR        NDL+VF+F ELK AT+GFSR LLIGEGGFGCVYRGVV
Sbjct: 61  FSPERLSFPKPLSQRWIGGLVPENDLKVFTFKELKLATKGFSRGLLIGEGGFGCVYRGVV 120

Query: 109 RVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDD 168
            VS     ++G DSK++VA+KQLNRQG QGHKEWINEV FLGVV HPNLVKLVGYCA+DD
Sbjct: 121 DVS----DSNGFDSKINVAVKQLNRQGLQGHKEWINEVKFLGVVNHPNLVKLVGYCADDD 176

Query: 169 ERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIF 227
           ERGMQRLLVYELM NKSLEDHL+ RV    L W+ RLKIAQDAA+GLAYLHEEMDFQLIF
Sbjct: 177 ERGMQRLLVYELMCNKSLEDHLVGRVVSVSLPWMTRLKIAQDAAQGLAYLHEEMDFQLIF 236

Query: 228 RDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKS 287
           RDFK+SNILLDE + AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG+LTAKS
Sbjct: 237 RDFKSSNILLDERFGAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTAKS 296

Query: 288 DVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGN-YCIK 346
           DVWSFGVVLYELITGRRAV+RN PR EQ LLEWV+PYVSDSKKFH I+DPRLEG  YC+K
Sbjct: 297 DVWSFGVVLYELITGRRAVDRNRPRGEQNLLEWVKPYVSDSKKFHAIVDPRLEGQYYCMK 356

Query: 347 SAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAE--IEDVKEEP 404
           S Q++AALA+KCL KQPKSRP+MSEVV ++G II E   + E    PV +   E +K E 
Sbjct: 357 SVQRVAALANKCLMKQPKSRPRMSEVVALIGRIIDE---EAEDAPPPVTDETEEIIKAEI 413

Query: 405 EAEAVVESAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
             E+  +  KQG+SY KKV D+RD +NL NKS+ KLDWRNWTPGLVR+W
Sbjct: 414 NGESEPKLKKQGSSYRKKVLDLRDKMNL-NKSLSKLDWRNWTPGLVRTW 461

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356542435|ref|XP_003539672.1| PREDICTED: probable receptor-like protein kinase At5g15080-like [Glycine max]

 Score =  629 bits (1622), Expect = e-178,   Method: Compositional matrix adjust.
 Identities = 316/464 (68%), Positives = 370/464 (79%), Gaps = 27/464 (5%)

Query: 1   MKCFHFSNGERERRDGGDDGGVVSR----TSKVSWARSLSVASSSVDTRRSEFDSDSRDW 56
           MKCF+FSNG  +           SR    TS+VSWARSLS+  +   T RS FDS+S ++
Sbjct: 1   MKCFYFSNGGEDEDSVAGAAPPSSRGGGSTSRVSWARSLSLMDTR-STSRSHFDSESTEF 59

Query: 57  SDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQ 116
           SD++ F+  L+QRRAN LR+FSF++LKSATR FSRALL+GEGGFG VYRG++        
Sbjct: 60  SDTVDFHHFLAQRRANHLRLFSFSDLKSATRAFSRALLVGEGGFGSVYRGLL-------- 111

Query: 117 TSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLL 176
                 + DVAIKQLNR G QGHKEWINE+N LGVVKHPNLVKLVGYCAEDDERG+QRLL
Sbjct: 112 -----DQNDVAIKQLNRNGHQGHKEWINELNLLGVVKHPNLVKLVGYCAEDDERGIQRLL 166

Query: 177 VYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI 235
           VYE M NKSLEDHLL+RVP T + W  RL+IA+DAARGLAYLHEEMDFQLIFRDFKTSNI
Sbjct: 167 VYEFMPNKSLEDHLLARVPSTIIPWGTRLRIARDAARGLAYLHEEMDFQLIFRDFKTSNI 226

Query: 236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVV 295
           LLDE++ AKLSDFGLARQGP EG G+VST+VVGT+GY APEYV TG+LTAKSDVWSFGVV
Sbjct: 227 LLDENFNAKLSDFGLARQGPSEGSGYVSTAVVGTIGYVAPEYVLTGKLTAKSDVWSFGVV 286

Query: 296 LYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALA 355
           LYELITGRR VERNLPRNEQKLL+WVRPYVSD +KFH I+DPRL+G YCIKSA KLA LA
Sbjct: 287 LYELITGRRVVERNLPRNEQKLLDWVRPYVSDPRKFHHILDPRLKGQYCIKSAHKLAILA 346

Query: 356 SKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVE---- 411
           +KCL KQPKSRPKMSEVV+ LG+II++    DE    P A +    EE E +  VE    
Sbjct: 347 NKCLMKQPKSRPKMSEVVESLGSIINDTVPHDEHI--PQAAVAATGEEKEEKLSVEDTQP 404

Query: 412 --SAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
             +AKQGN+YLKKVF+++D+V+LRNKS+G+LDW++W PGLVR+W
Sbjct: 405 EPAAKQGNNYLKKVFELKDMVSLRNKSVGRLDWKSWAPGLVRTW 448

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297746067|emb|CBI16123.3| unnamed protein product [Vitis vinifera]

 Score =  603 bits (1554), Expect = e-170,   Method: Compositional matrix adjust.
 Identities = 295/364 (81%), Positives = 328/364 (90%), Gaps = 10/364 (2%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ----GFQGHKEWINEVNFL 149
           +IGEGGFGCVYRGVVRV +D+      DSK+DVA+KQ +R     G QGHKEWINEVNFL
Sbjct: 1   MIGEGGFGCVYRGVVRVHADE----APDSKMDVAVKQKHRNWHLTGIQGHKEWINEVNFL 56

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           GVVKHPNLVKLVGYCAEDDERG+QRLLVYELM NKSLEDHLL+RVP+ L W+ RLKIAQD
Sbjct: 57  GVVKHPNLVKLVGYCAEDDERGIQRLLVYELMCNKSLEDHLLARVPSSLPWMTRLKIAQD 116

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
           AARGLAYLHEEMDFQLIFRDFKTSN+LLDED+ AKLSDFGLARQGP +G+ HVSTSVVGT
Sbjct: 117 AARGLAYLHEEMDFQLIFRDFKTSNVLLDEDFNAKLSDFGLARQGPSQGVSHVSTSVVGT 176

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
           VGYAAPEYV TGRLTAKSDVWSFGVVLYELITGRRAVERNLPR+EQKLLEWVRPYVSDSK
Sbjct: 177 VGYAAPEYVHTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRSEQKLLEWVRPYVSDSK 236

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
           KFHLI+DPRLEG YCIKSAQKLA+LA+KCL+KQPKSRPKMSEVV+ILGNIISEI+ Q+EV
Sbjct: 237 KFHLIVDPRLEGEYCIKSAQKLASLANKCLSKQPKSRPKMSEVVEILGNIISEIAPQEEV 296

Query: 390 TLQPVAEIEDVKEEPEAEAVVESAKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGL 449
             QP+ E ++VKE  EAE   E  KQGN+YL+KVFD++D+VNLR KS+GKLDWRNWTPG+
Sbjct: 297 APQPINETDNVKE--EAEEETEPIKQGNNYLRKVFDLKDMVNLRTKSVGKLDWRNWTPGM 354

Query: 450 VRSW 453
           VR+W
Sbjct: 355 VRTW 358

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224104437|ref|XP_002313435.1| predicted protein [Populus trichocarpa] gi|222849843|gb|EEE87390.1| predicted protein [Populus trichocarpa]

 Score =  559 bits (1440), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 268/318 (84%), Positives = 288/318 (90%), Gaps = 1/318 (0%)

Query: 136 FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV- 194
            QGH+EWINEVNFLGVVKHPNLVKLVGYCAEDDERG+QRLLVYELMHNKSLEDHLL+RV 
Sbjct: 1   LQGHREWINEVNFLGVVKHPNLVKLVGYCAEDDERGIQRLLVYELMHNKSLEDHLLARVL 60

Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
           P  L W+ RLKIAQDAARGLAYLHEEMDFQLIFRDFK SN+LLD D+ AKLSDFGLARQG
Sbjct: 61  PITLPWMTRLKIAQDAARGLAYLHEEMDFQLIFRDFKASNVLLDSDFNAKLSDFGLARQG 120

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
           PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVV+YELITGRRAVERNLPR E
Sbjct: 121 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVMYELITGRRAVERNLPRGE 180

Query: 315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
           QKLLEWV+P+VSDSKKFHLI+DPRLEG  CIKSAQKLAALA++CL KQPKSRPKMSE V+
Sbjct: 181 QKLLEWVKPFVSDSKKFHLIVDPRLEGQCCIKSAQKLAALANRCLAKQPKSRPKMSEAVE 240

Query: 375 ILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQGNSYLKKVFDIRDLVNLRN 434
           ILGNIISE SSQDE   +PV+EIE+VKEE   E   ES K GNSY KKVF IR++VNLRN
Sbjct: 241 ILGNIISETSSQDEGIPEPVSEIEEVKEEATGETGAESTKPGNSYRKKVFYIREMVNLRN 300

Query: 435 KSIGKLDWRNWTPGLVRS 452
           +S GKLDWRNWTP LVR+
Sbjct: 301 RSTGKLDWRNWTPRLVRT 318

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	453
TAIR|locus:2053250	462	AT2G28940 [Arabidopsis thalian	0.986	0.967	0.636	4.5e-146
TAIR|locus:2085069	418	AT3G09830 [Arabidopsis thalian	0.701	0.760	0.623	4e-106
TAIR|locus:2064920	435	AT2G39110 [Arabidopsis thalian	0.732	0.763	0.585	8.3e-106
TAIR|locus:2142639	420	AT5G03320 [Arabidopsis thalian	0.682	0.735	0.617	9.8e-103
TAIR|locus:2151992	410	AT5G47070 [Arabidopsis thalian	0.739	0.817	0.528	9.9e-87
TAIR|locus:2095517	453	AT3G28690 [Arabidopsis thalian	0.697	0.697	0.522	3.1e-83
TAIR|locus:2147805	493	AT5G15080 [Arabidopsis thalian	0.660	0.606	0.532	4.5e-82
TAIR|locus:2100282	490	AT3G01300 [Arabidopsis thalian	0.653	0.604	0.534	2e-81
TAIR|locus:2129326	388	AT4G17660 [Arabidopsis thalian	0.684	0.798	0.528	6e-80
TAIR|locus:2200863	424	AT1G61590 [Arabidopsis thalian	0.715	0.764	0.482	1.4e-78

TAIR|locus:2053250 AT2G28940 [Arabidopsis thaliana (taxid:3702)]

 Score = 1427 (507.4 bits), Expect = 4.5e-146, P = 4.5e-146
 Identities = 298/468 (63%), Positives = 332/468 (70%)

Query:     1 MKCFHFSNXXXXXXXXXXXX-----XVVSRTSKXX-XXXXXXXXXXXXD-TRRSEFDSDS 53
             MKCFHF+N                  VVSR S+               D TRRSEFDSD 
Sbjct:     1 MKCFHFTNGDKRTTTTIEEGVGGGDSVVSRASRLSWARSLSVASSTTSDPTRRSEFDSDW 60

Query:    54 RDWSDSLAFYELLSQR------RANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGV 107
                 + L F + LSQR        NDL+VF+F ELK AT+GF+R LLIGEGGFGCVYRGV
Sbjct:    61 SFSPERLTFPKPLSQRWIGGLVPENDLKVFTFKELKIATKGFNRGLLIGEGGFGCVYRGV 120

Query:   108 VRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED 167
             V VS     ++G DSK++VA+KQLNRQG QGHKEWINEVNFLGVV HPNLVKLVGYCA+D
Sbjct:   121 VDVSD----SNGFDSKINVAVKQLNRQGLQGHKEWINEVNFLGVVNHPNLVKLVGYCADD 176

Query:   168 DERGMQRLLVYELMHNKSLEDHLLSRVPT-PLAWIARLKIAQDAARGLAYLHEEMDFQLI 226
             DERGMQRLLVYELM NKSLEDHL+ RV +  L W+ RLKIAQDAA+GLAYLHEEMDFQLI
Sbjct:   177 DERGMQRLLVYELMCNKSLEDHLVGRVVSVSLPWMMRLKIAQDAAQGLAYLHEEMDFQLI 236

Query:   227 FRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAK 286
             FRDFK+SNILLDE + AKLSDFGLARQGPPEGLGH          YAAPEYVQTG+LTAK
Sbjct:   237 FRDFKSSNILLDERFGAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGKLTAK 296

Query:   287 SDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNY-CI 345
             SDVWSFGVVLYELITGRRAV+RN PR EQKLLEWV+PYVSDSKKFHLI+DPRLEG Y C+
Sbjct:   297 SDVWSFGVVLYELITGRRAVDRNRPRGEQKLLEWVKPYVSDSKKFHLIVDPRLEGQYYCM 356

Query:   346 XXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQPXXXXXXXXXXXX 405
                         CL KQPKSRPKMSEVV +LG II E  +++                  
Sbjct:   357 KSVQRVAALANKCLMKQPKSRPKMSEVVSLLGRIIDE-EAENVPPPVADETEEIIKAELN 415

Query:   406 XXXXXXXXKQGNSYLKKVFDIRDLVNLRNKSIGKLDWRNWTPGLVRSW 453
                     KQG+SY KKV D+RD +NL NKS+ KLDWRNWTPGLVR+W
Sbjct:   416 GESEPELKKQGSSYRKKVLDLRDKMNL-NKSLSKLDWRNWTPGLVRTW 462

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2085069 AT3G09830 [Arabidopsis thaliana (taxid:3702)]

 Score = 1050 (374.7 bits), Expect = 4.0e-106, P = 4.0e-106
 Identities = 202/324 (62%), Positives = 243/324 (75%)

Query:    70 RANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK 129
             RA++LR FS  +LKSAT+ FSR+++IGEGGFGCV+RG VR   D         K++VA+K
Sbjct:    65 RASNLREFSITDLKSATKNFSRSVMIGEGGFGCVFRGTVRNLEDS------SVKIEVAVK 118

Query:   130 QLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH 189
             QL ++G QGHKEW+ EVNFLG+V+H NLVKL+GYCAEDDERG+QRLLVYE M N+S+E H
Sbjct:   119 QLGKRGLQGHKEWVTEVNFLGIVEHTNLVKLLGYCAEDDERGIQRLLVYEYMPNRSVEFH 178

Query:   190 LLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG 249
             L  R  T L W  RL+IAQDAARGL YLHEEM+FQ+IFRDFK+SNILLDED+KAKLSDFG
Sbjct:   179 LSPRSLTVLTWDLRLRIAQDAARGLTYLHEEMEFQIIFRDFKSSNILLDEDWKAKLSDFG 238

Query:   250 LARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
             LAR GP EGL H          YAAPEY+QTGRLT+KSDVW +GV LYELITGRR V+RN
Sbjct:   239 LARLGPSEGLTHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFLYELITGRRPVDRN 298

Query:   310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKM 369
              P+ EQKLLEWVRPY+SD++KF LI+DPRLEG Y I            CL +  K+RPKM
Sbjct:   299 RPKGEQKLLEWVRPYLSDTRKFKLILDPRLEGKYPIKSVQKLAVVANRCLVRNSKARPKM 358

Query:   370 SEVVDILGNIISEISSQDEVTLQP 393
             SEV++++  I+   S      L P
Sbjct:   359 SEVLEMVNKIVEASSGNGSPQLVP 382

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

TAIR|locus:2064920 AT2G39110 [Arabidopsis thaliana (taxid:3702)]

 Score = 1047 (373.6 bits), Expect = 8.3e-106, P = 8.3e-106
 Identities = 199/340 (58%), Positives = 256/340 (75%)

Query:    47 SEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRG 106
             SEF+SD+   +   +   +LS+  +N+L+VF   +LK+AT+ FSR+L+IGEGGFG V+RG
Sbjct:    48 SEFNSDTSTATSITSSLHVLSETHSNNLKVFVLDDLKTATKNFSRSLMIGEGGFGGVFRG 107

Query:   107 VVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE 166
             V++   D  +      K+D+A+KQL+R+G QGHKEW+ EVN LGVV+HPNLVKL+GYCAE
Sbjct:   108 VIQNPQDSRK------KIDIAVKQLSRRGLQGHKEWVTEVNVLGVVEHPNLVKLIGYCAE 161

Query:   167 DDERGMQRLLVYELMHNKSLEDHLLSR-VPTPLAWIARLKIAQDAARGLAYLHEEMDFQL 225
             DDERG+QRLLVYE + N+S++DHL +R + TPL W  RLKIAQD ARGLAYLH+ M+FQ+
Sbjct:   162 DDERGIQRLLVYEYVQNRSVQDHLSNRFIVTPLPWSTRLKIAQDTARGLAYLHQGMEFQI 221

Query:   226 IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTA 285
             IFRDFK+SNILLDE++ AKLSDFGLAR GP +G+ H          YAAPEY+QTG LTA
Sbjct:   222 IFRDFKSSNILLDENWNAKLSDFGLARMGPSDGITHVSTAVVGTIGYAAPEYIQTGHLTA 281

Query:   286 KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCI 345
             KSDVWS+G+ LYELITGRR  +RN PRNEQ +LEW+RP++SD KKF +IIDPRLEGNY +
Sbjct:   282 KSDVWSYGIFLYELITGRRPFDRNRPRNEQNILEWIRPHLSDIKKFKMIIDPRLEGNYYL 341

Query:   346 XXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISS 385
                         CL  + K+RP MS+V ++L  I+ E SS
Sbjct:   342 KSALKLAAVANRCLMVKAKARPTMSQVSEMLERIV-ETSS 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006826 "iron ion transport" evidence=RCA

GO:0010106 "cellular response to iron ion starvation" evidence=RCA

GO:0010167 "response to nitrate" evidence=RCA

GO:0015706 "nitrate transport" evidence=RCA

TAIR|locus:2142639 AT5G03320 [Arabidopsis thaliana (taxid:3702)]

 Score = 1018 (363.4 bits), Expect = 9.8e-103, P = 9.8e-103
 Identities = 195/316 (61%), Positives = 240/316 (75%)

Query:    70 RANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK 129
             R N+LR F+  +LKSATR FSR+ +IGEGGFGCV+ G ++   D  +      K++VA+K
Sbjct:    62 RENNLREFTIGDLKSATRNFSRSGMIGEGGFGCVFWGTIKNLEDPSK------KIEVAVK 115

Query:   130 QLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH 189
             QL ++G QGHKEW+ EVNFLGVV+H NLVKL+G+CAEDDERG+QRLLVYE M N+S+E H
Sbjct:   116 QLGKRGLQGHKEWVTEVNFLGVVEHSNLVKLLGHCAEDDERGIQRLLVYEYMPNQSVEFH 175

Query:   190 LLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG 249
             L  R PT L W  RL+IAQDAARGL YLHEEMDFQ+IFRDFK+SNILLDE++ AKLSDFG
Sbjct:   176 LSPRSPTVLTWDLRLRIAQDAARGLTYLHEEMDFQIIFRDFKSSNILLDENWTAKLSDFG 235

Query:   250 LARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
             LAR GP  G  H          YAAPEY+QTGRLT+KSDVW +GV +YELITGRR ++RN
Sbjct:   236 LARLGPSPGSSHVSTDVVGTMGYAAPEYIQTGRLTSKSDVWGYGVFIYELITGRRPLDRN 295

Query:   310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKM 369
              P+ EQKLLEWVRPY+SD+++F LI+DPRLEG Y I            CLT+  K+RPKM
Sbjct:   296 KPKGEQKLLEWVRPYLSDTRRFRLIVDPRLEGKYMIKSVQKLAVVANLCLTRNAKARPKM 355

Query:   370 SEVVDILGNIISEISS 385
             SEV++++  I+ E SS
Sbjct:   356 SEVLEMVTKIV-EASS 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2151992 AT5G47070 [Arabidopsis thaliana (taxid:3702)]

 Score = 867 (310.3 bits), Expect = 9.9e-87, P = 9.9e-87
 Identities = 184/348 (52%), Positives = 227/348 (65%)

Query:    44 TRRSEFDSDSRDWSDSL----AFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGG 99
             T RSE  S +     SL    +  +L ++R  N LRVFS+ EL  AT  FSR L+IGEGG
Sbjct:    38 TNRSETSSFNLQTPRSLPSPRSIKDLYTEREQN-LRVFSYEELSKATYVFSRKLVIGEGG 96

Query:   100 FGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVK 159
             FG VY+G + +S+ D      D  L VAIK+LNRQG QGHK+W+ EV FLGVV HPN+VK
Sbjct:    97 FGIVYKGKI-LSNGDSS----DPPLVVAIKKLNRQGLQGHKQWLAEVQFLGVVNHPNVVK 151

Query:   160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE 219
             L+GYC+ED E G++RLLVYE M N+SLEDHL  R    L W  RL+I   AA GL YLH 
Sbjct:   152 LIGYCSEDGETGIERLLVYEYMSNRSLEDHLFPRRSHTLPWKKRLEIMLGAAEGLTYLH- 210

Query:   220 EMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQ 279
               D ++I+RDFK+SN+LLD+ +  KLSDFGLAR+GP     H          YAAPEYVQ
Sbjct:   211 --DLKVIYRDFKSSNVLLDDQFCPKLSDFGLAREGPDGDNTHVTTARVGTHGYAAPEYVQ 268

Query:   280 TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
             TG L  KSDV+SFGVVLYE+ITGRR +ERN P  E++LL+WV+ Y +DS++F +I+DPRL
Sbjct:   269 TGHLRLKSDVYSFGVVLYEIITGRRTIERNKPVAERRLLDWVKEYPADSQRFSMIVDPRL 328

Query:   340 EGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQD 387
               NY              CL K  K RP M  VV+ L  II E  S+D
Sbjct:   329 RNNYPAAGARSLAKLADLCLKKNDKERPTMEIVVERLKKIIEESDSED 376

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2095517 AT3G28690 [Arabidopsis thaliana (taxid:3702)]

 Score = 834 (298.6 bits), Expect = 3.1e-83, P = 3.1e-83
 Identities = 171/327 (52%), Positives = 216/327 (66%)

Query:    71 ANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ 130
             ++ LR+F F +LK ATR F    L+GEGGFGCV++G +  +       G  + L VA+K 
Sbjct:    85 SSKLRIFMFNDLKLATRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG--TGLTVAVKT 142

Query:   131 LNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL 190
             LN  G QGHKEW+ E+NFLG + HP+LVKLVGYC E+D    QRLLVYE M   SLE+HL
Sbjct:   143 LNPDGLQGHKEWLAEINFLGNLVHPSLVKLVGYCMEED----QRLLVYEFMPRGSLENHL 198

Query:   191 LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
               R   PL W  R+KIA  AA+GLA+LHEE +  +I+RDFKTSNILLD +Y AKLSDFGL
Sbjct:   199 FRRT-LPLPWSVRMKIALGAAKGLAFLHEEAEKPVIYRDFKTSNILLDGEYNAKLSDFGL 257

Query:   251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL 310
             A+  P E   H          YAAPEYV TG LT KSDV+SFGVVL E++TGRR+V+++ 
Sbjct:   258 AKDAPDEKKSHVSTRVMGTYGYAAPEYVMTGHLTTKSDVYSFGVVLLEILTGRRSVDKSR 317

Query:   311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMS 370
             P  EQ L+EWVRP++ D K+F+ ++DPRLEG+Y I            CL +  K+RPKMS
Sbjct:   318 PNGEQNLVEWVRPHLLDKKRFYRLLDPRLEGHYSIKGAQKATQVAAQCLNRDSKARPKMS 377

Query:   371 EVVDILG---NIISEISSQDEV-TLQP 393
             EVV+ L    N+    SS     T+QP
Sbjct:   378 EVVEALKPLPNLKDFASSSSSFQTMQP 404

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2147805 AT5G15080 [Arabidopsis thaliana (taxid:3702)]

 Score = 823 (294.8 bits), Expect = 4.5e-82, P = 4.5e-82
 Identities = 163/306 (53%), Positives = 208/306 (67%)

Query:    71 ANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ 130
             ++ LR F+F +LK +TR F    L+GEGGFGCV++G +  +       G  + L VA+K 
Sbjct:   124 SSHLRKFTFNDLKLSTRNFRPESLLGEGGFGCVFKGWIEENGTAPVKPG--TGLTVAVKT 181

Query:   131 LNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL 190
             LN  G QGHKEW+ E+NFLG + HPNLVKLVGYC EDD    QRLLVYE M   SLE+HL
Sbjct:   182 LNPDGLQGHKEWLAEINFLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHL 237

Query:   191 LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
               R   PL W  R+KIA  AA+GL++LHEE    +I+RDFKTSNILLD DY AKLSDFGL
Sbjct:   238 FRR-SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDADYNAKLSDFGL 296

Query:   251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL 310
             A+  P EG  H          YAAPEYV TG LT+KSDV+SFGVVL E++TGRR++++N 
Sbjct:   297 AKDAPDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNR 356

Query:   311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMS 370
             P  E  L+EW RP++ D ++F+ ++DPRLEG++ I            CL++ PK RPKMS
Sbjct:   357 PNGEHNLVEWARPHLLDKRRFYRLLDPRLEGHFSIKGAQKVTQLAAQCLSRDPKIRPKMS 416

Query:   371 EVVDIL 376
             +VV+ L
Sbjct:   417 DVVEAL 422

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2100282 AT3G01300 [Arabidopsis thaliana (taxid:3702)]

 Score = 817 (292.7 bits), Expect = 2.0e-81, P = 2.0e-81
 Identities = 162/303 (53%), Positives = 206/303 (67%)

Query:    74 LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
             L+ FSF +LK ATR F    L+GEGGFGCV++G V  +       G  + L VA+K LN 
Sbjct:   121 LKKFSFIDLKLATRNFRPESLLGEGGFGCVFKGWVEENGTAPVKPG--TGLTVAVKTLNP 178

Query:   134 QGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
              G QGHKEW+ E+N+LG + HPNLVKLVGYC EDD    QRLLVYE M   SLE+HL  R
Sbjct:   179 DGLQGHKEWLAEINYLGNLLHPNLVKLVGYCIEDD----QRLLVYEFMPRGSLENHLFRR 234

Query:   194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                PL W  R+KIA  AA+GL++LHEE    +I+RDFKTSNILLD +Y AKLSDFGLA+ 
Sbjct:   235 -SLPLPWSIRMKIALGAAKGLSFLHEEALKPVIYRDFKTSNILLDGEYNAKLSDFGLAKD 293

Query:   254 GPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN 313
              P EG  H          YAAPEYV TG LT+KSDV+SFGVVL E++TGRR++++N P  
Sbjct:   294 APDEGKTHVSTRVMGTYGYAAPEYVMTGHLTSKSDVYSFGVVLLEMLTGRRSMDKNRPNG 353

Query:   314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             E  L+EW RP++ D ++F+ ++DPRLEG++ +            CL++  K RPKMSEVV
Sbjct:   354 EHNLVEWARPHLLDKRRFYRLLDPRLEGHFSVKGAQKVTQLAAQCLSRDSKIRPKMSEVV 413

Query:   374 DIL 376
             ++L
Sbjct:   414 EVL 416

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2129326 AT4G17660 [Arabidopsis thaliana (taxid:3702)]

 Score = 803 (287.7 bits), Expect = 6.0e-80, P = 6.0e-80
 Identities = 169/320 (52%), Positives = 211/320 (65%)

Query:    68 QRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVA 127
             Q +  +LRVFSF EL  AT  FSR L IGEGGFG VY+  +   ++      H S L VA
Sbjct:    70 QNQNQNLRVFSFKELSDATCEFSRKLKIGEGGFGSVYKATI---NNPTVGDSHSSPLTVA 126

Query:   128 IKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE 187
             +K+LNRQ  QGHK+W+ EV+FLGVV HPN+V+L+GYC+ED ER    LLVYELM N+SLE
Sbjct:   127 VKKLNRQSLQGHKQWLAEVHFLGVVNHPNVVRLLGYCSEDRER----LLVYELMSNRSLE 182

Query:   188 DHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
             DHL +     L+W  RL+I   AA+GLAYLHE    Q+I+RDFK+SN+LL+E++  KLSD
Sbjct:   183 DHLFTLRTLTLSWKQRLEIMLGAAQGLAYLHE---IQVIYRDFKSSNVLLNEEFHPKLSD 239

Query:   248 FGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
             FGLAR+GP     H          YAAPEYV TG L    DV+SFGVVLYE+ITGRR +E
Sbjct:   240 FGLAREGPEGDNTHVTTARVGTDGYAAPEYVITGHLKTHCDVYSFGVVLYEIITGRRTLE 299

Query:   308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRP 367
             R  P  EQKLLEWV+ Y  +SK+F +I+D +L   Y I            C+ K  K RP
Sbjct:   300 RMKPLAEQKLLEWVKKYPINSKRFKMIVDSKLCNKYPIAMVRRVAKLADHCVNKIDKERP 359

Query:   368 KMSEVVDILGNIISEISSQD 387
              M+ VV+ L NII E +S+D
Sbjct:   360 TMAFVVESLTNIIEESNSED 379

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2200863 AT1G61590 [Arabidopsis thaliana (taxid:3702)]

 Score = 790 (283.2 bits), Expect = 1.4e-78, P = 1.4e-78
 Identities = 162/336 (48%), Positives = 215/336 (63%)

Query:    45 RRSEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVY 104
             RR  F   SR  S S    E L+Q    DL  F   ELK  T+ FS   L+GEGGFG VY
Sbjct:    57 RRLSFADLSR--SSSARINEDLAQTLGADLVDFQMCELKMITQSFSGNYLLGEGGFGKVY 114

Query:   105 RGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC 164
             +G V    DD+      ++  VA+K L+ +G QGH+EW++EV FLG +KHPNLVKL+GYC
Sbjct:   115 KGYV----DDYLRQSLKAQ-PVAVKLLDIEGLQGHREWLSEVIFLGQLKHPNLVKLIGYC 169

Query:   165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ 224
              E++ER    +L+YE M   SLE+HL  R+   L W  RLKIA  AA+GLA+LH+ ++  
Sbjct:   170 CEEEER----VLIYEFMPRGSLENHLFRRISLSLPWATRLKIAVAAAKGLAFLHD-LESP 224

Query:   225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLT 284
             +I+RDFKTSNILLD D+ AKLSDFGLA+ GP     H          YAAPEYV TG LT
Sbjct:   225 IIYRDFKTSNILLDSDFTAKLSDFGLAKMGPEGSKSHVTTRVMGTYGYAAPEYVSTGHLT 284

Query:   285 AKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYC 344
              KSDV+S+GVVL EL+TGRRA E++ P+N+Q +++W +PY++ S++   ++DPRL G Y 
Sbjct:   285 TKSDVYSYGVVLLELLTGRRATEKSRPKNQQNIIDWSKPYLTSSRRLRCVMDPRLAGQYS 344

Query:   345 IXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNII 380
             +            C++  PK RPKM  VV+ L ++I
Sbjct:   345 VKAAKDTALLALQCVSPNPKDRPKMLAVVEALESLI 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.921

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00024312001 SubName- Full=Chromosome chr6 scaffold_3, whole genome shotgun sequence; (438 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	453
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-51
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-51
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-50
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-50
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	5e-50
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	7e-49
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	1e-48
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	4e-37
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	9e-37
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-36
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	1e-33
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	9e-32
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	1e-30
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-30
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-28
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-28
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-28
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-27
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	1e-26
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-26
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-26
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-26
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	7e-26
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	9e-26
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	2e-25
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	3e-25
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-25
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-25
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	4e-25
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	2e-24
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	5e-24
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	6e-24
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	6e-24
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-23
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-23
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-23
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-23
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-23
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	5e-23
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	5e-23
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-23
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	1e-22
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-22
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-22
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-22
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	6e-22
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	7e-22
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-21
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-21
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-21
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-21
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	4e-21
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	4e-21
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	5e-21
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	6e-21
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-20
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	1e-20
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-20
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-20
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-20
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-20
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	3e-20
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-20
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-20
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-20
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	9e-20
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	1e-19
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-19
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-19
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-19
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-19
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-19
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-19
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-19
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	2e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	5e-19
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-19
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	7e-19
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	1e-18
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	2e-18
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	2e-18
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-18
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-18
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-18
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	5e-18
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	5e-18
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	6e-18
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	6e-18
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-18
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	9e-18
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	9e-18
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-17
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	1e-17
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-17
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-17
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-17
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	2e-17
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-17
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-17
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-17
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	6e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	6e-17
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-17
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-17
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-17
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	9e-17
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	1e-16
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	1e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	1e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-16
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-16
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-16
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-16
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	3e-16
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-16
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-16
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	5e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-16
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	6e-16
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-16
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	7e-16
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	9e-16
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-15
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-15
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-15
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-15
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	1e-15
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-15
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-15
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-15
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	3e-15
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	4e-15
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	4e-15
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	4e-15
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	5e-15
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	7e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	8e-15
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	9e-15
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	9e-15
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-14
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-14
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-14
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	1e-14
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-14
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-14
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-14
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-14
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-14
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	3e-14
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	3e-14
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	4e-14
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-14
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	7e-14
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-14
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	8e-14
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	9e-14
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	1e-13
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-13
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	2e-13
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	2e-13
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-13
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	2e-13
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-13
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	3e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-13
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	4e-13
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-13
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-13
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	5e-13
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	5e-13
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	6e-13
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	6e-13
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	7e-13
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-13
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	7e-13
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	8e-13
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-12
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-12
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-12
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-12
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-12
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-12
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-12
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	2e-12
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-12
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-12
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	3e-12
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-12
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	3e-12
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	4e-12
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	4e-12
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	4e-12
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	4e-12
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-12
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	7e-12
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	8e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	9e-12
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	1e-11
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	1e-11
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-11
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	1e-11
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	2e-11
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	2e-11
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-11
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-11
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-11
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	3e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	3e-11
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-11
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	4e-11
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	5e-11
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-11
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-11
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	6e-11
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	6e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	6e-11
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	7e-11
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	7e-11
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	8e-11
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	8e-11
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-11
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	1e-10
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-10
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-10
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-10
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	2e-10
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	2e-10
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	2e-10
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	3e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-10
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	3e-10
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-10
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-10
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	3e-10
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-10
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	4e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	5e-10
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	6e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	6e-10
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	7e-10
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	8e-10
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	9e-10
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	9e-10
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	9e-10
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	1e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	1e-09
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	2e-09
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	2e-09
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	2e-09
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-09
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	3e-09
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	3e-09
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-09
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	5e-09
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-09
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	1e-08
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	1e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	1e-08
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-08
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-08
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	3e-08
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	3e-08
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	3e-08
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-08
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	4e-08
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	4e-08
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	4e-08
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	6e-08
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	6e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	7e-08
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	8e-08
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	8e-08
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	9e-08
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	1e-07
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-07
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	2e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	2e-07
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	3e-07
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-07
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	8e-07
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	9e-07
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-06
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-06
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-06
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-06
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	5e-06
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	2e-05
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	2e-04
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	4e-04
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	8e-04
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	0.002
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	0.002

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  173 bits (442), Expect = 2e-51
 Identities = 88/284 (30%), Positives = 135/284 (47%), Gaps = 34/284 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           +GEG FG VY+G ++   D         +++VA+K L      Q  +E++ E   +  + 
Sbjct: 7   LGEGAFGEVYKGTLKGKGDG-------KEVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL+G C E++      ++V E M    L D+L    P  L+    L  A   ARG
Sbjct: 60  HPNIVKLLGVCTEEE----PLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARG 115

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL  +     I RD    N L+ E+   K+SDFGL+R    +    V    +  + + 
Sbjct: 116 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKL-PIRWM 171

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHL 333
           APE ++ G+ T+KSDVWSFGV+L+E+ T        +  N +     V  Y+        
Sbjct: 172 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMS-NAE-----VLEYLKKGY---- 221

Query: 334 IIDPRLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
               RL     C     +L  L  +C  + P+ RP  SE+V+IL
Sbjct: 222 ----RLPKPPNC---PPELYKLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  173 bits (441), Expect = 3e-51
 Identities = 83/288 (28%), Positives = 133/288 (46%), Gaps = 42/288 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GEG FG VY+G ++   +  +T        VA+K L      +  +E++ E + +  + 
Sbjct: 7   LGEGAFGEVYKGTLKGDGEGTET-------KVAVKTLKEGASEEEREEFLEEASIMKKLS 59

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+V+L+G C + +       +V E M    L D L       L     L++A   A+G
Sbjct: 60  HPNIVRLLGVCTQGE----PLYIVTEYMPGGDLLDFLRKH-GEKLTLKDLLQMALQIAKG 114

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL  +     + RD    N L+ E+   K+SDFGL+R    +            + + 
Sbjct: 115 MEYLESK---NFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWM 171

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDSKK 330
           APE ++ G+ T+KSDVWSFGV+L+E+ T G                   +PY  +S+ + 
Sbjct: 172 APESLKDGKFTSKSDVWSFGVLLWEIFTLGE------------------QPYPGMSNEEV 213

Query: 331 FHLIID-PRLEGN-YCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
             L+ D  RL     C     +L  L  +C    P+ RP  SE+V+ L
Sbjct: 214 LELLEDGYRLPRPENC---PDELYELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  171 bits (436), Expect = 2e-50
 Identities = 88/285 (30%), Positives = 133/285 (46%), Gaps = 37/285 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           +GEG FG VY+G ++             K++VA+K L      Q  +E++ E   +  + 
Sbjct: 7   LGEGAFGEVYKGKLKGKGGKK-------KVEVAVKTLKEDASEQQIEEFLREARIMRKLD 59

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL+G C E++       +V E M    L  +L    P  L+    L  A   ARG
Sbjct: 60  HPNVVKLLGVCTEEEPL----YIVMEYMEGGDLLSYLRKNRPK-LSLSDLLSFALQIARG 114

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL  +     I RD    N L+ E+   K+SDFGL+R    +   +        + + 
Sbjct: 115 MEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDY-YRKRGGKLPIRWM 170

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKFH 332
           APE ++ G+ T+KSDVWSFGV+L+E+ T G +      P       E V  Y+ +     
Sbjct: 171 APESLKEGKFTSKSDVWSFGVLLWEIFTLGEQ------PYPGMSNEE-VLEYLKNGY--- 220

Query: 333 LIIDPRLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
                RL     C     +L  L  +C  + P+ RP  SE+V+IL
Sbjct: 221 -----RLPQPPNC---PPELYDLMLQCWAEDPEDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  171 bits (435), Expect = 2e-50
 Identities = 83/284 (29%), Positives = 115/284 (40%), Gaps = 46/284 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
            +GEG FG VY    +            +   VAIK + ++  +  +E  + E+  L  +
Sbjct: 6   KLGEGSFGKVYLARDK-----------KTGKLVAIKVIKKKKIKKDRERILREIKILKKL 54

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPN+V+L     ++D+      LV E      L D L  R              +    
Sbjct: 55  KHPNIVRLYDVFEDEDKL----YLVMEYCEGGDLFDLLKKRGRLSEDEAR--FYLRQILS 108

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            L YLH +    ++ RD K  NILLDED   KL+DFGLARQ  P       T+ VGT  Y
Sbjct: 109 ALEYLHSK---GIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEK---LTTFVGTPEY 162

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS---K 329
            APE +         D+WS GV+LYEL+TG+                   P+  D    +
Sbjct: 163 MAPEVLLGKGYGKAVDIWSLGVILYELLTGK------------------PPFPGDDQLLE 204

Query: 330 KFHLIIDPRLEGNYCIKSA-QKLAALASKCLTKQPKSRPKMSEV 372
            F  I  P+            +   L  K L K P+ R    E 
Sbjct: 205 LFKKIGKPKPPFPPPEWDISPEAKDLIRKLLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  170 bits (433), Expect = 5e-50
 Identities = 86/295 (29%), Positives = 131/295 (44%), Gaps = 49/295 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +GEG FG VY+G ++               +VA+K L      +  K+++ E   +  + 
Sbjct: 3   LGEGAFGEVYKGKLK--------GKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG 54

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP-------TPLAWIARLKI 206
           HPN+V+L+G C E++       LV E M    L D+L    P       + L+    L  
Sbjct: 55  HPNVVRLLGVCTEEEPL----YLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSF 110

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A   A+G+ YL  +   + + RD    N L+ ED   K+SDFGL+R    +      T  
Sbjct: 111 AIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGG 167

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY- 324
              + + APE ++ G  T+KSDVWSFGV+L+E+ T G                    PY 
Sbjct: 168 KLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGA------------------TPYP 209

Query: 325 -VSDSKKFHLIIDP-RLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
            +S+ +    +    RL    YC     +L  L   C    P+ RP  SE+V+ L
Sbjct: 210 GLSNEEVLEYLRKGYRLPKPEYC---PDELYELMLSCWQLDPEDRPTFSELVERL 261

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  165 bits (421), Expect = 7e-49
 Identities = 84/285 (29%), Positives = 117/285 (41%), Gaps = 73/285 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           +GEGGFG VY    +            +   VAIK + ++      E  + E+  L  + 
Sbjct: 1   LGEGGFGTVYLARDK-----------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN 49

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL G   +++       LV E     SL+D LL      L+    L+I      G
Sbjct: 50  HPNIVKLYGVFEDENHLY----LVMEYCEGGSLKD-LLKENEGKLSEDEILRILLQILEG 104

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           L YLH      +I RD K  NILLD D  K KL+DFGL++    +    +  ++VGT  Y
Sbjct: 105 LEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK--SLLKTIVGTPAY 159

Query: 273 AAPE-YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
            APE  +  G  + KSD+WS GV+LYEL                                
Sbjct: 160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-------------------------------- 187

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
                             +L  L  K L K P+ RP   E+++ L
Sbjct: 188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  167 bits (424), Expect = 1e-48
 Identities = 90/284 (31%), Positives = 127/284 (44%), Gaps = 40/284 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVV 152
           +G G FG VY+         H+ +G      VA+K L ++    +  +    E+  L  +
Sbjct: 7   LGSGSFGTVYKAK-------HKGTGKI----VAVKILKKRSEKSKKDQTARREIRILRRL 55

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN+V+L+    + D       LV E      L D+L      PL+     KIA    R
Sbjct: 56  SHPNIVRLIDAFEDKDHL----YLVMEYCEGGDLFDYLSRG--GPLSEDEAKKIALQILR 109

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           GL YLH      +I RD K  NILLDE+   K++DFGLA++          T+ VGT  Y
Sbjct: 110 GLEYLHSN---GIIHRDLKPENILLDENGVVKIADFGLAKKL--LKSSSSLTTFVGTPWY 164

Query: 273 AAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
            APE +  G     K DVWS GV+LYEL+TG     +     E          +   +  
Sbjct: 165 MAPEVLLGGNGYGPKVDVWSLGVILYELLTG-----KPPFSGE--------NILDQLQLI 211

Query: 332 HLIIDPRLEGNYCIKS--AQKLAALASKCLTKQPKSRPKMSEVV 373
             I+ P LE +    S  +++   L  KCL K P  RP   E++
Sbjct: 212 RRILGPPLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEIL 255

Length = 260

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  136 bits (344), Expect = 4e-37
 Identities = 70/216 (32%), Positives = 103/216 (47%), Gaps = 24/216 (11%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F     IG+GGFG VY+   + +             +VAIK +  +  +  ++ INE+  
Sbjct: 2   FEILEKIGKGGFGEVYKARHKRT-----------GKEVAIKVIKLESKEKKEKIINEIQI 50

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIA 207
           L   KHPN+VK  G   + DE  +    V E     SL+D L S       + IA   + 
Sbjct: 51  LKKCKHPNIVKYYGSYLKKDELWI----VMEFCSGGSLKDLLKSTNQTLTESQIA--YVC 104

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           ++  +GL YLH      +I RD K +NILL  D + KL DFGL+ Q       +   ++V
Sbjct: 105 KELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARN---TMV 158

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           GT  + APE +       K+D+WS G+   EL  G+
Sbjct: 159 GTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGK 194

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  135 bits (342), Expect = 9e-37
 Identities = 76/282 (26%), Positives = 120/282 (42%), Gaps = 39/282 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEVNFLGV 151
           L+G G FG VY  +             D+   +A+K   L+    +  +    E+  L  
Sbjct: 7   LLGRGSFGSVYLALD-----------KDTGELMAVKSVELSGDSEEELEALEREIRILSS 55

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQD 209
           ++HPN+V+  G  +E DE      +  E +   SL   L    ++P P+  I +    + 
Sbjct: 56  LQHPNIVRYYG--SERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPV--IRKY--TRQ 109

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
              GLAYLH      ++ RD K +NIL+D D   KL+DFG A++      G  + SV GT
Sbjct: 110 ILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
             + APE ++       +D+WS G  + E+ TG+       P +E          +  S 
Sbjct: 167 PYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKP------PWSELGNPMAALYKIGSSG 220

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
           +    I   L        +++      KCL + PK RP   E
Sbjct: 221 E-PPEIPEHL--------SEEAKDFLRKCLRRDPKKRPTADE 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  134 bits (339), Expect = 2e-36
 Identities = 85/297 (28%), Positives = 125/297 (42%), Gaps = 63/297 (21%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEVNFLGV 151
            IG+G FG VY   VR           D KL   +K+  L+    +  ++ +NEV  L  
Sbjct: 7   QIGKGSFGKVYL--VR--------RKSDGKL-YVLKEIDLSNMSEKEREDALNEVKILKK 55

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLL-VYELMHNKSLEDHLLSR----VPTP----LAWIA 202
           + HPN++K      E       +L  V E      L   +  +     P P    L W  
Sbjct: 56  LNHPNIIKYYESFEEKG-----KLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFV 110

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH- 261
           +L +A      L YLH     +++ RD K  NI L  +   KL DFG+++      L   
Sbjct: 111 QLCLA------LKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKV-----LSST 156

Query: 262 --VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE-RNLPRNEQKLL 318
             ++ +VVGT  Y +PE  Q      KSD+WS G VLYEL T +   E  NL     K+L
Sbjct: 157 VDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKIL 216

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
           +    Y            P +   Y    + +L  L S  L K P+ RP +++++  
Sbjct: 217 K--GQY------------PPIPSQY----SSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  126 bits (319), Expect = 1e-33
 Identities = 72/212 (33%), Positives = 109/212 (51%), Gaps = 24/212 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           LIG G FG VY+G+       +  +G      VAIKQ++ +    +  K  + E++ L  
Sbjct: 7   LIGRGAFGVVYKGL-------NLETG----DFVAIKQISLEKIKEEALKSIMQEIDLLKN 55

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           +KHPN+VK +G   E  +      ++ E   N SL   +    P P + +A   + Q   
Sbjct: 56  LKHPNIVKYIG-SIETSD---SLYIILEYAENGSLRQIIKKFGPFPESLVAVY-VYQ-VL 109

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           +GLAYLHE+    +I RD K +NIL  +D   KL+DFG+A +     +     SVVGT  
Sbjct: 110 QGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLN--DVSKDDASVVGTPY 164

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           + APE ++    +  SD+WS G  + EL+TG 
Sbjct: 165 WMAPEVIEMSGASTASDIWSLGCTVIELLTGN 196

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  124 bits (312), Expect = 9e-32
 Identities = 91/329 (27%), Positives = 128/329 (38%), Gaps = 42/329 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
            +GEG FG VY                  +  VA+K L ++     KE    + E+  L 
Sbjct: 7   KLGEGSFGEVYLAR--------------DRKLVALKVLAKKLESKSKEVERFLREIQILA 52

Query: 151 VVKHP-NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL-LSRVPTPLAWIARLKIAQ 208
            + HP N+VKL  +  ++        LV E +   SLED L       PL+    L I  
Sbjct: 53  SLNHPPNIVKLYDFFQDEG----SLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILA 108

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-KAKLSDFGLARQ----GPPEGLGHVS 263
                L YLH +    +I RD K  NILLD D    KL DFGLA+     G    +  + 
Sbjct: 109 QILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALP 165

Query: 264 TSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVER-NLPRNEQKLLE 319
           ++ VGT GY APE +        ++ SD+WS G+ LYEL+TG    E         + L+
Sbjct: 166 STSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLK 225

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI-LGN 378
            +    + S    L        +           L  K L K PK+R   S  +   L  
Sbjct: 226 IILELPTPSLASPLSPSNPELISKAASD------LLKKLLAKDPKNRLSSSSDLSHDLLA 279

Query: 379 IISEISSQDEVTLQPVAEIEDVKEEPEAE 407
            +    S     L+P          P + 
Sbjct: 280 HLKLKESDLSDLLKPDDSAPLRLSLPPSL 308

Length = 384

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  119 bits (299), Expect = 1e-30
 Identities = 78/301 (25%), Positives = 127/301 (42%), Gaps = 51/301 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVVK 153
           +GEG FG V           +   G ++   VA+K LN  G + H  ++  E+  L  + 
Sbjct: 12  LGEGHFGKVELC-------RYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G C +   R ++  L+ E + + SL    L R    +     L  +    +G
Sbjct: 65  HENIVKYKGVCEKPGGRSLR--LIMEYLPSGSL-RDYLQRHRDQINLKRLLLFSSQICKG 121

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--VG 271
           + YL  +   + I RD    NIL++ +   K+SDFGLA+   PE   +      G   + 
Sbjct: 122 MDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAK-VLPEDKDYYYVKEPGESPIF 177

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           + APE ++T + ++ SDVWSFGV LYEL T                  +  P  S   +F
Sbjct: 178 WYAPECLRTSKFSSASDVWSFGVTLYELFT------------------YGDPSQSPPAEF 219

Query: 332 HLIIDPRLEGNY------CIKSAQKLAA----------LASKCLTKQPKSRPKMSEVVDI 375
             +I               +K  ++L            L   C   +P+ RP  ++++ I
Sbjct: 220 LRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILI 279

Query: 376 L 376
           +
Sbjct: 280 V 280

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 68/211 (32%), Positives = 104/211 (49%), Gaps = 27/211 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            IG+G FG V  G  R                VA+K L        + ++ E + +  ++
Sbjct: 13  TIGKGEFGDVMLGDYR-------------GQKVAVKCLKDDS-TAAQAFLAEASVMTTLR 58

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPNLV+L+G   + +       +V E M   SL D+L SR    +    +L  A D   G
Sbjct: 59  HPNLVQLLGVVLQGN----PLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL E+     + RD    N+L+ ED  AK+SDFGLA++      G  S  +   V + 
Sbjct: 115 MEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKE---ASQGQDSGKL--PVKWT 166

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT-GR 303
           APE ++  + + KSDVWSFG++L+E+ + GR
Sbjct: 167 APEALREKKFSTKSDVWSFGILLWEIYSFGR 197

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  112 bits (282), Expect = 2e-28
 Identities = 81/278 (29%), Positives = 114/278 (41%), Gaps = 49/278 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLGV 151
           +G+G FG V   +VR                 A+K L ++     KE    + E N L  
Sbjct: 1   LGKGSFGKVL--LVRKKDTGKL---------YAMKVLKKKKIIKRKEVEHTLTERNILSR 49

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           + HP +VKL  + A   E    +L LV E      L  HL           AR   A+  
Sbjct: 50  INHPFIVKL--HYAFQTEE---KLYLVLEYAPGGELFSHLSKEGRFSEER-ARFYAAE-I 102

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
              L YLH      +I+RD K  NILLD D   KL+DFGLA++   EG    + +  GT 
Sbjct: 103 VLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTP 157

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            Y APE +         D WS GV+LYE++TG+                   P+ ++ +K
Sbjct: 158 EYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGK------------------PPFYAEDRK 199

Query: 331 --FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
             +  I+   L   +    + +   L S  L K P  R
Sbjct: 200 EIYEKILKDPLR--FPEFLSPEARDLISGLLQKDPTKR 235

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score =  111 bits (279), Expect = 7e-28
 Identities = 93/290 (32%), Positives = 134/290 (46%), Gaps = 31/290 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           +GEG FG       +VS   +  +   +   VA+K L R+  Q +   W  E+N L  + 
Sbjct: 12  LGEGHFG-------KVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY 64

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI-AQDAAR 212
           H N+VK  G C+E   +G+Q  L+ E +   SL D+L    P     +A+L + AQ    
Sbjct: 65  HENIVKYKGCCSEQGGKGLQ--LIMEYVPLGSLRDYL----PKHKLNLAQLLLFAQQICE 118

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH----VSTSVVG 268
           G+AYLH +     I RD    N+LLD D   K+ DFGLA+  P    GH    V      
Sbjct: 119 GMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEYYRVREDGDS 172

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
            V + A E ++  + +  SDVWSFGV LYEL+T      +  P   +K  E + P     
Sbjct: 173 PVFWYAVECLKENKFSYASDVWSFGVTLYELLT--HCDSKQSPP--KKFEEMIGPKQGQM 228

Query: 329 KKFHLI-IDPRLEGNYCIKSA-QKLAALASKCLTKQPKSRPKMSEVVDIL 376
               LI +  R     C K+  Q++  L   C   + K RP    ++ IL
Sbjct: 229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPIL 278

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  110 bits (277), Expect = 7e-28
 Identities = 80/298 (26%), Positives = 126/298 (42%), Gaps = 65/298 (21%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
            IG+G FG VY+GV++               +VA+K          K  ++ E   L   
Sbjct: 2   KIGKGNFGDVYKGVLK------------GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQY 49

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ---- 208
            HPN+VKL+G C +         +V EL+   SL   L  R         RL + +    
Sbjct: 50  DHPNIVKLIGVCVQKQPI----YIVMELVPGGSLLTFL--RKKK-----NRLTVKKLLQM 98

Query: 209 --DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
             DAA G+ YL  +     I RD    N L+ E+   K+SDFG++R    E  G + T  
Sbjct: 99  SLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR----EEEGGIYTVS 151

Query: 267 VGT----VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            G     + + APE +  GR T++SDVWS+G++L+E  +        +   + +      
Sbjct: 152 DGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTR------ 205

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQ----KLAALASKCLTKQPKSRPKMSEVVDIL 376
                          R+E  Y + + Q    ++  L  +C    P++RP  SE+ + L
Sbjct: 206 --------------ERIESGYRMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNEL 249

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  108 bits (273), Expect = 5e-27
 Identities = 88/297 (29%), Positives = 126/297 (42%), Gaps = 50/297 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWINEVNFLGVVK 153
           +G+G FG VY G+             + +  VAIK +N     +   E++NE + +    
Sbjct: 14  LGQGSFGMVYEGLA------KGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN 67

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP-----TPLAWIARLKIAQ 208
             ++V+L+G  +     G   L+V ELM    L+ +L SR P       L      K  Q
Sbjct: 68  CHHVVRLLGVVS----TGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQ 123

Query: 209 DA---ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ------GPPEGL 259
            A   A G+AYL  +   + + RD    N ++ ED   K+ DFG+ R           G 
Sbjct: 124 MAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           G +       V + APE ++ G  T KSDVWSFGVVL+E+ T      + L  NE+    
Sbjct: 181 GLLP------VRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGL-SNEE---- 229

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
            V  +V D    HL        +       KL  L   C    PK RP   E+V  L
Sbjct: 230 -VLKFVIDGG--HL--------DLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  107 bits (269), Expect = 1e-26
 Identities = 74/213 (34%), Positives = 100/213 (46%), Gaps = 32/213 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G  R             K+DVAIK + R+G     ++I E   +  + H
Sbjct: 12  LGSGQFGVVHLGKWR------------GKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSH 58

Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           PNLV+L G C +      QR   +V E M N  L ++L  R    L     L +  D   
Sbjct: 59  PNLVQLYGVCTK------QRPIFIVTEYMANGCLLNYLRER-KGKLGTEWLLDMCSDVCE 111

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--- 269
            + YL        I RD    N L+ ED   K+SDFGLAR      L    TS  GT   
Sbjct: 112 AMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYV----LDDQYTSSQGTKFP 164

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           V +A PE     R ++KSDVWSFGV+++E+ + 
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSE 197

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  108 bits (271), Expect = 2e-26
 Identities = 83/281 (29%), Positives = 121/281 (43%), Gaps = 53/281 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G VY+   R +  +           VAIK++  +  Q  +  INE+  +   KH
Sbjct: 27  IGEGASGEVYKATDRATGKE-----------VAIKKMRLRK-QNKELIINEILIMKDCKH 74

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL--AWIARLKIAQDAAR 212
           PN+V         DE  +    V E M   SL D ++++    +    IA   + ++  +
Sbjct: 75  PNIVDYYDSYLVGDELWV----VMEYMDGGSLTD-IITQNFVRMNEPQIAY--VCREVLQ 127

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           GL YLH      +I RD K+ NILL +D   KL+DFG A Q   E       SVVGT  +
Sbjct: 128 GLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR--NSVVGTPYW 182

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS--KK 330
            APE ++      K D+WS G++  E+  G        P           PY+ +   + 
Sbjct: 183 MAPEVIKRKDYGPKVDIWSLGIMCIEMAEGE-------P-----------PYLREPPLRA 224

Query: 331 FHLIID---PRL-EGNYCIKSAQKLAALASKCLTKQPKSRP 367
             LI     P L       K + +     +KCL K P+ RP
Sbjct: 225 LFLITTKGIPPLKNPE---KWSPEFKDFLNKCLVKDPEKRP 262

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  107 bits (268), Expect = 2e-26
 Identities = 71/215 (33%), Positives = 100/215 (46%), Gaps = 32/215 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G            G      VA+K L + G    + ++ E   +  ++H
Sbjct: 14  LGAGQFGEVWMGTWN---------GT---TKVAVKTL-KPGTMSPEAFLQEAQIMKKLRH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L   C+E++       +V E M   SL D L S     L     + +A   A G+
Sbjct: 61  DKLVQLYAVCSEEEPI----YIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM 116

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS--TSVVGT--- 269
           AYL E      I RD    NIL+ E+   K++DFGLAR      L      T+  G    
Sbjct: 117 AYL-ESR--NYIHRDLAARNILVGENLVCKIADFGLAR------LIEDDEYTAREGAKFP 167

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GR 303
           + + APE    GR T KSDVWSFG++L E++T GR
Sbjct: 168 IKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  106 bits (266), Expect = 5e-26
 Identities = 83/300 (27%), Positives = 131/300 (43%), Gaps = 59/300 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN---EVNFLGV 151
           IG G FG V RG +++            ++DVAIK L + G    K+ ++   E + +G 
Sbjct: 12  IGGGEFGEVCRGRLKLPGKK--------EIDVAIKTL-KAGSSD-KQRLDFLTEASIMGQ 61

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN+++L G       +    +++ E M N SL D  L            + + +  A
Sbjct: 62  FDHPNIIRLEGVVT----KSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIA 116

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVG-- 268
            G+ YL  EM++  + RD    NIL++ +   K+SDFGL+R+    E      T+  G  
Sbjct: 117 SGMKYL-SEMNY--VHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA---TYTTKGGKI 170

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSD 327
            + + APE +   + T+ SDVWSFG+V++E+++ G                   RPY   
Sbjct: 171 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGE------------------RPYWDM 212

Query: 328 SKKFHLIIDPRLEGNY-------CIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
           S     +I   +E  Y       C      L  L   C  K    RP  S++V  L  +I
Sbjct: 213 SN--QDVIK-AVEDGYRLPPPMDC---PSALYQLMLDCWQKDRNERPTFSQIVSTLDKMI 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  105 bits (264), Expect = 7e-26
 Identities = 85/303 (28%), Positives = 141/303 (46%), Gaps = 58/303 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN----------RQGFQGHKEWI 143
            +G G FGCVY+  VR      + +   + L  A+K++N          R+  +   + +
Sbjct: 7   HLGSGAFGCVYK--VR------KKNNGQNLL--ALKEINVHNPAFGKDKRERDKSIGDIV 56

Query: 144 NEVNFLG-VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLS------RVP 195
           +EV  +   ++HPN+V+      E+D     RL +V +L+    L +H  S      R  
Sbjct: 57  SEVTIIKEQLRHPNIVRYYKTFLEND-----RLYIVMDLIEGAPLGEHFNSLKEKKQRFT 111

Query: 196 TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP 255
               W     I       L YLH+E   +++ RD   +NI+L ED K  ++DFGLA+Q  
Sbjct: 112 EERIW----NIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQ 165

Query: 256 PEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ 315
           PE      TSVVGT+ Y+ PE V+      K+DVW+FG +LY++ T         P    
Sbjct: 166 PES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCT------LQPPFYST 216

Query: 316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
            +L         +K    + +P  EG Y    ++ +  + + CLT   ++RP + +V  +
Sbjct: 217 NMLSLA------TKIVEAVYEPLPEGMY----SEDVTDVITSCLTPDAEARPDIIQVSAM 266

Query: 376 LGN 378
           + +
Sbjct: 267 ISD 269

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  105 bits (263), Expect = 9e-26
 Identities = 75/299 (25%), Positives = 113/299 (37%), Gaps = 61/299 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVV 152
            +G+G FG V RG    S            + VA+K L          +++ E   +  +
Sbjct: 2   KLGDGSFGVVRRGEWSTSGGKV--------IPVAVKCLKSDKLSDIMDDFLKEAAIMHSL 53

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL----LSRVPTPLAWIARLKIAQ 208
            H NL++L G            ++V EL    SL D L    L            ++IA 
Sbjct: 54  DHENLIRLYGVVLTH-----PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIAN 108

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
               G+ YL  +   + I RD    NILL  D K K+ DFGL R   P+   H       
Sbjct: 109 ----GMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMR-ALPQNEDHYVMEEHL 160

Query: 269 TVGYA--APEYVQTGRLTAKSDVWSFGVVLYELIT-------GRRAVE--RNLPRNEQKL 317
            V +A  APE ++T   +  SDVW FGV L+E+ T       G    +  + + +  ++L
Sbjct: 161 KVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERL 220

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
               RP                    C    Q +  +  +C    P  RP  + + + L
Sbjct: 221 ---ERP------------------EAC---PQDIYNVMLQCWAHNPADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  103 bits (259), Expect = 2e-25
 Identities = 80/279 (28%), Positives = 122/279 (43%), Gaps = 44/279 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G                K  VAIK + R+G    +++I E   +  + H
Sbjct: 12  IGSGQFGLVWLGYWL------------EKRKVAIKTI-REGAMSEEDFIEEAQVMMKLSH 58

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV+E M +  L D+L ++     +    L +  D   G+
Sbjct: 59  PKLVQLYGVCTERSPI----CLVFEFMEHGCLSDYLRAQRGK-FSQETLLGMCLDVCEGM 113

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AYL       +I RD    N L+ E+   K+SDFG+ R      L    TS  GT   V 
Sbjct: 114 AYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFV----LDDQYTSSTGTKFPVK 166

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           +++PE     + ++KSDVWSFGV+++E+ +  +    N   +E          V      
Sbjct: 167 WSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSE---------VVETINAG 217

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
             +  PRL       ++Q +  L   C  ++P+ RP  S
Sbjct: 218 FRLYKPRL-------ASQSVYELMQHCWKERPEDRPSFS 249

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  104 bits (261), Expect = 3e-25
 Identities = 77/307 (25%), Positives = 133/307 (43%), Gaps = 50/307 (16%)

Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-N 132
           LR+    EL+       +  ++G G FG VY+GV           G   K+ VAIK L  
Sbjct: 1   LRILKETELE-------KIKVLGSGAFGTVYKGVWIPE-------GEKVKIPVAIKVLRE 46

Query: 133 RQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS 192
               + +KE ++E   +  V HP++V+L+G C        Q  L+ +LM    L D++ +
Sbjct: 47  ETSPKANKEILDEAYVMASVDHPHVVRLLGICL-----SSQVQLITQLMPLGCLLDYVRN 101

Query: 193 RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
                +     L      A+G++YL E+   +L+ RD    N+L+      K++DFGLA+
Sbjct: 102 HKDN-IGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAK 157

Query: 253 QGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVE---- 307
               +   + +      + + A E +     T KSDVWS+GV ++EL+T G +  E    
Sbjct: 158 LLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217

Query: 308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             +P   +K     +P +     + +++                     KC     +SRP
Sbjct: 218 VEIPDLLEKGERLPQPPICTIDVYMVLV---------------------KCWMIDAESRP 256

Query: 368 KMSEVVD 374
              E+++
Sbjct: 257 TFKELIN 263

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 3e-25
 Identities = 64/213 (30%), Positives = 104/213 (48%), Gaps = 28/213 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G+   ++             VA+K L + G    K+++ E   +  ++H
Sbjct: 14  LGAGQFGEVWEGLWNNTTP------------VAVKTL-KPGTMDPKDFLAEAQIMKKLRH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P L++L   C  ++       +V ELM   SL ++L       L     + +A   A G+
Sbjct: 61  PKLIQLYAVCTLEEPI----YIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM 116

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AYL E  ++  I RD    N+L+ E+   K++DFGLAR    +    +  +  G    + 
Sbjct: 117 AYL-EAQNY--IHRDLAARNVLVGENNICKVADFGLARVIKED----IYEAREGAKFPIK 169

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GR 303
           + APE     R + KSDVWSFG++L E++T GR
Sbjct: 170 WTAPEAALYNRFSIKSDVWSFGILLTEIVTYGR 202

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  103 bits (258), Expect = 3e-25
 Identities = 75/276 (27%), Positives = 119/276 (43%), Gaps = 41/276 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           IG+G FG V++ VVR    D +          A+KQ++         +E I+E   L  +
Sbjct: 8   IGKGSFGVVFK-VVR--KADKRV--------YAMKQIDLSKMNRREREEAIDEARVLAKL 56

Query: 153 KHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
               +++      +       +L +V E   N  L   L  +   PL      +      
Sbjct: 57  DSSYIIRYYESFLDK-----GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQIL 111

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
            GLA+LH +   +++ RD K+ N+ LD     K+ D G+A+          + ++VGT  
Sbjct: 112 LGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN--FANTIVGTPY 166

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           Y +PE  +      KSDVW+ GVVLYE  TG+   + N   N+  L+           K 
Sbjct: 167 YLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDAN---NQGALI----------LKI 213

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
              + P +   Y    +Q+LA L  +CLTK  + RP
Sbjct: 214 IRGVFPPVSQMY----SQQLAQLIDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  103 bits (258), Expect = 4e-25
 Identities = 81/293 (27%), Positives = 132/293 (45%), Gaps = 46/293 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           +G G FG V +GV  + S          +++VA+K L       G KE++ E + +  + 
Sbjct: 3   LGHGNFGSVVKGVYLMKSG--------KEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD 54

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP +V+L+G C  +       +LV EL     L  +L  R   P++ +  L  A   A G
Sbjct: 55  HPCIVRLIGVCKGE-----PLMLVMELAPLGPLLKYLKKRREIPVSDLKEL--AHQVAMG 107

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVGTVGY 272
           +AYL E   F  + RD    N+LL   ++AK+SDFG++R  G        +T+    + +
Sbjct: 108 MAYL-ESKHF--VHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKW 164

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
            APE +  G+ ++KSDVWS+GV L+E  + G +      P  E K  E +          
Sbjct: 165 YAPECINYGKFSSKSDVWSYGVTLWEAFSYGAK------PYGEMKGAEVIA--------- 209

Query: 332 HLIIDPRLEGNYCI----KSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
                  LE    +    +  Q++ ++   C   +P+ RP  SE+        
Sbjct: 210 ------MLESGERLPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  101 bits (253), Expect = 2e-24
 Identities = 70/226 (30%), Positives = 101/226 (44%), Gaps = 28/226 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           IG+G FG V   +V+           D+K   A+K +N+Q        +  +NE   L  
Sbjct: 8   IGKGAFGKVC--IVQK---------RDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQE 56

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + HP LV L  + +  DE  M   LV +L+    L  HL  +V        +  I +   
Sbjct: 57  LNHPFLVNL--WYSFQDEENM--YLVVDLLLGGDLRYHLSQKVKFSEE-QVKFWICE-IV 110

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
             L YLH +    +I RD K  NILLDE     ++DF +A +  P+ L   +TS  GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPG 164

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE--RNLPRNEQ 315
           Y APE +     +   D WS GV  YE + G+R         R++ 
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQI 210

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  101 bits (254), Expect = 2e-24
 Identities = 79/282 (28%), Positives = 126/282 (44%), Gaps = 43/282 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLGVVK 153
           +G+G  G VY+         H+ +G   K+  A+K+++  G +  ++ +  E+  L   +
Sbjct: 9   LGQGSSGVVYKVR-------HKPTG---KI-YALKKIHVDGDEEFRKQLLRELKTLRSCE 57

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT----PLAWIARLKIAQD 209
            P +VK   Y A   E  +   +V E M   SL D LL +V       LA+IAR +I + 
Sbjct: 58  SPYVVKC--YGAFYKEGEIS--IVLEYMDGGSLAD-LLKKVGKIPEPVLAYIAR-QILK- 110

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
              GL YLH      +I RD K SN+L++   + K++DFG+++            + VGT
Sbjct: 111 ---GLDYLHT--KRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGT 163

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
           V Y +PE +Q    +  +D+WS G+ L E   G+      LP  +    E ++       
Sbjct: 164 VTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPF---LPPGQPSFFELMQAICDGPP 220

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
                  P L        + +     S CL K PK RP  +E
Sbjct: 221 -------PSLPAEEF---SPEFRDFISACLQKDPKKRPSAAE 252

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  100 bits (251), Expect = 5e-24
 Identities = 91/299 (30%), Positives = 135/299 (45%), Gaps = 43/299 (14%)

Query: 93  LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGV 151
             +G G FG VY G    +      SG    + VA+K L +    Q  KE++ E + +  
Sbjct: 1   NFLGSGAFGEVYEG--TATDILGPGSG---PIRVAVKTLRKGATDQEKKEFLKEAHLMSN 55

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL----LSRVPTPLAWIARL-KI 206
             HPN+VKL+G C  ++ +     ++ ELM    L  +L    + R   PL  +  L  I
Sbjct: 56  FNHPNIVKLLGVCLLNEPQ----YIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDI 111

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKA----KLSDFGLARQGPPEGLGH 261
             D A+G  YL E+M F  I RD    N L+ E  Y A    K+ DFGLAR         
Sbjct: 112 CLDVAKGCVYL-EQMHF--IHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEW 320
                +  V + APE +  G+ T +SDVWSFGV+++E++T G++        N Q++L+ 
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYP---ALNNQEVLQH 225

Query: 321 VRPYVSDSKKFHLIIDPRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN 378
           V                RL+    C     K+  L + C  + P  RP    + +IL N
Sbjct: 226 VTA------------GGRLQKPENC---PDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  100 bits (251), Expect = 6e-24
 Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 26/220 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVK 153
           +GEG FG V+ G       +      + K  VA+K L         K++  E   L   +
Sbjct: 13  LGEGAFGKVFLGECYHLEPE------NDKELVAVKTLKETASNDARKDFEREAELLTNFQ 66

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP------------TPLAWI 201
           H N+VK  G C E D      ++V+E M +  L   L S  P              L   
Sbjct: 67  HENIVKFYGVCTEGD----PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLS 122

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L+IA   A G+ YL  +     + RD  T N L+  D   K+ DFG++R         
Sbjct: 123 QLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYR 179

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           V    +  + +  PE +   + T +SDVWSFGVVL+E+ T
Sbjct: 180 VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  100 bits (250), Expect = 6e-24
 Identities = 65/209 (31%), Positives = 100/209 (47%), Gaps = 25/209 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G+ +            +++ VAIK L        +++  EV  L  ++H
Sbjct: 14  LGSGYFGEVWEGLWK------------NRVRVAIKILKSDDLLKQQDFQKEVQALKRLRH 61

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            +L+ L   C+  +       ++ ELM   SL   L S     L   + + +A   A G+
Sbjct: 62  KHLISLFAVCSVGEPV----YIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVSTSVVGTVGY 272
           AYL E+     I RD    NIL+ ED   K++DFGLAR  +       ++S+       +
Sbjct: 118 AYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV----YLSSDKKIPYKW 170

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            APE    G  + KSDVWSFG++LYE+ T
Sbjct: 171 TAPEAASHGTFSTKSDVWSFGILLYEMFT 199

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =   99 bits (250), Expect = 1e-23
 Identities = 65/240 (27%), Positives = 98/240 (40%), Gaps = 58/240 (24%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGH----KEWIN 144
           +IGEG F  V     + ++            + AIK     QL ++    +    KE + 
Sbjct: 8   IIGEGSFSTVVLAKEKETN-----------KEYAIKILDKRQLIKEKKVKYVKIEKEVLT 56

Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            +N      HP ++KL  Y  +D+E     L  V E   N  L  ++            R
Sbjct: 57  RLN-----GHPGIIKLY-YTFQDEEN----LYFVLEYAPNGELLQYIRKYGSLDEKCT-R 105

Query: 204 LKIAQ--DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ----GPPE 257
              A+   A   L YLH      +I RD K  NILLD+D   K++DFG A+       PE
Sbjct: 106 FYAAEILLA---LEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159

Query: 258 GLGHVST--------------SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                +T              S VGT  Y +PE +        SD+W+ G ++Y+++TG+
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 99.1 bits (247), Expect = 2e-23
 Identities = 69/234 (29%), Positives = 102/234 (43%), Gaps = 31/234 (13%)

Query: 81  ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGH 139
              SA R F   L  GEG FG VY+G +         +   S   VAIK L      +  
Sbjct: 2   IPLSAVR-FLEEL--GEGAFGKVYKGEL------TGPNERLSATSVAIKTLKENAEPKVQ 52

Query: 140 KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--- 196
           +E+  E   +  ++HPN+V L+G C ++    M    ++E + +  L + L+   P    
Sbjct: 53  QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCM----LFEYLAHGDLHEFLVRNSPHSDV 108

Query: 197 -----------PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
                       L     L IA   A G+ YL        + RD    N L+ E    K+
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKI 165

Query: 246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           SDFGL+R         V +  +  V +  PE +  G+ T +SD+WSFGVVL+E+
Sbjct: 166 SDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 98.6 bits (246), Expect = 2e-23
 Identities = 68/229 (29%), Positives = 100/229 (43%), Gaps = 51/229 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           IG G FG VY  V   + D  +         +A+K++  Q       KE  +E+  L ++
Sbjct: 8   IGGGTFGKVYTAV---NLDTGEL--------MAVKEIRIQDNDPKTIKEIADEMKVLELL 56

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVY----------ELMHNKSLEDHLLSRVPTPLAWIA 202
           KHPNLVK  G     ++     + ++          EL+ +  + D  + RV T      
Sbjct: 57  KHPNLVKYYGVEVHREK-----VYIFMEYCSGGTLEELLEHGRILDEHVIRVYT------ 105

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG----LARQGPPEG 258
            L++      GLAYLH      ++ RD K +NI LD +   KL DFG    L       G
Sbjct: 106 -LQLL----EGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAK---SDVWSFGVVLYELITGRR 304
               S    GT  Y APE +  G+       +D+WS G V+ E+ TG+R
Sbjct: 158 EEVQSL--AGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 98.7 bits (246), Expect = 3e-23
 Identities = 67/235 (28%), Positives = 102/235 (43%), Gaps = 23/235 (9%)

Query: 139 HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
            K+ + E+      K P +VK  G   ++    +   +  E     SL D +  +V    
Sbjct: 43  QKQILRELEINKSCKSPYIVKYYGAFLDESSSSIG--IAMEYCEGGSL-DSIYKKVKKRG 99

Query: 199 AWIAR---LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP 255
             I      KIA+   +GL+YLH     ++I RD K SNILL    + KL DFG++    
Sbjct: 100 GRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVS---- 152

Query: 256 PEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ 315
            E +  ++ +  GT  Y APE +Q    +  SDVWS G+ L E+   R       P  E 
Sbjct: 153 GELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFP---PEGEP 209

Query: 316 KL--LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
            L  +E +  Y+ +     L  +P       IK +++      +CL K P  RP 
Sbjct: 210 PLGPIELLS-YIVNMPNPELKDEPGNG----IKWSEEFKDFIKQCLEKDPTRRPT 259

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 97.8 bits (244), Expect = 4e-23
 Identities = 80/283 (28%), Positives = 119/283 (42%), Gaps = 44/283 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G G  G V +  V      H+ +G      +A+K +  +      K+ + E++ L    
Sbjct: 9   LGAGNSGVVSK--VL-----HRPTGKI----MAVKTIRLEINEAIQKQILRELDILHKCN 57

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAA 211
            P +V   G    + +  +      E M   SL D +L  V    P   +   KIA    
Sbjct: 58  SPYIVGFYGAFYNNGDISI----CMEYMDGGSL-DKILKEVQGRIPERILG--KIAVAVL 110

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           +GL YLHE    ++I RD K SNIL++   + KL DFG++ Q     +  ++ + VGT  
Sbjct: 111 KGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQL----VNSLAKTFVGTSS 164

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           Y APE +Q    + KSD+WS G+ L EL TGR       P           P     +  
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGR------FP-----YPPENDPPDGIFELL 213

Query: 332 HLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
             I++   PRL         Q      + CL K P+ RP   E
Sbjct: 214 QYIVNEPPPRLPSGKFSPDFQD---FVNLCLIKDPRERPSYKE 253

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 97.5 bits (243), Expect = 5e-23
 Identities = 91/299 (30%), Positives = 135/299 (45%), Gaps = 48/299 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVV 152
           +IG+G FGCVY G + + SD         K+  A+K LNR    +  ++++ E   +   
Sbjct: 2   VIGKGHFGCVYHGTL-IDSDGQ-------KIHCAVKSLNRITDLEEVEQFLKEGIIMKDF 53

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDA 210
            HPN++ L+G C   +  G   L+V   M +  L + + S    PT    I         
Sbjct: 54  SHPNVLSLLGICLPSE--GSP-LVVLPYMKHGDLRNFIRSETHNPTVKDLIG---FGLQV 107

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HVSTSVVG 268
           A+G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H  T    
Sbjct: 108 AKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
            V + A E +QT + T KSDVWSFGV+L+EL+T      R  P           PY  D 
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMT------RGAP-----------PY-PDV 206

Query: 329 KKF---HLIIDPR--LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
             F     ++  R  L+  YC      L  +   C   +P+ RP  SE+V  +  I S 
Sbjct: 207 DSFDITVYLLQGRRLLQPEYCPDP---LYEVMLSCWHPKPEMRPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 97.6 bits (243), Expect = 5e-23
 Identities = 85/301 (28%), Positives = 133/301 (44%), Gaps = 47/301 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGV 151
           ++GEG FG V  G  ++S DD       S+L VA+K +          +E+++E   +  
Sbjct: 6   ILGEGEFGSVMEG--QLSQDD------GSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKD 57

Query: 152 VKHPNLVKLVGYC--AEDDERGMQRLLVYELMHNKSLEDHLL-SRV---PTPLAWIARLK 205
             HPN++KL+G C  A   ++  + +++   M +  L   LL SR+   P  L     LK
Sbjct: 58  FDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK 117

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---GPPEGLGHV 262
              D A G+ YL        I RD    N +L ED    ++DFGL+++   G     G +
Sbjct: 118 FMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRI 174

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
           +      V + A E +     T+KSDVW+FGV ++E+ T          R +        
Sbjct: 175 AKM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT----------RGQT------- 214

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQ---KLAALASKCLTKQPKSRPKMSEVVDILGNI 379
           PY       H I D    GN   +      +L  L   C    PK RP  +++ ++L NI
Sbjct: 215 PYPGVEN--HEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272

Query: 380 I 380
           +
Sbjct: 273 L 273

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 97.3 bits (243), Expect = 6e-23
 Identities = 79/307 (25%), Positives = 122/307 (39%), Gaps = 71/307 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK--EWINEVNFLGVV 152
           IG+G FG V + V R S         D K+ +  K+++       +  + ++EVN L  +
Sbjct: 8   IGKGSFGTVRK-VRRKS---------DGKI-LVWKEIDYGNMTEKEKQQLVSEVNILREL 56

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMH-----------NKSLEDHLLSRVPTPLAWI 201
           KHPN+V+   Y     +R  Q L  Y +M             K  ++     +     W 
Sbjct: 57  KHPNIVR---YYDRIIDRSNQTL--YIVMEYCEGGDLAQLIQKCKKER--KYIEEEFIW- 108

Query: 202 ARLKIAQDAARGLAYLH--EEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +I       L   H   +    ++ RD K +NI LD +   KL DFGLA+      L
Sbjct: 109 ---RILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI-----L 160

Query: 260 GHVS---TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR---RAVERNLPRN 313
           GH S    + VGT  Y +PE +       KSD+WS G ++YEL        A      RN
Sbjct: 161 GHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTA------RN 214

Query: 314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
           + +L   ++       KF      R+   Y    + +L  +    L   P  RP      
Sbjct: 215 QLQLASKIK-----EGKF-----RRIPYRY----SSELNEVIKSMLNVDPDKRP---STE 257

Query: 374 DILGNII 380
           ++L   +
Sbjct: 258 ELLQLPL 264

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 67/232 (28%), Positives = 104/232 (44%), Gaps = 42/232 (18%)

Query: 95  IGEGGFGCVYR----GVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFL 149
           IG+G FG V++    G++     +  T        VA+K L  +       ++  E   +
Sbjct: 13  IGQGAFGRVFQARAPGLL---PYEPFTM-------VAVKMLKEEASADMQADFQREAALM 62

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT------------- 196
               HPN+VKL+G CA     G    L++E M    L + L  R P              
Sbjct: 63  AEFDHPNIVKLLGVCAV----GKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 197 -------PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG 249
                  PL+   +L IA+  A G+AYL E    + + RD  T N L+ E+   K++DFG
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFG 175

Query: 250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           L+R          S +    + +  PE +   R T +SDVW++GVVL+E+ +
Sbjct: 176 LSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 95.8 bits (238), Expect = 1e-22
 Identities = 84/288 (29%), Positives = 133/288 (46%), Gaps = 54/288 (18%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           L+G+G FG V++G ++             K  VA+K       Q  K ++++E   L   
Sbjct: 2   LLGKGNFGEVFKGTLK------------DKTPVAVKTCKEDLPQELKIKFLSEARILKQY 49

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDA 210
            HPN+VKL+G C        QR  +Y +M      D L  L +    L     +K A DA
Sbjct: 50  DHPNIVKLIGVCT-------QRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDA 102

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
           A G+AYL  +     I RD    N L+ E+   K+SDFG++RQ   E  G  S+S +  +
Sbjct: 103 AAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQ---EDDGIYSSSGLKQI 156

Query: 271 --GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
              + APE +  GR +++SDVWS+G++L+E  +                   V PY   +
Sbjct: 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFS-----------------LGVCPYPGMT 199

Query: 329 KKFHLIIDPRLEGNYCIKSAQK----LAALASKCLTKQPKSRPKMSEV 372
            +       ++E  Y +   QK    +  +  +C   +P++RPK SE+
Sbjct: 200 NQ---QAREQVEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 95.1 bits (237), Expect = 4e-22
 Identities = 82/259 (31%), Positives = 106/259 (40%), Gaps = 40/259 (15%)

Query: 126 VAIKQLNRQGFQGH-KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNK 184
           VAIK+++ +  Q    E   EV  +    HPN+VK        DE      LV   +   
Sbjct: 29  VAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL----WLVMPYLSGG 84

Query: 185 SLEDHLLSRVPT---PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY 241
           SL D + S  P      A IA   + ++  +GL YLH       I RD K  NILL ED 
Sbjct: 85  SLLDIMKSSYPRGGLDEAIIA--TVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDG 139

Query: 242 KAKLSDFG----LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVL 296
             K++DFG    LA  G  +    V  + VGT  + APE ++       K+D+WSFG+  
Sbjct: 140 SVKIADFGVSASLADGG--DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITA 197

Query: 297 YELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIID---PRLEGNYCIKSAQKL-A 352
            EL TG  A     P           P     K   L +    P LE     K   K   
Sbjct: 198 IELATG-AAPYSKYP-----------P----MKVLMLTLQNDPPSLETGADYKKYSKSFR 241

Query: 353 ALASKCLTKQPKSRPKMSE 371
            + S CL K P  RP   E
Sbjct: 242 KMISLCLQKDPSKRPTAEE 260

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 94.7 bits (236), Expect = 5e-22
 Identities = 82/296 (27%), Positives = 116/296 (39%), Gaps = 77/296 (26%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G +G VY+     + +            VAIK +  +     +    E++ L   +H
Sbjct: 11  IGSGTYGDVYKARDIATGEL-----------VAIKVIKLEPGDDFEIIQQEISMLKECRH 59

Query: 155 PNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIA---QDA 210
           PN+V   G           +L +V E     SL+D +      PL+    L+IA   ++ 
Sbjct: 60  PNIVAYFG-----SYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPLS---ELQIAYVCRET 110

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS---TSVV 267
            +GLAYLHE      I RD K +NILL ED   KL+DFG++ Q     L        S +
Sbjct: 111 LKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ-----LTATIAKRKSFI 162

Query: 268 GTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITG---------RRAVERNLPRNEQ 315
           GT  + APE       G    K D+W+ G+   EL             RA+   + ++  
Sbjct: 163 GTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFL-ISKSNF 221

Query: 316 KLLEWVRPYVSD----SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
                  P + D    S  FH  I                     KCLTK PK RP
Sbjct: 222 P-----PPKLKDKEKWSPVFHDFI--------------------KKCLTKDPKKRP 252

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 95.5 bits (237), Expect = 6e-22
 Identities = 89/287 (31%), Positives = 127/287 (44%), Gaps = 52/287 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLGV 151
           IG G FG VY            T+ H +++ VA+K+++  G Q +++W   I EV FL  
Sbjct: 29  IGHGSFGAVY----------FATNSHTNEV-VAVKKMSYSGKQTNEKWQDIIKEVKFLQQ 77

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           +KHPN ++  G C   +       LV E     + +  LL     PL  +    I   A 
Sbjct: 78  LKHPNTIEYKG-CYLKEHTAW---LVMEYCLGSASD--LLEVHKKPLQEVEIAAITHGAL 131

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           +GLAYLH      +I RD K  NILL E  + KL+DFG A +  P      + S VGT  
Sbjct: 132 QGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPY 182

Query: 272 YAAPEYV---QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
           + APE +     G+   K DVWS G+   EL       ER  P      +         S
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAM---------S 227

Query: 329 KKFHLIID--PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
             +H+  +  P L+ N    S +        CL K P+ RP  +E++
Sbjct: 228 ALYHIAQNDSPTLQSNEWTDSFRG---FVDYCLQKIPQERPASAELL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 94.6 bits (236), Expect = 7e-22
 Identities = 83/297 (27%), Positives = 120/297 (40%), Gaps = 66/297 (22%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F+    IG+G FG VY+ + + ++             VAIK ++ +  +   E I  E+ 
Sbjct: 3   FTLLECIGKGSFGEVYKAIDKRTNQV-----------VAIKVIDLEEAEDEIEDIQQEIQ 51

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
           FL   + P + K  G   +    G +  ++ E     S  D LL        +IA   I 
Sbjct: 52  FLSQCRSPYITKYYGSFLK----GSKLWIIMEYCGGGSCLD-LLKPGKLDETYIA--FIL 104

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST--- 264
           ++   GL YLHEE     I RD K +NILL E+   KL+DFG++ Q     L    +   
Sbjct: 105 REVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQ-----LTSTMSKRN 156

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR---------RAVERNLPRNEQ 315
           + VGT  + APE ++      K+D+WS G+   EL  G          R +   +P+N  
Sbjct: 157 TFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVL-FLIPKNNP 215

Query: 316 KLLEWVRPYVSDS-KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
             LE      S   K F                        S CL K PK RP   E
Sbjct: 216 PSLE--GNKFSKPFKDF-----------------------VSLCLNKDPKERPSAKE 247

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 94.3 bits (234), Expect = 1e-21
 Identities = 66/233 (28%), Positives = 112/233 (48%), Gaps = 34/233 (14%)

Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NR 133
           R+    EL+       +  L+G G FG V++G+           G   K+ VAIK + +R
Sbjct: 2   RILKETELR-------KLKLLGSGVFGTVHKGI-------WIPEGDSIKIPVAIKTIQDR 47

Query: 134 QGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
            G Q  +E  + +  +G + H  +V+L+G C      G    LV +L    SL DH+   
Sbjct: 48  SGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-----GASLQLVTQLSPLGSLLDHVRQH 102

Query: 194 VPT--P---LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF 248
             +  P   L W  ++      A+G+ YL E    +++ R+    NILL  D   +++DF
Sbjct: 103 RDSLDPQRLLNWCVQI------AKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADF 153

Query: 249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           G+A    P+   +  +     + + A E +  GR T +SDVWS+GV ++E+++
Sbjct: 154 GVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 64/210 (30%), Positives = 103/210 (49%), Gaps = 26/210 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +          +   L VA+K L     +   E++ E   +  +KH
Sbjct: 14  LGGGQYGEVYEGVWK---------KYS--LTVAVKTLKEDTMEVE-EFLKEAAVMKEIKH 61

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 62  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 117

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL E+ +F  I RD    N L+ E++  K++DFGL+R       G   T+  G    + 
Sbjct: 118 EYL-EKKNF--IHRDLAARNCLVGENHLVKVADFGLSRLMT----GDTYTAHAGAKFPIK 170

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           + APE +   + + KSDVW+FGV+L+E+ T
Sbjct: 171 WTAPESLAYNKFSIKSDVWAFGVLLWEIAT 200

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 93.0 bits (231), Expect = 2e-21
 Identities = 81/287 (28%), Positives = 133/287 (46%), Gaps = 54/287 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 12  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMKLSH 58

Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDA 210
             LV+L G C +      QR   +V E M N  L ++L    +   P      L++ +D 
Sbjct: 59  EKLVQLYGVCTK------QRPIYIVTEYMSNGCLLNYLREHGKRFQP---SQLLEMCKDV 109

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT- 269
             G+AYL  +   Q I RD    N L+D+    K+SDFGL+R      L    TS VG+ 
Sbjct: 110 CEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYV----LDDEYTSSVGSK 162

Query: 270 --VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVS 326
             V ++ PE +   + ++KSDVW+FGV+++E+ + G+   ER    N  + +E V     
Sbjct: 163 FPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYER---FNNSETVEKV----- 214

Query: 327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
              +   +  P L       +++K+ A+   C  ++ + RP   +++
Sbjct: 215 --SQGLRLYRPHL-------ASEKVYAIMYSCWHEKAEERPTFQQLL 252

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 94.0 bits (233), Expect = 2e-21
 Identities = 97/321 (30%), Positives = 134/321 (41%), Gaps = 61/321 (19%)

Query: 67  SQRRANDLRVFSFAEL---KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSK 123
           S  RA  L+    AEL   +   + F+    IG G FG VY                D +
Sbjct: 2   STSRAGSLKDPEIAELFFKEDPEKLFTDLREIGHGSFGAVY-------------FARDVR 48

Query: 124 LD--VAIKQLNRQGFQGHKEW---INEVNFLGVVKHPNLVKLVG-YCAEDDERGMQRLLV 177
            +  VAIK+++  G Q +++W   I EV FL  +KHPN ++  G Y  E         LV
Sbjct: 49  TNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTA-----WLV 103

Query: 178 YELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL 237
            E     + +  LL     PL  +    I   A +GLAYLH      +I RD K  NILL
Sbjct: 104 MEYCLGSASD--LLEVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILL 158

Query: 238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV---QTGRLTAKSDVWSFGV 294
            E  + KL+DFG A    P      + S VGT  + APE +     G+   K DVWS G+
Sbjct: 159 TEPGQVKLADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 212

Query: 295 VLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIID--PRLEGNYCIKSAQKLA 352
              EL       ER  P      +         S  +H+  +  P L+ N   + +    
Sbjct: 213 TCIEL------AERKPPLFNMNAM---------SALYHIAQNESPTLQSN---EWSDYFR 254

Query: 353 ALASKCLTKQPKSRPKMSEVV 373
                CL K P+ RP   E++
Sbjct: 255 NFVDSCLQKIPQDRPTSEELL 275

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 91.9 bits (228), Expect = 4e-21
 Identities = 71/222 (31%), Positives = 110/222 (49%), Gaps = 28/222 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG FG V +G         + +G    +      +  Q F      + E   +  + H
Sbjct: 14  IGEGEFGAVLQG---------EYTGQKVAVKNIKCDVTAQAF------LEETAVMTKLHH 58

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G    +   G+   +V ELM   +L + L +R    ++ I  L+ + D A G+
Sbjct: 59  KNLVRLLGVILHN---GLY--IVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM 113

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
            YL  +   +L+ RD    NIL+ ED  AK+SDFGLAR G       V  S +  V + A
Sbjct: 114 EYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----VDNSKL-PVKWTA 165

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
           PE ++  + ++KSDVWS+GV+L+E+ +  RA    +   E K
Sbjct: 166 PEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVK 207

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 76/302 (25%), Positives = 119/302 (39%), Gaps = 94/302 (31%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +GEG +G VY+ +       H+ +G      VAIK +  +     +E I E++ L    
Sbjct: 10  KLGEGSYGSVYKAI-------HKETGQ----VVAIKVVPVEE--DLQEIIKEISILKQCD 56

Query: 154 HPNLVKLVG-------------YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
            P +VK  G             YC       + ++       NK+L +  ++        
Sbjct: 57  SPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKIT------NKTLTEEEIA-------- 102

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
                I     +GL YLH     + I RD K  NILL+E+ +AKL+DFG++ Q     L 
Sbjct: 103 ----AILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQ-----LT 150

Query: 261 HV---STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR---------RA--- 305
                  +V+GT  + APE +Q      K+D+WS G+   E+  G+         RA   
Sbjct: 151 DTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFM 210

Query: 306 VERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS 365
           +    P           P +SD +K+                + +      KCL K P+ 
Sbjct: 211 IPNKPP-----------PTLSDPEKW----------------SPEFNDFVKKCLVKDPEE 243

Query: 366 RP 367
           RP
Sbjct: 244 RP 245

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 92.5 bits (230), Expect = 5e-21
 Identities = 71/226 (31%), Positives = 100/226 (44%), Gaps = 26/226 (11%)

Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKE 141
            S T    RAL  G G FG VY G+ R         G   +L VA+K L      Q   +
Sbjct: 6   DSITLL--RAL--GHGAFGEVYEGLYR------GRDGDAVELQVAVKTLPESCSEQDESD 55

Query: 142 WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL-LSRV----PT 196
           ++ E   +    H N+V+L+G   E     + R ++ ELM    L+  L  +R     P+
Sbjct: 56  FLMEALIMSKFNHQNIVRLIGVSFER----LPRFILLELMAGGDLKSFLRENRPRPERPS 111

Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQ 253
            L     L  A+D A+G  YL E      I RD    N LL        AK++DFG+AR 
Sbjct: 112 SLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
                        +  + +  PE    G  T+K+DVWSFGV+L+E+
Sbjct: 169 IYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 95.7 bits (238), Expect = 6e-21
 Identities = 70/246 (28%), Positives = 116/246 (47%), Gaps = 24/246 (9%)

Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
           +E+  +G ++HPN+VKL+G C  +        L++E +  K+L + L +     L+W  R
Sbjct: 732 SEIADMGKLQHPNIVKLIGLCRSEKGA----YLIHEYIEGKNLSEVLRN-----LSWERR 782

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
            KIA   A+ L +LH      ++  +     I++D   +  L      R   P GL    
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL------RLSLP-GLLCTD 835

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
           T    +  Y APE  +T  +T KSD++ FG++L EL+TG+   +     +   ++EW R 
Sbjct: 836 TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGS-IVEWARY 894

Query: 324 YVSDSKKFHL--IIDPRLEGNYCIKSAQKLAA--LASKCLTKQPKSRPKMSEVVDILGNI 379
             SD    HL   IDP + G+  +   + +    LA  C    P +RP  ++V+  L + 
Sbjct: 895 CYSDC---HLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESA 951

Query: 380 ISEISS 385
               SS
Sbjct: 952 SRSSSS 957

Length = 968

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 91.1 bits (226), Expect = 1e-20
 Identities = 80/294 (27%), Positives = 127/294 (43%), Gaps = 62/294 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G             ++    VAIK L +QG    + ++ E N +  ++H
Sbjct: 14  LGAGQFGEVWMGY------------YNGHTKVAIKSL-KQGSMSPEAFLAEANLMKQLQH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L     ++        ++ E M N SL D L +     L     + +A   A G+
Sbjct: 61  PRLVRLYAVVTQE-----PIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM 115

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           A++ E  ++  I RD + +NIL+ E    K++DFGLAR           T+  G    + 
Sbjct: 116 AFI-ERKNY--IHRDLRAANILVSETLCCKIADFGLARLIEDNEY----TAREGAKFPIK 168

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR---------AVERNLPRNEQKLLEWVR 322
           + APE +  G  T KSDVWSFG++L E++T  R          V +NL R  +       
Sbjct: 169 WTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRM------ 222

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
                         PR +   C    ++L  L   C  ++P+ RP    +  +L
Sbjct: 223 --------------PRPDN--C---PEELYELMRLCWKEKPEERPTFEYLRSVL 257

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.3 bits (226), Expect = 1e-20
 Identities = 68/231 (29%), Positives = 101/231 (43%), Gaps = 24/231 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ +       K+ VA+K L        K++  E   L  ++H
Sbjct: 13  LGEGAFGKVFL------AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH 66

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMH----NKSLEDHLLSRV-------PTPLAWIAR 203
            ++VK  G C E D      ++V+E M     NK L  H    V       P  L     
Sbjct: 67  EHIVKFYGVCVEGDPL----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQM 122

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
           L IAQ  A G+ YL  +     + RD  T N L+ E+   K+ DFG++R         V 
Sbjct: 123 LHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 179

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
              +  + +  PE +   + T +SDVWS GVVL+E+ T  +     L  NE
Sbjct: 180 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 230

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 90.9 bits (226), Expect = 1e-20
 Identities = 79/298 (26%), Positives = 118/298 (39%), Gaps = 57/298 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           IGEG +G VY+   +            +   VAIK++ +  F    E I      E+  L
Sbjct: 7   IGEGTYGVVYKARDK-----------LTGEIVAIKKI-KLRF--ESEGIPKTALREIKLL 52

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLK-IA 207
             + HPN++KL+     D  R    L LV+E M        L+      L   + +K   
Sbjct: 53  KELNHPNIIKLL-----DVFRHKGDLYLVFEFMDTDLY--KLIKDRQRGLP-ESLIKSYL 104

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSV 266
               +GLA+ H      ++ RD K  N+L++ +   KL+DFGLAR  G P       T  
Sbjct: 105 YQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRP---YTHY 158

Query: 267 VGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGR------------RAVERNL--- 310
           V T  Y APE +   +  +   D+WS G +  EL++ R              + R L   
Sbjct: 159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP 218

Query: 311 -PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
            P    K     R Y     K   +  P+L  N    ++ +   L S+ L   P  R 
Sbjct: 219 DPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPN----ASPQALDLLSQMLHYDPHKRI 272

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 89.9 bits (223), Expect = 2e-20
 Identities = 83/288 (28%), Positives = 129/288 (44%), Gaps = 48/288 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G  R            +++ VAIK +N +G    +++I E   +  + H
Sbjct: 12  LGSGQFGVVHLGKWR------------AQIKVAIKAIN-EGAMSEEDFIEEAKVMMKLSH 58

Query: 155 PNLVKLVGYCAEDDERGMQRLL--VYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           P LV+L G C +      Q+ L  V E M N  L ++L  R    L+    L + QD   
Sbjct: 59  PKLVQLYGVCTQ------QKPLYIVTEFMENGCLLNYLRQR-QGKLSKDMLLSMCQDVCE 111

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--- 269
           G+ YL E   F  I RD    N L+      K+SDFG+ R      L    TS  G    
Sbjct: 112 GMEYL-ERNSF--IHRDLAARNCLVSSTGVVKVSDFGMTRYV----LDDEYTSSSGAKFP 164

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
           V ++ PE     + ++KSDVWSFGV+++E+ T     E  +P  ++   E V      S+
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFT-----EGKMPFEKKSNYEVVEMI---SR 216

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG 377
            F L   P+L      +       +   C  ++P+ RP  +E++  + 
Sbjct: 217 GFRL-YRPKLASMTVYE-------VMYSCWHEKPEGRPTFAELLRAIT 256

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 90.9 bits (226), Expect = 2e-20
 Identities = 81/299 (27%), Positives = 130/299 (43%), Gaps = 34/299 (11%)

Query: 95  IGEGGFGCVY----RGVVRVSSDDHQTSG-HDSKLDVAIKQLNRQGFQGH--KEWINEVN 147
           +GEG FG V+     G+   S      +   D+ + VA+K L R     +  ++++ EV 
Sbjct: 13  LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVL-RPDASDNAREDFLKEVK 71

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK-- 205
            L  +  PN+ +L+G C  D    M    + E M N  L   L   V          K  
Sbjct: 72  ILSRLSDPNIARLLGVCTVDPPLCM----IMEYMENGDLNQFLQKHVAETSGLACNSKSL 127

Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                  +A   A G+ YL E ++F  + RD  T N L+ ++Y  K++DFG++R      
Sbjct: 128 SFSTLLYMATQIASGMRYL-ESLNF--VHRDLATRNCLVGKNYTIKIADFGMSRNLYSSD 184

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKL 317
              V       + + A E V  G+ T KSDVW+FGV L+E++T  R     +L  ++Q +
Sbjct: 185 YYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT-DQQVI 243

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
                 +  D ++ +L   PR     C K    +  L  +C  +  + RP   E+   L
Sbjct: 244 ENAGHFFRDDGRQIYL---PRPPN--CPKD---IYELMLECWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 90.2 bits (225), Expect = 2e-20
 Identities = 71/221 (32%), Positives = 104/221 (47%), Gaps = 43/221 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL----NRQGFQGHKEWINEVNFLG 150
           +GEG +G VY+          + +G      VA+K++      +G       + E++ L 
Sbjct: 7   LGEGTYGVVYKAR-------DKKTGEI----VALKKIRLDNEEEGIP--STALREISLLK 53

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK-IAQD 209
            +KHPN+VKL+     +     +  LV+E   +  L+   L + P PL+    +K I   
Sbjct: 54  ELKHPNIVKLLDVIHTER----KLYLVFEYC-DMDLK-KYLDKRPGPLS-PNLIKSIMYQ 106

Query: 210 AARGLAYLHEEMDFQLIF-RDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVV 267
             RGLAY H       I  RD K  NIL++ D   KL+DFGLAR  G P       T  V
Sbjct: 107 LLRGLAYCHS----HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL---RTYTHEV 159

Query: 268 GTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITGR 303
            T+ Y APE +    L +K      D+WS G +  E+ITG+
Sbjct: 160 VTLWYRAPEIL----LGSKHYSTAVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 90.4 bits (224), Expect = 3e-20
 Identities = 78/294 (26%), Positives = 132/294 (44%), Gaps = 44/294 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 14  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 67

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--------PLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 68  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 123

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           +A + A G+AYL+ +   + + RD    N ++  D+  K+ DFG+ R             
Sbjct: 124 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 180

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            +  V + APE ++ G  T  SD+WSFGVVL+E+ +      + L  NEQ L        
Sbjct: 181 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVL-------- 231

Query: 326 SDSKKFHLIIDPRLEGNYCIKS---AQKLAALASKCLTKQPKSRPKMSEVVDIL 376
               KF       ++G Y  +     +++  L   C    PK RP   E+V++L
Sbjct: 232 ----KF------VMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLL 275

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 90.1 bits (224), Expect = 3e-20
 Identities = 81/307 (26%), Positives = 109/307 (35%), Gaps = 70/307 (22%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-------HKEWINEV 146
           ++GEG +G V +   + + +            VAIK      F+         K  + EV
Sbjct: 8   VVGEGAYGVVLKCRNKATGEI-----------VAIK-----KFKESEDDEDVKKTALREV 51

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPL-AWIARL 204
             L  ++H N+V L             RL LV+E +    LE  LL   P  L     R 
Sbjct: 52  KVLRQLRHENIVNLKEAFRRKG-----RLYLVFEYVERTLLE--LLEASPGGLPPDAVRS 104

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
            I Q   + +AY H      +I RD K  NIL+ E    KL DFG AR           T
Sbjct: 105 YIWQ-LLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARA-LRARPASPLT 159

Query: 265 SVVGTVGYAAPE----YVQTGRLTAKSDVWSFGVVLYELITGR---------------RA 305
             V T  Y APE        G      DVW+ G ++ EL+ G                + 
Sbjct: 160 DYVATRWYRAPELLVGDTNYG---KPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQK 216

Query: 306 VERNLPRNEQKLLEWVRPYVSDSK----KFHLIIDPR-LEGNYCIKSAQKLAALASKCLT 360
               LP + Q+L        S+ +     F     P  LE  Y  K +         CL 
Sbjct: 217 CLGPLPPSHQELFS------SNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLR 270

Query: 361 KQPKSRP 367
             PK R 
Sbjct: 271 MDPKERL 277

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 89.3 bits (221), Expect = 5e-20
 Identities = 80/293 (27%), Positives = 130/293 (44%), Gaps = 46/293 (15%)

Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY G+ + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 66

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 67  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMI 122

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 123 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 179

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY 324
             +  V + +PE ++ G  T  SDVWSFGVVL+E+ T      + +  NEQ +L +V   
Sbjct: 180 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM-SNEQ-VLRFV--- 234

Query: 325 VSDSKKFHLIIDPRLEGNYCIKS---AQKLAALASKCLTKQPKSRPKMSEVVD 374
                         +EG    K       L  L   C    PK RP   E++ 
Sbjct: 235 --------------MEGGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS 273

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 89.0 bits (221), Expect = 5e-20
 Identities = 75/288 (26%), Positives = 129/288 (44%), Gaps = 51/288 (17%)

Query: 95  IGEGGFG--CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN--RQGFQGHKEWINEVNFLG 150
           +G+G FG   +YR     + DD           V  K++N  R   +  ++ +NE+  L 
Sbjct: 8   LGKGAFGEATLYRR----TEDDSL---------VVWKEVNLTRLSEKERRDALNEIVILS 54

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLV-YELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           +++HPN++    +  +D       LL+  E  +  +L D ++ +          L     
Sbjct: 55  LLQHPNIIAYYNHFMDD-----NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQ 109

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
               ++Y+H+     ++ RD KT NI L +    KL DFG+++    E     + +VVGT
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSM--AETVVGT 164

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
             Y +PE  Q  +   KSD+W+ G VLYEL+T +R  +   P N                
Sbjct: 165 PYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLN---------------- 208

Query: 330 KFHLIIDPRLEGNYC-IKS--AQKLAALASKCLTKQPKSRPKMSEVVD 374
               ++   ++GNY  + S  + +L +L    L + P+ RP   EV+D
Sbjct: 209 ----LVVKIVQGNYTPVVSVYSSELISLVHSLLQQDPEKRPTADEVLD 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 89.2 bits (221), Expect = 6e-20
 Identities = 80/295 (27%), Positives = 135/295 (45%), Gaps = 44/295 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGV 151
           +IG G FG V RG +++               VAIK L + G+     +++++E + +G 
Sbjct: 11  VIGAGEFGEVCRGRLKLPGKREIF--------VAIKTL-KSGYTEKQRRDFLSEASIMGQ 61

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN++ L G       +    +++ E M N +L D  L +       I  + + +  A
Sbjct: 62  FDHPNIIHLEGVVT----KSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIA 116

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG--- 268
            G+ YL  EM++  + RD    NIL++ +   K+SDFGL+R    +      TS +G   
Sbjct: 117 AGMKYL-SEMNY--VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKI 173

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY--VS 326
            + + APE +   + T+ SDVWS+G+V++E+++                    RPY  +S
Sbjct: 174 PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWDMS 216

Query: 327 DSKKFHLI-IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
           +    + I  D RL       +A  L  L   C  K   +RPK  ++V  L  +I
Sbjct: 217 NQDVINAIEQDYRLPPPMDCPTA--LHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 88.2 bits (219), Expect = 9e-20
 Identities = 68/227 (29%), Positives = 102/227 (44%), Gaps = 51/227 (22%)

Query: 94  LIGEGGFGCVYRGV------------VRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE 141
           L+G G FG VY G+            V ++ D              +KQL +        
Sbjct: 7   LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEA-------VKQLEQ-------- 51

Query: 142 WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHLLSR---VPTP 197
              E+  L  ++HPN+V+ +G   E+D      L ++ EL+   SL   LL +    P P
Sbjct: 52  ---EIALLSKLQHPNIVQYLGTEREED-----NLYIFLELVPGGSLAK-LLKKYGSFPEP 102

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
           +    RL   Q    GL YLH   D   + RD K +NIL+D +   KL+DFG+A+Q    
Sbjct: 103 VI---RLYTRQILL-GLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155

Query: 258 GLGHVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                + S  G+  + APE + Q G     +D+WS G  + E+ TG+
Sbjct: 156 SF---AKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 88.1 bits (219), Expect = 1e-19
 Identities = 68/215 (31%), Positives = 94/215 (43%), Gaps = 32/215 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-----QGFQGHKEWI-NEVNF 148
           +G GGFG V   +V+V S +            A+K + +      G Q H   I +E   
Sbjct: 1   LGVGGFGRVE--LVKVKSKNRT---------FALKCVKKRHIVETGQQEH---IFSEKEI 46

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           L    HP +VKL  Y    D++ +  L+  E      L   L  R      + AR  IA 
Sbjct: 47  LEECNHPFIVKL--YRTFKDKKYIYMLM--EYCLGGELWTILRDRGLFD-EYTARFYIAC 101

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
                  YLH      +I+RD K  N+LLD +   KL DFG A++      G  + +  G
Sbjct: 102 -VVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKK---LKSGQKTWTFCG 154

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           T  Y APE +         D WS G++LYEL+TGR
Sbjct: 155 TPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGR 189

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 88.5 bits (219), Expect = 1e-19
 Identities = 62/220 (28%), Positives = 95/220 (43%), Gaps = 26/220 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ H       K+ VA+K L        +++  E   L V++H
Sbjct: 13  LGEGAFGKVFL------AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQH 66

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT-------------PLAWI 201
            ++V+  G C E    G   L+V+E M +  L   L S  P               L   
Sbjct: 67  QHIVRFYGVCTE----GRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLG 122

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L IA   A G+ YL        + RD  T N L+ +    K+ DFG++R         
Sbjct: 123 QMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 179

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           V    +  + +  PE +   + T +SD+WSFGVVL+E+ T
Sbjct: 180 VGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFT 219

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 88.7 bits (220), Expect = 1e-19
 Identities = 87/287 (30%), Positives = 119/287 (41%), Gaps = 52/287 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLGV 151
           IG G FG VY                 +++ VAIK+++  G Q +++W   I EV FL  
Sbjct: 23  IGHGSFGAVY----------FARDVRTNEV-VAIKKMSYSGKQSNEKWQDIIKEVRFLQQ 71

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           ++HPN ++  G C   +       LV E     S  D +L     PL  +    I   A 
Sbjct: 72  LRHPNTIEYKG-CYLREHTAW---LVMEYCLG-SASD-ILEVHKKPLQEVEIAAICHGAL 125

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           +GLAYLH     + I RD K  NILL E    KL+DFG A    P      + S VGT  
Sbjct: 126 QGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSP------ANSFVGTPY 176

Query: 272 YAAPEYV---QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
           + APE +     G+   K DVWS G+   EL       ER  P      +         S
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAM---------S 221

Query: 329 KKFHLIID--PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
             +H+  +  P L  N     +         CL K P+ RP   E++
Sbjct: 222 ALYHIAQNDSPTLSSN---DWSDYFRNFVDSCLQKIPQDRPSSEELL 265

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 88.4 bits (220), Expect = 1e-19
 Identities = 67/234 (28%), Positives = 98/234 (41%), Gaps = 64/234 (27%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGHKEWIN-----EV 146
            +GEG +  VY+               D +    VAIK++     +  K+ IN     E+
Sbjct: 7   KLGEGTYAVVYKA-------------RDKETGRIVAIKKIKLGERKEAKDGINFTALREI 53

Query: 147 NFLGVVKHPNLVKLVG-YCAEDDERGMQRL-LVYELMH--------NKSLEDHLLSRVPT 196
             L  +KHPN++ L+  +  +        + LV+E M         +KS+       V T
Sbjct: 54  KLLQELKHPNIIGLLDVFGHK------SNINLVFEFMETDLEKVIKDKSI-------VLT 100

Query: 197 PLAWIARLK-IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-G 254
           P    A +K       RGL YLH      ++ RD K +N+L+  D   KL+DFGLAR  G
Sbjct: 101 P----ADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITGR 303
            P       T  V T  Y APE +      A+      D+WS G +  EL+   
Sbjct: 154 SP---NRKMTHQVVTRWYRAPELL----FGARHYGVGVDMWSVGCIFAELLLRV 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 88.0 bits (219), Expect = 1e-19
 Identities = 81/310 (26%), Positives = 122/310 (39%), Gaps = 63/310 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN----RQGFQGHKEWINEVNFLG 150
           IGEG +G VY+            +    +L VA+K++     ++GF      I E+  L 
Sbjct: 7   IGEGTYGQVYKA----------RNKKTGEL-VALKKIRMENEKEGFP--ITAIREIKLLQ 53

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH----LLSRVPTPLAWIARLK- 205
            ++HPN+V+L        +  +   +V+E M      DH    LL          +++K 
Sbjct: 54  KLRHPNIVRLKEIVTSKGKGSI--YMVFEYM------DHDLTGLLDSPEVKFT-ESQIKC 104

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
             +    GL YLH      ++ RD K SNIL++ D   KL+DFGLAR           T+
Sbjct: 105 YMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTN 160

Query: 266 VVGTVGYAAPEYV--QTGRLTAKSDVWSFGVVLYELITGRRAVERNLP-RNEQKLLE--- 319
            V T+ Y  PE +   T R   + D+WS G +L EL  G + +        E + LE   
Sbjct: 161 RVITLWYRPPELLLGAT-RYGPEVDMWSVGCILAELFLG-KPI---FQGSTELEQLEKIF 215

Query: 320 ----------WVRPYVSDSKKFHLIIDPRLEGN-----YCIKSAQKLAALASKCLTKQPK 364
                     W  P VS    F  +   +         +          L  K LT  PK
Sbjct: 216 ELCGSPTDENW--PGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPK 273

Query: 365 SRPKMSEVVD 374
            R    + + 
Sbjct: 274 KRISADQALQ 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 77/291 (26%), Positives = 129/291 (44%), Gaps = 54/291 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V  G       D++ +       VA+K +        + ++ E + +  ++H
Sbjct: 14  IGKGEFGDVMLG-------DYRGN------KVAVKCIKNDATA--QAFLAEASVMTQLRH 58

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G   E+        +V E M   SL D+L SR  + L     LK + D    +
Sbjct: 59  SNLVQLLGVIVEEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--VGY 272
            YL E  +F  + RD    N+L+ ED  AK+SDFGL ++         ST   G   V +
Sbjct: 116 EYL-EANNF--VHRDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKW 165

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFH 332
            APE ++  + + KSDVWSFG++L+E+ +  R     +P  +                  
Sbjct: 166 TAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD------------------ 207

Query: 333 LIIDPRLEGNYCIKSAQK----LAALASKCLTKQPKSRPKMSEVVDILGNI 379
             + PR+E  Y + +       +  +  +C      +RP   ++ + L +I
Sbjct: 208 --VVPRVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 69/235 (29%), Positives = 112/235 (47%), Gaps = 36/235 (15%)

Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           LR+    ELK       R  ++G G FG VY+G+           G   K+ VAIK LN 
Sbjct: 1   LRILKETELK-------RVKVLGSGAFGTVYKGI-------WVPEGETVKIPVAIKILNE 46

Query: 134 Q-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL------LVYELMHNKSL 186
             G + + E+++E   +  + HP+LV+L+G C     + + +L      L Y   H  ++
Sbjct: 47  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNI 106

Query: 187 EDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS 246
              LL      L W  ++      A+G+ YL E    +L+ RD    N+L+      K++
Sbjct: 107 GSQLL------LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 151

Query: 247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           DFGLAR    +   + +      + + A E +   + T +SDVWS+GV ++EL+T
Sbjct: 152 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 76/291 (26%), Positives = 121/291 (41%), Gaps = 47/291 (16%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW--INEV 146
           + +  ++G G FG V           H       +  V IKQ+  +     +     NE 
Sbjct: 2   YEKIRVVGRGAFGIV-----------HLCRRKADQKLVIIKQIPVEQMTKDERLAAQNEC 50

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             L ++ HPN+++      ED       ++V E     +L +++  R     + +    I
Sbjct: 51  QVLKLLSHPNIIEYYENFLEDK----ALMIVMEYAPGGTLAEYIQKRCN---SLLDEDTI 103

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHVS-- 263
                + L  LH      ++ RD KT NILLD+     K+ DFG+++      L   S  
Sbjct: 104 LHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKI-----LSSKSKA 158

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE-RNLPRNEQKLLEWVR 322
            +VVGT  Y +PE  +      KSD+W+ G VLYEL + +RA E  NLP    K++    
Sbjct: 159 YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM---- 214

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
                S  F  I D         + +  L  L    L   P  RP++S+++
Sbjct: 215 -----SGTFAPISD---------RYSPDLRQLILSMLNLDPSKRPQLSQIM 251

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 73/280 (26%), Positives = 112/280 (40%), Gaps = 32/280 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+GGFG V    V+ +           K+  A K+L+++     +G +  +NE   L  
Sbjct: 1   LGKGGFGEVCACQVKATG----------KM-YACKKLDKKRLKKRKGEQMALNEKKILEK 49

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI-AQDA 210
           V    +V L  Y  E  +      LV  LM+   L+ H+   V  P    AR    A   
Sbjct: 50  VSSRFIVSL-AYAFETKD---DLCLVMTLMNGGDLKYHI-YNVGEPGFPEARAIFYAAQI 104

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
             GL +LH+    ++++RD K  N+LLD+    ++SD GLA +      G       GT 
Sbjct: 105 ICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKG---GKKIKGRAGTP 158

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR---RAVERNLPRNEQKLLEWVRPYVSD 327
           GY APE +Q        D ++ G  LYE+I GR   R  +  + + E K        V  
Sbjct: 159 GYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA-VEY 217

Query: 328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             KF        E        ++L          + +  P
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGGSA--DEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 87.3 bits (216), Expect = 2e-19
 Identities = 76/300 (25%), Positives = 146/300 (48%), Gaps = 48/300 (16%)

Query: 90  SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVN 147
           ++  +IG G FG V+RG++++            ++ VAIK L + G+  +  +++++E +
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGR--------KEVAVAIKTL-KPGYTEKQRQDFLSEAS 58

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--TPLAWIARLK 205
            +G   H N+++L G       +    +++ E M N +L+ +L       +    +  L+
Sbjct: 59  IMGQFSHHNIIRLEGVVT----KFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLR 114

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVS 263
                A G+ YL  +M++  + RD    NIL++ + + K+SDFGL+R  +  PEG    S
Sbjct: 115 ---GIAAGMKYL-SDMNY--VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTS 168

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
              +  + + APE +   + T+ SDVWSFG+V++E+++                    RP
Sbjct: 169 GGKI-PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE-----------------RP 210

Query: 324 Y--VSDSKKFHLIIDP-RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
           Y  +S+ +    I D  RL       SA  +  L  +C  +    RP+  ++V++L  ++
Sbjct: 211 YWDMSNHEVMKAINDGFRLPAPMDCPSA--VYQLMLQCWQQDRARRPRFVDIVNLLDKLL 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 86.7 bits (215), Expect = 5e-19
 Identities = 82/295 (27%), Positives = 121/295 (41%), Gaps = 56/295 (18%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVN 147
           + R  LIG G +G VYRG        H  +G      VA+K +N          I  EV 
Sbjct: 3   YQRLELIGRGAYGAVYRGK-------HVPTGRV----VALKIINLDTPDDDVSDIQREVA 51

Query: 148 FLGVVKH---PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
            L  ++    PN+ K  G       R     ++ E     S+    L +   P+A     
Sbjct: 52  LLSQLRQSQPPNITKYYG-SYLKGPR---LWIIMEYAEGGSVRT--LMK-AGPIAEKYIS 104

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS- 263
            I ++    L Y+H+     +I RD K +NIL+      KL DFG+A       L   S 
Sbjct: 105 VIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAAL-----LNQNSS 156

Query: 264 --TSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
             ++ VGT  + APE +  G+    K+D+WS G+ +YE+ TG      N P ++      
Sbjct: 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATG------NPPYSDVDAF-- 208

Query: 321 VRPYVSDSKKFHLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                   +   LI     PRLE N   K  ++  A    CL ++PK R    E+
Sbjct: 209 --------RAMMLIPKSKPPRLEDNGYSKLLREFVAA---CLDEEPKERLSAEEL 252

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 86.4 bits (215), Expect = 6e-19
 Identities = 66/217 (30%), Positives = 102/217 (47%), Gaps = 35/217 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN--EVNFLGVV 152
           +G+G FG VY    +           ++   VAIK++ ++ F   +E +N  EV  L  +
Sbjct: 7   LGDGTFGSVYLARNK-----------ETGELVAIKKMKKK-FYSWEECMNLREVKSLRKL 54

Query: 153 K-HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
             HPN+VKL     E+DE     L  V+E M   +L   +  R   P +      I    
Sbjct: 55  NEHPNIVKLKEVFRENDE-----LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQI 108

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---GPPEGLGHVSTSVV 267
            +GLA++H+   F    RD K  N+L+      K++DFGLAR+    PP       T  V
Sbjct: 109 LQGLAHIHKHGFFH---RDLKPENLLVSGPEVVKIADFGLAREIRSRPP------YTDYV 159

Query: 268 GTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
            T  Y APE + ++   ++  D+W+ G ++ EL T R
Sbjct: 160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 85.6 bits (212), Expect = 7e-19
 Identities = 74/294 (25%), Positives = 126/294 (42%), Gaps = 65/294 (22%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKE-WINEVNFLGV 151
            +G+G +G VY+ V R+S  D+Q          A+K+++     Q  +E  +NE+  L  
Sbjct: 7   KLGKGSYGSVYK-VKRLS--DNQF--------YALKEVDLGSMSQKEREDAVNEIRILAS 55

Query: 152 VKHPN-------------LVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
           V HPN             L  ++ Y    D        + + +  +  +  L+   P   
Sbjct: 56  VNHPNIISYKEAFLDGNKLCIVMEYAPFGD--------LSKAISKRKKKRKLI---PEQE 104

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
            W    +I     RGL  LHE+   +++ RD K++NILL  +   K+ D G+++      
Sbjct: 105 IW----RIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLK--- 154

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
             +++ + +GT  Y APE  +    + KSD+WS G +LYE+ T         P  E + +
Sbjct: 155 -KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA-------PPFEARSM 206

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           + +R  V   K       P +   Y    +Q L       L  +PK RP   ++
Sbjct: 207 QDLRYKVQRGKY------PPIPPIY----SQDLQNFIRSMLQVKPKLRPNCDKI 250

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 82/286 (28%), Positives = 126/286 (44%), Gaps = 41/286 (14%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG V++G+      D++T     +  VAIK ++ +  +   E I  E+ 
Sbjct: 6   FTKLEKIGKGSFGEVFKGI------DNRT-----QKVVAIKIIDLEEAEDEIEDIQQEIT 54

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P + K  G   +D     +  ++ E +   S  D L    P PL       I 
Sbjct: 55  VLSQCDSPYVTKYYGSYLKD----TKLWIIMEYLGGGSALDLL---EPGPLDETQIATIL 107

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           ++  +GL YLH E   + I RD K +N+LL E  + KL+DFG+A Q     +     + V
Sbjct: 108 REILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFV 162

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
           GT  + APE ++     +K+D+WS G+   EL  G        P     L+    P    
Sbjct: 163 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNP---- 218

Query: 328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
                    P LEGNY    ++ L      CL K+P  RP   E++
Sbjct: 219 ---------PTLEGNY----SKPLKEFVEACLNKEPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 68/236 (28%), Positives = 98/236 (41%), Gaps = 54/236 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL----NRQGFQGHKEWINEVNFLG 150
           +GEG FG VY+                +   VA+K++     + GF      + E+  L 
Sbjct: 16  LGEGTFGEVYKARQI-----------KTGRVVALKKILMHNEKDGF--PITALREIKILK 62

Query: 151 VVKHPNLVKLVGYCAE-DDERGMQRLLVYELMHNKSLEDHLLS------RVPTPLAWIAR 203
            +KHPN+V L+    E  D+   +R  VY +       DH LS       V        +
Sbjct: 63  KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVT---PYMDHDLSGLLENPSV--------K 111

Query: 204 LKIAQ------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR----- 252
           L  +Q          G+ YLHE     ++ RD K +NIL+D     K++DFGLAR     
Sbjct: 112 LTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGLARPYDGP 168

Query: 253 ----QGPPEGLGHVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
               +G   G     T++V T  Y  PE +    R T   D+W  G V  E+ T R
Sbjct: 169 PPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRR 224

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 84.6 bits (209), Expect = 2e-18
 Identities = 79/295 (26%), Positives = 133/295 (45%), Gaps = 46/295 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V  G +++            ++ VAIK L + G+  +  +++++E + +G 
Sbjct: 11  VIGAGEFGEVCSGRLKLPGK--------REIPVAIKTL-KAGYTEKQRRDFLSEASIMGQ 61

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN++ L G       +    ++V E M N SL D  L +       I  + + +  A
Sbjct: 62  FDHPNIIHLEGVVT----KSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIA 116

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVSTSVVGT 269
            G+ YL    D   + RD    NIL++ +   K+SDFGL+R  +  PE   + +      
Sbjct: 117 SGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIP 172

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
           + + APE +   + T+ SDVWS+G+V++E+++                    RPY   S 
Sbjct: 173 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE-----------------RPYWEMSN 215

Query: 330 KFHLIIDPRLEGNYCIKSAQ----KLAALASKCLTKQPKSRPKMSEVVDILGNII 380
           +   +I    EG Y + +       L  L   C  K    RPK  ++V IL  +I
Sbjct: 216 QD--VIKAIEEG-YRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 85.2 bits (211), Expect = 2e-18
 Identities = 58/190 (30%), Positives = 86/190 (45%), Gaps = 32/190 (16%)

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
           KI+    RGL YL E+   +++ RD K SNIL++   + KL DFG++ Q     +  ++ 
Sbjct: 103 KISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMAN 156

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR--------RAVERNLPRNEQK 316
           S VGT  Y +PE +Q    T +SD+WS G+ L E+  GR        + +E    R   +
Sbjct: 157 SFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSE 216

Query: 317 L-----LEWVRPYVSDSKK----FHL---IID---PRLEGNYCIKSAQKLAALASKCLTK 361
                    V  +  DS +    F L   I++   P+L         Q       KCL K
Sbjct: 217 GEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQD---FVDKCLKK 273

Query: 362 QPKSRPKMSE 371
            PK R  + E
Sbjct: 274 NPKERADLKE 283

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 84.6 bits (209), Expect = 3e-18
 Identities = 70/217 (32%), Positives = 104/217 (47%), Gaps = 25/217 (11%)

Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NE 145
           + ++R   IG+G  G VY  +          +G +    VAIKQ+N Q  Q  KE I NE
Sbjct: 19  KKYTRFEKIGQGASGTVYTAI-------DVATGQE----VAIKQMNLQQ-QPKKELIINE 66

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +  +   KHPN+V  +      DE      +V E +   SL D +++        IA   
Sbjct: 67  ILVMRENKHPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTETCMDEGQIA--A 119

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           + ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q  PE      ++
Sbjct: 120 VCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRST 174

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +VGT  + APE V       K D+WS G++  E++ G
Sbjct: 175 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 84.0 bits (207), Expect = 4e-18
 Identities = 67/223 (30%), Positives = 105/223 (47%), Gaps = 33/223 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GV 151
           +IGEG FG V +  ++             ++D AIK++     +  H+++  E+  L  +
Sbjct: 2   VIGEGNFGQVLKARIKKDG---------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 52

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR-------- 203
             HPN++ L+G C   + RG   L +    H   L+    SRV       A         
Sbjct: 53  GHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 109

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                L  A D ARG+ YL ++   Q I RD    NIL+ E+Y AK++DFGL+R    + 
Sbjct: 110 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG---QE 163

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +    T     V + A E +     T  SDVWS+GV+L+E+++
Sbjct: 164 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 206

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 59/221 (26%), Positives = 97/221 (43%), Gaps = 27/221 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ +  S    K+ VA+K L        K++  E   L  ++H
Sbjct: 13  LGEGAFGKVFL------AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 66

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWI------------- 201
            ++VK  G C + D      ++V+E M +  L   L +  P  +  +             
Sbjct: 67  EHIVKFYGVCGDGDPL----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 122

Query: 202 -ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
              L IA   A G+ YL  +     + RD  T N L+  +   K+ DFG++R        
Sbjct: 123 SQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 179

Query: 261 HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            V    +  + +  PE +   + T +SDVWSFGV+L+E+ T
Sbjct: 180 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 220

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 83.3 bits (206), Expect = 5e-18
 Identities = 61/224 (27%), Positives = 101/224 (45%), Gaps = 34/224 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWI-------- 143
           LIG+G +G VY  +       + T+G      +A+KQ  L       H            
Sbjct: 8   LIGKGTYGRVYLAL-------NVTTGEM----MAVKQVELPATIAGRHDSRQKDMVKALR 56

Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHLLSRVPTPLAWIA 202
           +E+  L  + H N+V+ +G+     E   + L ++ E +   S+   L  R         
Sbjct: 57  SEIETLKDLDHLNIVQYLGF-----ETTEEYLSIFLEYVPGGSIGSCL--RTYGRFEEQL 109

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHV 262
                +    GLAYLH +    ++ RD K  N+L+D D   K+SDFG++++         
Sbjct: 110 VRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQ 166

Query: 263 STSVVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRR 304
           + S+ G+V + APE + +     +AK D+WS G V+ E+  GRR
Sbjct: 167 NMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 66/229 (28%), Positives = 98/229 (42%), Gaps = 34/229 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVVK 153
           +GEG FG V +          +  G      VA+K L         ++ ++E N L  V 
Sbjct: 8   LGEGEFGKVVKATA------FRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN 61

Query: 154 HPNLVKLVGYCAEDDE-------------RGMQRL--------LVYELMHNKSLEDHLLS 192
           HP+++KL G C++D               R   R         L  +   N S  D+   
Sbjct: 62  HPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDE 121

Query: 193 RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
           R    L     +  A   +RG+ YL E    +L+ RD    N+L+ E  K K+SDFGL+R
Sbjct: 122 R---ALTMGDLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSR 175

Query: 253 QGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
               E      +     V + A E +     T +SDVWSFGV+L+E++T
Sbjct: 176 DVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 83.9 bits (207), Expect = 6e-18
 Identities = 71/294 (24%), Positives = 124/294 (42%), Gaps = 33/294 (11%)

Query: 95  IGEGGFG----CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFL 149
           +GEG FG    C   G+     +          L VA+K L     +    +++ E+  +
Sbjct: 13  LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVL-VAVKMLRADVTKTARNDFLKEIKIM 71

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-----------VPTPL 198
             +K+PN+++L+G C  DD   M    + E M N  L   L  R           +P+ +
Sbjct: 72  SRLKNPNIIRLLGVCVSDDPLCM----ITEYMENGDLNQFLSQREIESTFTHANNIPS-V 126

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
           +    L +A   A G+ YL        + RD  T N L+   Y  K++DFG++R      
Sbjct: 127 SIANLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGD 183

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
              +    V  + + A E +  G+ T  SDVW+FGV L+E+ T  +    +L  +EQ + 
Sbjct: 184 YYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE 243

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                + +  ++ +L   P             +  L  +C ++  K RP  +++
Sbjct: 244 NTGEFFRNQGRQIYLSQTPLCPS--------PVFKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 83.1 bits (206), Expect = 7e-18
 Identities = 57/225 (25%), Positives = 93/225 (41%), Gaps = 50/225 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQG-HKEWINEVNFLGVV 152
           IGEG  G V++   R        +G      VA+K++  R+   G   + + E+  L   
Sbjct: 8   IGEGAHGIVFKAKDR-------ETGET----VALKKVALRRLEGGIPNQALREIKALQAC 56

Query: 153 KHPNLVKLV-------------GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLA 199
           +HP +VKL+              Y   D         + E++ +           P P A
Sbjct: 57  QHPYVVKLLDVFPHGSGFVLVMEYMPSD---------LSEVLRD--------EERPLPEA 99

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
            +      +   +G+AY+H      ++ RD K +N+L+  D   K++DFGLAR    E  
Sbjct: 100 QVKSY--MRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEE- 153

Query: 260 GHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGR 303
             + +  V T  Y APE +   R      D+W+ G +  EL+ G 
Sbjct: 154 PRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 82.4 bits (203), Expect = 9e-18
 Identities = 60/210 (28%), Positives = 99/210 (47%), Gaps = 27/210 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G             +++   VA+K L + G    + ++ E N +  ++H
Sbjct: 14  LGAGQFGEVWMGY------------YNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     +++       ++ E M   SL D L S     +     +  +   A G+
Sbjct: 61  DKLVRLYAVVTKEEPI----YIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 116

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AY+  +     I RD + +N+L+ E    K++DFGLAR           T+  G    + 
Sbjct: 117 AYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY----TAREGAKFPIK 169

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           + APE +  G  T KSDVWSFG++LYE++T
Sbjct: 170 WTAPEAINFGSFTIKSDVWSFGILLYEIVT 199

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 83.2 bits (206), Expect = 9e-18
 Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 63/232 (27%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-----NEVNFL 149
           IGEG +G VYR     S +            VA+K++        ++ I      E+  L
Sbjct: 15  IGEGTYGIVYRARDTTSGEI-----------VALKKVR---MDNERDGIPISSLREITLL 60

Query: 150 GVVKHPNLVKL---------------VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
             ++HPN+V+L               + YC +D                      LL  +
Sbjct: 61  LNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQDLAS-------------------LLDNM 101

Query: 195 PTPLAWIARLK-IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
           PTP +  +++K +     RGL YLHE     +I RD K SN+LL +    K++DFGLAR 
Sbjct: 102 PTPFS-ESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLART 157

Query: 254 -GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
            G P     ++  VV T+ Y APE +        + D+W+ G +L EL+  +
Sbjct: 158 YGLPA--KPMTPKVV-TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 76/310 (24%), Positives = 125/310 (40%), Gaps = 56/310 (18%)

Query: 89  FSRA-----LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEW 142
           F R+       +G G FG V+    +   ++        +  V +K L +   +    E+
Sbjct: 2   FPRSNLQEITTLGRGEFGEVFLAKAKGIEEE------GGETLVLVKALQKTKDENLQSEF 55

Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE--------LMHNKSLEDHLLSRV 194
             E++    + H N+V+L+G C E +   M  +L Y         L   KS ++ L    
Sbjct: 56  RRELDMFRKLSHKNVVRLLGLCREAEPHYM--ILEYTDLGDLKQFLRATKSKDEKL---K 110

Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
           P PL+   ++ +    A G+ +L      + + RD    N L+    + K+S   L++  
Sbjct: 111 PPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDV 167

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT------GRRAVER 308
                  +  +++  + + APE VQ    + KSDVWSFGV+++E+ T         + E 
Sbjct: 168 YNSEYYKLRNALI-PLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEE 226

Query: 309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
            L R +   LE   P                EG  C     KL     +C    PK RP 
Sbjct: 227 VLNRLQAGKLELPVP----------------EG--CPSRLYKLMT---RCWAVNPKDRPS 265

Query: 369 MSEVVDILGN 378
            SE+V  LG 
Sbjct: 266 FSELVSALGE 275

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 81/288 (28%), Positives = 123/288 (42%), Gaps = 41/288 (14%)

Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-E 145
             F++   IG+G FG VY+G+     D+       +K  VAIK ++ +  +   E I  E
Sbjct: 4   ELFTKLERIGKGSFGEVYKGI-----DNR------TKEVVAIKIIDLEEAEDEIEDIQQE 52

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +  L     P + +  G       +G +  ++ E +   S  D LL   P    +IA   
Sbjct: 53  ITVLSQCDSPYITRYYGSYL----KGTKLWIIMEYLGGGSALD-LLKPGPLEETYIA--T 105

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           I ++  +GL YLH E   + I RD K +N+LL E    KL+DFG+A Q     +     +
Sbjct: 106 ILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NT 160

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            VGT  + APE ++      K+D+WS G+   EL  G        P     L+    P  
Sbjct: 161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP-- 218

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
                      P LEG Y    ++        CL K P+ RP   E++
Sbjct: 219 -----------PTLEGQY----SKPFKEFVEACLNKDPRFRPTAKELL 251

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 82.7 bits (204), Expect = 1e-17
 Identities = 67/223 (30%), Positives = 106/223 (47%), Gaps = 33/223 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GV 151
           +IGEG FG V R +++             K++ AIK L     +  H+++  E+  L  +
Sbjct: 9   VIGEGNFGQVIRAMIKKDGL---------KMNAAIKMLKEFASENDHRDFAGELEVLCKL 59

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR-------- 203
             HPN++ L+G C   + RG   + +    +   L+    SRV       A+        
Sbjct: 60  GHHPNIINLLGAC---ENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTL 116

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                L+ A D A G+ YL E+   Q I RD    N+L+ E+  +K++DFGL+R    E 
Sbjct: 117 TSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRG---EE 170

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +    T     V + A E +     T KSDVWSFGV+L+E+++
Sbjct: 171 VYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 82.4 bits (203), Expect = 1e-17
 Identities = 73/294 (24%), Positives = 130/294 (44%), Gaps = 46/294 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           +GE  FG +Y+G + +   DH      ++L VAIK L +    Q   E+  E + +  + 
Sbjct: 13  LGECAFGKIYKGHLYLPGMDH------AQL-VAIKTLKDINNPQQWGEFQQEASLMAELH 65

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP---------------TPL 198
           HPN+V L+G   ++    M    ++E ++   L + L+ R P               + L
Sbjct: 66  HPNIVCLLGVVTQEQPVCM----LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSL 121

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                L IA   A G+ YL        + +D    NIL+ E    K+SD GL+R+     
Sbjct: 122 DHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREIYSAD 178

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
              V    +  + +  PE +  G+ ++ SD+WSFGVVL+E+ +    ++     + Q+++
Sbjct: 179 YYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS--FGLQPYYGFSNQEVI 236

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           E VR       K  L+               ++ +L ++C  + P  RP+  ++
Sbjct: 237 EMVR-------KRQLLPCSE-------DCPPRMYSLMTECWQEGPSRRPRFKDI 276

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 82.0 bits (202), Expect = 1e-17
 Identities = 67/213 (31%), Positives = 102/213 (47%), Gaps = 28/213 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 14  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 61  EKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 115

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR        +  T+  G    + 
Sbjct: 116 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIK 168

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           + APE    GR T KSDVWSFG++L EL T  R
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 81.9 bits (203), Expect = 1e-17
 Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 33/219 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDV-AIKQLNRQGFQGH---KEWINEVNFLG 150
           I +G +G V+  + +            S  D+ AIK + +          + + E + L 
Sbjct: 1   ISKGAYGRVF--LAK----------KKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS 48

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
             + P +VKL  Y +   ++ +   LV E +    L   LL  V +    +AR+ IA+  
Sbjct: 49  QAQSPYVVKL--YYSFQGKKNL--YLVMEYLPGGDLA-SLLENVGSLDEDVARIYIAEIV 103

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG---PPEGLGHVSTS-- 265
              L YLH      +I RD K  NIL+D +   KL+DFGL++ G       L        
Sbjct: 104 L-ALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK 159

Query: 266 -VVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITG 302
            +VGT  Y APE V  G+  +K+ D WS G +LYE + G
Sbjct: 160 RIVGTPDYIAPE-VILGQGHSKTVDWWSLGCILYEFLVG 197

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 82.8 bits (204), Expect = 2e-17
 Identities = 85/284 (29%), Positives = 116/284 (40%), Gaps = 58/284 (20%)

Query: 95  IGEGGFGCVY--RGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFL 149
           IG G FG VY  R V              +   VAIK+++  G Q +++W   I EV FL
Sbjct: 23  IGHGSFGAVYFARDV-------------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 150 GVVKHPNLVKLVG-YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             ++HPN ++  G Y  E         LV E     + +  LL     PL  +    +  
Sbjct: 70  QKLRHPNTIQYRGCYLREHTA-----WLVMEYCLGSASD--LLEVHKKPLQEVEIAAVTH 122

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
            A +GLAYLH      +I RD K  NILL E    KL DFG A    P      +   VG
Sbjct: 123 GALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANXFVG 173

Query: 269 TVGYAAPEYV---QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
           T  + APE +     G+   K DVWS G+   EL       ER  P      +       
Sbjct: 174 TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL------AERKPPLFNMNAM------- 220

Query: 326 SDSKKFHLIID--PRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             S  +H+  +  P L+  +  +  +        CL K P+ RP
Sbjct: 221 --SALYHIAQNESPALQSGHWSEYFRN---FVDSCLQKIPQDRP 259

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 82.4 bits (203), Expect = 2e-17
 Identities = 89/324 (27%), Positives = 141/324 (43%), Gaps = 71/324 (21%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVV 152
           +IGEG FG V +   R+  D         ++D AIK++     +  H+++  E+  L  +
Sbjct: 14  VIGEGNFGQVLKA--RIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 64

Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIAR------ 203
             HPN++ L+G C   + RG   L +    H   L+    SRV    P   IA       
Sbjct: 65  GHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 121

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                L  A D ARG+ YL ++   Q I RD    NIL+ E+Y AK++DFGL+R     G
Sbjct: 122 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSR-----G 173

Query: 259 LGHVSTSVVG--TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-------GRRAVE-- 307
                   +G   V + A E +     T  SDVWS+GV+L+E+++       G    E  
Sbjct: 174 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 233

Query: 308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             LP+  +  LE  +P   D + + L+                      +C  ++P  RP
Sbjct: 234 EKLPQGYR--LE--KPLNCDDEVYDLM---------------------RQCWREKPYERP 268

Query: 368 KMSEVVDILGNIISEISSQDEVTL 391
             ++++  L  ++ E  +    TL
Sbjct: 269 SFAQILVSLNRMLEERKTYVNTTL 292

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 80/281 (28%), Positives = 120/281 (42%), Gaps = 38/281 (13%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINE 145
           F +  ++G+GGFG V    VR +   +           A K+L ++  +   G    +NE
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMY-----------ACKKLEKKRIKKRKGESMALNE 50

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
              L  V    +V L  Y  E  +      LV  LM+   L+ H+             + 
Sbjct: 51  KQILEKVNSRFVVSL-AYAYETKD---ALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVF 106

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
            A +   GL  LH+E   ++++RD K  NILLD+    ++SD GLA   P    G     
Sbjct: 107 YAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKG 160

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            VGTVGY APE V+  R T   D W+ G +LYE+I G+   ++   R ++   E V   V
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQ---RKKKIKREEVERLV 217

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
            +           ++  Y  K +    +L    L K PK R
Sbjct: 218 KE-----------VQEEYSEKFSPDARSLCKMLLCKDPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 80.4 bits (198), Expect = 4e-17
 Identities = 62/208 (29%), Positives = 96/208 (46%), Gaps = 26/208 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G +R  +           L   +K           +++ E   L    H
Sbjct: 3   IGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKA----------KFLQEARILKQYSH 52

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PN+V+L+G C +         +V EL+        L +  P  L     +++ ++AA G+
Sbjct: 53  PNIVRLIGVCTQKQPI----YIVMELVQGGDFLTFLRTEGPR-LKVKELIQMVENAAAGM 107

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT----V 270
            YL  +     I RD    N L+ E    K+SDFG++R+   E  G V  S  G     V
Sbjct: 108 EYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSRE---EEDG-VYASTGGMKQIPV 160

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
            + APE +  GR +++SDVWSFG++L+E
Sbjct: 161 KWTAPEALNYGRYSSESDVWSFGILLWE 188

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 80.3 bits (198), Expect = 6e-17
 Identities = 70/268 (26%), Positives = 115/268 (42%), Gaps = 53/268 (19%)

Query: 126 VAIKQL----NRQGFQGH--KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE 179
           +A+KQ+    N    Q    +    E+  +  + HP++++++G   ED        L  E
Sbjct: 28  MAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFN----LFVE 83

Query: 180 LMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE 239
            M   S+  HLLS+          +   +   RGL+YLHE    Q+I RD K +N+L+D 
Sbjct: 84  WMAGGSVS-HLLSKY-GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDS 138

Query: 240 D-YKAKLSDFGLARQGPPE--GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL 296
              + +++DFG A +   +  G G     ++GT+ + APE ++  +     DVWS G V+
Sbjct: 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVI 198

Query: 297 YELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSA-------- 348
            E+ T +       P N +K           S    LI        + I SA        
Sbjct: 199 IEMATAK------PPWNAEKH----------SNHLALI--------FKIASATTAPSIPE 234

Query: 349 ---QKLAALASKCLTKQPKSRPKMSEVV 373
                L  +  +CL  QP+ RP   E++
Sbjct: 235 HLSPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 80.6 bits (199), Expect = 6e-17
 Identities = 52/175 (29%), Positives = 78/175 (44%), Gaps = 21/175 (12%)

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
           KIA     GL YL+     +++ RD K SNIL++   + KL DFG++     E +  ++ 
Sbjct: 107 KIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS----GELINSIAD 160

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP--RNEQKLLEWVR 322
           + VGT  Y +PE +Q G+ T KSDVWS G+ + EL  G+       P   +         
Sbjct: 161 TFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK------FPFAFSNIDDDGQDD 214

Query: 323 PYVSDSKKFHLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
           P +        I+    PRL  +      + L      CL K P  RP   ++  
Sbjct: 215 P-MGILDLLQQIVQEPPPRLPSS---DFPEDLRDFVDACLLKDPTERPTPQQLCA 265

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 80.0 bits (197), Expect = 7e-17
 Identities = 70/230 (30%), Positives = 109/230 (47%), Gaps = 30/230 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G              +    VA+K L + G    + ++ E   +  ++H
Sbjct: 14  LGNGQFGEVWMGT------------WNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 61  DKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 115

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AY+ E M++  I RD +++NIL+ +    K++DFGLAR        +  T+  G    + 
Sbjct: 116 AYI-ERMNY--IHRDLRSANILVGDGLVCKIADFGLARLIE----DNEYTARQGAKFPIK 168

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
           + APE    GR T KSDVWSFG++L EL+T  R     +  N +++LE V
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--NNREVLEQV 216

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 80.0 bits (197), Expect = 7e-17
 Identities = 54/207 (26%), Positives = 100/207 (48%), Gaps = 22/207 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVVK 153
           +G G FGCV +GV ++            ++DVAIK L  +  +    E + E   +  + 
Sbjct: 3   LGSGNFGCVKKGVYKMRK---------KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD 53

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT-PLAWIARLKIAQDAAR 212
           +P +V+++G C  +       +LV E+     L   L  +     ++ +  L      + 
Sbjct: 54  NPYIVRMIGVCEAEA-----LMLVMEMASGGPLNKFLSGKKDEITVSNVVEL--MHQVSM 106

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVGTVG 271
           G+ YL E  +F  + RD    N+LL   + AK+SDFGL++  G  +      ++    + 
Sbjct: 107 GMKYL-EGKNF--VHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLK 163

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYE 298
           + APE +   + +++SDVWS+G+ ++E
Sbjct: 164 WYAPECINFRKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 79.6 bits (196), Expect = 7e-17
 Identities = 77/289 (26%), Positives = 127/289 (43%), Gaps = 54/289 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN--RQGFQGHKEWINEVNFLGVV 152
           IGEG FG +Y  + +  SD              IK+++  +   +  +    EV  L  +
Sbjct: 8   IGEGSFGKIY--LAKAKSDSEH---------CVIKEIDLTKMPVKEKEASKKEVILLAKM 56

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVY-------ELMHNKSLEDHLLSRVPTPLAWIARLK 205
           KHPN+V       E+      RL +        +LM   + +  +L      L+W  ++ 
Sbjct: 57  KHPNIVTFFASFQENG-----RLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQIS 111

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK-AKLSDFGLARQGPPEGLGHVST 264
           +      GL ++H   D +++ RD K+ NI L ++   AKL DFG+ARQ        ++ 
Sbjct: 112 L------GLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAY 160

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY 324
           + VGT  Y +PE  Q      K+D+WS G VLYEL T +   E N     Q +L+  + Y
Sbjct: 161 TCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN--NLHQLVLKICQGY 218

Query: 325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
            +        I P          ++ L +L S+     P+ RP ++ ++
Sbjct: 219 FAP-------ISPNF--------SRDLRSLISQLFKVSPRDRPSITSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 80.0 bits (197), Expect = 9e-17
 Identities = 63/209 (30%), Positives = 101/209 (48%), Gaps = 15/209 (7%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVVK 153
           +GEG FG       +V    +   G ++   VA+K L  +    H  +   E+  L  + 
Sbjct: 12  LGEGHFG-------KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY 64

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G C ED   G++  L+ E + + SL+++L  R    +    +LK A    +G
Sbjct: 65  HENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PRNKNKINLKQQLKYAVQICKG 121

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVGTVGY 272
           + YL      Q + RD    N+L++ +++ K+ DFGL +     +    V   +   V +
Sbjct: 122 MDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFW 178

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            APE +   +    SDVWSFGV LYEL+T
Sbjct: 179 YAPECLIQSKFYIASDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 79.8 bits (197), Expect = 9e-17
 Identities = 56/177 (31%), Positives = 89/177 (50%), Gaps = 7/177 (3%)

Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  LV E +   S
Sbjct: 36  VAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR--LVMEYLPYGS 93

Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    L     L  A    +G+ YL  +   + + RD  T NIL++ + + K+
Sbjct: 94  LRDYL-QKHRERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKI 149

Query: 246 SDFGLARQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +   + V       + + APE +   + +  SDVWSFGVVLYEL T
Sbjct: 150 GDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 79.7 bits (196), Expect = 1e-16
 Identities = 79/305 (25%), Positives = 135/305 (44%), Gaps = 46/305 (15%)

Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           +R+    ELK       +  ++G G FG VY+G+           G + K+ VAIK L  
Sbjct: 1   MRILKETELK-------KVKVLGSGAFGTVYKGI-------WIPDGENVKIPVAIKVLRE 46

Query: 134 Q-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE--LMHNKSLEDHL 190
               + +KE ++E   +  V  P + +L+G C     + + +L+ Y   L + +  +D +
Sbjct: 47  NTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRI 106

Query: 191 LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
            S+    L W  ++      A+G++YL E    +L+ RD    N+L+      K++DFGL
Sbjct: 107 GSQ--DLLNWCVQI------AKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGL 155

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERN 309
           AR    +   + +      + + A E +   R T +SDVWS+GV ++EL+T G +  +  
Sbjct: 156 ARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215

Query: 310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM 369
             R    LLE          K   +  P +    C      +     KC     + RP+ 
Sbjct: 216 PAREIPDLLE----------KGERLPQPPI----CTIDVYMIMV---KCWMIDSECRPRF 258

Query: 370 SEVVD 374
            E+VD
Sbjct: 259 RELVD 263

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 80.4 bits (198), Expect = 1e-16
 Identities = 81/314 (25%), Positives = 139/314 (44%), Gaps = 55/314 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV- 152
           +GEG FG     VVR  +     S  D  + VA+K L      +   + I+E+  + ++ 
Sbjct: 20  LGEGCFG----QVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIG 75

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPL 198
           KH N++ L+G C ++   G   ++V E     +L + L +R P                L
Sbjct: 76  KHKNIINLLGVCTQE---GPLYVIV-EYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
           ++   +  A   ARG+ YL      + I RD    N+L+ ED   K++DFGLAR     G
Sbjct: 132 SFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLAR-----G 183

Query: 259 LGHV-----STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN 313
           +  +     +++    V + APE +     T +SDVWSFG++++E+ T   +    +P  
Sbjct: 184 VHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE 243

Query: 314 EQ-KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           E  KLL          ++ H +  P            +L  L  +C    P  RP   ++
Sbjct: 244 ELFKLL----------REGHRMDKPS-------NCTHELYMLMRECWHAVPTQRPTFKQL 286

Query: 373 VDILGNIISEISSQ 386
           V+ L  +++ +S +
Sbjct: 287 VEALDKVLAAVSEE 300

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 79.6 bits (196), Expect = 1e-16
 Identities = 73/293 (24%), Positives = 129/293 (44%), Gaps = 40/293 (13%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSS--DDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEV 146
           +++  ++G+G +G VY G+          Q     S +  A K+        +++   EV
Sbjct: 2   WTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKE--------YEKLQEEV 53

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
           + L  +KH N+V+ +G C +D+       +  E +   S+   +L+R   PL      K 
Sbjct: 54  DLLKSLKHVNIVQYLGTCLDDNTIS----IFMEFVPGGSISS-ILNRF-GPLPEPVFCKY 107

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS--- 263
            +    G+AYLH      ++ RD K +N++L  +   KL DFG AR+    GL H +   
Sbjct: 108 TKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL-HGTHSN 163

Query: 264 --TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
              S+ GT  + APE +       KSD+WS G  ++E+ TG+  +  ++ R         
Sbjct: 164 MLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLA-SMDRLAAMF---- 218

Query: 322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
             Y+      H  + PRL  ++    +       + CLT+    RP   +++ 
Sbjct: 219 --YIGA----HRGLMPRLPDSF----SAAAIDFVTSCLTRDQHERPSALQLLR 261

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 79.2 bits (195), Expect = 2e-16
 Identities = 80/281 (28%), Positives = 118/281 (41%), Gaps = 38/281 (13%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINE 145
           F +  ++G+GGFG V    VR +   +           A K+L ++  +   G    +NE
Sbjct: 2   FRQYRVLGKGGFGEVCACQVRATGKMY-----------ACKRLEKKRIKKRKGESMALNE 50

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
              L  V    +V L  Y  E  +      LV  +M+   L+ H+ +           L 
Sbjct: 51  KQILEKVNSQFVVNL-AYAYETKD---ALCLVLTIMNGGDLKFHIYNMGNPGFEEERALF 106

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
            A +   GL  LH E     ++RD K  NILLD+    ++SD GLA + P    G     
Sbjct: 107 YAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIRG 160

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            VGTVGY APE +   R T   D W  G ++YE+I G+        R E+   E V   V
Sbjct: 161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFR---GRKEKVKREEVDRRV 217

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
            ++           E  Y  K +++  ++    LTK PK R
Sbjct: 218 LET-----------EEVYSAKFSEEAKSICKMLLTKDPKQR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 66/218 (30%), Positives = 104/218 (47%), Gaps = 36/218 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ----LNRQGFQGHKEWINEVNFL 149
            IGEG +G VY+            +G      VA+K+    L+ +G       + E+  L
Sbjct: 6   EIGEGAYGTVYKA-------RDLNTGRF----VALKKVRVPLSEEGIP--LSTLREIALL 52

Query: 150 GVVK---HPNLVKLVGYCA-EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
             ++   HPN+V+L+  C     +R ++  LV+E +  + L    LS+ P P      +K
Sbjct: 53  KQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLAT-YLSKCPKPGLPPETIK 110

Query: 206 -IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS- 263
            + +   RG+ +LH     +++ RD K  NIL+  D + K++DFGLAR            
Sbjct: 111 DLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARI-----YSFEMA 162

Query: 264 -TSVVGTVGYAAPE-YVQTGRLTAKSDVWSFGVVLYEL 299
            TSVV T+ Y APE  +Q+   T   D+WS G +  EL
Sbjct: 163 LTSVVVTLWYRAPEVLLQSSYATP-VDMWSVGCIFAEL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 78.5 bits (193), Expect = 2e-16
 Identities = 81/303 (26%), Positives = 127/303 (41%), Gaps = 54/303 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-----NRQGFQGHKEWINEVNFL 149
           +GEG FG V  G         Q +  DS L VA+K +      R   +   ++++E   +
Sbjct: 7   LGEGEFGSVMEG---------QLNQDDSILKVAVKTMKIAICTRSEME---DFLSEAVCM 54

Query: 150 GVVKHPNLVKLVGYCAEDDERGM--QRLLVYELMHNKSLEDHLL-SRV---PTPLAWIAR 203
               HPN+++L+G C +  E       +++   M +  L   LL SR+   P  L     
Sbjct: 55  KEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQML 114

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---GPPEGLG 260
           +K   D A G+ YL  +     I RD    N +L+E+    ++DFGL+++   G     G
Sbjct: 115 VKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171

Query: 261 HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
            ++      V + A E +     T KSDVWSFGV ++E+ T          R +      
Sbjct: 172 RIAKM---PVKWIAIESLADRVYTTKSDVWSFGVTMWEIAT----------RGQTPY--- 215

Query: 321 VRPYVSDSKKFHLIIDPRLEGNYCIKSA---QKLAALASKCLTKQPKSRPKMSEVVDILG 377
             P V +S+    I D   +GN   +       L +L S C    PK RP    +   L 
Sbjct: 216 --PGVENSE----IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELE 269

Query: 378 NII 380
             +
Sbjct: 270 KAL 272

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 78.8 bits (194), Expect = 3e-16
 Identities = 77/305 (25%), Positives = 128/305 (41%), Gaps = 46/305 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQT--------SGHDSKLDVAIKQLNRQGFQGHK-EWINE 145
           +GEG FG V+   V V+  D  T         G    L VA+K L     +  + +++ E
Sbjct: 13  LGEGQFGEVHLCEV-VNPQDLPTLQFPFNVRKGR--PLLVAVKILRPDANKNARNDFLKE 69

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV----------- 194
           V  L  +K PN+++L+G C ++D   M    + E M N  L   L S             
Sbjct: 70  VKILSRLKDPNIIRLLGVCVDEDPLCM----ITEYMENGDLNQFLSSHHLDDKEENGNDA 125

Query: 195 -------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
                  P   ++ + L +A   A G+ YL        + RD  T N L+ E+   K++D
Sbjct: 126 VPPAHCLPAI-SYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIAD 181

Query: 248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
           FG++R         +    V  + + A E +  G+ T  SDVW+FGV L+E++   +   
Sbjct: 182 FGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241

Query: 308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
                +EQ ++E    +  D  +   +  P           Q L  L  +C ++  + RP
Sbjct: 242 YGELTDEQ-VIENAGEFFRDQGRQVYLFRPPP-------CPQGLYELMLQCWSRDCRERP 293

Query: 368 KMSEV 372
             S++
Sbjct: 294 SFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 78.4 bits (193), Expect = 3e-16
 Identities = 83/321 (25%), Positives = 134/321 (41%), Gaps = 76/321 (23%)

Query: 81  ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK 140
           EL + +    R  ++G G FG + RG +++ S          +L VAI  L R G    +
Sbjct: 1   ELDNKSIKIER--ILGTGRFGELCRGCLKLPSK--------RELPVAIHTL-RAGCSDKQ 49

Query: 141 E--WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
              ++ E   LG   H N+V+L G       RG   ++V E M N +L D  L +    L
Sbjct: 50  RRGFLAEALTLGQFDHSNIVRLEGVIT----RGNTMMIVTEYMSNGAL-DSFLRKHEGQL 104

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                + +    A G+ YL  EM +  + +      +L++ D   K+S F   R+   + 
Sbjct: 105 VAGQLMGMLPGLASGMKYL-SEMGY--VHKGLAAHKVLVNSDLVCKISGF---RRLQEDK 158

Query: 259 LGHVSTSVVG--TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRR----------- 304
              + T++ G   V +AAPE +Q    ++ SDVWSFG+V++E+++ G R           
Sbjct: 159 SEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVI 218

Query: 305 -AVERNL----PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCL 359
            AVE       PRN   LL              L++D                     C 
Sbjct: 219 KAVEDGFRLPAPRNCPNLLH------------QLMLD---------------------CW 245

Query: 360 TKQPKSRPKMSEVVDILGNII 380
            K+   RP+ S++  IL  ++
Sbjct: 246 QKERGERPRFSQIHSILSKMV 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 78.2 bits (192), Expect = 4e-16
 Identities = 65/218 (29%), Positives = 103/218 (47%), Gaps = 27/218 (12%)

Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLNRQGFQGHKEWIN 144
           + ++R   IG+G  G V+             +  D     +VAIKQ+N Q     +  IN
Sbjct: 19  KKYTRYEKIGQGASGTVF-------------TAIDVATGQEVAIKQINLQKQPKKELIIN 65

Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E+  +  +K+PN+V  +      DE      +V E +   SL D +++      A IA  
Sbjct: 66  EILVMKELKNPNIVNFLDSFLVGDEL----FVVMEYLAGGSLTD-VVTETCMDEAQIA-- 118

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
            + ++  + L +LH     Q+I RD K+ N+LL  D   KL+DFG   Q  PE      +
Sbjct: 119 AVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPE--QSKRS 173

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           ++VGT  + APE V       K D+WS G++  E++ G
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 77.8 bits (192), Expect = 4e-16
 Identities = 81/298 (27%), Positives = 124/298 (41%), Gaps = 47/298 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
            IGEG FG VY+GV          S  + K+ VA+K          +E ++ E   +   
Sbjct: 13  CIGEGQFGDVYQGVY--------MSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQF 64

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HP++VKL+G   E+        +V EL     L    L      L   + +  +   + 
Sbjct: 65  DHPHIVKLIGVITEN-----PVWIVMELAPLGELR-SYLQVNKYSLDLASLILYSYQLST 118

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            LAYL E   F  + RD    N+L+      KL DFGL+R    E     S   +  + +
Sbjct: 119 ALAYL-ESKRF--VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKL-PIKW 174

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY--VSDSKK 330
            APE +   R T+ SDVW FGV ++E+                 L+  V+P+  V ++  
Sbjct: 175 MAPESINFRRFTSASDVWMFGVCMWEI-----------------LMLGVKPFQGVKNND- 216

Query: 331 FHLIIDPRLE-GNYCIKSAQ---KLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
              +I  R+E G            L +L +KC    P  RP+ +E+   L +I+ E  
Sbjct: 217 ---VIG-RIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQEEK 270

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 4e-16
 Identities = 92/308 (29%), Positives = 126/308 (40%), Gaps = 76/308 (24%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGHKEWIN-EVNFL- 149
           +IGEG +G VY+                 K    VAIK ++       +E I  E N L 
Sbjct: 13  VIGEGTYGKVYKAR-------------HKKTGQLVAIKIMDIIE--DEEEEIKEEYNILR 57

Query: 150 GVVKHPNLVKLVGYCAEDDERGM--QRLLVYELMHNKSLED----HLLSRVPTPLAWIAR 203
               HPN+    G   + +  G   Q  LV EL    S+ D               WIA 
Sbjct: 58  KYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAY 117

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
             I ++  RGLAYLHE    ++I RD K  NILL ++ + KL DFG++ Q     LG  +
Sbjct: 118 --ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDST-LGRRN 171

Query: 264 TSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGR---------RA---V 306
           T  +GT  + APE +           A+SDVWS G+   EL  G+         RA   +
Sbjct: 172 TF-IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKI 230

Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
            RN P   +    W       SKKF+  I                    S+CL K  + R
Sbjct: 231 PRNPPPTLKSPENW-------SKKFNDFI--------------------SECLIKNYEQR 263

Query: 367 PKMSEVVD 374
           P M E+++
Sbjct: 264 PFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.5 bits (193), Expect = 4e-16
 Identities = 62/217 (28%), Positives = 109/217 (50%), Gaps = 23/217 (10%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 9   FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 61

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYE--LMHNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +   L + +  +D++ S+    L W  ++ 
Sbjct: 62  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQ--YLLNWCVQI- 118

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVST 264
                A+G+ YL E    +L+ RD    N+L+      K++DFGLA+  G  E   H   
Sbjct: 119 -----AKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEG 170

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             V  + + A E +     T +SDVWS+GV ++EL+T
Sbjct: 171 GKV-PIKWMALESILHRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 78.0 bits (193), Expect = 5e-16
 Identities = 66/225 (29%), Positives = 105/225 (46%), Gaps = 49/225 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQL----NRQGFQGHKEWINEVNF 148
           I EG +G VYR               D K    VA+K+L     ++GF      + E+N 
Sbjct: 13  IEEGTYGVVYRAR-------------DKKTGEIVALKKLKMEKEKEGFP--ITSLREINI 57

Query: 149 LGVVKHPNLVKL----VGYCAEDDERGMQRL-LVYELMHN--KSLEDHLLSRVPTPLAWI 201
           L  ++HPN+V +    VG         + ++ +V E + +  KSL + +      P    
Sbjct: 58  LLKLQHPNIVTVKEVVVG-------SNLDKIYMVMEYVEHDLKSLMETM----KQPFL-Q 105

Query: 202 ARLK-IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGL 259
           + +K +      G+A+LH+     ++ RD KTSN+LL+     K+ DFGLAR+ G P   
Sbjct: 106 SEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL-- 160

Query: 260 GHVSTSVVGTVGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITGR 303
               T +V T+ Y APE  +     +   D+WS G +  EL+T +
Sbjct: 161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 83/285 (29%), Positives = 125/285 (43%), Gaps = 44/285 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 14  LGQGCFGEVWMGT------------WNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 61  DKLVPLYAVVSEE-----PIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGM 115

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AY+ E M++  I RD + +NIL+ ++   K++DFGLAR        +  T+  G    + 
Sbjct: 116 AYI-ERMNY--IHRDLRAANILVGDNLVCKIADFGLARLIE----DNEYTARQGAKFPIK 168

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           + APE    GR T KSDVWSFG++L EL+T  R     +   E  +LE V       + +
Sbjct: 169 WTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQV------ERGY 220

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
            +   P  +G  C +S   L  L   C  K P  RP    +   L
Sbjct: 221 RM---PCPQG--CPES---LHELMKLCWKKDPDERPTFEYIQSFL 257

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 77.8 bits (192), Expect = 6e-16
 Identities = 55/202 (27%), Positives = 83/202 (41%), Gaps = 34/202 (16%)

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
           KIA    + L YL EE+  ++I RD K SNILLD +   KL DFG++        G +  
Sbjct: 111 KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGIS--------GQLVD 160

Query: 265 SVVGTVG-----YAAPEYVQTGRLTA---KSDVWSFGVVLYELITGRRAVERNLPRNE-Q 315
           S+  T       Y APE +          +SDVWS G+ LYE+ TG+       P  +  
Sbjct: 161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGK------FPYPKWN 214

Query: 316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
            + + +   V           P L  +   + +       + CL K    RPK  E+++ 
Sbjct: 215 SVFDQLTQVVKGDP-------PILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267

Query: 376 LGNIISEISSQDEVTLQPVAEI 397
               I +   ++      V  I
Sbjct: 268 --PFIKDYEERNVDVAAYVQRI 287

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 77.6 bits (191), Expect = 6e-16
 Identities = 79/281 (28%), Positives = 120/281 (42%), Gaps = 38/281 (13%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINE 145
           F    ++G+GGFG V    VR +   +           A K+L ++  +   G    +NE
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMY-----------ACKKLEKKRIKKRKGEAMALNE 50

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
              L  V    +V L  Y  E  +      LV  LM+   L+ H+ +           + 
Sbjct: 51  KQILEKVNSRFVVSL-AYAYETKD---ALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVF 106

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
            A +   GL  LH E   ++++RD K  NILLD+    ++SD GLA + P    G     
Sbjct: 107 YAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPE---GETIRG 160

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            VGTVGY APE V+  R T   D W  G ++YE+I G+    +   R E+   E V   V
Sbjct: 161 RVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQ---RKEKVKREEVERRV 217

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
            + ++            Y  K ++   ++  + LTK P  R
Sbjct: 218 KEDQE-----------EYSEKFSEAARSICRQLLTKDPGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 77.2 bits (190), Expect = 7e-16
 Identities = 69/226 (30%), Positives = 112/226 (49%), Gaps = 35/226 (15%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 2   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 50

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHN---KSLEDHLLSRVPTPLAWIA 202
           + L  + HPN+VKL+     D      +L LV+E +H    K ++   LS +P PL    
Sbjct: 51  SLLKELNHPNIVKLL-----DVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSY 105

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGH 261
             ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P     
Sbjct: 106 LFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---R 155

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
             T  V T+ Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 156 TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 77.1 bits (189), Expect = 9e-16
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 23/228 (10%)

Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ 134
           ++ S   +    + ++R   IG+G  G VY  +   +  +           VAIKQ+N Q
Sbjct: 7   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQE-----------VAIKQMNLQ 55

Query: 135 GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
                +  INE+  +   K+PN+V  +      DE      +V E +   SL D +++  
Sbjct: 56  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTET 110

Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
                 IA   + ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q 
Sbjct: 111 CMDEGQIA--AVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 165

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE      +++VGT  + APE V       K D+WS G++  E++ G
Sbjct: 166 TPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEG 211

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 77.4 bits (190), Expect = 1e-15
 Identities = 82/315 (26%), Positives = 137/315 (43%), Gaps = 55/315 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D +     +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 26  LGEGCFGQVV--MAEAIGLDKEKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 81

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  + +            
Sbjct: 82  KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQL 137

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 138 SFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARD----- 189

Query: 259 LGHV-----STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN 313
           + H+     +T+    V + APE +     T +SDVWSFGV+L+E+ T   +    +P  
Sbjct: 190 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249

Query: 314 EQ-KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           E  KLL          K+ H +  P            +L  +   C    P  RP   ++
Sbjct: 250 ELFKLL----------KEGHRMDKPS-------NCTNELYMMMRDCWHAVPSQRPTFKQL 292

Query: 373 VDILGNIISEISSQD 387
           V+ L  I++  S+Q+
Sbjct: 293 VEDLDRILALTSNQE 307

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 1e-15
 Identities = 67/226 (29%), Positives = 97/226 (42%), Gaps = 58/226 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN------- 147
           +G+GG+G V+    +           D+   VA+K++ +         +NEV        
Sbjct: 9   VGQGGYGQVFLAKKK-----------DTGEIVALKRMKKSLLF----KLNEVRHVLTERD 53

Query: 148 FLGVVKHPNLVKLVGYCAEDDER----------GMQRLLVYELMHNKSL-EDHLLSRVPT 196
            L   K   LVKL+ Y  +DDE           G  R L   L +   L EDH  +R   
Sbjct: 54  ILTTTKSEWLVKLL-YAFQDDEYLYLAMEYVPGGDFRTL---LNNLGVLSEDH--ARF-- 105

Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
              ++A +  A DA   L Y+H         RD K  N L+D     KL+DFGL++    
Sbjct: 106 ---YMAEMFEAVDALHELGYIH---------RDLKPENFLIDASGHIKLTDFGLSK---- 149

Query: 257 EGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            G+   + SVVG+  Y APE ++        D WS G +LYE + G
Sbjct: 150 -GIVTYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCG 194

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 63/218 (28%), Positives = 94/218 (43%), Gaps = 28/218 (12%)

Query: 91  RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-----KEWINE 145
           R  L+G+G FG VY     +  D       D+  ++A+KQ+                  E
Sbjct: 6   RGKLLGQGAFGRVY-----LCYD------VDTGRELAVKQVPFDPDSPETKKEVNALECE 54

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHLLSRVPTPLAWIARL 204
           +  L  ++H  +V+  G C  DDE     L ++ E M   S++D L  +    L      
Sbjct: 55  IQLLKNLQHERIVQYYG-CLRDDET----LSIFMEYMPGGSVKDQL--KAYGALTETVTR 107

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA-RQGPPEGLGHVS 263
           K  +    G+ YLH  M   ++ RD K +NIL D     KL DFG + R       G   
Sbjct: 108 KYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGM 164

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            SV GT  + +PE +       K+DVWS G  + E++T
Sbjct: 165 KSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLT 202

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 76.8 bits (189), Expect = 1e-15
 Identities = 63/213 (29%), Positives = 110/213 (51%), Gaps = 26/213 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-INEVNFLGVVK 153
           +GEG +  VY+G  R + +            VA+K+++    +G     I E++ +  +K
Sbjct: 8   LGEGTYATVYKGRNRTTGEI-----------VALKEIHLDAEEGTPSTAIREISLMKELK 56

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-VPTPLAWIARLKIAQDAAR 212
           H N+V+L      ++    + +LV+E M +K L+ ++ +  V   L             +
Sbjct: 57  HENIVRLHDVIHTEN----KLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLK 111

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVGTVG 271
           G+A+ HE    +++ RD K  N+L+++  + KL+DFGLAR  G P  +   S  VV T+ 
Sbjct: 112 GIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIP--VNTFSNEVV-TLW 165

Query: 272 YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
           Y AP+ +   R  + S D+WS G ++ E+ITGR
Sbjct: 166 YRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGR 198

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 76.7 bits (188), Expect = 1e-15
 Identities = 66/228 (28%), Positives = 105/228 (46%), Gaps = 23/228 (10%)

Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ 134
           ++ S   +    + ++R   IG+G  G VY  +   +  +           VAI+Q+N Q
Sbjct: 8   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQE-----------VAIRQMNLQ 56

Query: 135 GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
                +  INE+  +   K+PN+V  +      DE      +V E +   SL D +++  
Sbjct: 57  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTET 111

Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
                 IA   + ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q 
Sbjct: 112 CMDEGQIA--AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE      +++VGT  + APE V       K D+WS G++  E+I G
Sbjct: 167 TPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEG 212

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.0 bits (189), Expect = 1e-15
 Identities = 65/198 (32%), Positives = 93/198 (46%), Gaps = 18/198 (9%)

Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
           I E+  L     P +V   G    D E      +  E M   SL+  L      P   + 
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKEAKRIPEEILG 106

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHV 262
           ++ IA    RGLAYL E+   Q++ RD K SNIL++   + KL DFG++ Q     +  +
Sbjct: 107 KVSIA--VLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSM 158

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV- 321
           + S VGT  Y +PE +Q    + +SD+WS G+ L EL  GR  +    P  + K LE + 
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPI----PPPDAKELEAIF 214

Query: 322 -RPYVSDSKKFHLIIDPR 338
            RP V   +     I PR
Sbjct: 215 GRPVVDGEEGEPHSISPR 232

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 76.0 bits (188), Expect = 2e-15
 Identities = 69/217 (31%), Positives = 98/217 (45%), Gaps = 40/217 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLGV 151
           +G G FG V    VR     H+ SG       A+K L++      K+    +NE   L  
Sbjct: 9   LGTGSFGRVML--VR-----HKGSGKY----YALKILSKAKIVKLKQVEHVLNEKRILQS 57

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQ 208
           ++HP LV L G   +DD      L LV E +    L  HL    R P P   +AR   AQ
Sbjct: 58  IRHPFLVNLYG-SFQDD----SNLYLVMEYVPGGELFSHLRKSGRFPEP---VARFYAAQ 109

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST---S 265
                L YLH      +++RD K  N+LLD D   K++DFG A+         V     +
Sbjct: 110 VVL-ALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK--------RVKGRTYT 157

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           + GT  Y APE + +       D W+ G+++YE++ G
Sbjct: 158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 76.3 bits (188), Expect = 2e-15
 Identities = 62/224 (27%), Positives = 102/224 (45%), Gaps = 29/224 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV 152
            +GEG FG V +               +    VA+K L      +   + ++E+  + ++
Sbjct: 19  PLGEGAFGQVVKAEAV------GLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMI 72

Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-------------- 197
            KH N++ L+G C ++   G   ++V E   + +L D L +R P                
Sbjct: 73  GKHKNIINLLGVCTQE---GPLYVVV-EYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
           L     +  A   ARG+ +L  +   + I RD    N+L+ ED+  K++DFGLAR     
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                +T+    V + APE +     T +SDVWSFGV+L+E+ T
Sbjct: 186 DYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 76.8 bits (189), Expect = 2e-15
 Identities = 68/239 (28%), Positives = 104/239 (43%), Gaps = 53/239 (22%)

Query: 78  SFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTS----GHDSKLDVAIKQLNR 133
           S +EL+   R       IG G  G VY+ + R +   +        H+   D   +Q+ R
Sbjct: 72  SLSELERVNR-------IGSGAGGTVYKVIHRPTGRLYALKVIYGNHE---DTVRRQICR 121

Query: 134 QGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
                      E+  L  V HPN+VK    C +  +   +  ++ E M   SLE   ++ 
Sbjct: 122 -----------EIEILRDVNHPNVVK----CHDMFDHNGEIQVLLEFMDGGSLEGTHIAD 166

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG---- 249
               LA +AR  ++     G+AYLH      ++ RD K SN+L++     K++DFG    
Sbjct: 167 EQF-LADVARQILS-----GIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRI 217

Query: 250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQT----GRLTAKS-DVWSFGVVLYELITGR 303
           LA+   P        S VGT+ Y +PE + T    G     + D+WS GV + E   GR
Sbjct: 218 LAQTMDP------CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGR 270

Length = 353

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 75.6 bits (186), Expect = 3e-15
 Identities = 71/291 (24%), Positives = 126/291 (43%), Gaps = 60/291 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG       G+V +++D        +   VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 27  IGEGS-----TGIVCIATDKS------TGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQH 75

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PN+V++       DE      +V E +   +L D +++        IA   +     + L
Sbjct: 76  PNIVEMYSSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIA--TVCLAVLKAL 128

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST------SVVG 268
           ++LH +    +I RD K+ +ILL  D + KLSDFG   Q        VS       S+VG
Sbjct: 129 SFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ--------VSKEVPRRKSLVG 177

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
           T  + APE +       + D+WS G+++ E++ G        P           PY ++ 
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE-------P-----------PYFNEP 219

Query: 329 -----KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
                K+    + P+L      K + +L +   + L + P  R   +E+++
Sbjct: 220 PLQAMKRIRDNLPPKL--KNLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 75.8 bits (186), Expect = 4e-15
 Identities = 83/311 (26%), Positives = 137/311 (44%), Gaps = 46/311 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV- 152
           +GEG FG     VV   +        +  + VA+K L      +   + ++E+  + ++ 
Sbjct: 20  LGEGCFG----QVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPL 198
           KH N++ L+G C +D   G   +LV E     +L ++L +R P                L
Sbjct: 76  KHKNIINLLGACTQD---GPLYVLV-EYASKGNLREYLRARRPPGMDYSFDTCKLPEEQL 131

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
            +   +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 132 TFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNID 188

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
               +T+    V + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 189 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKL 248

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P            +L  +  +C    P  RP   ++V+ L 
Sbjct: 249 L----------KEGHRMDKP-------ANCTHELYMIMRECWHAVPSQRPTFKQLVEDLD 291

Query: 378 NIISEISSQDE 388
            +++ ++S DE
Sbjct: 292 RVLT-VTSTDE 301

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 75.0 bits (184), Expect = 4e-15
 Identities = 81/313 (25%), Positives = 128/313 (40%), Gaps = 63/313 (20%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEV 146
           F+   ++G+G FG V    ++      Q         VA+K L    F     +E++ E 
Sbjct: 1   FTLGRMLGKGEFGSVREAQLKSEDGSFQK--------VAVKMLKADIFSSSDIEEFLREA 52

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRL----LVYELMHNKSLEDHLL-SRV---PTPL 198
             +    HPN++KL+G       R   RL    ++   M +  L   LL SR+   P  L
Sbjct: 53  ACMKEFDHPNVIKLIGVSLR--SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTL 110

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA------- 251
                ++   D A G+ YL  +     I RD    N +L+E+    ++DFGL+       
Sbjct: 111 PLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167

Query: 252 --RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
             RQG    L          V + A E +     T  SDVW+FGV ++E++T        
Sbjct: 168 YYRQGCASKL---------PVKWLALESLADNVYTTHSDVWAFGVTMWEIMT-------- 210

Query: 310 LPRNEQKLLEWVRPY--VSDSKKF-HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
             R +        PY  V +S+ + +LI   RL+        + +  L  +C + +PK R
Sbjct: 211 --RGQT-------PYAGVENSEIYNYLIKGNRLKQP--PDCLEDVYELMCQCWSPEPKCR 259

Query: 367 PKMSEVVDILGNI 379
           P    + D L  I
Sbjct: 260 PSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 75.3 bits (185), Expect = 4e-15
 Identities = 77/304 (25%), Positives = 129/304 (42%), Gaps = 35/304 (11%)

Query: 89  FSRALL-----IGEGGFG----CVYRGVVRVSSDDHQTS-GHDSKLDVAIKQLNRQGFQG 138
           F R  L     +GEG FG    C   G+ +    D       +  + VA+K L     + 
Sbjct: 2   FPRKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKN 61

Query: 139 HK-EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP 197
            + +++ E+  +  +K PN+++L+  C   D   M    + E M N  L   L    P  
Sbjct: 62  ARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCM----ITEYMENGDLNQFLSRHEPQE 117

Query: 198 LAWIARLK---------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF 248
            A  A +          +A   A G+ YL   ++F  + RD  T N L+ ++Y  K++DF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYL-SSLNF--VHRDLATRNCLVGKNYTIKIADF 174

Query: 249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER 308
           G++R         +    V  + + + E +  G+ T  SDVW+FGV L+E++T  +    
Sbjct: 175 GMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPY 234

Query: 309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
           +   +EQ ++E    +  D  +   +  P L    C  S  KL      C  +  K RP 
Sbjct: 235 SQLSDEQ-VIENTGEFFRDQGRQVYLPKPAL----CPDSLYKLML---SCWRRNAKERPS 286

Query: 369 MSEV 372
             E+
Sbjct: 287 FQEI 290

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 75.6 bits (187), Expect = 5e-15
 Identities = 68/222 (30%), Positives = 99/222 (44%), Gaps = 36/222 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH----KEWINEVNFL 149
            IG G +G V       S+ D +T        VAIK+++   F       K  + E+  L
Sbjct: 7   PIGSGAYGVV------CSAVDKRTGR-----KVAIKKISNV-FD-DLIDAKRILREIKLL 53

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRV---PTPLAWIARLK 205
             ++H N++ L+             + +V ELM      +  L +V   P PL     ++
Sbjct: 54  RHLRHENIIGLLDILRPPSPEDFNDVYIVTELM------ETDLHKVIKSPQPLT-DDHIQ 106

Query: 206 --IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR-QGPPEGLGHV 262
             + Q   RGL YLH      +I RD K SNIL++ +   K+ DFGLAR   P E     
Sbjct: 107 YFLYQ-ILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGF 162

Query: 263 STSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
            T  V T  Y APE +  + R T   D+WS G +  EL+T +
Sbjct: 163 LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRK 204

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 74.0 bits (182), Expect = 7e-15
 Identities = 68/298 (22%), Positives = 121/298 (40%), Gaps = 63/298 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----GHKEWINEVNFL 149
           IG+G F  VY+ +  +               VA+K++  Q F+       ++ + E++ L
Sbjct: 10  IGKGQFSVVYKAICLLDG-----------RVVALKKV--QIFEMMDAKARQDCLKEIDLL 56

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYEL--------MHNKSLEDHLLSRVPTPLAWI 201
             + HPN++K +    E++E      +V EL        M     +   L  +P    W 
Sbjct: 57  KQLDHPNVIKYLASFIENNEL----NIVLELADAGDLSRMIKHFKKQKRL--IPERTIW- 109

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
              K        L ++H +   +++ RD K +N+ +      KL D GL R    +    
Sbjct: 110 ---KYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA- 162

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
            + S+VGT  Y +PE +       KSD+WS G +LYE+   +                  
Sbjct: 163 -AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQ------------------ 203

Query: 322 RPYVSDSKKFHLIIDPRLEGNYCIKSA----QKLAALASKCLTKQPKSRPKMSEVVDI 375
            P+  D    + +     + +Y    A    ++L  L S+C+   P+ RP +S V+ +
Sbjct: 204 SPFYGDKMNLYSLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.1 bits (182), Expect = 8e-15
 Identities = 56/200 (28%), Positives = 96/200 (48%), Gaps = 30/200 (15%)

Query: 179 ELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD 238
           E M   SL+  +  ++P  +  + R+ +A    +GL YL      +++ RD K SN+L++
Sbjct: 79  EFMDGGSLD--VYRKIPEHV--LGRIAVA--VVKGLTYL---WSLKILHRDVKPSNMLVN 129

Query: 239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
              + KL DFG++ Q     +  ++ + VGT  Y APE +   +    SDVWS G+   E
Sbjct: 130 TRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFME 185

Query: 299 LITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIID---PRL-EGNYCIKSAQKLAAL 354
           L  GR    + + +N+  L+          +    I+D   P L  G +    ++K    
Sbjct: 186 LALGRFPYPQ-IQKNQGSLMPL--------QLLQCIVDEDPPVLPVGQF----SEKFVHF 232

Query: 355 ASKCLTKQPKSRPKMSEVVD 374
            ++C+ KQPK RP    ++D
Sbjct: 233 ITQCMRKQPKERPAPENLMD 252

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 74.7 bits (184), Expect = 9e-15
 Identities = 37/98 (37%), Positives = 55/98 (56%), Gaps = 7/98 (7%)

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A +   GL +LHE     +I+RD K  N+LLD +   K++DFG+ ++G   G   V+TS 
Sbjct: 102 AAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG---VTTST 155

Query: 267 -VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
             GT  Y APE +         D W+ GV+LYE++ G+
Sbjct: 156 FCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQ 193

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 74.9 bits (185), Expect = 9e-15
 Identities = 69/229 (30%), Positives = 103/229 (44%), Gaps = 53/229 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-----NRQGFQGHKEWINEVNFL 149
           +G+G +G V++ + R +    +         VA+K++     N    Q       E+ FL
Sbjct: 15  LGKGAYGIVWKAIDRRT---KEV--------VALKKIFDAFRNATDAQ---RTFREIMFL 60

Query: 150 -GVVKHPNLVKLVG-YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             +  HPN+VKL+    AE+D+      LV+E M              T L  + R  I 
Sbjct: 61  QELGDHPNIVKLLNVIKAENDK---DIYLVFEYME-------------TDLHAVIRANIL 104

Query: 208 QDA---------ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---QGP 255
           +D           + L Y+H      +I RD K SNILL+ D + KL+DFGLAR   +  
Sbjct: 105 EDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161

Query: 256 PEGLGHVSTSVVGTVGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITGR 303
                 V T  V T  Y APE  + + R T   D+WS G +L E++ G+
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 74.5 bits (183), Expect = 1e-14
 Identities = 41/94 (43%), Positives = 55/94 (58%), Gaps = 9/94 (9%)

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST--SVVG 268
           A  L +LH      +I+RD K  NILLDE+   KL+DFGL++    E + H     S  G
Sbjct: 108 ALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFCG 160

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           TV Y APE V     T  +D WSFGV+++E++TG
Sbjct: 161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 194

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 73.3 bits (180), Expect = 1e-14
 Identities = 75/301 (24%), Positives = 129/301 (42%), Gaps = 65/301 (21%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN--RQGFQGHKEWINEV 146
           + +   IGEG FG     +V+   D  Q           IK++N  +   +  +E   EV
Sbjct: 2   YVKVKKIGEGSFGKAI--LVKSKEDGKQ---------YVIKEINISKMSPKEREESRKEV 50

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLL--------VYELMHNKS----LEDHLLSRV 194
             L  +KHPN+V+   Y    +E G   ++        +Y+ ++ +      ED +L   
Sbjct: 51  AVLSNMKHPNIVQ---YQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILD-- 105

Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
                W  ++ +A      L ++H   D +++ RD K+ NI L +D   KL DFG+AR  
Sbjct: 106 -----WFVQICLA------LKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARV- 150

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER-NLPRN 313
                  ++ + +GT  Y +PE  +      KSD+W+ G VLYE+ T + A E  N+   
Sbjct: 151 -LNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNL 209

Query: 314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
             K++    P VS                     +  L  L S+   + P+ RP ++ ++
Sbjct: 210 VLKIIRGSYPPVS------------------SHYSYDLRNLVSQLFKRNPRDRPSVNSIL 251

Query: 374 D 374
           +
Sbjct: 252 E 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 73.4 bits (180), Expect = 1e-14
 Identities = 81/295 (27%), Positives = 124/295 (42%), Gaps = 43/295 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           IG G FG V  G               SK  V +K+L           ++ EV     + 
Sbjct: 3   IGNGWFGKVLLGEAHRGM---------SKARVVVKELRASATPDEQLLFLQEVQPYRELN 53

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS-RVPTPLAWIARL--KIAQDA 210
           HPN+++ +G C E     +  LLV E      L+++L S R          +  ++A + 
Sbjct: 54  HPNVLQCLGQCIE----SIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEV 109

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
           A GL +LH+  DF  I  D    N  L  D   K+ D+GLA +  PE            +
Sbjct: 110 ASGLLWLHQ-ADF--IHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPL 166

Query: 271 GYAAPEYVQ-------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPR--NEQKLLEWV 321
            + APE V+           T KS++WS GV ++EL T   A ++  P   +EQ L + V
Sbjct: 167 RWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT---AADQPYPDLSDEQVLKQVV 223

Query: 322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
           R    D K    +  P+L+  Y    + +   +   C    P++RP   EV ++L
Sbjct: 224 RE--QDIK----LPKPQLDLKY----SDRWYEVMQFCWL-DPETRPTAEEVHELL 267

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 79/286 (27%), Positives = 122/286 (42%), Gaps = 41/286 (14%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG V++G+      D++T     +  VAIK ++ +  +   E I  E+ 
Sbjct: 6   FTKLERIGKGSFGEVFKGI------DNRT-----QQVVAIKIIDLEEAEDEIEDIQQEIT 54

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P + K  G       +G +  ++ E +   S  D LL   P     IA +   
Sbjct: 55  VLSQCDSPYVTKYYGSYL----KGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATM--L 107

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           ++  +GL YLH E   + I RD K +N+LL E    KL+DFG+A Q     +     + V
Sbjct: 108 KEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKR--NTFV 162

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
           GT  + APE +Q     +K+D+WS G+   EL  G        P     L+    P    
Sbjct: 163 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---- 218

Query: 328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
                    P L G +    ++        CL K P  RP   E++
Sbjct: 219 ---------PTLTGEF----SKPFKEFIDACLNKDPSFRPTAKELL 251

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.5 bits (180), Expect = 1e-14
 Identities = 77/281 (27%), Positives = 118/281 (41%), Gaps = 38/281 (13%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINE 145
           F    ++G+GGFG V    VR +   +           A K+L ++  +   G    +NE
Sbjct: 2   FRHYRVLGKGGFGEVCACQVRATGKMY-----------ACKKLEKKRIKKRKGEAMALNE 50

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
              L  V    +V L  Y  E  +      LV  +M+   L+ H+ +           + 
Sbjct: 51  KRILEKVNSRFVVSL-AYAYETKD---ALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIF 106

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
            A +   GL  L  E   ++++RD K  NILLD+    ++SD GLA Q P    G     
Sbjct: 107 YAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPE---GETVRG 160

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            VGTVGY APE +   + T   D W  G ++YE+I G+    +   R E+   E V   V
Sbjct: 161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRK---RKERVKREEVDRRV 217

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
            + ++            Y  K ++   ++    LTK PK R
Sbjct: 218 KEDQE-----------EYSEKFSEDAKSICRMLLTKNPKER 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 74.3 bits (183), Expect = 2e-14
 Identities = 69/246 (28%), Positives = 95/246 (38%), Gaps = 64/246 (26%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNF 148
           +IG G FG V+  +VR                 A+K L      ++    H     E + 
Sbjct: 8   VIGRGAFGEVW--LVRDKDTGQV---------YAMKVLRKSDMIKRNQIAH--VRAERDI 54

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHL--LSRVPTPLA--WIAR 203
           L     P +VKL  Y +  DE     L LV E M    L + L      P   A  +IA 
Sbjct: 55  LADADSPWIVKL--YYSFQDEE---HLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAE 109

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA------------ 251
           L +A D+   L ++H         RD K  NIL+D D   KL+DFGL             
Sbjct: 110 LVLALDSVHKLGFIH---------RDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYY 160

Query: 252 ---------------RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL 296
                          R+   +     + S VGT  Y APE ++      + D WS GV+L
Sbjct: 161 LNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL 220

Query: 297 YELITG 302
           YE++ G
Sbjct: 221 YEMLYG 226

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 72.5 bits (178), Expect = 2e-14
 Identities = 56/221 (25%), Positives = 85/221 (38%), Gaps = 30/221 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN----EVNFLG 150
           I +G FG VY    R + D             AIK L +       +  N        + 
Sbjct: 4   ISKGAFGSVYLAKKRSTGDY-----------FAIKVLKKSDMIAKNQVTNVKAERAIMMI 52

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
             + P + KL  Y +   +  +   LV E ++       + +    P  W    +   + 
Sbjct: 53  QGESPYVAKL--YYSFQSKDYL--YLVMEYLNGGDCASLIKTLGGLPEDWAK--QYIAEV 106

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
             G+  LH+     +I RD K  N+L+D+    KL+DFGL+R       G  +   VGT 
Sbjct: 107 VLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSR------NGLENKKFVGTP 157

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP 311
            Y APE +        SD WS G V++E + G        P
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 72.9 bits (179), Expect = 2e-14
 Identities = 64/219 (29%), Positives = 103/219 (47%), Gaps = 32/219 (14%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDV-AIKQLNRQGFQGHKEWINEVN 147
             R   +G G FG       RV     + S H   L V AI ++ R   + H    NE  
Sbjct: 3   LERIKTVGTGTFG-------RVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVH--NEKR 53

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIAR 203
            L  V HP +++L  +  E D+R +  L+  E +    L  +L +       T L + + 
Sbjct: 54  VLKEVSHPFIIRL--FWTEHDQRFLYMLM--EYVPGGELFSYLRNSGRFSNSTGLFYASE 109

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
           +  A      L YLH +   ++++RD K  NILLD++   KL+DFG A++     L   +
Sbjct: 110 IVCA------LEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKK-----LRDRT 155

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            ++ GT  Y APE +Q+       D W+ G+++YE++ G
Sbjct: 156 WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVG 194

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 72.7 bits (178), Expect = 3e-14
 Identities = 67/210 (31%), Positives = 99/210 (47%), Gaps = 22/210 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK- 153
           IG G +G VY+     + D H  SGH   L     Q N  G       + EV  L  ++ 
Sbjct: 8   IGVGAYGTVYK-----ARDPH--SGHFVALKSVRVQTNEDGLP--LSTVREVALLKRLEA 58

Query: 154 --HPNLVKLVGYCAED-DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK-IAQD 209
             HPN+V+L+  CA    +R  +  LV+E + ++ L  +L  +VP P      +K + + 
Sbjct: 59  FDHPNIVRLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQ 116

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
             RGL +LH      ++ RD K  NIL+    + KL+DFGLAR    +      T VV T
Sbjct: 117 FLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQ---MALTPVVVT 170

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           + Y APE +         D+WS G +  E+
Sbjct: 171 LWYRAPEVLLQSTYATPVDMWSVGCIFAEM 200

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 72.5 bits (178), Expect = 3e-14
 Identities = 53/185 (28%), Positives = 79/185 (42%), Gaps = 46/185 (24%)

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
           KIA    + L YLH ++   +I RD K SN+L++ + + KL DFG++        G++  
Sbjct: 107 KIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGIS--------GYLVD 156

Query: 265 SVVGTVG-----YAAPEYVQTGRLTA----KSDVWSFGVVLYELITGRRAVERNLPRNEQ 315
           SV  T+      Y APE +           KSDVWS G+ + EL TGR   +        
Sbjct: 157 SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS------- 209

Query: 316 KLLEWVRPY------VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM 369
               W  P+      V +         P+L      K + +     +KCL K  K RP  
Sbjct: 210 ----WKTPFQQLKQVVEEPS-------PQLPAE---KFSPEFQDFVNKCLKKNYKERPNY 255

Query: 370 SEVVD 374
            E++ 
Sbjct: 256 PELLQ 260

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 72.2 bits (177), Expect = 3e-14
 Identities = 61/234 (26%), Positives = 106/234 (45%), Gaps = 49/234 (20%)

Query: 91  RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-----NRQGFQGHKEWIN- 144
           +  LIG G FG VY G+       + +SG      +A+KQ+     +       +  ++ 
Sbjct: 4   KGALIGSGSFGSVYLGM-------NASSG----ELMAVKQVELPSVSASSKDRKRSMLDA 52

Query: 145 ---EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY-------ELMHN-KSLEDHLLSR 193
              E+  L  ++H N+V+ +G  +  D   +   L Y        L++N  + E+ L+  
Sbjct: 53  LAREIALLKELQHENIVQYLG--SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR- 109

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                         +   +GL YLH      +I RD K +NIL+D     K+SDFG++++
Sbjct: 110 -----------NFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKK 155

Query: 254 GPPE----GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                          S+ G+V + APE V+    T K+D+WS G ++ E++TG+
Sbjct: 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 72/229 (31%), Positives = 99/229 (43%), Gaps = 58/229 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--H-KEWINEVNFLGV 151
           +G G +G V       S+ D +T        VAIK+L+R  FQ   H K    E+  L  
Sbjct: 23  VGSGAYGQV------CSAFDTKT-----GRKVAIKKLSRP-FQSAIHAKRTYRELRLLKH 70

Query: 152 VKHPNLVKL--VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           + H N++ L  V   A   E      LV  LM         L+ +      +   K++ D
Sbjct: 71  MDHENVIGLLDVFTPASSLEDFQDVYLVTHLM------GADLNNI------VKCQKLSDD 118

Query: 210 AA--------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      +I RD K SNI ++ED + K+ DFGLAR    E  G+
Sbjct: 119 HIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGY 175

Query: 262 VSTSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
                V T  Y APE       Y QT       D+WS G ++ EL+TG+
Sbjct: 176 -----VATRWYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGK 213

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 72.4 bits (178), Expect = 4e-14
 Identities = 85/310 (27%), Positives = 127/310 (40%), Gaps = 66/310 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL--NRQGFQGHKEWINEVNFLGVV 152
           IGEG +G V++   R     ++ +G      VAIK+   +       K  + E+  L  +
Sbjct: 9   IGEGSYGVVFK--CR-----NRETGQI----VAIKKFVESEDDPVIKKIALREIRMLKQL 57

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPNLV L+    E   R  +  LV+E   +  L  + L + P  +      KI     +
Sbjct: 58  KHPNLVNLI----EVFRRKRKLHLVFEYCDHTVL--NELEKNPRGVPEHLIKKIIWQTLQ 111

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVSTSVVGTV 270
            + + H+      I RD K  NIL+ +  + KL DFG AR   GP +      T  V T 
Sbjct: 112 AVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY----TDYVATR 164

Query: 271 GYAAPEY----VQTGRLTAKSDVWSFGVVLYELITG----------------RRAVERNL 310
            Y APE      Q G      DVW+ G V  EL+TG                R+ +   +
Sbjct: 165 WYRAPELLVGDTQYG---PPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLI 221

Query: 311 PRNEQKLLEWVRPYVSDSKKFH--LIIDPR----LEGNYCIKSAQKLAALASKCLTKQPK 364
           PR++Q          S ++ F    I +P     LE  +   S+  L+ L   CL   P 
Sbjct: 222 PRHQQIF--------STNQFFKGLSIPEPETREPLESKFPNISSPALSFL-KGCLQMDPT 272

Query: 365 SRPKMSEVVD 374
            R    E+++
Sbjct: 273 ERLSCEELLE 282

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 72.2 bits (177), Expect = 5e-14
 Identities = 51/169 (30%), Positives = 77/169 (45%), Gaps = 18/169 (10%)

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDA 210
            HP L +L   C +  +R      V E ++   L  H+    R     A       A + 
Sbjct: 54  NHPFLTQLY-CCFQTPDR---LFFVMEFVNGGDLMFHIQKSRRFDEARARF----YAAEI 105

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
              L +LH++    +I+RD K  N+LLD +   KL+DFG+ ++G   G    +++  GT 
Sbjct: 106 TSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGK--TTSTFCGTP 160

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
            Y APE +Q        D W+ GV+LYE++ G    E     NE  L E
Sbjct: 161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFE---AENEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 72.2 bits (177), Expect = 6e-14
 Identities = 40/113 (35%), Positives = 60/113 (53%), Gaps = 8/113 (7%)

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A +    L +LH      +I+RD K  NILLD +   KL+DFG+ ++G   G+   +T+ 
Sbjct: 102 AAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTF 156

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
            GT  Y APE +Q        D W+ GV++YE++ G+   E +   NE  L E
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEAD---NEDDLFE 206

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 67/240 (27%), Positives = 108/240 (45%), Gaps = 47/240 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+             + ++    VA+K + + G    + ++ E N +  ++H
Sbjct: 14  LGAGQFGEVW------------MATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS----RVPTPLAWIARLKIAQDA 210
             LVKL     ++        ++ E M   SL D L S    + P P      +  +   
Sbjct: 61  DKLVKLHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLP----KLIDFSAQI 111

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG-T 269
           A G+A++ +      I RD + +NIL+      K++DFGLAR    E   + +       
Sbjct: 112 AEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLAR--VIEDNEYTAREGAKFP 166

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GR------------RAVERN--LPRNE 314
           + + APE +  G  T KSDVWSFG++L E++T GR            RA+ER   +PR E
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 71.9 bits (177), Expect = 7e-14
 Identities = 63/225 (28%), Positives = 96/225 (42%), Gaps = 44/225 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINEVNFLG 150
            IGEG +G V       S+    T      + VAIK++     Q F   +  + E+  L 
Sbjct: 12  YIGEGAYGMV------CSATHKPT-----GVKVAIKKISPFEHQTFC--QRTLREIKILR 58

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             KH N++ ++             + +V ELM         L ++      I    ++ D
Sbjct: 59  RFKHENIIGILDIIRPPSFESFNDVYIVQELMETD------LYKL------IKTQHLSND 106

Query: 210 AA--------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+ +   K+ DFGLAR   PE   H
Sbjct: 107 HIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEH-DH 162

Query: 262 VS--TSVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
               T  V T  Y APE +   +   K+ D+WS G +L E+++ R
Sbjct: 163 TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 71.6 bits (176), Expect = 8e-14
 Identities = 81/293 (27%), Positives = 118/293 (40%), Gaps = 60/293 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV- 152
            IG G  G VY+  +R      + +GH     +A+KQ+ R G +   + I  +  L VV 
Sbjct: 22  EIGSGTCGQVYK--MR-----FKKTGHV----MAVKQMRRTGNKEENKRI--LMDLDVVL 68

Query: 153 -KH--PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             H  P +VK  GY   D +      +  ELM   +  D LL R+  P+      K+   
Sbjct: 69  KSHDCPYIVKCYGYFITDSDV----FICMELM--STCLDKLLKRIQGPIPEDILGKMTVA 122

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
             + L YL E+    +I RD K SNILLD     KL DFG++        G +  S   T
Sbjct: 123 IVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGIS--------GRLVDSKAKT 172

Query: 270 VGYAAPEYVQTGRLTAK---------SDVWSFGVVLYELITGRRAVERNLPRNE--QKLL 318
                  Y+   R+            +DVWS G+ L EL TG+   +      E   K+L
Sbjct: 173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKIL 232

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
           +   P +  ++ F                +    +    CLTK  + RPK  E
Sbjct: 233 QEEPPSLPPNEGF----------------SPDFCSFVDLCLTKDHRKRPKYRE 269

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 71.3 bits (175), Expect = 9e-14
 Identities = 66/215 (30%), Positives = 95/215 (44%), Gaps = 31/215 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGV 151
           L+GEG +G V +         H+ +G      VAIK+           K  + E+  L  
Sbjct: 8   LVGEGSYGMVMKC-------KHKETGQI----VAIKKFLESEDDKMVKKIAMREIRMLKQ 56

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           ++H NLV L+        R  +RL LV+E + +  L+D  L + P  L      K     
Sbjct: 57  LRHENLVNLIEVF-----RRKKRLYLVFEFVDHTVLDD--LEKYPNGLDESRVRKYLFQI 109

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVSTSVVG 268
            RG+ + H      +I RD K  NIL+ +    KL DFG AR    P    G V T  V 
Sbjct: 110 LRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP----GEVYTDYVA 162

Query: 269 TVGYAAPEY-VQTGRLTAKSDVWSFGVVLYELITG 302
           T  Y APE  V   +     D+W+ G ++ E++TG
Sbjct: 163 TRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTG 197

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 68/220 (30%), Positives = 109/220 (49%), Gaps = 37/220 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR------QGFQGHKEWINEVN 147
           ++G+GG+G V++  VR      + +G D+    A+K L +      Q    H +   E N
Sbjct: 3   VLGKGGYGKVFQ--VR------KVTGADTGKIFAMKVLKKATIVRNQKDTAHTK--AERN 52

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY----EL-MHNKSLEDHLLSRVPTPLAWIA 202
            L  VKHP +V L+ Y  +   + +  +L Y    EL MH   LE   +    T   +++
Sbjct: 53  ILEAVKHPFIVDLI-YAFQTGGK-LYLILEYLSGGELFMH---LEREGIFMEDTACFYLS 107

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHV 262
            + +A      L +LH++    +I+RD K  NILLD     KL+DFGL ++   E  G V
Sbjct: 108 EISLA------LEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHE--GTV 156

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           + +  GT+ Y APE +         D WS G ++Y+++TG
Sbjct: 157 THTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTG 196

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 71.4 bits (175), Expect = 1e-13
 Identities = 35/92 (38%), Positives = 54/92 (58%), Gaps = 7/92 (7%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV-VGTVG 271
           GL +LH++    +I+RD K  N+LLD+D   K++DFG+ ++      G    S   GT  
Sbjct: 108 GLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKE---NMNGEGKASTFCGTPD 161

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           Y APE ++  +     D WSFGV+LYE++ G+
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQ 193

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 75/258 (29%), Positives = 110/258 (42%), Gaps = 44/258 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLGV 151
           +G G FG       RV    H+ +G       AIK L ++     K+      E + L  
Sbjct: 26  LGTGSFG-------RVRIAKHKGTGEY----YAIKCLKKREILKMKQVQHVAQEKSILME 74

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLA--WIARLKIA 207
           + HP +V +   C+  DE  +  LL  E +    L  HL    R P  +A  + A L +A
Sbjct: 75  LSHPFIVNM--MCSFQDENRVYFLL--EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLA 130

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
            +      YLH +    +I+RD K  N+LLD     K++DFG A++ P       + ++ 
Sbjct: 131 FE------YLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-----TFTLC 176

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP-RNEQKLLE------- 319
           GT  Y APE +Q+       D W+ GV+LYE I G      + P R  +K+L        
Sbjct: 177 GTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN 236

Query: 320 WVRPYVSDSKKFHLIIDP 337
           W      D  K  L  D 
Sbjct: 237 WFDGRARDLVKGLLQTDH 254

Length = 329

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 62/220 (28%), Positives = 99/220 (45%), Gaps = 27/220 (12%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVN 147
           F + L  G G FG V      V +  +  S  D+ + VA+K L        +E  ++E+ 
Sbjct: 39  FGKTL--GAGAFGKV------VEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELK 90

Query: 148 FLGVV-KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
            +  +  H N+V L+G C      G   L++ E      L + L  +  + L     L  
Sbjct: 91  IMSHLGNHENIVNLLGACT----IGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSF 146

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           +   A+G+A+L  +     I RD    N+LL      K+ DFGLAR      + + S  V
Sbjct: 147 SYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARD-----IMNDSNYV 198

Query: 267 VG-----TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           V       V + APE +     T +SDVWS+G++L+E+ +
Sbjct: 199 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 70.8 bits (173), Expect = 2e-13
 Identities = 69/242 (28%), Positives = 109/242 (45%), Gaps = 33/242 (13%)

Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
           I E+  L     P +V   G    D E      +  E M   SL+  L      P   + 
Sbjct: 51  IRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQILG 106

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHV 262
           ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     +  +
Sbjct: 107 KVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSM 158

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV- 321
           + S VGT  Y +PE +Q    + +SD+WS G+ L E+  GR  +    P  + K LE + 
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPI----PPPDAKELELMF 214

Query: 322 -RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
             P   D  +      PR  G       + L++         P SRP M+ + ++L  I+
Sbjct: 215 GCPVEGDPAESETSPRPRPPG-------RPLSSYG-------PDSRPPMA-IFELLDYIV 259

Query: 381 SE 382
           +E
Sbjct: 260 NE 261

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 70.0 bits (171), Expect = 2e-13
 Identities = 60/209 (28%), Positives = 93/209 (44%), Gaps = 18/209 (8%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+GGFG V    V+ +   +       KLD   K+L ++   G K  + E   L  V  
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACK----KLDK--KRLKKKS--GEKMALLEKEILEKVNS 52

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P +V L    A   E      LV  LM+   L+ H+ +     L     +  +     G+
Sbjct: 53  PFIVNL----AYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGI 108

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
            +LH      +++RD K  N+LLD+    +LSD GLA +      G   T   GT GY A
Sbjct: 109 LHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKD---GKTITQRAGTNGYMA 162

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           PE ++    +   D ++ G  +YE++ GR
Sbjct: 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGR 191

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 71.1 bits (174), Expect = 2e-13
 Identities = 47/158 (29%), Positives = 75/158 (47%), Gaps = 16/158 (10%)

Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E   L  V HP+++++          G    +V  L H  S     L++   PL     L
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLV----SGAITCMV--LPHYSSDLYTYLTKRSRPLPIDQAL 160

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHV 262
            I +    GL YLH +   ++I RD KT NI +++  +  + D G A+     P  LG  
Sbjct: 161 IIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLG-- 215

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
              + GTV   APE +   +  +K+D+WS G+VL+E++
Sbjct: 216 ---LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 69.3 bits (169), Expect = 3e-13
 Identities = 72/292 (24%), Positives = 118/292 (40%), Gaps = 51/292 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----GHKEWINEVNFL 149
           IG G F  VYR    +   D +         VA+K++  Q F+       ++ + E++ L
Sbjct: 10  IGRGQFSEVYRATCLL---DRKP--------VALKKV--QIFEMMDAKARQDCVKEIDLL 56

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL------SRVPTPLAWIAR 203
             + HPN++K +    ED+E      +V EL     L   +         +P    W   
Sbjct: 57  KQLNHPNVIKYLDSFIEDNELN----IVLELADAGDLSQMIKYFKKQKRLIPERTVW--- 109

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
            K        + ++H     +++ RD K +N+ +      KL D GL R    +     +
Sbjct: 110 -KYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--A 163

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
            S+VGT  Y +PE +       KSD+WS G +LYE+     A++     ++  L      
Sbjct: 164 HSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA----ALQSPFYGDKMNLF----- 214

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
             S  +K      P L   +    ++KL  L S C+   P  RP +  V  I
Sbjct: 215 --SLCQKIEQCDYPPLPTEH---YSEKLRELVSMCIYPDPDQRPDIGYVHQI 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 70.1 bits (171), Expect = 3e-13
 Identities = 78/311 (25%), Positives = 138/311 (44%), Gaps = 47/311 (15%)

Query: 95  IGEGGFGCVYRG-VVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG V     + +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 23  LGEGCFGQVVMAEALGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 77

Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   IAR+   Q
Sbjct: 78  GKHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQ 133

Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 134 MTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-K 316
                +T+    V + APE +     T +SDVWSFGV+++E+ T   +    +P  E  K
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 250

Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
           LL          K+ H +  P            +L  +   C    P  RP   ++V+ L
Sbjct: 251 LL----------KEGHRMDKP-------ANCTNELYMMMRDCWHAIPSHRPTFKQLVEDL 293

Query: 377 GNIISEISSQD 387
             I++  ++++
Sbjct: 294 DRILTLTTNEE 304

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 69.6 bits (171), Expect = 4e-13
 Identities = 62/228 (27%), Positives = 95/228 (41%), Gaps = 45/228 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW--------INEV 146
           IG G +G VY+   R +  D +        + AIK+     F+G KE           E+
Sbjct: 8   IGRGTYGRVYK-AKRKNGKDGK--------EYAIKK-----FKGDKEQYTGISQSACREI 53

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY------ELMHNKSLEDHLLSRVPTPLAW 200
             L  +KH N+V LV    E  ++ +  L  Y      +++            +P  +  
Sbjct: 54  ALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHR--QAKRVSIPPSMVK 111

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLAR--QG 254
               +I      G+ YLH      ++ RD K +NIL+     E    K+ D GLAR    
Sbjct: 112 SLLWQILN----GVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNA 164

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELIT 301
           P + L  +   VV T+ Y APE +   R  T   D+W+ G +  EL+T
Sbjct: 165 PLKPLADLDPVVV-TIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 68.8 bits (168), Expect = 4e-13
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 42/217 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHK-EWINEVNFLGVV 152
           +G G FG V +G+ ++           S+  VA+K L N       K E + E N +  +
Sbjct: 3   LGSGNFGTVKKGMYKMKK---------SEKTVAVKILKNDNNDPALKDELLREANVMQQL 53

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYE----------LMHNKSLEDHLLSRVPTPLAWIA 202
            +P +V+++G C          +LV E          L  NK + +  ++          
Sbjct: 54  DNPYIVRMIGIC-----EAESWMLVMELAELGPLNKFLQKNKHVTEKNIT---------- 98

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGH 261
             ++    + G+ YL EE +F  + RD    N+LL   + AK+SDFGL++  G  E    
Sbjct: 99  --ELVHQVSMGMKYL-EETNF--VHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYK 153

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
             T     V + APE +   + ++KSDVWSFGV+++E
Sbjct: 154 AKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 74/288 (25%), Positives = 127/288 (44%), Gaps = 54/288 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG       G+V ++ + H      S   VA+K ++ +  Q  +   NEV  +   +H
Sbjct: 29  IGEGS-----TGIVCIAREKH------SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 77

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++     +    G +  ++ E +   +L D ++S+       IA   + +   + L
Sbjct: 78  QNVVEMY----KSYLVGEELWVLMEFLQGGALTD-IVSQTRLNEEQIA--TVCESVLQAL 130

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---GPPEGLGHVSTSVVGTVG 271
            YLH +    +I RD K+ +ILL  D + KLSDFG   Q     P+       S+VGT  
Sbjct: 131 CYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK-----RKSLVGTPY 182

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS--- 328
           + APE +       + D+WS G+++ E++ G                    PY SDS   
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGE------------------PPYFSDSPVQ 224

Query: 329 --KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
             K+      P+L+  +  K +  L     + LT++P+ R    E++D
Sbjct: 225 AMKRLRDSPPPKLKNAH--KISPVLRDFLERMLTREPQERATAQELLD 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 69.8 bits (171), Expect = 5e-13
 Identities = 66/241 (27%), Positives = 104/241 (43%), Gaps = 43/241 (17%)

Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
                +L+     F    +IG G FG V   +VR     H+     SK   A+K L++  
Sbjct: 32  AEKITKLRMKAEDFDVIKVIGRGAFGEVQ--LVR-----HK----SSKQVYAMKLLSK-- 78

Query: 136 FQGHKE------WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH 189
           F+  K       W  E + +       +V+L  + A  D++ +   +V E M    L + 
Sbjct: 79  FEMIKRSDSAFFW-EERDIMAHANSEWIVQL--HYAFQDDKYL--YMVMEYMPGGDLVN- 132

Query: 190 LLSRVPTPLAW----IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L+S    P  W     A + +A DA   + ++H         RD K  N+LLD+    KL
Sbjct: 133 LMSNYDIPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKL 183

Query: 246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTA----KSDVWSFGVVLYELIT 301
           +DFG   +    G+    T+ VGT  Y +PE +++         + D WS GV LYE++ 
Sbjct: 184 ADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 242

Query: 302 G 302
           G
Sbjct: 243 G 243

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 69.5 bits (170), Expect = 5e-13
 Identities = 36/93 (38%), Positives = 53/93 (56%), Gaps = 9/93 (9%)

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           RGL Y+H      ++ RD K SNIL++E+   K+ DFGLAR   P+  G+VST       
Sbjct: 119 RGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRY----- 170

Query: 272 YAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           Y APE + T  +   + D+WS G +  E++ G+
Sbjct: 171 YRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.3 bits (167), Expect = 6e-13
 Identities = 75/284 (26%), Positives = 119/284 (41%), Gaps = 48/284 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSD-DHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +G+G F  +Y+GV+RV SD D    G +    V +K L     +    +    + +  + 
Sbjct: 3   LGQGTFTNIYKGVLRVQSDLDIVGPGQEVS--VVLKVLG-SDHRDSLAFFETASLMSQLS 59

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL-LSRVPTPLAWIARLKIAQDAAR 212
           H +LVKL G C  D     + ++V E +    L+  L   +    L W  +L +A+  A 
Sbjct: 60  HKHLVKLYGVCVRD-----ENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLAS 112

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL-----DEDYK--AKLSDFGLARQGPPEGLGHVSTS 265
            L YL E+   +L+  +    NIL+     +E Y    KLSD G+        +      
Sbjct: 113 ALHYL-EDK--KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPI-----TVLSREER 164

Query: 266 VVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
           V   + + APE ++ G+  LT  +D WSFG  L E+ +         P +     E  R 
Sbjct: 165 VE-RIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSN-----GEEPLSTLSSSEKERF 218

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           Y    +  H +  P            +LA L ++C T  P  RP
Sbjct: 219 Y----QDQHRLPMP---------DCAELANLINQCWTYDPTKRP 249

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 68.7 bits (168), Expect = 6e-13
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 6/105 (5%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L +LH+     +I+RD K  NILLD +    L+DFGL+++   E     + S  GT+ Y 
Sbjct: 118 LDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEE-EERAYSFCGTIEYM 173

Query: 274 APEYVQTGRLTAKS--DVWSFGVVLYELITGRRAVERNLPRNEQK 316
           APE ++ G        D WS GV+ +EL+TG      +  +N Q 
Sbjct: 174 APEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQS 218

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 70.0 bits (171), Expect = 7e-13
 Identities = 74/280 (26%), Positives = 117/280 (41%), Gaps = 48/280 (17%)

Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
           +E++ L    H  +VK       DD    + LL+ E      L   +  R+   L +   
Sbjct: 114 SELHCLAACDHFGIVKHFDDFKSDD----KLLLIMEYGSGGDLNKQIKQRLKEHLPF--- 166

Query: 204 LKIAQDAARGLAY------LHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
               Q+   GL +      L E    +++ RD K++NI L      KL DFG ++Q    
Sbjct: 167 ----QEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
               V++S  GT  Y APE  +  R + K+D+WS GV+LYEL+T                
Sbjct: 223 VSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLH-------------- 268

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNY----CIKSAQKLAALASKCLTKQPKSRPKM---- 369
               RP+   S++   I+   L G Y    C  S+  + AL    L+K P  RP      
Sbjct: 269 ----RPFKGPSQR--EIMQQVLYGKYDPFPCPVSS-GMKALLDPLLSKNPALRPTTQQLL 321

Query: 370 -SEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEA 408
            +E +  + N+  +I    E T+ P    E +++  E+  
Sbjct: 322 HTEFLKYVANLFQDIVRHSE-TISPHDREEILRQLQESGE 360

Length = 478

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 58/225 (25%), Positives = 102/225 (45%), Gaps = 40/225 (17%)

Query: 91  RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG 150
             +++G+G +G VY         D  T     ++ +AIK++  +  +  +    E+    
Sbjct: 12  ERVVLGKGTYGIVYAA------RDLST-----QVRIAIKEIPERDSRYVQPLHEEIALHS 60

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            +KH N+V+ +G  +E+        +  E +   SL   L S+      W   LK  +  
Sbjct: 61  YLKHRNIVQYLGSDSENG----FFKIFMEQVPGGSLSALLRSK------W-GPLKDNEQT 109

Query: 211 A--------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA--KLSDFGLARQGPPEGLG 260
                     GL YLH+    Q++ RD K  N+L++  Y    K+SDFG +++    G+ 
Sbjct: 110 IIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNT-YSGVVKISDFGTSKR--LAGIN 163

Query: 261 HVSTSVVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGR 303
             + +  GT+ Y APE +  G     A +D+WS G  + E+ TG+
Sbjct: 164 PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 68.1 bits (166), Expect = 7e-13
 Identities = 79/292 (27%), Positives = 126/292 (43%), Gaps = 60/292 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWINEVNFLGVV 152
           ++GEG FG       R     H  S  D K   A+K++   +     ++   E   L  +
Sbjct: 7   VVGEGSFG-------RALLVQHVNS--DQKY--AMKEIRLPKSSSAVEDSRKEAVLLAKM 55

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYE------LMHNKSLEDHLLSRVPTPLAWIARLKI 206
           KHPN+V       E  E      +V E      LM    L+   L    T L W  ++ +
Sbjct: 56  KHPNIVAF----KESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCL 111

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVST 264
                 G+ ++HE+   +++ RD K+ NI L ++ K KL DFG AR    P    G  + 
Sbjct: 112 ------GVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP----GAYAC 158

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY 324
           + VGT  Y  PE  +      KSD+WS G +LYEL T +                   P+
Sbjct: 159 TYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLK------------------HPF 200

Query: 325 VSDSKKFHLIIDPRLEGNYCIKSAQ---KLAALASKCLTKQPKSRPKMSEVV 373
            ++S K +LI+    +G+Y    +    +L +L  +   + P+SRP  + ++
Sbjct: 201 QANSWK-NLILKV-CQGSYKPLPSHYSYELRSLIKQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 68.2 bits (166), Expect = 8e-13
 Identities = 83/304 (27%), Positives = 128/304 (42%), Gaps = 63/304 (20%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F    L+G G +G VY+G        H  +G  +    AIK ++  G +  +E   E+N 
Sbjct: 8   FELVELVGNGTYGQVYKG-------RHVKTGQLA----AIKVMDVTGDE-EEEIKQEINM 55

Query: 149 LG-VVKHPNLVKLVGYCAEDDERGM--QRLLVYELMHNKSLEDHLLSRVPTPLA--WIAR 203
           L     H N+    G   + +  GM  Q  LV E     S+ D + +     L   WIA 
Sbjct: 56  LKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY 115

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
             I ++  RGL++LH+    ++I RD K  N+LL E+ + KL DFG++ Q     +G  +
Sbjct: 116 --ICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-LDRTVGRRN 169

Query: 264 TSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITG---------RRAVERN 309
           T  +GT  + APE +            KSD+WS G+   E+  G          RA+   
Sbjct: 170 T-FIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL- 227

Query: 310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM 369
           +PRN                       PRL+     K ++K  +    CL K    RP  
Sbjct: 228 IPRNPA---------------------PRLKSK---KWSKKFQSFIESCLVKNHSQRPTT 263

Query: 370 SEVV 373
            +++
Sbjct: 264 EQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 92/353 (26%), Positives = 143/353 (40%), Gaps = 91/353 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T      L VA+K+L+R  Q     K    E+  L  +
Sbjct: 25  VGSGAYGSV------CAAFDTKTG-----LRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 74  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 122

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 123 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 177

Query: 262 VSTSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
           V+T       Y APE       Y QT       D+WS G ++ EL+TGR           
Sbjct: 178 VATR-----WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLTGRT---------- 216

Query: 315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS---- 370
                 + P      +  LI+  RL G    +  +K+++ +++   +     PKM+    
Sbjct: 217 ------LFPGTDHIDQLKLIL--RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV 268

Query: 371 ------EVVDILGNII-----SEISSQDEVTLQPVAEIEDVKEEPEAEAVVES 412
                   VD+L  ++       I++   +     A+  D  +EP A+   +S
Sbjct: 269 FIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDDEPVADPYDQS 321

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 68.4 bits (167), Expect = 1e-12
 Identities = 41/110 (37%), Positives = 62/110 (56%), Gaps = 8/110 (7%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           GL +LH +    +I+RD K  N++LD D   K++DFG+ ++    G    ST   GT  Y
Sbjct: 108 GLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENV-FGDNRAST-FCGTPDY 162

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            APE +Q  + T   D WSFGV+LYE++ G+     +   +E +L E +R
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD---DEDELFESIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 67.4 bits (164), Expect = 1e-12
 Identities = 72/290 (24%), Positives = 120/290 (41%), Gaps = 47/290 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINEVNFLGV 151
           IG G F  VYR    +   D         + VA+K++   +    +   + I E++ L  
Sbjct: 10  IGRGQFSEVYRATCLL---DG--------VPVALKKVQIFDLMDAKARADCIKEIDLLKQ 58

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED---HLLSR---VPTPLAWIARLK 205
           + HPN++K      ED+E      +V EL     L     H   +   +P    W    K
Sbjct: 59  LNHPNVIKYYASFIEDNELN----IVLELADAGDLSRMIKHFKKQKRLIPEKTVW----K 110

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
                   L ++H     +++ RD K +N+ +      KL D GL R    +     + S
Sbjct: 111 YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHS 165

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
           +VGT  Y +PE +       KSD+WS G +LYE+     A++     ++  L        
Sbjct: 166 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMA----ALQSPFYGDKMNLY------- 214

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
           S  KK      P L  ++    +++L  L + C+   P+ RP ++ V D+
Sbjct: 215 SLCKKIEQCDYPPLPSDH---YSEELRQLVNMCINPDPEKRPDITYVYDV 261

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 68.1 bits (167), Expect = 1e-12
 Identities = 62/218 (28%), Positives = 93/218 (42%), Gaps = 25/218 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           IG G +G V   +   S              VAIK++    F      K  + E+  L  
Sbjct: 13  IGSGAYGVVCSAIDTRS-----------GKKVAIKKIPH-AFDVPTLAKRTLRELKILRH 60

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
            KH N++ +               +V +LM +  L   + S  P     I R  + Q   
Sbjct: 61  FKHDNIIAIRDILRPPGADFKDVYVVMDLMES-DLHHIIHSDQPLTEEHI-RYFLYQ-LL 117

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVSTSVVGT 269
           RGL Y+H      +I RD K SN+L++ED + ++ DFG+AR     P    +  T  V T
Sbjct: 118 RGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174

Query: 270 VGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAV 306
             Y APE + +    T   D+WS G +  E++ GRR +
Sbjct: 175 RWYRAPELLLSLPEYTTAIDMWSVGCIFAEML-GRRQL 211

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 66.9 bits (163), Expect = 2e-12
 Identities = 74/301 (24%), Positives = 127/301 (42%), Gaps = 78/301 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVV 152
           +G+G +G V   +VR  +D  Q           IK+LN +    +  K    E   L  +
Sbjct: 8   VGKGSYGEV--SLVRHRTDGKQ---------YVIKKLNLRNASRRERKAAEQEAQLLSQL 56

Query: 153 KHPNLVK--------------LVGYCAEDDERGMQRLLVYELMHNKS---LEDHLLSRVP 195
           KHPN+V               ++G+C   D       L ++L   K     E+ ++    
Sbjct: 57  KHPNIVAYRESWEGEDGLLYIVMGFCEGGD-------LYHKLKEQKGKLLPENQVVE--- 106

Query: 196 TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP 255
               W  ++ +A      L YLHE+    ++ RD KT N+ L      K+ D G+AR   
Sbjct: 107 ----WFVQIAMA------LQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARV-- 151

Query: 256 PEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ 315
            E    ++++++GT  Y +PE         KSDVW+ G  +YE+ T + A       N +
Sbjct: 152 LENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAF------NAK 205

Query: 316 KLLEWVRPYVSDSKKFHLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
            +   V          + II+   P +  +Y    + +L  L +  L+K+P+ RP +  +
Sbjct: 206 DMNSLV----------YRIIEGKLPPMPKDY----SPELGELIATMLSKRPEKRPSVKSI 251

Query: 373 V 373
           +
Sbjct: 252 L 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 72/287 (25%), Positives = 127/287 (44%), Gaps = 38/287 (13%)

Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEV 146
                 + IGEG       G+V ++++ H      +   VA+K+++ +  Q  +   NEV
Sbjct: 22  EYLDSFIKIGEGS-----TGIVCIATEKH------TGKQVAVKKMDLRKQQRRELLFNEV 70

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             +    H N+V +       DE      +V E +   +L D +++        IA + +
Sbjct: 71  VIMRDYHHENVVDMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIATVCL 125

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           +    R L+YLH +    +I RD K+ +ILL  D + KLSDFG   Q   E       S+
Sbjct: 126 S--VLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKR--KSL 178

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
           VGT  + APE +       + D+WS G+++ E+I G        P   +  L+ +R  + 
Sbjct: 179 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEP------PYFNEPPLQAMR-RIR 231

Query: 327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
           D+      + PR++ ++ + S   L       L ++P  R    E++
Sbjct: 232 DN------LPPRVKDSHKVSSV--LRGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 67.7 bits (165), Expect = 2e-12
 Identities = 68/224 (30%), Positives = 96/224 (42%), Gaps = 48/224 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +G G +G V       S+ D +T        VAIK+L R  FQ     K    E+  L  
Sbjct: 23  VGSGAYGTV------CSALDRRTGA-----KVAIKKLYRP-FQSELFAKRAYRELRLLKH 70

Query: 152 VKHPNLVKLVGYCAEDD--ERGMQRLLVYELM---------HNKSLEDHLLSRVPTPLAW 200
           +KH N++ L+     D   +R     LV   M         H K  ED +   V   L  
Sbjct: 71  MKHENVIGLLDVFTPDLSLDRFHDFYLVMPFMGTDLGKLMKHEKLSEDRIQFLVYQML-- 128

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
                      +GL Y+H      +I RD K  N+ ++ED + K+ DFGLARQ   E  G
Sbjct: 129 -----------KGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSEMTG 174

Query: 261 HVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGR 303
           +V T       Y APE +      T   D+WS G ++ E++TG+
Sbjct: 175 YVVTR-----WYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGK 213

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.5 bits (162), Expect = 2e-12
 Identities = 74/291 (25%), Positives = 117/291 (40%), Gaps = 59/291 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK-LDVAIKQLNRQGFQGHKE----WINEVNFL 149
           +G G    +Y G++    DD        K + V +K L+      H++    +    + +
Sbjct: 3   LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLD----PSHRDISLAFFETASMM 58

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             V H ++V L G C  D E     ++V E +    L D  + R    L    + K+A+ 
Sbjct: 59  RQVSHKHIVLLYGVCVRDVEN----IMVEEFVEFGPL-DLFMHRKSDVLTTPWKFKVAKQ 113

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILL-----DEDYKA--KLSDFG-----LARQGPPE 257
            A  L+YL    D  L+  +  T NILL     D +     KLSD G     L+RQ    
Sbjct: 114 LASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSRQ---- 166

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
                    V  + + APE V+  + L+  +D WSFG  L+E+          +P  ++ 
Sbjct: 167 -------ECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEI-----CYNGEIPLKDKT 214

Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           L E  R Y     +  L+            S ++LA L + C+   P  RP
Sbjct: 215 LAEKERFYEG---QCMLV----------TPSCKELADLMTHCMNYDPNQRP 252

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 9/92 (9%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST--SVVGTV 270
           GL YLHE    ++++RD K  N+LLD +   K++DFGL +    EG+G      +  GT 
Sbjct: 113 GLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK----EGMGFGDRTSTFCGTP 165

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            + APE +     T   D W  GV++YE++ G
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVG 197

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 67.4 bits (164), Expect = 2e-12
 Identities = 48/157 (30%), Positives = 76/157 (48%), Gaps = 28/157 (17%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            L YLH E +  +++RD K  N++LD+D   K++DFGL ++G  +G      +  GT  Y
Sbjct: 107 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEY 162

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVRPYVSDSK 329
            APE ++        D W  GVV+YE++ GR      LP   ++ +KL E +   + +  
Sbjct: 163 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELI---LMEEI 213

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
           +F   + P  +            +L S  L K PK R
Sbjct: 214 RFPRTLSPEAK------------SLLSGLLKKDPKQR 238

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 67.1 bits (164), Expect = 3e-12
 Identities = 47/156 (30%), Positives = 75/156 (48%), Gaps = 29/156 (18%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L YLH      +++RD K  N++LD+D   K++DFGL ++G  +  G    +  GT  Y 
Sbjct: 108 LGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYL 162

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVRPYVSDSKK 330
           APE ++        D W  GVV+YE++ GR      LP   ++ +KL E +   + +  +
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELI---LMEEIR 213

Query: 331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
           F     PR         + +  +L +  L K PK R
Sbjct: 214 F-----PR-------TLSPEAKSLLAGLLKKDPKQR 237

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 38/219 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-----INEVNFL 149
           IGEG +G VY+          + +G      VA+K++     +   E      I E++ L
Sbjct: 7   IGEGTYGVVYKA-------RDKLTGEI----VALKKIR---LETEDEGVPSTAIREISLL 52

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHN--KSLEDHLLSRVPTPLAWIARLKI 206
             + HPN+V+L+     +      +L LV+E +    K   D            I     
Sbjct: 53  KELNHPNIVRLLDVVHSE-----NKLYLVFEFLDLDLKKYMDSS-PLTGLDPPLIK--SY 104

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTS 265
                +G+AY H     +++ RD K  N+L+D +   KL+DFGLAR  G P       T 
Sbjct: 105 LYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV---RTYTH 158

Query: 266 VVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
            V T+ Y APE +   R  +   D+WS G +  E++  R
Sbjct: 159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 68/216 (31%), Positives = 93/216 (43%), Gaps = 34/216 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVN-FLG 150
           IG+G FG V   + +  +D             A+K L ++     KE    + E N  L 
Sbjct: 3   IGKGSFGKVL--LAKHKADGKF---------YAVKVLQKKAILKKKEQKHIMAERNVLLK 51

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL--SRVPTPLAWIARLKIAQ 208
            VKHP LV L  Y  +  ++      V + ++   L  HL      P P A       A 
Sbjct: 52  NVKHPFLVGL-HYSFQTADK---LYFVLDYVNGGELFFHLQRERSFPEPRARF----YAA 103

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV- 267
           + A  L YLH      +I+RD K  NILLD      L+DFGL +    EG+ H  T+   
Sbjct: 104 EIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK----EGIEHSKTTSTF 156

Query: 268 -GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            GT  Y APE ++        D W  G VLYE++ G
Sbjct: 157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 67.0 bits (163), Expect = 4e-12
 Identities = 68/214 (31%), Positives = 94/214 (43%), Gaps = 28/214 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEVN-FLG 150
           +IG+G FG       +V     +  G    + V  K+  LNR+     K  + E N  L 
Sbjct: 2   VIGKGSFG-------KVLLAKRKLDGKCYAVKVLQKKIVLNRKE---QKHIMAERNVLLK 51

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQ 208
            VKHP LV L  Y  +  E+      V + ++   L  HL      P P A   R   A+
Sbjct: 52  NVKHPFLVGL-HYSFQTTEK---LYFVLDFVNGGELFFHLQRERSFPEPRA---RFYAAE 104

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
             A  L YLH      +++RD K  NILLD      L+DFGL ++G        +T+  G
Sbjct: 105 -IASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGI--AQSDTTTTFCG 158

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           T  Y APE ++        D W  G VLYE++ G
Sbjct: 159 TPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 66.5 bits (162), Expect = 4e-12
 Identities = 39/111 (35%), Positives = 60/111 (54%), Gaps = 10/111 (9%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV-VGTVG 271
           GL +LH +    +++RD K  NILLD D   K++DFG+ ++     LG   T    GT  
Sbjct: 108 GLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENM---LGDAKTCTFCGTPD 161

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
           Y APE +   +     D WSFGV+LYE++ G+         +E++L + +R
Sbjct: 162 YIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFH---GHDEEELFQSIR 209

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 66.2 bits (161), Expect = 4e-12
 Identities = 64/214 (29%), Positives = 93/214 (43%), Gaps = 21/214 (9%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL---GV 151
           IGEG +G V++      + D +  G    L     Q   +G       I EV  L     
Sbjct: 9   IGEGAYGKVFK------ARDLKNGGRFVALKRVRVQTGEEGMP--LSTIREVAVLRHLET 60

Query: 152 VKHPNLVKLVGYCA-EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK-IAQD 209
            +HPN+V+L   C     +R  +  LV+E  H        L +VP P      +K +   
Sbjct: 61  FEHPNVVRLFDVCTVSRTDRETKLTLVFE--HVDQDLTTYLDKVPEPGVPTETIKDMMFQ 118

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
             RGL +LH     +++ RD K  NIL+    + KL+DFGLAR    +      TSVV T
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 172

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           + Y APE +         D+WS G +  E+   +
Sbjct: 173 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 73/301 (24%), Positives = 127/301 (42%), Gaps = 58/301 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-INEVNFLGVV 152
           L+ EG FG ++ G++       +  G +   +V +K +     +      + E   L  +
Sbjct: 13  LLQEGTFGRIFYGILI-----DEKPGKEE--EVFVKTVKDHASEIQVTLLLQESCLLYGL 65

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS------RVPTPLAWIARLKI 206
            H N++ ++  C ED E      ++Y  M+  +L+  L          P  L+    + +
Sbjct: 66  SHQNILPILHVCIEDGEPPF---VLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHM 122

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A   A G++YLH+     +I +D    N ++DE+ + K++D  L+R   P     +  + 
Sbjct: 123 AIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNE 179

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV 325
              V + A E +     ++ SDVWSFGV+L+EL+T G+                   PYV
Sbjct: 180 NRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQ------------------TPYV 221

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLA----------ALASKCLTKQPKSRPKMSEVVDI 375
                    IDP     Y +K   +LA          A+ + C    P+ RP  S++V  
Sbjct: 222 E--------IDPFEMAAY-LKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQC 272

Query: 376 L 376
           L
Sbjct: 273 L 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 81/301 (26%), Positives = 123/301 (40%), Gaps = 67/301 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK- 153
           IG+G +G V++ + + +         D   D+             +E   E N L  +  
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI------------DEEIEAEYNILKALSD 73

Query: 154 HPNLVKLVG-YCAEDDERGMQRLLVYELMHNKSLEDHLL------SRVPTPLAWIARLKI 206
           HPN+VK  G Y  +D + G Q  LV EL +  S+ D +        R+  P+  IA   I
Sbjct: 74  HPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI--IAY--I 129

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
             +A  GL +LH     + I RD K +NILL  +   KL DFG++ Q           + 
Sbjct: 130 LHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQ--LTSTRLRRNTS 184

Query: 267 VGTVGYAAPEYVQTGR-----LTAKSDVWSFGVVLYELITG---------RRAVERNLPR 312
           VGT  + APE +   +       A+ DVWS G+   EL  G          RA+ + +PR
Sbjct: 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFK-IPR 243

Query: 313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           N    L     + ++   F                         KCLTK  + RP +S++
Sbjct: 244 NPPPTLHQPELWSNEFNDF-----------------------IRKCLTKDYEKRPTVSDL 280

Query: 373 V 373
           +
Sbjct: 281 L 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 66.0 bits (161), Expect = 7e-12
 Identities = 33/97 (34%), Positives = 54/97 (55%), Gaps = 5/97 (5%)

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A + A GL +LH +    +I+RD K  N++LD +   K++DFG+ ++      G  + + 
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTF 161

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            GT  Y APE +         D W+FGV+LYE++ G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 33/91 (36%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            L +LHE     +I+RD K  N+LLD D   KL+D+G+ ++G   G G  +++  GT  Y
Sbjct: 108 ALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGL--GPGDTTSTFCGTPNY 162

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W+ GV+++E++ GR
Sbjct: 163 IAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 65.4 bits (159), Expect = 9e-12
 Identities = 72/279 (25%), Positives = 120/279 (43%), Gaps = 38/279 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G V    V+ S           KL VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 28  IGEGSTGIVCIATVKSSG----------KL-VAVKKMDLRKQQRRELLFNEVVIMRDYQH 76

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++       DE      +V E +   +L D +++        IA + +A    + L
Sbjct: 77  ENVVEMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA--VLKAL 129

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
           + LH +    +I RD K+ +ILL  D + KLSDFG   Q   E       S+VGT  + A
Sbjct: 130 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKSLVGTPYWMA 184

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE +       + D+WS G+++ E++ G        P    K++    P           
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP----------- 233

Query: 335 IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
             P+L+  +  K +  L     + L + P  R   +E++
Sbjct: 234 --PKLKNLH--KVSPSLKGFLDRLLVRDPAQRATAAELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 26/217 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL--NRQGFQGHKEWIN----EVN 147
           L+G+G FG VY     +  D       D+  ++A+KQ+  + +  +  KE +N    E+ 
Sbjct: 9   LLGQGAFGRVY-----LCYD------ADTGRELAVKQVQFDPESPETSKE-VNALECEIQ 56

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L  + H  +V+  G   +  ER +   +  E M   S++D L S     L      K  
Sbjct: 57  LLKNLLHERIVQYYGCLRDPMERTLS--IFMEHMPGGSIKDQLKSY--GALTENVTRKYT 112

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL-GHVSTSV 266
           +    G++YLH  M   ++ RD K +NIL D     KL DFG +++     L G    SV
Sbjct: 113 RQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSV 169

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            GT  + +PE +       K+D+WS G  + E++T +
Sbjct: 170 TGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 65.4 bits (159), Expect = 1e-11
 Identities = 67/214 (31%), Positives = 96/214 (44%), Gaps = 28/214 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN---EVN-FL 149
           +IG+G FG       +V     ++ G       A+K L ++     KE  +   E N  L
Sbjct: 2   VIGKGSFG-------KVLLAKRKSDGSF----YAVKVLQKKTILKKKEQNHIMAERNVLL 50

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             +KHP LV L  Y  +  E+      V + ++   L  HL  R    L   AR   A +
Sbjct: 51  KNLKHPFLVGL-HYSFQTAEK---LYFVLDYVNGGELFFHL-QRERCFLEPRARF-YAAE 104

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG-PPEGLGHVSTSVVG 268
            A  + YLH      +I+RD K  NILLD      L+DFGL ++G  PE     +++  G
Sbjct: 105 VASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE---TTSTFCG 158

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           T  Y APE ++        D W  G VLYE++ G
Sbjct: 159 TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 54/222 (24%), Positives = 101/222 (45%), Gaps = 28/222 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           +GE  FG VY+G +  ++   QT        VAIK L ++      +E+ +E      ++
Sbjct: 13  LGEDRFGKVYKGHLFGTAPGEQTQA------VAIKTLKDKAEGPLREEFKHEAMMRSRLQ 66

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPLA 199
           HPN+V L+G   ++    M    ++    +  L + L+ R P              + L 
Sbjct: 67  HPNIVCLLGVVTKEQPLSM----IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
               + I    A G+ +L       ++ +D  T N+L+ +    K+SD GL R+      
Sbjct: 123 PADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY 179

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             +  + +  + + +PE +  G+ +  SD+WS+GVVL+E+ +
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 66/224 (29%), Positives = 93/224 (41%), Gaps = 48/224 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--H-KEWINEVNFLGV 151
           IG G  G V       ++ D  T       +VAIK+L+R  FQ   H K    E+  + +
Sbjct: 24  IGSGAQGIV------CAAYDTVT-----GQNVAIKKLSRP-FQNVTHAKRAYRELVLMKL 71

Query: 152 VKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           V H N++ L+         E      LV ELM      D  L +V         +++  D
Sbjct: 72  VNHKNIIGLLNVFTPQKSLEEFQDVYLVMELM------DANLCQV---------IQMDLD 116

Query: 210 AAR----------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
             R          G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G 
Sbjct: 117 HERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GT 170

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
             + T  V T  Y APE +         D+WS G ++ E+I G 
Sbjct: 171 SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGT 214

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 53/214 (24%), Positives = 95/214 (44%), Gaps = 26/214 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+   +           ++ L  A K +  +  +  ++++ E++ L   KH
Sbjct: 13  LGDGAFGKVYKAQHK-----------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PN+V L      +++  +    + E     +L D ++  +   L       + +     L
Sbjct: 62  PNIVGLYEAYFYENKLWI----LIEFCDGGAL-DSIMLELERGLTEPQIRYVCRQMLEAL 116

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
            +LH     ++I RD K  NILL  D   KL+DFG++ +           + +GT  + A
Sbjct: 117 NFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKR--DTFIGTPYWMA 171

Query: 275 PEYV--QTGRLTA---KSDVWSFGVVLYELITGR 303
           PE V  +T +      K+D+WS G+ L EL    
Sbjct: 172 PEVVACETFKDNPYDYKADIWSLGITLIELAQME 205

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 90/358 (25%), Positives = 145/358 (40%), Gaps = 101/358 (28%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              S +D++L   VA+K+L+R  Q     +    E+  L 
Sbjct: 23  VGSGAYGSV-------------CSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 69

Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E   +  LV  LM           K  ++H+   +   L 
Sbjct: 70  HMKHENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLL- 128

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
                       RGL Y+H      +I RD K SN+ ++ED + ++ DFGLARQ   E  
Sbjct: 129 ------------RGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMT 173

Query: 260 GHVSTSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPR 312
           G+V+T       Y APE       Y QT       D+WS G ++ EL+ G+       P 
Sbjct: 174 GYVATR-----WYRAPEIMLNWMHYNQT------VDIWSVGCIMAELLKGKAL----FPG 218

Query: 313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE- 371
           N+         Y+   K+   ++           S + L  ++S+   K  +S P M + 
Sbjct: 219 ND---------YIDQLKRIMEVVG--------TPSPEVLKKISSEHARKYIQSLPHMPQQ 261

Query: 372 ------------VVDILGNII-----SEISSQDEVTLQPVAEIEDVKEEPEAEAVVES 412
                        +D+L  ++       IS+ + +     ++  D ++EPEAE   ES
Sbjct: 262 DLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDPEDEPEAEPYDES 319

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 64.1 bits (156), Expect = 2e-11
 Identities = 78/287 (27%), Positives = 118/287 (41%), Gaps = 59/287 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN------RQGFQGHKEWINEVNF 148
           +G+GGFG        VS+   + +G   KL  A K+LN      R+G++G    + E   
Sbjct: 1   LGKGGFG-------EVSACQMRATG---KL-YACKKLNKKRLKKRKGYEGA---MVEKRI 46

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS------RVPTPLAWIA 202
           L  V    +V L    A   +      LV  +M+   L  H+ +        P P A   
Sbjct: 47  LAKVHSRFIVSL----AYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFY 102

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA---RQGPPEGL 259
             +I      GL +LH+    ++I+RD K  N+LLD D   ++SD GLA   + G  +  
Sbjct: 103 TAQIIS----GLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTK 155

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           G+      GT G+ APE +Q        D ++ GV LYE+I  R        + E K  E
Sbjct: 156 GY-----AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENK--E 208

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
             +  ++DS              Y  K +    +     L K P+ R
Sbjct: 209 LKQRILNDSVT------------YPDKFSPASKSFCEALLAKDPEKR 243

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 60/216 (27%), Positives = 96/216 (44%), Gaps = 23/216 (10%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGV 151
           +IG+G +G V       S+ D  T        VAIK++N   +        + E+  L +
Sbjct: 7   VIGKGSYGVV------CSAIDTHTGEK-----VAIKKINDVFEHVSDATRILREIKLLRL 55

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           ++HP++V++         R  + + +V+ELM +   + H + +    L            
Sbjct: 56  LRHPDIVEIKHIMLPPSRREFKDIYVVFELMES---DLHQVIKANDDLTPEHHQFFLYQL 112

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS-TSVVGT 269
            R L Y+H    F    RD K  NIL + D K K+ DFGLAR    +    +  T  V T
Sbjct: 113 LRALKYIHTANVFH---RDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVAT 169

Query: 270 VGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGR 303
             Y APE   +   + T   D+WS G +  E++TG+
Sbjct: 170 RWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 64.5 bits (157), Expect = 2e-11
 Identities = 65/237 (27%), Positives = 99/237 (41%), Gaps = 59/237 (24%)

Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWI 143
             ++    +G G +G V       S+ D +T        VAIK+L+R  FQ     K   
Sbjct: 15  ERYTSLKQVGSGAYGSV------CSAIDKRT-----GEKVAIKKLSRP-FQSEIFAKRAY 62

Query: 144 NEVNFLGVVKHPNLVKLVG-YCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWI 201
            E+  L  ++H N++ L+  + +       Q   LV   M              T L  I
Sbjct: 63  RELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-------------TDLQKI 109

Query: 202 ARLKIAQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
               +++D  +        GL Y+H      +I RD K  N+ ++ED + K+ DFGLAR 
Sbjct: 110 MGHPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARH 166

Query: 254 GPPEGLGHVSTSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
              E  G+V T       Y APE       Y QT       D+WS G ++ E++TG+
Sbjct: 167 ADAEMTGYVVTR-----WYRAPEVILNWMHYNQT------VDIWSVGCIMAEMLTGK 212

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 31/97 (31%), Positives = 55/97 (56%), Gaps = 5/97 (5%)

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A + + GL +LH      +I+RD K  N++LD +   K++DFG+ ++   +G+   + + 
Sbjct: 107 AAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTF 161

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            GT  Y APE +         D W++GV+LYE++ G+
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 28/177 (15%)

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ--GPPEGLGHVSTSVVG 268
           ARG+ +L      + I RD    NILL E+   K+ DFGLAR     P+ +   S  +  
Sbjct: 184 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARL-- 238

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE---QKLLEWVRPYV 325
            + + APE +     T +SDVWSFGV+L+E+ +   +    +  NE   Q+L +  R   
Sbjct: 239 PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRA 298

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
            ++                  +  ++  +   C    PK RP  S +V+ILG+++ E
Sbjct: 299 PEN------------------ATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQE 337

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 63.9 bits (155), Expect = 3e-11
 Identities = 33/90 (36%), Positives = 50/90 (55%), Gaps = 5/90 (5%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L YLH      +++RD K  N++LD+D   K++DFGL ++G  +G      +  GT  Y 
Sbjct: 108 LEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYL 162

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           APE ++        D W  GVV+YE++ GR
Sbjct: 163 APEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 63.1 bits (154), Expect = 4e-11
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 37/216 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK- 153
           IGEG F  V +          + +G       AIK +  + F+   E +N +  +  ++ 
Sbjct: 7   IGEGTFSEVLKA-------QSRKTGKY----YAIKCMK-KHFKS-LEQVNNLREIQALRR 53

Query: 154 ---HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              HPN+++L+     D + G  RL LV+ELM + +L + +  R   PL           
Sbjct: 54  LSPHPNILRLIE-VLFDRKTG--RLALVFELM-DMNLYELIKGRK-RPLPEKRVKSYMYQ 108

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---QGPPEGLGHVSTSV 266
             + L ++H    F    RD K  NIL+  D   KL+DFG  R     PP       T  
Sbjct: 109 LLKSLDHMHRNGIFH---RDIKPENILIK-DDILKLADFGSCRGIYSKPP------YTEY 158

Query: 267 VGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELIT 301
           + T  Y APE + T G    K D+W+ G V +E+++
Sbjct: 159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILS 194

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 63.9 bits (155), Expect = 4e-11
 Identities = 34/101 (33%), Positives = 57/101 (56%), Gaps = 5/101 (4%)

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A + A GL +LH +    +I+RD K  N++LD +   K++DFG+ ++   +G+   + + 
Sbjct: 107 AAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTF 161

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
            GT  Y APE +         D W+FGV+LYE++ G+   E
Sbjct: 162 CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFE 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 36/94 (38%), Positives = 51/94 (54%), Gaps = 7/94 (7%)

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           RGL YLH      ++ RD K  N+L++ +   K+ DFGLAR   P+   H++  VV T  
Sbjct: 114 RGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVV-TQY 169

Query: 272 YAAPEYVQTG--RLTAKSDVWSFGVVLYELITGR 303
           Y APE +  G    T+  D+WS G +  EL+  R
Sbjct: 170 YRAPE-ILMGSRHYTSAVDIWSVGCIFAELLGRR 202

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 63.6 bits (155), Expect = 5e-11
 Identities = 36/96 (37%), Positives = 53/96 (55%), Gaps = 8/96 (8%)

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---QGPPEGLGHVSTSVVG 268
            GL Y+H      ++ RD K  N+L++ D + K+ DFGLAR   + P E  G + T  V 
Sbjct: 116 CGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFM-TEYVA 171

Query: 269 TVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
           T  Y APE + + +   K+ DVWS G +L EL+  +
Sbjct: 172 TRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 62.8 bits (153), Expect = 5e-11
 Identities = 65/226 (28%), Positives = 105/226 (46%), Gaps = 51/226 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-----INEVNFL 149
           IGEG +G VY+G        ++ +G      VA+K++     +  +E      I E++ L
Sbjct: 8   IGEGTYGVVYKGR-------NKKTGQI----VAMKKIR---LESEEEGVPSTAIREISLL 53

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             ++HPN+V L     ++      RL L++E + +  L+ +L S           L   Q
Sbjct: 54  KELQHPNIVCLQDVLMQES-----RLYLIFEFL-SMDLKKYLDS-----------LPKGQ 96

Query: 209 --DAARGLAYLHEEMD-------FQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
             DA    +YL++ +         +++ RD K  N+L+D     KL+DFGLAR  G P  
Sbjct: 97  YMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV- 155

Query: 259 LGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGR 303
              V T  V T+ Y APE +    R +   D+WS G +  E+ T +
Sbjct: 156 --RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKK 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 63.1 bits (153), Expect = 6e-11
 Identities = 65/214 (30%), Positives = 95/214 (44%), Gaps = 28/214 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVN-FL 149
           +IG+G FG       +V    H+    + K   A+K L ++     KE    ++E N  L
Sbjct: 2   VIGKGSFG-------KVLLARHKA---EEKF-YAVKVLQKKAILKKKEEKHIMSERNVLL 50

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             VKHP LV L  +  +  ++      V + ++   L  HL  R    L   AR   A +
Sbjct: 51  KNVKHPFLVGL-HFSFQTADK---LYFVLDYINGGELFYHL-QRERCFLEPRARF-YAAE 104

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG-PPEGLGHVSTSVVG 268
            A  L YLH      +++RD K  NILLD      L+DFGL ++     G    +++  G
Sbjct: 105 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG---TTSTFCG 158

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           T  Y APE +         D W  G VLYE++ G
Sbjct: 159 TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 192

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 62.9 bits (153), Expect = 6e-11
 Identities = 68/224 (30%), Positives = 98/224 (43%), Gaps = 38/224 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL----NRQGFQGHKEWINEVNFLG 150
           IGEG +G VY+        D  T        VA+K++     ++GF      I E+  L 
Sbjct: 15  IGEGTYGQVYKAR------DKDTGEL-----VALKKVRLDNEKEGFP--ITAIREIKILR 61

Query: 151 VVKHPNLVKLVGYCAED----DERGMQR--LLVYELMHNKSLEDH-LLSRVPTPLAWIAR 203
            + H N+V L     +     D +  +    LV+E M      DH L+  + + L   + 
Sbjct: 62  QLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM------DHDLMGLLESGLVHFSE 115

Query: 204 LKIA---QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
             I    +    GL Y H++     + RD K SNILL+   + KL+DFGLAR    E   
Sbjct: 116 DHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEE-S 171

Query: 261 HVSTSVVGTVGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITGR 303
              T+ V T+ Y  PE  +   R     DVWS G +L EL T +
Sbjct: 172 RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 63.2 bits (153), Expect = 6e-11
 Identities = 47/145 (32%), Positives = 71/145 (48%), Gaps = 27/145 (18%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            L YLH     ++++RD K  N++LD+D   K++DFGL ++G  +       +  GT  Y
Sbjct: 107 ALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEY 161

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWV-------- 321
            APE ++        D W  GVV+YE++ GR      LP   ++ +KL E +        
Sbjct: 162 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELILMEDIKFP 215

Query: 322 RPYVSDSKKF---HLIIDP--RLEG 341
           R   +D+K      LI DP  RL G
Sbjct: 216 RTLSADAKSLLSGLLIKDPNKRLGG 240

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 62.3 bits (151), Expect = 7e-11
 Identities = 63/215 (29%), Positives = 107/215 (49%), Gaps = 32/215 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVVK 153
           +GEG +  V++G  +++ +            VA+K++  +  +G     I EV+ L  +K
Sbjct: 13  LGEGTYATVFKGRSKLTENL-----------VALKEIRLEHEEGAPCTAIREVSLLKNLK 61

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHN--KSLEDHLLSRVPTPLAWIARLKIAQ-DA 210
           H N+V L  +     ER +   LV+E + +  K   D+  +     L  +  +KI     
Sbjct: 62  HANIVTL--HDIIHTERCLT--LVFEYLDSDLKQYLDNCGN-----LMSMHNVKIFMFQL 112

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR-QGPPEGLGHVSTSVVGT 269
            RGL+Y H+    +++ RD K  N+L++E  + KL+DFGLAR +  P      S  VV T
Sbjct: 113 LRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKT--YSNEVV-T 166

Query: 270 VGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITGR 303
           + Y  P+  + +   +   D+W  G +LYE+ TGR
Sbjct: 167 LWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 40/229 (17%)

Query: 89  FSRALLIGEGGFGCVY------------RGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF 136
           + R  L+G+G FG VY               V+   +  +TS   S L+           
Sbjct: 4   WRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALEC---------- 53

Query: 137 QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHLLSRVP 195
                   E+  L  ++H  +V+  G C  D  R  + L ++ E M   S++D L  +  
Sbjct: 54  --------EIQLLKNLQHERIVQYYG-CLRD--RAEKTLTIFMEYMPGGSVKDQL--KAY 100

Query: 196 TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP 255
             L      K  +    G++YLH  M   ++ RD K +NIL D     KL DFG +++  
Sbjct: 101 GALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157

Query: 256 PEGL-GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
              + G    SV GT  + +PE +       K+DVWS G  + E++T +
Sbjct: 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 31/90 (34%), Positives = 52/90 (57%), Gaps = 5/90 (5%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L +LHE     +I+RD K  N+LLD +   KL+D+G+ ++G     G  +++  GT  Y 
Sbjct: 109 LNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGI--RPGDTTSTFCGTPNYI 163

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           APE ++        D W+ GV+++E++ GR
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGR 193

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 62.8 bits (153), Expect = 8e-11
 Identities = 63/225 (28%), Positives = 95/225 (42%), Gaps = 47/225 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           IG G +G V       S+ + +T+       VAIK++    F      K  + E+  L  
Sbjct: 13  IGRGAYGIV------CSAKNSETNEK-----VAIKKIA-NAFDNRIDAKRTLREIKLLRH 60

Query: 152 VKHPNLVKLVGYCAEDDERGMQR------LLVYELMHNKSLEDHLLSRVPTPLA------ 199
           + H N++ +     +D      R       +VYELM     + H + R    L+      
Sbjct: 61  LDHENVIAI-----KDIMPPPHREAFNDVYIVYELMDT---DLHQIIRSSQTLSDDHCQY 112

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
           ++ +L       RGL Y+H      ++ RD K SN+LL+ +   K+ DFGLAR       
Sbjct: 113 FLYQL------LRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLAR--TTSEK 161

Query: 260 GHVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
           G   T  V T  Y APE +      T   DVWS G +  EL+  +
Sbjct: 162 GDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 62.9 bits (153), Expect = 8e-11
 Identities = 60/226 (26%), Positives = 95/226 (42%), Gaps = 46/226 (20%)

Query: 101 GCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKL 160
           GC   G+V  + D       D    VA+K++     Q  K  + E+  +  + H N+VK+
Sbjct: 14  GCGSNGLVFSAVDS------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKV 67

Query: 161 ---VGYCAEDDERGMQRL-------LVYELM---------HNKSLEDHLLSRVPTPLAWI 201
              +G    D    +  L       +V E M              E+H            
Sbjct: 68  YEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQGPLSEEH------------ 115

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPE--G 258
           ARL + Q   RGL Y+H      ++ RD K +N+ ++ ED   K+ DFGLAR   P    
Sbjct: 116 ARLFMYQ-LLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH 171

Query: 259 LGHVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
            G++S  +V T  Y +P  +      T   D+W+ G +  E++TG+
Sbjct: 172 KGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 62.4 bits (151), Expect = 1e-10
 Identities = 61/220 (27%), Positives = 100/220 (45%), Gaps = 34/220 (15%)

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP LV L   C + + R      V E ++   L  H+  +   P    AR   A+  +  
Sbjct: 55  HPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLA 108

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L YLHE     +I+RD K  N+LLD +   KL+D+G+ ++G     G  +++  GT  Y 
Sbjct: 109 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP--GDTTSTFCGTPNYI 163

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE-----RNLPRNEQKLLEWVRPYVSDS 328
           APE ++        D W+ GV+++E++ GR   +      N  +N +  L          
Sbjct: 164 APEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYL---------- 213

Query: 329 KKFHLIIDP--RLEGNYCIKSAQKLAALASKCLTKQPKSR 366
             F +I++   R+  +  +K+A  L +     L K PK R
Sbjct: 214 --FQVILEKQIRIPRSLSVKAASVLKSF----LNKDPKER 247

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 65/220 (29%), Positives = 108/220 (49%), Gaps = 39/220 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQG-HKEWINEVNFLGVV 152
           IGEG +G VY+   RV+++            +A+K++   Q  +G     I E++ L  +
Sbjct: 10  IGEGTYGVVYKARDRVTNE-----------TIALKKIRLEQEDEGVPSTAIREISLLKEM 58

Query: 153 KHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHL-----LSRVPTPLAWIARLKI 206
           +H N+V+L     +D     +RL LV+E + +  L+ H+      ++ P     + +  +
Sbjct: 59  QHGNIVRL-----QDVVHSEKRLYLVFEYL-DLDLKKHMDSSPDFAKNPR----LIKTYL 108

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQ-GPPEGLGHVST 264
            Q   RG+AY H     +++ RD K  N+L+D    A KL+DFGLAR  G P       T
Sbjct: 109 YQ-ILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV---RTFT 161

Query: 265 SVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGR 303
             V T+ Y APE +   R  +   D+WS G +  E++  +
Sbjct: 162 HEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Length = 294

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 73/299 (24%), Positives = 120/299 (40%), Gaps = 79/299 (26%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL----NRQGFQGHKEWINEVNFLG 150
           IG+G FG V++   +  +             VA+K++     ++GF      + E+  L 
Sbjct: 20  IGQGTFGEVFKARHK-KTKQI----------VALKKVLMENEKEGFPITA--LREIKILQ 66

Query: 151 VVKHPNLVKLVGYC-----AEDDERGMQRLLVYELMHNKSLEDH----LLSRVPTPLAWI 201
           ++KH N+V L+  C       +  +G    LV+E        +H    LLS         
Sbjct: 67  LLKHENVVNLIEICRTKATPYNRYKG-SFYLVFEFC------EHDLAGLLSNKNVKFTLS 119

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGL 259
              K+ +    GL Y+H     +++ RD K +NIL+ +D   KL+DFGLAR         
Sbjct: 120 EIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSK 176

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYE------------------LI 300
            +  T+ V T+ Y  PE +   R      D+W  G ++ E                  LI
Sbjct: 177 PNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLI 236

Query: 301 TGRRA---------VER-------NLPRN-EQKLLEWVRPYVSDSKKFHLI-----IDP 337
           +             V++        LP+  ++K+ E ++PYV D     LI     +DP
Sbjct: 237 SQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDP 295

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 61.9 bits (150), Expect = 2e-10
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 33/201 (16%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L +LH+     +++RD K  NILLD +    L+DFGL+++   E     + S  GT+ Y 
Sbjct: 118 LEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE-KERTYSFCGTIEYM 173

Query: 274 APEYV--QTGRLTAKSDVWSFGVVLYELITG------------RRAVERNLPRNEQKLLE 319
           APE +  + G   A  D WS G++++EL+TG            +  V R + + +     
Sbjct: 174 APEIIRGKGGHGKA-VDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPS 232

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKL-----------AALASKCLTKQPKSRPK 368
           ++ P   D     L  DP+       + A ++            ALA + +   P  RP 
Sbjct: 233 FIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLDWEALALRKV--NPPFRPS 290

Query: 369 MSEVVDILGNIISEISSQDEV 389
           +   +D+ GN   E ++ + V
Sbjct: 291 IRNELDV-GNFAEEFTNLEPV 310

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 24/211 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVVK 153
           +GEG +  VY+G  +++ +            VA+K++  +  +G     I EV+ L  +K
Sbjct: 14  LGEGTYATVYKGRSKLTDNL-----------VALKEIRLEHEEGAPCTAIREVSLLKDLK 62

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+V L  +     E+ +   LV+E + +K L+ +L     +      +L + Q   RG
Sbjct: 63  HANIVTL--HDIIHTEKSLT--LVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ-LLRG 116

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L Y H     +++ RD K  N+L++E  + KL+DFGLAR        + S  VV T+ Y 
Sbjct: 117 LNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY-SNEVV-TLWYR 171

Query: 274 APE-YVQTGRLTAKSDVWSFGVVLYELITGR 303
            P+  + +   + + D+W  G + YE+ TGR
Sbjct: 172 PPDILLGSTDYSTQIDMWGVGCIFYEMSTGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 61.1 bits (148), Expect = 2e-10
 Identities = 37/95 (38%), Positives = 52/95 (54%), Gaps = 16/95 (16%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA----RQGPPEGLGHVSTSVVG 268
           GL ++H      +++RD K +NILLDE    ++SD GLA    ++ P     H S   VG
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VG 157

Query: 269 TVGYAAPEYVQTGRLTAKSDVW-SFGVVLYELITG 302
           T GY APE +Q G     S  W S G +L++L+ G
Sbjct: 158 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 60/214 (28%), Positives = 97/214 (45%), Gaps = 24/214 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWIN----EVNF 148
           L+G G FG VY     +  D       D+  ++A+KQ+      Q   + +N    E+  
Sbjct: 9   LLGRGAFGEVY-----LCYD------ADTGRELAVKQVPFDPDSQETSKEVNALECEIQL 57

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           L  ++H  +V+  G C  D E     + V E M   S++D L  +    L      +  +
Sbjct: 58  LKNLRHDRIVQYYG-CLRDPEEKKLSIFV-EYMPGGSIKDQL--KAYGALTENVTRRYTR 113

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL-GHVSTSVV 267
              +G++YLH  M   ++ RD K +NIL D     KL DFG +++     + G    SV 
Sbjct: 114 QILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVT 170

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           GT  + +PE +       K+DVWS    + E++T
Sbjct: 171 GTPYWMSPEVISGEGYGRKADVWSVACTVVEMLT 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 61.4 bits (149), Expect = 3e-10
 Identities = 54/195 (27%), Positives = 83/195 (42%), Gaps = 64/195 (32%)

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
           ARG+ +L      + I RD    NILL E+   K+ DFGLAR                  
Sbjct: 183 ARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDI---------------- 223

Query: 271 GYAAPEYVQTG--RL---------------TAKSDVWSFGVVLYELITGRRAVERNLPRN 313
            Y  P+YV+ G  RL               T +SDVWSFGV+L+E+ +   +    +  +
Sbjct: 224 -YKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQID 282

Query: 314 E---QKLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           E   ++L E  R   P  +  + + +++D                     C    P+ RP
Sbjct: 283 EEFCRRLKEGTRMRAPEYATPEIYSIMLD---------------------CWHNNPEDRP 321

Query: 368 KMSEVVDILGNIISE 382
             SE+V+ILG+++ E
Sbjct: 322 TFSELVEILGDLLQE 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 62.6 bits (152), Expect = 3e-10
 Identities = 47/163 (28%), Positives = 78/163 (47%), Gaps = 18/163 (11%)

Query: 154 HPNLVKLVGYCAEDDERGMQRLL-VYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           HPN+V L+    +  E     L  V+E +  ++L + L +    P     RL + Q    
Sbjct: 37  HPNIVALL----DSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAGETGRL-MLQ-VLD 90

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHV-----ST 264
            LA  H   +  ++ RD K  NI++        AK+ DFG+    P      V     +T
Sbjct: 91  ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
            V+GT  Y APE ++   +T  SD++++G++  E +TG+R V+
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQ 190

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 60.8 bits (147), Expect = 3e-10
 Identities = 55/211 (26%), Positives = 98/211 (46%), Gaps = 28/211 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+               ++ +  A K ++ +  +  ++++ E++ L    H
Sbjct: 13  LGDGAFGKVYKA-----------QNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDH 61

Query: 155 PNLVKLV-GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           PN+VKL+  +  E++       ++ E     ++ D ++  +  PL       + +     
Sbjct: 62  PNIVKLLDAFYYENN-----LWILIEFCAGGAV-DAVMLELERPLTEPQIRVVCKQTLEA 115

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L YLHE    ++I RD K  NIL   D   KL+DFG++ +           S +GT  + 
Sbjct: 116 LNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWM 170

Query: 274 APEYV--QTGR---LTAKSDVWSFGVVLYEL 299
           APE V  +T +      K+DVWS G+ L E+
Sbjct: 171 APEVVMCETSKDRPYDYKADVWSLGITLIEM 201

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 60.9 bits (148), Expect = 3e-10
 Identities = 43/125 (34%), Positives = 66/125 (52%), Gaps = 23/125 (18%)

Query: 190 LLS----RVPTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA 243
           LLS    R+P  +A  ++A + +A D+   L Y+H         RD K  N+LLD++   
Sbjct: 91  LLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVH---------RDIKPDNVLLDKNGHI 141

Query: 244 KLSDFGLARQGPPEGLGHVSTSV-VGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLY 297
           +L+DFG   +   +G   V ++V VGT  Y +PE +Q      GR   + D WS GV +Y
Sbjct: 142 RLADFGSCLRLLADGT--VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMY 199

Query: 298 ELITG 302
           E++ G
Sbjct: 200 EMLYG 204

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 49/166 (29%), Positives = 78/166 (46%), Gaps = 23/166 (13%)

Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---- 200
           E + +     P +V+L  +CA  D++ +   +V E M    L + L+S    P  W    
Sbjct: 93  ERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLVN-LMSNYDVPEKWAKFY 147

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
            A + +A DA   +  +H         RD K  N+LLD+    KL+DFG   +    G+ 
Sbjct: 148 TAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 198

Query: 261 HVSTSVVGTVGYAAPEYVQT----GRLTAKSDVWSFGVVLYELITG 302
              T+ VGT  Y +PE +++    G    + D WS GV L+E++ G
Sbjct: 199 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 70/292 (23%), Positives = 119/292 (40%), Gaps = 53/292 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLN-RQGFQGHKEWINEVNFLGV 151
           +G+G FG VY     +  D    +    K+  ++ + +LN  +  Q ++E       L  
Sbjct: 8   LGKGSFGTVY-----LVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE----AQLLSK 58

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED------HLLSRVPTP--LAWIAR 203
           + HP +VK      E D       ++ E    + L+       H    +       W  +
Sbjct: 59  LDHPAIVKFHASFLERD----AFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQ 114

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
           L +      G+ Y+H+    +++ RD K  NI L  +   K+ DFG++R     G   ++
Sbjct: 115 LLL------GVHYMHQR---RILHRDLKAKNIFLKNNL-LKIGDFGVSRL--LMGSCDLA 162

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
           T+  GT  Y +PE ++     +KSD+WS G +LYE+     A E       Q  L  V  
Sbjct: 163 TTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFE------GQNFLSVVLR 216

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
            V           P L   Y    +++L ++    L K P  RP  +E++  
Sbjct: 217 IVEGPT-------PSLPETY----SRQLNSIMQSMLNKDPSLRPSAAEILRN 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 61.0 bits (148), Expect = 4e-10
 Identities = 48/162 (29%), Positives = 65/162 (40%), Gaps = 46/162 (28%)

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL---------- 250
           +AR  IA+     +  +H+ M F  I RD K  NIL+D D   KL+DFGL          
Sbjct: 102 LARFYIAE-LTCAIESVHK-MGF--IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS 157

Query: 251 --------ARQG---PPEGLGHVST--------------------SVVGTVGYAAPEYVQ 279
                    RQ    P E    +                      S+VGT  Y APE + 
Sbjct: 158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLL 217

Query: 280 TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEW 320
               T   D WS GV+LYE++ G+     + P   Q K++ W
Sbjct: 218 RTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINW 259

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 65/231 (28%), Positives = 102/231 (44%), Gaps = 64/231 (27%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-----INEVNFL 149
           +GEG +  VY+G           S    +L VA+K++  +    H+E      I E + L
Sbjct: 13  LGEGSYATVYKGR----------SKLTGQL-VALKEIRLE----HEEGAPFTAIREASLL 57

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLL--VYELMHN---KSLEDH----LLSRVPTPLAW 200
             +KH N+V L       D    ++ L  V+E +     + ++D      +  V      
Sbjct: 58  KDLKHANIVTL------HDIIHTKKTLTLVFEYLDTDLKQYMDDCGGGLSMHNV------ 105

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR-QGPPEGL 259
             RL + Q   RGLAY H+    +++ RD K  N+L+ E  + KL+DFGLAR +  P   
Sbjct: 106 --RLFLFQ-LLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPS-- 157

Query: 260 GHVSTSVVGTVGYAAP-------EYVQTGRLTAKSDVWSFGVVLYELITGR 303
               ++ V T+ Y  P       EY      +   D+W  G + YE+ TGR
Sbjct: 158 -KTYSNEVVTLWYRPPDVLLGSTEY------STSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 36/92 (39%), Positives = 52/92 (56%), Gaps = 6/92 (6%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            L +LH+     +I+RD K  NILLD +    L+DFGL+++   E     + S  GT+ Y
Sbjct: 117 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF-HEDEVERAYSFCGTIEY 172

Query: 273 AAPEYVQTGRLTAKS--DVWSFGVVLYELITG 302
            AP+ V+ G        D WS GV++YEL+TG
Sbjct: 173 MAPDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 59.1 bits (143), Expect = 5e-10
 Identities = 45/157 (28%), Positives = 65/157 (41%), Gaps = 22/157 (14%)

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLA--WIARLKIAQDA 210
           PN+V L  Y   +D       LV +      L  H+     +P      W A + +A DA
Sbjct: 45  PNMVCLHKYIVSED----SVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDA 100

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
                 LH E    ++ RD   +NILLD+    +L+ F    +      G    ++    
Sbjct: 101 ------LHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVENM---- 147

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
            Y APE       T   D WS G +L+EL+TG+  VE
Sbjct: 148 -YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVE 183

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 60.7 bits (147), Expect = 6e-10
 Identities = 44/165 (26%), Positives = 75/165 (45%), Gaps = 23/165 (13%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L  +H      +I RD K++NILL  +   KL DFG ++         V  +  GT  Y 
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHL 333
           APE  +    + K+D++S GV+LYEL+T +                  RP+  D +    
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK------------------RPF--DGENMEE 252

Query: 334 IIDPRLEGNY---CIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
           ++   L G Y       + ++  + +  L+  PK RP  S+++++
Sbjct: 253 VMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297

Length = 496

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.1 bits (145), Expect = 6e-10
 Identities = 68/245 (27%), Positives = 103/245 (42%), Gaps = 35/245 (14%)

Query: 118 SGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFLGVVKHPNLVKLVGYCAEDD--ER 170
           + +D+ LD  VAIK+L+R  FQ     K    E+  +  V H N++ L+         E 
Sbjct: 35  AAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93

Query: 171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF 230
                LV ELM     + +L   +   L       +      G+ +LH      +I RD 
Sbjct: 94  FQDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDL 145

Query: 231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVW 290
           K SNI++  D   K+ DFGLAR     G   + T  V T  Y APE +         D+W
Sbjct: 146 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIW 202

Query: 291 SFGVVLYELI------TGRRAVER----------NLPRNEQKLLEWVRPYVSDSKKFHLI 334
           S G ++ E++       GR  +++            P   +KL   VR YV +  K+  +
Sbjct: 203 SVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGL 262

Query: 335 IDPRL 339
             P+L
Sbjct: 263 TFPKL 267

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 60.2 bits (146), Expect = 6e-10
 Identities = 36/96 (37%), Positives = 47/96 (48%), Gaps = 13/96 (13%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-----GPPEGLGHVSTSVVG 268
           LAYLH      +I RD KT NI LDE   A L DFG A +       P+  G       G
Sbjct: 198 LAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWS-----G 249

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           T+   +PE +      AK+D+WS G+VL+E+     
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNV 285

Length = 392

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 59.6 bits (144), Expect = 7e-10
 Identities = 78/292 (26%), Positives = 125/292 (42%), Gaps = 45/292 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVVK 153
           +GEG +  VY+G+ R++       G      VA+K ++ +  +G     I E + L  +K
Sbjct: 13  LGEGSYATVYKGISRIN-------GQL----VALKVISMKTEEGVPFTAIREASLLKGLK 61

Query: 154 HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPL-AWIARLKIAQDAA 211
           H N+V L      D     + L  V+E MH    +   + + P  L  +  RL + Q   
Sbjct: 62  HANIVLL-----HDIIHTKETLTFVFEYMHTDLAQ--YMIQHPGGLHPYNVRLFMFQ-LL 113

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR-QGPPEGLGHVSTSVVGTV 270
           RGLAY+H +    ++ RD K  N+L+    + KL+DFGLAR +  P       +S V T+
Sbjct: 114 RGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIP---SQTYSSEVVTL 167

Query: 271 GYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW--------- 320
            Y  P+ +      ++  D+W  G +  E++ G+ A        EQ    W         
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTED 227

Query: 321 VRPYVSDSKKFH----LIIDPRLEGNYCIKSAQKLAA--LASKCLTKQPKSR 366
             P VS    +     L   P+       + ++   A  LAS+ L   PK R
Sbjct: 228 TWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDR 279

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 59.2 bits (143), Expect = 8e-10
 Identities = 37/110 (33%), Positives = 59/110 (53%), Gaps = 16/110 (14%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA----RQGPPEGLGHVSTSVVG 268
           GL ++H      +++RD K +NILLDE    ++SD GLA    ++ P     H S   VG
Sbjct: 109 GLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-----HAS---VG 157

Query: 269 TVGYAAPEYVQTGRLTAKSDVW-SFGVVLYELITGRRAVERNLPRNEQKL 317
           T GY APE +Q G     S  W S G +L++L+ G     ++  +++ ++
Sbjct: 158 THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 59.4 bits (144), Expect = 9e-10
 Identities = 62/217 (28%), Positives = 105/217 (48%), Gaps = 33/217 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL----NRQGFQGHKEWINEVNFLG 150
           IGEG +G V++   R   + H+         VA+K++    + +G       + E+  L 
Sbjct: 8   IGEGTYGTVFKAKNR---ETHEI--------VALKRVRLDDDDEGVPSSA--LREICLLK 54

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
            +KH N+V+L      D     ++L LV+E   ++ L+ +  S        I +  + Q 
Sbjct: 55  ELKHKNIVRLY-----DVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ- 107

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVG 268
             +GLA+ H      ++ RD K  N+L++++ + KL+DFGLAR  G P  +   S  VV 
Sbjct: 108 LLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIP--VRCYSAEVV- 161

Query: 269 TVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRR 304
           T+ Y  P+ +   +L + S D+WS G +  EL    R
Sbjct: 162 TLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 59.7 bits (144), Expect = 9e-10
 Identities = 39/117 (33%), Positives = 60/117 (51%), Gaps = 17/117 (14%)

Query: 193 RVPTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R+P  +A  ++A + IA D+   L Y+H         RD K  NIL+D +   +L+DFG 
Sbjct: 98  RLPEDMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGS 148

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITG 302
             +   +G    S+  VGT  Y +PE +Q      G+   + D WS GV +YE++ G
Sbjct: 149 CLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 59.2 bits (143), Expect = 9e-10
 Identities = 57/211 (27%), Positives = 102/211 (48%), Gaps = 24/211 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVVK 153
           +GEG +  V++G  +++ +            VA+K++  +  +G     I EV+ L  +K
Sbjct: 14  LGEGTYATVFKGRSKLTENL-----------VALKEIRLEHEEGAPCTAIREVSLLKDLK 62

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+V L      D        LV+E + +K L+ ++            ++ + Q   RG
Sbjct: 63  HANIVTLHDIVHTDK----SLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ-ILRG 116

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           LAY H     +++ RD K  N+L++E  + KL+DFGLAR        + S  VV T+ Y 
Sbjct: 117 LAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY-SNEVV-TLWYR 171

Query: 274 APE-YVQTGRLTAKSDVWSFGVVLYELITGR 303
            P+  + +   + + D+W  G + +E+ +GR
Sbjct: 172 PPDVLLGSSEYSTQIDMWGVGCIFFEMASGR 202

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 59.1 bits (143), Expect = 1e-09
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 36/181 (19%)

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
           +I     +GL +L EE    +I RD K +N+L++ + + KL DFG++       +  ++ 
Sbjct: 106 RITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGN----LVASLAK 159

Query: 265 SVVGTVGYAAPEYVQTGRLTA------KSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           + +G   Y APE +++G          +SDVWS G+ + E+  GR               
Sbjct: 160 TNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYP----------- 208

Query: 319 EWVRPYVSDS--KKFHLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
               P    +   +   I+D   P L   Y    AQ      +KCL K P  RP  ++++
Sbjct: 209 ----PETYANIFAQLSAIVDGDPPTLPSGYS-DDAQD---FVAKCLNKIPNRRPTYAQLL 260

Query: 374 D 374
           +
Sbjct: 261 E 261

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 58.9 bits (142), Expect = 1e-09
 Identities = 68/217 (31%), Positives = 96/217 (44%), Gaps = 26/217 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL-GVVK 153
           IG+G +G VY+           T+  D  L  A+K L+       +E   E N L  +  
Sbjct: 30  IGKGTYGKVYK----------VTNKKDGSL-AAVKILDPIS-DVDEEIEAEYNILQSLPN 77

Query: 154 HPNLVKLVG-YCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDA 210
           HPN+VK  G +   D   G Q  LV EL +  S+ + +  L      L       I   A
Sbjct: 78  HPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGA 137

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
             GL +LH     ++I RD K +NILL  +   KL DFG++ Q     L   ++  VGT 
Sbjct: 138 LLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS--VGTP 192

Query: 271 GYAAPEYVQTGR-----LTAKSDVWSFGVVLYELITG 302
            + APE +   +       A+ DVWS G+   EL  G
Sbjct: 193 FWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDG 229

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 49/178 (27%), Positives = 81/178 (45%), Gaps = 34/178 (19%)

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ--GPPEGLGHVSTSVVG 268
           A+G+ +L      + I RD    NILL E+   K+ DFGLAR     P+ +      +  
Sbjct: 189 AKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL-- 243

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KLLEWVR--- 322
            + + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L E  R   
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA 303

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
           P  +  + +  ++D                     C   +P  RP  SE+V+ LGN++
Sbjct: 304 PDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLL 340

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 80/306 (26%), Positives = 126/306 (41%), Gaps = 47/306 (15%)

Query: 79  FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG 138
            + L+     F    ++G G +G VY+G        H  +G  +    AIK ++    + 
Sbjct: 8   LSALRDPAGIFELVEVVGNGTYGQVYKG-------RHVKTGQLA----AIKVMDVT--ED 54

Query: 139 HKEWIN-EVNFLG-VVKHPNLVKLVGYCAEDDERGM--QRLLVYELMHNKSLEDHLLSRV 194
            +E I  E+N L     H N+    G   +    G   Q  LV E     S+ D + +  
Sbjct: 55  EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTK 114

Query: 195 PTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
              L   WIA   I ++  RGLA+LH     ++I RD K  N+LL E+ + KL DFG++ 
Sbjct: 115 GNALKEDWIAY--ICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 169

Query: 253 QGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVE 307
           Q     +G  +T  +GT  + APE +            +SD+WS G+   E+  G   + 
Sbjct: 170 Q-LDRTVGRRNT-FIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLC 227

Query: 308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
              P     L+    P             P+L+     K ++K       CL K   SRP
Sbjct: 228 DMHPMRALFLIPRNPP-------------PKLKSK---KWSKKFIDFIEGCLVKNYLSRP 271

Query: 368 KMSEVV 373
              +++
Sbjct: 272 STEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 51/166 (30%), Positives = 79/166 (47%), Gaps = 23/166 (13%)

Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---- 200
           E + +     P +V+L  + A  D+R +   +V E M    L + L+S    P  W    
Sbjct: 93  ERDIMAFANSPWVVQL--FYAFQDDRYL--YMVMEYMPGGDLVN-LMSNYDVPEKWARFY 147

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
            A + +A DA   + ++H         RD K  N+LLD+    KL+DFG   +   EG+ 
Sbjct: 148 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 198

Query: 261 HVSTSVVGTVGYAAPEYVQT----GRLTAKSDVWSFGVVLYELITG 302
              T+ VGT  Y +PE +++    G    + D WS GV LYE++ G
Sbjct: 199 RCDTA-VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 35/118 (29%), Positives = 47/118 (39%), Gaps = 30/118 (25%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL------------- 259
            L YLH  +    ++RD K  NILL E     LSDF L++Q   E               
Sbjct: 115 ALEYLHL-LGI--VYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRS 171

Query: 260 --------------GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                            S S VGT  Y APE +      +  D W+ G++LYE++ G 
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGT 229

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 58.2 bits (141), Expect = 3e-09
 Identities = 59/245 (24%), Positives = 98/245 (40%), Gaps = 66/245 (26%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLN----RQGFQGHKEWINEV-- 146
           +GEG +G V +               D+     VAIK++            ++ +     
Sbjct: 17  LGEGTYGKVEKAY-------------DTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63

Query: 147 NFLGV--------VKHPNLVKLVG-YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP 197
           +F  +        +KH N++ LV  Y   D        LV ++M +  L+  +  ++   
Sbjct: 64  HFTTLRELKIMNEIKHENIMGLVDVYVEGDFIN-----LVMDIMAS-DLKKVVDRKI--- 114

Query: 198 LAWIARLKIAQDAA------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA 251
                RL  +Q          GL  LH+   +  + RD   +NI ++     K++DFGLA
Sbjct: 115 -----RLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLA 166

Query: 252 RQ-GPPEGLGHVS-----------TSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYE 298
           R+ G P     +S           TS V T+ Y APE +    +     D+WS G +  E
Sbjct: 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226

Query: 299 LITGR 303
           L+TG+
Sbjct: 227 LLTGK 231

Length = 335

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 37/107 (34%), Positives = 54/107 (50%), Gaps = 6/107 (5%)

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L  LH+   F +I+RD K  NILLD      L DFGL +    +     + +  GT  Y 
Sbjct: 106 LENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNTFCGTPEYL 160

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAV-ERNLPRNEQKLLE 319
           APE +     T   D W+ GV+LYE++TG     + N+    +K+L+
Sbjct: 161 APELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ 207

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 73/281 (25%), Positives = 115/281 (40%), Gaps = 43/281 (15%)

Query: 124 LDVAIKQLNRQGFQGH---KEWINEVNFLGVVKHPNLVKLVG-YCAEDDERGMQRL-LVY 178
           ++VA+K+L+R  FQ     K    E+  L  V H N++ L+  +  +      Q + LV 
Sbjct: 47  INVAVKKLSRP-FQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105

Query: 179 ELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD 238
           ELM     + +L   +   L       +      G+ +LH      +I RD K SNI++ 
Sbjct: 106 ELM-----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 157

Query: 239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
            D   K+ DFGLAR         + T  V T  Y APE +         D+WS G ++ E
Sbjct: 158 SDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 214

Query: 299 LITG-------------RRAVER-NLPRNE--QKLLEWVRPYVSDSKKFHLIIDPRLEGN 342
           L+ G              + +E+   P  E   +L   VR YV +  ++  I    L  +
Sbjct: 215 LVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPD 274

Query: 343 YC---------IKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
           +          +K++Q    L SK L   P  R  + E + 
Sbjct: 275 WIFPSESERDKLKTSQA-RDLLSKMLVIDPDKRISVDEALR 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 57.7 bits (139), Expect = 5e-09
 Identities = 48/193 (24%), Positives = 90/193 (46%), Gaps = 19/193 (9%)

Query: 188 DHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
           D L++  P  L+++  +  +   A G+ +L  +     + RD    N+L+ E    K+ D
Sbjct: 227 DTLINESPA-LSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICD 282

Query: 248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
           FGLAR    +       S    + + APE +     T  SDVWSFG++L+E+ T      
Sbjct: 283 FGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPY 342

Query: 308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             LP NEQ        + +  K+ + +  P         ++ ++  +  KC  ++ + RP
Sbjct: 343 PELPMNEQ--------FYNAIKRGYRMAKP-------AHASDEIYEIMQKCWEEKFEIRP 387

Query: 368 KMSEVVDILGNII 380
             S++V ++G+++
Sbjct: 388 DFSQLVHLVGDLL 400

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 57.0 bits (137), Expect = 6e-09
 Identities = 63/218 (28%), Positives = 104/218 (47%), Gaps = 34/218 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVVK 153
           +GEG +  VY+G  +V          + KL VA+K +  Q  +G     I E + L  +K
Sbjct: 13  LGEGSYATVYKGKSKV----------NGKL-VALKVIRLQEEEGTPFTAIREASLLKGLK 61

Query: 154 HPNLVKLVGYCAEDDERGMQRL-LVYELMHN---KSLEDHLLSRVPTPLAWIARLKIAQD 209
           H N+V L      D     + L LV+E +H    + ++ H     P  +    +L + Q 
Sbjct: 62  HANIVLL-----HDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENV----KLFLFQ- 111

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR-QGPPEGLGHVSTSVVG 268
             RGL+Y+H+     ++ RD K  N+L+ +  + KL+DFGLAR +  P    H  ++ V 
Sbjct: 112 LLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS---HTYSNEVV 165

Query: 269 TVGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITGRRA 305
           T+ Y  P+  + +   +   D+W  G +  E+I G  A
Sbjct: 166 TLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAA 203

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 41/127 (32%), Positives = 55/127 (43%), Gaps = 24/127 (18%)

Query: 190 LLSRVPTPLA------WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA 243
           LL+R            ++A L +A  +   + Y+H         RD K  N+L+D     
Sbjct: 91  LLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVH---------RDIKPENVLIDRTGHI 141

Query: 244 KLSDFGLARQGPPEGLGHV-STSVVGTVGYAAPEYVQTGRLTAKS------DVWSFGVVL 296
           KL+DFG A +        V S   VGT  Y APE + T     K       D WS GV+ 
Sbjct: 142 KLADFGSAARLTAN--KMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIA 199

Query: 297 YELITGR 303
           YE+I GR
Sbjct: 200 YEMIYGR 206

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 55.9 bits (135), Expect = 1e-08
 Identities = 60/226 (26%), Positives = 103/226 (45%), Gaps = 38/226 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEV----NFL 149
           LI  G +G VY  +VR     H+    +++   A+K++N+Q     +  I +V    + L
Sbjct: 8   LISNGAYGAVY--LVR-----HK----ETRQRFAMKKINKQNLI-LRNQIQQVFVERDIL 55

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              ++P +V +  +C+ + +R +   +V E +        L +    P+  +AR+  A+ 
Sbjct: 56  TFAENPFVVSM--FCSFETKRHL--CMVMEYVEGGDCATLLKNIGALPVD-MARMYFAE- 109

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG-------PPEGLGHV 262
               L YLH   ++ ++ RD K  N+L+      KL+DFGL++ G         EG    
Sbjct: 110 TVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEK 166

Query: 263 ST------SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            T       V GT  Y APE +         D W+ G++LYE + G
Sbjct: 167 DTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 40/118 (33%), Positives = 61/118 (51%), Gaps = 19/118 (16%)

Query: 193 RVPTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R+P  +A  +IA + +A  +   L Y+H         RD K  N+LLD +   +L+DFG 
Sbjct: 98  RLPEDMARFYIAEMVLAIHSIHQLHYVH---------RDIKPDNVLLDMNGHIRLADFGS 148

Query: 251 ARQGPPEGLGHVSTSV-VGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITG 302
             +   +G   V +SV VGT  Y +PE +Q      G+   + D WS GV +YE++ G
Sbjct: 149 CLKMNQDGT--VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYG 204

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 61/220 (27%), Positives = 94/220 (42%), Gaps = 30/220 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY+   +   DD          D A+KQ+   G         E+  L  +KH
Sbjct: 9   VGRGTYGHVYKAKRKDGKDDR---------DYALKQIEGTGIS--MSACREIALLRELKH 57

Query: 155 PNLVKLVGYCAEDDERGMQRLLVY---ELMHNKSLEDHLLSRV---PTPLAWIARLKIAQ 208
           PN++ L        +R +  L  Y   +L H   ++ H  S+    P  L       +  
Sbjct: 58  PNVISLQKVFLSHADRKVWLLFDYAEHDLWH--IIKFHRASKANKKPVQLPRGMVKSLLY 115

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLAR--QGPPEGLGHV 262
               G+ YLH      ++ RD K +NIL+     E  + K++D G AR    P + L  +
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELIT 301
              VV T  Y APE +   R   K+ D+W+ G +  EL+T
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 64/219 (29%), Positives = 93/219 (42%), Gaps = 37/219 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFL-- 149
           IG+G FG VY           Q    D++   A+K L+++     KE    I E N L  
Sbjct: 1   IGKGTFGQVY-----------QVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVR 49

Query: 150 -GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL--SRVPTPLA--WIARL 204
             + + P +V L      D +      LV + M    L  HL    R     A  +IA L
Sbjct: 50  TLLDESPFIVGLKFSFQTDSDL----YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAEL 105

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
            +A      L +LH+   + +++RD K  NILLD      L DFGL++          + 
Sbjct: 106 VLA------LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSK--ANLTDNKTTN 154

Query: 265 SVVGTVGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITG 302
           +  GT  Y APE  +     T   D WS GV+++E+  G
Sbjct: 155 TFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 55.4 bits (134), Expect = 2e-08
 Identities = 43/140 (30%), Positives = 55/140 (39%), Gaps = 47/140 (33%)

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA-------R 252
           +IA   +A D+   L Y+H         RD K  N+LLD     KLSDFGL        R
Sbjct: 106 YIAETILAIDSIHKLGYIH---------RDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156

Query: 253 QGPPEGLGHVST-----------------------------SVVGTVGYAAPE-YVQTGR 282
                 L H                                S VGT  Y APE ++QTG 
Sbjct: 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG- 215

Query: 283 LTAKSDVWSFGVVLYELITG 302
              + D WS GV++YE++ G
Sbjct: 216 YNKECDWWSLGVIMYEMLVG 235

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 54.5 bits (131), Expect = 3e-08
 Identities = 52/218 (23%), Positives = 102/218 (46%), Gaps = 29/218 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G F  +++G+ R   D  +      K +V +K L++      + +    + +  + H
Sbjct: 3   LGQGTFTKIFKGIRREVGDYGELH----KTEVLLKVLDKSHRNYSESFFEAASMMSQLSH 58

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT-PLAWIARLKIAQDAARG 213
            +LV   G C   DE     ++V E +   SL+ +L        ++W  +L++A+  A  
Sbjct: 59  KHLVLNYGVCVCGDES----IMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWA 112

Query: 214 LAYLHEEMDFQLIFRDFKTSNILL--DEDYKA------KLSDFGLARQGPPEGLGHVSTS 265
           L +L ++    L   +    N+LL  +ED K       KLSD G++    P+ +      
Sbjct: 113 LHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPKEI------ 163

Query: 266 VVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITG 302
           ++  + +  PE ++  + L+  +D WSFG  L+E+ +G
Sbjct: 164 LLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 54.7 bits (132), Expect = 3e-08
 Identities = 47/169 (27%), Positives = 67/169 (39%), Gaps = 20/169 (11%)

Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+     ++HPN++  V     D E      +V  LM   S ED L +  P  L  +A 
Sbjct: 48  QEIITSRQLQHPNILPYVTSFIVDSEL----YVVSPLMAYGSCEDLLKTHFPEGLPELAI 103

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA--------RQGP 255
             I +D    L Y+H +     I R  K S+ILL  D K  LS    +        RQ  
Sbjct: 104 AFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRV 160

Query: 256 PEGLGHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITG 302
                  S      + + +PE +Q        KSD++S G+   EL  G
Sbjct: 161 VHDFPKSSVKN---LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANG 206

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 56/215 (26%), Positives = 96/215 (44%), Gaps = 36/215 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+               ++    A K +  +  +  ++++ E+  L    H
Sbjct: 20  LGDGAFGKVYKA-----------KNKETGALAAAKVIETKSEEELEDYMVEIEILATCNH 68

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P +VKL+G    D     +  ++ E     ++ D ++  +   L       I +     L
Sbjct: 69  PYIVKLLGAFYWDG----KLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVICRQMLEAL 123

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST-----SVVGT 269
            YLH     ++I RD K  N+LL  D   KL+DFG++ +       +V T     S +GT
Sbjct: 124 QYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAK-------NVKTLQRRDSFIGT 173

Query: 270 VGYAAPEYV--QTGRLTA---KSDVWSFGVVLYEL 299
             + APE V  +T + T    K+D+WS G+ L E+
Sbjct: 174 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEM 208

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 61/216 (28%), Positives = 90/216 (41%), Gaps = 27/216 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWINEVNFLGVVK 153
           IG G FG V  G V         SG+     V +K+L      Q   +++ E      ++
Sbjct: 3   IGNGWFGKVILGEV--------NSGYTPA-QVVVKELRVSASVQEQMKFLEEAQPYRSLQ 53

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS-RVPTPLAWIARL--KIAQDA 210
           H NL++ +G C E        LLV E      L+ +L S R    +        ++A + 
Sbjct: 54  HSNLLQCLGQCTEV----TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEI 109

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
           A GL +LH+      I  D    N LL  D   K+ D+GL+     E        +   +
Sbjct: 110 ALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166

Query: 271 GYAAPEYVQT--GRL-----TAKSDVWSFGVVLYEL 299
            + APE V    G L     T +S+VWS GV ++EL
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWEL 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 60/213 (28%), Positives = 93/213 (43%), Gaps = 25/213 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEW-INEVNFLGV 151
           ++GEG +G V +               ++K  VAIK+  + +  +  KE  + E+  L  
Sbjct: 8   VVGEGAYGVVLK-----------CRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRT 56

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT-PLAWIARLKIAQDA 210
           +K  N+V+L     E   R  +  LV+E +    LE  LL  +P        R  I Q  
Sbjct: 57  LKQENIVEL----KEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQ-L 109

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
            + + + H+     ++ RD K  N+L+  +   KL DFG AR    EG     T  V T 
Sbjct: 110 IKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARN-LSEGSNANYTEYVATR 165

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            Y +PE +         D+WS G +L EL  G+
Sbjct: 166 WYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 54.7 bits (131), Expect = 4e-08
 Identities = 63/228 (27%), Positives = 97/228 (42%), Gaps = 33/228 (14%)

Query: 125 DVAIKQLNRQGFQGH---KEWINEVNFLGVVKHPNLVKLVG-YCAEDDERGMQRL-LVYE 179
           +VAIK+L+R  FQ     K    E+  +  V H N++ L+  +  +      Q + +V E
Sbjct: 51  NVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME 109

Query: 180 LMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE 239
           LM     + +L   +   L       +      G+ +LH      +I RD K SNI++  
Sbjct: 110 LM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKS 161

Query: 240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           D   K+ DFGLAR     G   + T  V T  Y APE +         D+WS G ++ E+
Sbjct: 162 DCTLKILDFGLARTA---GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218

Query: 300 ITGR-------------RAVER---NLPRNEQKLLEWVRPYVSDSKKF 331
           I G              + +E+     P   +KL   VR YV +  K+
Sbjct: 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 266

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 54.3 bits (130), Expect = 4e-08
 Identities = 61/220 (27%), Positives = 95/220 (43%), Gaps = 30/220 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY+          +  G D K + A+KQ+   G         E+  L  +KH
Sbjct: 9   VGRGTYGHVYKA--------KRKDGKDEK-EYALKQIEGTGIS--MSACREIALLRELKH 57

Query: 155 PNLVKLVGYCAEDDERGMQRLLVY---ELMHNKSLEDHLLSRV---PTPLAWIARLKIAQ 208
           PN++ L        +R +  L  Y   +L H   ++ H  S+    P  L       +  
Sbjct: 58  PNVIALQKVFLSHSDRKVWLLFDYAEHDLWH--IIKFHRASKANKKPMQLPRSMVKSLLY 115

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLAR--QGPPEGLGHV 262
               G+ YLH      ++ RD K +NIL+     E  + K++D G AR    P + L  +
Sbjct: 116 QILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADL 172

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELIT 301
              VV T  Y APE +   R   K+ D+W+ G +  EL+T
Sbjct: 173 DPVVV-TFWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 54.1 bits (130), Expect = 6e-08
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 20/174 (11%)

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
           L  +   A+G+++L  +     I RD    NILL      K+ DFGLAR    +    V 
Sbjct: 217 LSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK 273

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
            +    V + APE +     T +SDVWS+G++L+E+ +   +    +P            
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMP------------ 321

Query: 324 YVSDSKKFHLIIDP-RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
              DSK + +I +  R+    C  +  ++  +   C    P  RP   ++V ++
Sbjct: 322 --VDSKFYKMIKEGYRMLSPEC--APSEMYDIMKSCWDADPLKRPTFKQIVQLI 371

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 54.2 bits (130), Expect = 6e-08
 Identities = 47/182 (25%), Positives = 77/182 (42%), Gaps = 17/182 (9%)

Query: 125 DVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNK 184
            V IK   R G         E + L  + HP++++L G    +       L++    +  
Sbjct: 119 HVVIKAGQRGGT------ATEAHILRAINHPSIIQLKGTFTYNK---FTCLILPR--YKT 167

Query: 185 SLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK 244
            L  +L ++    +  I  L I +   R + YLHE    ++I RD K  NI ++      
Sbjct: 168 DLYCYLAAKRNIAICDI--LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVC 222

Query: 245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           L DFG A   P +   +      GT+   APE +         D+WS G+VL+E+ T   
Sbjct: 223 LGDFGAACF-PVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHD 281

Query: 305 AV 306
           ++
Sbjct: 282 SL 283

Length = 391

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 54.3 bits (130), Expect = 7e-08
 Identities = 60/229 (26%), Positives = 103/229 (44%), Gaps = 32/229 (13%)

Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW 142
           +S  + +    +IG G FG VY  +             D+   VAIK++     Q  +  
Sbjct: 62  RSPNKSYKLGNIIGNGSFGVVYEAICI-----------DTSEKVAIKKV----LQDPQYK 106

Query: 143 INEVNFLGVVKHPNLVKLVGY----CAEDDERGMQRLLVYELMH---NKSLEDHLLSRVP 195
             E+  +  + H N++ L  Y    C + +E+ +   +V E +    +K ++ +  +   
Sbjct: 107 NRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHA 166

Query: 196 TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQG 254
            PL ++ +L   Q   R LAY+H +    +  RD K  N+L+D + +  KL DFG A+  
Sbjct: 167 LPL-FLVKLYSYQ-LCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221

Query: 255 PPEGLGHVSTSVVGTVGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITG 302
                G  S S + +  Y APE  +     T   D+WS G ++ E+I G
Sbjct: 222 LA---GQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267

Length = 440

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 53.0 bits (127), Expect = 8e-08
 Identities = 76/298 (25%), Positives = 121/298 (40%), Gaps = 61/298 (20%)

Query: 95  IGEGGFGCVYRGVVRVS---------SDDHQTSGHDS----KLDVAIKQLNRQGFQGHKE 141
           +G+G    +Y G +RV           +D       +    +L V +K L+         
Sbjct: 3   LGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALA 62

Query: 142 WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLA 199
           +    + +  V H +L  + G C     RG + ++V E + +  L D  L +     P+A
Sbjct: 63  FFETASLMSQVSHIHLAFVHGVCV----RGSENIMVEEFVEHGPL-DVCLRKEKGRVPVA 117

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-------KLSDFGLAR 252
           W  ++ +AQ  A  L+YL    D  L+  +    NILL     A       KLSD G+  
Sbjct: 118 W--KITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGV-- 170

Query: 253 QGPPEGLGHVS-TSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYEL-ITGRRAVERN 309
                    +S    V  + + APE V  G  L+  +D WSFG  L E+   G   ++  
Sbjct: 171 -----SFTALSREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKER 225

Query: 310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
            P  +++  E          K H + +P         S ++LA L S+CLT +P  RP
Sbjct: 226 TPSEKERFYE----------KKHRLPEP---------SCKELATLISQCLTYEPTQRP 264

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 53.9 bits (129), Expect = 8e-08
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 25/218 (11%)

Query: 97  EGGFGCVYRGVVRVSSDDHQ-------TSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL 149
            G FG ++   +R S+++ +       T+    K +  I +  + G +   +  NE+  L
Sbjct: 158 AGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILAL 217

Query: 150 GVVKHPNLVKLVGYCAEDDERGM--QRLL--VYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           G + H N++K+      +    M  Q+    +Y  M++++ +         PL    R  
Sbjct: 218 GRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWK-----DRPLLKQTR-A 271

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVS 263
           I +     + Y+H++    LI RD K  NI L+ D K  L DFG A   +   E   +  
Sbjct: 272 IMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDY-- 326

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
              VGTV   +PE +        +D+WS G++L ++++
Sbjct: 327 -GWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLS 363

Length = 501

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 53.2 bits (128), Expect = 9e-08
 Identities = 56/246 (22%), Positives = 101/246 (41%), Gaps = 33/246 (13%)

Query: 138 GHKEWI----NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLS 192
           GHK  I    NE+  L  +   N++K+ G+   D    + RL L+ E      L + L  
Sbjct: 57  GHKVLIDITENEIKNLRRIDSNNILKIYGFII-DIVDDLPRLSLILEYCTRGYLREVL-- 113

Query: 193 RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
                L++  +L +A D  +GL  L++  +    +++  + + L+ E+YK K+   GL +
Sbjct: 114 DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKP--YKNLTSVSFLVTENYKLKIICHGLEK 171

Query: 253 QGPPEGLGHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNL 310
                   +V+  V     Y + + +       T K D++S GVVL+E+ TG       +
Sbjct: 172 ILSSPPFKNVNFMV-----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTG------KI 220

Query: 311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
           P       E     ++ +    L +D  LE    +            C +     RP + 
Sbjct: 221 PFENLTTKEIYDLIINKNNSLKLPLDCPLEIKCIV----------EACTSHDSIKRPNIK 270

Query: 371 EVVDIL 376
           E++  L
Sbjct: 271 EILYNL 276

Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 52.4 bits (125), Expect = 1e-07
 Identities = 57/226 (25%), Positives = 93/226 (41%), Gaps = 27/226 (11%)

Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E+  +   KH N+V   G     D    +  +  E     SL+D  +  V  PL+     
Sbjct: 56  EIIMMKDCKHSNIVAYFGSYLRRD----KLWICMEFCGGGSLQD--IYHVTGPLSESQIA 109

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST 264
            ++++  +GL YLH +     + RD K +NILL ++   KL+DFG++ Q           
Sbjct: 110 YVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQ--ITATIAKRK 164

Query: 265 SVVGTVGYAAPEYV---QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
           S +GT  + APE     + G      D+W+ G+   EL       E   P  +   +  +
Sbjct: 165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL------AELQPPMFDLHPMRAL 218

Query: 322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             ++     F     P+L+    +K +          LTK PK RP
Sbjct: 219 --FLMTKSNFQ---PPKLKDK--MKWSNSFHHFVKMALTKNPKKRP 257

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 52.9 bits (127), Expect = 1e-07
 Identities = 34/103 (33%), Positives = 54/103 (52%), Gaps = 13/103 (12%)

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
           L+ +   A+G+ +L  +     I RD    N+LL +   AK+ DFGLAR      + + S
Sbjct: 215 LRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARD-----IMNDS 266

Query: 264 TSVVG-----TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             VV       V + APE +     T +SDVWS+G++L+E+ +
Sbjct: 267 NYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 45/156 (28%), Positives = 62/156 (39%), Gaps = 45/156 (28%)

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR------- 252
           +IA   +A DA   L ++H         RD K  N+LLD     KLSDFGL         
Sbjct: 106 YIAETVLAIDAIHQLGFIH---------RDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156

Query: 253 --------QGPPEGLG------------------HVSTSVVGTVGYAAPE-YVQTGRLTA 285
                     PP                       ++ S VGT  Y APE ++QTG    
Sbjct: 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTG-YNK 215

Query: 286 KSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLEW 320
             D WS GV++YE++ G        P+   +K++ W
Sbjct: 216 LCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.8 bits (124), Expect = 2e-07
 Identities = 53/219 (24%), Positives = 88/219 (40%), Gaps = 34/219 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V    +   +   +    + K + + K+ N    QG    I        ++H
Sbjct: 3   IGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRI--------LQH 54

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR-------LKIA 207
           PN+++ +G C E     +  LLV+E      L+ +L         W  R        ++A
Sbjct: 55  PNILQCLGQCVE----AIPYLLVFEYCELGDLKSYLSQE-----QWHRRNSQLLLLQRMA 105

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
            + A G+ ++H+      +  D    N  L  D   K+ D+G+      E          
Sbjct: 106 CEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKC 162

Query: 268 GTVGYAAPEYV---QTGRLTAK----SDVWSFGVVLYEL 299
             + + APE V     G +TA+    S+VW+ GV L+EL
Sbjct: 163 VPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 8/115 (6%)

Query: 223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR 282
             +++RD K  N+LLD+D   K++DFG A+      +   + ++ GT  Y APE +    
Sbjct: 150 LNIVYRDLKPENLLLDKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVG 204

Query: 283 LTAKSDVWSFGVVLYELITGRRAVERNLP-RNEQKLLEWV--RPYVSDSKKFHLI 334
               +D W+ G+ +YE++ G      N P    QK+LE +   P   D+   HL+
Sbjct: 205 HGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNCKHLM 259

Length = 340

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 51.7 bits (123), Expect = 6e-07
 Identities = 54/198 (27%), Positives = 85/198 (42%), Gaps = 58/198 (29%)

Query: 145 EVNFLGVVKHPNLVK---------------LVGYC-AEDDERGMQRLLVYELMHNKSLED 188
           EVN +  +KH N+V+               L+ +C A D  R +Q+   Y++     +E+
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK--CYKMF--GKIEE 117

Query: 189 HLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDF----QLIFRDFKTSNILLDEDYK-- 242
           H            A + I +     LAY H   D     +++ RD K  NI L    +  
Sbjct: 118 H------------AIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165

Query: 243 ---------------AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV--QTGRLTA 285
                          AK+ DFGL++    E + H   S VGT  Y +PE +  +T     
Sbjct: 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIESMAH---SCVGTPYYWSPELLLHETKSYDD 222

Query: 286 KSDVWSFGVVLYELITGR 303
           KSD+W+ G ++YEL +G+
Sbjct: 223 KSDMWALGCIIYELCSGK 240

Length = 1021

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 50.0 bits (119), Expect = 8e-07
 Identities = 37/118 (31%), Positives = 58/118 (49%), Gaps = 10/118 (8%)

Query: 185 SLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK 244
           SL+D  +  V  PL+ +    + ++  +GLAYLH +       RD K +NILL ++   K
Sbjct: 92  SLQD--IYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMH---RDIKGANILLTDNGDVK 146

Query: 245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV---QTGRLTAKSDVWSFGVVLYEL 299
           L+DFG+A +           S +GT  + APE     + G      D+W+ G+   EL
Sbjct: 147 LADFGVAAK--ITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 31/98 (31%), Positives = 47/98 (47%), Gaps = 3/98 (3%)

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
           L      ARG+ +L  +     + RD    N+LL +    K+ DFGLAR    +      
Sbjct: 240 LSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSK 296

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            S    V + APE +     T  SDVWS+G++L+E+ +
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 50.4 bits (120), Expect = 1e-06
 Identities = 50/177 (28%), Positives = 66/177 (37%), Gaps = 63/177 (35%)

Query: 195 PTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA- 251
           P  LA  +IA L  A ++   + ++H         RD K  NIL+D D   KL+DFGL  
Sbjct: 99  PEDLARFYIAELTCAVESVHKMGFIH---------RDIKPDNILIDRDGHIKLTDFGLCT 149

Query: 252 -----------------RQ---------GPPEG---------------------LGHVST 264
                            RQ         G P                       L H   
Sbjct: 150 GFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH--- 206

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEW 320
           S+VGT  Y APE +     T   D WS GV+LYE++ G+       P   Q K++ W
Sbjct: 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 45/156 (28%), Positives = 63/156 (40%), Gaps = 45/156 (28%)

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA-------R 252
           +IA   +A D+   L ++H         RD K  N+LLD     KLSDFGL        R
Sbjct: 106 YIAETVLAIDSIHQLGFIH---------RDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHR 156

Query: 253 QGPPEGLGH--------------------------VSTSVVGTVGYAAPE-YVQTGRLTA 285
                 L H                          ++ S VGT  Y APE ++QTG    
Sbjct: 157 TEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTG-YNK 215

Query: 286 KSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLEW 320
             D WS GV++YE++ G        P+   +K++ W
Sbjct: 216 LCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNW 251

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 49.4 bits (118), Expect = 3e-06
 Identities = 59/243 (24%), Positives = 96/243 (39%), Gaps = 60/243 (24%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQG----HKEWINEVN 147
           LIG+GG G VY               +D      VA+K++ R+         K ++ E  
Sbjct: 9   LIGKGGMGEVYLA-------------YDPVCSRRVALKKI-REDLSENPLLKKRFLREAK 54

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM---HNKSLEDHLLSRV------PTPL 198
               + HP +V +   C++ D        VY  M      +L+  LL  V         L
Sbjct: 55  IAADLIHPGIVPVYSICSDGD-------PVYYTMPYIEGYTLK-SLLKSVWQKESLSKEL 106

Query: 199 AW----IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA--R 252
           A      A L I       + Y+H +    ++ RD K  NILL    +  + D+G A  +
Sbjct: 107 AEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFK 163

Query: 253 QGPPEGLGHVSTS--------------VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
           +   E L  +                 +VGT  Y APE +     +  +D+++ GV+LY+
Sbjct: 164 KLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQ 223

Query: 299 LIT 301
           ++T
Sbjct: 224 MLT 226

Length = 932

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 48/174 (27%), Positives = 67/174 (38%), Gaps = 57/174 (32%)

Query: 195 PTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA- 251
           P  LA  +IA L +A ++   + ++H         RD K  NIL+D D   KL+DFGL  
Sbjct: 99  PEVLARFYIAELTLAIESVHKMGFIH---------RDIKPDNILIDLDGHIKLTDFGLCT 149

Query: 252 -----------------RQG---PPEGLGHVST------------------------SVV 267
                            RQ    P +    VS                         S+V
Sbjct: 150 GFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLV 209

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEW 320
           GT  Y APE +     T   D WS GV+L+E++ G+       P   Q K++ W
Sbjct: 210 GTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINW 263

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 48.4 bits (115), Expect = 5e-06
 Identities = 33/114 (28%), Positives = 47/114 (41%), Gaps = 15/114 (13%)

Query: 191 LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           L     PL       +A+     + Y+H E    +I RD KT N+L++      L DFG 
Sbjct: 250 LGARLRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGA 306

Query: 251 A------RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
           A         P          + GTV   APE +     T   D+WS G+V++E
Sbjct: 307 ACFARGSWSTP------FHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 49/215 (22%), Positives = 91/215 (42%), Gaps = 22/215 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG +G VY+   +        +G    L     +++ +G       + E++ L ++  
Sbjct: 9   IGEGTYGKVYKARDK-------NTGKLVALKKTRLEMDEEGIPPTA--LREISLLQMLSE 59

Query: 155 -PNLVKLVGYCAEDDERGMQRL-LVYELMHN--KSLEDHLLSRVPTPLAWIARLKIAQDA 210
              +V+L+     +++ G   L LV+E + +  K   D        PL            
Sbjct: 60  SIYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL 119

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-KAKLSDFGLARQ-GPPEGLGHVSTSVVG 268
            +G+A+ H+     ++ RD K  N+L+D+     K++D GL R    P  +   +  +V 
Sbjct: 120 LKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIP--VKSYTHEIV- 173

Query: 269 TVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           T+ Y APE +      +   D+WS G +  E+   
Sbjct: 174 TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRK 208

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 46.9 bits (111), Expect = 2e-05
 Identities = 38/131 (29%), Positives = 53/131 (40%), Gaps = 26/131 (19%)

Query: 195 PTPLAWIAR---------LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           P  L WI +          +I       L Y H E+   L+  D K  NIL++       
Sbjct: 216 PCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKPENILMETSDTV-- 271

Query: 246 SDFGLARQGPPE-------GLG------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSF 292
            D    R  PP+        LG      H  T++V T  Y +PE V        +D+WS 
Sbjct: 272 VDPVTNRALPPDPCRVRICDLGGCCDERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSM 331

Query: 293 GVVLYELITGR 303
           G ++YEL TG+
Sbjct: 332 GCIIYELYTGK 342

Length = 467

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 42.5 bits (101), Expect = 2e-04
 Identities = 31/95 (32%), Positives = 44/95 (46%), Gaps = 18/95 (18%)

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK--LSDFGLARQGPPEGLGHVSTSVV--G 268
            L  LH+     +I  D K  N+L D   K +  L D+GL +         + T     G
Sbjct: 121 ALNDLHKH---NIIHNDIKLENVLYDR-AKDRIYLCDYGLCK--------IIGTPSCYDG 168

Query: 269 TVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           T+ Y +PE +  G     S D W+ GV+ YEL+TG
Sbjct: 169 TLDYFSPEKI-KGHNYDVSFDWWAVGVLTYELLTG 202

Length = 267

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.1 bits (99), Expect = 4e-04
 Identities = 37/149 (24%), Positives = 55/149 (36%), Gaps = 56/149 (37%)

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR------- 252
           ++A   +A +A   L ++H         RD K  NIL+D     KLSDFGL+        
Sbjct: 106 YMAECVLAIEAVHKLGFIH---------RDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156

Query: 253 ----QGPPEGLGHVST----------------------------------SVVGTVGYAA 274
               Q   +G  + +                                   S VGT  Y A
Sbjct: 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIA 216

Query: 275 PE-YVQTGRLTAKSDVWSFGVVLYELITG 302
           PE ++Q G    + D WS G +++E + G
Sbjct: 217 PEIFLQQG-YGQECDWWSLGAIMFECLIG 244

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 40.1 bits (94), Expect = 8e-04
 Identities = 33/106 (31%), Positives = 42/106 (39%), Gaps = 24/106 (22%)

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
                L  LH         R  K+ NILL  D   KL   G      PE       S   
Sbjct: 25  QCLGALRELH---------RQAKSGNILLTWDGLLKL--DGSVAFKTPE------QSRPD 67

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
              + APE +Q    T K+D++S G+ LYE      A++  LP NE
Sbjct: 68  PY-FMAPEVIQGQSYTEKADIYSLGITLYE------ALDYELPYNE 106

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 39.5 bits (92), Expect = 0.002
 Identities = 50/221 (22%), Positives = 88/221 (39%), Gaps = 40/221 (18%)

Query: 94  LIGEGGFGCVY------------RGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE 141
           LIG GGFGCVY            + V ++ + +++T   ++ +   I  +++        
Sbjct: 19  LIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIAL----- 73

Query: 142 WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV---PTPL 198
           W N  N    + H  + K  G  +    R   R ++ E +   + E  +  R+      L
Sbjct: 74  WKNIHN----IDHLGIPKYYGCGSFKRCRMYYRFILLEKLVENTKE--IFKRIKCKNKKL 127

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                  I +D    L Y+HE     +   D K  NI++D + +  + D+G+A      G
Sbjct: 128 I----KNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHG 180

Query: 259 LGHVSTSV------VGTVGYAAPEYVQTGRLTAKSDVWSFG 293
             H+  S        GT+ YA  +      +T + D+ S G
Sbjct: 181 -KHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLG 220

Length = 294

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 38.2 bits (89), Expect = 0.002
 Identities = 35/165 (21%), Positives = 55/165 (33%), Gaps = 28/165 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV- 152
           L+  G    VY     +              D  +K    +     +E   EV  L ++ 
Sbjct: 5   LLKGGLTNRVYL----L---------GTKDEDYVLKINPSREKGADRE--REVAILQLLA 49

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +    V  V    E D       L+ E +  ++L++                 IA+  A 
Sbjct: 50  RKGLPVPKVLASGESDGWS---YLLMEWIEGETLDEVSEEEKE---------DIAEQLAE 97

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
            LA LH+     L   D    NIL+D+     + D+  A  GPP 
Sbjct: 98  LLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYGPPA 142

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	453
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.98
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.97
KOG1152	772	consensus Signal transduction serine/threonine kin	99.97
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.97
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.96
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.96
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.96
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.96
PLN00181	793	protein SPA1-RELATED; Provisional	99.95
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
PRK09188	365	serine/threonine protein kinase; Provisional	99.93
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.91
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.89
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.88
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.88
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.87
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.87
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.86
PRK12274	218	serine/threonine protein kinase; Provisional	99.86
PRK10345	210	hypothetical protein; Provisional	99.86
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.84
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.8
smart00090	237	RIO RIO-like kinase.	99.8
PRK14879	211	serine/threonine protein kinase; Provisional	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.79
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.78
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.78
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.77
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.71
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.66
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.53
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.52
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.49
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.44
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.39
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.35
KOG1243	690	consensus Protein kinase [General function predict	99.34
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.34
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.3
KOG3087	229	consensus Serine/threonine protein kinase [General	99.28
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.27
COG4248	637	Uncharacterized protein with protein kinase and he	99.27
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.25
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.18
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.09
PRK09902	216	hypothetical protein; Provisional	98.96
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.92
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.9
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.85
KOG2137	700	consensus Protein kinase [Signal transduction mech	98.85
PF01636	239	APH: Phosphotransferase enzyme family This family	98.53
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.52
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.51
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.46
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.43
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.39
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.35
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.32
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.29
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.29
PLN02876	822	acyl-CoA dehydrogenase	98.2
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.19
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.14
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.11
PRK10593	297	hypothetical protein; Provisional	98.05
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.01
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.0
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.93
PRK09550	401	mtnK methylthioribose kinase; Reviewed	97.77
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	97.75
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.62
PRK05231	319	homoserine kinase; Provisional	97.6
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.54
KOG2268	465	consensus Serine/threonine protein kinase [Signal	97.39
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	97.22
PLN02236	344	choline kinase	97.22
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.13
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	97.12
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.11
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.87
PLN02756	418	S-methyl-5-thioribose kinase	96.82
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.74
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.67
KOG2270	520	consensus Serine/threonine protein kinase involved	96.58
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	96.56
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	96.49
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	96.4
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.34
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	96.26
COG2334	331	Putative homoserine kinase type II (protein kinase	95.85
PRK12396	409	5-methylribose kinase; Reviewed	95.82
PRK06148	1013	hypothetical protein; Provisional	95.31
PTZ00384	383	choline kinase; Provisional	95.25
PTZ00296	442	choline kinase; Provisional	95.17
PRK11768	325	serine/threonine protein kinase; Provisional	94.88
COG3001	286	Uncharacterized protein conserved in bacteria [Fun	94.37

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-59  Score=457.96  Aligned_cols=291  Identities=56%  Similarity=0.918  Sum_probs=254.5

Q ss_pred             CCccccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC
Q 043568           73 DLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV  152 (453)
Q Consensus        73 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l  152 (453)
                      ..+.|++.++..||++|...++||+|+||.||+|.+.            ++..||||++........++|.+|+.++.++
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~------------~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l  128 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLS------------DGTVVAVKRLSSNSGQGEREFLNEVEILSRL  128 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEEC------------CCCEEEEEEecCCCCcchhHHHHHHHHHhcC
Confidence            6778999999999999999999999999999999985            3478999988765433156699999999999


Q ss_pred             CCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      +|||+|+|+|||.+.+.   +++||||||++|+|.++|+.....+++|..|++||.++|+||+|||..+.+.||||||||
T Consensus       129 ~H~Nlv~LlGyC~e~~~---~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKs  205 (361)
T KOG1187|consen  129 RHPNLVKLLGYCLEGGE---HRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKS  205 (361)
T ss_pred             CCcCcccEEEEEecCCc---eEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCH
Confidence            99999999999998774   269999999999999999987544899999999999999999999999888999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCcccccc-ccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV-VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      +|||||+++++||+|||+|+..+... .. .... .||.+|+|||++..+..+.|+|||||||+|+||+||+.|.+...+
T Consensus       206 sNILLD~~~~aKlsDFGLa~~~~~~~-~~-~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~  283 (361)
T KOG1187|consen  206 SNILLDEDFNAKLSDFGLAKLGPEGD-TS-VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRP  283 (361)
T ss_pred             HHeeECCCCCEEccCccCcccCCccc-cc-eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCC
Confidence            99999999999999999997654311 11 1122 899999999999999999999999999999999999999887666


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCC-Cccch-HHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLE-GNYCI-KSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      ..+..+++|+.+.+.+. .+..++|+.+. ..+.. .....+..++.+|++.+|.+||+|.+|++.|+.+..
T Consensus       284 ~~~~~l~~w~~~~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~~  354 (361)
T KOG1187|consen  284 RGELSLVEWAKPLLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGILS  354 (361)
T ss_pred             cccccHHHHHHHHHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhcc
Confidence            66667999998888766 78899999987 56654 678889999999999999999999999999965543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-51  Score=399.36  Aligned_cols=256  Identities=38%  Similarity=0.564  Sum_probs=213.0

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCee-EEEEEeccCCccc--HHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD-VAIKQLNRQGFQG--HKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~-vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      ..||+|+||+||+|.++             +.. ||||.+.......  .+.|.+|+.+|.+++|||||+++|+|.....
T Consensus        47 ~~iG~G~~g~V~~~~~~-------------g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~  113 (362)
T KOG0192|consen   47 EVLGSGSFGTVYKGKWR-------------GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPG  113 (362)
T ss_pred             hhcccCCceeEEEEEeC-------------CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence            35999999999999986             344 9999997654333  4589999999999999999999999998763


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc-eEeeccccccEEEcCCC-cEEEec
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ-LIFRDFKTSNILLDEDY-KAKLSD  247 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-iiH~Dlkp~NILl~~~~-~~kL~D  247 (453)
                         .++|||||+++|+|.++|+......+++..+++++.|||+||.|||++   + ||||||||+|||++.++ ++||+|
T Consensus       114 ---~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~D  187 (362)
T KOG0192|consen  114 ---SLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIAD  187 (362)
T ss_pred             ---ceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECC
Confidence               279999999999999999885557899999999999999999999999   6 99999999999999998 999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccc--cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ--TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      ||+++......  ...+...||+.|||||++.  ...|+.|+|||||||++|||+||+.||....+.  +.....+.   
T Consensus       188 FGlsr~~~~~~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~~~v~~---  260 (362)
T KOG0192|consen  188 FGLSREKVISK--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVASAVVV---  260 (362)
T ss_pred             Cccceeecccc--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHh---
Confidence            99998754321  2234478999999999999  669999999999999999999999999876541  11111111   


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                                 ...+...+..++..+..|+.+||..||..||++.+|+..|+.+......
T Consensus       261 -----------~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~  309 (362)
T KOG0192|consen  261 -----------GGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISS  309 (362)
T ss_pred             -----------cCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcc
Confidence                       1111222233678899999999999999999999999999999886654

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-50  Score=375.29  Aligned_cols=250  Identities=28%  Similarity=0.407  Sum_probs=208.4

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      ....+.||+|..|+|||+.|+           .++..+|+|++.... ....+++.+|+++++..+|||||.+||.|...
T Consensus        81 le~~~~lG~G~gG~V~kv~Hk-----------~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~  149 (364)
T KOG0581|consen   81 LERLGVLGSGNGGTVYKVRHK-----------PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSN  149 (364)
T ss_pred             hhhhhhcccCCCcEEEEEEEc-----------CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeC
Confidence            334568999999999999997           568899999995432 33457899999999999999999999999988


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccccccEEEcCCCcEEEe
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ..   ...|+||||++|+|++.+...  +.+++...-+|+.++++||.|||. +   +||||||||+|||++..|.+||+
T Consensus       150 ~~---~isI~mEYMDgGSLd~~~k~~--g~i~E~~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKic  221 (364)
T KOG0581|consen  150 GE---EISICMEYMDGGSLDDILKRV--GRIPEPVLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKIC  221 (364)
T ss_pred             Cc---eEEeehhhcCCCCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEec
Confidence            74   269999999999999988876  578899999999999999999996 5   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCC--ChhhHHHHHhhhhc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL--PRNEQKLLEWVRPY  324 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~--~~~~~~~~~~~~~~  324 (453)
                      |||.++.....    ...+.+||..|||||.+.+..|+.++||||||+.++|+.+|+.|+....  ......++..+...
T Consensus       222 DFGVS~~lvnS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~  297 (364)
T KOG0581|consen  222 DFGVSGILVNS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDE  297 (364)
T ss_pred             cccccHHhhhh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcC
Confidence            99999876532    5678899999999999999999999999999999999999999997641  12222333222110


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                ..|.+...   ..++++.+++..||++||.+|||+.++++
T Consensus       298 ----------ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~  334 (364)
T KOG0581|consen  298 ----------PPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQ  334 (364)
T ss_pred             ----------CCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                      01111111   36788999999999999999999999875

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-49  Score=373.53  Aligned_cols=250  Identities=29%  Similarity=0.476  Sum_probs=204.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..+|...+.||.|+||+||+|+++           .++..||||.+.+..  ....+.+..|+.+|+.++|||||.++++
T Consensus         9 ~~~y~~~~~iG~GsfavVykg~h~-----------~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~   77 (429)
T KOG0595|consen    9 VGDYELSREIGSGSFAVVYKGRHK-----------KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDC   77 (429)
T ss_pred             cccceehhhccCcceEEEEEeEec-----------cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEE
Confidence            467888889999999999999997           456889999998763  3445667899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC---
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED---  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~---  240 (453)
                      +..++.    .+||||||.||+|.+||+.+  ..+++.....++.|||.||++||++   +||||||||+||||+.+   
T Consensus        78 ~~~~~~----i~lVMEyC~gGDLs~yi~~~--~~l~e~t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~  148 (429)
T KOG0595|consen   78 IEDDDF----IYLVMEYCNGGDLSDYIRRR--GRLPEATARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARN  148 (429)
T ss_pred             EecCCe----EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCC
Confidence            998875    79999999999999999987  5788999999999999999999999   99999999999999765   


Q ss_pred             ---CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          241 ---YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       241 ---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                         -.+||+|||+|+...+   .....+.+|++.|||||+++...|+.|+|+||+|+|||+|++|+.||....+.+-...
T Consensus       149 ~~~~~LKIADFGfAR~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~  225 (429)
T KOG0595|consen  149 DTSPVLKIADFGFARFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLY  225 (429)
T ss_pred             CCCceEEecccchhhhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH
Confidence               5689999999998764   3446678999999999999999999999999999999999999999987655443222


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                      ++.       +..        +....+...+..+.+|+...+..+|.+|-++.+-.
T Consensus       226 ~~k-------~~~--------~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~  266 (429)
T KOG0595|consen  226 IKK-------GNE--------IVPVLPAELSNPLRELLISLLQRNPKDRISFEDFF  266 (429)
T ss_pred             Hhc-------ccc--------ccCchhhhccCchhhhhhHHHhcCccccCchHHhh
Confidence            111       111        11111222233455777777777777777665543

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.3e-49  Score=385.00  Aligned_cols=248  Identities=29%  Similarity=0.504  Sum_probs=211.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..|...+.||+|||+.||.+++.           ..+..||+|++.+...   ...+...+|++|.+.|+|||||+++++
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~-----------~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~   86 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDL-----------DTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF   86 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEc-----------CCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence            56999999999999999999975           4578899999976432   334668899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      |.+...    .|||.|+|.+++|..++..+  +++++.++..++.||+.||.|||++   +|+|||||..|+||+++.++
T Consensus        87 FEDs~n----VYivLELC~~~sL~el~Krr--k~ltEpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~V  157 (592)
T KOG0575|consen   87 FEDSNN----VYIVLELCHRGSLMELLKRR--KPLTEPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNV  157 (592)
T ss_pred             eecCCc----eEEEEEecCCccHHHHHHhc--CCCCcHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcE
Confidence            998876    69999999999999988855  7899999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||||......  .....+.+|||.|+|||++.....+..+||||+|||+|.||.|++||+...-.+...-+...  
T Consensus       158 KIgDFGLAt~le~~--~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~--  233 (592)
T KOG0575|consen  158 KIGDFGLATQLEYD--GERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLN--  233 (592)
T ss_pred             EecccceeeeecCc--ccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhc--
Confidence            99999999986643  23456789999999999999999999999999999999999999999865322221111110  


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                      ....+...+.+..+||.++|+.||.+|||+.+|+.
T Consensus       234 ----------------~Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~  268 (592)
T KOG0575|consen  234 ----------------EYSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD  268 (592)
T ss_pred             ----------------CcccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                            01123345678999999999999999999999985

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-48  Score=377.90  Aligned_cols=256  Identities=30%  Similarity=0.469  Sum_probs=212.3

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecc
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      +...+.||+|.||.||.|.++.            ...||||.++.. ....+.|.+|+.+|++|+|+|||+++|+|....
T Consensus       208 l~l~~~LG~G~FG~V~~g~~~~------------~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~  274 (468)
T KOG0197|consen  208 LKLIRELGSGQFGEVWLGKWNG------------STKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE  274 (468)
T ss_pred             HHHHHHhcCCccceEEEEEEcC------------CCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC
Confidence            3445689999999999999863            457999998654 344578999999999999999999999999877


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      +    ++||||||+.|+|.++|....+..+...+.+.++.|||+|++||+++   ++|||||...|||++++..+||+||
T Consensus       275 p----iyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDF  347 (468)
T KOG0197|consen  275 P----IYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDF  347 (468)
T ss_pred             c----eEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEccc
Confidence            5    79999999999999999987778899999999999999999999999   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccC
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      |||+...++ .........-...|+|||.+..+.++.|||||||||+||||+| |+.|+......+   +++.+      
T Consensus       348 GLAr~~~d~-~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e---v~~~l------  417 (468)
T KOG0197|consen  348 GLARLIGDD-EYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE---VLELL------  417 (468)
T ss_pred             ccccccCCC-ceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH---HHHHH------
Confidence            999954332 2222333344568999999999999999999999999999999 777776553322   22222      


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                              +...+-+.+..+|+.+.+|+..||..+|++|||++.+...|+.+...
T Consensus       418 --------e~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  418 --------ERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             --------hccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence                    11122233556789999999999999999999999998888887754

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-49  Score=355.76  Aligned_cols=258  Identities=26%  Similarity=0.361  Sum_probs=204.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee-
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY-  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~-  163 (453)
                      .+|.+.++||+|.||.|||+.+.           .++..+|.|.+.-...  ........|+.+|++|+|||||++++. 
T Consensus        19 ~~y~Il~~IG~GsFg~vykv~~~-----------~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~   87 (375)
T KOG0591|consen   19 ADYQILKKIGRGSFGEVYKVQCL-----------LDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHS   87 (375)
T ss_pred             HHHHHHHHHcCCcchheEEeeec-----------cCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHh
Confidence            35667779999999999999976           5678899999874332  334668899999999999999999984 


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeeccccccEEEcC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ--LIFRDFKTSNILLDE  239 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~NILl~~  239 (453)
                      +.++...   +.||||||.+|+|...++.  .....+++..+|+++.|++.||.++|+. .+.  |+||||||.||+|+.
T Consensus        88 f~~~~ev---lnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~-~~r~~VmHRDIKPaNIFl~~  163 (375)
T KOG0591|consen   88 FIEDNEV---LNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSK-IPRGTVMHRDIKPANIFLTA  163 (375)
T ss_pred             hhccchh---hHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhcc-ccccceeeccCcchheEEcC
Confidence            3333332   6899999999999998864  3356799999999999999999999994 224  999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      +|.+||+|||+++.+...  .......+|||.||+||.+...+|+.+|||||+||++|||+..++||.+..-.   .+.+
T Consensus       164 ~gvvKLGDfGL~r~l~s~--~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~---~L~~  238 (375)
T KOG0591|consen  164 NGVVKLGDFGLGRFLSSK--TTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLL---SLCK  238 (375)
T ss_pred             CCceeeccchhHhHhcch--hHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHH---HHHH
Confidence            999999999999987643  33456789999999999999999999999999999999999999999875211   1211


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      .+..    + .     -+.+.   ....+..+..||..|+..||+.||+.-.++..+.
T Consensus       239 KI~q----g-d-----~~~~p---~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  239 KIEQ----G-D-----YPPLP---DEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHc----C-C-----CCCCc---HHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            1110    0 0     01111   1356788999999999999999999654444443

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.8e-48  Score=365.00  Aligned_cols=251  Identities=25%  Similarity=0.422  Sum_probs=203.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-------HHHHHHHHHHhccCCCCcee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-------HKEWINEVNFLGVVKHPNLV  158 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~nIv  158 (453)
                      .+.|...+.||+|+||.|-+|..+           .+++.||||++++.....       .....+|+++|++|+|||||
T Consensus       171 ~d~yii~~~LGsGafg~Vkla~e~-----------~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV  239 (475)
T KOG0615|consen  171 NDYYIISKTLGSGAFGLVKLAYEK-----------KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIV  239 (475)
T ss_pred             cceeEeeeeecCCceeEEEEEEEc-----------ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEE
Confidence            456788889999999999999976           568899999998653222       22356999999999999999


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ++++++...+.    .|+||||++||.|.+++..+  +.+.+..-.-++.|++.||.|||+.   ||+||||||+|||++
T Consensus       240 ~~~d~f~~~ds----~YmVlE~v~GGeLfd~vv~n--k~l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~  310 (475)
T KOG0615|consen  240 RIKDFFEVPDS----SYMVLEYVEGGELFDKVVAN--KYLREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLS  310 (475)
T ss_pred             EEeeeeecCCc----eEEEEEEecCccHHHHHHhc--cccccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEec
Confidence            99999998875    59999999999999999887  4555556677899999999999999   999999999999997


Q ss_pred             CC---CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC---CCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          239 ED---YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR---LTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       239 ~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      .+   ..+||+|||+|+....   .....+.+||+.|.|||++.+..   +..++|+||+|||||-+++|.+||......
T Consensus       311 ~~~e~~llKItDFGlAK~~g~---~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~  387 (475)
T KOG0615|consen  311 NDAEDCLLKITDFGLAKVSGE---GSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD  387 (475)
T ss_pred             cCCcceEEEecccchhhcccc---ceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence            65   7799999999998652   45577889999999999998654   334889999999999999999999765432


Q ss_pred             h--hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          313 N--EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       313 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .  ..++.....               ..........+++..+||.+||..||++|||+.|+++
T Consensus       388 ~sl~eQI~~G~y---------------~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~  436 (475)
T KOG0615|consen  388 PSLKEQILKGRY---------------AFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN  436 (475)
T ss_pred             ccHHHHHhcCcc---------------cccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence            2  111111100               0011223456889999999999999999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-46  Score=349.29  Aligned_cols=243  Identities=27%  Similarity=0.388  Sum_probs=202.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...++||+|+||+||..+.+           ++++-+|+|++++....   ..+...+|..+|..++||.||+++-
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~-----------dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~y   92 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKK-----------DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIY   92 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEc-----------ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEE
Confidence            467999999999999999999876           56788999999876432   3466789999999999999999998


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .|++...    +|||+||+.||.|.-+|.+.  ..+++..+.-++..|+.||.|||++   +||||||||+|||||.+|+
T Consensus        93 sFQt~~k----LylVld~~~GGeLf~hL~~e--g~F~E~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GH  163 (357)
T KOG0598|consen   93 SFQTEEK----LYLVLDYLNGGELFYHLQRE--GRFSEDRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGH  163 (357)
T ss_pred             ecccCCe----EEEEEeccCCccHHHHHHhc--CCcchhHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCc
Confidence            8888775    89999999999999999876  5788887778889999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ++|+|||+++.....  +....+.+||+.|||||++.+..|+.++|.|||||++|||++|.+||.........+.+... 
T Consensus       164 i~LtDFgL~k~~~~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~-  240 (357)
T KOG0598|consen  164 IKLTDFGLCKEDLKD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKG-  240 (357)
T ss_pred             EEEeccccchhcccC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcC-
Confidence            999999999964322  23455689999999999999999999999999999999999999999876433222211100 


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  367 (453)
                                     + ....+.-.+.+..+++.++|..||++|.
T Consensus       241 ---------------k-~~~~p~~ls~~ardll~~LL~rdp~~RL  269 (357)
T KOG0598|consen  241 ---------------K-LPLPPGYLSEEARDLLKKLLKRDPRQRL  269 (357)
T ss_pred             ---------------c-CCCCCccCCHHHHHHHHHHhccCHHHhc
Confidence                           0 0011122467789999999999999996

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-46  Score=366.64  Aligned_cols=261  Identities=30%  Similarity=0.455  Sum_probs=212.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .+.+.....||+|.||+||+|.+.+              .||||+++....  ...+.|.+|+.++++-+|.||+-+.||
T Consensus       391 ~~ev~l~~rIGsGsFGtV~Rg~whG--------------dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~  456 (678)
T KOG0193|consen  391 PEEVLLGERIGSGSFGTVYRGRWHG--------------DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGA  456 (678)
T ss_pred             HHHhhccceeccccccceeeccccc--------------ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehh
Confidence            4445567789999999999999863              599999986643  345789999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      |..+.     +.||..+|+|.+|+.+|+-.. ..|+....+.|++|||+|+.|||.+   +|||||||..||||.++++|
T Consensus       457 ~~~p~-----~AIiTqwCeGsSLY~hlHv~e-tkfdm~~~idIAqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  457 CMNPP-----LAIITQWCEGSSLYTHLHVQE-TKFDMNTTIDIAQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             hcCCc-----eeeeehhccCchhhhhccchh-hhhhHHHHHHHHHHHHHhhhhhhhh---hhhhhhccccceEEccCCcE
Confidence            99876     489999999999999998764 6789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      ||+||||+.....-..........|...|||||+++.   .+|++.+||||||||+|||++|..||.....  ++.++..
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~--dqIifmV  605 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR--DQIIFMV  605 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh--hheEEEe
Confidence            9999999976433222233445678899999999874   5799999999999999999999999973322  2222111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      -+.+..        .|.   .....++++++.+|+..||..++++||.+.+|+..|+.+...
T Consensus       606 GrG~l~--------pd~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  606 GRGYLM--------PDL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             cccccC--------ccc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            111110        000   112345688999999999999999999999999988888774

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=8.7e-46  Score=364.10  Aligned_cols=268  Identities=26%  Similarity=0.421  Sum_probs=208.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||.||+|.+....      ....+..||||++..... .....+.+|+.++..+ +||||++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGID------KKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGA   79 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccC------CcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeE
Confidence            467999999999999999999864211      113456799999875432 2346789999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC-------------------------------------------------
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV-------------------------------------------------  194 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------  194 (453)
                      |.....   ..++||||+++|+|.+++....                                                 
T Consensus        80 ~~~~~~---~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (338)
T cd05102          80 CTKPNG---PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGS  156 (338)
T ss_pred             ecCCCC---ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcc
Confidence            876543   2689999999999999987532                                                 


Q ss_pred             -----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccc
Q 043568          195 -----------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS  263 (453)
Q Consensus       195 -----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  263 (453)
                                 ..++++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...........
T Consensus       157 ~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~  233 (338)
T cd05102         157 TNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRK  233 (338)
T ss_pred             cccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcc
Confidence                       13478888899999999999999998   9999999999999999999999999999864322211122


Q ss_pred             cccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCc
Q 043568          264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGN  342 (453)
Q Consensus       264 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  342 (453)
                      ....++..|+|||++.+..++.++|||||||++|||++ |..||.......  .+.....    ....      .    .
T Consensus       234 ~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~----~~~~------~----~  297 (338)
T cd05102         234 GSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE--EFCQRLK----DGTR------M----R  297 (338)
T ss_pred             cCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH--HHHHHHh----cCCC------C----C
Confidence            33456788999999998899999999999999999997 999987543221  1111110    0100      0    0


Q ss_pred             cchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          343 YCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       343 ~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .+...+..+.+|+.+||+.||.+|||+.+|++.|+.++.
T Consensus       298 ~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         298 APENATPEIYRIMLACWQGDPKERPTFSALVEILGDLLQ  336 (338)
T ss_pred             CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            122345679999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.6e-46  Score=336.82  Aligned_cols=266  Identities=27%  Similarity=0.360  Sum_probs=210.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-c-cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-Q-GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~-~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +.|....++|+|+||+|||++++           .+++.||||++..... . -.+-.++|+++|++|+|||+|.++++|
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk-----------~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVF   70 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNK-----------DTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVF   70 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccC-----------CcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHH
Confidence            45777789999999999999987           5688999999865433 2 234568999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    ++||+|||+..-|.+ |... +..++.....+++.|++.|+.|+|++   +||||||||+||||+.++.+|
T Consensus        71 rrkrk----lhLVFE~~dhTvL~e-Le~~-p~G~~~~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvK  141 (396)
T KOG0593|consen   71 RRKRK----LHLVFEYCDHTVLHE-LERY-PNGVPSELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVK  141 (396)
T ss_pred             Hhcce----eEEEeeecchHHHHH-HHhc-cCCCCHHHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEE
Confidence            87664    799999996655544 5443 56788888999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh--
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV--  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--  321 (453)
                      |+|||+|+....  .+...+..+.|.+|.|||.+.+ ..|+..+||||+||++.||++|.+-|.+....+....+...  
T Consensus       142 LCDFGFAR~L~~--pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG  219 (396)
T KOG0593|consen  142 LCDFGFARTLSA--PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLG  219 (396)
T ss_pred             eccchhhHhhcC--CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHc
Confidence            999999998763  2445778899999999999987 68999999999999999999999999876555544333321  


Q ss_pred             ------hhcccCccccccccCCcCCCc-----cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 ------RPYVSDSKKFHLIIDPRLEGN-----YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ------~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                            ...+.....+.-+.-|.....     --+..+.-+.+++..||..||.+|++.++++.
T Consensus       220 ~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~  283 (396)
T KOG0593|consen  220 NLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH  283 (396)
T ss_pred             ccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence                  112222222332222222221     12334567899999999999999999999874

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=9.1e-46  Score=357.67  Aligned_cols=255  Identities=25%  Similarity=0.375  Sum_probs=212.6

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCcee
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLV  158 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv  158 (453)
                      ++...+|..++.||+|+|++||+|+.+           .+++.||||++.+.-   ....+....|-.+|.+| .||.|+
T Consensus        69 kk~~~DF~Fg~~lGeGSYStV~~A~~~-----------~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgiv  137 (604)
T KOG0592|consen   69 KKTPNDFKFGKILGEGSYSTVVLAREK-----------ATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIV  137 (604)
T ss_pred             cCChhhcchhheeccccceeEEEeeec-----------CCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeE
Confidence            455678999999999999999999976           567899999997652   23335566888999999 899999


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      +|+-.|.+...    +|+|+||+++|+|.++|.+.  ..|++.....++.+|+.||+|||+.   |||||||||+|||||
T Consensus       138 kLy~TFQD~~s----LYFvLe~A~nGdll~~i~K~--Gsfde~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd  208 (604)
T KOG0592|consen  138 KLYFTFQDEES----LYFVLEYAPNGDLLDLIKKY--GSFDETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLD  208 (604)
T ss_pred             EEEEEeecccc----eEEEEEecCCCcHHHHHHHh--CcchHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEc
Confidence            99988887765    89999999999999999987  6788888899999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCC-----------ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          239 EDYKAKLSDFGLARQGPPEGLG-----------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~-----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      .|+++||+|||.|+.+.+....           .....++||..|.+||++..+..++.+|+|+||||||+|+.|.+||.
T Consensus       209 ~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFr  288 (604)
T KOG0592|consen  209 KDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFR  288 (604)
T ss_pred             CCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCc
Confidence            9999999999999976554322           11255899999999999999999999999999999999999999997


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .....   .+++.+..               +.-.++...++.+.+||.+.|..||.+|+|..+|.+.
T Consensus       289 a~Ney---liFqkI~~---------------l~y~fp~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  289 AANEY---LIFQKIQA---------------LDYEFPEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             cccHH---HHHHHHHH---------------hcccCCCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            65332   22222211               1112333446789999999999999999999998764

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-46  Score=351.27  Aligned_cols=257  Identities=26%  Similarity=0.420  Sum_probs=204.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .++...+.||+|+||+||++...           .++...|||.+........+.+.+|+.+|++++|||||+++|....
T Consensus        17 ~~~~~~~~lG~Gs~G~V~l~~~~-----------~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~   85 (313)
T KOG0198|consen   17 SNWSKGKLLGRGSFGSVYLATNK-----------KTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSS   85 (313)
T ss_pred             chhhhhccccCccceEEEEEEec-----------CCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCcccc
Confidence            45667789999999999999976           3367899999876533336678999999999999999999997444


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-CCcEEE
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKAKL  245 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kL  245 (453)
                      ...  ..+++.|||+++|+|.+++.+..+ .+++..+..+.+||++||.|||++   ||||+||||+|||++. ++.+||
T Consensus        86 ~~~--~~~~i~mEy~~~GsL~~~~~~~g~-~l~E~~v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~Kl  159 (313)
T KOG0198|consen   86 REN--DEYNIFMEYAPGGSLSDLIKRYGG-KLPEPLVRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKL  159 (313)
T ss_pred             ccC--eeeEeeeeccCCCcHHHHHHHcCC-CCCHHHHHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEe
Confidence            432  237999999999999999998766 899999999999999999999999   9999999999999999 799999


Q ss_pred             eccccccCCCC-CCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          246 SDFGLARQGPP-EGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~-~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|||+++.... ...........||+.|||||++..+ ...+++|||||||++.||+||+.||..... ....++.... 
T Consensus       160 aDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~-~~~~~~~ig~-  237 (313)
T KOG0198|consen  160 ADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFE-EAEALLLIGR-  237 (313)
T ss_pred             ccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcc-hHHHHHHHhc-
Confidence            99999987553 1112234467899999999999854 334699999999999999999999976311 1111111110 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                                  .. .....+...+.+..+++.+|+..+|++|||+.++++.
T Consensus       238 ------------~~-~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~h  276 (313)
T KOG0198|consen  238 ------------ED-SLPEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEH  276 (313)
T ss_pred             ------------cC-CCCCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhC
Confidence                        00 0113344567889999999999999999999998864

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-46  Score=380.18  Aligned_cols=266  Identities=29%  Similarity=0.492  Sum_probs=222.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+-...+.||+|+||.||+|.......      .+....||||.++..... ...+|.+|+++|+.|+|||||+|+|+|.
T Consensus       486 ~~i~~~~eLGegaFGkVf~a~~~~l~p------~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~  559 (774)
T KOG1026|consen  486 SDIVFKEELGEGAFGKVFLAEAYGLLP------GQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCR  559 (774)
T ss_pred             hheeehhhhcCchhhhhhhhhccCCCC------CccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence            344455689999999999998754321      245678999999877655 6789999999999999999999999999


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCC------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVP------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      +.++    +++|+|||..|+|.+||..+.+            .+++..+.+.||.|||.|+.||-++   .+|||||...
T Consensus       560 ~~~P----~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATR  632 (774)
T KOG1026|consen  560 EGDP----LCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATR  632 (774)
T ss_pred             cCCe----eEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhh
Confidence            9887    7999999999999999986532            2388899999999999999999999   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCCh
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPR  312 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~  312 (453)
                      |+|+.++..|||+|||+++.....+.........-..+|||||.+..+++|.+||||||||+|||+++ |+.|+++....
T Consensus       633 NCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  633 NCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             hceeccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            99999999999999999998766665555545556789999999999999999999999999999999 88998765432


Q ss_pred             hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         .+++.++             +..+ -..+.++|.++..|+..||+.+|++||+++||-..|+.....
T Consensus       713 ---EVIe~i~-------------~g~l-L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~~  765 (774)
T KOG1026|consen  713 ---EVIECIR-------------AGQL-LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQA  765 (774)
T ss_pred             ---HHHHHHH-------------cCCc-ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHhc
Confidence               3333322             1111 234567899999999999999999999999999999887754

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-45  Score=344.00  Aligned_cols=263  Identities=28%  Similarity=0.411  Sum_probs=214.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-HHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .+.|.....||.|..++||+|+..           ..+..||||+++.+.... ...+.+|+..|+.++||||++++..|
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~-----------p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sF   93 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCI-----------PTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSF   93 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeec-----------ccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEE
Confidence            467888899999999999999987           556899999998776554 47889999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    +++||.||.+|++.+.+....+..+++..+..|++++++||.|||.+   |.||||||+.||||+.+|.+|
T Consensus        94 vv~~~----LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~Vk  166 (516)
T KOG0582|consen   94 VVDSE----LWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVK  166 (516)
T ss_pred             Eecce----eEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEE
Confidence            88775    89999999999999999998888999999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCcc-c-cccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          245 LSDFGLARQGPPEGLGHV-S-TSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~-~-~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      |+|||.+..+...+.... . ...+||++|||||+++.  ..|+.|+||||||+..+||.+|..||....|...  +...
T Consensus       167 LadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv--Ll~t  244 (516)
T KOG0582|consen  167 LADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV--LLLT  244 (516)
T ss_pred             EcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH--HHHH
Confidence            999998876554432211 1 56699999999999653  5699999999999999999999999987654332  2111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +..   ......   ...+........+..+.+++..||..||.+|||++++++
T Consensus       245 Lqn---~pp~~~---t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk  292 (516)
T KOG0582|consen  245 LQN---DPPTLL---TSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK  292 (516)
T ss_pred             hcC---CCCCcc---cccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence            111   010000   111111222334568999999999999999999999875

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=351.86  Aligned_cols=268  Identities=25%  Similarity=0.381  Sum_probs=212.1

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHH--HHHHHHhccCC-CCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW--INEVNFLGVVK-HPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l~-h~nIv~l~  161 (453)
                      ..++|...++||.|+||.||+|+-.           ..+..||||++++.-.. .++.  ++|+..|++|+ ||||+++.
T Consensus         8 ~m~RY~~i~klGDGTfGsV~la~~~-----------~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~   75 (538)
T KOG0661|consen    8 FMDRYTVIRKLGDGTFGSVYLAKSK-----------ETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLK   75 (538)
T ss_pred             HHHHHHHHHHhcCCcceeEEEeeec-----------CCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhH
Confidence            3567888899999999999999865           56778999999765433 3333  58999999998 99999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.+.+.   .+++||||| ..+|++.++.+ +..|++..+..|+.||++||+|+|.+   |+.|||+||+|||+..+.
T Consensus        76 Evi~d~~~---~L~fVfE~M-d~NLYqLmK~R-~r~fse~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~  147 (538)
T KOG0661|consen   76 EVIRDNDR---ILYFVFEFM-DCNLYQLMKDR-NRLFSESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGND  147 (538)
T ss_pred             HHhhccCc---eEeeeHHhh-hhhHHHHHhhc-CCcCCHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccc
Confidence            99998874   389999999 77999999888 78999999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccc-cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLE  319 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~  319 (453)
                      .+||+|||+|+....   ....+..+.|.+|.|||++. .+.|+.+.||||+|||++|+.+.++.|.+....++.. +.+
T Consensus       148 ~iKiaDFGLARev~S---kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~  224 (538)
T KOG0661|consen  148 VIKIADFGLAREVRS---KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICE  224 (538)
T ss_pred             eeEeccccccccccc---CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHH
Confidence            999999999997653   23467889999999999764 6889999999999999999999999998764433321 222


Q ss_pred             hhh-hc---ccCccccccccCCcCC-------CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          320 WVR-PY---VSDSKKFHLIIDPRLE-------GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       320 ~~~-~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .+. |.   +..+..+...++-.+.       ...-...+.+..+||.+|++.||.+|||+.+.++.
T Consensus       225 VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  225 VLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence            110 00   0000111111111111       01122367889999999999999999999998864

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=347.21  Aligned_cols=270  Identities=26%  Similarity=0.332  Sum_probs=209.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .+.|..+++||+|+||.||+|++.           .++..||+|++.....  ....-..+||.||++|+||||++|.+.
T Consensus       116 ~~~feki~kIGeGTyg~VYkAr~~-----------~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~ei  184 (560)
T KOG0600|consen  116 ADSFEKIEKIGEGTYGQVYKARDL-----------ETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEI  184 (560)
T ss_pred             hHHHHHHHHhcCcchhheeEeeec-----------ccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeE
Confidence            456778889999999999999986           5678899999976652  334556799999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      ..+....  .+|||+|||+. +|..++.. ....|+..++..++.||+.||.|||++   +|+|||||.+|||||.+|.+
T Consensus       185 vt~~~~~--siYlVFeYMdh-DL~GLl~~-p~vkft~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~L  257 (560)
T KOG0600|consen  185 VTSKLSG--SIYLVFEYMDH-DLSGLLSS-PGVKFTEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVL  257 (560)
T ss_pred             EEecCCc--eEEEEEecccc-hhhhhhcC-CCcccChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCE
Confidence            9887322  37999999954 77776654 346799999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||||+++.... ....+..+-|++|.|||++.+ ..|+.++|+||.||||.||+.|++.|.+....++...+-.+-
T Consensus       258 KiaDFGLAr~y~~~~-~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklc  336 (560)
T KOG0600|consen  258 KIADFGLARFYTPSG-SAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLC  336 (560)
T ss_pred             EeccccceeeccCCC-CcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHh
Confidence            999999999876554 234678889999999999886 579999999999999999999999998765544433221110


Q ss_pred             hcccC----ccccc--cccCCcCCCc-----cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSD----SKKFH--LIIDPRLEGN-----YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~----~~~~~--~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .-..+    ..++.  ..+.+.....     .....+....+|+..+|..||.+|.|+.++++
T Consensus       337 GSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~  399 (560)
T KOG0600|consen  337 GSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ  399 (560)
T ss_pred             CCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence            00000    00111  1111111100     01223567889999999999999999998874

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-44  Score=352.53  Aligned_cols=249  Identities=28%  Similarity=0.411  Sum_probs=206.5

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC----Cc-ccHHHHHHHHHHhccCC-CCcee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ----GF-QGHKEWINEVNFLGVVK-HPNLV  158 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~----~~-~~~~~~~~E~~~l~~l~-h~nIv  158 (453)
                      ..++|...+.||+|+||+||.|.+.           .++..||||.+++.    .. ...+.+.+|+.++++++ ||||+
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~-----------~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~   83 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHR-----------LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNII   83 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeec-----------cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEe
Confidence            4678999999999999999999986           45688999987664    12 23455668999999998 99999


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ++++++.....    .++||||+.||+|.+++...  .++.+..+..+++|++.|++|||+.   +|+||||||+|||++
T Consensus        84 ~l~ev~~t~~~----~~ivmEy~~gGdL~~~i~~~--g~l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld  154 (370)
T KOG0583|consen   84 RLLEVFATPTK----IYIVMEYCSGGDLFDYIVNK--GRLKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLD  154 (370)
T ss_pred             EEEEEEecCCe----EEEEEEecCCccHHHHHHHc--CCCChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEec
Confidence            99999988775    79999999999999999984  6788889999999999999999999   999999999999999


Q ss_pred             CC-CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC-CC-CchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          239 ED-YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LT-AKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       239 ~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      .+ +++||+|||++....  .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.......  
T Consensus       155 ~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~--  230 (370)
T KOG0583|consen  155 GNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPN--  230 (370)
T ss_pred             CCCCCEEEeccccccccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHH--
Confidence            99 999999999999863  1233467789999999999999876 75 78999999999999999999998743221  


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHH-HHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKS-AQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                       +...+.   ...            -.++... +.++..|+.+||..||.+|+|+.+|+
T Consensus       231 -l~~ki~---~~~------------~~~p~~~~S~~~~~Li~~mL~~~P~~R~t~~~i~  273 (370)
T KOG0583|consen  231 -LYRKIR---KGE------------FKIPSYLLSPEARSLIEKMLVPDPSTRITLLEIL  273 (370)
T ss_pred             -HHHHHh---cCC------------ccCCCCcCCHHHHHHHHHHcCCCcccCCCHHHHh
Confidence             111111   000            0112222 67899999999999999999999998

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-45  Score=354.84  Aligned_cols=250  Identities=27%  Similarity=0.398  Sum_probs=213.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ..|..-.+||+|+-|.||.|...           ..+..||||++........+-+++|+.+|+..+|+|||++++.+..
T Consensus       273 ~~y~~~~kigqgaSG~vy~A~~~-----------~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv  341 (550)
T KOG0578|consen  273 SKYTDFKKIGQGATGGVYVARKI-----------STKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLV  341 (550)
T ss_pred             hhhcchhhhccccccceeeeeec-----------cCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcc
Confidence            45777779999999999999865           4567799999987776666778899999999999999999998887


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .++    ++.|||||+||+|.|.+...   .+++.++..|+++++.||+|||.+   +|+|||||.+|||++.+|.+||+
T Consensus       342 ~de----LWVVMEym~ggsLTDvVt~~---~~~E~qIA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKlt  411 (550)
T KOG0578|consen  342 GDE----LWVVMEYMEGGSLTDVVTKT---RMTEGQIAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLT  411 (550)
T ss_pred             cce----eEEEEeecCCCchhhhhhcc---cccHHHHHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEe
Confidence            765    79999999999999988664   589999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||++..+.....  .....+||+.|||||++....|++|+||||||++++||+-|++||....|.....++.-      
T Consensus       412 DFGFcaqi~~~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~------  483 (550)
T KOG0578|consen  412 DFGFCAQISEEQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIAT------  483 (550)
T ss_pred             eeeeeeccccccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhh------
Confidence            9999988765432  45678999999999999999999999999999999999999999987655443333211      


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               +..+.-..+...+..+.+++.+||..|+++||++.|+++
T Consensus       484 ---------ng~P~lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~  522 (550)
T KOG0578|consen  484 ---------NGTPKLKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE  522 (550)
T ss_pred             ---------cCCCCcCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence                     111112234456788999999999999999999999986

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=4.4e-44  Score=343.26  Aligned_cols=265  Identities=19%  Similarity=0.320  Sum_probs=208.4

Q ss_pred             CCccccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHh
Q 043568           73 DLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFL  149 (453)
Q Consensus        73 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l  149 (453)
                      +++.++..++.     ......||+|++|.||+|.+.             +..||||.+.......   .+.|.+|+.+|
T Consensus        11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l   72 (283)
T PHA02988         11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIFN-------------NKEVIIRTFKKFHKGHKVLIDITENEIKNL   72 (283)
T ss_pred             cceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC-------------CEEEEEEeccccccccHHHHHHHHHHHHHH
Confidence            44556666662     233357999999999999863             6789999987654333   46788999999


Q ss_pred             ccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       150 ~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      ++++||||++++|++.+........++||||+++|+|.+++...  ..+++...+.++.+++.||.|||+..  +++|||
T Consensus        73 ~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lH~~~--~~~Hrd  148 (283)
T PHA02988         73 RRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE--KDLSFKTKLDMAIDCCKGLYNLYKYT--NKPYKN  148 (283)
T ss_pred             HhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhC--CCCChhHHHHHHHHHHHHHHHHHhcC--CCCCCc
Confidence            99999999999999977222222378999999999999999765  56888999999999999999999742  788999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      |||+|||++.++.+||+|||+++.....     .....|+..|+|||++.+  ..++.++|||||||++|||++|+.||.
T Consensus       149 lkp~nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~  223 (283)
T PHA02988        149 LTSVSFLVTENYKLKIICHGLEKILSSP-----PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE  223 (283)
T ss_pred             CChhhEEECCCCcEEEcccchHhhhccc-----cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCC
Confidence            9999999999999999999999864322     224568899999999976  689999999999999999999999997


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      ......   +...+..   ...          ....+..++..+.+|+.+||+.||++|||+.++++.|+.+.
T Consensus       224 ~~~~~~---~~~~i~~---~~~----------~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~  280 (283)
T PHA02988        224 NLTTKE---IYDLIIN---KNN----------SLKLPLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYK  280 (283)
T ss_pred             CCCHHH---HHHHHHh---cCC----------CCCCCCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHH
Confidence            653222   2111110   000          11122245678999999999999999999999999998764

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=3.4e-44  Score=318.82  Aligned_cols=266  Identities=26%  Similarity=0.366  Sum_probs=207.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-c-HHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-G-HKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .+|...++||+|+||+||+|++.           .+++.||||+++..... + ....++|++.|+.++|+||+.++++|
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~-----------~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F   70 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDT-----------ETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVF   70 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEec-----------CCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhc
Confidence            45777889999999999999976           56888999999765432 2 34578999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    +.||+||| ..+|+..++.. ...++-..+..++.++++||+|||++   .|+||||||.|+|++++|.+|
T Consensus        71 ~~~~~----l~lVfEfm-~tdLe~vIkd~-~i~l~pa~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lK  141 (318)
T KOG0659|consen   71 PHKSN----LSLVFEFM-PTDLEVVIKDK-NIILSPADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLK  141 (318)
T ss_pred             cCCCc----eEEEEEec-cccHHHHhccc-ccccCHHHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEE
Confidence            88775    68999999 66899988765 46788888899999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh--
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV--  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~--  321 (453)
                      |+|||+|+.+...+.  ..+..+-|.+|.|||.+.+ ..|+..+||||.|||+.||+-|.+-|.+...-++...+-.+  
T Consensus       142 iADFGLAr~f~~p~~--~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LG  219 (318)
T KOG0659|consen  142 IADFGLARFFGSPNR--IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALG  219 (318)
T ss_pred             eecccchhccCCCCc--ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcC
Confidence            999999998776543  2344488999999998876 56999999999999999999999888776554443322111  


Q ss_pred             ------hhcccCcccccccc-CC-cCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 ------RPYVSDSKKFHLII-DP-RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ------~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                            +|.+..-.....+. -| ......-..++....+|+..||..||.+|+|+.|.++
T Consensus       220 TP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~  280 (318)
T KOG0659|consen  220 TPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALK  280 (318)
T ss_pred             CCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhc
Confidence                  11111111111110 11 1111123345667799999999999999999999875

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=6.6e-44  Score=355.16  Aligned_cols=266  Identities=25%  Similarity=0.413  Sum_probs=206.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|++...+.      ..+...||||.+..... .....+.+|+.+++.+ +|+||++++++
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~------~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~  110 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGK------EDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGA  110 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCc------ccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeE
Confidence            3478889999999999999998753211      13456799999975432 2345688999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC-------------------------------------------------
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV-------------------------------------------------  194 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------  194 (453)
                      |.....    .++||||+++|+|.+++....                                                 
T Consensus       111 ~~~~~~----~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (374)
T cd05106         111 CTHGGP----VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRP  186 (374)
T ss_pred             ecCCCC----eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCC
Confidence            987764    699999999999999986421                                                 


Q ss_pred             -------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCC
Q 043568          195 -------------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP  255 (453)
Q Consensus       195 -------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~  255 (453)
                                         ..++++..+++++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+++...
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~  263 (374)
T cd05106         187 VSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIM  263 (374)
T ss_pred             ccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeecc
Confidence                               12478888999999999999999998   99999999999999999999999999997643


Q ss_pred             CCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCccccccc
Q 043568          256 PEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI  334 (453)
Q Consensus       256 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  334 (453)
                      ............++..|+|||++.+..++.++|||||||++|||++ |+.||.......  .+......    .      
T Consensus       264 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~--~~~~~~~~----~------  331 (374)
T cd05106         264 NDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS--KFYKMVKR----G------  331 (374)
T ss_pred             CCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH--HHHHHHHc----c------
Confidence            3221112223345678999999998899999999999999999997 999987543221  11111110    0      


Q ss_pred             cCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          335 IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       335 ~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                          .....+...+.++.+++.+||+.||.+|||+.+|++.|++++
T Consensus       332 ----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         332 ----YQMSRPDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             ----cCccCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence                000111123577999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.1e-43  Score=353.82  Aligned_cols=265  Identities=24%  Similarity=0.372  Sum_probs=205.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++...      .....+..||||++.... ....+.+.+|+.+|+.+ +||||++++++
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~------~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~  107 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGL------FKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGA  107 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEecc------ccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            34688889999999999999986421      112446689999986443 23346788999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC-------------------------------------------------
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV-------------------------------------------------  194 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------  194 (453)
                      |...+.    .++|||||++|+|.+++....                                                 
T Consensus       108 ~~~~~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~  183 (375)
T cd05104         108 CTVGGP----TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKA  183 (375)
T ss_pred             eccCCc----ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccc
Confidence            987765    699999999999999986532                                                 


Q ss_pred             ------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          195 ------------------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       195 ------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                                              ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~  260 (375)
T cd05104         184 DKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGL  260 (375)
T ss_pred             ccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCcc
Confidence                                    12478888999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       251 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      ++...............++..|+|||++.+..++.++|||||||++|||++ |..||......  ..+...+..    ..
T Consensus       261 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~--~~~~~~~~~----~~  334 (375)
T cd05104         261 ARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVD--SKFYKMIKE----GY  334 (375)
T ss_pred             ceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCch--HHHHHHHHh----Cc
Confidence            986543221111223345678999999999999999999999999999998 78888653221  122222111    00


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .          ...+...+.++.+|+.+||+.||++|||+.+|++.|++.
T Consensus       335 ~----------~~~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         335 R----------MLSPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             c----------CCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence            0          001112356799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.8e-43  Score=338.05  Aligned_cols=251  Identities=29%  Similarity=0.429  Sum_probs=202.0

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .|...+.||+|+||.||+|.+.           .++..||||.+.....   .....+.+|+.+++.++|+||+++++++
T Consensus         1 ~f~~~~~lg~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~   69 (285)
T cd05631           1 TFRHYRVLGKGGFGEVCACQVR-----------ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAY   69 (285)
T ss_pred             CceEEEEEecCCCEEEEEEEEe-----------cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEE
Confidence            3777889999999999999976           4567899999865432   2234578999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        70 ~~~~~----~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~k  142 (285)
T cd05631          70 ETKDA----LCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIR  142 (285)
T ss_pred             ccCCe----EEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEE
Confidence            77654    79999999999999888765555789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~  323 (453)
                      |+|||++......   .......||..|+|||++.+..++.++|||||||++|||++|+.||.......... +......
T Consensus       143 l~Dfg~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (285)
T cd05631         143 ISDLGLAVQIPEG---ETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE  219 (285)
T ss_pred             EeeCCCcEEcCCC---CeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhc
Confidence            9999999864322   12234578999999999999999999999999999999999999997643322111 1111100


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                                     ....++...+..+.+|+.+||+.||.+||+     ++++++
T Consensus       220 ---------------~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~  260 (285)
T cd05631         220 ---------------DQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ  260 (285)
T ss_pred             ---------------ccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence                           001122334678999999999999999997     677764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-44  Score=347.88  Aligned_cols=251  Identities=26%  Similarity=0.455  Sum_probs=208.1

Q ss_pred             CCccccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC
Q 043568           73 DLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV  152 (453)
Q Consensus        73 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l  152 (453)
                      +...+.|++|..       ++-||.|+-|.||+|+++             ++.||||+++...       ..+|+-|++|
T Consensus       117 e~WeiPFe~IsE-------LeWlGSGaQGAVF~Grl~-------------netVAVKKV~elk-------ETdIKHLRkL  169 (904)
T KOG4721|consen  117 ELWEIPFEEISE-------LEWLGSGAQGAVFLGRLH-------------NETVAVKKVRELK-------ETDIKHLRKL  169 (904)
T ss_pred             hhccCCHHHhhh-------hhhhccCcccceeeeecc-------------CceehhHHHhhhh-------hhhHHHHHhc
Confidence            445566666553       457999999999999975             6789999875322       3578999999


Q ss_pred             CCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      +||||+.|.|+|.....    +|||||||..|-|...|+..  .++.-.....+..+||.|+.|||.+   .|||||||+
T Consensus       170 kH~NII~FkGVCtqsPc----yCIiMEfCa~GqL~~VLka~--~~itp~llv~Wsk~IA~GM~YLH~h---KIIHRDLKS  240 (904)
T KOG4721|consen  170 KHPNIITFKGVCTQSPC----YCIIMEFCAQGQLYEVLKAG--RPITPSLLVDWSKGIAGGMNYLHLH---KIIHRDLKS  240 (904)
T ss_pred             cCcceeeEeeeecCCce----eEEeeeccccccHHHHHhcc--CccCHHHHHHHHHHhhhhhHHHHHh---hHhhhccCC
Confidence            99999999999998775    79999999999999999876  5677777789999999999999999   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      -||||+.+..+||+|||-++.....   .....+.||..|||||++++.+.+.|+|||||||||||||||..||..-...
T Consensus       241 PNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss  317 (904)
T KOG4721|consen  241 PNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS  317 (904)
T ss_pred             CceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh
Confidence            9999999999999999999875432   2345679999999999999999999999999999999999999998642110


Q ss_pred             hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                                      -.+.-+-...+....+..+++.+.-|+++||+..|.+||++.+|+..|.-
T Consensus       318 ----------------AIIwGVGsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldI  367 (904)
T KOG4721|consen  318 ----------------AIIWGVGSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDI  367 (904)
T ss_pred             ----------------eeEEeccCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhh
Confidence                            11111122333444566788999999999999999999999999988853

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.6e-44  Score=350.67  Aligned_cols=266  Identities=29%  Similarity=0.462  Sum_probs=212.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++-...++||+|+||.||+|+++..+..       ....||||.....   ......+|++|+++|+.++|||||++||+
T Consensus       157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~-------~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGV  229 (474)
T KOG0194|consen  157 SDIELGKKLGEGAFGEVFKGKLKLKNGF-------KVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGV  229 (474)
T ss_pred             cCccccceeecccccEEEEEEEEecCCc-------eeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            3444557999999999999999743210       1223999998742   24556889999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +....+    ++||||+|.||+|.+||.+.. ..++..+++.++.++|.||+|||++   ++|||||-.+|+|++.++.+
T Consensus       230 a~~~~P----l~ivmEl~~gGsL~~~L~k~~-~~v~~~ek~~~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~v  301 (474)
T KOG0194|consen  230 AVLEEP----LMLVMELCNGGSLDDYLKKNK-KSLPTLEKLRFCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVV  301 (474)
T ss_pred             EcCCCc----cEEEEEecCCCcHHHHHHhCC-CCCCHHHHHHHHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeE
Confidence            998887    799999999999999999874 3689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||+++....-  ........-...|+|||.+..+.++.++|||||||++||+++ |..||.+....+   +..++.
T Consensus       302 KISDFGLs~~~~~~--~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~---v~~kI~  376 (474)
T KOG0194|consen  302 KISDFGLSRAGSQY--VMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYE---VKAKIV  376 (474)
T ss_pred             EeCccccccCCcce--eeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHH---HHHHHH
Confidence            99999999874311  111112234578999999999999999999999999999999 788887654332   222220


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                         .+          ..+...+...+.++..++.+||..+|++||||.++.+.|+.+......
T Consensus       377 ---~~----------~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~~  426 (474)
T KOG0194|consen  377 ---KN----------GYRMPIPSKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKEA  426 (474)
T ss_pred             ---hc----------CccCCCCCCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhcccc
Confidence               00          111112234578899999999999999999999999999998876554

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.1e-42  Score=337.03  Aligned_cols=274  Identities=26%  Similarity=0.394  Sum_probs=204.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCC-----CcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeE
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDH-----QTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKL  160 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~-----~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l  160 (453)
                      ++|...++||+|+||.||+|.+.......     .......+..||+|.+..... .....|.+|+.+|.+++||||+++
T Consensus         5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~   84 (304)
T cd05096           5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL   84 (304)
T ss_pred             hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence            57888899999999999999875321100     001113445799999875432 234678999999999999999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV-----------------PTPLAWIARLKIAQDAARGLAYLHEEMDF  223 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~  223 (453)
                      ++++...+.    .++||||+++|+|.+++....                 ...+++..++.++.||+.||.|||+.   
T Consensus        85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---  157 (304)
T cd05096          85 LGVCVDEDP----LCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL---  157 (304)
T ss_pred             EEEEecCCc----eEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---
Confidence            999987654    699999999999999886432                 12468888999999999999999998   


Q ss_pred             ceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhC-
Q 043568          224 QLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-  302 (453)
Q Consensus       224 ~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg-  302 (453)
                      +|+||||||+|||++.++.+||+|||+++...............++..|+|||++.++.++.++|||||||++|||+++ 
T Consensus       158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~  237 (304)
T cd05096         158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC  237 (304)
T ss_pred             CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence            9999999999999999999999999999865433222223344567899999999888999999999999999999974 


Q ss_pred             -CccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          303 -RRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       303 -~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                       ..||......   .................       ....+..++..+.+|+.+||+.+|++|||+.+|.+.|+
T Consensus       238 ~~~p~~~~~~~---~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         238 KEQPYGELTDE---QVIENAGEFFRDQGRQV-------YLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCCcCCHH---HHHHHHHHHhhhccccc-------cccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence             5566543221   22222211111110000       00112234678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.9e-43  Score=340.48  Aligned_cols=253  Identities=23%  Similarity=0.342  Sum_probs=206.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|..+.+||+|+||.||+|+-+           .++..+|+|++++...   ...+....|-.+|...++|+||+|+-
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk-----------~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyY  208 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKK-----------DTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYY  208 (550)
T ss_pred             cccchhheeeccccceeEEEEEEc-----------cCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEE
Confidence            578999999999999999999976           5678999999987643   34566788999999999999999998


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .|.+.+.    +||||||++||++..+|...  ..|++..+...+.+++.|+.-||+.   |+|||||||+|+|||..|+
T Consensus       209 sFQD~~~----LYLiMEylPGGD~mTLL~~~--~~L~e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GH  279 (550)
T KOG0605|consen  209 SFQDKEY----LYLIMEYLPGGDMMTLLMRK--DTLTEDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGH  279 (550)
T ss_pred             EecCCCe----eEEEEEecCCccHHHHHHhc--CcCchHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCC
Confidence            8888775    89999999999999999887  5788888888899999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCC----------------------CCCC------cc-----------------ccccccCcCCCCccc
Q 043568          243 AKLSDFGLARQGPP----------------------EGLG------HV-----------------STSVVGTVGYAAPEY  277 (453)
Q Consensus       243 ~kL~DFGla~~~~~----------------------~~~~------~~-----------------~~~~~gt~~y~aPE~  277 (453)
                      +||+|||||+-...                      ....      ..                 ....+|||.|||||+
T Consensus       280 iKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEV  359 (550)
T KOG0605|consen  280 IKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEV  359 (550)
T ss_pred             EeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHH
Confidence            99999999853110                      0000      00                 113489999999999


Q ss_pred             cccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHH
Q 043568          278 VQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALAS  356 (453)
Q Consensus       278 ~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  356 (453)
                      +.+..|+..+|.||||||+||||.|.+||....+..... ++.|... +.-              +.....+.+..+||.
T Consensus       360 ll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~-l~f--------------P~~~~~s~eA~DLI~  424 (550)
T KOG0605|consen  360 LLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRET-LKF--------------PEEVDLSDEAKDLIT  424 (550)
T ss_pred             HhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhh-ccC--------------CCcCcccHHHHHHHH
Confidence            999999999999999999999999999999887766543 3333321 111              111233578999999


Q ss_pred             HhhccCCCCCCC---HHHHHH
Q 043568          357 KCLTKQPKSRPK---MSEVVD  374 (453)
Q Consensus       357 ~cl~~dp~~RPs---~~ei~~  374 (453)
                      +|+. ||++|.-   ++||.+
T Consensus       425 rll~-d~~~RLG~~G~~EIK~  444 (550)
T KOG0605|consen  425 RLLC-DPENRLGSKGAEEIKK  444 (550)
T ss_pred             HHhc-CHHHhcCcccHHHHhc
Confidence            9999 9999965   566553

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=5.3e-43  Score=335.34  Aligned_cols=262  Identities=28%  Similarity=0.495  Sum_probs=209.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||.||+|.+.....      ......||+|.+..... .....|.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~------~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   78 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNE------RLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT   78 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCC------CcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEc
Confidence            467888899999999999998763211      13446799999865432 23456889999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      ....    .+++|||+++++|.+++.....              ..+++..++.++.|++.||.|||+.   +++|+|||
T Consensus        79 ~~~~----~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlk  151 (283)
T cd05048          79 KEQP----TCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLA  151 (283)
T ss_pred             CCCc----eEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---Ceeccccc
Confidence            6654    6899999999999999976432              4578889999999999999999998   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCC
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNL  310 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~  310 (453)
                      |+|||+++++.++|+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||....
T Consensus       152 p~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~  231 (283)
T cd05048         152 ARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS  231 (283)
T ss_pred             cceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9999999999999999999986543322223344567889999999988899999999999999999998 999987643


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      +.   .+...+..              ......+..++.++.+|+.+||+.||.+||++.+|++.|++
T Consensus       232 ~~---~~~~~i~~--------------~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         232 NQ---EVIEMIRS--------------RQLLPCPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             HH---HHHHHHHc--------------CCcCCCcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            32   22222211              00111233457889999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=7.3e-44  Score=344.88  Aligned_cols=247  Identities=31%  Similarity=0.440  Sum_probs=210.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|.+.+.||+|.||+||||+.+           .+.+.||+|.+.+...  ...+.+.+|++|++.++||||+.++++|
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK-----------~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esf   70 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRK-----------YTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESF   70 (808)
T ss_pred             cchhHHHHhcCCccceeeecccc-----------cceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhh
Confidence            57888889999999999999966           5678899999986653  3456788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....+    +++|.||+.| +|..+|...  ..+++..+..|+.+++.||.|||+.   +|+|||+||+|||++.++.+|
T Consensus        71 Et~~~----~~vVte~a~g-~L~~il~~d--~~lpEe~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~K  140 (808)
T KOG0597|consen   71 ETSAH----LWVVTEYAVG-DLFTILEQD--GKLPEEQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLK  140 (808)
T ss_pred             cccce----EEEEehhhhh-hHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCcee
Confidence            87765    7999999966 999999875  6789999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      ++|||+|+.+...  ....+...||+-|||||++.+++|+..+|+||+|||+|||++|++||...      .+.+.+...
T Consensus       141 lcdFg~Ar~m~~~--t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~------si~~Lv~~I  212 (808)
T KOG0597|consen  141 LCDFGLARAMSTN--TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYAR------SITQLVKSI  212 (808)
T ss_pred             echhhhhhhcccC--ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHH------HHHHHHHHH
Confidence            9999999986643  34567889999999999999999999999999999999999999999753      222223222


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..++.            ..+...+..+..++...|..||.+|.|..+++.
T Consensus       213 ~~d~v------------~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~  250 (808)
T KOG0597|consen  213 LKDPV------------KPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG  250 (808)
T ss_pred             hcCCC------------CCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence            22211            123356778999999999999999999998874

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=8e-43  Score=339.84  Aligned_cols=264  Identities=25%  Similarity=0.409  Sum_probs=207.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+|+..+.||+|+||+||+|++...       +......||||.+.... .....+|.+|+.+++.++||||++++|+|.
T Consensus         7 ~~f~~~~~lg~G~~g~Vy~~~~~~~-------~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~   79 (316)
T cd05108           7 TEFKKIKVLGSGAFGTVYKGLWIPE-------GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL   79 (316)
T ss_pred             hhceeeeeeecCCCceEEEEEEecC-------CCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEc
Confidence            5688999999999999999997532       11234569999986443 233567889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ...     .++++||+++|+|.+++.... ..+++...+.++.||+.||+|||+.   +|+||||||+|||++.++.+||
T Consensus        80 ~~~-----~~~v~e~~~~g~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl  150 (316)
T cd05108          80 TST-----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKI  150 (316)
T ss_pred             CCC-----ceeeeecCCCCCHHHHHHhcc-ccCCHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEecCCCcEEE
Confidence            654     479999999999999998652 4578889999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   +.....  
T Consensus       151 ~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~---~~~~~~--  225 (316)
T cd05108         151 TDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE---ISSILE--  225 (316)
T ss_pred             ccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHh--
Confidence            99999987543222111222344678999999999999999999999999999998 999986543222   111111  


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                        ....          ...+..++..+.+++.+||..+|.+||++.+++..|..+....
T Consensus       226 --~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~~  272 (316)
T cd05108         226 --KGER----------LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDP  272 (316)
T ss_pred             --CCCC----------CCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcCC
Confidence              0000          0111223457899999999999999999999999998887643

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=8.7e-43  Score=349.00  Aligned_cols=267  Identities=24%  Similarity=0.395  Sum_probs=208.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCC-CCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVK-HPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~  163 (453)
                      .++|.+.++||+|+||.||+|++....      .......||||++..... ...+.|.+|+.+|+++. ||||++++++
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~------~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~  109 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLS------RSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGA  109 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccC------CCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEE
Confidence            467888999999999999999875321      113345799999975432 23457899999999996 9999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC-------------------------------------------------
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV-------------------------------------------------  194 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------  194 (453)
                      |.....    .+||||||++|+|.++|....                                                 
T Consensus       110 ~~~~~~----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (400)
T cd05105         110 CTKSGP----IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADT  185 (400)
T ss_pred             EccCCc----eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccc
Confidence            987654    799999999999999886431                                                 


Q ss_pred             ---------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          195 ---------------------------------------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       195 ---------------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                                                                   ...+++..++.++.|++.||.|||+.   +|+|||
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~d  262 (400)
T cd05105         186 TQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRD  262 (400)
T ss_pred             cccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence                                                         12477888899999999999999998   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus       263 ikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~  342 (400)
T cd05105         263 LAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG  342 (400)
T ss_pred             CChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcc
Confidence            999999999999999999999986543222222233456788999999998899999999999999999997 8888865


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .....  .+......    ..          ....+...+..+.+++.+||+.+|++|||+.+|.+.|+.++.
T Consensus       343 ~~~~~--~~~~~~~~----~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~  399 (400)
T cd05105         343 MIVDS--TFYNKIKS----GY----------RMAKPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP  399 (400)
T ss_pred             cchhH--HHHHHHhc----CC----------CCCCCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence            43211  11111110    00          001122346789999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.8e-43  Score=333.33  Aligned_cols=254  Identities=35%  Similarity=0.559  Sum_probs=198.3

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  170 (453)
                      .+.||.|.||.||+|.+..       .....+..|+||.++.... ...+.|.+|++.+++++||||++++|+|..... 
T Consensus         4 ~~~ig~G~fg~v~~~~~~~-------~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~-   75 (259)
T PF07714_consen    4 IKQIGEGSFGKVYRAEWKQ-------KDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEP-   75 (259)
T ss_dssp             EEEEEEESSEEEEEEEEES-------TTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSS-
T ss_pred             eeEEccCCCcEEEEEEEEc-------ccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccccc-
Confidence            4689999999999999872       2235578899999965332 346789999999999999999999999995544 


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                         .++||||+++|+|.++|.......+++..++.|+.||+.||.|||+.   +++|++|+++|||++.++.+||+|||+
T Consensus        76 ---~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~  149 (259)
T PF07714_consen   76 ---LFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGL  149 (259)
T ss_dssp             ---EEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTT
T ss_pred             ---ccccccccccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccc
Confidence               79999999999999999988667899999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       251 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      +....................|+|||.+....++.++||||||+++|||++ |+.||.....   ..+...+...    .
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~---~~~~~~~~~~----~  222 (259)
T PF07714_consen  150 SRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDN---EEIIEKLKQG----Q  222 (259)
T ss_dssp             GEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCH---HHHHHHHHTT----E
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc---cccccccccc----c
Confidence            987532222223344567789999999998889999999999999999999 6788765422   2222222111    1


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      .          ...+..++..+.+++..||..+|++|||+.+|++.|
T Consensus       223 ~----------~~~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  223 R----------LPIPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             E----------TTSBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             c----------ceeccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence            0          011223467799999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=6.6e-43  Score=343.30  Aligned_cols=267  Identities=26%  Similarity=0.397  Sum_probs=207.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      ++|.+.++||+|+||.||+|.+....      ...+++.||+|++..... ...+.+.+|+.++.++ +|+||++++++|
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~------~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~   80 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIE------KSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGAC   80 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccc------cccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeE
Confidence            47888999999999999999764221      123457899999865432 2345678899999999 899999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC--------------------------------------------------
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------------------------------------------  194 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------  194 (453)
                      ...+.   ..+++|||+++++|.+++....                                                  
T Consensus        81 ~~~~~---~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  157 (337)
T cd05054          81 TKPGG---PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVE  157 (337)
T ss_pred             ecCCC---CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcc
Confidence            76543   3789999999999999886432                                                  


Q ss_pred             ---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccc
Q 043568          195 ---------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS  265 (453)
Q Consensus       195 ---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~  265 (453)
                               ..++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||++..............
T Consensus       158 ~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~  234 (337)
T cd05054         158 EDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  234 (337)
T ss_pred             cchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccC
Confidence                     12688999999999999999999998   999999999999999999999999999987543222222234


Q ss_pred             cccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccc
Q 043568          266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYC  344 (453)
Q Consensus       266 ~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  344 (453)
                      ..++..|+|||++.+..++.++|||||||++|||++ |..||.......  .+.....    ....          ...+
T Consensus       235 ~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~--~~~~~~~----~~~~----------~~~~  298 (337)
T cd05054         235 ARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE--EFCRRLK----EGTR----------MRAP  298 (337)
T ss_pred             CCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH--HHHHHHh----ccCC----------CCCC
Confidence            456778999999999999999999999999999998 999986533221  1111110    0000          0011


Q ss_pred             hHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          345 IKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       345 ~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      ...+.++.+++.+||+.+|++||++.+|++.|..++.
T Consensus       299 ~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~l~~~~~  335 (337)
T cd05054         299 EYATPEIYSIMLDCWHNNPEDRPTFSELVEILGDLLQ  335 (337)
T ss_pred             ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            2335679999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-43  Score=318.67  Aligned_cols=237  Identities=27%  Similarity=0.391  Sum_probs=202.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|.....||.|+||.|.+.+.+           .++..+|+|++++...-.   .+...+|-.+|+.+.||+++++++.
T Consensus        44 ~dfe~~~tlGtGSFGrV~LVr~k-----------~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t  112 (355)
T KOG0616|consen   44 QDFERLKTLGTGSFGRVHLVREK-----------HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGT  112 (355)
T ss_pred             hhhhheeeeccCccceEEEEEEc-----------cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEe
Confidence            46778889999999999999986           557889999998765433   3456789999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    +++||||++||.|..+|++.  ..++...+.-++.+|+.||+|||+.   +|++|||||+|||||.+|.+
T Consensus       113 ~~d~~~----lymvmeyv~GGElFS~Lrk~--~rF~e~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~i  183 (355)
T KOG0616|consen  113 FKDNSN----LYMVMEYVPGGELFSYLRKS--GRFSEPHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHI  183 (355)
T ss_pred             eccCCe----EEEEEeccCCccHHHHHHhc--CCCCchhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcE
Confidence            988775    79999999999999999886  5788888999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+....     ...+.+||+.|+|||++...+++.++|.|||||++|||+.|.+||....+.   .+.+.+. 
T Consensus       184 KitDFGFAK~v~~-----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---~iY~KI~-  254 (355)
T KOG0616|consen  184 KITDFGFAKRVSG-----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---QIYEKIL-  254 (355)
T ss_pred             EEEeccceEEecC-----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---HHHHHHH-
Confidence            9999999998542     356789999999999999999999999999999999999999999876552   2222221 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCC
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR  366 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  366 (453)
                                  ...+  .++.-.+.++.+|+...|+.|-.+|
T Consensus       255 ------------~~~v--~fP~~fs~~~kdLl~~LL~vD~t~R  283 (355)
T KOG0616|consen  255 ------------EGKV--KFPSYFSSDAKDLLKKLLQVDLTKR  283 (355)
T ss_pred             ------------hCcc--cCCcccCHHHHHHHHHHHhhhhHhh
Confidence                        1111  1233446679999999999999999

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.6e-42  Score=340.00  Aligned_cols=265  Identities=28%  Similarity=0.368  Sum_probs=204.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||++++.           .++..||+|.+..... .....+.+|+.+|+.++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   72 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHK-----------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF   72 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEEC-----------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            468999999999999999999976           4567899999875422 2346789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+..  +|+||||||+|||++.++.+|
T Consensus        73 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~k  144 (331)
T cd06649          73 YSDGE----ISICMEHMDGGSLDQVLKEA--KRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIK  144 (331)
T ss_pred             EECCE----EEEEeecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEE
Confidence            87654    79999999999999999765  46888899999999999999999852  699999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++......    ......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+.  .+.
T Consensus       145 l~Dfg~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~--~~~  218 (331)
T cd06649         145 LCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFG--RPV  218 (331)
T ss_pred             EccCccccccccc----ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhc--ccc
Confidence            9999998765322    1234578999999999999899999999999999999999999996543322111110  000


Q ss_pred             ccCcccc--------------------------------ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHH
Q 043568          325 VSDSKKF--------------------------------HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV  372 (453)
Q Consensus       325 ~~~~~~~--------------------------------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei  372 (453)
                      .......                                ..+.............+.++.+|+.+||..||++|||+.++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~el  298 (331)
T cd06649         219 VDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKML  298 (331)
T ss_pred             cccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHH
Confidence            0000000                                00000000000111346789999999999999999999999


Q ss_pred             HHH
Q 043568          373 VDI  375 (453)
Q Consensus       373 ~~~  375 (453)
                      ++.
T Consensus       299 l~h  301 (331)
T cd06649         299 MNH  301 (331)
T ss_pred             hcC
Confidence            863

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.2e-43  Score=369.82  Aligned_cols=269  Identities=29%  Similarity=0.467  Sum_probs=216.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-CcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+......||+|+||.||.|...+..      +......||||.+.+. ..+...+|++|..+|+.++|||||+++|+|.
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~------~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l  765 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVP------GSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCL  765 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCC------CCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeec
Confidence            34556678999999999999987432      1122567999999765 3456788999999999999999999999999


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRV-----PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      +...    .+|++|||++|+|..||++..     +..+.....+.++.|||+|+.||+++   ++|||||..+|+||+..
T Consensus       766 ~~~~----~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~  838 (1025)
T KOG1095|consen  766 DSGP----PLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDER  838 (1025)
T ss_pred             CCCC----cEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhC---CCcCcchhhhheeeccc
Confidence            9654    699999999999999998753     34688889999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  319 (453)
                      ..+||+|||+|+...............-...|||||.+..+.++.|+|||||||+|||++| |..||......+   +..
T Consensus       839 r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~---v~~  915 (1025)
T KOG1095|consen  839 RVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFE---VLL  915 (1025)
T ss_pred             CcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHH---HHH
Confidence            9999999999996554443333333233468999999999999999999999999999999 677776543222   221


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      .+.   . +.          +-..+..++..+.+||..||+.+|++||++..|++.+..+......
T Consensus       916 ~~~---~-gg----------RL~~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~~~  967 (1025)
T KOG1095|consen  916 DVL---E-GG----------RLDPPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAALG  967 (1025)
T ss_pred             HHH---h-CC----------ccCCCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhhcc
Confidence            111   1 11          1223456788899999999999999999999999999988876544

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=310.54  Aligned_cols=250  Identities=26%  Similarity=0.412  Sum_probs=213.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|..++.||+|-||.||.|+.+           .+.-.||+|++.+...   ....++.+|++|-+.|+||||+++|+
T Consensus        21 l~dfeigr~LgkgkFG~vYlarek-----------ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~   89 (281)
T KOG0580|consen   21 LDDFEIGRPLGKGKFGNVYLAREK-----------KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYG   89 (281)
T ss_pred             hhhccccccccCCccccEeEeeec-----------cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhh
Confidence            467999999999999999999976           5567899999976542   33467889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.+...    .||++||..+|+|...|.......++......++.|+|.||.|+|..   ++|||||||+|+|++.++.
T Consensus        90 ~fhd~~r----iyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~  162 (281)
T KOG0580|consen   90 YFHDSKR----IYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGE  162 (281)
T ss_pred             heeccce----eEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCC
Confidence            9998875    69999999999999999977778899999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||.+...+    .....+.+||..|.|||...+...+..+|+|++|++.||++.|.+||+.....   .....+.
T Consensus       163 lkiAdfGwsV~~p----~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---etYkrI~  235 (281)
T KOG0580|consen  163 LKIADFGWSVHAP----SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---ETYKRIR  235 (281)
T ss_pred             eeccCCCceeecC----CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---HHHHHHH
Confidence            9999999998744    23356789999999999999999999999999999999999999999876522   2222111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .               ..-.++...+....++|.+|+..+|.+|.+..++++.
T Consensus       236 k---------------~~~~~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h  273 (281)
T KOG0580|consen  236 K---------------VDLKFPSTISGGAADLISRLLVKNPIERLALTEVMDH  273 (281)
T ss_pred             H---------------ccccCCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence            1               0111234457789999999999999999999998763

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.5e-42  Score=329.43  Aligned_cols=260  Identities=25%  Similarity=0.427  Sum_probs=205.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+...        ...+..||+|.++.... .....|.+|+.++++++||||+++++++
T Consensus         4 ~~~~~~~~~ig~G~fg~V~~~~~~~~--------~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   75 (266)
T cd05064           4 NKSIKIERILGTGRFGELCRGCLKLP--------SKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVI   75 (266)
T ss_pred             hHHeEEeeeecccCCCeEEEEEEecC--------CCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            35688889999999999999987531        13467899999875432 2345789999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++|+|.+++... ...+++..++.++.|++.||+|||+.   +++||||||+|||++.++.++
T Consensus        76 ~~~~~----~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~  147 (266)
T cd05064          76 TRGNT----MMIVTEYMSNGALDSFLRKH-EGQLVAGQLMGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCK  147 (266)
T ss_pred             ecCCC----cEEEEEeCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEE
Confidence            86554    79999999999999998764 24788999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||.+........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   +..... 
T Consensus       148 l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~-  222 (266)
T cd05064         148 ISGFRRLQEDKSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD---VIKAVE-  222 (266)
T ss_pred             ECCCcccccccccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHH-
Confidence            999998765322111 11112345678999999999999999999999999999875 999987543322   221111 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                         +...          ...+..++..+.+++.+||+.+|.+||++.+|++.|..+
T Consensus       223 ---~~~~----------~~~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         223 ---DGFR----------LPAPRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             ---CCCC----------CCCCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence               0000          011233567799999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.4e-43  Score=336.13  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=199.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||+|.+.           .++..||+|++.....   .....+.+|+.+++.++||||++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   69 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDR-----------ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWT   69 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEc-----------CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhh
Confidence            46888999999999999999976           4567899999865322   234568899999999999999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+...    .++||||+++|+|.+++...  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~  140 (291)
T cd05612          70 EHDQRF----LYMLMEYVPGGELFSYLRNS--GRFSNSTGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHI  140 (291)
T ss_pred             hccCCe----EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCE
Confidence            876553    79999999999999999765  4688889999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   +...+..
T Consensus       141 kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~---~~~~i~~  212 (291)
T cd05612         141 KLTDFGFAKKLRDR-----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG---IYEKILA  212 (291)
T ss_pred             EEEecCcchhccCC-----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh
Confidence            99999999864321     234568999999999998889999999999999999999999997653322   1111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                         ..            ..++...+..+.+|+.+||..||.+||+     +.++++
T Consensus       213 ---~~------------~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  253 (291)
T cd05612         213 ---GK------------LEFPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKN  253 (291)
T ss_pred             ---CC------------cCCCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhc
Confidence               00            0111223567899999999999999995     777664

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-43  Score=342.09  Aligned_cols=254  Identities=23%  Similarity=0.339  Sum_probs=204.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||+|++.           .++..||||++....   ......+.+|+.++..++||||++++++
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~   69 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKK-----------DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYA   69 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEEC-----------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEE
Confidence            46889999999999999999976           446789999987542   2334668899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .+|||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  140 (333)
T cd05600          70 FQDDEY----LYLAMEYVPGGDFRTLLNNL--GVLSEDHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHI  140 (333)
T ss_pred             EEcCCE----EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCE
Confidence            887654    79999999999999999765  4688889999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||++.....     ......||+.|+|||++.+..++.++|||||||++|||++|..||....+......+.....
T Consensus       141 kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~  215 (333)
T cd05600         141 KLTDFGLSKGIVT-----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE  215 (333)
T ss_pred             EEEeCcCCccccc-----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc
Confidence            9999999986432     23456799999999999998999999999999999999999999976543322111111100


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ...         .+.. .......+.++.+++.+||..+|.+||++.++++.
T Consensus       216 ~~~---------~~~~-~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         216 TLQ---------RPVY-DDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             ccc---------CCCC-CccccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence            000         0000 00012346789999999999999999999999864

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-44  Score=338.27  Aligned_cols=249  Identities=28%  Similarity=0.418  Sum_probs=208.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..|.....||+|.||.||+|.+.           .+++.||+|++.... ....+++.+|+.+|.+++++||.++||.+.
T Consensus        13 ~~~~~~~~IgrGsfG~Vyk~~d~-----------~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl   81 (467)
T KOG0201|consen   13 LLYTKLELIGRGSFGEVYKAIDN-----------KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYL   81 (467)
T ss_pred             cccccchhccccccceeeeeeec-----------cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhhee
Confidence            34666789999999999999986           567889999998654 445678899999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    ++++||||.||++.+.|...  ..+.+..+.-|++++..||.|||++   +.+|||||+.|||+..+|.+||
T Consensus        82 ~g~~----LwiiMey~~gGsv~~lL~~~--~~~~E~~i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl  152 (467)
T KOG0201|consen   82 KGTK----LWIIMEYCGGGSVLDLLKSG--NILDEFEIAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKL  152 (467)
T ss_pred             eccc----HHHHHHHhcCcchhhhhccC--CCCccceeeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEE
Confidence            8765    79999999999999988765  3447777778899999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||.+-......  ......+||+.|||||++....|+.|+||||||++.+||++|.+|+....|..            
T Consensus       153 ~DfgVa~ql~~~~--~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr------------  218 (467)
T KOG0201|consen  153 ADFGVAGQLTNTV--KRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR------------  218 (467)
T ss_pred             Eecceeeeeechh--hccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce------------
Confidence            9999998765432  23377899999999999998899999999999999999999999997754421            


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           .-.++.......+....+..+.+++..||+.||+.||++.++++
T Consensus       219 -----vlflIpk~~PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLK  262 (467)
T KOG0201|consen  219 -----VLFLIPKSAPPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLK  262 (467)
T ss_pred             -----EEEeccCCCCCccccccCHHHHHHHHHHhhcCcccCcCHHHHhh
Confidence                 11111112222223356778999999999999999999999985

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=2.1e-42  Score=331.99  Aligned_cols=267  Identities=23%  Similarity=0.312  Sum_probs=201.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||+||+|+++           .++..||+|++....  ....+.+.+|+.+++.++||||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   69 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHK-----------ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAF   69 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEEC-----------CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhE
Confidence            46889999999999999999976           456789999987543  22346688999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||++++++..+...  ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        70 ~~~~~----~~lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~k  140 (287)
T cd07848          70 RRRGK----LYLVFEYVEKNMLELLEEM--PNGVPPEKVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLK  140 (287)
T ss_pred             ecCCE----EEEEEecCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEE
Confidence            77654    7999999988877654433  35688899999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh-hh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV-RP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~-~~  323 (453)
                      |+|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|+.||............... .+
T Consensus       141 l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (287)
T cd07848         141 LCDFGFARNLSEGS-NANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGP  219 (287)
T ss_pred             EeeccCcccccccc-cccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCC
Confidence            99999998754321 11223457899999999999888999999999999999999999999764432221111111 00


Q ss_pred             c-------ccCccccccccCCcCC------CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 Y-------VSDSKKFHLIIDPRLE------GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~-------~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .       ............+...      ..+....+..+.+|+.+||+.||++|||++++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~  283 (287)
T cd07848         220 LPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN  283 (287)
T ss_pred             CCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            0       0000000000001000      0111224567999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-43  Score=355.81  Aligned_cols=267  Identities=23%  Similarity=0.307  Sum_probs=219.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeee-
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGY-  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~-  163 (453)
                      ..++.+.++|.+|||+.||.|.+.           ..+..||+|++-..+....+...+|+.+|++|. |+|||.+++. 
T Consensus        36 ~~~v~V~~vLAEGGFa~VYla~~~-----------~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss  104 (738)
T KOG1989|consen   36 SHRVTVEKVLAEGGFAQVYLAQDV-----------KGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSS  104 (738)
T ss_pred             CEEEEEEEEEccCCcEEEEEEEec-----------CCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccc
Confidence            456778889999999999999976           233789999988777778888999999999996 9999999993 


Q ss_pred             eeec-ccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAED-DER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~-~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      .... ..+ ....+|.||||.||.|-|++..+....|++.++++|+.|+++|+++||.. .++|||||||-+||||+.++
T Consensus       105 ~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g  183 (738)
T KOG1989|consen  105 AINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADG  183 (738)
T ss_pred             cccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCC
Confidence            3332 222 35689999999999999999988878899999999999999999999997 67899999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccc-------cccccCcCCCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          242 KAKLSDFGLARQGPPEGLGHVS-------TSVVGTVGYAAPEYV---QTGRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~-------~~~~gt~~y~aPE~~---~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      +.||||||.+.-..........       -...-|+.|.|||++   .+.+.++|+|||||||+||-|+....||+....
T Consensus       184 ~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~  263 (738)
T KOG1989|consen  184 NYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK  263 (738)
T ss_pred             CEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc
Confidence            9999999998753322211111       123579999999976   467899999999999999999999999986421


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                                          ..+++....-+..+..+..|.+||..||+.||.+||++.+|+..+..+.....
T Consensus       264 --------------------laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~  316 (738)
T KOG1989|consen  264 --------------------LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPC  316 (738)
T ss_pred             --------------------eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCC
Confidence                                12333333333345778999999999999999999999999999988876543

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=2.4e-42  Score=327.42  Aligned_cols=256  Identities=26%  Similarity=0.434  Sum_probs=206.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .+|...+.||+|+||.||+|.+.           ..+..||+|.+... ......+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~-----------~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   73 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWK-----------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTR   73 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEe-----------cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcC
Confidence            45778889999999999999976           34678999998643 3345678999999999999999999999887


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    .++||||+++++|.+++.......+++..++.++.|++.||+|||+.   +++||||||+|||+++++.+||+
T Consensus        74 ~~~----~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~  146 (263)
T cd05052          74 EPP----FYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVA  146 (263)
T ss_pred             CCC----cEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeC
Confidence            654    68999999999999999876556789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++........ .......++..|+|||.+.+..++.++|||||||++|||++ |..||.......   ........ 
T Consensus       147 df~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~---~~~~~~~~-  221 (263)
T cd05052         147 DFGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ---VYELLEKG-  221 (263)
T ss_pred             CCcccccccccee-eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHCC-
Confidence            9999986543211 11122234568999999998899999999999999999998 888886543221   11111110 


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                                   .....+...+..+.+++.+||..+|++|||+.++++.|+.+
T Consensus       222 -------------~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         222 -------------YRMERPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             -------------CCCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence                         01112233467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.1e-42  Score=331.65  Aligned_cols=266  Identities=26%  Similarity=0.447  Sum_probs=211.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||.||+|.+....      .......+++|.+........+.+.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLS------PTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGD   78 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccC------CCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            45778889999999999999865321      113456799999876555555779999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      ...    .++||||+++++|.+++....              ...+++..++.++.||+.||+|||++   +|+||||||
T Consensus        79 ~~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp  151 (291)
T cd05094          79 GDP----LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLAT  151 (291)
T ss_pred             CCc----eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCc
Confidence            654    799999999999999997543              13478999999999999999999998   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCC
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLP  311 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~  311 (453)
                      +|||++.++.++|+|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       152 ~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  231 (291)
T cd05094         152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSN  231 (291)
T ss_pred             ceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence            999999999999999999976543322222344567889999999998899999999999999999999 9999865433


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ..   ..+....    .. ..         ......+..+.+++.+||+.+|++|||+.+|++.|.++...
T Consensus       232 ~~---~~~~~~~----~~-~~---------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         232 TE---VIECITQ----GR-VL---------ERPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             HH---HHHHHhC----CC-CC---------CCCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            22   2211111    00 00         01122456799999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.2e-43  Score=331.11  Aligned_cols=248  Identities=22%  Similarity=0.386  Sum_probs=208.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .+|.+.+.||+|+||.|-+|+..           ..++.||||.+++....+   .-.+.+|++||..|+||||+.++.+
T Consensus        53 HRyE~~etLGkGTYGKVk~A~e~-----------~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEV  121 (668)
T KOG0611|consen   53 HRYEITETLGKGTYGKVKLAYEH-----------KSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEV  121 (668)
T ss_pred             hHHHHHHHhcCCcccceeehhhc-----------cCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhh
Confidence            45777788999999999999864           568899999998775544   3457799999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      |...+.    .+|||||..+|.|+||+..+  ..+++.+...+++||..|+.|||++   +++|||||.+|||||.|+++
T Consensus       122 FENkdK----IvivMEYaS~GeLYDYiSer--~~LsErEaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~Ni  192 (668)
T KOG0611|consen  122 FENKDK----IVIVMEYASGGELYDYISER--GSLSEREARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNI  192 (668)
T ss_pred             hcCCce----EEEEEEecCCccHHHHHHHh--ccccHHHHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCe
Confidence            988775    79999999999999999987  6789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCC-CchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT-AKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||++..+...   ....+++|++.|.+||++.+.+|. +.+|-|||||+||.|+.|..||++...   ..++.-+.
T Consensus       193 KIADFGLSNly~~~---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh---k~lvrQIs  266 (668)
T KOG0611|consen  193 KIADFGLSNLYADK---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH---KRLVRQIS  266 (668)
T ss_pred             eeeccchhhhhccc---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH---HHHHHHhh
Confidence            99999999887643   346778999999999999998885 789999999999999999999986532   22222111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                          . +.+   .        .+..+....-||.+||..||++|.|+.+|....
T Consensus       267 ----~-GaY---r--------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsHW  304 (668)
T KOG0611|consen  267 ----R-GAY---R--------EPETPSDASGLIRWMLMVNPERRATIEDIASHW  304 (668)
T ss_pred             ----c-ccc---c--------CCCCCchHHHHHHHHHhcCcccchhHHHHhhhh
Confidence                0 000   1        122344577899999999999999999998653

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=7.3e-42  Score=328.60  Aligned_cols=266  Identities=27%  Similarity=0.455  Sum_probs=210.8

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .+|...+.||+|+||.||++.+....      .......+|+|.+..........+.+|+.++++++||||+++++++..
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~------~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLC------PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE   78 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCC------CCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec
Confidence            57888899999999999999864211      123456799999876554556779999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV-----------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      .+.    .++||||+++++|.+++....           ...+++..++.++.|++.||+|||+.   +++||||||+||
T Consensus        79 ~~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Ni  151 (288)
T cd05093          79 GDP----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNC  151 (288)
T ss_pred             CCc----cEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceE
Confidence            654    799999999999999987542           23589999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhh
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNE  314 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~  314 (453)
                      |+++++.+||+|||++................++..|+|||++.+..++.++|||||||++|+|++ |..||....... 
T Consensus       152 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~-  230 (288)
T cd05093         152 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE-  230 (288)
T ss_pred             EEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH-
Confidence            999999999999999986543222222233456788999999998889999999999999999998 888886543221 


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                        ....+..    ...      .    ..+...+..+.+|+.+||+.+|.+|||+.++++.|+++...
T Consensus       231 --~~~~i~~----~~~------~----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         231 --VIECITQ----GRV------L----QRPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             --HHHHHHc----CCc------C----CCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence              2221111    000      0    00112356799999999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-43  Score=347.13  Aligned_cols=249  Identities=27%  Similarity=0.416  Sum_probs=211.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .+-|..++-||.|+-|.|-+|++.           .+|+.+|||++.+..   ......+.+|+.+|+.+.||||+++|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~-----------~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~Lyd   79 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHA-----------ETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYD   79 (786)
T ss_pred             ccceeccccccCCCCceehhhhcc-----------cccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeee
Confidence            355788889999999999999986           678899999997652   122345789999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.+...    +|||.||+++|-|.++|..+  +++++.++.+++.||+.|+.|||..   +||||||||+|+|||..++
T Consensus        80 Vwe~~~~----lylvlEyv~gGELFdylv~k--G~l~e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~n  150 (786)
T KOG0588|consen   80 VWENKQH----LYLVLEYVPGGELFDYLVRK--GPLPEREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNN  150 (786)
T ss_pred             eeccCce----EEEEEEecCCchhHHHHHhh--CCCCCHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccC
Confidence            9988765    89999999999999999887  6788999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCC-CchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT-AKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||+|....+   +....+.+|.+.|.+||++++.+|. .++||||.|||||.||||+.||++.   ....++..+
T Consensus       151 IKIADFGMAsLe~~---gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDd---Nir~LLlKV  224 (786)
T KOG0588|consen  151 IKIADFGMASLEVP---GKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDD---NIRVLLLKV  224 (786)
T ss_pred             EeeeccceeecccC---CccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCc---cHHHHHHHH
Confidence            99999999987544   3345677899999999999998885 7899999999999999999999743   233333333


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      +.     +.+          +.+...+.+.++|+.+|+..||.+|.|+++|++.
T Consensus       225 ~~-----G~f----------~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH  263 (786)
T KOG0588|consen  225 QR-----GVF----------EMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH  263 (786)
T ss_pred             Hc-----Ccc----------cCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence            32     111          2244567889999999999999999999999874

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.2e-42  Score=339.60  Aligned_cols=242  Identities=26%  Similarity=0.390  Sum_probs=196.4

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      ++||+|+||.||+|.+.           .++..||||++....   ......+.+|+.++++++||||+++++++...+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~   69 (323)
T cd05571           1 KLLGKGTFGKVILVREK-----------ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDR   69 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCE
Confidence            36999999999999875           457789999987542   2234567889999999999999999999887654


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                          .++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        70 ----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG  140 (323)
T cd05571          70 ----LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             ----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCC
Confidence                79999999999999998765  5788999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       250 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      +++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+..   .  
T Consensus       141 ~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~---~~~~~~~~---~--  210 (323)
T cd05571         141 LCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---KLFELILM---E--  210 (323)
T ss_pred             CCcccccC--CCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH---HHHHHHHc---C--
Confidence            98753221  12234567999999999999999999999999999999999999999754321   11111110   0  


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                            +.    .++...+.++.+|+.+||..||++||     ++.++++
T Consensus       211 ------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  250 (323)
T cd05571         211 ------EI----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME  250 (323)
T ss_pred             ------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence                  00    11223467799999999999999999     7888864

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-43  Score=308.70  Aligned_cols=268  Identities=24%  Similarity=0.339  Sum_probs=216.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|.+.+.||+|||+-||.+...           .++..||+|++.....++.+..++|++..++++||||+++++++.
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~-----------s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l   88 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGL-----------STGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQL   88 (302)
T ss_pred             CceEEEeeeecCCCceeeeeeccc-----------CcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHH
Confidence            578999999999999999998743           456789999998888778888999999999999999999999987


Q ss_pred             eccc-ccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          166 EDDE-RGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       166 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .... .....||+++|+..|||.+.+....  +..+++.+.+.|+.+|++||++||.. .++++||||||.|||+++.+.
T Consensus        89 ~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~  167 (302)
T KOG2345|consen   89 REEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGL  167 (302)
T ss_pred             HhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCc
Confidence            6554 2345799999999999999987543  45799999999999999999999998 346999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCcc-------ccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          243 AKLSDFGLARQGPPEGLGHV-------STSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~-------~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      ++|.|||.++...-...+..       ......|..|.|||.+.   +...+.++|||||||+||+||.|..||+.... 
T Consensus       168 ~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~-  246 (302)
T KOG2345|consen  168 PVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ-  246 (302)
T ss_pred             eEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh-
Confidence            99999999986443221111       12456799999999986   45678999999999999999999999974311 


Q ss_pred             hhHHHHHhhhhcccCccccc-cccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          313 NEQKLLEWVRPYVSDSKKFH-LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                                    .+..+. .+.++.+.-+.....++.+.+||.+|++.||.+||++.+++..+..+.
T Consensus       247 --------------~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li  301 (302)
T KOG2345|consen  247 --------------QGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI  301 (302)
T ss_pred             --------------cCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence                          122222 122323333333447889999999999999999999999999887654

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=2.4e-42  Score=330.16  Aligned_cols=262  Identities=27%  Similarity=0.438  Sum_probs=207.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+.....      ......||||.+...... ..+.|.+|+++|+.++||||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   77 (280)
T cd05049           4 RDTIVLKRELGEGAFGKVFLGECYHLEP------ENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVC   77 (280)
T ss_pred             hHHhhHHhhccccCCceEeeeeeccccC------cCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEE
Confidence            3567788899999999999998753211      134568999998765443 457899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      .....    .++||||+++++|.+++....            ...+++..+..++.|++.||.|||+.   +++||||||
T Consensus        78 ~~~~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp  150 (280)
T cd05049          78 TEGDP----PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLAT  150 (280)
T ss_pred             ecCCC----eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---Ceecccccc
Confidence            87653    799999999999999997542            24578889999999999999999998   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCC
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLP  311 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~  311 (453)
                      +|||++.++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||.....
T Consensus       151 ~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~  230 (280)
T cd05049         151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN  230 (280)
T ss_pred             ceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            999999999999999999975432222122234456788999999999999999999999999999998 9999875433


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      ..   ..+....     ...         ...+...+..+.+++.+||+.||.+||++.||++.|+
T Consensus       231 ~~---~~~~~~~-----~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         231 EE---VIECITQ-----GRL---------LQRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             HH---HHHHHHc-----CCc---------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            22   2222110     000         0111234677999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-42  Score=330.80  Aligned_cols=262  Identities=27%  Similarity=0.367  Sum_probs=205.8

Q ss_pred             HHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--------------ccHHHHHHH
Q 043568           80 AELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--------------QGHKEWINE  145 (453)
Q Consensus        80 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--------------~~~~~~~~E  145 (453)
                      .+-.+..+.|.+...||+|.||.|-+|+..           .+++.||||++.+...              ...+...+|
T Consensus        90 ~~~~k~lNqy~l~~eiG~G~yGkVkLar~~-----------~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~E  158 (576)
T KOG0585|consen   90 DQDRKQLNQYELIKEIGSGQYGKVKLARDE-----------VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRRE  158 (576)
T ss_pred             cccceehhheehhhhhcCCccceEEEEeec-----------CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHH
Confidence            334455788999999999999999999976           4578899999965421              123567899


Q ss_pred             HHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-LAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       146 ~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      +.+|++++|||||+|+++..+....  .+|||+|||..|.+..   .....+ +...++.+++++++.||+|||.+   |
T Consensus       159 IailKkl~H~nVV~LiEvLDDP~s~--~~YlVley~s~G~v~w---~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q---g  230 (576)
T KOG0585|consen  159 IAILKKLHHPNVVKLIEVLDDPESD--KLYLVLEYCSKGEVKW---CPPDKPELSEQQARKYLRDVVLGLEYLHYQ---G  230 (576)
T ss_pred             HHHHHhcCCcCeeEEEEeecCcccC--ceEEEEEeccCCcccc---CCCCcccccHHHHHHHHHHHHHHHHHHHhc---C
Confidence            9999999999999999988766543  4899999999888654   222345 89999999999999999999999   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccCCCCC---CCCccccccccCcCCCCccccccCC----CCCchhHHHHHHHHH
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE---GLGHVSTSVVGTVGYAAPEYVQTGR----LTAKSDVWSFGVVLY  297 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~SlGvil~  297 (453)
                      ||||||||+|+||+++|++||+|||.+......   +........+||+.|+|||...++.    .+.+.||||+||.||
T Consensus       231 iiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLY  310 (576)
T KOG0585|consen  231 IIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLY  310 (576)
T ss_pred             eeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHH
Confidence            999999999999999999999999999865322   1122234579999999999987633    357889999999999


Q ss_pred             HHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          298 ELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       298 elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      .|+.|+.||.....   ..+.+             .+++..+.....++..+.+.+||.++|.+||+.|.+..+|....
T Consensus       311 CllfG~~PF~~~~~---~~l~~-------------KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hp  373 (576)
T KOG0585|consen  311 CLLFGQLPFFDDFE---LELFD-------------KIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRITLPDIKLHP  373 (576)
T ss_pred             HhhhccCCcccchH---HHHHH-------------HHhcCcccCCCcccccHHHHHHHHHHhhcChhheeehhhheecc
Confidence            99999999976432   22222             12222232222334567899999999999999999999987543

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-42  Score=339.88  Aligned_cols=246  Identities=24%  Similarity=0.373  Sum_probs=200.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|+++           .++..||||.+....   ......+.+|+.++++++||||+++++
T Consensus        17 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   85 (329)
T PTZ00263         17 LSDFEMGETLGTGSFGRVRIAKHK-----------GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMC   85 (329)
T ss_pred             chheEEEEEEEecCCeEEEEEEEC-----------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            367888999999999999999976           456789999986542   233456889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...+.    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        86 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~  156 (329)
T PTZ00263         86 SFQDENR----VYFLLEFVVGGELFTHLRKA--GRFPNDVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGH  156 (329)
T ss_pred             EEEcCCE----EEEEEcCCCCChHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCC
Confidence            9987654    79999999999999999865  4678888889999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+..   ..+.+.
T Consensus       157 ~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~---~~~~i~  228 (329)
T PTZ00263        157 VKVTDFGFAKKVPDR-----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFR---IYEKIL  228 (329)
T ss_pred             EEEeeccCceEcCCC-----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHH---HHHHHh
Confidence            999999999865322     234579999999999999899999999999999999999999997543321   111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      .     ..        +  ..+...+..+.+|+.+||+.||.+||+     +.+++.
T Consensus       229 ~-----~~--------~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~  270 (329)
T PTZ00263        229 A-----GR--------L--KFPNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN  270 (329)
T ss_pred             c-----CC--------c--CCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            0     00        0  011123567899999999999999997     566653

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.3e-43  Score=323.41  Aligned_cols=273  Identities=26%  Similarity=0.324  Sum_probs=212.1

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEecc--CCcccHHHHHHHHHHhccCCCCceeeEe
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .....|...+.||+|+||.|..|+++           .++..||||++..  ......++..+|+.+|+.++|+||+.++
T Consensus        19 ~i~~~y~~~~~iG~GAyGvVcsA~~~-----------~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~   87 (359)
T KOG0660|consen   19 EIPRYYVLIEPIGRGAYGVVCSAKDK-----------RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLL   87 (359)
T ss_pred             eccceecccccccCcceeeEEEEEEc-----------CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEE
Confidence            34566777889999999999999987           5678999999873  3344567788999999999999999999


Q ss_pred             eeeeecc-cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          162 GYCAEDD-ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       162 ~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      +++..+. ......|+|+|+| +.+|...|+..  +.++.....-++.||++||.|+|+.   +|+||||||+|+|++.+
T Consensus        88 di~~p~~~~~f~DvYiV~elM-etDL~~iik~~--~~L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~  161 (359)
T KOG0660|consen   88 DIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQ--QDLTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNAD  161 (359)
T ss_pred             eecccccccccceeEEehhHH-hhHHHHHHHcC--ccccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccC
Confidence            9987722 2224589999999 77899988775  4588888888999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccc-cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      ..+||+|||+|+...........+..+.|.+|.|||++. ...|+.+.||||.|||+.||++|++-|.+........++.
T Consensus       162 c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~  241 (359)
T KOG0660|consen  162 CDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLIL  241 (359)
T ss_pred             CCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence            999999999999875432233457778999999999875 5789999999999999999999999998766555544443


Q ss_pred             hhhhcccCcccccccc-----------CCcCCCc---cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLII-----------DPRLEGN---YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~-----------~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+.+...+ ..+..+.           ....+..   .-+.......+|+.+||..||.+|+|++|.++
T Consensus       242 ~~lGtP~~-e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~  309 (359)
T KOG0660|consen  242 ELLGTPSE-EDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA  309 (359)
T ss_pred             HhcCCCCH-HHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence            32221111 0000000           0000111   11244567899999999999999999999875

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=5.1e-42  Score=328.71  Aligned_cols=261  Identities=26%  Similarity=0.467  Sum_probs=205.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+|+..+.||+|+||+||+|.+...       +...+..||+|.+..... .....|.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~-------~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   77 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLP-------GMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVT   77 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecC-------CCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEe
Confidence            4577888999999999999986421       223567899999874432 23467889999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRV---------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                      ....    .++||||+++++|.+++....               ...+++...+.++.|++.||.|||+.   +|+||||
T Consensus        78 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dl  150 (283)
T cd05090          78 QEQP----VCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDL  150 (283)
T ss_pred             cCCc----eEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhc---Ceehhcc
Confidence            7654    699999999999999986432               23478888999999999999999998   9999999


Q ss_pred             ccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCC
Q 043568          231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERN  309 (453)
Q Consensus       231 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~  309 (453)
                      ||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       151 kp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             ccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            99999999999999999999986543322222334456778999999988889999999999999999998 88888654


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      .+.   .+.+.+..    ..          ....+...+..+.+++.+||+.+|.+||++.+|++.|..
T Consensus       231 ~~~---~~~~~~~~----~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         231 SNQ---EVIEMVRK----RQ----------LLPCSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             CHH---HHHHHHHc----CC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            322   22222111    00          001122345679999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=7.6e-42  Score=327.01  Aligned_cols=263  Identities=26%  Similarity=0.417  Sum_probs=204.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||+||+|.+...+       ......+++|.+..... ....++..|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~-------~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~   79 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEG-------DSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP   79 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCC-------CceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC
Confidence            46777889999999999999975211       11223588888754322 23456788999999999999999999885


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ...     .++++||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +++||||||+|||++.++.+||
T Consensus        80 ~~~-----~~~i~e~~~~gsL~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl  150 (279)
T cd05111          80 GAS-----LQLVTQLSPLGSLLDHVRQH-RDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQI  150 (279)
T ss_pred             CCc-----cEEEEEeCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEE
Confidence            432     58899999999999999764 34689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++...............++..|+|||++.++.++.++|||||||++|||++ |..||....+.....++.   . 
T Consensus       151 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~---~-  226 (279)
T cd05111         151 ADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE---K-  226 (279)
T ss_pred             cCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH---C-
Confidence            99999986543322222334567788999999998899999999999999999998 999987654332222211   0 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         ....   ..       +..++..+.+++.+||..+|.+|||+.++++.|..+.+.
T Consensus       227 ---~~~~---~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~  271 (279)
T cd05111         227 ---GERL---AQ-------PQICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD  271 (279)
T ss_pred             ---CCcC---CC-------CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence               1000   00       111345678899999999999999999999999887753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.4e-42  Score=327.95  Aligned_cols=269  Identities=25%  Similarity=0.349  Sum_probs=200.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccC---CCCceeeEe
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV---KHPNLVKLV  161 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~l~  161 (453)
                      ++|...+.||+|+||.||+|.+..          ..+..||||.+.....  .....+.+|+.+++.+   +||||++++
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~   70 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLK----------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLF   70 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcC----------CCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEE
Confidence            468889999999999999998642          2356799999865432  2234566777777665   699999999


Q ss_pred             eeeeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          162 GYCAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       162 ~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++|..... ....+++||||+. ++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~  146 (290)
T cd07862          71 DVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSS  146 (290)
T ss_pred             EEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCC
Confidence            99864321 1234799999995 6999999876556789999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~  319 (453)
                      +.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|++||......+.. .+..
T Consensus       147 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~  223 (290)
T cd07862         147 GQIKLADFGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD  223 (290)
T ss_pred             CCEEEccccceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence            99999999999865432   2234567899999999998889999999999999999999999999765433221 1111


Q ss_pred             hhhhcccCcccc-------ccccCCcCC---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKF-------HLIIDPRLE---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~-------~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....  .....       .....+...   .......+..+.+|+.+||+.||++|||+.++++
T Consensus       224 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~  286 (290)
T cd07862         224 VIGLP--GEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  286 (290)
T ss_pred             HhCCC--ChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence            11000  00000       000000000   0111234567889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=8e-42  Score=328.42  Aligned_cols=267  Identities=25%  Similarity=0.361  Sum_probs=201.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||.|+||+||+|.+.           .++..||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   72 (288)
T cd07871           4 LETYVKLDKLGEGTYATVFKGRSK-----------LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDII   72 (288)
T ss_pred             cccceEeeEEecCCCEEEEEEEEC-----------CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEE
Confidence            356888999999999999999875           4567899999865432 2345678999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||++ ++|.+++... ...+++..+..++.||+.||+|||++   +|+||||||+|||++.++.+|
T Consensus        73 ~~~~~----~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~k  143 (288)
T cd07871          73 HTERC----LTLVFEYLD-SDLKQYLDNC-GNLMSMHNVKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELK  143 (288)
T ss_pred             cCCCe----EEEEEeCCC-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEE
Confidence            76553    799999996 5899988654 34578889999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh-
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR-  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-  322 (453)
                      |+|||+++......  .......+++.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... 
T Consensus       144 l~DfG~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~  221 (288)
T cd07871         144 LADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLG  221 (288)
T ss_pred             ECcCcceeeccCCC--ccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            99999997643221  12234578999999998865 568999999999999999999999997654333222211110 


Q ss_pred             -------hcccCccccccccCCcCCC----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 -------PYVSDSKKFHLIIDPRLEG----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 -------~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             +.......+.....+....    ......+.++.+|+.+||..||.+|||++++++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~  284 (288)
T cd07871         222 TPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR  284 (288)
T ss_pred             CCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                   0000011111111111100    001123567899999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=1e-41  Score=322.51  Aligned_cols=256  Identities=25%  Similarity=0.435  Sum_probs=205.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...++||+|+||.||+|.+.            ++..||+|.+.... ...+.+.+|+.+++.++|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~------------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN------------NSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT   71 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec------------CCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEc
Confidence            357888899999999999999864            24579999876433 33567899999999999999999999887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .+++|||+++++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++|
T Consensus        72 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l  144 (261)
T cd05072          72 KEEP----IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKI  144 (261)
T ss_pred             CCCC----cEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEE
Confidence            6554    69999999999999999876666789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++........ .......++..|+|||++.+..++.++|||||||++|+|++ |..||.......   ....+...
T Consensus       145 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~~  220 (261)
T cd05072         145 ADFGLARVIEDNEY-TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD---VMSALQRG  220 (261)
T ss_pred             CCCccceecCCCce-eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH---HHHHHHcC
Confidence            99999987543211 11223345678999999988889999999999999999998 898986543222   21111110


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .    .          .......+.++.+++.+||..+|++||++.+|.+.|+++
T Consensus       221 ~----~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  261 (261)
T cd05072         221 Y----R----------MPRMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF  261 (261)
T ss_pred             C----C----------CCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence            0    0          001112456789999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=5.7e-42  Score=336.75  Aligned_cols=270  Identities=24%  Similarity=0.363  Sum_probs=199.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...++||+|+||.||+|++.           .++..||||.+....  ......+.+|+.+++.++||||+++++++.
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   69 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDT-----------HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIML   69 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEEC-----------CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEe
Confidence            4788899999999999999975           456789999986432  233456889999999999999999999987


Q ss_pred             ecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ..... ....++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        70 ~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~k  143 (338)
T cd07859          70 PPSRREFKDIYVVFELM-ESDLHQVIKAN--DDLTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLK  143 (338)
T ss_pred             ccCCCCCceEEEEEecC-CCCHHHHHHhc--ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEE
Confidence            54422 12479999999 57899988764  4688999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCC-CccccccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          245 LSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      |+|||+++....... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||...........+...
T Consensus       144 L~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~  223 (338)
T cd07859         144 ICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDL  223 (338)
T ss_pred             EccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence            999999986432211 112234579999999999875  67899999999999999999999999754332211111000


Q ss_pred             hhc--------ccCcc--ccccccCCcCCCc---cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPY--------VSDSK--KFHLIIDPRLEGN---YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~--------~~~~~--~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...        +....  .....+.......   .....+..+.+++.+||+.||++|||++++++
T Consensus       224 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~  289 (338)
T cd07859         224 LGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALA  289 (338)
T ss_pred             hCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            000        00000  0000000000000   01123567889999999999999999999985

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=2.2e-42  Score=326.94  Aligned_cols=257  Identities=30%  Similarity=0.480  Sum_probs=210.6

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ...+|...++||.|+||.||+|.+.           . +..+|+|.+..........+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~y~~~~~ig~g~~~~vy~~~~~-----------~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   71 (261)
T cd05148           4 PREEFTLERKLGSGYFGEVWEGLWK-----------N-RVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVC   71 (261)
T ss_pred             cHHHHHHhhhhccCCCccEEEeEec-----------C-CCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeE
Confidence            3567888899999999999999975           2 567999998776655667899999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.+|
T Consensus        72 ~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~k  144 (261)
T cd05148          72 SVGEP----VYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCK  144 (261)
T ss_pred             ecCCC----eEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEE
Confidence            87664    69999999999999999876667789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||++........  ......++..|+|||.+....++.++||||||+++|+|++ |+.||......   ........
T Consensus       145 l~d~g~~~~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~---~~~~~~~~  219 (261)
T cd05148         145 VADFGLARLIKEDVY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH---EVYDQITA  219 (261)
T ss_pred             EccccchhhcCCccc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHHh
Confidence            999999976543211  1223446778999999988889999999999999999998 88888654322   12221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .              .....+..++..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       220 ~--------------~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~  261 (261)
T cd05148         220 G--------------YRMPCPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI  261 (261)
T ss_pred             C--------------CcCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence            0              00111234467799999999999999999999999999763

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=7.8e-42  Score=324.34  Aligned_cols=261  Identities=26%  Similarity=0.451  Sum_probs=206.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+...+        .....||||.+..... .....|.+|+.+++.++||||+++++++
T Consensus         3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--------~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (266)
T cd05033           3 PSYVTIEKVIGGGEFGEVCRGRLKLPG--------KKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVV   74 (266)
T ss_pred             hHHceeeeEecCCccceEEEEEEccCC--------CCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEE
Confidence            357888999999999999999975321        2345799999865432 2345789999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+|+||||+|||+++++.++
T Consensus        75 ~~~~~----~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~  146 (266)
T cd05033          75 TKSRP----VMIITEYMENGSLDKFLREND-GKFTVGQLVGMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCK  146 (266)
T ss_pred             ecCCc----eEEEEEcCCCCCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEE
Confidence            76654    699999999999999987653 4789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||++................++..|+|||.+.+..++.++||||||+++|+|++ |..||.......   +......
T Consensus       147 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~  223 (266)
T cd05033         147 VSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQD---VIKAVED  223 (266)
T ss_pred             ECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHH---HHHHHHc
Confidence            999999987642211111222345678999999998899999999999999999998 998886543221   2221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .    ..          ...+..++..+.+|+.+||+.+|++||++.+|++.|.++
T Consensus       224 ~----~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         224 G----YR----------LPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             C----CC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0    00          001123467799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=7.2e-42  Score=350.92  Aligned_cols=253  Identities=26%  Similarity=0.332  Sum_probs=202.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      .|...+.||+|+||.||+|....          ..+..||+|.+..........+.+|+.+|+.++||||+++++++...
T Consensus        68 ~y~~~~~lg~G~~g~vy~a~~~~----------~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~  137 (478)
T PTZ00267         68 MYVLTTLVGRNPTTAAFVATRGS----------DPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD  137 (478)
T ss_pred             eEEEEEEEEeCCCcEEEEEEEcC----------CCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC
Confidence            38888999999999999998642          22567888987554444455678899999999999999999999876


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +.    .+|||||+++|+|.++|...  ...++++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       138 ~~----~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL  210 (478)
T PTZ00267        138 DK----LLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKL  210 (478)
T ss_pred             CE----EEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEE
Confidence            64    79999999999999988643  235688999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+......  
T Consensus       211 ~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~---~~~~~~~~--  285 (478)
T PTZ00267        211 GDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR---EIMQQVLY--  285 (478)
T ss_pred             EeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh--
Confidence            9999998754332222334567999999999999999999999999999999999999999654221   11111110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        . .    ..     ..+...+..+.+|+.+||..+|++||++.+++.
T Consensus       286 --~-~----~~-----~~~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~  322 (478)
T PTZ00267        286 --G-K----YD-----PFPCPVSSGMKALLDPLLSKNPALRPTTQQLLH  322 (478)
T ss_pred             --C-C----CC-----CCCccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence              0 0    00     112234567999999999999999999999874

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.1e-41  Score=325.46  Aligned_cols=263  Identities=27%  Similarity=0.459  Sum_probs=203.9

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++++|+..+.||+|+||.||+|.++...      ....+..||||.+.... .....+|.+|+.+++.++||||++++++
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~------~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~   77 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVV------KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGV   77 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCC------CCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            4678999999999999999999875321      11345679999986432 2234568899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      +.....    .++||||+++++|.+++....        ...+++..++.++.|++.||.|||+.   +++|+||||+||
T Consensus        78 ~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Ni  150 (277)
T cd05062          78 VSQGQP----TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC  150 (277)
T ss_pred             EcCCCC----eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheE
Confidence            876554    699999999999999987532        12467888899999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhh
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNE  314 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~  314 (453)
                      |+++++.++|+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||......  
T Consensus       151 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--  228 (277)
T cd05062         151 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--  228 (277)
T ss_pred             EEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            999999999999999876433222112223355788999999998899999999999999999999 67888654322  


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                       ........    .. .         ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       229 -~~~~~~~~----~~-~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         229 -QVLRFVME----GG-L---------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             -HHHHHHHc----CC-c---------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence             12111110    00 0         0011234567999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=1e-41  Score=327.87  Aligned_cols=264  Identities=28%  Similarity=0.433  Sum_probs=206.8

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +|...+.||+|+||.||+|+.....      +......+|+|.+..... .....+.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   74 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLK------GRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQ   74 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCC------CCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEec
Confidence            4777889999999999999875311      113346799998865432 234678899999999999999999999887


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV----------------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      .+.    .+++|||+.+++|.+++....                      ..++++..++.++.|++.||.|||+.   +
T Consensus        75 ~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~  147 (290)
T cd05045          75 DGP----LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---K  147 (290)
T ss_pred             CCC----cEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            654    689999999999999876421                      23578999999999999999999998   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CC
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GR  303 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~  303 (453)
                      |+||||||+|||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |.
T Consensus       148 ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~  227 (290)
T cd05045         148 LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG  227 (290)
T ss_pred             eehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCC
Confidence            99999999999999999999999999986533222112233455678999999988889999999999999999998 99


Q ss_pred             ccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          304 RAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .||....+.   .+........              ....+...+..+.+++.+||+.+|++||++.++++.|++++.
T Consensus       228 ~p~~~~~~~---~~~~~~~~~~--------------~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         228 NPYPGIAPE---RLFNLLKTGY--------------RMERPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             CCCCCCCHH---HHHHHHhCCC--------------CCCCCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            888654332   2222221100              011122345679999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=5.4e-43  Score=339.19  Aligned_cols=254  Identities=27%  Similarity=0.391  Sum_probs=215.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|..+++||+|+||.++..+++           .+...||+|.+.....  .......+|+.+++++.|||||.+.+.
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk-----------~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds   71 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHK-----------SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDS   71 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhc-----------cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccc
Confidence            357888899999999999998876           4456899999875543  333467899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+++..   .+|||+||+||+|.+.|.+..+..+++..+..++.|++.|+.|||+.   .|+|||||+.|||++.++.+
T Consensus        72 ~~~~~~~---l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~V  145 (426)
T KOG0589|consen   72 FEEDGQL---LCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKV  145 (426)
T ss_pred             hhcCCce---EEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCce
Confidence            9988753   79999999999999999988778899999999999999999999988   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+...+..  ....+.+||+.||+||.+.+.+|+.|+|||||||++|||++-+++|......   .++..+.+
T Consensus       146 kLgDfGlaK~l~~~~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---~Li~ki~~  220 (426)
T KOG0589|consen  146 KLGDFGLAKILNPED--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---ELILKINR  220 (426)
T ss_pred             eecchhhhhhcCCch--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---HHHHHHhh
Confidence            999999999876543  2467889999999999999999999999999999999999999999765322   22211111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                                    ..-...+...+.++..||..|+..+|..||++.+++..
T Consensus       221 --------------~~~~Plp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  221 --------------GLYSPLPSMYSSELRSLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             --------------ccCCCCCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence                          11122344567889999999999999999999999875

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-42  Score=342.78  Aligned_cols=244  Identities=26%  Similarity=0.440  Sum_probs=205.6

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccC-CCCceeeE
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVV-KHPNLVKL  160 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l  160 (453)
                      ..++|....+||+|.||+|+++..+           .+++.+|||++++...   ++.+..+.|-+|+... +||.++.+
T Consensus       366 ~l~~F~~l~vLGkGsFGkV~lae~k-----------~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L  434 (694)
T KOG0694|consen  366 TLDDFRLLAVLGRGSFGKVLLAELK-----------GTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNL  434 (694)
T ss_pred             cccceEEEEEeccCcCceEEEEEEc-----------CCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeec
Confidence            4678999999999999999999987           4567899999987753   4567788899998888 59999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      +.++...+.    +|+||||+.||++..+.+.   ..+++..+.-++..|+.||.|||++   +|||||||.+|||||.+
T Consensus       435 ~~~fQT~~~----l~fvmey~~Ggdm~~~~~~---~~F~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~e  504 (694)
T KOG0694|consen  435 FSCFQTKEH----LFFVMEYVAGGDLMHHIHT---DVFSEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTE  504 (694)
T ss_pred             ccccccCCe----EEEEEEecCCCcEEEEEec---ccccHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEccc
Confidence            999998875    8999999999995554443   5788988899999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      |++||+|||+++....  ......+.+||+.|||||++.+..|+.++|.|||||+|||||.|..||.+...   ..+.+-
T Consensus       505 Gh~kiADFGlcKe~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE---ee~Fds  579 (694)
T KOG0694|consen  505 GHVKIADFGLCKEGMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE---EEVFDS  579 (694)
T ss_pred             CcEEecccccccccCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH---HHHHHH
Confidence            9999999999997432  34457789999999999999999999999999999999999999999986532   223222


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                      +.   .+            ...|+...+.+...++.++|..+|++|.-+
T Consensus       580 I~---~d------------~~~yP~~ls~ea~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  580 IV---ND------------EVRYPRFLSKEAIAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             Hh---cC------------CCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence            21   00            113455678889999999999999999766

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-42  Score=335.51  Aligned_cols=242  Identities=24%  Similarity=0.331  Sum_probs=193.6

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ||+|+||.||+|.+.           .++..||+|.+....   ......+.+|+.++++++||||+++++++...+.  
T Consensus         1 lg~G~~g~Vy~~~~~-----------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--   67 (312)
T cd05585           1 IGKGSFGKVMQVRKR-----------DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEK--   67 (312)
T ss_pred             CCcCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCe--
Confidence            799999999999975           456789999986432   2334668899999999999999999998876654  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++
T Consensus        68 --~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~  140 (312)
T cd05585          68 --LYLVLAFINGGELFHHLQRE--GRFDLSRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLC  140 (312)
T ss_pred             --EEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECccc
Confidence              79999999999999999765  4688999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      +......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   ......   ....   
T Consensus       141 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~---~~~~~~---~~~~---  209 (312)
T cd05585         141 KLNMKDD--DKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVN---EMYRKI---LQEP---  209 (312)
T ss_pred             ccCccCC--CccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHH---HHHHHH---HcCC---
Confidence            8643221  2234567999999999999999999999999999999999999999754321   111111   1100   


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                               ..++...+..+.+++.+||..||.+||++..+.+.|
T Consensus       210 ---------~~~~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l  245 (312)
T cd05585         210 ---------LRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIK  245 (312)
T ss_pred             ---------CCCCCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHH
Confidence                     011223456789999999999999998654444333

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=8.5e-42  Score=335.02  Aligned_cols=266  Identities=25%  Similarity=0.349  Sum_probs=201.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+.           .++..+|+|.+..... .....+.+|+++++.++||||++++++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~-----------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   72 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHK-----------PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF   72 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEEC-----------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEE
Confidence            468999999999999999999875           4567899998865422 2345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||+++|+|.+++...  ..+++.....++.+++.||.|||+..  +|+|+||||+|||++.++.+|
T Consensus        73 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~k  144 (333)
T cd06650          73 YSDGE----ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIK  144 (333)
T ss_pred             EECCE----EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEE
Confidence            88654    79999999999999999765  46788888999999999999999742  799999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++......    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus       145 L~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~  220 (333)
T cd06650         145 LCDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEG  220 (333)
T ss_pred             EeeCCcchhhhhh----ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccC
Confidence            9999998764321    123456899999999999888999999999999999999999999754332221111000000


Q ss_pred             c-cCc---cc--------------------c----ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 V-SDS---KK--------------------F----HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~-~~~---~~--------------------~----~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      . ...   ..                    .    ..+.............+.++.+|+.+||+.||++|||+.+++.
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~  298 (333)
T cd06650         221 DPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMV  298 (333)
T ss_pred             CccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhh
Confidence            0 000   00                    0    0000000000000123467899999999999999999999974

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.1e-41  Score=329.66  Aligned_cols=265  Identities=24%  Similarity=0.388  Sum_probs=208.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+...      .....+..||||.+..... ...+.+.+|+.+++++ +||||++++++
T Consensus        34 ~~~~~~~~~ig~G~~g~V~~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  107 (302)
T cd05055          34 RNNLSFGKTLGAGAFGKVVEATAYGL------SKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGA  107 (302)
T ss_pred             HHHeEEcceeeccCCeeEEEEEEecC------CCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEE
Confidence            45799999999999999999986421      1123456899999875432 2345688999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .++||||+.+|+|.+++.......+++.++..++.+++.||.|||+.   +|+|+||||+|||++.++.+
T Consensus       108 ~~~~~~----~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  180 (302)
T cd05055         108 CTIGGP----ILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV  180 (302)
T ss_pred             EecCCc----eEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeE
Confidence            887664    69999999999999999865545589999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........  +.....
T Consensus       181 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~--~~~~~~  258 (302)
T cd05055         181 KICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSK--FYKLIK  258 (302)
T ss_pred             EECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHH--HHHHHH
Confidence            9999999986543221111223356788999999998899999999999999999998 8999865433221  111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .    ..          ....+...+.++.+++.+||+.+|++|||+.++++.|.++
T Consensus       259 ~----~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         259 E----GY----------RMAQPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             c----CC----------cCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            1    00          0011112356799999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.9e-42  Score=334.77  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=195.1

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      ++||+|+||.||++.+.           .++..||+|.+....   ......+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~   69 (323)
T cd05595           1 KLLGKGTFGKVILVREK-----------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDR   69 (323)
T ss_pred             CeeeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCE
Confidence            36999999999999875           456789999987542   2234567789999999999999999999887654


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                          .++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        70 ----~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg  140 (323)
T cd05595          70 ----LCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFG  140 (323)
T ss_pred             ----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccH
Confidence                79999999999999988765  4688999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       250 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      ++.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........   ..   ... 
T Consensus       141 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~---~~---~~~-  211 (323)
T cd05595         141 LCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFEL---IL---MEE-  211 (323)
T ss_pred             HhccccCCC--CccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHH---Hh---cCC-
Confidence            987532211  122345799999999999999999999999999999999999999975432211111   10   000 


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                             .    ..+...+..+.+|+.+||..||.+||     ++.++++
T Consensus       212 -------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~  250 (323)
T cd05595         212 -------I----RFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  250 (323)
T ss_pred             -------C----CCCCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence                   0    11223467789999999999999998     7887764

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=7.8e-42  Score=334.55  Aligned_cols=242  Identities=26%  Similarity=0.385  Sum_probs=196.0

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      ++||+|+||.||++.+.           .++..||||++....   ......+.+|+.+++.++||||+++++++...+.
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   69 (328)
T cd05593           1 KLLGKGTFGKVILVREK-----------ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDR   69 (328)
T ss_pred             CeeeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCE
Confidence            36999999999999875           457789999997542   2334678899999999999999999998887664


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                          .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+|||
T Consensus        70 ----~~lv~Ey~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG  140 (328)
T cd05593          70 ----LCFVMEYVNGGELFFHLSRE--RVFSEDRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFG  140 (328)
T ss_pred             ----EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCc
Confidence                79999999999999988765  4688999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       250 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      +++.....  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ....+.   ..  
T Consensus       141 ~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~---~~~~~~---~~--  210 (328)
T cd05593         141 LCKEGITD--AATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELIL---ME--  210 (328)
T ss_pred             CCccCCCc--ccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHH---HHHHhc---cC--
Confidence            98753221  112234579999999999998899999999999999999999999997543221   111110   00  


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                            ..    .++...+.++.+|+.+||..||.+||     ++.++++
T Consensus       211 ------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  250 (328)
T cd05593         211 ------DI----KFPRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMR  250 (328)
T ss_pred             ------Cc----cCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhc
Confidence                  00    11223456789999999999999997     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-41  Score=321.70  Aligned_cols=256  Identities=27%  Similarity=0.433  Sum_probs=205.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.            ....||+|.+.... ...+++.+|+.++++++||||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~------------~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWN------------NTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCT   71 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEec------------CCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEe
Confidence            456888999999999999999863            24579999986543 34567899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|
T Consensus        72 ~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l  144 (261)
T cd05068          72 LEEP----IYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKV  144 (261)
T ss_pred             cCCC----eeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEE
Confidence            7654    69999999999999999876556789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++....... ........+..|+|||++.+..++.++||||||+++|||++ |+.||.......   +...+.. 
T Consensus       145 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~-  219 (261)
T cd05068         145 ADFGLARVIKEDIY-EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE---VLQQVDQ-  219 (261)
T ss_pred             CCcceEEEccCCcc-cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHc-
Confidence            99999987542211 11112223457999999998899999999999999999999 888886543221   1111110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                         ..          ........+..+.+++.+||+.+|.+||++.++++.|+.+
T Consensus       220 ---~~----------~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~  261 (261)
T cd05068         220 ---GY----------RMPCPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF  261 (261)
T ss_pred             ---CC----------CCCCCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence               00          0011223457799999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=5.9e-42  Score=336.79  Aligned_cols=247  Identities=23%  Similarity=0.302  Sum_probs=200.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+..          .....||+|.+....   ......+.+|+.+++.++||||+++++
T Consensus        29 ~~~y~~~~~ig~G~~g~Vy~a~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~   98 (340)
T PTZ00426         29 YEDFNFIRTLGTGSFGRVILATYKN----------EDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYG   98 (340)
T ss_pred             hhhcEEEEEEeecCCeEEEEEEEEC----------CCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEE
Confidence            4578889999999999999998752          223579999986432   233466889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    +++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        99 ~~~~~~~----~~lv~Ey~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~  169 (340)
T PTZ00426         99 SFKDESY----LYLVLEFVIGGEFFTFLRRN--KRFPNDVGCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGF  169 (340)
T ss_pred             EEEeCCE----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCC
Confidence            9987654    79999999999999999765  4688889999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||....+...   ...+.
T Consensus       170 ikL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~---~~~i~  241 (340)
T PTZ00426        170 IKMTDFGFAKVVDTR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLI---YQKIL  241 (340)
T ss_pred             EEEecCCCCeecCCC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHH---HHHHh
Confidence            999999999864321     2345799999999999988899999999999999999999999976533211   11111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      .    . .          ..++...+..+.+++.+||+.+|++|+     +++++++
T Consensus       242 ~----~-~----------~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~  283 (340)
T PTZ00426        242 E----G-I----------IYFPKFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKE  283 (340)
T ss_pred             c----C-C----------CCCCCCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHc
Confidence            0    0 0          011222356688999999999999995     7888765

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.6e-42  Score=329.52  Aligned_cols=266  Identities=27%  Similarity=0.416  Sum_probs=208.4

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||.||+|.+....      .......+|+|.+.... ......+.+|+.++.++ +|+||+++++
T Consensus        10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~------~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~   83 (293)
T cd05053          10 PRDRLTLGKPLGEGAFGQVVKAEAVGLD------NPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLG   83 (293)
T ss_pred             CHhHeEEeeEecccccccEEEEEEecCC------CCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEE
Confidence            3467888899999999999999876321      11345679999986532 22345688999999999 8999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSR--------------VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR  228 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~  228 (453)
                      ++.....    .+++|||+++|+|.+++..+              ....+++..++.++.|++.||.|||+.   +|+||
T Consensus        84 ~~~~~~~----~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~  156 (293)
T cd05053          84 VCTQEGP----LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHR  156 (293)
T ss_pred             EEcCCCC----eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHC---Ccccc
Confidence            9987654    79999999999999998653              235688999999999999999999998   99999


Q ss_pred             ccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCcccc
Q 043568          229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVE  307 (453)
Q Consensus       229 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~  307 (453)
                      ||||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus       157 dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~  236 (293)
T cd05053         157 DLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP  236 (293)
T ss_pred             ccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCC
Confidence            9999999999999999999999987543322222223345678999999988899999999999999999998 888886


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      ..........   ...    ..          ....+...+..+.+|+.+||..+|++|||+.++++.|+.++
T Consensus       237 ~~~~~~~~~~---~~~----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         237 GIPVEELFKL---LKE----GY----------RMEKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             CCCHHHHHHH---HHc----CC----------cCCCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            5432221111   110    00          00112234567999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=1.4e-41  Score=319.99  Aligned_cols=248  Identities=27%  Similarity=0.446  Sum_probs=195.5

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .||+|+||.||+|++.           .++..||+|.+.... ......|.+|+++++.++||||+++++++.....   
T Consensus         2 ~lg~g~~g~vy~~~~~-----------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   67 (252)
T cd05084           2 RIGRGNFGEVFSGRLR-----------ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP---   67 (252)
T ss_pred             ccCcccCccEEEEEEe-----------cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCC---
Confidence            6999999999999976           456789999876432 2334678999999999999999999999987654   


Q ss_pred             eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR  252 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~  252 (453)
                       .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.
T Consensus        68 -~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~  142 (252)
T cd05084          68 -IYIVMELVQGGDFLTFLRTE-GPRLKVKELIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSR  142 (252)
T ss_pred             -eEEEEeeccCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCc
Confidence             69999999999999998754 34688999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          253 QGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       253 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ................+..|+|||.+.++.++.++|||||||++|||++ |..||..............           
T Consensus       143 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~-----------  211 (252)
T cd05084         143 EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQ-----------  211 (252)
T ss_pred             ccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHc-----------
Confidence            6432211111111223457999999998889999999999999999998 8888864332221111110           


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                            ......+...+..+.+++.+||+.+|++|||+.++.+.|.
T Consensus       212 ------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         212 ------GVRLPCPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             ------CCCCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHh
Confidence                  0011112234668999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.9e-41  Score=322.55  Aligned_cols=262  Identities=26%  Similarity=0.425  Sum_probs=201.0

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |...++||+|+||.||+|.+...         .....+|+|.++...  ......|.+|+.+++.++||||+++++++..
T Consensus         1 ~~i~~~ig~G~~g~V~~~~~~~~---------~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   71 (272)
T cd05075           1 LALGKTLGEGEFGSVMEGQLNQD---------DSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQ   71 (272)
T ss_pred             CccccccCcccCceEEEeEEccC---------CCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcc
Confidence            34667899999999999987531         122469999886542  2335678899999999999999999998865


Q ss_pred             ccc--ccceEEEEEEecCCCChHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          167 DDE--RGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       167 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ...  .....+++|||+++|+|.+++...    ....+++.....++.|++.||.|||++   +|+||||||+|||++.+
T Consensus        72 ~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~  148 (272)
T cd05075          72 TVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNEN  148 (272)
T ss_pred             CCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCC
Confidence            332  112368999999999999987432    234588999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  319 (453)
                      +.+||+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |+.||......   .+.+
T Consensus       149 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~---~~~~  225 (272)
T cd05075         149 MNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS---EIYD  225 (272)
T ss_pred             CCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHH
Confidence            9999999999987543322112233356778999999998899999999999999999999 78888653222   2222


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ...    .....          ..+...+..+.+++.+||+.+|++|||+.+|++.|+.+
T Consensus       226 ~~~----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         226 YLR----QGNRL----------KQPPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             HHH----cCCCC----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            111    11100          11223456799999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.5e-42  Score=351.74  Aligned_cols=265  Identities=23%  Similarity=0.301  Sum_probs=209.8

Q ss_pred             HHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCce
Q 043568           80 AELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNL  157 (453)
Q Consensus        80 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nI  157 (453)
                      .+.....++|...++||+|+||+||+|.+.           .++..||||.+.....  .....+.+|+.++..++|+||
T Consensus        25 ~~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~-----------~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~i   93 (496)
T PTZ00283         25 ATAKEQAKKYWISRVLGSGATGTVLCAKRV-----------SDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSI   93 (496)
T ss_pred             ccccccCCCEEEEEEEecCCCEEEEEEEEc-----------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcE
Confidence            334445689999999999999999999875           4567899999875432  334568899999999999999


Q ss_pred             eeEeeeeeecccc----cceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          158 VKLVGYCAEDDER----GMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       158 v~l~~~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      +++++.+...+..    ....++||||+++|+|.+++..+.  ...+++..+..++.|++.||.|||+.   +|+|||||
T Consensus        94 v~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLK  170 (496)
T PTZ00283         94 VKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIK  170 (496)
T ss_pred             EEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCC
Confidence            9998877654321    123679999999999999987542  35688999999999999999999998   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      |+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       171 P~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~  250 (496)
T PTZ00283        171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM  250 (496)
T ss_pred             HHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence            99999999999999999999875433222334456799999999999999999999999999999999999999975432


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .   .+.....   .  ..    .     ...+...+.++.+|+.+||+.+|.+||++.+++..
T Consensus       251 ~---~~~~~~~---~--~~----~-----~~~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        251 E---EVMHKTL---A--GR----Y-----DPLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             H---HHHHHHh---c--CC----C-----CCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            1   1111111   0  00    0     01223456789999999999999999999998763

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=3.3e-41  Score=322.76  Aligned_cols=261  Identities=26%  Similarity=0.435  Sum_probs=205.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|....+||+|+||.||++.....      .....+..+|+|.+..........|.+|+++++.++|+||+++++++..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~------~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   78 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNL------LPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTE   78 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecC------CCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEec
Confidence            4677788999999999999975421      1123456799999876655556789999999999999999999999887


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCC-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVP-------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      ...    .+++|||+++++|.+++....+             ..+++..++.++.|++.||+|||+.   +++||||||+
T Consensus        79 ~~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~  151 (280)
T cd05092          79 GRP----LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATR  151 (280)
T ss_pred             CCc----eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHh
Confidence            654    6999999999999999976532             3578999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCCh
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPR  312 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~  312 (453)
                      |||+++++.+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus       152 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~  231 (280)
T cd05092         152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNT  231 (280)
T ss_pred             hEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHH
Confidence            99999999999999999975433221122233445788999999998899999999999999999998 88888654322


Q ss_pred             hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      .....   ...    ...          ...+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       232 ~~~~~---~~~----~~~----------~~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         232 EAIEC---ITQ----GRE----------LERPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             HHHHH---HHc----Ccc----------CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            21111   100    000          0111234567899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=2.2e-41  Score=328.36  Aligned_cols=271  Identities=27%  Similarity=0.417  Sum_probs=209.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|.+.+.||+|+||.||+|.+.....    ........+|+|.+.... ......+.+|+.+++.+ +||||++++++
T Consensus        17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~   92 (307)
T cd05098          17 RDRLVLGKPLGEGCFGQVVMAEAIGLDK----EKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   92 (307)
T ss_pred             hHHeEEeeeeccCCCeeEEEeEEeccCC----cccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            3578899999999999999998753211    011234579999987542 23345688899999999 79999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      +...+.    .++||||+++|+|.+++..+.+              ..+++..++.++.|++.||+|||+.   +++|||
T Consensus        93 ~~~~~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~d  165 (307)
T cd05098          93 CTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRD  165 (307)
T ss_pred             EecCCc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Cccccc
Confidence            987664    7999999999999999976432              3588899999999999999999998   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       166 lkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         166 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             ccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            999999999999999999999876532211111222234568999999988889999999999999999998 7888765


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      .....   +......    ..          ....+...+.++.+|+.+||..+|.+|||+.+|++.|..++....
T Consensus       246 ~~~~~---~~~~~~~----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~  304 (307)
T cd05098         246 VPVEE---LFKLLKE----GH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTS  304 (307)
T ss_pred             CCHHH---HHHHHHc----CC----------CCCCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhh
Confidence            33211   1111110    00          011122346789999999999999999999999999999887643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.9e-41  Score=322.56  Aligned_cols=275  Identities=28%  Similarity=0.417  Sum_probs=205.5

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      |...+.||+|+||+||++.....       ...++..||+|.+..... .....|.+|+.+++.++||||+++++++...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~-------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   78 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPA-------NDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQ   78 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccc-------cCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC
Confidence            37788999999999998765311       124567899999865432 2356788999999999999999999998764


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ...  ..++||||+++++|.+++...   .+++..++.++.|++.||.|||+.   +|+||||||+|||+++++.++|+|
T Consensus        79 ~~~--~~~lv~e~~~~~~l~~~~~~~---~l~~~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~d  150 (283)
T cd05080          79 GGK--GLQLIMEYVPLGSLRDYLPKH---KLNLAQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGD  150 (283)
T ss_pred             CCc--eEEEEecCCCCCCHHHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEee
Confidence            432  368999999999999998763   589999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          248 FGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       248 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      ||+++........ .......++..|+|||.+....++.++||||||+++|||++|..|+....... ........... 
T Consensus       151 fg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~-~~~~~~~~~~~-  228 (283)
T cd05080         151 FGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKF-EEMIGPKQGQM-  228 (283)
T ss_pred             cccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchh-hhhhccccccc-
Confidence            9999865432111 11122345667999999988889999999999999999999999986432211 11111100000 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      .........+.......+...+..+.+++.+||+.+|++|||+.+|++.|+.+.
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         229 TVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             chhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            000011111111111223345678999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=1.2e-41  Score=326.09  Aligned_cols=261  Identities=23%  Similarity=0.390  Sum_probs=204.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +|...+.||+|+||.||+|.+..+..      ...+..||||.+...... ....|.+|+.++..++||||+++++++..
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~   79 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAP------GEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTK   79 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCC------CCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcC
Confidence            46667789999999999998754211      134578999998754332 23568899999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      ...    .++++||+.+++|.+++....              ...+++..++.++.|++.||.|||++   +|+||||||
T Consensus        80 ~~~----~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp  152 (283)
T cd05091          80 EQP----LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLAT  152 (283)
T ss_pred             CCc----eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHc---Cccccccch
Confidence            664    689999999999999985321              23578888999999999999999998   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCC
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLP  311 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~  311 (453)
                      +|||+++++.+||+|||+++...............+++.|+|||++.++.++.++|||||||++|||++ |..||.....
T Consensus       153 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  232 (283)
T cd05091         153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN  232 (283)
T ss_pred             hheEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence            999999999999999999886543322222334456789999999988889999999999999999998 7778765432


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      .   .+.+.+...    .          ....+..++..+.+|+.+||+.+|.+||++.+|+..|+.
T Consensus       233 ~---~~~~~i~~~----~----------~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         233 Q---DVIEMIRNR----Q----------VLPCPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             H---HHHHHHHcC----C----------cCCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            2   222222110    0          011223456779999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.8e-41  Score=322.95  Aligned_cols=264  Identities=26%  Similarity=0.429  Sum_probs=205.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||+||+|++...       +......||+|.+..... .....+.+|+.+++.++||||+++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~-------~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPD-------GENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGIC   78 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecC-------CCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEE
Confidence            45688889999999999999987522       112234689999865432 2346788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++++||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        79 ~~~~-----~~l~~~~~~~g~l~~~l~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~k  149 (279)
T cd05109          79 LTST-----VQLVTQLMPYGCLLDYVREN-KDRIGSQDLLNWCVQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVK  149 (279)
T ss_pred             cCCC-----cEEEEEcCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEE
Confidence            7643     57999999999999998764 24688999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.......   +...+..
T Consensus       150 L~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~  226 (279)
T cd05109         150 ITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPARE---IPDLLEK  226 (279)
T ss_pred             ECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH---HHHHHHC
Confidence            999999986543221111222345678999999988899999999999999999998 888886543221   2222211


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      .    ..          .......+..+.+++.+||..||++||++.++++.|..+...
T Consensus       227 ~----~~----------~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05109         227 G----ER----------LPQPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMARD  271 (279)
T ss_pred             C----Cc----------CCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhcC
Confidence            0    00          001123456789999999999999999999999998777653

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.9e-42  Score=339.43  Aligned_cols=253  Identities=23%  Similarity=0.305  Sum_probs=199.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...++||+|+||+||+|++.           .++..||||++....   ......+.+|+.+|..++||||++++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~   69 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKK-----------DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYS   69 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEE
Confidence            47889999999999999999976           456789999997542   2234567889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~  140 (364)
T cd05599          70 FQDENY----LYLIMEYLPGGDMMTLLMKK--DTFTEEETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHI  140 (364)
T ss_pred             EEcCCe----EEEEECCCCCcHHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCE
Confidence            987664    79999999999999999765  4689999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCc------------------------------------cccccccCcCCCCccccccCCCCCch
Q 043568          244 KLSDFGLARQGPPEGLGH------------------------------------VSTSVVGTVGYAAPEYVQTGRLTAKS  287 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~  287 (453)
                      ||+|||+++.........                                    ......||+.|+|||++....++.++
T Consensus       141 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  220 (364)
T cd05599         141 KLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKEC  220 (364)
T ss_pred             EEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCee
Confidence            999999987532211000                                    01124699999999999999999999


Q ss_pred             hHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC
Q 043568          288 DVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       288 DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  367 (453)
                      |||||||++|||++|..||....+....   ..+...   ...        +........+..+.+|+.+|+. +|.+|+
T Consensus       221 DiwSlG~il~el~~G~~Pf~~~~~~~~~---~~i~~~---~~~--------~~~~~~~~~s~~~~~li~~ll~-~p~~R~  285 (364)
T cd05599         221 DWWSLGVIMYEMLVGYPPFCSDNPQETY---RKIINW---KET--------LQFPDEVPLSPEAKDLIKRLCC-EAERRL  285 (364)
T ss_pred             eeecchhHHHHhhcCCCCCCCCCHHHHH---HHHHcC---CCc--------cCCCCCCCCCHHHHHHHHHHcc-CHhhcC
Confidence            9999999999999999999765432211   111100   000        0000111235678899999996 999999


Q ss_pred             C---HHHHHH
Q 043568          368 K---MSEVVD  374 (453)
Q Consensus       368 s---~~ei~~  374 (453)
                      +   +.++++
T Consensus       286 ~~~~~~~ll~  295 (364)
T cd05599         286 GNNGVNEIKS  295 (364)
T ss_pred             CCCCHHHHhc
Confidence            8   887765

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-41  Score=338.58  Aligned_cols=261  Identities=23%  Similarity=0.314  Sum_probs=197.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||+|....      ..+.+|+.+|++++||||+++++++.
T Consensus        91 ~~~y~~~~~lg~G~~g~V~~~~d~-----------~~~~~vaiK~~~~------~~~~~E~~il~~l~HpnIv~~~~~~~  153 (391)
T PHA03212         91 KAGFSILETFTPGAEGFAFACIDN-----------KTCEHVVIKAGQR------GGTATEAHILRAINHPSIIQLKGTFT  153 (391)
T ss_pred             cCCcEEEEEEcCCCCeEEEEEEEC-----------CCCCEEEEechhh------hhhHHHHHHHHhCCCCCCCCEeEEEE
Confidence            367999999999999999999976           4577899997532      34678999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++|+|++ +++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus       154 ~~~~----~~lv~e~~-~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL  223 (391)
T PHA03212        154 YNKF----TCLILPRY-KTDLYCYLAAK--RNIAICDILAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCL  223 (391)
T ss_pred             ECCe----eEEEEecC-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEE
Confidence            7553    68999999 57898888765  4678899999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh-----hHHHHHh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN-----EQKLLEW  320 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~-----~~~~~~~  320 (453)
                      +|||++....... ........||+.|+|||++.+..++.++|||||||++|||++|..||.......     ...+...
T Consensus       224 ~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i  302 (391)
T PHA03212        224 GDFGAACFPVDIN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLI  302 (391)
T ss_pred             EeCCccccccccc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHH
Confidence            9999997533211 112334579999999999999899999999999999999999998875432110     0111000


Q ss_pred             hhhcccCc--------cccccc---------cCCcCCC--ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDS--------KKFHLI---------IDPRLEG--NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~--------~~~~~~---------~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +.......        ..+...         ..+....  ......+.++.+|+.+||+.||.+|||+.|+++
T Consensus       303 ~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~  375 (391)
T PHA03212        303 IRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD  375 (391)
T ss_pred             HHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00000000        000000         0000000  001234668999999999999999999999985

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=2.2e-41  Score=338.80  Aligned_cols=265  Identities=23%  Similarity=0.394  Sum_probs=205.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCC-CCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVK-HPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~-h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||.||+|++....      .......||||++...... ....+.+|+.+|.++. ||||++++++|
T Consensus        37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~------~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~  110 (401)
T cd05107          37 DNLVLGRTLGSGAFGRVVEATAHGLS------HSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGAC  110 (401)
T ss_pred             HHeehhhhccCCCceeEEEEEEcCCC------CCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence            45777889999999999999975321      1134568999999754322 2356889999999997 99999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC--------------------------------------------------
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------------------------------------------  194 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------------------  194 (453)
                      .....    .++||||+++|+|.++++...                                                  
T Consensus       111 ~~~~~----~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         111 TKGGP----IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             ccCCC----cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            87654    699999999999999996532                                                  


Q ss_pred             ----------------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 043568          195 ----------------------------------------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR  228 (453)
Q Consensus       195 ----------------------------------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~  228 (453)
                                                                    ...+++...+.++.|++.||.|||+.   +|+||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHr  263 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHR  263 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcc
Confidence                                                          12367778899999999999999998   99999


Q ss_pred             ccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCcccc
Q 043568          229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVE  307 (453)
Q Consensus       229 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~  307 (453)
                      ||||+|||++.++.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.
T Consensus       264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999986432211111223456789999999998889999999999999999998 888886


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      .......  ....+..    ..          ....+...+.++.+|+.+||..+|.+||++.+|++.|+.++
T Consensus       344 ~~~~~~~--~~~~~~~----~~----------~~~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         344 ELPMNEQ--FYNAIKR----GY----------RMAKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCchHH--HHHHHHc----CC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            4322211  1111110    00          00112234678999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2e-41  Score=333.85  Aligned_cols=268  Identities=25%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+....      ....++.||||.+..... .....+.+|+.++.++ +||||++++++
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~   79 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGID------KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   79 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCC------ccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcce
Confidence            357899999999999999999864221      124567899999975432 2345688999999999 78999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC-------------------------------------------------
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV-------------------------------------------------  194 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------------------------------------------  194 (453)
                      +...+.   ..++||||+++|+|.+++....                                                 
T Consensus        80 ~~~~~~---~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (343)
T cd05103          80 CTKPGG---PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEK  156 (343)
T ss_pred             eecCCC---ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCC
Confidence            876543   2689999999999999986431                                                 


Q ss_pred             ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCC
Q 043568          195 ----------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG  258 (453)
Q Consensus       195 ----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~  258 (453)
                                      ...+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+|||++.......
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~  233 (343)
T cd05103         157 SLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDP  233 (343)
T ss_pred             ccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCc
Confidence                            12367888899999999999999998   99999999999999999999999999998643222


Q ss_pred             CCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCccccccccCC
Q 043568          259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDP  337 (453)
Q Consensus       259 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .........++..|+|||.+.+..++.++||||||+++|+|++ |..||.......  .+.....    ....      .
T Consensus       234 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~----~~~~------~  301 (343)
T cd05103         234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE--EFCRRLK----EGTR------M  301 (343)
T ss_pred             chhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH--HHHHHHh----ccCC------C
Confidence            1111223345678999999988899999999999999999997 888886532211  1111110    0000      0


Q ss_pred             cCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          338 RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       338 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .    .+...+..+.+++.+||+.+|++|||+.+|++.|+.+++
T Consensus       302 ~----~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         302 R----APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             C----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0    011124568999999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=5.5e-41  Score=316.68  Aligned_cols=251  Identities=27%  Similarity=0.470  Sum_probs=199.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||.||+|.+.            ....+|+|.+.... .....|.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~------------~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWR------------AQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCTQ   70 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEec------------cCceEEEEecccCC-ccHHHHHHHHHHHHHCCCCCceeEEEEEcc
Confidence            45777889999999999999864            23579999876432 335678899999999999999999999877


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||+++|+|.+++.... ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+
T Consensus        71 ~~~----~~iv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~  142 (256)
T cd05114          71 QKP----LYIVTEFMENGCLLNYLRQRQ-GKLSKDMLLSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVS  142 (256)
T ss_pred             CCC----EEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEEC
Confidence            654    799999999999999987643 3688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||+++...... ........++..|+|||++.+..++.++||||||+++|||++ |+.||......   .....+... 
T Consensus       143 d~g~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~---~~~~~i~~~-  217 (256)
T cd05114         143 DFGMTRYVLDDE-YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY---EVVEMISRG-  217 (256)
T ss_pred             CCCCccccCCCc-eeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHHCC-
Confidence            999988643221 111122345668999999988889999999999999999999 88888654322   222222110 


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                         ..   ...       +...+..+.+++.+||+.+|.+||++.++++.|
T Consensus       218 ---~~---~~~-------~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         218 ---FR---LYR-------PKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             ---CC---CCC-------CCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence               00   001       111346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.7e-41  Score=324.22  Aligned_cols=251  Identities=30%  Similarity=0.427  Sum_probs=201.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +|+..++||+|+||.||++.+.           .++..||||.+.....   .....+.+|+.+++.++||||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   69 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVR-----------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAY   69 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEc-----------CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            4778899999999999999875           4567899999865432   2234577899999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||++++++.++
T Consensus        70 ~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~  142 (285)
T cd05605          70 ETKDA----LCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIR  142 (285)
T ss_pred             cCCCe----EEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEE
Confidence            77653    79999999999999988765556789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~  323 (453)
                      |+|||++.......   ......|++.|+|||++.+..++.++|||||||++|||++|+.||......... .+...+..
T Consensus       143 l~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~  219 (285)
T cd05605         143 ISDLGLAVEIPEGE---TIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKE  219 (285)
T ss_pred             EeeCCCceecCCCC---ccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhh
Confidence            99999998643221   123457899999999999889999999999999999999999999754322111 11111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                                     ....++...+..+.+|+.+||..||.+||     ++.++++
T Consensus       220 ---------------~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05605         220 ---------------DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA  260 (285)
T ss_pred             ---------------cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence                           00112233467789999999999999999     7777754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=8.5e-41  Score=330.64  Aligned_cols=247  Identities=26%  Similarity=0.368  Sum_probs=191.1

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +|...++||+|+||+||+|++.           .++..||||++..... .....+.+|+.+++.++|+||+++++++..
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~  143 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHR-----------PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDH  143 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEEC-----------CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEecc
Confidence            3445678999999999999875           4567899999865432 234678899999999999999999999876


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    +++||||+++|+|.+..      ......+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       144 ~~~----~~lv~e~~~~~~L~~~~------~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~  210 (353)
T PLN00034        144 NGE----IQVLLEFMDGGSLEGTH------IADEQFLADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIA  210 (353)
T ss_pred             CCe----EEEEEecCCCCcccccc------cCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEc
Confidence            654    79999999999987532      345667788999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      |||+++.....  ........||..|+|||++..     ...+.++|||||||++|||++|+.||..........+....
T Consensus       211 DfG~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~  288 (353)
T PLN00034        211 DFGVSRILAQT--MDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAI  288 (353)
T ss_pred             ccccceecccc--cccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHH
Confidence            99999865322  112344579999999998743     23456899999999999999999999743322221211111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..    .          .........+.++.+||.+||..||++|||+.++++
T Consensus       289 ~~----~----------~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~  327 (353)
T PLN00034        289 CM----S----------QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQ  327 (353)
T ss_pred             hc----c----------CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            00    0          001112234677999999999999999999999986

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=2.4e-41  Score=323.15  Aligned_cols=262  Identities=27%  Similarity=0.452  Sum_probs=203.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +++|...+.||+|+||.||+|.+....      +......||+|.+..... .....|.+|+.+++.++|+||+++++++
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~------~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   78 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRD------GDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVS   78 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCC------CCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            577999999999999999999986311      112467899998864432 2345689999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP-----TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      .+...    .++||||+++++|.+++.....     ..+++..++.++.||+.||.|||+.   +++|+||||+|||++.
T Consensus        79 ~~~~~----~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~  151 (277)
T cd05036          79 FERLP----RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTC  151 (277)
T ss_pred             ccCCC----cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEec
Confidence            87654    5899999999999999876532     3589999999999999999999998   9999999999999986


Q ss_pred             CC---cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhH
Q 043568          240 DY---KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQ  315 (453)
Q Consensus       240 ~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~  315 (453)
                      ++   .+||+|||+++................+..|+|||++.+..++.++|||||||++|||++ |..||........ 
T Consensus       152 ~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~-  230 (277)
T cd05036         152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEV-  230 (277)
T ss_pred             cCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHH-
Confidence            54   599999999986532221111122334568999999998899999999999999999997 8888875433221 


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                        ...+..    ..          ....+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       231 --~~~~~~----~~----------~~~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         231 --MEFVTG----GG----------RLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             --HHHHHc----CC----------cCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence              111110    00          01112234577999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=6.2e-41  Score=324.55  Aligned_cols=265  Identities=25%  Similarity=0.355  Sum_probs=197.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++..... .....+.+|+.+++.++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   72 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSK-----------VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDII   72 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEEC-----------CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEE
Confidence            478999999999999999999975           3567899999875432 2234678899999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+ .++|.+++... ...++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        73 ~~~~~----~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~k  143 (303)
T cd07869          73 HTKET----LTLVFEYV-HTDLCQYMDKH-PGGLHPENVKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELK  143 (303)
T ss_pred             ecCCe----EEEEEECC-CcCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence            87653    79999999 57888877654 34678888999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||++......  ........+|+.|+|||++.+ ..++.++|||||||++|||++|..||........  .......
T Consensus       144 l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~~~~  219 (303)
T cd07869         144 LADFGLARAKSVP--SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQD--QLERIFL  219 (303)
T ss_pred             ECCCCcceeccCC--CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHH--HHHHHHH
Confidence            9999998754322  122344578999999998865 4588999999999999999999999976433211  1111100


Q ss_pred             cccCc----------------cccccccCCcCCCcc-chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDS----------------KKFHLIIDPRLEGNY-CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~----------------~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....                ..+.......+.... ....+..+.+|+.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~  287 (303)
T cd07869         220 VLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS  287 (303)
T ss_pred             HhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence            00000                000000000000000 0012356889999999999999999999875

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=8.6e-42  Score=312.25  Aligned_cols=270  Identities=25%  Similarity=0.342  Sum_probs=207.5

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-c-HHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-G-HKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~-~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.|++|+||.||+|+++           .+++.||+|+++..... + .---++|+.+|.+++|||||.+-.
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk-----------~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkE  142 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDK-----------KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKE  142 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccC-----------CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEE
Confidence            3456888889999999999999986           66889999999754321 1 123479999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +....+-.  ..|+|||||+ -+|...+... .+++...++.-++.|+++||+|||.+   .|+|||||++|+|++..|.
T Consensus       143 VVvG~~~d--~iy~VMe~~E-hDLksl~d~m-~q~F~~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~  215 (419)
T KOG0663|consen  143 VVVGSNMD--KIYIVMEYVE-HDLKSLMETM-KQPFLPGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGI  215 (419)
T ss_pred             EEeccccc--eeeeeHHHHH-hhHHHHHHhc-cCCCchHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCc
Confidence            88776543  3799999995 4788877765 36888899999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEW  320 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~  320 (453)
                      +||+|||+|+.+...  -...+..+-|.+|.|||.+.+ ..|+.+.|+||+|||+.||+++++.|.+....++.+ ++..
T Consensus       216 lKiaDFGLAR~ygsp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~l  293 (419)
T KOG0663|consen  216 LKIADFGLAREYGSP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKL  293 (419)
T ss_pred             EEecccchhhhhcCC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHH
Confidence            999999999987643  234677889999999999886 569999999999999999999999997765443322 2221


Q ss_pred             -------hhhcccCcccccc-----ccCCcCCCccc-hHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 -------VRPYVSDSKKFHL-----IIDPRLEGNYC-IKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 -------~~~~~~~~~~~~~-----~~~~~~~~~~~-~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             ++|.+..-.....     .....++..+. ...++.-.+|+..+|..||.+|.|+++.++
T Consensus       294 lGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~  360 (419)
T KOG0663|consen  294 LGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK  360 (419)
T ss_pred             hCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence                   1121111110000     00001111111 124577889999999999999999998775

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-43  Score=348.99  Aligned_cols=276  Identities=26%  Similarity=0.481  Sum_probs=226.9

Q ss_pred             cccHHHHHHHhcCC---------CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHH
Q 043568           76 VFSFAELKSATRGF---------SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINE  145 (453)
Q Consensus        76 ~~~~~~~~~~~~~f---------~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E  145 (453)
                      .++|+|...|...|         .+.++||.|-||.||+|+++..+        +....||||.|+... .....+|+.|
T Consensus       609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pg--------kre~~VAIKTLK~GytekqrrdFL~E  680 (996)
T KOG0196|consen  609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPG--------KREITVAIKTLKAGYTEKQRRDFLSE  680 (996)
T ss_pred             CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCC--------CcceeEEEeeeccCccHHHHhhhhhh
Confidence            46777776665554         45679999999999999987432        345689999997653 3445789999


Q ss_pred             HHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 043568          146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQL  225 (453)
Q Consensus       146 ~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  225 (453)
                      +.||.+++||||++|.|+.....+    .+||.|||+||+|+.||+.+.+ .+++.+..-++++||.|+.||-..   ++
T Consensus       681 AsIMGQFdHPNIIrLEGVVTks~P----vMIiTEyMENGsLDsFLR~~DG-qftviQLVgMLrGIAsGMkYLsdm---~Y  752 (996)
T KOG0196|consen  681 ASIMGQFDHPNIIRLEGVVTKSKP----VMIITEYMENGSLDSFLRQNDG-QFTVIQLVGMLRGIASGMKYLSDM---NY  752 (996)
T ss_pred             hhhcccCCCCcEEEEEEEEecCce----eEEEhhhhhCCcHHHHHhhcCC-ceEeehHHHHHHHHHHHhHHHhhc---Cc
Confidence            999999999999999999988776    6899999999999999998864 599999999999999999999998   99


Q ss_pred             EeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccC--cCCCCccccccCCCCCchhHHHHHHHHHHHHh-C
Q 043568          226 IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-G  302 (453)
Q Consensus       226 iH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt--~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g  302 (453)
                      |||||...|||++.+...|++|||+++...+.. ....+...|.  ..|.|||.+...++|.++|||||||++||.|+ |
T Consensus       753 VHRDLAARNILVNsnLvCKVsDFGLSRvledd~-~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyG  831 (996)
T KOG0196|consen  753 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP-EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYG  831 (996)
T ss_pred             hhhhhhhhheeeccceEEEeccccceeecccCC-CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccC
Confidence            999999999999999999999999999765433 2223333333  58999999999999999999999999999887 9


Q ss_pred             CccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          303 RRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      .+||.....   ++++..+.              ...+.+.+.++|..|.+|+..||++|-.+||++.+|+..|.++++.
T Consensus       832 ERPYWdmSN---QdVIkaIe--------------~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  832 ERPYWDMSN---QDVIKAIE--------------QGYRLPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             CCcccccch---HHHHHHHH--------------hccCCCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence            999876533   23332221              1122234567899999999999999999999999999999999986


Q ss_pred             hcc
Q 043568          383 ISS  385 (453)
Q Consensus       383 ~~~  385 (453)
                      ...
T Consensus       895 P~S  897 (996)
T KOG0196|consen  895 PNS  897 (996)
T ss_pred             chh
Confidence            544

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.3e-41  Score=322.40  Aligned_cols=276  Identities=25%  Similarity=0.366  Sum_probs=205.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||.||+|....       .....+..||+|.+........+.|.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   76 (284)
T cd05081           4 RHLKFIQQLGKGNFGSVELCRYDP-------LQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYS   76 (284)
T ss_pred             ccceeeeeccCCCCceEEEEEecC-------CcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEcc
Confidence            578888999999999999998531       1124567899999876655556788999999999999999999998865


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+..  .+++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        77 ~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~  150 (284)
T cd05081          77 AGRR--NLRLVMEYLPYGSLRDYLQKH-RERLDHRKLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIG  150 (284)
T ss_pred             CCCC--ceEEEEEecCCCCHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEEC
Confidence            4322  368999999999999998754 24689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++.......... ......++..|+|||++.+..++.++|||||||++|||++|..++......    .........
T Consensus       151 dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~----~~~~~~~~~  226 (284)
T cd05081         151 DFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE----FMRMMGNDK  226 (284)
T ss_pred             CCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh----hhhhccccc
Confidence            999998754322111 111223345699999999888999999999999999999987765432110    000000000


Q ss_pred             cCc---cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          326 SDS---KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       326 ~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ...   ..+................+..+.+|+.+||..+|++|||+.+|++.|+.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         227 QGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             ccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence            000   000000001111111233467899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=3.8e-41  Score=318.06  Aligned_cols=250  Identities=26%  Similarity=0.417  Sum_probs=197.6

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      .||+|+||.||+|.++..         .++..+|+|++.....  ...+.+.+|+.+++.+.||||+++++++....   
T Consensus         2 ~lg~G~~g~v~~~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~---   69 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMK---------KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAES---   69 (257)
T ss_pred             cCCCcCCcceEEeEEecC---------CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCC---
Confidence            589999999999986422         3467899999864432  23467899999999999999999999885432   


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||.|||++.++.+||+|||++
T Consensus        70 --~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~  142 (257)
T cd05116          70 --WMLVMELAELGPLNKFLQKN--KHVTEKNITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLS  142 (257)
T ss_pred             --cEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccc
Confidence              58999999999999999764  4688999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          252 RQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       252 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      .......... ......++..|+|||.+....++.++|||||||++|||++ |..||......   .+...+..    ..
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~---~~~~~i~~----~~  215 (257)
T cd05116         143 KALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN---EVTQMIES----GE  215 (257)
T ss_pred             cccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHC----CC
Confidence            8654322111 1122234578999999988889999999999999999998 99998754332   22222211    00


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                                ....+...+.++.++|.+||+.||++||++.+|.+.|++.
T Consensus       216 ----------~~~~~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         216 ----------RMECPQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             ----------CCCCCCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence                      0111223567899999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.8e-41  Score=322.09  Aligned_cols=267  Identities=24%  Similarity=0.392  Sum_probs=211.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||.||+|.+....       ......|++|.+.... ......+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~-------~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~   77 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEK-------PGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVC   77 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCC-------CCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            567888999999999999999986311       1235779999886432 23356688999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ......   .+++++|+++++|.+++.....      ..+++..++.++.|++.||.|||+.   +++|+||||+|||++
T Consensus        78 ~~~~~~---~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~  151 (280)
T cd05043          78 IEDGEP---PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVID  151 (280)
T ss_pred             ecCCCC---CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEc
Confidence            765332   6899999999999999875422      4689999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHH
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKL  317 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~  317 (453)
                      +++.+||+|||+++...............++..|+|||++.+..++.++|||||||++||+++ |+.||....+..   +
T Consensus       152 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~  228 (280)
T cd05043         152 EELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE---M  228 (280)
T ss_pred             CCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHH---H
Confidence            999999999999986543322222233456778999999988889999999999999999999 999987543322   2


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ..+...    ....          .....++..+.+++.+||..+|++|||+.++++.|..+...
T Consensus       229 ~~~~~~----~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         229 AAYLKD----GYRL----------AQPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             HHHHHc----CCCC----------CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            222211    0000          01122456799999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.3e-41  Score=338.12  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=196.8

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .|...+.||+|+||+||+|++.           .++..||||++.....   .....+.+|+.+++.++||||+++++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~-----------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~   70 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKV-----------DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSF   70 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEE
Confidence            5888899999999999999976           4567899999975432   2345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    +++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++++|
T Consensus        71 ~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~k  141 (381)
T cd05626          71 QDKDN----LYFVMDYIPGGDMMSLLIRM--EVFPEVLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIK  141 (381)
T ss_pred             ecCCE----EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEE
Confidence            87654    79999999999999998765  4678888889999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCC---------------------------------------------CccccccccCcCCCCccccc
Q 043568          245 LSDFGLARQGPPEGL---------------------------------------------GHVSTSVVGTVGYAAPEYVQ  279 (453)
Q Consensus       245 L~DFGla~~~~~~~~---------------------------------------------~~~~~~~~gt~~y~aPE~~~  279 (453)
                      |+|||+++.......                                             ........||+.|+|||++.
T Consensus       142 L~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  221 (381)
T cd05626         142 LTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLL  221 (381)
T ss_pred             EeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHc
Confidence            999999753210000                                             00012357999999999999


Q ss_pred             cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHH-
Q 043568          280 TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASK-  357 (453)
Q Consensus       280 ~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~-  357 (453)
                      +..++.++|||||||++|||++|..||....+..... +..+..       .        +........+.++.+|+.+ 
T Consensus       222 ~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------~--------~~~~~~~~~s~~~~dli~~l  286 (381)
T cd05626         222 RKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWEN-------T--------LHIPPQVKLSPEAVDLITKL  286 (381)
T ss_pred             CCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHcccc-------c--------cCCCCCCCCCHHHHHHHHHH
Confidence            8889999999999999999999999997654322211 111100       0        0001111235678889988 


Q ss_pred             -hhccCCCCCCCHHHHHH
Q 043568          358 -CLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       358 -cl~~dp~~RPs~~ei~~  374 (453)
                       |+..+|..||++.+++.
T Consensus       287 l~~~~~~~~R~~~~~~l~  304 (381)
T cd05626         287 CCSAEERLGRNGADDIKA  304 (381)
T ss_pred             ccCcccccCCCCHHHHhc
Confidence             44566667999999986

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=2.5e-41  Score=314.48  Aligned_cols=272  Identities=24%  Similarity=0.313  Sum_probs=205.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCc-eeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPN-LVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~n-Iv~l~~~  163 (453)
                      ..|...++||+|+||+||+|+.+           .++..||+|++......  ......+|+.+|+.|+|+| |+.++++
T Consensus        11 ~~~~~~eklGeGtyg~Vykar~~-----------~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv   79 (323)
T KOG0594|consen   11 FDYEKVEKLGEGTYGVVYKARSK-----------RTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDV   79 (323)
T ss_pred             HHHHHHHHhCCCCceEEEEEEEe-----------cCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEee
Confidence            34556668999999999999987           45678999999765432  3345689999999999999 9999999


Q ss_pred             eeeccc--ccceEEEEEEecCCCChHHhhhcCCC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          164 CAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVP--TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       164 ~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +.....  ....+++|+||+ .-+|.+++.....  ..++...+..++.||+.||+|||++   +|+||||||+||||++
T Consensus        80 ~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~  155 (323)
T KOG0594|consen   80 IHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISS  155 (323)
T ss_pred             eeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECC
Confidence            988662  112478999999 7799999987653  3677788899999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-H
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-L  317 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~  317 (453)
                      +|.+||+|||+|+...-.  ....+..++|..|.|||++.+. .|+...||||+|||++||++++..|.+....+... +
T Consensus       156 ~G~lKlaDFGlAra~~ip--~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~I  233 (323)
T KOG0594|consen  156 SGVLKLADFGLARAFSIP--MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRI  233 (323)
T ss_pred             CCcEeeeccchHHHhcCC--cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHH
Confidence            999999999999965422  2335678899999999998876 79999999999999999999999887765433222 2


Q ss_pred             HHhh-------hhcccCccccccccCCcC-CCccch---HHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          318 LEWV-------RPYVSDSKKFHLIIDPRL-EGNYCI---KSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       318 ~~~~-------~~~~~~~~~~~~~~~~~~-~~~~~~---~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .+..       +|...........+.... ......   .......+++.+||+.+|.+|.|+...+..
T Consensus       234 f~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  234 FRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             HHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence            1111       111110011110000000 001111   112478899999999999999999988764

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-41  Score=323.19  Aligned_cols=262  Identities=30%  Similarity=0.484  Sum_probs=206.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+.....      ......||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~------~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~   78 (277)
T cd05032           5 REKITLIRELGQGSFGMVYEGLAKGVVK------GEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVV   78 (277)
T ss_pred             hHHeeEEeEecCCCCceEEEEEEeccCC------CCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEE
Confidence            4578888999999999999999864221      2345789999986443 23345788999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL  236 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NIL  236 (453)
                      .....    .++||||+++|+|.+++.....        ..+++..++.++.|++.||.|||+.   +++|+||||+|||
T Consensus        79 ~~~~~----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nil  151 (277)
T cd05032          79 STGQP----TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCM  151 (277)
T ss_pred             cCCCC----cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEE
Confidence            87654    6999999999999999975432        2478889999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhH
Q 043568          237 LDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQ  315 (453)
Q Consensus       237 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~  315 (453)
                      ++.++.+||+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||.......  
T Consensus       152 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--  229 (277)
T cd05032         152 VAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEE--  229 (277)
T ss_pred             EcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHH--
Confidence            99999999999999976543322222334456789999999988889999999999999999998 888886543322  


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                       +.....    ....          ...+...+..+.+++.+||+.+|++|||+.++++.|+
T Consensus       230 -~~~~~~----~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         230 -VLKFVI----DGGH----------LDLPENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             -HHHHHh----cCCC----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence             222111    0100          0111223678999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-42  Score=337.92  Aligned_cols=253  Identities=25%  Similarity=0.338  Sum_probs=203.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|.+.           .++..||||++....   ......+.+|+.++..++||||++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   69 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDK-----------DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYS   69 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEEC-----------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhh
Confidence            47889999999999999999975           457789999987542   2334678899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    .++||||+++++|.+++...  ..++...+..++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~  140 (350)
T cd05573          70 FQDEEH----LYLVMEYMPGGDLMNLLIRK--DVFPEETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHI  140 (350)
T ss_pred             eecCCe----EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence            877654    79999999999999999876  5788899999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCC---------------------------CCccccccccCcCCCCccccccCCCCCchhHHHHHHHH
Q 043568          244 KLSDFGLARQGPPEG---------------------------LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL  296 (453)
Q Consensus       244 kL~DFGla~~~~~~~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil  296 (453)
                      ||+|||++.......                           .........||+.|+|||++.+..++.++|||||||++
T Consensus       141 kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il  220 (350)
T cd05573         141 KLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVIL  220 (350)
T ss_pred             EeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhh
Confidence            999999998654322                           00122345799999999999999999999999999999


Q ss_pred             HHHHhCCccccCCCChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 043568          297 YELITGRRAVERNLPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-MSEVVD  374 (453)
Q Consensus       297 ~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ei~~  374 (453)
                      |||++|+.||.......... +..|..       .        +........+..+.+|+.+|+. +|.+||+ +.++++
T Consensus       221 ~ell~g~~Pf~~~~~~~~~~~i~~~~~-------~--------~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~  284 (350)
T cd05573         221 YEMLYGFPPFYSDTLQETYNKIINWKE-------S--------LRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKS  284 (350)
T ss_pred             hhhccCCCCCCCCCHHHHHHHHhccCC-------c--------ccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhc
Confidence            99999999997654322111 111100       0        0000111146789999999997 9999999 999986


Q ss_pred             H
Q 043568          375 I  375 (453)
Q Consensus       375 ~  375 (453)
                      .
T Consensus       285 h  285 (350)
T cd05573         285 H  285 (350)
T ss_pred             C
Confidence            3

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.9e-41  Score=334.33  Aligned_cols=255  Identities=24%  Similarity=0.313  Sum_probs=196.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|.+.           .++..||||++....   ......+.+|+.++..++||||++++++
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~   69 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKK-----------DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYS   69 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            47889999999999999999875           456789999986532   2233567889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+...    +++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~v  140 (363)
T cd05628          70 FQDKLN----LYLIMEFLPGGDMMTLLMKK--DTLTEEETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHV  140 (363)
T ss_pred             EecCCe----EEEEEcCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCE
Confidence            887654    79999999999999999765  5788999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCC---------------------------------ccccccccCcCCCCccccccCCCCCchhHH
Q 043568          244 KLSDFGLARQGPPEGLG---------------------------------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVW  290 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~  290 (453)
                      ||+|||+++........                                 .......||+.|+|||++.+..++.++|||
T Consensus       141 kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Dvw  220 (363)
T cd05628         141 KLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWW  220 (363)
T ss_pred             EEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhh
Confidence            99999998754321100                                 001235799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhc--cCCCCCCC
Q 043568          291 SFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLT--KQPKSRPK  368 (453)
Q Consensus       291 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~--~dp~~RPs  368 (453)
                      ||||++|||++|+.||....+......   +...   ....  .+.+      ....+.++.+++.+++.  .++..||+
T Consensus       221 SlGvil~ell~G~~Pf~~~~~~~~~~~---i~~~---~~~~--~~p~------~~~~s~~~~~li~~l~~~~~~r~~r~~  286 (363)
T cd05628         221 SLGVIMYEMLIGYPPFCSETPQETYKK---VMNW---KETL--IFPP------EVPISEKAKDLILRFCCEWEHRIGAPG  286 (363)
T ss_pred             hhHHHHHHHHhCCCCCCCCCHHHHHHH---HHcC---cCcc--cCCC------cCCCCHHHHHHHHHHcCChhhcCCCCC
Confidence            999999999999999976543222111   1100   0000  0000      11234567788877554  23335689


Q ss_pred             HHHHHHH
Q 043568          369 MSEVVDI  375 (453)
Q Consensus       369 ~~ei~~~  375 (453)
                      +.+|++.
T Consensus       287 ~~ei~~h  293 (363)
T cd05628         287 VEEIKTN  293 (363)
T ss_pred             HHHHhCC
Confidence            9998753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.9e-41  Score=319.61  Aligned_cols=263  Identities=27%  Similarity=0.468  Sum_probs=204.3

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |...+.||+|+||.||+|.+...        ......||||.+.....  .....+.+|+..++.++||||+++++++..
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~--------~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   72 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQD--------DGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE   72 (273)
T ss_pred             CccccccCcCCCceEEEEEEecC--------CCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeecc
Confidence            56678999999999999987531        12346799999875432  234678999999999999999999998876


Q ss_pred             ccc--ccceEEEEEEecCCCChHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          167 DDE--RGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       167 ~~~--~~~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ...  .....+++|||+++|+|..++...    ....+++.....++.|++.||.|||+.   +++||||||+||+++++
T Consensus        73 ~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~  149 (273)
T cd05035          73 ASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLRED  149 (273)
T ss_pred             CCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCC
Confidence            543  112368999999999999988543    234688999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  319 (453)
                      +.+||+|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||......   .+.+
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~---~~~~  226 (273)
T cd05035         150 MTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH---EIYD  226 (273)
T ss_pred             CeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH---HHHH
Confidence            9999999999986543322222223345678999999988889999999999999999999 88888643221   2222


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ....    ...          ...+...+..+.+++.+||+.||.+|||+.++++.|.++
T Consensus       227 ~~~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         227 YLRH----GNR----------LKQPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             HHHc----CCC----------CCCCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            2211    000          011223467899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.1e-41  Score=318.23  Aligned_cols=256  Identities=29%  Similarity=0.441  Sum_probs=204.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...++||+|+||.||+|++..            ...||+|.+.... ...+.|.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~------------~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~   71 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNG------------TTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS   71 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecC------------CceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC
Confidence            3568899999999999999998641            2459999987533 34567899999999999999999999875


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ...     .++||||+++|+|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        72 ~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L  143 (262)
T cd05071          72 EEP-----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKV  143 (262)
T ss_pred             CCC-----cEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEe
Confidence            432     58999999999999999876556789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++........ .......++..|+|||+..+..++.++|||||||++|||++ |..||........   ...... 
T Consensus       144 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~---~~~~~~-  218 (262)
T cd05071         144 ADFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV---LDQVER-  218 (262)
T ss_pred             ccCCceeecccccc-ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH---HHHHhc-
Confidence            99999976543221 11223456778999999988899999999999999999999 7778865432221   111100 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                         ..          ........+..+.+|+.+|++.+|.+||++.++++.|+..+
T Consensus       219 ---~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         219 ---GY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             ---CC----------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHhc
Confidence               00          00112345677999999999999999999999999998754

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.7e-41  Score=317.19  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=201.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .+|...+.||+|+||.||+|...             +..||+|.+...  ...+.|.+|+.++++++|+||+++++++..
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~-------------~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR-------------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE   70 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc-------------CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEc
Confidence            46888899999999999999753             467999988543  234678999999999999999999998765


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.   ..++||||+++++|.+++.......+++..++.++.|++.||+|||++   +++||||||+||+++.++.+||+
T Consensus        71 ~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~  144 (256)
T cd05082          71 EKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVS  144 (256)
T ss_pred             CCC---ceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEec
Confidence            443   269999999999999999876556689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++......     .....++..|+|||++.+..++.++|||||||++|||++ |+.||......   .+...+..  
T Consensus       145 dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~---~~~~~~~~--  214 (256)
T cd05082         145 DFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK--  214 (256)
T ss_pred             CCccceecccc-----CCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHhc--
Confidence            99998764321     123345678999999998889999999999999999998 88888654221   12111111  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                        .          ........++..+.+++.+||+.+|++|||+.++++.|+.+
T Consensus       215 --~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~  256 (256)
T cd05082         215 --G----------YKMDAPDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI  256 (256)
T ss_pred             --C----------CCCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence              0          00111223467899999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=4.5e-41  Score=323.09  Aligned_cols=267  Identities=26%  Similarity=0.455  Sum_probs=205.6

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..++|...++||+|+||.||+|.+++..      .......||+|.+..... .....+.+|+.+++.++||||++++++
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   77 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDII------KGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGV   77 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccC------CCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            3578999999999999999999875321      112356799998864432 233468899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      +.....    .++||||+++|+|.+++....        ...+++..+..++.|++.||.|||++   +|+||||||+||
T Consensus        78 ~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~ni  150 (288)
T cd05061          78 VSKGQP----TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNC  150 (288)
T ss_pred             EcCCCC----cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheE
Confidence            877654    699999999999999997532        13456778889999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhh
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNE  314 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~  314 (453)
                      |++.++.++|+|||+++...............++..|+|||.+.++.++.++|||||||++|||++ |..||......  
T Consensus       151 li~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~--  228 (288)
T cd05061         151 MVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE--  228 (288)
T ss_pred             EEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence            999999999999999986443222222223345678999999998899999999999999999999 67787653322  


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                       .+.....    .....          ..+...+..+.+++.+||+.+|++|||+.++++.|.+...
T Consensus       229 -~~~~~~~----~~~~~----------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~  280 (288)
T cd05061         229 -QVLKFVM----DGGYL----------DQPDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLH  280 (288)
T ss_pred             -HHHHHHH----cCCCC----------CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcC
Confidence             1221111    00000          0112335689999999999999999999999998887653

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=5.6e-41  Score=324.97  Aligned_cols=269  Identities=25%  Similarity=0.415  Sum_probs=208.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.....    ........||+|.+.... ......+.+|+.+++.+ +||||++++++
T Consensus        14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~----~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          14 RDKLTLGKPLGEGCFGQVVMAEALGIDK----DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             HHHeeecceeeccCCceEEEEEEeccCC----CCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            4567888999999999999998642110    111334579999986432 23456788999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      +.....    .++||||+++|+|.+++....              ...+++..++.++.||+.||.|||++   +|+|||
T Consensus        90 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~d  162 (304)
T cd05101          90 CTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRD  162 (304)
T ss_pred             EecCCc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHC---Ceeecc
Confidence            887654    689999999999999997642              13578888999999999999999998   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|+|++ |..||..
T Consensus       163 lkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             cccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            999999999999999999999986543322222233446678999999988889999999999999999998 7777754


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ....   .+.....    ....          ...+..++..+.+|+.+||..+|.+|||+.+|++.|..+...
T Consensus       243 ~~~~---~~~~~~~----~~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         243 IPVE---ELFKLLK----EGHR----------MDKPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             CCHH---HHHHHHH----cCCc----------CCCCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            3222   1211111    0100          011223467799999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.6e-41  Score=317.41  Aligned_cols=253  Identities=29%  Similarity=0.445  Sum_probs=201.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||.||+|.+.            .+..+|+|.+..... ....|.+|+.++++++|+||+++++++..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~------------~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~   72 (260)
T cd05070           6 ESLQLIKKLGNGQFGEVWMGTWN------------GNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSE   72 (260)
T ss_pred             HHhhhhheeccccCceEEEEEec------------CCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECC
Confidence            46788889999999999999864            345699999865433 34679999999999999999999998754


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ..     .+++|||+++++|.+++.......+++..+..++.+++.||.|||+.   +|+|+||||+||++++++.++|+
T Consensus        73 ~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~  144 (260)
T cd05070          73 EP-----IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIA  144 (260)
T ss_pred             CC-----cEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeC
Confidence            32     58999999999999999876556789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++........ .......++..|+|||++.+..++.++||||||+++|+|++ |..||.......   ........ 
T Consensus       145 dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~~-  219 (260)
T cd05070         145 DFGLARLIEDNEY-TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNRE---VLEQVERG-  219 (260)
T ss_pred             CceeeeeccCccc-ccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHHcC-
Confidence            9999976543211 11122345678999999988889999999999999999999 888886543221   22211110 


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                                   .....+...+..+.+|+.+||..+|.+|||+.++.+.|+.
T Consensus       220 -------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         220 -------------YRMPCPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             -------------CCCCCCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence                         0011122345679999999999999999999999988864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=1.9e-42  Score=321.58  Aligned_cols=266  Identities=25%  Similarity=0.357  Sum_probs=201.8

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      -.|...+++|.|+||+||+|++.           .++..||||+.-.+.    +.--+|+.+|+.+.|||||+++-++..
T Consensus        24 i~~~~~~liG~GsFg~Vyq~~~~-----------e~~~~vAIKKv~~d~----r~knrEl~im~~l~HpNIV~L~~~f~~   88 (364)
T KOG0658|consen   24 ISYEAVRLIGSGSFGVVYQAKLR-----------ETEEEVAIKKVLQDK----RYKNRELQIMRKLDHPNIVRLLYFFSS   88 (364)
T ss_pred             EEEEeeEEEeecccceEEEEEEc-----------CCCceeEEEEecCCC----CcCcHHHHHHHhcCCcCeeeEEEEEEe
Confidence            34677789999999999999987           447889999874332    122379999999999999999998887


Q ss_pred             cccc-cceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-Cc
Q 043568          167 DDER-GMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YK  242 (453)
Q Consensus       167 ~~~~-~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-~~  242 (453)
                      ..+. .....|||||| ..||.+.++..  ....++...+.-+..||++||.|||+.   +|+||||||+|+|+|.+ |.
T Consensus        89 ~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~  164 (364)
T KOG0658|consen   89 STESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGV  164 (364)
T ss_pred             cCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCe
Confidence            7665 33467899999 55899988742  245677777777889999999999998   99999999999999975 99


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||.|+......   .......|..|.|||.+.+ ..|+.+.||||.|||+.||+-|++-|.+....+....+-.+
T Consensus       165 LKicDFGSAK~L~~~e---pniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~  241 (364)
T KOG0658|consen  165 LKICDFGSAKVLVKGE---PNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKV  241 (364)
T ss_pred             EEeccCCcceeeccCC---CceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHH
Confidence            9999999999865432   2355678899999998876 57999999999999999999999999875544433322211


Q ss_pred             hhcccCc------cccccccCCcCCC-----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDS------KKFHLIIDPRLEG-----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .......      ........+.+..     ......+++..+|+.++|..+|.+|.++.+++.
T Consensus       242 lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~  305 (364)
T KOG0658|consen  242 LGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA  305 (364)
T ss_pred             hCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            1111000      0001111122221     133456788999999999999999999999874

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.1e-40  Score=316.49  Aligned_cols=259  Identities=25%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||+|+..           .++..||||.+.....   .....+.+|+.+++.++||||++++++
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   70 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCL-----------LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDS   70 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEe-----------CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeee
Confidence            57889999999999999999976           4567899998764322   233568899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +...+.    .++|+||+++++|.+++...  ....++...++.++.|++.||.|||+.   +++|+||||+|||++.++
T Consensus        71 ~~~~~~----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~  143 (267)
T cd08228          71 FIEDNE----LNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATG  143 (267)
T ss_pred             EEECCe----EEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCC
Confidence            887653    79999999999999888542  234578889999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .++|+|||++.......  .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....... ..+...+
T Consensus       144 ~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~-~~~~~~~  220 (267)
T cd08228         144 VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-FSLCQKI  220 (267)
T ss_pred             CEEECccccceeccchh--HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccH-HHHHHHH
Confidence            99999999988654321  11234568899999999988889999999999999999999999986543221 1121111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ...          ..+.   ......+..+.+++.+||..+|.+||++.+|++.|+.+
T Consensus       221 ~~~----------~~~~---~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         221 EQC----------DYPP---LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             hcC----------CCCC---CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            100          0000   11223457799999999999999999999999998765

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1.3e-41  Score=332.59  Aligned_cols=242  Identities=26%  Similarity=0.375  Sum_probs=194.7

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      +.||+|+||.||++.+.           .++..||+|.+....   ......+..|+.++..++||||+++++++...+.
T Consensus         1 ~~lG~G~~g~V~~~~~~-----------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~   69 (325)
T cd05594           1 KLLGKGTFGKVILVKEK-----------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDR   69 (325)
T ss_pred             CeeeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCE
Confidence            36999999999999875           456789999987542   2234567889999999999999999998877654


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                          .++||||+++|+|..++...  ..+++..+..++.||+.||.|||+ .   +|+||||||+|||++.++.+||+||
T Consensus        70 ----~~lv~E~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Df  140 (325)
T cd05594          70 ----LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDF  140 (325)
T ss_pred             ----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecC
Confidence                79999999999999988765  468899999999999999999997 6   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..      . 
T Consensus       141 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~------~-  211 (325)
T cd05594         141 GLCKEGIKDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM------E-  211 (325)
T ss_pred             CCCeecCCCC--cccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc------C-
Confidence            9987532211  122345799999999999999999999999999999999999999975433221111100      0 


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                             ..    .++...+.++.+|+.+||+.||++|+     ++.++++
T Consensus       212 -------~~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~  251 (325)
T cd05594         212 -------EI----RFPRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ  251 (325)
T ss_pred             -------CC----CCCCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence                   00    11123456789999999999999996     8888875

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=9.9e-41  Score=321.69  Aligned_cols=275  Identities=26%  Similarity=0.425  Sum_probs=208.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCC-----cCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQ-----TSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~-----~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~  159 (453)
                      .++|...+.||+|+||.||+|.+...+....     .........||+|.+..... ...+.+.+|+.++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~   83 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR   83 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence            4578889999999999999998764321110     11223456799999875432 34567889999999999999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV---------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                      +++++...+.    .+++|||+++++|.+++....         ...+++..++.++.|++.||.|||+.   +|+|+||
T Consensus        84 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dl  156 (296)
T cd05051          84 LLGVCTVDPP----LCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESL---NFVHRDL  156 (296)
T ss_pred             EEEEEecCCC----cEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHc---Ccccccc
Confidence            9999987654    699999999999999997653         12689999999999999999999998   9999999


Q ss_pred             ccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh--CCccccC
Q 043568          231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT--GRRAVER  308 (453)
Q Consensus       231 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt--g~~p~~~  308 (453)
                      ||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|||||||++|||++  +..||..
T Consensus       157 kp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~  236 (296)
T cd05051         157 ATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH  236 (296)
T ss_pred             chhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986543322222334556789999999988889999999999999999998  6667654


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      ...   ................       ......+...+.++.+++.+||+.+|.+|||+.+|++.|.
T Consensus       237 ~~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         237 LTD---QQVIENAGHFFRDDGR-------QIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             cCh---HHHHHHHHhccccccc-------cccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            322   1222222111111100       0001112234578999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=4.9e-41  Score=328.44  Aligned_cols=245  Identities=25%  Similarity=0.405  Sum_probs=192.8

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHh---ccCCCCceeeEee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFL---GVVKHPNLVKLVG  162 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l---~~l~h~nIv~l~~  162 (453)
                      |...+.||+|+||.||+|.+.           .++..||||++....   ....+.+.+|+.++   +.++||||+++++
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~   69 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYK-----------KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFA   69 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceee
Confidence            567789999999999999875           456789999987532   22234566666554   6778999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|..++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        70 ~~~~~~~----~~lv~E~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~  139 (324)
T cd05589          70 CFQTEDH----VCFVMEYAAGGDLMMHIHT---DVFSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGF  139 (324)
T ss_pred             EEEcCCE----EEEEEcCCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCc
Confidence            9877654    7999999999999988764   4689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++.....  ........|++.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+.
T Consensus       140 ~kL~Dfg~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~---~~~~i~  214 (324)
T cd05589         140 VKIADFGLCKEGMGF--GDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE---VFDSIV  214 (324)
T ss_pred             EEeCcccCCccCCCC--CCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            999999998753221  122345679999999999999899999999999999999999999997543221   111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      .   ..        .    .++...+..+.+++.+||..||.+||+     +.++++
T Consensus       215 ~---~~--------~----~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~  256 (324)
T cd05589         215 N---DE--------V----RYPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK  256 (324)
T ss_pred             h---CC--------C----CCCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence            0   00        0    112234677899999999999999994     555543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=8.9e-41  Score=315.75  Aligned_cols=251  Identities=23%  Similarity=0.477  Sum_probs=197.1

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .||+|+||.||+|+++..         ..+..||+|++..... ...+.|.+|+.++++++||||+++++++....    
T Consensus         2 ~ig~G~~g~v~~~~~~~~---------~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~----   68 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMR---------KKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEA----   68 (257)
T ss_pred             ccCCCCcccEEEEEEecC---------CCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCC----
Confidence            389999999999987521         2345699999865432 23466889999999999999999999885432    


Q ss_pred             eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR  252 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~  252 (453)
                       .++||||+++++|.+++... ...+++..+++++.|++.||.|||++   +++||||||+|||++.++.+||+|||++.
T Consensus        69 -~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~  143 (257)
T cd05115          69 -LMLVMEMASGGPLNKFLSGK-KDEITVSNVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSK  143 (257)
T ss_pred             -eEEEEEeCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccc
Confidence             68999999999999998754 35789999999999999999999998   99999999999999999999999999997


Q ss_pred             CCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCccc
Q 043568          253 QGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKK  330 (453)
Q Consensus       253 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ......... ......++..|+|||++....++.++|||||||++|||++ |..||.......   +...+..    .. 
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~----~~-  215 (257)
T cd05115         144 ALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE---VMSFIEQ----GK-  215 (257)
T ss_pred             cccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHHC----CC-
Confidence            543221111 1122234578999999988889999999999999999996 999987653322   1111110    10 


Q ss_pred             cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                               ....+..++.++.+++.+||..+|++||++.+|.+.|+.+
T Consensus       216 ---------~~~~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         216 ---------RLDCPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             ---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence                     0112233467899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=6.6e-41  Score=316.88  Aligned_cols=254  Identities=27%  Similarity=0.439  Sum_probs=204.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...++||+|+||.||+|...            ++..||+|.+.... .....|.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~~~~~ig~G~~g~v~~~~~~------------~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   71 (260)
T cd05067           5 RETLKLVKKLGAGQFGEVWMGYYN------------GHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT   71 (260)
T ss_pred             hHHceeeeeeccCccceEEeeecC------------CCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc
Confidence            356888899999999999999853            35679999986543 34567899999999999999999999874


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ...     .+++|||+.+++|.+++.......+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        72 ~~~-----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l  143 (260)
T cd05067          72 QEP-----IYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKI  143 (260)
T ss_pred             cCC-----cEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEE
Confidence            432     69999999999999999876667889999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........++..|+|||++....++.++||||||+++|||++ |+.||........   ...... 
T Consensus       144 ~dfg~~~~~~~~~-~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~---~~~~~~-  218 (260)
T cd05067         144 ADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEV---IQNLER-  218 (260)
T ss_pred             ccCcceeecCCCC-cccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHH---HHHHHc-
Confidence            9999997654221 111223456778999999988889999999999999999999 9999975432221   111110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                         ..          ....+...+.++.+++.+||+.+|++|||+++++..|+.
T Consensus       219 ---~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         219 ---GY----------RMPRPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             ---CC----------CCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence               00          001112245679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5e-41  Score=328.25  Aligned_cols=245  Identities=27%  Similarity=0.389  Sum_probs=194.6

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHHHHHHHHhccCCCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||.||++.....        ...+..||||++....    ......+.+|+.+|+.++||||+++++++...+
T Consensus         2 ~~lg~G~~g~V~~~~~~~~--------~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~   73 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTG--------ADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGG   73 (323)
T ss_pred             ceeeecCCeEEEEEEEccc--------CCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCC
Confidence            5799999999999986421        2456789999987532    123355778999999999999999999988765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++++|.+++...  ..+.+..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        74 ~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Df  144 (323)
T cd05584          74 K----LYLILEYLSGGELFMHLERE--GIFMEDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDF  144 (323)
T ss_pred             e----EEEEEeCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeC
Confidence            4    79999999999999998765  4677888888999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+.   .  
T Consensus       145 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~---~~~~~~---~--  214 (323)
T cd05584         145 GLCKESIHEG--TVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK---TIDKIL---K--  214 (323)
T ss_pred             cCCeecccCC--CcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH---HHHHHH---c--
Confidence            9987533221  12334579999999999998889999999999999999999999997643221   111111   0  


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                              ..  ...+...+..+.+++.+||+.+|++||     ++.++++
T Consensus       215 --------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~  255 (323)
T cd05584         215 --------GK--LNLPPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS  255 (323)
T ss_pred             --------CC--CCCCCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence                    00  011223456789999999999999999     7777765

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=5.3e-41  Score=327.02  Aligned_cols=241  Identities=25%  Similarity=0.404  Sum_probs=190.5

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||.||+|.+.           .++..||||.+....   ......+..|..++..+ +||||+++++++....
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~   69 (316)
T cd05592           1 KVLGKGSFGKVMLAELK-----------GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKE   69 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence            36999999999999976           446789999987532   22344566677777654 8999999999987655


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|.+++...  ..++...+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~gg~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Df  140 (316)
T cd05592          70 H----LFFVMEYLNGGDLMFHIQSS--GRFDEARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADF  140 (316)
T ss_pred             E----EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccC
Confidence            3    79999999999999988765  4688888999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+..   . 
T Consensus       141 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~---~~~~~i~~---~-  211 (316)
T cd05592         141 GMCKENMNGE--GKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED---ELFDSILN---D-  211 (316)
T ss_pred             cCCeECCCCC--CccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc---C-
Confidence            9997543221  2234567999999999999889999999999999999999999999764322   11111110   0 


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS-EVV  373 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ei~  373 (453)
                                 ...++...+.++.+|+.+||+.+|.+||++. +++
T Consensus       212 -----------~~~~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05592         212 -----------RPHFPRWISKEAKDCLSKLFERDPTKRLGVDGDIR  246 (316)
T ss_pred             -----------CCCCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                       0011223456789999999999999999975 443

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=7e-41  Score=323.28  Aligned_cols=261  Identities=28%  Similarity=0.436  Sum_probs=203.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      ++|...++||+|+||.||+|.+...         .....+++|.+.... ....+.|.+|+.++.++ +||||+++++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~   72 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKD---------GLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGAC   72 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCC---------CCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEE
Confidence            5788899999999999999987532         112357888876432 23346788999999999 799999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                      ...+.    .++||||+++++|.+++....              ...+++..++.++.|++.||+|||+.   +|+||||
T Consensus        73 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dl  145 (297)
T cd05089          73 ENRGY----LYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDL  145 (297)
T ss_pred             ccCCc----ceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcC
Confidence            77654    699999999999999997532              13588899999999999999999998   9999999


Q ss_pred             ccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCC
Q 043568          231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERN  309 (453)
Q Consensus       231 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~  309 (453)
                      ||+|||++.++.+||+|||++......   ........+..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       146 kp~Nill~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         146 AARNVLVGENLASKIADFGLSRGEEVY---VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             CcceEEECCCCeEEECCcCCCccccce---eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            999999999999999999998643211   11112233567999999988889999999999999999998 99998754


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ....   +......    .          .....+...+..+.+|+.+||+.+|.+|||+.+|++.|..+....
T Consensus       223 ~~~~---~~~~~~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         223 TCAE---LYEKLPQ----G----------YRMEKPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CHHH---HHHHHhc----C----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            3322   1111110    0          000111234567999999999999999999999999999888654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=5e-41  Score=341.01  Aligned_cols=267  Identities=23%  Similarity=0.340  Sum_probs=195.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...++||+|+||.||+|++.           ..+..||||++....    ....+|+.+|+.++||||+++++++.
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~-----------~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~  129 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICI-----------DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYY  129 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEEC-----------CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEe
Confidence            568999999999999999999975           446789999885432    23457999999999999999998875


Q ss_pred             ecc----cccceEEEEEEecCCCChHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          166 EDD----ERGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       166 ~~~----~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      ...    .....+++||||++ ++|.+++..  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       130 ~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~  205 (440)
T PTZ00036        130 TECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDP  205 (440)
T ss_pred             ecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcC
Confidence            432    11223678999996 578777653  2345788999999999999999999998   9999999999999986


Q ss_pred             CC-cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-
Q 043568          240 DY-KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-  316 (453)
Q Consensus       240 ~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-  316 (453)
                      ++ .+||+|||+++......   ......||+.|+|||++.+ ..++.++|||||||++|||++|.+||.......... 
T Consensus       206 ~~~~vkL~DFGla~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~  282 (440)
T PTZ00036        206 NTHTLKLCDFGSAKNLLAGQ---RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR  282 (440)
T ss_pred             CCCceeeeccccchhccCCC---CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            64 79999999998654321   2234578999999998865 468999999999999999999999997654332211 


Q ss_pred             HHHhhh-hccc----Cccccccc-----cCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVR-PYVS----DSKKFHLI-----IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~-~~~~----~~~~~~~~-----~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +..... +...    .......+     ....+...++...+.++.+|+.+||..||.+|||+.++++
T Consensus       283 i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~  350 (440)
T PTZ00036        283 IIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA  350 (440)
T ss_pred             HHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence            111100 0000    00000000     0001111122234678999999999999999999999984

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=5.7e-41  Score=343.88  Aligned_cols=271  Identities=23%  Similarity=0.331  Sum_probs=197.3

Q ss_pred             HHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-----
Q 043568           79 FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-----  153 (453)
Q Consensus        79 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----  153 (453)
                      .+++...+++|...++||+|+||+||+|.+.           ..+..||||+++... .....+..|+.+++.++     
T Consensus       121 ~~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~-----------~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~  188 (467)
T PTZ00284        121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDR-----------KRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPA  188 (467)
T ss_pred             CCccccCCCcEEEEEEEEeccCEEEEEEEEc-----------CCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcc
Confidence            4445556789999999999999999999975           456789999986432 22334556776666664     


Q ss_pred             -CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          154 -HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       154 -h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                       |++|+++++++.....   .+++|||++ +++|.+++...  ..+++..+..|+.||+.||.|||++.  +||||||||
T Consensus       189 ~~~~i~~i~~~~~~~~~---~~~iv~~~~-g~~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~yLH~~~--gIiHrDlKP  260 (467)
T PTZ00284        189 DRFPLMKIQRYFQNETG---HMCIVMPKY-GPCLLDWIMKH--GPFSHRHLAQIIFQTGVALDYFHTEL--HLMHTDLKP  260 (467)
T ss_pred             cCcceeeeEEEEEcCCc---eEEEEEecc-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhcC--CeecCCCCH
Confidence             4568999998876443   378999998 88999988765  57889999999999999999999731  999999999


Q ss_pred             ccEEEcCCC----------------cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHH
Q 043568          233 SNILLDEDY----------------KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL  296 (453)
Q Consensus       233 ~NILl~~~~----------------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil  296 (453)
                      +|||++.++                .+||+|||++....     .......||+.|+|||++.+..++.++|||||||++
T Consensus       261 ~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil  335 (467)
T PTZ00284        261 ENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCII  335 (467)
T ss_pred             HHEEEecCCcccccccccccCCCCceEEECCCCccccCc-----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHH
Confidence            999998765                49999999886532     123456899999999999999999999999999999


Q ss_pred             HHHHhCCccccCCCChhhHHHHHhhhhcc-----------------cCccccccccCCc-----C--CCccchHHHHHHH
Q 043568          297 YELITGRRAVERNLPRNEQKLLEWVRPYV-----------------SDSKKFHLIIDPR-----L--EGNYCIKSAQKLA  352 (453)
Q Consensus       297 ~elltg~~p~~~~~~~~~~~~~~~~~~~~-----------------~~~~~~~~~~~~~-----~--~~~~~~~~~~~l~  352 (453)
                      |||++|+.||...........+......+                 .....+....++.     .  ...........+.
T Consensus       336 ~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  415 (467)
T PTZ00284        336 YELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLC  415 (467)
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHH
Confidence            99999999997654433222221111000                 0000000000000     0  0000011235678


Q ss_pred             HHHHHhhccCCCCCCCHHHHHH
Q 043568          353 ALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       353 ~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +||.+||..||++|||+.|+++
T Consensus       416 dli~~mL~~dP~~R~ta~e~L~  437 (467)
T PTZ00284        416 DLIYGLLHYDRQKRLNARQMTT  437 (467)
T ss_pred             HHHHHhCCcChhhCCCHHHHhc
Confidence            9999999999999999999986

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-41  Score=336.94  Aligned_cols=253  Identities=22%  Similarity=0.279  Sum_probs=196.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||++.+.           .++..||||++....   ......+.+|+.+++.++||||++++++
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~   69 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKK-----------DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYS   69 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEEC-----------CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            47888999999999999999875           456789999986432   2234568889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+...    .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~  140 (377)
T cd05629          70 FQDAQY----LYLIMEFLPGGDLMTMLIKY--DTFSEDVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHI  140 (377)
T ss_pred             EEcCCe----eEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCE
Confidence            987654    79999999999999999765  5678888889999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCC---------------------------------------------ccccccccCcCCCCcccc
Q 043568          244 KLSDFGLARQGPPEGLG---------------------------------------------HVSTSVVGTVGYAAPEYV  278 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~---------------------------------------------~~~~~~~gt~~y~aPE~~  278 (453)
                      ||+|||+++........                                             .......||+.|+|||++
T Consensus       141 kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  220 (377)
T cd05629         141 KLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIF  220 (377)
T ss_pred             EEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHH
Confidence            99999999632110000                                             000124699999999999


Q ss_pred             ccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHH
Q 043568          279 QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASK  357 (453)
Q Consensus       279 ~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  357 (453)
                      .+..++.++|||||||++|||++|..||....+..... +..|..       .+        ........+.++.+|+.+
T Consensus       221 ~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~-------~~--------~~p~~~~~s~~~~dli~~  285 (377)
T cd05629         221 LQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRE-------TL--------YFPDDIHLSVEAEDLIRR  285 (377)
T ss_pred             ccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCC-------cc--------CCCCCCCCCHHHHHHHHH
Confidence            98899999999999999999999999997654322111 111100       00        000011235678999999


Q ss_pred             hhccCCCCC---CCHHHHHHH
Q 043568          358 CLTKQPKSR---PKMSEVVDI  375 (453)
Q Consensus       358 cl~~dp~~R---Ps~~ei~~~  375 (453)
                      ||. +|.+|   +++.+++..
T Consensus       286 lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         286 LIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             Hhc-CHhhcCCCCCHHHHhcC
Confidence            997 67665   588888753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=9e-41  Score=317.13  Aligned_cols=255  Identities=24%  Similarity=0.329  Sum_probs=201.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|++.           .++..||+|++..........+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~y~~~~~lg~g~~g~vy~~~~~-----------~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~   76 (267)
T cd06646           8 QHDYELIQRVGSGTYGDVYKARNL-----------HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYL   76 (267)
T ss_pred             hhhcchhheeecCCCeEEEEEEEC-----------CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEE
Confidence            357889999999999999999975           456789999987554445567889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|
T Consensus        77 ~~~~----~~iv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l  147 (267)
T cd06646          77 SREK----LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKL  147 (267)
T ss_pred             eCCE----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEE
Confidence            7653    79999999999999988754  4688999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|||++.......  .......|+..|+|||.+.   ...++.++|||||||++|||++|+.||....+.....  ....
T Consensus       148 ~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~--~~~~  223 (267)
T cd06646         148 ADFGVAAKITATI--AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALF--LMSK  223 (267)
T ss_pred             CcCccceeecccc--cccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhhe--eeec
Confidence            9999998653221  1123456889999999874   3457889999999999999999999986443221100  0000


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                            .   ....+...  .....+..+.+++.+||..+|++|||+++|++.
T Consensus       224 ------~---~~~~~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  265 (267)
T cd06646         224 ------S---NFQPPKLK--DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTH  265 (267)
T ss_pred             ------C---CCCCCCCc--cccccCHHHHHHHHHHhhCChhhCcCHHHHhcC
Confidence                  0   00011111  112345689999999999999999999998864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=9.7e-41  Score=314.90  Aligned_cols=250  Identities=30%  Similarity=0.488  Sum_probs=204.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||.|+||.||+|...             +..||+|.+..... ..+.+.+|+.+++.++|+||+++++++.
T Consensus         5 ~~~~~~~~~ig~g~~g~v~~~~~~-------------~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~   70 (256)
T cd05039           5 SKELKLGATIGKGEFGDVMLGDYR-------------GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVL   70 (256)
T ss_pred             hhhccceeeeecCCCceEEEEEec-------------CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEc
Confidence            357888899999999999999853             56799999875543 4678999999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        71 ~~~~----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l  143 (256)
T cd05039          71 QGNP----LYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKV  143 (256)
T ss_pred             CCCC----eEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEE
Confidence            7443    79999999999999999877555789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++.....     ......+..|+|||++..+.++.++||||||+++|||++ |..||......   .+...... 
T Consensus       144 ~d~g~~~~~~~~-----~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~-  214 (256)
T cd05039         144 SDFGLAKEASQG-----QDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPHVEK-  214 (256)
T ss_pred             cccccccccccc-----cccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHhc-
Confidence            999999875321     112345678999999988889999999999999999997 98888654322   12111111 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                         .          .....+...+..+.+++.+||..+|++|||+.++++.|..
T Consensus       215 ---~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         215 ---G----------YRMEAPEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             ---C----------CCCCCccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhc
Confidence               0          0001122346789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1.4e-40  Score=314.17  Aligned_cols=251  Identities=28%  Similarity=0.445  Sum_probs=199.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||+||+|.+.            ....+|||.+.... .....|.+|+.++++++||||+++++++..
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~------------~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   70 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWR------------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTK   70 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEec------------CCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEcc
Confidence            45777889999999999999764            23469999886433 345679999999999999999999999876


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +++|+||||+|||++.++.+||+
T Consensus        71 ~~~----~~lv~e~~~~~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~  142 (256)
T cd05113          71 QRP----IYIVTEYMSNGCLLNYLREHG-KRFQPSQLLEMCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVS  142 (256)
T ss_pred             CCC----cEEEEEcCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEEC
Confidence            654    699999999999999987643 3689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||+++....... .......++..|+|||.+.+..++.++|||||||++|+|++ |..||.......   .......  
T Consensus       143 d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~---~~~~~~~--  216 (256)
T cd05113         143 DFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE---TVEKVSQ--  216 (256)
T ss_pred             CCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH---HHHHHhc--
Confidence            9999876433211 11122345678999999988889999999999999999998 888886543221   1111110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                        ...          ...+...+..+.+++.+||+.+|.+||++.+|+..|
T Consensus       217 --~~~----------~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~  255 (256)
T cd05113         217 --GLR----------LYRPHLASEKVYAIMYSCWHEKAEERPTFQQLLSSI  255 (256)
T ss_pred             --CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhh
Confidence              000          000112356799999999999999999999998776

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=4.9e-41  Score=327.80  Aligned_cols=237  Identities=27%  Similarity=0.414  Sum_probs=191.1

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||+||+|.++           .++..||||++....   ......+..|..++..+ +||||+++++++...+
T Consensus         1 ~~lg~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~   69 (320)
T cd05590           1 RVLGKGSFGKVMLARLK-----------ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPD   69 (320)
T ss_pred             CeeeeCCCeEEEEEEEc-----------CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCC
Confidence            36999999999999976           456789999987532   23345677899998876 7999999999987765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    +++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~iv~Ey~~~g~L~~~i~~~--~~l~~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~Df  140 (320)
T cd05590          70 R----LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADF  140 (320)
T ss_pred             E----EEEEEcCCCCchHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeC
Confidence            4    79999999999999988765  4688899999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+..   ..
T Consensus       141 G~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~---~~~~~i~~---~~  212 (320)
T cd05590         141 GMCKEGIFNG--KTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED---DLFEAILN---DE  212 (320)
T ss_pred             CCCeecCcCC--CcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH---HHHHHHhc---CC
Confidence            9987532211  1234457999999999999889999999999999999999999999754322   12211110   00


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                                  ...+...+.++.+++.+||+.||.+||++
T Consensus       213 ------------~~~~~~~~~~~~~li~~~L~~dP~~R~~~  241 (320)
T cd05590         213 ------------VVYPTWLSQDAVDILKAFMTKNPTMRLGS  241 (320)
T ss_pred             ------------CCCCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence                        01112245678999999999999999998

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.6e-41  Score=327.08  Aligned_cols=242  Identities=25%  Similarity=0.386  Sum_probs=193.4

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCC-ceeeEeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHP-NLVKLVGY  163 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~-nIv~l~~~  163 (453)
                      +|...+.||+|+||.||+|.+.           .++..||||++....   ......+..|+.++..+.|+ +|++++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~   69 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERK-----------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSC   69 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEE
Confidence            4788899999999999999975           446789999987532   23446688899999999765 58888888


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~  140 (324)
T cd05587          70 FQTMDR----LYFVMEYVNGGDLMYHIQQV--GKFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHI  140 (324)
T ss_pred             EEcCCE----EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCE
Confidence            776553    79999999999999998765  4678899999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .....+..
T Consensus       141 kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~  215 (324)
T cd05587         141 KIADFGMCKENIFGG--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQSIME  215 (324)
T ss_pred             EEeecCcceecCCCC--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHc
Confidence            999999987532111  1233457999999999999999999999999999999999999999754322   12111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                         .            ...++...+..+.+++.+||..||.+||+.
T Consensus       216 ---~------------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~  246 (324)
T cd05587         216 ---H------------NVSYPKSLSKEAVSICKGLLTKHPAKRLGC  246 (324)
T ss_pred             ---C------------CCCCCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence               0            001122345678999999999999999986

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=5.6e-41  Score=329.13  Aligned_cols=254  Identities=27%  Similarity=0.365  Sum_probs=197.6

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      +|...+.||+|+||+||++....        +...+..||+|++.+..    ....+.+..|+.+++.+ +||||+++++
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~--------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVT--------GHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHY   72 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcc--------cCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEE
Confidence            57888999999999999998642        12456789999986432    22345678899999999 5999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++|+|.+++..+  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        73 ~~~~~~~----~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~  143 (332)
T cd05614          73 AFQTEAK----LHLILDYVSGGEMFTHLYQR--DNFSEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGH  143 (332)
T ss_pred             EEecCCE----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCC
Confidence            8876654    79999999999999999765  5688899999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhh-HHHHHh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLEW  320 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~-~~~~~~  320 (453)
                      +||+|||+++....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||........ ..+...
T Consensus       144 ~kl~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~  222 (332)
T cd05614         144 VVLTDFGLSKEFLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRR  222 (332)
T ss_pred             EEEeeCcCCccccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHH
Confidence            99999999986433221 122345799999999998764 478899999999999999999999964322211 111111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      ...           .++    ..+...+..+.+++.+||+.||++||     +++++++
T Consensus       223 ~~~-----------~~~----~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~  266 (332)
T cd05614         223 ILK-----------CDP----PFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE  266 (332)
T ss_pred             Hhc-----------CCC----CCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence            110           011    11223456789999999999999999     6666654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=7.7e-41  Score=325.83  Aligned_cols=241  Identities=25%  Similarity=0.420  Sum_probs=191.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      +.||+|+||+||+|.+.           .++..||||.+....   ......+..|..++..+ +||||+++++++...+
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~   69 (316)
T cd05619           1 KMLGKGSFGKVFLAELK-----------GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKE   69 (316)
T ss_pred             CeeeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCC
Confidence            36999999999999976           446789999987542   23345567788888764 9999999999998766


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Df  140 (316)
T cd05619          70 N----LFFVMEYLNGGDLMFHIQSC--HKFDLPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADF  140 (316)
T ss_pred             E----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccC
Confidence            4    79999999999999998764  4678889999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+..     
T Consensus       141 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~---~~~~~i~~-----  210 (316)
T cd05619         141 GMCKENMLG--DAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE---ELFQSIRM-----  210 (316)
T ss_pred             CcceECCCC--CCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH---HHHHHHHh-----
Confidence            998753221  11234457999999999999889999999999999999999999999754322   22211110     


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS-EVV  373 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ei~  373 (453)
                            ..+.    ++...+.++.+++.+||..||.+||++. ++.
T Consensus       211 ------~~~~----~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  246 (316)
T cd05619         211 ------DNPC----YPRWLTREAKDILVKLFVREPERRLGVKGDIR  246 (316)
T ss_pred             ------CCCC----CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence                  0011    1112356789999999999999999997 554

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=6e-41  Score=319.08  Aligned_cols=258  Identities=28%  Similarity=0.408  Sum_probs=203.9

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      .+++.|...+.||+|+||.||+|.+.           ..+..||+|.+.... .....+.+|+.++.++ +||||+++++
T Consensus         3 ~~~~~y~~~~~lg~g~~g~vy~~~~~-----------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~   70 (272)
T cd06637           3 DPAGIFELVELVGNGTYGQVYKGRHV-----------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYG   70 (272)
T ss_pred             ChhhhhhHHHheeecCCeEEEEEEEc-----------CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEee
Confidence            45778888999999999999999875           456789999986543 3456788999999998 7999999999


Q ss_pred             eeeeccccc--ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDERG--MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++......+  ...++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +|+|+||||+||+++++
T Consensus        71 ~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~  147 (272)
T cd06637          71 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTEN  147 (272)
T ss_pred             EEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCC
Confidence            998654321  2478999999999999999876556789999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      +.++|+|||++.......  .......|+..|+|||++.     ...++.++|||||||++|||++|+.||....+....
T Consensus       148 ~~~~l~Dfg~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~  225 (272)
T cd06637         148 AEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRAL  225 (272)
T ss_pred             CCEEEccCCCceeccccc--ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence            999999999997643221  1234457899999999986     345788999999999999999999999654322111


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...   .   .  ..     .+..   .....+..+.+|+.+||..+|.+|||+.++++
T Consensus       226 ~~~---~---~--~~-----~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  268 (272)
T cd06637         226 FLI---P---R--NP-----APRL---KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK  268 (272)
T ss_pred             HHH---h---c--CC-----CCCC---CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence            110   0   0  00     0000   11124567899999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=9e-41  Score=314.75  Aligned_cols=250  Identities=28%  Similarity=0.397  Sum_probs=203.9

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||+|++.           .++..|++|.+....  ......+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   69 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRK-----------ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFL   69 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEc-----------CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeec
Confidence            4777889999999999999975           456789999986432  234567889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++.......+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        70 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l  142 (256)
T cd08529          70 DKGK----LNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKI  142 (256)
T ss_pred             cCCE----EEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEE
Confidence            7654    79999999999999999876556789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||+++......  .......|++.|+|||++.+..++.++|||||||++++|++|+.||......   ........  
T Consensus       143 ~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~~--  215 (256)
T cd08529         143 GDLGVAKLLSDNT--NFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG---ALILKIIR--  215 (256)
T ss_pred             cccccceeccCcc--chhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc--
Confidence            9999988654321  1223456889999999999989999999999999999999999999754321   11111110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         ..         ........+..+.+++.+||+.+|++||++.++++
T Consensus       216 ---~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  252 (256)
T cd08529         216 ---GV---------FPPVSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLR  252 (256)
T ss_pred             ---CC---------CCCCccccCHHHHHHHHHHccCCcccCcCHHHHhh
Confidence               00         00111134567999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=3e-41  Score=335.69  Aligned_cols=255  Identities=23%  Similarity=0.277  Sum_probs=200.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      ..++|...++||+|+||.||+|.+.           .++..||+|.+....   ......+.+|+.+++.++||||++++
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~  109 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHK-----------SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLH  109 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEE
Confidence            4678999999999999999999976           456789999986432   22334577899999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    .++||||+++|+|.+++...   .++...+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus       110 ~~~~~~~~----~~lv~Ey~~gg~L~~~l~~~---~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~  179 (370)
T cd05596         110 YAFQDDKY----LYMVMEYMPGGDLVNLMSNY---DIPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSG  179 (370)
T ss_pred             EEEecCCE----EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCC
Confidence            98876653    79999999999999988653   577788888999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccC----CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG----RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      .+||+|||++........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........   
T Consensus       180 ~~kL~DfG~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~---  255 (370)
T cd05596         180 HLKLADFGTCMKMDANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT---  255 (370)
T ss_pred             CEEEEeccceeeccCCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH---
Confidence            999999999986543221 122346799999999998653    478999999999999999999999976543211   


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS--RPKMSEVVDI  375 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ei~~~  375 (453)
                      ...+.   ....        .+........+.++.+|+.+||..+|.+  |||+.++++.
T Consensus       256 ~~~i~---~~~~--------~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         256 YSKIM---DHKN--------SLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHH---cCCC--------cCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            11110   0000        0011111234678999999999999988  9999998753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.6e-40  Score=317.48  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=194.7

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ||+|+||.||++...           .++..||+|.+.....   .....+..|++++++++||||+++++++.....  
T Consensus         1 lg~G~~g~Vy~~~~~-----------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~--   67 (277)
T cd05607           1 LGKGGFGEVCAVQVK-----------NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTH--   67 (277)
T ss_pred             CCCCCceEEEEEEEc-----------cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCe--
Confidence            799999999999876           4577899999864322   123455679999999999999999998876553  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.++|+|||++
T Consensus        68 --~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~  142 (277)
T cd05607          68 --LCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLA  142 (277)
T ss_pred             --EEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceee
Confidence              79999999999999988776666789999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh-HHHHHhhhhcccCccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLEWVRPYVSDSKK  330 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  330 (453)
                      ......   .......|+..|+|||++.+..++.++|||||||++|||++|+.||........ ..+..   .....   
T Consensus       143 ~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~~---  213 (277)
T cd05607         143 VELKDG---KTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKR---RTLED---  213 (277)
T ss_pred             eecCCC---ceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHH---Hhhcc---
Confidence            765422   122345789999999999988899999999999999999999999865432111 11111   11100   


Q ss_pred             cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                             .... .....+.++.+|+.+||+.||++||++.++++.
T Consensus       214 -------~~~~-~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~  250 (277)
T cd05607         214 -------EVKF-EHQNFTEESKDICRLFLAKKPEDRLGSREKNDD  250 (277)
T ss_pred             -------cccc-ccccCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence                   0000 011245678999999999999999999877643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-41  Score=328.89  Aligned_cols=264  Identities=27%  Similarity=0.443  Sum_probs=218.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-HHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ......++||+|.||.|.++...            .+..||||.++...... ..+|.+|+++|.+|+||||++++|+|.
T Consensus       538 s~L~~~ekiGeGqFGEVhLCeve------------g~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~  605 (807)
T KOG1094|consen  538 SRLRFKEKIGEGQFGEVHLCEVE------------GPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCV  605 (807)
T ss_pred             hheehhhhhcCcccceeEEEEec------------CceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeee
Confidence            44566779999999999999863            36889999998765444 488999999999999999999999999


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      .++.    +++|+|||++|+|.++|.++....+....-.+|+.|||.|++||.+-   ++|||||.+.|||++.++++||
T Consensus       606 ~DeP----icmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKi  678 (807)
T KOG1094|consen  606 QDDP----LCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKI  678 (807)
T ss_pred             cCCc----hHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEe
Confidence            9887    69999999999999999988655555566788999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh--CCccccCCCChhhHHHHHhhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT--GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt--g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|||+++........+.....+-...|||||.+.-++++.++|||+||+.+||+++  ...||....   ..++++....
T Consensus       679 adfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt---~e~vven~~~  755 (807)
T KOG1094|consen  679 ADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLT---DEQVVENAGE  755 (807)
T ss_pred             cCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhh---HHHHHHhhhh
Confidence            99999997666655666666677889999999999999999999999999999876  567876542   2234444444


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .+........+.       .+.-++..+.+|+.+||..+.++||+++++...|.+.
T Consensus       756 ~~~~~~~~~~l~-------~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  756 FFRDQGRQVVLS-------RPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             hcCCCCcceecc-------CCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            343333222222       2345678899999999999999999999999888664

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=321.23  Aligned_cols=274  Identities=23%  Similarity=0.383  Sum_probs=202.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCC---CCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDD---HQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~---~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ++|...+.||+|+||.||++.+...+..   ...........||+|.+..... .....|.+|++++++++||||+++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~   84 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG   84 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence            5788899999999999999986532110   0001112234699999865422 23456889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCC----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRV----------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      ++.....    .++||||+++++|.+++....          ...+++..++.++.|++.||.|||+.   +++|+||||
T Consensus        85 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp  157 (295)
T cd05097          85 VCVSDDP----LCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASL---NFVHRDLAT  157 (295)
T ss_pred             EEcCCCc----cEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhc---CeeccccCh
Confidence            9977654    699999999999999986532          12468889999999999999999998   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh--CCccccCCC
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT--GRRAVERNL  310 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt--g~~p~~~~~  310 (453)
                      +|||++.++.+||+|||++................++..|+|||++.++.++.++|||||||++|+|++  +..||....
T Consensus       158 ~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~  237 (295)
T cd05097         158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLS  237 (295)
T ss_pred             hhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccC
Confidence            999999999999999999976543222222233455778999999988899999999999999999998  556665432


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      ..   ................       .....+...+..+.+|+.+||+.+|++|||+.+|++.|.
T Consensus       238 ~~---~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         238 DE---QVIENTGEFFRNQGRQ-------IYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             hH---HHHHHHHHhhhhcccc-------ccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            21   1111111111100000       000011123568999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=1.8e-41  Score=332.33  Aligned_cols=253  Identities=23%  Similarity=0.271  Sum_probs=200.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||++.+.           .++..||+|++.....   .....+.+|+.+++.++||||++++++
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~   69 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREK-----------ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYA   69 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeE
Confidence            47889999999999999999876           4567899999875422   234568889999999999999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~  141 (330)
T cd05601          70 FQDKDN----LYLVMEYQPGGDLLSLLNRY-EDQFDEDMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHI  141 (330)
T ss_pred             EecCCe----EEEEECCCCCCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCE
Confidence            877553    79999999999999998765 34788999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccc------cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      ||+|||++........ .......||+.|+|||++.      ...++.++|||||||++|||++|+.||.......... 
T Consensus       142 kL~Dfg~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~-  219 (330)
T cd05601         142 KLADFGSAARLTANKM-VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYN-  219 (330)
T ss_pred             EeccCCCCeECCCCCc-eeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHH-
Confidence            9999999986543221 1233457899999999986      4567899999999999999999999997643322111 


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        .+...    ..       .+........+..+.+|+..||. +|.+|||+.+++.
T Consensus       220 --~i~~~----~~-------~~~~~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~  262 (330)
T cd05601         220 --NIMNF----QR-------FLKFPEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC  262 (330)
T ss_pred             --HHHcC----CC-------ccCCCCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence              11100    00       00001112346778999999998 9999999999874

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.5e-40  Score=315.40  Aligned_cols=260  Identities=25%  Similarity=0.375  Sum_probs=206.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||+|...           .++..+|||.+.....   .....+.+|+.+++.++||||++++++
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~-----------~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~   70 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCL-----------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS   70 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeec-----------CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhhe
Confidence            46788889999999999999975           4567899998764322   234578899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +...+.    .+++|||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+||||+||+++.++
T Consensus        71 ~~~~~~----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~  143 (267)
T cd08229          71 FIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATG  143 (267)
T ss_pred             eEeCCe----EEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCC
Confidence            987654    79999999999999988642  235689999999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .++|+|||++.......  .......|+..|+|||++.+..++.++||||||+++|+|++|..||....... .......
T Consensus       144 ~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~  220 (267)
T cd08229         144 VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKKI  220 (267)
T ss_pred             CEEECcchhhhccccCC--cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchH-HHHhhhh
Confidence            99999999987654321  11234568899999999988889999999999999999999999986532211 1111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      .          ....+..   .....+..+.+++.+||..+|.+|||+.+|++.+.++.
T Consensus       221 ~----------~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~  266 (267)
T cd08229         221 E----------QCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH  266 (267)
T ss_pred             h----------cCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence            0          0000111   11234678999999999999999999999999988753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.7e-40  Score=323.25  Aligned_cols=269  Identities=26%  Similarity=0.447  Sum_probs=207.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||.||+|.+.....    ........+|+|.+..... .....+.+|+.+++.+ +||||+++++++
T Consensus        12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~----~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (314)
T cd05099          12 DRLVLGKPLGEGCFGQVVRAEAYGIDK----SRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVC   87 (314)
T ss_pred             HHeeeeeeecCCCcccEEEeeecccCC----ccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence            568888999999999999998642110    0113356799999875432 3345688999999999 699999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                      .....    .++||||+++|+|.+++....              ...+++..+..++.|++.||.|||++   +|+||||
T Consensus        88 ~~~~~----~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dl  160 (314)
T cd05099          88 TQEGP----LYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDL  160 (314)
T ss_pred             ccCCc----eEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHC---Ceeeccc
Confidence            76553    699999999999999997642              23588899999999999999999998   9999999


Q ss_pred             ccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCC
Q 043568          231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERN  309 (453)
Q Consensus       231 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~  309 (453)
                      ||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         161 AARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             cceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            99999999999999999999986543221111222234567999999988889999999999999999999 88888654


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ....   +......    ...          ...+..++.++.+++.+||..+|++|||+.++++.|..+....
T Consensus       241 ~~~~---~~~~~~~----~~~----------~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~  297 (314)
T cd05099         241 PVEE---LFKLLRE----GHR----------MDKPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAV  297 (314)
T ss_pred             CHHH---HHHHHHc----CCC----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHh
Confidence            3221   2211110    000          0112234567899999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=1.6e-40  Score=315.66  Aligned_cols=261  Identities=24%  Similarity=0.463  Sum_probs=204.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|++...+        .....+|+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~--------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   75 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPG--------RKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVV   75 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCC--------CCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEE
Confidence            457888899999999999999975321        223579999986542 23346788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||+++++|.+++.... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+|
T Consensus        76 ~~~~~----~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~k  147 (268)
T cd05063          76 TKFKP----AMIITEYMENGALDKYLRDHD-GEFSSYQLVGMLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECK  147 (268)
T ss_pred             ccCCC----cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEE
Confidence            87654    699999999999999987642 5689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCcc-ccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHV-STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||++........... ......+..|+|||++.+..++.++|||||||++|||++ |..||.......   +...+.
T Consensus       148 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~---~~~~i~  224 (268)
T cd05063         148 VSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE---VMKAIN  224 (268)
T ss_pred             ECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH---HHHHHh
Confidence            999999976543211111 111223457999999988889999999999999999998 999986543221   211111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .    ..          ........+..+.+++.+||..+|.+||++.+|++.|.++
T Consensus       225 ~----~~----------~~~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         225 D----GF----------RLPAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             c----CC----------CCCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            0    00          0011223457799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=4.1e-41  Score=336.46  Aligned_cols=251  Identities=25%  Similarity=0.314  Sum_probs=195.0

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +|...++||+|+||+||+|++.           .++..||+|++.....   .....+.+|+.+++.++||||+++++++
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~-----------~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~   70 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKV-----------DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSF   70 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEEC-----------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEE
Confidence            5888999999999999999975           4567899999875422   2345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    .++|||||++|+|.+++...  ..++...+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        71 ~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~k  141 (382)
T cd05625          71 QDKDN----LYFVMDYIPGGDMMSLLIRM--GIFPEDLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIK  141 (382)
T ss_pred             EeCCE----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEE
Confidence            87654    79999999999999998765  4678888889999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCC---------------------------------------------CCccccccccCcCCCCccccc
Q 043568          245 LSDFGLARQGPPEG---------------------------------------------LGHVSTSVVGTVGYAAPEYVQ  279 (453)
Q Consensus       245 L~DFGla~~~~~~~---------------------------------------------~~~~~~~~~gt~~y~aPE~~~  279 (453)
                      |+|||++.......                                             .........||+.|+|||++.
T Consensus       142 L~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~  221 (382)
T cd05625         142 LTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLL  221 (382)
T ss_pred             EeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhc
Confidence            99999975321000                                             000012346999999999999


Q ss_pred             cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHh
Q 043568          280 TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKC  358 (453)
Q Consensus       280 ~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c  358 (453)
                      +..++.++|||||||++|||++|+.||....+..... +..+..               .+........+.++.+++.+|
T Consensus       222 ~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~---------------~~~~p~~~~~s~~~~~li~~l  286 (382)
T cd05625         222 RTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQT---------------SLHIPPQAKLSPEASDLIIKL  286 (382)
T ss_pred             CCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCC---------------CcCCCCcccCCHHHHHHHHHH
Confidence            9899999999999999999999999997654332211 111100               000011122356678888887


Q ss_pred             hccCCCCCCC---HHHHHH
Q 043568          359 LTKQPKSRPK---MSEVVD  374 (453)
Q Consensus       359 l~~dp~~RPs---~~ei~~  374 (453)
                      + .+|.+|++   +.+++.
T Consensus       287 ~-~~p~~R~~~~~~~ei~~  304 (382)
T cd05625         287 C-RGPEDRLGKNGADEIKA  304 (382)
T ss_pred             c-cCHhHcCCCCCHHHHhc
Confidence            5 59999997   777654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.5e-41  Score=327.14  Aligned_cols=242  Identities=26%  Similarity=0.407  Sum_probs=193.6

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||.||+|++.           .++..||||++....   ......+..|..++..+ +||||+++++++....
T Consensus         1 ~~lG~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~   69 (321)
T cd05591           1 KVLGKGSFGKVMLAELK-----------GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKD   69 (321)
T ss_pred             CccccCCCeEEEEEEEC-----------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence            36999999999999975           446789999987542   23345677899998866 8999999999998765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~E~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Df  140 (321)
T cd05591          70 R----LFFVMEYVNGGDLMFQIQRS--RKFDEPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADF  140 (321)
T ss_pred             e----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeec
Confidence            4    79999999999999988765  4688889999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |++.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .....+..   ..
T Consensus       141 g~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~---~~~~~i~~---~~  212 (321)
T cd05591         141 GMCKEGILNG--VTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED---DLFESILH---DD  212 (321)
T ss_pred             ccceecccCC--ccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH---HHHHHHHc---CC
Confidence            9987533221  1234457999999999999889999999999999999999999999764322   22221110   00


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-------CHHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-------KMSEVVD  374 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-------s~~ei~~  374 (453)
                              .    ..+...+.++.+++.+||..||++||       ++.++++
T Consensus       213 --------~----~~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~  253 (321)
T cd05591         213 --------V----LYPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ  253 (321)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence                    0    01112356789999999999999999       6777764

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=8.6e-41  Score=323.64  Aligned_cols=262  Identities=28%  Similarity=0.457  Sum_probs=203.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.++..         .....+|+|.+.... ......+.+|+.++.++ +||||++++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~a~~~~~---------~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~   76 (303)
T cd05088           6 WNDIKFQDVIGEGNFGQVLKARIKKD---------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGA   76 (303)
T ss_pred             hhhceeeeeecCCCCceEEEEEEccC---------CceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEE
Confidence            46788889999999999999997521         122457888775432 23346788999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      +...+.    .++||||+++++|.+++....              ...+++..++.++.|++.||+|||+.   +|+|||
T Consensus        77 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~d  149 (303)
T cd05088          77 CEHRGY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRD  149 (303)
T ss_pred             ECCCCC----ceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhC---Cccccc
Confidence            877654    699999999999999997542              23578899999999999999999998   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||++......   .......++..|+|||++.+..++.++|||||||++|||+| |..||..
T Consensus       150 lkp~Nili~~~~~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  226 (303)
T cd05088         150 LAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG  226 (303)
T ss_pred             cchheEEecCCCcEEeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCccc
Confidence            9999999999999999999998642211   11122234678999999988889999999999999999998 9999865


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .....   .......    .          .....+...+..+.+|+.+||+.+|++||++.++++.|..++...
T Consensus       227 ~~~~~---~~~~~~~----~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         227 MTCAE---LYEKLPQ----G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             CChHH---HHHHHhc----C----------CcCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            43221   1111110    0          000111223567899999999999999999999999998877653

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-40  Score=314.07  Aligned_cols=251  Identities=30%  Similarity=0.464  Sum_probs=198.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .+|...+.||+|+||.||+|.+.            ....+|+|.+.... .....|.+|+.+++.++||||+++++++..
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~------------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR------------GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK   70 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec------------CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcC
Confidence            34777889999999999999864            24569999986433 334578899999999999999999999876


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    .++||||+++++|.+++.... ..+++..++.++.|++.||+|||+.   +++||||||+||+++.++.+||+
T Consensus        71 ~~~----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~  142 (256)
T cd05059          71 QRP----IFIVTEYMANGCLLNYLRERK-GKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVS  142 (256)
T ss_pred             CCc----eEEEEecCCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEEC
Confidence            654    699999999999999997653 3689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||+++...... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||....+..   .......  
T Consensus       143 dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~~~~--  216 (256)
T cd05059         143 DFGLARYVLDDQ-YTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSE---VVESVSA--  216 (256)
T ss_pred             Ccccceeccccc-ccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHH---HHHHHHc--
Confidence            999987643221 111122234467999999998899999999999999999999 788886543221   1111110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                        ..          ....+...+..+.+++.+||..+|++|||+.++++.|
T Consensus       217 --~~----------~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         217 --GY----------RLYRPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             --CC----------cCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence              00          0011123467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.8e-41  Score=326.17  Aligned_cols=242  Identities=25%  Similarity=0.383  Sum_probs=194.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      +|...+.||+|+||.||+|.+.           .++..||||.+....   ......+..|..++..+ +|++|++++++
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~   69 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERK-----------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSC   69 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEE
Confidence            5788899999999999999976           456789999987542   22334567788888877 68999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~E~~~~g~L~~~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~  140 (323)
T cd05616          70 FQTMDR----LYFVMEYVNGGDLMYQIQQV--GRFKEPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHI  140 (323)
T ss_pred             EecCCE----EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcE
Confidence            877654    79999999999999988765  4688899999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+..
T Consensus       141 kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~---~~~~~i~~  215 (323)
T cd05616         141 KIADFGMCKENMWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSIME  215 (323)
T ss_pred             EEccCCCceecCCCC--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence            999999997533211  1234567999999999999999999999999999999999999999764322   12111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                         .          .  ..++...+.++.+|+.+||+.+|.+|++.
T Consensus       216 ---~----------~--~~~p~~~s~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05616         216 ---H----------N--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  246 (323)
T ss_pred             ---C----------C--CCCCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence               0          0  01122346778999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=1.6e-40  Score=318.14  Aligned_cols=245  Identities=26%  Similarity=0.364  Sum_probs=193.5

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ||+|+||+||++.+.           .++..||+|.+.....   ...+.+..|+.+++.++||||+++.+++.....  
T Consensus         1 lg~G~~g~Vy~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~--   67 (280)
T cd05608           1 LGKGGFGEVSACQMR-----------ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTD--   67 (280)
T ss_pred             CCCCCceeEEEEEEc-----------cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCe--
Confidence            799999999999876           4567899999865432   233567889999999999999999998876654  


Q ss_pred             ceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                        .++||||+++|+|.+++...  ....+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|+|||
T Consensus        68 --~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg  142 (280)
T cd05608          68 --LCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLG  142 (280)
T ss_pred             --EEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCc
Confidence              79999999999999887542  235689999999999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh-HHHHHhhhhcccCc
Q 043568          250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLEWVRPYVSDS  328 (453)
Q Consensus       250 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~  328 (453)
                      ++.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .......   .   
T Consensus       143 ~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~---~---  214 (280)
T cd05608         143 LAVELKDGQ--SKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRI---L---  214 (280)
T ss_pred             cceecCCCC--ccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhh---c---
Confidence            997643321  122345789999999999999999999999999999999999999975432111 1111110   0   


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                             ...  ...+...+..+.+++.+||+.||++||     +++++++
T Consensus       215 -------~~~--~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~  256 (280)
T cd05608         215 -------NDS--VTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT  256 (280)
T ss_pred             -------ccC--CCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence                   000  012234567899999999999999999     5566664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=3.1e-41  Score=336.61  Aligned_cols=253  Identities=24%  Similarity=0.255  Sum_probs=197.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .+|...+.||+|+||.||+|.+.           .++..||||++....   ......+.+|+.+|+.++||||+++++.
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~   69 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKV-----------DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYS   69 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-----------CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEE
Confidence            36889999999999999999975           456789999986432   1234567899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    +++||||+++|+|.+++...  ..++...+..++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~i  140 (376)
T cd05598          70 FQDKDN----LYFVMDYIPGGDMMSLLIRL--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHI  140 (376)
T ss_pred             EEcCCE----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCE
Confidence            887654    79999999999999999765  4678888888999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCC-----------------------------------------CCccccccccCcCCCCccccccCC
Q 043568          244 KLSDFGLARQGPPEG-----------------------------------------LGHVSTSVVGTVGYAAPEYVQTGR  282 (453)
Q Consensus       244 kL~DFGla~~~~~~~-----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~  282 (453)
                      ||+|||++.......                                         .........||+.|+|||++.+..
T Consensus       141 kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  220 (376)
T cd05598         141 KLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG  220 (376)
T ss_pred             EEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCC
Confidence            999999975321000                                         000012347999999999999999


Q ss_pred             CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccC
Q 043568          283 LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQ  362 (453)
Q Consensus       283 ~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~d  362 (453)
                      ++.++|||||||++|||++|+.||....+......+....      .        ..........+..+.+++.+|+ .+
T Consensus       221 ~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~------~--------~~~~~~~~~~s~~~~~li~~l~-~~  285 (376)
T cd05598         221 YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWE------T--------TLHIPSQAKLSREASDLILRLC-CG  285 (376)
T ss_pred             CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccC------c--------cccCCCCCCCCHHHHHHHHHHh-cC
Confidence            9999999999999999999999997654432221111000      0        0000111234567888888876 59


Q ss_pred             CCCCC---CHHHHHH
Q 043568          363 PKSRP---KMSEVVD  374 (453)
Q Consensus       363 p~~RP---s~~ei~~  374 (453)
                      |.+|+   ++.++++
T Consensus       286 p~~R~~~~t~~ell~  300 (376)
T cd05598         286 AEDRLGKNGADEIKA  300 (376)
T ss_pred             HhhcCCCCCHHHHhC
Confidence            99999   8888875

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-40  Score=313.55  Aligned_cols=252  Identities=23%  Similarity=0.346  Sum_probs=201.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-----ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-----QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      ++|...+.||+|+||.||+|.+.           .++..||+|.+.....     .....+.+|+.++++++||||++++
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~-----------~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   70 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDV-----------DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYY   70 (263)
T ss_pred             CcccccceecCCCceEEEEEEEc-----------CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeE
Confidence            57899999999999999999865           4467899999864321     1235688899999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    .++|+||+++++|.+++...  ..++...+..++.|++.||.|||+.   +|+|+||+|+||+++.++
T Consensus        71 ~~~~~~~~----~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~  141 (263)
T cd06625          71 GCLRDDET----LSIFMEYMPGGSVKDQLKAY--GALTETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAG  141 (263)
T ss_pred             EEEccCCe----EEEEEEECCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            99987663    79999999999999998765  4678888899999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .++|+|||+++......... ......++..|+|||++.+..++.++||||||+++|||++|+.||........  ....
T Consensus       142 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~  219 (263)
T cd06625         142 NVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAA--IFKI  219 (263)
T ss_pred             CEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHH--HHHH
Confidence            99999999987643221111 11335678899999999998899999999999999999999999865422211  1110


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..              .......+...+..+.+++.+||..+|.+|||+.++++
T Consensus       220 ~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  259 (263)
T cd06625         220 AT--------------QPTNPQLPSHVSPDARNFLRRTFVENAKKRPSAEELLR  259 (263)
T ss_pred             hc--------------cCCCCCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhh
Confidence            00              00011122334667899999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=2.4e-40  Score=313.15  Aligned_cols=253  Identities=30%  Similarity=0.436  Sum_probs=201.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|.....||+|+||.||+|.+.            ....+|+|.+.... .....+.+|+.+++.++||||+++++++..
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~------------~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   72 (260)
T cd05069           6 ESLRLDVKLGQGCFGEVWMGTWN------------GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSE   72 (260)
T ss_pred             HHeeeeeeecCcCCCeEEEEEEc------------CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcC
Confidence            46888889999999999999864            22469999876433 344678899999999999999999998754


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ..     .++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||++++++.++|+
T Consensus        73 ~~-----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~  144 (260)
T cd05069          73 EP-----IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIA  144 (260)
T ss_pred             CC-----cEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEEC
Confidence            32     58999999999999999876556789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++....... ........++..|+|||...+..++.++||||||+++|||++ |..||....+..   .........
T Consensus       145 dfg~~~~~~~~~-~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~~~  220 (260)
T cd05069         145 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE---VLEQVERGY  220 (260)
T ss_pred             CCccceEccCCc-ccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHcCC
Confidence            999997643221 111223346778999999988889999999999999999999 888886543222   111111100


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                                    ....+...+..+.+++.+||..+|.+||++.+|++.|++
T Consensus       221 --------------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         221 --------------RMPCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             --------------CCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence                          001122346779999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.1e-40  Score=319.86  Aligned_cols=251  Identities=29%  Similarity=0.397  Sum_probs=204.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...+.||+|+||.||+|++.           ..+..||+|.+..........+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~   87 (296)
T cd06654          19 KKKYTRFEKIGQGASGTVYTAMDV-----------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL   87 (296)
T ss_pred             ccceeeEEEecCCCCeEEEEEEEC-----------CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            357888999999999999999865           446789999987666566677899999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++..   ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++|
T Consensus        88 ~~~~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl  157 (296)
T cd06654          88 VGDE----LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL  157 (296)
T ss_pred             eCCE----EEEeecccCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEE
Confidence            7553    7999999999999998865   3578889999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++.......  .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||....+...  .......  
T Consensus       158 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~--~~~~~~~--  231 (296)
T cd06654         158 TDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATN--  231 (296)
T ss_pred             Cccccchhccccc--cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh--HHHHhcC--
Confidence            9999987643321  112345788999999999888899999999999999999999999975543211  1111100  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                 .......+...+..+.+++.+||..+|++|||+.+|++
T Consensus       232 -----------~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~  269 (296)
T cd06654         232 -----------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (296)
T ss_pred             -----------CCCCCCCccccCHHHHHHHHHHCcCCcccCcCHHHHhh
Confidence                       00000112234567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.9e-40  Score=317.20  Aligned_cols=269  Identities=27%  Similarity=0.364  Sum_probs=199.0

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccC---CCCceeeEee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVV---KHPNLVKLVG  162 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~  162 (453)
                      +|...+.||+|+||+||+|.+.           .++..||+|.+......  ....+.+|+.+++.+   +||||+++++
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~   69 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDP-----------HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMD   69 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEEC-----------CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeee
Confidence            4788899999999999999976           45778999998754222  224556777777665   7999999999


Q ss_pred             eeeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          163 YCAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       163 ~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      ++..... .....++||||+. ++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus        70 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~  145 (288)
T cd07863          70 VCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGG  145 (288)
T ss_pred             eeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCC
Confidence            8875432 2234789999996 5899988776556689999999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~~  320 (453)
                      .+||+|||++......   .......||..|+|||++.+..++.++|||||||++|+|++|++||......... .+...
T Consensus       146 ~~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~  222 (288)
T cd07863         146 QVKLADFGLARIYSCQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDL  222 (288)
T ss_pred             CEEECccCccccccCc---ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHH
Confidence            9999999999865422   1223457899999999999889999999999999999999999998654332211 11111


Q ss_pred             hhhcccCc--ccc---ccccCCcCC---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDS--KKF---HLIIDPRLE---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~--~~~---~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ........  ...   .....+...   .......+..+.+|+.+||+.||++|||+.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~  284 (288)
T cd07863         223 IGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ  284 (288)
T ss_pred             hCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            10000000  000   000000000   0111234567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.4e-41  Score=327.86  Aligned_cols=248  Identities=22%  Similarity=0.379  Sum_probs=193.1

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||.||+|.+.           .++..||||++....   ......+..|..++..+ +||||+++++++....
T Consensus         1 ~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~   69 (329)
T cd05588           1 RVIGRGSYAKVLLVELK-----------KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTES   69 (329)
T ss_pred             CeEeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCC
Confidence            36999999999999976           456789999997542   22345678899999988 7999999999987765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    +++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~g~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Df  140 (329)
T cd05588          70 R----LFFVIEFVSGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDY  140 (329)
T ss_pred             E----EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcC
Confidence            4    79999999999999988765  5789999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh--hHHHHHhhhhccc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN--EQKLLEWVRPYVS  326 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~  326 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......  .....++..... 
T Consensus       141 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~-  217 (329)
T cd05588         141 GMCKEGIRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVI-  217 (329)
T ss_pred             ccccccccC--CCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHH-
Confidence            998753211  122345679999999999999999999999999999999999999996322111  000001110000 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC------HHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK------MSEVV  373 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs------~~ei~  373 (453)
                              .....  ..+...+..+.+++.+||+.||.+||+      +.+++
T Consensus       218 --------~~~~~--~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~  260 (329)
T cd05588         218 --------LEKQI--RIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIK  260 (329)
T ss_pred             --------HcCCC--CCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHh
Confidence                    00000  112234567899999999999999998      55665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=1.4e-40  Score=316.28  Aligned_cols=260  Identities=26%  Similarity=0.461  Sum_probs=203.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+|...+.||+|+||.||+|.+...+        .....||||.+.... ......|..|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~--------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~   75 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPG--------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT   75 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCC--------CCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEEC
Confidence            34778889999999999999976321        224579999986542 233567999999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+||
T Consensus        76 ~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl  147 (269)
T cd05065          76 KSRP----VMIITEFMENGALDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKV  147 (269)
T ss_pred             CCCc----eEEEEecCCCCcHHHHHhhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEE
Confidence            6654    69999999999999998764 34688999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccc-cc--cCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhh
Q 043568          246 SDFGLARQGPPEGLGHVSTS-VV--GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~-~~--gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  321 (453)
                      +|||++.............. ..  .+..|+|||++.+..++.++|||||||++|||++ |..||......   ....++
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~---~~~~~i  224 (269)
T cd05065         148 SDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ---DVINAI  224 (269)
T ss_pred             CCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH---HHHHHH
Confidence            99999876433211111111 11  2457999999998899999999999999999886 99998654322   222222


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ....    .          ...+..++..+.+++.+||..+|.+||++.+|+..|+++
T Consensus       225 ~~~~----~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         225 EQDY----R----------LPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             HcCC----c----------CCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1100    0          011123456789999999999999999999999988765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-40  Score=324.64  Aligned_cols=241  Identities=25%  Similarity=0.412  Sum_probs=191.6

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||.||+|.+.           .++..||+|.+....   ......+..|..++..+ +||||+++++++...+
T Consensus         1 ~~lg~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~   69 (316)
T cd05620           1 KVLGKGSFGKVLLAELK-----------GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKE   69 (316)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCC
Confidence            36999999999999976           456789999987542   22345567788888754 8999999999988765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+.+|+|.+++...  ..+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~E~~~~g~L~~~i~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Df  140 (316)
T cd05620          70 H----LFFVMEFLNGGDLMFHIQDK--GRFDLYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADF  140 (316)
T ss_pred             E----EEEEECCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCcc
Confidence            4    79999999999999988764  4678889999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+.+.+...    
T Consensus       141 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~---~~~~~~~~~----  211 (316)
T cd05620         141 GMCKENVFG--DNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED---ELFESIRVD----  211 (316)
T ss_pred             CCCeecccC--CCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHhC----
Confidence            998753211  11234567999999999999999999999999999999999999999754322   222211100    


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS-EVV  373 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ei~  373 (453)
                             .+    .++...+.++.+|+.+||..||++||++. +++
T Consensus       212 -------~~----~~~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~  246 (316)
T cd05620         212 -------TP----HYPRWITKESKDILEKLFERDPTRRLGVVGNIR  246 (316)
T ss_pred             -------CC----CCCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence                   00    11112356789999999999999999984 444

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-40  Score=312.92  Aligned_cols=252  Identities=28%  Similarity=0.479  Sum_probs=199.0

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ++||+|+||.||+|++...+        .....+|+|.+..... ...+.+.+|+.+++.+.||||+++++++....   
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~--------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~---   69 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKS--------GKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP---   69 (257)
T ss_pred             CccCccCceeEEEeEeeccC--------CCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCc---
Confidence            36999999999999875321        1346899999875543 24567899999999999999999999876432   


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++...  ..+++..++.++.|++.||.|||..   +++|+||||+|||++.++.+||+|||++
T Consensus        70 --~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~  142 (257)
T cd05060          70 --LMLVMELAPLGPLLKYLKKR--REIPVSDLKELAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMS  142 (257)
T ss_pred             --eEEEEEeCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEecccccc
Confidence              69999999999999999875  3789999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          252 RQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       252 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      +......... ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.....   ..+...+...    .
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~---~~~~~~~~~~----~  215 (257)
T cd05060         143 RALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG---AEVIAMLESG----E  215 (257)
T ss_pred             ceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH---HHHHHHHHcC----C
Confidence            8654322111 1112234568999999998899999999999999999998 8999865432   2222222111    0


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .          ...+...+..+.+++.+||..+|.+||++.++++.|+.+
T Consensus       216 ~----------~~~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         216 R----------LPRPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             c----------CCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhc
Confidence            0          011223456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-40  Score=325.08  Aligned_cols=242  Identities=26%  Similarity=0.420  Sum_probs=194.0

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||+||+|.+.           .++..||||++....   ......+..|..++..+ +||||+++++++...+
T Consensus         1 ~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~   69 (318)
T cd05570           1 KVLGKGSFGKVLLAELK-----------GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKD   69 (318)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCC
Confidence            36999999999999976           446789999987542   23345677899999888 7999999999987765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|..++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Df  140 (318)
T cd05570          70 R----LFFVMEYVNGGDLMFHIQRS--GRFDEPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADF  140 (318)
T ss_pred             E----EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEeccc
Confidence            4    79999999999999988765  4689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......   .+...+..   . 
T Consensus       141 g~~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~---~~~~~i~~---~-  211 (318)
T cd05570         141 GMCKEGILGG--VTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED---ELFQSILE---D-  211 (318)
T ss_pred             CCCeecCcCC--CcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH---HHHHHHHc---C-
Confidence            9987532211  1223456899999999999999999999999999999999999999754321   11111110   0 


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM-----SEVVD  374 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ei~~  374 (453)
                       .      .    ..+...+..+.+|+.+||..||.+||++     .++++
T Consensus       212 -~------~----~~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~  251 (318)
T cd05570         212 -E------V----RYPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG  251 (318)
T ss_pred             -C------C----CCCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence             0      0    1122345678999999999999999999     76654

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.3e-40  Score=313.80  Aligned_cols=255  Identities=27%  Similarity=0.370  Sum_probs=192.0

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .||+|+||.||+|.+.+.         .....+|+|.+..... .....|.+|+.++++++||||+++++++.+...   
T Consensus         2 ~lg~G~~g~Vy~~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---   69 (269)
T cd05087           2 EIGNGWFGKVILGEVNSG---------YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTP---   69 (269)
T ss_pred             cccccCCceEEEEEEcCC---------CCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCC---
Confidence            599999999999986421         3456799999865432 233578899999999999999999999877654   


Q ss_pred             eEEEEEEecCCCChHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRV---PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                       .++||||+++|+|.+++....   ....++..+..++.|++.||.|||+.   +++|+||||+||+++.++++||+|||
T Consensus        70 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg  145 (269)
T cd05087          70 -YLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYG  145 (269)
T ss_pred             -cEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCcc
Confidence             689999999999999997542   23466777888999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCCCccccccccCcCCCCccccccC-------CCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhh
Q 043568          250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-------RLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       250 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  321 (453)
                      ++................++..|+|||++...       .++.++||||||+++|||++ |+.||...........  .+
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~--~~  223 (269)
T cd05087         146 LSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTY--TV  223 (269)
T ss_pred             ccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHH--Hh
Confidence            99764332221222334578889999988642       35789999999999999996 9999965433221111  00


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      ..     . .....++.+    ....+..+.+++..|+ .+|++|||+.+|+..|.
T Consensus       224 ~~-----~-~~~~~~~~~----~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         224 RE-----Q-QLKLPKPRL----KLPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             hc-----c-cCCCCCCcc----CCCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            00     0 000111111    1223566889999999 68999999999998774

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=3.1e-40  Score=318.52  Aligned_cols=274  Identities=23%  Similarity=0.404  Sum_probs=203.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCC-----cCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeE
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQ-----TSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKL  160 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~-----~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l  160 (453)
                      ++|+..+.||+|+||.||++.+........     .........||+|.+..... .....|.+|+.+++.++|+||+++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~   84 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL   84 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            568899999999999999986542111000     01123456799999875432 334678999999999999999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCC---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP---------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      ++++...+.    .++||||+++++|.+++.....         ..+++..++.++.|++.||+|||+.   +++|+|||
T Consensus        85 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlk  157 (296)
T cd05095          85 LAVCITSDP----LCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSL---NFVHRDLA  157 (296)
T ss_pred             EEEEecCCc----cEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHC---CeecccCC
Confidence            999987665    6999999999999999876432         2467888999999999999999998   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh--CCccccCC
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT--GRRAVERN  309 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt--g~~p~~~~  309 (453)
                      |+|||++.++.++|+|||+++...............++..|++||....+.++.++|||||||++|||++  |..||...
T Consensus       158 p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         158 TRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             hheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            9999999999999999999986543221111223345678999999888889999999999999999998  66777543


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      ....   .............. . ..     ...+..++..+.+|+.+||+.||.+||++.+|++.|+
T Consensus       238 ~~~~---~~~~~~~~~~~~~~-~-~~-----~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~  295 (296)
T cd05095         238 SDEQ---VIENTGEFFRDQGR-Q-VY-----LPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLL  295 (296)
T ss_pred             ChHH---HHHHHHHHHhhccc-c-cc-----CCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            2221   11111111100000 0 00     0111234577999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=8.6e-41  Score=327.32  Aligned_cols=244  Identities=23%  Similarity=0.372  Sum_probs=189.9

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||.||+|.+.           .++..||+|.+....   ......+..|+.++.++ +||||+++++++....
T Consensus         1 ~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~   69 (329)
T cd05618           1 RVIGRGSYAKVLLVRLK-----------KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTES   69 (329)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCC
Confidence            36999999999999976           456789999987542   22345577899988877 8999999999988765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|..++...  ..+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~E~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~Df  140 (329)
T cd05618          70 R----LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDY  140 (329)
T ss_pred             E----EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeC
Confidence            4    79999999999999988765  5688999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh--hHHHHHhhhhccc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN--EQKLLEWVRPYVS  326 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~--~~~~~~~~~~~~~  326 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......  ......+..... 
T Consensus       141 G~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i-  217 (329)
T cd05618         141 GMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-  217 (329)
T ss_pred             CccccccCC--CCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHH-
Confidence            999753221  112345679999999999999999999999999999999999999995321110  000001110000 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                              ....  ...+...+..+.+|+.+||+.||.+||++
T Consensus       218 --------~~~~--~~~p~~~~~~~~~ll~~~L~~dP~~R~~~  250 (329)
T cd05618         218 --------LEKQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  250 (329)
T ss_pred             --------hcCC--CCCCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence                    0000  01222345678999999999999999984

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=5.6e-40  Score=310.71  Aligned_cols=257  Identities=30%  Similarity=0.483  Sum_probs=196.1

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      +.||+|+||.||+|.+...        ......||+|.+.... ......+.+|+.+++.++||||+++++++...+.. 
T Consensus         1 ~~lg~g~~g~v~~~~~~~~--------~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~-   71 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDS--------DGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS-   71 (262)
T ss_pred             CcccccCCceEEEEEEecC--------CCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCC-
Confidence            3689999999999987532        1345679999985432 23356788999999999999999999988654432 


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+.+|+|.+++.... ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+|||++
T Consensus        72 --~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~  145 (262)
T cd05058          72 --PLVVLPYMKHGDLRNFIRSET-HNPTVKDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLA  145 (262)
T ss_pred             --cEEEEecCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCcccc
Confidence              689999999999999987643 3467778889999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCC--ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCC-ccccCCCChhhHHHHHhhhhcccCc
Q 043568          252 RQGPPEGLG--HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR-RAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       252 ~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      +........  .......++..|+|||.+.+..++.++|||||||++|||++|. +||......   .+......    .
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~---~~~~~~~~----~  218 (262)
T cd05058         146 RDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSF---DITVYLLQ----G  218 (262)
T ss_pred             ccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHH---HHHHHHhc----C
Confidence            754322111  1112345677899999998889999999999999999999964 455433221   12111110    0


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      ..      +    ..+...+..+.+++.+||..+|++||++.+|++.|+++..
T Consensus       219 ~~------~----~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         219 RR------L----LQPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             CC------C----CCCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            00      0    0011235679999999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-40  Score=312.68  Aligned_cols=255  Identities=30%  Similarity=0.459  Sum_probs=204.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...++||+|+||+||+|.+.            +...||||.+.... .....+.+|+.++++++|+||+++++++.
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~------------~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   71 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWN------------GTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCS   71 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEc------------CCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeee
Confidence            467889999999999999999864            24579999987543 34577999999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++.......+++..+..++.+++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        72 ~~~~----~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l  144 (261)
T cd05034          72 EEEP----IYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKI  144 (261)
T ss_pred             cCCc----eEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEE
Confidence            6544    69999999999999999887666789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |+.||......   .........
T Consensus       145 ~d~g~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~---~~~~~~~~~  220 (261)
T cd05034         145 ADFGLARLIEDDE-YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNR---EVLEQVERG  220 (261)
T ss_pred             Cccccceeccchh-hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHHcC
Confidence            9999987654211 111122334578999999998889999999999999999999 89998654322   122211110


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      .              ....+...+..+.+++.+||..+|.+||++.++.+.|+.
T Consensus       221 ~--------------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         221 Y--------------RMPRPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             C--------------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence            0              001112235679999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=2.8e-40  Score=317.24  Aligned_cols=252  Identities=31%  Similarity=0.440  Sum_probs=200.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .|+..++||+|+||.||++.+.           .+++.||||.+......   ....+.+|+.++++++|+||+++++.+
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~   69 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVR-----------ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAY   69 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEc-----------CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEE
Confidence            3677789999999999999976           45678999998654322   234577899999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++
T Consensus        70 ~~~~~----~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~  142 (285)
T cd05630          70 ETKDA----LCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIR  142 (285)
T ss_pred             ecCCE----EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEE
Confidence            77654    79999999999999998766556789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++.......   ......|+..|+|||++.+..++.++|||||||++|+|++|+.||..................
T Consensus       143 l~Dfg~~~~~~~~~---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~  219 (285)
T cd05630         143 ISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKE  219 (285)
T ss_pred             EeeccceeecCCCc---cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhh
Confidence            99999987643221   123457899999999999989999999999999999999999999754322111111110000


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                                    ....+....+..+.+|+.+||+.||++|||     +.++++
T Consensus       220 --------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~  260 (285)
T cd05630         220 --------------VQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE  260 (285)
T ss_pred             --------------hhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence                          000112234567899999999999999999     777775

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=7.1e-40  Score=310.61  Aligned_cols=260  Identities=23%  Similarity=0.367  Sum_probs=206.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||+|.+.           .++..||+|.+....   ......+.+|+.++++++|+||++++++
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~   70 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICL-----------LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLAS   70 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEc-----------CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeee
Confidence            67889999999999999999975           356789999886432   2235678899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +...+.    .++||||+++++|.+++...  ....+++..++.++.+++.||.|||+.   +|+||||+|+||+++.++
T Consensus        71 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~  143 (267)
T cd08224          71 FIENNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATG  143 (267)
T ss_pred             eecCCe----EEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCC
Confidence            987654    69999999999999988643  235688999999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .++|+|||++.......  .......++..|+|||.+.+..++.++|||||||++|+|++|+.||...... ...+.+..
T Consensus       144 ~~~l~d~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~  220 (267)
T cd08224         144 VVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-LYSLCKKI  220 (267)
T ss_pred             cEEEeccceeeeccCCC--cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCcc-HHHHHhhh
Confidence            99999999987643321  1123456889999999998888999999999999999999999998643211 11111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      ..    .         ..........+..+.+++.+||..+|.+|||+.+|++.|..+.
T Consensus       221 ~~----~---------~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         221 EK----C---------DYPPLPADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             hc----C---------CCCCCChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            00    0         0000011134567999999999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=3.5e-40  Score=314.69  Aligned_cols=250  Identities=26%  Similarity=0.424  Sum_probs=191.1

Q ss_pred             eecCCCceEEEEEEEeecCCCCC-------------cCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeE
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQ-------------TSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKL  160 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~-------------~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l  160 (453)
                      +||+|+||.||+|.+...+....             .........||+|.+..........|.+|+.+++.++||||+++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~   81 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV   81 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence            69999999999998754321110             11122345699999865544445678899999999999999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      +++|.....    .++||||+++|+|..++... ...+++..++.++.|++.||+|||+.   +|+||||||+|||++..
T Consensus        82 ~~~~~~~~~----~~lv~ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~  153 (274)
T cd05076          82 HGVCVRGSE----NIMVEEFVEHGPLDVCLRKE-KGRVPVAWKITVAQQLASALSYLEDK---NLVHGNVCAKNILLARL  153 (274)
T ss_pred             EEEEEeCCc----eEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHcC---CccCCCCCcccEEEecc
Confidence            999987664    68999999999999988653 34678899999999999999999998   99999999999999764


Q ss_pred             C-------cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHH-hCCccccCCCC
Q 043568          241 Y-------KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELI-TGRRAVERNLP  311 (453)
Q Consensus       241 ~-------~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~ell-tg~~p~~~~~~  311 (453)
                      +       .+||+|||++.....      .....++..|+|||.+.+ ..++.++|||||||++|||+ +|..||....+
T Consensus       154 ~~~~~~~~~~kl~d~g~~~~~~~------~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~  227 (274)
T cd05076         154 GLAEGTSPFIKLSDPGVSFTALS------REERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTP  227 (274)
T ss_pred             CcccCccceeeecCCcccccccc------ccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccCh
Confidence            3       389999998864321      122357788999998865 56899999999999999995 68888876543


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      ..........       .        ..    +......+.+++.+||+.+|++|||+.+|++.|
T Consensus       228 ~~~~~~~~~~-------~--------~~----~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         228 SEKERFYEKK-------H--------RL----PEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHHHHhc-------c--------CC----CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            3222211100       0        00    011234688999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1e-40  Score=331.68  Aligned_cols=258  Identities=22%  Similarity=0.287  Sum_probs=199.8

Q ss_pred             HHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCcee
Q 043568           82 LKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLV  158 (453)
Q Consensus        82 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv  158 (453)
                      +....++|...+.||+|+||.||++.+.           .++..||+|.+.+..   ......+.+|+.+++.++||||+
T Consensus        38 ~~~~~~~y~~~~~lG~G~fg~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv  106 (370)
T cd05621          38 LQMKAEDYDVVKVIGRGAFGEVQLVRHK-----------SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVV  106 (370)
T ss_pred             cCCCHHHCeEEEEEEecCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEe
Confidence            3444678999999999999999999976           456789999986432   22345678899999999999999


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ++++++.....    .++||||+++|+|.+++...   .++...+..++.||+.||.|||+.   +|+||||||+|||++
T Consensus       107 ~~~~~~~~~~~----~~lv~Ey~~gg~L~~~l~~~---~~~~~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~  176 (370)
T cd05621         107 QLFCAFQDDKY----LYMVMEYMPGGDLVNLMSNY---DVPEKWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLD  176 (370)
T ss_pred             eEEEEEEcCCE----EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEC
Confidence            99999887654    79999999999999988653   578888899999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC----CCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG----RLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      .++.+||+|||++........ .......||+.|+|||++.+.    .++.++|||||||++|||++|+.||........
T Consensus       177 ~~~~~kL~DFG~a~~~~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~  255 (370)
T cd05621         177 KHGHLKLADFGTCMKMDETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGT  255 (370)
T ss_pred             CCCCEEEEecccceecccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHH
Confidence            999999999999986543221 122456799999999998753    378899999999999999999999976432211


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS--RPKMSEVVDI  375 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ei~~~  375 (453)
                         ...+.   .....        +........+..+.+++..||..++.+  ||++.++++.
T Consensus       256 ---~~~i~---~~~~~--------~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         256 ---YSKIM---DHKNS--------LNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             ---HHHHH---hCCcc--------cCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence               11110   00000        000111234667889999999755543  8899988763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-40  Score=336.08  Aligned_cols=263  Identities=23%  Similarity=0.306  Sum_probs=196.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...+.||+|+||.||+|.+.           ..+..||||...      ...+.+|+.+|++|+|+||+++++++.
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~-----------~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~  230 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHP-----------DYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRV  230 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEEC-----------CCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEE
Confidence            457999999999999999999976           446789999642      234678999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++|||++ .++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||
T Consensus       231 ~~~~----~~lv~e~~-~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL  301 (461)
T PHA03211        231 VGGL----TCLVLPKY-RSDLYTYLGAR-LRPLGLAQVTAVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICL  301 (461)
T ss_pred             ECCE----EEEEEEcc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEE
Confidence            7654    68999999 57899888654 24789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCCh-----hhHHHHHh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPR-----NEQKLLEW  320 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~-----~~~~~~~~  320 (453)
                      +|||+++...............||..|+|||++.+..++.++|||||||+||||++|..++......     ....+...
T Consensus       302 ~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~  381 (461)
T PHA03211        302 GDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRI  381 (461)
T ss_pred             cccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHH
Confidence            9999998654322222233457999999999999999999999999999999999988765432111     11112221


Q ss_pred             hhhcccCcccccc---------c-------cCCcCCCcc---chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHL---------I-------IDPRLEGNY---CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~---------~-------~~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +.........+..         .       ..+......   .......+.+||.+||+.||.+|||+.|+++
T Consensus       382 i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~  454 (461)
T PHA03211        382 IRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLR  454 (461)
T ss_pred             HHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhh
Confidence            1110000000000         0       000000000   0022346889999999999999999999986

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=4.7e-40  Score=310.30  Aligned_cols=253  Identities=27%  Similarity=0.422  Sum_probs=201.1

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ++||+|+||.||+|.+...        ......||||.+..... ...+.|.+|+.++++++||||+++++++.. .   
T Consensus         1 ~~ig~g~~~~v~~~~~~~~--------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~---   68 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTS--------GGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-H---   68 (257)
T ss_pred             CcCCccCcccEEeeeEecC--------CCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-C---
Confidence            3689999999999997531        12234699999977655 456789999999999999999999999887 3   


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                       ..++||||+++++|.+++.......+++...+.++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++
T Consensus        69 -~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~  144 (257)
T cd05040          69 -PLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLM  144 (257)
T ss_pred             -eEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEecccccc
Confidence             279999999999999999876445789999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          252 RQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       252 ~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      ......... .......++..|+|||++.+..++.++|||||||++|||++ |..||.......   +......   ...
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~---~~~~~~~---~~~  218 (257)
T cd05040         145 RALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ---ILKKIDK---EGE  218 (257)
T ss_pred             ccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHh---cCC
Confidence            875432211 11223457789999999998899999999999999999999 999986443222   1111110   000


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      .          ...+...+..+.+++.+||+.+|++|||+.+|++.|.
T Consensus       219 ~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         219 R----------LERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             c----------CCCCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence            0          0011234567999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=5.6e-40  Score=318.65  Aligned_cols=266  Identities=27%  Similarity=0.354  Sum_probs=201.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||.||++.+.           .++..+|+|.+..... .....+.+|++++++++||||+++++++.
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~-----------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   69 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHR-----------PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFY   69 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEc-----------CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe
Confidence            46889999999999999999875           4467799998865422 23456889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+..  +++|+||||+|||++.++.+||
T Consensus        70 ~~~~----~~lv~ey~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l  141 (308)
T cd06615          70 SDGE----ISICMEHMDGGSLDQVLKKA--GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKL  141 (308)
T ss_pred             eCCE----EEEEeeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEE
Confidence            7664    79999999999999999765  56888899999999999999999732  8999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++......    ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||...................
T Consensus       142 ~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~  217 (308)
T cd06615         142 CDFGVSGQLIDS----MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEG  217 (308)
T ss_pred             ccCCCccccccc----ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccc
Confidence            999998764322    1234578899999999988889999999999999999999999986543222111111100000


Q ss_pred             cCccc--------------------cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          326 SDSKK--------------------FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       326 ~~~~~--------------------~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .....                    .................+.++.+++.+||..+|++|||+.+|++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  287 (308)
T cd06615         218 EAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH  287 (308)
T ss_pred             cccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            00000                    000000000000001245679999999999999999999998864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=4e-40  Score=316.10  Aligned_cols=251  Identities=30%  Similarity=0.436  Sum_probs=199.1

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      |...++||+|+||+||+|.+.           .++..||+|.+......   ....+.+|+.+|+.++|+||+++++++.
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~   70 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVR-----------ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYE   70 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEEC-----------CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEe
Confidence            667789999999999999875           45678999998654322   2345788999999999999999998887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+++++|.+++.......+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|
T Consensus        71 ~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl  143 (285)
T cd05632          71 TKDA----LCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRI  143 (285)
T ss_pred             cCCE----EEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEE
Confidence            7654    79999999999999988765556799999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++......   .......|+..|+|||++.+..++.++|||||||++|+|++|..||...............   .
T Consensus       144 ~Dfg~~~~~~~~---~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~---~  217 (285)
T cd05632         144 SDLGLAVKIPEG---ESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRR---V  217 (285)
T ss_pred             ecCCcceecCCC---CcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh---h
Confidence            999998764322   1123457899999999999889999999999999999999999999754322211111100   0


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      ...           ...+....+..+.+|+.+||+.||++||+     +.+++.
T Consensus       218 ~~~-----------~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~  260 (285)
T cd05632         218 LET-----------EEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR  260 (285)
T ss_pred             hcc-----------ccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence            000           00112234567899999999999999999     555553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.3e-40  Score=330.04  Aligned_cols=266  Identities=22%  Similarity=0.270  Sum_probs=199.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...+.||+|+||.||++...+         ...+..||+|.+...     ..+.+|+.+|+.++||||+++++++.
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~---------~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~  156 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHG---------DEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYR  156 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcC---------CccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEe
Confidence            4579999999999999999997542         134678999987543     23568999999999999999999887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++|||++ +++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.++|
T Consensus       157 ~~~~----~~lv~e~~-~~~l~~~l~~~--~~l~~~~~~~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l  226 (392)
T PHA03207        157 WKST----VCMVMPKY-KCDLFTYVDRS--GPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVL  226 (392)
T ss_pred             eCCE----EEEEehhc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence            6553    79999999 57888888443  5789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++................||+.|+|||++.+..++.++|||||||++|||++|+.||...........+..+...+
T Consensus       227 ~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~  306 (392)
T PHA03207        227 GDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCM  306 (392)
T ss_pred             ccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHh
Confidence            99999976543322223345679999999999999999999999999999999999999997644322111111110000


Q ss_pred             c-Ccccccc-----------ccCCcCCCcc-------chHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          326 S-DSKKFHL-----------IIDPRLEGNY-------CIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       326 ~-~~~~~~~-----------~~~~~~~~~~-------~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      . ....+..           .........+       ....+.++.++|.+||..||++|||+.+++..
T Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        307 QVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             ccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence            0 0000000           0000000000       01234578899999999999999999999863

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=4.5e-40  Score=319.48  Aligned_cols=266  Identities=24%  Similarity=0.355  Sum_probs=200.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||.||+|++.           .++..||+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   74 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSK-----------LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVH   74 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEec-----------CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEe
Confidence            57889999999999999999875           3467899999875432 23346788999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        75 ~~~~----~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl  145 (309)
T cd07872          75 TDKS----LTLVFEYLD-KDLKQYMDDC-GNIMSMHNVKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKL  145 (309)
T ss_pred             eCCe----EEEEEeCCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence            7654    799999996 5888887654 34578888999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh-
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP-  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-  323 (453)
                      +|||++.......  .......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||......+....+..... 
T Consensus       146 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~  223 (309)
T cd07872         146 ADFGLARAKSVPT--KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGT  223 (309)
T ss_pred             CccccceecCCCc--cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCC
Confidence            9999997643221  12234567899999998865 5688999999999999999999999976544332222211100 


Q ss_pred             -------cccCccccccccCCcCC----CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 -------YVSDSKKFHLIIDPRLE----GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 -------~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             .+...........+...    .......+.++.+|+.+||..||.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~  285 (309)
T cd07872         224 PTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK  285 (309)
T ss_pred             CCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence                   00000000000000000    0011234567899999999999999999999985

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=4.9e-40  Score=315.80  Aligned_cols=262  Identities=29%  Similarity=0.472  Sum_probs=203.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|.....||+|+||.||+|.+....      .......||+|.+..... .....|.+|+.+++.++||||+++++++
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~   77 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLL------PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVC   77 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccC------CCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEE
Confidence            467889999999999999999864211      013457899999865432 2346788999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      .....    .++||||+++|+|.+++....                    ...+++..++.++.|++.||.|||+.   +
T Consensus        78 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~  150 (288)
T cd05050          78 AVGKP----MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---K  150 (288)
T ss_pred             cCCCc----cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            87654    699999999999999997532                    12478888999999999999999998   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CC
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GR  303 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~  303 (453)
                      ++||||||+|||++.++.++|+|||++.................+..|+|||.+.+..++.++|||||||++|||++ |.
T Consensus       151 i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~  230 (288)
T cd05050         151 FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGM  230 (288)
T ss_pred             eecccccHhheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCC
Confidence            99999999999999999999999999875432221111223345677999999988899999999999999999998 77


Q ss_pred             ccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          304 RAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      .||......   .....+..    ....          ..+...+.++.+|+.+||+.+|.+|||+.|+++.|+
T Consensus       231 ~p~~~~~~~---~~~~~~~~----~~~~----------~~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~  287 (288)
T cd05050         231 QPYYGMAHE---EVIYYVRD----GNVL----------SCPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQ  287 (288)
T ss_pred             CCCCCCCHH---HHHHHHhc----CCCC----------CCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhh
Confidence            888644322   12211110    0000          011234577999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.8e-40  Score=330.58  Aligned_cols=269  Identities=25%  Similarity=0.333  Sum_probs=199.9

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|+..+.||+|+||.||+|.+.           .++..||||++....  ....+.+.+|+.+++.++||||+++++++.
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~   69 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDP-----------RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQ   69 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEEC-----------CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheec
Confidence            4788899999999999999875           456789999986432  233467889999999999999999999988


Q ss_pred             eccccc-ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDERG-MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...... ...++||||+. ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~k  143 (372)
T cd07853          70 PPHIDPFEEIYVVTELMQ-SDLHKIIVSP--QPLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLK  143 (372)
T ss_pred             CCCccccceEEEEeeccc-cCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEE
Confidence            665211 24799999995 6888877654  5789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...... ........+|..|+|||++.+. .++.++|||||||++|||++|+.||....+......+.....
T Consensus       144 L~Dfg~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g  222 (372)
T cd07853         144 ICDFGLARVEEPDE-SKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLG  222 (372)
T ss_pred             eccccceeecccCc-cccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcC
Confidence            99999998643321 1223345688999999998764 578999999999999999999999976544332221111000


Q ss_pred             cccCc------cccc-cc----cCC-cCC--CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDS------KKFH-LI----IDP-RLE--GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~------~~~~-~~----~~~-~~~--~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....      .... .+    ..+ ...  .......+.++.+|+.+||+.||++|||+.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  287 (372)
T cd07853         223 TPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALA  287 (372)
T ss_pred             CCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhc
Confidence            00000      0000 00    000 000  0111223567899999999999999999999875

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1.1e-40  Score=325.85  Aligned_cols=238  Identities=27%  Similarity=0.370  Sum_probs=188.5

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHH-HhccCCCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVN-FLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||+||+|++.           .++..||||++.....   .....+..|.. +++.++||||+++++++...+
T Consensus         1 ~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~   69 (323)
T cd05575           1 KVIGKGSFGKVLLAKHK-----------ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTAD   69 (323)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCC
Confidence            36999999999999976           4577899999865421   22344555555 567899999999999987765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Df  140 (323)
T cd05575          70 K----LYFVLDYVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF  140 (323)
T ss_pred             E----EEEEEcCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEecc
Confidence            4    79999999999999988764  5688889999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |++......  ........||+.|+|||++.+..++.++|||||||++|||++|..||.......   +.+.+.   ...
T Consensus       141 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~---~~~~i~---~~~  212 (323)
T cd05575         141 GLCKEGIEH--SKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAE---MYDNIL---NKP  212 (323)
T ss_pred             CCCcccccC--CCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHH---HHHHHH---cCC
Confidence            998753221  122345579999999999999999999999999999999999999997543211   111111   000


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS  370 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  370 (453)
                              .    ......+..+.+++.+||+.||.+||++.
T Consensus       213 --------~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (323)
T cd05575         213 --------L----RLKPNISVSARHLLEGLLQKDRTKRLGAK  242 (323)
T ss_pred             --------C----CCCCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence                    0    01122366789999999999999999985

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.3e-41  Score=328.99  Aligned_cols=260  Identities=27%  Similarity=0.433  Sum_probs=215.0

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      +....++||.|.||.||.|+|+           ...-.||||.++.+ .-..++|+.|+.+|+.++|||+|+|+|+|...
T Consensus       268 dItMkhKLGGGQYGeVYeGvWK-----------kyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~E  335 (1157)
T KOG4278|consen  268 DITMKHKLGGGQYGEVYEGVWK-----------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE  335 (1157)
T ss_pred             heeeeeccCCCcccceeeeeee-----------ccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccC
Confidence            3444568999999999999997           44567999999654 34568899999999999999999999999987


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ..    +|||.|||..|+|.+||+.-....++-...+.++.||+.|++||..+   ++|||||...|+|+.++..+|++|
T Consensus       336 pP----FYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvAD  408 (1157)
T KOG4278|consen  336 PP----FYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVAD  408 (1157)
T ss_pred             CC----eEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeec
Confidence            76    79999999999999999987777788888899999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhccc
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||++++..... .......-...|.|||-+.-..++.|+|||+|||+||||.| |-.||.+-.......+++       
T Consensus       409 FGLsRlMtgDTY-TAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLE-------  480 (1157)
T KOG4278|consen  409 FGLSRLMTGDTY-TAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLE-------  480 (1157)
T ss_pred             cchhhhhcCCce-ecccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHh-------
Confidence            999998764321 11222334568999999998999999999999999999998 667776543222222221       


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                                ...+-..+..|++.+.+|+..||+.+|.+||++.||-+.++.++...+
T Consensus       481 ----------kgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf~~sS  528 (1157)
T KOG4278|consen  481 ----------KGYRMDGPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMFSSSS  528 (1157)
T ss_pred             ----------ccccccCCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHhcccc
Confidence                      112223355678899999999999999999999999999998886543

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.3e-40  Score=327.85  Aligned_cols=269  Identities=26%  Similarity=0.321  Sum_probs=199.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||.||+|.+.           ..+..||||.+....  ......+.+|+.+++.++||||+++++
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   83 (355)
T cd07874          15 VLKRYQNLKPIGSGAQGIVCAAYDA-----------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLN   83 (355)
T ss_pred             hhhceeEEEEeeecCCEEEEEEEec-----------CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceee
Confidence            4578999999999999999999865           346789999987542  223466789999999999999999999


Q ss_pred             eeeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.....  .....++||||++ ++|.+.+..    .+++..+..++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        84 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~  155 (355)
T cd07874          84 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD  155 (355)
T ss_pred             eeeccccccccceeEEEhhhhc-ccHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCC
Confidence            8865432  1124799999995 467766643    478888899999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~  319 (453)
                      +.+||+|||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||.......... ...
T Consensus       156 ~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~  232 (355)
T cd07874         156 CTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIE  232 (355)
T ss_pred             CCEEEeeCcccccCCCc---cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999999864322   22344578999999999998899999999999999999999999997543221110 000


Q ss_pred             ---------------hhhhcccCccccccccCCc------C--CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          320 ---------------WVRPYVSDSKKFHLIIDPR------L--EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       320 ---------------~~~~~~~~~~~~~~~~~~~------~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                                     ....+.........+..+.      .  ........+..+.+|+.+||..||++|||+.++++.
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         233 QLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                           0000000000000000000      0  001112234678999999999999999999999863

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=6.2e-40  Score=310.91  Aligned_cols=250  Identities=24%  Similarity=0.424  Sum_probs=191.4

Q ss_pred             eecCCCceEEEEEEEeecCCCCC-cCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQ-TSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~-~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .||+|+||.||+|+......... .........||+|.+..........|..|+.+++.++||||+++++++.....   
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~---   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE---   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC---
Confidence            68999999999998643221110 11123445699999876554555678899999999999999999999987654   


Q ss_pred             eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc-------EEE
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK-------AKL  245 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~-------~kL  245 (453)
                       .++||||+++|+|..++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.       +++
T Consensus        79 -~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l  153 (262)
T cd05077          79 -NIMVEEFVEFGPLDLFMHRK-SDVLTTPWKFKVAKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKL  153 (262)
T ss_pred             -CEEEEecccCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEe
Confidence             58999999999999888654 34689999999999999999999998   9999999999999987664       899


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccc-cCCCCCchhHHHHHHHHHHHH-hCCccccCCCChhhHHHHHhhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYELI-TGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~SlGvil~ell-tg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|||++.....      .....++..|+|||.+. +..++.++|||||||++|||+ +|..|+..........+..    
T Consensus       154 ~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~----  223 (262)
T cd05077         154 SDPGIPITVLS------RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFYE----  223 (262)
T ss_pred             CCCCCCccccC------cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHHh----
Confidence            99999875432      22346788999999886 467899999999999999998 5777775432221111100    


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                           ...          ......+..+.+|+.+||+.||.+||++.+|++.|
T Consensus       224 -----~~~----------~~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         224 -----GQC----------MLVTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             -----cCc----------cCCCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence                 000          00111246789999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=5.5e-40  Score=313.98  Aligned_cols=263  Identities=27%  Similarity=0.432  Sum_probs=206.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+|...+.||+|+||+||+|.+...       +......+|+|.+..... .....+.+|+.++++++||||++++++|.
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~-------~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   79 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPE-------GEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL   79 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecC-------CCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            5678888999999999999997532       112245799998865543 23467889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..     ..++||||+++|+|.+++.... ..+++..++.++.|++.||+|||+.   +++|+||||+|||++.++.+||
T Consensus        80 ~~-----~~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL  150 (279)
T cd05057          80 SS-----QVQLITQLMPLGCLLDYVRNHK-DNIGSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKI  150 (279)
T ss_pred             cC-----ceEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEE
Confidence            62     2699999999999999997653 3589999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++...............++..|+|||.+....++.++||||||+++|||++ |+.||.......   +...+.. 
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~---~~~~~~~-  226 (279)
T cd05057         151 TDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE---IPDLLEK-  226 (279)
T ss_pred             CCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhC-
Confidence            99999987543221111122234568999999988889999999999999999998 999987643322   2111110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         ...          ...+..++..+.+++.+||..+|.+||++.++++.|..+...
T Consensus       227 ---~~~----------~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~~  271 (279)
T cd05057         227 ---GER----------LPQPPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMARD  271 (279)
T ss_pred             ---CCC----------CCCCCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhC
Confidence               000          011112345688999999999999999999999999988653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.4e-41  Score=327.91  Aligned_cols=242  Identities=26%  Similarity=0.349  Sum_probs=193.7

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeecccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDER  170 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  170 (453)
                      +.||+|+||.||++.....        ...+..||+|++.....  .....+..|+.++++++||||+++++++...+. 
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~--------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~-   72 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITG--------PDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGK-   72 (318)
T ss_pred             ceeeeCCCEEEEEEEEecc--------CCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCE-
Confidence            5799999999999876421        24577899999875432  233457789999999999999999999887654 


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                         .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus        73 ---~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~  144 (318)
T cd05582          73 ---LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL  144 (318)
T ss_pred             ---EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccC
Confidence               79999999999999998764  5689999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccc
Q 043568          251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK  330 (453)
Q Consensus       251 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+..   ..  
T Consensus       145 ~~~~~~~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~---~~~~i~~---~~--  214 (318)
T cd05582         145 SKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKE---TMTMILK---AK--  214 (318)
T ss_pred             CcccCCCC--CceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHH---HHHHHHc---CC--
Confidence            87643221  12334679999999999998889999999999999999999999997543221   1111110   00  


Q ss_pred             cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHH
Q 043568          331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE  371 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  371 (453)
                                ...+...+..+.+|+.+||+.||++||++.+
T Consensus       215 ----------~~~p~~~~~~~~~li~~~l~~~P~~R~~a~~  245 (318)
T cd05582         215 ----------LGMPQFLSPEAQSLLRALFKRNPANRLGAGP  245 (318)
T ss_pred             ----------CCCCCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence                      0112234567899999999999999999655

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.2e-40  Score=319.62  Aligned_cols=264  Identities=27%  Similarity=0.448  Sum_probs=204.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+...+       ......||+|.+..... .....+.+|+.+++.++||||++++|+|
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~-------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~   78 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEG-------ETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVC   78 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCC-------CcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEE
Confidence            356778889999999999999875321       11234689998865432 2234688999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++++||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.+|
T Consensus        79 ~~~~-----~~~v~e~~~~g~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~k  149 (303)
T cd05110          79 LSPT-----IQLVTQLMPHGCLLDYVHEH-KDNIGSQLLLNWCVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVK  149 (303)
T ss_pred             cCCC-----ceeeehhcCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHhhc---CeeccccccceeeecCCCceE
Confidence            7543     47899999999999998764 34678889999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||.......   ..+....
T Consensus       150 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~---~~~~~~~  226 (303)
T cd05110         150 ITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTRE---IPDLLEK  226 (303)
T ss_pred             EccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHC
Confidence            999999986543222112223445778999999988899999999999999999998 888886543222   2221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                          ....          ..+..++..+.+++.+||..+|++||++.++++.|..+...
T Consensus       227 ----~~~~----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         227 ----GERL----------PQPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             ----CCCC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence                0000          00112345789999999999999999999999999887653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.6e-40  Score=311.02  Aligned_cols=252  Identities=32%  Similarity=0.528  Sum_probs=203.0

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-HHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ++||+|+||.||+|.+....        ..+..||+|.+....... ...+.+|+.+++.++|+||+++++++.....  
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~--------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~--   70 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKD--------GKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEP--   70 (262)
T ss_pred             CccccCCceEEEEEEEecCC--------CCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCc--
Confidence            36999999999999976210        226789999987654333 6788999999999999999999999987443  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRV-------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~-------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                        .++||||+++++|.+++....       ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.+|
T Consensus        71 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~  145 (262)
T cd00192          71 --LYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVK  145 (262)
T ss_pred             --eEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEE
Confidence              799999999999999998752       36789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||.+................++..|+|||.+....++.++||||||+++|||++ |..||......   .+.+....
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~~~~  222 (262)
T cd00192         146 ISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE---EVLEYLRK  222 (262)
T ss_pred             EcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH---HHHHHHHc
Confidence            999999987654332222345567889999999988889999999999999999999 58888765221   22222111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                          ..          ....+...+.++.+++.+||..+|.+|||+.++++.|
T Consensus       223 ----~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l  261 (262)
T cd00192         223 ----GY----------RLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERL  261 (262)
T ss_pred             ----CC----------CCCCCccCChHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence                00          0111223467899999999999999999999999876

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=4.2e-40  Score=313.32  Aligned_cols=251  Identities=29%  Similarity=0.488  Sum_probs=195.0

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeeeeeeccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~  171 (453)
                      +||+|+||.||+|.+...         .....+|+|.+.... ......+.+|+.++.++ +||||+++++++.....  
T Consensus         2 ~lg~g~~g~v~~~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~--   70 (270)
T cd05047           2 VIGEGNFGQVLKARIKKD---------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGY--   70 (270)
T ss_pred             cCCCCCCceEEEEEEcCC---------CCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCC--
Confidence            699999999999997521         112457889886432 23346788999999999 89999999999987654  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                        .++||||+++|+|.+++....              ...+++..++.++.|++.||+|||+.   +++||||||+|||+
T Consensus        71 --~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili  145 (270)
T cd05047          71 --LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILV  145 (270)
T ss_pred             --ceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEE
Confidence              699999999999999987542              13478899999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHH
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQK  316 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~  316 (453)
                      +.++.+||+|||++......   ........+..|+|||++....++.++|||||||++|||++ |..||......   .
T Consensus       146 ~~~~~~kl~dfgl~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~---~  219 (270)
T cd05047         146 GENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA---E  219 (270)
T ss_pred             cCCCeEEECCCCCccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH---H
Confidence            99999999999998642211   11112234567999999988889999999999999999997 99998653221   1


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      .......    ...          ...+...+..+.+|+.+||..+|.+|||+.+++..|..++
T Consensus       220 ~~~~~~~----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         220 LYEKLPQ----GYR----------LEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             HHHHHhC----CCC----------CCCCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            1111110    000          0111223567899999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-40  Score=324.78  Aligned_cols=260  Identities=27%  Similarity=0.448  Sum_probs=215.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-CcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .....++||.|.||.||+|+..+..       +..+..||||..+.. ..+..+.|+.|+.+|+.++||||++++|+|.+
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~-------kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e  462 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPE-------KGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE  462 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccc-------cCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec
Confidence            3445568999999999999987431       244567999998764 34556789999999999999999999999998


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ..     .+||||.++-|.|..||..+. ..++......++.||+.||+|||+.   .+|||||...|||+.+...+||+
T Consensus       463 ~P-----~WivmEL~~~GELr~yLq~nk-~sL~l~tL~ly~~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLa  533 (974)
T KOG4257|consen  463 QP-----MWIVMELAPLGELREYLQQNK-DSLPLRTLTLYCYQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLA  533 (974)
T ss_pred             cc-----eeEEEecccchhHHHHHHhcc-ccchHHHHHHHHHHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeec
Confidence            76     599999999999999998763 5678888889999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||+++...+...... +...-...|||||-+.-..++.++|||-|||.+||+++ |..||.+-...             
T Consensus       534 DFGLSR~~ed~~yYka-S~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNs-------------  599 (974)
T KOG4257|consen  534 DFGLSRYLEDDAYYKA-SRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNS-------------  599 (974)
T ss_pred             ccchhhhccccchhhc-cccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccccc-------------
Confidence            9999998876554332 23344568999999999999999999999999999987 88999753221             


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                         ..+. .+...-+.+.+++||+.|..|+.+||+.+|.+||++.+|...|..+..
T Consensus       600 ---DVI~-~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  600 ---DVIG-HIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             ---ceEE-EecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence               1111 122222345577889999999999999999999999999999988876

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=5e-40  Score=325.91  Aligned_cols=268  Identities=26%  Similarity=0.336  Sum_probs=198.6

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||.||+|.+.           ..+..||||++....  ......+.+|+.+++.++||||+++++
T Consensus        19 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   87 (359)
T cd07876          19 VLKRYQQLKPIGSGAQGIVCAAFDT-----------VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLN   87 (359)
T ss_pred             hhhceEEEEEeecCCCEEEEEEEEc-----------CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            3578999999999999999999875           456789999986542  233467889999999999999999999


Q ss_pred             eeeecccc--cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++......  ....++||||++ ++|.+.+..    .++...+..++.|++.||.|||++   +|+||||||+|||++.+
T Consensus        88 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~  159 (359)
T cd07876          88 VFTPQKSLEEFQDVYLVMELMD-ANLCQVIHM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD  159 (359)
T ss_pred             eeccCCCccccceeEEEEeCCC-cCHHHHHhc----cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCC
Confidence            98754421  123699999995 466666643    477888889999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~  319 (453)
                      +.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +..
T Consensus       160 ~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~  236 (359)
T cd07876         160 CTLKILDFGLARTACTN---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIE  236 (359)
T ss_pred             CCEEEecCCCccccccC---ccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999999764321   12344578999999999999999999999999999999999999997543221100 000


Q ss_pred             ---------------hhhhcccCccc-----cccccCCcC---CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 ---------------WVRPYVSDSKK-----FHLIIDPRL---EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ---------------~~~~~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                     ....+......     +........   ........+..+.+|+.+||..||++|||+.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  314 (359)
T cd07876         237 QLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALR  314 (359)
T ss_pred             hcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhc
Confidence                           00000000000     000000000   00011123467899999999999999999999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=4.3e-40  Score=312.73  Aligned_cols=257  Identities=22%  Similarity=0.372  Sum_probs=202.2

Q ss_pred             HHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEe
Q 043568           82 LKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        82 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      ++.+++++.....||+|+||.||+|++.           .++..||+|.+........+.+.+|+.++++++|+||++++
T Consensus         3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   71 (268)
T cd06624           3 YEYEYDENGERVVLGKGTYGIVYAARDL-----------STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYL   71 (268)
T ss_pred             cccccccCCceEEEecCCceEEEEeEec-----------CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeee
Confidence            4456778888889999999999999875           45678999998766555667899999999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL--AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++...+.    .++|+||+++++|.+++.... .++  ++..+..++.||+.||+|||+.   +|+||||||+||+++.
T Consensus        72 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~  143 (268)
T cd06624          72 GSDSENGF----FKIFMEQVPGGSLSALLRSKW-GPLKDNEQTIIFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNT  143 (268)
T ss_pred             eeeccCCE----EEEEEecCCCCCHHHHHHHhc-ccCCCcHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcC
Confidence            99887654    799999999999999997642 234  7788889999999999999998   9999999999999976


Q ss_pred             -CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC--CCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          240 -DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       240 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                       ++.++|+|||++.......  .......|+..|+|||++.+..  ++.++||||||+++|+|++|+.||......... 
T Consensus       144 ~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~-  220 (268)
T cd06624         144 YSGVVKISDFGTSKRLAGIN--PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAA-  220 (268)
T ss_pred             CCCeEEEecchhheecccCC--CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhh-
Confidence             6789999999987643221  1122346889999999986643  788999999999999999999998643221110 


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .  +......            .....+...+.++.+++.+||+.+|.+|||+.+++.
T Consensus       221 ~--~~~~~~~------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  264 (268)
T cd06624         221 M--FKVGMFK------------IHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ  264 (268)
T ss_pred             H--hhhhhhc------------cCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence            0  0000000            011122334577999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=8.1e-40  Score=310.78  Aligned_cols=260  Identities=26%  Similarity=0.463  Sum_probs=204.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||.||+|.+...+        .....+|+|.+..... ...+.|.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~--------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   75 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPG--------KREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVT   75 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCC--------CCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEe
Confidence            56888899999999999999875221        2245799999865432 23467899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|
T Consensus        76 ~~~~----~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l  147 (267)
T cd05066          76 KSKP----VMIVTEYMENGSLDAFLRKHD-GQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKV  147 (267)
T ss_pred             cCCc----cEEEEEcCCCCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEe
Confidence            6654    699999999999999997653 4689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCcc-ccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          246 SDFGLARQGPPEGLGHV-STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|||++........... .....++..|+|||++.+..++.++||||||+++||+++ |..||.......   .......
T Consensus       148 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~---~~~~~~~  224 (267)
T cd05066         148 SDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD---VIKAIEE  224 (267)
T ss_pred             CCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH---HHHHHhC
Confidence            99999987543221111 112233568999999998889999999999999999887 999986543322   1111111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                          ...          .......+..+.+++.+||+.+|.+||++.++++.|.++
T Consensus       225 ----~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         225 ----GYR----------LPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             ----CCc----------CCCCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence                000          011123456789999999999999999999999998775

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=3.8e-40  Score=348.84  Aligned_cols=263  Identities=24%  Similarity=0.310  Sum_probs=203.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...++||+|+||.||+|++.           ..+..||||++.....   ...+.|.+|+.++++++||||++++++
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~-----------~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v   70 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDP-----------VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSI   70 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEEC-----------CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEE
Confidence            57899999999999999999975           4567899999875422   224578999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV---------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      +.+.+.    .++||||++||+|.+++....         ...+++..++.++.||+.||+|||+.   +|+||||||+|
T Consensus        71 ~~d~~~----lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeN  143 (932)
T PRK13184         71 CSDGDP----VYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDN  143 (932)
T ss_pred             EeeCCE----EEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchhe
Confidence            987654    799999999999999886421         23456778899999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCC----------------ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHH
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLG----------------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE  298 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~e  298 (453)
                      ||++.++.++|+|||+++........                .......||+.|+|||++.+..++.++|||||||++||
T Consensus       144 ILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyE  223 (932)
T PRK13184        144 ILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQ  223 (932)
T ss_pred             EEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHH
Confidence            99999999999999999865211000                01123469999999999999999999999999999999


Q ss_pred             HHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHH
Q 043568          299 LITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-KMSEVVDILG  377 (453)
Q Consensus       299 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ei~~~L~  377 (453)
                      |++|+.||.......   ....  ..         ...+.. .......+..+.+++.+||..||++|| +++++++.|+
T Consensus       224 LLTG~~PF~~~~~~k---i~~~--~~---------i~~P~~-~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le  288 (932)
T PRK13184        224 MLTLSFPYRRKKGRK---ISYR--DV---------ILSPIE-VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLE  288 (932)
T ss_pred             HHHCCCCCCCcchhh---hhhh--hh---------ccChhh-ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            999999996532211   1000  00         000000 000123456789999999999999995 5777888887


Q ss_pred             HhHhh
Q 043568          378 NIISE  382 (453)
Q Consensus       378 ~~~~~  382 (453)
                      .....
T Consensus       289 ~~lq~  293 (932)
T PRK13184        289 PHLQG  293 (932)
T ss_pred             HHHhc
Confidence            77653

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.9e-40  Score=311.67  Aligned_cols=255  Identities=27%  Similarity=0.355  Sum_probs=208.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .+.|...+.||+|.-|+||++.++           .++..+|+|++.+....   ...+...|-+||+.++||.++.||+
T Consensus        76 l~~f~llk~LG~GdiG~VyL~~l~-----------~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa  144 (459)
T KOG0610|consen   76 LRHFRLLKRLGCGDIGTVYLVELR-----------GTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYA  144 (459)
T ss_pred             HHHHHHHHHcCCCCceeEEEEEec-----------CCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhh
Confidence            345677779999999999999987           34578999999876543   3456678999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .+..+..    .+||||||+||+|...++++....++...+.-++.+++-||+|||-.   |||+|||||+||||-++|+
T Consensus       145 ~fet~~~----~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGH  217 (459)
T KOG0610|consen  145 SFETDKY----SCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGH  217 (459)
T ss_pred             eeeccce----eEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCc
Confidence            9988775    69999999999999999999888999999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCC---------------------------------CCC---------------------Ccccccccc
Q 043568          243 AKLSDFGLARQGPP---------------------------------EGL---------------------GHVSTSVVG  268 (453)
Q Consensus       243 ~kL~DFGla~~~~~---------------------------------~~~---------------------~~~~~~~~g  268 (453)
                      +.|+||.|+.....                                 ...                     .......+|
T Consensus       218 IMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVG  297 (459)
T KOG0610|consen  218 IMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVG  297 (459)
T ss_pred             EEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCcccccccc
Confidence            99999998753211                                 000                     001234589


Q ss_pred             CcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHH
Q 043568          269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSA  348 (453)
Q Consensus       269 t~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  348 (453)
                      |-.|+|||++.+..-+.++|.|+|||++||||.|..||-+......                +..++...+.-......+
T Consensus       298 ThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~T----------------l~NIv~~~l~Fp~~~~vs  361 (459)
T KOG0610|consen  298 THEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKET----------------LRNIVGQPLKFPEEPEVS  361 (459)
T ss_pred             ccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhh----------------HHHHhcCCCcCCCCCcch
Confidence            9999999999999999999999999999999999999976543221                222222222222233556


Q ss_pred             HHHHHHHHHhhccCCCCCCC----HHHHHH
Q 043568          349 QKLAALASKCLTKQPKSRPK----MSEVVD  374 (453)
Q Consensus       349 ~~l~~li~~cl~~dp~~RPs----~~ei~~  374 (453)
                      ..+.+||++.|.+||.+|..    +.||.+
T Consensus       362 ~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  362 SAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             hHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            78999999999999999988    777764

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=6.9e-40  Score=313.43  Aligned_cols=250  Identities=25%  Similarity=0.381  Sum_probs=195.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...++||+|+||.||+|++.           .++..||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   69 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHL-----------LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFF   69 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEc-----------CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            36778889999999999999875           456789999986542 233457889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|..+      ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++|
T Consensus        70 ~~~~----~~lv~e~~~~~~l~~~------~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l  136 (279)
T cd06619          70 VENR----ISICTEFMDGGSLDVY------RKIPEHVLGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKL  136 (279)
T ss_pred             ECCE----EEEEEecCCCCChHHh------hcCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEE
Confidence            7654    6899999999999754      2467788889999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-HHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-LEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-~~~~~~~  324 (453)
                      +|||++......    ......||..|+|||++.+..++.++|||||||++|+|++|+.||........... ...... 
T Consensus       137 ~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-  211 (279)
T cd06619         137 CDFGVSTQLVNS----IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQC-  211 (279)
T ss_pred             eeCCcceecccc----cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHH-
Confidence            999999764322    23345789999999999988899999999999999999999999864322111000 000000 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .         .+...........+.++.+++.+||+.+|++||++.++++
T Consensus       212 ~---------~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~  252 (279)
T cd06619         212 I---------VDEDPPVLPVGQFSEKFVHFITQCMRKQPKERPAPENLMD  252 (279)
T ss_pred             H---------hccCCCCCCCCcCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            0         0000000011123567899999999999999999999875

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4.8e-41  Score=299.49  Aligned_cols=254  Identities=25%  Similarity=0.395  Sum_probs=205.9

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-----c---cHHHHHHHHHHhccC-CC
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-----Q---GHKEWINEVNFLGVV-KH  154 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-----~---~~~~~~~E~~~l~~l-~h  154 (453)
                      ..-+.|...++||.|..++|-++.++           .++.++|+|++.....     .   ..+.-.+|+.||+++ .|
T Consensus        14 ~fy~~y~pkeilgrgvss~vrRci~k-----------~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GH   82 (411)
T KOG0599|consen   14 GFYAKYEPKEILGRGVSSVVRRCIHK-----------ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGH   82 (411)
T ss_pred             hHHhhcChHHHhcccchhhhhhhhhc-----------ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCC
Confidence            44567888889999999999999876           5677899999864321     1   123456899999999 69


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      |||+++.+++..+..    .++|+|.|+.|.|.|+|...  ..+++....+|++|+.+|+.|||..   +||||||||+|
T Consensus        83 P~II~l~D~yes~sF----~FlVFdl~prGELFDyLts~--VtlSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpEN  153 (411)
T KOG0599|consen   83 PYIIDLQDVYESDAF----VFLVFDLMPRGELFDYLTSK--VTLSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPEN  153 (411)
T ss_pred             CcEEEeeeeccCcch----hhhhhhhcccchHHHHhhhh--eeecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhh
Confidence            999999999988765    69999999999999999876  6889999999999999999999999   99999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc------CCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT------GRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ||++++.++||+|||+++...+.   ......+||++|+|||.+..      ..|+..+|+||+|||+|.|+.|.+||..
T Consensus       154 ILlddn~~i~isDFGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwH  230 (411)
T KOG0599|consen  154 ILLDDNMNIKISDFGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWH  230 (411)
T ss_pred             eeeccccceEEeccceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhH
Confidence            99999999999999999987653   34567899999999999864      3588999999999999999999999964


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ........++..        +++      ....+...+.+....+||.+||+.||.+|.|++|++.
T Consensus       231 RkQmlMLR~Ime--------Gky------qF~speWadis~~~KdLIsrlLqVdp~~Ritake~La  282 (411)
T KOG0599|consen  231 RKQMLMLRMIME--------GKY------QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA  282 (411)
T ss_pred             HHHHHHHHHHHh--------ccc------ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence            322111111110        110      1111223355778999999999999999999999885

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.8e-40  Score=315.99  Aligned_cols=276  Identities=26%  Similarity=0.386  Sum_probs=204.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +.|...+.||+|+||.||++.+..       .+...+..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~-------~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (284)
T cd05079           4 RFLKRIRDLGEGHFGKVELCRYDP-------EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICT   76 (284)
T ss_pred             hhhhhceecCCCCceeEEEEEEcc-------CCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEe
Confidence            457788899999999999998641       122456789999986543 233467899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+..  ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +++||||||+|||++.++.++|
T Consensus        77 ~~~~~--~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l  150 (284)
T cd05079          77 EDGGN--GIKLIMEFLPSGSLKEYLPRN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKI  150 (284)
T ss_pred             cCCCC--ceEEEEEccCCCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEE
Confidence            75322  268999999999999998654 24689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++........ .......++..|+|||++.+..++.++|||||||++|||++++.|........    .....+.
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~----~~~~~~~  226 (284)
T cd05079         151 GDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF----LKMIGPT  226 (284)
T ss_pred             CCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh----hhhcccc
Confidence            999999865432211 11223456778999999988889999999999999999999876643211100    0000000


Q ss_pred             ccCc--cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          325 VSDS--KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       325 ~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ....  ...................+..+.+|+.+||+.+|.+|||+.++++.|+.+
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         227 HGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             cccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0000  000000000000111223567899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=2.1e-40  Score=324.33  Aligned_cols=244  Identities=23%  Similarity=0.341  Sum_probs=190.7

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccC-CCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||.||+|.+.           .++..||+|++.....   .....+.+|+.++.++ +||||+++++++....
T Consensus         1 ~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   69 (327)
T cd05617           1 RVIGRGSYAKVLLVRLK-----------KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTS   69 (327)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCC
Confidence            36999999999999976           4567899999975422   2345678899999888 6999999999987765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    +++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Df  140 (327)
T cd05617          70 R----LFLVIEYVNGGDLMFHMQRQ--RKLPEEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDY  140 (327)
T ss_pred             E----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEecc
Confidence            4    79999999999999988764  4689999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||............+.......  
T Consensus       141 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--  216 (327)
T cd05617         141 GMCKEGLGP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVIL--  216 (327)
T ss_pred             ccceeccCC--CCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHH--
Confidence            998753221  1223456799999999999999999999999999999999999999964321111110010000000  


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                             ...  ...+...+..+.+++.+||+.||.+||++
T Consensus       217 -------~~~--~~~p~~~~~~~~~li~~~L~~dP~~R~~~  248 (327)
T cd05617         217 -------EKP--IRIPRFLSVKASHVLKGFLNKDPKERLGC  248 (327)
T ss_pred             -------hCC--CCCCCCCCHHHHHHHHHHhccCHHHcCCC
Confidence                   000  01122345678999999999999999985

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.7e-40  Score=322.04  Aligned_cols=242  Identities=24%  Similarity=0.383  Sum_probs=193.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCC-CCceeeEeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVK-HPNLVKLVGY  163 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~~  163 (453)
                      +|...++||+|+||+||+|.++           .++..||+|++....   ....+.+..|+.++..+. |++|++++++
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~   69 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERK-----------GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSC   69 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeE
Confidence            4777889999999999999876           456789999987532   233456788999998885 5778888888


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~Ey~~~g~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~i  140 (323)
T cd05615          70 FQTVDR----LYFVMEYVNGGDLMYHIQQV--GKFKEPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHI  140 (323)
T ss_pred             EecCCE----EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCE
Confidence            776553    79999999999999998765  4688999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+..
T Consensus       141 kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~---~~~~~i~~  215 (323)
T cd05615         141 KIADFGMCKEHMVDG--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED---ELFQSIME  215 (323)
T ss_pred             EEeccccccccCCCC--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH---HHHHHHHh
Confidence            999999987533221  1233456999999999999889999999999999999999999999764322   12111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                         ..            ..++...+.++.+++.+||+.+|.+|++.
T Consensus       216 ---~~------------~~~p~~~~~~~~~li~~~l~~~p~~R~~~  246 (323)
T cd05615         216 ---HN------------VSYPKSLSKEAVSICKGLMTKHPSKRLGC  246 (323)
T ss_pred             ---CC------------CCCCccCCHHHHHHHHHHcccCHhhCCCC
Confidence               00            01122345678999999999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=7.4e-40  Score=316.17  Aligned_cols=251  Identities=28%  Similarity=0.399  Sum_probs=203.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...+.||+|+||.||+|...           .++..||+|.+........+.+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~y~~~~~lg~g~~g~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   86 (297)
T cd06656          18 KKKYTRFEKIGQGASGTVYTAIDI-----------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL   86 (297)
T ss_pred             hhhceeeeeeccCCCeEEEEEEEC-----------CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            367899999999999999999865           456789999997665555677889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +++||||||+|||++.++.++|
T Consensus        87 ~~~~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l  156 (297)
T cd06656          87 VGDE----LWVVMEYLAGGSLTDVVTE---TCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKL  156 (297)
T ss_pred             cCCE----EEEeecccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            7654    7999999999999998865   3578889999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++.......  .......+++.|+|||.+.+..++.++|||||||++|+|++|..||....+......  ..    
T Consensus       157 ~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~--~~----  228 (297)
T cd06656         157 TDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA----  228 (297)
T ss_pred             CcCccceEccCCc--cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheee--ec----
Confidence            9999987654322  112345688999999999988899999999999999999999999965432111000  00    


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               .........+...+..+.+++.+||..+|++||++.+|++
T Consensus       229 ---------~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (297)
T cd06656         229 ---------TNGTPELQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ  268 (297)
T ss_pred             ---------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                     0000001112234567899999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=2.7e-40  Score=314.14  Aligned_cols=256  Identities=30%  Similarity=0.506  Sum_probs=198.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      +.||+|+||.||+|++.....     ....+..+|||.+.... ......|.+|+.+++.++||||+++++++.....  
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~-----~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   73 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILG-----PGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEP--   73 (269)
T ss_pred             CccccccceeEEeeeeccccc-----CcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCC--
Confidence            369999999999998753211     11234679999886543 2345678999999999999999999999876654  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-----
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRV-----PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-----  241 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-----  241 (453)
                        .++||||+++++|.+++....     ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++     
T Consensus        74 --~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~  148 (269)
T cd05044          74 --QYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADR  148 (269)
T ss_pred             --eEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCc
Confidence              699999999999999997542     23478899999999999999999998   999999999999999877     


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  320 (453)
                      .++|+|||++................++..|+|||++.++.++.++|||||||++|||++ |..||.......   ....
T Consensus       149 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~---~~~~  225 (269)
T cd05044         149 VVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQE---VLQH  225 (269)
T ss_pred             ceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHH---HHHH
Confidence            899999999976543222222233456788999999999999999999999999999998 999986443221   1111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      +.    ....          .......+..+.+++.+||..+|.+||++.+|++.|.
T Consensus       226 ~~----~~~~----------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         226 VT----AGGR----------LQKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             Hh----cCCc----------cCCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            11    0000          0112234678999999999999999999999999885

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=4.1e-40  Score=310.45  Aligned_cols=251  Identities=25%  Similarity=0.361  Sum_probs=202.6

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +|...+.||+|+||.||++.+.           .++..+|+|.+.... ....+.+.+|+.+++.++||||+++++++..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   69 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHV-----------NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEA   69 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEc-----------CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEE
Confidence            4778899999999999999875           346789999986432 3345678899999999999999999999877


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    +++||||+++++|.+++.......++....+.++.|++.||.|||+.   +|+|+||||+||++++++.++|+
T Consensus        70 ~~~----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~  142 (255)
T cd08219          70 DGH----LYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLG  142 (255)
T ss_pred             CCE----EEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEc
Confidence            654    79999999999999998765556788999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||++.......  .......|++.|+|||++.+..++.++||||||+++|+|++|..||........   ......   
T Consensus       143 dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~---~~~~~~---  214 (255)
T cd08219         143 DFGSARLLTSPG--AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL---ILKVCQ---  214 (255)
T ss_pred             ccCcceeecccc--cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHH---HHHHhc---
Confidence            999997654321  123345789999999999988899999999999999999999999975432211   111100   


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                        ...    .     ..+...+..+.+|+.+||+.||.+|||+.+|+..
T Consensus       215 --~~~----~-----~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         215 --GSY----K-----PLPSHYSYELRSLIKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             --CCC----C-----CCCcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence              000    0     0112245678999999999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=6.2e-40  Score=322.04  Aligned_cols=268  Identities=26%  Similarity=0.425  Sum_probs=206.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      .+|...+.||+|+||.||+|.+......    .......||+|.+.... ......+.+|+.+++++ +||||++++++|
T Consensus        12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~----~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   87 (334)
T cd05100          12 TRLTLGKPLGEGCFGQVVMAEAIGIDKD----KPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGAC   87 (334)
T ss_pred             hHeeecceeccccCCcEEEEEEeccCCc----cCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence            4688889999999999999986532110    11233479999886432 23356789999999999 899999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                      .....    .+++|||+++|+|.+++....              ...+++..++.++.|++.||.|||+.   +|+||||
T Consensus        88 ~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dl  160 (334)
T cd05100          88 TQDGP----LYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDL  160 (334)
T ss_pred             ccCCc----eEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHC---Ceecccc
Confidence            87654    699999999999999997542              23478889999999999999999998   9999999


Q ss_pred             ccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCC
Q 043568          231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERN  309 (453)
Q Consensus       231 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~  309 (453)
                      ||+|||++.++.+||+|||+++...............++..|+|||++.+..++.++|||||||++|||++ |..||...
T Consensus       161 kp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~  240 (334)
T cd05100         161 AARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  240 (334)
T ss_pred             ccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence            99999999999999999999986543221111222344568999999999899999999999999999998 78888654


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ....   +...+..    ..          ....+...+..+.+++.+||+.+|.+|||+.++++.|..+...
T Consensus       241 ~~~~---~~~~~~~----~~----------~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         241 PVEE---LFKLLKE----GH----------RMDKPANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             CHHH---HHHHHHc----CC----------CCCCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            3221   1111110    00          0011223456799999999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=1.1e-39  Score=314.76  Aligned_cols=250  Identities=28%  Similarity=0.422  Sum_probs=204.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .+|...+.||.|+||.||+|++.           .++..||+|.+........+.+.+|+.+++.++||||+++++++..
T Consensus        19 ~~y~~~~~lg~g~~g~vy~~~~~-----------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   87 (296)
T cd06655          19 KKYTRYEKIGQGASGTVFTAIDV-----------ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV   87 (296)
T ss_pred             ceEEEEEEEecCCCeEEEEEEEc-----------CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEec
Confidence            46899999999999999999865           4567899999876655566788999999999999999999999977


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++|+||+++++|.+++...   .+++..++.++.+++.||.|||+.   +++||||||+||+++.++.+||+
T Consensus        88 ~~~----~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~  157 (296)
T cd06655          88 GDE----LFVVMEYLAGGSLTDVVTET---CMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLT  157 (296)
T ss_pred             Cce----EEEEEEecCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEc
Confidence            554    79999999999999988653   688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||++........  ......++..|+|||.+.+..++.++|||||||++|+|++|+.||....+........  ..   
T Consensus       158 dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~--~~---  230 (296)
T cd06655         158 DFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA--TN---  230 (296)
T ss_pred             cCccchhcccccc--cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hc---
Confidence            9999876543221  1234568899999999998889999999999999999999999997654322211110  00   


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ..       +.  ...+...+..+.++|.+||..+|.+|||+.+|++
T Consensus       231 -~~-------~~--~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~  268 (296)
T cd06655         231 -GT-------PE--LQNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ  268 (296)
T ss_pred             -CC-------cc--cCCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence             00       00  0112234567899999999999999999999984

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.8e-40  Score=321.68  Aligned_cols=251  Identities=26%  Similarity=0.375  Sum_probs=211.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCC-CCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVK-HPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~-h~nIv~l~  161 (453)
                      ...|...+.||+|.||.||+++.+           .++..+|+|.+.+....   ....+.+|+.+|+++. |||||.++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~-----------~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~  102 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREK-----------STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLK  102 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEec-----------CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEE
Confidence            456888889999999999999986           44788999999876543   3457889999999998 99999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC--
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE--  239 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~--  239 (453)
                      +.+.....    .++|||+|.||.|.+.+...   .+++..+..++.|++.++.|||+.   ||+||||||+|+|+..  
T Consensus       103 ~~~e~~~~----~~lvmEL~~GGeLfd~i~~~---~~sE~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~  172 (382)
T KOG0032|consen  103 DAFEDPDS----VYLVMELCEGGELFDRIVKK---HYSERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKD  172 (382)
T ss_pred             EEEEcCCe----EEEEEEecCCchHHHHHHHc---cCCHHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeecccc
Confidence            99998875    79999999999999999887   389999999999999999999998   9999999999999954  


Q ss_pred             --CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          240 --DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       240 --~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                        ++.+|++|||++.....   .......+||+.|+|||++....|+..+||||+||++|.|++|.+||...........
T Consensus       173 ~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~  249 (382)
T KOG0032|consen  173 EGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA  249 (382)
T ss_pred             CCCCcEEEeeCCCceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence              35799999999998654   3346778999999999999999999999999999999999999999987654332221


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +...              +...........+..+.+++..|+..||.+|+|+.++++
T Consensus       250 i~~~--------------~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~  292 (382)
T KOG0032|consen  250 ILRG--------------DFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQ  292 (382)
T ss_pred             HHcC--------------CCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhc
Confidence            1110              112222333455788999999999999999999999987

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.1e-39  Score=310.13  Aligned_cols=254  Identities=28%  Similarity=0.399  Sum_probs=189.4

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .||+|+||.||+|.....         .....+|+|.+..... .....|.+|+.+++.++||||+++++++.....   
T Consensus         2 ~lg~G~fg~v~~~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~---   69 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRG---------MSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIP---   69 (269)
T ss_pred             cCCccCCceEEEEEEecC---------CCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCc---
Confidence            589999999999976421         2345789998764432 234568899999999999999999999987654   


Q ss_pred             eEEEEEEecCCCChHHhhhcCCC---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVP---TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~---~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                       .++||||+++|+|.+++.....   ...++...+.++.||+.||+|||+.   +|+||||||+|||++.++.+||+|||
T Consensus        70 -~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg  145 (269)
T cd05042          70 -YLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYG  145 (269)
T ss_pred             -eEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccc
Confidence             7999999999999999976532   2346777889999999999999998   99999999999999999999999999


Q ss_pred             cccCCCCCCCCccccccccCcCCCCcccccc-------CCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhh
Q 043568          250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-------GRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       250 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  321 (453)
                      ++................++..|+|||++..       ..++.++|||||||++|||++ |..||....+..  .+....
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~--~~~~~~  223 (269)
T cd05042         146 LALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ--VLKQVV  223 (269)
T ss_pred             cccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH--HHHHHh
Confidence            9875433221111233456678999998753       356789999999999999999 677776543221  111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      ..     .. ..+..+    ..+...+..+.+++..|| .||++|||+++|++.|
T Consensus       224 ~~-----~~-~~~~~~----~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         224 RE-----QD-IKLPKP----QLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             hc-----cC-ccCCCC----cccccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            10     00 001111    122334567788999998 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.7e-40  Score=324.71  Aligned_cols=241  Identities=27%  Similarity=0.358  Sum_probs=189.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHH-HhccCCCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVN-FLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||+||+|.+.           .++..||+|++....   ......+..|.. +++.++||||+++++++...+
T Consensus         1 ~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~   69 (325)
T cd05604           1 KVIGKGSFGKVLLAKRK-----------LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTE   69 (325)
T ss_pred             CceeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCC
Confidence            36999999999999875           457789999986532   122345556655 467899999999999887765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~Df  140 (325)
T cd05604          70 K----LYFVLDFVNGGELFFHLQRE--RSFPEPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDF  140 (325)
T ss_pred             E----EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeec
Confidence            4    79999999999999988764  5788999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|..||.......   +.....   ...
T Consensus       141 G~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~---~~~~~~---~~~  212 (325)
T cd05604         141 GLCKEGIAQ--SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE---MYDNIL---HKP  212 (325)
T ss_pred             CCcccCCCC--CCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH---HHHHHH---cCC
Confidence            998753221  112345679999999999999999999999999999999999999997643221   111111   000


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                                +  ......+..+.+++.+||..+|.+||++.+.+
T Consensus       213 ----------~--~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~  245 (325)
T cd05604         213 ----------L--VLRPGASLTAWSILEELLEKDRQRRLGAKEDF  245 (325)
T ss_pred             ----------c--cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence                      0  01112356788999999999999999986443

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=4.7e-40  Score=314.69  Aligned_cols=276  Identities=26%  Similarity=0.385  Sum_probs=206.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +.|...+.||+|+||.||+|.+...       ....+..||||.+...... ....|.+|+.+++.+.||||+++++++.
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~-------~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~   76 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPL-------GDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCE   76 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCC-------CCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeee
Confidence            3566778999999999999987521       1245678999998755443 4578999999999999999999999887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      .....  ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        77 ~~~~~--~~~lv~e~~~~~~l~~~l~~~~-~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l  150 (284)
T cd05038          77 KPGGR--SLRLIMEYLPSGSLRDYLQRHR-DQINLKRLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKI  150 (284)
T ss_pred             cCCCC--ceEEEEecCCCCCHHHHHHhCc-cccCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEE
Confidence            64322  3699999999999999997653 3589999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++......... .......++..|+|||.+.+..++.++||||||++++||++|..|+.........    +..+.
T Consensus       151 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~----~~~~~  226 (284)
T cd05038         151 SDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLR----MIGIA  226 (284)
T ss_pred             cccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhcc----ccccc
Confidence            999999876532111 1112234556799999998889999999999999999999999987543211100    00000


Q ss_pred             c--cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          325 V--SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       325 ~--~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .  .....+...+........+..++.++.+|+.+||+.+|.+|||+.+|+++|+++
T Consensus       227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         227 QGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             cccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence            0  000000000011111111223457899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=3.4e-40  Score=328.16  Aligned_cols=262  Identities=22%  Similarity=0.280  Sum_probs=201.7

Q ss_pred             cHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCC
Q 043568           78 SFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKH  154 (453)
Q Consensus        78 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h  154 (453)
                      .+.++....++|...+.||+|+||.||++.+.           .++..||+|++....   ......+.+|+.+++.++|
T Consensus        34 ~~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~-----------~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~h  102 (371)
T cd05622          34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS  102 (371)
T ss_pred             HHhhcCcchhhcEEEEEEeecCCeEEEEEEEC-----------CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCC
Confidence            34455556789999999999999999999976           456789999986432   1233457789999999999


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      |||+++++++.....    .++||||+++|+|.+++...   .++...+..++.||+.||.|||+.   +|+||||||+|
T Consensus       103 p~iv~~~~~~~~~~~----~~lv~Ey~~gg~L~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~N  172 (371)
T cd05622         103 PWVVQLFYAFQDDRY----LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDN  172 (371)
T ss_pred             CCCCeEEEEEEcCCE----EEEEEcCCCCCcHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHH
Confidence            999999999876553    79999999999999988653   578888889999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC----CCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG----RLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      ||++.++.+||+|||+++....... .......||+.|+|||++.+.    .++.++|||||||++|||++|..||....
T Consensus       173 Ill~~~~~ikL~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  251 (371)
T cd05622         173 MLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  251 (371)
T ss_pred             EEECCCCCEEEEeCCceeEcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence            9999999999999999986543221 123456799999999998753    37899999999999999999999997643


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS--RPKMSEVVDI  375 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ei~~~  375 (453)
                      ....   ...+.   .....        +........+..+.+++.+||..++.+  ||++.+|++.
T Consensus       252 ~~~~---~~~i~---~~~~~--------~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h  304 (371)
T cd05622         252 LVGT---YSKIM---NHKNS--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH  304 (371)
T ss_pred             HHHH---HHHHH---cCCCc--------ccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence            2211   11111   00000        000111234677899999999844433  6788888764

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=1.6e-39  Score=309.15  Aligned_cols=261  Identities=26%  Similarity=0.444  Sum_probs=204.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...++||+|+||.||+|.+....        .....||||...... ....+.+.+|+.+++.++||||+++++++.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~--------~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   77 (270)
T cd05056           6 EDITLGRCIGEGQFGDVYQGVYMSPE--------NEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT   77 (270)
T ss_pred             hhceeeeeeCCccceeEEEEEEecCC--------CCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEc
Confidence            45778889999999999999875321        223569999876543 334567899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ...     .++||||+++|+|.+++... ...+++..++.++.+++.||.|||+.   +++|+||||+|||++.++.++|
T Consensus        78 ~~~-----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l  148 (270)
T cd05056          78 ENP-----VWIVMELAPLGELRSYLQVN-KYSLDLASLILYSYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKL  148 (270)
T ss_pred             CCC-----cEEEEEcCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEE
Confidence            543     58999999999999999764 24689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++....... .......++..|+|||.+....++.++||||||+++|||++ |..||........   .....  
T Consensus       149 ~d~g~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~---~~~~~--  222 (270)
T cd05056         149 GDFGLSRYLEDESY-YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV---IGRIE--  222 (270)
T ss_pred             ccCceeeecccccc-eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH---HHHHH--
Confidence            99999986543221 11222334568999999988889999999999999999986 9999865432211   11111  


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                        .....          ..+..++..+.+++.+|+..+|.+|||+.++++.|.++..+
T Consensus       223 --~~~~~----------~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         223 --NGERL----------PMPPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             --cCCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence              00000          11223466899999999999999999999999999987653

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.4e-40  Score=328.24  Aligned_cols=252  Identities=23%  Similarity=0.324  Sum_probs=195.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||++.+.           .++..||||++....   ......+..|+.++..++||||++++++
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~   69 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKK-----------DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYS   69 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            46888999999999999999976           456789999986432   2334567889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    ++|||||+++|+|.+++...  ..++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~v  140 (360)
T cd05627          70 FQDKRN----LYLIMEFLPGGDMMTLLMKK--DTLSEEATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHV  140 (360)
T ss_pred             EEcCCE----EEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCE
Confidence            877654    79999999999999999765  4688889999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCC---------------------------------ccccccccCcCCCCccccccCCCCCchhHH
Q 043568          244 KLSDFGLARQGPPEGLG---------------------------------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVW  290 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~  290 (453)
                      ||+|||+++........                                 .......||+.|+|||++.+..++.++|||
T Consensus       141 kL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Diw  220 (360)
T cd05627         141 KLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWW  220 (360)
T ss_pred             EEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceec
Confidence            99999998753211000                                 001235799999999999999999999999


Q ss_pred             HHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC--
Q 043568          291 SFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK--  368 (453)
Q Consensus       291 SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs--  368 (453)
                      ||||++|||++|+.||....+......+   ...   ....  .+.+      ....+.++.+|+.+|+ .+|.+|++  
T Consensus       221 SlGvilyel~tG~~Pf~~~~~~~~~~~i---~~~---~~~~--~~p~------~~~~s~~~~~li~~l~-~~p~~R~~~~  285 (360)
T cd05627         221 SLGVIMYEMLIGYPPFCSETPQETYRKV---MNW---KETL--VFPP------EVPISEKAKDLILRFC-TDSENRIGSN  285 (360)
T ss_pred             cccceeeecccCCCCCCCCCHHHHHHHH---HcC---CCce--ecCC------CCCCCHHHHHHHHHhc-cChhhcCCCC
Confidence            9999999999999999765443221111   100   0000  0000      1123567888998876 49999986  


Q ss_pred             -HHHHH
Q 043568          369 -MSEVV  373 (453)
Q Consensus       369 -~~ei~  373 (453)
                       +.+++
T Consensus       286 ~~~ei~  291 (360)
T cd05627         286 GVEEIK  291 (360)
T ss_pred             CHHHHh
Confidence             45554

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=3.9e-40  Score=310.55  Aligned_cols=247  Identities=30%  Similarity=0.497  Sum_probs=199.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||.||+|..             .+..||+|.+....  ....+.+|+.++++++||||+++++++..
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~-------------~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   70 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY-------------TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH   70 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc-------------CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC
Confidence            4578889999999999999863             35679999985432  34678899999999999999999999865


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ..     .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +++||||||+|||++.++.+||+
T Consensus        71 ~~-----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~  142 (254)
T cd05083          71 NG-----LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVS  142 (254)
T ss_pred             CC-----cEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEEC
Confidence            43     58999999999999999876556789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++......     ......+..|+|||++.++.++.++|||||||++|||++ |+.||...........   ...  
T Consensus       143 Dfg~~~~~~~~-----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~---~~~--  212 (254)
T cd05083         143 DFGLARVGSMG-----VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKEC---VEK--  212 (254)
T ss_pred             CCccceecccc-----CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHH---HhC--
Confidence            99998764321     122334568999999988899999999999999999998 8888865433221111   110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                        ..          ....+...+..+.+++.+||+.+|++||++.+|++.|+.
T Consensus       213 --~~----------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         213 --GY----------RMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             --CC----------CCCCCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence              00          001112345778999999999999999999999988753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=6.9e-40  Score=311.07  Aligned_cols=254  Identities=26%  Similarity=0.369  Sum_probs=200.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|++.           .++..||+|.+..........+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~   76 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNV-----------NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYL   76 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEc-----------CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            356777889999999999999875           456789999987655445566889999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        77 ~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l  147 (267)
T cd06645          77 RRDK----LWICMEFCGGGSLQDIYHVT--GPLSESQIAYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKL  147 (267)
T ss_pred             eCCE----EEEEEeccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence            7654    79999999999999988765  4688999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|||++......  ........|+..|+|||++.   ...++.++|||||||++|+|++|..||....+.......  ..
T Consensus       148 ~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~--~~  223 (267)
T cd06645         148 ADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM--TK  223 (267)
T ss_pred             CcceeeeEccCc--ccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh--hc
Confidence            999998754321  11223457899999999874   456889999999999999999999998654332211111  00


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..         ...+....  ....+..+.+++.+||..+|++|||+.+|++
T Consensus       224 ~~---------~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~  264 (267)
T cd06645         224 SN---------FQPPKLKD--KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ  264 (267)
T ss_pred             cC---------CCCCcccc--cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence            00         00011100  1123457899999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=4e-42  Score=302.02  Aligned_cols=251  Identities=25%  Similarity=0.396  Sum_probs=204.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++.|+..+.||+|.|+.||++.+.           .+++.+|+|.++...  ..+.+++.+|+.|.+.|+||||+++.+.
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~-----------~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~t   78 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHK-----------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS   78 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhc-----------cchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhh
Confidence            566777789999999999999875           668889999886442  3456788899999999999999999988


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---C
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---D  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~  240 (453)
                      ..+...    .+||+|+|+|+.|..-|-.+  .-+++..+-..++||+++|.|+|.+   +|||||+||.|+||.+   .
T Consensus        79 i~~~~~----~ylvFe~m~G~dl~~eIV~R--~~ySEa~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~  149 (355)
T KOG0033|consen   79 IQEESF----HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKG  149 (355)
T ss_pred             hcccce----eEEEEecccchHHHHHHHHH--HHHHHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCC
Confidence            776654    69999999999998777665  4567777888999999999999999   9999999999999954   3


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .-+||+|||+|.....   .......+|||+|||||++...+|+..+|||+.|||||-|+.|.+||.+...   ..+.+.
T Consensus       150 A~vKL~~FGvAi~l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~---~rlye~  223 (355)
T KOG0033|consen  150 AAVKLADFGLAIEVND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ---HRLYEQ  223 (355)
T ss_pred             CceeecccceEEEeCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH---HHHHHH
Confidence            3489999999987652   3456678999999999999999999999999999999999999999986432   233332


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                      +...           +-...+.+....+++..+|+.+||..||.+|.|+.|.+
T Consensus       224 I~~g-----------~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL  265 (355)
T KOG0033|consen  224 IKAG-----------AYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEAL  265 (355)
T ss_pred             Hhcc-----------ccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHh
Confidence            2211           01112223345577899999999999999999998865

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.4e-40  Score=311.40  Aligned_cols=252  Identities=33%  Similarity=0.541  Sum_probs=200.5

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHH--HHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK--EWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~--~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |+..+.||+|+||+||+++..           .++..||+|.+.........  ...+|+.++++++||||+++++++..
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~-----------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~   69 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNK-----------KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQD   69 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEET-----------TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEEC-----------CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccc
Confidence            456789999999999999976           55678999999876543322  34569999999999999999999988


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||+++++|.+++...  ..+++..++.++.|++.||.+||+.   +|+|+||||+|||++.++.++|+
T Consensus        70 ~~~----~~~v~~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~  140 (260)
T PF00069_consen   70 DNY----LYIVMEYCPGGSLQDYLQKN--KPLSEEEILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLI  140 (260)
T ss_dssp             SSE----EEEEEEEETTEBHHHHHHHH--SSBBHHHHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEES
T ss_pred             ccc----cccccccccccccccccccc--ccccccccccccccccccccccccc---ccccccccccccccccccccccc
Confidence            554    78999999999999999833  5789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccc-cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh-c
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP-Y  324 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-~  324 (453)
                      |||.+.....  .........++..|+|||++. +..++.++||||||+++|+|++|..||................. .
T Consensus       141 Dfg~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~  218 (260)
T PF00069_consen  141 DFGSSVKLSE--NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRP  218 (260)
T ss_dssp             SGTTTEESTS--TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTH
T ss_pred             cccccccccc--cccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhccccc
Confidence            9999975311  122345667899999999998 78899999999999999999999999986522222222221111 0


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....            .........+.+++.+||+.||++|||+.++++
T Consensus       219 ~~~~~------------~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~  256 (260)
T PF00069_consen  219 LPSSS------------QQSREKSEELRDLIKKMLSKDPEQRPSAEELLK  256 (260)
T ss_dssp             HHHHT------------TSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred             ccccc------------cccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            00000            000011378999999999999999999999874

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=9.3e-40  Score=308.14  Aligned_cols=251  Identities=25%  Similarity=0.371  Sum_probs=201.6

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|++|.||++.+.           .++..||+|.+.....  ...+.+.+|+.++++++|+||+++++.+.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHR-----------TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWE   69 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEc-----------CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeec
Confidence            4788899999999999999975           3456899999865432  33456889999999999999999998875


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.   .++++|||+++++|.+++.......+++.++..++.+++.||.+||+.   +|+||||||+||+++.++.++|
T Consensus        70 ~~~~---~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l  143 (257)
T cd08223          70 GEDG---LLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKV  143 (257)
T ss_pred             CCCC---EEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEE
Confidence            4332   368999999999999999876556789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++.......  .......+++.|+|||++.+..++.++||||||+++++|++|+.||.......  .......   
T Consensus       144 ~df~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~--~~~~~~~---  216 (257)
T cd08223         144 GDLGIARVLENQC--DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNS--LVYRIIE---  216 (257)
T ss_pred             ecccceEEecccC--CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHH--HHHHHHh---
Confidence            9999997653221  12334568899999999999999999999999999999999999986432211  1111100   


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         ...         ...+...+..+.+++.+||+.+|++|||+.++++
T Consensus       217 ---~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  253 (257)
T cd08223         217 ---GKL---------PPMPKDYSPELGELIATMLSKRPEKRPSVKSILR  253 (257)
T ss_pred             ---cCC---------CCCccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence               000         0112234578999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.2e-39  Score=306.17  Aligned_cols=246  Identities=30%  Similarity=0.476  Sum_probs=195.0

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      +||+|+||.||+|.+.            ++..+|+|.+...... ....|.+|+.+++.++||||+++++++.....   
T Consensus         2 ~ig~g~~g~vy~~~~~------------~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~---   66 (250)
T cd05085           2 LLGKGNFGEVFKGTLK------------DKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP---   66 (250)
T ss_pred             ccCCCCCceEEEEEec------------CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCc---
Confidence            6999999999999853            3567999998654322 23468899999999999999999999987654   


Q ss_pred             eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR  252 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~  252 (453)
                       .++||||+++++|.+++.... ..+++..++.++.+++.||.|||+.   +++||||||+||+++.++.+||+|||++.
T Consensus        67 -~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~  141 (250)
T cd05085          67 -IYIVMELVPGGDFLSFLRKKK-DELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSR  141 (250)
T ss_pred             -cEEEEECCCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccce
Confidence             699999999999999887643 4678999999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          253 QGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       253 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      ...... ........++..|+|||++.+..++.++||||||+++|+|++ |..||........   ...+..    ..  
T Consensus       142 ~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~---~~~~~~----~~--  211 (250)
T cd05085         142 QEDDGI-YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA---REQVEK----GY--  211 (250)
T ss_pred             eccccc-cccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH---HHHHHc----CC--
Confidence            543221 111122344678999999998889999999999999999998 8889865432221   111111    00  


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                              ....+...+..+.+++.+||+.+|++||++.++++.|.
T Consensus       212 --------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         212 --------RMSCPQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA  249 (250)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence                    00112234678999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=9.6e-40  Score=324.48  Aligned_cols=267  Identities=26%  Similarity=0.324  Sum_probs=198.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           ..+..||||++....  ......+.+|+.+++.++||||++++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~   91 (364)
T cd07875          23 LKRYQNLKPIGSGAQGIVCAAYDA-----------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV   91 (364)
T ss_pred             hcceeEEEEeecCCCeEEEEEEEC-----------CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCcccccee
Confidence            578999999999999999999875           446789999987542  2334668899999999999999999998


Q ss_pred             eeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.....  .....++||||++ ++|.+++..    .+++..+..++.|++.||.|||++   +|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~  163 (364)
T cd07875          92 FTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC  163 (364)
T ss_pred             ecccccccccCeEEEEEeCCC-CCHHHHHHh----cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCC
Confidence            765432  1224799999995 577777643    477888899999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~  320 (453)
                      .+||+|||+++.....   .......||..|+|||++.+..++.++|||||||++|+|++|+.||.......... +...
T Consensus       164 ~~kL~DfG~a~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~  240 (364)
T cd07875         164 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  240 (364)
T ss_pred             cEEEEeCCCccccCCC---CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999864322   12344578999999999999999999999999999999999999997543322111 1000


Q ss_pred             ---------------hhhcccCcccc-----ccccCCcC---CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 ---------------VRPYVSDSKKF-----HLIIDPRL---EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ---------------~~~~~~~~~~~-----~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                     +..+..+....     ........   ...........+.+|+.+||..||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~  317 (364)
T cd07875         241 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  317 (364)
T ss_pred             cCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence                           00000000000     00000000   00011122457899999999999999999999886

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1e-39  Score=323.28  Aligned_cols=261  Identities=23%  Similarity=0.334  Sum_probs=194.1

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ...+|...+.||+|+||.||+|++.           ..+..||+|.....      ....|+.++++++||||+++++++
T Consensus        64 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~  126 (357)
T PHA03209         64 ASLGYTVIKTLTPGSEGRVFVATKP-----------GQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTL  126 (357)
T ss_pred             hhcCcEEEEEecCCCCeEEEEEEEC-----------CCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheE
Confidence            3568999999999999999999975           34568999975332      235699999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+ .++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       127 ~~~~~----~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~k  197 (357)
T PHA03209        127 VSGAI----TCMVLPHY-SSDLYTYLTKR-SRPLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVC  197 (357)
T ss_pred             EeCCe----eEEEEEcc-CCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEE
Confidence            87654    68999999 57888888654 35789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh--------HH
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE--------QK  316 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~--------~~  316 (453)
                      |+|||++......   .......||..|+|||++.+..++.++|||||||++|||+++..++....+...        ..
T Consensus       198 l~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~  274 (357)
T PHA03209        198 IGDLGAAQFPVVA---PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSH  274 (357)
T ss_pred             EecCccccccccC---cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHH
Confidence            9999999753221   122345799999999999998999999999999999999997666543322221        11


Q ss_pred             HHHhhhhcccCccccc---------cccCC--cCCCc-------cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFH---------LIIDP--RLEGN-------YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~---------~~~~~--~~~~~-------~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +.............+.         .+++.  .....       .....+..+.+||.+||+.||.+|||+.|+++
T Consensus       275 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~  350 (357)
T PHA03209        275 LLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILN  350 (357)
T ss_pred             HHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhc
Confidence            1111110000000000         00000  00000       01123456778999999999999999999875

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=3e-40  Score=323.05  Aligned_cols=241  Identities=26%  Similarity=0.348  Sum_probs=189.0

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHH-HhccCCCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVN-FLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      +.||+|+||+||+|++.           .++..||+|++.....   .....+..|.. +++.++||||+++++++...+
T Consensus         1 ~~lg~G~fg~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~   69 (325)
T cd05602           1 KVIGKGSFGKVLLARHK-----------AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTAD   69 (325)
T ss_pred             CeeeeCCCeEEEEEEEC-----------CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCC
Confidence            36999999999999975           4467899999865321   22234445544 567889999999999987765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|.+++...  ..+.......++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~Df  140 (325)
T cd05602          70 K----LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDF  140 (325)
T ss_pred             e----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccC
Confidence            4    79999999999999998764  4577788888999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+..   ..
T Consensus       141 G~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i~~---~~  212 (325)
T cd05602         141 GLCKENIEH--NGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE---MYDNILN---KP  212 (325)
T ss_pred             CCCcccccC--CCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHH---HHHHHHh---CC
Confidence            999753221  112345679999999999999999999999999999999999999997543221   1111110   00


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                                  .......+..+.+++.+||+.+|.+||++.+.+
T Consensus       213 ------------~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~  245 (325)
T cd05602         213 ------------LQLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  245 (325)
T ss_pred             ------------cCCCCCCCHHHHHHHHHHcccCHHHCCCCCCCH
Confidence                        011223456789999999999999999987544

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=5.8e-40  Score=314.75  Aligned_cols=267  Identities=28%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCC
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHP  155 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~  155 (453)
                      +.++.+..++++|...+.||+|+||.||+|.+.           ..+..+|+|.+.... .....+.+|+.+++.+ +||
T Consensus         8 ~~~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~-----------~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~   75 (286)
T cd06638           8 IIFDSFPDPSDTWEIIETIGKGTYGKVFKVLNK-----------KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHP   75 (286)
T ss_pred             EEeecCCCcccceeeeeeeccCCCcEEEEEEEC-----------CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCC
Confidence            455666778899999999999999999999975           446789999876432 2345688899999999 799


Q ss_pred             ceeeEeeeeeecc-cccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          156 NLVKLVGYCAEDD-ERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       156 nIv~l~~~~~~~~-~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      ||+++++++.... ..+...++||||+++++|.+++...  ....+++..+..++.|++.||.|||+.   +|+||||||
T Consensus        76 ~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp  152 (286)
T cd06638          76 NVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKG  152 (286)
T ss_pred             CeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhC---CccccCCCH
Confidence            9999999886432 2223579999999999999987642  234688888999999999999999998   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      +||+++.++.++|+|||++.......  .......|++.|+|||++..     ..++.++|||||||++|||++|+.||.
T Consensus       153 ~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~  230 (286)
T cd06638         153 NNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA  230 (286)
T ss_pred             HhEEECCCCCEEEccCCceeecccCC--CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCC
Confidence            99999999999999999987654321  12234578999999998753     457889999999999999999999986


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ...+...  +.....     ..      .+.+  ..+...+..+.+|+.+||+.+|++|||+.+|++.
T Consensus       231 ~~~~~~~--~~~~~~-----~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~  283 (286)
T cd06638         231 DLHPMRA--LFKIPR-----NP------PPTL--HQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH  283 (286)
T ss_pred             CCchhHH--Hhhccc-----cC------CCcc--cCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence            5432211  111000     00      0000  0111234579999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=317.53  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=211.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc--HHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .+=|...+-||+|.|++|-+|++.           .++..||||++.+...+.  ...+.+|++.|+.++|||||++|++
T Consensus        17 AGLYDLekTlG~GHFAVVKLArHV-----------FTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEV   85 (864)
T KOG4717|consen   17 AGLYDLEKTLGRGHFAVVKLARHV-----------FTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEV   85 (864)
T ss_pred             eeeehhhhhhcCCceehhhhhhhh-----------cccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeeh
Confidence            345777778999999999999876           678899999998776544  4568899999999999999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE-cCCCc
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL-DEDYK  242 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl-~~~~~  242 (453)
                      ......    +|||+|+-++|+|+|||.++. ..+.+....+++.||+.|+.|+|+.   .+|||||||+||.+ ..-|-
T Consensus        86 iDTQTK----lyLiLELGD~GDl~DyImKHe-~Gl~E~La~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGl  157 (864)
T KOG4717|consen   86 IDTQTK----LYLILELGDGGDLFDYIMKHE-EGLNEDLAKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGL  157 (864)
T ss_pred             hcccce----EEEEEEecCCchHHHHHHhhh-ccccHHHHHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCc
Confidence            877654    899999999999999998874 5788888999999999999999998   99999999999876 56788


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCC-CchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT-AKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||++..+.+.   ...++.+|.+.|-|||++.+..|+ +++||||||||||.|++|+.||+.....         
T Consensus       158 VKLTDFGFSNkf~PG---~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------  225 (864)
T KOG4717|consen  158 VKLTDFGFSNKFQPG---KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------  225 (864)
T ss_pred             eEeeeccccccCCCc---chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------
Confidence            999999999876653   345678899999999999998886 6899999999999999999999865332         


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             ..+..++|-..  ..+...+.++.+||..||..||++|.+.++|+.
T Consensus       226 -------ETLTmImDCKY--tvPshvS~eCrdLI~sMLvRdPkkRAslEeI~s  269 (864)
T KOG4717|consen  226 -------ETLTMIMDCKY--TVPSHVSKECRDLIQSMLVRDPKKRASLEEIVS  269 (864)
T ss_pred             -------hhhhhhhcccc--cCchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence                   33333444332  345677899999999999999999999999874

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=2.2e-39  Score=306.56  Aligned_cols=254  Identities=24%  Similarity=0.418  Sum_probs=202.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.            .+..+|+|.+.... .....|.+|+.+++.++|+||+++++++.
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~------------~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   71 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYN------------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT   71 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEec------------CCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEc
Confidence            467889999999999999999853            23569999876432 33467889999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      . ..    .+++|||+++++|.+++.......+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.+||
T Consensus        72 ~-~~----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l  143 (260)
T cd05073          72 K-EP----IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKI  143 (260)
T ss_pred             C-CC----eEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEE
Confidence            6 22    69999999999999999876566789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........++..|+|||++....++.++|||||||++|+|++ |..||.......   +...... 
T Consensus       144 ~d~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~---~~~~~~~-  218 (260)
T cd05073         144 ADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRALER-  218 (260)
T ss_pred             CCCcceeeccCCC-cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHH---HHHHHhC-
Confidence            9999997643221 111223345678999999988889999999999999999999 888886543221   1111110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                         ...          .......+.++.+++.+||+.+|++||++.++.+.|+.
T Consensus       219 ---~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         219 ---GYR----------MPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             ---CCC----------CCCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence               000          01112345679999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.8e-40  Score=321.72  Aligned_cols=238  Identities=25%  Similarity=0.343  Sum_probs=187.5

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHH-HhccCCCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVN-FLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~-~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      ++||+|+||+||+|++.           .++..||+|++.....   .....+..|.. +++.++||||+++++++...+
T Consensus         1 ~~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~   69 (321)
T cd05603           1 KVIGKGSFGKVLLAKRK-----------SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAE   69 (321)
T ss_pred             CeeeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCC
Confidence            36999999999999975           4567899999865321   22344555654 578899999999999887765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|..++...  ..++...+..++.||+.||.|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Df  140 (321)
T cd05603          70 K----LYFVLDYVNGGELFFHLQRE--RCFLEPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDF  140 (321)
T ss_pred             E----EEEEEcCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccC
Confidence            4    79999999999999888764  5678888889999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|..||......   .+.+.+..   . 
T Consensus       141 g~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~---~~~~~i~~---~-  211 (321)
T cd05603         141 GLCKEGVEP--EETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS---QMYDNILH---K-  211 (321)
T ss_pred             CCCccCCCC--CCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH---HHHHHHhc---C-
Confidence            998753221  11234457899999999999889999999999999999999999999764321   11111110   0 


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS  370 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  370 (453)
                               .  ...+...+..+.+++.+||+.+|.+||++.
T Consensus       212 ---------~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~  242 (321)
T cd05603         212 ---------P--LQLPGGKTVAACDLLVGLLHKDQRRRLGAK  242 (321)
T ss_pred             ---------C--CCCCCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence                     0  011223456789999999999999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=8e-40  Score=313.23  Aligned_cols=265  Identities=26%  Similarity=0.347  Sum_probs=207.3

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCC
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHP  155 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~  155 (453)
                      .+..++..+.+.|...+.||.|+||.||+|.+.           ..+..+|+|.+.... .....+..|+.++.++ +|+
T Consensus         6 ~~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~   73 (282)
T cd06636           6 IDLSALRDPAGIFELVEVVGNGTYGQVYKGRHV-----------KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHR   73 (282)
T ss_pred             hhhhhhcChhhhhhhheeeccCCCeEEEEEEEc-----------CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCC
Confidence            356666677889999999999999999999975           446789999986543 2345688899999998 799


Q ss_pred             ceeeEeeeeeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          156 NLVKLVGYCAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       156 nIv~l~~~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      ||+++++++.....  .....+++|||+++|+|.+++.......+++..++.++.||+.||.|||+.   +|+|+||||+
T Consensus        74 ~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~  150 (282)
T cd06636          74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQ  150 (282)
T ss_pred             cEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHH
Confidence            99999999865321  123479999999999999999876556788888999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ||+++.++.++|+|||++.......  .......|+..|+|||.+.     ...++.++|||||||++|||++|..||..
T Consensus       151 nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~  228 (282)
T cd06636         151 NVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCD  228 (282)
T ss_pred             HEEECCCCCEEEeeCcchhhhhccc--cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccc
Confidence            9999999999999999987643211  1223457899999999876     34578899999999999999999999965


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..+........                ............+..+.+++.+||+.||.+|||+.+|++
T Consensus       229 ~~~~~~~~~~~----------------~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~  278 (282)
T cd06636         229 MHPMRALFLIP----------------RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK  278 (282)
T ss_pred             cCHHhhhhhHh----------------hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence            43222111100                000000111234568999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-39  Score=305.89  Aligned_cols=248  Identities=29%  Similarity=0.468  Sum_probs=196.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ++||+|+||.||+|.+.           . +..||+|.+...... ....|.+|+.++++++||||+++++++.....  
T Consensus         1 ~~lg~g~~g~v~~~~~~-----------~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   66 (251)
T cd05041           1 EKIGKGNFGDVYKGVLK-----------G-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP--   66 (251)
T ss_pred             CccccCCCceEEEEEEe-----------C-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCC--
Confidence            36999999999999875           3 678999998755433 45678999999999999999999999887664  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++... ...+++..++.++.+++.||.|||++   +++||||||+|||++.++.++|+|||++
T Consensus        67 --~~~v~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~  140 (251)
T cd05041          67 --IYIVMELVPGGSLLTFLRKK-KNRLTVKKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMS  140 (251)
T ss_pred             --eEEEEEcCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeecccc
Confidence              69999999999999998764 24678889999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKK  330 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ................++..|+|||.+.++.++.++|||||||++|||++ |..||.............   ..    . 
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~---~~----~-  212 (251)
T cd05041         141 REEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIE---SG----Y-  212 (251)
T ss_pred             ccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHh---cC----C-
Confidence            76432111111122234567999999988899999999999999999999 788886543322211111   00    0 


Q ss_pred             cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                               ....+...+..+.+++.+||..+|.+|||+.++++.|.
T Consensus       213 ---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         213 ---------RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ---------CCCCCccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence                     00112234568999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=1.1e-39  Score=311.14  Aligned_cols=261  Identities=25%  Similarity=0.405  Sum_probs=204.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+|.....||+|+||.||+|+.+...      .......|++|.+...... ....+.+|++++++++||||+++++++.
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~------~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   78 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIE------EEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCR   78 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCC------cCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEEC
Confidence            56888889999999999999975321      1234567999988654433 3467899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCC-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVP-------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ....    .++||||+++|+|.+++.....       ..+++..+..++.|++.||.|||+.   +|+||||||+|||++
T Consensus        79 ~~~~----~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~  151 (275)
T cd05046          79 EAEP----HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVS  151 (275)
T ss_pred             CCCc----ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEe
Confidence            7654    6999999999999999976541       2689999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHH
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKL  317 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~  317 (453)
                      .++.++|+|||++....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||......   .+
T Consensus       152 ~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~---~~  227 (275)
T cd05046         152 SQREVKVSLLSLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE---EV  227 (275)
T ss_pred             CCCcEEEcccccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH---HH
Confidence            99999999999987543221 112233456778999999988889999999999999999999 77787543221   12


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      ......     ...        ........+..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       228 ~~~~~~-----~~~--------~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         228 LNRLQA-----GKL--------ELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             HHHHHc-----CCc--------CCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            211110     000        00111234568999999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=2.9e-39  Score=309.69  Aligned_cols=266  Identities=23%  Similarity=0.328  Sum_probs=197.9

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||+|++.           .++..||||.+....  ......+.+|+.+++.++||||+++++++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   69 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNK-----------KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLM   69 (285)
T ss_pred             CceEeeEecccCceEEEEEEEC-----------CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEe
Confidence            4778889999999999999975           446789999986442  223467889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....    .++||||++ ++|.+++..... ..+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.++
T Consensus        70 ~~~~----~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~  141 (285)
T cd07861          70 QESR----LYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIK  141 (285)
T ss_pred             eCCe----EEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEE
Confidence            7553    799999996 689888865432 5789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~  322 (453)
                      |+|||++......  ........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||......... .......
T Consensus       142 l~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~  219 (285)
T cd07861         142 LADFGLARAFGIP--VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILG  219 (285)
T ss_pred             ECcccceeecCCC--cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhC
Confidence            9999999764322  112234467899999998865 45789999999999999999999999754322211 1111000


Q ss_pred             hc-------ccCccccccccCCcCC---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PY-------VSDSKKFHLIIDPRLE---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~-------~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..       ................   .......+.++.+++.+||..||.+|||+.+|+.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~  281 (285)
T cd07861         220 TPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN  281 (285)
T ss_pred             CCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence            00       0000000000000000   0001124677889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1.9e-39  Score=305.76  Aligned_cols=250  Identities=28%  Similarity=0.417  Sum_probs=203.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||.||+|.+.           .++..+|+|.+.....  .+.+.+|+.+++.++||||+++++++..
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~   69 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHK-----------ETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFK   69 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEc-----------CCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeec
Confidence            67888999999999999999976           3457899999865432  6789999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++++||+++++|.+++... ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        70 ~~~----~~l~~e~~~~~~L~~~l~~~-~~~l~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~  141 (256)
T cd06612          70 NTD----LWIVMEYCGAGSVSDIMKIT-NKTLTEEEIAAILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLA  141 (256)
T ss_pred             CCc----EEEEEecCCCCcHHHHHHhC-ccCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEc
Confidence            653    79999999999999998653 35789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||++.......  .......++..|+|||++.+..++.++||||||+++|+|++|+.||....+.......   ..   
T Consensus       142 dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~---~~---  213 (256)
T cd06612         142 DFGVSGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMI---PN---  213 (256)
T ss_pred             ccccchhcccCc--cccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhh---cc---
Confidence            999998754322  1233456889999999999889999999999999999999999998754322111100   00   


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               ........+...+..+.+++.+||+.+|.+|||+.+|++
T Consensus       214 ---------~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~  252 (256)
T cd06612         214 ---------KPPPTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ  252 (256)
T ss_pred             ---------CCCCCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence                     000001112234567999999999999999999999875

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=6.8e-40  Score=348.29  Aligned_cols=258  Identities=24%  Similarity=0.383  Sum_probs=200.8

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      ...++|.+.+.||+|+||+||+|.+.           ..+..||+|.+.....  .....|..|+.+|+.|+|||||+++
T Consensus        10 ~~l~~YeIl~kLG~GgFGtVYLAkdk-----------~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~   78 (1021)
T PTZ00266         10 SRLNEYEVIKKIGNGRFGEVFLVKHK-----------RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYI   78 (1021)
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEEC-----------CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEE
Confidence            34678999999999999999999976           4567899999875432  2346788999999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEeeccccccE
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMD----FQLIFRDFKTSNI  235 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~----~~iiH~Dlkp~NI  235 (453)
                      +++......  .++|||||+++|+|.++|....  ...+++..++.|+.||+.||.|||+...    .+||||||||+||
T Consensus        79 d~f~de~~~--~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNI  156 (1021)
T PTZ00266         79 DRFLNKANQ--KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNI  156 (1021)
T ss_pred             EEEEecCCC--EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHe
Confidence            988764432  3799999999999999987532  3468999999999999999999998521    2599999999999


Q ss_pred             EEcC-----------------CCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc--CCCCCchhHHHHHHHH
Q 043568          236 LLDE-----------------DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVL  296 (453)
Q Consensus       236 Ll~~-----------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil  296 (453)
                      ||+.                 .+.+||+|||++......   .......||+.|+|||++.+  ..++.++|||||||||
T Consensus       157 LL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~---s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~IL  233 (1021)
T PTZ00266        157 FLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE---SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCII  233 (1021)
T ss_pred             EeecCccccccccccccccCCCCceEEccCCcccccccc---ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHH
Confidence            9964                 334899999999865432   12345579999999999864  4588999999999999


Q ss_pred             HHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          297 YELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       297 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      |||++|..||.......  .++..+..    .        +.+.   ....+.++.+||..||..+|.+||++.+++.
T Consensus       234 YELLTGk~PF~~~~~~~--qli~~lk~----~--------p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~  294 (1021)
T PTZ00266        234 YELCSGKTPFHKANNFS--QLISELKR----G--------PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLG  294 (1021)
T ss_pred             HHHHHCCCCCCcCCcHH--HHHHHHhc----C--------CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence            99999999996543221  11111110    0        0000   0123567999999999999999999999984

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=3e-39  Score=306.55  Aligned_cols=250  Identities=26%  Similarity=0.416  Sum_probs=198.6

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---------HHHHHHHHHHhccCCCCcee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---------HKEWINEVNFLGVVKHPNLV  158 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---------~~~~~~E~~~l~~l~h~nIv  158 (453)
                      +|.....||+|+||.||+|.+.           ..+..||+|.+.......         .+.+.+|+.++++++||||+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~   69 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNA-----------SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIV   69 (267)
T ss_pred             CccccceeecCCCeEEEEEEec-----------CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCee
Confidence            4677889999999999999875           346789999886543221         24678899999999999999


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ++++++.....    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||+|+||+++
T Consensus        70 ~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~  140 (267)
T cd06628          70 QYLGSSLDADH----LNIFLEYVPGGSVAALLNNY--GAFEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVD  140 (267)
T ss_pred             eEEEEEEeCCc----cEEEEEecCCCCHHHHHHhc--cCccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEc
Confidence            99999887654    68999999999999999765  5678888899999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCc----cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGH----VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      .++.++|+|||+++.........    ......|+..|+|||.+.+..++.++|||||||++|+|++|+.||......  
T Consensus       141 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~--  218 (267)
T cd06628         141 NKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL--  218 (267)
T ss_pred             CCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH--
Confidence            99999999999988654221110    112345888999999998888999999999999999999999999754221  


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..+.....           ...+    ..+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       219 ~~~~~~~~-----------~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  263 (267)
T cd06628         219 QAIFKIGE-----------NASP----EIPSNISSEAIDFLEKTFEIDHNKRPTAAELLK  263 (267)
T ss_pred             HHHHHHhc-----------cCCC----cCCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence            11111000           0011    112234677999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=2.4e-39  Score=313.12  Aligned_cols=266  Identities=24%  Similarity=0.350  Sum_probs=199.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||.||+|.+.           .++..||+|.+..... .....+.+|+.+++.++||||+++++++.
T Consensus         6 ~~y~~~~~lg~g~~g~vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~   74 (301)
T cd07873           6 ETYIKLDKLGEGTYATVYKGRSK-----------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH   74 (301)
T ss_pred             cceEEeeEeccCcCEEEEEEEEc-----------CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEe
Confidence            56888999999999999999875           3467899999864432 23456788999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+||
T Consensus        75 ~~~~----~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  145 (301)
T cd07873          75 TEKS----LTLVFEYLD-KDLKQYLDDC-GNSINMHNVKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKL  145 (301)
T ss_pred             cCCe----EEEEEeccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEE
Confidence            7654    799999996 6899888764 34678889999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++.......  .......+++.|+|||++.+ ..++.++|||||||++|||++|+.||...........+......
T Consensus       146 ~dfg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~  223 (301)
T cd07873         146 ADFGLARAKSIPT--KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGT  223 (301)
T ss_pred             CcCcchhccCCCC--CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999997643221  12234467899999998865 45788999999999999999999999765432221111111000


Q ss_pred             cc--------CccccccccCCcCCC----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VS--------DSKKFHLIIDPRLEG----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~--------~~~~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..        ..........+....    ......+..+.+||.+||..||.+|||+.++++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~  285 (301)
T cd07873         224 PTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK  285 (301)
T ss_pred             CChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00        000000000011000    111234567899999999999999999999885

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=1.1e-39  Score=312.29  Aligned_cols=250  Identities=25%  Similarity=0.417  Sum_probs=197.8

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecc
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      |...+.||+|+||.||+|.+.           ..+..+|+|.+..........+.+|+.+++.++||||+++++++....
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~   75 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNK-----------ETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN   75 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEEC-----------CCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCC
Confidence            455678999999999999875           446789999987655555677899999999999999999999988765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++++|..++... ..++++..+..++.|++.||.|||+.   +++||||||+|||++.++.+||+||
T Consensus        76 ~----~~~v~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~df  147 (282)
T cd06643          76 N----LWILIEFCAGGAVDAVMLEL-ERPLTEPQIRVVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADF  147 (282)
T ss_pred             E----EEEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccc
Confidence            3    79999999999999887653 35789999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |++......  ........++..|+|||++.     +..++.++|||||||++|||++|+.||....+..  ........
T Consensus       148 g~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~~  223 (282)
T cd06643         148 GVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR--VLLKIAKS  223 (282)
T ss_pred             ccccccccc--ccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH--HHHHHhhc
Confidence            998764322  11233457899999999984     3457889999999999999999999986543221  11111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           .      .+..  ..+...+..+.+++.+||+.+|.+||++.++++
T Consensus       224 -----~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  261 (282)
T cd06643         224 -----E------PPTL--AQPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ  261 (282)
T ss_pred             -----C------CCCC--CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                 0      0000  111234567999999999999999999998864

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=3.8e-39  Score=314.02  Aligned_cols=200  Identities=26%  Similarity=0.381  Sum_probs=161.3

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      +.+||+|+||+||+|++...         ..+..||+|.+....  ....+.+|+.+|++++||||+++++++...... 
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~---------~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-   73 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDG---------KDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADR-   73 (317)
T ss_pred             ccccccCCCeEEEEEEEccC---------CCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCc-
Confidence            45899999999999987532         345789999986543  234577899999999999999999988654332 


Q ss_pred             ceEEEEEEecCCCChHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE----cCC
Q 043568          172 MQRLLVYELMHNKSLEDHLLSR-------VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL----DED  240 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl----~~~  240 (453)
                       ..+++|||+ +++|.+++...       ....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.+
T Consensus        74 -~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~  148 (317)
T cd07868          74 -KVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER  148 (317)
T ss_pred             -EEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCc
Confidence             378999999 56888877532       123588889999999999999999998   99999999999999    456


Q ss_pred             CcEEEeccccccCCCCCCC-CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          241 YKAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      +.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|++||..
T Consensus       149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~  218 (317)
T cd07868         149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccC
Confidence            7899999999986543211 112235678999999999876 4589999999999999999999999964

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=2.9e-39  Score=304.71  Aligned_cols=251  Identities=26%  Similarity=0.399  Sum_probs=204.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|+..++||.|+||.||.+...           .++..+++|.+....  ......+.+|+.++++++|+||+++++++.
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~   69 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRT-----------EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFM   69 (256)
T ss_pred             CceEeeEecccCCceEEEEEEc-----------CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEe
Confidence            5888899999999999998865           456789999986543  334567889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +...    ++++|||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.+||
T Consensus        70 ~~~~----~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl  142 (256)
T cd08221          70 DDNT----LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKL  142 (256)
T ss_pred             cCCe----EEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEE
Confidence            7654    79999999999999999876556789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++........  ......+++.|+|||.+.+..++.++||||||+++|||++|..||....+......+  ..   
T Consensus       143 ~d~~~~~~~~~~~~--~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~--~~---  215 (256)
T cd08221         143 GDFGISKILGSEYS--MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKI--VQ---  215 (256)
T ss_pred             CcCcceEEcccccc--cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHH--Hc---
Confidence            99999986543321  234457899999999998888899999999999999999999998654322211110  10   


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                         ....         ......+..+.+++.+||..+|.+||++.++++.
T Consensus       216 ---~~~~---------~~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~  253 (256)
T cd08221         216 ---GNYT---------PVVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ  253 (256)
T ss_pred             ---CCCC---------CCccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence               0000         0112345679999999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.4e-39  Score=316.86  Aligned_cols=263  Identities=22%  Similarity=0.292  Sum_probs=194.4

Q ss_pred             cceecCC--CceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           92 ALLIGEG--GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        92 ~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      ..+||+|  +||+||++.++           .++..||+|.+.....  .....+.+|+.+++.++||||+++++++...
T Consensus         3 ~~~ig~G~~~~~~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~   71 (327)
T cd08227           3 LTVIGRGFEDLMTVNLARYK-----------PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD   71 (327)
T ss_pred             hhhccccccceEEEEEEeec-----------ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC
Confidence            4689999  78999999976           5678899999875432  2235577899999999999999999999877


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      +.    .++||||+++|+|.+++..+....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.++++|
T Consensus        72 ~~----~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~  144 (327)
T cd08227          72 NE----LWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSG  144 (327)
T ss_pred             CE----EEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcc
Confidence            64    79999999999999999766556789999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCC-----CccccccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          248 FGLARQGPPEGL-----GHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       248 FGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      |+.+........     ........++..|+|||++.+  ..++.++|||||||++|||++|+.||.......  .....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~--~~~~~  222 (327)
T cd08227         145 LRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ--MLLEK  222 (327)
T ss_pred             cchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH--HHHHH
Confidence            986543221110     001123356788999999876  468999999999999999999999996532211  11111


Q ss_pred             hhhccc---Cc-----cc-------------ccc--c-------cCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH
Q 043568          321 VRPYVS---DS-----KK-------------FHL--I-------IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS  370 (453)
Q Consensus       321 ~~~~~~---~~-----~~-------------~~~--~-------~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  370 (453)
                      ......   +.     ..             ...  .       .............+..+.+|+.+||+.||++|||+.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~  302 (327)
T cd08227         223 LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSAS  302 (327)
T ss_pred             hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHH
Confidence            100000   00     00             000  0       000000011223456899999999999999999999


Q ss_pred             HHHH
Q 043568          371 EVVD  374 (453)
Q Consensus       371 ei~~  374 (453)
                      ++++
T Consensus       303 ell~  306 (327)
T cd08227         303 TLLN  306 (327)
T ss_pred             HHhc
Confidence            9986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-39  Score=309.68  Aligned_cols=249  Identities=31%  Similarity=0.460  Sum_probs=202.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||.|+||.||+|++.           .++..||+|.+.... ......+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   69 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDK-----------RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFL   69 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEEC-----------CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEE
Confidence            36788889999999999999975           456789999987543 334567889999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    +++|+||+++++|.+++...   ++++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|
T Consensus        70 ~~~~----~~~v~e~~~~~~L~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l  139 (274)
T cd06609          70 KGSK----LWIIMEYCGGGSCLDLLKPG---KLDETYIAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKL  139 (274)
T ss_pred             ECCe----EEEEEEeeCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEE
Confidence            7643    79999999999999998764   789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||+++......  .......++..|+|||++.+..++.++|||||||++|+|++|..||....+..   ....+..  
T Consensus       140 ~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~---~~~~~~~--  212 (274)
T cd06609         140 ADFGVSGQLTSTM--SKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR---VLFLIPK--  212 (274)
T ss_pred             cccccceeecccc--cccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH---HHHHhhh--
Confidence            9999998754321  12334578889999999998889999999999999999999999996543221   1111100  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        .      ..+.+...   ..+..+.+++.+||..+|++|||++++++
T Consensus       213 --~------~~~~~~~~---~~~~~~~~~l~~~l~~~p~~Rpt~~~il~  250 (274)
T cd06609         213 --N------NPPSLEGN---KFSKPFKDFVSLCLNKDPKERPSAKELLK  250 (274)
T ss_pred             --c------CCCCCccc---ccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence              0      00111110   14567899999999999999999999975

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-41  Score=327.96  Aligned_cols=245  Identities=33%  Similarity=0.485  Sum_probs=203.4

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      -|...+-||.|+||.||-|++.           .+...||||++...+.+.   ..++++|+..|++++|||++.+-||+
T Consensus        27 lf~dLrEIGHGSFGAVYfArd~-----------~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCy   95 (948)
T KOG0577|consen   27 LFSDLREIGHGSFGAVYFARDV-----------RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCY   95 (948)
T ss_pred             HHHHHHHhcCCccceeEEeecc-----------CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCccccccee
Confidence            3556667999999999999976           567889999998665544   46788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .+|||||| -|+-.|.|.-+ .+++....+..|+.+.+.||+|||++   +.||||||..||||++.|.||
T Consensus        96 Lre~T----aWLVMEYC-lGSAsDlleVh-kKplqEvEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VK  166 (948)
T KOG0577|consen   96 LREHT----AWLVMEYC-LGSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVK  166 (948)
T ss_pred             eccch----HHHHHHHH-hccHHHHHHHH-hccchHHHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeee
Confidence            88765    69999999 77888877654 36899999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      |+|||.|....+      ...++|||.|||||++.   .+.|+-++|||||||...||.-.++|++......  .+....
T Consensus       167 LaDFGSAsi~~P------AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS--ALYHIA  238 (948)
T KOG0577|consen  167 LADFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS--ALYHIA  238 (948)
T ss_pred             eccccchhhcCc------hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH--HHHHHH
Confidence            999999987554      46789999999999875   4789999999999999999999999987653221  111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .   .+.        |.+.   ..+.+..+..++..||+.-|.+|||.++++.
T Consensus       239 Q---Nes--------PtLq---s~eWS~~F~~Fvd~CLqKipqeRptse~ll~  277 (948)
T KOG0577|consen  239 Q---NES--------PTLQ---SNEWSDYFRNFVDSCLQKIPQERPTSEELLK  277 (948)
T ss_pred             h---cCC--------CCCC---CchhHHHHHHHHHHHHhhCcccCCcHHHHhh
Confidence            1   111        1111   3457888999999999999999999988764

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=7.1e-40  Score=309.65  Aligned_cols=246  Identities=24%  Similarity=0.423  Sum_probs=191.3

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccce
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQ  173 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  173 (453)
                      .||+|+||.||+|.....++.    +......||+|.+........+.+..|+.+++.++||||+++++++.....    
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~----~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~----   73 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDY----GELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDE----   73 (258)
T ss_pred             CCCcccchhheeeeecccccc----cccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCC----
Confidence            699999999999987532110    112345689998865544445678899999999999999999999987654    


Q ss_pred             EEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc--------EEE
Q 043568          174 RLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK--------AKL  245 (453)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~--------~kL  245 (453)
                      .++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.        +++
T Consensus        74 ~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l  149 (258)
T cd05078          74 SIMVQEYVKFGSLDTYLKKNK-NLINISWKLEVAKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKL  149 (258)
T ss_pred             cEEEEecCCCCcHHHHHhcCC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEe
Confidence            689999999999999997653 3688999999999999999999998   9999999999999987765        699


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCC-ccccCCCChhhHHHHHhhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR-RAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~-~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|||++.....      .....++..|+|||++.+ ..++.++|||||||++|||++|. .|+....+........    
T Consensus       150 ~d~g~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~----  219 (258)
T cd05078         150 SDPGISITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE----  219 (258)
T ss_pred             cccccccccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH----
Confidence            99999875432      233567889999999976 45799999999999999999995 4544322221111110    


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                         ..            ...+.....++.+|+.+||+.+|++|||+.+|++.|
T Consensus       220 ---~~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l  257 (258)
T cd05078         220 ---DR------------HQLPAPKWTELANLINQCMDYEPDFRPSFRAIIRDL  257 (258)
T ss_pred             ---cc------------ccCCCCCcHHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence               00            011122346789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=4e-39  Score=306.69  Aligned_cols=263  Identities=25%  Similarity=0.443  Sum_probs=202.0

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |...++||+|+||.||+|.+...        ...+..||||++.....  ...+++.+|+.+++.++||||+++++++..
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~--------~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   72 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSE--------DGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLR   72 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeecc--------CCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEcc
Confidence            55677899999999999987531        13467899999865432  235678899999999999999999998876


Q ss_pred             ccccc--ceEEEEEEecCCCChHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          167 DDERG--MQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       167 ~~~~~--~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ....+  ...+++++|+.+|+|.+++...    ....+++...+.++.|++.||+|||+.   +|+||||||+||+++.+
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~  149 (273)
T cd05074          73 SRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNEN  149 (273)
T ss_pred             CCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCC
Confidence            54322  1247899999999999887532    123578888999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~  319 (453)
                      +.+||+|||+++...............++..|++||.+....++.++|||||||++|||++ |..||......   .+..
T Consensus       150 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~---~~~~  226 (273)
T cd05074         150 MTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS---EIYN  226 (273)
T ss_pred             CCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH---HHHH
Confidence            9999999999986543221112233445678999999988889999999999999999999 78887644321   2222


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ....    ....          ......+..+.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       227 ~~~~----~~~~----------~~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         227 YLIK----GNRL----------KQPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             HHHc----CCcC----------CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            1110    0000          01123456799999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=3.1e-39  Score=306.58  Aligned_cols=253  Identities=24%  Similarity=0.368  Sum_probs=196.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-----ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-----QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .+|...++||+|+||.||+|.+.           ..+..||+|.+.....     .....+.+|+.+++.++||||++++
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   70 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDV-----------DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYY   70 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEc-----------CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEE
Confidence            47889999999999999999875           4467899998864322     2235688899999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....  ...++++||+++++|.+++...  ..+++...+.++.|++.||.|||+.   +|+||||||+||+++.++
T Consensus        71 ~~~~~~~~--~~~~l~~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~  143 (266)
T cd06651          71 GCLRDRAE--KTLTIFMEYMPGGSVKDQLKAY--GALTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAG  143 (266)
T ss_pred             EEEEcCCC--CEEEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCC
Confidence            98875432  1368999999999999999765  4578889999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCC-CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .++|+|||++........ ........++..|+|||++.+..++.++|||||||++|||++|+.||........  +...
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~--~~~~  221 (266)
T cd06651         144 NVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA--IFKI  221 (266)
T ss_pred             CEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH--HHHH
Confidence            999999999875432111 1112234688999999999888899999999999999999999999975422211  1110


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .    ...      ..    ...+......+.+++ +||..+|++||++.+|+.
T Consensus       222 ~----~~~------~~----~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~  260 (266)
T cd06651         222 A----TQP------TN----PQLPSHISEHARDFL-GCIFVEARHRPSAEELLR  260 (266)
T ss_pred             h----cCC------CC----CCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence            0    000      01    111223445677777 688899999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.6e-39  Score=304.33  Aligned_cols=248  Identities=27%  Similarity=0.457  Sum_probs=191.1

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      +.||+|+||.||+|.+...+... .........+++|.+...... ...|.+|+.+++.++||||+++++++.. ..   
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~-~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~---   74 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLD-IVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DE---   74 (259)
T ss_pred             CcccccccceEEEEEEeccCCcc-ccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CC---
Confidence            36999999999999987432110 000122346888887644333 6788999999999999999999999987 33   


Q ss_pred             eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-------cEEE
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-------KAKL  245 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-------~~kL  245 (453)
                       .++||||+++|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++       .+||
T Consensus        75 -~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          75 -NIMVEEYVKFGPLDVFLHREK-NNVSLHWKLDVAKQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             -cEEEEEcCCCCcHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEe
Confidence             589999999999999998753 3788999999999999999999998   999999999999999888       7999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccC--CCCCchhHHHHHHHHHHHHhC-CccccCCCChhhHHHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG--RLTAKSDVWSFGVVLYELITG-RRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|||++.....      .....++..|+|||++...  .++.++|||||||++|||++| ..|+.............   
T Consensus       150 ~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~---  220 (259)
T cd05037         150 SDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQ---  220 (259)
T ss_pred             CCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHh---
Confidence            99999986432      2234567789999999876  789999999999999999994 66665432221111111   


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                          ....            .+......+.+++.+||..+|.+|||+.+|++.|
T Consensus       221 ----~~~~------------~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         221 ----DQHR------------LPMPDCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             ----cCCC------------CCCCCchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence                0000            0001126789999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-39  Score=303.56  Aligned_cols=254  Identities=29%  Similarity=0.399  Sum_probs=204.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||.|+||.||+|.+.           .++..+|+|.+........+.+.+|+.++++++||||+++++++..
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~   71 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDI-----------ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLR   71 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEec-----------CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEe
Confidence            57888999999999999999875           3456799999876655566789999999999999999999999877


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    ++++|||+++++|.+++... ...++...+..++.|++.||.|||+.   +|+|+||+|+||+++.++.+||+
T Consensus        72 ~~~----~~l~~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~  143 (262)
T cd06613          72 RDK----LWIVMEYCGGGSLQDIYQVT-RGPLSELQIAYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLA  143 (262)
T ss_pred             CCE----EEEEEeCCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEEC
Confidence            654    79999999999999988764 24688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccC---CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG---RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |||++.......  .......++..|+|||.+.+.   .++.++||||||+++|||++|+.||....+.......  ...
T Consensus       144 d~g~~~~~~~~~--~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~--~~~  219 (262)
T cd06613         144 DFGVSAQLTATI--AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLI--SKS  219 (262)
T ss_pred             ccccchhhhhhh--hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--Hhc
Confidence            999987644321  122345788899999998776   7899999999999999999999999754432221111  000


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .         ...+  ........+.++.+++.+||..+|.+|||+.+|+.
T Consensus       220 ~---------~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~  259 (262)
T cd06613         220 N---------FPPP--KLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ  259 (262)
T ss_pred             c---------CCCc--cccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            0         0000  01122345678999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=2.6e-39  Score=311.43  Aligned_cols=252  Identities=25%  Similarity=0.396  Sum_probs=200.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +.|+..++||.|+||.||+|.+.           ..+..||+|.+..........+.+|+.+++.++||||+++++++..
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~   80 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNK-----------ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYW   80 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEEC-----------CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEe
Confidence            56888889999999999999875           4467899999876655556778999999999999999999999876


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||+++++|..++... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.++|+
T Consensus        81 ~~~----~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~  152 (292)
T cd06644          81 DGK----LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLA  152 (292)
T ss_pred             CCe----EEEEEecCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEc
Confidence            653    79999999999999877654 24689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      |||++......  ........+++.|+|||++.     ...++.++|||||||++|||++|..||....+..  .+....
T Consensus       153 dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~~  228 (292)
T cd06644         153 DFGVSAKNVKT--LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIA  228 (292)
T ss_pred             cCccceecccc--ccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH--HHHHHh
Confidence            99998753321  11223456889999999985     3456889999999999999999999986543211  111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..     .      .+..  ..+...+.++.+++.+||..+|++||++.++++
T Consensus       229 ~~-----~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  268 (292)
T cd06644         229 KS-----E------PPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE  268 (292)
T ss_pred             cC-----C------CccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence            00     0      0000  112234567899999999999999999999875

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.9e-39  Score=312.18  Aligned_cols=267  Identities=28%  Similarity=0.370  Sum_probs=207.7

Q ss_pred             cccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CC
Q 043568           76 VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KH  154 (453)
Q Consensus        76 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h  154 (453)
                      .++..++..++++|...+.||+|+||.||++...           .++..+|+|.+.... .....+.+|+.+++++ +|
T Consensus        11 ~~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~-----------~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h   78 (291)
T cd06639          11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNK-----------KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNH   78 (291)
T ss_pred             hhhcccCCCCCCCeEEEEEeecCCCeEEEEEEEC-----------CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCC
Confidence            3556777778999999999999999999999875           456789999986432 2345677899999999 89


Q ss_pred             CceeeEeeeeeeccc-ccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          155 PNLVKLVGYCAEDDE-RGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      |||+++++++...+. .+..+++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +++|+|||
T Consensus        79 ~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlk  155 (291)
T cd06639          79 PNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNN---RIIHRDVK  155 (291)
T ss_pred             CCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCC
Confidence            999999999986542 123479999999999999988642  235689999999999999999999998   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-----CCCCchhHHHHHHHHHHHHhCCccc
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-----RLTAKSDVWSFGVVLYELITGRRAV  306 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~SlGvil~elltg~~p~  306 (453)
                      |+||+++.++.+||+|||++.......  .......|+..|+|||.+...     .++.++|||||||++|||++|+.||
T Consensus       156 p~nili~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~  233 (291)
T cd06639         156 GNNILLTTEGGVKLVDFGVSAQLTSTR--LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL  233 (291)
T ss_pred             HHHEEEcCCCCEEEeecccchhccccc--ccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCC
Confidence            999999999999999999988644221  112345688999999998643     3688999999999999999999998


Q ss_pred             cCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....+..  .+......     . ...+.       .+......+.+|+.+||+.+|++||++.++++
T Consensus       234 ~~~~~~~--~~~~~~~~-----~-~~~~~-------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~  286 (291)
T cd06639         234 FDMHPVK--TLFKIPRN-----P-PPTLL-------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE  286 (291)
T ss_pred             CCCcHHH--HHHHHhcC-----C-CCCCC-------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence            7543221  11111110     0 00000       11223457999999999999999999999875

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=317.81  Aligned_cols=256  Identities=21%  Similarity=0.278  Sum_probs=195.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||++++.           .++..||+|++.+..   ....+.+.+|+.++..++|+||++++++
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   69 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMK-----------NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYA   69 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEEC-----------CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            47888999999999999999976           456789999986432   2234568889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .++||||+++|+|.+++... ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~  141 (331)
T cd05597          70 FQDENN----LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHI  141 (331)
T ss_pred             EecCCe----EEEEEecCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCE
Confidence            887654    79999999999999998753 34688889999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      ||+|||++........ .......||+.|+|||++..     ..++.++|||||||++|||++|+.||........... 
T Consensus       142 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~-  219 (331)
T cd05597         142 RLADFGSCLRLLADGT-VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-  219 (331)
T ss_pred             EEEECCceeecCCCCC-ccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHH-
Confidence            9999999876433221 11233569999999999863     4578899999999999999999999975432211111 


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCC--CCCCHHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPK--SRPKMSEVVDI  375 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~--~RPs~~ei~~~  375 (453)
                        +   ........      +. ......+..+.+++.+|+..+++  .||++.++++.
T Consensus       220 --i---~~~~~~~~------~~-~~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         220 --I---MNHKEHFQ------FP-PDVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             --H---HcCCCccc------CC-CccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence              1   00000000      00 01112466788999998865443  37888888753

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-39  Score=321.12  Aligned_cols=266  Identities=26%  Similarity=0.358  Sum_probs=197.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||+||+|.+.           .++..||||.+....  ......+.+|+.+|+.++||||+++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   81 (343)
T cd07878          13 VPERYQNLTPVGSGAYGSVCSAYDT-----------RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLD   81 (343)
T ss_pred             hhhhhhhheecccCCCeEEEEEEEC-----------CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhh
Confidence            3578999999999999999999875           456789999986532  223456778999999999999999999


Q ss_pred             eeeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.....  .....+++++++ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus        82 ~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~  154 (343)
T cd07878          82 VFTPATSIENFNEVYLVTNLM-GADLNNIVKC---QKLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNED  154 (343)
T ss_pred             hhcccccccccCcEEEEeecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCC
Confidence            8864332  113468999998 8899887754   4688999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LL  318 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~  318 (453)
                      +.+||+|||+++.....     .....||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.......... +.
T Consensus       155 ~~~kl~Dfg~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~  229 (343)
T cd07878         155 CELRILDFGLARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIM  229 (343)
T ss_pred             CCEEEcCCccceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99999999999864321     234578999999999876 568999999999999999999999997543222111 11


Q ss_pred             Hhhhhc-------ccCccccccccC--CcCCC----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPY-------VSDSKKFHLIID--PRLEG----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~-------~~~~~~~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......       +... .......  +....    .........+.+|+.+||..||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~  297 (343)
T cd07878         230 EVVGTPSPEVLKKISSE-HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALA  297 (343)
T ss_pred             HHhCCCCHHHHHhcchh-hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            100000       0000 0000000  00000    000112345789999999999999999999985

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=4.7e-39  Score=307.29  Aligned_cols=249  Identities=27%  Similarity=0.412  Sum_probs=202.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..|...+.||.|+||.||+|.+.           ..+..||+|.+.... ......+.+|+.+++.++||||+++++++.
T Consensus         4 ~~y~~~~~lg~g~~~~vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (277)
T cd06640           4 ELFTKLERIGKGSFGEVFKGIDN-----------RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYL   72 (277)
T ss_pred             HhhhhhhhcccCCCeEEEEEEEc-----------cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            34667788999999999999875           346789999987543 234567889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++..   .++++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        73 ~~~~----~~lv~e~~~~~~L~~~i~~---~~l~~~~~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l  142 (277)
T cd06640          73 KGTK----LWIIMEYLGGGSALDLLRA---GPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKL  142 (277)
T ss_pred             ECCE----EEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEE
Confidence            7654    7999999999999998865   3678888999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++.......  .......++..|+|||++.+..++.++|||||||++|||++|..||....+.......       
T Consensus       143 ~dfg~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~-------  213 (277)
T cd06640         143 ADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI-------  213 (277)
T ss_pred             cccccceeccCCc--cccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhh-------
Confidence            9999997654322  1223456888999999998888999999999999999999999998754332211110       


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                                ............+..+.+++.+||..+|++||++.+++..
T Consensus       214 ----------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06640         214 ----------PKNNPPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH  253 (277)
T ss_pred             ----------hcCCCCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence                      0000112233467789999999999999999999999754

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.5e-39  Score=310.61  Aligned_cols=246  Identities=28%  Similarity=0.429  Sum_probs=198.1

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      |...+.||+|+||.||+|.+.           ..+..||+|.+.... ....+.+.+|+.++++++||||+++++++...
T Consensus         6 y~~~~~l~~g~~~~vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~   74 (277)
T cd06642           6 FTKLERIGKGSFGEVYKGIDN-----------RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG   74 (277)
T ss_pred             HHHHHHhcCCCCeeEEEEEEc-----------CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC
Confidence            555668999999999999875           446789999986443 23345788999999999999999999998776


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ..    .++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +++|+||+|+||++++++.++|+|
T Consensus        75 ~~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~d  144 (277)
T cd06642          75 TK----LWIIMEYLGGGSALDLLKP---GPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLAD  144 (277)
T ss_pred             Cc----eEEEEEccCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEcc
Confidence            54    7999999999999998864   4688899999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccC
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      ||++.......  .......++..|+|||++.+..++.++|||||||++|||++|+.|+....+...   .....    .
T Consensus       145 fg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~---~~~~~----~  215 (277)
T cd06642         145 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV---LFLIP----K  215 (277)
T ss_pred             ccccccccCcc--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH---Hhhhh----c
Confidence            99997654321  122334688999999999988899999999999999999999999864432211   11000    0


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .          .........+..+.+++.+||..+|.+||++.+++.
T Consensus       216 ~----------~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  252 (277)
T cd06642         216 N----------SPPTLEGQYSKPFKEFVEACLNKDPRFRPTAKELLK  252 (277)
T ss_pred             C----------CCCCCCcccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            0          001112234667999999999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.9e-39  Score=309.09  Aligned_cols=253  Identities=26%  Similarity=0.419  Sum_probs=202.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|.+.+.||.|+||.||+|.+.           .++..+|+|.+........+.|.+|+.++++++||||+++++++.
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   72 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHK-----------ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYF   72 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEc-----------CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEe
Confidence            456888889999999999999875           346789999987655555678999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++... ..++++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|
T Consensus        73 ~~~~----~~lv~e~~~~~~L~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l  144 (280)
T cd06611          73 YENK----LWILIEFCDGGALDSIMLEL-ERGLTEPQIRYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKL  144 (280)
T ss_pred             cCCe----EEEEeeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEE
Confidence            7654    79999999999999988764 34689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +|||++.......  .......+++.|+|||.+.     ...++.++||||||+++|+|++|+.||.......  .+...
T Consensus       145 ~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~--~~~~~  220 (280)
T cd06611         145 ADFGVSAKNKSTL--QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR--VLLKI  220 (280)
T ss_pred             ccCccchhhcccc--cccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH--HHHHH
Confidence            9999987643221  1223456899999999875     3457789999999999999999999997543221  11111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..     ..      .+.+  ..+...+..+.+++.+||..+|.+||++.++++
T Consensus       221 ~~-----~~------~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (280)
T cd06611         221 LK-----SE------PPTL--DQPSKWSSSFNDFLKSCLVKDPDDRPTAAELLK  261 (280)
T ss_pred             hc-----CC------CCCc--CCcccCCHHHHHHHHHHhccChhhCcCHHHHhc
Confidence            10     00      0000  011234567899999999999999999999875

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=5.3e-39  Score=304.74  Aligned_cols=253  Identities=24%  Similarity=0.330  Sum_probs=197.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-----ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-----QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .+|...++||+|+||.||+|.+.           .++..||||.+.....     ...+.+.+|+.++++++||||++++
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~-----------~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   70 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDA-----------DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYY   70 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEc-----------CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEE
Confidence            47888999999999999999875           4567899998853321     1235688899999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.+....  .++++|||+++++|.+++...  ..+++...+.++.|++.||.|||+.   +++|+||||+|||++.++
T Consensus        71 ~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~  143 (265)
T cd06652          71 GCLRDPMER--TLSIFMEHMPGGSIKDQLKSY--GALTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVG  143 (265)
T ss_pred             eEeccCCCc--eEEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCC
Confidence            988664322  368999999999999998765  4578888899999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .++|+|||++......... .......|+..|+|||++.+..++.++|||||||++|||++|+.||.......  .+...
T Consensus       144 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~--~~~~~  221 (265)
T cd06652         144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA--AIFKI  221 (265)
T ss_pred             CEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH--HHHHH
Confidence            9999999998764321111 11233468899999999988889999999999999999999999986542211  11111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..    .          ......+...+..+.+++.+|+. +|++||++++|++
T Consensus       222 ~~----~----------~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~  260 (265)
T cd06652         222 AT----Q----------PTNPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR  260 (265)
T ss_pred             hc----C----------CCCCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence            00    0          00111233455678899999995 9999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.8e-39  Score=309.07  Aligned_cols=256  Identities=26%  Similarity=0.395  Sum_probs=202.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||+||+|.+.           ..+..||+|++.... ....+.+.+|+.+++.++||||+++++++.
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~-----------~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHI-----------PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFL   73 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEc-----------CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEe
Confidence            46777789999999999999875           456789999886543 233567899999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    +++||||+++++|.+++...  .++++.....++.+++.||.|||+..  +++|+||||+||+++.++.++|
T Consensus        74 ~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l  145 (284)
T cd06620          74 NENN----ICMCMEFMDCGSLDRIYKKG--GPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKL  145 (284)
T ss_pred             cCCE----EEEEEecCCCCCHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEE
Confidence            7753    79999999999999988764  46889999999999999999999732  8999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCCh-----hhHHHHHh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPR-----NEQKLLEW  320 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~-----~~~~~~~~  320 (453)
                      +|||++......    ......|+..|+|||++.+..++.++|||||||++|+|++|+.||......     ....+...
T Consensus       146 ~d~gl~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~  221 (284)
T cd06620         146 CDFGVSGELINS----IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDL  221 (284)
T ss_pred             ccCCcccchhhh----ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHH
Confidence            999998754221    123457899999999998888999999999999999999999999754332     11111122


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ........       .+.+   .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       222 ~~~~~~~~-------~~~~---~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~  266 (284)
T cd06620         222 LQQIVQEP-------PPRL---PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM  266 (284)
T ss_pred             HHHHhhcc-------CCCC---CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            11111100       0011   011245679999999999999999999999875

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.3e-39  Score=307.32  Aligned_cols=266  Identities=26%  Similarity=0.345  Sum_probs=200.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|.....||+|+||.||+|+++           .++..||+|++.....  ...+.+.+|+.+++.++||||+++++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~   69 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNR-----------ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVF   69 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEEC-----------CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            46888899999999999999975           4467899999864422  2345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|..++...  ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.++
T Consensus        70 ~~~~~----~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~  140 (286)
T cd07847          70 RRKRK----LHLVFEYCDHTVLNELEKNP--RGVPEHLIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIK  140 (286)
T ss_pred             eeCCE----EEEEEeccCccHHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEE
Confidence            87654    79999999998888876543  4689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH-Hhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL-EWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~-~~~~  322 (453)
                      |+|||++........  ......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......+..... ....
T Consensus       141 l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~  218 (286)
T cd07847         141 LCDFGFARILTGPGD--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLG  218 (286)
T ss_pred             ECccccceecCCCcc--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            999999987543221  1234467889999999876 56789999999999999999999999765433222111 1111


Q ss_pred             hccc-------CccccccccCCcCCCc-----cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVS-------DSKKFHLIIDPRLEGN-----YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~-------~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....       ..........+.....     .....+..+.+|+.+||+.+|++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  282 (286)
T cd07847         219 DLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE  282 (286)
T ss_pred             CCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence            1000       0000000001111000     01123567899999999999999999998874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-39  Score=308.42  Aligned_cols=259  Identities=31%  Similarity=0.407  Sum_probs=204.1

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      .++++|...+.||+|+||.||+|.+.           ..+..+++|.+..... ....+.+|+.+++++ .|+||+++++
T Consensus         3 ~~~~~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~   70 (275)
T cd06608           3 DPTGIFELVEVIGEGTYGKVYKARHK-----------KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYG   70 (275)
T ss_pred             CchhheeheeeecCCCCeEEEEEEEC-----------CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEE
Confidence            35789999999999999999999975           3457899999865432 346788999999999 7999999999


Q ss_pred             eeeeccc--ccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          163 YCAEDDE--RGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       163 ~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ++.....  .+..+++||||+++++|.+++....  ...+++..+..++.|++.||.|||+.   +++|+||+|+||+++
T Consensus        71 ~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~  147 (275)
T cd06608          71 AFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLT  147 (275)
T ss_pred             EEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEc
Confidence            9987552  2345799999999999999887543  46789999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                      .++.++|+|||++......  ........|+..|+|||++..     ..++.++|||||||++|+|++|..||....+..
T Consensus       148 ~~~~~~l~d~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~  225 (275)
T cd06608         148 KNAEVKLVDFGVSAQLDST--LGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMR  225 (275)
T ss_pred             cCCeEEECCCccceecccc--hhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHH
Confidence            9999999999998764322  122344568999999998753     346789999999999999999999996432211


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        .+......             ...........+..+.+|+.+||..||++|||+.++++
T Consensus       226 --~~~~~~~~-------------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~  271 (275)
T cd06608         226 --ALFKIPRN-------------PPPTLKSPENWSKKFNDFISECLIKNYEQRPFMEELLE  271 (275)
T ss_pred             --HHHHhhcc-------------CCCCCCchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence              11111100             00001112234678999999999999999999999875

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=3.6e-39  Score=303.88  Aligned_cols=256  Identities=32%  Similarity=0.565  Sum_probs=201.2

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      |...+.||.|+||.||+|.+...+       ......||+|.+...... ..+.+..|+.++..++|+||+++++++...
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~-------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   73 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLS-------GEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE   73 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCC-------CCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC
Confidence            355678999999999999976321       123478999998655433 467889999999999999999999999876


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ..    .+++|||+++++|.+++.......+++..+..++.|++.||+|||+.   +++|+||||+||+++.++.++|+|
T Consensus        74 ~~----~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~d  146 (258)
T smart00219       74 EP----LMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISD  146 (258)
T ss_pred             Ce----eEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcc
Confidence            53    79999999999999999875443389999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhccc
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      ||++.......... .....+++.|+|||.+.+..++.++||||||+++++|++ |..||.....   ..+.+....   
T Consensus       147 fg~~~~~~~~~~~~-~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~---~~~~~~~~~---  219 (258)
T smart00219      147 FGLSRDLYDDDYYK-KKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSN---EEVLEYLKK---  219 (258)
T ss_pred             cCCceecccccccc-cccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCH---HHHHHHHhc---
Confidence            99998754332111 112336789999999988889999999999999999998 7777764322   122221110   


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                       ...          .......+.++.+++.+||..+|++|||+.++++.|
T Consensus       220 -~~~----------~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      220 -GYR----------LPKPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             -CCC----------CCCCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence             000          011112467799999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1e-38  Score=310.76  Aligned_cols=200  Identities=26%  Similarity=0.387  Sum_probs=160.9

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      +.+||+|+||.||+|++...         ..+..||+|.+....  ....+.+|+.+++.++||||+++++++...... 
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~---------~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~-   73 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDG---------KDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDR-   73 (317)
T ss_pred             ceEeccCCCeeEEEEEecCC---------CccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCC-
Confidence            35799999999999987532         345689999986543  234678999999999999999999998754332 


Q ss_pred             ceEEEEEEecCCCChHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE----cCC
Q 043568          172 MQRLLVYELMHNKSLEDHLLSR-------VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL----DED  240 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl----~~~  240 (453)
                       ..++||||+. ++|.+++...       ....+++..+..++.||+.||.|||+.   +|+||||||+|||+    +.+
T Consensus        74 -~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~  148 (317)
T cd07867          74 -KVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPER  148 (317)
T ss_pred             -eEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCC
Confidence             3789999985 5787776432       123588889999999999999999998   99999999999999    567


Q ss_pred             CcEEEeccccccCCCCCCCC-ccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          241 YKAKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      +.+||+|||+++........ .......||+.|+|||++.+ ..++.++|||||||++|||+||+.||..
T Consensus       149 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~  218 (317)
T cd07867         149 GRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHC  218 (317)
T ss_pred             CcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccc
Confidence            78999999999865432211 12234578999999999876 4589999999999999999999999864

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1.1e-38  Score=303.40  Aligned_cols=255  Identities=23%  Similarity=0.389  Sum_probs=188.3

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .||+|+||.||+|.....         .....+++|.+.... ....+.|.+|+.+++.++||||++++++|.....   
T Consensus         2 ~lg~G~~g~v~~~~~~~~---------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~---   69 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTD---------TGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIP---   69 (268)
T ss_pred             cCCCCcCceEEEEEEEcC---------CCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCc---
Confidence            599999999999976421         223457788776443 2345689999999999999999999999987654   


Q ss_pred             eEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                       .++||||+++|+|.+++....  ...++......++.||+.||.|||+.   +++||||||+|||++.++.++|+|||+
T Consensus        70 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~  145 (268)
T cd05086          70 -YLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI  145 (268)
T ss_pred             -cEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEeccccc
Confidence             699999999999999997642  23456677788999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccccccCcCCCCcccccc-------CCCCCchhHHHHHHHHHHHHhC-CccccCCCChhhHHHHHhhh
Q 043568          251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-------GRLTAKSDVWSFGVVLYELITG-RRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       251 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +................++..|+|||++..       ..++.++|||||||++|||+++ ..||....+.   .....+.
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~---~~~~~~~  222 (268)
T cd05086         146 GPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR---EVLNHVI  222 (268)
T ss_pred             ccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH
Confidence            864322111112234567889999998753       2457899999999999999975 5566543221   1111110


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                         .  .....+.++.+.    ......+.+++..|| .+|.+||++.+|++.|.
T Consensus       223 ---~--~~~~~~~~~~~~----~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~  267 (268)
T cd05086         223 ---K--DQQVKLFKPQLE----LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT  267 (268)
T ss_pred             ---h--hcccccCCCccC----CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence               0  001111222222    224567888999999 67999999999998773

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=2.4e-39  Score=311.87  Aligned_cols=245  Identities=28%  Similarity=0.418  Sum_probs=196.9

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ...||+|+||.||++.+.           ..+..||||.+........+.+.+|+.+++.++||||+++++++...+.  
T Consensus        27 ~~~lg~g~~g~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~--   93 (292)
T cd06658          27 FIKIGEGSTGIVCIATEK-----------HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDE--   93 (292)
T ss_pred             hhcccCCCCeEEEEEEEC-----------CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCe--
Confidence            346999999999999865           4467899999876554556678899999999999999999999877654  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+||+++.++.++|+|||++
T Consensus        94 --~~lv~e~~~~~~L~~~~~~---~~l~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~  165 (292)
T cd06658          94 --LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFC  165 (292)
T ss_pred             --EEEEEeCCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcch
Confidence              7999999999999998854   3578899999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      .......  .......|+..|+|||.+.+..++.++||||||+++|||++|+.||....+......   ....       
T Consensus       166 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~---~~~~-------  233 (292)
T cd06658         166 AQVSKEV--PKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRR---IRDN-------  233 (292)
T ss_pred             hhccccc--ccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---HHhc-------
Confidence            7543221  122345689999999999888899999999999999999999999975433221111   1100       


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         ..+.+..  ....+..+.+++.+||..+|.+|||+.++++
T Consensus       234 ---~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  271 (292)
T cd06658         234 ---LPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQ  271 (292)
T ss_pred             ---CCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence               0111111  1123557889999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-41  Score=305.78  Aligned_cols=248  Identities=28%  Similarity=0.420  Sum_probs=208.8

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecc
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~  168 (453)
                      |.+..+||+|+||.||+|.++           .++..+|||.+...  .+..++++|+.+|+++..|++|++||.+....
T Consensus        35 FDi~~KLGEGSYGSV~KAIH~-----------EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s  101 (502)
T KOG0574|consen   35 FDIVGKLGEGSYGSVHKAIHR-----------ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS  101 (502)
T ss_pred             HHHHHHhcCCcchHHHHHHHh-----------ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCC
Confidence            455668999999999999987           67889999997543  46788999999999999999999999877666


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    ++||||||..|++.+.++.+ .+++.+.++..++++.+.||+|||..   .-||||||..||||+.+|.+||+||
T Consensus       102 D----LWIVMEYCGAGSiSDI~R~R-~K~L~E~EIs~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADF  173 (502)
T KOG0574|consen  102 D----LWIVMEYCGAGSISDIMRAR-RKPLSEQEISAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADF  173 (502)
T ss_pred             c----eEeehhhcCCCcHHHHHHHh-cCCccHHHHHHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhc
Confidence            5    79999999999999988765 47899999999999999999999988   8899999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |.|-...+.  .....++.||+.|||||++..-.|+.++||||||+...||.-|++||..-.|...              
T Consensus       174 GVAGQLTDT--MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA--------------  237 (502)
T KOG0574|consen  174 GVAGQLTDT--MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA--------------  237 (502)
T ss_pred             cccchhhhh--HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce--------------
Confidence            999876543  2234678999999999999999999999999999999999999999975433210              


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       .+-...+|......+...+.++.++++.||..+|++|-|+-++++
T Consensus       238 -IFMIPT~PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~  282 (502)
T KOG0574|consen  238 -IFMIPTKPPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCE  282 (502)
T ss_pred             -eEeccCCCCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhh
Confidence             000111222233346677899999999999999999999988875

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.6e-39  Score=313.27  Aligned_cols=254  Identities=25%  Similarity=0.329  Sum_probs=201.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|.+.           .++..||+|.+......   ..+.+..|+++++.++||||++++++
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~   69 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLK-----------GTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYAS   69 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEc-----------CCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheee
Confidence            46888899999999999999875           34678999998765433   34568899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+.+++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+
T Consensus        70 ~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~  142 (316)
T cd05574          70 FQTETY----LCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHI  142 (316)
T ss_pred             eecCCE----EEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCE
Confidence            876553    79999999999999998866556789999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCC---------------------------ccccccccCcCCCCccccccCCCCCchhHHHHHHHH
Q 043568          244 KLSDFGLARQGPPEGLG---------------------------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL  296 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil  296 (453)
                      +|+|||++.........                           .......||..|+|||++.+..++.++||||||+++
T Consensus       143 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll  222 (316)
T cd05574         143 MLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILL  222 (316)
T ss_pred             EEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHH
Confidence            99999998754321100                           011134688999999999988899999999999999


Q ss_pred             HHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC----HHHH
Q 043568          297 YELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK----MSEV  372 (453)
Q Consensus       297 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~ei  372 (453)
                      |+|++|..||.......  .+....              ............+..+.+++.+||..+|++|||    +.++
T Consensus       223 ~~l~~g~~pf~~~~~~~--~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~l  286 (316)
T cd05574         223 YEMLYGTTPFKGSNRDE--TFSNIL--------------KKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEI  286 (316)
T ss_pred             HHHhhCCCCCCCCchHH--HHHHHh--------------cCCccCCCccccCHHHHHHHHHHccCCHhHCCCchhhHHHH
Confidence            99999999996543221  111111              000000111124678999999999999999999    5555


Q ss_pred             HH
Q 043568          373 VD  374 (453)
Q Consensus       373 ~~  374 (453)
                      +.
T Consensus       287 l~  288 (316)
T cd05574         287 KQ  288 (316)
T ss_pred             Hc
Confidence            54

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=5.4e-39  Score=308.09  Aligned_cols=267  Identities=27%  Similarity=0.351  Sum_probs=200.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||.||+|.+.           .++..||+|.+....  ....+.+.+|+.++++++|+||+++++++
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~-----------~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~   69 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNK-----------ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAF   69 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeC-----------CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheE
Confidence            46888999999999999999975           346789999986532  23346789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||++++.+..++...  ..+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.+|
T Consensus        70 ~~~~~----~~iv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~k  140 (288)
T cd07833          70 RRKGR----LYLVFEYVERTLLELLEASP--GGLPPDAVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLK  140 (288)
T ss_pred             EECCE----EEEEEecCCCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEE
Confidence            87553    79999999887776655443  4588999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh-hh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW-VR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~-~~  322 (453)
                      |+|||++........ .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......+....... ..
T Consensus       141 l~d~g~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~  219 (288)
T cd07833         141 LCDFGFARALRARPA-SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLG  219 (288)
T ss_pred             EEeeecccccCCCcc-ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            999999987543321 123445788999999999887 889999999999999999999999875432221111110 00


Q ss_pred             hccc-------Ccccccc--ccCCc----CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVS-------DSKKFHL--IIDPR----LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~-------~~~~~~~--~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....       .......  ..+..    ....++...+.++.+++.+||..+|++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  284 (288)
T cd07833         220 PLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ  284 (288)
T ss_pred             CCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence            0000       0000000  00000    000112223678999999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.8e-40  Score=320.41  Aligned_cols=241  Identities=25%  Similarity=0.349  Sum_probs=186.2

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccC---CCCceeeEeeeeeecc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVV---KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~  168 (453)
                      ||+|+||+||+|++.           .++..||||++.....   .....+..|..++..+   .||||+++++++....
T Consensus         1 lG~G~~g~Vy~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~   69 (330)
T cd05586           1 IGKGTFGQVYQVRKK-----------DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDS   69 (330)
T ss_pred             CCCCCceEEEEEEEC-----------CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCC
Confidence            799999999999975           4567899999864322   2233455677777655   6999999999988766


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++|+|.+++...  ..+++..+..++.||+.||+|||+.   +|+||||||+|||++.++.+||+||
T Consensus        70 ~----~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Df  140 (330)
T cd05586          70 D----LYLVTDYMSGGELFWHLQKE--GRFSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDF  140 (330)
T ss_pred             e----EEEEEcCCCCChHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecC
Confidence            4    79999999999999988764  5688999999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccC
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      |++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||.......   +...+..    
T Consensus       141 g~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~---~~~~i~~----  211 (330)
T cd05586         141 GLSKANLTDN--KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ---MYRNIAF----  211 (330)
T ss_pred             CcCcCCCCCC--CCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH---HHHHHHc----
Confidence            9987533221  123456799999999998754 48999999999999999999999997543221   1111110    


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC----HHHHHH
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK----MSEVVD  374 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs----~~ei~~  374 (453)
                      . .      ..+.   ....+..+.+++.+||+.||.+||+    +.++++
T Consensus       212 ~-~------~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~  252 (330)
T cd05586         212 G-K------VRFP---KNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE  252 (330)
T ss_pred             C-C------CCCC---CccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence            0 0      0000   0123567889999999999999985    555543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=5.1e-39  Score=305.96  Aligned_cols=255  Identities=25%  Similarity=0.407  Sum_probs=197.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---c-------cHHHHHHHHHHhccCCCCce
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---Q-------GHKEWINEVNFLGVVKHPNL  157 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~-------~~~~~~~E~~~l~~l~h~nI  157 (453)
                      +|...+.||+|+||.||+|...           .++..||+|.+.....   .       ..+.+.+|+.+++.++||||
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~-----------~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i   70 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNV-----------TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNI   70 (272)
T ss_pred             ceeecceecccCceEEEEEeec-----------CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            4677889999999999999865           3467899998753211   0       12457889999999999999


Q ss_pred             eeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      +++++++...+.    .++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +++||||+|+||++
T Consensus        71 ~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~  141 (272)
T cd06629          71 VQYLGFETTEEY----LSIFLEYVPGGSIGSCLRTY--GRFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLV  141 (272)
T ss_pred             ceEEEEeccCCc----eEEEEecCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEE
Confidence            999999877654    79999999999999999775  5788889999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC--CCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      +.++.++|+|||++................|+..|+|||.+....  ++.++||||||+++|+|++|..||.......  
T Consensus       142 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--  219 (272)
T cd06629         142 DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA--  219 (272)
T ss_pred             cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH--
Confidence            999999999999997643221111223456889999999987654  7899999999999999999999986432211  


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+.+...      ..    ..+..........+..+.+++.+||..+|.+|||+.+|++
T Consensus       220 ~~~~~~~------~~----~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  268 (272)
T cd06629         220 AMFKLGN------KR----SAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQ  268 (272)
T ss_pred             HHHHhhc------cc----cCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence            1111100      00    0011111122234678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.1e-38  Score=302.42  Aligned_cols=251  Identities=25%  Similarity=0.409  Sum_probs=197.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc------ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF------QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      +|...+.||+|+||.||+|...            ++..+|||.+.....      .....+.+|+.+++.++|+||++++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~------------~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~   68 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN------------QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYL   68 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc------------CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEe
Confidence            4777889999999999999752            356799998864321      1235588999999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    .++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +|+|+||+|+||++++++
T Consensus        69 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~  139 (265)
T cd06631          69 GTCLDDNT----ISIFMEFVPGGSISSILNRF--GPLPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNG  139 (265)
T ss_pred             eEeecCCe----EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCC
Confidence            99987643    79999999999999999765  4678889999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCC----CCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          242 KAKLSDFGLARQGPPEG----LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      .++|+|||++.......    .........|+..|+|||++.+..++.++|||||||++|+|++|..||...........
T Consensus       140 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~  219 (265)
T cd06631         140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY  219 (265)
T ss_pred             eEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHH
Confidence            99999999987542211    11112345689999999999988899999999999999999999999965422211110


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .  ..     ..    ...+    ..+...+.++.+++.+||..+|.+||++.+++.
T Consensus       220 ~--~~-----~~----~~~~----~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~  261 (265)
T cd06631         220 I--GA-----HR----GLMP----RLPDSFSAAAIDFVTSCLTRDQHERPSALQLLR  261 (265)
T ss_pred             h--hh-----cc----CCCC----CCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            0  00     00    0001    112234677899999999999999999999874

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1.2e-38  Score=300.41  Aligned_cols=251  Identities=30%  Similarity=0.505  Sum_probs=198.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .+|...+.||+|+||.||+|.+.            .+..+|+|.+.... .....|.+|++++++++||||+++++++..
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~------------~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   70 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL------------EKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTE   70 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe------------CCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEcc
Confidence            46777889999999999999864            24579999886433 334678999999999999999999999876


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||+++++|.+++.... ..+++..++.++.+++.||.|||+.   +++|+||||+||+++.++.++|+
T Consensus        71 ~~~----~~~v~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~  142 (256)
T cd05112          71 RSP----ICLVFEFMEHGCLSDYLRAQR-GKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVS  142 (256)
T ss_pred             CCc----eEEEEEcCCCCcHHHHHHhCc-cCCCHHHHHHHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEEC
Confidence            654    699999999999999987643 4678899999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++....... ........++..|+|||.+.++.++.++||||||+++|||++ |..||......   .+......  
T Consensus       143 d~g~~~~~~~~~-~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~---~~~~~~~~--  216 (256)
T cd05112         143 DFGMTRFVLDDQ-YTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS---EVVETINA--  216 (256)
T ss_pred             CCcceeecccCc-ccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH---HHHHHHhC--
Confidence            999987643221 111223345678999999998889999999999999999998 88888654321   11111110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                        ..   ....+.       ..+..+.+|+.+||+.+|++|||+.++++.|
T Consensus       217 --~~---~~~~~~-------~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         217 --GF---RLYKPR-------LASQSVYELMQHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             --CC---CCCCCC-------CCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence              00   001111       1356799999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=3.3e-39  Score=316.56  Aligned_cols=256  Identities=20%  Similarity=0.269  Sum_probs=195.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...++||+|+||.||++.++           ..+..+|+|.+.+..   ......+..|+.++..++|+||++++++
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   69 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLK-----------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYA   69 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEEC-----------CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            47888999999999999999976           446789999986432   1223457889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    +++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~ey~~~g~L~~~l~~~-~~~l~~~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~  141 (332)
T cd05623          70 FQDENN----LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHI  141 (332)
T ss_pred             EecCCE----EEEEEeccCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCE
Confidence            877654    79999999999999999763 24688888999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      ||+|||++....... ........||+.|+|||++.     ...++.++|||||||++|||++|+.||........... 
T Consensus       142 kL~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~-  219 (332)
T cd05623         142 RLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK-  219 (332)
T ss_pred             EEeecchheecccCC-cceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHH-
Confidence            999999987543221 11223457999999999986     34688999999999999999999999975432221111 


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCC--CCCHHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS--RPKMSEVVDI  375 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ei~~~  375 (453)
                        +.   .......      . .......+.++.+|+.+|+..++.+  |+++.++++.
T Consensus       220 --i~---~~~~~~~------~-p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         220 --IM---NHKERFQ------F-PAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             --Hh---CCCcccc------C-CCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence              11   0000000      0 0111234677899999988655444  6888888754

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.8e-39  Score=309.95  Aligned_cols=266  Identities=26%  Similarity=0.390  Sum_probs=199.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...++||+|+||.||+|.+.           ..+..||+|.+......  ..+.+.+|+++++.++||||+++++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   69 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHK-----------ETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF   69 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEEC-----------CCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhc
Confidence            46888899999999999999975           34678999987643322  345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|..+....  ..+++..++.++.|++.||.|||+.   +++|+||+|+||++++++.++
T Consensus        70 ~~~~~----~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~  140 (286)
T cd07846          70 RRKKR----LYLVFEFVDHTVLDDLEKYP--NGLDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVK  140 (286)
T ss_pred             ccCCe----EEEEEecCCccHHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEE
Confidence            76553    79999999999998876543  4589999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~  322 (453)
                      |+|||++.......  .......++..|+|||++.+ ..++.++||||||+++|||++|++||......... .+.....
T Consensus       141 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~  218 (286)
T cd07846         141 LCDFGFARTLAAPG--EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLG  218 (286)
T ss_pred             EEeeeeeeeccCCc--cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhC
Confidence            99999988654322  22334568899999999875 45788999999999999999999988654322211 1111111


Q ss_pred             hcccCc-------cccccccCCcCCC-----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDS-------KKFHLIIDPRLEG-----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~-------~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......       ........+....     ......+..+.+|+.+||..+|.+||++.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  282 (286)
T cd07846         219 NLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH  282 (286)
T ss_pred             CCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence            000000       0000000000000     011234678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=2.4e-39  Score=317.43  Aligned_cols=255  Identities=20%  Similarity=0.274  Sum_probs=195.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||++++.           ..+..||+|.+....   ......+..|+.++..++|+||++++++
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~   69 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMK-----------HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYA   69 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            47889999999999999999876           456789999986432   2223457889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .++||||+++|+|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        70 ~~~~~~----~~lv~Ey~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~  141 (331)
T cd05624          70 FQDENY----LYLVMDYYVGGDLLTLLSKF-EDRLPEDMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHI  141 (331)
T ss_pred             EEcCCE----EEEEEeCCCCCcHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCE
Confidence            887654    79999999999999999763 24688888999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      ||+|||++........ .......||+.|+|||++.+     +.++.++|||||||++|||++|+.||........   .
T Consensus       142 kl~DfG~a~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~---~  217 (331)
T cd05624         142 RLADFGSCLKMNQDGT-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVET---Y  217 (331)
T ss_pred             EEEeccceeeccCCCc-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHH---H
Confidence            9999999976543221 11234579999999999875     5678999999999999999999999975432211   1


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS--RPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ei~~  374 (453)
                      ..+.   ......      ... ......+.++.+++.+|+..++.+  |+++.++++
T Consensus       218 ~~i~---~~~~~~------~~p-~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~  265 (331)
T cd05624         218 GKIM---NHEERF------QFP-SHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKK  265 (331)
T ss_pred             HHHH---cCCCcc------cCC-CccccCCHHHHHHHHHHccCchhhcCCCCHHHHhc
Confidence            1110   000000      000 011234677999999999865544  457777764

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=6.2e-39  Score=303.28  Aligned_cols=252  Identities=23%  Similarity=0.350  Sum_probs=202.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||.|+||.||++.+.           .++..||+|.+.....  ...+.+..|+.+++.++||||+++++++.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRK-----------SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRII   69 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeec-----------CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeee
Confidence            4778889999999999999875           4567899999865432  23456889999999999999999999887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCceEeeccccccEEEc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLH-----EEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH-----~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ....  ...+++|||+++++|.+++...  ...++++..++.++.+++.||.|||     +.   +++|+||||+||+++
T Consensus        70 ~~~~--~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~---~i~h~dl~p~nili~  144 (265)
T cd08217          70 DRSN--QTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGN---TVLHRDLKPANIFLD  144 (265)
T ss_pred             cCCC--CEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccC---cceecCCCHHHEEEe
Confidence            5432  2368999999999999998653  2457899999999999999999999     66   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      .++.+||+|||++.......  .......+++.|+|||.+.+..++.++||||||+++++|++|..||.....   ..+.
T Consensus       145 ~~~~~kl~d~g~~~~~~~~~--~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~---~~~~  219 (265)
T cd08217         145 ANNNVKLGDFGLAKILGHDS--SFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ---LQLA  219 (265)
T ss_pred             cCCCEEEecccccccccCCc--ccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH---HHHH
Confidence            99999999999998754322  112345789999999999988899999999999999999999999976431   1222


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +....    . .         ....+...+..+.+++.+||+.+|.+|||+.+|++
T Consensus       220 ~~~~~----~-~---------~~~~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~  261 (265)
T cd08217         220 SKIKE----G-K---------FRRIPYRYSSELNEVIKSMLNVDPDKRPSTEELLQ  261 (265)
T ss_pred             HHHhc----C-C---------CCCCccccCHHHHHHHHHHccCCcccCCCHHHHhh
Confidence            22111    0 0         01122234678999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.2e-38  Score=302.11  Aligned_cols=257  Identities=31%  Similarity=0.452  Sum_probs=204.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||.|+||+||+|...           .++..+|+|++..... .....+.+|+.+++.++|+||+++++.+.
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICL-----------PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFV   69 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEc-----------CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEe
Confidence            47889999999999999999865           3467899999865432 34577899999999999999999999887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....    .++||||+++++|.+++..... ..+++.....++.|++.||.|||+.   +++||||+|+||++++++.++
T Consensus        70 ~~~~----~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~  142 (267)
T cd06610          70 VGDE----LWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVK  142 (267)
T ss_pred             eCCE----EEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEE
Confidence            7553    7999999999999999976543 5789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCC--ccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          245 LSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      |+|||++.........  .......|+..|+|||++... .++.++|||||||++|+|++|+.||....+..  .+....
T Consensus       143 l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~~  220 (267)
T cd06610         143 IADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK--VLMLTL  220 (267)
T ss_pred             EcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh--hHHHHh
Confidence            9999998765433221  122345689999999998876 78999999999999999999999996543221  111111


Q ss_pred             hhcccCccccccccCCcCCCc-cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGN-YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..   ..        +.+... .....+..+.+++.+||..||++|||+.+|++
T Consensus       221 ~~---~~--------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~  263 (267)
T cd06610         221 QN---DP--------PSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK  263 (267)
T ss_pred             cC---CC--------CCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            11   00        011100 01244678899999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=6.4e-39  Score=302.13  Aligned_cols=249  Identities=27%  Similarity=0.392  Sum_probs=200.8

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||++...           .++..+|||.+.....  .....+.+|+.+++.++||||+++++++.
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRK-----------ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFL   69 (256)
T ss_pred             CceEEEEecccCceEEEEEEEc-----------CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEe
Confidence            5788899999999999999875           3567899999875432  33567889999999999999999999887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-CcEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~k  244 (453)
                      ....    .++||||+++++|.+++.......+++..+..++.+++.||.|||+.   +++|+||+|+||+++.+ +.+|
T Consensus        70 ~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~  142 (256)
T cd08220          70 EDKA----LMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVK  142 (256)
T ss_pred             cCCE----EEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEE
Confidence            6543    79999999999999999876566789999999999999999999998   99999999999999854 4689


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++.......   ......++..|+|||.+.+..++.++||||||+++|+|++|+.||.......   ....... 
T Consensus       143 l~d~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~---~~~~~~~-  215 (256)
T cd08220         143 IGDFGISKILSSKS---KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA---LVLKIMS-  215 (256)
T ss_pred             EccCCCceecCCCc---cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH---HHHHHHh-
Confidence            99999998654321   1234568899999999998889999999999999999999999986543221   1111100 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          ..         ....+...+..+.+++.+||..+|.+|||+.+++.
T Consensus       216 ----~~---------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~  252 (256)
T cd08220         216 ----GT---------FAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA  252 (256)
T ss_pred             ----cC---------CCCCCCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence                00         00111224567999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=6.5e-39  Score=307.57  Aligned_cols=253  Identities=25%  Similarity=0.393  Sum_probs=198.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|+..+.||+|+||.||++.+.           ..+..||+|.+.... ......+.+|+.++++++||||+++++++.
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-----------~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHR-----------PTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFF   69 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEc-----------CCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhhee
Confidence            35778889999999999999875           356789999886432 223467889999999999999999999888


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....    .++||||+++++|..++.... ...+++..+..++.+++.||.|||+..  +|+|+||||+||+++.++.++
T Consensus        70 ~~~~----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~  143 (286)
T cd06622          70 IEGA----VYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVK  143 (286)
T ss_pred             cCCe----EEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEE
Confidence            7654    799999999999999887532 247899999999999999999999632  899999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCC------CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR------LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      |+|||++......    ......++..|+|||.+.+..      ++.++|||||||++|+|++|+.||............
T Consensus       144 l~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~  219 (286)
T cd06622         144 LCDFGVSGNLVAS----LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQL  219 (286)
T ss_pred             EeecCCcccccCC----ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHH
Confidence            9999998764321    123446888999999986543      478999999999999999999999654322211111


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....             +. .....+...+.++.+++.+||..+|.+||++.+++.
T Consensus       220 ~~~~-------------~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~  261 (286)
T cd06622         220 SAIV-------------DG-DPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLE  261 (286)
T ss_pred             HHHh-------------hc-CCCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhc
Confidence            1110             00 001122235677899999999999999999999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1e-38  Score=305.82  Aligned_cols=266  Identities=24%  Similarity=0.355  Sum_probs=200.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||+|.+.           .++..||+|++.....  .....+.+|+.++++++||||+++++++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDR-----------ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFP   69 (286)
T ss_pred             CceEEeecccCCCcEEEEEEEC-----------CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEe
Confidence            4778889999999999999975           3467899999875542  23467899999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+ +++|.+++.... .++++..++.++.||+.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        70 ~~~~----~~~v~e~~-~~~L~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l  140 (286)
T cd07832          70 HGSG----FVLVMEYM-PSDLSEVLRDEE-RPLPEAQVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKI  140 (286)
T ss_pred             cCCe----eEEEeccc-CCCHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEE
Confidence            7553    79999999 999999887643 5789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhh--
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWV--  321 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~--  321 (453)
                      +|||++........ .......++..|+|||++.+. .++.++||||||++++||++|.+||.......... .....  
T Consensus       141 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~  219 (286)
T cd07832         141 ADFGLARLFSEEEP-RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGT  219 (286)
T ss_pred             eeeeecccccCCCC-CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCC
Confidence            99999987543221 123345789999999998654 46899999999999999999987776543221111 11100  


Q ss_pred             -----hhcccCccccccccCCcCC----CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 -----RPYVSDSKKFHLIIDPRLE----GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 -----~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           .+..........+..+...    .....+.+..+.+++.+||..+|++|||+++++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~  281 (286)
T cd07832         220 PNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR  281 (286)
T ss_pred             CChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence                 0000000000000000000    0011234578999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=9.6e-39  Score=309.53  Aligned_cols=257  Identities=23%  Similarity=0.336  Sum_probs=200.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||++.+.           ..+..||+|.+.....   .....+.+|+.+++.++||||++++++
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~   69 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHK-----------ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCS   69 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEEC-----------CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEE
Confidence            46888999999999999999976           4467899999875432   234567899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +...+.    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        70 ~~~~~~----~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~  140 (305)
T cd05609          70 FETKRH----LCMVMEYVEGGDCATLLKNI--GALPVDMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHI  140 (305)
T ss_pred             EecCCE----EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCE
Confidence            876653    79999999999999999765  4688899999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCC-------------ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          244 KLSDFGLARQGPPEGLG-------------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~-------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      +|+|||+++........             .......++..|+|||.+.+..++.++|||||||++|||++|..||....
T Consensus       141 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~  220 (305)
T cd05609         141 KLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDT  220 (305)
T ss_pred             EEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999998742111000             01122457889999999988889999999999999999999999997543


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      +..   +......   .     ....+..    ....+..+.+++.+||+.+|++||++.++.+.|..
T Consensus       221 ~~~---~~~~~~~---~-----~~~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~  273 (305)
T cd05609         221 PEE---LFGQVIS---D-----DIEWPEG----DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQH  273 (305)
T ss_pred             HHH---HHHHHHh---c-----ccCCCCc----cccCCHHHHHHHHHHhccChhhccCccCHHHHHhC
Confidence            221   1111100   0     0000110    11245678999999999999999998777766654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=6.2e-39  Score=309.75  Aligned_cols=246  Identities=27%  Similarity=0.398  Sum_probs=197.8

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ...||+|+||.||+|.+.           .++..||+|.+........+.+.+|+.+++.++||||+++++++...+.  
T Consensus        26 ~~~ig~g~~g~v~~~~~~-----------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~--   92 (297)
T cd06659          26 YIKIGEGSTGIVCIAREK-----------HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEE--   92 (297)
T ss_pred             hhhcCCCCceeEEEEEEc-----------CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCe--
Confidence            347999999999999875           4567899999876555556778899999999999999999999887654  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|..++..   ..+++..++.++.|++.||.|||+.   +++||||||+||+++.++.+||+|||++
T Consensus        93 --~~iv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~  164 (297)
T cd06659          93 --LWVLMEFLQGGALTDIVSQ---TRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFC  164 (297)
T ss_pred             --EEEEEecCCCCCHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhH
Confidence              7999999999999997754   4688999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      .......  .......|+..|+|||++.+..++.++|||||||++|||++|+.||....+.....   .......     
T Consensus       165 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~---~~~~~~~-----  234 (297)
T cd06659         165 AQISKDV--PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMK---RLRDSPP-----  234 (297)
T ss_pred             hhccccc--ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHhccCC-----
Confidence            7543321  11234578999999999998889999999999999999999999997543322211   1111000     


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                           +.  .......+..+.+++.+||+.+|.+||++.++++.
T Consensus       235 -----~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         235 -----PK--LKNAHKISPVLRDFLERMLTREPQERATAQELLDH  271 (297)
T ss_pred             -----CC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                 00  00111235678999999999999999999999873

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=6.4e-39  Score=302.35  Aligned_cols=250  Identities=26%  Similarity=0.400  Sum_probs=202.0

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|+..+.||+|+||.||++...           .++..||+|.+....  ....+++.+|+.+++.++||||+++++++.
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSK-----------EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFE   69 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEc-----------CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeec
Confidence            4788899999999999999875           456789999986432  233467889999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+.+++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+|||++.++.++|
T Consensus        70 ~~~~----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l  142 (256)
T cd08218          70 ENGN----LYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKL  142 (256)
T ss_pred             CCCe----EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEE
Confidence            6653    79999999999999998765555688999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++.......  .......|++.|+|||++.+..++.++|||||||++++|++|+.||.......  ........  
T Consensus       143 ~d~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~--~~~~~~~~--  216 (256)
T cd08218         143 GDFGIARVLNSTV--ELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKN--LVLKIIRG--  216 (256)
T ss_pred             eeccceeecCcch--hhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHH--HHHHHhcC--
Confidence            9999997653321  11234568899999999998889999999999999999999999986542211  11111110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          ..         ...+...+..+.+++.+||+.+|.+||++.+|++
T Consensus       217 ----~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~  252 (256)
T cd08218         217 ----SY---------PPVSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE  252 (256)
T ss_pred             ----CC---------CCCcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence                00         0112234667999999999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=7.8e-39  Score=304.16  Aligned_cols=255  Identities=28%  Similarity=0.464  Sum_probs=199.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----------cccHHHHHHHHHHhcc-CCCCc
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----------FQGHKEWINEVNFLGV-VKHPN  156 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----------~~~~~~~~~E~~~l~~-l~h~n  156 (453)
                      +|...+.||+|+||.||+|.+..          ..+..+|+|.+....          ......+.+|+.++.+ ++|||
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~----------~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~   70 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKN----------NGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPN   70 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcC----------CCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCC
Confidence            47788899999999999999762          135689999875321          1223557789998875 79999


Q ss_pred             eeeEeeeeeecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          157 LVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       157 Iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      |+++++++...+.    .++||||+++++|.+++...  ....+++..++.++.|++.||.|||+..  +++|+||+|.|
T Consensus        71 i~~~~~~~~~~~~----~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~n  144 (269)
T cd08528          71 IVRYYKTFLENDR----LYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNN  144 (269)
T ss_pred             eeeEEeeEccCCe----EEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHH
Confidence            9999999987654    79999999999999987542  2356889999999999999999999631  89999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      ||++.++.++|+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||........
T Consensus       145 il~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~  221 (269)
T cd08528         145 IMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSL  221 (269)
T ss_pred             EEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHH
Confidence            999999999999999998754322   23456789999999999988899999999999999999999999865432211


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                         ......     ..    ..+.    .....+..+.+++.+||+.||++||++.++..++.
T Consensus       222 ---~~~~~~-----~~----~~~~----~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         222 ---ATKIVE-----AV----YEPL----PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             ---HHHHhh-----cc----CCcC----CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence               111100     00    0000    01123567999999999999999999999998774

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-40  Score=325.26  Aligned_cols=245  Identities=24%  Similarity=0.416  Sum_probs=200.8

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccce
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQ  173 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  173 (453)
                      +||+|+||+||.|++.           .+...+|||.+........+-+..|+.+.++|+|.|||+++|.|.+++.    
T Consensus       582 VLGKGTYG~VYA~RD~-----------~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf----  646 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDM-----------DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGF----  646 (1226)
T ss_pred             EeecCceeEEEeeccc-----------cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCe----
Confidence            7999999999999987           4567899999976665555667889999999999999999999877663    


Q ss_pred             EEEEEEecCCCChHHhhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc-CCCcEEEecccc
Q 043568          174 RLLVYELMHNKSLEDHLLSRVPTPL--AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGL  250 (453)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~~l--~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGl  250 (453)
                      +-|.||-++||+|.++|... -.|+  ++.+.--+.+||++||.|||..   .|||||||-+|||++ ..|.+||+|||-
T Consensus       647 ~kIFMEqVPGGSLSsLLrsk-WGPlKDNEstm~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGT  722 (1226)
T KOG4279|consen  647 FKIFMEQVPGGSLSSLLRSK-WGPLKDNESTMNFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGT  722 (1226)
T ss_pred             EEEEeecCCCCcHHHHHHhc-cCCCccchhHHHHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEeccccc
Confidence            67899999999999999764 2344  6777778889999999999998   999999999999995 689999999999


Q ss_pred             ccCCCCCCCCccccccccCcCCCCccccccC--CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG--RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       251 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      ++....  ......+..||..|||||++..+  .|+.++|||||||.+.||.||++||........ .++          
T Consensus       723 sKRLAg--inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqA-AMF----------  789 (1226)
T KOG4279|consen  723 SKRLAG--INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQA-AMF----------  789 (1226)
T ss_pred             chhhcc--CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhH-hhh----------
Confidence            987543  33445678899999999999865  488999999999999999999999965322111 110          


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          .+---+.-.+.+...+.+...+|.+|+.++|.+||++.++++
T Consensus       790 ----kVGmyKvHP~iPeelsaeak~FilrcFepd~~~R~sA~~LL~  831 (1226)
T KOG4279|consen  790 ----KVGMYKVHPPIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ  831 (1226)
T ss_pred             ----hhcceecCCCCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence                011112223456677889999999999999999999999875

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-39  Score=321.43  Aligned_cols=203  Identities=26%  Similarity=0.353  Sum_probs=175.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-C-----CceeeEe
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-H-----PNLVKLV  161 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h-----~nIv~l~  161 (453)
                      +|.+.++||+|+||.|-+|.+.           .+++.||||+++.. ..-..+-..|+.+|..|+ |     -|+|+++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~-----------~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~  254 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDH-----------KTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRML  254 (586)
T ss_pred             EEEEEEEecccccceeEEEEec-----------CCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEee
Confidence            6788999999999999999986           56889999999644 233455667999999997 4     3899999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-  240 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-  240 (453)
                      +||...+.    +|||+|.+ ..+|+++|+.+.-.+++...+..|+.||+.||.+||+.   +|||+||||+||||... 
T Consensus       255 d~F~fr~H----lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~  326 (586)
T KOG0667|consen  255 DYFYFRNH----LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPK  326 (586)
T ss_pred             eccccccc----eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCC
Confidence            99998875    79999999 78999999998888899999999999999999999998   99999999999999653 


Q ss_pred             -CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          241 -YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       241 -~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                       ..+||+|||.|......     .....-+..|.|||++.+.+|+.+.||||||||++||++|.+.|.+....+..
T Consensus       327 r~~vKVIDFGSSc~~~q~-----vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl  397 (586)
T KOG0667|consen  327 RSRIKVIDFGSSCFESQR-----VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL  397 (586)
T ss_pred             cCceeEEecccccccCCc-----ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence             46999999999885432     22567788999999999999999999999999999999998888776555443

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=7e-39  Score=302.07  Aligned_cols=248  Identities=27%  Similarity=0.422  Sum_probs=199.1

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-----ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-----QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      +|...+.||+|+||.||+|+..           .++..|++|.+.....     ...+.+.+|+.+++.++|+||+++++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~   69 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNL-----------DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLG   69 (258)
T ss_pred             CccccceeeecCCceEEEEEEc-----------CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheee
Confidence            4677889999999999999875           3567899999865432     23467889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    ++++|||+++++|.+++...  .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        70 ~~~~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~  140 (258)
T cd06632          70 TEREEDN----LYIFLELVPGGSLAKLLKKY--GSFPEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGV  140 (258)
T ss_pred             eEecCCe----EEEEEEecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence            9876654    79999999999999999765  4688999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCC-CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||++.......   ......|+..|+|||.+.... ++.++|+||||+++|+|++|+.||....+..  ......
T Consensus       141 ~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~  215 (258)
T cd06632         141 VKLADFGMAKQVVEFS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVA--AVFKIG  215 (258)
T ss_pred             EEEccCccceeccccc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHH--HHHHHH
Confidence            9999999987654322   234456889999999987766 8999999999999999999999986543211  111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .     ....         ...+...+..+.+++.+||..+|.+||++.+++.
T Consensus       216 ~-----~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  254 (258)
T cd06632         216 R-----SKEL---------PPIPDHLSDEAKDFILKCLQRDPSLRPTAAELLE  254 (258)
T ss_pred             h-----cccC---------CCcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence            0     0000         0112234567899999999999999999999875

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.1e-38  Score=303.27  Aligned_cols=260  Identities=25%  Similarity=0.356  Sum_probs=202.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||.|++|.||+|.+.           ..+..+|+|.+..... .....+.+|++++++++||||+++++++.
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   69 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLK-----------NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFL   69 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEEC-----------CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEE
Confidence            46888899999999999999975           3467899999875432 34567899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      .....  .+++||||+++++|.+++...  ....++......++.|++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        70 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~  144 (287)
T cd06621          70 DESSS--SIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQV  144 (287)
T ss_pred             ccCCC--eEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeE
Confidence            65432  379999999999999887542  235678889999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCC--hhhHHHHHhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP--RNEQKLLEWV  321 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~--~~~~~~~~~~  321 (453)
                      +|+|||++.......    .....++..|+|||.+.+..++.++|||||||++|+|++|..||.....  ........+.
T Consensus       145 ~l~dfg~~~~~~~~~----~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  220 (287)
T cd06621         145 KLCDFGVSGELVNSL----AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYI  220 (287)
T ss_pred             EEeeccccccccccc----cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHH
Confidence            999999987643221    2234678899999999988999999999999999999999999975422  1112222222


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....    . ..+.+ ..  ......+..+.+++.+||..+|.+|||+.+|++
T Consensus       221 ~~~~----~-~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~  265 (287)
T cd06621         221 VNMP----N-PELKD-EP--GNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE  265 (287)
T ss_pred             hcCC----c-hhhcc-CC--CCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence            1100    0 00000 00  001224678999999999999999999999886

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.6e-39  Score=303.47  Aligned_cols=254  Identities=24%  Similarity=0.417  Sum_probs=200.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc------ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF------QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      +|+..+.||+|+||.||+|...           .++..||+|.+.....      ...+.+.+|+.++++++|+||++++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~   69 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDV-----------KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRML   69 (268)
T ss_pred             CccccceecCcCceEEEEEEEc-----------CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhh
Confidence            5788899999999999999865           4567899999864321      1246788999999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.+.+.    .++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +++|+||+|+||+++.++
T Consensus        70 ~~~~~~~~----~~~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~  140 (268)
T cd06630          70 GATCEDSH----FNLFVEWMAGGSVSHLLSKY--GAFKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTG  140 (268)
T ss_pred             ceeccCCe----EEEEEeccCCCcHHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            99987654    79999999999999998764  4688899999999999999999998   999999999999998776


Q ss_pred             -cEEEeccccccCCCCCCCC--ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          242 -KAKLSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       242 -~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                       .++|+|||++.........  .......++..|+|||.+.+..++.++||||||+++++|++|..||............
T Consensus       141 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~  220 (268)
T cd06630         141 QRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI  220 (268)
T ss_pred             CEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHH
Confidence             5999999998765432111  1122346889999999998888999999999999999999999998654322211111


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....             .......+...+.++.+++.+||..+|.+|||+.+++.
T Consensus       221 ~~~~~-------------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~  263 (268)
T cd06630         221 FKIAS-------------ATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK  263 (268)
T ss_pred             HHHhc-------------cCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence            11000             00011223345678999999999999999999999874

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=1.5e-38  Score=353.83  Aligned_cols=264  Identities=27%  Similarity=0.472  Sum_probs=208.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ...|...++||+|+||.||+|++.           .++..||||.+......    ...|+.++++++|||||+++|+|.
T Consensus       689 ~~~~~~~~~ig~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~  753 (968)
T PLN00113        689 LSSLKEENVISRGKKGASYKGKSI-----------KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCR  753 (968)
T ss_pred             HhhCCcccEEccCCCeeEEEEEEC-----------CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEE
Confidence            456788889999999999999975           45678999998643321    235688999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++|+|.+++.     .++|..+.+++.|+|.||+|||..+.++|+||||||+||+++.++.+++
T Consensus       754 ~~~~----~~lv~Ey~~~g~L~~~l~-----~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~  824 (968)
T PLN00113        754 SEKG----AYLIHEYIEGKNLSEVLR-----NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL  824 (968)
T ss_pred             cCCC----CEEEEeCCCCCcHHHHHh-----cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEE
Confidence            7664    699999999999999995     3789999999999999999999765669999999999999999998887


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      . ||.+.....      .....+|+.|+|||++.+..++.++|||||||++|||+||+.||..... ....+.+|.+...
T Consensus       825 ~-~~~~~~~~~------~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~-~~~~~~~~~~~~~  896 (968)
T PLN00113        825 R-LSLPGLLCT------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFG-VHGSIVEWARYCY  896 (968)
T ss_pred             E-ecccccccc------CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccC-CCCcHHHHHHHhc
Confidence            5 665543221      1233688999999999999999999999999999999999999854322 2233445554332


Q ss_pred             cCccccccccCCcCCCc--cchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          326 SDSKKFHLIIDPRLEGN--YCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      .. ......+++.+...  .......++.+++.+||+.+|++||||.+|++.|+.+...
T Consensus       897 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~~  954 (968)
T PLN00113        897 SD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASRS  954 (968)
T ss_pred             Cc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhcc
Confidence            22 22334455555332  2345566889999999999999999999999999988764

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1.1e-38  Score=305.53  Aligned_cols=265  Identities=23%  Similarity=0.310  Sum_probs=195.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||+|++.           .++..||+|.+.....  .....+.+|+.++++++||||+++++++.
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~-----------~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~   69 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNR-----------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLH   69 (284)
T ss_pred             CceeEEEecccCCeEEEEEEEC-----------CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhc
Confidence            4778889999999999999976           4567899999865422  22356778999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +...    .++|+||++ ++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.++.+||
T Consensus        70 ~~~~----~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l  140 (284)
T cd07839          70 SDKK----LTLVFEYCD-QDLKKYFDSC-NGDIDPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKL  140 (284)
T ss_pred             cCCc----eEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEE
Confidence            7654    799999995 5888877654 35689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhH--HHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--KLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~--~~~~~~~  322 (453)
                      +|||+++......  .......++..|+|||++.+. .++.++|||||||++|+|++|..|+.........  .+.....
T Consensus       141 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~  218 (284)
T cd07839         141 ADFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  218 (284)
T ss_pred             CccchhhccCCCC--CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhC
Confidence            9999998643221  112345678999999998764 4789999999999999999999886543322111  0100000


Q ss_pred             -------hcccCccccccccC--CcCC-CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 -------PYVSDSKKFHLIID--PRLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 -------~~~~~~~~~~~~~~--~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             +.............  .... .......+.++.+++.+||+.||.+|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~  280 (284)
T cd07839         219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ  280 (284)
T ss_pred             CCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence                   00000000000000  0000 0111234678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.7e-38  Score=306.01  Aligned_cols=252  Identities=29%  Similarity=0.397  Sum_probs=202.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|...           .++..||+|.+..........+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~   86 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDV-----------ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYL   86 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEc-----------CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheee
Confidence            367889999999999999999864           346779999987555455677899999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++|+||+++++|.+++...   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|
T Consensus        87 ~~~~----~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL  156 (293)
T cd06647          87 VGDE----LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL  156 (293)
T ss_pred             eCCc----EEEEEecCCCCcHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEE
Confidence            7654    79999999999999998753   578889999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++........  ......+++.|+|||.+....++.++|||||||++|+|++|+.||....+......  ..    
T Consensus       157 ~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~--~~----  228 (293)
T cd06647         157 TDFGFCAQITPEQS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYL--IA----  228 (293)
T ss_pred             ccCcceeccccccc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheee--hh----
Confidence            99999876543321  22344688999999999888899999999999999999999999975432211000  00    


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                               .............+..+.+++.+||..+|.+||++.+++..
T Consensus       229 ---------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         229 ---------TNGTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             ---------cCCCCCCCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                     00000111122345678999999999999999999998853

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2e-38  Score=305.96  Aligned_cols=265  Identities=24%  Similarity=0.333  Sum_probs=198.6

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-----cHHHHHHHHHHhccCCCCceeeEee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      +|...+.||+|+||.||+|.+.           .++..||||.+......     ....+..|+.+++.++|+||+++++
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~-----------~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~   69 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDK-----------ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLD   69 (298)
T ss_pred             CceeeeeeeeccccEEEEEEEC-----------CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhh
Confidence            4777889999999999999975           34678999998755332     2345678999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+ +++|.+++.... ..+++..++.++.||++||.|||++   +|+|+||||+|||++.++.
T Consensus        70 ~~~~~~~----~~lv~e~~-~~~L~~~i~~~~-~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~  140 (298)
T cd07841          70 VFGHKSN----INLVFEFM-ETDLEKVIKDKS-IVLTPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGV  140 (298)
T ss_pred             eeecCCE----EEEEEccc-CCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCC
Confidence            9987543    79999999 999999997653 4789999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEW  320 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~  320 (453)
                      ++|+|||++.......  .......++..|+|||.+.+ ..++.++|||||||++|||++|.+||....+..... ....
T Consensus       141 ~~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~  218 (298)
T cd07841         141 LKLADFGLARSFGSPN--RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEA  218 (298)
T ss_pred             EEEccceeeeeccCCC--ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHH
Confidence            9999999998654321  12233456888999998864 467899999999999999999987776544322111 1110


Q ss_pred             hh-hcc---cCccccccccCCcCC-----CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VR-PYV---SDSKKFHLIIDPRLE-----GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~-~~~---~~~~~~~~~~~~~~~-----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .. +..   ...............     .......+..+.+++.+||..+|++|||+.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~  281 (298)
T cd07841         219 LGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALE  281 (298)
T ss_pred             cCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhh
Confidence            00 000   000000000000000     0011234578999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=3.5e-38  Score=298.31  Aligned_cols=252  Identities=27%  Similarity=0.397  Sum_probs=205.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|++|.||+|++.           .++..||||++..... .....+.+|+.++.+++|+||+++++++.
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~-----------~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHK-----------PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFY   69 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEc-----------CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc
Confidence            46888899999999999999976           3567899999876543 34577999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....    +++||||+++++|.+++...  .+++...++.++.|++.||.|||+ .   +++|+||+|+||+++.++.++
T Consensus        70 ~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~  140 (264)
T cd06623          70 KEGE----ISIVLEYMDGGSLADLLKKV--GKIPEPVLAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVK  140 (264)
T ss_pred             cCCe----EEEEEEecCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEE
Confidence            7654    79999999999999999765  578999999999999999999999 8   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||................. 
T Consensus       141 l~df~~~~~~~~~~~--~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-  217 (264)
T cd06623         141 IADFGISKVLENTLD--QCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-  217 (264)
T ss_pred             EccCccceecccCCC--cccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-
Confidence            999999986543221  12345688999999999988899999999999999999999999976542122222222210 


Q ss_pred             ccCccccccccCCcCCCccchH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIK-SAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         .         . ....+.. .+..+.+++.+||..+|++|||+.++++
T Consensus       218 ---~---------~-~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~  255 (264)
T cd06623         218 ---G---------P-PPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ  255 (264)
T ss_pred             ---C---------C-CCCCCcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence               0         0 0011122 4678999999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3e-39  Score=307.82  Aligned_cols=278  Identities=26%  Similarity=0.425  Sum_probs=204.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhcc--CCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV--VKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~~  164 (453)
                      .......+||+|.||+||||.+.             ++.||||++..   +....|.+|-+|.+.  +.|+||++++++-
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~-------------~~~VAVKifp~---~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e  273 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD-------------NRLVAVKIFPE---QEKQSFQNEKNIYSLPGMKHENILQFIGAE  273 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc-------------CceeEEEecCH---HHHHHHHhHHHHHhccCccchhHHHhhchh
Confidence            44566678999999999999975             57899999864   345667777777664  5899999999887


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEeeccccccEEEc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM------DFQLIFRDFKTSNILLD  238 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~iiH~Dlkp~NILl~  238 (453)
                      .......+.++||++|.+.|+|.+||..+   .++|....+|+..+++||+|||...      .++|+|||||+.|||+.
T Consensus       274 kr~t~~~~eywLVt~fh~kGsL~dyL~~n---tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK  350 (534)
T KOG3653|consen  274 KRGTADRMEYWLVTEFHPKGSLCDYLKAN---TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVK  350 (534)
T ss_pred             ccCCccccceeEEeeeccCCcHHHHHHhc---cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEc
Confidence            76665556799999999999999999885   8999999999999999999999764      46899999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC-CC-----CchhHHHHHHHHHHHHhCCccccC-CCC
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LT-----AKSDVWSFGVVLYELITGRRAVER-NLP  311 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DV~SlGvil~elltg~~p~~~-~~~  311 (453)
                      +|++..|+|||+|..+.+.......-..+||..|||||++.+.. +.     .+.||||+|.|||||+++...+.. ..+
T Consensus       351 ~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp  430 (534)
T KOG3653|consen  351 NDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVP  430 (534)
T ss_pred             cCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCC
Confidence            99999999999998877655444455689999999999997632 22     368999999999999997655431 111


Q ss_pred             hhhHHHHHhh--hhcccCccc--cccccCCcCCCcc-chHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          312 RNEQKLLEWV--RPYVSDSKK--FHLIIDPRLEGNY-CIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       312 ~~~~~~~~~~--~~~~~~~~~--~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .-...+-..+  .|-+.+...  ...-..|.++... .-.....+.+.+..||..||+-|.|+.=+.+.+.++....
T Consensus       431 ~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~~  507 (534)
T KOG3653|consen  431 EYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMMLW  507 (534)
T ss_pred             cccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhccC
Confidence            1000000000  000000000  0000111111110 1123567899999999999999999998888887766543

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=303.63  Aligned_cols=267  Identities=26%  Similarity=0.367  Sum_probs=195.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|..+           .++..||||.+...... ....+.+|+.+++.++||||+++++++
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   72 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSK-----------LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDII   72 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEc-----------CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEE
Confidence            367889999999999999999875           34678999998654322 234577899999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+. ++|.+++.... ..+++.....++.|++.||.|||+.   +|+|+||||+|||++.++.+|
T Consensus        73 ~~~~~----~~lv~e~~~-~~L~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~k  143 (291)
T cd07844          73 HTKKT----LTLVFEYLD-TDLKQYMDDCG-GGLSMHNVRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELK  143 (291)
T ss_pred             ecCCe----EEEEEecCC-CCHHHHHHhCC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEE
Confidence            86654    799999996 59999887653 4788899999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-H-HHHhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-K-LLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~-~~~~~  321 (453)
                      |+|||+++......  .......++..|+|||++.+ ..++.++||||||+++|+|++|+.||......... . +....
T Consensus       144 l~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~  221 (291)
T cd07844         144 LADFGLARAKSVPS--KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVL  221 (291)
T ss_pred             ECccccccccCCCC--ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhc
Confidence            99999987543211  11223456889999998865 45889999999999999999999999654321111 1 10000


Q ss_pred             hh-------cccCcccccc----ccCCcCCCcc--chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RP-------YVSDSKKFHL----IIDPRLEGNY--CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~-------~~~~~~~~~~----~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..       ..........    ...+......  .......+.+++.+||+.+|++|||+.+++.
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~  287 (291)
T cd07844         222 GTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK  287 (291)
T ss_pred             CCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence            00       0000000000    0000000000  0111267889999999999999999999874

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1.4e-38  Score=304.86  Aligned_cols=263  Identities=24%  Similarity=0.364  Sum_probs=197.8

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|+..+.||.|+||.||+|++.           .++..||||.+....  ......+.+|+.++++++||||+++++++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   69 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNK-----------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH   69 (284)
T ss_pred             CceeeeeecCCCceEEEEEEEC-----------CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcc
Confidence            5788899999999999999875           346789999886443  223357889999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+. ++|.+++.......+++..++.++.|++.||+|||+.   +++|+||+|+||+++.++.+||
T Consensus        70 ~~~~----~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l  141 (284)
T cd07860          70 TENK----LYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKL  141 (284)
T ss_pred             cCCc----EEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEE
Confidence            6554    799999995 6899988776566789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCC-CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++.......  .......++..|+|||++.+.. ++.++|||||||++|||+||+.||.......  .+.......
T Consensus       142 ~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~~~~  217 (284)
T cd07860         142 ADFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID--QLFRIFRTL  217 (284)
T ss_pred             eeccchhhcccCc--cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHHHHh
Confidence            9999987643221  1123345788999999887644 6889999999999999999999996543221  111111100


Q ss_pred             ccCcc--------------ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSK--------------KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~--------------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....              .+........ .......+..+.++|.+||+.||.+|||+.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  280 (284)
T cd07860         218 GTPDEVVWPGVTSLPDYKPSFPKWARQDF-SKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALA  280 (284)
T ss_pred             CCCChhhhhhhhHHHHHHhhcccccccCH-HHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence            00000              0000000000 0001123467889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=2.6e-38  Score=303.57  Aligned_cols=249  Identities=27%  Similarity=0.421  Sum_probs=199.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      +|...+.||+|++|.||+|.+.           ..+..+|+|++........+.+.+|+.+++.++||||+++++++...
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~   88 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDK-----------STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG   88 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEEC-----------CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC
Confidence            3445568999999999999875           34678999998655445556788999999999999999999998765


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      +.    .++++||+++++|.+++..   .++++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+|
T Consensus        89 ~~----~~~v~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d  158 (285)
T cd06648          89 DE----LWVVMEFLEGGALTDIVTH---TRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSD  158 (285)
T ss_pred             Ce----EEEEEeccCCCCHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcc
Confidence            54    7999999999999998876   3688889999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccC
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      ||++.......  .......|+..|+|||.+.+..++.++|||||||++|+|++|+.||....+......   .....  
T Consensus       159 ~g~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~---~~~~~--  231 (285)
T cd06648         159 FGFCAQVSKEV--PRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKR---IRDNL--  231 (285)
T ss_pred             cccchhhccCC--cccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHH---HHhcC--
Confidence            99887543221  112345689999999999888899999999999999999999999875433222111   11100  


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                              .+...  .....+..+.+++.+||..+|++|||+.++++
T Consensus       232 --------~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  268 (285)
T cd06648         232 --------PPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN  268 (285)
T ss_pred             --------CCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence                    00000  11124567999999999999999999999885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.3e-39  Score=303.45  Aligned_cols=254  Identities=29%  Similarity=0.421  Sum_probs=200.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||.|+||.||++.+.           ..+..+|+|.+..... .....+.+|+.++++++||||+++++++.
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~   69 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHR-----------PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFY   69 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEc-----------CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeee
Confidence            35777789999999999999975           4567899999876532 34467889999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....    +++++||+++++|.+++.... ..++......++.|++.||.|||+ .   +++|+||||+||+++.++.++
T Consensus        70 ~~~~----~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~  141 (265)
T cd06605          70 NNGD----ISICMEYMDGGSLDKILKEVQ-GRIPERILGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIK  141 (265)
T ss_pred             cCCE----EEEEEEecCCCcHHHHHHHcc-CCCCHHHHHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEE
Confidence            7654    799999999999999987653 578888999999999999999999 7   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||.+.......    .....++..|+|||.+.+..++.++||||||+++|+|++|..||........ ...+.....
T Consensus       142 l~d~g~~~~~~~~~----~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~~~~~~~  216 (265)
T cd06605         142 LCDFGVSGQLVNSL----AKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPD-GIFELLQYI  216 (265)
T ss_pred             EeecccchhhHHHH----hhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccc-cHHHHHHHH
Confidence            99999987643211    1226788999999999988999999999999999999999999865421110 111111111


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....       .+.+.   ....+.++.++|.+||..+|.+|||+.+++.
T Consensus       217 ~~~~-------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~  256 (265)
T cd06605         217 VNEP-------PPRLP---SGKFSPDFQDFVNLCLIKDPRERPSYKELLE  256 (265)
T ss_pred             hcCC-------CCCCC---hhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence            0000       00110   1114667999999999999999999999874

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.3e-38  Score=304.54  Aligned_cols=245  Identities=25%  Similarity=0.378  Sum_probs=199.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||++.+.           ..+..||+|.+.....   .....+.+|++++++++||||++++++
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   69 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHK-----------GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGS   69 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEc-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeE
Confidence            46888899999999999999975           3567899999865322   234668899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    +++||||+++++|.+++...  ..++...+..++.|++.||.|||+.   +|+|+||+|.|||++.++.+
T Consensus        70 ~~~~~~----~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~  140 (290)
T cd05580          70 FQDDSN----LYLVMEYVPGGELFSHLRKS--GRFPEPVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYI  140 (290)
T ss_pred             EEcCCe----EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCE
Confidence            877654    79999999999999999775  5788899999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||++......     .....+++.|+|||.+.+...+.++||||||+++|+|++|..||......   ....... 
T Consensus       141 kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~~~~~~~-  211 (290)
T cd05580         141 KITDFGFAKRVKGR-----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI---QIYEKIL-  211 (290)
T ss_pred             EEeeCCCccccCCC-----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHh-
Confidence            99999999875432     23456889999999998888899999999999999999999998654321   1111110 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                        . . .      .    ..+...+..+.+++.+||..+|.+||     ++.+++.
T Consensus       212 --~-~-~------~----~~~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~  253 (290)
T cd05580         212 --E-G-K------V----RFPSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN  253 (290)
T ss_pred             --c-C-C------c----cCCccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence              0 0 0      0    11122356789999999999999999     6666653

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=3.4e-38  Score=298.58  Aligned_cols=253  Identities=30%  Similarity=0.434  Sum_probs=199.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||+|.+.           .++..||+|.+......  ....+.+|+.+++.++|+||+++++++.
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~   69 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNL-----------DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEV   69 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEEC-----------CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEe
Confidence            4778899999999999999875           34678999998765443  5677899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++|+||+++++|.+++...  ..+++..+..++.+++.||.|||+.   +|+|+||+|+||++++++.+||
T Consensus        70 ~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl  140 (264)
T cd06626          70 HREK----VYIFMEYCSGGTLEELLEHG--RILDEHVIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKL  140 (264)
T ss_pred             cCCE----EEEEEecCCCCcHHHHHhhc--CCCChHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEE
Confidence            6553    79999999999999998764  4578888999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCcc--ccccccCcCCCCccccccCC---CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          246 SDFGLARQGPPEGLGHV--STSVVGTVGYAAPEYVQTGR---LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +|||++...........  .....++..|+|||++.+..   ++.++||||||+++|+|++|+.||........  ....
T Consensus       141 ~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~--~~~~  218 (264)
T cd06626         141 GDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQ--IMFH  218 (264)
T ss_pred             cccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHH--HHHH
Confidence            99999987543322111  12356788999999998766   88999999999999999999999965422111  1110


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...     .     ..+.+.  .....+..+.+++.+||+.+|.+|||+.+++.
T Consensus       219 ~~~-----~-----~~~~~~--~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~  260 (264)
T cd06626         219 VGA-----G-----HKPPIP--DSLQLSPEGKDFLDRCLESDPKKRPTASELLQ  260 (264)
T ss_pred             Hhc-----C-----CCCCCC--cccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            000     0     000111  11123567889999999999999999999864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=321.05  Aligned_cols=253  Identities=26%  Similarity=0.405  Sum_probs=205.3

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      ..++||+|.||+|++|.|+..+        .+...||||.+...... ...+|++|+.+|.+|+|||+++|||+..+.. 
T Consensus       114 l~e~LG~GsFgvV~rg~Wt~ps--------gk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp-  184 (1039)
T KOG0199|consen  114 LYELLGEGSFGVVKRGTWTQPS--------GKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQP-  184 (1039)
T ss_pred             HHHHhcCcceeeEeeccccCCC--------CcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccch-
Confidence            3458999999999999997432        34567999999876544 5688999999999999999999999998744 


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                          ..+|||+++.|+|.+.|++.....|-......++.|||.|+.||.++   ++|||||...|+||...-.+||+|||
T Consensus       185 ----~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFG  257 (1039)
T KOG0199|consen  185 ----AMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFG  257 (1039)
T ss_pred             ----hhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeeccc
Confidence                57999999999999999985556777778889999999999999999   99999999999999999999999999


Q ss_pred             cccCCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccC
Q 043568          250 LARQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       250 la~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      |.+.+....... ......-...|+|||.++...++.++|||+|||.||||+| |..||-+.....   +++.       
T Consensus       258 LmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~q---IL~~-------  327 (1039)
T KOG0199|consen  258 LMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQ---ILKN-------  327 (1039)
T ss_pred             ceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHH---HHHh-------
Confidence            999765432221 2223344578999999999999999999999999999999 677876543322   2111       


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                             +|..-+..-+..|++++.+++..||..+|.+|||+..|.+.+
T Consensus       328 -------iD~~erLpRPk~csedIY~imk~cWah~paDRptFsair~~~  369 (1039)
T KOG0199|consen  328 -------IDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL  369 (1039)
T ss_pred             -------ccccccCCCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence                   121112223456789999999999999999999999997543

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=3.9e-38  Score=303.33  Aligned_cols=268  Identities=24%  Similarity=0.330  Sum_probs=199.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||.||+|.+.           .++..+|+|.+......  ....+.+|+.++++++||||+++++++
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~   73 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDK-----------KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVV   73 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEEC-----------CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEE
Confidence            56888889999999999999975           44678999998754322  234567899999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....  ...++||||+. ++|.+++.... ..+++..++.++.|++.||.|||+.   +++|+||||+|||++.++.++
T Consensus        74 ~~~~~--~~~~lv~e~~~-~~L~~~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~  146 (293)
T cd07843          74 VGSNL--DKIYMVMEYVE-HDLKSLMETMK-QPFLQSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILK  146 (293)
T ss_pred             EecCC--CcEEEEehhcC-cCHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEE
Confidence            76531  13799999996 59999887643 4689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~  322 (453)
                      |+|||++.......  .......+++.|+|||.+.+. .++.++||||||+++|+|++|..||.......... +.....
T Consensus       147 l~d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~  224 (293)
T cd07843         147 ICDFGLAREYGSPL--KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLG  224 (293)
T ss_pred             EeecCceeeccCCc--cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhC
Confidence            99999998654321  122345678899999988754 46899999999999999999999997543322211 111100


Q ss_pred             -------hcccC----c-cccccccCCcCCCccchH-HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 -------PYVSD----S-KKFHLIIDPRLEGNYCIK-SAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 -------~~~~~----~-~~~~~~~~~~~~~~~~~~-~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             +.+..    . ..........+...++.. .++.+.+++.+||+.+|++|||+.|++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~  289 (293)
T cd07843         225 TPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK  289 (293)
T ss_pred             CCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence                   00000    0 000000111111112222 4677899999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-38  Score=301.31  Aligned_cols=248  Identities=28%  Similarity=0.429  Sum_probs=197.4

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCC---CCceeeEeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK---HPNLVKLVGY  163 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~---h~nIv~l~~~  163 (453)
                      .|+..+.||+|+||.||+|.+.           .++..||+|.+.... ......+.+|+.+++.+.   ||||++++++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~   70 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHV-----------PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGS   70 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEc-----------CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeee
Confidence            4677789999999999999975           456789999986542 334567889999999986   9999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+++++|.+++...   ++++...+.++.|++.||.|||+.   +|+|+||+|+||+++.++.+
T Consensus        71 ~~~~~~----~~lv~e~~~~~~L~~~~~~~---~l~~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~  140 (277)
T cd06917          71 YLKGPR----LWIIMEYAEGGSVRTLMKAG---PIAEKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNV  140 (277)
T ss_pred             eeeCCE----EEEEEecCCCCcHHHHHHcc---CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCE
Confidence            876553    79999999999999988653   788999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|+|||++.......  .......|+..|+|||.+.++ .++.++|||||||++|+|++|..||.........   ....
T Consensus       141 ~l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~---~~~~  215 (277)
T cd06917         141 KLCDFGVAALLNQNS--SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAM---MLIP  215 (277)
T ss_pred             EEccCCceeecCCCc--cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhh---hccc
Confidence            999999998754332  122345689999999988754 5689999999999999999999999654321111   1000


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          .      ...+.+..   ...+.++.+++.+||..||.+||++.+++.
T Consensus       216 ----~------~~~~~~~~---~~~~~~~~~~i~~~l~~~p~~R~~~~~il~  254 (277)
T cd06917         216 ----K------SKPPRLED---NGYSKLLREFVAACLDEEPKERLSAEELLK  254 (277)
T ss_pred             ----c------CCCCCCCc---ccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence                0      00011111   114567999999999999999999999975

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.2e-38  Score=302.16  Aligned_cols=267  Identities=25%  Similarity=0.328  Sum_probs=196.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++++|...+.||+|+||.||+|.+.           .++..||+|.+...... ....+.+|+.+++.++|+||++++++
T Consensus         3 ~~~~y~~~~~ig~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~   71 (291)
T cd07870           3 AATSYLNLEKLGEGSYATVYKGISR-----------INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI   71 (291)
T ss_pred             ccceeEEEEEEEecCCEEEEEEEEc-----------CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEE
Confidence            4678999999999999999999875           34678999998654322 23467889999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++.+
T Consensus        72 ~~~~~~----~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~  142 (291)
T cd07870          72 IHTKET----LTFVFEYMH-TDLAQYMIQH-PGGLHPYNVRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGEL  142 (291)
T ss_pred             EecCCe----EEEEEeccc-CCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcE
Confidence            876553    799999995 7787777554 24577888889999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||+++......  .......+++.|+|||++.+ ..++.++|||||||++|||++|..||.......+ .+.+...
T Consensus       143 ~l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~-~~~~~~~  219 (291)
T cd07870         143 KLADFGLARAKSIPS--QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFE-QLEKIWT  219 (291)
T ss_pred             EEeccccccccCCCC--CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHH-HHHHHHH
Confidence            999999987643221  11234457899999999875 4578899999999999999999999975433211 1111100


Q ss_pred             -hcccCc---------cc-cccccCCcCCCcc-----chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 -PYVSDS---------KK-FHLIIDPRLEGNY-----CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 -~~~~~~---------~~-~~~~~~~~~~~~~-----~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ......         .. .............     ....+..+.+++.+|+..||.+|||+.+++.
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~  287 (291)
T cd07870         220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL  287 (291)
T ss_pred             HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence             000000         00 0000000000000     0112467889999999999999999999864

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=4.2e-38  Score=300.70  Aligned_cols=247  Identities=28%  Similarity=0.440  Sum_probs=198.9

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      |...+.||.|+||.||+|.+.           .++..||||.+.... ......+.+|+.++++++||||+++++++...
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~   74 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDN-----------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD   74 (277)
T ss_pred             hhhheeEeecCCeEEEEEEEC-----------CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC
Confidence            667778999999999999865           446789999876433 23346788999999999999999999999876


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ..    .++||||+++++|.+++..   ..+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.++|+|
T Consensus        75 ~~----~~lv~e~~~~~~l~~~i~~---~~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~d  144 (277)
T cd06641          75 TK----LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLAD  144 (277)
T ss_pred             Ce----EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEee
Confidence            54    7999999999999998865   3688999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccC
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      ||++.......  .......++..|+|||.+.+..++.++|||||||++|+|++|..||....+..   ....+..    
T Consensus       145 fg~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~---~~~~~~~----  215 (277)
T cd06641         145 FGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK---VLFLIPK----  215 (277)
T ss_pred             cccceecccch--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH---HHHHHhc----
Confidence            99987654321  11234568889999999988888999999999999999999999986533221   1111100    


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ..          ........+..+.+++.+||..+|.+||++.+++..
T Consensus       216 ~~----------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         216 NN----------PPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             CC----------CCCCCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence            00          001122345778999999999999999999999873

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.5e-38  Score=300.26  Aligned_cols=248  Identities=28%  Similarity=0.388  Sum_probs=202.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +|...++||.|+||.||+|.+.           .++..||+|.+.....   ...+.+.+|+.++++++||||+++++++
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   69 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKR-----------DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSF   69 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEc-----------cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhh
Confidence            5788899999999999999875           4567899999875432   3456789999999999999999999988


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++|+||+.+++|.+++...  .+++...+..++.|++.||.|||+.   +++|+||+|+||++++++.++
T Consensus        70 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~  140 (258)
T cd05578          70 QDEEN----MYLVVDLLLGGDLRYHLSQK--VKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVH  140 (258)
T ss_pred             cCCCe----EEEEEeCCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEE
Confidence            76553    79999999999999999765  5788999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++.......   ......|+..|+|||.+.+..++.++||||||+++|+|++|..||..........+...... 
T Consensus       141 l~d~~~~~~~~~~~---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~-  216 (258)
T cd05578         141 ITDFNIATKVTPDT---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQET-  216 (258)
T ss_pred             EeecccccccCCCc---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhcc-
Confidence            99999988754322   23445688999999999888899999999999999999999999976543222222111110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH--HHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM--SEVV  373 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~--~ei~  373 (453)
                                    .....+...+..+.+++.+||..+|.+||++  .+++
T Consensus       217 --------------~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~  253 (258)
T cd05578         217 --------------ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK  253 (258)
T ss_pred             --------------ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence                          0111223346789999999999999999999  5544

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-38  Score=301.39  Aligned_cols=265  Identities=23%  Similarity=0.331  Sum_probs=198.5

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |+..+.||.|++|.||+|.+.           .++..||+|++.....  .....+.+|+.+++.++||||+++++++..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~   69 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDK-----------LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHS   69 (283)
T ss_pred             CchheEecCCCCeEEEEEEEc-----------CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheecc
Confidence            567789999999999999975           4567899999865432  234568899999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .+++|||+ +++|.+++.......+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+
T Consensus        70 ~~~----~~iv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~  141 (283)
T cd07835          70 ENK----LYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLA  141 (283)
T ss_pred             CCe----EEEEEecc-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEe
Confidence            653    79999999 57999998876555789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHHhhhhc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEWVRPY  324 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~~~  324 (453)
                      |||++.......  .......++..|+|||++.+. .++.++||||||+++|+|++|+.||......... .+.+.....
T Consensus       142 df~~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (283)
T cd07835         142 DFGLARAFGVPV--RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTP  219 (283)
T ss_pred             ecccccccCCCc--cccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCC
Confidence            999997643221  112334568899999987654 5789999999999999999999999754332211 111110000


Q ss_pred             c-------cCcccccccc---CCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 V-------SDSKKFHLII---DPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~-------~~~~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .       .........+   ............+..+.+++.+||+.+|.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~  279 (283)
T cd07835         220 DEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ  279 (283)
T ss_pred             ChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            0       0000000000   000001112234567899999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=3.8e-38  Score=303.83  Aligned_cols=264  Identities=17%  Similarity=0.190  Sum_probs=189.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccH-----------HHHHHHHHHhccCCC
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-----------KEWINEVNFLGVVKH  154 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~-----------~~~~~E~~~l~~l~h  154 (453)
                      .++|...++||+|+||+||+|.+....        .....+|+|..........           .....++..+..+.|
T Consensus        11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~--------~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h   82 (294)
T PHA02882         11 GKEWKIDKLIGCGGFGCVYETQCASDH--------CINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDH   82 (294)
T ss_pred             CCceEEeeEEecCCCceEEEEEEcCCc--------ccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCC
Confidence            367999999999999999999875210        1144577776433221110           112344556677899


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      +||+++++++..........+++++++ ..++.+.+...  ...++..+..++.|++.||.|||+.   +|+||||||+|
T Consensus        83 ~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~iiHrDiKp~N  156 (294)
T PHA02882         83 LGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRI--KCKNKKLIKNIMKDMLTTLEYIHEH---GISHGDIKPEN  156 (294)
T ss_pred             CCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhh--ccCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHH
Confidence            999999998766554333357788877 44666665543  3356778889999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                      ||++.++.++|+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus       157 ill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~  236 (294)
T PHA02882        157 IMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF  236 (294)
T ss_pred             EEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence            99999999999999999865322111     1123346999999999999999999999999999999999999999765


Q ss_pred             CChhhH-HH--HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          310 LPRNEQ-KL--LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       310 ~~~~~~-~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      ...... ..  .++.....          ...+   .....+..+.+++..|+..+|++||++.+|++.|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~----------~~~~---~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        237 GHNGNLIHAAKCDFIKRLH----------EGKI---KIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             ccchHHHHHhHHHHHHHhh----------hhhh---ccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            322111 10  11111110          0111   0122357799999999999999999999999876

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=5.9e-38  Score=301.02  Aligned_cols=254  Identities=30%  Similarity=0.435  Sum_probs=205.2

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..+++|...+.||+|+||.||+|.+.           ..+..||+|++..... ....+.+|+.+++.++|+||++++++
T Consensus        16 ~~~~~~~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~   83 (286)
T cd06614          16 DPRELYKNLEKIGEGASGEVYKATDR-----------ATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDS   83 (286)
T ss_pred             CccccchHhHhccCCCCeEEEEEEEc-----------cCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEE
Confidence            35677888899999999999999975           3467899999875443 46778899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++|+||+++++|.+++.... ..+++..++.++.+++.||.|||+.   +|+|+||+|+||+++.++.+
T Consensus        84 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~-~~l~~~~~~~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~  155 (286)
T cd06614          84 YLVGDE----LWVVMEYMDGGSLTDIITQNF-VRMNEPQIAYVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSV  155 (286)
T ss_pred             EEECCE----EEEEEeccCCCcHHHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCE
Confidence            987754    799999999999999998763 4789999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|+|||++.......  .......++..|+|||++.+..++.++|||||||++|+|++|..||....+.....  .....
T Consensus       156 ~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~--~~~~~  231 (286)
T cd06614         156 KLADFGFAAQLTKEK--SKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALF--LITTK  231 (286)
T ss_pred             EECccchhhhhccch--hhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHHhc
Confidence            999999987543221  12234467889999999988889999999999999999999999986543322111  11100


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                            ..     +  ........+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       232 ------~~-----~--~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~  269 (286)
T cd06614         232 ------GI-----P--PLKNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ  269 (286)
T ss_pred             ------CC-----C--CCcchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                  00     0  00011224577999999999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=2.3e-38  Score=298.48  Aligned_cols=250  Identities=27%  Similarity=0.413  Sum_probs=200.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||+|..+           .++..+|+|.+.....  ...+.+.+|+.+++.++|+||+++++++.
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~   69 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAK-----------SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQ   69 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEc-----------CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheec
Confidence            5788899999999999999976           4467799999865422  33457889999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-cEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-KAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~k  244 (453)
                      ....    .++|+||+++++|.+++.......+++..+..++.|++.||.|||+.   +++|+||||+||++++++ .+|
T Consensus        70 ~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~  142 (257)
T cd08225          70 ENGR----LFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAK  142 (257)
T ss_pred             cCCe----EEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEE
Confidence            7654    79999999999999999876555789999999999999999999998   999999999999999875 469


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||.+.......  .......|++.|+|||++.+..++.++||||||++++||++|..||.......  ........ 
T Consensus       143 l~d~~~~~~~~~~~--~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~~~-  217 (257)
T cd08225         143 LGDFGIARQLNDSM--ELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ--LVLKICQG-  217 (257)
T ss_pred             ecccccchhccCCc--ccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH--HHHHHhcc-
Confidence            99999987654321  12234568999999999988889999999999999999999999986532211  11111110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           .    ..     ......+..+.+++.+||..+|++|||+.++++
T Consensus       218 -----~----~~-----~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~  253 (257)
T cd08225         218 -----Y----FA-----PISPNFSRDLRSLISQLFKVSPRDRPSITSILK  253 (257)
T ss_pred             -----c----CC-----CCCCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence                 0    00     011233567999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-38  Score=302.26  Aligned_cols=252  Identities=27%  Similarity=0.376  Sum_probs=193.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHH-hccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNF-LGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~-l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||.||+|++.           .++..||+|.+..... .....+..|+.+ ++.++||||+++++++
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~   69 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHV-----------PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGAL   69 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEc-----------CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEE
Confidence            47888999999999999999976           4578899999875432 233456667665 5667999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .....    .++||||++ |+|.+++...  ....+++..++.++.|++.||.|||++.  +++||||||+|||++.++.
T Consensus        70 ~~~~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~  142 (283)
T cd06617          70 FREGD----VWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQ  142 (283)
T ss_pred             ecCCc----EEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCC
Confidence            86654    799999995 7888877643  2356899999999999999999999853  8999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCcccccc----CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT----GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      +||+|||++......   .......++..|+|||.+.+    ..++.++|||||||++|+|++|+.||....... ..+.
T Consensus       143 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~-~~~~  218 (283)
T cd06617         143 VKLCDFGISGYLVDS---VAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPF-QQLK  218 (283)
T ss_pred             EEEeecccccccccc---cccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCH-HHHH
Confidence            999999999864321   11233568899999998864    456889999999999999999999986432111 1111


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....           ..+.+   .....+.++.+++.+||..+|.+||++.+|++
T Consensus       219 ~~~~~-----------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~  260 (283)
T cd06617         219 QVVEE-----------PSPQL---PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ  260 (283)
T ss_pred             HHHhc-----------CCCCC---CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11100           00000   01124577999999999999999999999875

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=6.7e-38  Score=309.94  Aligned_cols=268  Identities=26%  Similarity=0.330  Sum_probs=199.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||.||+|.+.           .++..||||.+....  ......+.+|+.++++++||||+++++
T Consensus        14 ~~~~y~~~~~lg~g~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   82 (353)
T cd07850          14 VLKRYQNLKPIGSGAQGIVCAAYDT-----------VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLN   82 (353)
T ss_pred             hhcceEEEEEeccCCCEEEEEEEEC-----------CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceee
Confidence            4578999999999999999999875           456789999986432  233456778999999999999999999


Q ss_pred             eeeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.....  .....++||||+ .++|.+.+...    ++...+..++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        83 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~----l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~  154 (353)
T cd07850          83 VFTPQKSLEEFQDVYLVMELM-DANLCQVIQMD----LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSD  154 (353)
T ss_pred             eeccCCCccccCcEEEEEecc-CCCHHHHHhhc----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCC
Confidence            8865432  112369999999 46888877543    78888899999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~  319 (453)
                      +.+||+|||++......   .......++..|+|||++.+..++.++|||||||++|+|++|+.||......... .+..
T Consensus       155 ~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~  231 (353)
T cd07850         155 CTLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIE  231 (353)
T ss_pred             CCEEEccCccceeCCCC---CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence            99999999999865322   1123456889999999999999999999999999999999999999654321111 0100


Q ss_pred             h---------------hhhcccCc-----cccccccCCc----CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 W---------------VRPYVSDS-----KKFHLIIDPR----LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~---------------~~~~~~~~-----~~~~~~~~~~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .               ...+....     ..+.......    .........+..+.+++.+||..||++|||+.+++.
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~  310 (353)
T cd07850         232 QLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQ  310 (353)
T ss_pred             hcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            0               00000000     0000000000    000011234667899999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.5e-37  Score=291.22  Aligned_cols=250  Identities=32%  Similarity=0.461  Sum_probs=203.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      +|...+.||+|++|.||++.+.           .++..+++|++..........+.+|+.+++.++|+||+++++++...
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~   69 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHK-----------RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK   69 (253)
T ss_pred             CceeeeeeccCCceEEEEEEEC-----------CCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC
Confidence            4677889999999999999975           35678999999766555667899999999999999999999998776


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ..    .++++||+++++|.+++.... ..+++..+..++.+++.||.+||..   +++||||+|+||+++.++.++|+|
T Consensus        70 ~~----~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d  141 (253)
T cd05122          70 DE----LWIVMEFCSGGSLKDLLKSTN-QTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLID  141 (253)
T ss_pred             Ce----EEEEEecCCCCcHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEee
Confidence            53    799999999999999887653 5789999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccC
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      ||.+........   .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..............       
T Consensus       142 ~~~~~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~-------  211 (253)
T cd05122         142 FGLSAQLSDTKA---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIAT-------  211 (253)
T ss_pred             cccccccccccc---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHh-------
Confidence            999987554321   3456788999999999888899999999999999999999999875432221111110       


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ....     ..  ......+..+.+++.+||..||++|||+.++++
T Consensus       212 -~~~~-----~~--~~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~  250 (253)
T cd05122         212 -NGPP-----GL--RNPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK  250 (253)
T ss_pred             -cCCC-----Cc--CcccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence             0000     00  001112567999999999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=8.7e-38  Score=293.99  Aligned_cols=254  Identities=27%  Similarity=0.398  Sum_probs=204.4

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|++|.||+|.+.           .++..|++|++.....  ...+.+.+|+.++++++||||+++++++.
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDK-----------DTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSER   69 (260)
T ss_pred             CceeeeEeeecCceEEEEEEEC-----------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEe
Confidence            4777889999999999999975           3567899999875543  34577899999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ...  ...+++++||+++++|.+++....  .+++..++.++.+++.||.|||+.   +++|+||+|+||+++.++.++|
T Consensus        70 ~~~--~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l  142 (260)
T cd06606          70 DEE--KNTLNIFLEYVSGGSLSSLLKKFG--KLPEPVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKL  142 (260)
T ss_pred             cCC--CCeEEEEEEecCCCcHHHHHHHcC--CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEE
Confidence            762  113799999999999999988753  889999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||.+................++..|+|||.+.+...+.++||||||+++++|++|..||...... .......     
T Consensus       143 ~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~-----  216 (260)
T cd06606         143 ADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNP-MAALYKI-----  216 (260)
T ss_pred             cccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCch-HHHHHhc-----
Confidence            9999998765432211134457889999999998888999999999999999999999999754311 1111110     


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               .........+...+..+.+++.+|+..+|.+||++.+++.
T Consensus       217 ---------~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~  256 (260)
T cd06606         217 ---------GSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ  256 (260)
T ss_pred             ---------cccCCCcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence                     0001111122334678999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=5.7e-38  Score=304.42  Aligned_cols=248  Identities=32%  Similarity=0.464  Sum_probs=196.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ...|...+.||+|+||+||+|++.           .++..||+|.+.....   .....+.+|+.+++.++||||+++++
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~-----------~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~   82 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDV-----------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKG   82 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEc-----------CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            355888889999999999999975           3467899999864432   22356889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +|...+.    .++||||+. |+|.+++... ...+++..+..++.|++.||.|||+.   +|+|+||+|+||+++.++.
T Consensus        83 ~~~~~~~----~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~  153 (307)
T cd06607          83 CYLREHT----AWLVMEYCL-GSASDILEVH-KKPLQEVEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGT  153 (307)
T ss_pred             EEEeCCe----EEEEHHhhC-CCHHHHHHHc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCC
Confidence            9987664    699999995 6777766543 24689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      ++|+|||++.....      .....++..|+|||++.   ...++.++||||||+++|||++|..||............ 
T Consensus       154 ~kL~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~-  226 (307)
T cd06607         154 VKLADFGSASLVSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI-  226 (307)
T ss_pred             EEEeecCcceecCC------CCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHH-
Confidence            99999999876432      22346788999999874   356889999999999999999999998654322111100 


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                        .   . ..      .+.+   .....+..+.+++.+||+.+|.+||++.+|+..
T Consensus       227 --~---~-~~------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  267 (307)
T cd06607         227 --A---Q-ND------SPTL---SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH  267 (307)
T ss_pred             --h---c-CC------CCCC---CchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence              0   0 00      0000   112346679999999999999999999999863

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.2e-39  Score=316.93  Aligned_cols=246  Identities=23%  Similarity=0.388  Sum_probs=197.7

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC----CcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ----GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~----~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      ..+||+|+|-+||||.+.           ..+.+||--.++..    .....+.|..|+.+|+.|+||||+++|.++.+.
T Consensus        45 ~evLGrGafKtVYka~De-----------~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~  113 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDE-----------EEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDT  113 (632)
T ss_pred             hhhcccccceeeeecccc-----------ccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecC
Confidence            347999999999999975           55777887655422    223457899999999999999999999999987


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-CCcEEEe
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKAKLS  246 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~  246 (453)
                      ...  ..-+|+|.+..|+|..|+.+.  ..++......|++||++||.|||++ .|+|||||||.+||||+. -|.|||+
T Consensus       114 ~n~--~in~iTEL~TSGtLr~Y~kk~--~~vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIG  188 (632)
T KOG0584|consen  114 DNK--TINFITELFTSGTLREYRKKH--RRVNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIG  188 (632)
T ss_pred             CCc--eeeeeeecccCCcHHHHHHHh--ccCCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeec
Confidence            653  357899999999999999987  5677778899999999999999998 789999999999999975 6889999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |+|||+....    .....+.|||.|||||++. ..|+..+||||||+.++||+|+..||.....  ...++..+...+.
T Consensus       189 DLGLAtl~r~----s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n--~AQIYKKV~SGiK  261 (632)
T KOG0584|consen  189 DLGLATLLRK----SHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTN--PAQIYKKVTSGIK  261 (632)
T ss_pred             chhHHHHhhc----cccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCC--HHHHHHHHHcCCC
Confidence            9999997543    2245589999999999997 7899999999999999999999999965422  2233333322111


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       +..+..+-            .+++.++|.+||.. ..+|||+.|++.
T Consensus       262 -P~sl~kV~------------dPevr~fIekCl~~-~~~R~sa~eLL~  295 (632)
T KOG0584|consen  262 -PAALSKVK------------DPEVREFIEKCLAT-KSERLSAKELLK  295 (632)
T ss_pred             -HHHhhccC------------CHHHHHHHHHHhcC-chhccCHHHHhh
Confidence             11111111            24688999999999 999999999985

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-37  Score=297.52  Aligned_cols=266  Identities=23%  Similarity=0.353  Sum_probs=199.0

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +|+..+.||.|++|.||+|++.           .++..||||.+...... ....+.+|+.++++++||||+++++++..
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   69 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNR-----------TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHT   69 (284)
T ss_pred             CceEeeeeccCCceEEEEEEEC-----------CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEee
Confidence            5788899999999999999975           45678999998755332 34667889999999999999999999988


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      .+.    .++||||++ ++|.+++.... ...+++..+..++.|++.||.|||+.   +++||||||+||++++++.++|
T Consensus        70 ~~~----~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l  141 (284)
T cd07836          70 ENK----LMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKL  141 (284)
T ss_pred             CCc----EEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEE
Confidence            764    699999997 58888886543 34689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhh-
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVR-  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~-  322 (453)
                      +|||++.......  .......++..|++||++.+ ..++.++|||||||++|+|++|+.||.......... +..... 
T Consensus       142 ~d~g~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~  219 (284)
T cd07836         142 ADFGLARAFGIPV--NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGT  219 (284)
T ss_pred             eecchhhhhcCCc--cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCC
Confidence            9999997643221  11234567889999998865 457889999999999999999999997654322111 111100 


Q ss_pred             hc------ccCccccccccCCc---CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PY------VSDSKKFHLIIDPR---LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~------~~~~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +.      +.....+.......   .........+..+.+++.+||+.||.+||++.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  280 (284)
T cd07836         220 PTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ  280 (284)
T ss_pred             CChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence            00      00000000000000   000111234567899999999999999999999874

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=1e-37  Score=300.60  Aligned_cols=267  Identities=24%  Similarity=0.326  Sum_probs=197.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|++|+||+|.+.           .++..||+|.+.....  .....+.+|+.++++++||||+++++++
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   70 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDR-----------VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVV   70 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEec-----------CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEE
Confidence            57888999999999999999975           4567899999865432  2345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-CCcE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKA  243 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~  243 (453)
                      .....    .++||||++ ++|.+++.......+++.....++.||+.||.|||++   +++|+||+|+||+++. ++.+
T Consensus        71 ~~~~~----~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~  142 (294)
T PLN00009         71 HSEKR----LYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNAL  142 (294)
T ss_pred             ecCCe----EEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEE
Confidence            87653    799999995 6888888766555578888889999999999999998   9999999999999985 5679


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWV  321 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~  321 (453)
                      ||+|||++......  ........+++.|+|||++.+ ..++.++|||||||++|+|++|..||.......... .....
T Consensus       143 kl~dfg~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~  220 (294)
T PLN00009        143 KLADFGLARAFGIP--VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRIL  220 (294)
T ss_pred             EEcccccccccCCC--ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            99999999764322  112234567899999998866 457899999999999999999999997654322211 11110


Q ss_pred             h-hc---ccCccccccccC--CcCCC----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 R-PY---VSDSKKFHLIID--PRLEG----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~-~~---~~~~~~~~~~~~--~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      . +.   +...........  +....    ......+..+.+++.+||+.+|++||++.++++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~  283 (294)
T PLN00009        221 GTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE  283 (294)
T ss_pred             CCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0 00   000000000000  00000    011234567899999999999999999999985

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.3e-38  Score=304.10  Aligned_cols=254  Identities=28%  Similarity=0.402  Sum_probs=192.9

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCC-CCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVK-HPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~  165 (453)
                      +|.....||+|+||.||++.+.           ..+..||+|.+..... .....+.+|+.++.++. ||||+++++++.
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~   73 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHK-----------PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALF   73 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEEC-----------CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEe
Confidence            4555668999999999999976           4567899999875432 33457889999999996 999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDH---LLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ....    .+++|||+. ++|.++   +.......+++.....++.+++.||+|||+..  +++||||||+|||++.++.
T Consensus        74 ~~~~----~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~  146 (288)
T cd06616          74 REGD----CWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGN  146 (288)
T ss_pred             cCCc----EEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCc
Confidence            6554    689999984 455543   33333467899999999999999999999742  8999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccC---CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG---RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      ++|+|||++.......   ......|+..|+|||++.+.   .++.++|||||||++|+|++|+.||.....     ...
T Consensus       147 ~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~-----~~~  218 (288)
T cd06616         147 IKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS-----VFD  218 (288)
T ss_pred             EEEeecchhHHhccCC---ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch-----HHH
Confidence            9999999987543221   12344688999999998765   689999999999999999999999865421     111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ........       ..+.+........+.++.+|+.+||+.+|.+|||+.+|+.
T Consensus       219 ~~~~~~~~-------~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~  266 (288)
T cd06616         219 QLTQVVKG-------DPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLE  266 (288)
T ss_pred             HHhhhcCC-------CCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            11110000       0111111222335678999999999999999999999885

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=8.6e-38  Score=307.21  Aligned_cols=271  Identities=27%  Similarity=0.374  Sum_probs=200.0

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC--CcccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      ..++|...+.||+|+||.||+|.+.           .++..+|+|++...  .......+.+|+.+++++ +||||++++
T Consensus         5 ~~~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~   73 (337)
T cd07852           5 ILRKYEILQKLGKGAYGIVWKAIDR-----------RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLL   73 (337)
T ss_pred             hhhHHHHhHhhcCCCCeeEEEEEEc-----------CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCcccee
Confidence            3577888899999999999999875           34678999988542  223345677899999999 999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++...+.  ..+++||||++ ++|..++...   .+++..+..++.|++.||.|||+.   +|+|+||||+|||++.++
T Consensus        74 ~~~~~~~~--~~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~  144 (337)
T cd07852          74 NVIKAEND--KDIYLVFEYME-TDLHAVIRAN---ILEDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDC  144 (337)
T ss_pred             eeeccCCC--ceEEEEecccc-cCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCC
Confidence            99876432  23799999996 6999888664   778889999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCC---ccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          242 KAKLSDFGLARQGPPEGLG---HVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      .+||+|||++.........   .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||....+......
T Consensus       145 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~  224 (337)
T cd07852         145 RVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEK  224 (337)
T ss_pred             cEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHH
Confidence            9999999999865433211   12234568999999998764 5578999999999999999999999975443322111


Q ss_pred             HHhhhhcccC----------cc-ccccccCCc--CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          318 LEWVRPYVSD----------SK-KFHLIIDPR--LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       318 ~~~~~~~~~~----------~~-~~~~~~~~~--~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ..........          .. .+.......  .........+.++.+++.+||+.+|.+|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         225 IIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence            1100000000          00 000000000  0001111246789999999999999999999999863

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-38  Score=309.63  Aligned_cols=269  Identities=26%  Similarity=0.337  Sum_probs=199.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +++|...++||+|+||.||+|++.           .++..||||.+.... ......+.+|+.++++++||||+++++++
T Consensus         4 ~~~y~i~~~lg~G~~g~vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   72 (336)
T cd07849           4 GPRYQNLSYIGEGAYGMVCSATHK-----------PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDII   72 (336)
T ss_pred             ccceEEEEEEEecCCeEEEEEEEc-----------CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhhee
Confidence            578999999999999999999875           456789999986432 22345688899999999999999999987


Q ss_pred             eecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          165 AEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       165 ~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      ...... ....++|+||+. ++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~---~~l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~  145 (336)
T cd07849          73 RPPSFESFNDVYIVQELME-TDLYKLIKT---QHLSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDL  145 (336)
T ss_pred             ecccccccceEEEEehhcc-cCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCE
Confidence            765421 224789999995 588887754   4689999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCC-CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          244 KLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       244 kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      ||+|||++........ ........|+..|+|||.+.+ ..++.++|||||||++|+|++|+.||............   
T Consensus       146 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~---  222 (336)
T cd07849         146 KICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLI---  222 (336)
T ss_pred             EECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH---
Confidence            9999999976433211 111234568999999998754 56889999999999999999999999654322111111   


Q ss_pred             hhcccC--ccccccccCCc-----------CCCc---cchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          322 RPYVSD--SKKFHLIIDPR-----------LEGN---YCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       322 ~~~~~~--~~~~~~~~~~~-----------~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ......  ...+..+.+..           ....   .....+.++.+++.+||+.+|++|||+.++++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         223 LGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             HHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            000000  00000000000           0000   011235678999999999999999999999864

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=9.5e-38  Score=298.25  Aligned_cols=241  Identities=28%  Similarity=0.390  Sum_probs=191.5

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ||+|+||+||++.+.           .++..||+|.+....   ......+..|+.++++++||||+++++++...+.  
T Consensus         1 lg~g~~g~vy~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~--   67 (277)
T cd05577           1 LGKGGFGEVCACQVK-----------ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDD--   67 (277)
T ss_pred             CCCCCceeEEEEEEc-----------CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCe--
Confidence            699999999999875           456789999986432   2234557789999999999999999999876653  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +++||||+|+||+++.++.++|+|||++
T Consensus        68 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~  142 (277)
T cd05577          68 --LCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLA  142 (277)
T ss_pred             --EEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcch
Confidence              79999999999999999876556789999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh-HHHHHhhhhcccCccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLEWVRPYVSDSKK  330 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~-~~~~~~~~~~~~~~~~  330 (453)
                      .....   ........++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ..+.....   .    
T Consensus       143 ~~~~~---~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~----  212 (277)
T cd05577         143 VELKG---GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTL---E----  212 (277)
T ss_pred             hhhcc---CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccc---c----
Confidence            76432   1122345678899999999888899999999999999999999999965433111 11111000   0    


Q ss_pred             cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHH
Q 043568          331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE  371 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  371 (453)
                              .....+...+..+.+++.+||+.+|.+||++.+
T Consensus       213 --------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~  245 (277)
T cd05577         213 --------MAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRG  245 (277)
T ss_pred             --------ccccCCccCCHHHHHHHHHHccCChhHccCCCc
Confidence                    001112234677999999999999999994444

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=2.7e-37  Score=299.46  Aligned_cols=273  Identities=23%  Similarity=0.334  Sum_probs=199.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|.....||+|+||.||+|...           .++..||||.+.....  .....+.+|+.++++++||||++++++
T Consensus        11 ~~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   79 (310)
T cd07865          11 VSKYEKLAKIGQGTFGEVFKARHK-----------KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI   79 (310)
T ss_pred             hhheEEEEEeecCCCEEEEEEEEC-----------CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEE
Confidence            457999999999999999999975           4567899998864322  223456789999999999999999999


Q ss_pred             eeecccc----cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          164 CAEDDER----GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       164 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      |......    ....++||||+. ++|.+++... ...+++..++.++.|++.||.|||++   +++|+||||+||+++.
T Consensus        80 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~  154 (310)
T cd07865          80 CRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNK-NVKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITK  154 (310)
T ss_pred             EecccccccCCCceEEEEEcCCC-cCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECC
Confidence            8765431    234699999995 5888877654 34689999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCC--ccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      ++.+||+|||++.........  .......++..|+|||++.+. .++.++||||||+++|||++|+.||....+.....
T Consensus       155 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~  234 (310)
T cd07865         155 DGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLT  234 (310)
T ss_pred             CCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            999999999999765432211  112344678899999988654 47889999999999999999999997654433322


Q ss_pred             HHHhhhhccc-----CccccccccCCcCCCcc---------chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVS-----DSKKFHLIIDPRLEGNY---------CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~-----~~~~~~~~~~~~~~~~~---------~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+........     ........-........         .......+.+||.+||..||.+|||+.++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~  306 (310)
T cd07865         235 LISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN  306 (310)
T ss_pred             HHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence            2222211000     00000000000000000         0012345789999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=4.3e-38  Score=308.96  Aligned_cols=272  Identities=25%  Similarity=0.321  Sum_probs=203.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|...           .++..||+|++....  ......+.+|+.+|++++||||++++++
T Consensus         4 ~~~y~~~~~lg~g~~g~v~~~~~~-----------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   72 (334)
T cd07855           4 GSRYKPIENIGSGAYGVVCSAIDT-----------RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDI   72 (334)
T ss_pred             hhceeeeeeeecCCCeEEEEEEEc-----------CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHh
Confidence            478999999999999999999875           456789999987542  2345667889999999999999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +..........++||||+ +++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        73 ~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~  146 (334)
T cd07855          73 LRPPGADFKDVYVVMDLM-ESDLHHIIHSD--QPLTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCEL  146 (334)
T ss_pred             ccccCCCCceEEEEEehh-hhhHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcE
Confidence            876554444589999999 46899988654  4589999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCC--ccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          244 KLSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      ||+|||++.........  .......|+..|+|||.+.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus       147 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~  226 (334)
T cd07855         147 RIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILS  226 (334)
T ss_pred             EecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHH
Confidence            99999999764332211  11234578899999998865 5688999999999999999999999965433222111111


Q ss_pred             hhhccc-------Ccccccccc---CCcCC---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVS-------DSKKFHLII---DPRLE---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~-------~~~~~~~~~---~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......       .........   .....   .......+..+.+++.+||+.+|.+|||+.+++.
T Consensus       227 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~  293 (334)
T cd07855         227 VLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ  293 (334)
T ss_pred             HhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence            000000       000000000   00000   0011234678999999999999999999998876

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-38  Score=325.98  Aligned_cols=280  Identities=20%  Similarity=0.270  Sum_probs=189.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCC--------CCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCc
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSG--------HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPN  156 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~--------~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n  156 (453)
                      ..++|...+.||+|+||+||+|.++..........        ......++.|.+. ........+.+|+.+|++++|||
T Consensus       146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn  224 (501)
T PHA03210        146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN  224 (501)
T ss_pred             hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence            45789999999999999999998653211000000        0000011112111 11123456889999999999999


Q ss_pred             eeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          157 LVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV---PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       157 Iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      |+++++++...+.    .++|++++ +++|.+++....   ...........++.||+.||.|||++   +|+||||||+
T Consensus       225 Iv~l~~~~~~~~~----~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~---gIiHrDLKP~  296 (501)
T PHA03210        225 ILKIEEILRSEAN----TYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLE  296 (501)
T ss_pred             cCcEeEEEEECCe----eEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHH
Confidence            9999999987764    68999998 567887775432   12233556778999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccc-cCCCCh
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV-ERNLPR  312 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~-~~~~~~  312 (453)
                      |||++.++.+||+|||+++....... .......||..|+|||++.+..++.++|||||||++|||++|..++ ......
T Consensus       297 NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~  375 (501)
T PHA03210        297 NIFLNCDGKIVLGDFGTAMPFEKERE-AFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGK  375 (501)
T ss_pred             HEEECCCCCEEEEeCCCceecCcccc-cccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCC
Confidence            99999999999999999986543221 1223467999999999999999999999999999999999988644 333222


Q ss_pred             hhHHHHHhhhhcccCccc-------cccccCC-cC---CCc-----cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          313 NEQKLLEWVRPYVSDSKK-------FHLIIDP-RL---EGN-----YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~-------~~~~~~~-~~---~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....+.+.+.........       +...++. .+   ...     .....+..+.+++.+||..||++|||+.|++.
T Consensus       376 ~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~  453 (501)
T PHA03210        376 PGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA  453 (501)
T ss_pred             HHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence            222222221110000000       0000000 00   000     01123456788999999999999999999985

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-37  Score=294.94  Aligned_cols=253  Identities=22%  Similarity=0.320  Sum_probs=198.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-----cccHHHHHHHHHHhccCCCCceeeEe
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-----FQGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .+|...+.||+|+||.||+|.+.           .++..||+|.+....     ......+.+|+.++++++||||++++
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~   70 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDA-----------DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYY   70 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEc-----------CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEE
Confidence            47889999999999999999875           446789999875321     22345788999999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....  ..+++++||+++++|.+++...  ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++
T Consensus        71 ~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~  143 (264)
T cd06653          71 GCLRDPEE--KKLSIFVEYMPGGSIKDQLKAY--GALTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAG  143 (264)
T ss_pred             EEEEcCCC--CEEEEEEEeCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCC
Confidence            99866432  2368999999999999998765  4578888999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCC-CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .++|+|||+++....... ........++..|+|||++.+..++.++|||||||++|+|++|+.||.......  .+...
T Consensus       144 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~--~~~~~  221 (264)
T cd06653         144 NVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA--AIFKI  221 (264)
T ss_pred             CEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH--HHHHH
Confidence            999999999986432111 111224568899999999988889999999999999999999999996542211  11111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..              .......+...+..+.+++.+||. +|..||++.+++.
T Consensus       222 ~~--------------~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~  260 (264)
T cd06653         222 AT--------------QPTKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR  260 (264)
T ss_pred             Hc--------------CCCCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence            10              001112233456789999999999 5799999998764

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=1.6e-37  Score=297.19  Aligned_cols=242  Identities=26%  Similarity=0.374  Sum_probs=186.8

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhc---cCCCCceeeEeeeeeec
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLG---VVKHPNLVKLVGYCAED  167 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~---~l~h~nIv~l~~~~~~~  167 (453)
                      +||+|+||.||++.+.           .++..+|+|.+......   ....+.+|..+++   ..+||||+.+++++...
T Consensus         1 ~lg~G~~g~Vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~   69 (279)
T cd05633           1 IIGRGGFGEVYGCRKA-----------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP   69 (279)
T ss_pred             CcccCCCeEEEEEEEC-----------CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC
Confidence            4899999999999875           45678999998654321   1233445544433   44799999999988876


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      +.    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+|+||||+|||+++++.++|+|
T Consensus        70 ~~----~~lv~e~~~~~~L~~~i~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~d  140 (279)
T cd05633          70 DK----LCFILDLMNGGDLHYHLSQH--GVFSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISD  140 (279)
T ss_pred             Ce----EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEcc
Confidence            54    69999999999999988765  4689999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      ||++......    ......|+..|+|||.+.+ ..++.++|||||||++|+|++|..||..........+.....    
T Consensus       141 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----  212 (279)
T cd05633         141 LGLACDFSKK----KPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----  212 (279)
T ss_pred             CCcceecccc----CccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhh----
Confidence            9998754322    1233468999999999864 568899999999999999999999997543322221111110    


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                                 ......+...+.++.+++.+||..||.+||     |++++++
T Consensus       213 -----------~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~  254 (279)
T cd05633         213 -----------TVNVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKE  254 (279)
T ss_pred             -----------cCCcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHh
Confidence                       001112233567899999999999999999     5888765

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=1.9e-37  Score=301.02  Aligned_cols=269  Identities=28%  Similarity=0.330  Sum_probs=198.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||+|.+......  ....+.+|+.++++++|+||++++++
T Consensus         6 ~~~y~~~~~ig~g~~~~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   74 (309)
T cd07845           6 VTEFEKLNRIGEGTYGIVYRARDT-----------TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEV   74 (309)
T ss_pred             ccceeEeeeeeecCCEEEEEEEEC-----------CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEE
Confidence            567999999999999999999975           45678999998644322  23356789999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +......  ..++||||+. ++|.+++... ...+++..+..++.|++.||.|||+.   +++||||||+||+++.++.+
T Consensus        75 ~~~~~~~--~~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~  147 (309)
T cd07845          75 VVGKHLD--SIFLVMEYCE-QDLASLLDNM-PTPFSESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCL  147 (309)
T ss_pred             EecCCCC--eEEEEEecCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCE
Confidence            8764321  3699999995 5888887654 35789999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||++.......  .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||....+......+....
T Consensus       148 kL~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~  225 (309)
T cd07845         148 KIADFGLARTYGLPA--KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLL  225 (309)
T ss_pred             EECccceeeecCCcc--CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            999999998754321  12233456788999999865 557899999999999999999999997654433222111110


Q ss_pred             hc--------ccCccccccccCCcCCCcc----chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PY--------VSDSKKFHLIIDPRLEGNY----CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~--------~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..        ............+......    ....+..+.++|.+||+.||++|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~  289 (309)
T cd07845         226 GTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE  289 (309)
T ss_pred             CCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence            00        0000000000000000000    0113567889999999999999999999885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.3e-37  Score=303.21  Aligned_cols=248  Identities=32%  Similarity=0.458  Sum_probs=195.5

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      |...+.||+|+||.||+|++.           .++..||+|.+.....   .....+.+|+.+++.++|||++++++++.
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~-----------~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   95 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDV-----------RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL   95 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEc-----------CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            666778999999999999875           3467899999865432   23356889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+. |+|.+.+... ..++++..+..++.+++.||.|||+.   +|+||||+|+||+++.++.++|
T Consensus        96 ~~~~----~~lv~e~~~-g~l~~~~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl  166 (317)
T cd06635          96 REHT----AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKL  166 (317)
T ss_pred             eCCe----EEEEEeCCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEE
Confidence            7664    699999995 5787777543 35689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|||++.....      .....|+..|+|||++.   .+.++.++|||||||++|||++|+.||........  ......
T Consensus       167 ~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~  238 (317)
T cd06635         167 ADFGSASIASP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ  238 (317)
T ss_pred             ecCCCccccCC------cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH--HHHHHh
Confidence            99999876432      23446888999999874   45688999999999999999999999865422111  111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      .    .          .........+..+.+++.+||+.+|.+||++.+|++.+-.
T Consensus       239 ~----~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~  280 (317)
T cd06635         239 N----E----------SPTLQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFV  280 (317)
T ss_pred             c----c----------CCCCCCccccHHHHHHHHHHccCCcccCcCHHHHHhChhh
Confidence            0    0          0001112345678999999999999999999999875543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.4e-37  Score=295.75  Aligned_cols=261  Identities=23%  Similarity=0.307  Sum_probs=193.0

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCC-CCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVK-HPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~  166 (453)
                      |...+.||+|+||.||+|.+.           .++..||+|.+..... .......+|+.++.++. |+||+++++++.+
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   69 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSR-----------KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFD   69 (282)
T ss_pred             CceEeeccccccceEEEEEEc-----------CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEec
Confidence            566788999999999999975           4567899999865422 22234567999999985 9999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ....  ..++||||++ ++|.+++.... ..+++..++.++.|++.||.|||+.   +++||||||+||+++. +.+||+
T Consensus        70 ~~~~--~~~lv~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~  141 (282)
T cd07831          70 RKTG--RLALVFELMD-MNLYELIKGRK-RPLPEKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLA  141 (282)
T ss_pred             CCCC--cEEEEEecCC-ccHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEE
Confidence            6211  3799999995 68888877642 4789999999999999999999998   9999999999999999 999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++.......   ......++..|+|||++.. ..++.++|||||||++|||++|..||....+.+.   +.......
T Consensus       142 dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~---~~~~~~~~  215 (282)
T cd07831         142 DFGSCRGIYSKP---PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQ---IAKIHDVL  215 (282)
T ss_pred             ecccccccccCC---CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHH---HHHHHHHc
Confidence            999998654321   1233467899999997654 5678999999999999999999999976543221   11111100


Q ss_pred             cCc-c---------ccccccCCcCCC----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDS-K---------KFHLIIDPRLEG----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~-~---------~~~~~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ... .         .......+....    ......+..+.+++.+||+.+|++|||+.++++
T Consensus       216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~  278 (282)
T cd07831         216 GTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR  278 (282)
T ss_pred             CCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence            000 0         000000000000    011234688999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-37  Score=294.67  Aligned_cols=243  Identities=24%  Similarity=0.343  Sum_probs=194.3

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ||.|+||.||+|++.           ..+..||+|.+.....   ...+.+.+|+.+++.++||||+++++++.....  
T Consensus         1 lg~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   67 (262)
T cd05572           1 LGVGGFGRVELVKVK-----------SKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKY--   67 (262)
T ss_pred             CCCCCceEEEEEEEC-----------CCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCc--
Confidence            799999999999975           3467899999875432   234678899999999999999999999876654  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++...  ..++...+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        68 --~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~  140 (262)
T cd05572          68 --IYMLMEYCLGGELWTILRDR--GLFDEYTARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFA  140 (262)
T ss_pred             --cEEEEecCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcc
Confidence              79999999999999999765  4588889999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      .......   ......++..|+|||.+....++.++|+||||+++|+|++|..||....... ........         
T Consensus       141 ~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~---------  207 (262)
T cd05572         141 KKLKSGQ---KTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP-MEIYNDIL---------  207 (262)
T ss_pred             cccCccc---ccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCH-HHHHHHHh---------
Confidence            8754321   2234568899999999988889999999999999999999999997654211 11111110         


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                          .......++...+..+.+++.+||+.+|.+||+     +.|+++
T Consensus       208 ----~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~  251 (262)
T cd05572         208 ----KGNGKLEFPNYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK  251 (262)
T ss_pred             ----ccCCCCCCCcccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence                000111122233678999999999999999999     666654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=2.3e-37  Score=298.11  Aligned_cols=269  Identities=19%  Similarity=0.267  Sum_probs=197.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCC-CCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVK-HPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~-h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||.||+|.+.           .++..||||.+.....  .....+.+|+.+++.+. ||||++++++
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~-----------~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~   69 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDK-----------NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDV   69 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEEC-----------CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeee
Confidence            46888999999999999999975           4567899998764422  23457888999999994 6999999999


Q ss_pred             eeeccc-ccceEEEEEEecCCCChHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          164 CAEDDE-RGMQRLLVYELMHNKSLEDHLLSRV---PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       164 ~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +..... .....++||||+++ +|.+++....   ...+++..++.++.||+.||.|||+.   +|+||||||+||+++.
T Consensus        70 ~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~  145 (295)
T cd07837          70 EHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDK  145 (295)
T ss_pred             EeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEec
Confidence            876554 22236899999975 8988886543   24689999999999999999999998   9999999999999998


Q ss_pred             -CCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-H
Q 043568          240 -DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-K  316 (453)
Q Consensus       240 -~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~  316 (453)
                       ++.+||+|||++.......  .......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....+.... .
T Consensus       146 ~~~~~kl~dfg~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~  223 (295)
T cd07837         146 QKGLLKIADLGLGRAFSIPV--KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLH  223 (295)
T ss_pred             CCCeEEEeecccceecCCCc--cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence             8999999999987643221  11233457889999998865 45789999999999999999999999764332221 1


Q ss_pred             HHHhhhhcccCcccccccc-------CCcCC----CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFHLII-------DPRLE----GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~-------~~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +......  ..........       .+...    .......+..+.++|.+||..||.+||++.+++.
T Consensus       224 ~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~  290 (295)
T cd07837         224 IFKLLGT--PTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT  290 (295)
T ss_pred             HHHHhCC--CChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence            1111100  0000000000       00000    0011234677999999999999999999998874

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=1.7e-37  Score=298.91  Aligned_cols=244  Identities=27%  Similarity=0.414  Sum_probs=195.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .+||+|+||.||+|...           .++..||||++..........+.+|+.+++.++|+||+++++++...+.   
T Consensus        26 ~~lg~g~~g~v~~~~~~-----------~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~---   91 (292)
T cd06657          26 IKIGEGSTGIVCIATVK-----------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDE---   91 (292)
T ss_pred             HHcCCCCCeEEEEEEEc-----------CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCE---
Confidence            47999999999999875           4577899999865444455678899999999999999999999987654   


Q ss_pred             eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR  252 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~  252 (453)
                       .++||||+++++|.+++..   ..+++.....++.|++.||+|||+.   +++||||+|+||+++.++.++|+|||++.
T Consensus        92 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~  164 (292)
T cd06657          92 -LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCA  164 (292)
T ss_pred             -EEEEEecCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccce
Confidence             7999999999999998754   3578889999999999999999998   99999999999999999999999999987


Q ss_pred             CCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccc
Q 043568          253 QGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFH  332 (453)
Q Consensus       253 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (453)
                      ......  .......|+..|+|||.+.+..++.++||||||+++|+|++|..||.............   ....      
T Consensus       165 ~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~---~~~~------  233 (292)
T cd06657         165 QVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR---DNLP------  233 (292)
T ss_pred             eccccc--ccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---hhCC------
Confidence            543221  12234568899999999988889999999999999999999999987543322211111   1000      


Q ss_pred             cccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          333 LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       333 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          +.+.  .....+..+.+++.+||..+|.+||++.+++.
T Consensus       234 ----~~~~--~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~  269 (292)
T cd06657         234 ----PKLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  269 (292)
T ss_pred             ----cccC--CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence                0000  01123556889999999999999999999886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-37  Score=301.95  Aligned_cols=272  Identities=21%  Similarity=0.254  Sum_probs=196.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +|...+.||+|+||.||+|.+...         ..+..||+|.+....   ......+.+|+.+++.++||||+++++++
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~---------~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   71 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNG---------KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVF   71 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCC---------CCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEE
Confidence            477888999999999999997521         146789999987632   33346678899999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC--
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV---PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE--  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~--  239 (453)
                      .....  ...++||||++ ++|.+++....   ...++...+..++.|++.||.|||+.   +|+||||||+|||++.  
T Consensus        72 ~~~~~--~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~  145 (316)
T cd07842          72 LEHAD--KSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEG  145 (316)
T ss_pred             eCCCC--ceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCC
Confidence            87632  23799999996 46777664322   23688899999999999999999998   9999999999999999  


Q ss_pred             --CCcEEEeccccccCCCCCCC-CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChh--
Q 043568          240 --DYKAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRN--  313 (453)
Q Consensus       240 --~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~--  313 (453)
                        ++.+||+|||++........ ........++..|+|||.+.+ ..++.++|||||||++++|++|+.||.......  
T Consensus       146 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~  225 (316)
T cd07842         146 PERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKK  225 (316)
T ss_pred             CccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccc
Confidence              99999999999986543221 112234567899999998876 457899999999999999999999997543321  


Q ss_pred             -----hHHHHHhhhhcc----------cCcccccc----ccCCcCC-Cc----cch--HHHHHHHHHHHHhhccCCCCCC
Q 043568          314 -----EQKLLEWVRPYV----------SDSKKFHL----IIDPRLE-GN----YCI--KSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       314 -----~~~~~~~~~~~~----------~~~~~~~~----~~~~~~~-~~----~~~--~~~~~l~~li~~cl~~dp~~RP  367 (453)
                           ...+........          ........    ....... ..    ...  ..+..+.+++.+||+.||++||
T Consensus       226 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp  305 (316)
T cd07842         226 SNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRI  305 (316)
T ss_pred             cchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCc
Confidence                 011111000000          00000000    0000000 00    000  3345789999999999999999


Q ss_pred             CHHHHHH
Q 043568          368 KMSEVVD  374 (453)
Q Consensus       368 s~~ei~~  374 (453)
                      |+.++++
T Consensus       306 s~~eil~  312 (316)
T cd07842         306 TAEEALE  312 (316)
T ss_pred             CHHHHhc
Confidence            9999874

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.1e-38  Score=311.66  Aligned_cols=246  Identities=26%  Similarity=0.379  Sum_probs=206.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc--HHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~--~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ...|.....||+|.|++|..|++.           .++..||||.+.+.....  ...+.+|+.+|..|+|||||+++.+
T Consensus        55 vg~y~i~~tig~g~f~~V~La~~~-----------~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v  123 (596)
T KOG0586|consen   55 VGLYVIIKTIGKGNFAKVKLARHI-----------LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSV  123 (596)
T ss_pred             ccceeeeeeeccceeEEEEeeEec-----------CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeee
Confidence            678999999999999999999987           457889999998765433  3458899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      ......    +|+||||+.+|.+++||.++  ..+....+..++.|+..|++|||++   .|||||||++||||+.+.++
T Consensus       124 ~~t~~~----lylV~eya~~ge~~~yl~~~--gr~~e~~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mni  194 (596)
T KOG0586|consen  124 IETEAT----LYLVMEYASGGELFDYLVKH--GRMKEKEARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNI  194 (596)
T ss_pred             eeecce----eEEEEEeccCchhHHHHHhc--ccchhhhhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccce
Confidence            987765    89999999999999999987  3455577888999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||++..+..   .....+.+|++.|.|||++.+..| ++++|+||+|++||.|+.|..||++..-           
T Consensus       195 kIaDfgfS~~~~~---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~l-----------  260 (596)
T KOG0586|consen  195 KIADFGFSTFFDY---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNL-----------  260 (596)
T ss_pred             eeeccccceeecc---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccc-----------
Confidence            9999999998763   344567899999999999998765 5899999999999999999999986422           


Q ss_pred             hcccCccccccccCCcCCCcc--chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNY--CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               ..+-.+.+.+.+  +.-.+.++.+|++++|.++|.+|+++.+|.+
T Consensus       261 ---------k~Lr~rvl~gk~rIp~~ms~dce~lLrk~lvl~Pskr~~~dqim~  305 (596)
T KOG0586|consen  261 ---------KELRPRVLRGKYRIPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMK  305 (596)
T ss_pred             ---------ccccchheeeeecccceeechhHHHHHHhhccCccccCCHHHhhh
Confidence                     111222222222  1223557889999999999999999999874

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2.7e-37  Score=302.53  Aligned_cols=261  Identities=23%  Similarity=0.287  Sum_probs=192.9

Q ss_pred             eecCC--CceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           94 LIGEG--GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        94 ~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      .||+|  +||+||++.+.           ..+..||||.+.....  ...+.+.+|+.+++.++||||+++++++...+.
T Consensus         5 ~ig~g~~~~~~v~~a~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~   73 (328)
T cd08226           5 EIGRGFCNLTSVYLARHT-----------PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSW   73 (328)
T ss_pred             HhCCcccCceeEEEEEEc-----------CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCc
Confidence            56776  99999999875           4578899999865432  234678899999999999999999999987654


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                          .++||||+.+++|.+++.......+++..+..++.|++.||+|||+.   +|+||||||+|||++.++.++++||+
T Consensus        74 ----~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~  146 (328)
T cd08226          74 ----LWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLS  146 (328)
T ss_pred             ----eEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechH
Confidence                69999999999999998876556789999999999999999999998   99999999999999999999999998


Q ss_pred             cccCCCCCCCCc-----cccccccCcCCCCccccccC--CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          250 LARQGPPEGLGH-----VSTSVVGTVGYAAPEYVQTG--RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       250 la~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      .+..........     ......++..|+|||++.+.  .++.++|||||||++|||++|..||.......  .+.....
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~--~~~~~~~  224 (328)
T cd08226         147 HLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQ--MLLQKLK  224 (328)
T ss_pred             HHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHH--HHHHHhc
Confidence            654321111000     01122356679999998763  47899999999999999999999997543221  1111110


Q ss_pred             h-cc-cCc-----------------------------cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHH
Q 043568          323 P-YV-SDS-----------------------------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE  371 (453)
Q Consensus       323 ~-~~-~~~-----------------------------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  371 (453)
                      . .. ...                             ..........+........+..+.+|+.+||+.||++|||+.+
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e  304 (328)
T cd08226         225 GPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASS  304 (328)
T ss_pred             CCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHH
Confidence            0 00 000                             0000001111122223345678999999999999999999999


Q ss_pred             HHH
Q 043568          372 VVD  374 (453)
Q Consensus       372 i~~  374 (453)
                      +++
T Consensus       305 ~l~  307 (328)
T cd08226         305 LLS  307 (328)
T ss_pred             Hhh
Confidence            974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=3.3e-37  Score=297.96  Aligned_cols=272  Identities=27%  Similarity=0.319  Sum_probs=201.2

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      ...++|...+.||+|+||.||+|++.           .++..||||.+.....  .....+.+|+.+++.++||||++++
T Consensus         4 ~~~~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~   72 (302)
T cd07864           4 RCVDKFDIIGQIGEGTYGQVYKARDK-----------DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLK   72 (302)
T ss_pred             hhhhhhheeeeecccCCEEEEEEEEC-----------CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeee
Confidence            45678999999999999999999975           3467899999875432  2335677899999999999999999


Q ss_pred             eeeeeccc------ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          162 GYCAEDDE------RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       162 ~~~~~~~~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      +++.....      ....+++|+||+++ +|.+.+... ...+++..+..++.|++.||+|||+.   +|+|+||||+||
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~ni  147 (302)
T cd07864          73 EIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESG-LVHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNI  147 (302)
T ss_pred             heecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHE
Confidence            99876541      11247999999965 777777654 34789999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      ++++++.+||+|||++........ .......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........
T Consensus       148 li~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~  226 (302)
T cd07864         148 LLNNKGQIKLADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQ  226 (302)
T ss_pred             EECCCCcEEeCcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHH
Confidence            999999999999999986543221 12233456788999998865 4578999999999999999999999975443322


Q ss_pred             HHHHHhhhhcccCccccccc--------cC------CcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLI--------ID------PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~--------~~------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...+........ ......+        .+      ..+. ......+..+.+++.+||..+|.+|||+.+++.
T Consensus       227 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~  298 (302)
T cd07864         227 LELISRLCGSPC-PAVWPDVIKLPYFNTMKPKKQYRRRLR-EEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN  298 (302)
T ss_pred             HHHHHHHhCCCC-hhhcccccccccccccccccccccchh-hhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            222111100000 0000000        00      0000 011124678999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.3e-38  Score=308.16  Aligned_cols=252  Identities=27%  Similarity=0.419  Sum_probs=200.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC--CcccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      ...|+++++||+||.+.||++.-            .+.+.||+|++...  +.+....|.+|+..|.+| .|.+||.|++
T Consensus       360 g~~Yeilk~iG~GGSSkV~kV~~------------s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~D  427 (677)
T KOG0596|consen  360 GREYEILKQIGSGGSSKVFKVLN------------SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYD  427 (677)
T ss_pred             cchhhHHHhhcCCCcceeeeeec------------CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEee
Confidence            35588899999999999999874            33567888876543  234457799999999999 5999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      |-..++.    +|+||||- ..+|...|..+......| .+..+..|++.|+.++|.+   ||||.||||.|+|+- .|.
T Consensus       428 YEv~d~~----lYmvmE~G-d~DL~kiL~k~~~~~~~~-~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLlV-kG~  497 (677)
T KOG0596|consen  428 YEVTDGY----LYMVMECG-DIDLNKILKKKKSIDPDW-FLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLLV-KGR  497 (677)
T ss_pred             eeccCce----EEEEeecc-cccHHHHHHhccCCCchH-HHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEEE-eee
Confidence            9887654    89999987 679999998876655556 5666789999999999999   999999999999986 578


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccC-----------CCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-----------RLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      +||+|||+|.......+.......+||+.||+||.+...           +.+.++||||||||||+|+.|+.||.... 
T Consensus       498 LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~-  576 (677)
T KOG0596|consen  498 LKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII-  576 (677)
T ss_pred             EEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH-
Confidence            999999999988877666677788999999999998532           25678999999999999999999996421 


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccch-HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCI-KSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          ..+          .++..+.+|...-+++. ....++.++++.||..||.+|||+.++++
T Consensus       577 ----n~~----------aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq  626 (677)
T KOG0596|consen  577 ----NQI----------AKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ  626 (677)
T ss_pred             ----HHH----------HHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence                011          22334445533322321 11234999999999999999999999885

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.1e-37  Score=306.50  Aligned_cols=270  Identities=25%  Similarity=0.343  Sum_probs=201.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC--CcccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||.+...  .......+.+|+.+++.++||||++++++
T Consensus         4 ~~~y~~~~~lg~G~~~~vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~   72 (337)
T cd07858           4 DTKYVPIKPIGRGAYGIVCSAKNS-----------ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDI   72 (337)
T ss_pred             ccceeEEEEeccCCCeEEEEEEec-----------CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHh
Confidence            467999999999999999999975           45778999998653  22334567789999999999999999998


Q ss_pred             eeecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          164 CAEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       164 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +...... ....++||||+ +++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||+||+++.++.
T Consensus        73 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~  146 (337)
T cd07858          73 MPPPHREAFNDVYIVYELM-DTDLHQIIRSS--QTLSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCD  146 (337)
T ss_pred             eecccccccCcEEEEEeCC-CCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCC
Confidence            8754321 12379999999 47899888764  5689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||++.......  .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||...............
T Consensus       147 ~kL~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~  224 (337)
T cd07858         147 LKICDFGLARTTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITEL  224 (337)
T ss_pred             EEECcCccccccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHH
Confidence            9999999998654321  12334567899999998765 46889999999999999999999999654322211111100


Q ss_pred             -hhcccC------cccccccc-------CCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          322 -RPYVSD------SKKFHLII-------DPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       322 -~~~~~~------~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                       .+...+      ........       ++... ......+.++.+++.+||+.+|++|||+.++++.
T Consensus       225 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h  291 (337)
T cd07858         225 LGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFA-RLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH  291 (337)
T ss_pred             hCCCChHHhhhcCchhhhHHHHhcCcccccCHH-HHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence             000000      00000000       00000 0112356778999999999999999999999865

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=1.8e-37  Score=291.91  Aligned_cols=250  Identities=27%  Similarity=0.400  Sum_probs=203.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||.|+||.||++.+.           .++..||+|.+.....  .....+.+|+++++.++|||++++++.+.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~   69 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRK-----------SDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFE   69 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEc-----------CCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEe
Confidence            5778889999999999999975           3467899999876543  44567889999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      ....    .++|+||+++++|.+++....  ...+++..+..++.+++.||.|||+.   +++|+||+|+||+++.++.+
T Consensus        70 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~  142 (258)
T cd08215          70 EKGK----LCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLV  142 (258)
T ss_pred             cCCE----EEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcE
Confidence            7643    799999999999999998753  46789999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|+|||++.......  .......|++.|+|||.+.+..++.++||||||+++++|++|..||......   .+......
T Consensus       143 ~l~d~~~~~~~~~~~--~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~---~~~~~~~~  217 (258)
T cd08215         143 KLGDFGISKVLSSTV--DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL---ELALKILK  217 (258)
T ss_pred             EECCccceeecccCc--ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH---HHHHHHhc
Confidence            999999998754332  1233457889999999998888999999999999999999999998654321   11111100


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           ..         ....+...+..+.+++.+||..+|.+|||+.++++
T Consensus       218 -----~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~  254 (258)
T cd08215         218 -----GQ---------YPPIPSQYSSELRNLVSSLLQKDPEERPSIAQILQ  254 (258)
T ss_pred             -----CC---------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence                 00         01112234577999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-37  Score=293.54  Aligned_cols=266  Identities=26%  Similarity=0.353  Sum_probs=198.1

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |...+.||.|+||.||+|++.           ..+..+|+|.+....  ......+.+|+.+++.++||||+++++++..
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~-----------~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   69 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNK-----------KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTS   69 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEEC-----------CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEec
Confidence            566789999999999999975           346789999997653  2334568899999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ..  ....++||||++ ++|.+++.... ..+++..++.++.|++.||+|||+.   +++|+||+|+||++++++.+||+
T Consensus        70 ~~--~~~~~lv~e~~~-~~l~~~~~~~~-~~~~~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~  142 (287)
T cd07840          70 KG--KGSIYMVFEYMD-HDLTGLLDSPE-VKFTESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLA  142 (287)
T ss_pred             CC--CCcEEEEecccc-ccHHHHHhccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEc
Confidence            62  113799999996 58988886542 5789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||++........ .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...........+.......
T Consensus       143 d~g~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~  221 (287)
T cd07840         143 DFGLARPYTKRNS-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP  221 (287)
T ss_pred             cccceeeccCCCc-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCC
Confidence            9999986543321 12234467889999998764 467899999999999999999999997654332211111100000


Q ss_pred             cCccccccc--------cCC------cCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLI--------IDP------RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~--------~~~------~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      . ...+...        ..+      .+...+...++..+.+++.+||..+|.+||++.++++
T Consensus       222 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  283 (287)
T cd07840         222 T-DENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ  283 (287)
T ss_pred             c-hhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence            0 0000000        000      0000011112678899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-39  Score=316.07  Aligned_cols=251  Identities=24%  Similarity=0.400  Sum_probs=203.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      .|.++.-||.|+||.||+|+.+           ..+...|-|++........++|+-|+.||..+.||+||+|++.++..
T Consensus        33 ~WeIiGELGDGAFGKVyKA~nk-----------et~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~e  101 (1187)
T KOG0579|consen   33 HWEIIGELGDGAFGKVYKAVNK-----------ETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFE  101 (1187)
T ss_pred             HHHHHhhhcCccchhhhhhhcc-----------cchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhcc
Confidence            3556667999999999999865           44556788988877777888999999999999999999999987776


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      +.    ++|+.|||.||-++..+..- +.++...++.-++.|++.||.|||++   +|||||||..|||++-+|.++|+|
T Consensus       102 nk----LwiliEFC~GGAVDaimlEL-~r~LtE~QIqvvc~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLAD  173 (1187)
T KOG0579|consen  102 NK----LWILIEFCGGGAVDAIMLEL-GRVLTEDQIQVVCYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLAD  173 (1187)
T ss_pred             Cc----eEEEEeecCCchHhHHHHHh-ccccchHHHHHHHHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeec
Confidence            64    79999999999998877654 46889999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||.+.....  .......+.||+.|||||+..     ..+|+.++||||||+.|.||..+.+|.....+..  .++....
T Consensus       174 FGVSAKn~~--t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMR--VllKiaK  249 (1187)
T KOG0579|consen  174 FGVSAKNKS--TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMR--VLLKIAK  249 (1187)
T ss_pred             ccccccchh--HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHH--HHHHHhh
Confidence            999865221  122346789999999999875     3689999999999999999999999876543321  1211111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         +++.          ..-.+...+..+.+++.+||..||..||++.++++
T Consensus       250 ---SePP----------TLlqPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~  288 (1187)
T KOG0579|consen  250 ---SEPP----------TLLQPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK  288 (1187)
T ss_pred             ---cCCC----------cccCcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence               0000          11124566788999999999999999999999875

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=9.5e-38  Score=295.18  Aligned_cols=247  Identities=26%  Similarity=0.372  Sum_probs=195.0

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ||.|+||.||++++.           .++..+|+|.+.....   .....+.+|+.++++++||||+++++.+.....  
T Consensus         1 lg~g~~~~vy~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~--   67 (265)
T cd05579           1 ISKGAYGRVFLAKKK-----------STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKN--   67 (265)
T ss_pred             CCCCCceEEEEEEEC-----------CCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcE--
Confidence            689999999999975           3467899999865433   345678899999999999999999988876543  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .+++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        68 --~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~  140 (265)
T cd05579          68 --LYLVMEYLPGGDLASLLENV--GSLDEDVARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLS  140 (265)
T ss_pred             --EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccc
Confidence              79999999999999999775  3789999999999999999999998   9999999999999999999999999998


Q ss_pred             cCCCCCCC------CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          252 RQGPPEGL------GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       252 ~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      ........      ........++..|+|||.+.....+.++||||||+++|+|++|..||....+..   .......  
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~~--  215 (265)
T cd05579         141 KVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE---IFQNILN--  215 (265)
T ss_pred             hhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHhc--
Confidence            76433211      112234567889999999988889999999999999999999999997543222   1111110  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                         ...        ........+..+.+++.+||+.+|.+|||+..+.+.|.
T Consensus       216 ---~~~--------~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~  256 (265)
T cd05579         216 ---GKI--------EWPEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKN  256 (265)
T ss_pred             ---CCc--------CCCccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhc
Confidence               000        00000113677899999999999999999966665553

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-38  Score=280.11  Aligned_cols=251  Identities=28%  Similarity=0.448  Sum_probs=195.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCC-CCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK-HPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~  165 (453)
                      +......||.|+.|+|++++.+           .++..+|||.+.+.. ....++++..+.++..-+ .|+||+.+|||.
T Consensus        93 dl~~l~dlGsGtcG~V~k~~~r-----------s~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi  161 (391)
T KOG0983|consen   93 DLENLGDLGSGTCGQVWKMRFR-----------STGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFI  161 (391)
T ss_pred             HhhhHHhhcCCCccceEEEEEc-----------ccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEe
Confidence            3444557999999999999987           457889999997664 344577888888877664 899999999999


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      .+..    .++.||.| ..-++.+|. +...++++...-++...++.||.||..++  +|+|||+||+|||+|+.|++||
T Consensus       162 ~n~d----V~IcMelM-s~C~ekLlk-rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKl  233 (391)
T KOG0983|consen  162 TNTD----VFICMELM-STCAEKLLK-RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKL  233 (391)
T ss_pred             eCch----HHHHHHHH-HHHHHHHHH-HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEe
Confidence            8776    58899998 444555444 44567888888899999999999998774  9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|||++-.+.+.   ...+...|-+.|||||.+..   ..|+..+||||||+.++||.||+.||......  ...+..+.
T Consensus       234 CDFGIsGrlvdS---kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~td--Fe~ltkvl  308 (391)
T KOG0983|consen  234 CDFGISGRLVDS---KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTD--FEVLTKVL  308 (391)
T ss_pred             ecccccceeecc---cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCcc--HHHHHHHH
Confidence            999999775542   33556789999999999863   46889999999999999999999999874322  12222111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..          ..|.+.+.  ...++.+++++..||..|+.+||...++++
T Consensus       309 n~----------ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~  348 (391)
T KOG0983|consen  309 NE----------EPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLE  348 (391)
T ss_pred             hc----------CCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhc
Confidence            10          01222211  125678999999999999999999998875

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=5.7e-38  Score=312.59  Aligned_cols=277  Identities=29%  Similarity=0.381  Sum_probs=208.0

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      +...+.||+||||.||+|+++           .+|..||||.++... ....+...+|+++|++|+|+|||+++++-.+.
T Consensus        15 W~~~e~LG~Ga~g~V~rgrnk-----------etG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~   83 (732)
T KOG4250|consen   15 WEMDERLGKGAFGNVYRGRNK-----------ETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETK   83 (732)
T ss_pred             eeehhhhcCCccceeeeeccc-----------ccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCcc
Confidence            445568999999999999976           678899999998654 34567788999999999999999999875544


Q ss_pred             cc--ccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc--CCCc
Q 043568          168 DE--RGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYK  242 (453)
Q Consensus       168 ~~--~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~--~~~~  242 (453)
                      ..  .....++|||||.+|+|...|..-. ...+++.+.+.++.+++.||.|||.+   +||||||||.||++-  .+|+
T Consensus        84 ~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq  160 (732)
T KOG4250|consen   84 FLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQ  160 (732)
T ss_pred             ccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCc
Confidence            31  0234689999999999999997643 35799999999999999999999998   999999999999983  3344


Q ss_pred             --EEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          243 --AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       243 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                        .||+|||.|+..++.   ......+||..|++||.+.. +.|+..+|.|||||++|++.||..||..........-+.
T Consensus       161 ~IyKLtDfG~Arel~d~---s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~  237 (732)
T KOG4250|consen  161 SIYKLTDFGAARELDDN---SLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIM  237 (732)
T ss_pred             eEEeeecccccccCCCC---CeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhh
Confidence              699999999987653   35778999999999999984 889999999999999999999999996543322111111


Q ss_pred             hhhhcccCc-----------cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC--CHHHHHHHHHHhHhh
Q 043568          320 WVRPYVSDS-----------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP--KMSEVVDILGNIISE  382 (453)
Q Consensus       320 ~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP--s~~ei~~~L~~~~~~  382 (453)
                      |........           +.+..-..-.............+-..+..+|..+|++|.  ...+....+..+++.
T Consensus       238 ~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL~~  313 (732)
T KOG4250|consen  238 WHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDILNL  313 (732)
T ss_pred             hhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHHhh
Confidence            111000000           000000000112233445556778888999999999998  766666666666653

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=1.8e-38  Score=331.12  Aligned_cols=259  Identities=26%  Similarity=0.401  Sum_probs=193.2

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEe
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .+...+|....+||+||||.||+++.+           -++..||||++.... ......+.+|+..|++|+|||||+++
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNK-----------lDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYy  543 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNK-----------LDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYY  543 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeec-----------ccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeee
Confidence            345677888889999999999999976           568899999987553 23345678999999999999999998


Q ss_pred             eeeeecc-------------------------------------------------------------------------
Q 043568          162 GYCAEDD-------------------------------------------------------------------------  168 (453)
Q Consensus       162 ~~~~~~~-------------------------------------------------------------------------  168 (453)
                      ..+.+..                                                                         
T Consensus       544 sAWVEs~~~~~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~  623 (1351)
T KOG1035|consen  544 SAWVESTAELTVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDS  623 (1351)
T ss_pred             hhhhccCCccccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccc
Confidence            7554422                                                                         


Q ss_pred             ------------------------------------c------ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHH
Q 043568          169 ------------------------------------E------RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI  206 (453)
Q Consensus       169 ------------------------------------~------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i  206 (453)
                                                          +      ....+||-||||+..+|.+++..+.... .....+++
T Consensus       624 dedg~~~S~tS~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~-~~d~~wrL  702 (1351)
T KOG1035|consen  624 DEDGRNLSNTSDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS-QRDEAWRL  702 (1351)
T ss_pred             cccccccccccccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch-hhHHHHHH
Confidence                                                0      0023788999999988888887653211 35567899


Q ss_pred             HHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCC------C----------CCCCccccccccCc
Q 043568          207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP------P----------EGLGHVSTSVVGTV  270 (453)
Q Consensus       207 ~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~------~----------~~~~~~~~~~~gt~  270 (453)
                      +++|++||+|+|+.   |||||||||.||+|++++.|||+|||+|+...      .          .......+..+||.
T Consensus       703 FreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTa  779 (1351)
T KOG1035|consen  703 FREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTA  779 (1351)
T ss_pred             HHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccccccccee
Confidence            99999999999999   99999999999999999999999999998611      0          00111245678999


Q ss_pred             CCCCccccccC---CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCC--ccch
Q 043568          271 GYAAPEYVQTG---RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEG--NYCI  345 (453)
Q Consensus       271 ~y~aPE~~~~~---~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~  345 (453)
                      .|+|||++.+.   .|+.|+|+|||||||+||+.   ||...  .+-..++...+             +..+..  .+..
T Consensus       780 lYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts--MERa~iL~~LR-------------~g~iP~~~~f~~  841 (1351)
T KOG1035|consen  780 LYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTS--MERASILTNLR-------------KGSIPEPADFFD  841 (1351)
T ss_pred             eeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCch--HHHHHHHHhcc-------------cCCCCCCccccc
Confidence            99999999764   59999999999999999986   34322  11111222111             111111  1122


Q ss_pred             HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          346 KSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       346 ~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +....-..+|.++++.||.+|||+.|++.
T Consensus       842 ~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  842 PEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            23345678999999999999999999874

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=3.9e-37  Score=294.34  Aligned_cols=262  Identities=24%  Similarity=0.317  Sum_probs=199.4

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |...+.||+|++|.||+|...           .++..+|+|.+......  ....+.+|+.++++++|+||+++++++..
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~   69 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDK-----------LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRH   69 (283)
T ss_pred             CccceeeecCCCceEEEEEcC-----------CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhcc
Confidence            556778999999999999865           45778999998754332  34678899999999999999999999887


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||++ ++|.+++.... ..+++..+..++.+++.||.|||+.   +|+|+||||+||+++.++.++|+
T Consensus        70 ~~~----~~~v~e~~~-~~l~~~l~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~  140 (283)
T cd05118          70 KGD----LYLVFEFMD-TDLYKLIKDRQ-RGLPESLIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLA  140 (283)
T ss_pred             CCC----EEEEEeccC-CCHHHHHHhhc-ccCCHHHHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEe
Confidence            654    799999996 48888887643 5789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH-Hhhhhc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL-EWVRPY  324 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~-~~~~~~  324 (453)
                      |||.+.......  .......++..|+|||.+.+. .++.++||||||+++|+|++|+.||......+..... ......
T Consensus       141 df~~~~~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd05118         141 DFGLARSFGSPV--RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTP  218 (283)
T ss_pred             eeeeeEecCCCc--ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCC
Confidence            999998755432  122345688899999998876 7899999999999999999999998665432221111 100000


Q ss_pred             ccCccccccccC---------C----cCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIID---------P----RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~---------~----~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .  ........+         +    ..........+.++.++|.+||..||.+||++.+++.
T Consensus       219 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~  279 (283)
T cd05118         219 D--PEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA  279 (283)
T ss_pred             c--hHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence            0  000000000         0    0001112235678999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-37  Score=290.77  Aligned_cols=245  Identities=24%  Similarity=0.311  Sum_probs=188.7

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHh-ccCCCCceeeEeeeeeecc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFL-GVVKHPNLVKLVGYCAEDD  168 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l-~~l~h~nIv~l~~~~~~~~  168 (453)
                      +.||+|+||.||+|.+.           ..+..||||.+......   ....+..|..++ ...+|+||+++++++...+
T Consensus         2 ~~l~~g~~~~v~~a~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~   70 (260)
T cd05611           2 KPISKGAFGSVYLAKKR-----------STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKD   70 (260)
T ss_pred             ccCCcCCCeeEEEEEec-----------CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCC
Confidence            46999999999999875           34678999998654322   223344555544 4558999999999997765


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +++||||+|+||+++.++.++|+||
T Consensus        71 ~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~df  141 (260)
T cd05611          71 Y----LYLVMEYLNGGDCASLIKTL--GGLPEDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDF  141 (260)
T ss_pred             e----EEEEEeccCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeec
Confidence            3    79999999999999998765  4678888999999999999999998   9999999999999999999999999


Q ss_pred             ccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       249 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      |++.....      .....++..|+|||.+.+..++.++||||||+++|+|++|..||.......   .......     
T Consensus       142 g~~~~~~~------~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~---~~~~~~~-----  207 (260)
T cd05611         142 GLSRNGLE------NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA---VFDNILS-----  207 (260)
T ss_pred             ccceeccc------cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH---HHHHHHh-----
Confidence            99876332      234468889999999988888999999999999999999999996543221   1111100     


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      ..      ..........++..+.+++.+||+.+|++||++.++.+.|.
T Consensus       208 ~~------~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~  250 (260)
T cd05611         208 RR------INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKS  250 (260)
T ss_pred             cc------cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHc
Confidence            00      00001111234677999999999999999998876655543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=9.9e-37  Score=289.78  Aligned_cols=250  Identities=20%  Similarity=0.293  Sum_probs=191.9

Q ss_pred             HHHHHHhcCCCcccee--cCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCc
Q 043568           80 AELKSATRGFSRALLI--GEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPN  156 (453)
Q Consensus        80 ~~~~~~~~~f~~~~~l--G~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n  156 (453)
                      .+.....++|...+.+  |+|+||.||++..+           .++..+|+|.+........     |+.....+ +|||
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~   70 (267)
T PHA03390          7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHK-----------PTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPN   70 (267)
T ss_pred             HHHHHHHHhhccccceeecCCCceEEEEEEEc-----------CCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCC
Confidence            3444455677776766  99999999999875           4567899999865432221     22222222 7999


Q ss_pred             eeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEE
Q 043568          157 LVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL  236 (453)
Q Consensus       157 Iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NIL  236 (453)
                      |+++++++...+.    .++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +++||||||+||+
T Consensus        71 iv~~~~~~~~~~~----~~iv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil  141 (267)
T PHA03390         71 FIKLYYSVTTLKG----HVLIMDYIKDGDLFDLLKKE--GKLSEAEVKKIIRQLVEALNDLHKH---NIIHNDIKLENVL  141 (267)
T ss_pred             EEEEEEEEecCCe----eEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEE
Confidence            9999999987664    79999999999999999765  3889999999999999999999998   9999999999999


Q ss_pred             EcCCC-cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          237 LDEDY-KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       237 l~~~~-~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      ++.++ .++|+|||++......      ....++..|+|||++.+..++.++||||||+++|||++|+.||....... .
T Consensus       142 ~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~-~  214 (267)
T PHA03390        142 YDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEE-L  214 (267)
T ss_pred             EeCCCCeEEEecCccceecCCC------ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcch-h
Confidence            99988 9999999998764321      23468899999999998889999999999999999999999997443221 1


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-MSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ei~~  374 (453)
                      ....+.... .          ..  .......+..+.+++.+||+.+|.+||+ ++++++
T Consensus       215 ~~~~~~~~~-~----------~~--~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~  261 (267)
T PHA03390        215 DLESLLKRQ-Q----------KK--LPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK  261 (267)
T ss_pred             hHHHHHHhh-c----------cc--CCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence            111111110 0          00  0111235677999999999999999996 588763

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-38  Score=318.34  Aligned_cols=262  Identities=27%  Similarity=0.442  Sum_probs=217.0

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-CcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      +...++||+|+||+||+|.+.       +.+..-+.+||||++... ......+++.|+.+|.+|+|||+++++|+|..+
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~-------Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s  770 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWI-------PEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS  770 (1177)
T ss_pred             hhhhceeccccceeEEeeeEe-------cCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc
Confidence            445668999999999999986       334456788999998754 344568899999999999999999999999987


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      .     +.||++|++.|+|.+|++.+ ...+.....+.|..|||+|+.|||.+   .++||||-..|||+.+...+||+|
T Consensus       771 ~-----~qlvtq~mP~G~LlDyvr~h-r~~igsq~lLnw~~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitd  841 (1177)
T KOG1025|consen  771 T-----LQLVTQLMPLGCLLDYVREH-RDNIGSQDLLNWCYQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITD  841 (1177)
T ss_pred             h-----HHHHHHhcccchHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEe
Confidence            7     47999999999999999875 35777888899999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhccc
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      ||+++...+...........-.+.|||-|.++...++.++|||||||.+||+|| |..|+++....+-.++++       
T Consensus       842 fgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle-------  914 (1177)
T KOG1025|consen  842 FGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE-------  914 (1177)
T ss_pred             cchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh-------
Confidence            999998776654433344444577999999999999999999999999999999 888887653332222221       


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .+.          +-..++.++.++..++.+||..|+..||+++++...+.++.+..
T Consensus       915 ~ge----------RLsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ardp  961 (1177)
T KOG1025|consen  915 KGE----------RLSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMARDP  961 (1177)
T ss_pred             ccc----------cCCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhcCc
Confidence            111          22335567888999999999999999999999999998887653

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-37  Score=287.74  Aligned_cols=248  Identities=31%  Similarity=0.476  Sum_probs=201.6

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|++|.||+|++.           ..+..||+|.+.....  .....+.+|++++++++|||++++++++.
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNL-----------ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIE   69 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEc-----------CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEE
Confidence            4778889999999999999875           3457899999876644  34567899999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .+++|||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||+|+||+++.++.++|
T Consensus        70 ~~~~----~~~v~e~~~~~~L~~~~~~~--~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l  140 (254)
T cd06627          70 TSDS----LYIILEYAENGSLRQIIKKF--GPFPESLVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKL  140 (254)
T ss_pred             eCCE----EEEEEecCCCCcHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEE
Confidence            7543    79999999999999998765  5789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||......  ........   
T Consensus       141 ~d~~~~~~~~~~~~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~--~~~~~~~~---  213 (254)
T cd06627         141 ADFGVATKLNDVSK--DDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM--AALFRIVQ---  213 (254)
T ss_pred             eccccceecCCCcc--cccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH--HHHHHHhc---
Confidence            99999987553321  123456889999999998878899999999999999999999998654321  11111100   


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         ..         ....+...+..+.+++.+||..+|++|||+.+++.
T Consensus       214 ---~~---------~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~  250 (254)
T cd06627         214 ---DD---------HPPLPEGISPELKDFLMQCFQKDPNLRPTAKQLLK  250 (254)
T ss_pred             ---cC---------CCCCCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence               00         00112234577999999999999999999999874

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=4.6e-37  Score=300.82  Aligned_cols=268  Identities=25%  Similarity=0.347  Sum_probs=200.0

Q ss_pred             HHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCcee
Q 043568           81 ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLV  158 (453)
Q Consensus        81 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv  158 (453)
                      ++..++++|...+.||.|+||.||+|.+.           .++..||||.+....  ....+.+.+|+.+++.++||||+
T Consensus         4 ~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv   72 (328)
T cd07856           4 TVFEITNRYVDLQPVGMGAFGLVCSARDQ-----------LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENII   72 (328)
T ss_pred             ceeccccceEEEEeecccCCeEEEEEEEC-----------CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCee
Confidence            44557899999999999999999999875           457789999886432  22346788999999999999999


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ++++++.....   ..++++||+ +++|.+++..   .+++......++.|++.||.|||+.   +|+||||+|+|||++
T Consensus        73 ~~~~~~~~~~~---~~~lv~e~~-~~~L~~~~~~---~~~~~~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~  142 (328)
T cd07856          73 SLSDIFISPLE---DIYFVTELL-GTDLHRLLTS---RPLEKQFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILIN  142 (328)
T ss_pred             eEeeeEecCCC---cEEEEeehh-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeEC
Confidence            99999876443   268999999 6789888764   3577888889999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      .++.++|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||....+......
T Consensus       143 ~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~  217 (328)
T cd07856         143 ENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI  217 (328)
T ss_pred             CCCCEEeCccccccccCCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence            9999999999998754321     223467889999998766 5689999999999999999999999975443221111


Q ss_pred             H-Hhhhhc-------ccCccccccccCCcCCCc-----cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 L-EWVRPY-------VSDSKKFHLIIDPRLEGN-----YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~-~~~~~~-------~~~~~~~~~~~~~~~~~~-----~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      . +.....       ..................     .....+..+.++|.+||+.+|++|||+.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~  287 (328)
T cd07856         218 ITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALA  287 (328)
T ss_pred             HHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1 100000       000000000000000001     11234578999999999999999999998864

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=2.1e-37  Score=291.58  Aligned_cols=248  Identities=25%  Similarity=0.377  Sum_probs=201.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||+|+||.||++.+.           .++..+|+|.+.....  .....+.+|+.+++.++|+||+++++++.
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRL-----------SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFL   69 (256)
T ss_pred             CceEeeeecCCCceeEEEEEEC-----------CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhc
Confidence            4778889999999999999865           4567899999875432  23456789999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      ...    ..++||||+++++|.+++....  ...+++..++.++.+++.||.|||+.   +++|+||+|.||+++.++.+
T Consensus        70 ~~~----~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~  142 (256)
T cd08530          70 DGN----KLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLV  142 (256)
T ss_pred             cCC----EEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcE
Confidence            764    3799999999999999987632  35688999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||++......    ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......   +..... 
T Consensus       143 kl~d~g~~~~~~~~----~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~---~~~~~~-  214 (256)
T cd08530         143 KIGDLGISKVLKKN----MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD---LRYKVQ-  214 (256)
T ss_pred             EEeeccchhhhccC----CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHh-
Confidence            99999999875433    2234568899999999998889999999999999999999999997543221   111110 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          ...         ....+...+.++.+++.+||..+|++|||+.++++
T Consensus       215 ----~~~---------~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~  252 (256)
T cd08530         215 ----RGK---------YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA  252 (256)
T ss_pred             ----cCC---------CCCCchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence                000         01112245677999999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=2.6e-37  Score=304.46  Aligned_cols=271  Identities=23%  Similarity=0.297  Sum_probs=199.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...+.||.|+||.||+|.+.           .++..||+|.+........+.+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~-----------~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~   72 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDS-----------DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG   72 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEEC-----------CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhc
Confidence            368999999999999999999875           456789999987666566677889999999999999999998776


Q ss_pred             eccccc----------ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          166 EDDERG----------MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       166 ~~~~~~----------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      ......          ...++||||++ ++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Ni  145 (342)
T cd07854          73 PSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANV  145 (342)
T ss_pred             ccccccccccccccccceEEEEeeccc-ccHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHE
Confidence            543211          13689999996 689888754   3688899999999999999999998   999999999999


Q ss_pred             EEc-CCCcEEEeccccccCCCCCCCC-ccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          236 LLD-EDYKAKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       236 Ll~-~~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      +++ .++.+||+|||++......... .......++..|+|||.+.. ..++.++|||||||++|+|++|+.||....+.
T Consensus       146 li~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~  225 (342)
T cd07854         146 FINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHEL  225 (342)
T ss_pred             EEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence            997 4567899999999764322111 11223467889999998654 56788999999999999999999999765443


Q ss_pred             hhHHHHHhhhhcccCc--c--------ccc-cccCCcCC-CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          313 NEQKLLEWVRPYVSDS--K--------KFH-LIIDPRLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~--~--------~~~-~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..........+.....  .        ... ....+... .......+.++.+++.+||+.||.+|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~  299 (342)
T cd07854         226 EQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM  299 (342)
T ss_pred             HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence            3222211111110000  0        000 00000000 0001124567889999999999999999999974

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-37  Score=302.74  Aligned_cols=273  Identities=24%  Similarity=0.334  Sum_probs=198.7

Q ss_pred             cHHHHHHH----hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhcc
Q 043568           78 SFAELKSA----TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGV  151 (453)
Q Consensus        78 ~~~~~~~~----~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~  151 (453)
                      +.+|+..+    .++|...+.||+|+||.||+|++.           .++..||||++....  ......+.+|+.+++.
T Consensus         2 ~~~~~~~~~~~~~~~y~~~~~ig~g~~g~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~   70 (342)
T cd07879           2 YREEVNKTVWELPERYTSLKQVGSGAYGSVCSAIDK-----------RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKH   70 (342)
T ss_pred             chhhhhhhhhccccceEEEEEeeecCCeEEEEEEeC-----------CCCcEEEEEEecCccccccchhHHHHHHHHHHh
Confidence            34445444    378999999999999999999875           346789999986532  2223568899999999


Q ss_pred             CCCCceeeEeeeeeecccc--cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          152 VKHPNLVKLVGYCAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       152 l~h~nIv~l~~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      ++||||+++++++......  ...+++|+||+. .+|..++.    ..+++..+..++.|++.||.|||+.   +|+|||
T Consensus        71 l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~d  142 (342)
T cd07879          71 MQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIMG----HPLSEDKVQYLVYQMLCGLKYIHSA---GIIHRD  142 (342)
T ss_pred             cCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCC
Confidence            9999999999998754321  124689999995 47776542    3578889999999999999999998   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      |||+|||++.++.+||+|||+++.....     .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||..
T Consensus       143 lkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~  217 (342)
T cd07879         143 LKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKG  217 (342)
T ss_pred             CCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999999998764321     234467889999999876 4688999999999999999999999976


Q ss_pred             CCChhhHHHHHhhhhccc----C---ccccccccC--CcC-CCcc---chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          309 NLPRNEQKLLEWVRPYVS----D---SKKFHLIID--PRL-EGNY---CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~----~---~~~~~~~~~--~~~-~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .........+....+...    +   .........  +.. ....   ....+..+.+|+.+||+.||.+||++.+++.
T Consensus       218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~  296 (342)
T cd07879         218 KDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALE  296 (342)
T ss_pred             CCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            432221111111000000    0   000000000  000 0000   0123567889999999999999999999984

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-36  Score=291.23  Aligned_cols=268  Identities=25%  Similarity=0.351  Sum_probs=197.3

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccC---CCCceeeEeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVV---KHPNLVKLVGY  163 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l---~h~nIv~l~~~  163 (453)
                      |...+.||+|+||.||+|+++           .++..||+|.+......  ....+.+|+.+++++   +||||++++++
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~   69 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDL-----------NTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDV   69 (287)
T ss_pred             CeEEEEecccCceEEEEEEEC-----------CCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEE
Confidence            567789999999999999975           34678999998743222  234566788777665   69999999999


Q ss_pred             eeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          164 CAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       164 ~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +...+. .....+++|||+. ++|.+++.......+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        70 ~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~  145 (287)
T cd07838          70 CHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQ  145 (287)
T ss_pred             EeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCC
Confidence            987653 2234789999995 5899988775555789999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~  321 (453)
                      +||+|||++.......   ......++..|+|||.+.+..++.++|||||||++|||++|..||......... .+.+..
T Consensus       146 ~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~  222 (287)
T cd07838         146 VKIADFGLARIYSFEM---ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVI  222 (287)
T ss_pred             EEEeccCcceeccCCc---ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHc
Confidence            9999999997754321   122345788999999999889999999999999999999999998754432211 111111


Q ss_pred             hhcc----cCccc-cccccCCcCC---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYV----SDSKK-FHLIIDPRLE---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~----~~~~~-~~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....    ..... ..........   .......+..+.+++.+||+.||.+||++.+++.
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~  283 (287)
T cd07838         223 GLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ  283 (287)
T ss_pred             CCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence            0000    00000 0000000000   1112234577889999999999999999999874

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.8e-37  Score=297.31  Aligned_cols=273  Identities=25%  Similarity=0.308  Sum_probs=198.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||.||+|++.           .++..+|||.+......  ....+.+|+.+++.++||||++++++
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   75 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQI-----------KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDM   75 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEEC-----------CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhh
Confidence            578999999999999999999975           44678999998644322  23457789999999999999999998


Q ss_pred             eeecccc----cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          164 CAEDDER----GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       164 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +......    ...+++||||+. ++|...+... ...+++..+..++.|+++||.|||+.   +|+|+||||+|||+++
T Consensus        76 ~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~-~~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~  150 (311)
T cd07866          76 AVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENP-SVKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDN  150 (311)
T ss_pred             eecccccccccCceEEEEEecCC-cCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECC
Confidence            8665432    234789999995 5677766553 34789999999999999999999998   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCC---------ccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          240 DYKAKLSDFGLARQGPPEGLG---------HVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                      ++.++|+|||++.........         ...+...+++.|+|||.+.+ ..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         151 QGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             CCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999764322111         11234467889999998765 45889999999999999999999999765


Q ss_pred             CChhhHHHH-Hhhhhccc----Ccccccccc----CCcCCCcc---chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          310 LPRNEQKLL-EWVRPYVS----DSKKFHLII----DPRLEGNY---CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       310 ~~~~~~~~~-~~~~~~~~----~~~~~~~~~----~~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ........+ ........    .........    ........   .......+.+++.+||..+|.+|||+.+++.
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~  307 (311)
T cd07866         231 SDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE  307 (311)
T ss_pred             CHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence            443222211 11100000    000000000    00000000   0122357889999999999999999998874

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=292.82  Aligned_cols=270  Identities=26%  Similarity=0.374  Sum_probs=203.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhcc--CCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV--VKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~  163 (453)
                      .+.....+.||+|.||.||+|.++             |..||||++...   +...+.+|.+|.+.  |+|+||+.+++.
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wr-------------Ge~VAVKiF~sr---dE~SWfrEtEIYqTvmLRHENILgFIaa  273 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWR-------------GEDVAVKIFSSR---DERSWFRETEIYQTVMLRHENILGFIAA  273 (513)
T ss_pred             hheeEEEEEecCccccceeecccc-------------CCceEEEEeccc---chhhhhhHHHHHHHHHhccchhhhhhhc
Confidence            456777889999999999999997             578999999754   34557788888774  499999999988


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEeeccccccEEEc
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEE-----MDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~-----~~~~iiH~Dlkp~NILl~  238 (453)
                      -..+...-.+++||.+|-+.|||+|||..   .+++....++++..+|.||+|||..     +.|.|.|||||+.|||+.
T Consensus       274 D~~~~gs~TQLwLvTdYHe~GSL~DyL~r---~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVK  350 (513)
T KOG2052|consen  274 DNKDNGSWTQLWLVTDYHEHGSLYDYLNR---NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVK  350 (513)
T ss_pred             cccCCCceEEEEEeeecccCCcHHHHHhh---ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEc
Confidence            77666555789999999999999999987   4889999999999999999999943     468999999999999999


Q ss_pred             CCCcEEEeccccccCCCCC--CCCccccccccCcCCCCccccccCC------CCCchhHHHHHHHHHHHHhC--------
Q 043568          239 EDYKAKLSDFGLARQGPPE--GLGHVSTSVVGTVGYAAPEYVQTGR------LTAKSDVWSFGVVLYELITG--------  302 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~SlGvil~elltg--------  302 (453)
                      .++..-|+|+|||......  ......+..+||..|||||++...-      .-..+||||||.|+||+.-+        
T Consensus       351 kn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~e  430 (513)
T KOG2052|consen  351 KNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVE  430 (513)
T ss_pred             cCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEeh
Confidence            9999999999999764432  1222345679999999999986432      12458999999999999863        


Q ss_pred             --CccccCCCChhhHHHHHhhhhcccCccccccccCCcCCC-ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          303 --RRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       303 --~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                        +.||..-.+.+...-  ..+..+.     ..-..|.+.. -...+....+.+|++.||..||.-|-|+-.|.+.|.++
T Consensus       431 ey~~Pyyd~Vp~DPs~e--eMrkVVC-----v~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l  503 (513)
T KOG2052|consen  431 EYQLPYYDVVPSDPSFE--EMRKVVC-----VQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKL  503 (513)
T ss_pred             hhcCCcccCCCCCCCHH--HHhccee-----ecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHH
Confidence              345554332221100  0000000     0001111111 11335567899999999999999999999999988877


Q ss_pred             Hh
Q 043568          380 IS  381 (453)
Q Consensus       380 ~~  381 (453)
                      .+
T Consensus       504 ~~  505 (513)
T KOG2052|consen  504 SN  505 (513)
T ss_pred             hc
Confidence            64

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=1.4e-36  Score=290.48  Aligned_cols=242  Identities=26%  Similarity=0.383  Sum_probs=187.1

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHH---HhccCCCCceeeEeeeeeec
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVN---FLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~---~l~~l~h~nIv~l~~~~~~~  167 (453)
                      +||+|+||.||+|.+.           ..+..||+|.+......   ....+..|..   .++...||||+++++++...
T Consensus         1 ~ig~g~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~   69 (278)
T cd05606           1 IIGRGGFGEVYGCRKA-----------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP   69 (278)
T ss_pred             CcccCCCeEEEEEEEe-----------cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC
Confidence            4899999999999875           44678999998754322   1222344443   44556899999999988876


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      +.    .++||||+.+++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|
T Consensus        70 ~~----~~~v~e~~~g~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~d  140 (278)
T cd05606          70 DK----LSFILDLMNGGDLHYHLSQH--GVFSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISD  140 (278)
T ss_pred             CE----EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEcc
Confidence            54    79999999999999988754  5789999999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      ||++......    ......|+..|+|||++.++ .++.++|||||||++|||++|+.||................    
T Consensus       141 fg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----  212 (278)
T cd05606         141 LGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTL----  212 (278)
T ss_pred             CcCccccCcc----CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhh----
Confidence            9998754322    12345789999999998754 68999999999999999999999997653322211111000    


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                             ...+    ..+...+..+.+++.+||..+|.+||     ++.++++
T Consensus       213 -------~~~~----~~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~  254 (278)
T cd05606         213 -------TMAV----ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  254 (278)
T ss_pred             -------ccCC----CCCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence                   0011    11222367899999999999999999     8888874

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=8.5e-37  Score=297.06  Aligned_cols=244  Identities=32%  Similarity=0.490  Sum_probs=192.3

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      |...+.||+|+||+||+|++.           ..+..||+|.+.....   .....+.+|+.+++.++|||++++++++.
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~-----------~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   91 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNS-----------HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL   91 (313)
T ss_pred             hhcceeeccCCCeEEEEEEEC-----------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEE
Confidence            556678999999999999875           4567899999865432   22356789999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+. |+|.+++... ..++++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.+||
T Consensus        92 ~~~~----~~lv~e~~~-~~l~~~l~~~-~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL  162 (313)
T cd06633          92 KEHT----AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKL  162 (313)
T ss_pred             eCCE----EEEEEecCC-CCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEE
Confidence            7654    699999994 6788777654 35689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|||++.....      .....|+..|+|||++.   ...++.++|||||||++|+|++|..||...........   ..
T Consensus       163 ~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~---~~  233 (313)
T cd06633         163 ADFGSASKSSP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH---IA  233 (313)
T ss_pred             eecCCCcccCC------CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHH---HH
Confidence            99999865322      23456889999999984   45688899999999999999999999865432221111   00


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .     ..     .+.   ......+..+.+++.+||+.+|.+||++.+++.
T Consensus       234 ~-----~~-----~~~---~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~  272 (313)
T cd06633         234 Q-----ND-----SPT---LQSNEWTDSFRGFVDYCLQKIPQERPASAELLR  272 (313)
T ss_pred             h-----cC-----CCC---CCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            0     00     000   011123456899999999999999999999884

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.6e-37  Score=301.00  Aligned_cols=270  Identities=27%  Similarity=0.348  Sum_probs=202.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...+.||.|+||.||+|+..           ..+..||||.+....  ....+.+.+|+.+++.++||||+++++++.
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~   69 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDK-----------RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILR   69 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeC-----------CCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhc
Confidence            5788899999999999999975           346789999987543  334567889999999999999999999988


Q ss_pred             eccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          166 EDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       166 ~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .... .....++||||++ ++|.+++...  .++++..++.++.+++.||.|||+.   +|+||||||.|||++.++.++
T Consensus        70 ~~~~~~~~~~~lv~e~~~-~~l~~~l~~~--~~l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~  143 (330)
T cd07834          70 PPSPEDFNDVYIVTELME-TDLHKVIKSP--QPLTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLK  143 (330)
T ss_pred             ccCcccccceEEEecchh-hhHHHHHhCC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            7651 1224799999996 5899888765  3789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCC-ccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||++......... .......++..|+|||++.+. .++.++||||||+++|+|++|..||...........+....
T Consensus       144 L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~  223 (330)
T cd07834         144 ICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL  223 (330)
T ss_pred             EcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc
Confidence            9999999875433210 113345678999999999887 78999999999999999999999997654322211111000


Q ss_pred             hccc-------CccccccccC---CcCC---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVS-------DSKKFHLIID---PRLE---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~-------~~~~~~~~~~---~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....       ..........   ....   .......+..+.+++.+||+.+|.+|||+.+++.
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  288 (330)
T cd07834         224 GTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALA  288 (330)
T ss_pred             CCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            0000       0000000000   0000   0011224677899999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-36  Score=291.49  Aligned_cols=264  Identities=26%  Similarity=0.362  Sum_probs=197.1

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCC-CCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVK-HPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~  166 (453)
                      |...+.||+|+||+||+|+..           ..+..||||.+..... .......+|+..+++++ ||||+++++++..
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   69 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNK-----------ETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRE   69 (283)
T ss_pred             CeeheeeccCCceEEEEEEEC-----------CCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhc
Confidence            566789999999999999975           3467899999865432 22234567999999998 9999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    .++||||+ +|+|.+++.......+++..++.++.|++.+|.|||+.   +++|+||+|+||+++.++.++|+
T Consensus        70 ~~~----~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~  141 (283)
T cd07830          70 NDE----LYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIA  141 (283)
T ss_pred             CCc----EEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEe
Confidence            553    79999999 88999998876556789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhhc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRPY  324 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~  324 (453)
                      |||++.......   ......++..|+|||++.. ..++.++||||||++++||++|+.||.......... ......+.
T Consensus       142 d~~~~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~  218 (283)
T cd07830         142 DFGLAREIRSRP---PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTP  218 (283)
T ss_pred             ecccceeccCCC---CcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCC
Confidence            999998654321   2234568889999998754 557899999999999999999999986654322211 11110000


Q ss_pred             cc----CccccccccCCcCC-------CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VS----DSKKFHLIIDPRLE-------GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~----~~~~~~~~~~~~~~-------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..    +........+....       .......+..+.+++.+||..+|++|||+.|++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  279 (283)
T cd07830         219 TKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ  279 (283)
T ss_pred             ChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence            00    00000000000000       0011122467999999999999999999999875

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=9.9e-37  Score=299.04  Aligned_cols=272  Identities=24%  Similarity=0.278  Sum_probs=194.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      +|...+.||+|+||.||++.+...         ..+..||+|.+....  ....+.+.+|+.+++++ +||||+++++++
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~---------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~   71 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAET---------SEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMD   71 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCC---------CcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeee
Confidence            477888999999999999997521         125679999986432  22346688999999999 599999999986


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ..........+++++|+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        72 ~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~k  145 (332)
T cd07857          72 IVFPGNFNELYLYEELM-EADLHQIIRSG--QPLTDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELK  145 (332)
T ss_pred             eeccccCCcEEEEEecc-cCCHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEE
Confidence            54422223468889988 47899988654  5788999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCC--ccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHh
Q 043568          245 LSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEW  320 (453)
Q Consensus       245 L~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~  320 (453)
                      |+|||+++........  .......||..|+|||++.+ ..++.++|||||||++|+|++|..||.......... +...
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~  225 (332)
T cd07857         146 ICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQV  225 (332)
T ss_pred             eCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHH
Confidence            9999999865432111  11233578999999998765 468999999999999999999999986543211100 0000


Q ss_pred             hh--------hcccCc-cccccccC--CcCC-CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VR--------PYVSDS-KKFHLIID--PRLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~--------~~~~~~-~~~~~~~~--~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..        ...... ........  +... .......+..+.+++.+||+.||.+|||+.+++.
T Consensus       226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~  291 (332)
T cd07857         226 LGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE  291 (332)
T ss_pred             hCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence            00        000000 00000000  0000 0011123567999999999999999999999874

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=5.9e-37  Score=297.45  Aligned_cols=247  Identities=31%  Similarity=0.453  Sum_probs=193.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      +.|...+.||+|+||.||+|++.           .++..+|+|.+.....   .....+.+|+.+++.++|+|+++++++
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   83 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDV-----------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC   83 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEc-----------CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEE
Confidence            34666678999999999999975           3467899999864322   234568899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+. |+|.+++... ..++++..+..++.|++.||.|||+.   +++||||||+|||++.++.+
T Consensus        84 ~~~~~~----~~lv~e~~~-~~l~~~~~~~-~~~l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~  154 (308)
T cd06634          84 YLREHT----AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV  154 (308)
T ss_pred             EEcCCe----eEEEEEccC-CCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcE
Confidence            987654    699999995 6888877543 34688999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +|+|||++.....      .....++..|+|||.+.   ...++.++|||||||++|+|++|..||........  ....
T Consensus       155 kl~dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~--~~~~  226 (308)
T cd06634         155 KLGDFGSASIMAP------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI  226 (308)
T ss_pred             EECCcccceeecC------cccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH--HHHH
Confidence            9999999876432      22346888999999874   35678899999999999999999999865422111  1111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ...     .      .+.   ......+..+.+||.+||..+|.+||++.+++..
T Consensus       227 ~~~-----~------~~~---~~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~  267 (308)
T cd06634         227 AQN-----E------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  267 (308)
T ss_pred             hhc-----C------CCC---cCcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence            100     0      000   0112345678999999999999999999998864

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=1.5e-36  Score=298.07  Aligned_cols=268  Identities=24%  Similarity=0.312  Sum_probs=195.1

Q ss_pred             hcCCCc-cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc--------------HHHHHHHHHHhc
Q 043568           86 TRGFSR-ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--------------HKEWINEVNFLG  150 (453)
Q Consensus        86 ~~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~--------------~~~~~~E~~~l~  150 (453)
                      .++|.. .+.||.|+||+||+|.+.           ..+..||||.+.......              ...+.+|+.+++
T Consensus         7 ~~ry~~~~~~ig~G~~g~vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~   75 (335)
T PTZ00024          7 SERYIQKGAHLGEGTYGKVEKAYDT-----------LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN   75 (335)
T ss_pred             ccchhhhhhcccCCCceeEEEEEEC-----------CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHH
Confidence            345653 467999999999999875           456789999986442221              124778999999


Q ss_pred             cCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       151 ~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                      .++||||+++++++...+.    .++||||+. |+|.+++...  ..+++.....++.|++.||.|||+.   +|+|+||
T Consensus        76 ~l~h~~iv~~~~~~~~~~~----~~lv~e~~~-~~l~~~l~~~--~~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl  145 (335)
T PTZ00024         76 EIKHENIMGLVDVYVEGDF----INLVMDIMA-SDLKKVVDRK--IRLTESQVKCILLQILNGLNVLHKW---YFMHRDL  145 (335)
T ss_pred             hCCCcceeeeeEEEecCCc----EEEEEeccc-cCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---Ceecccc
Confidence            9999999999999887654    799999995 6899988754  4688889999999999999999998   9999999


Q ss_pred             ccccEEEcCCCcEEEeccccccCCCCCCC------------CccccccccCcCCCCccccccC-CCCCchhHHHHHHHHH
Q 043568          231 KTSNILLDEDYKAKLSDFGLARQGPPEGL------------GHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLY  297 (453)
Q Consensus       231 kp~NILl~~~~~~kL~DFGla~~~~~~~~------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~  297 (453)
                      +|+|||++.++.++|+|||++........            ........++..|+|||.+.+. .++.++|||||||++|
T Consensus       146 ~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~  225 (335)
T PTZ00024        146 SPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFA  225 (335)
T ss_pred             cHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHH
Confidence            99999999999999999999876441110            1111233568899999998764 4689999999999999


Q ss_pred             HHHhCCccccCCCChhhHH-HHHhhhhcc----cCccccc--cccCCcCC---CccchHHHHHHHHHHHHhhccCCCCCC
Q 043568          298 ELITGRRAVERNLPRNEQK-LLEWVRPYV----SDSKKFH--LIIDPRLE---GNYCIKSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       298 elltg~~p~~~~~~~~~~~-~~~~~~~~~----~~~~~~~--~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RP  367 (453)
                      ||++|..||.......... +........    .......  ........   .......+..+.+++.+||+.+|++||
T Consensus       226 el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~  305 (335)
T PTZ00024        226 ELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI  305 (335)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhcc
Confidence            9999999997654332211 111110000    0000000  00000000   001122356789999999999999999


Q ss_pred             CHHHHHH
Q 043568          368 KMSEVVD  374 (453)
Q Consensus       368 s~~ei~~  374 (453)
                      |+.+++.
T Consensus       306 s~~~~l~  312 (335)
T PTZ00024        306 SAKEALK  312 (335)
T ss_pred             CHHHHhc
Confidence            9999985

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.3e-36  Score=295.61  Aligned_cols=245  Identities=27%  Similarity=0.361  Sum_probs=183.2

Q ss_pred             CCCeeEEEEEeccC--CcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCC
Q 043568          121 DSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL  198 (453)
Q Consensus       121 ~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l  198 (453)
                      .++..||||++...  .......+.+|+.+++.++||||+++++++.....    .+++|||+++|+|.+++.......+
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~----~~~~~e~~~~~~l~~~l~~~~~~~~   98 (314)
T cd08216          23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSE----LYVVSPLMAYGSCEDLLKTHFPEGL   98 (314)
T ss_pred             CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCe----EEEEEeccCCCCHHHHHHHhcccCC
Confidence            34678999998754  23445679999999999999999999999887654    7999999999999999987656678


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCC-----CccccccccCcCCC
Q 043568          199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL-----GHVSTSVVGTVGYA  273 (453)
Q Consensus       199 ~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~  273 (453)
                      ++.....++.|++.||.|||++   +|+||||||+|||++.++.+||+|||.+........     ........++..|+
T Consensus        99 ~~~~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~  175 (314)
T cd08216          99 PELAIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWL  175 (314)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeecccccccccccccccccccccccc
Confidence            8999999999999999999998   999999999999999999999999998865432111     11123446778899


Q ss_pred             Ccccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc----ccCc------ccccc----ccCC
Q 043568          274 APEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY----VSDS------KKFHL----IIDP  337 (453)
Q Consensus       274 aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~----~~~~------~~~~~----~~~~  337 (453)
                      |||++..  ..++.++|||||||++|||++|..||.......  ...+.....    +...      .....    ..++
T Consensus       176 aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (314)
T cd08216         176 SPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQ--MLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHP  253 (314)
T ss_pred             CHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHhccCccccccCchhhhcCCcCccccccccc
Confidence            9999875  358899999999999999999999997543221  111111100    0000      00000    0000


Q ss_pred             c----CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          338 R----LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       338 ~----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .    .........+.++.+++.+||..||++|||+.++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~  294 (314)
T cd08216         254 NNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN  294 (314)
T ss_pred             chhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence            0    011122334568899999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=6.5e-37  Score=292.18  Aligned_cols=250  Identities=26%  Similarity=0.378  Sum_probs=200.8

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCC-CCceeeEee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVK-HPNLVKLVG  162 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h~nIv~l~~  162 (453)
                      ++|...+.||+|+||.||+|++.           .++..||+|++....   ......+.+|+.+++++. ||||+++++
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~-----------~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~   69 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEK-----------ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYY   69 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEc-----------CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHH
Confidence            46888899999999999999976           357789999986532   223456889999999998 999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +++|+||+|+||+++.++.
T Consensus        70 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~  140 (280)
T cd05581          70 TFQDEEN----LYFVLEYAPNGELLQYIRKY--GSLDEKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMH  140 (280)
T ss_pred             HhcCCce----EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCC
Confidence            8876554    79999999999999999875  4789999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCC------------------ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCc
Q 043568          243 AKLSDFGLARQGPPEGLG------------------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR  304 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~  304 (453)
                      ++|+|||++.........                  .......++..|+|||.+....++.++||||||+++++|++|+.
T Consensus       141 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~  220 (280)
T cd05581         141 IKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKP  220 (280)
T ss_pred             EEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCC
Confidence            999999998865433211                  11234467899999999988889999999999999999999999


Q ss_pred             cccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH----HHHHH
Q 043568          305 AVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM----SEVVD  374 (453)
Q Consensus       305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~----~ei~~  374 (453)
                      ||.......   .......               .....+...+..+.+++.+||+.+|.+||++    ++++.
T Consensus       221 p~~~~~~~~---~~~~~~~---------------~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~  276 (280)
T cd05581         221 PFRGSNEYL---TFQKILK---------------LEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA  276 (280)
T ss_pred             CCCCccHHH---HHHHHHh---------------cCCCCCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence            997543211   1111110               0011122336779999999999999999999    66653

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.2e-36  Score=299.95  Aligned_cols=276  Identities=25%  Similarity=0.319  Sum_probs=203.0

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCC
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKH  154 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h  154 (453)
                      ....++..++++|...+.||+|+||.||+|.+.           .++..||+|++....  ....+.+.+|+.++++++|
T Consensus         7 ~~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h   75 (345)
T cd07877           7 ELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDT-----------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH   75 (345)
T ss_pred             hHHHHHhhccCceEEEEEeeecCCeEEEEEEEc-----------CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCC
Confidence            345566678899999999999999999999865           456789999986532  2234567889999999999


Q ss_pred             CceeeEeeeeeecccc--cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          155 PNLVKLVGYCAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      |||+++++++......  ....+++++++ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||
T Consensus        76 ~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp  148 (345)
T cd07877          76 ENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKP  148 (345)
T ss_pred             CcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCh
Confidence            9999999988654321  12357888887 8899887764   3588999999999999999999998   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      +||+++.++.+||+|||++.....     ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||.....
T Consensus       149 ~NIll~~~~~~kl~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~  223 (345)
T cd07877         149 SNLAVNEDCELKILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH  223 (345)
T ss_pred             HHEEEcCCCCEEEecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999999999999999876432     1234567899999998866 5688999999999999999999999965433


Q ss_pred             hhhHHH-HHhhh-------hcccCcc--ccccccCCcCCC---ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          312 RNEQKL-LEWVR-------PYVSDSK--KFHLIIDPRLEG---NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       312 ~~~~~~-~~~~~-------~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ...... .....       +.+....  ............   ......+..+.+++.+||+.||.+||++.+++..
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         224 IDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             HHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence            221111 11000       0000000  000000000000   0011235678999999999999999999998853

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=1.4e-36  Score=291.69  Aligned_cols=258  Identities=26%  Similarity=0.356  Sum_probs=199.1

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      +|...+.||+|+||.||+++....        ...+..||||.+....    ....+.+.+|+.++.++ +||||+++++
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~--------~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~   72 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGG--------HDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHY   72 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEecc--------ccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhhe
Confidence            477788999999999999986421        1346789999986432    12345688999999999 6999999998


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +++||||||.||+++.++.
T Consensus        73 ~~~~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~  143 (288)
T cd05583          73 AFQTDTK----LHLILDYVNGGELFTHLYQR--EHFTESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGH  143 (288)
T ss_pred             eeecCCE----EEEEEecCCCCcHHHHHhhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCC
Confidence            8876553    68999999999999998764  4688889999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCC--CCCchhHHHHHHHHHHHHhCCccccCCCChh-hHHHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRRAVERNLPRN-EQKLLE  319 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SlGvil~elltg~~p~~~~~~~~-~~~~~~  319 (453)
                      ++|+|||++........ .......|+..|+|||.+.+..  .+.++||||||+++|||++|..||....... ...+..
T Consensus       144 ~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~  222 (288)
T cd05583         144 VVLTDFGLSKEFLAEEE-ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISR  222 (288)
T ss_pred             EEEEECccccccccccc-cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHH
Confidence            99999999876543221 1123346889999999987654  7889999999999999999999986432211 111111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      ...   ..        .+    ..+...+..+.+++.+||+.+|++|||+.++.+.|..
T Consensus       223 ~~~---~~--------~~----~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         223 RIL---KS--------KP----PFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHH---cc--------CC----CCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            110   00        01    1112235678999999999999999999988877654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=1.4e-36  Score=293.06  Aligned_cols=254  Identities=28%  Similarity=0.416  Sum_probs=192.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           ..+..||||.+..... .....+..|+.++.++ .||||++++++
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~   82 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFK-----------KTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGY   82 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEEC-----------CCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhhee
Confidence            466888899999999999999975           3467899999875432 2345567788777666 59999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+ +++|.+++... ..++++..+..++.|++.||.|||+.  .+|+||||+|+||++++++.+
T Consensus        83 ~~~~~~----~~~v~e~~-~~~l~~l~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~  154 (296)
T cd06618          83 FITDSD----VFICMELM-STCLDKLLKRI-QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNV  154 (296)
T ss_pred             eecCCe----EEEEeecc-CcCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCE
Confidence            987654    79999998 55777766543 34789999999999999999999973  189999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCC----CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR----LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      ||+|||++.......   ......++..|+|||.+.+..    ++.++||||||+++|+|++|+.||...... ...+..
T Consensus       155 kL~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~-~~~~~~  230 (296)
T cd06618         155 KLCDFGISGRLVDSK---AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE-FEVLTK  230 (296)
T ss_pred             EECccccchhccCCC---cccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhH-HHHHHH
Confidence            999999987643221   123345788999999987543    788999999999999999999998643211 111111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ....    ..       +..  ......+.++.+|+.+||..+|.+||++.+++..
T Consensus       231 ~~~~----~~-------~~~--~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  273 (296)
T cd06618         231 ILQE----EP-------PSL--PPNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH  273 (296)
T ss_pred             HhcC----CC-------CCC--CCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            1110    00       000  0011245679999999999999999999999854

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-37  Score=281.58  Aligned_cols=258  Identities=23%  Similarity=0.306  Sum_probs=204.5

Q ss_pred             HhcCCCccc-eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           85 ATRGFSRAL-LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      .|++|.+.. +||-|-.|.|-.+.++           .+++.+|+|++...     ....+|+++.=.. .|||||.+++
T Consensus        59 itedY~is~qvLG~GinGkV~~C~~k-----------~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~Iid  122 (400)
T KOG0604|consen   59 ITEDYSISWQVLGAGINGKVVQCVHK-----------RTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIID  122 (400)
T ss_pred             chhhheehhhhhccccCCceEEEEec-----------cchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeeh
Confidence            366666554 7999999999999987           56788999998543     3345788876555 6999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---  239 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---  239 (453)
                      ++.........+++|||.|+||.|...+..+....+++.++..|+.||+.|+.|||+.   +|.||||||+|+|.+.   
T Consensus       123 VyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~  199 (400)
T KOG0604|consen  123 VYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSP  199 (400)
T ss_pred             hhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCC
Confidence            9987766556688999999999999999999889999999999999999999999999   9999999999999964   


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      |..+||+|||+|+....   .....+.+-|+.|.|||++...+|+...|+||+|||+|-||+|.+||.......   +  
T Consensus       200 na~lKLtDfGFAK~t~~---~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~a---i--  271 (400)
T KOG0604|consen  200 NAPLKLTDFGFAKETQE---PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---I--  271 (400)
T ss_pred             CcceEecccccccccCC---CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCcc---C--
Confidence            55699999999997442   122456678999999999999999999999999999999999999997653210   0  


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        .|....  ++ ..-.-....+.....++...++|+.+|..+|.+|.|+.++++
T Consensus       272 --spgMk~--rI-~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~  321 (400)
T KOG0604|consen  272 --SPGMKR--RI-RTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD  321 (400)
T ss_pred             --ChhHHh--Hh-hccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence              000000  00 000011112223456788999999999999999999999875

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=8.5e-39  Score=335.02  Aligned_cols=253  Identities=28%  Similarity=0.376  Sum_probs=197.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      +-++.....||.|.||.||.|...           .++.-.|+|.+.-..  ....+.+.+|+.++..++|||+|+++|+
T Consensus      1234 ~~rWqrg~~Ig~G~fG~VYtavN~-----------~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGV 1302 (1509)
T KOG4645|consen 1234 TFRWQRGNFIGGGTFGKVYTAVNL-----------DTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGV 1302 (1509)
T ss_pred             eeeeccccccCCcceeeeEEeecC-----------CccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCce
Confidence            567888889999999999999875           557789999886443  2334667899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      -.+.+.    .+|.||||++|+|.+.+...  .-.++.....+..|++.|++|||++   |||||||||+||||+.+|.+
T Consensus      1303 EvHRek----v~IFMEyC~~GsLa~ll~~g--ri~dE~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~i 1373 (1509)
T KOG4645|consen 1303 EVHREK----VYIFMEYCEGGSLASLLEHG--RIEDEMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLI 1373 (1509)
T ss_pred             eecHHH----HHHHHHHhccCcHHHHHHhc--chhhhhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcE
Confidence            888876    58999999999999988654  2334444455678999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCC--CCccccccccCcCCCCccccccCC---CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          244 KLSDFGLARQGPPEG--LGHVSTSVVGTVGYAAPEYVQTGR---LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       244 kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      |++|||.|.......  .........||+.|||||++.+..   -..++||||||||++||+||+.||......  -.+.
T Consensus      1374 K~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne--~aIM 1451 (1509)
T KOG4645|consen 1374 KYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE--WAIM 1451 (1509)
T ss_pred             EeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch--hHHH
Confidence            999999998654432  111224568999999999997643   456899999999999999999999654211  1111


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      -.+              -..-....+...+.+-.+++.+||..||++|.++.++++
T Consensus      1452 y~V--------------~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle 1493 (1509)
T KOG4645|consen 1452 YHV--------------AAGHKPQIPERLSSEGRDFLEHCLEQDPKMRWTASQLLE 1493 (1509)
T ss_pred             hHH--------------hccCCCCCchhhhHhHHHHHHHHHhcCchhhhHHHHHHH
Confidence            000              001112334457788899999999999999998887664

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=294.43  Aligned_cols=249  Identities=29%  Similarity=0.414  Sum_probs=205.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .+.|+.-++||+||||.||-+..+           .++.-+|.|.+.+...   .+....++|-.+|.+++.+.||.+--
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvr-----------aTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaY  252 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVR-----------ATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAY  252 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEe-----------cchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEee
Confidence            356888889999999999999876           5678899999876543   33455678999999999999999866


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .+...+.    ++||+..|.||+|.-||.......+++..+.-++.+|+.||++||..   .||+|||||+|||||+.|+
T Consensus       253 AfeTkd~----LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~Gh  325 (591)
T KOG0986|consen  253 AFETKDA----LCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGH  325 (591)
T ss_pred             eecCCCc----eEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCC
Confidence            6665554    89999999999999999998888899999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ++|+|.|||..+...   ......+||.+|||||++.+..|+...|.|||||+||||+.|+.||..........-++  +
T Consensus       326 vRISDLGLAvei~~g---~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvd--r  400 (591)
T KOG0986|consen  326 VRISDLGLAVEIPEG---KPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVD--R  400 (591)
T ss_pred             eEeeccceEEecCCC---CccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHH--H
Confidence            999999999987643   23455699999999999999999999999999999999999999997543322211111  0


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                      ....            ....++...+++..+|....|..||.+|...
T Consensus       401 r~~~------------~~~ey~~kFS~eakslc~~LL~Kdp~~RLGc  435 (591)
T KOG0986|consen  401 RTLE------------DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGC  435 (591)
T ss_pred             HHhc------------chhhcccccCHHHHHHHHHHHccCHHHhccC
Confidence            0011            1123455667889999999999999999643

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=4.8e-36  Score=288.36  Aligned_cols=253  Identities=26%  Similarity=0.377  Sum_probs=193.6

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc----ccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF----QGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      +|+..+.||+|+||.||++.....        ..++..||+|.+.....    ...+.+.+|+.+++++ +|+||+++++
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~--------~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~   72 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSG--------HDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHY   72 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccC--------CCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceee
Confidence            477888999999999999986421        13567899999865322    2345678899999999 6999999998


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++...  .++++..+..++.|++.||.|||+.   +++||||+|+|||++.++.
T Consensus        73 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~  143 (290)
T cd05613          73 AFQTDTK----LHLILDYINGGELFTHLSQR--ERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGH  143 (290)
T ss_pred             EeecCCe----EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCC
Confidence            8876543    68999999999999999765  4678888889999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccC--CCCCchhHHHHHHHHHHHHhCCccccCCCChh-hHHHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG--RLTAKSDVWSFGVVLYELITGRRAVERNLPRN-EQKLLE  319 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SlGvil~elltg~~p~~~~~~~~-~~~~~~  319 (453)
                      +||+|||++........ .......|+..|+|||.+.+.  .++.++||||||+++|+|++|..||....... ...+..
T Consensus       144 ~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~  222 (290)
T cd05613         144 VVLTDFGLSKEFHEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISR  222 (290)
T ss_pred             EEEeeCccceecccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHH
Confidence            99999999976543221 112345688999999998753  46789999999999999999999986432211 111111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVV  373 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~  373 (453)
                      ...   ..        .    ..++...+..+.+++.+||+.+|.+||     ++.+++
T Consensus       223 ~~~---~~--------~----~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~  266 (290)
T cd05613         223 RIL---KS--------E----PPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIK  266 (290)
T ss_pred             Hhh---cc--------C----CCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHH
Confidence            110   00        0    011223456789999999999999997     555554

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.7e-36  Score=297.33  Aligned_cols=266  Identities=25%  Similarity=0.342  Sum_probs=198.2

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||.||+|.+.           .++..||||.+.....  .....+.+|+.+|+.++||||+++++
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   81 (343)
T cd07880          13 VPDRYRDLKQVGSGAYGTVCSALDR-----------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD   81 (343)
T ss_pred             cccceEEEEEeeecCCeEEEEEEEC-----------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceee
Confidence            4678999999999999999999875           4567899999864322  22356789999999999999999999


Q ss_pred             eeeeccccc--ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDERG--MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.......  ...++||||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~  154 (343)
T cd07880          82 VFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKH---EKLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNED  154 (343)
T ss_pred             eecCCccccccceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCC
Confidence            987654221  2368999999 7899888764   4688999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLL  318 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~  318 (453)
                      +.++|+|||++......     .....+++.|+|||.+.+ ..++.++|||||||++|+|++|..||......... .+.
T Consensus       155 ~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~  229 (343)
T cd07880         155 CELKILDFGLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIM  229 (343)
T ss_pred             CCEEEeecccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999999864321     234467889999999876 45889999999999999999999999754322111 111


Q ss_pred             Hhhhh-------cccCccccccccC--CcCC----CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRP-------YVSDSKKFHLIID--PRLE----GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~-------~~~~~~~~~~~~~--~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....       .+... .......  +...    .......+..+.+++.+|++.||.+|||+.+++.
T Consensus       230 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~  297 (343)
T cd07880         230 KVTGTPSKEFVQKLQSE-DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA  297 (343)
T ss_pred             HhcCCCCHHHHHhhcch-hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00000       00000 0000000  0000    0011234567899999999999999999999884

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-36  Score=286.89  Aligned_cols=264  Identities=28%  Similarity=0.379  Sum_probs=198.0

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      |+....||+|+||.||+|+..           .++..||+|.+....  ....+.+..|+.+++.++|+||+++++++..
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~   69 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDK-----------KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHT   69 (282)
T ss_pred             CeeehcccccCcceEEEeeec-----------CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhc
Confidence            456678999999999999975           446789999987653  2334678899999999999999999999887


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||++ ++|.+++.... ..+++..+..++.+++.||.|||+.   +|+||||+|+||+++.++.++|+
T Consensus        70 ~~~----~~~v~e~~~-~~l~~~i~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~  140 (282)
T cd07829          70 ERK----LYLVFEYCD-MDLKKYLDKRP-GPLSPNLIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLA  140 (282)
T ss_pred             CCc----eEEEecCcC-cCHHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEe
Confidence            643    799999996 69999987653 4689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhH-HHHHhhh--
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KLLEWVR--  322 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~~~~~~~--  322 (453)
                      |||++.......  .......++..|+|||.+.+. .++.++|||||||++|||++|+.||......... .+.....  
T Consensus       141 d~g~~~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  218 (282)
T cd07829         141 DFGLARAFGIPL--RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTP  218 (282)
T ss_pred             cCCcccccCCCc--cccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCC
Confidence            999998654322  122334567889999998766 7899999999999999999999998654322211 1111100  


Q ss_pred             -----hcccCccccccccCCcCCC---ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 -----PYVSDSKKFHLIIDPRLEG---NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 -----~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           +...+..............   ......+..+.+++.+||..+|++||++.+++.
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~  278 (282)
T cd07829         219 TEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK  278 (282)
T ss_pred             cHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence                 0000000000000000000   001122567999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=2.9e-36  Score=284.97  Aligned_cols=249  Identities=24%  Similarity=0.354  Sum_probs=191.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---C--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---G--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      +|...++||+|+||.||++.+..           .+..+++|.++..   .  ......+..|+.+++.++||||+++++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   69 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKK-----------AVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHA   69 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecC-----------CCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHH
Confidence            47788899999999999998752           2233555554321   1  123345778999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.....    .++||||+++++|.+++..  .....+++..++.++.|++.||.|||+.   +++|+||+|+||+++. 
T Consensus        70 ~~~~~~~----~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~---~i~h~~l~~~nili~~-  141 (260)
T cd08222          70 SFLERDA----FCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR---RILHRDLKAKNIFLKN-  141 (260)
T ss_pred             HHhcCCc----eEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc---CccccCCChhheEeec-
Confidence            9876654    6999999999999998864  2235789999999999999999999998   9999999999999975 


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.++|+|||++.......  .......|+..|+|||.+.+..++.++||||||+++|+|++|..||......   .....
T Consensus       142 ~~~~l~d~g~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~---~~~~~  216 (260)
T cd08222         142 NLLKIGDFGVSRLLMGSC--DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL---SVVLR  216 (260)
T ss_pred             CCEeecccCceeecCCCc--ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH---HHHHH
Confidence            569999999987653321  1223456888999999998888899999999999999999999998643211   11111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...    .      ..+    ..+...+.++.+++.+||..+|++||++.++++
T Consensus       217 ~~~----~------~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~  256 (260)
T cd08222         217 IVE----G------PTP----SLPETYSRQLNSIMQSMLNKDPSLRPSAAEILR  256 (260)
T ss_pred             HHc----C------CCC----CCcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence            100    0      001    112345678999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-37  Score=282.10  Aligned_cols=242  Identities=27%  Similarity=0.379  Sum_probs=197.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...++||+|+||.|-+++-+           .+++.+|+|++++.-...   ...-+.|-++|...+||.+..+--
T Consensus       167 m~dFdfLKvLGkGTFGKVIL~rEK-----------at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKY  235 (516)
T KOG0690|consen  167 MEDFDFLKVLGKGTFGKVILCREK-----------ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKY  235 (516)
T ss_pred             cchhhHHHHhcCCccceEEEEeec-----------ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhh
Confidence            577888999999999999999865           567899999998764333   334567999999999999988876


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .+...+.    +|+||||..||.|.-+|.+.  ..+++....-.-..|+.||.|||+.   +||+||||.+|.|||.+|+
T Consensus       236 sFQt~dr----lCFVMeyanGGeLf~HLsre--r~FsE~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGH  306 (516)
T KOG0690|consen  236 SFQTQDR----LCFVMEYANGGELFFHLSRE--RVFSEDRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGH  306 (516)
T ss_pred             hhccCce----EEEEEEEccCceEeeehhhh--hcccchhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCc
Confidence            6666664    89999999999999988764  5677766677788999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++..-.  ........+||+.|+|||++....|+.++|.|.+||++|||++|+.||......   .+++.+.
T Consensus       307 IKitDFGLCKE~I~--~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---kLFeLIl  381 (516)
T KOG0690|consen  307 IKITDFGLCKEEIK--YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---KLFELIL  381 (516)
T ss_pred             eEeeecccchhccc--ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---HHHHHHH
Confidence            99999999986322  234567889999999999999999999999999999999999999999764322   2222211


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  367 (453)
                                   -..+  .++...+++...|+...|..||.+|.
T Consensus       382 -------------~ed~--kFPr~ls~eAktLLsGLL~kdP~kRL  411 (516)
T KOG0690|consen  382 -------------MEDL--KFPRTLSPEAKTLLSGLLKKDPKKRL  411 (516)
T ss_pred             -------------hhhc--cCCccCCHHHHHHHHHHhhcChHhhc
Confidence                         0011  13344567888999999999999995

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.4e-36  Score=297.63  Aligned_cols=266  Identities=26%  Similarity=0.338  Sum_probs=199.4

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|.....||+|+||.||+|.+.           .++..||||++....  ......+.+|+.+++.++||||+++++
T Consensus        13 ~~~~y~~~~~ig~g~~g~vy~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   81 (343)
T cd07851          13 VPDRYQNLSPVGSGAYGQVCSAFDT-----------KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLD   81 (343)
T ss_pred             ccCceEEEEEeccCCceEEEEEEEC-----------CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHH
Confidence            4678999999999999999999975           346789999986532  223456778999999999999999998


Q ss_pred             eeeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.....  .....++|+||+ +++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.+
T Consensus        82 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~  154 (343)
T cd07851          82 VFTPASSLEDFQDVYLVTHLM-GADLNNIVKC---QKLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNED  154 (343)
T ss_pred             HhhccccccccccEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCC
Confidence            7765442  122478999999 7799998865   4689999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-H
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-L  318 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-~  318 (453)
                      +.++|+|||++......     .....++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........... .
T Consensus       155 ~~~kL~dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~  229 (343)
T cd07851         155 CELKILDFGLARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIM  229 (343)
T ss_pred             CCEEEcccccccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            99999999999865321     234467889999998865 4678999999999999999999999976543222111 1


Q ss_pred             HhhhhcccC-------ccccccccC---CcCCCcc---chHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSD-------SKKFHLIID---PRLEGNY---CIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~-------~~~~~~~~~---~~~~~~~---~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .... ...+       .......+.   ......+   ....+..+.+++.+||+.+|.+|||+.+|+.
T Consensus       230 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~  297 (343)
T cd07851         230 NLVG-TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA  297 (343)
T ss_pred             HhcC-CCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence            1100 0000       000000000   0000000   1123678999999999999999999999874

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-36  Score=311.76  Aligned_cols=268  Identities=28%  Similarity=0.481  Sum_probs=210.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++....+.||+|.||.|++|.........    ......||||.++.... ...+.+..|+++|+.+ .|+||+.++|+
T Consensus       295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~----~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~  370 (609)
T KOG0200|consen  295 RENLKLGKYLGEGAFGQVVKALLFGLSKAL----LSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGA  370 (609)
T ss_pred             hhhccccceeecccccceEeEEEeeccccc----ccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheee
Confidence            344555669999999999999876432110    12367899999875533 4567899999999999 79999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC-------C-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV-------P-------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------~-------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      |.....    .++|+||+..|+|.++|+...       .       ..+.....+.++.|||.|++||++.   ++||||
T Consensus       371 ~t~~~~----~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRD  443 (609)
T KOG0200|consen  371 CTQDGP----LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRD  443 (609)
T ss_pred             eccCCc----eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhC---Cccchh
Confidence            999544    799999999999999998764       0       1388889999999999999999999   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCcccccccc--CcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccc
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG--TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV  306 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~  306 (453)
                      |...|||++.+..+||+|||+|+...+..... .....|  ...|||||.+....++.++|||||||+||||+| |..|+
T Consensus       444 LAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  444 LAARNVLITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hhhhhEEecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence            99999999999999999999999654433222 122222  345999999999999999999999999999999 66777


Q ss_pred             cCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .+-.+  ...+.++++.    +.+          ...+..++.++.+++..||+.+|++||++.++.+.|+..+.
T Consensus       523 p~~~~--~~~l~~~l~~----G~r----------~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l~  581 (609)
T KOG0200|consen  523 PGIPP--TEELLEFLKE----GNR----------MEQPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHLQ  581 (609)
T ss_pred             CCCCc--HHHHHHHHhc----CCC----------CCCCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHHH
Confidence            65221  1222333332    221          12234557889999999999999999999999999998654

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-35  Score=277.98  Aligned_cols=237  Identities=30%  Similarity=0.396  Sum_probs=191.7

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEeeeeeeccccc
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~  171 (453)
                      ||+|+||.||++.+.           ..+..+|+|.+......   ....+..|+.+++.++||||+++++.+.....  
T Consensus         1 lg~G~~~~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~--   67 (250)
T cd05123           1 LGKGSFGKVLLVRKK-----------DTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEK--   67 (250)
T ss_pred             CCCCCceEEEEEEEC-----------CCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCe--
Confidence            699999999999875           34678999998765332   34578899999999999999999998876553  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                        .++||||+++++|.+++...  ..+++.....++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||++
T Consensus        68 --~~~v~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~  140 (250)
T cd05123          68 --LYLVLEYAPGGELFSHLSKE--GRFSEERARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLA  140 (250)
T ss_pred             --eEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcc
Confidence              79999999999999999765  3688999999999999999999998   9999999999999999999999999999


Q ss_pred             cCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       252 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      .......  .......++..|+|||.+.+...+.++|+||||+++|+|++|..||.....   ......+..   .    
T Consensus       141 ~~~~~~~--~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~---~~~~~~~~~---~----  208 (250)
T cd05123         141 KELSSEG--SRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR---KEIYEKILK---D----  208 (250)
T ss_pred             eecccCC--CcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH---HHHHHHHhc---C----
Confidence            7654321  123455788999999999888889999999999999999999999965432   111111110   0    


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE  371 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  371 (453)
                              ....+...+..+.+++.+||..||++||++.+
T Consensus       209 --------~~~~~~~~~~~l~~~i~~~l~~~p~~R~~~~~  240 (250)
T cd05123         209 --------PLRFPEFLSPEARDLISGLLQKDPTKRLGSGG  240 (250)
T ss_pred             --------CCCCCCCCCHHHHHHHHHHhcCCHhhCCCccc
Confidence                    01112223677899999999999999999954

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-36  Score=302.76  Aligned_cols=265  Identities=28%  Similarity=0.378  Sum_probs=219.1

Q ss_pred             cHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCc
Q 043568           78 SFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPN  156 (453)
Q Consensus        78 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n  156 (453)
                      .++.+..-++-|.+.+.||.|.+|.||+++.+           .+++..|+|++... .+..+++..|.++|+.+ .|||
T Consensus        10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~-----------~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpn   77 (953)
T KOG0587|consen   10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHV-----------KTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPN   77 (953)
T ss_pred             chhhCCCCCCccEEEEEEeeccceeEEEEeee-----------ecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCC
Confidence            34444455788999999999999999999976           45677899987654 34456788899999988 7999


Q ss_pred             eeeEeeeeeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          157 LVKLVGYCAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       157 Iv~l~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      ++.++|++...+. .+-+++||||||.+||.-|++..-.+..+.|..+..|++.++.||.+||..   .++|||||-.||
T Consensus        78 v~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~Ni  154 (953)
T KOG0587|consen   78 VATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNV  154 (953)
T ss_pred             cceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceE
Confidence            9999999886554 335799999999999999999887788899999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-----CCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-----RLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      |++.++.+||+|||++...+..  .....+..||+.|||||++...     .|+..+|+||||++..||.-|.+|+....
T Consensus       155 LLT~e~~VKLvDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmH  232 (953)
T KOG0587|consen  155 LLTENAEVKLVDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMH  232 (953)
T ss_pred             EEeccCcEEEeeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcc
Confidence            9999999999999999875532  3345678999999999998643     46778999999999999999999987654


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      |...               -+....+|.++..-+....+++.++|..||..|.++||++.++++
T Consensus       233 Pmra---------------LF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~  281 (953)
T KOG0587|consen  233 PMRA---------------LFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK  281 (953)
T ss_pred             hhhh---------------hccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence            4211               111123444444456788999999999999999999999999874

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-36  Score=272.28  Aligned_cols=264  Identities=24%  Similarity=0.379  Sum_probs=208.3

Q ss_pred             ccccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-C
Q 043568           75 RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-K  153 (453)
Q Consensus        75 ~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~  153 (453)
                      ..=+|+|+.+.|.     ++||+|+|+.|-.++..           .++.+||||++.+..........+|++++.+. .
T Consensus        71 ~~g~F~d~YkLt~-----e~LGeGAyasVqtcv~i-----------~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqg  134 (463)
T KOG0607|consen   71 LSGKFEDMYKLTS-----ELLGEGAYASVQTCVSI-----------QTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQG  134 (463)
T ss_pred             ccchHHHHHHhHH-----HHhcCccceeeeeeeee-----------ccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcC
Confidence            3345778877774     57999999999988755           56789999999988666778889999999999 6


Q ss_pred             CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       154 h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      |+||+.++++|.++..    +|||||-|.||+|..+|.++  ..+++.++-++.++|+.||.|||.+   ||.||||||+
T Consensus       135 h~nilqLiefFEdd~~----FYLVfEKm~GGplLshI~~~--~~F~E~EAs~vvkdia~aLdFlH~k---gIAHRDlKPE  205 (463)
T KOG0607|consen  135 HKNILQLIEFFEDDTR----FYLVFEKMRGGPLLSHIQKR--KHFNEREASRVVKDIASALDFLHTK---GIAHRDLKPE  205 (463)
T ss_pred             CccHHHHHHHhcccce----EEEEEecccCchHHHHHHHh--hhccHHHHHHHHHHHHHHHHHHhhc---CcccccCCcc
Confidence            9999999999988775    79999999999999999987  6899999999999999999999999   9999999999


Q ss_pred             cEEEcCCCc---EEEeccccccCCCCCC-----CCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHH
Q 043568          234 NILLDEDYK---AKLSDFGLARQGPPEG-----LGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELI  300 (453)
Q Consensus       234 NILl~~~~~---~kL~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~ell  300 (453)
                      |||-.....   +||+||.+..-.....     ......+.+|+..|||||+..     ...|+.+.|.||||||||-||
T Consensus       206 NiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImL  285 (463)
T KOG0607|consen  206 NILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIML  285 (463)
T ss_pred             ceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHH
Confidence            999976554   7999998875322111     112234668999999999863     246889999999999999999


Q ss_pred             hCCccccCCCChh------------hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC
Q 043568          301 TGRRAVERNLPRN------------EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK  368 (453)
Q Consensus       301 tg~~p~~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  368 (453)
                      +|.+||.+....+            ...+++-++..     .+      ..........+.+..+|+...+..++.+|.+
T Consensus       286 sGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEG-----kY------eFPdkdWahIS~eakdlisnLlvrda~~rls  354 (463)
T KOG0607|consen  286 SGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEG-----KY------EFPDKDWAHISSEAKDLISNLLVRDAKQRLS  354 (463)
T ss_pred             hCCCCccCccCCcCCccCCCccHHHHHHHHHHHhcc-----CC------cCChhhhHHhhHHHHHHHHHHHhccHHhhhh
Confidence            9999997654321            12233222210     00      0111123345778899999999999999999


Q ss_pred             HHHHHH
Q 043568          369 MSEVVD  374 (453)
Q Consensus       369 ~~ei~~  374 (453)
                      +.+++.
T Consensus       355 a~~vln  360 (463)
T KOG0607|consen  355 AAQVLN  360 (463)
T ss_pred             hhhccC
Confidence            988875

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=1.4e-36  Score=275.43  Aligned_cols=208  Identities=27%  Similarity=0.354  Sum_probs=167.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..|.....||+|+||.||+|+-..+++       .....+|||+++....  .-.....+|+.+++.++||||+.+..++
T Consensus        24 ~~ye~ig~Ig~GTYG~VykA~~~~~n~-------kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vf   96 (438)
T KOG0666|consen   24 FEYEGIGKIGRGTYGKVYKAVRKNTND-------KRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVF   96 (438)
T ss_pred             HHhhccceecccccceeeEeeeccCCc-------ccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHH
Confidence            457788899999999999997553321       1135799999975521  2235578999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC---CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV---PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-  240 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~---~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-  240 (453)
                      ...+.   ..++++||.+. +|...|+-+.   ...++-.....|+.||+.|+.|||++   =|+||||||.|||+..+ 
T Consensus        97 l~~d~---~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdg  169 (438)
T KOG0666|consen   97 LSHDK---KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDG  169 (438)
T ss_pred             hccCc---eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccC
Confidence            88643   37999999955 6777675432   34678888899999999999999998   89999999999999877 


Q ss_pred             ---CcEEEeccccccCCCCCCC-CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          241 ---YKAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       241 ---~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                         |.+||+|||+++.+...-. -.....++-|.+|.|||.+.+ ..||++.||||.|||+.||+|..+.|..
T Consensus       170 perG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g  242 (438)
T KOG0666|consen  170 PERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG  242 (438)
T ss_pred             CccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence               8999999999997653321 112356788999999999887 4699999999999999999999887754

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=4.7e-35  Score=310.89  Aligned_cols=147  Identities=26%  Similarity=0.346  Sum_probs=128.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|.+.++||+|+||+||+|.+.           ..+..||||++......   ....+..|+.++..++||||+++++
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~-----------~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~   71 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKK-----------NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYY   71 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC-----------CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEE
Confidence            367899999999999999999975           45678999998754322   2356889999999999999999998


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .+|||||+.+++|.+++...  ..+++..++.++.||+.||.|||..   +|+||||||+||||+.++.
T Consensus        72 ~~~~~~~----~~lVmEy~~g~~L~~li~~~--~~l~~~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~  142 (669)
T cd05610          72 SLQSANN----VYLVMEYLIGGDVKSLLHIY--GYFDEEMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGH  142 (669)
T ss_pred             EEEECCE----EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCC
Confidence            8876553    79999999999999998764  4678888999999999999999998   9999999999999999999


Q ss_pred             EEEecccccc
Q 043568          243 AKLSDFGLAR  252 (453)
Q Consensus       243 ~kL~DFGla~  252 (453)
                      +||+|||+++
T Consensus       143 vkL~DFGls~  152 (669)
T cd05610         143 IKLTDFGLSK  152 (669)
T ss_pred             EEEEeCCCCc
Confidence            9999999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=286.84  Aligned_cols=258  Identities=25%  Similarity=0.365  Sum_probs=202.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-Cc------ccHHHHHHHHHHhccCCCCceee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GF------QGHKEWINEVNFLGVVKHPNLVK  159 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~------~~~~~~~~E~~~l~~l~h~nIv~  159 (453)
                      ++|..+++||+|||+.||+|.+.           ...+.||||+-... ++      ...+...+|..|.+.|.||.||+
T Consensus       463 ~RYLlLhLLGrGGFSEVyKAFDl-----------~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVK  531 (775)
T KOG1151|consen  463 DRYLLLHLLGRGGFSEVYKAFDL-----------TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVK  531 (775)
T ss_pred             HHHHHHHHhccccHHHHHHhccc-----------chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeee
Confidence            56788889999999999999975           45778999985322 11      22355789999999999999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc-
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-  238 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~-  238 (453)
                      +|+|+.-+...   +|-|+|||+|.+|+-||..+  ..+++.++..|+.||+.||.||... .++|||-||||.||||- 
T Consensus       532 lYDyfslDtds---FCTVLEYceGNDLDFYLKQh--klmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~  605 (775)
T KOG1151|consen  532 LYDYFSLDTDS---FCTVLEYCEGNDLDFYLKQH--KLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVN  605 (775)
T ss_pred             eeeeeeecccc---ceeeeeecCCCchhHHHHhh--hhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEec
Confidence            99999877653   79999999999999999876  6789999999999999999999987 67999999999999994 


Q ss_pred             --CCCcEEEeccccccCCCCCCCCc-----cccccccCcCCCCccccccC----CCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          239 --EDYKAKLSDFGLARQGPPEGLGH-----VSTSVVGTVGYAAPEYVQTG----RLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       239 --~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~----~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                        .-|.+||+|||+++.+.......     ......||.+|++||.+.-+    +.+.|+||||+|||+|.++.|+.||.
T Consensus       606 GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFG  685 (775)
T KOG1151|consen  606 GTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFG  685 (775)
T ss_pred             CcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCC
Confidence              35679999999999877654432     23456899999999988633    47889999999999999999999998


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                      .+..  .+++++...- +. ..        .+..+..+..+.+...+|.+||+..-++|....++.
T Consensus       686 hnqs--QQdILqeNTI-lk-At--------EVqFP~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA  739 (775)
T KOG1151|consen  686 HNQS--QQDILQENTI-LK-AT--------EVQFPPKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA  739 (775)
T ss_pred             Cchh--HHHHHhhhch-hc-ce--------eccCCCCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence            6532  2333322110 00 00        011111223456788999999999999998877765

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=3.6e-35  Score=274.03  Aligned_cols=221  Identities=23%  Similarity=0.250  Sum_probs=176.1

Q ss_pred             CCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEE
Q 043568           98 GGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLV  177 (453)
Q Consensus        98 G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv  177 (453)
                      |.||.||++.+.           .++..||+|.+....     .+.+|...+....||||+++++++.....    .++|
T Consensus         4 g~~~~v~~~~~~-----------~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~----~~lv   63 (237)
T cd05576           4 GVIDKVLLVMDT-----------RTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDS----VFLV   63 (237)
T ss_pred             cccceEEEEEEc-----------cCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCe----EEEE
Confidence            899999999976           456789999986543     23345555556679999999999887654    7999


Q ss_pred             EEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCC
Q 043568          178 YELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE  257 (453)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~  257 (453)
                      |||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||.+......
T Consensus        64 ~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~  138 (237)
T cd05576          64 LQHAEGGKLWSHISKF--LNIPEECVKRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS  138 (237)
T ss_pred             EecCCCCCHHHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc
Confidence            9999999999998765  4588999999999999999999998   9999999999999999999999999988654321


Q ss_pred             CCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCC
Q 043568          258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDP  337 (453)
Q Consensus       258 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                           .....++..|+|||.+.+..++.++||||+|+++|||++|..|+......                  ...... 
T Consensus       139 -----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~------------------~~~~~~-  194 (237)
T cd05576         139 -----CDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG------------------INTHTT-  194 (237)
T ss_pred             -----cccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh------------------cccccc-
Confidence                 22345677899999998888999999999999999999999876532110                  000000 


Q ss_pred             cCCCccchHHHHHHHHHHHHhhccCCCCCCCHH
Q 043568          338 RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS  370 (453)
Q Consensus       338 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  370 (453)
                         ...+...+..+.+++.+||+.||.+||++.
T Consensus       195 ---~~~~~~~~~~~~~li~~~l~~dp~~R~~~~  224 (237)
T cd05576         195 ---LNIPEWVSEEARSLLQQLLQFNPTERLGAG  224 (237)
T ss_pred             ---cCCcccCCHHHHHHHHHHccCCHHHhcCCC
Confidence               011122456789999999999999999973

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=100.00  E-value=6.6e-35  Score=271.86  Aligned_cols=276  Identities=24%  Similarity=0.386  Sum_probs=227.7

Q ss_pred             HHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCce
Q 043568           79 FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNL  157 (453)
Q Consensus        79 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nI  157 (453)
                      .+++.....+++...++-+|+||.||+|.++.-++.      .+.+.|-+|.++.... -....|+.|.-.+..+.|||+
T Consensus       276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~------n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nl  349 (563)
T KOG1024|consen  276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTY------NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNL  349 (563)
T ss_pred             HHhhhhhhhheechhhhhcCchhheeeeeecccCCc------chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCc
Confidence            344555566788888999999999999998743222      3455678888765432 334678899999999999999


Q ss_pred             eeEeeeeeecccccceEEEEEEecCCCChHHhhh------cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL------SRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      ..+.+++.+....   ++.+|.++.-|+|..+|.      ....+.++..+...++.|++.|++|||++   ++||.||.
T Consensus       350 l~V~~V~ie~~~~---P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~---~ViHkDiA  423 (563)
T KOG1024|consen  350 LSVLGVSIEDYAT---PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIA  423 (563)
T ss_pred             cceeEEEeeccCc---ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhc---Ccccchhh
Confidence            9999999987654   789999999999999997      22345677888899999999999999999   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCC
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNL  310 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~  310 (453)
                      ..|++||+...+||+|=.+++...+.+......+......||+||.+.+..|+.++|||||||++|||+| |+.|+..-.
T Consensus       424 aRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeID  503 (563)
T KOG1024|consen  424 ARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEID  503 (563)
T ss_pred             hhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccC
Confidence            9999999999999999999999888877777777778889999999999999999999999999999999 788887655


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      |.+....+       .++.++          ..+.++|+++..++.-||...|++||++++++..|.++..++
T Consensus       504 PfEm~~yl-------kdGyRl----------aQP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  504 PFEMEHYL-------KDGYRL----------AQPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             HHHHHHHH-------hcccee----------cCCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence            55443332       222222          224468899999999999999999999999999999887654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-35  Score=292.73  Aligned_cols=241  Identities=25%  Similarity=0.351  Sum_probs=195.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      +++.|.....+|.|+|+.|-++.+.           .+++..++|++.+...    +-.+|+.++... +||||+++.+.
T Consensus       320 ~~~~y~~~~~~~~gs~s~~~~~~~~-----------~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v  384 (612)
T KOG0603|consen  320 FTESYEFREELGEGSFSAVKYCESS-----------PTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDV  384 (612)
T ss_pred             cchhhccccccCCCCccceeeeecc-----------ccccchhheecccccc----ccccccchhhhhcCCCcceeecce
Confidence            3567777788999999999999876           5577899999976522    223577666666 79999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE-cCCCc
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL-DEDYK  242 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl-~~~~~  242 (453)
                      +.+...    .++|||++.|+-|.+.+...   +.....+..|+.+|+.|+.|||.+   |+|||||||+|||+ ++.++
T Consensus       385 ~~~~~~----~~~v~e~l~g~ell~ri~~~---~~~~~e~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~  454 (612)
T KOG0603|consen  385 YEDGKE----IYLVMELLDGGELLRRIRSK---PEFCSEASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGH  454 (612)
T ss_pred             ecCCce----eeeeehhccccHHHHHHHhc---chhHHHHHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCc
Confidence            887664    79999999999988888765   222367778999999999999998   99999999999999 69999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ++|+|||.++.....     ....+-|..|.|||++....|++++|+||||++||+||+|+.||......  ..+...+ 
T Consensus       455 lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i-  526 (612)
T KOG0603|consen  455 LRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRI-  526 (612)
T ss_pred             EEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhh-
Confidence            999999999875432     34556789999999999999999999999999999999999999765332  1221111 


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                      ..+.+....+....+|+..||+.||.+||+|.++..
T Consensus       527 ----------------~~~~~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~  562 (612)
T KOG0603|consen  527 ----------------QMPKFSECVSDEAKDLLQQLLQVDPALRLGADEIGA  562 (612)
T ss_pred             ----------------cCCccccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence                            112222456788999999999999999999999874

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-35  Score=276.54  Aligned_cols=242  Identities=26%  Similarity=0.411  Sum_probs=196.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      ..+|....+||+|+||.|.+|..+           .+.+.+|||++++.-.   ++.+--+.|-++|... +-|.++.+.
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerk-----------gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlH  416 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERK-----------GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLH  416 (683)
T ss_pred             ecccceEEEeccCccceeeeeccc-----------CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHH
Confidence            346888999999999999999865           3457899999986532   3334456788888877 567889998


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      .++..-+.    +|+||||+.||+|--+++..  ..+.+..+.-++..||-||-+||++   |||+||||..|||||.+|
T Consensus       417 ScFQTmDR----LyFVMEyvnGGDLMyhiQQ~--GkFKEp~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eG  487 (683)
T KOG0696|consen  417 SCFQTMDR----LYFVMEYVNGGDLMYHIQQV--GKFKEPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEG  487 (683)
T ss_pred             HHhhhhhh----eeeEEEEecCchhhhHHHHh--cccCCchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCC
Confidence            88888775    79999999999999888876  4566777888899999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      ++||+|||+++.--..  .....+..||+.|+|||++...+|+..+|.|||||+|||||.|++||++....   .+.+.+
T Consensus       488 HiKi~DFGmcKEni~~--~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~---elF~aI  562 (683)
T KOG0696|consen  488 HIKIADFGMCKENIFD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED---ELFQAI  562 (683)
T ss_pred             ceEeeecccccccccC--CcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH
Confidence            9999999999863222  22356789999999999999999999999999999999999999999876432   232222


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  367 (453)
                      .             +.  .-.++...+.+...+....|...|.+|.
T Consensus       563 ~-------------eh--nvsyPKslSkEAv~ickg~ltK~P~kRL  593 (683)
T KOG0696|consen  563 M-------------EH--NVSYPKSLSKEAVAICKGLLTKHPGKRL  593 (683)
T ss_pred             H-------------Hc--cCcCcccccHHHHHHHHHHhhcCCcccc
Confidence            1             11  1124455678889999999999999994

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-36  Score=310.58  Aligned_cols=260  Identities=23%  Similarity=0.275  Sum_probs=206.2

Q ss_pred             HHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHHHHhccCCCC
Q 043568           79 FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEVNFLGVVKHP  155 (453)
Q Consensus        79 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~  155 (453)
                      ..++.-..++|.+.++||+|+||.|...+++           .++..||+|++++-   .......|..|-.+|..-+.+
T Consensus        67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k-----------~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~  135 (1317)
T KOG0612|consen   67 VKELRLKAEDFEILKVIGRGAFGEVALVRHK-----------STEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSE  135 (1317)
T ss_pred             HHHHhCCHHhhHHHHHhcccccceeEEEEee-----------ccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcH
Confidence            4445555789999999999999999999987           56788999999863   223445688899999988899


Q ss_pred             ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      =|+.+.-.|.+...    +|+|||||+||+|-.++.+..  +++...+.-++..|+.||.-||+.   |+|||||||+||
T Consensus       136 Wiv~LhyAFQD~~~----LYlVMdY~pGGDlltLlSk~~--~~pE~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNv  206 (1317)
T KOG0612|consen  136 WIVQLHYAFQDERY----LYLVMDYMPGGDLLTLLSKFD--RLPEDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNV  206 (1317)
T ss_pred             HHHHHHHHhcCccc----eEEEEecccCchHHHHHhhcC--CChHHHHHHHHHHHHHHHHHHHhc---cceeccCCccee
Confidence            99999877777664    899999999999999988763  678887888889999999999998   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      |||..|++||+|||.+-.+...+ .-.....+|||.|++||++..     +.|++.+|.||+||++|||+.|..||....
T Consensus       207 Lld~~GHikLADFGsClkm~~dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYads  285 (1317)
T KOG0612|consen  207 LLDKSGHIKLADFGSCLKMDADG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADS  285 (1317)
T ss_pred             EecccCcEeeccchhHHhcCCCC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHH
Confidence            99999999999999987765443 234567799999999999863     579999999999999999999999997542


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC---HHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK---MSEVVD  374 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs---~~ei~~  374 (453)
                            +++-.........        .+..+.....+.+..+||.+.+. +|+.|..   +++|..
T Consensus       286 ------lveTY~KIm~hk~--------~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik~  337 (1317)
T KOG0612|consen  286 ------LVETYGKIMNHKE--------SLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIKN  337 (1317)
T ss_pred             ------HHHHHHHHhchhh--------hcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHHh
Confidence                  2221111111111        11111123467889999998875 7888887   777764

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-34  Score=243.92  Aligned_cols=265  Identities=23%  Similarity=0.297  Sum_probs=195.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +|...++||+|+||+||+|+.+           .+.+.||+|.+....  ..-....++|+-+|+.+.|.|||+++++..
T Consensus         3 ~ydkmekigegtygtvfkarn~-----------~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlh   71 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNR-----------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH   71 (292)
T ss_pred             chHHHHhhcCCcceeeEecccC-----------CccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhc
Confidence            4555678999999999999876           557789999986443  223466889999999999999999999877


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      .+..    +-+|+||| ..+|..+...- ...++......++.|+++||.|+|++   ++.||||||+|.||+.+|.+||
T Consensus        72 sdkk----ltlvfe~c-dqdlkkyfdsl-ng~~d~~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkl  142 (292)
T KOG0662|consen   72 SDKK----LTLVFEFC-DQDLKKYFDSL-NGDLDPEIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKL  142 (292)
T ss_pred             cCce----eEEeHHHh-hHHHHHHHHhc-CCcCCHHHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEe
Confidence            6654    78999999 66788877654 35678888899999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCcc-ccCCCChhhHHHHHhhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRA-VERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~  323 (453)
                      +|||+++.+.-.  -......+-|.+|.+|.++.+. -|+...|+||-|||+.|+.....| |.+....+...-+-+...
T Consensus       143 adfglarafgip--vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg  220 (292)
T KOG0662|consen  143 ADFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLG  220 (292)
T ss_pred             cccchhhhcCCc--eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhC
Confidence            999999976532  2234566789999999998875 588999999999999999985544 554433332222222211


Q ss_pred             cccCc--cccccccCCcCCCccc---------hHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDS--KKFHLIIDPRLEGNYC---------IKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~--~~~~~~~~~~~~~~~~---------~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...+.  ..+..+.|...-.-++         +.....-.+|+++.+.-+|.+|.++++.++
T Consensus       221 ~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq  282 (292)
T KOG0662|consen  221 TPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ  282 (292)
T ss_pred             CCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence            11111  1112222222221121         112234468899999999999999987664

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-35  Score=284.96  Aligned_cols=244  Identities=26%  Similarity=0.400  Sum_probs=197.4

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      .++||.|.||+||-|+++           .+++.||||++.+....  ...++.+|+.||..++||.||.+-..|...+.
T Consensus       569 devLGSGQFG~VYgg~hR-----------ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHR-----------KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPER  637 (888)
T ss_pred             HhhccCCcceeeecceec-----------ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCce
Confidence            458999999999999987           67889999999876543  34678899999999999999999988887775


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC---CcEEEe
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED---YKAKLS  246 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~---~~~kL~  246 (453)
                          .+.|||-+ +|++.+.|.......+++..-.-++.||+.||.|||-+   +|+|.||||+||||.+.   ..+||+
T Consensus       638 ----vFVVMEKl-~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlC  709 (888)
T KOG4236|consen  638 ----VFVVMEKL-HGDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLC  709 (888)
T ss_pred             ----EEEEehhh-cchHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeec
Confidence                69999999 66777777666667788877777889999999999998   99999999999999643   469999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+|+.....   .....++||+.|+|||+++...|+..-|+||.|||+|--++|..||.......+  -++.+     
T Consensus       710 DFGfARiIgEk---sFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdInd--QIQNA-----  779 (888)
T KOG4236|consen  710 DFGFARIIGEK---SFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDIND--QIQNA-----  779 (888)
T ss_pred             cccceeecchh---hhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCccchhH--Hhhcc-----
Confidence            99999997653   345678999999999999999999999999999999999999999964422111  11100     


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                           . ++-|   .+...+.+.+..+||...|+..-.+|-|...-+
T Consensus       780 -----a-FMyP---p~PW~eis~~AidlIn~LLqVkm~kRysvdk~l  817 (888)
T KOG4236|consen  780 -----A-FMYP---PNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL  817 (888)
T ss_pred             -----c-cccC---CCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence                 0 1111   112234567789999999999999998876644

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-34  Score=271.47  Aligned_cols=157  Identities=20%  Similarity=0.279  Sum_probs=134.5

Q ss_pred             HHHhhcCCCccccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHH
Q 043568           66 LSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINE  145 (453)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E  145 (453)
                      ...++.++.......|... .++|.+.++||-|.|++||+|.+.           +..+.||+|+.+.. ....+..+.|
T Consensus        58 ~~dY~kGGYHpV~IGD~F~-~gRY~v~rKLGWGHFSTVWLawDt-----------q~~r~VAlKVvKSA-qhYtEaAlDE  124 (590)
T KOG1290|consen   58 PEDYRKGGYHPVRIGDVFN-GGRYHVQRKLGWGHFSTVWLAWDT-----------QNKRYVALKVVKSA-QHYTEAALDE  124 (590)
T ss_pred             hhhhhcCCCceeecccccc-CceEEEEEeccccccceeEEEeec-----------cCCeEEEEEEEehh-hHHHHHHHHH
Confidence            3455566677666666653 478999999999999999999987           56788999998543 2334567789


Q ss_pred             HHHhccCC-----C---CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 043568          146 VNFLGVVK-----H---PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYL  217 (453)
Q Consensus       146 ~~~l~~l~-----h---~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L  217 (453)
                      |++|++++     |   .+||+|++.|...+.++.+.++|+|++ |.+|..+|....-..++...+.+|++||+.||.||
T Consensus       125 IklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYL  203 (590)
T KOG1290|consen  125 IKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYL  203 (590)
T ss_pred             HHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHH
Confidence            99999883     3   359999999999999999999999999 89999999988878899999999999999999999


Q ss_pred             HhCCCCceEeeccccccEEEc
Q 043568          218 HEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       218 H~~~~~~iiH~Dlkp~NILl~  238 (453)
                      |..|  +|||.||||+|||+.
T Consensus       204 H~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  204 HREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             HHhc--CccccCCCcceeeee
Confidence            9997  999999999999994

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.5e-36  Score=265.63  Aligned_cols=272  Identities=24%  Similarity=0.378  Sum_probs=200.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..|....+||+|.||.||+|+.+           .+++.||+|+.-..+  .......++|+.+|..|.|+|++.+++.|
T Consensus        17 ~~yek~~kigqGtfgeVFkAr~~-----------n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic   85 (376)
T KOG0669|consen   17 SKYEKLAKIGQGTFGEVFKARSK-----------NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEIC   85 (376)
T ss_pred             hHHHHHHhcCCchHHHHHHHhhc-----------CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHH
Confidence            34555668999999999999865           456678998754322  12224467999999999999999999999


Q ss_pred             eecccccc----eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          165 AEDDERGM----QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       165 ~~~~~~~~----~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ........    .+++||.+|+ -+|...|... ...++...+.+++.++..||.|+|..   .|+|||+|++|+||+.+
T Consensus        86 ~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~-~vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~d  160 (376)
T KOG0669|consen   86 RTKATPTNRDRATFYLVFDFCE-HDLAGLLSNR-KVRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKD  160 (376)
T ss_pred             hhccCCcccccceeeeeHHHhh-hhHHHHhcCc-cccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCC
Confidence            76543332    3899999995 4777767654 35688889999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCC--CCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          241 YKAKLSDFGLARQGPPEG--LGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      +.+||+|||+++.+....  .....++.+-|..|.+||.+.+ ..|+++.|||+-|||+.||.||.+-+.++.......+
T Consensus       161 gilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~  240 (376)
T KOG0669|consen  161 GILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHL  240 (376)
T ss_pred             ceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHH
Confidence            999999999997654322  2233567788999999998876 5699999999999999999999999887655544444


Q ss_pred             HHhh--------hhcccCcccccccc-CCcCCCccc--hH------HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 LEWV--------RPYVSDSKKFHLII-DPRLEGNYC--IK------SAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~~~~--------~~~~~~~~~~~~~~-~~~~~~~~~--~~------~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +...        +|...+-.-+..+- .|...+.+.  .+      -.++..+|+..++..||.+|+++.+++.
T Consensus       241 Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~aln  314 (376)
T KOG0669|consen  241 ISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALN  314 (376)
T ss_pred             HHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhc
Confidence            4322        11111111111110 111111110  00      1236789999999999999999998874

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.5e-35  Score=273.71  Aligned_cols=272  Identities=24%  Similarity=0.318  Sum_probs=206.2

Q ss_pred             cccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC-
Q 043568           76 VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH-  154 (453)
Q Consensus        76 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-  154 (453)
                      +|...|..  +++|.+...+|+|+||.|-.+.++           ..+..||||+++.-. ...+..+-|+++|.++.+ 
T Consensus        80 v~~~gD~l--~~Ry~i~~~lGeGtFGkV~ec~D~-----------~~~~~vAlKIik~V~-kYreAa~iEi~vLqki~~~  145 (415)
T KOG0671|consen   80 VYQVGDIL--TNRYEIVDLLGEGTFGKVVECWDR-----------ETKEHVALKIIKNVD-KYREAALIEIEVLQKINES  145 (415)
T ss_pred             EEEecccc--ccceehhhhhcCCcccceEEEeec-----------CCCceehHHHHHHHH-HHhhHHHHHHHHHHHHHhc
Confidence            44444444  789999999999999999999876           346789999986432 223445669999999942 


Q ss_pred             -Cc----eeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          155 -PN----LVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       155 -~n----Iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                       |+    +|.+.+++.-.+.    .+||+|.+ |.|+.++|..+.-.+++...+..|+.|++++++|||+.   +++|.|
T Consensus       146 DP~g~~rcv~m~~wFdyrgh----iCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~---kl~HTD  217 (415)
T KOG0671|consen  146 DPNGKFRCVQMRDWFDYRGH----ICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDL---KLTHTD  217 (415)
T ss_pred             CCCCceEEEeeehhhhccCc----eEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhc---ceeecC
Confidence             33    6777777766554    69999998 88999999998888999999999999999999999998   999999


Q ss_pred             cccccEEEcC--------------------CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhH
Q 043568          230 FKTSNILLDE--------------------DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDV  289 (453)
Q Consensus       230 lkp~NILl~~--------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV  289 (453)
                      |||+|||+.+                    +..++|+|||.|+....     .....+.|..|.|||++.+-.++..+||
T Consensus       218 LKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e-----~hs~iVsTRHYRAPEViLgLGwS~pCDv  292 (415)
T KOG0671|consen  218 LKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHE-----HHSTIVSTRHYRAPEVILGLGWSQPCDV  292 (415)
T ss_pred             CChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceecc-----CcceeeeccccCCchheeccCcCCccCc
Confidence            9999999931                    33589999999987432     2367789999999999999999999999


Q ss_pred             HHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccC--------------c----------cccccccCCcCCC----
Q 043568          290 WSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD--------------S----------KKFHLIIDPRLEG----  341 (453)
Q Consensus       290 ~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~--------------~----------~~~~~~~~~~~~~----  341 (453)
                      ||+||||+|+.+|...|+.....+...+.+.+...++.              +          ++.....++....    
T Consensus       293 WSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~  372 (415)
T KOG0671|consen  293 WSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYM  372 (415)
T ss_pred             eeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHh
Confidence            99999999999999999877655544444333211110              0          0000000000000    


Q ss_pred             ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          342 NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       342 ~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....+..+|.+|+.+||..||.+|+|+.|++.
T Consensus       373 ~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~  405 (415)
T KOG0671|consen  373 LQDDLEHVQLFDLLRRMLEFDPARRITLREALS  405 (415)
T ss_pred             ccCcHHHhHHHHHHHHHHccCccccccHHHHhc
Confidence            012234567999999999999999999999875

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-36  Score=269.16  Aligned_cols=252  Identities=29%  Similarity=0.416  Sum_probs=193.2

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeeeeeec
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGYCAED  167 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~  167 (453)
                      +....||.|+||+|+|-.++           +.++..|||++..... ...++++.|.....+- +.||||++||.+...
T Consensus        67 qdlg~iG~G~fG~V~KM~hk-----------~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~E  135 (361)
T KOG1006|consen   67 QDLGEIGNGAFGTVNKMLHK-----------PSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSE  135 (361)
T ss_pred             HHHHHhcCCcchhhhhhhcC-----------ccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcC
Confidence            34457999999999998876           6788999999986654 4457788888865554 799999999998877


Q ss_pred             ccccceEEEEEEecCCCChHHh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          168 DERGMQRLLVYELMHNKSLEDH---LLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      +.    .++.||+| ..||..+   +.......+++...-.|....+.||.||-...  .|||||+||+||||+..|.+|
T Consensus       136 Gd----cWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vK  208 (361)
T KOG1006|consen  136 GD----CWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVK  208 (361)
T ss_pred             Cc----eeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEe
Confidence            76    79999999 5666543   33333456788777888888999999998763  999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||++-..-.   +...+...|-..|||||.+..  ..|+.++||||||+.|||+.||..|+.....     +++-+.
T Consensus       209 LCDFGIcGqLv~---SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s-----vfeql~  280 (361)
T KOG1006|consen  209 LCDFGICGQLVD---SIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS-----VFEQLC  280 (361)
T ss_pred             eecccchHhHHH---HHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH-----HHHHHH
Confidence            999999876432   223456688899999999864  3489999999999999999999999976432     111111


Q ss_pred             hcc-cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYV-SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ... .+...+       .....+.+.+..+..+|..||..|-..||...++.+
T Consensus       281 ~Vv~gdpp~l-------~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~  326 (361)
T KOG1006|consen  281 QVVIGDPPIL-------LFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK  326 (361)
T ss_pred             HHHcCCCCee-------cCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence            111 111111       011123456778999999999999999999998775

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.1e-33  Score=261.14  Aligned_cols=239  Identities=34%  Similarity=0.458  Sum_probs=192.4

Q ss_pred             CceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-HHHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEE
Q 043568           99 GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLV  177 (453)
Q Consensus        99 ~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv  177 (453)
                      +||.||+|++.           .++..+|+|++....... .+.+.+|+..+++++|+||+++++++.....    .+++
T Consensus         1 ~~g~v~~~~~~-----------~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----~~l~   65 (244)
T smart00220        1 SFGKVYLARDK-----------KTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDK----LYLV   65 (244)
T ss_pred             CceEEEEEEEC-----------CCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCE----EEEE
Confidence            58999999975           346789999987655444 6789999999999999999999999987643    7999


Q ss_pred             EEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCC
Q 043568          178 YELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE  257 (453)
Q Consensus       178 ~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~  257 (453)
                      +||+++++|.+++....  .+++..++.++.+++.+|.+||+.   +++|+||+|.||+++.++.++|+|||.+......
T Consensus        66 ~e~~~~~~L~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~  140 (244)
T smart00220       66 MEYCDGGDLFDLLKKRG--RLSEDEARFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPG  140 (244)
T ss_pred             EeCCCCCCHHHHHHhcc--CCCHHHHHHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccc
Confidence            99999999999987653  388899999999999999999998   9999999999999999999999999999875532


Q ss_pred             CCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCC
Q 043568          258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDP  337 (453)
Q Consensus       258 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  337 (453)
                      .   ......++..|++||.+....++.++||||||+++++|++|..||....  ....+.+.........         
T Consensus       141 ~---~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~--~~~~~~~~~~~~~~~~---------  206 (244)
T smart00220      141 G---LLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDD--QLLELFKKIGKPKPPF---------  206 (244)
T ss_pred             c---ccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC--cHHHHHHHHhccCCCC---------
Confidence            1   2345668899999999988889999999999999999999999986531  1112222211100000         


Q ss_pred             cCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          338 RLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       338 ~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         .......+..+.+++.+||..+|.+||++.++++
T Consensus       207 ---~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~  240 (244)
T smart00220      207 ---PPPEWKISPEAKDLIRKLLVKDPEKRLTAEEALQ  240 (244)
T ss_pred             ---ccccccCCHHHHHHHHHHccCCchhccCHHHHhh
Confidence               0000004567999999999999999999999985

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.7e-34  Score=297.15  Aligned_cols=271  Identities=18%  Similarity=0.220  Sum_probs=169.2

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...++||+|+||.||+|++....       ...+..||||++.....  .+.+..|  .++...+.+++.++..+
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~-------~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~  198 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQ-------SKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGF  198 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCc-------cccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhh
Confidence            5788999999999999999999986210       02267899998764321  1222222  12222233333332221


Q ss_pred             eec-c-cccceEEEEEEecCCCChHHhhhcCCCC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          165 AED-D-ERGMQRLLVYELMHNKSLEDHLLSRVPT------------------PLAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       165 ~~~-~-~~~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      ... . ......+|||||+.+++|.+++......                  ......+..++.||+.||.|||+.   +
T Consensus       199 ~~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---g  275 (566)
T PLN03225        199 LEPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---G  275 (566)
T ss_pred             hcccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---C
Confidence            110 0 1122479999999999999988754210                  011233557899999999999998   9


Q ss_pred             eEeeccccccEEEcC-CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC----------------------
Q 043568          225 LIFRDFKTSNILLDE-DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG----------------------  281 (453)
Q Consensus       225 iiH~Dlkp~NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------  281 (453)
                      |+||||||+|||++. ++.+||+|||+|+...... ........+|+.|+|||.+...                      
T Consensus       276 IiHRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~-~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~  354 (566)
T PLN03225        276 IVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI-NYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQL  354 (566)
T ss_pred             EEeCcCCHHHEEEeCCCCcEEEEeCCCcccccccc-ccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccc
Confidence            999999999999986 6899999999998643221 2233456789999999965422                      


Q ss_pred             CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCc----c--chHHHHHHHHHH
Q 043568          282 RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGN----Y--CIKSAQKLAALA  355 (453)
Q Consensus       282 ~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~~l~~li  355 (453)
                      .++.++|||||||+||||+++..++....    ..+.........+...+.....+.....    +  .........+|+
T Consensus       355 ~~~~k~DVwSlGviL~el~~~~~~~~~~~----~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi  430 (566)
T PLN03225        355 NLPDRFDIYSAGLIFLQMAFPNLRSDSNL----IQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELL  430 (566)
T ss_pred             cCCCCcccHHHHHHHHHHHhCcCCCchHH----HHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHH
Confidence            23456799999999999999766543211    1111000000000000000011110000    0  001123456899


Q ss_pred             HHhhccCCCCCCCHHHHHH
Q 043568          356 SKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       356 ~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+||+.||++|||+.++++
T Consensus       431 ~~mL~~dP~kR~ta~e~L~  449 (566)
T PLN03225        431 KSMMRFKGRQRISAKAALA  449 (566)
T ss_pred             HHHccCCcccCCCHHHHhC
Confidence            9999999999999999986

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=2e-33  Score=284.95  Aligned_cols=274  Identities=19%  Similarity=0.259  Sum_probs=184.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCC-----CcCCCCCCeeEEEEEeccCCcccHHH--------------HHHHH
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDH-----QTSGHDSKLDVAIKQLNRQGFQGHKE--------------WINEV  146 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~-----~~~~~~~~~~vavK~l~~~~~~~~~~--------------~~~E~  146 (453)
                      .++|...++||+|+||+||+|.+...+...     .......+..||||++........++              +..|+
T Consensus       144 ~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~  223 (507)
T PLN03224        144 SDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEA  223 (507)
T ss_pred             ccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHH
Confidence            678999999999999999999864322110     01122345679999986543322223              34577


Q ss_pred             HHhccCCCCce-----eeEeeeeeecccc----cceEEEEEEecCCCChHHhhhcCCC----------------------
Q 043568          147 NFLGVVKHPNL-----VKLVGYCAEDDER----GMQRLLVYELMHNKSLEDHLLSRVP----------------------  195 (453)
Q Consensus       147 ~~l~~l~h~nI-----v~l~~~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~----------------------  195 (453)
                      .++.+++|.++     ++++++|......    ....+|||||+++++|.++|+....                      
T Consensus       224 ~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~  303 (507)
T PLN03224        224 YMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQ  303 (507)
T ss_pred             HHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhccc
Confidence            77777766554     7788887653211    1236999999999999999875311                      


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCc
Q 043568          196 TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAP  275 (453)
Q Consensus       196 ~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aP  275 (453)
                      ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....... ........+|+.|+||
T Consensus       304 ~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~-~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        304 DKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGI-NFNPLYGMLDPRYSPP  379 (507)
T ss_pred             ccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEEECCCCcEEEEeCcCccccccCC-ccCccccCCCcceeCh
Confidence            1346777889999999999999998   99999999999999999999999999997643221 1111223457899999


Q ss_pred             cccccCC--------------------C--CCchhHHHHHHHHHHHHhCCc-cccCCCChhh------HHHHHhhhhccc
Q 043568          276 EYVQTGR--------------------L--TAKSDVWSFGVVLYELITGRR-AVERNLPRNE------QKLLEWVRPYVS  326 (453)
Q Consensus       276 E~~~~~~--------------------~--~~~~DV~SlGvil~elltg~~-p~~~~~~~~~------~~~~~~~~~~~~  326 (453)
                      |.+....                    +  ..+.||||+|||+|+|++|.. |+........      ..+..|. ..  
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r-~~--  456 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWR-MY--  456 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHH-hh--
Confidence            9875322                    1  134799999999999999875 5542211110      0111111 00  


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCC---CCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQP---KSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp---~~RPs~~ei~~  374 (453)
                              .............+....+|+.+||..+|   .+|+|+.|+++
T Consensus       457 --------~~~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~  499 (507)
T PLN03224        457 --------KGQKYDFSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS  499 (507)
T ss_pred             --------cccCCCcccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence                    00011111122345778999999999766   68999999875

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-33  Score=285.83  Aligned_cols=244  Identities=30%  Similarity=0.434  Sum_probs=181.2

Q ss_pred             CCccceecCCCceE-EEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeeeee
Q 043568           89 FSRALLIGEGGFGC-VYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYCAE  166 (453)
Q Consensus        89 f~~~~~lG~G~~g~-Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~  166 (453)
                      |...+++|.|+.|+ ||+|..             .++.||||++-..   ......+|+..|+.- .|||||++++.-.+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~y-------------e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d  574 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVY-------------EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQD  574 (903)
T ss_pred             eccHHHcccCCCCcEEEEEee-------------CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccC
Confidence            44556789999876 499985             4679999987432   223456899999988 79999999765444


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC-CC-CCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---C-
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV-PT-PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---D-  240 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~-~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~-  240 (453)
                      ..    ..||+.|.| ..+|.+++.... .. .......+.++.|++.||++||+.   +||||||||+||||+.   + 
T Consensus       575 ~q----F~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~  646 (903)
T KOG1027|consen  575 RQ----FLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADG  646 (903)
T ss_pred             Cc----eEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCc
Confidence            43    379999999 789999998741 11 111134567889999999999997   9999999999999975   3 


Q ss_pred             -CcEEEeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhC-CccccCCCChhhHHH
Q 043568          241 -YKAKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-RRAVERNLPRNEQKL  317 (453)
Q Consensus       241 -~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg-~~p~~~~~~~~~~~~  317 (453)
                       ..++|+|||+++........ .......||.+|+|||++....-+.++||||||||+|..++| .+||......+. .+
T Consensus       647 ~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~-NI  725 (903)
T KOG1027|consen  647 TLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA-NI  725 (903)
T ss_pred             ceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh-hh
Confidence             46899999999986644322 224567899999999999998889999999999999999996 889976432211 11


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                      +       .....+..     +..  ..++  +..+||.+|++++|..||++.+|+
T Consensus       726 l-------~~~~~L~~-----L~~--~~d~--eA~dLI~~ml~~dP~~RPsa~~VL  765 (903)
T KOG1027|consen  726 L-------TGNYTLVH-----LEP--LPDC--EAKDLISRMLNPDPQLRPSATDVL  765 (903)
T ss_pred             h-------cCccceee-----ecc--CchH--HHHHHHHHhcCCCcccCCCHHHHh
Confidence            1       00011100     000  0111  688999999999999999999997

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.9e-33  Score=270.52  Aligned_cols=244  Identities=26%  Similarity=0.328  Sum_probs=188.9

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      -|..++.||-|+||.|.++.-.           ++...||.|.|.+.+.-   .......|-.||..-+.+-||+||-.|
T Consensus       630 mFvkik~iGvGAFGeV~Lv~Kv-----------DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF  698 (1034)
T KOG0608|consen  630 MFVKIKTIGVGAFGEVCLVRKV-----------DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF  698 (1034)
T ss_pred             ceEEEeeecccccceeEEEeec-----------chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe
Confidence            3777888999999999998754           44678999999766432   234466799999999999999999888


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    +|+||+|++||++-.+|.+.  .-|.+..+.-++.+++.|+++.|..   |+|||||||+|||||.+|++|
T Consensus       699 QDkdn----LYFVMdYIPGGDmMSLLIrm--gIFeE~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIK  769 (1034)
T KOG0608|consen  699 QDKDN----LYFVMDYIPGGDMMSLLIRM--GIFEEDLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIK  769 (1034)
T ss_pred             ccCCc----eEEEEeccCCccHHHHHHHh--ccCHHHHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCcee
Confidence            88776    89999999999999999876  5677777777788999999999998   999999999999999999999


Q ss_pred             EeccccccCCCC--------CCCCc--------------------------------cccccccCcCCCCccccccCCCC
Q 043568          245 LSDFGLARQGPP--------EGLGH--------------------------------VSTSVVGTVGYAAPEYVQTGRLT  284 (453)
Q Consensus       245 L~DFGla~~~~~--------~~~~~--------------------------------~~~~~~gt~~y~aPE~~~~~~~~  284 (453)
                      |+||||++-+.-        .+...                                .....+||+.|+|||++....|+
T Consensus       770 LTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~  849 (1034)
T KOG0608|consen  770 LTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYT  849 (1034)
T ss_pred             eeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCcc
Confidence            999999963211        00000                                01134799999999999999999


Q ss_pred             CchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCC
Q 043568          285 AKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQP  363 (453)
Q Consensus       285 ~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  363 (453)
                      ..+|.||.|||||||+.|+.||-...+.+.+. ++.|-           ..    +.-.++.+.+.+..+||.++. .++
T Consensus       850 q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~-----------~~----l~~~~~~~ls~e~~~li~kLc-~sa  913 (1034)
T KOG0608|consen  850 QLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWR-----------NF----LHIPYQGNLSKEALDLIQKLC-CSA  913 (1034)
T ss_pred             ccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehh-----------hc----cccccccccCHHHHHHHHHHh-cCh
Confidence            99999999999999999999998776655432 22221           11    122344455666777775543 345


Q ss_pred             CCCC
Q 043568          364 KSRP  367 (453)
Q Consensus       364 ~~RP  367 (453)
                      +.|.
T Consensus       914 d~RL  917 (1034)
T KOG0608|consen  914 DSRL  917 (1034)
T ss_pred             hhhh
Confidence            5564

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-33  Score=253.46  Aligned_cols=245  Identities=23%  Similarity=0.367  Sum_probs=192.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccH---HHHHHHHHHhccC-CCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~---~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      .++|...++||+|+|++|-.+.++           .+.+.+|+|++++.-..+.   .=.+.|-.+..+. +||.+|-+.
T Consensus       249 l~df~ll~vigrgsyakvl~~~~~-----------~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglh  317 (593)
T KOG0695|consen  249 LQDFDLLRVIGRGSYAKVLLVRLK-----------KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLH  317 (593)
T ss_pred             cccceeeeeecCcchhhhhheehc-----------ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehh
Confidence            578999999999999999999876           4567899999976543322   2234566666655 799999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      .++.....    +++|.||++||+|--++..+  ..+++..+.-+...|+.||.|||+.   |||+||||..|+|||..|
T Consensus       318 scfqtesr----lffvieyv~ggdlmfhmqrq--rklpeeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeg  388 (593)
T KOG0695|consen  318 SCFQTESR----LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEG  388 (593)
T ss_pred             hhhcccce----EEEEEEEecCcceeeehhhh--hcCcHHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCC
Confidence            99887764    89999999999998888765  5678887777888999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCC-----ChhhHH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL-----PRNEQK  316 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~-----~~~~~~  316 (453)
                      ++||+|+|+++..-.  ......+.+||+.|+|||++++..|...+|.|+|||+++|||.|+.||..-.     ...+..
T Consensus       389 hikltdygmcke~l~--~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy  466 (593)
T KOG0695|consen  389 HIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY  466 (593)
T ss_pred             ceeecccchhhcCCC--CCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH
Confidence            999999999986432  2345678899999999999999999999999999999999999999996422     111222


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  367 (453)
                      +++.+.             ...++  .+...+-....+++.-|+.||.+|.
T Consensus       467 lfqvil-------------ekqir--iprslsvkas~vlkgflnkdp~erl  502 (593)
T KOG0695|consen  467 LFQVIL-------------EKQIR--IPRSLSVKASHVLKGFLNKDPKERL  502 (593)
T ss_pred             HHHHHh-------------hhccc--ccceeehhhHHHHHHhhcCCcHHhc
Confidence            222221             11111  1112234466788899999999995

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.98  E-value=8.4e-34  Score=272.01  Aligned_cols=243  Identities=23%  Similarity=0.321  Sum_probs=197.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++..+.-||-||||.|=+....           .....+|+|.+++...   ...+....|-+||...+.|.||++|-.
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~-----------~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrT  488 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVN-----------SQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRT  488 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEec-----------ccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHH
Confidence            44555667999999999887754           2233588998876543   334557789999999999999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+...    .|+.||-|-||.|...|..+  ..++.....-++..+++|++|||++   +||+|||||+|++|+.+|-+
T Consensus       489 frd~ky----vYmLmEaClGGElWTiLrdR--g~Fdd~tarF~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~  559 (732)
T KOG0614|consen  489 FRDSKY----VYMLMEACLGGELWTILRDR--GSFDDYTARFYVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYL  559 (732)
T ss_pred             hccchh----hhhhHHhhcCchhhhhhhhc--CCcccchhhhhHHHHHHHHHHHHhc---CceeccCChhheeeccCCce
Confidence            887764    68899999999999999887  5777777778889999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||.|||+|+.....   ...-+.+||+.|.|||++.+...+.++|.||||+++||||+|.+||....|.....++-.-. 
T Consensus       560 KLVDFGFAKki~~g---~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGi-  635 (732)
T KOG0614|consen  560 KLVDFGFAKKIGSG---RKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGI-  635 (732)
T ss_pred             EEeehhhHHHhccC---CceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhh-
Confidence            99999999986543   34567899999999999999999999999999999999999999999876655443322110 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK  368 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs  368 (453)
                              .       .-.++...+....+||.+....+|.+|..
T Consensus       636 --------d-------~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG  665 (732)
T KOG0614|consen  636 --------D-------KIEFPRRITKTATDLIKKLCRDNPTERLG  665 (732)
T ss_pred             --------h-------hhhcccccchhHHHHHHHHHhcCcHhhhc
Confidence                    0       01223344667889999999999999976

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.98  E-value=1.3e-32  Score=236.46  Aligned_cols=202  Identities=26%  Similarity=0.346  Sum_probs=164.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-CcccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      +....+..||+|+||.|-+-++.           +++...|+|.+... ..+..++.++|+.+..+. .+|.+|++||..
T Consensus        46 d~L~~i~elGrGayG~vekmrh~-----------~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~  114 (282)
T KOG0984|consen   46 DDLVGIEELGRGAYGVVEKMRHI-----------QSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGAL  114 (282)
T ss_pred             hhhhhhhhhcCCccchhhheeec-----------cCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhh
Confidence            33444557999999999887776           67899999998754 234456778899887655 799999999977


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      .....    .++.||.| ..||+.+...-  .+..+++...-+|+..+..||.|||++.  .+||||+||+||||+.+|+
T Consensus       115 ~regd----vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~Gq  187 (282)
T KOG0984|consen  115 FREGD----VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQ  187 (282)
T ss_pred             hcccc----EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCc
Confidence            76655    69999999 66887765432  2467888888999999999999999984  9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCcccccc----CCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT----GRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                      +|++|||++-...+.   -..+...|-..|||||.+..    ..|+.++||||||+.+.||.+++.||+..
T Consensus       188 VKiCDFGIsG~L~dS---iAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w  255 (282)
T KOG0984|consen  188 VKICDFGISGYLVDS---IAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW  255 (282)
T ss_pred             EEEcccccceeehhh---hHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence            999999999775432   12334678899999998763    46899999999999999999999999764

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.97  E-value=2.9e-30  Score=234.11  Aligned_cols=211  Identities=38%  Similarity=0.603  Sum_probs=181.0

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeeecccccce
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQ  173 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  173 (453)
                      ||+|++|.||++...           ..+..+++|.+...... ....+.+|+..++.+.|++|+++++++.....    
T Consensus         1 l~~g~~~~v~~~~~~-----------~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~----   65 (215)
T cd00180           1 LGEGGFGTVYLARDK-----------KTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENH----   65 (215)
T ss_pred             CCcCCceEEEEEEec-----------CCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCe----
Confidence            689999999999874           34678999998765432 34678999999999999999999999987643    


Q ss_pred             EEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-CCcEEEecccccc
Q 043568          174 RLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKAKLSDFGLAR  252 (453)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~  252 (453)
                      .++++||+.+++|.+++.... ..+++..+..++.+++.+|.+||+.   +++|+||+|.||+++. ++.++|+|||.+.
T Consensus        66 ~~~~~e~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~  141 (215)
T cd00180          66 LYLVMEYCEGGSLKDLLKENE-GKLSEDEILRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSK  141 (215)
T ss_pred             EEEEEecCCCCcHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceE
Confidence            699999999999999987642 4688899999999999999999998   9999999999999999 8999999999998


Q ss_pred             CCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCcccc
Q 043568          253 QGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF  331 (453)
Q Consensus       253 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~  331 (453)
                      .......  ......+...|++||.+... ..+.++|+|++|+++++|                                
T Consensus       142 ~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------  187 (215)
T cd00180         142 LLTSDKS--LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------  187 (215)
T ss_pred             EccCCcc--hhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH--------------------------------
Confidence            6543221  13345678899999999877 888999999999999999                                


Q ss_pred             ccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       332 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                                       ..+.+++..|++.+|.+||++.++++.
T Consensus       188 -----------------~~~~~~l~~~l~~~p~~R~~~~~l~~~  214 (215)
T cd00180         188 -----------------PELKDLIRKMLQKDPEKRPSAKEILEH  214 (215)
T ss_pred             -----------------HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence                             247799999999999999999998764

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=9.3e-33  Score=246.55  Aligned_cols=272  Identities=25%  Similarity=0.341  Sum_probs=199.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC--CcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .+.+..+.||-|+||+||..++.           ++++.||.|++...  +....+.+.+|+.+|..++|.|++..+++.
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDP-----------RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDIL  121 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDP-----------RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDIL  121 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCC-----------CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhc
Confidence            45667789999999999988765           66788999987532  234457788999999999999999998876


Q ss_pred             eeccccc-ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          165 AEDDERG-MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       165 ~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      .-..... ...|.+.|.| ..+|...|-.  +++++-..+.-++.||++||.|||+.   +|.||||||.|.|+++|..+
T Consensus       122 QPph~dfFqEiYV~TELm-QSDLHKIIVS--PQ~Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvL  195 (449)
T KOG0664|consen  122 QPANPSFFQELYVLTELM-QSDLHKIIVS--PQALTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCIL  195 (449)
T ss_pred             CCCCchHHHHHHHHHHHH-Hhhhhheecc--CCCCCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceE
Confidence            6544321 1256778888 6677776654  36676666777889999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||+++....... ...+..+-|..|.|||++++ ..|+.+.||||.|||+.||+..+-.|....|....+++....
T Consensus       196 KICDFGLARvee~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLL  274 (449)
T KOG0664|consen  196 KICDFGLARTWDQRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLL  274 (449)
T ss_pred             Eecccccccccchhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHh
Confidence            9999999997554332 23455677899999999987 469999999999999999999998888777766555443221


Q ss_pred             hc--------ccCccccccccC----CcCCCcc----chHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          323 PY--------VSDSKKFHLIID----PRLEGNY----CIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       323 ~~--------~~~~~~~~~~~~----~~~~~~~----~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      ..        ..++.+.+.+..    |....-+    +.....+...+...++..||.+|.+..+.+..+
T Consensus       275 GTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  275 GTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             CCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence            10        111111111111    1111011    112234566788889999999999988876543

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=3.7e-31  Score=230.84  Aligned_cols=261  Identities=20%  Similarity=0.310  Sum_probs=194.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~  164 (453)
                      .++|++.+++|+|.|+.||.|...           .+++.++||++++.   ..+.+.+|+.||..|. ||||++++++.
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~-----------~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV  102 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINI-----------TNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIV  102 (338)
T ss_pred             cchHHHHHHHcCccHhhHhccccc-----------CCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhh
Confidence            567888999999999999999854           45678999999753   3456789999999996 99999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-CcE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKA  243 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-~~~  243 (453)
                      .++...  .+.||+||+.+.+.....     ..++...+...+.+++.||.|||+.   ||+|||+||.|++||.. -.+
T Consensus       103 ~Dp~Sk--tpaLiFE~v~n~Dfk~ly-----~tl~d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkL  172 (338)
T KOG0668|consen  103 KDPESK--TPSLIFEYVNNTDFKQLY-----PTLTDYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKL  172 (338)
T ss_pred             cCcccc--CchhHhhhhccccHHHHh-----hhhchhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhcee
Confidence            876532  478999999887766533     3456667778899999999999999   99999999999999864 569


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh--
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW--  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~--  320 (453)
                      +|+|+|+|.+..+...   ....+.+..|--||.+.. ..|+..-|+|||||+|..|+..+.||........ +++..  
T Consensus       173 rlIDWGLAEFYHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~D-QLVkIak  248 (338)
T KOG0668|consen  173 RLIDWGLAEFYHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYD-QLVKIAK  248 (338)
T ss_pred             eeeecchHhhcCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHH-HHHHHHH
Confidence            9999999999876543   345566777889998875 5688899999999999999999999976543322 22221  


Q ss_pred             ----------hhhcc-cCccccccccCCcCC--------CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 ----------VRPYV-SDSKKFHLIIDPRLE--------GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ----------~~~~~-~~~~~~~~~~~~~~~--------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                +..+. .-...+..++....+        .....-.+++..+|+.+.|..|-.+|||+.|...
T Consensus       249 VLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~  321 (338)
T KOG0668|consen  249 VLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA  321 (338)
T ss_pred             HhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence                      11110 001111111111000        0001112477899999999999999999998764

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.97  E-value=8.5e-32  Score=265.87  Aligned_cols=254  Identities=26%  Similarity=0.365  Sum_probs=207.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|.....+|.|+||.|||++++           ..+...|||+++.....+..-..+|+-+++..+||||+.++|.+.
T Consensus        14 ~ddyellqrvgsgTygdvyKaRd~-----------~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsyl   82 (829)
T KOG0576|consen   14 QDDYELLQRVGSGTYGDVYKARDK-----------RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYL   82 (829)
T ss_pred             ccchhheeeecCCcccchhhhccc-----------ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhh
Confidence            457888889999999999999987           567789999998777777778889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    ++++||||.+|+|.+..+..  .++++.++..+++...+||+|||+.   +-+|||||-.|||+++.|.+|+
T Consensus        83 r~dk----lwicMEycgggslQdiy~~T--gplselqiayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvkl  153 (829)
T KOG0576|consen   83 RRDK----LWICMEYCGGGSLQDIYHVT--GPLSELQIAYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKL  153 (829)
T ss_pred             hhcC----cEEEEEecCCCcccceeeec--ccchhHHHHHHHhhhhccchhhhcC---CcccccccccceeecccCceee
Confidence            8776    79999999999999965543  6889999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV---QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +|||.+-.+...  -.......||+.|||||+.   +.+.|...+|||++|+...|+--.++|.....+.....+...  
T Consensus       154 aDfgvsaqitat--i~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTk--  229 (829)
T KOG0576|consen  154 ADFGVSAQITAT--IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTK--  229 (829)
T ss_pred             cccCchhhhhhh--hhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhc--
Confidence            999998765432  1234678999999999976   357899999999999999999888888765444332222211  


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..+.         .+.+  .......+.+.++++.|+..+|++|||++.++.
T Consensus       230 S~~q---------pp~l--kDk~kws~~fh~fvK~altknpKkRptaeklL~  270 (829)
T KOG0576|consen  230 SGFQ---------PPTL--KDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ  270 (829)
T ss_pred             cCCC---------CCcc--cCCccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence            1010         0111  112345677999999999999999999988764

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.97  E-value=6.2e-31  Score=255.91  Aligned_cols=197  Identities=25%  Similarity=0.422  Sum_probs=168.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--------cHHHHHHHHHHhccCC---CC
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--------GHKEWINEVNFLGVVK---HP  155 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~---h~  155 (453)
                      .+|.-...+|.|+||.|+.|+++           .....|+||.+.+...-        .....-.|+.||..|+   |+
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K-----------~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~  629 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHK-----------ENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHE  629 (772)
T ss_pred             ccceeeeeccccccceEEEeeec-----------ccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCcc
Confidence            45888889999999999999987           55788999998765321        1122346999999997   99


Q ss_pred             ceeeEeeeeeecccccceEEEEEEec-CCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELM-HNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~-~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      ||++++++|.+++.    ++|+||-- ++-+|.++|..+  ..+++.++.-|+.|++.|+++||+.   +|||||||-+|
T Consensus       630 NIlKlLdfFEddd~----yyl~te~hg~gIDLFd~IE~k--p~m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikden  700 (772)
T KOG1152|consen  630 NILKLLDFFEDDDY----YYLETEVHGEGIDLFDFIEFK--PRMDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDEN  700 (772)
T ss_pred             chhhhhheeecCCe----eEEEecCCCCCcchhhhhhcc--CccchHHHHHHHHHHHhcccccccc---Cceeccccccc
Confidence            99999999998875    78999964 677899999876  6788999999999999999999999   99999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCcccc
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      |.++.+|-+||+|||.|.....    ......+||..|.|||++.+.+| +..-|||++|++||.++....||.
T Consensus       701 vivd~~g~~klidfgsaa~~ks----gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  701 VIVDSNGFVKLIDFGSAAYTKS----GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             EEEecCCeEEEeeccchhhhcC----CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence            9999999999999999876432    23567899999999999998776 466899999999999999988875

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.97  E-value=3.3e-29  Score=230.61  Aligned_cols=200  Identities=33%  Similarity=0.457  Sum_probs=170.6

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      |...+.||.|++|.||+|.+.           ..+..+|+|.+...... ..+.+.+|+..+++++|+|++++++++...
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~-----------~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~   69 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDK-----------GTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP   69 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEc-----------CCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC
Confidence            556788999999999999975           34578999999766544 567889999999999999999999998776


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ..    .++++||+++++|.+++..... .+++.....++.+++.+|.+||+.   +++|+||+|.||+++.++.++|+|
T Consensus        70 ~~----~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d  141 (225)
T smart00221       70 EP----LYLVMEYCEGGDLFDYLRKKGG-KLSEEEARFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLAD  141 (225)
T ss_pred             Cc----eEEEEeccCCCCHHHHHHhccc-CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEee
Confidence            54    6999999999999999876532 278899999999999999999998   999999999999999999999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCcccc-ccCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ||.+........ .......++..|++||.+ ....++.++|||+||+++++|++|+.||..
T Consensus       142 ~g~~~~~~~~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      142 FGLARFIHRDLA-ALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             CceeeEecCccc-ccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence            999987543320 122445678899999998 667788899999999999999999999954

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.9e-30  Score=229.67  Aligned_cols=255  Identities=22%  Similarity=0.386  Sum_probs=190.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      .+.|.+.+.||+|.||.+-++.++           ++++.+|+|.+.+. .....+|.+|...--.| .|.||+.-|++.
T Consensus        23 ~d~y~I~k~lgeG~FgkIlL~eHr-----------~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~va   90 (378)
T KOG1345|consen   23 EDVYTINKQLGEGRFGKILLAEHR-----------QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVA   90 (378)
T ss_pred             hhhhhHHHHhcccceeeEEeeecc-----------CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHH
Confidence            466888889999999999999987           56788999988654 34568899998876666 689999988766


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE-c-CCCc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL-D-EDYK  242 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl-~-~~~~  242 (453)
                      .....   .+++++||++.|+|..-+..   ..+.+..-.+++.|++.||.|+|++   ++||||||.+|||| + +..+
T Consensus        91 Fqt~d---~YvF~qE~aP~gdL~snv~~---~GigE~~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~r  161 (378)
T KOG1345|consen   91 FQTSD---AYVFVQEFAPRGDLRSNVEA---AGIGEANTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYR  161 (378)
T ss_pred             hhcCc---eEEEeeccCccchhhhhcCc---ccccHHHHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccE
Confidence            55444   27899999999999986655   4677777889999999999999999   99999999999999 3 3447


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccC-----CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-----RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      +||+|||+.+..+.     ......-+..|.+||.....     ...+.+|||.||+|+|.+|||..||+.. .......
T Consensus       162 vKlcDFG~t~k~g~-----tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka-~~~d~~Y  235 (378)
T KOG1345|consen  162 VKLCDFGLTRKVGT-----TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKA-SIMDKPY  235 (378)
T ss_pred             EEeeecccccccCc-----eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhh-hccCchH
Confidence            99999999876432     12333456789999976532     2467899999999999999999999843 2233344


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      .+|..-....        .+++...+. ..+..+..+.++-|.++|++|-...++.+.-
T Consensus       236 ~~~~~w~~rk--------~~~~P~~F~-~fs~~a~r~Fkk~lt~~~~drcki~~~kk~r  285 (378)
T KOG1345|consen  236 WEWEQWLKRK--------NPALPKKFN-PFSEKALRLFKKSLTPRFKDRCKIWTAKKMR  285 (378)
T ss_pred             HHHHHHhccc--------CccCchhhc-ccCHHHHHHHHHhcCCcccccchhHHHHHHH
Confidence            4443221111        112221211 2345678899999999999996665555543

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=234.16  Aligned_cols=266  Identities=27%  Similarity=0.332  Sum_probs=195.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC--CcccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..+|.....+|.|.- .|.-|.+.           -.++.||+|++...  .....+...+|+.++..++|+||++++.+
T Consensus        16 ~~Ry~nL~p~~~g~~-~v~~a~D~-----------v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~   83 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQ-IVVAAFDQ-----------VLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNV   83 (369)
T ss_pred             eeeeeeecccCCCCc-eEEecchh-----------hccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeec
Confidence            356777778898887 66666654           34678999987644  23345667899999999999999999998


Q ss_pred             eeeccccc--ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDERG--MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.-.....  ...++||||| ..+|...+.-    .++......|+.|++.|+.|||+.   +|+||||||+||++..+.
T Consensus        84 ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~~----elDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~  155 (369)
T KOG0665|consen   84 FTPQKTLEEFQEVYLVMELM-DANLCQVILM----ELDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDC  155 (369)
T ss_pred             cCccccHHHHHhHHHHHHhh-hhHHHHHHHH----hcchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchh
Confidence            87543221  2368999999 7789888773    466778889999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh-------
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-------  314 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~-------  314 (453)
                      .+||.|||+|+....   ....+..+.|..|.|||++.+..+.+.+||||+|||+.||++|+.-|.+...-+.       
T Consensus       156 ~lKi~dfg~ar~e~~---~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~  232 (369)
T KOG0665|consen  156 TLKILDFGLARTEDT---DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQ  232 (369)
T ss_pred             heeeccchhhcccCc---ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHH
Confidence            999999999987443   2345677889999999999988899999999999999999999988764322111       


Q ss_pred             ---------HHHHHhhhhcccCccc-----ccc-ccCCcCCC--ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          315 ---------QKLLEWVRPYVSDSKK-----FHL-IIDPRLEG--NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       315 ---------~~~~~~~~~~~~~~~~-----~~~-~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               .++...++.+......     +.. +.|.....  +.+......+.+|+.+||..||++|-++.+++.
T Consensus       233 lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~  309 (369)
T KOG0665|consen  233 LGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR  309 (369)
T ss_pred             hcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence                     1111111111111100     000 01111111  111223456889999999999999999998875

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.96  E-value=1e-29  Score=244.64  Aligned_cols=272  Identities=24%  Similarity=0.268  Sum_probs=201.5

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC---
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK---  153 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---  153 (453)
                      +.+.|+.  -.+|.+....|+|-|++|.+|.+.           ..+..||||++... ....+.=++|++||++|+   
T Consensus       424 v~igE~L--D~RY~V~~~~GkGvFs~Vvra~D~-----------~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD  489 (752)
T KOG0670|consen  424 VRIGELL--DSRYEVQGYTGKGVFSTVVRARDQ-----------ARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDAD  489 (752)
T ss_pred             Eehhhhh--cceeEEEeccccceeeeeeecccc-----------CCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccC
Confidence            3445544  467888888999999999999875           33458999999643 334455568999999996   


Q ss_pred             ---CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          154 ---HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       154 ---h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                         --|+++|+-.|.....    +|||+|-+ ..+|.+.|.+.+ ...|....+..++.|+.-||..|-..   +|+|.|
T Consensus       490 ~Edk~Hclrl~r~F~hknH----LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c---~vlHaD  561 (752)
T KOG0670|consen  490 PEDKFHCLRLFRHFKHKNH----LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKC---GVLHAD  561 (752)
T ss_pred             chhhhHHHHHHHHhhhcce----eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhc---Ceeecc
Confidence               2478888877776554    89999988 789999998754 34577778889999999999999987   999999


Q ss_pred             cccccEEEcCC-CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          230 FKTSNILLDED-YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~-~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      |||.|||+++. ..+||||||.|.......    .+...-+..|.|||++.+.+|+...|+||.||.||||.||+..|.+
T Consensus       562 IKPDNiLVNE~k~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG  637 (752)
T KOG0670|consen  562 IKPDNILVNESKNILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPG  637 (752)
T ss_pred             cCccceEeccCcceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCC
Confidence            99999999874 558999999998754322    3344556789999999999999999999999999999999999987


Q ss_pred             CCChhhHHHHHhhhhcccC-----c------------------------cccccccCCcC--------CC-----ccchH
Q 043568          309 NLPRNEQKLLEWVRPYVSD-----S------------------------KKFHLIIDPRL--------EG-----NYCIK  346 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~-----~------------------------~~~~~~~~~~~--------~~-----~~~~~  346 (453)
                      ........+..-+..-++.     +                        .....+.....        .+     .....
T Consensus       638 ~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~  717 (752)
T KOG0670|consen  638 RTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPK  717 (752)
T ss_pred             CCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHH
Confidence            6655554443322111100     0                        00000000000        00     11223


Q ss_pred             HHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          347 SAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       347 ~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....+.+|+..||..||++|.|..+.++
T Consensus       718 ~~~~~rdLLdkml~LdP~KRit~nqAL~  745 (752)
T KOG0670|consen  718 IVQQLRDLLDKMLILDPEKRITVNQALK  745 (752)
T ss_pred             HHHHHHHHHHHHhccChhhcCCHHHHhc
Confidence            4568899999999999999999988764

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.96  E-value=8.2e-29  Score=234.17  Aligned_cols=207  Identities=28%  Similarity=0.425  Sum_probs=166.7

Q ss_pred             HHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeE
Q 043568           82 LKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKL  160 (453)
Q Consensus        82 ~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l  160 (453)
                      +....+.|...++||+|.|++||+|++...        ......||+|.+....  ......+|+++|..+ -+.||+++
T Consensus        31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~--------~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~  100 (418)
T KOG1167|consen   31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQ--------DTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKL  100 (418)
T ss_pred             hhhhhhhhhhhccccccchhhhhhhhHhhh--------ccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcc
Confidence            334467799999999999999999997631        2356789999987654  335678999999999 69999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-  239 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-  239 (453)
                      .+++...+.    .++|+||++.....+++..     ++...+...++.+..||.++|+.   |||||||||+|+|.+. 
T Consensus       101 ~~~~rnnd~----v~ivlp~~~H~~f~~l~~~-----l~~~~i~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~  168 (418)
T KOG1167|consen  101 NGCFRNNDQ----VAIVLPYFEHDRFRDLYRS-----LSLAEIRWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRR  168 (418)
T ss_pred             hhhhccCCe----eEEEecccCccCHHHHHhc-----CCHHHHHHHHHHHHHHhhhhhcc---CccccCCCccccccccc
Confidence            999887775    6999999999998887754     45677888899999999999999   9999999999999974 


Q ss_pred             CCcEEEeccccccC-----------------CCC-C----------------CCC--------ccccccccCcCCCCccc
Q 043568          240 DYKAKLSDFGLARQ-----------------GPP-E----------------GLG--------HVSTSVVGTVGYAAPEY  277 (453)
Q Consensus       240 ~~~~kL~DFGla~~-----------------~~~-~----------------~~~--------~~~~~~~gt~~y~aPE~  277 (453)
                      .+.-.|.|||+|..                 ..+ .                +..        .......||++|.|||+
T Consensus       169 t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEv  248 (418)
T KOG1167|consen  169 TQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEV  248 (418)
T ss_pred             cCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHH
Confidence            56789999999871                 000 0                000        00123479999999998


Q ss_pred             ccc-CCCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          278 VQT-GRLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       278 ~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      +.. ...+.++||||.|||++.+++++.||....
T Consensus       249 L~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~  282 (418)
T KOG1167|consen  249 LFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAK  282 (418)
T ss_pred             HhhccCcCCccceeeccceeehhhccccccccCc
Confidence            764 567899999999999999999999997643

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.95  E-value=1.7e-28  Score=266.62  Aligned_cols=200  Identities=18%  Similarity=0.239  Sum_probs=139.8

Q ss_pred             cCCC-CceeeEeeeeeeccccc---ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 043568          151 VVKH-PNLVKLVGYCAEDDERG---MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLI  226 (453)
Q Consensus       151 ~l~h-~nIv~l~~~~~~~~~~~---~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii  226 (453)
                      .++| +||.+++++|......+   ...++++||+ +++|.++|... ...+++..++.++.||+.||.|||++   +|+
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---gIv  102 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP-DRSVDAFECFHVFRQIVEIVNAAHSQ---GIV  102 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc-cccccHHHHHHHHHHHHHHHHHHHhC---Cee
Confidence            4456 68888888873322111   1257788887 77999999753 35689999999999999999999998   999


Q ss_pred             eeccccccEEEcCC-------------------CcEEEeccccccCCCCCCC--------------CccccccccCcCCC
Q 043568          227 FRDFKTSNILLDED-------------------YKAKLSDFGLARQGPPEGL--------------GHVSTSVVGTVGYA  273 (453)
Q Consensus       227 H~Dlkp~NILl~~~-------------------~~~kL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y~  273 (453)
                      ||||||+||||+..                   +.+||+|||+++.......              ........||+.||
T Consensus       103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~  182 (793)
T PLN00181        103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT  182 (793)
T ss_pred             eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence            99999999999654                   4456666666653211000              00011246889999


Q ss_pred             CccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHH
Q 043568          274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA  353 (453)
Q Consensus       274 aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  353 (453)
                      |||++.+..++.++|||||||+||||++|..|+.....    .+......          ...+..     .........
T Consensus       183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~----~~~~~~~~----------~~~~~~-----~~~~~~~~~  243 (793)
T PLN00181        183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSR----TMSSLRHR----------VLPPQI-----LLNWPKEAS  243 (793)
T ss_pred             ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHH----HHHHHHHh----------hcChhh-----hhcCHHHHH
Confidence            99999999999999999999999999998887642110    11110000          000000     011234568


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 043568          354 LASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       354 li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ++.+||..+|.+||++.+|++
T Consensus       244 ~~~~~L~~~P~~Rps~~eil~  264 (793)
T PLN00181        244 FCLWLLHPEPSCRPSMSELLQ  264 (793)
T ss_pred             HHHHhCCCChhhCcChHHHhh
Confidence            889999999999999999975

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.95  E-value=5.3e-27  Score=208.42  Aligned_cols=169  Identities=25%  Similarity=0.282  Sum_probs=128.0

Q ss_pred             CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccc
Q 043568          184 KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS  263 (453)
Q Consensus       184 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  263 (453)
                      |||.+++..+ ..++++..++.++.|++.||.|||+.   +      ||+|||++.++.+|+  ||++......      
T Consensus         1 GsL~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~------   62 (176)
T smart00750        1 VSLADILEVR-GRPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE------   62 (176)
T ss_pred             CcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc------
Confidence            7899999764 35799999999999999999999998   5      999999999999999  9999875432      


Q ss_pred             cccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCcc
Q 043568          264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNY  343 (453)
Q Consensus       264 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  343 (453)
                       ...||+.|+|||++.+..++.++|||||||++|||++|+.||........ .+......... .       .+.. ...
T Consensus        63 -~~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~-~~~~~~~~~~~-~-------~~~~-~~~  131 (176)
T smart00750       63 -QSRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSA-ILEILLNGMPA-D-------DPRD-RSN  131 (176)
T ss_pred             -cCCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcH-HHHHHHHHhcc-C-------Cccc-ccc
Confidence             22689999999999999999999999999999999999999865432111 11111111000 0       0000 001


Q ss_pred             chHHHH--HHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          344 CIKSAQ--KLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       344 ~~~~~~--~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      ......  .+.+++.+||..+|.+||++.++++.+..+..
T Consensus       132 ~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      132 LESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            112233  69999999999999999999999998876654

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=9.9e-25  Score=212.71  Aligned_cols=264  Identities=22%  Similarity=0.252  Sum_probs=199.1

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC----CceeeEeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH----PNLVKLVGY  163 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h----~nIv~l~~~  163 (453)
                      +|.+..+||+|+||.||.+.+...          ....+|+|............+..|+.++..+..    +++..+++.
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~----------~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~   88 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSE----------KNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDH   88 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCC----------CCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEe
Confidence            899999999999999999997521          145789998765433332367788888888863    588888888


Q ss_pred             ee-ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC--
Q 043568          164 CA-EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED--  240 (453)
Q Consensus       164 ~~-~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~--  240 (453)
                      .. ....    .++||+.+ |.+|.++........++..+.+.|+.|++.+|.+||+.   |++||||||+|+++...  
T Consensus        89 G~~~~~~----~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~  160 (322)
T KOG1164|consen   89 GRSTEDF----NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSR  160 (322)
T ss_pred             ccCCCce----eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCC
Confidence            74 3332    58999998 99999977666567899999999999999999999998   99999999999999764  


Q ss_pred             ---CcEEEecccccc--CCCCCCCC---c--c-ccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          241 ---YKAKLSDFGLAR--QGPPEGLG---H--V-STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       241 ---~~~kL~DFGla~--~~~~~~~~---~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                         ..+.|.|||+++  ........   .  . .....||..|+++....+...+.+.|+||++.++.|++.|..||...
T Consensus       161 ~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~  240 (322)
T KOG1164|consen  161 SEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEAL  240 (322)
T ss_pred             cccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccc
Confidence               469999999998  32222111   0  1 23456999999999999999999999999999999999999999654


Q ss_pred             CChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          310 LPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       310 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ....... +........         ...     .....+.++.++...+-..+...+|....+...|.......
T Consensus       241 ~~~~~~~~~~~~~~~~~---------~~~-----~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  241 EMTDLKSKFEKDPRKLL---------TDR-----FGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             cccchHHHHHHHhhhhc---------ccc-----ccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            4322211 111111000         000     22223566777777777899999999999999988877654

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-25  Score=203.11  Aligned_cols=268  Identities=18%  Similarity=0.245  Sum_probs=210.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      .-+|.++++||+|.||+.+.|+.-           -++++||||.-...  ....++..|.+..+.| ..++|...+-|.
T Consensus        27 G~hyrVGkKIGeGsFG~lf~G~Nl-----------~nne~VAIKfEPrk--S~APQLrdEYr~YKlL~g~~GIP~vYYFG   93 (449)
T KOG1165|consen   27 GPHYRVGKKIGEGSFGVLFLGKNL-----------YNNEPVAIKFEPRK--SEAPQLRDEYRTYKLLGGTEGIPQVYYFG   93 (449)
T ss_pred             cccceeccccccCcceeeeccccc-----------ccCceEEEEecccc--CCcchHHHHHHHHHHHcCCCCCCceeeec
Confidence            347999999999999999999865           46889999975433  3445677888888888 468888887655


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC----
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED----  240 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~----  240 (453)
                      ...-.    -.||+|++ |.||+|+ ....+..|+..+++.+|.|++.-++|+|++   .+|.|||||+|+||...    
T Consensus        94 qeG~~----NiLVidLL-GPSLEDL-FD~CgR~FSvKTV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~  164 (449)
T KOG1165|consen   94 QEGKY----NILVIDLL-GPSLEDL-FDLCGRRFSVKTVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKD  164 (449)
T ss_pred             cccch----hhhhhhhh-CcCHHHH-HHHhcCcccHHhHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCC
Confidence            54433    38999999 9999994 455567899999999999999999999999   99999999999999643    


Q ss_pred             -CcEEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          241 -YKAKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       241 -~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                       ..+.|+|||+|+.+.+..+.     .......||..||+-....+...+...|+-|||-+++..|-|..||.+......
T Consensus       165 ~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tn  244 (449)
T KOG1165|consen  165 ANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTN  244 (449)
T ss_pred             CceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcch
Confidence             34899999999976543321     234577899999999999999999999999999999999999999987543333


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      ..-.+.+-          +-.........|...|.++...+.-.-..+-.+-|...-+...+..+++....
T Consensus       245 K~kYeKIG----------e~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~  305 (449)
T KOG1165|consen  245 KEKYEKIG----------ETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGE  305 (449)
T ss_pred             HHHHHHhc----------cccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCC
Confidence            22222221          11111122345667788999999999999999999999999998888887654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.93  E-value=1.2e-25  Score=219.19  Aligned_cols=168  Identities=19%  Similarity=0.136  Sum_probs=128.8

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-----cccHHHHHHHHHHhccCCCCcee
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-----FQGHKEWINEVNFLGVVKHPNLV  158 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~nIv  158 (453)
                      ...++|...+.||+|+||+||+|.+..          .++..||||++....     ......|.+|+++|++++|+||+
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~----------~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv   84 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAG----------DPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVV   84 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcC----------CCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCC
Confidence            346789999999999999999998752          245668999875331     11245688999999999999998


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc-ccccEEE
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF-KTSNILL  237 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl-kp~NILl  237 (453)
                      +.+..+   +    ..+|||||++|++|.. +...     .   ...++.++++||.|||+.   ||+|||| ||+|||+
T Consensus        85 ~~l~~~---~----~~~LVmE~~~G~~L~~-~~~~-----~---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv  145 (365)
T PRK09188         85 PQLLAT---G----KDGLVRGWTEGVPLHL-ARPH-----G---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLM  145 (365)
T ss_pred             cEEEEc---C----CcEEEEEccCCCCHHH-hCcc-----c---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEE
Confidence            533221   1    1599999999999973 2111     1   146788999999999998   9999999 9999999


Q ss_pred             cCCCcEEEeccccccCCCCCCCCcc------ccccccCcCCCCcccccc
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGHV------STSVVGTVGYAAPEYVQT  280 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~  280 (453)
                      +.++.+||+|||+|+.....+....      .+...+++.|+|||++..
T Consensus       146 ~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~  194 (365)
T PRK09188        146 GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP  194 (365)
T ss_pred             cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence            9999999999999987554331111      145678899999999864

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.93  E-value=4.4e-26  Score=203.88  Aligned_cols=248  Identities=23%  Similarity=0.351  Sum_probs=192.5

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      ..+|.+...|..|+|++.             +..+++|+++....  ...++|..|.-.|+-+.||||++++|.|..+..
T Consensus       195 ~tkl~e~hsgelwrgrwq-------------gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppn  261 (448)
T KOG0195|consen  195 ITKLAESHSGELWRGRWQ-------------GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPN  261 (448)
T ss_pred             hhhhccCCCccccccccc-------------CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCC
Confidence            346889999999999986             33578888875443  234678899999999999999999999998764


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                          +.++..||+.|+|+..|+.......+..++.+++.++|+|++|||+. .+-|.---|.+..+++|++.+++|+ .+
T Consensus       262 ----lv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-ma  335 (448)
T KOG0195|consen  262 ----LVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MA  335 (448)
T ss_pred             ----ceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cc
Confidence                79999999999999999988767778889999999999999999997 3445556789999999999998874 12


Q ss_pred             cccCCCCCCCCccccccccCcCCCCccccccCCCC---CchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT---AKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       250 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      -+++      +.......-.+.||+||.+...+-+   .++|+|||++++|||.|...||....+.+-.-.         
T Consensus       336 d~kf------sfqe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmk---------  400 (448)
T KOG0195|consen  336 DTKF------SFQEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMK---------  400 (448)
T ss_pred             ccee------eeeccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhh---------
Confidence            1221      2223344567899999999865533   579999999999999999999976544321110         


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                             +.-..++...++..+..+.+|+.-|++.||.+||.+..|+-.|+++.
T Consensus       401 -------ialeglrv~ippgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  401 -------IALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             -------hhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence                   00111222344556778999999999999999999999999988753

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=3.8e-25  Score=194.76  Aligned_cols=275  Identities=21%  Similarity=0.268  Sum_probs=215.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC-CceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH-PNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~  164 (453)
                      .+.|...++||.|+||.+|.|...           .++..||||+-...  ....++..|..+.+.|++ ..|..+..|.
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i-----------~~ge~VAiK~Es~~--a~hpqL~yEskvY~iL~~g~GiP~i~~y~   80 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISI-----------TSGEEVAIKLESSK--AKHPQLLYESKVYRILQGGVGIPHIRHYG   80 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeec-----------cCCceEEEEeeccc--CCCcchhHHHHHHHHhccCCCCchhhhhc
Confidence            568999999999999999999875           56789999985433  334567789999999965 6677777777


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---CC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DY  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~~  241 (453)
                      .+...    -.+||+.+ |.||++... -....++..+.+.++-|++.-++|+|.+   ++|||||||+|+|+.-   -.
T Consensus        81 ~e~~y----nvlVMdLL-GPsLEdLfn-fC~R~ftmkTvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~  151 (341)
T KOG1163|consen   81 TEKDY----NVLVMDLL-GPSLEDLFN-FCSRRFTMKTVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCN  151 (341)
T ss_pred             ccccc----ceeeeecc-CccHHHHHH-HHhhhhhHHhHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccc
Confidence            66655    38999999 999999553 3345788899999999999999999999   9999999999999964   44


Q ss_pred             cEEEeccccccCCCCCCC-----CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          242 KAKLSDFGLARQGPPEGL-----GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      .+.|+|||+|+.+.+...     ........||..|.+--...+...+...|+-|+|.+|..+.-|..||++.......+
T Consensus       152 kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~Q  231 (341)
T KOG1163|consen  152 KLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQ  231 (341)
T ss_pred             eEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHH
Confidence            589999999987543321     122356789999999888777788899999999999999999999999876655544


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcccCcccCC
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQ  392 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~~~~~~~  392 (453)
                      ..+.+..     .++     .......|...|.++.-.+.-|-...-++-|...-+-+.+.-++..++.+.+-...
T Consensus       232 KyEkI~E-----kK~-----s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iyD  297 (341)
T KOG1163|consen  232 KYEKISE-----KKM-----STPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIYD  297 (341)
T ss_pred             HHHHHHH-----hhc-----CCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEee
Confidence            4433321     111     11122346667889999999999999999999999999998888887766554433

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.91  E-value=1.1e-22  Score=196.63  Aligned_cols=260  Identities=33%  Similarity=0.457  Sum_probs=195.4

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCC-ceeeEeeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHP-NLVKLVGYC  164 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~-nIv~l~~~~  164 (453)
                      |.....||.|+||.||++.+.              ..+++|.+......   ....|.+|+.+++.+.|+ +|+++++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~--------------~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~   67 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR--------------KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFF   67 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec--------------cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEE
Confidence            566778999999999999863              56899998765433   367799999999999988 799999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-c
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-K  242 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-~  242 (453)
                      .....    .+++++|+.+++|.+++..... ..+.......++.|++.++.|+|+.   +++||||||+||+++..+ .
T Consensus        68 ~~~~~----~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~  140 (384)
T COG0515          68 QDEGS----LYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRV  140 (384)
T ss_pred             ecCCE----EEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCe
Confidence            54432    5899999999999976665422 2678888999999999999999999   999999999999999988 7


Q ss_pred             EEEeccccccCCCCCCCCc----cccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCCCCh-hh
Q 043568          243 AKLSDFGLARQGPPEGLGH----VSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPR-NE  314 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~~~~-~~  314 (453)
                      ++++|||++..........    ......||..|++||.+.+   ..++...|+||+|++++++++|..||...... ..
T Consensus       141 ~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~  220 (384)
T COG0515         141 VKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSAT  220 (384)
T ss_pred             EEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccH
Confidence            9999999998544332221    2467789999999999987   57889999999999999999999997654321 01


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ......+......      .................+.+++..|+..+|..|.+..+....
T Consensus       221 ~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         221 SQTLKIILELPTP------SLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             HHHHHHHHhcCCc------ccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1121111111100      000000000002223578899999999999999999887654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=1.3e-24  Score=225.26  Aligned_cols=259  Identities=20%  Similarity=0.239  Sum_probs=185.8

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEe-ccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l-~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      ....++|.|++|.|+.........      ......+++| . ..... .....+..|+.+-..++|||++..+..+.+.
T Consensus       321 ~~~~~~g~ga~g~~~~~~~~~~~~------~~~~~~~r~~-~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~  393 (601)
T KOG0590|consen  321 KPGRVLGSGAYGSVRIAKRRSDLK------SFPEKEFRVR-VKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEI  393 (601)
T ss_pred             CccceeeecccCceEEEEecCCCc------cchhhhhhcc-cCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhc
Confidence            356689999999887776542211      0111223332 1 11111 1112256788888999999999888877776


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      ...    .-+||||++ +|...+...  ..+....+-.++.|++.|+.|||+.   ||.|||||++|++++.+|.+||+|
T Consensus       394 ~~~----~~~mE~~~~-Dlf~~~~~~--~~~~~~e~~c~fKqL~~Gv~y~h~~---GiahrdlK~enll~~~~g~lki~D  463 (601)
T KOG0590|consen  394 DGI----LQSMEYCPY-DLFSLVMSN--GKLTPLEADCFFKQLLRGVKYLHSM---GLAHRDLKLENLLVTENGILKIID  463 (601)
T ss_pred             ccc----hhhhhcccH-HHHHHHhcc--cccchhhhhHHHHHHHHHHHHHHhc---CceeccCccccEEEecCCceEEee
Confidence            652    334999999 999988775  4567777888999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCCCC--ccccccccCcCCCCccccccCCCCC-chhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          248 FGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       248 FGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      ||.+.........  .......|+..|+|||.+....|.+ ..||||.|+|+..|.+|+.||......+...... .   
T Consensus       464 fg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~-~---  539 (601)
T KOG0590|consen  464 FGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN-N---  539 (601)
T ss_pred             cCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh-c---
Confidence            9999875544333  4566789999999999999988876 5899999999999999999997544332211000 0   


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        ....   .....-........+.....++.+||+.+|.+|.|+++|++
T Consensus       540 --~~~~---~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~  584 (601)
T KOG0590|consen  540 --YSDQ---RNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILN  584 (601)
T ss_pred             --cccc---cccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhh
Confidence              0000   00000001123345678889999999999999999999985

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.89  E-value=3.3e-23  Score=188.33  Aligned_cols=175  Identities=10%  Similarity=0.070  Sum_probs=132.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHH---------HHHHHHHhccCCCCc
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---------WINEVNFLGVVKHPN  156 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h~n  156 (453)
                      .++|...++||.|+||.||....             ++..+|||++..........         +.+|+..+.++.||+
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~-------------~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~G   96 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDT-------------DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEG   96 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEec-------------CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCC
Confidence            68899999999999999998643             24469999997543322222         679999999999999


Q ss_pred             eeeEeeeeeecccc----cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          157 LVKLVGYCAEDDER----GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       157 Iv~l~~~~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      |..+.+++......    ....+|||||++|.+|.++..      ++.    ....+++.+|..||..   |++|||+||
T Consensus        97 I~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp  163 (232)
T PRK10359         97 LASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE------ISE----DVKAKIKASIESLHQH---GMVSGDPHK  163 (232)
T ss_pred             CCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh------ccH----HHHHHHHHHHHHHHHc---CCccCCCCh
Confidence            99999886654311    123689999999999988631      222    3456899999999999   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT  301 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt  301 (453)
                      +||+++.++ ++|+|||...........              .-++....+..++|+||||+.+.-+..
T Consensus       164 ~Nili~~~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~~  217 (232)
T PRK10359        164 GNFIVSKNG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYKK  217 (232)
T ss_pred             HHEEEeCCC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHHH
Confidence            999999988 999999988764321100              013344556789999999998876643

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.88  E-value=1.2e-22  Score=201.74  Aligned_cols=218  Identities=25%  Similarity=0.407  Sum_probs=165.8

Q ss_pred             hccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce-Ee
Q 043568          149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQL-IF  227 (453)
Q Consensus       149 l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i-iH  227 (453)
                      |+.+.|.|+.+++|.+.+...    .++|.+||..|+|.|.+... ...+++.....++++|+.||.|||+.   +| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~----~~~i~~~c~rGsl~D~i~~~-~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPE----MIVIWEYCSRGSLLDILSNE-DIKLDYFFILSFIRDISKGLAYLHNS---PIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecCCc----eEEEEeeecCccHHhHHhcc-ccCccHHHHHHHHHHHHHHHHHHhcC---cceee
Confidence            467899999999999998843    79999999999999988873 56889999999999999999999987   44 99


Q ss_pred             eccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-------CCCCchhHHHHHHHHHHHH
Q 043568          228 RDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-------RLTAKSDVWSFGVVLYELI  300 (453)
Q Consensus       228 ~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DV~SlGvil~ell  300 (453)
                      +.|++.|+++|..+.+||+|||+.................-..-|.|||.++..       ..+.++||||||++++|++
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~  152 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEIL  152 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHH
Confidence            999999999999999999999998775321111112233345679999998763       1467899999999999999


Q ss_pred             hCCccccCCCChh-hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          301 TGRRAVERNLPRN-EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       301 tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      +...||....... ...++..+..      .....+.|.+....  ...+++..++..||..+|.+||++..|-..++.+
T Consensus       153 ~r~~~~~~~~~~~~~~eii~~~~~------~~~~~~rP~i~~~~--e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~  224 (484)
T KOG1023|consen  153 FRSGPFDLRNLVEDPDEIILRVKK------GGSNPFRPSIELLN--ELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTI  224 (484)
T ss_pred             hccCccccccccCChHHHHHHHHh------cCCCCcCcchhhhh--hcchHHHHHHHHhcccChhhCccHHHHHhhhhhh
Confidence            9999997633221 1233333222      01111222222111  3345799999999999999999999999888777


Q ss_pred             Hhh
Q 043568          380 ISE  382 (453)
Q Consensus       380 ~~~  382 (453)
                      ...
T Consensus       225 ~~~  227 (484)
T KOG1023|consen  225 NKG  227 (484)
T ss_pred             ccc
Confidence            764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.88  E-value=1.9e-22  Score=181.00  Aligned_cols=139  Identities=17%  Similarity=0.131  Sum_probs=106.0

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--c-------HHH-----------------HHHH
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--G-------HKE-----------------WINE  145 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~-------~~~-----------------~~~E  145 (453)
                      ...||+|+||.||+|.+.            +++.||||+++.....  .       ...                 ...|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------------~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   69 (190)
T cd05147           2 NGCISTGKEANVYHATTA------------NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKE   69 (190)
T ss_pred             CCccccccceEEEEEECC------------CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHH
Confidence            357999999999999853            4678999998654211  1       111                 2349


Q ss_pred             HHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCc
Q 043568          146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYL-HEEMDFQ  224 (453)
Q Consensus       146 ~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~  224 (453)
                      +.++.++.++++.....+... .     .+|||||++++++...+...  .+++....+.++.|++.+|.+| |+.   +
T Consensus        70 ~~~l~~l~~~~v~~p~~~~~~-~-----~~iVmE~i~g~~l~~~~~~~--~~~~~~~~~~i~~qi~~~L~~l~H~~---g  138 (190)
T cd05147          70 MRNLKRLVTAGIPCPEPILLK-S-----HVLVMEFIGDDGWAAPRLKD--APLSESKARELYLQVIQIMRILYQDC---R  138 (190)
T ss_pred             HHHHHHHHHCCCCCCcEEEec-C-----CEEEEEEeCCCCCcchhhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence            999999988776443322211 1     38999999888776543332  4688889999999999999999 677   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccCC
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQG  254 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~  254 (453)
                      |+||||||+|||++ ++.++|+|||+|...
T Consensus       139 iiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147         139 LVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             cccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            99999999999998 578999999999753

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.87  E-value=2.7e-23  Score=216.04  Aligned_cols=246  Identities=23%  Similarity=0.274  Sum_probs=174.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHH---HHHHHhccCCCCceeeEeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWI---NEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~---~E~~~l~~l~h~nIv~l~~~  163 (453)
                      +|...+.||.+.|=+|.+|+++             ...|+||++-+.. .-....|.   .|++ ....+|||.+++.-.
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~-------------eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~   89 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDR-------------EGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKV   89 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCC-------------CceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHH
Confidence            5666778999999999999864             2349999986654 23334444   4555 455689999998766


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      -.....    .|||-+|. .-+|+|.|..+  .-+...+..-|+-|++.||..+|..   ||+|||||.+||||++-+-+
T Consensus        90 ~~t~kA----AylvRqyv-khnLyDRlSTR--PFL~~iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~  159 (1431)
T KOG1240|consen   90 LVTDKA----AYLVRQYV-KHNLYDRLSTR--PFLVLIEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWL  159 (1431)
T ss_pred             HHhhHH----HHHHHHHH-hhhhhhhhccc--hHHHHHHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechh
Confidence            444332    47788888 66899998876  4466667778899999999999999   99999999999999999999


Q ss_pred             EEeccccccC--CCCCCCCc---cccccccCcCCCCccccccC----------C-CCCchhHHHHHHHHHHHHh-CCccc
Q 043568          244 KLSDFGLARQ--GPPEGLGH---VSTSVVGTVGYAAPEYVQTG----------R-LTAKSDVWSFGVVLYELIT-GRRAV  306 (453)
Q Consensus       244 kL~DFGla~~--~~~~~~~~---~~~~~~gt~~y~aPE~~~~~----------~-~~~~~DV~SlGvil~ellt-g~~p~  306 (453)
                      .|+||...+.  .+..+...   ...+...-.+|+|||.+...          . .+++.||||+||+++||++ |+++|
T Consensus       160 ~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF  239 (1431)
T KOG1240|consen  160 YLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLF  239 (1431)
T ss_pred             hhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcc
Confidence            9999987653  22222211   22233445689999987541          2 6789999999999999998 56666


Q ss_pred             cCCCChhhHHHHHhhhhcccC-ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          307 ERNLPRNEQKLLEWVRPYVSD-SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ...      ++..+-.....+ ...++.+-|            ..+++|+..|++.||.+|.++++.++.
T Consensus       240 ~LS------QL~aYr~~~~~~~e~~Le~Ied------------~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  240 TLS------QLLAYRSGNADDPEQLLEKIED------------VSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             cHH------HHHhHhccCccCHHHHHHhCcC------------ccHHHHHHHHHccCchhccCHHHHHHh
Confidence            421      222211110000 001111111            248899999999999999999999875

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.87  E-value=2.3e-22  Score=188.21  Aligned_cols=238  Identities=24%  Similarity=0.328  Sum_probs=154.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCC---------
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKH---------  154 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h---------  154 (453)
                      ..+.....||.|+++.||.+++.           ++++++|||+.....   ....+++.+|......+.+         
T Consensus        12 r~l~~~~~i~~g~~~~v~~v~d~-----------~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~   80 (288)
T PF14531_consen   12 RTLVRGRIIGKGGFSIVFEVTDV-----------ETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYR   80 (288)
T ss_dssp             EEEEEEEEEEEETTEEEEEEEET-----------TTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHH
T ss_pred             eEEEEccccccCCceEEEEEEEc-----------cCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHH
Confidence            34566779999999999999986           668999999976443   2345677777766666433         


Q ss_pred             -CceeeEeeeeeeccc----------ccc---eEEEEEEecCCCChHHhhh---cCCC--CCCCHHHHHHHHHHHHHHHH
Q 043568          155 -PNLVKLVGYCAEDDE----------RGM---QRLLVYELMHNKSLEDHLL---SRVP--TPLAWIARLKIAQDAARGLA  215 (453)
Q Consensus       155 -~nIv~l~~~~~~~~~----------~~~---~~~lv~e~~~~gsL~~~l~---~~~~--~~l~~~~~~~i~~~ia~~L~  215 (453)
                       -.++..++.......          ...   ..+++|+-+ .++|.+.+.   ....  ..+....++.+..|+++.++
T Consensus        81 ~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA  159 (288)
T PF14531_consen   81 HLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVA  159 (288)
T ss_dssp             HH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHH
T ss_pred             hceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHH
Confidence             123333333322110          000   247788887 778887754   2222  23445567788899999999


Q ss_pred             HHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc--------CCCCCch
Q 043568          216 YLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT--------GRLTAKS  287 (453)
Q Consensus       216 ~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~  287 (453)
                      +||+.   |++|+||+|+|+|++.+|.++|+||+.......     .......+..|.|||....        -.++.+.
T Consensus       160 ~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~-----~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~  231 (288)
T PF14531_consen  160 NLHSY---GLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGT-----RYRCSEFPVAFTPPELESCAGQFGQNNAPYTFAT  231 (288)
T ss_dssp             HHHHT---TEEEST-SGGGEEE-TTS-EEE--GGGEEETTE-----EEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHH
T ss_pred             HHhhc---ceEecccceeeEEEcCCCCEEEcChHHHeecCc-----eeeccCCCcccCChhhhhhhcccCcccceeeecc
Confidence            99999   999999999999999999999999998766332     1111445688999997644        2478899


Q ss_pred             hHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCC
Q 043568          288 DVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR  366 (453)
Q Consensus       288 DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R  366 (453)
                      |.|+||+++|.|.+|+.||....+...            ...          .-..|.+.++.+..||..+|+.||.+|
T Consensus       232 DaW~LG~~ly~lWC~~lPf~~~~~~~~------------~~~----------~f~~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  232 DAWQLGITLYSLWCGRLPFGLSSPEAD------------PEW----------DFSRCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHHHHHHHHHHSS-STCCCGGGST------------SGG----------GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred             CHHHHHHHHHHHHHccCCCCCCCcccc------------ccc----------cchhcCCcCHHHHHHHHHHccCCcccC
Confidence            999999999999999999975422110            000          112244778999999999999999987

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.86  E-value=2.7e-21  Score=173.93  Aligned_cols=140  Identities=17%  Similarity=0.127  Sum_probs=108.3

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---------------------c-----HHHHHHH
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---------------------G-----HKEWINE  145 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---------------------~-----~~~~~~E  145 (453)
                      ...||+|+||.||+|.+.            ++..||||+++.....                     .     ...+..|
T Consensus         2 ~~~ig~G~~~~Vy~a~~~------------~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E   69 (190)
T cd05145           2 NGCISTGKEANVYHARTG------------DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKE   69 (190)
T ss_pred             CceeecCCCcEEEEEEcC------------CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHH
Confidence            457999999999999853            4678999998754211                     0     1123578


Q ss_pred             HHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCc
Q 043568          146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQ  224 (453)
Q Consensus       146 ~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~  224 (453)
                      ...+.++.|++|.....+....      .+|||||++++++.......  ..++......++.+++.+|.+||+ .   |
T Consensus        70 ~~~l~~l~~~~i~~p~~~~~~~------~~lVmE~~~g~~~~~~~l~~--~~~~~~~~~~i~~~l~~~l~~lH~~~---g  138 (190)
T cd05145          70 FRNLKRLYEAGVPVPEPILLKK------NVLVMEFIGDDGSPAPRLKD--VPLEEEEAEELYEQVVEQMRRLYQEA---G  138 (190)
T ss_pred             HHHHHHHHhCCCCCceEEEecC------CEEEEEEecCCCchhhhhhh--ccCCHHHHHHHHHHHHHHHHHHHHhC---C
Confidence            9999999999875444333221      38999999888654432222  456777889999999999999999 7   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccCCC
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGP  255 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~  255 (453)
                      |+||||||+|||++ ++.++|+|||++....
T Consensus       139 ivHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         139 LVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            99999999999999 8999999999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.86  E-value=7.6e-21  Score=169.34  Aligned_cols=187  Identities=18%  Similarity=0.138  Sum_probs=138.8

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc----cHHHHHHHHHHhccCC-CCceeeEeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ----GHKEWINEVNFLGVVK-HPNLVKLVGY  163 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~----~~~~~~~E~~~l~~l~-h~nIv~l~~~  163 (453)
                      +.....|++|+||+||.+.             ..+..++.+.+.....-    ....|.+|+++|++|. |++|++++++
T Consensus         4 ~~~~~~l~~~~f~~v~~~~-------------~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~   70 (218)
T PRK12274          4 PAVNEPLKSDTFGRILLVR-------------GGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW   70 (218)
T ss_pred             cccceeecCCCcceEEEee-------------cCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE
Confidence            3456789999999999665             34567887777644321    1225789999999995 5889999886


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc-ccccEEEcCCCc
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF-KTSNILLDEDYK  242 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl-kp~NILl~~~~~  242 (453)
                      .   .     .+++|||+.|.+|...+..         ....++.+++.+|.++|..   ||+|||| ||+|||++.++.
T Consensus        71 ~---~-----~~lvmeyI~G~~L~~~~~~---------~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~  130 (218)
T PRK12274         71 D---G-----RHLDRSYLAGAAMYQRPPR---------GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGS  130 (218)
T ss_pred             c---C-----EEEEEeeecCccHHhhhhh---------hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCC
Confidence            1   1     4899999999998764321         1135678999999999999   9999999 799999999999


Q ss_pred             EEEeccccccCCCCCCCC----c---c----ccccccCcCCCCccccccC-CCC-CchhHHHHHHHHHHHHhCCccccC
Q 043568          243 AKLSDFGLARQGPPEGLG----H---V----STSVVGTVGYAAPEYVQTG-RLT-AKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~----~---~----~~~~~gt~~y~aPE~~~~~-~~~-~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ++|+|||++.........    .   .    ......++.|++|+...-- ..+ ...+.++-|.-+|.++|++.+...
T Consensus       131 i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~  209 (218)
T PRK12274        131 PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE  209 (218)
T ss_pred             EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence            999999999865543210    0   0    1123467888888754321 233 567999999999999999987643

>PRK10345 hypothetical protein; Provisional

Probab=99.86  E-value=6.2e-21  Score=172.89  Aligned_cols=142  Identities=16%  Similarity=0.194  Sum_probs=109.0

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-----CCCceeeEeee
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-----KHPNLVKLVGY  163 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-----~h~nIv~l~~~  163 (453)
                      .....+||+|+||.||.  +.           .++. .+||++........+.+.+|+.+++.+     .||||++++|+
T Consensus         4 L~~~~~LG~G~~~~Vy~--hp-----------~~~~-k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~   69 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYA--HP-----------EDAQ-RCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGT   69 (210)
T ss_pred             cCCcceecCCCceEEEE--CC-----------CCcC-eEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEE
Confidence            34556899999999995  43           2233 479988765445567899999999999     57999999999


Q ss_pred             eeecccccceEEEEEEe--cCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEeeccccccEEEcC-
Q 043568          164 CAEDDERGMQRLLVYEL--MHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL-AYLHEEMDFQLIFRDFKTSNILLDE-  239 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~--~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L-~~LH~~~~~~iiH~Dlkp~NILl~~-  239 (453)
                      +.++...+..+.+|+||  +.++||.+++...   .++..  ..++.+++.++ .|||++   +|+||||||+|||++. 
T Consensus        70 ~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~---~~~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~  141 (210)
T PRK10345         70 VETDCGTGYVYDVIADFDGKPSITLTEFAEQC---RYEED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRI  141 (210)
T ss_pred             EEeCCCCeEEEEEEecCCCCcchhHHHHHHcc---cccHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEecc
Confidence            98875433334478999  5579999999653   34444  35577888777 999999   9999999999999974 


Q ss_pred             ---CCcEEEecccccc
Q 043568          240 ---DYKAKLSDFGLAR  252 (453)
Q Consensus       240 ---~~~~kL~DFGla~  252 (453)
                         ++.++|+||+.+.
T Consensus       142 ~~~~~~~~LiDg~G~~  157 (210)
T PRK10345        142 SESEVIPVVCDNIGES  157 (210)
T ss_pred             CCCCCcEEEEECCCCc
Confidence               3479999955443

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.8e-21  Score=181.64  Aligned_cols=201  Identities=22%  Similarity=0.308  Sum_probs=142.2

Q ss_pred             CCCceeeEeeeeeecc-----------------------cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHH
Q 043568          153 KHPNLVKLVGYCAEDD-----------------------ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD  209 (453)
Q Consensus       153 ~h~nIv~l~~~~~~~~-----------------------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  209 (453)
                      .|||||+++++|.+.-                       ..+..+|+||.-+ ..||..++..+   ..+.....-|+.|
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~---~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTR---HRSYRTGRVILAQ  349 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcC---CCchHHHHHHHHH
Confidence            5999999999887642                       1134589999877 67999999876   3455566778899


Q ss_pred             HHHHHHHHHhCCCCceEeeccccccEEE--cCCC--cEEEeccccccCCCCCCC----CccccccccCcCCCCccccccC
Q 043568          210 AARGLAYLHEEMDFQLIFRDFKTSNILL--DEDY--KAKLSDFGLARQGPPEGL----GHVSTSVVGTVGYAAPEYVQTG  281 (453)
Q Consensus       210 ia~~L~~LH~~~~~~iiH~Dlkp~NILl--~~~~--~~kL~DFGla~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~  281 (453)
                      +++|+.|||++   ||.|||+|++|||+  |+|+  .+.|+|||++-.....+.    ........|...-||||+....
T Consensus       350 lLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~  426 (598)
T KOG4158|consen  350 LLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV  426 (598)
T ss_pred             HHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence            99999999999   99999999999998  4444  378999998754222111    1122345788899999998643


Q ss_pred             C------CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHH
Q 043568          282 R------LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALA  355 (453)
Q Consensus       282 ~------~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  355 (453)
                      +      --.|+|.|+.|.+.||+++...||......   .+         +.....+-.-    ...+..++..+.+|+
T Consensus       427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem---~L---------~~r~Yqe~qL----Palp~~vpp~~rqlV  490 (598)
T KOG4158|consen  427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEM---LL---------DTRTYQESQL----PALPSRVPPVARQLV  490 (598)
T ss_pred             CCCceeeccchhhhhhhhhhHHHHhccCCcccccchh---ee---------chhhhhhhhC----CCCcccCChHHHHHH
Confidence            2      125899999999999999999999762110   00         0000111011    123445677899999


Q ss_pred             HHhhccCCCCCCCHHHHHHHH
Q 043568          356 SKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       356 ~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      ...|+.||.+||+..-....|
T Consensus       491 ~~lL~r~pskRvsp~iAANvl  511 (598)
T KOG4158|consen  491 FDLLKRDPSKRVSPNIAANVL  511 (598)
T ss_pred             HHHhcCCccccCCccHHHhHH
Confidence            999999999999865444333

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.84  E-value=7.9e-22  Score=195.97  Aligned_cols=229  Identities=26%  Similarity=0.371  Sum_probs=176.4

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCC-CCceeeEeeeeeecccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVK-HPNLVKLVGYCAEDDER  170 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  170 (453)
                      ++|+|+||.|++..-        ..+.+.+..+|.|++.+....  .......|..++..++ ||.++++.-.+..+.. 
T Consensus         1 vlg~g~~gkvfLvrk--------~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~k-   71 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRK--------AGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGK-   71 (612)
T ss_pred             CCCcCCCcchHHHHH--------hccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccc-
Confidence            379999999997653        223456778999998755321  1224556888888886 9999999877666554 


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                         .+++++|..||.|...+...  ..+...........++-+++++|+.   +|+|||+|++||+++.+|++++.|||+
T Consensus        72 ---l~l~ld~~rgg~lft~l~~~--~~f~~~~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfgl  143 (612)
T KOG0603|consen   72 ---LYLILDFLRGGDLFTRLSKE--VMFDELDVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGL  143 (612)
T ss_pred             ---hhHhhhhcccchhhhccccC--CchHHHHHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchh
Confidence               78999999999999888765  3455555566677899999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccc
Q 043568          251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK  330 (453)
Q Consensus       251 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ++..-..      ...+||..|||||++.  ....++|.||||++++||+||..||..    +....+            
T Consensus       144 ske~v~~------~~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~I------------  199 (612)
T KOG0603|consen  144 SKEAVKE------KIACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRI------------  199 (612)
T ss_pred             hhHhHhh------hhcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHH------------
Confidence            9875432      1228999999999998  567889999999999999999999975    111111            


Q ss_pred             cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                            +......+......+.+++..++..+|.+|.-.
T Consensus       200 ------l~~~~~~p~~l~~~a~~~~~~l~~r~p~nrLg~  232 (612)
T KOG0603|consen  200 ------LKAELEMPRELSAEARSLFRQLFKRNPENRLGA  232 (612)
T ss_pred             ------hhhccCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence                  011123344567778899999999999999655

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=1.5e-19  Score=191.49  Aligned_cols=251  Identities=18%  Similarity=0.193  Sum_probs=176.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC---CCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK---HPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~  161 (453)
                      ....|.+.+.||+|+||.||+|...            ++..||+|+=+....   -+|.-=..++.+|+   -+-|+++.
T Consensus       696 ~~~~~~I~~e~G~g~y~~vy~a~~~------------~~~~~alK~e~P~~~---WEfYI~~q~~~RLk~~~~~~~~~~~  760 (974)
T KOG1166|consen  696 GGEKFCISKEIGEGSYGSVYVATHS------------NGKLVALKVEKPPNP---WEFYICLQVMERLKPQMLPSIMHIS  760 (974)
T ss_pred             cceeEEEEeeeccccceEEEEeecC------------CCcEEEEEeecCCCc---eeeeehHHHHHhhchhhhcchHHHH
Confidence            3566888889999999999999864            278899998654421   11111123334443   23344444


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc---
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---  238 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~---  238 (453)
                      ..+.-.+.    .+||+||.+.|||.+++...  +.++|.....++.|++..+++||..   +||||||||+|.||.   
T Consensus       761 ~a~~~~~~----S~lv~ey~~~Gtlld~~N~~--~~m~e~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~  831 (974)
T KOG1166|consen  761 SAHVFQNA----SVLVSEYSPYGTLLDLINTN--KVMDEYLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREI  831 (974)
T ss_pred             HHHccCCc----ceeeeeccccccHHHhhccC--CCCCchhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeeccc
Confidence            44443343    48999999999999998843  6789999999999999999999999   999999999999994   


Q ss_pred             ----CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          239 ----EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       239 ----~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                          ...-++|+|||.+-.+..-..........+|-.+-.+|...+.+++...|.|.|+.+++-||.|+..=        
T Consensus       832 ~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q--------  903 (974)
T KOG1166|consen  832 CADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME--------  903 (974)
T ss_pred             CCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH--------
Confidence                23448999999997654333333456678899999999999999999999999999999999997421        


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                                ..++..+  .++..++....   -+...+++..+|+.|-..=|...++...|+.++.+
T Consensus       904 ----------~~~g~~~--~~~~~~~Ry~~---~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~  956 (974)
T KOG1166|consen  904 ----------VKNGSSW--MVKTNFPRYWK---RDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAE  956 (974)
T ss_pred             ----------hcCCcce--eccccchhhhh---HHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHH
Confidence                      0111111  11111111111   12345677778875555557777777777776654

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.80  E-value=1.1e-20  Score=184.52  Aligned_cols=172  Identities=27%  Similarity=0.384  Sum_probs=129.2

Q ss_pred             eEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                      .++|.|++|...+|.+||.++. ....++...+.++.|++.|+.|   +   +.+|+|+||.||++..+..+||+|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhe
Confidence            3789999999999999997543 4457788889999999999999   5   9999999999999999999999999998


Q ss_pred             cCCCCCC----CCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhccc
Q 043568          252 RQGPPEG----LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       252 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      .......    .....+..+||..||+||++.+..|+.++||||||+||+|++. =..+++..      ..         
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~------~t---------  468 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI------AT---------  468 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH------Hh---------
Confidence            8654332    1223456789999999999999999999999999999999998 23222211      11         


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS  370 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  370 (453)
                          +..+-+..+...+..+. ++-..|+.+++.+.|.+||++.
T Consensus       469 ----~~d~r~g~ip~~~~~d~-p~e~~ll~~lls~~p~~RP~~~  507 (516)
T KOG1033|consen  469 ----LTDIRDGIIPPEFLQDY-PEEYTLLQQLLSPSPEERPSAI  507 (516)
T ss_pred             ----hhhhhcCCCChHHhhcC-cHHHHHHHHhcCCCcccCchHH
Confidence                11111111111111111 1235799999999999999443

>smart00090 RIO RIO-like kinase

Probab=99.80  E-value=2.6e-19  Score=166.09  Aligned_cols=142  Identities=18%  Similarity=0.143  Sum_probs=109.5

Q ss_pred             CCCccceecCCCceEEEEEE-EeecCCCCCcCCCCCCeeEEEEEeccCCcc------------------------cHHHH
Q 043568           88 GFSRALLIGEGGFGCVYRGV-VRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------------------------GHKEW  142 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~-~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------------------------~~~~~  142 (453)
                      .|...+.||+|+||.||+|+ +.           .++..||||.+......                        ....+
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~-----------~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   97 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFD-----------GSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWA   97 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecC-----------CCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHH
Confidence            47788899999999999998 32           35788999998643210                        01235


Q ss_pred             HHHHHHhccCCCC--ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 043568          143 INEVNFLGVVKHP--NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEE  220 (453)
Q Consensus       143 ~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~  220 (453)
                      .+|+.++.++.+.  .+.+++++   ..     .+|||||+++++|...+...  ..+.......++.|++.+|.+||+.
T Consensus        98 ~~E~~~L~~L~~~~i~~p~~~~~---~~-----~~lV~E~~~g~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~LH~~  167 (237)
T smart00090       98 EKEFRNLQRLYEAGVPVPKPIAW---RR-----NVLVMEFIGGDGLPAPRLKD--VEPEEEEEFELYDDILEEMRKLYKE  167 (237)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEe---cC-----ceEEEEEecCCccccccccc--CCcchHHHHHHHHHHHHHHHHHHhc
Confidence            6899999999753  34455543   11     38999999998887655332  3455556778999999999999999


Q ss_pred             CCCc-eEeeccccccEEEcCCCcEEEeccccccCC
Q 043568          221 MDFQ-LIFRDFKTSNILLDEDYKAKLSDFGLARQG  254 (453)
Q Consensus       221 ~~~~-iiH~Dlkp~NILl~~~~~~kL~DFGla~~~  254 (453)
                         + |+||||||+||+++ ++.++|+|||.+...
T Consensus       168 ---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      168 ---GELVHGDLSEYNILVH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             ---CCEEeCCCChhhEEEE-CCCEEEEEChhhhcc
Confidence               8 99999999999999 889999999998763

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.79  E-value=7.8e-19  Score=160.68  Aligned_cols=134  Identities=23%  Similarity=0.325  Sum_probs=109.6

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc--------HHHHHHHHHHhccCCCCceeeEeeee
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--------HKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +.||+|++|.||+|.+.             +..+++|+........        ...+.+|+.++..+.|+||.....++
T Consensus         2 ~~l~~G~~~~vy~~~~~-------------~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~   68 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFL-------------GIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYF   68 (211)
T ss_pred             cccccCceEEEEEEeeC-------------CCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEE
Confidence            47999999999999853             4568999865432211        23577899999999999987766666


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .+++|||++|++|.+++....     . .+..++.+++.+|.+||+.   +++|||++|.|||++ ++.++
T Consensus        69 ~~~~~----~~lv~e~~~G~~L~~~~~~~~-----~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~  134 (211)
T PRK14879         69 VDPEN----FIIVMEYIEGEPLKDLINSNG-----M-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIY  134 (211)
T ss_pred             EeCCC----CEEEEEEeCCcCHHHHHHhcc-----H-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEE
Confidence            55443    589999999999999886531     1 7788999999999999998   999999999999999 78899


Q ss_pred             EeccccccC
Q 043568          245 LSDFGLARQ  253 (453)
Q Consensus       245 L~DFGla~~  253 (453)
                      |+|||++..
T Consensus       135 liDf~~a~~  143 (211)
T PRK14879        135 LIDFGLAEF  143 (211)
T ss_pred             EEECCcccC
Confidence            999998865

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.79  E-value=2e-19  Score=187.36  Aligned_cols=210  Identities=26%  Similarity=0.420  Sum_probs=146.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|..++.|..|+||.||..+++           ...+.+|+|. +++.           .|++     ||..+-|   
T Consensus        82 e~df~~IklisngAygavylvrh~-----------~trqrfa~ki-Nkq~-----------lilR-----nilt~a~---  130 (1205)
T KOG0606|consen   82 ESDFNTIKLISNGAYGAVYLVRHK-----------ETRQRFAMKI-NKQN-----------LILR-----NILTFAG---  130 (1205)
T ss_pred             ccccceeEeeccCCCCceeeeecc-----------ccccchhhcc-cccc-----------hhhh-----ccccccC---
Confidence            578999999999999999999876           4466788843 3322           1111     1222211   


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                       .      .+.|      |+-...+..-.  +++.        +.+.+++|||+.   +|+|||+||+|.||+.-|++|+
T Consensus       131 -n------pfvv------gDc~tllk~~g--~lPv--------dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKl  184 (1205)
T KOG0606|consen  131 -N------PFVV------GDCATLLKNIG--PLPV--------DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKL  184 (1205)
T ss_pred             -C------ccee------chhhhhcccCC--CCcc--------hhhHHhHhhccC---CeecCCCCCCcceeeecccccc
Confidence             1      1233      33333343332  2321        227789999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCc-------------cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          246 SDFGLARQGPPEGLGH-------------VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~-------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      +|||+++.........             ....++||+.|.|||++....|...+|.|++|+|+||.+-|..||++..+.
T Consensus       185 TDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe  264 (1205)
T KOG0606|consen  185 TDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE  264 (1205)
T ss_pred             cchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence            9999987532211111             123468999999999999999999999999999999999999999987665


Q ss_pred             hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC
Q 043568          313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP  367 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP  367 (453)
                      +....+      +.+...+.         +.....+.+.++++.+.|..+|..|-
T Consensus       265 elfg~v------isd~i~wp---------E~dea~p~Ea~dli~~LL~qnp~~Rl  304 (1205)
T KOG0606|consen  265 ELFGQV------ISDDIEWP---------EEDEALPPEAQDLIEQLLRQNPLCRL  304 (1205)
T ss_pred             HHHhhh------hhhhcccc---------ccCcCCCHHHHHHHHHHHHhChHhhc
Confidence            432221      11111111         11223457899999999999999994

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.78  E-value=1e-18  Score=158.41  Aligned_cols=131  Identities=26%  Similarity=0.398  Sum_probs=103.4

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--------cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--------GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .||+|+||.||+|.+.             +..+++|........        ....+.+|++++..+.|+++.....++.
T Consensus         1 ~ig~G~~~~vy~~~~~-------------~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~   67 (199)
T TIGR03724         1 LIAKGAEAIIYLGDFL-------------GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDV   67 (199)
T ss_pred             CCCCCceEEEEEeecC-------------CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEE
Confidence            4899999999999843             457999986543211        1255778999999998887554444444


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||++|++|.+++.....         .++.+++.+|.+||+.   +++|||++|.||+++ ++.+++
T Consensus        68 ~~~~----~~lv~e~~~g~~l~~~~~~~~~---------~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~l  130 (199)
T TIGR03724        68 DPDN----KTIVMEYIEGKPLKDVIEEGND---------ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYL  130 (199)
T ss_pred             ECCC----CEEEEEEECCccHHHHHhhcHH---------HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEE
Confidence            4332    4899999999999998755311         7789999999999998   999999999999999 899999


Q ss_pred             eccccccCC
Q 043568          246 SDFGLARQG  254 (453)
Q Consensus       246 ~DFGla~~~  254 (453)
                      +|||++...
T Consensus       131 iDfg~a~~~  139 (199)
T TIGR03724       131 IDFGLGKYS  139 (199)
T ss_pred             EECCCCcCC
Confidence            999998763

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.78  E-value=1.2e-18  Score=181.26  Aligned_cols=140  Identities=24%  Similarity=0.339  Sum_probs=110.6

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--------ccHHHHHHHHHHhccCCC
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--------QGHKEWINEVNFLGVVKH  154 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h  154 (453)
                      ......|...++||+|+||+||+|.+..             ..+++|+......        .....+.+|+++++.++|
T Consensus       329 ~~~~~~~~~~~~iG~G~~g~Vy~~~~~~-------------~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~  395 (535)
T PRK09605        329 EEVKRRKIPDHLIGKGAEADIKKGEYLG-------------RDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARR  395 (535)
T ss_pred             cccccccCccceeccCCcEEEEEEeecC-------------ccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcc
Confidence            3345556778899999999999998642             2344443221111        112468899999999999


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      ++|+....++.....    .++||||+++++|.+++.          ....++.+++.+|.+||+.   +++||||||+|
T Consensus       396 ~~i~~p~~~~~~~~~----~~lv~E~~~g~~L~~~l~----------~~~~~~~~i~~~L~~lH~~---giiHrDlkp~N  458 (535)
T PRK09605        396 AGVPTPVIYDVDPEE----KTIVMEYIGGKDLKDVLE----------GNPELVRKVGEIVAKLHKA---GIVHGDLTTSN  458 (535)
T ss_pred             cCCCeeEEEEEeCCC----CEEEEEecCCCcHHHHHH----------HHHHHHHHHHHHHHHHHhC---CCccCCCChHH
Confidence            999888777766443    589999999999999875          3467899999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeccccccC
Q 043568          235 ILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~  253 (453)
                      ||+ .++.++|+|||+++.
T Consensus       459 ILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        459 FIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEE-ECCcEEEEeCccccc
Confidence            999 678899999999976

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.77  E-value=3.5e-18  Score=154.82  Aligned_cols=144  Identities=17%  Similarity=0.107  Sum_probs=109.1

Q ss_pred             HHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--c--------------------c
Q 043568           81 ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--Q--------------------G  138 (453)
Q Consensus        81 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~--------------------~  138 (453)
                      ++......|...+.||+|+||.||+|...            ++..||||++.....  .                    .
T Consensus         9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~------------~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   76 (198)
T cd05144           9 TLVKRGVVESLGNQIGVGKESDVYLALDP------------DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLS   76 (198)
T ss_pred             HHHHcCchhhcCCccccCcceEEEEEEcC------------CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHh
Confidence            44444444777889999999999999852            467899998754320  0                    0


Q ss_pred             HHHHHHHHHHhccCCCC--ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 043568          139 HKEWINEVNFLGVVKHP--NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAY  216 (453)
Q Consensus       139 ~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~  216 (453)
                      ...+..|+.++..+.|+  .++..++.    ..    .++||||+++++|......        .....++.+++.++.+
T Consensus        77 ~~~~~~E~~~l~~l~~~~i~v~~~~~~----~~----~~lv~e~~~g~~L~~~~~~--------~~~~~~~~~i~~~l~~  140 (198)
T cd05144          77 RLAAQKEFAALKALYEEGFPVPKPIDW----NR----HAVVMEYIDGVELYRVRVL--------EDPEEVLDEILEEIVK  140 (198)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCceeec----CC----ceEEEEEeCCcchhhcccc--------ccHHHHHHHHHHHHHH
Confidence            12356789999999877  44444432    11    4899999999999775431        2345788999999999


Q ss_pred             HHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCC
Q 043568          217 LHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP  255 (453)
Q Consensus       217 LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~  255 (453)
                      +|+.   +|+||||||+||+++.++.++|+|||++....
T Consensus       141 lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         141 AYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             HHHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            9998   99999999999999999999999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.71  E-value=8e-17  Score=138.40  Aligned_cols=136  Identities=22%  Similarity=0.207  Sum_probs=111.1

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC--CceeeEeeeeeecc
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH--PNLVKLVGYCAEDD  168 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~  168 (453)
                      ..+.||+|.++.||++...             +..+++|.......  ...+.+|+.+++.+.|  .++++++++....+
T Consensus         2 ~~~~i~~g~~~~v~~~~~~-------------~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~   66 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTK-------------DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDG   66 (155)
T ss_pred             cceecccccccceEEEEec-------------CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCC
Confidence            3467999999999999863             25799999765432  4678899999999976  58899888776543


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecc
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                      .    .+++|||++++.+..+         +......++.+++.+|.+||.....+++|+||+|.||++++.+.++++||
T Consensus        67 ~----~~~v~e~~~g~~~~~~---------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df  133 (155)
T cd05120          67 W----SYLLMEWIEGETLDEV---------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDW  133 (155)
T ss_pred             c----cEEEEEecCCeecccC---------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEec
Confidence            2    6999999988877654         44566778899999999999864457999999999999999899999999


Q ss_pred             ccccCC
Q 043568          249 GLARQG  254 (453)
Q Consensus       249 Gla~~~  254 (453)
                      |.+...
T Consensus       134 ~~~~~~  139 (155)
T cd05120         134 EYAGYG  139 (155)
T ss_pred             ccccCC
Confidence            998763

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=1.7e-16  Score=147.56  Aligned_cols=138  Identities=20%  Similarity=0.220  Sum_probs=105.7

Q ss_pred             ceec-CCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-------------ccHHHHHHHHHHhccCCCCce-
Q 043568           93 LLIG-EGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-------------QGHKEWINEVNFLGVVKHPNL-  157 (453)
Q Consensus        93 ~~lG-~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l~h~nI-  157 (453)
                      .+|| .||.|+||+....             +..++||.+.....             .....+.+|+.++.+|.|++| 
T Consensus        37 ~~lg~~~g~gtv~~v~~~-------------~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~  103 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP-------------GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLP  103 (239)
T ss_pred             ceeecCCCCccEEEEEeC-------------CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCC
Confidence            4688 8999999988742             45799998754221             123457889999999998775 


Q ss_pred             -eeEeeeeeecccccceEEEEEEecCC-CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          158 -VKLVGYCAEDDERGMQRLLVYELMHN-KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       158 -v~l~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                       ++.+++...........++||||++| .+|.+++...   +++..    .+.+++.+|.+||..   ||+||||||.||
T Consensus       104 vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~~---~l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NI  173 (239)
T PRK01723        104 VPRPIAARVVRHGLFYRADILIERIEGARDLVALLQEA---PLSEE----QWQAIGQLIARFHDA---GVYHADLNAHNI  173 (239)
T ss_pred             CceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhcC---CCCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhE
Confidence             77777755443322224699999997 6899887542   34433    357899999999999   999999999999


Q ss_pred             EEcCCCcEEEeccccccC
Q 043568          236 LLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~  253 (453)
                      |++.++.++|+|||.+..
T Consensus       174 Lv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        174 LLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             EEcCCCCEEEEECCCccc
Confidence            999999999999999876

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.67  E-value=3e-16  Score=140.75  Aligned_cols=136  Identities=21%  Similarity=0.165  Sum_probs=95.2

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHH----------------------HHHHH
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEW----------------------INEVN  147 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~----------------------~~E~~  147 (453)
                      .+.||+|+||+||+|.+.            ++..||||++......  ....+                      ..|..
T Consensus         2 ~~~lg~G~~g~Vy~a~~~------------~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~   69 (187)
T cd05119           2 GGPIGTGKEADVYLALDG------------DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFR   69 (187)
T ss_pred             CcccccccceeEEEEECC------------CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHH
Confidence            457999999999999853            3578999998643211  11111                      34566


Q ss_pred             HhccCCCC--ceeeEeeeeeecccccceEEEEEEecCCCChHHh-hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCC
Q 043568          148 FLGVVKHP--NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH-LLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDF  223 (453)
Q Consensus       148 ~l~~l~h~--nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~-l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~  223 (453)
                      .+..+.+.  .+.+.+++.        ..++||||++++++... +...   ... .....++.+++.++.++|. .   
T Consensus        70 ~l~~l~~~~~~~~~~~~~~--------~~~lv~e~~~g~~~~~~~l~~~---~~~-~~~~~~~~~~~~~l~~lh~~~---  134 (187)
T cd05119          70 NLKRLYEAGVPVPKPIDLN--------RHVLVMEFIGGDGIPAPRLKDV---RLL-EDPEELYDQILELMRKLYREA---  134 (187)
T ss_pred             HHHHHHHcCCCCCceEecC--------CCEEEEEEeCCCCccChhhhhh---hhc-ccHHHHHHHHHHHHHHHhhcc---
Confidence            66666433  244444431        14899999998544321 1111   011 4567889999999999999 6   


Q ss_pred             ceEeeccccccEEEcCCCcEEEeccccccCCC
Q 043568          224 QLIFRDFKTSNILLDEDYKAKLSDFGLARQGP  255 (453)
Q Consensus       224 ~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~  255 (453)
                      +|+|+||||+||+++ ++.++|+|||.+....
T Consensus       135 ~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         135 GLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             CcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            999999999999999 9999999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.66  E-value=8.6e-18  Score=174.67  Aligned_cols=256  Identities=23%  Similarity=0.301  Sum_probs=186.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCC-CCceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVK-HPNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~  164 (453)
                      .|...+.||+|+|+.|-......          .....+|+|.+....  .........|..+-..+. |+|++++++..
T Consensus        21 ~~~~~~~ig~gs~~~~~~~~~~~----------~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~   90 (601)
T KOG0590|consen   21 QYKLSRSIGKGSFSSSALASNSR----------DPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPS   90 (601)
T ss_pred             cccccccccccccchhhhhhhcC----------CCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCcc
Confidence            34555569999999997765421          334567777766543  222344445888888886 99999999988


Q ss_pred             eecccccceEEEEEEecCCCChHHhh-hcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEeeccccccEEEcCCC-
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHL-LSRVPTPLAWIARLKIAQDAARGLAYLH-EEMDFQLIFRDFKTSNILLDEDY-  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l-~~~~~~~l~~~~~~~i~~~ia~~L~~LH-~~~~~~iiH~Dlkp~NILl~~~~-  241 (453)
                      .....    .+++++|..++++.+.+ .... ...+....-..+.|+..++.|+| ..   ++.|+||||+|.+++..+ 
T Consensus        91 ~~~~~----~~~~~~~s~g~~~f~~i~~~~~-~~~~~~~~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~  162 (601)
T KOG0590|consen   91 SSPRS----YLLSLSYSDGGSLFSKISHPDS-TGTSSSSASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGS  162 (601)
T ss_pred             CCCcc----cccccCcccccccccccccCCc-cCCCCcchhhhhhhhccCccccCccc---ccccCCCCCccchhccCCC
Confidence            77665    68999999999999988 3332 13444456677899999999999 76   999999999999999999 


Q ss_pred             cEEEeccccccCCCC-CCCCcccccccc-CcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          242 KAKLSDFGLARQGPP-EGLGHVSTSVVG-TVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       242 ~~kL~DFGla~~~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      .++++|||+|..... .+.........| ++.|+|||...+. ...+..|+||.|+++.-+++|..|+........ ...
T Consensus       163 ~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~-~~~  241 (601)
T KOG0590|consen  163 ALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDG-RYS  241 (601)
T ss_pred             cccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccc-cce
Confidence            999999999998776 454555556678 9999999998874 556789999999999999999999875433221 111


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .|..    ....        ..............+++.+++..+|..|.+.+++..
T Consensus       242 ~~~~----~~~~--------~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~  285 (601)
T KOG0590|consen  242 SWKS----NKGR--------FTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKL  285 (601)
T ss_pred             eecc----cccc--------cccCccccCChhhhhcccccccCCchhccccccccc
Confidence            1110    0000        001111223456778899999999999999888753

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.53  E-value=5.2e-14  Score=142.04  Aligned_cols=142  Identities=19%  Similarity=0.156  Sum_probs=97.7

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc--------------------------H------
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--------------------------H------  139 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~--------------------------~------  139 (453)
                      .+.||.|++|.||+|+++            +++.||||+........                          .      
T Consensus       122 ~~plasaSigQVh~A~l~------------~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e  189 (437)
T TIGR01982       122 EKPLAAASIAQVHRARLV------------DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKE  189 (437)
T ss_pred             CcceeeeehhheEEEEec------------CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHH
Confidence            357999999999999974            46789999975431100                          0      


Q ss_pred             --------HHHHHHHHHhccCC----CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHH
Q 043568          140 --------KEWINEVNFLGVVK----HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA  207 (453)
Q Consensus       140 --------~~~~~E~~~l~~l~----h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~  207 (453)
                              -+|.+|+..+.++.    |.+-+.+-.++.+...   ..+|||||++|++|.+...... ...+   +..++
T Consensus       190 ~~~~l~~Eldf~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~---~~vLvmE~i~G~~L~~~~~~~~-~~~~---~~~ia  262 (437)
T TIGR01982       190 FEKTLRRELDLRREAANASELGENFKNDPGVYVPEVYWDRTS---ERVLTMEWIDGIPLSDIAALDE-AGLD---RKALA  262 (437)
T ss_pred             HHHHHHHHHCHHHHHHHHHHHHHhcCCCCCEEeCCEehhhcC---CceEEEEeECCcccccHHHHHh-cCCC---HHHHH
Confidence                    02455666665552    3333333333332221   2589999999999998765321 1222   34566


Q ss_pred             HHHHH-HHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCC
Q 043568          208 QDAAR-GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP  255 (453)
Q Consensus       208 ~~ia~-~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~  255 (453)
                      ..++. .+..+|..   |++|+|+||.||+++.++.++|+|||++...+
T Consensus       263 ~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       263 ENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            66665 47788987   99999999999999999999999999987644

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.52  E-value=2e-14  Score=143.47  Aligned_cols=252  Identities=22%  Similarity=0.250  Sum_probs=183.6

Q ss_pred             cCCCccceecC--CCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           87 RGFSRALLIGE--GGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        87 ~~f~~~~~lG~--G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      ..|.....+|.  |.+|.||.+....         ..+...+|+|.-+...  ......=.+|+...+.+ .|+|.++.+
T Consensus       114 ~~~~~~~~~g~~~g~~~s~~~~~~~~---------~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~  184 (524)
T KOG0601|consen  114 QRFPISSRTGSLPGSKGSVFKSRCTN---------SESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDS  184 (524)
T ss_pred             hhcccccccccCCCCCceeecccCCc---------ccCCcccccccccCCCCCccccccccchhhcccccCccccccccC
Confidence            45777778999  9999999987621         2556789998843222  12223335677777777 599999977


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEeeccccccEEE
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR----GLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~----~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      ..+...+.    .++-.|+| +.+|..+..... ..++....+..+.+...    ||.++|+.   +++|-|+||.||++
T Consensus       185 ~~~e~~~~----lfiqtE~~-~~sl~~~~~~~~-~~~p~~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~  255 (524)
T KOG0601|consen  185 PAWEGSGI----LFIQTELC-GESLQSYCHTPC-NFLPDNLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFT  255 (524)
T ss_pred             cccccCCc----ceeeeccc-cchhHHhhhccc-ccCCchhhhhHHhhhhhcccccccccCCC---cccccccchhheec
Confidence            77776665    68888998 688888877653 23555667777778877    99999998   99999999999999


Q ss_pred             cCC-CcEEEeccccccCCCCCCCCccc---cccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          238 DED-YKAKLSDFGLARQGPPEGLGHVS---TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       238 ~~~-~~~kL~DFGla~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                      ..+ ...+++|||+...+.........   ....|...|++||... +.++...|||++|.++++..++...+.....  
T Consensus       256 ~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~--  332 (524)
T KOG0601|consen  256 TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSVGKN--  332 (524)
T ss_pred             ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccCCCC--
Confidence            999 78999999999877655433222   2336788899999874 5678999999999999999998765432200  


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                     ..+..+-..-+..+++.....++..++..++..+|..|++.+.+..
T Consensus       333 ---------------~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~  378 (524)
T KOG0601|consen  333 ---------------SSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTA  378 (524)
T ss_pred             ---------------CCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence                           1111111112344455555667777999999999999999877653

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.49  E-value=2.2e-14  Score=132.55  Aligned_cols=203  Identities=21%  Similarity=0.265  Sum_probs=140.3

Q ss_pred             hccCCCCceeeEeeeeeeccc-ccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 043568          149 LGVVKHPNLVKLVGYCAEDDE-RGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQL  225 (453)
Q Consensus       149 l~~l~h~nIv~l~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~i  225 (453)
                      |-++.|.|||++..|+.+... ......++.|||+.|+|..+|++.  ....+......+++.||..||.|||+. .|.|
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            445579999999999887554 233468899999999999999853  345677777788999999999999995 7899


Q ss_pred             EeeccccccEEEcCCCcEEEeccccccCCCCCC--CCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCC
Q 043568          226 IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG--LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR  303 (453)
Q Consensus       226 iH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~  303 (453)
                      +|+++....|++..++-+|++--.-........  .........+-++|.+||.-.....+.++|||+||+..+||.-|.
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailE  279 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILE  279 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhe
Confidence            999999999999999988875322111100000  011122345678999999877777888999999999999998876


Q ss_pred             ccccCCCCh-hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          304 RAVERNLPR-NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       304 ~p~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                      .-....... ........+         +..+-+.            .-..++..|++..|..||+|.+++
T Consensus       280 iq~tnseS~~~~ee~ia~~---------i~~len~------------lqr~~i~kcl~~eP~~rp~ar~ll  329 (458)
T KOG1266|consen  280 IQSTNSESKVEVEENIANV---------IIGLENG------------LQRGSITKCLEGEPNGRPDARLLL  329 (458)
T ss_pred             eccCCCcceeehhhhhhhh---------eeeccCc------------cccCcCcccccCCCCCCcchhhhh
Confidence            432111100 000000000         0000011            123578899999999999999875

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.44  E-value=4.2e-13  Score=118.18  Aligned_cols=131  Identities=19%  Similarity=0.144  Sum_probs=94.8

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCcee-eEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLV-KLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~~  170 (453)
                      .+.|+.|.++.||++...             +..|++|....... ....+.+|+.+++.+.+.+++ +++.+..  .. 
T Consensus         3 ~~~l~~G~~~~vy~~~~~-------------~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~-   65 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA-------------NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDP--ET-   65 (170)
T ss_pred             eeecCCcccCceEEEEEC-------------CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeC--CC-
Confidence            356899999999998742             45799998754321 223467899999988655544 4444332  11 


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccccccEEEcCCCcEEEecc
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM--DFQLIFRDFKTSNILLDEDYKAKLSDF  248 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~Dlkp~NILl~~~~~~kL~DF  248 (453)
                         .++||||++|.++.+.  .     .   ....++.+++++|..||+..  ..+++|+|++|.||+++ ++.++++||
T Consensus        66 ---~~lv~e~i~G~~l~~~--~-----~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf  131 (170)
T cd05151          66 ---GVLITEFIEGSELLTE--D-----F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDW  131 (170)
T ss_pred             ---CeEEEEecCCCccccc--c-----c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEec
Confidence               3799999999887653  0     0   11245678999999999872  12369999999999999 678999999


Q ss_pred             ccccC
Q 043568          249 GLARQ  253 (453)
Q Consensus       249 Gla~~  253 (453)
                      |.+..
T Consensus       132 ~~a~~  136 (170)
T cd05151         132 EYAGM  136 (170)
T ss_pred             ccccC
Confidence            98765

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.39  E-value=1.4e-12  Score=133.42  Aligned_cols=148  Identities=14%  Similarity=0.153  Sum_probs=92.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--------------------------c--
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--------------------------G--  138 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--------------------------~--  138 (453)
                      ..|.. +.||.|++|.||+|+++           .+++.||||+..+.-..                          .  
T Consensus       120 ~~fd~-~PlasaSiaQVh~A~l~-----------~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~  187 (537)
T PRK04750        120 DDFDI-KPLASASIAQVHFARLK-----------DNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPR  187 (537)
T ss_pred             HhcCh-hhhcCCCccEEEEEEEC-----------CCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHH
Confidence            34666 68999999999999986           33678999998643100                          0  


Q ss_pred             ------H------HHHHHHHHHhccCC----CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHH
Q 043568          139 ------H------KEWINEVNFLGVVK----HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA  202 (453)
Q Consensus       139 ------~------~~~~~E~~~l~~l~----h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~  202 (453)
                            .      -+|.+|+..+.++.    +.+.+.+-.++.+-..   ..+|||||++|+.|.+.-.-. ....+.. 
T Consensus       188 ~~v~e~~~~l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st---~~VLvmE~i~G~~l~d~~~l~-~~g~d~~-  262 (537)
T PRK04750        188 EVVAEFEKTLHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCS---ETVMVMERMYGIPVSDVAALR-AAGTDMK-  262 (537)
T ss_pred             HHHHHHHHHHHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCC---CceEEEeeecCccHHhHHHHH-hcCCCHH-
Confidence                  0      12445555555552    4444443333333211   258999999999998742111 1112211 


Q ss_pred             HHHHHHHHHH-HHHHHHhCCCCceEeeccccccEEEcCCC----cEEEeccccccCCCC
Q 043568          203 RLKIAQDAAR-GLAYLHEEMDFQLIFRDFKTSNILLDEDY----KAKLSDFGLARQGPP  256 (453)
Q Consensus       203 ~~~i~~~ia~-~L~~LH~~~~~~iiH~Dlkp~NILl~~~~----~~kL~DFGla~~~~~  256 (453)
                        .++...+. -+..+...   |++|+|+||.||+++.++    .+++.|||++...+.
T Consensus       263 --~la~~~v~~~~~Qif~~---GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        263 --LLAERGVEVFFTQVFRD---GFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             --HHHHHHHHHHHHHHHhC---CeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence              11221111 12233445   999999999999999888    999999999976543

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.35  E-value=2.1e-11  Score=119.52  Aligned_cols=282  Identities=15%  Similarity=0.184  Sum_probs=188.3

Q ss_pred             CceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEEE
Q 043568           99 GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY  178 (453)
Q Consensus        99 ~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~  178 (453)
                      .-.+.||+...           .++..|++|+++............-+++++++.|+|||++.+++.........++|||
T Consensus       288 ~~~Ttyk~~s~-----------~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvY  356 (655)
T KOG3741|consen  288 FSITTYKATSN-----------VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVY  356 (655)
T ss_pred             ccceeEeeeec-----------cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEE
Confidence            44678999865           5577899999954333322223345788899999999999999885554445689999


Q ss_pred             EecCC-CChHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          179 ELMHN-KSLEDHLLSRV-------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       179 e~~~~-gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      +|+++ ++|.++-....             +...++...|.++.|++.||.++|+.   |+.-+-|.|.+||++.+.+++
T Consensus       357 DYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIr  433 (655)
T KOG3741|consen  357 DYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIR  433 (655)
T ss_pred             ecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEE
Confidence            99876 68887655432             23467788999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+..|.......+.              .  |.+.   --.+-|.=.||.+++.|.||..--........ .-.+     
T Consensus       434 iS~C~i~Dvl~~d~--------------~--~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~-s~~~-----  488 (655)
T KOG3741|consen  434 ISGCGIMDVLQEDP--------------T--EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQS-SHLT-----  488 (655)
T ss_pred             EecccceeeecCCC--------------C--cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHH-HHHH-----
Confidence            99888776543221              0  1111   12467999999999999999642111110000 0011     


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH-HHhHhhhccc---------------Cc
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL-GNIISEISSQ---------------DE  388 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L-~~~~~~~~~~---------------~~  388 (453)
                                       ......+.++.+++......++++ -++.+++.++ ..+...++..               +.
T Consensus       489 -----------------~I~~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~~~~~ff~vmes~q~~~d~mE~~Ls~emEN  550 (655)
T KOG3741|consen  489 -----------------RITTTYSTDLRNVVEYLESLNFRE-KSIQDLLPMIGSRFFTVMESVQLKTDVMETELSREMEN  550 (655)
T ss_pred             -----------------HhhhhhhHHHHHHHHHHHhcCccc-ccHHHHHHHHHHHHHHHHHhHHHHHHHHHHHHHHHHhc
Confidence                             111234667888998888888887 5777766543 1222111110               00


Q ss_pred             ccC-CCcccccccccCchhhhhhhhhhcCCcchhcccChhhhhhhcccCccc
Q 043568          389 VTL-QPVAEIEDVKEEPEAEAVVESAKQGNSYLKKVFDIRDLVNLRNKSIGK  439 (453)
Q Consensus       389 ~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  439 (453)
                      .+. ........+.+.++.-.-....+.|..+.-++|  +|.+.++.++.|.
T Consensus       551 GRLfRll~Kln~I~dR~e~~~D~~WSesG~~fmi~LF--RDYlFHqvtedg~  600 (655)
T KOG3741|consen  551 GRLFRLLLKLNFIDDRPEYVDDPDWSESGDRFMIKLF--RDYLFHQVTEDGK  600 (655)
T ss_pred             chHHHHHHHHhhhccCcccccCCcchhccceehHHHH--HHhhheEeccCCC
Confidence            010 111222234445555555677888999999999  9999999888886

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.34  E-value=3.9e-11  Score=121.29  Aligned_cols=165  Identities=18%  Similarity=0.227  Sum_probs=121.6

Q ss_pred             CCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCH
Q 043568          121 DSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW  200 (453)
Q Consensus       121 ~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~  200 (453)
                      .++.+|.|...+...........+.+..|+.++||||++++......+.    .|||+|-+  ..|..++.+..     .
T Consensus        35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~----~ylvTErV--~Pl~~~lk~l~-----~  103 (690)
T KOG1243|consen   35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGT----LYLVTERV--RPLETVLKELG-----K  103 (690)
T ss_pred             ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCc----eEEEeecc--ccHHHHHHHhH-----H
Confidence            4566788888765554334456778999999999999999998887764    79999987  45677676542     3


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc
Q 043568          201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT  280 (453)
Q Consensus       201 ~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  280 (453)
                      ....--+.||+.||.|||..+  +++|++|.-+.|+++..|..||++|.++......+.  ......--..|..|+.+..
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~  179 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDP  179 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCc
Confidence            344455789999999999775  999999999999999999999999998765332211  1111122234566665432


Q ss_pred             CCCCCchhHHHHHHHHHHHHhC
Q 043568          281 GRLTAKSDVWSFGVVLYELITG  302 (453)
Q Consensus       281 ~~~~~~~DV~SlGvil~elltg  302 (453)
                      ..  -..|.|-|||+++|++.|
T Consensus       180 s~--~s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  180 SE--WSIDSWGLGCLIEELFNG  199 (690)
T ss_pred             cc--cchhhhhHHHHHHHHhCc
Confidence            22  346999999999999999

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.34  E-value=2e-11  Score=108.90  Aligned_cols=143  Identities=17%  Similarity=0.108  Sum_probs=97.2

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--c-------------------cc-HHHHH----HHH
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--F-------------------QG-HKEWI----NEV  146 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~-------------------~~-~~~~~----~E~  146 (453)
                      ..||.|--+.||.|...+..     .....+..+|||+.+...  .                   .. .+.+.    +|+
T Consensus         3 g~i~~GKEa~V~~~~~~~~~-----~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~   77 (197)
T cd05146           3 GCISTGKESVVLHANGGSNE-----TEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEM   77 (197)
T ss_pred             CccccCcceEEEEEecCccc-----ccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHH
Confidence            46999999999999743110     001135689999974210  0                   01 12233    799


Q ss_pred             HHhccCC--CCceeeEeeeeeecccccceEEEEEEecCCCChHH-hhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCC
Q 043568          147 NFLGVVK--HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARLKIAQDAARGLAYL-HEEMD  222 (453)
Q Consensus       147 ~~l~~l~--h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~-~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~  222 (453)
                      +.|.++.  .-++..++++  . .     -+|||||+.+..+.. .+..   ..++......+..+++.+|..| |..  
T Consensus        78 r~L~rl~~~Gv~vP~pi~~--~-~-----~~lvME~Ig~~~~~~~~Lkd---~~~~~~~~~~i~~~i~~~l~~l~H~~--  144 (197)
T cd05146          78 HNLKRMQKAGIPCPEVVVL--K-K-----HVLVMSFIGDDQVPAPKLKD---AKLNDEEMKNAYYQVLSMMKQLYKEC--  144 (197)
T ss_pred             HHHHHHHHcCCCCCeEEEe--c-C-----CEEEEEEcCCCCccchhhhc---cccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence            9999984  3567777764  1 1     389999996643322 1222   2334445567789999999999 777  


Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccCCC
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP  255 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~  255 (453)
                       +||||||++.|||++ ++.+.|+|||.+....
T Consensus       145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             -CeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence             999999999999997 4679999999887643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.30  E-value=2.4e-12  Score=128.73  Aligned_cols=247  Identities=21%  Similarity=0.182  Sum_probs=171.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHH--HHHHHHHhccC-CCCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE--WINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~--~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      .+.+|..+..||.|.|+.|+....+.          .++..|++|.+.........+  -..|+.+...+ .|.+++..+
T Consensus       263 ~~~df~~v~~i~~~~~~~~~~~~~r~----------~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~  332 (524)
T KOG0601|consen  263 KLTDFGLVSKISDGNFSSVFKVSKRP----------EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN  332 (524)
T ss_pred             ecCCcceeEEccCCccccceeeeecC----------CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC
Confidence            35679999999999999999876431          456679999876543332222  23566666666 588888876


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-  240 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-  240 (453)
                      ..+.....    .++--|||+++++...+..  ...++...++++..|++.++.++|+.   .++|+|+||+||++..+ 
T Consensus       333 ~~W~~~r~----~~ip~e~~~~~s~~l~~~~--~~~~d~~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~  403 (524)
T KOG0601|consen  333 SSWSQLRQ----GYIPLEFCEGGSSSLRSVT--SQMLDEDPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDG  403 (524)
T ss_pred             CCcccccc----ccCchhhhcCcchhhhhHH--HHhcCcchhhhhHHHHHhccccccch---hhhcccccccceeeccch
Confidence            66655543    4788999999998876632  24466667888999999999999998   99999999999999886 


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCC--CccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA--APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      +.-+++|||+.+...-     ........-+++  +|.......+..+.|+||||.-+.+.+++..--...         
T Consensus       404 ~~~~~~~~~~~t~~~~-----~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~---------  469 (524)
T KOG0601|consen  404 FFSKLGDFGCWTRLAF-----SSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG---------  469 (524)
T ss_pred             hhhhccccccccccce-----ecccccccccccccchhhccccccccccccccccccccccccCcccCccc---------
Confidence            7889999999875221     112223333444  555555677889999999999999999986533211         


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                                .....+...... ..+ ....++..+...+...++..||.+.++....
T Consensus       470 ----------~~~~~i~~~~~p-~~~-~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~  515 (524)
T KOG0601|consen  470 ----------VQSLTIRSGDTP-NLP-GLKLQLQVLLKVMINPDRKRRPSAVELSLHS  515 (524)
T ss_pred             ----------ccceeeeccccc-CCC-chHHhhhhhhhhhcCCccccchhhhhhcccc
Confidence                      111111111111 111 1236788889999999999999988776443

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.28  E-value=5.6e-11  Score=102.13  Aligned_cols=143  Identities=22%  Similarity=0.250  Sum_probs=103.1

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--------cHHHHHHHHHHhccCCCCceeeEee
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--------GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ...+|-+|+-+.|+++.+.             ++...||.=....+.        ......+|+++|.++.--.|.-..-
T Consensus        11 ~l~likQGAEArv~~~~~~-------------Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l   77 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS-------------GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRL   77 (229)
T ss_pred             cceeeeccceeeEeeeccC-------------CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceE
Confidence            5568999999999999853             667777763322221        1245678999999886444332222


Q ss_pred             eeeecccccceEEEEEEecCC-CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          163 YCAEDDERGMQRLLVYELMHN-KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      ++.+...    -.|+|||++| .++.+++...............++..|-+.+.-||..   +||||||..+||+|..++
T Consensus        78 ~~~D~~~----~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~n---diiHGDLTTSNill~~~~  150 (229)
T KOG3087|consen   78 IFIDTYG----GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDN---DIIHGDLTTSNILLRSDG  150 (229)
T ss_pred             EEEecCC----CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhC---CeecccccccceEEecCC
Confidence            3433333    2799999976 4888988876544444444467889999999999998   999999999999996554


Q ss_pred             c---EEEeccccccC
Q 043568          242 K---AKLSDFGLARQ  253 (453)
Q Consensus       242 ~---~kL~DFGla~~  253 (453)
                      .   +.++|||++..
T Consensus       151 ~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  151 NQITPILIDFGLSSV  165 (229)
T ss_pred             CcCceEEEeecchhc
Confidence            3   58999999865

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.27  E-value=5.5e-11  Score=102.66  Aligned_cols=131  Identities=23%  Similarity=0.327  Sum_probs=95.5

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc--------HHHHHHHHHHhccCCCCceeeEeeee
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--------HKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++++|+-+.+|.+.+.             +.++++|.=.+.....        .....+|++++.++.--.|.-.+=|.
T Consensus         2 ~~i~~GAEa~i~~~~~~-------------g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~d   68 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL-------------GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYD   68 (204)
T ss_pred             chhhCCcceeEEeeecc-------------CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEE
Confidence            35889999999998653             3456677533332211        23456899999988543333333233


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    ..|+|||++|..|.+.+...         ...++..+-.-+.-||..   ||+||||.++||++..+. +.
T Consensus        69 vD~~~----~~I~me~I~G~~lkd~l~~~---------~~~~~r~vG~~vg~lH~~---givHGDLTtsNiIl~~~~-i~  131 (204)
T COG3642          69 VDPDN----GLIVMEYIEGELLKDALEEA---------RPDLLREVGRLVGKLHKA---GIVHGDLTTSNIILSGGR-IY  131 (204)
T ss_pred             EcCCC----CEEEEEEeCChhHHHHHHhc---------chHHHHHHHHHHHHHHhc---CeecCCCccceEEEeCCc-EE
Confidence            34433    47999999999999888765         245677888888899998   999999999999998765 99


Q ss_pred             EeccccccC
Q 043568          245 LSDFGLARQ  253 (453)
Q Consensus       245 L~DFGla~~  253 (453)
                      ++||||+..
T Consensus       132 ~IDfGLg~~  140 (204)
T COG3642         132 FIDFGLGEF  140 (204)
T ss_pred             EEECCcccc
Confidence            999999976

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=99.27  E-value=3.6e-10  Score=108.46  Aligned_cols=269  Identities=19%  Similarity=0.217  Sum_probs=164.2

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeeeee--
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYCAE--  166 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~--  166 (453)
                      ..+..||+|+-+.+|.--              .....+-|+..........   +.+..|... .||-+..-+.+=..  
T Consensus        14 ~~gr~LgqGgea~ly~l~--------------e~~d~VAKIYh~Pppa~~a---qk~a~la~~p~~p~~~~rvaWPqa~L   76 (637)
T COG4248          14 PPGRPLGQGGEADLYTLG--------------EVRDQVAKIYHAPPPAAQA---QKVAELAATPDAPLLNYRVAWPQATL   76 (637)
T ss_pred             CCCccccCCccceeeecc--------------hhhchhheeecCCCchHHH---HHHHHhccCCCCcchhhhhcccHHHh
Confidence            345679999999999532              1122445666544332222   223344444 56644331111100  


Q ss_pred             -cccccceEEEEEEecCCCC-hHHhhh----cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          167 -DDERGMQRLLVYELMHNKS-LEDHLL----SRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       167 -~~~~~~~~~lv~e~~~~gs-L~~~l~----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                       ....+...-+.|..+.+.- +..++.    ++.-....|...+++++.+|.+.+-||.+   |.+-||++++|+|++++
T Consensus        77 ~G~~~~~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~  153 (637)
T COG4248          77 HGGRRGKVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDD  153 (637)
T ss_pred             hCCCccceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecC
Confidence             1111111456777776542 222222    12234578999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhC-CccccCCC----
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITG-RRAVERNL----  310 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg-~~p~~~~~----  310 (453)
                      +.+.|.|=.......   ........+|...|++||.-.     +..-+...|.|.|||++++++.| ++||.+-.    
T Consensus       154 ~~V~LVdsDsfqi~~---ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~  230 (637)
T COG4248         154 SKVVLVDSDSFQINA---NGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD  230 (637)
T ss_pred             ceEEEEcccceeecc---CCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence            999999854333221   123345668999999999754     34567789999999999999987 88986421    


Q ss_pred             -C-hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhcc--CCCCCCCHHHHHHHHHHhHhhhc
Q 043568          311 -P-RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTK--QPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       311 -~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~--dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                       + ..+..+.....-+   ......-..+......-.-.+..+..|..+|+..  ++.-|||++.++..|..+..++.
T Consensus       231 ap~p~E~~Ia~g~f~y---a~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~~L~  305 (637)
T COG4248         231 APNPLETDIAHGRFAY---ASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQQLK  305 (637)
T ss_pred             CCCcchhhhhcceeee---chhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHHhhh
Confidence             1 1111221111111   1111111111111111223457788999999953  46789999999999988877654

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.25  E-value=9.6e-11  Score=107.63  Aligned_cols=145  Identities=19%  Similarity=0.243  Sum_probs=107.3

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCC--CceeeEeeeeeeccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKH--PNLVKLVGYCAEDDE  169 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~  169 (453)
                      +.||.|..+.||++...            ++..+++|....... .....+.+|+.+++.+.+  .++.+++.+......
T Consensus         4 ~~l~~G~~n~~~~v~~~------------~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~   71 (223)
T cd05154           4 RQLSGGQSNLTYLLTAG------------GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSV   71 (223)
T ss_pred             eecCCCccceEEEEEec------------CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCc
Confidence            46899999999998753            236799998754332 234568899999999965  446777777665431


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM----------------------------  221 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------------  221 (453)
                      .+ ..++||||++|.++.+.+..   ..++......++.+++++|..||+..                            
T Consensus        72 ~~-~~~~v~e~i~G~~l~~~~~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (223)
T cd05154          72 LG-TPFYVMERVDGRVLRDRLLR---PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYD  147 (223)
T ss_pred             cC-CceEEEEEeCCEecCCCCCC---CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHH
Confidence            11 25899999999988875532   24566677777888888888888421                            


Q ss_pred             -------------------------CCceEeeccccccEEEcC--CCcEEEeccccccC
Q 043568          222 -------------------------DFQLIFRDFKTSNILLDE--DYKAKLSDFGLARQ  253 (453)
Q Consensus       222 -------------------------~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~  253 (453)
                                               ...++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         148 ASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             hhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                                     246799999999999998  66789999998875

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.18  E-value=8.7e-12  Score=131.08  Aligned_cols=249  Identities=21%  Similarity=0.225  Sum_probs=161.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .+.|...+-+-.|.++.++.+.-...           +-..++|+....   .....+....+-.++-...+|-++...-
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~s-----------gh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~  871 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGS-----------GHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFP  871 (1205)
T ss_pred             CccceecccccCCCCcccccCCcccc-----------ccccchhhhccchhhccccccccCCccCccccCCCCceecccC
Confidence            45566666788899999987764321           112333332211   1112222223333333334565555443


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      -+.-...    ..|+++|+.+++|...|+...  ..+.......+..+..++++||+.   .+.|+|++|.|+|+..+++
T Consensus       872 s~~~rsP----~~L~~~~~~~~~~~Skl~~~~--~~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~l~~~~gh  942 (1205)
T KOG0606|consen  872 SFPCRSP----LPLVGHYLNGGDLPSKLHNSG--CLSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSLLIAYDGH  942 (1205)
T ss_pred             CCCCCCC----cchhhHHhccCCchhhhhcCC--CcccccccchhHHHHhhhhccccc---hhhcccccccchhhcccCC
Confidence            3222222    689999999999999888753  333333344556788899999997   7999999999999999999


Q ss_pred             EEEeccccccCCCCC----CC-------------------------CccccccccCcCCCCccccccCCCCCchhHHHHH
Q 043568          243 AKLSDFGLARQGPPE----GL-------------------------GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFG  293 (453)
Q Consensus       243 ~kL~DFGla~~~~~~----~~-------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlG  293 (453)
                      .+++|||........    +.                         ........||+.|.+||.+.+......+|.|++|
T Consensus       943 ~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g 1022 (1205)
T KOG0606|consen  943 RPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSG 1022 (1205)
T ss_pred             cccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhh
Confidence            999999833211000    00                         0012245789999999999999999999999999


Q ss_pred             HHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCC-CccchHHHHHHHHHHHHhhccCCCCCCCHH
Q 043568          294 VVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMS  370 (453)
Q Consensus       294 vil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~  370 (453)
                      ++++|.++|.+||....+...   ++             .+....+. ...+...+....+++.+.+..+|.+|-.+.
T Consensus      1023 ~~l~e~l~g~pp~na~tpq~~---f~-------------ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1023 VCLFEVLTGIPPFNAETPQQI---FE-------------NILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             hhhhhhhcCCCCCCCcchhhh---hh-------------ccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc
Confidence            999999999999976544321   11             11111111 112334466788999999999999997765

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.09  E-value=2.8e-09  Score=100.44  Aligned_cols=128  Identities=16%  Similarity=0.101  Sum_probs=91.9

Q ss_pred             CeeEEEEEeccCCcc-----------cHHHHHHHHHHhccCCC--CceeeEeeeeeecccc-cceEEEEEEecCCC-ChH
Q 043568          123 KLDVAIKQLNRQGFQ-----------GHKEWINEVNFLGVVKH--PNLVKLVGYCAEDDER-GMQRLLVYELMHNK-SLE  187 (453)
Q Consensus       123 ~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~~-~~~~~lv~e~~~~g-sL~  187 (453)
                      +..|.||........           ....+.+|...+.+|..  -..+.++++....... ....+||+|++++. +|.
T Consensus        45 g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~  124 (268)
T PRK15123         45 GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLE  124 (268)
T ss_pred             CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHH
Confidence            467999976443311           11147789999888843  3344555565432211 12358999999876 899


Q ss_pred             HhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-------CCcEEEeccccccC
Q 043568          188 DHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-------DYKAKLSDFGLARQ  253 (453)
Q Consensus       188 ~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-------~~~~kL~DFGla~~  253 (453)
                      +++......+.+...+..++.+++..+.-||..   ||+|+|+++.|||++.       ++.+.|+||+.+..
T Consensus       125 ~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        125 DYCADWATNPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            988643234455667778999999999999999   9999999999999975       46799999998854

>PRK09902 hypothetical protein; Provisional

Probab=98.96  E-value=1.8e-08  Score=90.24  Aligned_cols=143  Identities=18%  Similarity=0.115  Sum_probs=106.9

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC------cccHHHHHHHHHHhccCC--CCceeeEeeeeee
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG------FQGHKEWINEVNFLGVVK--HPNLVKLVGYCAE  166 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~------~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~  166 (453)
                      -|+||.+.|++-...             +..+-+|.-...-      ......|.+|+..|.+|.  .-++.++..+...
T Consensus        26 ~~rgG~SgV~r~~~~-------------g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~   92 (216)
T PRK09902         26 YRRNGMSGVQCVERN-------------GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAV   92 (216)
T ss_pred             cCCCCcceEEEEEeC-------------CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeee
Confidence            578999999987643             3368888754111      224577999999999984  3335555533333


Q ss_pred             cccccceEEEEEEecCC-CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc--E
Q 043568          167 DDERGMQRLLVYELMHN-KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK--A  243 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~--~  243 (453)
                      ......+-+||+|-++| -+|.+++....-.+.+...+..++.+++..|.-||..   |+.|+|+.+.|||++.++.  +
T Consensus        93 k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v  169 (216)
T PRK09902         93 KIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEA  169 (216)
T ss_pred             ccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeE
Confidence            33334457899997754 6899988775445667777889999999999999999   9999999999999986667  9


Q ss_pred             EEeccccccC
Q 043568          244 KLSDFGLARQ  253 (453)
Q Consensus       244 kL~DFGla~~  253 (453)
                      +++||.-++.
T Consensus       170 ~lIDlEk~r~  179 (216)
T PRK09902        170 GFLDLEKSRR  179 (216)
T ss_pred             EEEEhhccch
Confidence            9999987764

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.92  E-value=6.7e-09  Score=92.34  Aligned_cols=97  Identities=22%  Similarity=0.260  Sum_probs=62.7

Q ss_pred             HHHHHHHhccCCCC--ceeeEeeeeeecccccceEEEEEEecC--CCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH-
Q 043568          142 WINEVNFLGVVKHP--NLVKLVGYCAEDDERGMQRLLVYELMH--NKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAY-  216 (453)
Q Consensus       142 ~~~E~~~l~~l~h~--nIv~l~~~~~~~~~~~~~~~lv~e~~~--~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~-  216 (453)
                      ..+|.+.|.++..-  ++.+++++.  .      -+|||||++  |..+.. |....   ++......++.+++..+.. 
T Consensus        55 ~~~E~~~L~~l~~~Gv~vP~p~~~~--~------~~ivME~I~~~G~~~~~-l~~~~---~~~~~~~~~~~~il~~~~~~  122 (188)
T PF01163_consen   55 AKKEFRNLKRLYEAGVPVPKPYDYN--R------NVIVMEYIGEDGVPLPR-LKDVD---LSPEEPKELLEEILEEIIKM  122 (188)
T ss_dssp             HHHHHHHHHHCCCTT-SS--EEEEE--T------TEEEEE--EETTEEGGC-HHHCG---GGGSTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCccCCcEEEEe--C------CEEEEEecCCCccchhh-HHhcc---ccchhHHHHHHHHHHHHHHH
Confidence            56899999999755  567776542  2      289999997  544443 33221   1112335567777775555 


Q ss_pred             HHhCCCCceEeeccccccEEEcCCCcEEEeccccccCC
Q 043568          217 LHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG  254 (453)
Q Consensus       217 LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~  254 (453)
                      +|..   ||+||||.+.|||++++ .+.|+|||.+...
T Consensus       123 ~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  123 LHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHCT---TEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             HHhc---CceecCCChhhEEeecc-eEEEEecCcceec
Confidence            4676   99999999999999987 8999999988753

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.90  E-value=2.9e-08  Score=90.27  Aligned_cols=110  Identities=25%  Similarity=0.236  Sum_probs=86.7

Q ss_pred             HHHHHHHHHhccCC--CCceeeEeeeeeecccccceEEEEEEecCCC-ChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 043568          140 KEWINEVNFLGVVK--HPNLVKLVGYCAEDDERGMQRLLVYELMHNK-SLEDHLLSRVPTPLAWIARLKIAQDAARGLAY  216 (453)
Q Consensus       140 ~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~  216 (453)
                      ....+|...+..|.  .-.+.+.+++...........+||+|++++. +|.+++.....  ++......++.+++..+.-
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~--~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ--LDPSQRRELLRALARLIAK  133 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc--cchhhHHHHHHHHHHHHHH
Confidence            45778888888774  3446677777766444334468999999884 89998876422  4555677889999999999


Q ss_pred             HHhCCCCceEeeccccccEEEcCCC---cEEEeccccccCC
Q 043568          217 LHEEMDFQLIFRDFKTSNILLDEDY---KAKLSDFGLARQG  254 (453)
Q Consensus       217 LH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~DFGla~~~  254 (453)
                      ||..   ||+|+|+++.|||++.+.   .+.|+||+-++..
T Consensus       134 lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  134 LHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999   999999999999999887   8999999987763

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.85  E-value=2.4e-08  Score=91.57  Aligned_cols=135  Identities=19%  Similarity=0.113  Sum_probs=93.1

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--c--------------------ccHHHHHHHH
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--F--------------------QGHKEWINEV  146 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~--------------------~~~~~~~~E~  146 (453)
                      ...++.||-|--+.||.|..            +.+.++|||.-....  .                    -......+|.
T Consensus        93 e~iG~~IGvGKEsdVY~~~~------------~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf  160 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAID------------PKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREF  160 (304)
T ss_pred             HhhccccccCccceEEEEEC------------CCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHH
Confidence            44567899999999999985            356789999742110  0                    0112356899


Q ss_pred             HHhccCCCC--ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          147 NFLGVVKHP--NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       147 ~~l~~l~h~--nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      ++|.+|...  .+.+.+++-.        -++||||++|-.|...-       ++....-.++..|++-+.-+-..   |
T Consensus       161 ~~L~~L~~~G~~VP~P~~~nR--------HaVvMe~ieG~eL~~~r-------~~~en~~~il~~il~~~~~~~~~---G  222 (304)
T COG0478         161 EALQRLYPEGVKVPKPIAWNR--------HAVVMEYIEGVELYRLR-------LDVENPDEILDKILEEVRKAYRR---G  222 (304)
T ss_pred             HHHHHhhhcCCCCCCcccccc--------ceeeeehcccceeeccc-------CcccCHHHHHHHHHHHHHHHHHc---C
Confidence            999999654  6777765422        27999999887766522       11122233344444444444444   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccC
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      |||||+.+-||++++||.+.++||--+..
T Consensus       223 iVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         223 IVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             ccccCCchheEEEecCCCEEEEeCccccc
Confidence            99999999999999999999999976654

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.85  E-value=9.8e-10  Score=111.74  Aligned_cols=150  Identities=20%  Similarity=0.295  Sum_probs=104.2

Q ss_pred             HHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCc-------cccccccCcCCCCcccccc
Q 043568          208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH-------VSTSVVGTVGYAAPEYVQT  280 (453)
Q Consensus       208 ~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~  280 (453)
                      .+++.||.|+|.+.  ++||+.|.|++|.++.++..||+.|+.+..........       ......-...|.|||++.+
T Consensus       106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            34558999999874  99999999999999999999999999886543311100       1112244567999999998


Q ss_pred             CCCCCchhHHHHHHHHHHHHhCCcc-ccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhh
Q 043568          281 GRLTAKSDVWSFGVVLYELITGRRA-VERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCL  359 (453)
Q Consensus       281 ~~~~~~~DV~SlGvil~elltg~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl  359 (453)
                      ...+.++|+||+||++|-+..|..+ +...........              ....+..-...+..+.+.++.+-+.+++
T Consensus       184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~--------------~~~~~~~~~~~~s~~~p~el~~~l~k~l  249 (700)
T KOG2137|consen  184 TTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF--------------SRNLLNAGAFGYSNNLPSELRESLKKLL  249 (700)
T ss_pred             ccccccccceeeeeEEEEEecCCcchhhccCCcchhhh--------------hhcccccccccccccCcHHHHHHHHHHh
Confidence            8889999999999999999955444 322211111000              0001111111223466788999999999


Q ss_pred             ccCCCCCCCHHHHH
Q 043568          360 TKQPKSRPKMSEVV  373 (453)
Q Consensus       360 ~~dp~~RPs~~ei~  373 (453)
                      ..++.-||++..+.
T Consensus       250 ~~~~~~rp~~~~l~  263 (700)
T KOG2137|consen  250 NGDSAVRPTLDLLL  263 (700)
T ss_pred             cCCcccCcchhhhh
Confidence            99999999877664

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.53  E-value=1.2e-06  Score=80.89  Aligned_cols=146  Identities=20%  Similarity=0.196  Sum_probs=85.2

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCC--ceeeEeeeeeeccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHP--NLVKLVGYCAEDDE  169 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~~  169 (453)
                      .+.|+.|..+.||+....             +..+++|.....  .....+.+|+.+++.+...  .+.+++.++.....
T Consensus         2 i~~l~~G~~n~~~~v~~~-------------~~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~   66 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTD-------------DGRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEF   66 (239)
T ss_dssp             EEEEEESSSSEEEEEEET-------------TSEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEE
T ss_pred             CccCCCCCeeeEEEEEEC-------------CcEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccc
Confidence            357899999999998753             247999997543  3456677899998888433  45677765544433


Q ss_pred             ccceEEEEEEecCCCChHH----------------hh---hcC--CCCCCCHHHH---------HHH------------H
Q 043568          170 RGMQRLLVYELMHNKSLED----------------HL---LSR--VPTPLAWIAR---------LKI------------A  207 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~----------------~l---~~~--~~~~l~~~~~---------~~i------------~  207 (453)
                      .+ ..+++|++++|.++..                .+   +..  ...++.+...         ...            .
T Consensus        67 ~~-~~~~~~~~i~g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (239)
T PF01636_consen   67 NG-FPYLLMEYIPGRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDL  145 (239)
T ss_dssp             TS-EEEEEEEEESSEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHH
T ss_pred             cc-cceEEEEEeccccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhh
Confidence            22 3689999999988877                11   111  0111111110         000            1


Q ss_pred             HHHHH-HHHHHHhC----CCCceEeeccccccEEEc-CCCcEEEeccccccC
Q 043568          208 QDAAR-GLAYLHEE----MDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQ  253 (453)
Q Consensus       208 ~~ia~-~L~~LH~~----~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~  253 (453)
                      ..+.. .+..++..    ....++|+|+.|.|||++ +++.+-|+||+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  146 EELEERLLQELEALLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHHHHHHHHHHHHHHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             HHHHHHHHHHHHhhhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence            11222 33333321    234799999999999999 667678999987654

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.52  E-value=3.2e-07  Score=93.72  Aligned_cols=146  Identities=21%  Similarity=0.186  Sum_probs=92.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--------------------------cc---
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--------------------------QG---  138 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--------------------------~~---  138 (453)
                      .|.. +.|+.++-|.||+|++.            +++.||||+..+.-.                          -.   
T Consensus       127 eF~~-~PiAsASIaQVH~A~L~------------sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~  193 (517)
T COG0661         127 EFEP-EPIASASIAQVHRAVLK------------SGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVE  193 (517)
T ss_pred             HcCC-CchhhhhHhhheeEEec------------CCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHH
Confidence            3443 57999999999999985            378999999743100                          00   


Q ss_pred             -HH----------HHHHHHHHhccCC----CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHH
Q 043568          139 -HK----------EWINEVNFLGVVK----HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR  203 (453)
Q Consensus       139 -~~----------~~~~E~~~l~~l~----h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~  203 (453)
                       ..          ++.+|+..+.++.    ...=+++-.++.+-..   ..+|+|||++|-.+.+...-.. ..++....
T Consensus       194 vv~e~~~~l~~ElDy~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~---~~VLtmE~i~Gi~i~d~~~l~~-~g~d~k~i  269 (517)
T COG0661         194 VVDEFEKRLREELDYRREAANAERFRENFKDDPDVYVPKVYWEYTT---RRVLTMEWIDGIKISDIAALKS-AGIDRKEL  269 (517)
T ss_pred             HHHHHHHHHHHHhCHHHHHHHHHHHHHHcCCCCCeEeceeehhccC---CcEEEEEeeCCEecccHHHHHh-cCCCHHHH
Confidence             01          2445666666552    2222333334433221   1589999999999888743222 34443322


Q ss_pred             HHHHHHHHHH-HHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCC
Q 043568          204 LKIAQDAARG-LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP  256 (453)
Q Consensus       204 ~~i~~~ia~~-L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~  256 (453)
                         +..++++ +..+-..   |++|.|.+|.||+++.+|++.+.|||+....++
T Consensus       270 ---a~~~~~~f~~q~~~d---gffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         270 ---AELLVRAFLRQLLRD---GFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ---HHHHHHHHHHHHHhc---CccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence               2222222 2222223   999999999999999999999999999876543

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.51  E-value=2.1e-06  Score=78.13  Aligned_cols=153  Identities=18%  Similarity=0.151  Sum_probs=101.2

Q ss_pred             ccHHHHHHHhcCCCccce---ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc----------------
Q 043568           77 FSFAELKSATRGFSRALL---IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ----------------  137 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~---lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~----------------  137 (453)
                      .+.+.+.....+..+..+   |+.|--+.||+|..            .++..+|||+.......                
T Consensus        35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~------------~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~  102 (268)
T COG1718          35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAET------------GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRN  102 (268)
T ss_pred             HHHHHHHHHhcCCceeeeEeeecCCcceEEEeecc------------CCCceEEEEEEehhhhhhhhHHHHHhcChhhhc
Confidence            456666666666666554   55788889999873            34678999998532111                


Q ss_pred             ---cHHH-----HHHHHHHhccC--CCCceeeEeeeeeecccccceEEEEEEecCCC-ChHHhhhcCCCCCCCHHHHHHH
Q 043568          138 ---GHKE-----WINEVNFLGVV--KHPNLVKLVGYCAEDDERGMQRLLVYELMHNK-SLEDHLLSRVPTPLAWIARLKI  206 (453)
Q Consensus       138 ---~~~~-----~~~E~~~l~~l--~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i  206 (453)
                         +.++     ..+|...|.++  .+-.+.+.+++..        -.|||||+... .-.-.|..   .++.......+
T Consensus       103 ~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~--------nVLvMEfIg~~g~pAP~LkD---v~~e~~e~~~~  171 (268)
T COG1718         103 SRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAFRN--------NVLVMEFIGDDGLPAPRLKD---VPLELEEAEGL  171 (268)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceeecC--------CeEEEEeccCCCCCCCCccc---CCcCchhHHHH
Confidence               1111     23578888777  3555666665542        27999999443 11111211   22233245666


Q ss_pred             HHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCC
Q 043568          207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP  255 (453)
Q Consensus       207 ~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~  255 (453)
                      ..++++.+.-|-..+  ++||+||..-|||+. ++.+.|+|||-|....
T Consensus       172 ~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         172 YEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHHHHHHHHhc--CcccccchhhheEEE-CCeEEEEECccccccC
Confidence            778888888887733  999999999999999 8899999999887643

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.46  E-value=2.8e-06  Score=78.31  Aligned_cols=139  Identities=18%  Similarity=0.142  Sum_probs=81.6

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCc--eeeEeeeeeecccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPN--LVKLVGYCAEDDER  170 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~~~~~~~~  170 (453)
                      ..||+|..+.||+..               +..+++|......  ......+|.++++.+..-.  +.+.++++...+. 
T Consensus         7 ~~i~~G~t~~~y~~~---------------~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~-   68 (226)
T TIGR02172         7 TQTGEGGNGESYTHK---------------TGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGR-   68 (226)
T ss_pred             eeecCCCCcceeEec---------------CCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCe-
Confidence            479999999999732               2247888865422  3345678999998885433  4666666654443 


Q ss_pred             cceEEEEEEecCCCC-hHHhh---------------------hcCCCCCCCHHHHHH-HHH----------HHHH-HHHH
Q 043568          171 GMQRLLVYELMHNKS-LEDHL---------------------LSRVPTPLAWIARLK-IAQ----------DAAR-GLAY  216 (453)
Q Consensus       171 ~~~~~lv~e~~~~gs-L~~~l---------------------~~~~~~~l~~~~~~~-i~~----------~ia~-~L~~  216 (453)
                         ..+|||+++|.+ +...+                     +.-............ +..          .+.. ...+
T Consensus        69 ---~glv~e~i~G~~~~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~  145 (226)
T TIGR02172        69 ---LGLIYELIVGKRSFSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAF  145 (226)
T ss_pred             ---eeeeeeecCCccchhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHH
Confidence               468999998864 21111                     111001111111100 000          0111 1222


Q ss_pred             HHhC-CCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          217 LHEE-MDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       217 LH~~-~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      |... ..+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus       146 l~~~~~~~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       146 IKEVPDTSTCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             HHhCCCCCceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            2211 134679999999999999888 99999998765

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.43  E-value=8.1e-06  Score=72.87  Aligned_cols=100  Identities=25%  Similarity=0.228  Sum_probs=80.7

Q ss_pred             HHHHHhccCCC-CceeeEeeeeeecccccceEEEEEEecCCCChHHh---hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 043568          144 NEVNFLGVVKH-PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH---LLSRVPTPLAWIARLKIAQDAARGLAYLHE  219 (453)
Q Consensus       144 ~E~~~l~~l~h-~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~---l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~  219 (453)
                      .|..+|..+.+ +++++++|+|-.        ++|.||...+++...   +...  ...+|..|++|+.++++.+.+|+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~--------~~v~E~~~~~~~~~~~~~l~~~--~~~~w~~R~~iA~~lL~~l~~l~~   77 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR--------FYVVEYVGAGSLYGIYRPLSQF--LQSPWEQRAKIALQLLELLEELDH   77 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC--------EEEEEeecCccccccccccccc--cccCHHHHHHHHHHHHHHHHHHhc
Confidence            58888888866 699999999943        789999987766431   1111  245899999999999999999998


Q ss_pred             CCCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          220 EMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       220 ~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ...-.+.-.|++++|+-+++++++|++|...+..
T Consensus        78 ~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   78 GPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             CCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            5433588899999999999999999999987654

Proteins in this uncharacterised family are described as transmembrane proteins.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.39  E-value=5.2e-06  Score=74.80  Aligned_cols=141  Identities=11%  Similarity=0.089  Sum_probs=89.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHH---------HHHHHHHhccCCC--
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---------WINEVNFLGVVKH--  154 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~---------~~~E~~~l~~l~h--  154 (453)
                      .++|...+++-.....-|.+-..             ++..+++|..........+.         ..+++..+.++..  
T Consensus        30 ~~~~~~~kv~k~~~r~~ValIei-------------~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g   96 (229)
T PF06176_consen   30 DNNYKIIKVFKNTKRNYVALIEI-------------DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEG   96 (229)
T ss_pred             hCCceEEEeecCCCccEEEEEEE-------------CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcC
Confidence            56777777777777777766553             35679999876543222222         2244444444432  


Q ss_pred             -CceeeEeeeeeecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          155 -PNLVKLVGYCAEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       155 -~nIv~l~~~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                       -.++.++.+....... ....+|+|||++|..|.+...      ++.    .++..+++++.-||..   |+.|||..|
T Consensus        97 ~~~~~~~yl~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hp  163 (229)
T PF06176_consen   97 FTEPADPYLAAEKKIFRYTSSYVLLMEYIEGVELNDIED------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHP  163 (229)
T ss_pred             ccccccceeeeeeeeccceeEEEEEEEEecCeecccchh------cCH----HHHHHHHHHHHHHHHc---CCccCCCCc
Confidence             2233333222222111 123568999999988876432      121    2456677889999999   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccC
Q 043568          233 SNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~  253 (453)
                      .|++++.++ ++++||+..+.
T Consensus       164 gNFlv~~~~-i~iID~~~k~~  183 (229)
T PF06176_consen  164 GNFLVSNNG-IRIIDTQGKRM  183 (229)
T ss_pred             CcEEEECCc-EEEEECccccc
Confidence            999998655 99999987654

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.35  E-value=5.9e-06  Score=77.24  Aligned_cols=139  Identities=19%  Similarity=0.146  Sum_probs=82.2

Q ss_pred             ecCCCc-eEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeeeeecccccc
Q 043568           95 IGEGGF-GCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        95 lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~~  172 (453)
                      |-.|.. ..||+....             +..++||......   ...+.+|+.+++.+. +--+.+++++....+.   
T Consensus         6 ~~~g~~~~~v~~~~~~-------------~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~---   66 (244)
T cd05150           6 VTEGQSGATVYRLDGK-------------NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGR---   66 (244)
T ss_pred             cCCCCCcCeEEEEcCC-------------CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCc---
Confidence            455555 788987631             2468888865432   334668999888883 4446677776654422   


Q ss_pred             eEEEEEEecCCCChHHhh-------------------hcCCC--CCCCH--HHHHHHHH--------------------H
Q 043568          173 QRLLVYELMHNKSLEDHL-------------------LSRVP--TPLAW--IARLKIAQ--------------------D  209 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l-------------------~~~~~--~~l~~--~~~~~i~~--------------------~  209 (453)
                       .++|||+++|.+|....                   +....  .++..  ...+....                    .
T Consensus        67 -~~lv~e~i~G~~l~~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  145 (244)
T cd05150          67 -AWLLTSAVPGVPAAALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWS  145 (244)
T ss_pred             -cEEEEEeeCCccHhHhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCC
Confidence             58999999998876432                   11100  01110  00010000                    0


Q ss_pred             HHHHHHHHHhC----CCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          210 AARGLAYLHEE----MDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       210 ia~~L~~LH~~----~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      +...+..|-..    ..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus       146 ~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         146 AEELYAELEATRPAEEDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             HHHHHHHHHhhCCCcCceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            11112222111    134699999999999999987788999987754

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.32  E-value=3.8e-06  Score=72.46  Aligned_cols=129  Identities=16%  Similarity=0.159  Sum_probs=87.9

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceee-Eeeeeeecc
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVK-LVGYCAEDD  168 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~-l~~~~~~~~  168 (453)
                      .....||+|++|.||+|.++             +..+|+|+-..+  .....+..|+++|..+.-.++.+ ++.|..  +
T Consensus        25 ~v~~~L~KG~~s~Vyl~~~~-------------~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~--~   87 (201)
T COG2112          25 RVEKELAKGTTSVVYLGEWR-------------GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE--D   87 (201)
T ss_pred             hhhhhhhcccccEEEEeecc-------------CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech--h
Confidence            34457999999999999975             457999985433  34567889999999998776644 443322  2


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc-cccEEEcCCCcEEEec
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK-TSNILLDEDYKAKLSD  247 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk-p~NILl~~~~~~kL~D  247 (453)
                            ++.|||+.|-.|.+.-...     +-..    +..+++.---|-..   ||-|+.|. |..++|..++.+.|+|
T Consensus        88 ------~i~me~i~G~~L~~~~~~~-----~rk~----l~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iID  149 (201)
T COG2112          88 ------FIRMEYIDGRPLGKLEIGG-----DRKH----LLRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIID  149 (201)
T ss_pred             ------hhhhhhhcCcchhhhhhcc-----cHHH----HHHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEE
Confidence                  5679999888887754421     1112    23344443334444   99999997 5555555555999999


Q ss_pred             cccccC
Q 043568          248 FGLARQ  253 (453)
Q Consensus       248 FGla~~  253 (453)
                      |.-|+.
T Consensus       150 Fd~At~  155 (201)
T COG2112         150 FDSATF  155 (201)
T ss_pred             ccchhh
Confidence            998874

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.29  E-value=3.1e-06  Score=86.23  Aligned_cols=158  Identities=18%  Similarity=0.144  Sum_probs=97.5

Q ss_pred             CCCccccHHHHHHHh------------cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--
Q 043568           72 NDLRVFSFAELKSAT------------RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--  137 (453)
Q Consensus        72 ~~~~~~~~~~~~~~~------------~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--  137 (453)
                      ...+.|+++|+....            ..|.. +.||.-+.|.||+|+++            +++.||||+-++.-..  
T Consensus       135 D~~Pp~~~ee~~~i~e~ElG~~ie~if~~f~~-~piaaASlaQVhrA~L~------------~G~~VaVKVQ~P~l~~~~  201 (538)
T KOG1235|consen  135 DQAPPFPWEEAFKIFEEELGAPIEDIFSEFDE-EPIAAASLAQVHRARLK------------NGEDVAVKVQHPGLEKLI  201 (538)
T ss_pred             ccCCCCCHHHHHHHHHHHhCCCHHHHHHhcCc-chhhhcchhheEEEEec------------CCCEEEEEecCcChHHHH
Confidence            345667777775432            23433 46999999999999986            3778999995321000  


Q ss_pred             -----------------------------------cHHHHHHHHHHhccC----CCCc------eeeEeeeeeecccccc
Q 043568          138 -----------------------------------GHKEWINEVNFLGVV----KHPN------LVKLVGYCAEDDERGM  172 (453)
Q Consensus       138 -----------------------------------~~~~~~~E~~~l~~l----~h~n------Iv~l~~~~~~~~~~~~  172 (453)
                                                         ..=+|.+|++...++    .|-+      |.+++-.+..      
T Consensus       202 ~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~Nae~~~~~f~~~~~~~~V~VP~Vy~~~st------  275 (538)
T KOG1235|consen  202 MLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAKNAERFRENFKDFSLLTYVLVPKVYWDLST------  275 (538)
T ss_pred             HHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHHhHHHHHHHHHhcccccceeCCeehhhcCc------
Confidence                                               001245555544443    3555      4444322222      


Q ss_pred             eEEEEEEecCCCChHHh--hhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC----CCcEEEe
Q 043568          173 QRLLVYELMHNKSLEDH--LLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE----DYKAKLS  246 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~--l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~----~~~~kL~  246 (453)
                      ..+|+||||+|..+.|.  |.+.   .++-..+..-+.++..-+-+.|     |++|+|-+|.||++..    ++.+.+-
T Consensus       276 ~RVLtME~~~G~~i~Dl~~i~~~---gi~~~~i~~~l~~~~~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~ivll  347 (538)
T KOG1235|consen  276 KRVLTMEYVDGIKINDLDAIDKR---GISPHDILNKLVEAYLEQIFKT-----GFFHADPHPGNILVRPNPEGDEEIVLL  347 (538)
T ss_pred             ceEEEEEecCCccCCCHHHHHHc---CCCHHHHHHHHHHHHHHHHHhc-----CCccCCCCCCcEEEecCCCCCccEEEE
Confidence            26999999999877764  3332   3444333333333322222222     9999999999999984    6789999


Q ss_pred             ccccccCCCC
Q 043568          247 DFGLARQGPP  256 (453)
Q Consensus       247 DFGla~~~~~  256 (453)
                      |||+.....+
T Consensus       348 DhGl~~~is~  357 (538)
T KOG1235|consen  348 DHGLYAVISH  357 (538)
T ss_pred             cccccccccH
Confidence            9999887543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.29  E-value=5.1e-08  Score=98.43  Aligned_cols=184  Identities=19%  Similarity=0.148  Sum_probs=127.2

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCc-eeeEeeeeeecc
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPN-LVKLVGYCAEDD  168 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~  168 (453)
                      ...+-.++|+++.+||.+..           . .+...++.+...     ....-++++|.+++||| .+..++-+...+
T Consensus       245 ~~fh~fvK~altknpKkRpt-----------a-eklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~  307 (829)
T KOG0576|consen  245 EFFHNFVKGALTKNPKKRPT-----------A-EKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGED  307 (829)
T ss_pred             HHHHHHHHHHhcCCCccCCC-----------h-hhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCccc
Confidence            33445789999999988642           1 122334444322     33445899999999999 555554443333


Q ss_pred             cccceEEEEEEecCCC-ChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          169 ERGMQRLLVYELMHNK-SLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                          ...++++++.++ +..... ......+...+...+.+.-+++|++||+.   .=+|+|    |||..+ +..+.+|
T Consensus       308 ----~~~i~~~i~s~~rs~~~~~-~~se~~~~~~~~~~~~r~et~~l~~l~~~---~~~~~d----~~l~s~-~~~~~~~  374 (829)
T KOG0576|consen  308 ----YLWIPMRICSTGRSSALEM-TVSEIALEQYQFAYPLRKETRPLAELHSS---YKVHRD----NILGSE-EEVKLLD  374 (829)
T ss_pred             ----ccchhhhhhcCCccccccC-ChhhHhhhhhhhhhhhhhhcccccccccc---cccCcc----cccccc-ccccccc
Confidence                268899999777 222211 11112344445566677788899999986   458888    887765 6789999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccc
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV  306 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~  306 (453)
                      |+....+....   ......+|+.++|||+...+.+....|+|++|+-..+|--|-+|-
T Consensus       375 ~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr  430 (829)
T KOG0576|consen  375 FAVPPQLTRTM---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR  430 (829)
T ss_pred             ccCCcccCccc---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence            99987765432   345678999999999999999999999999998877777776654

>PLN02876 acyl-CoA dehydrogenase

Probab=98.20  E-value=2.8e-05  Score=85.42  Aligned_cols=154  Identities=16%  Similarity=0.221  Sum_probs=92.0

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCC-CCce--eeEeeeeeec
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK-HPNL--VKLVGYCAED  167 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~-h~nI--v~l~~~~~~~  167 (453)
                      ...|+.|.++.+|+......         .....+++|+..... ......+.+|+.+|+.+. |.+|  .+++++|.+.
T Consensus        43 v~~l~gG~sn~ty~l~~~~~---------~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~  113 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNG---------GSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDA  113 (822)
T ss_pred             EEEeCCCCcCceEEEEECCC---------CcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCC
Confidence            45789999999998765311         111357777754322 223456889999999995 6664  8888888664


Q ss_pred             ccccceEEEEEEecCCCChHHh-----------------------hhcCCC---------CCCCHH--HHHHHH------
Q 043568          168 DERGMQRLLVYELMHNKSLEDH-----------------------LLSRVP---------TPLAWI--ARLKIA------  207 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~-----------------------l~~~~~---------~~l~~~--~~~~i~------  207 (453)
                      ...+ ..++||||++|..+.+.                       |+.-..         .+..+.  +.-.+.      
T Consensus       114 ~v~G-~~flVME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~  192 (822)
T PLN02876        114 SVIG-TAFYIMEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLAS  192 (822)
T ss_pred             CcCC-CceEEEEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHh
Confidence            3222 26899999987653221                       111100         111111  111110      


Q ss_pred             ---------HHHHHHHHHHHhCCC--------CceEeeccccccEEEcC-CCc-EEEeccccccCCC
Q 043568          208 ---------QDAARGLAYLHEEMD--------FQLIFRDFKTSNILLDE-DYK-AKLSDFGLARQGP  255 (453)
Q Consensus       208 ---------~~ia~~L~~LH~~~~--------~~iiH~Dlkp~NILl~~-~~~-~kL~DFGla~~~~  255 (453)
                               -.+...+.+|..+..        +.+||+|+++.|||++. ++. .-|.||+++...+
T Consensus       193 ~~~~~~~~~~~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~Gd  259 (822)
T PLN02876        193 TGEGKPPRNPKMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTLGN  259 (822)
T ss_pred             hcccCCCCChhHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeeccccCC
Confidence                     112334566644321        35999999999999985 333 5789999987643

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.19  E-value=3.7e-05  Score=69.05  Aligned_cols=133  Identities=21%  Similarity=0.291  Sum_probs=92.4

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----------------cccHHHHHHHHHHhccCC-
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----------------FQGHKEWINEVNFLGVVK-  153 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----------------~~~~~~~~~E~~~l~~l~-  153 (453)
                      ....||+|+.-.||.-              +......||+.....                ....+++.+|+.....+. 
T Consensus         5 ~~~~i~~G~~R~cy~H--------------P~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~   70 (199)
T PF10707_consen    5 ESDLIAQGGERDCYQH--------------PDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSL   70 (199)
T ss_pred             CCcccccCCCceEEEC--------------CCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhh
Confidence            3457999999999952              344568899987655                223566777877766665 


Q ss_pred             -----CCceeeEeeeeeecccccceEEEEEEecCC------CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043568          154 -----HPNLVKLVGYCAEDDERGMQRLLVYELMHN------KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMD  222 (453)
Q Consensus       154 -----h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~------gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~  222 (453)
                           +.+|.+++|+..++-.    .-+|+|.+.+      .||.+++...   .++. ...   ..+-+-..||-.+  
T Consensus        71 ~~~~~~~~i~r~~G~veT~~G----~Glv~e~I~d~dG~~s~TL~~~l~~~---~~~~-~~~---~~L~~f~~~l~~~--  137 (199)
T PF10707_consen   71 RRGVDWSHIPRFYGFVETNLG----LGLVVELIRDADGNISPTLEDYLKEG---GLTE-ELR---QALDEFKRYLLDH--  137 (199)
T ss_pred             ccCCcccccccEeEEEecCCc----eEEEEEEEECCCCCcCccHHHHHHcC---CccH-HHH---HHHHHHHHHHHHc--
Confidence                 8899999999988776    4678887632      3688888553   3444 333   3333445567766  


Q ss_pred             CceEeeccccccEEEcCC---C-cEEEec-cccc
Q 043568          223 FQLIFRDFKTSNILLDED---Y-KAKLSD-FGLA  251 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~---~-~~kL~D-FGla  251 (453)
                       .|+.+||+|.||++..+   . .+.|+| ||..
T Consensus       138 -~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  138 -HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             -CCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence             89999999999999532   2 577777 4443

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.14  E-value=2.2e-05  Score=72.90  Aligned_cols=31  Identities=19%  Similarity=0.289  Sum_probs=26.6

Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      +.++|+|+.+.|||++.+...-|+||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4699999999999998776667999998765

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.11  E-value=3.7e-05  Score=68.53  Aligned_cols=138  Identities=24%  Similarity=0.325  Sum_probs=97.1

Q ss_pred             CCccccHHHHHHHhcCCCccceecCCCc-eEEEEEEEeecCCCCCcCCCCCCeeEEEEEecc---CC-------c-----
Q 043568           73 DLRVFSFAELKSATRGFSRALLIGEGGF-GCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR---QG-------F-----  136 (453)
Q Consensus        73 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~---~~-------~-----  136 (453)
                      .+..|++     .+.+++..+.||.|.- |.||+..+.             +..+|+|++..   ..       .     
T Consensus        28 KL~~F~~-----h~~~I~flefLg~g~~~~~V~kv~I~-------------g~~YALKlf~~~~~~~~~~~~~~~~~~~~   89 (207)
T PF13095_consen   28 KLEPFTH-----HGDDIEFLEFLGHGSHDGYVFKVEID-------------GRIYALKLFRFWDYTEPDYTRERFAGHET   89 (207)
T ss_pred             CcCCcCC-----CCCcEeeeeecCCCCceeEEEEEEEC-------------CeEEEEEEeeccccCCCcccccccccccc
Confidence            4556666     2378889999999999 999999975             56899999321   00       0     


Q ss_pred             ------ccHHHHHHHHHHhccCC---CCce--eeEeeeeeecc--------------cccceEEEEEEecCCCChHHhhh
Q 043568          137 ------QGHKEWINEVNFLGVVK---HPNL--VKLVGYCAEDD--------------ERGMQRLLVYELMHNKSLEDHLL  191 (453)
Q Consensus       137 ------~~~~~~~~E~~~l~~l~---h~nI--v~l~~~~~~~~--------------~~~~~~~lv~e~~~~gsL~~~l~  191 (453)
                            ....-|..|.+...+|+   +.++  |+++||..-..              .....+.||.||++...      
T Consensus        90 ~~~~~~~y~~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------  163 (207)
T PF13095_consen   90 SLSTPAHYADPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------  163 (207)
T ss_pred             ccchhhhhcChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------
Confidence                  01134778888888884   4566  99999986542              11124678888876543      


Q ss_pred             cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccc
Q 043568          192 SRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA  251 (453)
Q Consensus       192 ~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla  251 (453)
                           .+.    .+-+.++.+-|..+|..   ||+-+|+++.|..     .-||+|||.+
T Consensus       164 -----~~~----~~~~~~~~~dl~~~~k~---gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  164 -----PLQ----IRDIPQMLRDLKILHKL---GIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             -----ccc----hhHHHHHHHHHHHHHHC---CeeeccCcccccc-----CCEEEecccC
Confidence                 111    22346677788889998   9999999999976     3488999864

>PRK10593 hypothetical protein; Provisional

Probab=98.05  E-value=9.5e-05  Score=71.20  Aligned_cols=79  Identities=13%  Similarity=0.112  Sum_probs=54.4

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC---CceeeEeeeeeecc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH---PNLVKLVGYCAEDD  168 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~~~~~  168 (453)
                      ...||.|..+.||+....             +..+++|..+.  ......|.+|+..|+.|.-   ..+.+++++|....
T Consensus        19 ~~~i~~G~~~~vy~~~~~-------------~~~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~   83 (297)
T PRK10593         19 VECISEQPYAALWALYDS-------------QGNPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQ   83 (297)
T ss_pred             eeecCCccceeEEEEEcC-------------CCCEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCC
Confidence            346999999999987532             22467777432  1133578899999998842   46888888876532


Q ss_pred             cccceEEEEEEecCCCCh
Q 043568          169 ERGMQRLLVYELMHNKSL  186 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL  186 (453)
                      ..+ ..+||||+++++++
T Consensus        84 ~~g-~~~LVmE~i~G~~~  100 (297)
T PRK10593         84 SPG-PDVLLLERLRGVSV  100 (297)
T ss_pred             cCC-CeEEEEeccCCEec
Confidence            211 26999999998765

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.01  E-value=1.4e-05  Score=86.37  Aligned_cols=199  Identities=23%  Similarity=0.240  Sum_probs=140.4

Q ss_pred             HHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043568          143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMD  222 (453)
Q Consensus       143 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~  222 (453)
                      .-|+..+..+.|+|++.+++|..+....+....+..++|..-++...+...  ...+....+.+..++..||.|+|+.  
T Consensus       230 E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v--~~i~~~~~r~~~~~~~~GL~~~h~~--  305 (1351)
T KOG1035|consen  230 EIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSV--GSIPLETLRILHQKLLEGLAYLHSL--  305 (1351)
T ss_pred             HHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhc--cccCHHHHHHHHHHHhhhHHHHHHh--
Confidence            457777888899999999999888766553344556888888888888776  4566667777889999999999997  


Q ss_pred             CceEeeccccc---cEEEcCCCcEEEe--ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCc--hhHHHHHHH
Q 043568          223 FQLIFRDFKTS---NILLDEDYKAKLS--DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAK--SDVWSFGVV  295 (453)
Q Consensus       223 ~~iiH~Dlkp~---NILl~~~~~~kL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~DV~SlGvi  295 (453)
                       ...|.-|..+   +.-.+..+.+.++  ||+.+...+....   .....-+..+.+||......+..+  .|+|.+|..
T Consensus       306 -~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~---~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll  381 (1351)
T KOG1035|consen  306 -SLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEK---SFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLL  381 (1351)
T ss_pred             -ccceeEEecccccccccCccceeecchhhhcccccCCCccc---chhhcCccccccccccccccchhhhhhHHHHHHHH
Confidence             5666665555   4445667777777  9988877654332   223345566788888776555544  799999999


Q ss_pred             HHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          296 LYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       296 l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      +..+..|..+-.....                   ...++        +......+.+...+|+..++++|+++.+++..
T Consensus       382 ~~~~~~~~~i~~~~~~-------------------~~~~l--------~~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~  434 (1351)
T KOG1035|consen  382 LLQLSQGEDISEKSAV-------------------PVSLL--------DVLSTSELLDALPKCLDEDSEERLSALELLTH  434 (1351)
T ss_pred             HhhhhhcCcccccccc-------------------hhhhh--------ccccchhhhhhhhhhcchhhhhccchhhhhhc
Confidence            9999998765332110                   00000        00111157788899999999999999998865


Q ss_pred             H
Q 043568          376 L  376 (453)
Q Consensus       376 L  376 (453)
                      .
T Consensus       435 ~  435 (1351)
T KOG1035|consen  435 P  435 (1351)
T ss_pred             h
Confidence            3

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.00  E-value=3.8e-05  Score=72.33  Aligned_cols=137  Identities=15%  Similarity=0.113  Sum_probs=76.8

Q ss_pred             ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCce-eeEeeeeeecccccce
Q 043568           95 IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNL-VKLVGYCAEDDERGMQ  173 (453)
Q Consensus        95 lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~~~  173 (453)
                      +..|-.+.+|+...             ++..+++|..........-...+|..+++.+....+ .++++.+  .      
T Consensus         4 ~~~G~tn~~y~~~~-------------~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~--~------   62 (256)
T TIGR02721         4 LSGGLTNRSWRIEH-------------PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVN--E------   62 (256)
T ss_pred             CCCcCcCCeEEEEe-------------CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEe--C------
Confidence            56677889998762             245688887543321111134678888888854333 3344332  1      


Q ss_pred             EEEEEEecCCCChHHh-----------------hhcCC--CCCCCHHHHH-HHHHH---------HHHHHHHHHhC----
Q 043568          174 RLLVYELMHNKSLEDH-----------------LLSRV--PTPLAWIARL-KIAQD---------AARGLAYLHEE----  220 (453)
Q Consensus       174 ~~lv~e~~~~gsL~~~-----------------l~~~~--~~~l~~~~~~-~i~~~---------ia~~L~~LH~~----  220 (453)
                      ..+||||++|.++...                 |+...  ..+++....+ ....+         +...+..+-..    
T Consensus        63 ~~~v~e~i~G~~~~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~  142 (256)
T TIGR02721        63 HWLLVEWLEGEVITLDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPA  142 (256)
T ss_pred             CEEEEEeccCcccccccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCC
Confidence            1689999998766421                 11111  1122222111 11101         11112222111    


Q ss_pred             -CCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          221 -MDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       221 -~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                       ..+.++|+|+.|.||++++++ +.|+||+.+..
T Consensus       143 ~~~~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       143 PLPLAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CCCCeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence             123689999999999999877 78999998865

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.93  E-value=0.00012  Score=67.79  Aligned_cols=31  Identities=23%  Similarity=0.377  Sum_probs=27.5

Q ss_pred             CceEeeccccccEEEcC-CCcEEEeccccccC
Q 043568          223 FQLIFRDFKTSNILLDE-DYKAKLSDFGLARQ  253 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~  253 (453)
                      ..++|+|+.+.|||++. ++.+.|+||..|..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            47999999999999998 57899999988765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=97.77  E-value=0.00073  Score=67.28  Aligned_cols=76  Identities=20%  Similarity=0.124  Sum_probs=51.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC------C-cccHHHHHHHHHHhccCC---CCceeeEee
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ------G-FQGHKEWINEVNFLGVVK---HPNLVKLVG  162 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~---h~nIv~l~~  162 (453)
                      +.||.|.+..||+....           ...+.|+||.-...      . .-....+..|.+.|..+.   -.++.+++.
T Consensus        32 ~elggGn~N~VyrV~~~-----------~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~  100 (401)
T PRK09550         32 REIGDGNLNLVFRVSDT-----------EGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYH  100 (401)
T ss_pred             eEcCCCceEEEEEEEeC-----------CCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEE
Confidence            46999999999999864           12247999985421      1 123456777888888762   346777877


Q ss_pred             eeeecccccceEEEEEEecCCCC
Q 043568          163 YCAEDDERGMQRLLVYELMHNKS  185 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gs  185 (453)
                      +..+.      .++||||+++..
T Consensus       101 ~D~~~------~~lVME~L~~~~  117 (401)
T PRK09550        101 YDEEL------AVTVMEDLSDHK  117 (401)
T ss_pred             ECCCC------CEEEEecCCCcc
Confidence            64322      489999998744

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=97.75  E-value=0.00021  Score=68.82  Aligned_cols=146  Identities=18%  Similarity=0.138  Sum_probs=83.4

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCC--ceeeEeeeeeecc-
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHP--NLVKLVGYCAEDD-  168 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~--nIv~l~~~~~~~~-  168 (453)
                      ...|..|....+|+....             +..+++|+...   ........|+.++..+.+-  .+.+++....... 
T Consensus        19 i~~i~~G~~n~~y~v~~~-------------~~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~   82 (296)
T cd05153          19 FEGISAGIENTNYFVTTD-------------SGRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYL   82 (296)
T ss_pred             eecccCccccceEEEEeC-------------CCcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEe
Confidence            446778888899987532             23588998754   2334566788888877432  3455543211100 


Q ss_pred             -cccceEEEEEEecCCCChHH----h----------hhcC----CC-----CCCCHHHHH----------HHHHHHHHHH
Q 043568          169 -ERGMQRLLVYELMHNKSLED----H----------LLSR----VP-----TPLAWIARL----------KIAQDAARGL  214 (453)
Q Consensus       169 -~~~~~~~lv~e~~~~gsL~~----~----------l~~~----~~-----~~l~~~~~~----------~i~~~ia~~L  214 (453)
                       ......++|++|++|.++..    .          ++..    ..     ....|....          .....+..++
T Consensus        83 ~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~  162 (296)
T cd05153          83 SELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADEL  162 (296)
T ss_pred             eeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHH
Confidence             00112589999998876532    0          1110    00     011222111          0111223344


Q ss_pred             HHHHh----CCCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          215 AYLHE----EMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       215 ~~LH~----~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      .++..    ....++||+|+.|.|||+++++.+.|.||+.+..
T Consensus       163 ~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         163 ARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             HHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            45443    1234799999999999999987788999988764

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.62  E-value=0.00043  Score=66.87  Aligned_cols=147  Identities=22%  Similarity=0.226  Sum_probs=82.9

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCce-eeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNL-VKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~  171 (453)
                      +.|..|--..||+.......     .....+..+++|+..... .......+|..++..+....+ .++++++.  +   
T Consensus         4 ~~l~gGltN~~y~v~~~~~~-----~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~--~---   72 (302)
T cd05156           4 SKISGGLTNAVYKVSLPDED-----ALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFP--N---   72 (302)
T ss_pred             EEecCcccceeEEEEcCCcc-----cccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeC--C---
Confidence            45677777899988643110     012235679999865432 222345678888888743333 34554442  1   


Q ss_pred             ceEEEEEEecCCCChHHh-----------------hhcCCCC-------CCC--HHHHHH--------------------
Q 043568          172 MQRLLVYELMHNKSLEDH-----------------LLSRVPT-------PLA--WIARLK--------------------  205 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~-----------------l~~~~~~-------~l~--~~~~~~--------------------  205 (453)
                         .+|+||++|.++...                 ++.....       ..+  +...-.                    
T Consensus        73 ---~~v~e~i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  149 (302)
T cd05156          73 ---GRIEEFIPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLL  149 (302)
T ss_pred             ---CchhheeCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhh
Confidence               358999988776431                 1111000       011  101000                    


Q ss_pred             ------HHHHHHHHHHHHHh------CCCCceEeeccccccEEEcCC----CcEEEeccccccC
Q 043568          206 ------IAQDAARGLAYLHE------EMDFQLIFRDFKTSNILLDED----YKAKLSDFGLARQ  253 (453)
Q Consensus       206 ------i~~~ia~~L~~LH~------~~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~  253 (453)
                            +...+...+..|-.      .....++|+|+.+.|||++.+    +.+.|+||..|..
T Consensus       150 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         150 EVELSLFLEDEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             hhhHHHHHHHHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence                  11122223334432      234589999999999999985    8899999998764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=97.60  E-value=0.0012  Score=64.31  Aligned_cols=32  Identities=25%  Similarity=0.317  Sum_probs=27.3

Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..++||+|+.|.|||++.+...-|+||+.+..
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~  217 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN  217 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence            45899999999999999766568999998765

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.54  E-value=0.0021  Score=62.18  Aligned_cols=147  Identities=16%  Similarity=0.123  Sum_probs=80.7

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC--CceeeEeeeeeecc-
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH--PNLVKLVGYCAEDD-  168 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~-  168 (453)
                      ...++.|....+|+....             +..+++|+.....  .......|+.++..|..  -++.+++....... 
T Consensus        27 i~~~~~G~~n~~y~v~t~-------------~~~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~   91 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD-------------VGRYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQL   91 (307)
T ss_pred             ccccCCccccceEEEEeC-------------CCcEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCee
Confidence            345777777899987521             2358888765421  23345567777777732  22444443221100 


Q ss_pred             -cccceEEEEEEecCCCChHH--------------hhhcCC---CCC-------CCHHHHH------------HHHHHHH
Q 043568          169 -ERGMQRLLVYELMHNKSLED--------------HLLSRV---PTP-------LAWIARL------------KIAQDAA  211 (453)
Q Consensus       169 -~~~~~~~lv~e~~~~gsL~~--------------~l~~~~---~~~-------l~~~~~~------------~i~~~ia  211 (453)
                       ......+++++|++|..+..              .++...   +.+       -.|....            .....+.
T Consensus        92 ~~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~  171 (307)
T TIGR00938        92 STLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELD  171 (307)
T ss_pred             hhcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHH
Confidence             00123689999998865421              011100   000       1111110            0011233


Q ss_pred             HHHHHHHh----CCCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          212 RGLAYLHE----EMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       212 ~~L~~LH~----~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..++++..    ....++||+|+.+.||+++.++...|+||+.+..
T Consensus       172 ~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~  217 (307)
T TIGR00938       172 KELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFACT  217 (307)
T ss_pred             HHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence            34555532    2245899999999999999888778999998754

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=97.39  E-value=0.00023  Score=67.33  Aligned_cols=146  Identities=19%  Similarity=0.160  Sum_probs=96.5

Q ss_pred             ccHHHHHHHhcC---CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEecc--CCc---------------
Q 043568           77 FSFAELKSATRG---FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGF---------------  136 (453)
Q Consensus        77 ~~~~~~~~~~~~---f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~--~~~---------------  136 (453)
                      +.|-.|+...++   ++.++.||-|--+.||.+.+            ..+.+.++|.-..  ..+               
T Consensus        79 yDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d------------~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~  146 (465)
T KOG2268|consen   79 YDYLALKTLSNRGSVESVGNQIGVGKESDIYVVAD------------EEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKS  146 (465)
T ss_pred             chHHHHHHHHhcchhhhhccccccccccceEEEec------------CCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCc
Confidence            455555554443   67788999999999999875            3466788876321  100               


Q ss_pred             ---ccH--HHHHHHHHHhccCC-C-CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHH
Q 043568          137 ---QGH--KEWINEVNFLGVVK-H-PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD  209 (453)
Q Consensus       137 ---~~~--~~~~~E~~~l~~l~-h-~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~  209 (453)
                         ...  -...+|...|+.|. | --+.+.++++.        -++|||++.+-.|...-+-.     +..   .+...
T Consensus       147 ~sWlyLSRlaa~kEfafmkaL~e~gfpVPkpiD~~R--------H~Vvmelv~g~Pl~~v~~v~-----d~~---~ly~~  210 (465)
T KOG2268|consen  147 GSWLYLSRLAATKEFAFMKALYERGFPVPKPIDHNR--------HCVVMELVDGYPLRQVRHVE-----DPP---TLYDD  210 (465)
T ss_pred             cchhhhHHHHHHHHHHHHHHHHHcCCCCCCcccccc--------eeeHHHhhcccceeeeeecC-----ChH---HHHHH
Confidence               001  12357888888883 3 34566665543        27899999888877632221     111   22334


Q ss_pred             HHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       210 ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      +..-+.-|-.+   |+||+|..-=||++++++.++++||--+..
T Consensus       211 lm~~Iv~la~~---GlIHgDFNEFNimv~dd~~i~vIDFPQmvS  251 (465)
T KOG2268|consen  211 LMGLIVRLANH---GLIHGDFNEFNIMVKDDDKIVVIDFPQMVS  251 (465)
T ss_pred             HHHHHHHHHHc---CceecccchheeEEecCCCEEEeechHhhc
Confidence            44445556666   999999999999999999999999976544

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=97.22  E-value=0.0054  Score=59.04  Aligned_cols=131  Identities=17%  Similarity=0.259  Sum_probs=75.2

Q ss_pred             CeeEEEEEecc--CCcccHHHHHHHHHHhccCC--CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCC---
Q 043568          123 KLDVAIKQLNR--QGFQGHKEWINEVNFLGVVK--HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP---  195 (453)
Q Consensus       123 ~~~vavK~l~~--~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---  195 (453)
                      ++.+++. ...  ..........+|+.+|+.+.  -.-+...+++|.+.. .+ ..+.||+|++|..+.+.+.....   
T Consensus        48 ~~~~vlR-~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~-~g-~pf~v~~~veGe~~~~~~~~~~~~~~  124 (321)
T COG3173          48 GQKYVLR-KPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGY-LG-TPFYVMEWVEGEVVWSALPPESLGRQ  124 (321)
T ss_pred             CceEEEe-cCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCC-CC-CceEEEEEecceeccCcCCcccchHH
Confidence            5567777 321  11223344557888887773  234566678887766 22 26999999988443322211000   


Q ss_pred             -------------------------C--------CCCHHHHHHHH--------HHHHHHHHHHHhCC-----CCceEeec
Q 043568          196 -------------------------T--------PLAWIARLKIA--------QDAARGLAYLHEEM-----DFQLIFRD  229 (453)
Q Consensus       196 -------------------------~--------~l~~~~~~~i~--------~~ia~~L~~LH~~~-----~~~iiH~D  229 (453)
                                               .        -..|...++.+        -....-..+|+.+.     .+.++|||
T Consensus       125 ~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD  204 (321)
T COG3173         125 FALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGD  204 (321)
T ss_pred             HHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCC
Confidence                                     0        00111111100        01112334444432     24799999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPP  256 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~  256 (453)
                      +.+.||+++.+.-+-|.||+++...++
T Consensus       205 ~~~gNlii~~~~~~gVlDwe~~~lGDP  231 (321)
T COG3173         205 YRPGNLIIDPGRPTGVLDWELATLGDP  231 (321)
T ss_pred             cccCCEEEeCCCeeEEEeccccccCCc
Confidence            999999999888899999999987543

>PLN02236 choline kinase

Probab=97.22  E-value=0.0037  Score=61.48  Aligned_cols=145  Identities=14%  Similarity=0.164  Sum_probs=80.2

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCce-eeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNL-VKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~~  171 (453)
                      ..|-.|--..+|+.......       ...+..|++|........... -.+|..+++.+..-++ .++++++..     
T Consensus        42 ~~l~gGlTN~~y~v~~~~~~-------~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~-----  108 (344)
T PLN02236         42 IPLKGAMTNEVFQIKWPTKE-------GNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPN-----  108 (344)
T ss_pred             EEcCCcccceeEEEEeCCCC-------CCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECC-----
Confidence            35656778899987643110       122457899987544322212 2578888888854444 344554421     


Q ss_pred             ceEEEEEEecCCCChHHh-----------------hhcCC-C--C-CCCHHHHHHHHHH-----------------HHHH
Q 043568          172 MQRLLVYELMHNKSLEDH-----------------LLSRV-P--T-PLAWIARLKIAQD-----------------AARG  213 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~-----------------l~~~~-~--~-~l~~~~~~~i~~~-----------------ia~~  213 (453)
                         ..|++|+++.+|...                 ++... +  . +..+....+++.+                 +...
T Consensus       109 ---g~v~efi~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~  185 (344)
T PLN02236        109 ---GRVEEFIHARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDE  185 (344)
T ss_pred             ---ceEEEeeCCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHH
Confidence               257999987776421                 11111 0  1 1112222222211                 1111


Q ss_pred             HHHH----Hh-CCCCceEeeccccccEEEcC-CCcEEEeccccccC
Q 043568          214 LAYL----HE-EMDFQLIFRDFKTSNILLDE-DYKAKLSDFGLARQ  253 (453)
Q Consensus       214 L~~L----H~-~~~~~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~  253 (453)
                      +..|    .. .....++|+|+++.|||+++ ++.+.|+||..+..
T Consensus       186 ~~~L~~~~~~~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        186 INLLEKELSGDDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             HHHHHHHhcccCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            2222    21 12347899999999999986 46899999988764

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.13  E-value=0.0042  Score=59.13  Aligned_cols=32  Identities=34%  Similarity=0.541  Sum_probs=26.6

Q ss_pred             CceEeeccccccEEEcCCCc-EEEeccccccCC
Q 043568          223 FQLIFRDFKTSNILLDEDYK-AKLSDFGLARQG  254 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~-~kL~DFGla~~~  254 (453)
                      +.++|+|++|.|||+++++. .-|.||+.+...
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG  217 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG  217 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence            35899999999999997555 469999988763

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=97.12  E-value=0.007  Score=57.76  Aligned_cols=73  Identities=16%  Similarity=0.203  Sum_probs=44.3

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC---CCCceeeEeeeeeecc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV---KHPNLVKLVGYCAEDD  168 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l---~h~nIv~l~~~~~~~~  168 (453)
                      ...|+.|....+|+..             .++..+.||.-..   .....|..|+.-|+.|   .--.+.+.+++....+
T Consensus        22 ~~~v~GG~i~~a~~~~-------------~~~~~~FvK~~~~---~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~   85 (288)
T PF03881_consen   22 IEPVSGGDINEAYRLD-------------TDGGSYFVKVNSE---SGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDD   85 (288)
T ss_dssp             EEEE--SSSSEEEEEE-------------TTS-EEEEEEEEG---GGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SS
T ss_pred             eEecCCCChhheEEEE-------------CCCccEEEEecCh---hhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecC
Confidence            3468989999999876             3466899998752   2335677888877777   3455778888776654


Q ss_pred             cccceEEEEEEecCCC
Q 043568          169 ERGMQRLLVYELMHNK  184 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~g  184 (453)
                      .    .+|||||++.+
T Consensus        86 ~----~fLlle~l~~~   97 (288)
T PF03881_consen   86 D----AFLLLEFLEMG   97 (288)
T ss_dssp             C----CEEEEE-----
T ss_pred             C----ceEEEEeecCC
Confidence            4    38999999776

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.11  E-value=0.00013  Score=80.96  Aligned_cols=177  Identities=12%  Similarity=0.041  Sum_probs=120.8

Q ss_pred             EEEEEeccCCcccHHH-----HHHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCC--CCC
Q 043568          126 VAIKQLNRQGFQGHKE-----WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--TPL  198 (453)
Q Consensus       126 vavK~l~~~~~~~~~~-----~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--~~l  198 (453)
                      +.+|+.+....+...+     ...|..-++...|+++...+.-.....  ....+.+++|+.+|.+.+.|.+...  .++
T Consensus      1255 Fk~~I~ke~d~e~LsePlkemll~e~de~~~~~h~~~~~~p~rI~ps~--s~ee~~r~~~~~~g~~f~iIikg~ee~~~l 1332 (2724)
T KOG1826|consen 1255 FKFSIYKEYDFENLSEPLKEMLLSERDELREAKHYLTEVDPLRIPPSE--STEEYIRSLYVEFGKLFSIIIKGLEESPDL 1332 (2724)
T ss_pred             eEEEeehhhhHHHHhhHHHHhhhhhhhhhhhhhceeeecccccCCCCC--ChHHHHHHHHHHHhHHHHHHHhccccCCcc
Confidence            4556554444433332     234444555668988877654333222  1235789999999999998876432  223


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCC--CceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcc
Q 043568          199 AWIARLKIAQDAARGLAYLHEEMD--FQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPE  276 (453)
Q Consensus       199 ~~~~~~~i~~~ia~~L~~LH~~~~--~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE  276 (453)
                      ...-......+...+..-+|+..+  .--+|++||+.|.+|..+..+|++++|+.+...+.  ........+++.|+.|+
T Consensus      1333 d~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~--~sf~Gl~l~sp~~v~ql 1410 (2724)
T KOG1826|consen 1333 DRSPVHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPV--LSFFGLELCSPIYVLQL 1410 (2724)
T ss_pred             hhchHHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCch--HhhhhhhhCCHHHHHHH
Confidence            333333333343555666665532  23689999999999999999999999999943321  23345667888999999


Q ss_pred             ccccCCCCCchhHHHHHHHHHHHHhCCccc
Q 043568          277 YVQTGRLTAKSDVWSFGVVLYELITGRRAV  306 (453)
Q Consensus       277 ~~~~~~~~~~~DV~SlGvil~elltg~~p~  306 (453)
                      +...-.++.++|+|..|+.+|+..-|..+|
T Consensus      1411 i~N~ik~t~rsdilr~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1411 IKNEIKFTKRSDILRRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHhhhhHHHHHHHHHHHHHHhcccHHH
Confidence            998888999999999999999998887765

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.87  E-value=0.003  Score=57.52  Aligned_cols=30  Identities=33%  Similarity=0.485  Sum_probs=21.7

Q ss_pred             ceEeeccccccEEE-cCCCcEEEeccccccC
Q 043568          224 QLIFRDFKTSNILL-DEDYKAKLSDFGLARQ  253 (453)
Q Consensus       224 ~iiH~Dlkp~NILl-~~~~~~kL~DFGla~~  253 (453)
                      .++|+||.|.|||+ +.++.++|+||..|..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            68999999999999 8899999999988754

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PLN02756 S-methyl-5-thioribose kinase

Probab=96.82  E-value=0.021  Score=56.86  Aligned_cols=73  Identities=15%  Similarity=0.050  Sum_probs=48.3

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----c---ccHHHHHHHHHHhccCC---CCceeeEe
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----F---QGHKEWINEVNFLGVVK---HPNLVKLV  161 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~---~~~~~~~~E~~~l~~l~---h~nIv~l~  161 (453)
                      .+.||.|....||+....             +..++||.-....    .   -....-..|+..|+.+.   ..++.+++
T Consensus        37 ~~eiggGn~N~VyrV~~~-------------~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy  103 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS-------------SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVY  103 (418)
T ss_pred             EEEcCCCceeeEEEEEcC-------------CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEE
Confidence            457899999999996631             2359999864211    1   12233344566666553   35788899


Q ss_pred             eeeeecccccceEEEEEEecCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHN  183 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~  183 (453)
                      .++.+..      +++|||+++
T Consensus       104 ~~ded~~------vlvME~L~~  119 (418)
T PLN02756        104 HFDRTMA------LIGMRYLEP  119 (418)
T ss_pred             EECCCCC------EEEEeecCC
Confidence            8887543      789999977

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.74  E-value=0.006  Score=59.77  Aligned_cols=60  Identities=15%  Similarity=0.115  Sum_probs=40.2

Q ss_pred             EEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEeeccccccEEEcC
Q 043568          174 RLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYL-HEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~L-H~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      ..|+-+|..|-++..++....   .++....+++.--+.||--+ --.   +.+|.|+.|.||++--
T Consensus       320 ~vl~E~~~~Gl~v~~~v~~~~---~pe~l~kkva~lg~~AllkMl~vD---NFvHaDlHPGNVlirf  380 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVKWKS---QPEALVKKVAKLGVNALLKMLIVD---NFVHADLHPGNVLIRF  380 (565)
T ss_pred             ceeeeeccccccHHhhhhccc---ChHHHHHHHHHHHHHHHHHHHHhh---cceecccCCCcEEEEe
Confidence            456777888999999887753   23334444544444454333 223   8999999999999953

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.67  E-value=0.0037  Score=62.85  Aligned_cols=165  Identities=25%  Similarity=0.339  Sum_probs=94.1

Q ss_pred             HHHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 043568          139 HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLH  218 (453)
Q Consensus       139 ~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH  218 (453)
                      ..+++.-..+++.+.|+|+...+.+.......   ..+|+|++ +.||++.+..+.   +..      ....      -|
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r---~IVV~e~~-~~Sled~~~~~~---l~~------~s~~------~~   86 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKHER---VIVVMEHY-TMSLEDILKTGN---LKD------ESLL------AH   86 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCccce---EEEEehhh-ccchHHHHHhcc---cch------hhhc------cc
Confidence            34566678888999999999999887665553   68999999 889999887763   110      1111      11


Q ss_pred             hCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHH
Q 043568          219 EEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE  298 (453)
Q Consensus       219 ~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~e  298 (453)
                           ++.|-.     |       .+++| -++...                    |     .+..+|+||||+|.++.|
T Consensus        87 -----~~~~~~-----~-------~~~td-~~~t~~--------------------~-----~~~~pKsdVwsl~~i~~e  123 (725)
T KOG1093|consen   87 -----GVLHLN-----I-------IYITD-HFLTKY--------------------P-----SPIGPKSDVWSLGFIILE  123 (725)
T ss_pred             -----ccceeh-----h-------hhccc-cccccC--------------------C-----CCCCcchhhhhHHHHHHH
Confidence                 333322     2       23333 111100                    0     011249999999999999


Q ss_pred             HHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHH
Q 043568          299 LITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE  371 (453)
Q Consensus       299 lltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  371 (453)
                      +.-|..-+.....   ......+..+...+.....+...   ......+...+.++...|+-..|..||...+
T Consensus       124 l~L~~~l~~~~~~---s~~l~~i~k~~~~d~~~~~~a~e---~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~  190 (725)
T KOG1093|consen  124 LYLGISLEAELTE---SEYLEILLKYYTDDQELLSTAME---HLIQLLADKKRLPLLKKCLWLEPIIRPLPME  190 (725)
T ss_pred             HHHhhHHHHHHHH---HHHHHHHHHhccCchhHHHHHHH---HHHHHhhhHhHHHHhccCCccccccccchhH
Confidence            9998765432211   11222222222222111110000   0122344567889999999999999985544

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.58  E-value=0.019  Score=55.73  Aligned_cols=137  Identities=18%  Similarity=0.186  Sum_probs=90.0

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---------c------------c-HH---H-HHHHHH
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---------Q------------G-HK---E-WINEVN  147 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---------~------------~-~~---~-~~~E~~  147 (453)
                      -|..|--+.||.|+-            .++..+|||+.+..-.         .            . .+   - ...|++
T Consensus       151 CiSTGKEANVYHat~------------~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~R  218 (520)
T KOG2270|consen  151 CISTGKEANVYHATE------------EDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMR  218 (520)
T ss_pred             ccccCccceeEeeec------------CCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHH
Confidence            577899999999874            3466799999742100         0            0 01   1 246888


Q ss_pred             HhccCCCCceeeEeeeeeecccccceEEEEEEecCCCC-hHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceE
Q 043568          148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS-LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLI  226 (453)
Q Consensus       148 ~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gs-L~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~ii  226 (453)
                      -|.+++.-.|.-.--+....      -+|||+|+.+.. -.-.|..   ..++...+..+-++++.-+.-|.+.|  ++|
T Consensus       219 NLkRl~~aGIP~PePIlLk~------hVLVM~FlGrdgw~aPkLKd---~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LV  287 (520)
T KOG2270|consen  219 NLKRLNNAGIPCPEPILLKN------HVLVMEFLGRDGWAAPKLKD---ASLSTSKARELYQQCVRIMRRLYQKC--RLV  287 (520)
T ss_pred             HHHHHHhcCCCCCCceeeec------ceEeeeeccCCCCcCccccc---ccCChHHHHHHHHHHHHHHHHHHHHh--cee
Confidence            88888654433211111111      279999994322 1112222   34566667777788888888888876  999


Q ss_pred             eeccccccEEEcCCCcEEEeccccccCC
Q 043568          227 FRDFKTSNILLDEDYKAKLSDFGLARQG  254 (453)
Q Consensus       227 H~Dlkp~NILl~~~~~~kL~DFGla~~~  254 (453)
                      |.||.--|+|+- +|.+.|+|.+-+...
T Consensus       288 HADLSEfN~Lyh-dG~lyiIDVSQSVE~  314 (520)
T KOG2270|consen  288 HADLSEFNLLYH-DGKLYIIDVSQSVEH  314 (520)
T ss_pred             ccchhhhhheEE-CCEEEEEEccccccC
Confidence            999999999985 678999999887653

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=96.56  E-value=0.035  Score=54.40  Aligned_cols=80  Identities=15%  Similarity=0.090  Sum_probs=47.9

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC------C-cccHHHHHHHHHHhccCC--CC-ceeeEeee
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ------G-FQGHKEWINEVNFLGVVK--HP-NLVKLVGY  163 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~------~-~~~~~~~~~E~~~l~~l~--h~-nIv~l~~~  163 (453)
                      .||.|....||++...           ..+..|+||.-...      + .-...+..-|...|+...  -| .+.+++.|
T Consensus         2 EigdGnlN~VfrV~~~-----------~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~   70 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQ-----------EGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF   70 (370)
T ss_pred             cCCCCceEEEEEEEcC-----------CCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE
Confidence            4799999999999853           22256999985321      1 122344456777776652  24 45566654


Q ss_pred             eeecccccceEEEEEEecCCC-ChHHhh
Q 043568          164 CAEDDERGMQRLLVYELMHNK-SLEDHL  190 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~g-sL~~~l  190 (453)
                      -.+.      ..+|||+++.. .|.+.|
T Consensus        71 D~e~------~~~vMEdL~~~~ilR~~L   92 (370)
T TIGR01767        71 DTEM------AVTVMEDLSHHKIARKGL   92 (370)
T ss_pred             cccc------ceehHhhCccchHHHHHH
Confidence            3322      37999999553 343444

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=96.49  E-value=0.019  Score=51.73  Aligned_cols=138  Identities=17%  Similarity=0.178  Sum_probs=86.7

Q ss_pred             eEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHH
Q 043568          125 DVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR  203 (453)
Q Consensus       125 ~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~  203 (453)
                      +..+|++...... ...-|..+..++++++  .|+++.     .+ .+..+-++.|+|....           -..    
T Consensus        87 ~L~lKKi~slp~~~~~~~y~nky~v~Armh--GilrL~-----ND-n~~~yGvIlE~Cy~~~-----------i~~----  143 (308)
T PF07387_consen   87 PLFLKKIRSLPCCINDALYFNKYRVFARMH--GILRLK-----ND-NNYKYGVILERCYKIK-----------INF----  143 (308)
T ss_pred             hhhhhhccCCCcccchhhhhhhhhHHHHhh--heeEee-----cC-CCceeEEEEeeccCcc-----------cch----
Confidence            4667777554444 4566778899988875  367765     12 3445778999983211           111    


Q ss_pred             HHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC
Q 043568          204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL  283 (453)
Q Consensus       204 ~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  283 (453)
                      ..++..=+.+|.-.|+. +.+.+|||-.|+||+-|..|.+||.|-+.--.              .+..|.--|+   ...
T Consensus       144 ~N~i~agi~~L~~fH~~-~~~~lHGD~np~NiM~D~~G~lKlVDP~~Ll~--------------~~V~~vN~~Y---~~l  205 (308)
T PF07387_consen  144 SNFITAGIKDLMDFHSE-NQHCLHGDCNPDNIMCDKFGYLKLVDPVCLLE--------------NQVNMVNIEY---ESL  205 (308)
T ss_pred             hHHHHHhHHHHHHhhcc-CCCeecCCCChhheeecCCCCEEecChhhhhh--------------heeeEEeeec---ccc
Confidence            11222224567788965 45899999999999999999999999764321              1111222111   235


Q ss_pred             CCchhHHHHHHHHHHHHhCC
Q 043568          284 TAKSDVWSFGVVLYELITGR  303 (453)
Q Consensus       284 ~~~~DV~SlGvil~elltg~  303 (453)
                      |+++.+=+|=.-++++....
T Consensus       206 T~~aE~~~fv~s~l~~v~~~  225 (308)
T PF07387_consen  206 TQEAEVKVFVKSCLKLVEKQ  225 (308)
T ss_pred             ChHHHHHHHHHHHHHHHHHH
Confidence            77788877777777776643

The function of this family is unknown.

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=96.40  E-value=0.03  Score=54.77  Aligned_cols=30  Identities=23%  Similarity=0.378  Sum_probs=26.1

Q ss_pred             ceEeeccccccEEEcC-CCcEEEeccccccC
Q 043568          224 QLIFRDFKTSNILLDE-DYKAKLSDFGLARQ  253 (453)
Q Consensus       224 ~iiH~Dlkp~NILl~~-~~~~kL~DFGla~~  253 (453)
                      -++|.|+.+.|||+++ ++.++++||..|-.
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            5899999999999975 57899999998754

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.34  E-value=0.015  Score=56.24  Aligned_cols=105  Identities=18%  Similarity=0.244  Sum_probs=71.7

Q ss_pred             EEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          174 RLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       174 ~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      .|++|++- |++|.- +     ....+.+.+.|+.+.+..+.-+..+  ...-|||+...||||+ +|++-|+||-+++.
T Consensus       301 ~yl~~kdh-gt~is~-i-----k~~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         301 LYLHFKDH-GTPISI-I-----KADRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             EEEEEecC-Cceeee-e-----ecccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence            45566654 444432 1     2346888999999999988888876  4899999999999999 99999999999996


Q ss_pred             CCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHH
Q 043568          254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL  296 (453)
Q Consensus       254 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil  296 (453)
                      ..+.+       ....-..--|-.+. +.-+..-+||-+--.+
T Consensus       371 ~~~q~-------~isy~rldhp~lF~-G~dd~QFeIYrlMr~l  405 (488)
T COG5072         371 SYSQG-------IISYNRLDHPDLFN-GVDDYQFEIYRLMRRL  405 (488)
T ss_pred             ccCCc-------eeeccccCchhhhc-CccceeeeHHHHHHHH
Confidence            43321       11112223455555 3337777888754443

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=96.26  E-value=0.053  Score=52.39  Aligned_cols=31  Identities=23%  Similarity=0.309  Sum_probs=26.5

Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..++||||+.+.||+++. +.+.|+||+.+..
T Consensus       186 ~~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~  216 (313)
T TIGR02906       186 IRGFCHQDYAYHNILLKD-NEVYVIDFDYCTI  216 (313)
T ss_pred             cCceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence            358999999999999987 6789999987654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=95.85  E-value=0.092  Score=51.11  Aligned_cols=29  Identities=31%  Similarity=0.517  Sum_probs=26.0

Q ss_pred             eEeeccccccEEEcCCCc-EEEeccccccC
Q 043568          225 LIFRDFKTSNILLDEDYK-AKLSDFGLARQ  253 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~-~kL~DFGla~~  253 (453)
                      +||+|+.|.|||++.+.. +.+.|||-+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            999999999999998885 89999997754

>PRK12396 5-methylribose kinase; Reviewed

Probab=95.82  E-value=0.052  Score=53.83  Aligned_cols=75  Identities=19%  Similarity=0.189  Sum_probs=47.4

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-----C-cccHHHHHHHHHHhccCC--CC-ceeeEee
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-----G-FQGHKEWINEVNFLGVVK--HP-NLVKLVG  162 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-----~-~~~~~~~~~E~~~l~~l~--h~-nIv~l~~  162 (453)
                      ...||.|.-..||++.+.           ..+..|+||.-...     + .-..++..-|.++|+.+.  -| ++.+++.
T Consensus        34 ~~eigdGnlN~VfrV~~~-----------~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~  102 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDE-----------QKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYL  102 (409)
T ss_pred             eeEcCCCceEEEEEEeeC-----------CCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEE
Confidence            347899999999999863           11346999985321     1 123455566777777663  34 4666665


Q ss_pred             eeeecccccceEEEEEEecCC
Q 043568          163 YCAEDDERGMQRLLVYELMHN  183 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~  183 (453)
                      |-.+.      ..+|||+++.
T Consensus       103 ~D~e~------~~~vMEdL~~  117 (409)
T PRK12396        103 FDSVM------NCCVMEDLSD  117 (409)
T ss_pred             ECcHH------hhHHHHhCcc
Confidence            53332      3789999854

>PRK06148 hypothetical protein; Provisional

Probab=95.31  E-value=0.17  Score=57.03  Aligned_cols=32  Identities=41%  Similarity=0.494  Sum_probs=26.8

Q ss_pred             CCceEeeccccccEEEcCCC--cEE-EeccccccC
Q 043568          222 DFQLIFRDFKTSNILLDEDY--KAK-LSDFGLARQ  253 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~--~~k-L~DFGla~~  253 (453)
                      ..++||+|+.+.|||++.++  .+. |+|||-+..
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            44899999999999999875  554 999998765

>PTZ00384 choline kinase; Provisional

Probab=95.25  E-value=0.21  Score=49.84  Aligned_cols=30  Identities=23%  Similarity=0.153  Sum_probs=24.8

Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ...+|.|+-+.|||.++ ..+.++||..|..
T Consensus       227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            47899999999999765 4599999987754

>PTZ00296 choline kinase; Provisional

Probab=95.17  E-value=0.2  Score=50.92  Aligned_cols=85  Identities=11%  Similarity=0.047  Sum_probs=47.4

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCcee-eEeeeeeeccc
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLV-KLVGYCAEDDE  169 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv-~l~~~~~~~~~  169 (453)
                      ..+.|..|=-..+|+........   ......+..|.+++.......-. .-..|..+++.+..-+|. ++++.+.  + 
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~---~~~~~~~~~~lvRiyG~~te~lI-dR~~E~~v~~~ls~~gi~P~l~~~f~--g-  181 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETA---NNYPSIRRRVLFRIYGKDVDELY-NPISEFEVYKTMSKYRIAPQLLNTFS--G-  181 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCC---ccccCcCceEEEEecCCCcccee-CHHHHHHHHHHHHHCCCCCceEEEeC--C-
Confidence            34467777778889887542110   00011245688888754322211 234688888877554443 4444432  1 


Q ss_pred             ccceEEEEEEecCCCChH
Q 043568          170 RGMQRLLVYELMHNKSLE  187 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~  187 (453)
                           ..|.+|++|.+|.
T Consensus       182 -----g~I~efi~g~~l~  194 (442)
T PTZ00296        182 -----GRIEEWLYGDPLR  194 (442)
T ss_pred             -----CEEEEeeCCccCC
Confidence                 4689999887553

>PRK11768 serine/threonine protein kinase; Provisional

Probab=94.88  E-value=0.84  Score=44.53  Aligned_cols=30  Identities=27%  Similarity=0.333  Sum_probs=25.2

Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..++||+|+.+.|||++ + .+.|+||+-+..
T Consensus       195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~  224 (325)
T PRK11768        195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM  224 (325)
T ss_pred             CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence            34789999999999995 4 578999998765

>COG3001 Uncharacterized protein conserved in bacteria [Function unknown]

Probab=94.37  E-value=0.65  Score=42.45  Aligned_cols=59  Identities=19%  Similarity=0.206  Sum_probs=39.5

Q ss_pred             CCeeEEEEEeccCCcccHHHHHHHHHHhccCC---CCceeeEeeeeeecccccceEEEEEEecCCCChH
Q 043568          122 SKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK---HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE  187 (453)
Q Consensus       122 ~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~  187 (453)
                      ...++.||.-..   .....|..|+.-|+.+.   .-++.+++.+....+.    .||||||++-+.+.
T Consensus        38 g~~~~FvK~n~~---~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~----sylVle~L~~~~~d   99 (286)
T COG3001          38 GTDPFFVKCNQR---EQLSMFTAEADGLELLARSNTITVPKVIAVGASRDH----SYLVLEYLPTGPLD   99 (286)
T ss_pred             CCcceEEEecch---hhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCe----eEEEEeeccCCCCC
Confidence            345788997432   33456778877776663   4556777666555543    69999999887665

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	453
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-44
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-43
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-42
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		9e-42
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		6e-34
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		7e-34
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		7e-34
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-32
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-19
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-19
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		2e-19
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		2e-19
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-19
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-19
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-19
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-19
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-19
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-19
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-19
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		7e-19
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-19
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-18
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-18
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-18
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-18
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		3e-18
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		3e-18
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		3e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		3e-18
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		3e-18
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		4e-18
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		4e-18
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		4e-18
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		4e-18
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		4e-18
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		4e-18
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-18
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		4e-18
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		5e-18
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-18
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		6e-18
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		6e-18
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		6e-18
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-18
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		6e-18
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-18
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-18
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-18
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-18
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		7e-18
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		8e-18
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		8e-18
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		8e-18
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		9e-18
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-18
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		9e-18
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-17
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		1e-17
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-17
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-17
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-17
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-17
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		2e-17
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		2e-17
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-17
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		3e-17
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-17
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-17
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		3e-17
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		4e-17
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-17
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-17
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-17
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-17
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-17
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-17
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-17
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-17
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-17
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-17
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		6e-17
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-17
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-17
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		7e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		8e-17
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		9e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		9e-17
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		1e-16
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		1e-16
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		1e-16
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		1e-16
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		1e-16
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		1e-16
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		1e-16
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		1e-16
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		1e-16
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		1e-16
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		1e-16
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-16
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-16
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		2e-16
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-16
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-16
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-16
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-16
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-16
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-16
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		4e-16
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-16
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-16
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-16
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-16
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		6e-16
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-16
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-16
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		8e-16
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		9e-16
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		1e-15
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-15
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		1e-15
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		1e-15
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		1e-15
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-15
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-15
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		1e-15
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		1e-15
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-15
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-15
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		1e-15
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-15
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-15
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-15
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-15
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		1e-15
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-15
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		1e-15
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-15
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		2e-15
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-15
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-15
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		2e-15
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-15
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-15
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-15
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		2e-15
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-15
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		3e-15
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		3e-15
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		3e-15
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-15
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-15
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-15
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		4e-15
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-15
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-15
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-15
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-15
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		4e-15
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-15
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-15
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-15
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-15
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-15
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-15
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		4e-15
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-15
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-15
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-15
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		4e-15
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		4e-15
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		4e-15
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		4e-15
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		5e-15
3a4o_X	286	Lyn Kinase Domain Length = 286		5e-15
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-15
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		5e-15
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		5e-15
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-15
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		5e-15
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		5e-15
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		6e-15
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		6e-15
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-15
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-15
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		6e-15
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		6e-15
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		6e-15
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		6e-15
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		6e-15
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		7e-15
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		7e-15
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		7e-15
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		7e-15
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		7e-15
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		7e-15
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		8e-15
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		8e-15
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-15
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		9e-15
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-15
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-14
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		1e-14
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		1e-14
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		1e-14
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-14
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-14
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-14
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-14
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		2e-14
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-14
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-14
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-14
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-14
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-14
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-14
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-14
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-14
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-14
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-14
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		3e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		3e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		4e-14
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-14
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		5e-14
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		5e-14
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		5e-14
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		6e-14
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		6e-14
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		6e-14
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		8e-14
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		8e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		9e-14
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		9e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-13
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-13
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-13
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		1e-13
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		1e-13
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		1e-13
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		1e-13
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-13
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-13
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		1e-13
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-13
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-13
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-13
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-13
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		3e-13
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-13
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-13
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		3e-13
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-13
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-13
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-13
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-13
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-13
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		6e-13
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		6e-13
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-13
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		7e-13
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		7e-13
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-13
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		7e-13
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		7e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-13
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		7e-13
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		7e-13
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		7e-13
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-13
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		7e-13
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		7e-13
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-13
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-13
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-13
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-13
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		8e-13
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		8e-13
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		8e-13
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-13
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		8e-13
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		8e-13
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		8e-13
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		8e-13
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		8e-13
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		8e-13
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		8e-13
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		8e-13
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-13
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		9e-13
3a7f_A	303	Human Mst3 Kinase Length = 303		9e-13
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		9e-13
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		9e-13
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		9e-13
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		9e-13
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		9e-13
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		9e-13
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		9e-13
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		9e-13
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-12
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		1e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		1e-12
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		1e-12
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		1e-12
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-12
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-12
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		2e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-12
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-12
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-12
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-12
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-12
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		3e-12
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-12
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		3e-12
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-12
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-12
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		4e-12
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-12
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-12
3b2t_A	311	Structure Of Phosphotransferase Length = 311		5e-12
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		5e-12
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-12
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		5e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-12
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		6e-12
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-12
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-12
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		7e-12
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		7e-12
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-12
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-12
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		8e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-12
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-12
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-12
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		9e-12
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		9e-12
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-12
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-11
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-11
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-11
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		2e-11
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		2e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		2e-11
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-11
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-11
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		2e-11
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		2e-11
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-11
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		2e-11
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-11
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-11
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		3e-11
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-11
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		3e-11
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-11
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		3e-11
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		4e-11
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		4e-11
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		5e-11
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		5e-11
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-11
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		6e-11
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		6e-11
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		6e-11
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		6e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		7e-11
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		7e-11
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-10
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-10
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-10
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		2e-10
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-10
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		3e-10
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		3e-10
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-10
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		3e-10
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		3e-10
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		3e-10
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		3e-10
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-10
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-10
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		4e-10
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		4e-10
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		4e-10
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-10
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		4e-10
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		5e-10
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		5e-10
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-10
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-10
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		5e-10
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		5e-10
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-10
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		5e-10
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-10
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		6e-10
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-10
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		7e-10
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		7e-10
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		7e-10
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		7e-10
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		7e-10
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		7e-10
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-10
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-10
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		7e-10
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		7e-10
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		7e-10
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		7e-10
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-10
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		8e-10
4fl3_A	635	Structural And Biophysical Characterization Of The		8e-10
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-10
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-10
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		8e-10
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		9e-10
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		9e-10
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		9e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-10
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		9e-10
4fl2_A	636	Structural And Biophysical Characterization Of The		9e-10
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		9e-10
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		9e-10
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		9e-10
3hec_A	348	P38 In Complex With Imatinib Length = 348		9e-10
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		9e-10
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		9e-10
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		9e-10
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		9e-10
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		9e-10
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-10
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		9e-10
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		1e-09
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-09
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		1e-09
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		1e-09
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		1e-09
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-09
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		1e-09
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-09
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-09
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		1e-09
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-09
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-09
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-09
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-09
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-09
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-09
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-09
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		1e-09
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-09
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-09
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		1e-09
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		1e-09
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-09
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		2e-09
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		2e-09
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		2e-09
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-09
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		2e-09
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-09
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-09
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-09
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		2e-09
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-09
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		2e-09
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		2e-09
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-09
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-09
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		2e-09
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-09
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		2e-09
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-09
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-09
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-09
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		2e-09
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-09
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-09
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-09
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		2e-09
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-09
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		2e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		3e-09
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		3e-09
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		3e-09
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		3e-09
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		3e-09
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		3e-09
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		3e-09
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		3e-09
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-09
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-09
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-09
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		3e-09
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		3e-09
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		3e-09
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		3e-09
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		3e-09
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		3e-09
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		3e-09
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		3e-09
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		3e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		3e-09
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		3e-09
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		3e-09
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		3e-09
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		3e-09
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		3e-09
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-09
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		3e-09
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		3e-09
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		3e-09
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		3e-09
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		3e-09
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		3e-09
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-09
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		4e-09
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-09
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		4e-09
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-09
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		4e-09
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-09
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		4e-09
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		4e-09
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		4e-09
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		4e-09
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		4e-09
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		4e-09
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		4e-09
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		4e-09
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		4e-09
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		4e-09
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-09
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		4e-09
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-09
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		4e-09
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-09
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		4e-09
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		4e-09
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		4e-09
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		4e-09
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		4e-09
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		4e-09
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		4e-09
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		4e-09
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		4e-09
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		4e-09
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		4e-09
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		4e-09
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		4e-09
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		4e-09
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		4e-09
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		4e-09
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-09
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		5e-09
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		5e-09
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		5e-09
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		5e-09
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		5e-09
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		5e-09
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-09
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-09
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		5e-09
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		5e-09
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		5e-09
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		5e-09
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-09
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		6e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		6e-09
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		6e-09
4ae6_A	343	Structure And Function Of The Human Sperm-specific		6e-09
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-09
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		6e-09
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		6e-09
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		6e-09
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		6e-09
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		6e-09
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		6e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		6e-09
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		7e-09
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-09
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		7e-09
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		7e-09
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-09
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		7e-09
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		7e-09
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		7e-09
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		7e-09
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		8e-09
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		8e-09
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		8e-09
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		8e-09
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		8e-09
4ae9_A	343	Structure And Function Of The Human Sperm-specific		8e-09
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		8e-09
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		8e-09
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		8e-09
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		8e-09
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		8e-09
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		8e-09
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-09
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		9e-09
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		9e-09
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		9e-09
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		9e-09
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		9e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-08
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-08
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-08
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		1e-08
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-08
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-08
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-08
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		1e-08
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-08
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		1e-08
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		1e-08
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-08
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-08
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-08
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-08
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		1e-08
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-08
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		1e-08
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		1e-08
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-08
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-08
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-08
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-08
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-08
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-08
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		1e-08
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		1e-08
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-08
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-08
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-08
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-08
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		1e-08
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-08
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		1e-08
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		1e-08
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		1e-08
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-08
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-08
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-08
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-08
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-08
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-08
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		2e-08
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-08
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-08
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-08
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-08
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		2e-08
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		2e-08
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-08
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		2e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-08
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-08
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		3e-08
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		3e-08
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		3e-08
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		3e-08
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-08
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-08
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		3e-08
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-08
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		3e-08
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		3e-08
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		3e-08
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		3e-08
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		3e-08
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		3e-08
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		3e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		3e-08
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-08
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		3e-08
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		3e-08
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		3e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-08
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		3e-08
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		3e-08
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-08
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		3e-08
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		3e-08
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-08
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-08
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		4e-08
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		4e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		4e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		4e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		4e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		4e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		4e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		4e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		4e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		4e-08
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		4e-08
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-08
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		4e-08
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-08
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-08
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		4e-08
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		4e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		4e-08
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-08
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		4e-08
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		4e-08
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		4e-08
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		4e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		4e-08
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-08
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-08
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-08
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		5e-08
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		5e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		5e-08
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-08
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		5e-08
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		5e-08
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-08
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		5e-08
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		6e-08
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		6e-08
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-08
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-08
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		6e-08
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-08
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-08
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		7e-08
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-08
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-08
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-08
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-08
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-08
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-08
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		7e-08
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-08
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-08
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		8e-08
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		9e-08
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-07
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-07
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		1e-07
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-07
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		1e-07
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		1e-07
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-07
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		1e-07
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		1e-07
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		1e-07
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		1e-07
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		1e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		1e-07
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		1e-07
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-07
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		1e-07
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-07
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		2e-07
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-07
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-07
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-07
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-07
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-07
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		2e-07
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-07
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-07
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-07
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-07
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-07
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		2e-07
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-07
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-07
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-07
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		2e-07
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		3e-07
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		3e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		3e-07
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		3e-07
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		3e-07
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		3e-07
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		3e-07
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-07
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		4e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		4e-07
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-07
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		4e-07
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		4e-07
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		4e-07
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		4e-07
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		5e-07
4exu_A	371	Mapk13, Inactive Form Length = 371		5e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-07
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		5e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		5e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		5e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		5e-07
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		5e-07
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		5e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		6e-07
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-07
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-07
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-07
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		8e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		9e-07
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		9e-07
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		9e-07
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		9e-07
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		9e-07
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		1e-06
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		1e-06
3soa_A	444	Full-Length Human Camkii Length = 444		1e-06
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		1e-06
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-06
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-06
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-06
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-06
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		2e-06
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-06
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		3e-06
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		4e-06
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		4e-06
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		4e-06
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		4e-06
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		4e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-06
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-06
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		6e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		7e-06
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		7e-06
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		7e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-06
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-06
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		7e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		9e-06
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		1e-05
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		1e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-05
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		1e-05
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		1e-05
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		1e-05
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-05
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		1e-05
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-05
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		1e-05
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-05
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-05
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-05
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-05
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-05
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		2e-05
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-05
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		2e-05
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-05
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-05
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		2e-05
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-05
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		2e-05
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		2e-05
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-05
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-05
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		3e-05
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-05
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		3e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		3e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		3e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		3e-05
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		4e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		4e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		4e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		4e-05
2buj_A	317	Crystal Structure Of The Human Serine-Threonine Kin		4e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		5e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		5e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		5e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		5e-05
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		6e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		8e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-05
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		8e-05
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		8e-05
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		9e-05
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		1e-04
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		1e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		2e-04
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		2e-04
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-04
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		3e-04
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		3e-04
2oza_A	356	Structure Of P38alpha Complex Length = 356		3e-04
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		3e-04
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		3e-04
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		3e-04
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		3e-04
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		3e-04
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		3e-04
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		3e-04
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-04
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		4e-04
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		4e-04
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		4e-04
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		4e-04
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		4e-04
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		5e-04
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		5e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		5e-04
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		6e-04
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-04
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		6e-04
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		9e-04

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 122/315 (38%), Positives = 178/315 (56%), Gaps = 24/315 (7%)
Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           L+ FS  EL+ A+  FS   ++G GGFG VY+G  R++         D  L VA+K+L  
Sbjct: 25  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKG--RLA---------DGTL-VAVKRLKE 72
Query: 134 QGFQGHK-EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS 192
           +  QG + ++  EV  + +  H NL++L G+C    ER    LLVY  M N S+   L  
Sbjct: 73  ERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRE 128
Query: 193 RVPT--PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R  +  PL W  R +IA  +ARGLAYLH+  D ++I RD K +NILLDE+++A + DFGL
Sbjct: 129 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 188
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE--R 308
           A+    +   H          + APEY+ TG+ + K+DV+ +GV+L ELITG+RA +  R
Sbjct: 189 AKLMDYKDX-HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 247
Query: 309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPK 368
               ++  LL+WV+  + + KK   ++D  L+GNY              C    P  RPK
Sbjct: 248 LANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 306
Query: 369 MSEVVDIL-GNIISE 382
           MSEVV +L G+ ++E
Sbjct: 307 MSEVVRMLEGDGLAE 321

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  174 bits (441), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 122/315 (38%), Positives = 178/315 (56%), Gaps = 24/315 (7%)
Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           L+ FS  EL+ A+  F    ++G GGFG VY+G  R++         D  L VA+K+L  
Sbjct: 17  LKRFSLRELQVASDNFXNKNILGRGGFGKVYKG--RLA---------DGXL-VAVKRLKE 64
Query: 134 QGFQGHK-EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS 192
           +  QG + ++  EV  + +  H NL++L G+C    ER    LLVY  M N S+   L  
Sbjct: 65  ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTER----LLVYPYMANGSVASCLRE 120
Query: 193 RVPT--PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R  +  PL W  R +IA  +ARGLAYLH+  D ++I RD K +NILLDE+++A + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE--R 308
           A+    +   H          + APEY+ TG+ + K+DV+ +GV+L ELITG+RA +  R
Sbjct: 181 AKLMDYKDX-HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239
Query: 309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPK 368
               ++  LL+WV+  + + KK   ++D  L+GNY              C    P  RPK
Sbjct: 240 LANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298
Query: 369 MSEVVDIL-GNIISE 382
           MSEVV +L G+ ++E
Sbjct: 299 MSEVVRMLEGDGLAE 313

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 110/297 (37%), Positives = 159/297 (53%), Gaps = 22/297 (7%)
Query: 79  FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG 138
             +L+ AT  F    LIG G FG VY+GV+R  +             VA+K+   +  QG
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK------------VALKRRTPESSQG 78
Query: 139 HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL-SRVPT- 196
            +E+  E+  L   +HP+LV L+G+C E +E     +L+Y+ M N +L+ HL  S +PT 
Sbjct: 79  IEEFETEIETLSFCRHPHLVSLIGFCDERNEM----ILIYKYMENGNLKRHLYGSDLPTM 134
Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
            ++W  RL+I   AARGL YLH      +I RD K+ NILLDE++  K++DFG++++G  
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 257 EGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
            G  H          Y  PEY   GRLT KSDV+SFGVVL+E++  R A+ ++LPR    
Sbjct: 192 LGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
           L EW      ++ +   I+DP L                  CL    + RP M +V+
Sbjct: 252 LAEWAVE-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score =  167 bits (424), Expect = 9e-42,   Method: Compositional matrix adjust.
 Identities = 109/297 (36%), Positives = 158/297 (53%), Gaps = 22/297 (7%)
Query: 79  FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG 138
             +L+ AT  F    LIG G FG VY+GV+R  +             VA+K+   +  QG
Sbjct: 31  LVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAK------------VALKRRTPESSQG 78
Query: 139 HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL-SRVPT- 196
            +E+  E+  L   +HP+LV L+G+C E +E     +L+Y+ M N +L+ HL  S +PT 
Sbjct: 79  IEEFETEIETLSFCRHPHLVSLIGFCDERNEM----ILIYKYMENGNLKRHLYGSDLPTM 134
Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
            ++W  RL+I   AARGL YLH      +I RD K+ NILLDE++  K++DFG++++G  
Sbjct: 135 SMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTE 191
Query: 257 EGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
               H          Y  PEY   GRLT KSDV+SFGVVL+E++  R A+ ++LPR    
Sbjct: 192 LDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVN 251
Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
           L EW      ++ +   I+DP L                  CL    + RP M +V+
Sbjct: 252 LAEWAVE-SHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVL 307

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  142 bits (357), Expect = 6e-34,   Method: Compositional matrix adjust.
 Identities = 99/250 (39%), Positives = 137/250 (54%), Gaps = 28/250 (11%)
Query: 77  FSFAELKSATRGFSRALL------IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ 130
           FSF ELK+ T  F    +      +GEGGFG VY+G V  ++   +     + +D+  ++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA--AMVDITTEE 72
Query: 131 LNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL 190
           L +Q       +  E+  +   +H NLV+L+G+ ++ D+      LVY  M N SL D L
Sbjct: 73  LKQQ-------FDQEIKVMAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRL 121
Query: 191 --LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF 248
             L   P PL+W  R KIAQ AA G+ +LHE      I RD K++NILLDE + AK+SDF
Sbjct: 122 SCLDGTP-PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF 177
Query: 249 GLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER 308
           GLAR                   Y APE ++ G +T KSD++SFGVVL E+ITG  AV+ 
Sbjct: 178 GLARASEKFAQTVMXSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 309 NLPRNEQKLL 318
           +  R  Q LL
Sbjct: 237 H--REPQLLL 244

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 100/250 (40%), Positives = 138/250 (55%), Gaps = 28/250 (11%)
Query: 77  FSFAELKSATRGFSRALL------IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ 130
           FSF ELK+ T  F    +      +GEGGFG VY+G V  ++   +     + +D+  ++
Sbjct: 9   FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA--AMVDITTEE 66
Query: 131 LNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL 190
           L +Q       +  E+  +   +H NLV+L+G+ ++ D+      LVY  M N SL D L
Sbjct: 67  LKQQ-------FDQEIKVMAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRL 115
Query: 191 --LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF 248
             L   P PL+W  R KIAQ AA G+ +LHE      I RD K++NILLDE + AK+SDF
Sbjct: 116 SCLDGTP-PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF 171
Query: 249 GLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER 308
           GLAR                   Y APE ++ G +T KSD++SFGVVL E+ITG  AV+ 
Sbjct: 172 GLARASEKFAQXVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 230
Query: 309 NLPRNEQKLL 318
           +  R  Q LL
Sbjct: 231 H--REPQLLL 238

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score =  141 bits (356), Expect = 7e-34,   Method: Compositional matrix adjust.
 Identities = 100/250 (40%), Positives = 138/250 (55%), Gaps = 28/250 (11%)
Query: 77  FSFAELKSATRGFSRALL------IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ 130
           FSF ELK+ T  F    +      +GEGGFG VY+G V  ++   +     + +D+  ++
Sbjct: 15  FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLA--AMVDITTEE 72
Query: 131 LNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL 190
           L +Q       +  E+  +   +H NLV+L+G+ ++ D+      LVY  M N SL D L
Sbjct: 73  LKQQ-------FDQEIKVMAKCQHENLVELLGFSSDGDDL----CLVYVYMPNGSLLDRL 121
Query: 191 --LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF 248
             L   P PL+W  R KIAQ AA G+ +LHE      I RD K++NILLDE + AK+SDF
Sbjct: 122 SCLDGTP-PLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF 177
Query: 249 GLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER 308
           GLAR                   Y APE ++ G +T KSD++SFGVVL E+ITG  AV+ 
Sbjct: 178 GLARASEKFAQTVMXXRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 236
Query: 309 NLPRNEQKLL 318
           +  R  Q LL
Sbjct: 237 H--REPQLLL 244

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score =  135 bits (341), Expect = 4e-32,   Method: Compositional matrix adjust.
 Identities = 100/250 (40%), Positives = 137/250 (54%), Gaps = 28/250 (11%)
Query: 77  FSFAELKSATRGF-SRALLIG-----EGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ 130
           FSF ELK+ T  F  R + +G     EGGFG VY+G V  ++   +     + +D+  ++
Sbjct: 6   FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLA--AMVDITTEE 63
Query: 131 LNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL 190
           L +Q       +  E+      +H NLV+L+G+ ++ D+      LVY    N SL D L
Sbjct: 64  LKQQ-------FDQEIKVXAKCQHENLVELLGFSSDGDDL----CLVYVYXPNGSLLDRL 112
Query: 191 --LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF 248
             L   P PL+W  R KIAQ AA G+ +LHE      I RD K++NILLDE + AK+SDF
Sbjct: 113 SCLDGTP-PLSWHXRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDF 168
Query: 249 GLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER 308
           GLAR                   Y APE ++ G +T KSD++SFGVVL E+ITG  AV+ 
Sbjct: 169 GLARASEKFAQXVXXSRIVGTTAYXAPEALR-GEITPKSDIYSFGVVLLEIITGLPAVDE 227
Query: 309 NLPRNEQKLL 318
           +  R  Q LL
Sbjct: 228 H--REPQLLL 235

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 47/293 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK--EWINEVNFLGVV 152
           IG G FG V           H+   H S  DVA+K L  Q F   +  E++ EV  +  +
Sbjct: 45  IGAGSFGTV-----------HRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 153 KHPNLVKLVGYCAEDDERG-----MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
           +HPN+V  +G   +          + R  +Y L+H     + L  R         RL +A
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER--------RRLSMA 143
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
            D A+G+ YLH   +  ++ RD K+ N+L+D+ Y  K+ DFGL+R      L        
Sbjct: 144 YDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFL--XSKXAA 200
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE ++      KSDV+SFGV+L+EL T ++      P      + +    +  
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNII 380
            +  +  +   +EG                C T +P  RP  + ++D+L  +I
Sbjct: 261 PRNLNPQVAAIIEG----------------CWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 36  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 78
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 79  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 132
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA +       H        
Sbjct: 133 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 189
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 190 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 248

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 16  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 58
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 59  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 112
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA +       H        
Sbjct: 113 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 169
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 228

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 111/240 (46%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 44  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 86
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 87  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 140
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA +       H        
Sbjct: 141 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGS 197
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 256

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/293 (26%), Positives = 127/293 (43%), Gaps = 47/293 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK--EWINEVNFLGVV 152
           IG G FG V           H+   H S  DVA+K L  Q F   +  E++ EV  +  +
Sbjct: 45  IGAGSFGTV-----------HRAEWHGS--DVAVKILMEQDFHAERVNEFLREVAIMKRL 91
Query: 153 KHPNLVKLVGYCAEDDERG-----MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
           +HPN+V  +G   +          + R  +Y L+H     + L  R         RL +A
Sbjct: 92  RHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDER--------RRLSMA 143
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
            D A+G+ YLH   +  ++ R+ K+ N+L+D+ Y  K+ DFGL+R      L        
Sbjct: 144 YDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAA 200
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE ++      KSDV+SFGV+L+EL T ++      P      + +    +  
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEI 260
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNII 380
            +  +  +   +EG                C T +P  RP  + ++D+L  +I
Sbjct: 261 PRNLNPQVAAIIEG----------------CWTNEPWKRPSFATIMDLLRPLI 297

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 43  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 85
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 86  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 139
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 140 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 196
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 197 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 255

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 18  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 60
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 61  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 114
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 115 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 171
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 172 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 230

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 44  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 86
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 87  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 140
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 141 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 197
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 198 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 256

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 16  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 58
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 59  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 112
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 113 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 228

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 21  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 63
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 64  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 117
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 118 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 233

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 110/240 (45%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 21  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 63
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 64  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 117
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 118 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 174
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 175 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 233

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 77/240 (32%), Positives = 109/240 (45%), Gaps = 35/240 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 16  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 58
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY         Q  +V +     SL  HL   + T    I  + IA+ 
Sbjct: 59  RKTRHVNILLFMGYSTAP-----QLAIVTQWCEGSSLYHHL-HIIETKFEMIKLIDIARQ 112
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 113 TAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGS 169
Query: 270 XXYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
             + APE ++       + +SDV++FG+VLYEL+TG+     N+   +Q +    R Y+S
Sbjct: 170 ILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYS-NINNRDQIIFMVGRGYLS 228

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 32  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 74
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL +   T       + IA+ 
Sbjct: 75  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQ 128
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            ARG+ YLH +    +I RD K++NI L ED   K+ DFGLA +       H        
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 270 XXYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGR 303
             + APE ++   +   + +SDV++FG+VLYEL+TG+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 70/221 (31%), Positives = 106/221 (47%), Gaps = 36/221 (16%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG GGFG VYR          + + HD   D++      Q  +  ++   E     ++K
Sbjct: 14  IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDIS------QTIENVRQ---EAKLFAMLK 64
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDAA 211
           HPN++ L G C ++        LV E      L + +LS  R+P  +     +  A   A
Sbjct: 65  HPNIIALRGVCLKEP----NLCLVMEFARGGPL-NRVLSGKRIPPDIL----VNWAVQIA 115
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYK--------AKLSDFGLARQGPPEGLGHXX 263
           RG+ YLH+E    +I RD K+SNIL+ +  +         K++DFGLAR+       H  
Sbjct: 116 RGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW------HRT 169
Query: 264 XXXXXXXXYA--APEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   YA  APE ++    +  SDVWS+GV+L+EL+TG
Sbjct: 170 TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTG 210

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 18  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 70
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 71  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 126
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 127 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 32  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 74
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY         Q  +V +     SL  HL +   T       + IA+ 
Sbjct: 75  RKTRHVNILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQ 128
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            ARG+ YLH +    +I RD K++NI L ED   K+ DFGLA +       H        
Sbjct: 129 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGS 185
Query: 270 XXYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGR 303
             + APE ++   +   + +SDV++FG+VLYEL+TG+
Sbjct: 186 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 79
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 80  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 192
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/236 (28%), Positives = 112/236 (47%), Gaps = 24/236 (10%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQ 134
           VF   E + A    + +  +G+G FG VY GV + V  D+ +T        VAIK +N  
Sbjct: 5   VFVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEA 57
Query: 135 GFQGHK-EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
                + E++NE + +      ++V+L+G  ++    G   L++ ELM    L+ +L S 
Sbjct: 58  ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSL 113
Query: 194 VP--------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
            P         P +    +++A + A G+AYL+     + + RD    N ++ ED+  K+
Sbjct: 114 RPEMENNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKI 170
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFG+ R                   + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 171 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 72/217 (33%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-----RQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K LN      Q  Q  K   NEV  L
Sbjct: 20  IGSGSFGTVYKG-----------KWHG---DVAVKMLNVTAPTPQQLQAFK---NEVGVL 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +      Q  +V +     SL  HL +   T       + IA+ 
Sbjct: 63  RKTRHVNILLFMGYSTKP-----QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQ 116
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            ARG+ YLH +    +I RD K++NI L ED   K+ DFGLA         H        
Sbjct: 117 TARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGS 173
Query: 270 XXYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGR 303
             + APE ++   +   + +SDV++FG+VLYEL+TG+
Sbjct: 174 ILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 210

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GEG FG       +VS   +  +   +   VA+K L    G Q    W  E++ L  + 
Sbjct: 22  LGEGHFG-------KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H +++K  G C +  E+ +Q  LV E +   SL D+L  R    LA +  L  AQ    G
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYL-PRHSIGLAQL--LLFAQQICEG 129
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX--XXXX 271
           +AYLH +     I R+    N+LLD D   K+ DFGLA+   PEG  +            
Sbjct: 130 MAYLHSQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVF 185
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           + APE ++  +    SDVWSFGV LYEL+T
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           LR+    ELK       R  ++G G FG VY+G+           G   K+ VAIK LN 
Sbjct: 32  LRILKETELK-------RVKVLGSGAFGTVYKGI-------WVPEGETVKIPVAIKILNE 77
Query: 134 Q-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM------HNKSL 186
             G + + E+++E   +  + HP+LV+L+G C     + + +L+ +  +      H  ++
Sbjct: 78  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNI 137
Query: 187 EDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS 246
              LL      L W  ++      A+G+ YL E    +L+ RD    N+L+      K++
Sbjct: 138 GSQLL------LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 182
Query: 247 DFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           DFGLAR    +   +          + A E +   + T +SDVWS+GV ++EL+T
Sbjct: 183 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           LR+    ELK       R  ++G G FG VY+G+           G   K+ VAIK LN 
Sbjct: 9   LRILKETELK-------RVKVLGSGAFGTVYKGI-------WVPEGETVKIPVAIKILNE 54
Query: 134 Q-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM------HNKSL 186
             G + + E+++E   +  + HP+LV+L+G C     + + +L+ +  +      H  ++
Sbjct: 55  TTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLEYVHEHKDNI 114
Query: 187 EDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS 246
              LL      L W  ++      A+G+ YL E    +L+ RD    N+L+      K++
Sbjct: 115 GSQLL------LNWCVQI------AKGMMYLEER---RLVHRDLAARNVLVKSPNHVKIT 159
Query: 247 DFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           DFGLAR    +   +          + A E +   + T +SDVWS+GV ++EL+T
Sbjct: 160 DFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 72/210 (34%), Positives = 102/210 (48%), Gaps = 19/210 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GEG FG       +VS   +  +   +   VA+K L    G Q    W  E++ L  + 
Sbjct: 22  LGEGHFG-------KVSLYCYDPTNDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLY 74
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H +++K  G C +  E+ +Q  LV E +   SL D+L  R    LA +  L  AQ    G
Sbjct: 75  HEHIIKYKGCCEDQGEKSLQ--LVMEYVPLGSLRDYL-PRHSIGLAQL--LLFAQQICEG 129
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX--XXXX 271
           +AYLH +     I R+    N+LLD D   K+ DFGLA+   PEG  +            
Sbjct: 130 MAYLHAQ---HYIHRNLAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPVF 185
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           + APE ++  +    SDVWSFGV LYEL+T
Sbjct: 186 WYAPECLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 78
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 79  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 72
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 73  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 36  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 88  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 143
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 144 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPV 200
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 26  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 78
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 79  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 134
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 135 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 191
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 192 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 27  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 79
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 80  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 135
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 136 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 192
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 193 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 85
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 86  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 141
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 23  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 75
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--------PLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 76  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 131
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 132 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 188
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 189 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 33  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 85
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--------PLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 86  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMI 141
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 142 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 198
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 199 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 105/217 (48%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 55  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 107
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 108 NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 163
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R            
Sbjct: 164 QMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGG 220
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 221 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 79/298 (26%), Positives = 123/298 (41%), Gaps = 34/298 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 35  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 87  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 142
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 143 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 199
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            + A E +QT + T KSDVWSFGV+L+EL+T      R  P         +  Y+   ++
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMT------RGAPPYPDVNTFDITVYLLQGRR 253
Query: 331 FHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDE 388
                   L+  YC             C   + + RP  SE+V  +  I S    + E
Sbjct: 254 L-------LQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHE 301

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 55  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 106
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 107 SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 162
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 163 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 219
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 220 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 250

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 29  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 80
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 81  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 136
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 137 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 193
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 194 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 224

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 56  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 107
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 108 SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 163
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 164 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 220
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 221 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 251

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GEG FG       +VS   +  +   +   VA+K L    G Q    W  E+  L  + 
Sbjct: 17  LGEGHFG-------KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 69
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI-AQDAAR 212
           H ++VK  G C +  E+ +Q  LV E +   SL D+L    P     +A+L + AQ    
Sbjct: 70  HEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICE 123
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX--XXX 270
           G+AYLH +     I R     N+LLD D   K+ DFGLA+   PEG  +           
Sbjct: 124 GMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPV 179
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE ++  +    SDVWSFGV LYEL+T
Sbjct: 180 FWYAPECLKECKFYYASDVWSFGVTLYELLT 210

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 37  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 89  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 144
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 145 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 34  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 86  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 141
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 142 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 198
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 32  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 83
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 84  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 139
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 140 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 196
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 197 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 227

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 36  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 87
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 88  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 143
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 144 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 200
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 201 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 231

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 35  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 86
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 87  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 142
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 143 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 199
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 200 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 230

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 38  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 90  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 145
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 146 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 202
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 72/211 (34%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GEG FG       +VS   +  +   +   VA+K L    G Q    W  E+  L  + 
Sbjct: 16  LGEGHFG-------KVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY 68
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI-AQDAAR 212
           H ++VK  G C +  E+ +Q  LV E +   SL D+L    P     +A+L + AQ    
Sbjct: 69  HEHIVKYKGCCEDQGEKSVQ--LVMEYVPLGSLRDYL----PRHCVGLAQLLLFAQQICE 122
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX--XXX 270
           G+AYLH +     I R     N+LLD D   K+ DFGLA+   PEG  +           
Sbjct: 123 GMAYLHAQ---HYIHRALAARNVLLDNDRLVKIGDFGLAK-AVPEGHEYYRVREDGDSPV 178
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE ++  +    SDVWSFGV LYEL+T
Sbjct: 179 FWYAPECLKECKFYYASDVWSFGVTLYELLT 209

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 38  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 89
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 90  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 145
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 146 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPV 202
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 203 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 37  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 89  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 144
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL--GHXXXXXXXXX 270
           G+ YL  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 145 GMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPV 201
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 37  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 89  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 144
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 145 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 64/211 (30%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G + + +D         K+  A+K LNR    G   +++ E   +   
Sbjct: 42  VIGRGHFGCVYHGTL-LDNDG-------KKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 93
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 94  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 149
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 150 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 206
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 207 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 237

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 120/285 (42%), Gaps = 38/285 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + R+G    +++I E   +  + H
Sbjct: 15  IGSGQFGLVHLGYWL------------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 61
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV+E M +  L D+L ++     A    L +  D   G+
Sbjct: 62  PKLVQLYGVCLEQ----APICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 116
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AYL E     +I RD    N L+ E+   K+SDFG+ R    +              +A+
Sbjct: 117 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 172
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE     R ++KSDVWSFGV+++E+ +  +    N   +E          V D      +
Sbjct: 173 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRL 223
Query: 335 IDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNI 379
             PRL   +              C  ++P+ RP  S ++  L  I
Sbjct: 224 YKPRLASTH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEI 261

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 96  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 147
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 148 SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 203
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 204 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 261 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 291

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 63/211 (29%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 37  VIGRGHFGCVYHGTL--------LDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 89  SHPNVLSLLGICLRSEG---SPLVVLPYMKHGDLRNFIRNETHNPTVK-DLIGFGLQVAK 144
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HXXXXXXXXX 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H         
Sbjct: 145 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 201
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + A E +QT + T KSDVWSFGV+L+EL+T
Sbjct: 202 KWMALESLQTQKFTTKSDVWSFGVLLWELMT 232

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/287 (27%), Positives = 121/287 (42%), Gaps = 38/287 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + R+G    +++I E   +  + H
Sbjct: 15  IGSGQFGLVHLGYWL------------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 61
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV+E M +  L D+L ++     A    L +  D   G+
Sbjct: 62  PKLVQLYGVCLEQ----APICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 116
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AYL E     +I RD    N L+ E+   K+SDFG+ R    +              +A+
Sbjct: 117 AYLEEA---SVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 172
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE     R ++KSDVWSFGV+++E+ +  +    N   +E          V D      +
Sbjct: 173 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRL 223
Query: 335 IDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIIS 381
             PRL   +              C  ++P+ RP  S ++  L  I +
Sbjct: 224 YKPRLASTH-------VYQIMNHCWKERPEDRPAFSRLLRQLAAIAA 263

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 104/217 (47%), Gaps = 24/217 (11%)
Query: 95  IGEGGFGCVYRGVVR-VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVV 152
           +G+G FG VY GV + V  D+ +T        VAIK +N       + E++NE + +   
Sbjct: 20  LGQGSFGMVYEGVAKGVVKDEPETR-------VAIKTVNEAASMRERIEFLNEASVMKEF 72
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARL 204
              ++V+L+G  ++    G   L++ ELM    L+ +L S  P         P +    +
Sbjct: 73  NCHHVVRLLGVVSQ----GQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSLSKMI 128
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           ++A + A G+AYL+     + + RD    N  + ED+  K+ DFG+ R            
Sbjct: 129 QMAGEIADGMAYLNAN---KFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGG 185
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + +PE ++ G  T  SDVWSFGVVL+E+ T
Sbjct: 186 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 120/285 (42%), Gaps = 38/285 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + R+G    +++I E   +  + H
Sbjct: 13  IGSGQFGLVHLGYWL------------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 59
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV+E M +  L D+L ++     A    L +  D   G+
Sbjct: 60  PKLVQLYGVCLEQ----APICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 114
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AYL E     +I RD    N L+ E+   K+SDFG+ R    +              +A+
Sbjct: 115 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 170
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE     R ++KSDVWSFGV+++E+ +  +    N   +E          V D      +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRL 221
Query: 335 IDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNI 379
             PRL   +              C  ++P+ RP  S ++  L  I
Sbjct: 222 YKPRLASTH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEI 259

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 120/285 (42%), Gaps = 38/285 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + R+G    +++I E   +  + H
Sbjct: 18  IGSGQFGLVHLGYWL------------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 64
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV+E M +  L D+L ++     A    L +  D   G+
Sbjct: 65  PKLVQLYGVCLEQ----APICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 119
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AYL E     +I RD    N L+ E+   K+SDFG+ R    +              +A+
Sbjct: 120 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 175
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE     R ++KSDVWSFGV+++E+ +  +    N   +E          V D      +
Sbjct: 176 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRL 226
Query: 335 IDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNI 379
             PRL   +              C  ++P+ RP  S ++  L  I
Sbjct: 227 YKPRLASTH-------VYQIMNHCWRERPEDRPAFSRLLRQLAEI 264

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 83/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGLAR 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLARV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 24/231 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ +       K+ VA+K L        K++  E   L  ++H
Sbjct: 21  LGEGAFGKVFL------AECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQH 74
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMH----NKSLEDHLLSRV-------PTPLAWIAR 203
            ++VK  G C E D      ++V+E M     NK L  H    V       PT L     
Sbjct: 75  EHIVKFYGVCVEGDPL----IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQM 130
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXX 263
           L IAQ  A G+ YL  +     + RD  T N L+ E+   K+ DFG++R           
Sbjct: 131 LHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVG 187
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                   +  PE +   + T +SDVWS GVVL+E+ T  +     L  NE
Sbjct: 188 GHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE 238

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/212 (33%), Positives = 100/212 (47%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           +GEG FG       +VS   +  +   +   VA+K L       H+  W  E++ L  + 
Sbjct: 39  LGEGHFG-------KVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY 91
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H +++K  G C +     +Q  LV E +   SL D+L  R    LA +  L  AQ    G
Sbjct: 92  HEHIIKYKGCCEDAGAASLQ--LVMEYVPLGSLRDYL-PRHSIGLAQL--LLFAQQICEG 146
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX----XX 269
           +AYLH +     I RD    N+LLD D   K+ DFGLA+  P    GH            
Sbjct: 147 MAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE---GHEXYRVREDGDSP 200
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             + APE ++  +    SDVWSFGV LYEL+T
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 80/300 (26%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 19  LGGGQFGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 66
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 67  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T G        P    +LLE      RP     K
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEK 238
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 239 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 277

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 83/330 (25%), Positives = 145/330 (43%), Gaps = 49/330 (14%)
Query: 70  RANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK 129
           R +   V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK
Sbjct: 17  RGSTQTVHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIK 67
Query: 130 QLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE 187
            L + G+  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL 
Sbjct: 68  TL-KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL- 121
Query: 188 DHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
           D  L +       I  + + +  A G+ YL    D   + RD    NIL++ +   K+SD
Sbjct: 122 DSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSD 178
Query: 248 FGLAR--QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRR 304
           FGL+R  +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R
Sbjct: 179 FGLSRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGER 237
Query: 305 AV----ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLT 360
                  +++ +   +      P    +  + L++D                     C  
Sbjct: 238 PYWEMSNQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQ 276
Query: 361 KQPKSRPKMSEVVDILGNIISEISSQDEVT 390
           K   +RPK  ++V IL  +I    S   +T
Sbjct: 277 KDRNNRPKFEQIVSILDKLIRNPGSLKIIT 306

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGFVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 77/296 (26%), Positives = 133/296 (44%), Gaps = 48/296 (16%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V  G +++            +L VAIK L + G+  +  ++++ E + +G 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGK--------RELPVAIKTL-KVGYTEKQRRDFLGEASIMGQ 79
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN++ L G       +    ++V E M N SL D  L +       I  + + +  +
Sbjct: 80  FDHPNIIHLEGVVT----KSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGIS 134
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHXXXXXXXX 269
            G+ YL    D   + RD    NIL++ +   K+SDFGL+R  +  PE   +        
Sbjct: 135 AGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEA-AYTTRGGKIP 190
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE----WVRPY 324
             + APE +   + T+ SDVWS+G+V++E+++ G R       ++  K +E       P 
Sbjct: 191 IRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPM 250
Query: 325 VSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNII 380
              +  + L++D                     C  K+  SRPK  E+V++L  +I
Sbjct: 251 DCPAALYQLMLD---------------------CWQKERNSRPKFDEIVNMLDKLI 285

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 109/216 (50%), Gaps = 21/216 (9%)
Query: 90  SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK--EWINEVN 147
           +R  +IG G FG VY+G+++ SS   +       + VAIK L + G+   +  +++ E  
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKE-------VPVAIKTL-KAGYTEKQRVDFLGEAG 98
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +G   H N+++L G  ++        +++ E M N +L D  L       + +  + + 
Sbjct: 99  IMGQFSHHNIIRLEGVISKYKPM----MIITEYMENGAL-DKFLREKDGEFSVLQLVGML 153
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHXXXX 265
           +  A G+ YL    +   + RD    NIL++ +   K+SDFGL+R  +  PE   +    
Sbjct: 154 RGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-YTTSG 209
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 + APE +   + T+ SDVWSFG+V++E++T
Sbjct: 210 GKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 33  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 82
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 83  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 137
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 138 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 194
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 195 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 253
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 254 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 292
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 293 PKFEQIVSILDKLIRNPGSLKIIT 316

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 119/285 (41%), Gaps = 38/285 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + R+G    +++I E   +  + H
Sbjct: 16  IGSGQFGLVHLGYWL------------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 62
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV E M +  L D+L ++     A    L +  D   G+
Sbjct: 63  PKLVQLYGVCLEQ----APICLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 117
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AYL E     +I RD    N L+ E+   K+SDFG+ R    +              +A+
Sbjct: 118 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 173
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE     R ++KSDVWSFGV+++E+ +  +    N   +E          V D      +
Sbjct: 174 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRL 224
Query: 335 IDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNI 379
             PRL   +              C  ++P+ RP  S ++  L  I
Sbjct: 225 YKPRLASTH-------VYQIMNHCWRERPEDRPAFSRLLRQLAEI 262

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 124/300 (41%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 19  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 66
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 67  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFT-AHAGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T G        P    +LLE      RP     K
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEK 238
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 239 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 277

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEXMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEXMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGAVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 55
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 56  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 110
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 167
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 168 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 227 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 265
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 266 PKFEQIVSILDKLIRNPGSLKIIT 289

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 143/324 (44%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 6   VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 55
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 56  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEXMENGSL-DSFLRK 110
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL+R 
Sbjct: 111 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLSRV 167
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 168 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 226
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 227 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 265
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 266 PKFEQIVSILDKLIRNPGSLKIIT 289

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 82/324 (25%), Positives = 142/324 (43%), Gaps = 49/324 (15%)
Query: 76  VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG 135
           V  FA+   AT   S   ++G G FG V  G +++ S          ++ VAIK L + G
Sbjct: 35  VHEFAKELDATN-ISIDKVVGAGEFGEVCSGRLKLPSK--------KEISVAIKTL-KVG 84
Query: 136 F--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
           +  +  ++++ E + +G   HPN+++L G       +    ++V E M N SL D  L +
Sbjct: 85  YTEKQRRDFLGEASIMGQFDHPNIIRLEGVVT----KSKPVMIVTEYMENGSL-DSFLRK 139
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                  I  + + +  A G+ YL    D   + RD    NIL++ +   K+SDFGL R 
Sbjct: 140 HDAQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRV 196
Query: 253 -QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV---- 306
            +  PE   +          + +PE +   + T+ SDVWS+G+VL+E+++ G R      
Sbjct: 197 LEDDPEA-AYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMS 255
Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
            +++ +   +      P    +  + L++D                     C  K   +R
Sbjct: 256 NQDVIKAVDEGYRLPPPMDCPAALYQLMLD---------------------CWQKDRNNR 294
Query: 367 PKMSEVVDILGNIISEISSQDEVT 390
           PK  ++V IL  +I    S   +T
Sbjct: 295 PKFEQIVSILDKLIRNPGSLKIIT 318

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 119/285 (41%), Gaps = 38/285 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + ++G     ++I E   +  + H
Sbjct: 35  IGSGQFGLVHLGYWL------------NKDKVAIKTI-KEGSMSEDDFIEEAEVMMKLSH 81
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV+E M +  L D+L ++     A    L +  D   G+
Sbjct: 82  PKLVQLYGVCLEQ----APICLVFEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 136
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AYL E     +I RD    N L+ E+   K+SDFG+ R    +              +A+
Sbjct: 137 AYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWAS 192
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE     R ++KSDVWSFGV+++E+ +  +    N   +E          V D      +
Sbjct: 193 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---------VVEDISTGFRL 243
Query: 335 IDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNI 379
             PRL   +              C  ++P+ RP  S ++  L  I
Sbjct: 244 YKPRLASTH-------VYQIMNHCWKERPEDRPAFSRLLRQLAEI 281

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ H       K+ VA+K L        +++  E   L +++H
Sbjct: 26  LGEGAFGKVF------LAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH 79
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-------------VPTPLAWI 201
            ++V+  G C E    G   L+V+E M +  L   L S               P PL   
Sbjct: 80  QHIVRFFGVCTE----GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 135
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L +A   A G+ YL        + RD  T N L+ +    K+ DFG++R         
Sbjct: 136 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 192
Query: 262 XXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                     +  PE +   + T +SDVWSFGVVL+E+ T
Sbjct: 193 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 232

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ H       K+ VA+K L        +++  E   L +++H
Sbjct: 20  LGEGAFGKVFL------AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-------------VPTPLAWI 201
            ++V+  G C E    G   L+V+E M +  L   L S               P PL   
Sbjct: 74  QHIVRFFGVCTE----GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 129
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L +A   A G+ YL        + RD  T N L+ +    K+ DFG++R         
Sbjct: 130 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 186
Query: 262 XXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                     +  PE +   + T +SDVWSFGVVL+E+ T
Sbjct: 187 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 226

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 25  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 79  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + RD    N ++  D+  K+ DFG+ R             
Sbjct: 135 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGK 191
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
                 + APE ++ G  T  SD+WSFGVVL+E+ +      + L  NEQ L      +V
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVL-----KFV 245
Query: 326 SDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
            D            + + C             C    PK RP   E+V++L
Sbjct: 246 MDGGYLD-------QPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 61/220 (27%), Positives = 93/220 (42%), Gaps = 26/220 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ H       K+ VA+K L        +++  E   L +++H
Sbjct: 49  LGEGAFGKVFL------AECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH 102
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-------------VPTPLAWI 201
            ++V+  G C E    G   L+V+E M +  L   L S               P PL   
Sbjct: 103 QHIVRFFGVCTE----GRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L +A   A G+ YL        + RD  T N L+ +    K+ DFG++R         
Sbjct: 159 QLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215
Query: 262 XXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                     +  PE +   + T +SDVWSFGVVL+E+ T
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT 255

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 22  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 75
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 76  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 131
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + RD    N ++  D+  K+ DFG+ R             
Sbjct: 132 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGK 188
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
                 + APE ++ G  T  SD+WSFGVVL+E+ +      + L  NEQ L      +V
Sbjct: 189 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVL-----KFV 242
Query: 326 SDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
            D            + + C             C    PK RP   E+V++L
Sbjct: 243 MDGGYLD-------QPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLL 283

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 22  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 69  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 123
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 124 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTA 179
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 180 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 209

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 23  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 69
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 70  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 125 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 181 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 210

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 25  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 79  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + RD    N ++  D+  K+ DFG+ R             
Sbjct: 135 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGK 191
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 + APE ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 21  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 68  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEXTAREGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 27  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 74  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 128
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 129 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTA 184
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 117/302 (38%), Gaps = 43/302 (14%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G G FG V +   R               DVAIKQ+  +  +  K +I E+  L  V 
Sbjct: 15  VVGRGAFGVVCKAKWRAK-------------DVAIKQIESESER--KAFIVELRQLSRVN 59
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR-LKIAQDAAR 212
           HPN+VKL G C           LV E     SL + L    P P    A  +      ++
Sbjct: 60  HPNIVKLYGACLNP------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 113
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHXXXXXXXXXX 271
           G+AYLH      LI RD K  N+LL       K+ DFG A       +            
Sbjct: 114 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAA 168
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           + APE  +    + K DV+S+G++L+E+IT R+  +           E   P        
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-----------EIGGPAFRIMWAV 217
Query: 332 HLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTL 391
           H    P L  N               C +K P  RP M E+V I+ +++      DE   
Sbjct: 218 HNGTRPPLIKN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 273
Query: 392 QP 393
            P
Sbjct: 274 YP 275

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 30  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 76
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 77  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 131
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 132 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTA 187
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 188 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 217

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 29  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 75
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 76  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 130
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 131 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTA 186
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 187 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 25  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 79  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + RD    N ++  D+  K+ DFG+ R             
Sbjct: 135 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGK 191
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
                 + APE ++ G  T  SD+WSFGVVL+E+ +      + L  NEQ L      +V
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVL-----KFV 245
Query: 326 SDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
            D            + + C             C    PK RP   E+V++L
Sbjct: 246 MDGGYLD-------QPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 21  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 68  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEXTAREGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 84.0 bits (206), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 83/302 (27%), Positives = 117/302 (38%), Gaps = 43/302 (14%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G G FG V +   R               DVAIKQ+  +  +  K +I E+  L  V 
Sbjct: 16  VVGRGAFGVVCKAKWRAK-------------DVAIKQIESESER--KAFIVELRQLSRVN 60
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR-LKIAQDAAR 212
           HPN+VKL G C           LV E     SL + L    P P    A  +      ++
Sbjct: 61  HPNIVKLYGACLNP------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQ 114
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHXXXXXXXXXX 271
           G+AYLH      LI RD K  N+LL       K+ DFG A       +            
Sbjct: 115 GVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAA 169
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           + APE  +    + K DV+S+G++L+E+IT R+  +           E   P        
Sbjct: 170 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFD-----------EIGGPAFRIMWAV 218
Query: 332 HLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTL 391
           H    P L  N               C +K P  RP M E+V I+ +++      DE   
Sbjct: 219 HNGTRPPLIKN----LPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQ 274
Query: 392 QP 393
            P
Sbjct: 275 YP 276

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/301 (25%), Positives = 135/301 (44%), Gaps = 48/301 (15%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V  G +++             + VAIK L + G+  +  ++++ E + +G 
Sbjct: 50  VIGAGEFGEVCSGRLKLPGK--------RDVAVAIKTL-KVGYTEKQRRDFLCEASIMGQ 100
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN+V L G       RG   ++V E M N +L D  L +       I  + + +  A
Sbjct: 101 FDHPNVVHLEGVVT----RGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIA 155
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHXXXXXXXX 269
            G+ YL    D   + RD    NIL++ +   K+SDFGL+R  +  PE + +        
Sbjct: 156 AGMRYL---ADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAV-YTTTGGKIP 211
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV----ERNLPRNEQKLLEWVRPY 324
             + APE +Q  + T+ SDVWS+G+V++E+++ G R       +++ +  ++      P 
Sbjct: 212 VRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPAPM 271
Query: 325 VSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEIS 384
              +    L++D                     C  K+   RPK  ++V IL  +I   +
Sbjct: 272 DCPAGLHQLMLD---------------------CWQKERAERPKFEQIVGILDKMIRNPN 310
Query: 385 S 385
           S
Sbjct: 311 S 311

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 16  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 62
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 63  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 117
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 118 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTA 173
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 174 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 203

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 21  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 68  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 27  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 74  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 128
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 129 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTA 184
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 185 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 214

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 123/299 (41%), Gaps = 46/299 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 19  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 66
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 67  PNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 123 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T G        P    +LLE      RP     K
Sbjct: 179 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDYRMERPEGCPEK 238
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDE 388
            + L+                       C    P  RP  +E+      +  E S  DE
Sbjct: 239 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDE 276

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 26  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 73  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 128 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 184 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 213

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 31  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 77
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 78  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 132
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 133 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DNEYTAREGAKFPIKWTA 188
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 189 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 218

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 25  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 79  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + RD    N ++  D+  K+ DFG+ R             
Sbjct: 135 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 191
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
                 + APE ++ G  T  SD+WSFGVVL+E+ +      + L  NEQ L      +V
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQVL-----KFV 245
Query: 326 SDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
            D            + + C             C    PK RP   E+V++L
Sbjct: 246 MDGGYLD-------QPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLL 286

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 63/238 (26%), Positives = 114/238 (47%), Gaps = 31/238 (13%)
Query: 77  FSFAELKSATRGFSRAL---------LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVA 127
           F+F +   A R F++ +         +IG G FG V  G ++V            ++ VA
Sbjct: 10  FTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGK--------REICVA 61
Query: 128 IKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           IK L + G+  +  +++++E + +G   HPN++ L G       +    +++ E M N S
Sbjct: 62  IKTL-KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVT----KCKPVMIITEYMENGS 116
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D  L +       I  + + +    G+ YL    D   + RD    NIL++ +   K+
Sbjct: 117 L-DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSAVHRDLAARNILVNSNLVCKV 172
Query: 246 SDFGLAR--QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           SDFG++R  +  PE   +          + APE +   + T+ SDVWS+G+V++E+++
Sbjct: 173 SDFGMSRVLEDDPEA-AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 229

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 125/291 (42%), Gaps = 38/291 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 24  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 77
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 78  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 133
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + RD    N ++  D+  K+ DFG+ R             
Sbjct: 134 MAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
                 + APE ++ G  T  SD+WSFGVVL+E+ +      + L  NEQ     V  +V
Sbjct: 191 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGL-SNEQ-----VLKFV 244
Query: 326 SDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
            D            + + C             C    PK RP   E+V++L
Sbjct: 245 MDGGYLD-------QPDNC---PERVTDLMRMCWQFNPKMRPTFLEIVNLL 285

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/239 (26%), Positives = 113/239 (47%), Gaps = 31/239 (12%)
Query: 77  FSFAELKSATRGFSRAL---------LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVA 127
           F+F +   A R F++ +         +IG G FG V  G +++            ++ VA
Sbjct: 14  FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGK--------REIFVA 65
Query: 128 IKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           IK L + G+  +  +++++E + +G   HPN++ L G       +    +++ E M N S
Sbjct: 66  IKTL-KSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVT----KSTPVMIITEFMENGS 120
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D  L +       I  + + +  A G+ YL    D   + RD    NIL++ +   K+
Sbjct: 121 L-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYL---ADMNYVHRDLAARNILVNSNLVCKV 176
Query: 246 SDFGLAR---QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           SDFGL+R       +              + APE +Q  + T+ SDVWS+G+V++E+++
Sbjct: 177 SDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 235

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 21  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 69  PNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 241 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 74  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 129
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 185
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 246 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 284

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 21  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 69  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 241 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 21  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 69  PNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 241 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 21  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 69  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 240
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 241 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 279

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 17  LGAGQFGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 63
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 64  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 118
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I R+ + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 119 AFIEER---NYIHRNLRAANILVSDTLSCKIADFGLARL-IEDNEYTAREGAKFPIKWTA 174
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 175 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 204

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 136/321 (42%), Gaps = 57/321 (17%)
Query: 78  SFAELKSATRGFSRAL---------LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAI 128
           ++ E   A R F+R +         +IG G  G V  G +RV             + VAI
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ--------RDVPVAI 82
Query: 129 KQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSL 186
           K L + G+  +  +++++E + +G   HPN+++L G       RG   ++V E M N SL
Sbjct: 83  KAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMIVTEYMENGSL 137
Query: 187 EDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS 246
            D  L         +  + + +    G+ YL    D   + RD    N+L+D +   K+S
Sbjct: 138 -DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 247 DFGLAR--QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GR 303
           DFGL+R  +  P+   +          + APE +     ++ SDVWSFGVV++E++  G 
Sbjct: 194 DFGLSRVLEDDPDA-AYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 304 RA----VERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCL 359
           R       R++  + ++      P         L++D                     C 
Sbjct: 253 RPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLD---------------------CW 291
Query: 360 TKQPKSRPKMSEVVDILGNII 380
            K    RP+ S++V +L  +I
Sbjct: 292 HKDRAQRPRFSQIVSVLDALI 312

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/216 (31%), Positives = 98/216 (45%), Gaps = 34/216 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-----NRQGFQGHKEWINEVNFL 149
           IG G FG VY+G             H    DVA+K L       + FQ  +   NEV  L
Sbjct: 44  IGSGSFGTVYKG-----------KWHG---DVAVKILKVVDPTPEQFQAFR---NEVAVL 86
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +H N++  +GY  +D+       +V +     SL  HL  +  T       + IA+ 
Sbjct: 87  RKTRHVNILLFMGYMTKDN-----LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQ 140
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ YLH +    +I RD K++NI L E    K+ DFGLA                  
Sbjct: 141 TAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGS 197
Query: 270 XXYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITG 302
             + APE ++       + +SDV+S+G+VLYEL+TG
Sbjct: 198 VLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTG 233

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 71/238 (29%), Positives = 107/238 (44%), Gaps = 25/238 (10%)
Query: 73  DLRVFSFAELKSATRGFSRAL-----LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVA 127
           DL     AE+K       R +     +IG+G FG VY G               +++  A
Sbjct: 2   DLDSALLAEVKDVLIPHERVVTHSDRVIGKGHFGVVYHG--------EYIDQAQNRIQCA 53
Query: 128 IKQLNR-QGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSL 186
           IK L+R    Q  + ++ E   +  + HPN++ L+G     +  G+  +L+  + H   L
Sbjct: 54  IKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPE--GLPHVLLPYMCHGDLL 111
Query: 187 EDHLLSRVPTPLAWIARL-KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           +     R P     +  L       ARG+ YL E+   + + RD    N +LDE +  K+
Sbjct: 112 Q---FIRSPQRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKV 165
Query: 246 SDFGLARQGPPEGL--GHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +DFGLAR                     + A E +QT R T KSDVWSFGV+L+EL+T
Sbjct: 166 ADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLT 223

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 56  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 109
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 110 HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 165
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR     G       
Sbjct: 166 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 222
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 223 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 99/213 (46%), Gaps = 32/213 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 22  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 69
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 70  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 125
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR------QGPPEGLGHXXXXXXX 268
            YL ++     I RD    N L+ E++  K++DFGL+R         P G          
Sbjct: 126 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG-------AKF 175
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
              + APE +   + + KSDVW+FGV+L+E+ T
Sbjct: 176 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 79/306 (25%), Positives = 126/306 (41%), Gaps = 58/306 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 23  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 70
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 71  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR------QGPPEGLGHXXXXXXX 268
            YL ++     I RD    N L+ E++  K++DFGL+R         P G          
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAG-------AKF 176
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRP 323
              + APE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP
Sbjct: 177 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 236
Query: 324 YVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEI 383
                K + L+                       C    P  RP  +E+      +  E 
Sbjct: 237 EGCPEKVYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQES 275
Query: 384 SSQDEV 389
           S  DEV
Sbjct: 276 SISDEV 281

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 66/216 (30%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 79  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 133 HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR     G       
Sbjct: 189 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGC 245
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/221 (26%), Positives = 94/221 (42%), Gaps = 27/221 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+       ++ +  S    K+ VA+K L        K++  E   L  ++H
Sbjct: 23  LGEGAFGKVFL------AECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 76
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWI------------- 201
            ++VK  G C + D      ++V+E M +  L   L +  P  +  +             
Sbjct: 77  EHIVKFYGVCGDGDPL----IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132
Query: 202 -ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
              L IA   A G+ YL  +     + RD  T N L+  +   K+ DFG++R        
Sbjct: 133 SQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYY 189
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                      +  PE +   + T +SDVWSFGV+L+E+ T
Sbjct: 190 RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFT 230

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 74  PNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 185
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +   + + KSDVW+FGV+L+E+ T
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 34  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 81
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 82  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 137
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 138 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 193
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 194 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 253
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 254 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 292

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 25  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 78
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 79  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 134
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + R+    N ++  D+  K+ DFG+ R             
Sbjct: 135 MAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 191
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 + APE ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 192 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 103/233 (44%), Gaps = 42/233 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHK-EWINEVNFLG 150
           IGEG FG V++          +  G   ++    VA+K L  +     + ++  E   + 
Sbjct: 55  IGEGAFGRVFQA---------RAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMA 105
Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS------------------ 192
              +PN+VKL+G CA     G    L++E M    L + L S                  
Sbjct: 106 EFDNPNIVKLLGVCA----VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRA 161
Query: 193 RV----PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDF 248
           RV    P PL+   +L IA+  A G+AYL E    + + RD  T N L+ E+   K++DF
Sbjct: 162 RVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADF 218
Query: 249 GLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           GL+R                   +  PE +   R T +SDVW++GVVL+E+ +
Sbjct: 219 GLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 63/210 (30%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G  G V+ G           +GH     VA+K L +QG      ++ E N +  ++H
Sbjct: 21  LGAGQAGEVWMGYY---------NGHTK---VAVKSL-KQGSMSPDAFLAEANLMKQLQH 67
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 68  QRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ E      I RD + +NIL+ +    K++DFGLAR    +              + A
Sbjct: 123 AFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIE-DAEXTAREGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE +  G  T KSDVWSFG++L E++T  R
Sbjct: 179 PEAINYGTFTIKSDVWSFGILLTEIVTHGR 208

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 23  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 70
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 71  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 182
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 242
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 243 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 281

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 74  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 185
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 245
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 246 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 284

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 74  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 185
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +   + + KSDVW+FGV+L+E+ T
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 77/300 (25%), Positives = 125/300 (41%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 23  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 70
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 71  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 126
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 127 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 182
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 183 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 242
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 243 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 281

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVV 152
           +IGEG FG V +   R+  D         ++D AIK++     +  H+++  E+  L  +
Sbjct: 22  VIGEGNFGQVLKA--RIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 72
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIAR------ 203
             HPN++ L+G C   + RG   L +    H   L+    SRV    P   IA       
Sbjct: 73  GHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 129
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                L  A D ARG+ YL ++   Q I RD    NIL+ E+Y AK++DFGL+R    + 
Sbjct: 130 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG---QE 183
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +            + A E +     T  SDVWS+GV+L+E+++
Sbjct: 184 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 226

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/216 (26%), Positives = 102/216 (47%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G+G FG VY G  R           +++  VA+K +N     +   E++NE + +    
Sbjct: 26  LGQGSFGMVYEGNAR------DIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT 79
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  +    +G   L+V ELM +  L+ +L S  P         P      ++
Sbjct: 80  CHHVVRLLGVVS----KGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQ 135
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A + A G+AYL+ +   + + R+    N ++  D+  K+ DFG+ R             
Sbjct: 136 MAAEIADGMAYLNAK---KFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 + APE ++ G  T  SD+WSFGVVL+E+ +
Sbjct: 193 GLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVV 152
           +IGEG FG V +   R+  D         ++D AIK++     +  H+++  E+  L  +
Sbjct: 32  VIGEGNFGQVLKA--RIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 82
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIAR------ 203
             HPN++ L+G C   + RG   L +    H   L+    SRV    P   IA       
Sbjct: 83  GHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 139
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                L  A D ARG+ YL ++   Q I RD    NIL+ E+Y AK++DFGL+R    + 
Sbjct: 140 SSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG---QE 193
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +            + A E +     T  SDVWS+GV+L+E+++
Sbjct: 194 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 236

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 22  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 69
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 70  PNLVQLLGVCT----REPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 125
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 126 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTA 181
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +   + + KSDVW+FGV+L+E+ T
Sbjct: 182 PESLAYNKFSIKSDVWAFGVLLWEIAT 208

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 25  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 73  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 128
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 129 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 184
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +   + + KSDVW+FGV+L+E+ T
Sbjct: 185 PESLAYNKFSIKSDVWAFGVLLWEIAT 211

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 26  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 74  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 129
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 130 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXT-AHAGAKFPIKWTA 185
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +   + + KSDVW+FGV+L+E+ T
Sbjct: 186 PESLAYNKFSIKSDVWAFGVLLWEIAT 212

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 21  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 69  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +   + + KSDVW+FGV+L+E+ T
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 98/207 (47%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 21  LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 69  PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 125 EYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +   + + KSDVW+FGV+L+E+ T
Sbjct: 181 PESLAYNKFSIKSDVWAFGVLLWEIAT 207

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 24/229 (10%)
Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           LR+    EL+       +  ++G G FG VY+G+           G + K+ VAIK L  
Sbjct: 11  LRILKETELR-------KVKVLGSGAFGTVYKGI-------WIPDGENVKIPVAIKVLRE 56
Query: 134 Q-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS 192
               + +KE ++E   +  V  P + +L+G C     + + +L+ Y  + +   E+    
Sbjct: 57  NTSPKANKEILDEAYVMAGVGSPYVSRLLGICLTSTVQLVTQLMPYGCLLDHVRENRGRL 116
Query: 193 RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
                L W  ++      A+G++YL    D +L+ RD    N+L+      K++DFGLAR
Sbjct: 117 GSQDLLNWCMQI------AKGMSYLE---DVRLVHRDLAARNVLVKSPNHVKITDFGLAR 167
Query: 253 QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
               +   +          + A E +   R T +SDVWS+GV ++EL+T
Sbjct: 168 LLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMT 216

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 80/321 (24%), Positives = 135/321 (42%), Gaps = 57/321 (17%)
Query: 78  SFAELKSATRGFSRAL---------LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAI 128
           ++ E   A R F+R +         +IG G  G V  G +RV             + VAI
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQ--------RDVPVAI 82
Query: 129 KQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSL 186
           K L + G+  +  +++++E + +G   HPN+++L G       RG   ++V E M N SL
Sbjct: 83  KAL-KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVT----RGRLAMIVTEYMENGSL 137
Query: 187 EDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS 246
            D  L         +  + + +    G+ YL    D   + RD    N+L+D +   K+S
Sbjct: 138 -DTFLRTHDGQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVS 193
Query: 247 DFGLAR--QGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GR 303
           DFGL+R  +  P+              + APE +     ++ SDVWSFGVV++E++  G 
Sbjct: 194 DFGLSRVLEDDPDA-AXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 304 RA----VERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCL 359
           R       R++  + ++      P         L++D                     C 
Sbjct: 253 RPYWNMTNRDVISSVEEGYRLPAPMGCPHALHQLMLD---------------------CW 291
Query: 360 TKQPKSRPKMSEVVDILGNII 380
            K    RP+ S++V +L  +I
Sbjct: 292 HKDRAQRPRFSQIVSVLDALI 312

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V  G  R +              VA+K +        + ++ E + +  ++H
Sbjct: 14  IGKGEFGDVMLGDYRGNK-------------VAVKCIKNDATA--QAFLAEASVMTQLRH 58
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G   E  E+G    +V E M   SL D+L SR  + L     LK + D    +
Sbjct: 59  SNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 115
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL        + RD    N+L+ ED  AK+SDFGL ++                  + A
Sbjct: 116 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTA 167
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP 311
           PE ++  + + KSDVWSFG++L+E+ +  R     +P
Sbjct: 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 204

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 76/300 (25%), Positives = 126/300 (42%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 228 LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 275
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 276 PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I R+    N L+ E++  K++DFGL+R    +              + A
Sbjct: 332 EYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 387
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 447
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 448 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V  G  R +              VA+K +        + ++ E + +  ++H
Sbjct: 201 IGKGEFGDVMLGDYRGNK-------------VAVKCIKNDATA--QAFLAEASVMTQLRH 245
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G   E  E+G    +V E M   SL D+L SR  + L     LK + D    +
Sbjct: 246 SNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL        + RD    N+L+ ED  AK+SDFGL ++                  + A
Sbjct: 303 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTA 354
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP 311
           PE ++  + + KSDVWSFG++L+E+ +  R     +P
Sbjct: 355 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 391

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 100/217 (46%), Gaps = 26/217 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V  G  R +              VA+K +        + ++ E + +  ++H
Sbjct: 29  IGKGEFGDVMLGDYRGNK-------------VAVKCIKNDATA--QAFLAEASVMTQLRH 73
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G   E  E+G    +V E M   SL D+L SR  + L     LK + D    +
Sbjct: 74  SNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL        + RD    N+L+ ED  AK+SDFGL ++                  + A
Sbjct: 131 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTA 182
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP 311
           PE ++  + + KSDVWSFG++L+E+ +  R     +P
Sbjct: 183 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIP 219

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 102
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L +     +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 103 LRDYLQAHAER-IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 158
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/227 (30%), Positives = 105/227 (46%), Gaps = 24/227 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G              +    VAIK L + G    + ++ E   +  +KH
Sbjct: 17  LGNGQFGEVWMGT------------WNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKH 63
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M+  SL D L       L     + +A   A G+
Sbjct: 64  DKLVQLYAVVSEEP-----IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM 118
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  I RD +++NIL+      K++DFGLAR    +              + A
Sbjct: 119 AYI-ERMNY--IHRDLRSANILVGNGLICKIADFGLARL-IEDNEXTARQGAKFPIKWTA 174
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
           PE    GR T KSDVWSFG++L EL+T  R     +  N +++LE V
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM--NNREVLEQV 219

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 41  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 98
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 99  LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 154
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 155 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V RG ++                VAIK L + G+  +  +E+++E + +G 
Sbjct: 23  VIGAGEFGEVCRGRLKAPGKKESC--------VAIKTL-KGGYTERQRREFLSEASIMGQ 73
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
            +HPN+++L G         M  +++ E M N +L D  L         I  + + +  A
Sbjct: 74  FEHPNIIRLEGVVTNS----MPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIA 128
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---QGPPEGLGHXXXXXXX 268
            G+ YL E      + RD    NIL++ +   K+SDFGL+R   +   +           
Sbjct: 129 SGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKI 185
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
              + APE +   + T+ SD WS+G+V++E+++
Sbjct: 186 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 218

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 64/217 (29%), Positives = 99/217 (45%), Gaps = 26/217 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V  G  R +              VA+K +        + ++ E + +  ++H
Sbjct: 20  IGKGEFGDVMLGDYRGNK-------------VAVKCIKNDATA--QAFLAEASVMTQLRH 64
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G   E  E+G    +V E M   SL D+L SR  + L     LK + D    +
Sbjct: 65  SNLVQLLGVIVE--EKG-GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 121
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL        + RD    N+L+ ED  AK+SDFGL ++                  + A
Sbjct: 122 EYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEA-----SSTQDTGKLPVKWTA 173
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP 311
           PE ++    + KSDVWSFG++L+E+ +  R     +P
Sbjct: 174 PEALREAAFSTKSDVWSFGILLWEIYSFGRVPYPRIP 210

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 99
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 100 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 47  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 104
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 105 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 160
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 161 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 49  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 106
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 107 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 162
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 163 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +  + 
Sbjct: 39  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN 92
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 93  HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 149 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 40  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 97
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 98  LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 153
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 154 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 46  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 103
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 104 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 159
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 160 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKIRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 106/223 (47%), Gaps = 33/223 (14%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVV 152
           +IGEG FG V +   R+  D         ++D AIK++     +  H+++  E+  L  +
Sbjct: 29  VIGEGNFGQVLKA--RIKKDG-------LRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 79
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIAR------ 203
             HPN++ L+G C   + RG   L +    H   L+    SRV    P   IA       
Sbjct: 80  GHHPNIINLLGAC---EHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTL 136
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                L  A D ARG+ YL ++   Q I R+    NIL+ E+Y AK++DFGL+R    + 
Sbjct: 137 SSQQLLHFAADVARGMDYLSQK---QFIHRNLAARNILVGENYVAKIADFGLSRG---QE 190
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +            + A E +     T  SDVWS+GV+L+E+++
Sbjct: 191 VYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 233

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 117
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 118 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 173
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 99
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 100 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155
Query: 246 SDFGLARQGPPEG-LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +               + APE +   + +  SDVWSFGVVLYEL T
Sbjct: 156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 102
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 103 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 158
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINE 145
           R   R   +GEG FG       +V    +   G ++   VA+K L  +    H  +   E
Sbjct: 21  RFLKRIRDLGEGHFG-------KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 73
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +  L  + H N+VK  G C ED   G++  L+ E + + SL+++L  +    +    +LK
Sbjct: 74  IEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLK 130
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
            A    +G+ YL      Q + RD    N+L++ +++ K+ DFGL +    +        
Sbjct: 131 YAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 187
Query: 266 XXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  APE +   +    SDVWSFGV L+EL+T
Sbjct: 188 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 224

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 48  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 105
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 106 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 161
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 162 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 192 LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 239 EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 294 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 349
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 42  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 99
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 100 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 155
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 156 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 100/217 (46%), Gaps = 15/217 (6%)
Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINE 145
           R   R   +GEG FG       +V    +   G ++   VA+K L  +    H  +   E
Sbjct: 9   RFLKRIRDLGEGHFG-------KVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKE 61
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +  L  + H N+VK  G C ED   G++  L+ E + + SL+++L  +    +    +LK
Sbjct: 62  IEILRNLYHENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYL-PKNKNKINLKQQLK 118
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
            A    +G+ YL      Q + RD    N+L++ +++ K+ DFGL +    +        
Sbjct: 119 YAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKD 175
Query: 266 XXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  APE +   +    SDVWSFGV L+EL+T
Sbjct: 176 DRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLT 212

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 101/213 (47%), Gaps = 22/213 (10%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V RG ++                VAIK L + G+  +  +E+++E + +G 
Sbjct: 21  VIGAGEFGEVCRGRLKAPGKKESC--------VAIKTL-KGGYTERQRREFLSEASIMGQ 71
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
            +HPN+++L G         M  +++ E M N +L D  L         I  + + +  A
Sbjct: 72  FEHPNIIRLEGVVTNS----MPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIA 126
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---QGPPEGLGHXXXXXXX 268
            G+ YL E      + RD    NIL++ +   K+SDFGL+R   +   +           
Sbjct: 127 SGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKI 183
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
              + APE +   + T+ SD WS+G+V++E+++
Sbjct: 184 PIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 73  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 130
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 131 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 186
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 187 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 192 LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 239 EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 294 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 349
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 16  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 62
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 63  EKLVQLYAVVSEEP-----IXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 117
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 118 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE-DNEXTARQGAKFPIKWTA 173
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 174 PEAALYGRFTIKSDVWSFGILLTELTTKGR 203

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 54/177 (30%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 60  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 117
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 118 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 173
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 174 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEXTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V  G ++V            ++ VAIK L + G+  +  +++++E + +G 
Sbjct: 21  VIGVGEFGEVCSGRLKVPGK--------REICVAIKTL-KAGYTDKQRRDFLSEASIMGQ 71
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN++ L G       +    +++ E M N SL D  L +       I  + + +   
Sbjct: 72  FDHPNIIHLEGVVT----KCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIG 126
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHXXXXXXXX 269
            G+ YL    D   + RD    NIL++ +   K+SDFG++R  +  PE   +        
Sbjct: 127 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA-AYTTRGGKIP 182
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             + APE +   + T+ SDVWS+G+V++E+++
Sbjct: 183 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 214

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 127/300 (42%), Gaps = 46/300 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 267 LGGGQYGEVYEGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 314
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C     R     ++ E M   +L D+L       +  +  L +A   +  +
Sbjct: 315 PNLVQLLGVCT----REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAM 370
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL E+ +F  I R+    N L+ E++  K++DFGL+R    +              + A
Sbjct: 371 EYL-EKKNF--IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 426
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE----WVRPYVSDSK 329
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++  +LLE      RP     K
Sbjct: 427 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEK 486
Query: 330 KFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
            + L+                       C    P  RP  +E+      +  E S  DEV
Sbjct: 487 VYELM---------------------RACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 525

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 95/207 (45%), Gaps = 21/207 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G             +++   VA+K L + G    + ++ E N +  ++H
Sbjct: 21  LGAGQFGEVWMGY------------YNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 67
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L      ++       ++ E M   SL D L S     +     +  +   A G+
Sbjct: 68  DKLVRLYAVVTREE----PIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 123
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+  +     I RD + +N+L+ E    K++DFGLAR    +              + A
Sbjct: 124 AYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTA 179
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +  G  T KSDVWSFG++LYE++T
Sbjct: 180 PEAINFGCFTIKSDVWSFGILLYEIVT 206

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 93/216 (43%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +  + 
Sbjct: 53  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN 106
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 107 HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 163 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 100/213 (46%), Gaps = 14/213 (6%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++GEG FG V  G ++      Q  G   K+ V   +L+    +  +E+++E   +    
Sbjct: 41  ILGEGEFGSVMEGNLK------QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS 94
Query: 154 HPNLVKLVGYCAEDDERGMQR-LLVYELMHNKSLEDHLL-SRV---PTPLAWIARLKIAQ 208
           HPN+++L+G C E   +G+ + +++   M    L  +LL SR+   P  +     LK   
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMV 154
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX 268
           D A G+ YL        + RD    N +L +D    ++DFGL+++               
Sbjct: 155 DIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM 211
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
              + A E +     T+KSDVW+FGV ++E+ T
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIAT 244

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 104/212 (49%), Gaps = 22/212 (10%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V  G ++V            ++ VAIK L + G+  +  +++++E + +G 
Sbjct: 15  VIGVGEFGEVCSGRLKVPGK--------REICVAIKTL-KAGYTDKQRRDFLSEASIMGQ 65
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN++ L G       +    +++ E M N SL D  L +       I  + + +   
Sbjct: 66  FDHPNIIHLEGVVT----KCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIG 120
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHXXXXXXXX 269
            G+ YL    D   + RD    NIL++ +   K+SDFG++R  +  PE   +        
Sbjct: 121 SGMKYLS---DMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEA-AYTTRGGKIP 176
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             + APE +   + T+ SDVWS+G+V++E+++
Sbjct: 177 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 208

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 39  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 92
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 93  HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 149 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 205
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 65  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 118
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 119 HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 174
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 175 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 231
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 232 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/233 (27%), Positives = 110/233 (47%), Gaps = 33/233 (14%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG      ++V+   H+ +G      + +K+L R   +  + ++ EV  +  ++
Sbjct: 17  VLGKGCFG----QAIKVT---HRETGEV----MVMKELIRFDEETQRTFLKEVKVMRCLE 65
Query: 154 HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           HPN++K +G   +D     +RL  + E +   +L   ++  + +   W  R+  A+D A 
Sbjct: 66  HPNVLKFIGVLYKD-----KRLNFITEYIKGGTLRG-IIKSMDSQYPWSQRVSFAKDIAS 119
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR-----QGPPEGLGHXXX--- 264
           G+AYLH      +I RD  + N L+ E+    ++DFGLAR     +  PEGL        
Sbjct: 120 GMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDR 176
Query: 265 ----XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN 313
                      + APE +       K DV+SFG+VL E+I    A    LPR 
Sbjct: 177 KKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT 229

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 45  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 98
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 99  HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 154
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 155 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 211
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 212 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 15  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 61
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 62  EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 116
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 117 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 172
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 173 PEAALYGRFTIKSDVWSFGILLTELTTKGR 202

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 38  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 92  HQNIVRCIGVSLQS----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 148 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 98/220 (44%), Gaps = 42/220 (19%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 275 LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 321
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 322 EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR----------QGPPEGLGHXXX 264
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR          QG          
Sbjct: 377 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG---------- 423
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
                  + APE    GR T KSDVWSFG++L EL T  R
Sbjct: 424 -AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 462

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 82/308 (26%), Positives = 128/308 (41%), Gaps = 70/308 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-------EVN 147
           IG+GGFG V++G  R+  D         K  VAIK L     +G  E I        EV 
Sbjct: 27  IGKGGFGLVHKG--RLVKD---------KSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +  + HPN+VKL G         M+ +   +L H    + H       P+ W  +L++ 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH-------PIKWSVKLRLM 128
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYK--AKLSDFGLARQGPPEGLGHX 262
            D A G+ Y+  + +  ++ RD ++ NI L   DE+    AK++DFGL++Q       H 
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHS 182
Query: 263 XXXXXXXXXYAAPEYV--QTGRLTAKSDVWSFGVVLYELITGRRAVER---------NLP 311
                    + APE +  +    T K+D +SF ++LY ++TG    +          N+ 
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSE 371
           R      E +RP + +         PRL                  C +  PK RP  S 
Sbjct: 243 RE-----EGLRPTIPED------CPPRLRN------------VIELCWSGDPKKRPHFSY 279
Query: 372 VVDILGNI 379
           +V  L  +
Sbjct: 280 IVKELSEL 287

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 17  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 63
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 64  EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 118
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 119 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 174
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 175 PEAALYGRFTIKSDVWSFGILLTELTTKGR 204

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 55  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 108
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 109 HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 164
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 165 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 221
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 222 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 192 LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 239 EKLVQLYAVVSEEP-----IYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 294 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 349
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 350 PEAALYGRFTIKSDVWSFGILLTELTTKGR 379

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 53  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVYSEQDELDFLMEALIISKFN 106
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 107 HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 163 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 38  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 91
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 92  HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 148 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 204
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 30  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 83
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 84  HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 139
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 140 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 196
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 197 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 53  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 106
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 107 HQNIVRCIGVSLQS----LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 162
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+AR             
Sbjct: 163 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGC 219
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 220 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 67/220 (30%), Positives = 99/220 (45%), Gaps = 42/220 (19%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 193 LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGNMSPEAFLQEAQVMKKLRH 239
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 240 EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 294
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL----------ARQGPPEGLGHXXX 264
           AY+ E M++  + RD + +NIL+ E+   K++DFGL          ARQG          
Sbjct: 295 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQG---------- 341
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
                  + APE    GR T KSDVWSFG++L EL T  R
Sbjct: 342 -AKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 380

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 96/207 (46%), Gaps = 21/207 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G             +++   VA+K L + G    + ++ E N +  ++H
Sbjct: 20  LGAGQFGEVWMGY------------YNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQH 66
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     +++       ++ E M   SL D L S     +     +  +   A G+
Sbjct: 67  DKLVRLYAVVTKEE----PIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+  +     I RD + +N+L+ E    K++DFGLAR    +              + A
Sbjct: 123 AYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARV-IEDNEYTAREGAKFPIKWTA 178
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +  G  T KS+VWSFG++LYE++T
Sbjct: 179 PEAINFGCFTIKSNVWSFGILLYEIVT 205

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 88/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 43  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEYLPYGS 100
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L D+L  +    +  I  L+      +G+ YL  +   + I R+  T NIL++ + + K+
Sbjct: 101 LRDYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRNILVENENRVKI 156
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +   +          +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 157 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 87/177 (49%), Gaps = 7/177 (3%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           VA+K+L     +  +++  E+  L  ++H N+VK  G C     R ++  L+ E +   S
Sbjct: 45  VAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK--LIMEFLPYGS 102
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
           L ++L  +    +  I  L+      +G+ YL  +   + I RD  T NIL++ + + K+
Sbjct: 103 LREYL-QKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI 158
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            DFGL +  P +              +  APE +   + +  SDVWSFGVVLYEL T
Sbjct: 159 GDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 19  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 65
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 66  EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 120
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 121 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 176
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 177 PEAALYGRFTIKSDVWSFGILLTELTTKGR 206

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 23  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 69
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M+  SL D L       L     + ++   A G+
Sbjct: 70  EKLVQLYAVVSEEP-----IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 125 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE-DNEWTARQGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 98/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 23  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 69
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M+  SL D L       L     + ++   A G+
Sbjct: 70  EKLVQLYAVVSEEP-----IYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 125 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE-DNEYTARQGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 181 PEAALYGRFTIKSDVWSFGILLTELTTKGR 210

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD   +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLAAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/211 (28%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           +G G FG V +GV R+            ++DVAIK L +QG +    +E + E   +  +
Sbjct: 18  LGCGNFGSVRQGVYRM---------RKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 67
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS-RVPTPLAWIARLKIAQDAA 211
            +P +V+L+G C  +       +LV E+     L   L+  R   P++ +A L      +
Sbjct: 68  DNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVS 120
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL E+     + RD    N+LL   + AK+SDFGL++  G  +             
Sbjct: 121 MGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 177
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + +++SDVWS+GV ++E ++
Sbjct: 178 KWYAPECINFRKFSSRSDVWSYGVTMWEALS 208

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 101/228 (44%), Gaps = 24/228 (10%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWI-NE 145
           F    L+G+G F  VYR            S H + L+VAIK ++++     G  + + NE
Sbjct: 13  FKVGNLLGKGSFAGVYRA----------ESIH-TGLEVAIKMIDKKAMYKAGMVQRVQNE 61
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           V     +KHP++++L  Y  + +       LV E+ HN  +  +L +RV  P +      
Sbjct: 62  VKIHCQLKHPSILELYNYFEDSN----YVYLVLEMCHNGEMNRYLKNRV-KPFSENEARH 116
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                  G+ YLH      ++ RD   SN+LL  +   K++DFGLA Q       H    
Sbjct: 117 FMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLC 173
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN 313
                 Y +PE         +SDVWS G + Y L+ GR   + +  +N
Sbjct: 174 GTPN--YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 60/207 (28%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +  S           L VA+K L     +  +E++ E   +  +KH
Sbjct: 40  LGGGQYGEVYVGVWKKYS-----------LTVAVKTLKEDTMEV-EEFLKEAAVMKEIKH 87
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C  +        +V E M   +L D+L       +  +  L +A   +  +
Sbjct: 88  PNLVQLLGVCTLEP----PFYIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAM 143
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            YL ++     I RD    N L+ E++  K++DFGL+R    +              + A
Sbjct: 144 EYLEKK---NFIHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 199
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT 301
           PE +     + KSDVW+FGV+L+E+ T
Sbjct: 200 PESLAYNTFSIKSDVWAFGVLLWEIAT 226

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 27  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 79
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 80  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 136
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 137 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 188
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 189 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 237

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 17  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 126
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M    L D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V    +D       S L VA+K L      Q   +++ E   +    
Sbjct: 39  LGHGAFGEVYEGQVSGMPND------PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 92
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQ 208
           H N+V+ +G   +     + R ++ ELM    L+  L    P P     LA +  L +A+
Sbjct: 93  HQNIVRCIGVSLQS----LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 148
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           D A G  YL E      I RD    N LL        AK+ DFG+A+             
Sbjct: 149 DIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGC 205
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                 +  PE    G  T+K+D WSFGV+L+E+ +
Sbjct: 206 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 11  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 120
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 121 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 172
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 173 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 18  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 127
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 128 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 21  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 130
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 131 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 182
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 17  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 126
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 20  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 129
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 19  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 128
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 18  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 70
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 71  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI- 127
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 128 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 179
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 180 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 228

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 127/308 (41%), Gaps = 70/308 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-------EVN 147
           IG+GGFG V++G  R+  D         K  VAIK L     +G  E I        EV 
Sbjct: 27  IGKGGFGLVHKG--RLVKD---------KSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +  + HPN+VKL G         M+ +   +L H    + H       P+ W  +L++ 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH-------PIKWSVKLRLM 128
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYK--AKLSDFGLARQGPPEGLGHX 262
            D A G+ Y+  + +  ++ RD ++ NI L   DE+    AK++DFG ++Q       H 
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQS-----VHS 182
Query: 263 XXXXXXXXXYAAPEYV--QTGRLTAKSDVWSFGVVLYELITGRRAVER---------NLP 311
                    + APE +  +    T K+D +SF ++LY ++TG    +          N+ 
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSE 371
           R      E +RP + +         PRL                  C +  PK RP  S 
Sbjct: 243 RE-----EGLRPTIPED------CPPRLRN------------VIELCWSGDPKKRPHFSY 279
Query: 372 VVDILGNI 379
           +V  L  +
Sbjct: 280 IVKELSEL 287

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 42  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 94
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 95  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 151
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 152 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 203
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 204 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 252

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 23  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 75
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 76  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 132
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 133 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 184
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 185 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 233

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 17  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 126
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 20  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 129
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 20  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 129
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 64/210 (30%), Positives = 97/210 (46%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 26  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 72
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M    L D L   +   L     + +A   A G+
Sbjct: 73  EKLVQLYAVVSEEP-----IYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +              + A
Sbjct: 128 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 183
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
           PE    GR T KSDVWSFG++L EL T  R
Sbjct: 184 PEAALYGRFTIKSDVWSFGILLTELTTKGR 213

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/235 (27%), Positives = 102/235 (43%), Gaps = 47/235 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+               ++    VA+K + + G    + ++ E N +  ++H
Sbjct: 190 LGAGQFGEVWMAT------------YNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 236
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LVKL     ++        ++ E M   SL D L S   +       +  +   A G+
Sbjct: 237 DKLVKLHAVVTKEP-----IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 291
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ +      I RD + +NIL+      K++DFGLAR G                 + A
Sbjct: 292 AFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVG-----------AKFPIKWTA 337
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT-GR------------RAVERN--LPRNE 314
           PE +  G  T KSDVWSFG++L E++T GR            RA+ER   +PR E
Sbjct: 338 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 392

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 24  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 133
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 20  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 72
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 73  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 129
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 130 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 181
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 182 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 230

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 19  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 128
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 180
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 110/229 (48%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 17  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHKDNIGSQYL--LNWCVQI- 126
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 81/308 (26%), Positives = 127/308 (41%), Gaps = 70/308 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-------EVN 147
           IG+GGFG V++G  R+  D         K  VAIK L     +G  E I        EV 
Sbjct: 27  IGKGGFGLVHKG--RLVKD---------KSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +  + HPN+VKL G         M+ +   +L H    + H       P+ W  +L++ 
Sbjct: 76  IMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLDKAH-------PIKWSVKLRLM 128
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYK--AKLSDFGLARQGPPEGLGHX 262
            D A G+ Y+  + +  ++ RD ++ NI L   DE+    AK++DF L++Q       H 
Sbjct: 129 LDIALGIEYMQNQ-NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQS-----VHS 182
Query: 263 XXXXXXXXXYAAPEYV--QTGRLTAKSDVWSFGVVLYELITGRRAVER---------NLP 311
                    + APE +  +    T K+D +SF ++LY ++TG    +          N+ 
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMI 242
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSE 371
           R      E +RP + +         PRL                  C +  PK RP  S 
Sbjct: 243 RE-----EGLRPTIPED------CPPRLRN------------VIELCWSGDPKKRPHFSY 279
Query: 372 VVDILGNI 379
           +V  L  +
Sbjct: 280 IVKELSEL 287

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 34/254 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ-LNRQGFQGHKEWINEVNFLGVVK 153
           +GEG FG       +V    H T+G    L +  K+ L +   QG  E   E+++L +++
Sbjct: 21  LGEGSFG-------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP+++KL       DE     ++V E   N+ L D+++ R    ++     +  Q     
Sbjct: 72  HPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFDYIVQR--DKMSEQEARRFFQQIISA 124
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H     +++ RD K  N+LLDE    K++DFGL+        G+          YA
Sbjct: 125 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYA 178
Query: 274 APEYVQTGRLTA--KSDVWSFGVVLYELITGRRAVE--------RNLPRNEQKLLEWVRP 323
           APE V +G+L A  + DVWS GV+LY ++  R   +        +N+      L +++ P
Sbjct: 179 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSP 237
Query: 324 YVSDSKKFHLIIDP 337
             +   K  LI++P
Sbjct: 238 GAAGLIKRMLIVNP 251

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 34/254 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ-LNRQGFQGHKEWINEVNFLGVVK 153
           +GEG FG       +V    H T+G    L +  K+ L +   QG  E   E+++L +++
Sbjct: 22  LGEGSFG-------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 72
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP+++KL       DE     ++V E   N+ L D+++ R    ++     +  Q     
Sbjct: 73  HPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFDYIVQR--DKMSEQEARRFFQQIISA 125
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H     +++ RD K  N+LLDE    K++DFGL+        G+          YA
Sbjct: 126 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYA 179
Query: 274 APEYVQTGRLTA--KSDVWSFGVVLYELITGRRAVE--------RNLPRNEQKLLEWVRP 323
           APE V +G+L A  + DVWS GV+LY ++  R   +        +N+      L +++ P
Sbjct: 180 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSP 238
Query: 324 YVSDSKKFHLIIDP 337
             +   K  LI++P
Sbjct: 239 GAAGLIKRMLIVNP 252

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 34/254 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ-LNRQGFQGHKEWINEVNFLGVVK 153
           +GEG FG       +V    H T+G    L +  K+ L +   QG  E   E+++L +++
Sbjct: 12  LGEGSFG-------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP+++KL       DE     ++V E   N+ L D+++ R    ++     +  Q     
Sbjct: 63  HPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFDYIVQR--DKMSEQEARRFFQQIISA 115
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H     +++ RD K  N+LLDE    K++DFGL+        G+          YA
Sbjct: 116 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYA 169
Query: 274 APEYVQTGRLTA--KSDVWSFGVVLYELITGRRAVE--------RNLPRNEQKLLEWVRP 323
           APE V +G+L A  + DVWS GV+LY ++  R   +        +N+      L +++ P
Sbjct: 170 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSP 228
Query: 324 YVSDSKKFHLIIDP 337
             +   K  LI++P
Sbjct: 229 GAAGLIKRMLIVNP 242

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 71/254 (27%), Positives = 119/254 (46%), Gaps = 34/254 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ-LNRQGFQGHKEWINEVNFLGVVK 153
           +GEG FG       +V    H T+G    L +  K+ L +   QG  E   E+++L +++
Sbjct: 16  LGEGSFG-------KVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIE--REISYLRLLR 66
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP+++KL       DE     ++V E   N+ L D+++ R    ++     +  Q     
Sbjct: 67  HPHIIKLYDVIKSKDEI----IMVIEYAGNE-LFDYIVQR--DKMSEQEARRFFQQIISA 119
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H     +++ RD K  N+LLDE    K++DFGL+        G+          YA
Sbjct: 120 VEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTD---GNFLKTSCGSPNYA 173
Query: 274 APEYVQTGRLTA--KSDVWSFGVVLYELITGRRAVE--------RNLPRNEQKLLEWVRP 323
           APE V +G+L A  + DVWS GV+LY ++  R   +        +N+      L +++ P
Sbjct: 174 APE-VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSP 232
Query: 324 YVSDSKKFHLIIDP 337
             +   K  LI++P
Sbjct: 233 GAAGLIKRMLIVNP 246

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 14  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 66
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 67  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 123
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 124 -----AEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 175
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 176 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 224

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G +R  +           L   +K           +++ E   L    H
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK----------AKFLQEARILKQYSH 171
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS-----RVPTPLAWIARLKIAQD 209
           PN+V+L+G C +         +V EL+        L +     RV T       L++  D
Sbjct: 172 PNIVRLIGVCTQKQPI----YIVMELVQGGDFLTFLRTEGARLRVKT------LLQMVGD 221
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
           AA G+ YL  +     I RD    N L+ E    K+SDFG++R+                
Sbjct: 222 AAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP 278
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             + APE +  GR +++SDVWSFG++L+E  +
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
           ++GEG FG VY GV         T+    K++VA+K   +     +KE +++E   +  +
Sbjct: 15  ILGEGFFGEVYEGV--------YTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 66
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HP++VKL+G   E+    +  L  Y  +       H L R    L  +  +  +    +
Sbjct: 67  DHPHIVKLIGIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICK 120
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            +AYL        + RD    NIL+      KL DFGL+R    E   +          +
Sbjct: 121 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKW 176
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            +PE +   R T  SDVW F V ++E+++
Sbjct: 177 MSPESINFRRFTTASDVWMFAVCMWEILS 205

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 28/212 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G +R  +           L   +K           +++ E   L    H
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLK----------AKFLQEARILKQYSH 171
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS-----RVPTPLAWIARLKIAQD 209
           PN+V+L+G C +         +V EL+        L +     RV T       L++  D
Sbjct: 172 PNIVRLIGVCTQKQPI----YIVMELVQGGDFLTFLRTEGARLRVKT------LLQMVGD 221
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
           AA G+ YL  +     I RD    N L+ E    K+SDFG++R+                
Sbjct: 222 AAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVP 278
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
             + APE +  GR +++SDVWSFG++L+E  +
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFS 310

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
           ++GEG FG VY GV         T+    K++VA+K   +     +KE +++E   +  +
Sbjct: 31  ILGEGFFGEVYEGV--------YTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 82
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HP++VKL+G   E+    +  L  Y  +       H L R    L  +  +  +    +
Sbjct: 83  DHPHIVKLIGIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICK 136
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            +AYL        + RD    NIL+      KL DFGL+R    E   +          +
Sbjct: 137 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKW 192
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            +PE +   R T  SDVW F V ++E+++
Sbjct: 193 MSPESINFRRFTTASDVWMFAVCMWEILS 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 102/213 (47%), Gaps = 22/213 (10%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
           +IG G FG V  G +++            ++ VAIK L + G+  +  +++++E + +G 
Sbjct: 14  VIGAGEFGEVCSGHLKLPGK--------REIFVAIKTL-KSGYTEKQRRDFLSEASIMGQ 64
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
             HPN++ L G       +    +++ E M N SL D  L +       I  + + +  A
Sbjct: 65  FDHPNVIHLEGVVT----KSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIA 119
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---QGPPEGLGHXXXXXXX 268
            G+ YL    D   + R     NIL++ +   K+SDFGL+R       +           
Sbjct: 120 AGMKYL---ADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKI 176
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
              + APE +Q  + T+ SDVWS+G+V++E+++
Sbjct: 177 PIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMS 209

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 19/209 (9%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
           ++GEG FG VY GV         T+    K++VA+K   +     +KE +++E   +  +
Sbjct: 19  ILGEGFFGEVYEGV--------YTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNL 70
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HP++VKL+G   E+    +  L  Y  +       H L R    L  +  +  +    +
Sbjct: 71  DHPHIVKLIGIIEEEPTWIIMELYPYGEL------GHYLERNKNSLKVLTLVLYSLQICK 124
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            +AYL        + RD    NIL+      KL DFGL+R    E   +          +
Sbjct: 125 AMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY-YKASVTRLPIKW 180
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            +PE +   R T  SDVW F V ++E+++
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILS 209

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 24/228 (10%)
Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NR 133
           R+F   EL+       +  ++G G FG V++GV           G   K+ V IK + ++
Sbjct: 26  RIFKETELR-------KLKVLGSGVFGTVHKGV-------WIPEGESIKIPVCIKVIEDK 71
Query: 134 QGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
            G Q  +   + +  +G + H ++V+L+G C      G    LV + +   SL DH+   
Sbjct: 72  SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYLPLGSLLDHVRQH 126
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
               L     L      A+G+ YL E     ++ R+    N+LL    + +++DFG+A  
Sbjct: 127 RGA-LGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 182
Query: 254 GPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            PP+              + A E +  G+ T +SDVWS+GV ++EL+T
Sbjct: 183 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 58/211 (27%), Positives = 96/211 (45%), Gaps = 30/211 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  +             + DVA+K + ++G     E+  E   +  + H
Sbjct: 16  LGSGQFGVVKLGKWK------------GQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSH 62
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLKIAQDA 210
           P LVK  G C+++        +V E + N  L ++L S      P+ L     L++  D 
Sbjct: 63  PKLVKFYGVCSKE----YPIYIVTEYISNGCLLNYLRSHGKGLEPSQL-----LEMCYDV 113
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
             G+A+L      Q I RD    N L+D D   K+SDFG+ R    +             
Sbjct: 114 CEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPV 169
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            ++APE     + ++KSDVW+FG++++E+ +
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFS 200

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAI +L      + +KE ++E  
Sbjct: 51  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIMELREATSPKANKEILDEAY 103
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 104 VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 160
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 161 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 212
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 213 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 261

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++  G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 17  FKKIKVLSSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 126
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 178
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++  G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 24  FKKIKVLSSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 133
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 103/211 (48%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           +G G FG V +GV R+            ++DVAIK L +QG +    +E + E   +  +
Sbjct: 344 LGCGNFGSVRQGVYRM---------RKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 393
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS-RVPTPLAWIARLKIAQDAA 211
            +P +V+L+G C  +       +LV E+     L   L+  R   P++ +A L      +
Sbjct: 394 DNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREEIPVSNVAEL--LHQVS 446
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL E+     + R+    N+LL   + AK+SDFGL++  G  +             
Sbjct: 447 MGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPL 503
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + +++SDVWS+GV ++E ++
Sbjct: 504 KWYAPECINFRKFSSRSDVWSYGVTMWEALS 534

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 21  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 73
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 74  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 130
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFG A+    E   +    
Sbjct: 131 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 182
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 183 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 231

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/228 (27%), Positives = 105/228 (46%), Gaps = 24/228 (10%)
Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NR 133
           R+F   EL+       +  ++G G FG V++GV           G   K+ V IK + ++
Sbjct: 8   RIFKETELR-------KLKVLGSGVFGTVHKGV-------WIPEGESIKIPVCIKVIEDK 53
Query: 134 QGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
            G Q  +   + +  +G + H ++V+L+G C      G    LV + +   SL DH+   
Sbjct: 54  SGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-----GSSLQLVTQYLPLGSLLDHVRQH 108
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
               L     L      A+G+ YL E     ++ R+    N+LL    + +++DFG+A  
Sbjct: 109 RGA-LGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADL 164
Query: 254 GPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            PP+              + A E +  G+ T +SDVWS+GV ++EL+T
Sbjct: 165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++  G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 24  FKKIKVLSSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 133
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFGLA+    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG 185
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 19  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 128
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFG A+    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 19  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 128
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFG A+    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 17  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 69
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 70  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 126
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFG A+    E   +    
Sbjct: 127 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 178
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 179 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 24  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 76
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 77  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 133
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFG A+    E   +    
Sbjct: 134 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 185
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 186 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 234

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 21/229 (9%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 19  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 71
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLK 205
            +  V +P++ +L+G C     + + +L+ +  +  + +  +D++ S+    L W  ++ 
Sbjct: 72  VMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL--LNWCVQI- 128
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                A+G+ YL    D +L+ RD    N+L+      K++DFG A+    E   +    
Sbjct: 129 -----AKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEG 180
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
                 + A E +     T +SDVWS+GV ++EL+T        +P +E
Sbjct: 181 GKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 229

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 78/240 (32%), Positives = 100/240 (41%), Gaps = 37/240 (15%)
Query: 70  RANDLRVFSFAEL---KSATRGFSRALLIGEGGFGCVYRGV-VRVSSDDHQTSGHDSKLD 125
           RA  L+    AEL       + FS    IG G FG VY    VR S              
Sbjct: 34  RAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV------------ 81
Query: 126 VAIKQLNRQGFQGHKEW---INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMH 182
           VAIK+++  G Q +++W   I EV FL  ++HPN ++  G       R     LV E   
Sbjct: 82  VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL----REHTAWLVMEYCL 137
Query: 183 NKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK 242
             + +  LL     PL  +    +   A +GLAYLH      +I RD K  NILL E   
Sbjct: 138 GSASD--LLEVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGL 192
Query: 243 AKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYV---QTGRLTAKSDVWSFGVVLYEL 299
            KL DFG A    P               + APE +     G+   K DVWS G+   EL
Sbjct: 193 VKLGDFGSASIMAPAN------XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 246

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 69/231 (29%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + V+ 
Sbjct: 15  IGKGNFA-------KVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 64
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWI----ARLKIAQD 209
           HPN+VKL     E  E      LV E      + D+L++       W+    AR K  Q 
Sbjct: 65  HPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAH-----GWMKEKEARAKFRQI 115
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            +  + Y H++    ++ RD K  N+LLD D   K++DFG + +      G+        
Sbjct: 116 VS-AVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---FGNKLDTFCGS 168
Query: 270 XXYAAPEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
             YAAPE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 169 PPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 213

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 106/256 (41%), Gaps = 41/256 (16%)
Query: 74  LRVFSFAELKSATRGFSRALLI-----GEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAI 128
           L V +F  L+     F R  L+     GEG FG V      V +      G      VA+
Sbjct: 5   LSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKV------VKATAFHLKGRAGYTTVAV 58
Query: 129 KQLNRQGFQGH-KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE 187
           K L         ++ ++E N L  V HP+++KL G C++D       LL+ E     SL 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL----LLIVEYAKYGSLR 114
Query: 188 DHLL-SRVPTP---------------------LAWIARLKIAQDAARGLAYLHEEMDFQL 225
             L  SR   P                     L     +  A   ++G+ YL E    +L
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKL 171
Query: 226 IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTA 285
           + RD    NIL+ E  K K+SDFGL+R    E              + A E +     T 
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTT 231
Query: 286 KSDVWSFGVVLYELIT 301
           +SDVWSFGV+L+E++T
Sbjct: 232 QSDVWSFGVLLWEIVT 247

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 105/256 (41%), Gaps = 41/256 (16%)
Query: 74  LRVFSFAELKSATRGFSRALLI-----GEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAI 128
           L V +F  L+     F R  L+     GEG FG V      V +      G      VA+
Sbjct: 5   LSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKV------VKATAFHLKGRAGYTTVAV 58
Query: 129 KQLNRQGFQGH-KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE 187
           K L         ++ ++E N L  V HP+++KL G C++D       LL+ E     SL 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL----LLIVEYAKYGSLR 114
Query: 188 DHLL-SRVPTP---------------------LAWIARLKIAQDAARGLAYLHEEMDFQL 225
             L  SR   P                     L     +  A   ++G+ YL E     L
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSL 171
Query: 226 IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTA 285
           + RD    NIL+ E  K K+SDFGL+R    E              + A E +     T 
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTT 231
Query: 286 KSDVWSFGVVLYELIT 301
           +SDVWSFGV+L+E++T
Sbjct: 232 QSDVWSFGVLLWEIVT 247

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 72/218 (33%), Positives = 92/218 (42%), Gaps = 34/218 (15%)
Query: 89  FSRALLIGEGGFGCVYRGV-VRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---IN 144
           FS    IG G FG VY    VR S              VAIK+++  G Q +++W   I 
Sbjct: 17  FSDLREIGHGSFGAVYFARDVRNSEV------------VAIKKMSYSGKQSNEKWQDIIK 64
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV FL  ++HPN ++  G       R     LV E     + +  LL     PL  +   
Sbjct: 65  EVRFLQKLRHPNTIQYRGCYL----REHTAWLVMEYCLGSASD--LLEVHKKPLQEVEIA 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
            +   A +GLAYLH      +I RD K  NILL E    KL DFG A    P        
Sbjct: 119 AVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPAN------ 169
Query: 265 XXXXXXXYAAPEYV---QTGRLTAKSDVWSFGVVLYEL 299
                  + APE +     G+   K DVWS G+   EL
Sbjct: 170 XFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/256 (29%), Positives = 106/256 (41%), Gaps = 41/256 (16%)
Query: 74  LRVFSFAELKSATRGFSRALLI-----GEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAI 128
           L V +F  L+     F R  L+     GEG FG V      V +      G      VA+
Sbjct: 5   LSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKV------VKATAFHLKGRAGYTTVAV 58
Query: 129 KQLNRQGFQGH-KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE 187
           K L         ++ ++E N L  V HP+++KL G C++D       LL+ E     SL 
Sbjct: 59  KMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPL----LLIVEYAKYGSLR 114
Query: 188 DHLL-SRVPTP---------------------LAWIARLKIAQDAARGLAYLHEEMDFQL 225
             L  SR   P                     L     +  A   ++G+ YL E    +L
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKL 171
Query: 226 IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTA 285
           + RD    NIL+ E  K K+SDFGL+R    E              + A E +     T 
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTT 231
Query: 286 KSDVWSFGVVLYELIT 301
           +SDVWSFGV+L+E++T
Sbjct: 232 QSDVWSFGVLLWEIVT 247

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 129/314 (41%), Gaps = 45/314 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 92  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 147
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 265 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 378 NIISEISSQDEVTL 391
            I++  S+Q+ + L
Sbjct: 308 RIVALTSNQEYLDL 321

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 23/229 (10%)
Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ 134
           ++ S   +    + ++R   IG+G  G VY  +   +  +           VAI+Q+N Q
Sbjct: 8   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQE-----------VAIRQMNLQ 56
Query: 135 GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
                +  INE+  +   K+PN+V  +      DE      +V E +   SL D +++  
Sbjct: 57  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTET 111
Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
                 IA   + ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q 
Sbjct: 112 CMDEGQIA--AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            PE              + APE V       K D+WS G++  E+I G 
Sbjct: 167 TPE--QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 99/229 (43%), Gaps = 23/229 (10%)
Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ 134
           ++ S   +    + ++R   IG+G  G VY  +   +  +           VAI+Q+N Q
Sbjct: 8   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQE-----------VAIRQMNLQ 56
Query: 135 GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
                +  INE+  +   K+PN+V  +      DE      +V E +   SL D +++  
Sbjct: 57  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTET 111
Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
                 IA   + ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q 
Sbjct: 112 CMDEGQIA--AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            PE              + APE V       K D+WS G++  E+I G 
Sbjct: 167 TPE--QSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 81/314 (25%), Positives = 129/314 (41%), Gaps = 45/314 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 92  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQL 147
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 205 XXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 265 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 378 NIISEISSQDEVTL 391
            I++  S+Q+ + L
Sbjct: 308 RIVALTSNQEXLDL 321

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 21  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 76
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 77  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQL 132
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 133 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 249
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 250 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 292
Query: 378 NIISEISSQD 387
            I++  S+Q+
Sbjct: 293 RIVALTSNQE 302

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ 134
           ++ S   +    + ++R   IG+G  G VY  +   +  +           VAI+Q+N Q
Sbjct: 8   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQE-----------VAIRQMNLQ 56
Query: 135 GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
                +  INE+  +   K+PN+V  +      DE      +V E +   SL D +++  
Sbjct: 57  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTET 111
Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
                 IA   + ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q 
Sbjct: 112 CMDEGQIA--AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 166
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            PE              + APE V       K D+WS G++  E+I G 
Sbjct: 167 TPE--QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 100/229 (43%), Gaps = 23/229 (10%)
Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ 134
           ++ S   +    + ++R   IG+G  G VY  +   +  +           VAI+Q+N Q
Sbjct: 9   KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQE-----------VAIRQMNLQ 57
Query: 135 GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
                +  INE+  +   K+PN+V  +      DE      +V E +   SL D +++  
Sbjct: 58  QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTET 112
Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
                 IA   + ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q 
Sbjct: 113 CMDEGQIA--AVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQI 167
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            PE              + APE V       K D+WS G++  E+I G 
Sbjct: 168 TPE--QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 126 VAIKQLNRQGFQGHKEWI-NEVNFLGVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMH 182
           VAIK + ++  +G +  + NE+  L  +KHPN+V L      DD  E G    L+ +L+ 
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGHLYLIMQLVS 99
Query: 183 NKSLEDHLLSRVPTPLAWIARLKIAQDAAR-------GLAYLHEEMDFQLIFRDFKTSNI 235
              L D ++ +              +DA+R        + YLH   D  ++ RD K  N+
Sbjct: 100 GGELFDRIVEK---------GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENL 147
Query: 236 L---LDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSF 292
           L   LDED K  +SDFGL++   P   G           Y APE +     +   D WS 
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 293 GVVLYELITGRRAVERNLPRNEQKLLEWV--------RPY---VSDSKK 330
           GV+ Y L+ G          N+ KL E +         PY   +SDS K
Sbjct: 205 GVIAYILLCGYPPF---YDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG V++G+      D++T        VAIK ++ +  +   E I  E+ 
Sbjct: 29  FTKLEKIGKGSFGEVFKGI------DNRTQKV-----VAIKIIDLEEAEDEIEDIQQEIT 77
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P + K  G   +D     +  ++ E +   S  D L    P PL       I 
Sbjct: 78  VLSQCDSPYVTKYYGSYLKD----TKLWIIMEYLGGGSALDLL---EPGPLDETQIATIL 130
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
           ++  +GL YLH E   + I RD K +N+LL E  + KL+DFG+A Q     +        
Sbjct: 131 REILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFV 185
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE ++     +K+D+WS G+   EL  G        P     L+    P    
Sbjct: 186 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---- 241
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
                    P LEGNY              CL K+P  RP   E++
Sbjct: 242 ---------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELL 274

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 50
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 106
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 107 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 158
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 103/235 (43%), Gaps = 37/235 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+             + ++    VA+K + + G    + ++ E N +  ++H
Sbjct: 23  LGAGQFGEVW------------MATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 69
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LVKL     ++        ++ E M   SL D L S   +       +  +   A G+
Sbjct: 70  DKLVKLHAVVTKEP-----IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ +      I RD + +NIL+      K++DFGLAR    +              + A
Sbjct: 125 AFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIE-DNEYTAREGAKFPIKWTA 180
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT-GR------------RAVERN--LPRNE 314
           PE +  G  T KSDVWSFG++L E++T GR            RA+ER   +PR E
Sbjct: 181 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 235

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/235 (27%), Positives = 102/235 (43%), Gaps = 37/235 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+               ++    VA+K + + G    + ++ E N +  ++H
Sbjct: 196 LGAGQFGEVWMAT------------YNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 242
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LVKL     ++        ++ E M   SL D L S   +       +  +   A G+
Sbjct: 243 DKLVKLHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           A++ +      I RD + +NIL+      K++DFGLAR    +              + A
Sbjct: 298 AFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARV-IEDNEYTAREGAKFPIKWTA 353
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELIT-GR------------RAVERN--LPRNE 314
           PE +  G  T KSDVWSFG++L E++T GR            RA+ER   +PR E
Sbjct: 354 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 408

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 29  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 84
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 85  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 140
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 141 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 197
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 198 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 257
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 258 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 300
Query: 378 NIISEISSQD 387
            I++  S+Q+
Sbjct: 301 RIVALTSNQE 310

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 53  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 109 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 158
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 25  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 80
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 81  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 136
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 137 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 193
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 194 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 253
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 254 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 296
Query: 378 NIISEISSQD 387
            I++  S+Q+
Sbjct: 297 RIVALTSNQE 306

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 60
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 61  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 117 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 166
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 167 YTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 92  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQL 147
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 265 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 378 NIISEISSQD 387
            I++  S+Q+
Sbjct: 308 RIVALTSNQE 317

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 49
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 105
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 106 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 157
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 158 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 12  FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 60
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 61  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 116
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 117 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 166
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 167 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 210

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 110 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 159
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 36  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 91
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 92  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 147
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 148 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 204
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 205 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 264
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 265 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 307
Query: 378 NIISEISSQD 387
            I++  S+Q+
Sbjct: 308 RIVALTSNQE 317

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 126 VAIKQLNRQGFQGHKEWI-NEVNFLGVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMH 182
           VAIK + ++  +G +  + NE+  L  +KHPN+V L      DD  E G    L+ +L+ 
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGHLYLIMQLVS 99
Query: 183 NKSLEDHLLSRVPTPLAWIARLKIAQDAAR-------GLAYLHEEMDFQLIFRDFKTSNI 235
              L D ++ +              +DA+R        + YLH   D  ++ RD K  N+
Sbjct: 100 GGELFDRIVEK---------GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENL 147
Query: 236 L---LDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSF 292
           L   LDED K  +SDFGL++   P   G           Y APE +     +   D WS 
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 293 GVVLYELITGRRAVERNLPRNEQKLLEWV--------RPY---VSDSKK 330
           GV+ Y L+ G          N+ KL E +         PY   +SDS K
Sbjct: 205 GVIAYILLCGYPPF---YDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 110 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 159
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 YTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 110 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 159
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 53  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 109 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 158
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK---EWINEVNFLGV 151
           +G G FG       +V   +HQ +GH     VA+K LNRQ  +      +   E+  L +
Sbjct: 19  LGVGTFG-------KVKIGEHQLTGHK----VAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
            +HP+++KL    +   +  M    V E +    L D++       +  +   ++ Q   
Sbjct: 68  FRHPHIIKLYQVISTPTDFFM----VMEYVSGGELFDYICKH--GRVEEMEARRLFQQIL 121
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
             + Y H  M   ++ RD K  N+LLD    AK++DFGL+        G           
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRTSCGSPN 175
Query: 272 YAAPEYVQTGRLTA--KSDVWSFGVVLYELITG 302
           YAAPE V +GRL A  + D+WS GV+LY L+ G
Sbjct: 176 YAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 49
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 105
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 106 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 157
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 158 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 65/213 (30%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK---EWINEVNFLGV 151
           +G G FG       +V    H+ +GH     VA+K LNRQ  +      +   E+  L +
Sbjct: 24  LGVGTFG-------KVKVGKHELTGHK----VAVKILNRQKIRSLDVVGKIRREIQNLKL 72
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
            +HP+++KL    +   +  M    V E +    L D++       L      ++ Q   
Sbjct: 73  FRHPHIIKLYQVISTPSDIFM----VMEYVSGGELFDYICKN--GRLDEKESRRLFQQIL 126
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ Y H  M   ++ RD K  N+LLD    AK++DFGL+        G           
Sbjct: 127 SGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNM---MSDGEFLRXSCGSPN 180
Query: 272 YAAPEYVQTGRLTA--KSDVWSFGVVLYELITG 302
           YAAPE + +GRL A  + D+WS GV+LY L+ G
Sbjct: 181 YAAPEVI-SGRLYAGPEVDIWSSGVILYALLCG 212

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 49
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 105
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 106 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 157
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 158 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 63/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 9   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 57
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 58  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 113
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 114 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 163
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 164 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 28  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 83
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 84  KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 139
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 140 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 196
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 197 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 256
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 257 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 299
Query: 378 NIISEISSQD 387
            I++  S+Q+
Sbjct: 300 RIVALTSNQE 309

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 50
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 106
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 107 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 158
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 52
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 108
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 109 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 160
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 51
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 107
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 108 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 159
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 78/286 (27%), Positives = 118/286 (41%), Gaps = 41/286 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG V++G+      D++T        VAIK ++ +  +   E I  E+ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGI------DNRTQKV-----VAIKIIDLEEAEDEIEDIQQEIT 57
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P + K  G   +D     +  ++ E +   S  D L    P PL       I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKD----TKLWIIMEYLGGGSALDLL---EPGPLDETQIATIL 110
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
           ++  +GL YLH E   + I RD K +N+LL E  + KL+DFG+A Q     +        
Sbjct: 111 REILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFV 165
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE ++     +K+D+WS G+   EL  G        P     L+    P    
Sbjct: 166 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---- 221
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
                    P LEGNY              CL K+P  RP   E++
Sbjct: 222 ---------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 49
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 105
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 106 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 157
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 158 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 53  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 109 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 158
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 126 VAIKQLNRQGFQGHKEWI-NEVNFLGVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMH 182
           VAIK + ++  +G +  + NE+  L  +KHPN+V L      DD  E G    L+ +L+ 
Sbjct: 46  VAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGHLYLIMQLVS 99
Query: 183 NKSLEDHLLSRVPTPLAWIARLKIAQDAAR-------GLAYLHEEMDFQLIFRDFKTSNI 235
              L D ++ +              +DA+R        + YLH   D  ++ RD K  N+
Sbjct: 100 GGELFDRIVEK---------GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENL 147
Query: 236 L---LDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSF 292
           L   LDED K  +SDFGL++   P   G           Y APE +     +   D WS 
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 293 GVVLYELITGRRAVERNLPRNEQKLLEWV--------RPY---VSDSKK 330
           GV+ Y L+ G          N+ KL E +         PY   +SDS K
Sbjct: 205 GVIAYILLCGYPPF---YDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 50
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 106
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 107 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV- 158
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 52
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 108
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 109 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 160
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 119/286 (41%), Gaps = 41/286 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG V++G+      D++T        VAIK ++ +  +   E I  E+ 
Sbjct: 24  FTKLEKIGKGSFGEVFKGI------DNRTQKV-----VAIKIIDLEEAEDEIEDIQQEIT 72
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P + K  G   +D     +  ++ E +   S  D L    P PL       I 
Sbjct: 73  VLSQCDSPYVTKYYGSYLKD----TKLWIIMEYLGGGSALDLL---EPGPLDETQIATIL 125
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
           ++  +GL YLH E   + I RD K +N+LL E  + KL+DFG+A Q     +        
Sbjct: 126 REILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFV 180
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE ++     +K+D+WS G+   EL  G        P     L+    P    
Sbjct: 181 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---- 236
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
                    P LEGNY              CL K+P  RP   E++
Sbjct: 237 ---------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELL 269

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 68/229 (29%), Positives = 99/229 (43%), Gaps = 48/229 (20%)
Query: 126 VAIKQLNRQGFQGHKEWI-NEVNFLGVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMH 182
           VAIK + ++  +G +  + NE+  L  +KHPN+V L      DD  E G    L+ +L+ 
Sbjct: 46  VAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVAL------DDIYESGGHLYLIMQLVS 99
Query: 183 NKSLEDHLLSRVPTPLAWIARLKIAQDAAR-------GLAYLHEEMDFQLIFRDFKTSNI 235
              L D ++ +              +DA+R        + YLH   D  ++ RD K  N+
Sbjct: 100 GGELFDRIVEK---------GFYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENL 147
Query: 236 L---LDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSF 292
           L   LDED K  +SDFGL++   P   G           Y APE +     +   D WS 
Sbjct: 148 LYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSI 204
Query: 293 GVVLYELITGRRAVERNLPRNEQKLLEWV--------RPY---VSDSKK 330
           GV+ Y L+ G          N+ KL E +         PY   +SDS K
Sbjct: 205 GVIAYILLCGYPPF---YDENDAKLFEQILKAEYEFDSPYWDDISDSAK 250

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 51
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 107
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 108 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 159
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 53  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 108
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 109 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 158
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 51
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 107
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 108 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV- 159
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 64/229 (27%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 53
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL 
Sbjct: 54  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLI 109
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 110 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 161
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 162 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 207

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 79/286 (27%), Positives = 119/286 (41%), Gaps = 41/286 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG V++G+      D++T        VAIK ++ +  +   E I  E+ 
Sbjct: 9   FTKLEKIGKGSFGEVFKGI------DNRTQKV-----VAIKIIDLEEAEDEIEDIQQEIT 57
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P + K  G   +D     +  ++ E +   S  D L    P PL       I 
Sbjct: 58  VLSQCDSPYVTKYYGSYLKD----TKLWIIMEYLGGGSALDLL---EPGPLDETQIATIL 110
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
           ++  +GL YLH E   + I RD K +N+LL E  + KL+DFG+A Q     +        
Sbjct: 111 REILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNXFV 165
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE ++     +K+D+WS G+   EL  G        P     L+    P    
Sbjct: 166 GTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNP---- 221
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
                    P LEGNY              CL K+P  RP   E++
Sbjct: 222 ---------PTLEGNYS----KPLKEFVEACLNKEPSFRPTAKELL 254

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F +   IGEG +G VY+   +++ +    +    +LD   + +           I E++ 
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGE--VVALXKIRLDTETEGVPSTA-------IREISL 55
Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIARLK 205
           L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL      +
Sbjct: 56  LKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 111
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXX 264
           + Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P        
Sbjct: 112 LLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYT 161
Query: 265 XXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                  Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 162 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 61/223 (27%), Positives = 106/223 (47%), Gaps = 29/223 (13%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F +   IGEG +G VY+   +++ +    +    +LD   + +           I E++ 
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGE--VVALXKIRLDTETEGVPSTA-------IREISL 54
Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIARLK 205
           L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL      +
Sbjct: 55  LKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ 110
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXX 264
           + Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P        
Sbjct: 111 LLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RTYT 160
Query: 265 XXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                  Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 109/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 6   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 54
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 55  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 110
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 111 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 160
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 80/310 (25%), Positives = 127/310 (40%), Gaps = 45/310 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV- 152
           +GEG FG V   +      D       +K  VA+K L     +    + I+E+  + ++ 
Sbjct: 77  LGEGAFGQVV--LAEAIGLDKDKPNRVTK--VAVKMLKSDATEKDLSDLISEMEMMKMIG 132
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 133 KHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR      
Sbjct: 189 SSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 245
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-KL 317
                        + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  KL
Sbjct: 246 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKL 305
Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILG 377
           L          K+ H +  P    N               C    P  RP   ++V+ L 
Sbjct: 306 L----------KEGHRMDKPSNCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDLD 348
Query: 378 NIISEISSQD 387
            I++  S+Q+
Sbjct: 349 RIVALTSNQE 358

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 98/213 (46%), Gaps = 29/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK---EWINEVNFLGV 151
           +G G FG       +V   +HQ +GH     VA+K LNRQ  +      +   E+  L +
Sbjct: 19  LGVGTFG-------KVKIGEHQLTGHK----VAVKILNRQKIRSLDVVGKIKREIQNLKL 67
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
            +HP+++KL    +   +  M    V E +    L D++       +  +   ++ Q   
Sbjct: 68  FRHPHIIKLYQVISTPTDFFM----VMEYVSGGELFDYICKH--GRVEEMEARRLFQQIL 121
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
             + Y H  M   ++ RD K  N+LLD    AK++DFGL+        G           
Sbjct: 122 SAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD---GEFLRDSCGSPN 175
Query: 272 YAAPEYVQTGRLTA--KSDVWSFGVVLYELITG 302
           YAAPE V +GRL A  + D+WS GV+LY L+ G
Sbjct: 176 YAAPE-VISGRLYAGPEVDIWSCGVILYALLCG 207

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 108/226 (47%), Gaps = 27/226 (11%)
Query: 84  SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW- 142
           S++  F +   +G G +  VY+G+       ++T+G    + VA+K++     +G     
Sbjct: 2   SSSSQFKQLEKLGNGTYATVYKGL-------NKTTG----VYVALKEVKLDSEEGTPSTA 50
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ +  +KH N+V+L      ++    +  LV+E M N   K ++   +   P  L 
Sbjct: 51  IREISLMKELKHENIVRLYDVIHTEN----KLTLVFEFMDNDLKKYMDSRTVGNTPRGLE 106
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                       +GLA+ HE    +++ RD K  N+L+++  + KL DFGLAR  G P  
Sbjct: 107 LNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV- 162
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
             +          Y AP+ +   R  + S D+WS G +L E+ITG+
Sbjct: 163 --NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGK 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + V+ 
Sbjct: 22  IGKGNFA-------KVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR- 212
           HPN+VKL     E  E      LV E      + D+L++          R+K  +  A+ 
Sbjct: 72  HPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKF 119
Query: 213 -----GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                 + Y H++    ++ RD K  N+LLD D   K++DFG + +      G+      
Sbjct: 120 RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---FGNKLDTFC 173
Query: 268 XXXXYAAPEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
               YAAPE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + V+ 
Sbjct: 22  IGKGNFA-------KVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR- 212
           HPN+VKL     E  E      LV E      + D+L++          R+K  +  A+ 
Sbjct: 72  HPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKF 119
Query: 213 -----GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                 + Y H++    ++ RD K  N+LLD D   K++DFG + +      G+      
Sbjct: 120 RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---FGNKLDAFC 173
Query: 268 XXXXYAAPEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
               YAAPE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 174 GAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 16  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 62
Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQD 209
             LV+L G C +      QR   ++ E M N  L ++L     R  T       L++ +D
Sbjct: 63  EKLVQLYGVCTK------QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKD 112
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               + YL  +   Q + RD    N L+++    K+SDFGL+R    +            
Sbjct: 113 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFP 168
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER----NLPRNEQKLLEWVRPY 324
             ++ PE +   + ++KSD+W+FGV+++E+ + G+   ER        +  + L   RP+
Sbjct: 169 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 228
Query: 325 VSDSKKFHLI 334
           ++  K + ++
Sbjct: 229 LASEKVYTIM 238

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 102/233 (43%), Gaps = 42/233 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + V+ 
Sbjct: 22  IGKGNFA-------KVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR- 212
           HPN+VKL     E  E      LV E      + D+L++          R+K  +  A+ 
Sbjct: 72  HPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAH--------GRMKEKEARAKF 119
Query: 213 -----GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                 + Y H++    ++ RD K  N+LLD D   K++DFG + +      G+      
Sbjct: 120 RQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---FGNKLDTFC 173
Query: 268 XXXXYAAPEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
               YAAPE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 174 GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/217 (28%), Positives = 95/217 (43%), Gaps = 23/217 (10%)
Query: 87  RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEV 146
           + ++R   IG+G  G VY  +   +  +           VAI+Q+N Q     +  INE+
Sbjct: 21  KKYTRFEKIGQGASGTVYTAMDVATGQE-----------VAIRQMNLQQQPKKELIINEI 69
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             +   K+PN+V  +      DE      +V E +   SL D +++        IA   +
Sbjct: 70  LVMRENKNPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTD-VVTETCMDEGQIA--AV 122
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
            ++  + L +LH     Q+I R+ K+ NILL  D   KL+DFG   Q  PE         
Sbjct: 123 CRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPE--QSKRSTM 177
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                + APE V       K D+WS G++  E+I G 
Sbjct: 178 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 214

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 12  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 58
Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQD 209
             LV+L G C +      QR   ++ E M N  L ++L     R  T       L++ +D
Sbjct: 59  EKLVQLYGVCTK------QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKD 108
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               + YL  +   Q + RD    N L+++    K+SDFGL+R    +            
Sbjct: 109 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFP 164
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER----NLPRNEQKLLEWVRPY 324
             ++ PE +   + ++KSD+W+FGV+++E+ + G+   ER        +  + L   RP+
Sbjct: 165 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 224
Query: 325 VSDSKKFHLI 334
           ++  K + ++
Sbjct: 225 LASEKVYTIM 234

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 65/230 (28%), Positives = 112/230 (48%), Gaps = 35/230 (15%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 49
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL----LSRVPTPL 198
           I E++ L  + HPN+VKL+     ++    +  LV+E +H + L+D +    L+ +P PL
Sbjct: 50  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLH-QDLKDFMDASALTGIPLPL 104
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPE 257
                 ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P 
Sbjct: 105 IKSYLFQLLQ----GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV 157
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                         Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 158 ---RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 17  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 63
Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQD 209
             LV+L G C +      QR   ++ E M N  L ++L     R  T       L++ +D
Sbjct: 64  EKLVQLYGVCTK------QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKD 113
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               + YL  +   Q + RD    N L+++    K+SDFGL+R    +            
Sbjct: 114 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFP 169
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER----NLPRNEQKLLEWVRPY 324
             ++ PE +   + ++KSD+W+FGV+++E+ + G+   ER        +  + L   RP+
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 229
Query: 325 VSDSKKFHLI 334
           ++  K + ++
Sbjct: 230 LASEKVYTIM 239

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/225 (27%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 5   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 53
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H    K ++   L+ +P PL     
Sbjct: 54  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYL 109
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GL++ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 110 FQLLQ----GLSFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 159
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 203

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 23  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 69
Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQD 209
             LV+L G C +      QR   ++ E M N  L ++L     R  T       L++ +D
Sbjct: 70  EKLVQLYGVCTK------QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKD 119
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               + YL  +   Q + RD    N L+++    K+SDFGL+R    +            
Sbjct: 120 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFP 175
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER----NLPRNEQKLLEWVRPY 324
             ++ PE +   + ++KSD+W+FGV+++E+ + G+   ER        +  + L   RP+
Sbjct: 176 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 235
Query: 325 VSDSKKFHLI 334
           ++  K + ++
Sbjct: 236 LASEKVYTIM 245

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 17  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 63
Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQD 209
             LV+L G C +      QR   ++ E M N  L ++L     R  T       L++ +D
Sbjct: 64  EKLVQLYGVCTK------QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKD 113
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               + YL  +   Q + RD    N L+++    K+SDFGL+R    +            
Sbjct: 114 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSRGSKFP 169
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER----NLPRNEQKLLEWVRPY 324
             ++ PE +   + ++KSD+W+FGV+++E+ + G+   ER        +  + L   RP+
Sbjct: 170 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 229
Query: 325 VSDSKKFHLI 334
           ++  K + ++
Sbjct: 230 LASEKVYTIM 239

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + V+ 
Sbjct: 22  IGKGNFA-------KVKLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL     E  E      LV E      + D+L++         AR K  Q  +  
Sbjct: 72  HPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-ARAKFRQIVS-A 125
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H++    ++ RD K  N+LLD D   K++DFG + +      G+          YA
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---FGNKLDTFCGSPPYA 179
Query: 274 APEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           APE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 32  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 78
Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQD 209
             LV+L G C +      QR   ++ E M N  L ++L     R  T       L++ +D
Sbjct: 79  EKLVQLYGVCTK------QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKD 128
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               + YL  +   Q + RD    N L+++    K+SDFGL+R    +            
Sbjct: 129 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT-SSVGSKFP 184
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER----NLPRNEQKLLEWVRPY 324
             ++ PE +   + ++KSD+W+FGV+++E+ + G+   ER        +  + L   RP+
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244
Query: 325 VSDSKKFHLI 334
           ++  K + ++
Sbjct: 245 LASEKVYTIM 254

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 101/227 (44%), Gaps = 30/227 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + V+ 
Sbjct: 22  IGKGNFA-------KVKLARHILTGKEVAVRIIDKTQLNSSSLQ---KLFREVRIMKVLN 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL     E  E      LV E      + D+L++         AR K  Q  +  
Sbjct: 72  HPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-ARAKFRQIVS-A 125
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H++    ++ RD K  N+LLD D   K++DFG + +      G+          YA
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADMNIKIADFGFSNEFT---FGNKLDEFCGSPPYA 179
Query: 274 APEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           APE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 112/250 (44%), Gaps = 37/250 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 32  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 78
Query: 155 PNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQD 209
             LV+L G C +      QR   ++ E M N  L ++L     R  T       L++ +D
Sbjct: 79  EKLVQLYGVCTK------QRPIFIITEYMANGCLLNYLREMRHRFQTQ----QLLEMCKD 128
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               + YL  +   Q + RD    N L+++    K+SDFGL+R    +            
Sbjct: 129 VCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRY-VLDDEETSSVGSKFP 184
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER----NLPRNEQKLLEWVRPY 324
             ++ PE +   + ++KSD+W+FGV+++E+ + G+   ER        +  + L   RP+
Sbjct: 185 VRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPH 244
Query: 325 VSDSKKFHLI 334
           ++  K + ++
Sbjct: 245 LASEKVYTIM 254

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/239 (25%), Positives = 102/239 (42%), Gaps = 27/239 (11%)
Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW 142
           K + + F     +G G FG V+    R +   +       ++ V +KQ+           
Sbjct: 2   KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTN------- 54
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL--SRVPTPLAW 200
            +E   L +V HP ++++ G   +      Q  ++ + +    L   L    R P P+A 
Sbjct: 55  -DERLMLSIVTHPFIIRMWGTFQD----AQQIFMIMDYIEGGELFSLLRKSQRFPNPVAK 109
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
                 A +    L YLH +    +I+RD K  NILLD++   K++DFG A+  P     
Sbjct: 110 FY----AAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVP----- 157
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV-ERNLPRNEQKLL 318
                      Y APE V T       D WSFG+++YE++ G     + N  +  +K+L
Sbjct: 158 DVTYXLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 65/229 (28%), Positives = 110/229 (48%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 52
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN--KSLED-HLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +H   K+  D   L+ +P PL 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLHQDLKTFMDASALTGIPLPLI 108
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 109 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 160
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 79/314 (25%), Positives = 129/314 (41%), Gaps = 54/314 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 36  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 89
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VP--TP-------LA 199
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  TP       L 
Sbjct: 90  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLT 146
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
               +  +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    +  
Sbjct: 147 LEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD 203
Query: 260 GHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---K 316
                       + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +
Sbjct: 204 XVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRR 263
Query: 317 LLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
           L E  R   P  +  + +  ++D                     C   +P  RP  SE+V
Sbjct: 264 LKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELV 302
Query: 374 DILGNIISEISSQD 387
           + LGN++   + QD
Sbjct: 303 EHLGNLLQANAQQD 316

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + ++ 
Sbjct: 23  IGKGNFA-------KVKLARHVLTGREVAVKIIDKTQLNPTSLQ---KLFREVRIMKILN 72
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL     E  E      LV E      + D+L++         AR K  Q  +  
Sbjct: 73  HPNIVKLF----EVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKE-ARAKFRQIVS-A 126
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H++    ++ RD K  N+LLD D   K++DFG + +     +G+          YA
Sbjct: 127 VQYCHQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFT---VGNKLDTFCGSPPYA 180
Query: 274 APEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           APE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIITLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEEDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/227 (29%), Positives = 100/227 (44%), Gaps = 30/227 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV    V+ 
Sbjct: 22  IGKGNFA-------KVKLARHILTGKEVAVKIIDKTQLNSSSLQ---KLFREVRIXKVLN 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL     E  E      LV E      + D+L++         AR K  Q  +  
Sbjct: 72  HPNIVKLF----EVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKE-ARAKFRQIVS-A 125
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H++    ++ RD K  N+LLD D   K++DFG + +      G+          YA
Sbjct: 126 VQYCHQKF---IVHRDLKAENLLLDADXNIKIADFGFSNEFT---FGNKLDAFCGAPPYA 179
Query: 274 APEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           APE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 180 APELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 220

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 77/311 (24%), Positives = 131/311 (42%), Gaps = 47/311 (15%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 84
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 85  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 140
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 141 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLTARNVLVTENNVMKIADFGLARDINNI 197
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-K 316
                         + APE +     T +SDVWSFGV+++E+ T   +    +P  E  K
Sbjct: 198 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 257
Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
           LL          K+ H +  P    N               C    P  RP   ++V+ L
Sbjct: 258 LL----------KEGHRMDKPANCTN-------ELYMMMRDCWHAVPSQRPTFKQLVEDL 300
Query: 377 GNIISEISSQD 387
             I++  ++Q+
Sbjct: 301 DRILTLTTNQE 311

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 143
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 144 GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 199
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 200 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 256
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 257 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + ++ 
Sbjct: 23  IGKGNFA-------KVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 72
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL     E  E      L+ E      + D+L++         AR K  Q  +  
Sbjct: 73  HPNIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-ARSKFRQIVS-A 126
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H++   +++ RD K  N+LLD D   K++DFG + +     +G           YA
Sbjct: 127 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDAFCGAPPYA 180
Query: 274 APEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           APE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 181 APELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 221

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 64/253 (25%), Positives = 108/253 (42%), Gaps = 37/253 (14%)
Query: 65  LLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKL 124
           L++Q +   L+  S     SA R       +GE  FG VY+G +   +   QT       
Sbjct: 11  LINQHKQAKLKEISL----SAVRFMEE---LGEDRFGKVYKGHLFGPAPGEQTQA----- 58
Query: 125 DVAIKQLNRQGFQG--HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMH 182
            VAIK L  +  +G   +E+ +E      ++HPN+V L+G   +D    M    ++    
Sbjct: 59  -VAIKTLKDKA-EGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM----IFSYCS 112
Query: 183 NKSLEDHLLSRVP--------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR 228
           +  L + L+ R P              + L     + +    A G+ YL       ++ +
Sbjct: 113 HGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHK 169
Query: 229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSD 288
           D  T N+L+ +    K+SD GL R+                  + APE +  G+ +  SD
Sbjct: 170 DLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSD 229
Query: 289 VWSFGVVLYELIT 301
           +WS+GVVL+E+ +
Sbjct: 230 IWSYGVVLWEVFS 242

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIIHLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 102/227 (44%), Gaps = 30/227 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           IG+G F        +V    H  +G +  + +  K QLN    Q   +   EV  + ++ 
Sbjct: 20  IGKGNFA-------KVKLARHILTGREVAIKIIDKTQLNPTSLQ---KLFREVRIMKILN 69
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+VKL     E  E      L+ E      + D+L++         AR K  Q  +  
Sbjct: 70  HPNIVKLF----EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKE-ARSKFRQIVS-A 123
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + Y H++   +++ RD K  N+LLD D   K++DFG + +     +G           YA
Sbjct: 124 VQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFT---VGGKLDTFCGSPPYA 177
Query: 274 APEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           APE  Q  +    + DVWS GV+LY L++G      +LP + Q L E
Sbjct: 178 APELFQGKKYDGPEVDVWSLGVILYTLVSG------SLPFDGQNLKE 218

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 77/313 (24%), Positives = 127/313 (40%), Gaps = 53/313 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 37  LGRGAFGQV------IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 90
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTP--------LAW 200
            H N+V L+G C +    G   +++ E     +L  +L S+    VP          L  
Sbjct: 91  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTL 147
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
              +  +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    +   
Sbjct: 148 EHLIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDX 204
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KL 317
                      + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L
Sbjct: 205 VRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL 264
Query: 318 LEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVD 374
            E  R   P  +  + +  ++D                     C   +P  RP  SE+V+
Sbjct: 265 KEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVE 303
Query: 375 ILGNIISEISSQD 387
            LGN++   + QD
Sbjct: 304 HLGNLLQANAQQD 316

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 97/223 (43%), Gaps = 30/223 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +GE  FG VY+G +   +   QT        VAIK L  +  +G   +E+ +E      +
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQTQA------VAIKTLKDKA-EGPLREEFRHEAMLRARL 69
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPL 198
           +HPN+V L+G   +D    M    ++    +  L + L+ R P              + L
Sbjct: 70  QHPNVVCLLGVVTKDQPLSM----IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSAL 125
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                + +    A G+ YL       ++ +D  T N+L+ +    K+SD GL R+     
Sbjct: 126 EPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD 182
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                        + APE +  G+ +  SD+WS+GVVL+E+ +
Sbjct: 183 YYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 89
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 90  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 145
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 146 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 202
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 203 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 86
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 87  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 142
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 143 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 199
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 200 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 26  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 80  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 292
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 293 VEHLGNLLQANAQQD 307

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 102/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   +++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMRIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 64/225 (28%), Positives = 108/225 (48%), Gaps = 33/225 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEV 146
           F +   IGEG +G VY+   +++ +            VA+K+  L+ +        I E+
Sbjct: 4   FQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTAIREI 52
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN--KSLED-HLLSRVPTPLAWIAR 203
           + L  + HPN+VKL+     ++    +  LV+E +H   K+  D   L+ +P PL     
Sbjct: 53  SLLKELNHPNIVKLLDVIHTEN----KLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYL 108
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHX 262
            ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P      
Sbjct: 109 FQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV---RT 158
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                    Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 202

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++ E     +L ++L +R P  +     I R+   Q
Sbjct: 98  GKHKNIINLLGACTQDG----PLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 26  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 80  HHLNVVNLLGACTKP---GGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 193
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 194 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 292
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 293 VEHLGNLLQANAQQD 307

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 50
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMH---NKSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +     K ++   L+ +P PL 
Sbjct: 51  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLSMDLKKFMDASALTGIPLPLI 106
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 107 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV- 158
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 159 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 204

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 35  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 89  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 146 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIXKDP 202
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 301
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 302 VEHLGNLLQANAQQD 316

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 52
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMH---NKSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +     K ++   L+ +P PL 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFLSMDLKKFMDASALTGIPLPLI 108
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 109 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPENLLINTEGAIKLADFGLARAFGVPV- 160
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 59/187 (31%), Positives = 84/187 (44%), Gaps = 18/187 (9%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 60  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKEAKRIPEEI 115
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    RGLAYL E+   Q++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 116 LGKVSIA--VLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 167
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
                      Y APE +Q    + +SD+WS G+ L EL  GR  +    P  + K LE 
Sbjct: 168 SMANSFVGTRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI----PPPDAKELEA 223
Query: 321 V--RPYV 325
           +  RP V
Sbjct: 224 IFGRPVV 230

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  L VAIK   N       ++++ E   +    
Sbjct: 18  IGEGQFGDVHQGIY--------MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 70  HPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 123
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 179
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 35  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 89  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 146 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 203 DXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 301
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 302 VEHLGNLLQANAQQD 316

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  L VAIK   N       ++++ E   +    
Sbjct: 15  IGEGQFGDVHQGIY--------MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 67  HPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 120
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 121 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 176
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 177 APESINFRRFTSASDVWMFGVCMWEIL 203

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           IGEG FG V++G+          S  +  L VAIK          +E ++ E   +    
Sbjct: 20  IGEGQFGDVHQGIY--------MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 72  HPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 125
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 126 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 181
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 182 APESINFRRFTSASDVWMFGVCMWEIL 208

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           IGEG FG V++G+          S  +  L VAIK          +E ++ E   +    
Sbjct: 46  IGEGQFGDVHQGIY--------MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 97
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 98  HPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 151
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 152 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 207
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 208 APESINFRRFTSASDVWMFGVCMWEIL 234

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 103/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D    +  ++ Y    N  L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIINLLGACTQDGP--LYVIVAYASKGN--LREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  L VAIK   N       ++++ E   +    
Sbjct: 23  IGEGQFGDVHQGIY--------MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 75  HPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 128
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 129 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 184
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 185 APESINFRRFTSASDVWMFGVCMWEIL 211

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 58/207 (28%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  L VAIK   N       ++++ E   +    
Sbjct: 21  IGEGQFGDVHQGIY--------MSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 72
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 73  HPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 126
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 127 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 182
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 183 APESINFRRFTSASDVWMFGVCMWEIL 209

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/232 (27%), Positives = 104/232 (44%), Gaps = 32/232 (13%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN--RQGFQGHKEWINEV 146
           + R   IGEG FG   + ++  S++D +           IK++N  R   +  +E   EV
Sbjct: 26  YVRLQKIGEGSFG---KAILVKSTEDGR--------QYVIKEINISRMSSKEREESRREV 74
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLV-----YELMHNKSLEDHLLSRVPTPLAWI 201
             L  +KHPN+V+   Y    +E G   +++      +L    + +  +L +    L W 
Sbjct: 75  AVLANMKHPNIVQ---YRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWF 131
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            ++ +A      L ++H   D +++ RD K+ NI L +D   +L DFG+AR         
Sbjct: 132 VQICLA------LKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARV--LNSTVE 180
Query: 262 XXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN 313
                     Y +PE  +      KSD+W+ G VLYEL T + A E    +N
Sbjct: 181 LARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKN 232

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 26  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 80  HHLNVVNLLGACTKP---GGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 292
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 293 VEHLGNLLQANAQQD 307

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 26  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 79
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 80  HHLNVVNLLGACTKP---GGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 136
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 137 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 193
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 194 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 253
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 254 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 292
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 293 VEHLGNLLQANAQQD 307

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 35/230 (15%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 52
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL----LSRVPTPL 198
           I E++ L  + HPN+VKL+     ++    +  LV+E + +  L+D +    L+ +P PL
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-SMDLKDFMDASALTGIPLPL 107
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPE 257
                 ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P 
Sbjct: 108 IKSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 160
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                         Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 ---RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 77/286 (26%), Positives = 116/286 (40%), Gaps = 41/286 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG VY+G+     D+H      +K  VAIK ++ +  +   E I  E+ 
Sbjct: 21  FTKLDRIGKGSFGEVYKGI-----DNH------TKEVVAIKIIDLEEAEDEIEDIQQEIT 69
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P + +  G       +  +  ++ E +   S  D L    P PL       I 
Sbjct: 70  VLSQCDSPYITRYFGSYL----KSTKLWIIMEYLGGGSALDLL---KPGPLEETYIATIL 122
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
           ++  +GL YLH E   + I RD K +N+LL E    KL+DFG+A Q     +        
Sbjct: 123 REILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNXFV 177
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE ++      K+D+WS G+   EL  G        P     L+    P    
Sbjct: 178 GTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP---- 233
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
                    P LEG +              CL K P+ RP   E++
Sbjct: 234 ---------PTLEGQHS----KPFKEFVEACLNKDPRFRPTAKELL 266

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           +G GGFG V R +       HQ +G      VAIKQ  ++    ++E W  E+  +  + 
Sbjct: 23  LGTGGFGYVLRWI-------HQDTGEQ----VAIKQCRQELSPKNRERWCLEIQIMKKLN 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYEL--MHNKSLEDHLLSRVPTPLAWIARLK------ 205
           HPN+V      A +   G+Q+L   +L  +  +  E   L +          LK      
Sbjct: 72  HPNVVS-----AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 126
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHX 262
           +  D +  L YLHE    ++I RD K  NI+L    +    K+ D G A++      G  
Sbjct: 127 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGEL 180
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
                    Y APE ++  + T   D WSFG + +E ITG R
Sbjct: 181 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 222

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/230 (27%), Positives = 111/230 (48%), Gaps = 35/230 (15%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 51
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL----LSRVPTPL 198
           I E++ L  + HPN+VKL+     ++    +  LV+E + +  L+D +    L+ +P PL
Sbjct: 52  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEFL-SMDLKDFMDASALTGIPLPL 106
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPE 257
                 ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P 
Sbjct: 107 IKSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 159
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                         Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 160 ---RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 205

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 35  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 89  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 146 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 202
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 203 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 262
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 263 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 301
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 302 VEHLGNLLQANAQQD 316

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 64/222 (28%), Positives = 96/222 (43%), Gaps = 34/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           +G GGFG V R +       HQ +G      VAIKQ  ++    ++E W  E+  +  + 
Sbjct: 22  LGTGGFGYVLRWI-------HQDTGEQ----VAIKQCRQELSPKNRERWCLEIQIMKKLN 70
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYEL--MHNKSLEDHLLSRVPTPLAWIARLK------ 205
           HPN+V      A +   G+Q+L   +L  +  +  E   L +          LK      
Sbjct: 71  HPNVVS-----AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRT 125
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHX 262
           +  D +  L YLHE    ++I RD K  NI+L    +    K+ D G A++      G  
Sbjct: 126 LLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKE---LDQGEL 179
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
                    Y APE ++  + T   D WSFG + +E ITG R
Sbjct: 180 CTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFR 221

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 72  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 125
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLK--- 205
            H N+V L+G C +    G   +++ E     +L  +L S+    VP  +A     K   
Sbjct: 126 HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 182
Query: 206 -------IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                   +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 183 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 239
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 240 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 299
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 300 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 338
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 339 VEHLGNLLQANAQQD 353

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 93/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  + VAIK   N       ++++ E   +    
Sbjct: 18  IGEGQFGDVHQGIY--------MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 70  HPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLSTA 123
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 179
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 104/229 (45%), Gaps = 42/229 (18%)
Query: 98  GGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINEVNFLGVVKH 154
           G FGCV++   ++ +D            VA+K     ++Q +Q  +E  +       +KH
Sbjct: 26  GRFGCVWKA--QLMNDF-----------VAVKIFPLQDKQSWQSEREIFSTPG----MKH 68
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NL++ +          ++  L+       SL D+L   + T   W     +A+  +RGL
Sbjct: 69  ENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLKGNIIT---WNELCHVAETMSRGL 125
Query: 215 AYLHEEMDF--------QLIFRDFKTSNILLDEDYKAKLSDFGLA---RQGPPEGLGHXX 263
           +YLHE++ +         +  RDFK+ N+LL  D  A L+DFGLA     G P G  H  
Sbjct: 126 SYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTH-- 183
Query: 264 XXXXXXXXYAAPEYVQTG-----RLTAKSDVWSFGVVLYELITGRRAVE 307
                   Y APE ++           + D+++ G+VL+EL++  +A +
Sbjct: 184 -GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/224 (26%), Positives = 101/224 (45%), Gaps = 29/224 (12%)
Query: 95  IGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +GEG FG  V    V +  D  + +     + VA+K L     +    + ++E+  + ++
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEA-----VTVAVKMLKDDATEKDLSDLVSEMEMMKMI 97
Query: 153 -KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQ 208
            KH N++ L+G C +D        ++       +L ++L +R P  + +   I R+   Q
Sbjct: 98  GKHKNIINLLGACTQDG----PLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQ 153
Query: 209 -----------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                        ARG+ YL  +   + I RD    N+L+ E+   K++DFGLAR     
Sbjct: 154 MTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNI 210
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWSFGV+++E+ T
Sbjct: 211 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 104/255 (40%), Gaps = 28/255 (10%)
Query: 55  DWSDSLAFYELLSQRRANDLRVFSFAELKSATRG-FSRALLIGEGGFGCVYRGVVRVSSD 113
           D+ DS+ F   L          + + E +  T+  F +  ++G+GGFG V    VR +  
Sbjct: 160 DYLDSIYFNRFLQ---------WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGK 210
Query: 114 DHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQ 173
            +     + K     K        G    +NE   L  V    +V L  Y  E  +    
Sbjct: 211 MYACKKLEKKRIKKRK--------GEAMALNEKQILEKVNSRFVVSL-AYAYETKD---A 258
Query: 174 RLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS 233
             LV  LM+   L+ H+             +  A +   GL  LH E   ++++RD K  
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPE 315
Query: 234 NILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFG 293
           NILLD+    ++SD GLA   P    G           Y APE V+  R T   D W+ G
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 294 VVLYELITGRRAVER 308
            +LYE+I G+   ++
Sbjct: 373 CLLYEMIAGQSPFQQ 387

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  + VAIK   N       ++++ E   +    
Sbjct: 18  IGEGQFGDVHQGIY--------MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R    L   + +  A   +  
Sbjct: 70  HPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTA 123
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +              + 
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTXXKASKGKLPIKWM 179
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 69/255 (27%), Positives = 104/255 (40%), Gaps = 28/255 (10%)
Query: 55  DWSDSLAFYELLSQRRANDLRVFSFAELKSATRG-FSRALLIGEGGFGCVYRGVVRVSSD 113
           D+ DS+ F   L          + + E +  T+  F +  ++G+GGFG V    VR +  
Sbjct: 160 DYLDSIYFNRFLQ---------WKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGK 210
Query: 114 DHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQ 173
            +     + K     K        G    +NE   L  V    +V L  Y  E  +    
Sbjct: 211 MYACKKLEKKRIKKRK--------GEAMALNEKQILEKVNSRFVVSL-AYAYETKD---A 258
Query: 174 RLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS 233
             LV  LM+   L+ H+             +  A +   GL  LH E   ++++RD K  
Sbjct: 259 LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPE 315
Query: 234 NILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFG 293
           NILLD+    ++SD GLA   P    G           Y APE V+  R T   D W+ G
Sbjct: 316 NILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALG 372
Query: 294 VVLYELITGRRAVER 308
            +LYE+I G+   ++
Sbjct: 373 CLLYEMIAGQSPFQQ 387

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 63/223 (28%), Positives = 94/223 (42%), Gaps = 51/223 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG +G VY+ +       H+ +G      VAIKQ+  +     +E I E++ +     
Sbjct: 37  LGEGSYGSVYKAI-------HKETGQI----VAIKQVPVES--DLQEIIKEISIMQQCDS 83
Query: 155 PNLVKLVG-------------YCAEDDERGMQRLLVYELMHNKSL-EDHLLSRVPTPLAW 200
           P++VK  G             YC       + RL       NK+L ED + +        
Sbjct: 84  PHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRL------RNKTLTEDEIAT-------- 129
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
                I Q   +GL YLH     + I RD K  NILL+ +  AKL+DFG+A  G      
Sbjct: 130 -----ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVA--GQLTDXM 179
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                      + APE +Q       +D+WS G+   E+  G+
Sbjct: 180 AKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGK 222

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 78/315 (24%), Positives = 128/315 (40%), Gaps = 55/315 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 37  LGRGAFGQV------IEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 90
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VP---TP-------L 198
            H N+V L+G C +    G   +++ E     +L  +L S+    VP    P       L
Sbjct: 91  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFL 147
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    + 
Sbjct: 148 TLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 204
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--- 315
                        + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   
Sbjct: 205 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 264
Query: 316 KLLEWVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEV 372
           +L E  R   P  +  + +  ++D                     C   +P  RP  SE+
Sbjct: 265 RLKEGTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSEL 303
Query: 373 VDILGNIISEISSQD 387
           V+ LGN++   + QD
Sbjct: 304 VEHLGNLLQANAQQD 318

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  + VAIK   N       ++++ E   +    
Sbjct: 398 IGEGQFGDVHQGIY--------MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R    L   + +  A   +  
Sbjct: 450 HPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTA 503
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+  +   KL DFGL+R    +   +          + 
Sbjct: 504 LAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 559
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEW 142
           +   F +   IGEG +G VY+   +++ +            VA+K+  L+ +        
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEV-----------VALKKIRLDTETEGVPSTA 52
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLA 199
           I E++ L  + HPN+VKL+     ++    +  LV+E +     K ++   L+ +P PL 
Sbjct: 53  IREISLLKELNHPNIVKLLDVIHTEN----KLYLVFEHVDQDLKKFMDASALTGIPLPLI 108
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEG 258
                ++ Q    GLA+ H     +++ RD K  N+L++ +   KL+DFGLAR  G P  
Sbjct: 109 KSYLFQLLQ----GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV- 160
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
                        Y APE +   +  + + D+WS G +  E++T RRA+
Sbjct: 161 --RTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVT-RRAL 206

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 92/207 (44%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  + VAIK   N       ++++ E   +    
Sbjct: 18  IGEGQFGDVHQGIY--------MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 69
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   +  
Sbjct: 70  HPHIVKLIGVITENPV-----WIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLSTA 123
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+      KL DFGL+R    +   +          + 
Sbjct: 124 LAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 179
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 180 APESINFRRFTSASDVWMFGVCMWEIL 206

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V   + R     +   G ++   VA+KQL   G    +++  E+  L  +  
Sbjct: 18  LGKGNFGSV--ELCR-----YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 70
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             +VK  G       + ++  LV E + +  L D  L R    L     L  +    +G+
Sbjct: 71  DFIVKYRGVSYGPGRQSLR--LVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGM 127
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY-A 273
            YL      + + RD    NIL++ +   K++DFGLA+  P +   +          +  
Sbjct: 128 EYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           APE +     + +SDVWSFGVVLYEL T
Sbjct: 185 APESLSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 51/304 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 35  LGRGAFGQV------IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLKIAQ 208
            H N+V L+G C +    G   +++ E     +L  +L S+    VP    +   L +  
Sbjct: 89  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 209 ------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
                   A+G+ +L      + I RD    NILL E    K+ DFGLAR    +     
Sbjct: 146 LICYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 202
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KLLE 319
                    + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L E
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 262
Query: 320 WVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
             R   P  +  + +  ++D                     C   +P  RP  SE+V+ L
Sbjct: 263 GTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 301
Query: 377 GNII 380
           GN++
Sbjct: 302 GNLL 305

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLG-VV 152
           +G G FG V      V +        D+ L VA+K L        KE  ++E+  +  + 
Sbjct: 54  LGAGAFGKV------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG 107
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--------PLAWIARL 204
           +H N+V L+G C      G   L++ E      L + L  +           PL     L
Sbjct: 108 QHENIVNLLGACT----HGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLL 163
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             +   A+G+A+L  +     I RD    N+LL   + AK+ DFGLAR    +       
Sbjct: 164 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 220
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + APE +     T +SDVWS+G++L+E+ +
Sbjct: 221 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/217 (27%), Positives = 93/217 (42%), Gaps = 23/217 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLG-VV 152
           +G G FG V      V +        D+ L VA+K L        KE  ++E+  +  + 
Sbjct: 46  LGAGAFGKV------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG 99
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--------PLAWIARL 204
           +H N+V L+G C      G   L++ E      L + L  +           PL     L
Sbjct: 100 QHENIVNLLGACT----HGGPVLVITEYCCYGDLLNFLRRKAEADLDKEDGRPLELRDLL 155
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             +   A+G+A+L  +     I RD    N+LL   + AK+ DFGLAR    +       
Sbjct: 156 HFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKG 212
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                  + APE +     T +SDVWS+G++L+E+ +
Sbjct: 213 NARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V   + R     +   G ++   VA+KQL   G    +++  E+  L  +  
Sbjct: 19  LGKGNFGSV--ELCR-----YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 71
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             +VK  G       + ++  LV E + +  L D  L R    L     L  +    +G+
Sbjct: 72  DFIVKYRGVSYGPGRQSLR--LVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGM 128
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY-A 273
            YL      + + RD    NIL++ +   K++DFGLA+  P +   +          +  
Sbjct: 129 EYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           APE +     + +SDVWSFGVVLYEL T
Sbjct: 186 APESLSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 75/304 (24%), Positives = 124/304 (40%), Gaps = 51/304 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFL-GVV 152
           +G G FG V      + +D        +   VA+K L        H+  ++E+  L  + 
Sbjct: 35  LGRGAFGQV------IEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIG 88
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLKIAQ 208
            H N+V L+G C +    G   +++ E     +L  +L S+    VP    +   L +  
Sbjct: 89  HHLNVVNLLGACTKP---GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEH 145
Query: 209 ------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
                   A+G+ +L      + I RD    NILL E    K+ DFGLAR    +     
Sbjct: 146 LIXYSFQVAKGMEFLASR---KXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVR 202
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KLLE 319
                    + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L E
Sbjct: 203 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFXRRLKE 262
Query: 320 WVR---PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDIL 376
             R   P  +  + +  ++D                     C   +P  RP  SE+V+ L
Sbjct: 263 GTRMRAPDYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHL 301
Query: 377 GNII 380
           GN++
Sbjct: 302 GNLL 305

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/164 (31%), Positives = 82/164 (50%), Gaps = 17/164 (10%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIA 202
           E+  L  + HPN+VKLV     DD       +V+EL++   + +     VPT  PL+   
Sbjct: 86  EIAILKKLDHPNVVKLVEVL--DDPNEDHLYMVFELVNQGPVME-----VPTLKPLSEDQ 138
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
                QD  +G+ YLH +   ++I RD K SN+L+ ED   K++DFG++ +   +G    
Sbjct: 139 ARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEF--KGSDAL 193
Query: 263 XXXXXXXXXYAAPEYVQTGR--LTAKS-DVWSFGVVLYELITGR 303
                    + APE +   R   + K+ DVW+ GV LY  + G+
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 14/208 (6%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V   + R     +   G ++   VA+KQL   G    +++  E+  L  +  
Sbjct: 31  LGKGNFGSV--ELCR-----YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 83
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             +VK  G       + ++  LV E + +  L D  L R    L     L  +    +G+
Sbjct: 84  DFIVKYRGVSYGPGRQSLR--LVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGM 140
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY-A 273
            YL      + + RD    NIL++ +   K++DFGLA+  P +   +          +  
Sbjct: 141 EYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           APE +     + +SDVWSFGVVLYEL T
Sbjct: 198 APESLSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/207 (27%), Positives = 91/207 (43%), Gaps = 19/207 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           IGEG FG V++G+          S  +  + VAIK   N       ++++ E   +    
Sbjct: 398 IGEGQFGDVHQGIY--------MSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L   L  R    L   + +  A   +  
Sbjct: 450 HPHIVKLIGVITENP-----VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTA 503
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAYL  +   + + RD    N+L+      KL DFGL+R    +   +          + 
Sbjct: 504 LAYLESK---RFVHRDIAARNVLVSATDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWM 559
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELI 300
           APE +   R T+ SDVW FGV ++E++
Sbjct: 560 APESINFRRFTSASDVWMFGVCMWEIL 586

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 143 INEVNFL-GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWI 201
           + EV+ L  V  HPN+++L     +  E      LV++LM    L D+L  +V   L+  
Sbjct: 58  LKEVDILRKVSGHPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEK 111
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
              KI +     +  LH+     ++ RD K  NILLD+D   KL+DFG + Q  P   G 
Sbjct: 112 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GE 165
Query: 262 XXXXXXXXXXYAAPEYVQTGR------LTAKSDVWSFGVVLYELITG 302
                     Y APE ++            + D+WS GV++Y L+ G
Sbjct: 166 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 212

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 96/220 (43%), Gaps = 25/220 (11%)
Query: 95  IGEGGFGCVYRG----------VVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V             V++V+    +++ H  + +  + +L      G  E  N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--N 111
Query: 145 EVNFLGVVKH--PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE-DHLLSRVPTPLAWI 201
            VN LG   H  P LV +  YC   D      LL +    ++ LE D   +   + L+  
Sbjct: 112 IVNLLGACTHGGPVLV-ITEYCCYGD------LLNFLRRKSRVLETDPAFAIANSTLSTR 164
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L  +   A+G+A+L  +     I RD    N+LL   + AK+ DFGLAR    +    
Sbjct: 165 DLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYI 221
Query: 262 XXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                     + APE +     T +SDVWS+G++L+E+ +
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN--EVNFLGV 151
           ++G+G FG V+  +V+      + SG D++   A+K L +   +         E + L  
Sbjct: 31  VLGQGSFGKVF--LVK------KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLA----WIARLKIA 207
           V HP +VKL  Y  + + +     L+ + +    L   L   V         ++A L +A
Sbjct: 83  VNHPFIVKL-HYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
            D    L          +I+RD K  NILLDE+   KL+DFGL++    E + H      
Sbjct: 139 LDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYS 185
Query: 268 X--XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                 Y APE V     T  +D WSFGV+++E++TG
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 143 INEVNFL-GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWI 201
           + EV+ L  V  HPN+++L     +  E      LV++LM    L D+L  +V   L+  
Sbjct: 71  LKEVDILRKVSGHPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEK 124
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
              KI +     +  LH+     ++ RD K  NILLD+D   KL+DFG + Q  P   G 
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GE 178
Query: 262 XXXXXXXXXXYAAPEYVQTGR------LTAKSDVWSFGVVLYELITG 302
                     Y APE ++            + D+WS GV++Y L+ G
Sbjct: 179 KLRSVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/167 (30%), Positives = 77/167 (46%), Gaps = 19/167 (11%)
Query: 143 INEVNFL-GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWI 201
           + EV+ L  V  HPN+++L     +  E      LV++LM    L D+L  +V   L+  
Sbjct: 71  LKEVDILRKVSGHPNIIQL----KDTYETNTFFFLVFDLMKKGELFDYLTEKVT--LSEK 124
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
              KI +     +  LH+     ++ RD K  NILLD+D   KL+DFG + Q  P   G 
Sbjct: 125 ETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GE 178
Query: 262 XXXXXXXXXXYAAPEYVQTGR------LTAKSDVWSFGVVLYELITG 302
                     Y APE ++            + D+WS GV++Y L+ G
Sbjct: 179 KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/215 (28%), Positives = 94/215 (43%), Gaps = 29/215 (13%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG V+       SD  Q           +K  +R   +  ++ + EVN      
Sbjct: 32  VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN------ 85
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLA----WIARLKIAQD 209
           HP +VKL  Y  + + +     L+ + +    L   L   V         ++A L +A D
Sbjct: 86  HPFIVKL-HYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALD 141
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX- 268
               L          +I+RD K  NILLDE+   KL+DFGL++    E + H        
Sbjct: 142 HLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYSFC 188
Query: 269 -XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
               Y APE V     T  +D WSFGV+++E++TG
Sbjct: 189 GTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 223

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 33/217 (15%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN--EVNFLGV 151
           ++G+G FG V+  +V+      + SG D++   A+K L +   +         E + L  
Sbjct: 31  VLGQGSFGKVF--LVK------KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLA----WIARLKIA 207
           V HP +VKL  Y  + + +     L+ + +    L   L   V         ++A L +A
Sbjct: 83  VNHPFIVKL-HYAFQTEGK---LYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALA 138
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
            D    L          +I+RD K  NILLDE+   KL+DFGL++    E + H      
Sbjct: 139 LDHLHSLG---------IIYRDLKPENILLDEEGHIKLTDFGLSK----ESIDHEKKAYS 185
Query: 268 X--XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                 Y APE V     T  +D WSFGV+++E++TG
Sbjct: 186 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTG 222

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 31/224 (13%)
Query: 95  IGEGGFGCVYRG----------VVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V             V++V+    +++ H  + +  + +L      G  E  N
Sbjct: 54  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--N 111
Query: 145 EVNFLGVVKH--PNLVKLVGYCAEDDERGMQRL-----LVYELMHNKSLEDHLLSRVPTP 197
            VN LG   H  P LV +  YC   D     R      L Y    + + E+ L SR    
Sbjct: 112 IVNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSR---- 166
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                 L  +   A+G+A+L  +     I RD    N+LL   + AK+ DFGLAR    +
Sbjct: 167 ----DLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 219
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWS+G++L+E+ +
Sbjct: 220 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/219 (25%), Positives = 93/219 (42%), Gaps = 15/219 (6%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F+   ++G+G FG V    ++      Q  G   K+ V + + +       +E++ E   
Sbjct: 25  FTLGRMLGKGEFGSVREAQLK------QEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLL-SRV---PTPLAWIA 202
           +    HP++ KLVG       +G     +++   M +  L   LL SR+   P  L    
Sbjct: 79  MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
            ++   D A G+ YL        I RD    N +L ED    ++DFGL+R+         
Sbjct: 139 LVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                    + A E +     T  SDVW+FGV ++E++T
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMT 234

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/221 (28%), Positives = 96/221 (43%), Gaps = 27/221 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLG-VV 152
           +G G FG V      V +        D+ L VA+K L        KE  ++E+  +  + 
Sbjct: 54  LGAGAFGKV------VEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG 107
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRV--PTPLAWIAR----- 203
           +H N+V L+G C      G   L++ E      L + L   SRV    P   IA      
Sbjct: 108 QHENIVNLLGACT----HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163
Query: 204 ---LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
              L  +   A+G+A+L  +     I RD    N+LL   + AK+ DFGLAR    +   
Sbjct: 164 RDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                      + APE +     T +SDVWS+G++L+E+ +
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 14/208 (6%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V   + R     +   G ++   VA+KQL   G    +++  E+  L  +  
Sbjct: 15  LGKGNFGSVE--LCR-----YDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHS 67
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             +VK  G         ++  LV E + +  L D  L R    L     L  +    +G+
Sbjct: 68  DFIVKYRGVSYGPGRPELR--LVMEYLPSGCLRD-FLQRHRARLDASRLLLYSSQICKGM 124
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY-A 273
            YL      + + RD    NIL++ +   K++DFGLA+  P +              +  
Sbjct: 125 EYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           APE +     + +SDVWSFGVVLYEL T
Sbjct: 182 APESLSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/218 (26%), Positives = 98/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 39  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 87
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +C +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 88  RDVMSRLDHPFFVKLY-FCFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 141
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 142 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 197
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 198 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 235

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 20  LGDGSFGVVRRGEWDAPSG--------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L       L      + A   A
Sbjct: 72  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVA 125
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ YL  +   + I RD    N+LL      K+ DFGL R   P+   H          
Sbjct: 126 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQEHRKVP 181
Query: 272 YA--APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +A  APE ++T   +  SD W FGV L+E+ T
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 16  LGDGSFGVVRRGEWDAPSG--------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L       L      + A   A
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVA 121
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ YL  +   + I RD    N+LL      K+ DFGL R   P+   H          
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQEHRKVP 177
Query: 272 YA--APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +A  APE ++T   +  SD W FGV L+E+ T
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 16  LGDGSFGVVRRGEWDAPSG--------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L       L      + A   A
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVA 121
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ YL  +   + I RD    N+LL      K+ DFGL R   P+   H          
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHXVMQEHRKVP 177
Query: 272 YA--APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +A  APE ++T   +  SD W FGV L+E+ T
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 41/222 (18%)
Query: 95  IGEGGFG--CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN---EVNFL 149
           IG+G FG  C+                +D+K   A+K +N+Q      E  N   E+  +
Sbjct: 23  IGKGSFGKVCI-------------VQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV----PTPLAWIARLK 205
             ++HP LV L  Y  +D+E      +V +L+    L  HL   V     T   +I  L 
Sbjct: 70  QGLEHPFLVNL-WYSFQDEE---DMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELV 125
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +A D      YL  +   ++I RD K  NILLDE     ++DF +A   P E        
Sbjct: 126 MALD------YLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET---QITT 173
Query: 266 XXXXXXYAAPEYVQTGRLTAKS---DVWSFGVVLYELITGRR 304
                 Y APE   + +    S   D WS GV  YEL+ GRR
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/212 (29%), Positives = 89/212 (41%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 26  LGDGSFGVVRRGEWDAPSG--------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L       L      + A   A
Sbjct: 78  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVA 131
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ YL  +   + I RD    N+LL      K+ DFGL R   P+   H          
Sbjct: 132 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHXVMQEHRKVP 187
Query: 272 YA--APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +A  APE ++T   +  SD W FGV L+E+ T
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 102/222 (45%), Gaps = 46/222 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGV 151
           +GEG FG V              + + ++  VA+K ++RQ  +    H     E+++L +
Sbjct: 17  LGEGSFGKV-----------KLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKL 65
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           ++HP+++KL        +  M  ++ Y       L D++          + + ++ +D  
Sbjct: 66  LRHPHIIKLYDVITTPTDIVM--VIEYA---GGELFDYI----------VEKKRMTEDEG 110
Query: 212 R--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXX 263
           R         + Y H     +++ RD K  N+LLD++   K++DFGL+        G+  
Sbjct: 111 RRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTD---GNFL 164
Query: 264 XXXXXXXXYAAPEYVQTGRLTA--KSDVWSFGVVLYELITGR 303
                   YAAPE +  G+L A  + DVWS G+VLY ++ GR
Sbjct: 165 KTSCGSPNYAAPEVI-NGKLYAGPEVDVWSCGIVLYVMLVGR 205

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 24/221 (10%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHK-EW 142
           AT  +     IG G +G VY+     + D H  SGH     VA+K +    G +G     
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK-----ARDPH--SGHF----VALKSVRVPNGEEGLPIST 50
Query: 143 INEVNFL---GVVKHPNLVKLVGYCAED-DERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
           + EV  L      +HPN+V+L+  CA    +R ++  LV+E + ++ L  +L    P  L
Sbjct: 51  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 109
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                  + +   RGL +LH      ++ RD K  NIL+      KL+DFGLAR      
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YS 163
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
                        Y APE +         D+WS G +  E+
Sbjct: 164 YQMALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 16  LGDGSFGVVRRGEWDAPSG--------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L       L      + A   A
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVA 121
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ YL  +   + I RD    N+LL      K+ DFGL R   P+   H          
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQEHRKVP 177
Query: 272 YA--APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +A  APE ++T   +  SD W FGV L+E+ T
Sbjct: 178 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 20  LGDGSFGVVRRGEWDAPSG--------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 71
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L       L      + A   A
Sbjct: 72  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVA 125
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ YL  +   + I RD    N+LL      K+ DFGL R   P+   H          
Sbjct: 126 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQEHRKVP 181
Query: 272 YA--APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +A  APE ++T   +  SD W FGV L+E+ T
Sbjct: 182 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 38/115 (33%), Positives = 55/115 (47%), Gaps = 8/115 (6%)
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
           A +    L +LH   D  +I+RD K  N+LLD +   KL+DFG+ ++G   G+       
Sbjct: 130 AAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGV--TTATF 184
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
                Y APE +Q        D W+ GV+LYE++ G    E     NE  L E +
Sbjct: 185 CGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEA---ENEDDLFEAI 236

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 88/212 (41%), Gaps = 23/212 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 26  LGDGSFGVVRRGEWDAPSG--------KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L       L      + A   A
Sbjct: 78  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKHQGHFLLGTLS-RYAVQVA 131
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            G+ YL  +   + I RD    N+LL      K+ DFGL R   P+   H          
Sbjct: 132 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMR-ALPQNDDHYVMQEHRKVP 187
Query: 272 YA--APEYVQTGRLTAKSDVWSFGVVLYELIT 301
           +A  APE ++T   +  SD W FGV L+E+ T
Sbjct: 188 FAWCAPESLKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 65/218 (29%), Positives = 97/218 (44%), Gaps = 36/218 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 26  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK------I 206
           KH N++ L+      D     R L  E  ++  L  HL+      +   A+L       +
Sbjct: 75  KHENVIGLL------DVFTPARSL--EEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFL 126
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
                RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+     
Sbjct: 127 IYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY----- 178
Query: 267 XXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                Y APE +          D+WS G ++ EL+TGR
Sbjct: 179 VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQL---NRQGFQGHKEWINEVNFL 149
           +G GG   VY                D+ L+  VAIK +    R+  +  K +  EV+  
Sbjct: 19  LGGGGMSTVYLA-------------EDTILNIKVAIKAIFIPPREKEETLKRFEREVHNS 65
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             + H N+V ++    EDD       LV E +   +L +++ S    PL+    +     
Sbjct: 66  SQLSHQNIVSMIDVDEEDD----CYYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQ 119
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
              G+ + H   D +++ RD K  NIL+D +   K+ DFG+A+      L          
Sbjct: 120 ILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNHVLGT 175
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
             Y +PE  +       +D++S G+VLYE++ G 
Sbjct: 176 VQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE 209

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/218 (28%), Positives = 106/218 (48%), Gaps = 35/218 (16%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDV----AIKQLNRQGFQGHKEWINEVNFL 149
           ++G+G FG V+  V +V+  D   SGH   + V     +K  +R   +  ++ + +VN  
Sbjct: 35  VLGQGSFGKVFL-VRKVTRPD---SGHLYAMKVLKKATLKVRDRVRTKMERDILADVN-- 88
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWI---ARLKI 206
               HP +VKL  Y  + + +     L+ + +    L     +R+   + +     +  +
Sbjct: 89  ----HPFVVKL-HYAFQTEGK---LYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYL 136
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
           A+  A GL +LH      +I+RD K  NILLDE+   KL+DFGL++    E + H     
Sbjct: 137 AE-LALGLDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSK----EAIDHEKKAY 188
Query: 267 XX--XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y APE V     +  +D WS+GV+++E++TG
Sbjct: 189 SFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTG 226

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 94/224 (41%), Gaps = 24/224 (10%)
Query: 95  IGEGGFGCVYRG----------VVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V             V++V+    +++ H  + +  + +L      G  E  N
Sbjct: 39  LGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE--N 96
Query: 145 EVNFLGVVKH--PNLVKLVGYCAEDD-----ERGMQRLLVYELMHNKSLEDHLLSRVPTP 197
            VN LG   H  P LV +  YC   D      R  + +L   L   +  E  L      P
Sbjct: 97  IVNLLGACTHGGPVLV-ITEYCCYGDLLNFLRRKAEAMLGPSLAPGQDPEG-LDKEDGRP 154
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
           L     L  +   A+G+A+L  +     I RD    N+LL   + AK+ DFGLAR    +
Sbjct: 155 LELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 211
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                         + APE +     T +SDVWS+G++L+E+ +
Sbjct: 212 SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 24/221 (10%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHK-EW 142
           AT  +     IG G +G VY+     + D H  SGH     VA+K +    G +G     
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK-----ARDPH--SGHF----VALKSVRVPNGEEGLPIST 50
Query: 143 INEVNFL---GVVKHPNLVKLVGYCAED-DERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
           + EV  L      +HPN+V+L+  CA    +R ++  LV+E + ++ L  +L    P  L
Sbjct: 51  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 109
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                  + +   RGL +LH      ++ RD K  NIL+      KL+DFGLAR      
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YS 163
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
                        Y APE +         D+WS G +  E+
Sbjct: 164 YQMALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 95/221 (42%), Gaps = 24/221 (10%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHK-EW 142
           AT  +     IG G +G VY+     + D H  SGH     VA+K +    G +G     
Sbjct: 2   ATSRYEPVAEIGVGAYGTVYK-----ARDPH--SGHF----VALKSVRVPNGEEGLPIST 50
Query: 143 INEVNFL---GVVKHPNLVKLVGYCAED-DERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
           + EV  L      +HPN+V+L+  CA    +R ++  LV+E + ++ L  +L    P  L
Sbjct: 51  VREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGL 109
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                  + +   RGL +LH      ++ RD K  NIL+      KL+DFGLAR      
Sbjct: 110 PAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YS 163
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
                        Y APE +         D+WS G +  E+
Sbjct: 164 YQMALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 204

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           IG G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 35  IGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 132
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 133 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT 185
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 186 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 91/220 (41%), Gaps = 19/220 (8%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKL-DVAIKQLNRQGFQGHKEWI 143
           AT  +     IG G +G VY+     + D H  SGH   L  V +      G       +
Sbjct: 7   ATSRYEPVAEIGVGAYGTVYK-----ARDPH--SGHFVALKSVRVPNGGGGGGGLPISTV 59
Query: 144 NEVNFL---GVVKHPNLVKLVGYCAED-DERGMQRLLVYELMHNKSLEDHLLSRVPTPLA 199
            EV  L      +HPN+V+L+  CA    +R ++  LV+E + ++ L  +L    P  L 
Sbjct: 60  REVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYLDKAPPPGLP 118
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
                 + +   RGL +LH      ++ RD K  NIL+      KL+DFGLAR       
Sbjct: 119 AETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARI---YSY 172
Query: 260 GHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
                       Y APE +         D+WS G +  E+
Sbjct: 173 QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEM 212

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       SS D +     S L +A+K+L+R  Q     K    E+  L  +
Sbjct: 59  VGSGAYGSV------CSSYDVK-----SGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 108 KHENVIGLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 156
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 157 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 211
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 212 -----VATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELM---------HNKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 60/219 (27%), Positives = 96/219 (43%), Gaps = 29/219 (13%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEV 146
           ++   ++G+G FG V +   R++  ++           A+K +N+   +       + EV
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEY-----------AVKVINKASAKNKDTSTILREV 72
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             L  + HPN++KL     E  E      +V EL     L D ++ R        AR  I
Sbjct: 73  ELLKKLDHPNIMKLF----EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--I 126
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXX 263
            +    G+ Y+H+     ++ RD K  NILL+   +D   K+ DFGL+            
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKM 180
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y APE ++ G    K DVWS GV+LY L++G
Sbjct: 181 KDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSG 218

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEV 146
           ++   ++G+G FG V +   R++  ++           A+K +N+   +       + EV
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEY-----------AVKVINKASAKNKDTSTILREV 72
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             L  + HPN++KL     E  E      +V EL     L D ++ R        AR  I
Sbjct: 73  ELLKKLDHPNIMKLF----EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--I 126
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXX 263
            +    G+ Y+H+     ++ RD K  NILL+   +D   K+ DFGL+            
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT---KM 180
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y APE V  G    K DVWS GV+LY L++G
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   IG G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTIGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E M    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYMPGGDMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    K++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 61/219 (27%), Positives = 95/219 (43%), Gaps = 29/219 (13%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEV 146
           ++   ++G+G FG V +   R++  ++           A+K +N+   +       + EV
Sbjct: 24  YNIVCMLGKGSFGEVLKCKDRITQQEY-----------AVKVINKASAKNKDTSTILREV 72
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             L  + HPN++KL     E  E      +V EL     L D ++ R        AR  I
Sbjct: 73  ELLKKLDHPNIMKLF----EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAAR--I 126
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXX 263
            +    G+ Y+H+     ++ RD K  NILL+   +D   K+ DFGL+            
Sbjct: 127 IKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKM 180
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y APE V  G    K DVWS GV+LY L++G
Sbjct: 181 KDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 37  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 134
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 135 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 188 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 64
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 65  LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 117
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 118 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
            + APE +   + ++KSDVWSFGV+++E  +  +   R +  +E
Sbjct: 175 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 218

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELM---------HNKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 37  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 134
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 135 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 188 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 25  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 74
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 75  LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 127
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 128 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 184
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 185 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 35  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 132
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 133 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT 185
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 186 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   IG G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTIGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E M    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYMPGGDMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    K++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 38/231 (16%)
Query: 81  ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK 140
           ++KS  + + +   +GEG F  VY+      + D  T+       VAIK++        K
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYK------ARDKNTNQ-----IVAIKKIKLGHRSEAK 52
Query: 141 EWIN-----EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNK---SLEDHLLS 192
           + IN     E+  L  + HPN++ L+              LV++ M       ++D+ L 
Sbjct: 53  DGINRTALREIKLLQELSHPNIIGLLDAFGHKSNIS----LVFDFMETDLEVIIKDNSLV 108
Query: 193 RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
             P+ +     + +     +GL YLH+     ++ RD K +N+LLDE+   KL+DFGLA+
Sbjct: 109 LTPSHIKAYMLMTL-----QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160
Query: 253 Q--GPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELI 300
               P     H          Y APE +   R+     D+W+ G +L EL+
Sbjct: 161 SFGSPNRAYXH----QVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELL 207

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 105/248 (42%), Gaps = 29/248 (11%)
Query: 65  LLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKL 124
           + S   A  L     + L+     F    L+G G +G VY+G        H  +G  +  
Sbjct: 2   MASDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKG-------RHVKTGQLA-- 52
Query: 125 DVAIKQLNRQGFQGHKEWINEVNFLGVVKHP-NLVKLVGYCAEDDERGM--QRLLVYELM 181
             AIK ++  G +  +E   E+N L    H  N+    G   + +  GM  Q  LV E  
Sbjct: 53  --AIKVMDVTGDE-EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFC 109
Query: 182 HNKSLEDHLLSRVPTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE 239
              S+ D + +     L   WIA   I ++  RGL++LH+    ++I RD K  N+LL E
Sbjct: 110 GAGSVTDLIKNTKGNTLKEEWIAY--ICREILRGLSHLHQH---KVIHRDIKGQNVLLTE 164
Query: 240 DYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQT-----GRLTAKSDVWSFGV 294
           + + KL DFG++ Q   +              + APE +            KSD+WS G+
Sbjct: 165 NAEVKLVDFGVSAQ--LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGI 222
Query: 295 VLYELITG 302
              E+  G
Sbjct: 223 TAIEMAEG 230

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 56/224 (25%), Positives = 99/224 (44%), Gaps = 24/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 13  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 62
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 63  LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 115
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 116 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 172
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE 314
            + APE +   + ++KSDVWSFGV+++E  +  +   R +  +E
Sbjct: 173 KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE 216

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 37  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 134
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 135 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT 187
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 188 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 68
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 69  LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 121
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 122 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 178
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 19  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 68
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 69  LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 121
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 122 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPV 178
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 179 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 33  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 82
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 83  LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 135
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 136 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 192
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 193 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 377 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 426
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 427 LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 479
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 480 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 536
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 537 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 84
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 85  LDNPYIVRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 137
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL E      + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 35  LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 84
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 85  LDNPYIVRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 137
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL E      + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 138 MGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 194
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 195 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 6/159 (3%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E      + HP +V +      +   G    +V E +   +L D  +     P+     +
Sbjct: 62  EAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAI 119
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG-HXX 263
           ++  DA + L + H+     +I RD K +NI++      K+ DFG+AR     G      
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y +PE  +   + A+SDV+S G VLYE++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 35  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 132
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 133 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 185
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 186 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 57/220 (25%), Positives = 99/220 (45%), Gaps = 30/220 (13%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHD---SKLDVAIKQLNRQGFQGHKEWIN-EVNFL 149
           +IG G    V R V       H+ +GH+     ++V  ++L+ +  +  +E    E + L
Sbjct: 101 VIGRGVSSVVRRCV-------HRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 150 -GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             V  HP+++ L+    +  E      LV++LM    L D+L  +V   L+      I +
Sbjct: 154 RQVAGHPHIITLI----DSYESSSFMFLVFDLMRKGELFDYLTEKVA--LSEKETRSIMR 207
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX 268
                +++LH      ++ RD K  NILLD++ + +LSDFG +    P   G        
Sbjct: 208 SLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEP---GEKLRELCG 261
Query: 269 XXXYAAPEYVQTGR------LTAKSDVWSFGVVLYELITG 302
              Y APE ++            + D+W+ GV+L+ L+ G
Sbjct: 262 TPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG 301

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 29  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 75
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 76  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 126
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 127 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 179
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 180 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 24/211 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG---HDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV 151
           +G G FG V +G  ++       +     +   D A+K           E + E N +  
Sbjct: 378 LGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKD----------ELLAEANVMQQ 427
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 428 LDNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 480
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++     E             
Sbjct: 481 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 537
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
            + APE +   + ++KSDVWSFGV+++E  +
Sbjct: 538 KWYAPECINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 26  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 72
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 73  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 123
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 124 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 176
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 177 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 41  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 138
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 139 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT 191
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 192 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 27  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 124
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 125 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 177
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 178 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 37  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 83
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 84  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 134
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 135 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 187
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 188 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 35  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 81
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 82  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 132
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 133 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 185
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 186 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 32  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 129
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 130 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT 182
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 183 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 43/159 (27%), Positives = 70/159 (44%), Gaps = 6/159 (3%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E      + HP +V +      +   G    +V E +   +L D  +     P+     +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAI 119
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG-HXX 263
           ++  DA + L + H+     +I RD K +NIL+      K+ DFG+AR     G      
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQT 176
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y +PE  +   + A+SDV+S G VLYE++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 27  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 73
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 74  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 124
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 125 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 177
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 178 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 32  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 129
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 130 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 182
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 183 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 28  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 74
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 75  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 125
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 126 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 178
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 179 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 32  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 129
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 130 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 182
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 183 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 94/224 (41%), Gaps = 48/224 (21%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +G G +G V       S+ D +T        VAIK+L R  FQ     K    E+  L  
Sbjct: 33  VGSGAYGAV------CSAVDGRTGAK-----VAIKKLYRP-FQSELFAKRAYRELRLLKH 80
Query: 152 VKHPNLVKLVGYCAEDD--ERGMQRLLVYELM---------HNKSLEDHLLSRVPTPLAW 200
           ++H N++ L+     D+  +      LV   M         H K  ED +   V   L  
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQML-- 138
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
                      +GL Y+H      +I RD K  N+ ++ED + K+ DFGLARQ   E  G
Sbjct: 139 -----------KGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXG 184
Query: 261 HXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                      Y APE +    R T   D+WS G ++ E+ITG+
Sbjct: 185 X-----VVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 36  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 133
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 134 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT 186
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 187 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 32  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 78
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 79  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 129
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 130 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 182
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 183 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 42  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 139
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 140 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 192
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 193 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 36  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 133
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 134 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 186
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 187 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 42  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 88
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 139
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 140 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 192
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 193 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 53  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 150
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 151 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX 203
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 204 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 50  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 96
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 97  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 147
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 148 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 200
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 201 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 41  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 87
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 88  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 138
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 139 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 191
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 192 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 26  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 123
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 124 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 178
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 179 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 30  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 127
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 128 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 182
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 183 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 53  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 99
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 100 HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 150
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 151 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 203
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 204 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 36  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 82
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 83  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 133
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 134 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 186
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 187 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 40  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 89  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 137
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 138 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 192
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 193 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 67/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 49  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 95
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 96  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 146
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 147 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 199
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 200 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 30  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 78
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 79  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 131
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+DE    +++DFG A++         G
Sbjct: 132 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKGRTWXLCG 187
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 188 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 221

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH E +  +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 260 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEY 315
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 6/159 (3%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E      + HP +V +      +   G    +V E +   +L D  +     P+     +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAI 119
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG-HXX 263
           ++  DA + L + H+     +I RD K +NI++      K+ DFG+AR     G      
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y +PE  +   + A+SDV+S G VLYE++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 4/91 (4%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH E +  +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 263 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEY 318
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 349

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 88/199 (44%), Gaps = 25/199 (12%)
Query: 136 FQGHKEWINE--VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
            Q  + W NE  V  L  +KH N+++ +G         +   L+       SL D L + 
Sbjct: 57  IQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN 116
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDF-------QLIFRDFKTSNILLDEDYKAKLS 246
           V   ++W     IA+  ARGLAYLHE++          +  RD K+ N+LL  +  A ++
Sbjct: 117 V---VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIA 173
Query: 247 DFGLA---RQGPPEGLGHXXXXXXXXXXYAAPEYVQTG-----RLTAKSDVWSFGVVLYE 298
           DFGLA     G   G  H          Y APE ++           + D+++ G+VL+E
Sbjct: 174 DFGLALKFEAGKSAGDTH---GQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWE 230
Query: 299 LITGRRAVERNLPRNEQKL 317
           L +  R    + P +E  L
Sbjct: 231 LAS--RCTAADGPVDEYML 247

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 6/159 (3%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E      + HP +V +      +   G    +V E +   +L D  +     P+     +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAI 119
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG-HXX 263
           ++  DA + L + H+     +I RD K +NI++      K+ DFG+AR     G      
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y +PE  +   + A+SDV+S G VLYE++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 6/159 (3%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E      + HP +V +      +   G    +V E +   +L D  +     P+     +
Sbjct: 79  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAI 136
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG-HXX 263
           ++  DA + L + H+     +I RD K +NI++      K+ DFG+AR     G      
Sbjct: 137 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 193
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y +PE  +   + A+SDV+S G VLYE++TG
Sbjct: 194 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 232

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 6/159 (3%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E      + HP +V +      +   G    +V E +   +L D  +     P+     +
Sbjct: 62  EAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD--IVHTEGPMTPKRAI 119
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG-HXX 263
           ++  DA + L + H+     +I RD K +NI++      K+ DFG+AR     G      
Sbjct: 120 EVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQT 176
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y +PE  +   + A+SDV+S G VLYE++TG
Sbjct: 177 AAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTG 215

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEVNFLGVV 152
           +GEG +G VY+      + D Q         VA+K+  L+ +        I E++ L  +
Sbjct: 29  VGEGTYGVVYK------AKDSQGR------IVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI-AQDAA 211
            HPN+V L+       ER +   LV+E M  K L+  +L    T L   +++KI      
Sbjct: 77  HHPNIVSLIDVI--HSERCLT--LVFEFM-EKDLKK-VLDENKTGLQ-DSQIKIYLYQLL 129
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXXX 269
           RG+A+ H+    +++ RD K  N+L++ D   KL+DFGLAR    P     H        
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH----EVVT 182
Query: 270 XXYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGR 303
             Y AP+ +  + + +   D+WS G +  E+ITG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 50  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 147
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 148 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 202
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 203 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 13/112 (11%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH E +  +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 120 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 175
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWV 321
            APE ++        D W  GVV+YE++ GR      LP   ++ +KL E +
Sbjct: 176 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELI 221

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 13/112 (11%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH E +  +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 121 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 176
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWV 321
            APE ++        D W  GVV+YE++ GR      LP   ++ +KL E +
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELI 222

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 24/212 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG V      +   D + +G +  + V  K+  +Q     +  + EV  L  + 
Sbjct: 39  VLGKGSFGEV------ILCKD-KITGQECAVKVISKRQVKQK-TDKESLLREVQLLKQLD 90
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN++KL  +    +++G    LV E+     L D ++SR     + +   +I +    G
Sbjct: 91  HPNIMKLYEFF---EDKGY-FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSG 144
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
           + Y+H+    +++ RD K  N+LL+   +D   ++ DFGL+                   
Sbjct: 145 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTA 198
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            Y APE V  G    K DVWS GV+LY L++G
Sbjct: 199 YYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 229

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/225 (30%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G           Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 G-----XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 49  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 98  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 146
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 147 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 201
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 202 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 13/112 (11%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH E +  +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 122 ALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKXFCGTPEY 177
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWV 321
            APE ++        D W  GVV+YE++ GR      LP   ++ +KL E +
Sbjct: 178 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKLFELI 223

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 36  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 85  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 133
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G+
Sbjct: 134 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGY 188
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 189 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 32/215 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEVNFLGVV 152
           +GEG +G VY+      + D Q         VA+K+  L+ +        I E++ L  +
Sbjct: 29  VGEGTYGVVYK------AKDSQGR------IVALKRIRLDAEDEGIPSTAIREISLLKEL 76
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI-AQDAA 211
            HPN+V L+       ER +   LV+E M  K L+  +L    T L   +++KI      
Sbjct: 77  HHPNIVSLIDVI--HSERCLT--LVFEFM-EKDLKK-VLDENKTGLQ-DSQIKIYLYQLL 129
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXXX 269
           RG+A+ H+    +++ RD K  N+L++ D   KL+DFGLAR    P     H        
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH----EVVT 182
Query: 270 XXYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGR 303
             Y AP+ +  + + +   D+WS G +  E+ITG+
Sbjct: 183 LWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/213 (29%), Positives = 91/213 (42%), Gaps = 25/213 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHK-EWINEVNFL--- 149
           IGEG +G V++      + D +  G      VA+K++  Q G +G     I EV  L   
Sbjct: 19  IGEGAYGKVFK------ARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 150 GVVKHPNLVKLVGYCA-EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK-IA 207
              +HPN+V+L   C     +R  +  LV+E  H        L +VP P      +K + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFE--HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
               RGL +LH     +++ RD K  NIL+    + KL+DFGLAR               
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
               Y APE +         D+WS G +  E+ 
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMF 213

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     KE    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKEIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    K++DFGLA++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 98/229 (42%), Gaps = 41/229 (17%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV-- 151
           LIG G +G VY+G    S D+           VA+K  +   F   + +INE N   V  
Sbjct: 20  LIGRGRYGAVYKG----SLDERP---------VAVKVFS---FANRQNFINEKNIYRVPL 63
Query: 152 VKHPNLVK-LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           ++H N+ + +VG      +  M+ LLV E   N SL  +L         W++  ++A   
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSD---WVSSCRLAHSV 120
Query: 211 ARGLAYLHEEM------DFQLIFRDFKTSNILLDEDYKAKLSDFGLA------RQGPPEG 258
            RGLAYLH E+         +  RD  + N+L+  D    +SDFGL+      R   P  
Sbjct: 121 TRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGE 180
Query: 259 LGHXXXXXXXXXXYAAPEYVQTG-------RLTAKSDVWSFGVVLYELI 300
             +          Y APE ++             + D+++ G++ +E+ 
Sbjct: 181 EDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 112 QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 167
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 168 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 219
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +    P  + K LE 
Sbjct: 220 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 275
Query: 321 V 321
           +
Sbjct: 276 M 276

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +           +SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------NSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---KVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHK-EWINEVNFL--- 149
           IGEG +G V++      + D +  G      VA+K++  Q G +G     I EV  L   
Sbjct: 19  IGEGAYGKVFK------ARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 150 GVVKHPNLVKLVGYCA-EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK-IA 207
              +HPN+V+L   C     +R  +  LV+E  H        L +VP P      +K + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFE--HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
               RGL +LH     +++ RD K  NIL+    + KL+DFGLAR               
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
               Y APE +         D+WS G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELM---------HNKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGL R    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 62/212 (29%), Positives = 91/212 (42%), Gaps = 25/212 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHK-EWINEVNFL--- 149
           IGEG +G V++      + D +  G      VA+K++  Q G +G     I EV  L   
Sbjct: 19  IGEGAYGKVFK------ARDLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHL 68
Query: 150 GVVKHPNLVKLVGYCA-EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK-IA 207
              +HPN+V+L   C     +R  +  LV+E  H        L +VP P      +K + 
Sbjct: 69  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFE--HVDQDLTTYLDKVPEPGVPTETIKDMM 126
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
               RGL +LH     +++ RD K  NIL+    + KL+DFGLAR               
Sbjct: 127 FQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARI---YSFQMALTSVV 180
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
               Y APE +         D+WS G +  E+
Sbjct: 181 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEM 212

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   IG G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTIGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    K++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG V     +++       G +  + V  K+  +Q     +  + EV  L  + 
Sbjct: 33  VLGKGSFGEVILCKDKIT-------GQECAVKVISKRQVKQK-TDKESLLREVQLLKQLD 84
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN++KL  +    +++G    LV E+     L D ++SR     + +   +I +    G
Sbjct: 85  HPNIMKLYEFF---EDKGY-FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSG 138
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
           + Y+H+    +++ RD K  N+LL+   +D   ++ DFGL+                   
Sbjct: 139 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTA 192
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            Y APE +  G    K DVWS GV+LY L++G
Sbjct: 193 YYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 10  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 58
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 59  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 112
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 113 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 168
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 169 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 206

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ D+GLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHK 140
           K     F    ++GEG F  V       +S ++           AIK L ++    +   
Sbjct: 5   KKRPEDFKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKV 53
Query: 141 EWIN-EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPL 198
            ++  E + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +  
Sbjct: 54  PYVTRERDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFD 107
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
               R   A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE 
Sbjct: 108 ETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 163
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                        Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 164 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 207

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 9   FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 57
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 58  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 111
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 112 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 167
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 168 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 205

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 116/286 (40%), Gaps = 41/286 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVN 147
           F++   IG+G FG V++G+      D++T     +  VAIK ++ +  +   E I  E+ 
Sbjct: 25  FTKLERIGKGSFGEVFKGI------DNRT-----QQVVAIKIIDLEEAEDEIEDIQQEIT 73
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L       + K  G       +G +  ++ E +   S  D LL   P     IA +   
Sbjct: 74  VLSQCDSSYVTKYYGSYL----KGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATM--L 126
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
           ++  +GL YLH E   + I RD K +N+LL E    KL+DFG+A Q     +        
Sbjct: 127 KEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFV 181
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
               + APE +Q     +K+D+WS G+   EL  G        P     L+    P    
Sbjct: 182 GTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---- 237
Query: 328 SKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
                    P L G++              CL K P  RP   E++
Sbjct: 238 ---------PTLVGDFT----KSFKEFIDACLNKDPSFRPTAKELL 270

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 77  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 132
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 133 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 184
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +    P  + K LE 
Sbjct: 185 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 240
Query: 321 V 321
           +
Sbjct: 241 M 241

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 106 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 321 V 321
           +
Sbjct: 214 M 214

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/224 (25%), Positives = 98/224 (43%), Gaps = 25/224 (11%)
Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHK 140
           K     F    ++GEG F  V       +S ++           AIK L ++    +   
Sbjct: 6   KKRPEDFKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKV 54
Query: 141 EWIN-EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPL 198
            ++  E + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +  
Sbjct: 55  PYVTRERDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFD 108
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
               R   A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE 
Sbjct: 109 ETCTRFYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 164
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                        Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 165 KQARANXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 208

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 106 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 321 V 321
           +
Sbjct: 214 M 214

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHKETGNH----FAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  Y  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 69  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 124
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 125 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 176
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV 306
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +
Sbjct: 177 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 222

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 33/262 (12%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           + R   +G+GGF   Y           + +  D+K   A K + +         ++   E
Sbjct: 28  YMRGRFLGKGGFAKCY-----------EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 76
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +     + +P++V   G+  +DD       +V E+   +SL + L  R        AR  
Sbjct: 77  IAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 131
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           + Q   +G+ YLH     ++I RD K  N+ L++D   K+ DFGLA +   E  G     
Sbjct: 132 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKD 185
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKL 317
                 Y APE +     + + D+WS G +LY L+ G+   E +        + +NE  +
Sbjct: 186 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSV 245
Query: 318 LEWVRPYVSDSKKFHLIIDPRL 339
              + P  S   +  L  DP L
Sbjct: 246 PRHINPVASALIRRMLHADPTL 267

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 33/262 (12%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           + R   +G+GGF   Y           + +  D+K   A K + +         ++   E
Sbjct: 44  YMRGRFLGKGGFAKCY-----------EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +     + +P++V   G+  +DD       +V E+   +SL + L  R        AR  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           + Q   +G+ YLH     ++I RD K  N+ L++D   K+ DFGLA +   E  G     
Sbjct: 148 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKT 201
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKL 317
                 Y APE +     + + D+WS G +LY L+ G+   E +        + +NE  +
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSV 261
Query: 318 LEWVRPYVSDSKKFHLIIDPRL 339
              + P  S   +  L  DP L
Sbjct: 262 PRHINPVASALIRRMLHADPTL 283

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 106 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 321 V 321
           +
Sbjct: 214 M 214

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 80/181 (44%), Gaps = 16/181 (8%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 106 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +    P  + K LE 
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI----PPPDAKELEL 213
Query: 321 V 321
           +
Sbjct: 214 M 214

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              S +D++L   VA+K+L+R  Q     +    E+  L 
Sbjct: 36  VGSGAYGSV-------------CSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---NKSLEDHLLSRVPTPLAWIARLK 205
            +KH N++ L  V   A   E   +  LV  LM    N  ++   LS             
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKSQALSDEHVQF------- 135
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +     RGL Y+H      +I RD K SN+ ++ED + ++ DFGLARQ   E  G+    
Sbjct: 136 LVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY---- 188
Query: 266 XXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                 Y APE +          D+WS G ++ EL+ G+
Sbjct: 189 -VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHKETGNH----FAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  Y  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHKETGNH----FAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  Y  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EYSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 30  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 127
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G 
Sbjct: 128 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG- 181
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 182 ----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 17  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 63
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 64  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 118
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 119 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSCHAP----SSRRTTLS 168
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 94/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L++  Q     K    E+  L 
Sbjct: 42  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLK 88
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 89  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 139
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  
Sbjct: 140 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 192
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 193 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    R            SK  +A+K     QL + G +   +   EV   
Sbjct: 20  LGKGKFGNVYLARER-----------QSKFILALKVLFKTQLEKAGVE--HQLRREVEIQ 66
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LSR        +I  L   
Sbjct: 67  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--- 121
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL  + + K++DFG +   P            
Sbjct: 122 ---ANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRTTLC 171
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
               Y  PE ++      K D+WS GV+ YE + G    E
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 33  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 79
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 80  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 134
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 135 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 184
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 185 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 226

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 16  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 64
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 65  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 119 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 174
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 175 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 212

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 26  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 75  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 123
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G 
Sbjct: 124 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG- 177
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 178 ----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 80
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 81  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 134
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 135 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 191 AFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 68/223 (30%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 30  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 127
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G 
Sbjct: 128 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAG- 181
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 182 ----FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 66/262 (25%), Positives = 110/262 (41%), Gaps = 33/262 (12%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           + R   +G+GGF   Y           + +  D+K   A K + +         ++   E
Sbjct: 44  YMRGRFLGKGGFAKCY-----------EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +     + +P++V   G+  +DD       +V E+   +SL + L  R        AR  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           + Q   +G+ YLH     ++I RD K  N+ L++D   K+ DFGLA +   E  G     
Sbjct: 148 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKX 201
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKL 317
                 Y APE +     + + D+WS G +LY L+ G+   E +        + +NE  +
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSV 261
Query: 318 LEWVRPYVSDSKKFHLIIDPRL 339
              + P  S   +  L  DP L
Sbjct: 262 PRHINPVASALIRRMLHADPTL 283

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 19  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 65
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 66  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 121 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 170
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 21  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 67
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 68  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 122
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 123 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 172
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 173 GTLDYLPPEXIEGRXHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 12/166 (7%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 50  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 105
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 106 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 157
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV 306
                      Y +PE +Q    + +SD+WS G+ L E+  GR  +
Sbjct: 158 SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/262 (24%), Positives = 109/262 (41%), Gaps = 33/262 (12%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           + R   +G+GGF   Y           + +  D+K   A K + +         ++   E
Sbjct: 44  YMRGRFLGKGGFAKCY-----------EITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           +     + +P++V   G+  +DD       +V E+   +SL + L  R        AR  
Sbjct: 93  IAIHKSLDNPHVVGFHGFFEDDD----FVYVVLEICRRRSLLE-LHKRRKAVTEPEARYF 147
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           + Q   +G+ YLH     ++I RD K  N+ L++D   K+ DFGLA +   E  G     
Sbjct: 148 MRQ-TIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLATKI--EFDGERKKD 201
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKL 317
                 Y APE +     + + D+WS G +LY L+ G+   E +        + +NE  +
Sbjct: 202 LCGTPNYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKETYIRIKKNEYSV 261
Query: 318 LEWVRPYVSDSKKFHLIIDPRL 339
              + P  S   +  L  DP L
Sbjct: 262 PRHINPVASALIRRMLHADPTL 283

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 79
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 80  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 133
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 134 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 189
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 190 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 75/281 (26%), Positives = 115/281 (40%), Gaps = 58/281 (20%)
Query: 68  QRRANDLR-VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDV 126
           +++A D++ +F F E    T  FS  +L  E   G ++                      
Sbjct: 14  KKQAEDIKKIFEFKET-LGTGAFSEVVLAEEKATGKLF---------------------- 50
Query: 127 AIKQLNRQGFQGHKEWI-NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNK 184
           A+K + ++  +G +  I NE+  L  +KH N+V L     ED       L LV +L+   
Sbjct: 51  AVKCIPKKALKGKESSIENEIAVLRKIKHENIVAL-----EDIYESPNHLYLVMQLVSGG 105
Query: 185 SLEDHLLSR-VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DED 240
            L D ++ +   T       ++   DA   + YLH      ++ RD K  N+L    DE+
Sbjct: 106 ELFDRIVEKGFYTEKDASTLIRQVLDA---VYYLHR---MGIVHRDLKPENLLYYSQDEE 159
Query: 241 YKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
            K  +SDFGL++    EG G           Y APE +     +   D WS GV+ Y L+
Sbjct: 160 SKIMISDFGLSKM---EGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILL 216
Query: 301 TGRRAVERNLPRNEQKLLEWV--------RPY---VSDSKK 330
            G          N+ KL E +         PY   +SDS K
Sbjct: 217 CGYPPF---YDENDSKLFEQILKAEYEFDSPYWDDISDSAK 254

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 42  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 88
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 89  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 143
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 144 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 193
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 99/215 (46%), Gaps = 24/215 (11%)
Query: 90  SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL 149
           S+  ++G G FG V           H+     + L +A K +  +G +  +E  NE++ +
Sbjct: 92  SKTEILGGGRFGQV-----------HKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVM 140
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             + H NL++L  Y A + +  +  +LV E +    L D ++      L  +  +   + 
Sbjct: 141 NQLDHANLIQL--YDAFESKNDI--VLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQ 195
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNIL-LDEDYKA-KLSDFGLARQGPPEGLGHXXXXXX 267
              G+ ++H+     ++  D K  NIL ++ D K  K+ DFGLAR+  P           
Sbjct: 196 ICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR---EKLKVNF 249
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
               + APE V    ++  +D+WS GV+ Y L++G
Sbjct: 250 GTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG 284

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 21  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 67
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 68  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 122
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 123 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 172
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+GG+G V++ V +V+  +   +G    + V  K +  +  +       E N L  VK
Sbjct: 24  VLGKGGYGKVFQ-VRKVTGAN---TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHN----KSLEDHLLSRVPTPLAWIARLKIAQD 209
           HP +V L+ Y  +    G +  L+ E +        LE   +    T   ++A + +A  
Sbjct: 80  HPFIVDLI-YAFQT---GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA-- 133
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               L +LH++    +I+RD K  NI+L+     KL+DFGL ++   +G           
Sbjct: 134 ----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGT 184
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y APE +         D WS G ++Y+++TG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 80
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 81  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 134
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 135 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFAEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 83
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 84  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 137
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 138 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 193
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 194 SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 31  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 79
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 80  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 133
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 134 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 189
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 190 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 227

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 32  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 80
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 81  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 134
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 135 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 190
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 191 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 44  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 106/262 (40%), Gaps = 26/262 (9%)
Query: 123 KLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM 181
           K  VAIK++N +  Q    E + E+  +    HPN+V         DE      LV +L+
Sbjct: 40  KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL----WLVMKLL 95
Query: 182 HNKSLED---HLLSRVPTPLAWIARLKIA---QDAARGLAYLHEEMDFQLIFRDFKTSNI 235
              S+ D   H++++       +    IA   ++   GL YLH+      I RD K  NI
Sbjct: 96  SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNI 152
Query: 236 LLDEDYKAKLSDFGLA---RQGPPEGLGHXXXXXXXXXXYAAPEYVQTGR-LTAKSDVWS 291
           LL ED   +++DFG++     G                 + APE ++  R    K+D+WS
Sbjct: 153 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS 212
Query: 292 FGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXX 351
           FG+   EL TG     +  P     L     P   ++     + D  +   Y        
Sbjct: 213 FGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG----VQDKEMLKKY----GKSF 264
Query: 352 XXXXXXCLTKQPKSRPKMSEVV 373
                 CL K P+ RP  +E++
Sbjct: 265 RKMISLCLQKDPEKRPTAAELL 286

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 69/223 (30%), Positives = 96/223 (43%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 50  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 99  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 147
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E  G 
Sbjct: 148 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXG- 201
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 202 ----XVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG V     +++       G +  + V  K+  +Q     +  + EV  L  + 
Sbjct: 56  VLGKGSFGEVILCKDKIT-------GQECAVKVISKRQVKQK-TDKESLLREVQLLKQLD 107
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN++KL  +    +++G    LV E+     L D ++SR     + +   +I +    G
Sbjct: 108 HPNIMKLYEFF---EDKGY-FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSG 161
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
           + Y+H+    +++ RD K  N+LL+   +D   ++ DFGL+                   
Sbjct: 162 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTA 215
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            Y APE +  G    K DVWS GV+LY L++G
Sbjct: 216 YYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 246

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+GG+G V++ V +V+  +   +G    + V  K +  +  +       E N L  VK
Sbjct: 24  VLGKGGYGKVFQ-VRKVTGAN---TGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK 79
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHN----KSLEDHLLSRVPTPLAWIARLKIAQD 209
           HP +V L+ Y  +    G +  L+ E +        LE   +    T   ++A + +A  
Sbjct: 80  HPFIVDLI-YAFQT---GGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMA-- 133
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
               L +LH++    +I+RD K  NI+L+     KL+DFGL ++   +G           
Sbjct: 134 ----LGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFCGT 184
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y APE +         D WS G ++Y+++TG
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTG 217

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              S +D++L   VA+K+L+R  Q     +    E+  L 
Sbjct: 28  VGSGAYGSV-------------CSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 74
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---NKSLEDHLLSRVPTPLAWIARLK 205
            +KH N++ L  V   A   E   +  LV  LM    N  ++   LS             
Sbjct: 75  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF------- 127
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +     RGL Y+H      +I RD K SN+ ++ED + ++ DFGLARQ   E  G+    
Sbjct: 128 LVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMTGY---- 180
Query: 266 XXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                 Y APE +          D+WS G ++ EL+ G+
Sbjct: 181 -VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 218

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 82
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 83  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 136
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 137 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 82
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 83  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 136
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 137 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTELC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 82
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 83  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 136
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 137 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 68/262 (25%), Positives = 106/262 (40%), Gaps = 26/262 (9%)
Query: 123 KLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM 181
           K  VAIK++N +  Q    E + E+  +    HPN+V         DE      LV +L+
Sbjct: 35  KEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDEL----WLVMKLL 90
Query: 182 HNKSLED---HLLSRVPTPLAWIARLKIA---QDAARGLAYLHEEMDFQLIFRDFKTSNI 235
              S+ D   H++++       +    IA   ++   GL YLH+      I RD K  NI
Sbjct: 91  SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNI 147
Query: 236 LLDEDYKAKLSDFGLA---RQGPPEGLGHXXXXXXXXXXYAAPEYVQTGR-LTAKSDVWS 291
           LL ED   +++DFG++     G                 + APE ++  R    K+D+WS
Sbjct: 148 LLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWS 207
Query: 292 FGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXX 351
           FG+   EL TG     +  P     L     P   ++     + D  +   Y        
Sbjct: 208 FGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETG----VQDKEMLKKY----GKSF 259
Query: 352 XXXXXXCLTKQPKSRPKMSEVV 373
                 CL K P+ RP  +E++
Sbjct: 260 RKMISLCLQKDPEKRPTAAELL 281

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 19  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 65
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 66  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 121 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 170
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 19  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 65
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 66  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 121 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALC 170
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLXG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 76/159 (47%), Gaps = 11/159 (6%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIAR 203
           E + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R
Sbjct: 80  ERDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTR 133
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXX 263
              A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE      
Sbjct: 134 FYTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARA 189
Query: 264 XXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                   Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 190 NXFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 228

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG V     +++       G +  + V  K+  +Q     +  + EV  L  + 
Sbjct: 57  VLGKGSFGEVILCKDKIT-------GQECAVKVISKRQVKQK-TDKESLLREVQLLKQLD 108
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN++KL  +    +++G    LV E+     L D ++SR     + +   +I +    G
Sbjct: 109 HPNIMKLYEFF---EDKGY-FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSG 162
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
           + Y+H+    +++ RD K  N+LL+   +D   ++ DFGL+                   
Sbjct: 163 ITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIGTA 216
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            Y APE +  G    K DVWS GV+LY L++G
Sbjct: 217 YYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 247

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 60/220 (27%), Positives = 91/220 (41%), Gaps = 35/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    R            SK  +A+K     QL + G +   +   EV   
Sbjct: 20  LGKGKFGNVYLARER-----------QSKFILALKVLFKTQLEKAGVE--HQLRREVEIQ 66
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LSR        +I  L   
Sbjct: 67  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITEL--- 121
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL  + + K++DFG +   P            
Sbjct: 122 ---ANALSYCHSK---RVIHRDIKPENLLLGSNGELKIADFGWSVHAP----SSRRDTLC 171
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
               Y  PE ++      K D+WS GV+ YE + G    E
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 64  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 112
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 113 KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 165
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 166 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGATWTLCG 221
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 222 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 37  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 85
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 86  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 139
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 140 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 195
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 196 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 233

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 35  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 83
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 84  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 137
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 138 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 193
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 194 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 231

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 21  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 67
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 68  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 122
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 123 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLC 172
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 108/238 (45%), Gaps = 35/238 (14%)
Query: 76  VFSFAELKSATR-----GFSRALL-----IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD 125
           V +  + K+A R     G  R LL     IGEG       G+V ++ + H      S   
Sbjct: 24  VVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGS-----TGIVCLAREKH------SGRQ 72
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLV-GYCAEDDERGMQRLLVYELMHNK 184
           VA+K ++ +  Q  +   NEV  +   +H N+V++   Y       G +  ++ E +   
Sbjct: 73  VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-----GEELWVLMEFLQGG 127
Query: 185 SLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK 244
           +L D ++S+V      IA   + +   + LAYLH +    +I RD K+ +ILL  D + K
Sbjct: 128 ALTD-IVSQVRLNEEQIA--TVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVK 181
Query: 245 LSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           LSDFG   Q   +              + APE +       + D+WS G+++ E++ G
Sbjct: 182 LSDFGFCAQISKD--VPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDG 237

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLAG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 38  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 86
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 87  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEPHA---R 139
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 140 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 195
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 196 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 229

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 82
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 83  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 136
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 137 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 193 XFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAG 230

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE L              APE + +       D W+ GV++YE+  G
Sbjct: 201 TPEAL--------------APEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 43/156 (27%), Positives = 74/156 (47%), Gaps = 20/156 (12%)
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR---VPTPLAWIARLKIAQDA 210
           HPN+VKL     E     +   LV EL++   L + +  +     T  ++I R  ++   
Sbjct: 65  HPNIVKL----HEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVS--- 117
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              ++++H   D  ++ RD K  N+L    +++ + K+ DFG AR  PP+          
Sbjct: 118 --AVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN--QPLKTPC 170
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
               YAAPE +         D+WS GV+LY +++G+
Sbjct: 171 FTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQ 206

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 18  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 64
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 65  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 119
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 120 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLC 169
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 15  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 61
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 62  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 116
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 117 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 166
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 167 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 208

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 17  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 63
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 64  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 118
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 119 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDTLC 168
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 17  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 63
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 64  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 118
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 119 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLC 168
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 210

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 20  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 66
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 67  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 121
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 122 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 171
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 172 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 213

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/218 (26%), Positives = 97/218 (44%), Gaps = 25/218 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWIN-E 145
           F    ++GEG F  V       +S ++           AIK L ++    +    ++  E
Sbjct: 34  FKFGKILGEGSFSTVVLARELATSREY-----------AIKILEKRHIIKENKVPYVTRE 82
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLED-HLLSRVPTPLAWIARL 204
            + +  + HP  VKL  +  +DDE+     L + L + K+ E    + ++ +      R 
Sbjct: 83  RDVMSRLDHPFFVKLY-FTFQDDEK-----LYFGLSYAKNGELLKYIRKIGSFDETCTRF 136
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
             A+  +  L YLH +    +I RD K  NILL+ED   +++DFG A+   PE       
Sbjct: 137 YTAEIVS-ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARAN 192
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  Y +PE +        SD+W+ G ++Y+L+ G
Sbjct: 193 XFVGTAQYVSPELLTEKSAXKSSDLWALGCIIYQLVAG 230

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRAALC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 73/163 (44%), Gaps = 12/163 (7%)
Query: 141 EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
           + I E+  L     P +V   G    D E      +  E M   SL+  L      P   
Sbjct: 53  QIIRELQVLHECNSPYIVGFYGAFYSDGEIS----ICMEHMDGGSLDQVLKKAGRIPEQI 108
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
           + ++ IA    +GL YL E+   +++ RD K SNIL++   + KL DFG++ Q     + 
Sbjct: 109 LGKVSIA--VIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----ID 160
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                      Y +PE +Q    + +SD+WS G+ L E+  GR
Sbjct: 161 EMANEFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGR 203

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 23/208 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG       G+V ++++ H          VA+K+++ +  Q  +   NEV  +    H
Sbjct: 53  IGEGS-----TGIVCIATEKHTGK------QVAVKKMDLRKQQRRELLFNEVVIMRDYHH 101
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V +       DE      +V E +   +L D +++        IA   +     R L
Sbjct: 102 DNVVDMYSSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIA--TVCLSVLRAL 154
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           +YLH +    +I RD K+ +ILL  D + KLSDFG   Q   E              + A
Sbjct: 155 SYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE--VPKRKXLVGTPYWMA 209
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITG 302
           PE +       + D+WS G+++ E+I G
Sbjct: 210 PEVISRLPYGTEVDIWSLGIMVIEMIDG 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     KE    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKEIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    +++DFGLA++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 85  ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGH 139
           A   F     +G+G FG VY    +            SK  +A+K     QL + G +  
Sbjct: 32  ALEDFEIGRPLGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE-- 78
Query: 140 KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--P 197
            +   EV     ++HPN+++L GY    D   +  +L Y  +     E   LS+      
Sbjct: 79  HQLRREVEIQSHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRT 136
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
             +I  L      A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P  
Sbjct: 137 ATYITEL------ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP-- 185
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
                         Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 186 --SSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 235

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 30/183 (16%)
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
           A+G+ +L      + I RD    NILL E    K+ DFGLAR    +             
Sbjct: 210 AKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 266
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KLLEWVR---PY 324
            + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L E  R   P 
Sbjct: 267 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD 326
Query: 325 VSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEIS 384
            +  + +  ++D                     C   +P  RP  SE+V+ LGN++   +
Sbjct: 327 YTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQANA 365
Query: 385 SQD 387
            QD
Sbjct: 366 QQD 368

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 79/184 (42%), Gaps = 30/184 (16%)
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ +L      + I RD    NILL E    K+ DFGLAR    +            
Sbjct: 207 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 263
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KLLEWVR---P 323
             + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L E  R   P
Sbjct: 264 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 323
Query: 324 YVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNIISEI 383
             +  + +  ++D                     C   +P  RP  SE+V+ LGN++   
Sbjct: 324 DYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLLQAN 362
Query: 384 SSQD 387
           + QD
Sbjct: 363 AQQD 366

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTXLC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
           G  YLH     ++I RD K  N+ L+ED + K+ DFGLA +   E  G           Y
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNY 183
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKLLEWVRPY 324
            APE +     + + DVWS G ++Y L+ G+   E +        + +NE  + + + P 
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 243
Query: 325 VSDSKKFHLIIDP 337
            +   +  L  DP
Sbjct: 244 AASLIQKMLQTDP 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 94/219 (42%), Gaps = 38/219 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              S +D++L   VA+K+L+R  Q     +    E+  L 
Sbjct: 36  VGSGAYGSV-------------CSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLK 82
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---NKSLEDHLLSRVPTPLAWIARLK 205
            +KH N++ L  V   A   E   +  LV  LM    N  ++   LS             
Sbjct: 83  HLKHENVIGLLDVFTPATSIEDFSEVYLVTTLMGADLNNIVKCQALSDEHVQF------- 135
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +     RGL Y+H      +I RD K SN+ ++ED + ++ DFGLARQ   E  G+    
Sbjct: 136 LVYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGY---- 188
Query: 266 XXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                 Y APE +          D+WS G ++ EL+ G+
Sbjct: 189 -VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGK 226

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 65/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 64  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 112
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 113 KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFXEPHA---R 165
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 166 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 221
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 222 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 79/176 (44%), Gaps = 30/176 (17%)
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
           ARG+ +L      + I RD    NILL E+   K+ DFGLAR                  
Sbjct: 209 ARGMEFLSSR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKNPDYVRKGDTRLPL 265
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE---QKLLEWVR---PY 324
            + APE +     + KSDVWS+GV+L+E+ +   +    +  +E    +L E +R   P 
Sbjct: 266 KWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDEDFCSRLREGMRMRAPE 325
Query: 325 VSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNII 380
            S  + + +++D                     C  + PK RP+ +E+V+ LG+++
Sbjct: 326 YSTPEIYQIMLD---------------------CWHRDPKERPRFAELVEKLGDLL 360

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
           G  YLH     ++I RD K  N+ L+ED + K+ DFGLA +   E  G           Y
Sbjct: 133 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNY 187
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKLLEWVRPY 324
            APE +     + + DVWS G ++Y L+ G+   E +        + +NE  + + + P 
Sbjct: 188 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 247
Query: 325 VSDSKKFHLIIDP 337
            +   +  L  DP
Sbjct: 248 AASLIQKMLQTDP 260

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 111/261 (42%), Gaps = 51/261 (19%)
Query: 57  SDSLAFYELLSQRRANDLRVF-SFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDH 115
           S+S    E L++ + + L+ + S A+  +    F R   +G G FG       RV    H
Sbjct: 3   SNSSDVKEFLAKAKEDFLKKWESPAQNTAHLDQFERIKTLGTGSFG-------RVMLVKH 55
Query: 116 QTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLGVVKHPNLVKLVGYCAEDDERGM 172
           + +G+      A+K L++Q     K+    +NE   L  V  P LVKL  +  +D+    
Sbjct: 56  KETGNH----YAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKL-EFSFKDNS--- 107
Query: 173 QRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF 230
              +V E +    +  HL  + R   P A   R   AQ       YLH      LI+RD 
Sbjct: 108 NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---RFYAAQ-IVLTFEYLH---SLDLIYRDL 160
Query: 231 KTSNILLDEDYKAKLSDFGLARQ---------GPPEGLGHXXXXXXXXXXYAAPEYVQTG 281
           K  N+L+D+    +++DFG A++         G PE              Y APE + + 
Sbjct: 161 KPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCGTPE--------------YLAPEIILSK 206
Query: 282 RLTAKSDVWSFGVVLYELITG 302
                 D W+ GV++YE+  G
Sbjct: 207 GYNKAVDWWALGVLIYEMAAG 227

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/229 (26%), Positives = 99/229 (43%), Gaps = 39/229 (17%)
Query: 97  EGGFGCVYRGVVRVSSDDH-------QTSGHDSKLDVAIKQLNRQGF------------- 136
           EG  G  Y  V ++ S  +       + +GH  K   AIK + +  F             
Sbjct: 31  EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEK---AIKVIKKSQFDKGRYSDDNKNIE 87
Query: 137 QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT 196
           + H+E  NE++ L  + HPN++KL  +   +D++     LV E      L + +++R   
Sbjct: 88  KFHEEIYNEISLLKSLDHPNIIKL--FDVFEDKKYF--YLVTEFYEGGELFEQIINRHKF 143
Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED---YKAKLSDFGLARQ 253
                A   I +    G+ YLH+     ++ RD K  NILL+        K+ DFGL+  
Sbjct: 144 DECDAAN--IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSF 198
Query: 254 GPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
              +   +          Y APE ++  +   K DVWS GV++Y L+ G
Sbjct: 199 FSKD---YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCG 243

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
           G  YLH     ++I RD K  N+ L+ED + K+ DFGLA +   E  G           Y
Sbjct: 129 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKTLCGTPNY 183
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKLLEWVRPY 324
            APE +     + + DVWS G ++Y L+ G+   E +        + +NE  + + + P 
Sbjct: 184 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 243
Query: 325 VSDSKKFHLIIDP 337
            +   +  L  DP
Sbjct: 244 AASLIQKMLQTDP 256

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 16  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 62
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 63  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 117
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 118 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLC 167
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 168 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 209

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 70  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLM 115
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 170
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 171 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 224
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKL 312

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 61/222 (27%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 19  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 65
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 66  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 121 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLC 170
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
           G  YLH     ++I RD K  N+ L+ED + K+ DFGLA +   E  G           Y
Sbjct: 153 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNY 207
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKLLEWVRPY 324
            APE +     + + DVWS G ++Y L+ G+   E +        + +NE  + + + P 
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 267
Query: 325 VSDSKKFHLIIDP 337
            +   +  L  DP
Sbjct: 268 AASLIQKMLQTDP 280

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 38/117 (32%), Positives = 61/117 (52%), Gaps = 10/117 (8%)
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
           A +   GL +LH +    +++RD K  NILLD+D   K++DFG+ ++     LG      
Sbjct: 124 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN---MLGDAKTNX 177
Query: 267 XX-XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
                 Y APE +   +     D WSFGV+LYE++ G+        ++E++L   +R
Sbjct: 178 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIR 231

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 94/227 (41%), Gaps = 25/227 (11%)
Query: 80  AELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH 139
           A  K     F    L+G+G FG V   +VR  +              A+K L ++     
Sbjct: 1   ARAKVTMNDFDYLKLLGKGTFGKVI--LVREKATGRY---------YAMKILRKEVIIAK 49
Query: 140 KE---WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT 196
            E    + E   L   +HP L  L  Y  +  +R      V E  +   L  HL SR   
Sbjct: 50  DEVAHTVTESRVLQNTRHPFLTAL-KYAFQTHDR---LCFVMEYANGGELFFHL-SRERV 104
Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
                AR   A+  +  L YLH      +++RD K  N++LD+D   K++DFGL ++G  
Sbjct: 105 FTEERARFYGAEIVS-ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 160
Query: 257 EGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           +G             Y APE ++        D W  GVV+YE++ GR
Sbjct: 161 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 205

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYLL 132
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 133 YQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYV 186
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
           G  YLH     ++I RD K  N+ L+ED + K+ DFGLA +   E  G           Y
Sbjct: 151 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNY 205
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKLLEWVRPY 324
            APE +     + + DVWS G ++Y L+ G+   E +        + +NE  + + + P 
Sbjct: 206 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 265
Query: 325 VSDSKKFHLIIDP 337
            +   +  L  DP
Sbjct: 266 AASLIQKMLQTDP 278

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 101/212 (47%), Gaps = 26/212 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVVK 153
           +GEG +  VY+G  +++ +            VA+K++  +  +G     I EV+ L  +K
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-----------VALKEIRLEHEEGAPCTAIREVSLLKDLK 58
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+V L  +     E+ +   LV+E + +K L+ +L            +L + Q   RG
Sbjct: 59  HANIVTL--HDIIHTEKSLT--LVFEYL-DKDLKQYLDDCGNIINMHNVKLFLFQ-LLRG 112
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           LAY H +   +++ RD K  N+L++E  + KL+DFGLAR    + +            + 
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARA---KSIPTKTYDNEVVTLWY 166
Query: 274 APEYVQTGR--LTAKSDVWSFGVVLYELITGR 303
            P  +  G    + + D+W  G + YE+ TGR
Sbjct: 167 RPPDILLGSTDYSTQIDMWGVGCIFYEMATGR 198

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 30/90 (33%), Positives = 46/90 (51%), Gaps = 3/90 (3%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH +    +I RD K  NILL+ED   +++DFG A+   PE              Y
Sbjct: 144 ALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQY 200
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            +PE +     +  SD+W+ G ++Y+L+ G
Sbjct: 201 VSPELLTEKSASKSSDLWALGCIIYQLVAG 230

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/224 (24%), Positives = 92/224 (41%), Gaps = 33/224 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F    LIG GGFG V++   R+    +            IK++     +  +E    V  
Sbjct: 13  FKEIELIGSGGFGQVFKAKHRIDGKTY-----------VIKRVKYNNEKAERE----VKA 57
Query: 149 LGVVKHPNLVKLVG------YCAEDDERGMQR------LLVYELMHNKSLEDHLLSRVPT 196
           L  + H N+V   G      Y  E   +   R       +  E     +LE  +  R   
Sbjct: 58  LAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGE 117
Query: 197 PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
            L  +  L++ +   +G+ Y+H +   +LI RD K SNI L +  + K+ DFGL      
Sbjct: 118 KLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN 174
Query: 257 EGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
           +G             Y +PE + +     + D+++ G++L EL+
Sbjct: 175 DG---KRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 215

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 37/117 (31%), Positives = 60/117 (51%), Gaps = 10/117 (8%)
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
           A +   GL +LH +    +++RD K  NILLD+D   K++DFG+ ++     LG      
Sbjct: 125 AAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKEN---MLGDAKTNE 178
Query: 267 XX-XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
                 Y APE +   +     D WSFGV+LYE++ G+        ++E++L   +R
Sbjct: 179 FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHG---QDEEELFHSIR 232

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+  FGLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHKETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 25  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 70
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYLL 125
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 126 YQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYV 179
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKL 267

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 31  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 76
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 77  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 131
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 132 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 185
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 186 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 245
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 246 EFMKKLQPTVRNYVENRPKYAGLTFPKL 273

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 13/133 (9%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
           G  YLH     ++I RD K  N+ L+ED + K+ DFGLA +   E  G           Y
Sbjct: 127 GCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKV--EYDGERKKVLCGTPNY 181
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN--------LPRNEQKLLEWVRPY 324
            APE +     + + DVWS G ++Y L+ G+   E +        + +NE  + + + P 
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPV 241
Query: 325 VSDSKKFHLIIDP 337
            +   +  L  DP
Sbjct: 242 AASLIQKMLQTDP 254

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 132
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 133 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 186
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHKETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    K++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIIISKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 36  FERIKTLGTGSFG-------RVMLVKHKETGNH----YAMKILDKQKVVKLKQIEHTLNE 84
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 85  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEPHA---R 137
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 138 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 193
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 194 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 227

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHKETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 70  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSRP-FQNQTHAKRAYRELVLM 115
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 116 KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 170
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 171 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 224
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 225 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 284
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 285 EFMKKLQPTVRNYVENRPKYAGLTFPKL 312

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 33  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 78
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 133
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 134 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 187
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 247
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKL 275

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 33  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 78
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 79  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 133
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 134 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 187
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 247
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 248 EFMKKLQPTVRNYVENRPKYAGLTFPKL 275

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHKETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 78  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 132
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 133 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 186
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 19  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 65
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 66  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 121 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRDDLC 170
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ D GLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++Y++  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYQMAAG 234

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 78  KXVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYLL 132
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 133 YQMLXGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYV 186
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 18  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 64
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 65  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 119
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K+++FG +   P            
Sbjct: 120 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLC 169
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 170 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 211

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 95/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 64  FERIKTLGTGSFG-------RVMLVKHKETGNH----YAMKILDKQKVVKLKQIEHTLNE 112
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 113 KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 165
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 166 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 221
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 222 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 255

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH      +++RD K  N++LD+D   K++DFGL ++G  +  G           Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEY 171
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 25  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 70
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 71  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 125
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 126 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 179
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKL 267

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 63/263 (23%), Positives = 106/263 (40%), Gaps = 43/263 (16%)
Query: 125 DVAIKQLNRQGFQGHK--EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMH 182
           D+ +K L  + +   K  ++  E   L +  HPN++ ++G C           L+   M 
Sbjct: 35  DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC--QSPPAPHPTLITHWMP 92
Query: 183 NKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK 242
             SL + L       +     +K A D ARG+A+LH  ++  +      + ++++DED  
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMT 151
Query: 243 AKLS--DFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQ-----TGRLTAKSDVWSFGVV 295
           A++S  D   + Q P                + APE +Q     T R +A  D+WSF V+
Sbjct: 152 ARISMADVKFSFQSP---------GRMYAPAWVAPEALQKKPEDTNRRSA--DMWSFAVL 200
Query: 296 LYELITGRRAVE--RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXX 353
           L+EL+T         N+    +  LE +RP +      H+                    
Sbjct: 201 LWELVTREVPFADLSNMEIGMKVALEGLRPTIPPGISPHV------------------SK 242
Query: 354 XXXXCLTKQPKSRPKMSEVVDIL 376
               C+ + P  RPK   +V IL
Sbjct: 243 LMKICMNEDPAKRPKFDMIVPIL 265

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 29  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 77
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 78  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 130
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 131 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG 186
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 187 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 220

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 106/270 (39%), Gaps = 68/270 (25%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------VAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            VV H N++ L+         E      +V ELM      D  LS+V         +++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLSQV---------IQME 122
Query: 208 QDAAR----------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
            D  R          G+ +LH      +I RD K SNI++  D   K+ DFGLAR     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--- 176
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RR 304
           G             Y APE +         D+WS GV++ E+I G              +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 305 AVER---NLPRNEQKLLEWVRPYVSDSKKF 331
            +E+     P   +KL   VR YV +  K+
Sbjct: 237 VIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 26  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 71
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 126
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 127 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 180
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 240
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKL 268

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 70/268 (26%), Positives = 104/268 (38%), Gaps = 48/268 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ LD  VAIK+L+R  FQ     K    E+  +
Sbjct: 26  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSR-PFQNQTHAKRAYRELVLM 71
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      LV ELM     + +L   +   L       + 
Sbjct: 72  KCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLL 126
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 127 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 180
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 181 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 240
Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRL 339
              +KL   VR YV +  K+  +  P+L
Sbjct: 241 EFMKKLQPTVRNYVENRPKYAGLTFPKL 268

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 103/267 (38%), Gaps = 46/267 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNR--QGFQGHKEWINEVNFLG 150
           IG G  G V              + +D+ LD  VAIK+L+R  Q     K    E+  + 
Sbjct: 32  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 151 VVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
            V H N++ L+         E      LV ELM     + +L   +   L       +  
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSYLLY 133
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX 268
               G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G          
Sbjct: 134 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVV 187
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLPR 312
              Y APE +         D+WS G ++ E++       GR  +++            P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 313 NEQKLLEWVRPYVSDSKKFHLIIDPRL 339
             +KL   VR YV +  K+  +  P+L
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/163 (30%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
           ++EV  L  + HPN++KL  +   +D+R     LV E+     L D ++ R     + + 
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFF--EDKRNY--YLVMEVYRGGELFDEIILR--QKFSEVD 105
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGL 259
              I +    G  YLH+     ++ RD K  N+LL+    D   K+ DFGL+       +
Sbjct: 106 AAVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---V 159
Query: 260 GHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           G           Y APE ++  +   K DVWS GV+LY L+ G
Sbjct: 160 GGKMKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 201

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     QG      E+  +  + 
Sbjct: 27  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLD 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 125
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 126 LYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 178
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 31/91 (34%), Positives = 47/91 (51%), Gaps = 5/91 (5%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH      +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEY 171
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    K++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 59/222 (26%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 21  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 67
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y        E   LS+        +I  L   
Sbjct: 68  SHLRHPNILRLYGYF--HDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--- 122
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 123 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 172
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH      +++RD K  N++LD+D   K++DFGL ++G  +  G           Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEY 171
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 97/212 (45%), Gaps = 24/212 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG V     +++       G +  + V  K+  +Q     +  + EV  L  + 
Sbjct: 33  VLGKGSFGEVILCKDKIT-------GQECAVKVISKRQVKQK-TDKESLLREVQLLKQLD 84
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+ KL  +    +++G    LV E+     L D ++SR     + +   +I +    G
Sbjct: 85  HPNIXKLYEFF---EDKGY-FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSG 138
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXX 270
           + Y H+    +++ RD K  N+LL+   +D   ++ DFGL+                   
Sbjct: 139 ITYXHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKXKDKIGTA 192
Query: 271 XYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            Y APE +  G    K DVWS GV+LY L++G
Sbjct: 193 YYIAPEVLH-GTYDEKCDVWSTGVILYILLSG 223

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ D GLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH      +++RD K  N++LD+D   K++DFGL ++G  +  G           Y
Sbjct: 122 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKXFCGTPEY 176
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 177 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 207

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 76/163 (46%), Gaps = 16/163 (9%)
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
           ++EV  L  + HPN++KL  Y   +D+R     LV E+     L D ++ R     + + 
Sbjct: 69  LDEVAVLKQLDHPNIMKL--YEFFEDKRNY--YLVMEVYRGGELFDEIILR--QKFSEVD 122
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGL 259
              I +    G  YLH+     ++ RD K  N+LL+    D   K+ DFGL+       +
Sbjct: 123 AAVIMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFE---V 176
Query: 260 GHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           G           Y APE ++  +   K DVWS GV+LY L+ G
Sbjct: 177 GGKMKERLGTAYYIAPEVLRK-KYDEKCDVWSCGVILYILLCG 218

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     QG      E+  +  + 
Sbjct: 27  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLD 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 125
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 126 LYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 178
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 179 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 69/267 (25%), Positives = 103/267 (38%), Gaps = 46/267 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNR--QGFQGHKEWINEVNFLG 150
           IG G  G V              + +D+ LD  VAIK+L+R  Q     K    E+  + 
Sbjct: 32  IGSGAQGIV-------------CAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 151 VVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
            V H N++ L+         E      LV ELM     + +L   +   L       +  
Sbjct: 79  XVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLXQVIQMELDHERMSYLLY 133
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX 268
               G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G          
Sbjct: 134 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDXTLKILDFGLARTA---GTSFMMTPYVV 187
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI------TGRRAVER----------NLPR 312
              Y APE +         D+WS G ++ E++       GR  +++            P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 313 NEQKLLEWVRPYVSDSKKFHLIIDPRL 339
             +KL   VR YV +  K+  +  P+L
Sbjct: 248 FMKKLQPTVRNYVENRPKYAGLTFPKL 274

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 68/222 (30%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     QG      E+  +  + 
Sbjct: 27  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQGKAFKNRELQIMRKLD 71
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTL-----PVIYV-K 125
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 126 LYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 178
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 179 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH      +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEY 171
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFXEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    K++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 19  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 65
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 66  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 120
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K+++FG +   P            
Sbjct: 121 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIANFGWSVHAP----SSRRTTLC 170
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 171 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 212

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 67/223 (30%), Positives = 95/223 (42%), Gaps = 46/223 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGVV 152
           +G G +G V       ++ D +T GH     VA+K+L+R  Q     K    E+  L  +
Sbjct: 30  VGSGAYGSV------CAAFDTKT-GHR----VAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 153 KHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLAWI 201
           KH N++ L  V   A   E      LV  LM           K  +DH+           
Sbjct: 79  KHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV----------- 127
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
            +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ DF LAR    E  G+
Sbjct: 128 -QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMTGY 182
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE +          D+WS G ++ EL+TGR
Sbjct: 183 -----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 5/91 (5%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXY 272
            L YLH      +++RD K  N++LD+D   K++DFGL ++G  +G             Y
Sbjct: 117 ALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKXFCGTPEY 171
Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            APE ++        D W  GVV+YE++ GR
Sbjct: 172 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 73/270 (27%), Positives = 106/270 (39%), Gaps = 68/270 (25%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            VV H N++ L+         E      +V ELM      D  LS+V         +++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLSQV---------IQME 122
Query: 208 QDAAR----------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
            D  R          G+ +LH      +I RD K SNI++  D   K+ DFGLAR     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--- 176
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RR 304
           G             Y APE +         D+WS GV++ E+I G              +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 305 AVER---NLPRNEQKLLEWVRPYVSDSKKF 331
            +E+     P   +KL   VR YV +  K+
Sbjct: 237 VIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G V    VR S           KL VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 28  IGEGSTGIVCIATVRSSG----------KL-VAVKKMDLRKQQRRELLFNEVVIMRDYQH 76
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++       DE      +V E +   +L D +++        IA + +A    + L
Sbjct: 77  ENVVEMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA--VLQAL 129
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           + LH +    +I RD K+ +ILL  D + KLSDFG   Q   E              + A
Sbjct: 130 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMA 184
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           PE +       + D+WS G+++ E++ G        P    K++
Sbjct: 185 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 66/225 (29%), Positives = 93/225 (41%), Gaps = 50/225 (22%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSK--LDVAIKQLNR--QGFQGHKEWINEVNFLG 150
           +G G +G V              +  D+K  L VA+K+L+R  Q     K    E+  L 
Sbjct: 30  VGSGAYGSV-------------CAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLK 76
Query: 151 VVKHPNLVKL--VGYCAEDDERGMQRLLVYELMH---------NKSLEDHLLSRVPTPLA 199
            +KH N++ L  V   A   E      LV  LM           K  +DH+         
Sbjct: 77  HMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHV--------- 127
Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              +  I Q   RGL Y+H      +I RD K SN+ ++ED + K+ D GLAR    E  
Sbjct: 128 ---QFLIYQ-ILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT 180
Query: 260 GHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           G+          Y APE +          D+WS G ++ EL+TGR
Sbjct: 181 GY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G V    VR S           KL VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 32  IGEGSTGIVCIATVRSSG----------KL-VAVKKMDLRKQQRRELLFNEVVIMRDYQH 80
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++       DE      +V E +   +L D +++        IA + +A    + L
Sbjct: 81  ENVVEMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA--VLQAL 133
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           + LH +    +I RD K+ +ILL  D + KLSDFG   Q   E              + A
Sbjct: 134 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMA 188
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           PE +       + D+WS G+++ E++ G        P    K++
Sbjct: 189 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 232

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 62/222 (27%), Positives = 94/222 (42%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +            SK  +A+K     QL + G +   +   EV   
Sbjct: 21  LGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 67
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y        E   LS+        +I  L   
Sbjct: 68  SHLRHPNILRLYGYF--HDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITEL--- 122
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 123 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRXXLX 172
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 173 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 214

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/168 (29%), Positives = 80/168 (47%), Gaps = 26/168 (15%)
Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
           + EV  L ++ HPN++KL  +   +D+R     LV E      L D ++ R+      + 
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFF--EDKRNY--YLVMECYKGGELFDEIIHRMK--FNEVD 137
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLA-----RQG 254
              I +    G+ YLH+     ++ RD K  N+LL+   +D   K+ DFGL+     ++ 
Sbjct: 138 AAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK 194
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             E LG           Y APE ++  +   K DVWS GV+L+ L+ G
Sbjct: 195 MKERLG--------TAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAG 233

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVPGGEMFSHLRRIGRFXEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G V    VR S           KL VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 37  IGEGSTGIVCIATVRSSG----------KL-VAVKKMDLRKQQRRELLFNEVVIMRDYQH 85
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++       DE      +V E +   +L D +++        IA + +A    + L
Sbjct: 86  ENVVEMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA--VLQAL 138
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           + LH +    +I RD K+ +ILL  D + KLSDFG   Q   E              + A
Sbjct: 139 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMA 193
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           PE +       + D+WS G+++ E++ G        P    K++
Sbjct: 194 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 237

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 36/175 (20%)
Query: 143 INEVNFLGVVKHPNLVK---------------LVGYCAEDDERGMQRLLVYELMHNKSLE 187
           ++EVN L  +KHPN+V+               ++ YC   D   +  ++       + L+
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD---LASVITKGTKERQYLD 109
Query: 188 DHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
           +  + RV T L  +A  +  + +  G   LH         RD K +N+ LD     KL D
Sbjct: 110 EEFVLRVMTQLT-LALKECHRRSDGGHTVLH---------RDLKPANVFLDGKQNVKLGD 159
Query: 248 FGLARQGPPEGLGHXXXXXXX---XXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           FGLAR      L H             Y +PE +       KSD+WS G +LYEL
Sbjct: 160 FGLARI-----LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G V    VR S           KL VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 39  IGEGSTGIVCIATVRSSG----------KL-VAVKKMDLRKQQRRELLFNEVVIMRDYQH 87
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++       DE      +V E +   +L D +++        IA + +A    + L
Sbjct: 88  ENVVEMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA--VLQAL 140
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           + LH +    +I RD K+ +ILL  D + KLSDFG   Q   E              + A
Sbjct: 141 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMA 195
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           PE +       + D+WS G+++ E++ G        P    K++
Sbjct: 196 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 239

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 36/175 (20%)
Query: 143 INEVNFLGVVKHPNLVK---------------LVGYCAEDDERGMQRLLVYELMHNKSLE 187
           ++EVN L  +KHPN+V+               ++ YC   D   +  ++       + L+
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD---LASVITKGTKERQYLD 109
Query: 188 DHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
           +  + RV T L  +A  +  + +  G   LH         RD K +N+ LD     KL D
Sbjct: 110 EEFVLRVMTQLT-LALKECHRRSDGGHTVLH---------RDLKPANVFLDGKQNVKLGD 159
Query: 248 FGLARQGPPEGLGHXXXXXXX---XXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           FGLAR      L H             Y +PE +       KSD+WS G +LYEL
Sbjct: 160 FGLARI-----LNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/213 (27%), Positives = 88/213 (41%), Gaps = 27/213 (12%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL--NRQGFQGHKEWINEVNFLGV 151
           L+GEG +G V +               D+   VAIK+   +       K  + E+  L  
Sbjct: 32  LVGEGSYGMVMK-----------CRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQ 80
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           ++H NLV L+  C    ++  +  LV+E + +  L+D  L   P  L +    K      
Sbjct: 81  LRHENLVNLLEVC----KKKKRWYLVFEFVDHTILDD--LELFPNGLDYQVVQKYLFQII 134
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXX 270
            G+ + H      +I RD K  NIL+ +    KL DFG AR    P   G          
Sbjct: 135 NGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---GEVYDDEVATR 188
Query: 271 XYAAPEYVQTGRLTAKS-DVWSFGVVLYELITG 302
            Y APE +       K+ DVW+ G ++ E+  G
Sbjct: 189 WYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 94/228 (41%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ SG+      A+K L++Q     K+    +NE
Sbjct: 43  FDRIKTLGTGSFG-------RVMLVKHKESGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E +    +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYVAGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y AP  + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPAIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 91/222 (40%), Gaps = 35/222 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNFL 149
           +G+G FG VY    +             K  +A+K     QL + G +   +   EV   
Sbjct: 13  LGKGKFGNVYLAREK-----------QRKFILALKVLFKAQLEKAGVE--HQLRREVEIQ 59
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIA 207
             ++HPN+++L GY    D   +  +L Y  +     E   LS+        +I  L   
Sbjct: 60  SHLRHPNILRLYGYF--HDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITEL--- 114
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
              A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P            
Sbjct: 115 ---ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLC 164
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
               Y  PE ++      K D+WS GV+ YE + G+   E N
Sbjct: 165 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN 206

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+               ++ +  A K ++ +  +  ++++ E++ L    H
Sbjct: 45  LGDGAFGKVYKA-----------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 155 PNLVKLV-GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           PN+VKL+  +  E++       ++ E     ++ D ++  +  PL       + +     
Sbjct: 94  PNIVKLLDAFYYENN-----LWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L YLH   D ++I RD K  NIL   D   KL+DFG++ +                  + 
Sbjct: 148 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRTIQRRDSFIGTPYWM 202
Query: 274 APEYV--QTGR---LTAKSDVWSFGVVLYEL 299
           APE V  +T +      K+DVWS G+ L E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R   R + ++       +K  +   + +++  +       E+  + V++H
Sbjct: 59  LGTGAFGVVHRVTERATGNNFA-----AKFVMTPHESDKETVR------KEIQTMSVLRH 107
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELM------------HNKSLEDHLLSRVPTPLAWIA 202
           P LV L     +D+E     +++YE M            HNK  ED  +           
Sbjct: 108 PTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADEHNKMSEDEAV----------- 152
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL--DEDYKAKLSDFGLARQGPPEGLG 260
             +  +   +GL ++HE      +  D K  NI+       + KL DFGL     P+   
Sbjct: 153 --EYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 204
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      +AAPE  +   +   +D+WS GV+ Y L++G
Sbjct: 205 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 246

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 63/241 (26%), Positives = 102/241 (42%), Gaps = 40/241 (16%)
Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW 142
           ++  R  +    +G+G +G V+RG+    S             VA+K  + +  Q    W
Sbjct: 4   RTVARQVALVECVGKGRYGEVWRGLWHGES-------------VAVKIFSSRDEQS---W 47
Query: 143 INEVNFLGVV--KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-LA 199
             E      V  +H N++  +           Q  L+     + SL D L  +   P LA
Sbjct: 48  FRETEIYNTVLLRHDNILGFIASDMTSRNSSTQLWLITHYHEHGSLYDFLQRQTLEPHLA 107
Query: 200 WIARLKIAQDAARGLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--- 251
               L++A  AA GLA+LH E+        +  RDFK+ N+L+  + +  ++D GLA   
Sbjct: 108 ----LRLAVSAACGLAHLHVEIFGTQGKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMH 163
Query: 252 RQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLT------AKSDVWSFGVVLYELITGRRA 305
            QG  + L            Y APE +     T        +D+W+FG+VL+E+   RR 
Sbjct: 164 SQG-SDYLDIGNNPRVGTKRYMAPEVLDEQIRTDCFESYKWTDIWAFGLVLWEI--ARRT 220
Query: 306 V 306
           +
Sbjct: 221 I 221

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/175 (28%), Positives = 74/175 (42%), Gaps = 36/175 (20%)
Query: 143 INEVNFLGVVKHPNLVK---------------LVGYCAEDDERGMQRLLVYELMHNKSLE 187
           ++EVN L  +KHPN+V+               ++ YC   D   +  ++       + L+
Sbjct: 53  VSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGD---LASVITKGTKERQYLD 109
Query: 188 DHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD 247
           +  + RV T L  +A  +  + +  G   LH         RD K +N+ LD     KL D
Sbjct: 110 EEFVLRVMTQLT-LALKECHRRSDGGHTVLH---------RDLKPANVFLDGKQNVKLGD 159
Query: 248 FGLARQGPPEGLGHXXXXXXX---XXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
           FGLAR      L H             Y +PE +       KSD+WS G +LYEL
Sbjct: 160 FGLARI-----LNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYEL 209

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 19/219 (8%)
Query: 95  IGEGGFGCVYRGVVR--VSSDDHQT--------SGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V        + SD   T        S H ++ +  + +L    + G+   +N
Sbjct: 47  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH--MN 104
Query: 145 EVNFLG--VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
            VN LG   +  P LV +  YC   D     R      + +K+    ++      L    
Sbjct: 105 IVNLLGACTIGGPTLV-ITEYCCYGDLLNFLRRKRDSFICSKT-SPAIMEDDELALDLED 162
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
            L  +   A+G+A+L  +     I RD    NILL      K+ DFGLAR    +     
Sbjct: 163 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 219
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                    + APE +     T +SDVWS+G+ L+EL +
Sbjct: 220 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G V    VR S           KL VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 159 IGEGSTGIVCIATVRSSG----------KL-VAVKKMDLRKQQRRELLFNEVVIMRDYQH 207
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++       DE      +V E +   +L D +++        IA + +A    + L
Sbjct: 208 ENVVEMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA--VLQAL 260
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           + LH +    +I RD K+ +ILL  D + KLSDFG   Q   E              + A
Sbjct: 261 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMA 315
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           PE +       + D+WS G+++ E++ G        P    K++
Sbjct: 316 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 359

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINAMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/222 (23%), Positives = 91/222 (40%), Gaps = 48/222 (21%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R   R + ++       +K  +   + +++  +       E+  + V++H
Sbjct: 165 LGTGAFGVVHRVTERATGNNFA-----AKFVMTPHESDKETVR------KEIQTMSVLRH 213
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELM------------HNKSLEDHLLSRVPTPLAWIA 202
           P LV L     +D+E     +++YE M            HNK  ED  +  +        
Sbjct: 214 PTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADEHNKMSEDEAVEYM-------- 261
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLG 260
                +   +GL ++HE      +  D K  NI+       + KL DFGL     P+   
Sbjct: 262 -----RQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK--- 310
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      +AAPE  +   +   +D+WS GV+ Y L++G
Sbjct: 311 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 52/211 (24%), Positives = 94/211 (44%), Gaps = 28/211 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+               ++ +  A K ++ +  +  ++++ E++ L    H
Sbjct: 45  LGDGAFGKVYKA-----------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 155 PNLVKLV-GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           PN+VKL+  +  E++       ++ E     ++ D ++  +  PL       + +     
Sbjct: 94  PNIVKLLDAFYYENN-----LWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L YLH   D ++I RD K  NIL   D   KL+DFG++ +                  + 
Sbjct: 148 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRXIQRRDSFIGTPYWM 202
Query: 274 APEYV--QTGR---LTAKSDVWSFGVVLYEL 299
           APE V  +T +      K+DVWS G+ L E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEIXINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 19/219 (8%)
Query: 95  IGEGGFGCVYRGVVR--VSSDDHQT--------SGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V        + SD   T        S H ++ +  + +L    + G+   +N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH--MN 111
Query: 145 EVNFLG--VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
            VN LG   +  P LV +  YC   D     R      + +K+    ++      L    
Sbjct: 112 IVNLLGACTIGGPTLV-ITEYCCYGDLLNFLRRKRDSFICSKT-SPAIMEDDELALDLED 169
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
            L  +   A+G+A+L  +     I RD    NILL      K+ DFGLAR    +     
Sbjct: 170 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARHIKNDSNYVV 226
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                    + APE +     T +SDVWS+G+ L+EL +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 53/211 (25%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+               ++ +  A K ++ +  +  ++++ E++ L    H
Sbjct: 45  LGDGAFGKVYKA-----------QNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 93
Query: 155 PNLVKLV-GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           PN+VKL+  +  E++       ++ E     ++ D ++  +  PL       + +     
Sbjct: 94  PNIVKLLDAFYYENN-----LWILIEFCAGGAV-DAVMLELERPLTESQIQVVCKQTLDA 147
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L YLH   D ++I RD K  NIL   D   KL+DFG++ +                  + 
Sbjct: 148 LNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKN--TRXIQRRDXFIGTPYWM 202
Query: 274 APEYV--QTGR---LTAKSDVWSFGVVLYEL 299
           APE V  +T +      K+DVWS G+ L E+
Sbjct: 203 APEVVMCETSKDRPYDYKADVWSLGITLIEM 233

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 61  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 105
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 159
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 160 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 212
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 213 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 98/224 (43%), Gaps = 23/224 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG  G V    VR S           KL VA+K+++ +  Q  +   NEV  +   +H
Sbjct: 82  IGEGSTGIVCIATVRSSG----------KL-VAVKKMDLRKQQRRELLFNEVVIMRDYQH 130
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+V++       DE      +V E +   +L D +++        IA + +A    + L
Sbjct: 131 ENVVEMYNSYLVGDEL----WVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLA--VLQAL 183
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
           + LH +    +I RD K+ +ILL  D + KLSDFG   Q   E              + A
Sbjct: 184 SVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE--VPRRKXLVGTPYWMA 238
Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           PE +       + D+WS G+++ E++ G        P    K++
Sbjct: 239 PELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 282

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/229 (26%), Positives = 98/229 (42%), Gaps = 42/229 (18%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVN 147
           +++   IGEG +G V       S+ DH       K  VAIK+++    Q + +  + E+ 
Sbjct: 45  YTQLQYIGEGAYGMV------SSAYDHV-----RKTRVAIKKISPFEHQTYCQRTLREIQ 93
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSLE-DHLLSRVPTP 197
            L   +H N++ +           M+ + +         Y+L+ ++ L  DH+       
Sbjct: 94  ILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICY----- 148
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
                         RGL Y+H      ++ RD K SN+L++     K+ DFGLAR   PE
Sbjct: 149 --------FLYQILRGLKYIHSA---NVLHRDLKPSNLLINTTCDLKICDFGLARIADPE 197
Query: 258 GLGHXXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
              H            Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 198 H-DHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 93/228 (40%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 43  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 91
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P LVKL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 92  KRILQAVNFPFLVKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEPHA---R 144
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    +++DFG A++         G
Sbjct: 145 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKGRTWXLCG 200
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 201 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 234

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/224 (29%), Positives = 99/224 (44%), Gaps = 33/224 (14%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG V++  + V SD+           VAIK++     Q  +    E+ 
Sbjct: 41  AYTNCKVIGNGSFGVVFQAKL-VESDE-----------VAIKKV----LQDKRFKNRELQ 84
Query: 148 FLGVVKHPNLVKLVGYCAED----DERGMQRLLVY--ELMHNKSLEDHLLSRVPTPLAWI 201
            + +VKHPN+V L  +   +    DE  +  +L Y  E ++  S     L +   P+  I
Sbjct: 85  IMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQT-MPMLLI 143
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLG 260
            +L + Q   R LAY+H      +  RD K  N+LLD      KL DFG A+       G
Sbjct: 144 -KLYMYQ-LLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKI---LIAG 195
Query: 261 HXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                      Y APE +      T   D+WS G V+ EL+ G+
Sbjct: 196 EPNVSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 19/219 (8%)
Query: 95  IGEGGFGCVYRGVVR--VSSDDHQT--------SGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V        + SD   T        S H ++ +  + +L    + G+   +N
Sbjct: 49  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH--MN 106
Query: 145 EVNFLG--VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
            VN LG   +  P LV +  YC   D     R      + +K+    ++      L    
Sbjct: 107 IVNLLGACTIGGPTLV-ITEYCCYGDLLNFLRRKRDSFICSKT-SPAIMEDDELALDLED 164
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
            L  +   A+G+A+L  +     I RD    NILL      K+ DFGLAR    +     
Sbjct: 165 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 221
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                    + APE +     T +SDVWS+G+ L+EL +
Sbjct: 222 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 21/231 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V++         H+ +G    L   + +  ++GF      + E+  L ++KH
Sbjct: 26  IGQGTFGEVFKA-------RHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKH 76
Query: 155 PNLVKLVGYC---AEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            N+V L+  C   A    R    + LV++   +      LLS V          ++ Q  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQML 134
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXX 268
             GL Y+H     +++ RD K +N+L+  D   KL+DFGLAR          +       
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 269 XXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
              Y  PE +   R      D+W  G ++ E+ T    ++ N  +++  L+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 33  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLA 79
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 130
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 131 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 182
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/227 (29%), Positives = 95/227 (41%), Gaps = 40/227 (17%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+  
Sbjct: 58  YTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQI 102
Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPL 198
           +  + H N+V+L  +     E+  +  L          VY +  + S     L     P+
Sbjct: 103 MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PV 157
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPE 257
            ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q    
Sbjct: 158 IYV-KLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---L 209
Query: 258 GLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
             G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 210 VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 256

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+ 
Sbjct: 40  SYTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQ 84
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTP 197
            +  + H N+V+L  +     E+  +  L          VY +  + S     L     P
Sbjct: 85  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----P 139
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPP 256
           + ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q   
Sbjct: 140 VIYV-KLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 191
Query: 257 EGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 192 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 239

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 19/219 (8%)
Query: 95  IGEGGFGCVYRGVVR--VSSDDHQT--------SGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V        + SD   T        S H ++ +  + +L    + G+   +N
Sbjct: 31  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH--MN 88
Query: 145 EVNFLG--VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
            VN LG   +  P LV +  YC   D     R      + +K+    ++      L    
Sbjct: 89  IVNLLGACTIGGPTLV-ITEYCCYGDLLNFLRRKRDSFICSKT-SPAIMEDDELALDLED 146
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
            L  +   A+G+A+L  +     I RD    NILL      K+ DFGLAR    +     
Sbjct: 147 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 203
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                    + APE +     T +SDVWS+G+ L+EL +
Sbjct: 204 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 92/221 (41%), Gaps = 38/221 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 51  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 97
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK------ 205
            +H N++ +           + R    E M +  L  HL+      L     L       
Sbjct: 98  FRHENIIGI---------NDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICY 148
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
                 RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H    
Sbjct: 149 FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DHTGFL 204
Query: 266 XXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                   Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 205 TEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 13  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 61
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 62  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 115
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 116 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 172
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 173 APELLKRREFHAEPVDVWSCGIVLTAMLAG 202

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P L KL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLTKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    K++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P L KL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLTKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    K++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 61  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 105
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 159
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 160 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 212
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 213 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 254

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+ 
Sbjct: 29  SYTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQ 73
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTP 197
            +  + H N+V+L  +     E+  +  L          VY +  + S     L     P
Sbjct: 74  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----P 128
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPP 256
           + ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q   
Sbjct: 129 VIYV-KLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 180
Query: 257 EGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 181 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 228

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEIXINKMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 58/219 (26%), Positives = 89/219 (40%), Gaps = 19/219 (8%)
Query: 95  IGEGGFGCVYRGVVR--VSSDDHQT--------SGHDSKLDVAIKQLNRQGFQGHKEWIN 144
           +G G FG V        + SD   T        S H ++ +  + +L    + G+   +N
Sbjct: 54  LGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNH--MN 111
Query: 145 EVNFLG--VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
            VN LG   +  P LV +  YC   D     R      + +K+    ++      L    
Sbjct: 112 IVNLLGACTIGGPTLV-ITEYCCYGDLLNFLRRKRDSFICSKT-SPAIMEDDELALDLED 169
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHX 262
            L  +   A+G+A+L  +     I RD    NILL      K+ DFGLAR    +     
Sbjct: 170 LLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVV 226
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
                    + APE +     T +SDVWS+G+ L+EL +
Sbjct: 227 KGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 39  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 83
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 137
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 138 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 190
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 55  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 99
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 100 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 153
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 154 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 206
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 207 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 248

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 65  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 109
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 110 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 163
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 164 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 216
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 217 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 258

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+ 
Sbjct: 34  SYTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQ 78
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTP 197
            +  + H N+V+L  +     E+  +  L          VY +  + S     L     P
Sbjct: 79  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----P 133
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPP 256
           + ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q   
Sbjct: 134 VIYV-KLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 185
Query: 257 EGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 186 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 233

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 64/228 (28%), Positives = 93/228 (40%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H+ +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIRTLGTGSFG-------RVMLVKHKETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
                 V  P LVKL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 93  KRIQQAVNFPFLVKL-EFSFKDNS---NLYMVLEYAPGGEMFSHLRRIGRFSEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+L+D+    K++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP LV L   C + + R      V E ++   L  H+  +   P    AR   A+  +  
Sbjct: 80  HPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLA 133
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXXXXX 271
           L YLHE     +I+RD K  N+LLD +   KL+D+G+ ++G  P    G           
Sbjct: 134 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----GDTTSXFCGTPN 186
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           Y APE ++        D W+ GV+++E++ GR
Sbjct: 187 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 218

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 71/152 (46%), Gaps = 15/152 (9%)
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP LV L   C + + R      V E ++   L  H+  +   P    AR   A+  +  
Sbjct: 112 HPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLA 165
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXXXXX 271
           L YLHE     +I+RD K  N+LLD +   KL+D+G+ ++G  P    G           
Sbjct: 166 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----GDTTSTFCGTPN 218
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           Y APE ++        D W+ GV+++E++ GR
Sbjct: 219 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 39  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 83
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 84  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 137
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 138 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 190
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 191 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 232

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVVK 153
           IGEG +G V      V+           K+ VAIK+++    Q + +  + E+  L   +
Sbjct: 33  IGEGAYGMVCSAYDNVN-----------KVRVAIKKISPFEHQTYCQRTLREIKILLAFR 81
Query: 154 HPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWIAR 203
           H N++ +           M+ + +         Y+L+  + L  DH+             
Sbjct: 82  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------- 130
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXX 263
                   RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H  
Sbjct: 131 --FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDH-DHTG 184
Query: 264 XXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                     Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 63/228 (27%), Positives = 92/228 (40%), Gaps = 50/228 (21%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINE 145
           F R   +G G FG       RV    H  +G+      A+K L++Q     K+    +NE
Sbjct: 44  FERIKTLGTGSFG-------RVMLVKHMETGNH----YAMKILDKQKVVKLKQIEHTLNE 92
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIAR 203
              L  V  P L KL  +  +D+       +V E      +  HL  + R   P A   R
Sbjct: 93  KRILQAVNFPFLTKL-EFSFKDNS---NLYMVMEYAPGGEMFSHLRRIGRFXEPHA---R 145
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---------G 254
              AQ       YLH      LI+RD K  N+++D+    K++DFG A++         G
Sbjct: 146 FYAAQ-IVLTFEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKGRTWXLCG 201
Query: 255 PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            PE              Y APE + +       D W+ GV++YE+  G
Sbjct: 202 TPE--------------YLAPEIILSKGYNKAVDWWALGVLIYEMAAG 235

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 172 MQRL-LVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR 228
           M RL  V E ++   L  H+  + R   P A    +  A + A GL +L  +    +I+R
Sbjct: 414 MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAEIAIGLFFLQSK---GIIYR 466
Query: 229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSD 288
           D K  N++LD +   K++DFG+ ++   +G+            Y APE +         D
Sbjct: 467 DLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIAYQPYGKSVD 524
Query: 289 VWSFGVVLYELITGRRAVE 307
            W+FGV+LYE++ G+   E
Sbjct: 525 WWAFGVLLYEMLAGQAPFE 543

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/210 (28%), Positives = 86/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 32  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 76
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 77  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 130
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 131 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 183
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 184 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 225

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 73/156 (46%), Gaps = 15/156 (9%)
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP LV L   C + + R      V E ++   L  H+  +   P    AR   A+  +  
Sbjct: 69  HPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLA 122
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXXXXX 271
           L YLHE     +I+RD K  N+LLD +   KL+D+G+ ++G  P    G           
Sbjct: 123 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----GDTTSXFCGTPN 175
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
           Y APE ++        D W+ GV+++E++ GR   +
Sbjct: 176 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 211

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 15/152 (9%)
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP LV L   C + + R      V E ++   L  H+  +   P    AR   A+  +  
Sbjct: 65  HPFLVGLHS-CFQTESR---LFFVIEYVNGGDLMFHMQRQRKLPEEH-ARFYSAE-ISLA 118
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXXXXX 271
           L YLHE     +I+RD K  N+LLD +   KL+D+G+ ++G  P    G           
Sbjct: 119 LNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP----GDTTSXFCGTPN 171
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           Y APE ++        D W+ GV+++E++ GR
Sbjct: 172 YIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 203

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 21/231 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V++         H+ +G    L   + +  ++GF      + E+  L ++KH
Sbjct: 25  IGQGTFGEVFKA-------RHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKH 75
Query: 155 PNLVKLVGYC---AEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            N+V L+  C   A    R    + LV++   +      LLS V          ++ Q  
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDL--AGLLSNVLVKFTLSEIKRVMQML 133
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXX 268
             GL Y+H     +++ RD K +N+L+  D   KL+DFGLAR          +       
Sbjct: 134 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 190
Query: 269 XXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
              Y  PE +   R      D+W  G ++ E+ T    ++ N  +++  L+
Sbjct: 191 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 241

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+ 
Sbjct: 21  SYTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQ 65
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTP 197
            +  + H N+V+L  +     E+  +  L          VY +  + S     L     P
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----P 120
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPP 256
           + ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q   
Sbjct: 121 VIYV-KLYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 172
Query: 257 EGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 90/216 (41%), Gaps = 32/216 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +G G FG           D H      S L+  IK +N+   Q   E I  E+  L  + 
Sbjct: 30  LGSGAFG-----------DVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLA----WIARLKIAQD 209
           HPN++K+  +   +D   M   +V E      L + ++S      A    ++A L   + 
Sbjct: 79  HPNIIKI--FEVFEDYHNM--YIVMETCEGGELLERIVSAQARGKALSEGYVAEL--MKQ 132
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK---AKLSDFGLARQGPPEGLGHXXXXX 266
               LAY H +    ++ +D K  NIL  +       K+ DFGLA     +         
Sbjct: 133 MMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD---EHSTNA 186
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                Y APE  +   +T K D+WS GVV+Y L+TG
Sbjct: 187 AGTALYMAPEVFKRD-VTFKCDIWSAGVVMYFLLTG 221

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 28  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 72
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 73  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 126
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 127 LYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 179
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 180 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 221

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 85/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG +G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 15  LGEGAYGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 63
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 64  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 117
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 118 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 174
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 175 APELLKRREFHAEPVDVWSCGIVLTAMLAG 204

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 105/270 (38%), Gaps = 68/270 (25%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            VV H N++ L+         E      +V ELM      D  LS+V         +++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLSQV---------IQME 122
Query: 208 QDAAR----------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
            D  R          G+ +LH      +I RD K SNI++  D   K+ DFGLAR     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--- 176
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RR 304
           G             Y APE +         D+WS G ++ E+I G              +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 305 AVER---NLPRNEQKLLEWVRPYVSDSKKF 331
            +E+     P   +KL   VR YV +  K+
Sbjct: 237 VIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/222 (29%), Positives = 93/222 (41%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 106 VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 150
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 151 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 204
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 205 LYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 257
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 258 NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 299

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 96/228 (42%), Gaps = 40/228 (17%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+ 
Sbjct: 21  SYTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQ 65
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTP 197
            +  + H N+V+L  +     E+  +  L          VY +  + S     L     P
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----P 120
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPP 256
           + ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q   
Sbjct: 121 VIYV-KLYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 172
Query: 257 EGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 68/139 (48%), Gaps = 12/139 (8%)
Query: 172 MQRL-LVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR 228
           M RL  V E ++   L  H+  + R   P A    +  A + A GL +L  +    +I+R
Sbjct: 93  MDRLYFVMEYVNGGDLMYHIQQVGRFKEPHA----VFYAAEIAIGLFFLQSK---GIIYR 145
Query: 229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSD 288
           D K  N++LD +   K++DFG+ ++   +G+            Y APE +         D
Sbjct: 146 DLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKXFCGTPDYIAPEIIAYQPYGKSVD 203
Query: 289 VWSFGVVLYELITGRRAVE 307
            W+FGV+LYE++ G+   E
Sbjct: 204 WWAFGVLLYEMLAGQAPFE 222

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 31  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 128
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 129 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DH 180
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 30/177 (16%)
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ +L      + I RD    NILL E    K+ DFGLAR    +            
Sbjct: 200 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 256
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KLLEWVR---P 323
             + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L E  R   P
Sbjct: 257 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 316
Query: 324 YVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNII 380
             +  + +  ++D                     C   +P  RP  SE+V+ LGN++
Sbjct: 317 DYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLL 352

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 66/228 (28%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+ 
Sbjct: 21  SYTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQ 65
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTP 197
            +  + H N+V+L  +     E+  +  L          VY +  + S     L     P
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----P 120
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPP 256
           + ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q   
Sbjct: 121 VIYV-KLYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 172
Query: 257 EGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 173 LVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 72/270 (26%), Positives = 105/270 (38%), Gaps = 68/270 (25%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            VV H N++ L+         E      +V ELM      D  LS+V         +++ 
Sbjct: 78  KVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLSQV---------IQME 122
Query: 208 QDAAR----------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
            D  R          G+ +LH      +I RD K SNI++  D   K+ DFGLAR     
Sbjct: 123 LDHERMSYLLYQMLVGIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--- 176
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RR 304
           G             Y APE +         D+WS G ++ E+I G              +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 305 AVER---NLPRNEQKLLEWVRPYVSDSKKF 331
            +E+     P   +KL   VR YV +  K+
Sbjct: 237 VIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 59/231 (25%), Positives = 92/231 (39%), Gaps = 39/231 (16%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGV 151
           LIG G +G VY    +           +++ +VAIK++NR  +     K  + E+  L  
Sbjct: 33  LIGRGSYGYVYLAYDK-----------NTEKNVAIKKVNRMFEDLIDCKRILREITILNR 81
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           +K   +++L      DD      L +   + +  L+   L + P  L       I  +  
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKK--LFKTPIFLTEEHIKTILYNLL 139
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ------------------ 253
            G  ++HE     +I RD K +N LL++D   K+ DFGLAR                   
Sbjct: 140 LGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 254 -GP-PEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKS-DVWSFGVVLYELIT 301
            GP  + L            Y APE +       KS D+WS G +  EL+ 
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 31  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 128
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 129 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DH 180
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/222 (30%), Positives = 94/222 (42%), Gaps = 40/222 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG G FG VY           Q    DS   VAIK++     Q  +    E+  +  + 
Sbjct: 31  VIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQIMRKLD 75
Query: 154 HPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTPLAWIAR 203
           H N+V+L  +     E+  +  L          VY +  + S     L     P+ ++ +
Sbjct: 76  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTL-----PVIYV-K 129
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPPEGLGHX 262
           L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  
Sbjct: 130 LYMYQ-LFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ---LVRGEP 182
Query: 263 XXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
                    Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 183 NVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 224

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 21/231 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V++         H+ +G    L   + +  ++GF      + E+  L ++KH
Sbjct: 26  IGQGTFGEVFKA-------RHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKH 76
Query: 155 PNLVKLVGYC---AEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            N+V L+  C   A    R    + LV++   +      LLS V          ++ Q  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQML 134
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXX 268
             GL Y+H     +++ RD K +N+L+  D   KL+DFGLAR          +       
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 269 XXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
              Y  PE +   R      D+W  G ++ E+ T    ++ N  +++  L+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/177 (27%), Positives = 76/177 (42%), Gaps = 30/177 (16%)
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A+G+ +L      + I RD    NILL E    K+ DFGLAR    +            
Sbjct: 202 VAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ---KLLEWVR---P 323
             + APE +     T +SDVWSFGV+L+E+ +   +    +  +E+   +L E  R   P
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP 318
Query: 324 YVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVVDILGNII 380
             +  + +  ++D                     C   +P  RP  SE+V+ LGN++
Sbjct: 319 DYTTPEMYQTMLD---------------------CWHGEPSQRPTFSELVEHLGNLL 354

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 21/231 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V++         H+ +G    L   + +  ++GF      + E+  L ++KH
Sbjct: 26  IGQGTFGEVFKA-------RHRKTGQKVALKKVLMENEKEGFPITA--LREIKILQLLKH 76
Query: 155 PNLVKLVGYC---AEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            N+V L+  C   A    R    + LV++   +      LLS V          ++ Q  
Sbjct: 77  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA--GLLSNVLVKFTLSEIKRVMQML 134
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG--PPEGLGHXXXXXXX 268
             GL Y+H     +++ RD K +N+L+  D   KL+DFGLAR          +       
Sbjct: 135 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVV 191
Query: 269 XXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
              Y  PE +   R      D+W  G ++ E+ T    ++ N  +++  L+
Sbjct: 192 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALI 242

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 31  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 128
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 129 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 180
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGHKE-WINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 35  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLR 81
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 132
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 133 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DH 184
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 31  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 77
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 78  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 128
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 129 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDH-DH 180
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 181 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM     + +L   +   L       + 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLL 132
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 133 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPEV 186
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RRAVER---NLP 311
               Y APE +         D+WS G ++ E+I G              + +E+     P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 312 RNEQKLLEWVRPYVSDSKKF 331
              +KL   VR YV +  K+
Sbjct: 247 EFMKKLQPTVRTYVENRPKY 266

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 36/216 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLGVVK 153
           +G G FG V+R V + +              V + +     +   K  + NE++ +  + 
Sbjct: 59  LGSGAFGVVHRCVEKATGR------------VFVAKFINTPYPLDKYTVKNEISIMNQLH 106
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVY----ELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           HP L+ L  + A +D+  M  +L +    EL    + ED+ +S           +   + 
Sbjct: 107 HPKLINL--HDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEV-------INYMRQ 157
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXX 266
           A  GL ++HE     ++  D K  NI+  E  KA   K+ DFGLA +  P+ +       
Sbjct: 158 ACEGLKHMHEH---SIVHLDIKPENIMC-ETKKASSVKIIDFGLATKLNPDEI---VKVT 210
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                +AAPE V    +   +D+W+ GV+ Y L++G
Sbjct: 211 TATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 79  FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG 138
           F ++++    F+ +L  G+G F  +++GV R   D     G   + +V +K L++     
Sbjct: 2   FHKIRNEDLIFNESL--GQGTFTKIFKGVRREVGD----YGQLHETEVLLKVLDKAHRNY 55
Query: 139 HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
            + +    + +  + H +LV   G C   DE     +LV E +   SL D  L +    +
Sbjct: 56  SESFFEAASMMSKLSHKHLVLNYGVCVCGDEN----ILVQEFVKFGSL-DTYLKKNKNCI 110
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL--DEDYKA------KLSDFGL 250
             + +L++A+  A  + +L E     LI  +    NILL  +ED K       KLSD G+
Sbjct: 111 NILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELITG 302
           +    P+ +            +  PE ++  + L   +D WSFG  L+E+ +G
Sbjct: 168 SITVLPKDI------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 35  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 132
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 133 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDH-DH 184
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 33  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 79
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 80  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 130
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 131 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 182
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 183 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 227

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 38/103 (36%), Positives = 48/103 (46%), Gaps = 9/103 (8%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           KI     + L +L E  + ++I RD K SNILLD     KL DFG++ Q           
Sbjct: 129 KITLATVKALNHLKE--NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD---SIAKT 183
Query: 265 XXXXXXXYAAPEYVQTGR----LTAKSDVWSFGVVLYELITGR 303
                  Y APE +           +SDVWS G+ LYEL TGR
Sbjct: 184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR 226

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 29  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 75
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 126
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 127 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 178
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 29  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 75
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 76  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 126
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 127 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 178
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 179 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 223

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM     + +L   +   L       + 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLL 132
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 133 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 186
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RRAVER---NLP 311
               Y APE +         D+WS G ++ E+I G              + +E+     P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 312 RNEQKLLEWVRPYVSDSKKF 331
              +KL   VR YV +  K+
Sbjct: 247 EFMKKLQPTVRTYVENRPKY 266

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 36  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 133
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 134 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 185
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 186 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 37  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 83
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 84  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 134
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 135 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 186
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 187 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 231

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 28  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 74
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 75  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 125
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 126 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 177
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 178 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 222

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 35  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 132
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 133 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 184
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVVK 153
           IGEG +G V      V+           K+ VAIK+++    Q + +  + E+  L   +
Sbjct: 39  IGEGAYGMVCSAYDNVN-----------KVRVAIKKISPFEHQTYCQRTLREIKILLRFR 87
Query: 154 HPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWIAR 203
           H N++ +           M+ + +         Y+L+  + L  DH+             
Sbjct: 88  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------- 136
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXX 263
                   RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H  
Sbjct: 137 --FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTG 190
Query: 264 XXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                     Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 191 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 233

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 57/223 (25%), Positives = 92/223 (41%), Gaps = 42/223 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVVK 153
           IGEG +G V      V+           K+ VAIK+++    Q + +  + E+  L   +
Sbjct: 31  IGEGAYGMVCSAYDNVN-----------KVRVAIKKISPFEHQTYCQRTLREIKILLRFR 79
Query: 154 HPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWIAR 203
           H N++ +           M+ + +         Y+L+  + L  DH+             
Sbjct: 80  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY----------- 128
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXX 263
                   RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H  
Sbjct: 129 --FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DHTG 182
Query: 264 XXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                     Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 183 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 225

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 33  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 78
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM     + +L   +   L       + 
Sbjct: 79  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLL 133
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 134 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 187
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RRAVER---NLP 311
               Y APE +         D+WS G ++ E+I G              + +E+     P
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247
Query: 312 RNEQKLLEWVRPYVSDSKKF 331
              +KL   VR YV +  K+
Sbjct: 248 EFMKKLQPTVRTYVENRPKY 267

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 35  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 132
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 133 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 184
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 185 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 60/225 (26%), Positives = 96/225 (42%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 36  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 82
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 83  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 133
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 134 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 185
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 186 TGFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 230

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 51  IGEGAYGMV-------------CSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLR 97
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 98  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 148
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 149 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 200
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 201 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 245

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 93/223 (41%), Gaps = 47/223 (21%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +G G +G V   + + S +            VAIK+L+R  FQ     K    E+  L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEK-----------VAIKKLSR-PFQSEIFAKRAYRELLLLKH 79
Query: 152 VKHPNLVKLVG-YCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           ++H N++ L+  +      R      LV   M              T L  I  LK +++
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-------------TDLQKIMGLKFSEE 126
Query: 210 AA--------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     +GL Y+H      ++ RD K  N+ ++ED + K+ DFGLAR    E  G+
Sbjct: 127 KIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY 183
Query: 262 XXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                     Y APE + +        D+WS G ++ E++TG+
Sbjct: 184 -----VVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/228 (29%), Positives = 95/228 (41%), Gaps = 40/228 (17%)
Query: 88  GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVN 147
            ++   +IG G FG VY           Q    DS   VAIK++     Q  +    E+ 
Sbjct: 21  SYTDTKVIGNGSFGVVY-----------QAKLCDSGELVAIKKV----LQDKRFKNRELQ 65
Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLL----------VYELMHNKSLEDHLLSRVPTP 197
            +  + H N+V+L  +     E+     L          VY +  + S     L     P
Sbjct: 66  IMRKLDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTL-----P 120
Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-KLSDFGLARQGPP 256
           + ++ +L + Q   R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q   
Sbjct: 121 VIYV-KLYMYQ-LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--- 172
Query: 257 EGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              G           Y APE +      T+  DVWS G VL EL+ G+
Sbjct: 173 LVRGEPNVSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQ 220

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 62/237 (26%), Positives = 95/237 (40%), Gaps = 35/237 (14%)
Query: 118 SGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFLGVVKHPNLVKLVGYCAEDD--ER 170
           + +D+ L+  VAIK+L+R  FQ     K    E+  +  V H N++ L+         E 
Sbjct: 44  AAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 102
Query: 171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF 230
                +V ELM     + +L   +   L       +      G+ +LH      +I RD 
Sbjct: 103 FQDVYIVMELM-----DANLCQVIQMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDL 154
Query: 231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVW 290
           K SNI++  D   K+ DFGLAR     G             Y APE +         D+W
Sbjct: 155 KPSNIVVKSDCTLKILDFGLARTA---GTSFMMVPFVVTRYYRAPEVILGMGYKENVDIW 211
Query: 291 SFGVVLYELITG-------------RRAVER---NLPRNEQKLLEWVRPYVSDSKKF 331
           S G ++ E+I G              + +E+     P   +KL   VR YV +  K+
Sbjct: 212 SVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKY 268

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/226 (26%), Positives = 92/226 (40%), Gaps = 34/226 (15%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++ EGGF  VY         + Q  G  S  + A+K+L     + ++  I EV F+  + 
Sbjct: 35  VLAEGGFAFVY---------EAQDVG--SGREYALKRLLSNEEEKNRAIIQEVCFMKKLS 83
Query: 154 -HPNLVKLVGYCA----EDDERGMQRLLVYELMHNKSLEDHLLSRVPT--PLAWIARLKI 206
            HPN+V+     +    E D    + LL+ EL   + +E   L ++ +  PL+    LKI
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVE--FLKKMESRGPLSCDTVLKI 141
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR----------QGPP 256
                R + ++H +    +I RD K  N+LL      KL DFG A               
Sbjct: 142 FYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 257 EGLGHXXXXXXXXXXYAAPEYV---QTGRLTAKSDVWSFGVVLYEL 299
             L            Y  PE +       +  K D+W+ G +LY L
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/216 (26%), Positives = 91/216 (42%), Gaps = 24/216 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG+G F  V R + R      +T    +   V + +         ++   E +   ++K
Sbjct: 31  VIGKGAFSVVRRCINR------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR- 212
           HP++V+L+   + D   GM   +V+E M    L   ++ R      ++    +A    R 
Sbjct: 85  HPHIVELLETYSSD---GML-YMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQ 138
Query: 213 ---GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
               L Y H   D  +I RD K  N+LL   +     KL DFG+A Q    GL       
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGL--VAGGR 193
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                + APE V+        DVW  GV+L+ L++G
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/184 (28%), Positives = 76/184 (41%), Gaps = 17/184 (9%)
Query: 124 LDVAIKQLNRQGFQGH---KEWINEVNFLGVVKHPNLVKLVGYCAEDD--ERGMQRLLVY 178
           ++VA+K+L+R  FQ     K    E+  L  V H N++ L+         E      LV 
Sbjct: 50  INVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 108
Query: 179 ELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD 238
           ELM     + +L   +   L       +      G+ +LH      +I RD K SNI++ 
Sbjct: 109 ELM-----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 160
Query: 239 EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
            D   K+ DFGLAR                   Y APE +      A  D+WS G ++ E
Sbjct: 161 SDCTLKILDFGLARTA---CTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIMGE 217
Query: 299 LITG 302
           L+ G
Sbjct: 218 LVKG 221

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 29/97 (29%), Positives = 52/97 (53%), Gaps = 5/97 (5%)
Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
           A + + GL +LH+     +I+RD K  N++LD +   K++DFG+ ++   +G+       
Sbjct: 126 AAEISIGLFFLHKR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGV--TTREF 180
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                Y APE +         D W++GV+LYE++ G+
Sbjct: 181 CGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 217

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/210 (28%), Positives = 84/210 (40%), Gaps = 22/210 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +GEG  G V   V RV+ +            VA+K ++ +      E I  E+    ++ 
Sbjct: 14  LGEGAAGEVQLAVNRVTEEA-----------VAVKIVDMKRAVDCPENIKKEICINKMLN 62
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G+  E    G  + L  E      L D +   +  P     R         G
Sbjct: 63  HENVVKFYGHRRE----GNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRF--FHQLMAG 116
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           + YLH      +  RD K  N+LLDE    K+SDFGLA                    Y 
Sbjct: 117 VVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYV 173
Query: 274 APEYVQTGRLTAKS-DVWSFGVVLYELITG 302
           APE ++     A+  DVWS G+VL  ++ G
Sbjct: 174 APELLKRREFHAEPVDVWSCGIVLTAMLAG 203

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAIK+++    Q + +  + E+  L  
Sbjct: 35  IGEGAYGMV-------------CSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLR 81
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICY--------- 132
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 133 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 184
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 104/270 (38%), Gaps = 68/270 (25%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM      D  LS+V         +++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLSQV---------IQME 122
Query: 208 QDAAR----------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
            D  R          G+ +LH      +I RD K SNI++  D   K+ DFGLAR     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA--- 176
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RR 304
           G             Y APE +         D+WS G ++ E+I G              +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 305 AVER---NLPRNEQKLLEWVRPYVSDSKKF 331
            +E+     P   +KL   VR YV +  K+
Sbjct: 237 VIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 94/225 (41%), Gaps = 46/225 (20%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDS--KLDVAIKQLNRQGFQGH-KEWINEVNFLGV 151
           IGEG +G V              S +D+  K+ VAI++++    Q + +  + E+  L  
Sbjct: 35  IGEGAYGMV-------------CSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLR 81
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLV---------YELMHNKSL-EDHLLSRVPTPLAWI 201
            +H N++ +           M+ + +         Y+L+  + L  DH+           
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICY--------- 132
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P+   H
Sbjct: 133 ----FLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDH-DH 184
Query: 262 XXXXXXXXXX--YAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
                       Y APE +   +   KS D+WS G +L E+++ R
Sbjct: 185 TGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/243 (24%), Positives = 101/243 (41%), Gaps = 36/243 (14%)
Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW 142
           ++  R  +    +G+G +G V+RG  +               +VA+K  + +     K W
Sbjct: 4   RTVARDITLLECVGKGRYGEVWRGSWQGE-------------NVAVKIFSSRD---EKSW 47
Query: 143 INEVNFLGVV--KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW 200
             E      V  +H N++  +           Q  L+       SL D+L     T L  
Sbjct: 48  FRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDT 104
Query: 201 IARLKIAQDAARGLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQ 253
           ++ L+I    A GLA+LH E+        +  RD K+ NIL+ ++ +  ++D GLA    
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164
Query: 254 GPPEGLGHXXXXXXXXXXYAAPEYV-QTGRLTA-----KSDVWSFGVVLYELITGRRAVE 307
                L            Y APE + +T ++       + D+W+FG+VL+E+   RR V 
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVS 222
Query: 308 RNL 310
             +
Sbjct: 223 NGI 225

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 60/249 (24%), Positives = 102/249 (40%), Gaps = 36/249 (14%)
Query: 77  FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF 136
             F   ++  R  +    +G+G +G V+RG  +               +VA+K  + +  
Sbjct: 27  LPFLVQRTVARQITLLECVGKGRYGEVWRGSWQGE-------------NVAVKIFSSRD- 72
Query: 137 QGHKEWINEVNFLGVV--KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
              K W  E      V  +H N++  +           Q  L+       SL D+L    
Sbjct: 73  --EKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL-- 128
Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFG 249
            T L  ++ L+I    A GLA+LH E+        +  RD K+ NIL+ ++ +  ++D G
Sbjct: 129 -TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLG 187
Query: 250 LA--RQGPPEGLGHXXXXXXXXXXYAAPEYV-QTGRLTA-----KSDVWSFGVVLYELIT 301
           LA         L            Y APE + +T ++       + D+W+FG+VL+E+  
Sbjct: 188 LAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV-- 245
Query: 302 GRRAVERNL 310
            RR V   +
Sbjct: 246 ARRMVSNGI 254

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 104/270 (38%), Gaps = 68/270 (25%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM      D  LS+V         +++ 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM------DANLSQV---------IQME 122
Query: 208 QDAAR----------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
            D  R          G+ +LH      +I RD K SNI++  D   K+ DFGLAR     
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDATLKILDFGLARTA--- 176
Query: 258 GLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RR 304
           G             Y APE +         D+WS G ++ E+I G              +
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 305 AVER---NLPRNEQKLLEWVRPYVSDSKKF 331
            +E+     P   +KL   VR YV +  K+
Sbjct: 237 VIEQLGTPSPEFMKKLQPTVRTYVENRPKY 266

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 67/260 (25%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 77
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM     + +L   +   L       + 
Sbjct: 78  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLL 132
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 133 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 186
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-------------RRAVER---NLP 311
               Y APE +         D+WS G ++ E+I G              + +E+     P
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 312 RNEQKLLEWVRPYVSDSKKF 331
              +KL   VR YV +  K+
Sbjct: 247 EFMKKLQPTVRTYVENRPKY 266

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 59/233 (25%), Positives = 105/233 (45%), Gaps = 29/233 (12%)
Query: 79  FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG 138
           F ++++    F+ +L  G+G F  +++GV R   D     G   + +V +K L++     
Sbjct: 2   FHKIRNEDLIFNESL--GQGTFTKIFKGVRREVGD----YGQLHETEVLLKVLDKAHRNY 55
Query: 139 HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPL 198
            + +    + +  + H +LV   G C   DE     +LV E +   SL D  L +    +
Sbjct: 56  SESFFEAASMMSKLSHKHLVLNYGVCFCGDEN----ILVQEFVKFGSL-DTYLKKNKNCI 110
Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL--DEDYKA------KLSDFGL 250
             + +L++A+  A  + +L E     LI  +    NILL  +ED K       KLSD G+
Sbjct: 111 NILWKLEVAKQLAWAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGI 167
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELITG 302
           +    P+ +            +  PE ++  + L   +D WSFG  L+E+ +G
Sbjct: 168 SITVLPKDI------LQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSG 214

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 63  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 116
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 170
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 90/230 (39%), Gaps = 38/230 (16%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
           +          + APE V    L  ++D+WS GV+ Y L++G                  
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG------------------ 213
Query: 321 VRPYVSDSKKFHL----IIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSR 366
             P++ D+K+  L     ++   E  Y               L K PK R
Sbjct: 214 ASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 63  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 116
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 117 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 170
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 171 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 212

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 58/232 (25%), Positives = 98/232 (42%), Gaps = 38/232 (16%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
           ++G G FG V      +++  +  S     + VA+K L  +     +E  ++E+  +  +
Sbjct: 52  VLGSGAFGKV------MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 105
Query: 153 -KHPNLVKLVG-------------YCAEDD---------ERGMQRLLVYELMHNKSLEDH 189
             H N+V L+G             YC   D         E+  +  + YE  + K LE+ 
Sbjct: 106 GSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE--NQKRLEEE 163
Query: 190 LLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG 249
               V   L +   L  A   A+G+ +L  +     + RD    N+L+      K+ DFG
Sbjct: 164 EDLNV---LTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFG 217
Query: 250 LARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           LAR    +              + APE +  G  T KSDVWS+G++L+E+ +
Sbjct: 218 LARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILILELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG +G VY+            + +     +   +L ++        I E++ L  +KH
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+VKL       D    ++ LV    H       LL      L  +           G+
Sbjct: 60  SNIVKLY------DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXXXYA 273
           AY H   D +++ RD K  N+L++ + + K++DFGLAR  G P               Y 
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEVVTLWYR 167
Query: 274 APEYVQ-TGRLTAKSDVWSFGVVLYELITG 302
           AP+ +  + + +   D+WS G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG +G VY+            + +     +   +L ++        I E++ L  +KH
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+VKL       D    ++ LV    H       LL      L  +           G+
Sbjct: 60  SNIVKLY------DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXXXYA 273
           AY H   D +++ RD K  N+L++ + + K++DFGLAR  G P               Y 
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEVVTLWYR 167
Query: 274 APEYVQ-TGRLTAKSDVWSFGVVLYELITG 302
           AP+ +  + + +   D+WS G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 90/215 (41%), Gaps = 30/215 (13%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVN-FL 149
           +IG+G FG V   + R  +++         +  A+K L ++     KE    ++E N  L
Sbjct: 45  VIGKGSFGKVL--LARHKAEE---------VFYAVKVLQKKAILKKKEEKHIMSERNVLL 93
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             VKHP LV L       D    +   V + ++   L  HL  R    L   AR   A +
Sbjct: 94  KNVKHPFLVGLHFSFQTAD----KLYFVLDYINGGELFYHL-QRERCFLEPRARF-YAAE 147
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX- 268
            A  L YLH      +++RD K  NILLD      L+DFGL +    E + H        
Sbjct: 148 IASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNSTTSTFC 200
Query: 269 -XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
               Y APE +         D W  G VLYE++ G
Sbjct: 201 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYG 235

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 87/210 (41%), Gaps = 24/210 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG +G VY+            + +     +   +L ++        I E++ L  +KH
Sbjct: 10  IGEGTYGVVYKA----------QNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKH 59
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+VKL       D    ++ LV    H       LL      L  +           G+
Sbjct: 60  SNIVKLY------DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI 113
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXXXXYA 273
           AY H   D +++ RD K  N+L++ + + K++DFGLAR  G P               Y 
Sbjct: 114 AYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV---RKYTHEIVTLWYR 167
Query: 274 APEYVQ-TGRLTAKSDVWSFGVVLYELITG 302
           AP+ +  + + +   D+WS G +  E++ G
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNG 197

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---- 200
           E + +     P +V+L  +CA  D++ +   +V E M    L  +L+S    P  W    
Sbjct: 125 ERDIMAFANSPWVVQL--FCAFQDDKYL--YMVMEYMPGGDLV-NLMSNYDVPEKWAKFY 179
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
            A + +A DA   +  +H         RD K  N+LLD+    KL+DFG   +    G+ 
Sbjct: 180 TAEVVLALDAIHSMGLIH---------RDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV 230
Query: 261 HXXXXXXXXXXYAAPEYVQT----GRLTAKSDVWSFGVVLYELITG 302
           H          Y +PE +++    G    + D WS GV L+E++ G
Sbjct: 231 H-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 275

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/214 (23%), Positives = 85/214 (39%), Gaps = 33/214 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINEVNFLGV 151
           IG G F  VYR    +             + VA+K++   +    +   + I E++ L  
Sbjct: 40  IGRGQFSEVYRAACLLDG-----------VPVALKKVQIFDLMDAKARADCIKEIDLLKQ 88
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE---DHLLSR---VPTPLAWIARLK 205
           + HPN++K      ED+E      +V EL     L     H   +   +P    W   ++
Sbjct: 89  LNHPNVIKYYASFIEDNELN----IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQ 144
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           +       L ++H     +++ RD K +N+ +      KL D GL R    +        
Sbjct: 145 LCS----ALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHS 195
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
                 Y +PE +       KSD+WS G +LYE+
Sbjct: 196 LVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 229

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 107/272 (39%), Gaps = 45/272 (16%)
Query: 80  AELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSK-LDVAIKQLNRQGFQG 138
           AEL +    ++    I  G +G V  GV             DS+ + VAIK++      G
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGV-------------DSEGIPVAIKRVFNTVSDG 61
Query: 139 H-----------KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHN--- 183
                       K  + E+  L    HPN++ L       +E  M +L LV ELM     
Sbjct: 62  RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 184 KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA 243
           + + D  +   P  + +     +      GL  LHE     ++ RD    NILL ++   
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILL-----GLHVLHEA---GVVHRDLHPGNILLADNNDI 173
Query: 244 KLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITG 302
            + DF LAR+   +              Y APE V Q    T   D+WS G V+ E+   
Sbjct: 174 TICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-N 229
Query: 303 RRAVERNLPRNEQ--KLLEWV-RPYVSDSKKF 331
           R+A+ R      Q  K++E V  P + D   F
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 107/272 (39%), Gaps = 45/272 (16%)
Query: 80  AELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSK-LDVAIKQLNRQGFQG 138
           AEL +    ++    I  G +G V  GV             DS+ + VAIK++      G
Sbjct: 15  AELHAMQSPYTVQRFISSGSYGAVCAGV-------------DSEGIPVAIKRVFNTVSDG 61
Query: 139 H-----------KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHN--- 183
                       K  + E+  L    HPN++ L       +E  M +L LV ELM     
Sbjct: 62  RTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLA 121
Query: 184 KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA 243
           + + D  +   P  + +     +      GL  LHE     ++ RD    NILL ++   
Sbjct: 122 QVIHDQRIVISPQHIQYFMYHILL-----GLHVLHEA---GVVHRDLHPGNILLADNNDI 173
Query: 244 KLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITG 302
            + DF LAR+   +              Y APE V Q    T   D+WS G V+ E+   
Sbjct: 174 TICDFNLAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMF-N 229
Query: 303 RRAVERNLPRNEQ--KLLEWV-RPYVSDSKKF 331
           R+A+ R      Q  K++E V  P + D   F
Sbjct: 230 RKALFRGSTFYNQLNKIVEVVGTPKIEDVVMF 261

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 51/183 (27%), Positives = 80/183 (43%), Gaps = 14/183 (7%)
Query: 126 VAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS 185
           +A+KQ+ R G +   + I  +  L VV   +    +  C           +  ELM   +
Sbjct: 53  IAVKQMRRSGNKEENKRI--LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCA 110
Query: 186 LEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL 245
            +     + P P   + ++ +A    + L YL E+    +I RD K SNILLDE  + KL
Sbjct: 111 EKLKKRMQGPIPERILGKMTVA--IVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKL 166
Query: 246 SDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTA-----KSDVWSFGVVLYELI 300
            DFG++ +   +              Y APE +     T      ++DVWS G+ L EL 
Sbjct: 167 CDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELA 223
Query: 301 TGR 303
           TG+
Sbjct: 224 TGQ 226

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 58/231 (25%), Positives = 97/231 (41%), Gaps = 36/231 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-- 152
           +G+G +G V+RG  +               +VA+K  + +     K W  E      V  
Sbjct: 16  VGKGRYGEVWRGSWQGE-------------NVAVKIFSSRD---EKSWFRETELYNTVML 59
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +           Q  L+       SL D+L     T L  ++ L+I    A 
Sbjct: 60  RHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIAS 116
Query: 213 GLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQGPPEGLGHXXXX 265
           GLA+LH E+        +  RD K+ NIL+ ++ +  ++D GLA         L      
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 266 XXXXXXYAAPEYV-QTGRLTA-----KSDVWSFGVVLYELITGRRAVERNL 310
                 Y APE + +T ++       + D+W+FG+VL+E+   RR V   +
Sbjct: 177 RVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEV--ARRMVSNGI 225

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  ++HPN++ L     E  E     +L+ EL+    L D L  +    L      
Sbjct: 64  EVSILKEIQHPNVITL----HEVYENKTDVILIGELVAGGELFDFLAEK--ESLTEEEAT 117
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH     Q+   D K  NI LLD +    + K+ DFGLA +      G
Sbjct: 118 EFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI---DFG 171
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 172 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 97/236 (41%), Gaps = 43/236 (18%)
Query: 81  ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDV-AIKQLNRQGFQGH 139
           +L+     +    +IG G FG V            Q   H S   V A+K L++  F+  
Sbjct: 63  DLRMKAEDYEVVKVIGRGAFGEV------------QLVRHKSTRKVYAMKLLSK--FEMI 108
Query: 140 KE-----WINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
           K      +  E + +     P +V+L  Y  +DD       +V E M    L  +L+S  
Sbjct: 109 KRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDR---YLYMVMEYMPGGDLV-NLMSNY 163
Query: 195 PTPLAW----IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
             P  W     A + +A DA   + ++H         RD K  N+LLD+    KL+DFG 
Sbjct: 164 DVPEKWARFYTAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGT 214
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQT----GRLTAKSDVWSFGVVLYELITG 302
             +   EG+            Y +PE +++    G    + D WS GV LYE++ G
Sbjct: 215 CMKMNKEGMVR-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 269

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 23/166 (13%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---- 200
           E + +     P +V+L  Y  +DD       +V E M    L  +L+S    P  W    
Sbjct: 124 ERDIMAFANSPWVVQLF-YAFQDDR---YLYMVMEYMPGGDLV-NLMSNYDVPEKWARFY 178
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
            A + +A DA   + ++H         RD K  N+LLD+    KL+DFG   +   EG+ 
Sbjct: 179 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 261 HXXXXXXXXXXYAAPEYVQT----GRLTAKSDVWSFGVVLYELITG 302
                      Y +PE +++    G    + D WS GV LYE++ G
Sbjct: 230 R-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 72/166 (43%), Gaps = 23/166 (13%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---- 200
           E + +     P +V+L  Y  +DD       +V E M    L  +L+S    P  W    
Sbjct: 124 ERDIMAFANSPWVVQLF-YAFQDDR---YLYMVMEYMPGGDLV-NLMSNYDVPEKWARFY 178
Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
            A + +A DA   + ++H         RD K  N+LLD+    KL+DFG   +   EG+ 
Sbjct: 179 TAEVVLALDAIHSMGFIH---------RDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV 229
Query: 261 HXXXXXXXXXXYAAPEYVQT----GRLTAKSDVWSFGVVLYELITG 302
                      Y +PE +++    G    + D WS GV LYE++ G
Sbjct: 230 R-CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 274

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 37  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 82
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM     + +L   +   L       + 
Sbjct: 83  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLL 137
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 138 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 191
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT------GRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP 251
Query: 312 RNEQKLLEWVRPYVSDSKKF 331
              +KL   VR YV +  K+
Sbjct: 252 EFMKKLQPTVRTYVENRPKY 271

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/237 (23%), Positives = 92/237 (38%), Gaps = 46/237 (19%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F    LIG GGFG V++   R+          D K  V    + R  +   K    EV  
Sbjct: 14  FKEIELIGSGGFGQVFKAKHRI----------DGKTYV----IRRVKYNNEKAE-REVKA 58
Query: 149 LGVVKHPNLVKLVG------YCAEDDERGMQR-------------------LLVYELMHN 183
           L  + H N+V   G      Y  E  +  ++                     +  E    
Sbjct: 59  LAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDK 118
Query: 184 KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA 243
            +LE  +  R    L  +  L++ +   +G+ Y+H +   +LI RD K SNI L +  + 
Sbjct: 119 GTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHRDLKPSNIFLVDTKQV 175
Query: 244 KLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
           K+ DFGL      +G             Y +PE + +     + D+++ G++L EL+
Sbjct: 176 KIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELL 229

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           +G+G F  V R V       H+T+G    L+ A K +N +       ++   E      +
Sbjct: 37  LGKGAFSVVRRCV-------HKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKL 85
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+V+L     E+        LV++L+    L + +++R     A  +     Q    
Sbjct: 86  QHPNIVRLHDSIQEES----FHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQILE 139
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXX 269
            +AY H      ++ R+ K  N+LL    K    KL+DFGLA +       H        
Sbjct: 140 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG- 195
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y +PE ++    +   D+W+ GV+LY L+ G
Sbjct: 196 --YLSPEVLKKDPYSKPVDIWACGVILYILLVG 226

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 99/259 (38%), Gaps = 46/259 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNR--QGFQGHKEWINEVNFLG 150
           IG G  G V              + +D+ L+  VAIK+L+R  Q     K    E+  + 
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 151 VVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
            V H N++ L+         E      +V ELM     + +L   +   L       +  
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLY 133
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX 268
               G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G          
Sbjct: 134 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVV 187
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT------GRRAVER----------NLPR 312
              Y APE +         D+WS G ++ E++       GR  +++            P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPA 247
Query: 313 NEQKLLEWVRPYVSDSKKF 331
             +KL   VR YV +  K+
Sbjct: 248 FMKKLQPTVRNYVENRPKY 266

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 65/259 (25%), Positives = 99/259 (38%), Gaps = 46/259 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNR--QGFQGHKEWINEVNFLG 150
           IG G  G V              + +D+ L+  VAIK+L+R  Q     K    E+  + 
Sbjct: 32  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMK 78
Query: 151 VVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
            V H N++ L+         E      +V ELM     + +L   +   L       +  
Sbjct: 79  CVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLLY 133
Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX 268
               G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G          
Sbjct: 134 QMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMEPEVV 187
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT------GRRAVER----------NLPR 312
              Y APE +         D+WS G ++ E++       GR  +++            P 
Sbjct: 188 TRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCPE 247
Query: 313 NEQKLLEWVRPYVSDSKKF 331
             +KL   VR YV +  K+
Sbjct: 248 FMKKLQPTVRTYVENRPKY 266

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 66/260 (25%), Positives = 100/260 (38%), Gaps = 48/260 (18%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGH---KEWINEVNFL 149
           IG G  G V              + +D+ L+  VAIK+L+R  FQ     K    E+  +
Sbjct: 26  IGSGAQGIV-------------CAAYDAILERNVAIKKLSRP-FQNQTHAKRAYRELVLM 71
Query: 150 GVVKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             V H N++ L+         E      +V ELM     + +L   +   L       + 
Sbjct: 72  KCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSYLL 126
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
                G+ +LH      +I RD K SNI++  D   K+ DFGLAR     G         
Sbjct: 127 YQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTA---GTSFMMTPYV 180
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT------GRRAVER----------NLP 311
               Y APE +         D+WS G ++ E++       GR  +++            P
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP 240
Query: 312 RNEQKLLEWVRPYVSDSKKF 331
              +KL   VR YV +  K+
Sbjct: 241 EFMKKLQPTVRTYVENRPKY 260

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G F  V R V +  + ++           A K +N +      H++   E     ++
Sbjct: 39  LGKGAFSVVRRCVKKTPTQEY-----------AAKIINTKKLSARDHQKLEREARICRLL 87
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPN+V+L    +E+   G    LV++L+    L + +++R      + +    +    +
Sbjct: 88  KHPNIVRLHDSISEE---GFH-YLVFDLVTGGELFEDIVAR-----EYYSEADASHCIHQ 138
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXX 269
            L  ++      ++ RD K  N+LL    K    KL+DFGLA +   +G           
Sbjct: 139 ILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGEQQAWFGFAGT 196
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y +PE ++        D+W+ GV+LY L+ G
Sbjct: 197 PGYLSPEVLRKDPYGKPVDIWACGVILYILLVG 229

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EVN L  ++HPN++ L        E     +L+ EL+    L D L  +    L      
Sbjct: 58  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEAT 111
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH +   ++   D K  NI LLD++    + KL DFG+A +      G
Sbjct: 112 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---G 165
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 166 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 207

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EVN L  ++HPN++ L        E     +L+ EL+    L D L  +    L      
Sbjct: 65  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEAT 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH +   ++   D K  NI LLD++    + KL DFG+A +      G
Sbjct: 119 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---G 172
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 173 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 30/93 (32%), Positives = 48/93 (51%), Gaps = 9/93 (9%)
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXX 271
           +GL Y+H      ++ RD K  N+ ++ED + K+ DFGLAR    E  G+          
Sbjct: 155 KGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGY-----VVTRW 206
Query: 272 YAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
           Y APE + +        D+WS G ++ E++TG+
Sbjct: 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 239

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 98/241 (40%), Gaps = 52/241 (21%)
Query: 89  FSRALLIGEGGFGCV----------YRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQ 137
           F    ++G+G FG V          Y  + ++   + + S   S++ + +  LN Q   +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVR 66
Query: 138 GHKEWINEVNFL----GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
            +  W+   NF+     V K   L   + YC    E G     +Y+L+H+++L       
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYC----ENGT----LYDLIHSENLNQQ---- 114
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                 W    ++ +     L+Y+H +    +I RD K  NI +DE    K+ DFGLA+ 
Sbjct: 115 --RDEYW----RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 253 ------------QGPPEGLGHXXXXXXXXXXYAAPEYVQ-TGRLTAKSDVWSFGVVLYEL 299
                       Q  P G             Y A E +  TG    K D++S G++ +E+
Sbjct: 166 VHRSLDILKLDSQNLP-GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 300 I 300
           I
Sbjct: 225 I 225

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 74/162 (45%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EVN L  ++HPN++ L        E     +L+ EL+    L D L  +    L      
Sbjct: 79  EVNILREIRHPNIITLHDIF----ENKTDVVLILELVSGGELFDFLAEK--ESLTEDEAT 132
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
           +  +    G+ YLH +   ++   D K  NI LLD++    + KL DFG+A +      G
Sbjct: 133 QFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA---G 186
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           +          + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 187 NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 228

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 36/117 (30%), Positives = 55/117 (47%), Gaps = 17/117 (14%)
Query: 193 RVPTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R+P  +A  ++A + IA D+   L Y+H         RD K  NIL+D +   +L+DFG 
Sbjct: 171 RLPEEMARFYLAEMVIAIDSVHQLHYVH---------RDIKPDNILMDMNGHIRLADFGS 221
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITG 302
             +   +G             Y +PE +Q      GR   + D WS GV +YE++ G
Sbjct: 222 CLKLMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           +G+G F  V R V       H+T+G    L+ A K +N +       ++   E      +
Sbjct: 13  LGKGAFSVVRRCV-------HKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKL 61
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+V+L     E+        LV++L+    L + +++R     A  +     Q    
Sbjct: 62  QHPNIVRLHDSIQEES----FHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQILE 115
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXX 269
            +AY H      ++ R+ K  N+LL    K    KL+DFGLA +       H        
Sbjct: 116 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG- 171
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y +PE ++    +   D+W+ GV+LY L+ G
Sbjct: 172 --YLSPEVLKKDPYSKPVDIWACGVILYILLVG 202

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           +G+G F  V R V       H+T+G    L+ A K +N +       ++   E      +
Sbjct: 14  LGKGAFSVVRRCV-------HKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+V+L     E+        LV++L+    L + +++R     A  +     Q    
Sbjct: 63  QHPNIVRLHDSIQEES----FHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQILE 116
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXX 269
            +AY H      ++ R+ K  N+LL    K    KL+DFGLA +       H        
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG- 172
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y +PE ++    +   D+W+ GV+LY L+ G
Sbjct: 173 --YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 75/184 (40%), Gaps = 17/184 (9%)
Query: 124 LDVAIKQLNRQGFQGH---KEWINEVNFLGVVKHPNLVKLVGYCAEDD--ERGMQRLLVY 178
           ++VA+K+L+R  FQ     K    E+  L  V H N++ L+         E      LV 
Sbjct: 48  INVAVKKLSR-PFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKTLEEFQDVYLVM 106
Query: 179 ELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD 238
           ELM     + +L   +   L       +      G+ +LH      +I RD K SNI++ 
Sbjct: 107 ELM-----DANLCQVIHMELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVK 158
Query: 239 EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
            D   K+ DFGLAR                   Y APE +         D+WS G ++ E
Sbjct: 159 SDCTLKILDFGLARTA---STNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 215
Query: 299 LITG 302
           L+ G
Sbjct: 216 LVKG 219

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 93  LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV 152
           +++G+G +G VY G               +++ +AIK++  +  +  +    E+     +
Sbjct: 28  VVLGKGTYGIVYAG-----------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL 76
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK------- 205
           KH N+V+ +G  +E+   G  ++ + E +   SL   L S+      W   LK       
Sbjct: 77  KHKNIVQYLGSFSEN---GFIKIFM-EQVPGGSLSALLRSK------W-GPLKDNEQTIG 125
Query: 206 -IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA--KLSDFGLARQGPPEGLGHX 262
              +    GL YLH   D Q++ RD K  N+L++  Y    K+SDFG +++    G+   
Sbjct: 126 FYTKQILEGLKYLH---DNQIVHRDIKGDNVLIN-TYSGVLKISDFGTSKR--LAGINPC 179
Query: 263 XXXXXXXXXYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGR 303
                    Y APE +  G       +D+WS G  + E+ TG+
Sbjct: 180 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 222

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 28/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           +G+G F  V R V       H+T+G    L+ A K +N +       ++   E      +
Sbjct: 14  LGKGAFSVVRRCV-------HKTTG----LEFAAKIINTKKLSARDFQKLEREARICRKL 62
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+V+L     E+        LV++L+    L + +++R     A  +     Q    
Sbjct: 63  QHPNIVRLHDSIQEES----FHYLVFDLVTGGELFEDIVAREFYSEADASHC--IQQILE 116
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXX 269
            +AY H      ++ R+ K  N+LL    K    KL+DFGLA +       H        
Sbjct: 117 SIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPG- 172
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y +PE ++    +   D+W+ GV+LY L+ G
Sbjct: 173 --YLSPEVLKKDPYSKPVDIWACGVILYILLVG 203

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 97/241 (40%), Gaps = 52/241 (21%)
Query: 89  FSRALLIGEGGFGCV----------YRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQ 137
           F    ++G+G FG V          Y  + ++   + + S   S++ + +  LN Q   +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEV-MLLASLNHQYVVR 66
Query: 138 GHKEWINEVNFL----GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
            +  W+   NF+     V K   L   + YC        +   +Y+L+H+++L       
Sbjct: 67  YYAAWLERRNFVKPMTAVKKKSTLFIQMEYC--------ENRTLYDLIHSENLNQQ---- 114
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                 W    ++ +     L+Y+H +    +I RD K  NI +DE    K+ DFGLA+ 
Sbjct: 115 --RDEYW----RLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKN 165
Query: 253 ------------QGPPEGLGHXXXXXXXXXXYAAPEYVQ-TGRLTAKSDVWSFGVVLYEL 299
                       Q  P G             Y A E +  TG    K D++S G++ +E+
Sbjct: 166 VHRSLDILKLDSQNLP-GSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM 224
Query: 300 I 300
           I
Sbjct: 225 I 225

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 57/238 (23%), Positives = 92/238 (38%), Gaps = 42/238 (17%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGV 151
           LIG G +G VY    +           ++  +VAIK++NR  +     K  + E+  L  
Sbjct: 35  LIGRGSYGYVYLAYDK-----------NANKNVAIKKVNRMFEDLIDCKRILREITILNR 83
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           +K   +++L      +D      L +   + +  L+   L + P  L       I  +  
Sbjct: 84  LKSDYIIRLHDLIIPEDLLKFDELYIVLEIADSDLKK--LFKTPIFLTEQHVKTILYNLL 141
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ------------------ 253
            G  ++HE     +I RD K +N LL++D   K+ DFGLAR                   
Sbjct: 142 LGEKFIHES---GIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEE 198
Query: 254 ----GP-PEGLGHXXXXXXXXXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRA 305
               GP  + L            Y APE +      T   D+WS G +  EL+   ++
Sbjct: 199 NEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAELLNMMKS 256

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 35/238 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           FS   +IG GGFG VY G  +           D+    A+K L+++     QG    +NE
Sbjct: 191 FSVHRIIGRGGFGEVY-GCRKA----------DTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARL 204
              L +V   +   +V  C         +L  + +LM+   L  HL        A +   
Sbjct: 240 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF- 296
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA----RQGPPEGLG 260
             A +   GL ++H      +++RD K +NILLDE    ++SD GLA    ++ P   +G
Sbjct: 297 -YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 261 HXXXXXXXXXXYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                      Y APE +Q G    + +D +S G +L++L+ G     ++  +++ ++
Sbjct: 353 --------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 52/213 (24%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G F  V R V  ++  ++           A K +N +      H++   E     ++
Sbjct: 30  LGKGAFSVVRRCVKVLAGQEY-----------AAKIINTKKLSARDHQKLEREARICRLL 78
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPN+V+L    +E+        L+++L+    L + +++R     A  +     Q    
Sbjct: 79  KHPNIVRLHDSISEEG----HHYLIFDLVTGGELFEDIVAREYYSEADASH--CIQQILE 132
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXX 269
            + + H+     ++ RD K  N+LL    K    KL+DFGLA +   EG           
Sbjct: 133 AVLHCHQ---MGVVHRDLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGT 187
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y +PE ++        D+W+ GV+LY L+ G
Sbjct: 188 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVG 220

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 57/184 (30%), Positives = 79/184 (42%), Gaps = 23/184 (12%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDD-ERGMQRLLVYELMHNKSLEDHLLSR-VPTPLAWI 201
           NE+  L  +KH N+V L     ED  E      LV +L+    L D +L R V T     
Sbjct: 55  NEIAVLKKIKHENIVTL-----EDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKD-- 107
Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEG 258
           A L I Q     + YLHE     ++ RD K  N+L    +E+ K  ++DFGL++    E 
Sbjct: 108 ASLVI-QQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQ 160
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
            G           Y APE +     +   D WS GV+ Y L+ G           E KL 
Sbjct: 161 NG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYE---ETESKLF 216
Query: 319 EWVR 322
           E ++
Sbjct: 217 EKIK 220

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 35/238 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           FS   +IG GGFG VY G  +           D+    A+K L+++     QG    +NE
Sbjct: 190 FSVHRIIGRGGFGEVY-GCRKA----------DTGKMYAMKCLDKKRIKMKQGETLALNE 238
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARL 204
              L +V   +   +V  C         +L  + +LM+   L  HL        A +   
Sbjct: 239 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF- 295
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA----RQGPPEGLG 260
             A +   GL ++H      +++RD K +NILLDE    ++SD GLA    ++ P   +G
Sbjct: 296 -YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 351
Query: 261 HXXXXXXXXXXYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                      Y APE +Q G    + +D +S G +L++L+ G     ++  +++ ++
Sbjct: 352 --------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 35/238 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           FS   +IG GGFG VY G  +           D+    A+K L+++     QG    +NE
Sbjct: 191 FSVHRIIGRGGFGEVY-GCRKA----------DTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARL 204
              L +V   +   +V  C         +L  + +LM+   L  HL        A +   
Sbjct: 240 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF- 296
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA----RQGPPEGLG 260
             A +   GL ++H      +++RD K +NILLDE    ++SD GLA    ++ P   +G
Sbjct: 297 -YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 261 HXXXXXXXXXXYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                      Y APE +Q G    + +D +S G +L++L+ G     ++  +++ ++
Sbjct: 353 --------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 56/223 (25%), Positives = 99/223 (44%), Gaps = 40/223 (17%)
Query: 93  LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV 152
           +++G+G +G VY G               +++ +AIK++  +  +  +    E+     +
Sbjct: 14  VVLGKGTYGIVYAG-----------RDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL 62
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK------- 205
           KH N+V+ +G  +E+   G  ++ + E +   SL   L S+      W   LK       
Sbjct: 63  KHKNIVQYLGSFSEN---GFIKIFM-EQVPGGSLSALLRSK------W-GPLKDNEQTIG 111
Query: 206 -IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA--KLSDFGLARQGPPEGLGHX 262
              +    GL YLH   D Q++ RD K  N+L++  Y    K+SDFG +++    G+   
Sbjct: 112 FYTKQILEGLKYLH---DNQIVHRDIKGDNVLINT-YSGVLKISDFGTSKR--LAGINPC 165
Query: 263 XXXXXXXXXYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGR 303
                    Y APE +  G       +D+WS G  + E+ TG+
Sbjct: 166 TETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGK 208

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 62/238 (26%), Positives = 105/238 (44%), Gaps = 35/238 (14%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINE 145
           FS   +IG GGFG VY G  +           D+    A+K L+++     QG    +NE
Sbjct: 191 FSVHRIIGRGGFGEVY-GCRKA----------DTGKMYAMKCLDKKRIKMKQGETLALNE 239
Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARL 204
              L +V   +   +V  C         +L  + +LM+   L  HL        A +   
Sbjct: 240 RIMLSLVSTGDCPFIV--CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRF- 296
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA----RQGPPEGLG 260
             A +   GL ++H      +++RD K +NILLDE    ++SD GLA    ++ P   +G
Sbjct: 297 -YAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 352
Query: 261 HXXXXXXXXXXYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                      Y APE +Q G    + +D +S G +L++L+ G     ++  +++ ++
Sbjct: 353 --------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 66/264 (25%), Positives = 105/264 (39%), Gaps = 45/264 (17%)
Query: 125 DVAIKQLNRQGFQGHK--EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMH 182
           D+ +K L  + +   K  ++  E   L +  HPN++ ++G C           L+     
Sbjct: 35  DIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGAC--QSPPAPHPTLITHWXP 92
Query: 183 NKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK 242
             SL + L       +     +K A D ARG A+LH  ++  +      + ++ +DED  
Sbjct: 93  YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLHT-LEPLIPRHALNSRSVXIDEDXT 151
Query: 243 AKLS--DFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQ-----TGRLTAKSDVWSFGVV 295
           A++S  D   + Q P                + APE +Q     T R +A  D WSF V+
Sbjct: 152 ARISXADVKFSFQSP---------GRXYAPAWVAPEALQKKPEDTNRRSA--DXWSFAVL 200
Query: 296 LYELITGRRAVERNLPRNE---QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXX 352
           L+EL+T R     +L   E   +  LE +RP +      H+                   
Sbjct: 201 LWELVT-REVPFADLSNXEIGXKVALEGLRPTIPPGISPHV------------------S 241
Query: 353 XXXXXCLTKQPKSRPKMSEVVDIL 376
                C  + P  RPK   +V IL
Sbjct: 242 KLXKICXNEDPAKRPKFDXIVPIL 265

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 60/213 (28%), Positives = 86/213 (40%), Gaps = 29/213 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL--NRQGFQGHKEWINEVNFLGVV 152
           IGEG +G V++               D+   VAIK+   +       K  + E+  L  +
Sbjct: 11  IGEGSYGVVFK-----------CRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL 59
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPNLV L+    E   R  +  LV+E   +  L  H L R    +       I     +
Sbjct: 60  KHPNLVNLL----EVFRRKRRLHLVFEYCDHTVL--HELDRYQRGVPEHLVKSITWQTLQ 113
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHXXXXXXXXX 270
            + + H+      I RD K  NIL+ +    KL DFG AR   GP +             
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSD----YYDDEVATR 166
Query: 271 XYAAPE-YVQTGRLTAKSDVWSFGVVLYELITG 302
            Y +PE  V   +     DVW+ G V  EL++G
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 50/211 (23%), Positives = 95/211 (45%), Gaps = 23/211 (10%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G F  V R V  ++  ++      + + +  K+L+ +    H++   E     ++KH
Sbjct: 19  LGKGAFSVVRRCVKVLAGQEY------AAMIINTKKLSARD---HQKLEREARICRLLKH 69
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PN+V+L    +E+        L+++L+    L + +++R     A  +     Q     +
Sbjct: 70  PNIVRLHDSISEEG----HHYLIFDLVTGGELFEDIVAREYYSEADASHC--IQQILEAV 123
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXXXX 271
            + H+     ++ R+ K  N+LL    K    KL+DFGLA +   EG             
Sbjct: 124 LHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIE--VEGEQQAWFGFAGTPG 178
Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           Y +PE ++        D+W+ GV+LY L+ G
Sbjct: 179 YLSPEVLRKDPYGKPVDLWACGVILYILLVG 209

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 64/236 (27%), Positives = 94/236 (39%), Gaps = 49/236 (20%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINE 145
           F    L+GEG +G V        S  H+ +G      VAIK++   ++  F      + E
Sbjct: 13  FQLKSLLGEGAYGVV-------CSATHKPTGEI----VAIKKIEPFDKPLFALRT--LRE 59
Query: 146 VNFLGVVKHPNLVKLVGYCAEDD-ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           +  L   KH N++ +      D  E   +  ++ ELM         L RV      I+  
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRV------ISTQ 107
Query: 205 KIAQD--------AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---- 252
            ++ D          R +  LH      +I RD K SN+L++ +   K+ DFGLAR    
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 253 ----QGPPEGLGHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                  P G             Y APE + T  + +   DVWS G +L EL   R
Sbjct: 165 SAADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 88/215 (40%), Gaps = 20/215 (9%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVV 152
           IG G +G V       SS   + +G      VAIK++          K  + E+  L   
Sbjct: 62  IGNGAYGVV-------SSARRRLTGQQ----VAIKKIPNAFDVVTNAKRTLRELKILKHF 110
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KH N++ +          G  +  VY ++     + H +     PL             R
Sbjct: 111 KHDNIIAIKDILRPTVPYGEFKS-VYVVLDLMESDLHQIIHSSQPLTLEHVRYFLYQLLR 169
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ--GPPEGLGHXXXXXXXXX 270
           GL Y+H     Q+I RD K SN+L++E+ + K+ DFG+AR     P    +         
Sbjct: 170 GLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATR 226
Query: 271 XYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRR 304
            Y APE + +    T   D+WS G +  E++  R+
Sbjct: 227 WYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 261

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 93/236 (39%), Gaps = 49/236 (20%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINE 145
           F    L+GEG +G V        S  H+ +G      VAIK++   ++  F      + E
Sbjct: 13  FQLKSLLGEGAYGVV-------CSATHKPTGEI----VAIKKIEPFDKPLFALRT--LRE 59
Query: 146 VNFLGVVKHPNLVKLVGYCAEDD-ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           +  L   KH N++ +      D  E   +  ++ ELM         L RV      I+  
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRV------ISTQ 107
Query: 205 KIAQD--------AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---- 252
            ++ D          R +  LH      +I RD K SN+L++ +   K+ DFGLAR    
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 253 ----QGPPEGLGHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                  P G             Y APE + T  + +   DVWS G +L EL   R
Sbjct: 165 SAADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 93/222 (41%), Gaps = 31/222 (13%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G GG G V+  V            +D    VAIK++     Q  K  + E+  +  + H
Sbjct: 19  LGCGGNGLVFSAV-----------DNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDH 67
Query: 155 PNLVKLV------GYCAEDDERGMQRL----LVYELMHNKSLEDHLLSRVPTPLAWIARL 204
            N+VK+       G    DD   +  L    +V E M       ++L + P  L   ARL
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDL--ANVLEQGPL-LEEHARL 124
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPE--GLGH 261
            + Q   RGL Y+H      ++ RD K +N+ ++ ED   K+ DFGLAR   P     GH
Sbjct: 125 FMYQ-LLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGH 180
Query: 262 XXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                      +    +     T   D+W+ G +  E++TG+
Sbjct: 181 LSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 63/236 (26%), Positives = 93/236 (39%), Gaps = 49/236 (20%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINE 145
           F    L+GEG +G V        S  H+ +G      VAIK++   ++  F      + E
Sbjct: 13  FQLKSLLGEGAYGVV-------CSATHKPTGEI----VAIKKIEPFDKPLFALRT--LRE 59
Query: 146 VNFLGVVKHPNLVKLVGYCAEDD-ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           +  L   KH N++ +      D  E   +  ++ ELM         L RV      I+  
Sbjct: 60  IKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQTD------LHRV------ISTQ 107
Query: 205 KIAQD--------AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---- 252
            ++ D          R +  LH      +I RD K SN+L++ +   K+ DFGLAR    
Sbjct: 108 MLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE 164
Query: 253 ----QGPPEGLGHXXXXXXXXXXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR 303
                  P G             Y APE + T  + +   DVWS G +L EL   R
Sbjct: 165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 32/96 (33%), Positives = 49/96 (51%), Gaps = 6/96 (6%)
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ--GPPEGLGHXXXXXXXX 269
           RGL Y+H     Q+I RD K SN+L++E+ + K+ DFG+AR     P    +        
Sbjct: 170 RGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVAT 226
Query: 270 XXYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRR 304
             Y APE + +    T   D+WS G +  E++  R+
Sbjct: 227 RWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQ 262

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 18/167 (10%)
Query: 139 HKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH-----LLSR 193
           + ++ NE+  +  +K+   +   G     DE      ++YE M N S+        +L +
Sbjct: 87  YDDFKNELQIITDIKNEYCLTCEGIITNYDEV----YIIYEYMENDSILKFDEYFFVLDK 142
Query: 194 VPTPLAWIARLK-IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
             T    I  +K I +      +Y+H E +  +  RD K SNIL+D++ + KLSDFG + 
Sbjct: 143 NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESE 200
Query: 253 QGPPEGLGHXXXXXXXXXXYAAPEYV--QTGRLTAKSDVWSFGVVLY 297
               + +            +  PE+   ++    AK D+WS G+ LY
Sbjct: 201 YMVDKKIK----GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 93/222 (41%), Gaps = 26/222 (11%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F    + G+G FG V  G         +++G    + VAIK++ +     ++E +  +  
Sbjct: 25  FQVERMAGQGTFGTVQLG-------KEKSTG----MSVAIKKVIQDPRFRNRE-LQIMQD 72
Query: 149 LGVVKHPNLVKLVGY---CAEDDERGMQRLLVYELMHN---KSLEDHLLSRVPTPLAWIA 202
           L V+ HPN+V+L  Y     E D R +   +V E + +   +   ++   +V  P   I 
Sbjct: 73  LAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIK 132
Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKAKLSDFGLARQGPPEGLGH 261
                    R +  LH      +  RD K  N+L++E D   KL DFG A++  P     
Sbjct: 133 VFLF--QLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---SE 186
Query: 262 XXXXXXXXXXYAAPEYV-QTGRLTAKSDVWSFGVVLYELITG 302
                     Y APE +      T   D+WS G +  E++ G
Sbjct: 187 PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLG 228

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 16/184 (8%)
Query: 122 SKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM 181
           +++  A K++ +   +    +  E+  +  + HPN+++L     E  E      LV EL 
Sbjct: 33  TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY----ETFEDNTDIYLVMELC 88
Query: 182 HNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---D 238
               L + ++ +     +  AR  I +D    +AY H+     +  RD K  N L     
Sbjct: 89  TGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDS 143
Query: 239 EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
            D   KL DFGLA +  P   G           Y +P+ ++ G    + D WS GV++Y 
Sbjct: 144 PDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYV 199
Query: 299 LITG 302
           L+ G
Sbjct: 200 LLCG 203

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 65/254 (25%), Positives = 103/254 (40%), Gaps = 61/254 (24%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLNRQGFQGHKEWINEVNFLGVV 152
           IG+G +G     VVRV+ ++   +    K+     I+Q+N +  +  K    EV  +  +
Sbjct: 34  IGQGSYG-----VVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKL 85
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL-----------------LSRVP 195
            HPN+ +L  Y   +DE+ +   LV EL H   L D L                     P
Sbjct: 86  HHPNIARL--YEVYEDEQYI--CLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICP 141
Query: 196 TP-----------------LAWIARLKIAQDAAR----GLAYLHEEMDFQLIFRDFKTSN 234
            P                 L ++ R K+  +  R     L YLH +    +  RD K  N
Sbjct: 142 CPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPEN 198
Query: 235 ILL--DEDYKAKLSDFGLARQ--GPPEGLGHXXXXXXXXXXYAAPEYVQTGRLT--AKSD 288
            L   ++ ++ KL DFGL+++      G  +          + APE + T   +   K D
Sbjct: 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCD 258
Query: 289 VWSFGVVLYELITG 302
            WS GV+L+ L+ G
Sbjct: 259 AWSAGVLLHLLLMG 272

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 79/184 (42%), Gaps = 16/184 (8%)
Query: 122 SKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELM 181
           +++  A K++ +   +    +  E+  +  + HPN+++L     E  E      LV EL 
Sbjct: 50  TRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY----ETFEDNTDIYLVMELC 105
Query: 182 HNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---D 238
               L + ++ +     +  AR  I +D    +AY H+     +  RD K  N L     
Sbjct: 106 TGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDS 160
Query: 239 EDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
            D   KL DFGLA +  P   G           Y +P+ ++ G    + D WS GV++Y 
Sbjct: 161 PDSPLKLIDFGLAARFKP---GKMMRTKVGTPYYVSPQVLE-GLYGPECDEWSAGVMMYV 216
Query: 299 LITG 302
           L+ G
Sbjct: 217 LLCG 220

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 75/166 (45%), Gaps = 23/166 (13%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HPN++KL     E  E   +  LV EL+    L D ++ +      + + 
Sbjct: 97  TEIGVLLRLSHPNIIKL----KEIFETPTEISLVLELVTGGELFDRIVEK-----GYYSE 147
Query: 204 LKIAQDAAR----GLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPP 256
            + A DA +     +AYLHE     ++ RD K  N+L      D   K++DFGL++    
Sbjct: 148 -RDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH 203
Query: 257 EGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
           + L            Y APE ++      + D+WS G++ Y L+ G
Sbjct: 204 QVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCG 246

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 69/258 (26%), Positives = 110/258 (42%), Gaps = 38/258 (14%)
Query: 83  KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKE 141
           K     F    ++G G +G V+  +VR      + SGHD+    A+K L +    Q  K 
Sbjct: 50  KVGIENFELLKVLGTGAYGKVF--LVR------KISGHDTGKLYAMKVLKKATIVQKAKT 101
Query: 142 WINEVNFLGVVKH----PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--- 194
             +      V++H    P LV L  + A   E  +  +L Y  ++   L  HL  R    
Sbjct: 102 TEHTRTERQVLEHIRQSPFLVTL--HYAFQTETKLHLILDY--INGGELFTHLSQRERFT 157
Query: 195 -PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                 ++  + +A      L +LH+     +I+RD K  NILLD +    L+DFGL+++
Sbjct: 158 EHEVQIYVGEIVLA------LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE 208
Query: 254 GPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDV--WSFGVVLYELITGRRAVERNLP 311
              +              Y AP+ V+ G       V  WS GV++YEL+TG      +  
Sbjct: 209 FVADET-ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267
Query: 312 RNEQ-----KLLEWVRPY 324
           +N Q     ++L+   PY
Sbjct: 268 KNSQAEISRRILKSEPPY 285

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-- 152
           IG+G FG V+RG  R               +VA+K  + +     + W  E      V  
Sbjct: 12  IGKGRFGEVWRGKWRGE-------------EVAVKIFSSRE---ERSWFREAEIYQTVML 55
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +    +D+    Q  LV +   + SL D+L     T    I   K+A   A 
Sbjct: 56  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI---KLALSTAS 112
Query: 213 GLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQGPPEGLGHXXXX 265
           GLA+LH E+        +  RD K+ NIL+ ++    ++D GLA       + +      
Sbjct: 113 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 172
Query: 266 XXXXXXYAAPEYVQTG------RLTAKSDVWSFGVVLYEL 299
                 Y APE +             ++D+++ G+V +E+
Sbjct: 173 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 212

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-- 152
           IG+G FG V+RG  R               +VA+K  + +     + W  E      V  
Sbjct: 50  IGKGRFGEVWRGKWRGE-------------EVAVKIFSSRE---ERSWFREAEIYQTVML 93
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +    +D+    Q  LV +   + SL D+L     T    I   K+A   A 
Sbjct: 94  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI---KLALSTAS 150
Query: 213 GLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQGPPEGLGHXXXX 265
           GLA+LH E+        +  RD K+ NIL+ ++    ++D GLA       + +      
Sbjct: 151 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 210
Query: 266 XXXXXXYAAPEYVQTG------RLTAKSDVWSFGVVLYEL 299
                 Y APE +             ++D+++ G+V +E+
Sbjct: 211 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 250

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-- 152
           IG+G FG V+RG  R               +VA+K  + +     + W  E      V  
Sbjct: 11  IGKGRFGEVWRGKWRGE-------------EVAVKIFSSRE---ERSWFREAEIYQTVML 54
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +    +D+    Q  LV +   + SL D+L     T    I   K+A   A 
Sbjct: 55  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI---KLALSTAS 111
Query: 213 GLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQGPPEGLGHXXXX 265
           GLA+LH E+        +  RD K+ NIL+ ++    ++D GLA       + +      
Sbjct: 112 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 171
Query: 266 XXXXXXYAAPEYVQTG------RLTAKSDVWSFGVVLYEL 299
                 Y APE +             ++D+++ G+V +E+
Sbjct: 172 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 211

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-- 152
           IG+G FG V+RG  R               +VA+K  + +     + W  E      V  
Sbjct: 37  IGKGRFGEVWRGKWRGE-------------EVAVKIFSSRE---ERSWFREAEIYQTVML 80
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +    +D+    Q  LV +   + SL D+L     T    I   K+A   A 
Sbjct: 81  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI---KLALSTAS 137
Query: 213 GLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQGPPEGLGHXXXX 265
           GLA+LH E+        +  RD K+ NIL+ ++    ++D GLA       + +      
Sbjct: 138 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 197
Query: 266 XXXXXXYAAPEYVQTG------RLTAKSDVWSFGVVLYEL 299
                 Y APE +             ++D+++ G+V +E+
Sbjct: 198 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 237

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 77/175 (44%), Gaps = 18/175 (10%)
Query: 133 RQGFQGHKEWINEVNFLGVVKH-PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLL 191
           R+G     E ++E+  L + K  P ++ L     E  E   + +L+ E      +    L
Sbjct: 66  RRGQDCRAEILHEIAVLELAKSCPRVINL----HEVYENTSEIILILEYAAGGEIFSLCL 121
Query: 192 SRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK---AKLSDF 248
             +   ++    +++ +    G+ YLH+     ++  D K  NILL   Y     K+ DF
Sbjct: 122 PELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDF 178
Query: 249 GLARQGPPEGLGHXXX--XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELIT 301
           G++R+     +GH            Y APE +    +T  +D+W+ G++ Y L+T
Sbjct: 179 GMSRK-----IGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLT 228

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/155 (30%), Positives = 71/155 (45%), Gaps = 17/155 (10%)
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN++ L      DD  G    +V ELM    L D +L +     +      +     +
Sbjct: 74  QHPNIITLKD--VYDD--GKYVYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITK 127
Query: 213 GLAYLHEEMDFQLIFRDFKTSNIL-LDED---YKAKLSDFGLARQGPPE-GLGHXXXXXX 267
            + YLH +    ++ RD K SNIL +DE       ++ DFG A+Q   E GL        
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LMTPC 181
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
               + APE ++     A  D+WS GV+LY ++TG
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTG 216

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R        D QT         A+K++  + F+     + E+     +  
Sbjct: 66  VGRGSFGEVHR------MKDKQTG-----FQCAVKKVRLEVFR-----VEELVACAGLSS 109
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAAR 212
           P +V L G   E    G    +  EL+   SL   +  +  +P   A    L     A  
Sbjct: 110 PRIVPLYGAVRE----GPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----LYYLGQALE 161
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHXXXXX---XX 268
           GL YLH     +++  D K  N+LL  D  +A L DFG A    P+GLG           
Sbjct: 162 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 218
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
              + APE V      AK D+WS   ++  ++ G
Sbjct: 219 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 252

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 94/221 (42%), Gaps = 37/221 (16%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G GGFG V+   ++ +   +     + K     +   R+G+QG    + E   L  V 
Sbjct: 192 VLGRGGFGEVFACQMKATGKLYACKKLNKK-----RLKKRKGYQGA---MVEKKILAKV- 242
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS--------RVPTPLAWIARLK 205
           H   +  + Y  E         LV  +M+   +  H+ +        + P  + + A++ 
Sbjct: 243 HSRFIVSLAYAFETK---TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQI- 298
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA---RQGPPEGLGHX 262
                  GL +LH+     +I+RD K  N+LLD+D   ++SD GLA   + G  +  G+ 
Sbjct: 299 -----VSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY- 349
Query: 263 XXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                    + APE +         D ++ GV LYE+I  R
Sbjct: 350 ----AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA---RQGPPEGLGHXXXXXXXX 269
           GL +LH+     +I+RD K  N+LLD+D   ++SD GLA   + G  +  G+        
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGT 352
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
             + APE +         D ++ GV LYE+I  R
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-- 152
           IG+G FG V+RG  R               +VA+K  + +     + W  E      V  
Sbjct: 17  IGKGRFGEVWRGKWRGE-------------EVAVKIFSSRE---ERSWFREAEIYQTVML 60
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +    +D+    Q  LV +   + SL D+L     T    I   K+A   A 
Sbjct: 61  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI---KLALSTAS 117
Query: 213 GLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQGPPEGLGHXXXX 265
           GLA+LH E+        +  RD K+ NIL+ ++    ++D GLA       + +      
Sbjct: 118 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 177
Query: 266 XXXXXXYAAPEYVQTG------RLTAKSDVWSFGVVLYEL 299
                 Y APE +             ++D+++ G+V +E+
Sbjct: 178 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 217

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 54/220 (24%), Positives = 91/220 (41%), Gaps = 34/220 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-- 152
           IG+G FG V+RG  R               +VA+K  + +     + W  E      V  
Sbjct: 14  IGKGRFGEVWRGKWRGE-------------EVAVKIFSSRE---ERSWFREAEIYQTVML 57
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +    +D+    Q  LV +   + SL D+L     T    I   K+A   A 
Sbjct: 58  RHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMI---KLALSTAS 114
Query: 213 GLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLA--RQGPPEGLGHXXXX 265
           GLA+LH E+        +  RD K+ NIL+ ++    ++D GLA       + +      
Sbjct: 115 GLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNH 174
Query: 266 XXXXXXYAAPEYVQTG------RLTAKSDVWSFGVVLYEL 299
                 Y APE +             ++D+++ G+V +E+
Sbjct: 175 RVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEI 214

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA---RQGPPEGLGHXXXXXXXX 269
           GL +LH+     +I+RD K  N+LLD+D   ++SD GLA   + G  +  G+        
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGT 352
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
             + APE +         D ++ GV LYE+I  R
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 31/94 (32%), Positives = 47/94 (50%), Gaps = 11/94 (11%)
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA---RQGPPEGLGHXXXXXXXX 269
           GL +LH+     +I+RD K  N+LLD+D   ++SD GLA   + G  +  G+        
Sbjct: 301 GLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGY-----AGT 352
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
             + APE +         D ++ GV LYE+I  R
Sbjct: 353 PGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R        D QT         A+K++  + F+     + E+     +  
Sbjct: 82  VGRGSFGEVHR------MKDKQTG-----FQCAVKKVRLEVFR-----VEELVACAGLSS 125
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAAR 212
           P +V L G   E    G    +  EL+   SL   +  +  +P   A    L     A  
Sbjct: 126 PRIVPLYGAVRE----GPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----LYYLGQALE 177
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHXXXXX---XX 268
           GL YLH     +++  D K  N+LL  D  +A L DFG A    P+GLG           
Sbjct: 178 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 234
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
              + APE V      AK D+WS   ++  ++ G
Sbjct: 235 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 268

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 10/131 (7%)
Query: 175 LLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN 234
           L++ E M    L   +  R           +I +D    + +LH      +  RD K  N
Sbjct: 83  LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPEN 139
Query: 235 ILL---DEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWS 291
           +L    ++D   KL+DFG A++     L            Y APE +   +     D+WS
Sbjct: 140 LLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWS 195
Query: 292 FGVVLYELITG 302
            GV++Y L+ G
Sbjct: 196 LGVIMYILLCG 206

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG+G F  V R + R      +T    +   V + +         ++   E +   ++K
Sbjct: 31  VIGKGPFSVVRRCINR------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 84
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR- 212
           HP++V+L+   + D   GM   +V+E M    L   ++ R      ++    +A    R 
Sbjct: 85  HPHIVELLETYSSD---GML-YMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQ 138
Query: 213 ---GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
               L Y H   D  +I RD K   +LL   +     KL  FG+A Q    GL       
Sbjct: 139 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGR 193
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                + APE V+        DVW  GV+L+ L++G
Sbjct: 194 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/213 (25%), Positives = 92/213 (43%), Gaps = 27/213 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           IG+G F  V R V          +GH+     A K +N +      H++   E     ++
Sbjct: 12  IGKGAFSVVRRCV-------KLCTGHE----YAAKIINTKKLSARDHQKLEREARICRLL 60
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KH N+V+L    +E+   G    LV++L+    L + +++R     A  +     Q    
Sbjct: 61  KHSNIVRLHDSISEE---GFH-YLVFDLVTGGELFEDIVAREYYSEADASH--CIQQILE 114
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXXXXXX 269
            + + H+     ++ RD K  N+LL    K    KL+DFGLA +   +G           
Sbjct: 115 AVLHCHQ---MGVVHRDLKPENLLLASKCKGAAVKLADFGLAIE--VQGDQQAWFGFAGT 169
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y +PE ++        D+W+ GV+LY L+ G
Sbjct: 170 PGYLSPEVLRKEAYGKPVDIWACGVILYILLVG 202

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 17/118 (14%)
Query: 193 RVPTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           ++P  +A  +I  + +A D+   L Y+H         RD K  N+LLD +   +L+DFG 
Sbjct: 171 KLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGS 221
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGR 303
             +   +G             Y +PE +Q      G+   + D WS GV +YE++ G 
Sbjct: 222 CLKMNDDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 278

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 55/216 (25%), Positives = 89/216 (41%), Gaps = 24/216 (11%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           +IG+G F  V R + R      +T    +   V + +         ++   E +   ++K
Sbjct: 33  VIGKGPFSVVRRCINR------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK 86
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR- 212
           HP++V+L+   + D   GM   +V+E M    L   ++ R      ++    +A    R 
Sbjct: 87  HPHIVELLETYSSD---GML-YMVFEFMDGADLCFEIVKRADA--GFVYSEAVASHYMRQ 140
Query: 213 ---GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHXXXXX 266
               L Y H   D  +I RD K   +LL   +     KL  FG+A Q    GL       
Sbjct: 141 ILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGR 195
Query: 267 XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                + APE V+        DVW  GV+L+ L++G
Sbjct: 196 VGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSG 231

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 34/131 (25%), Positives = 54/131 (41%), Gaps = 10/131 (7%)
Query: 175 LLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN 234
           L++ E M    L   +  R           +I +D    + +LH      +  RD K  N
Sbjct: 102 LIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPEN 158
Query: 235 ILL---DEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWS 291
           +L    ++D   KL+DFG A++     L            Y APE +   +     D+WS
Sbjct: 159 LLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 292 FGVVLYELITG 302
            GV++Y L+ G
Sbjct: 215 LGVIMYILLCG 225

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 58/214 (27%), Positives = 86/214 (40%), Gaps = 33/214 (15%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R        D QT         A+K++  + F+     + E+     +  
Sbjct: 80  LGRGSFGEVHR------MKDKQTG-----FQCAVKKVRLEVFR-----VEELVACAGLSS 123
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAAR 212
           P +V L G   E    G    +  EL+   SL   +  +  +P   A    L     A  
Sbjct: 124 PRIVPLYGAVRE----GPWVNIFMELLEGGSLGQLIKQMGCLPEDRA----LYYLGQALE 175
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHXXXXX---XX 268
           GL YLH     +++  D K  N+LL  D  +A L DFG A    P+GLG           
Sbjct: 176 GLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPG 232
Query: 269 XXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
              + APE V      AK D+WS   ++  ++ G
Sbjct: 233 TETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNG 266

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 73/294 (24%), Positives = 118/294 (40%), Gaps = 63/294 (21%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN------EVN 147
           L+G+GGFG V+ G        H+ +    +L VAIK + R    G     +      EV 
Sbjct: 38  LLGKGGFGTVFAG--------HRLT---DRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVA 86
Query: 148 FLGVVK----HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            L  V     HP +++L+ +  E  E  M  L++   +  + L D++  + P      +R
Sbjct: 87  LLWKVGAGGGHPGVIRLLDW-FETQEGFM--LVLERPLPAQDLFDYITEKGPLGEG-PSR 142
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEGLGHX 262
               Q  A  + + H      ++ RD K  NIL+D     AKL DFG         L H 
Sbjct: 143 CFFGQVVA-AIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSG------ALLHD 192
Query: 263 XXXXX--XXXXYAAPEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
                      Y+ PE++   +  A  + VWS G++LY+++ G    ER+     Q++LE
Sbjct: 193 EPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-----QEILE 247
Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
                               E ++              CL  +P SRP + E++
Sbjct: 248 -------------------AELHFPAHVSPDCCALIRRCLAPKPSSRPSLEEIL 282

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 17/118 (14%)
Query: 193 RVPTPLA--WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           ++P  +A  +I  + +A D+   L Y+H         RD K  N+LLD +   +L+DFG 
Sbjct: 187 KLPEDMARFYIGEMVLAIDSIHQLHYVH---------RDIKPDNVLLDVNGHIRLADFGS 237
Query: 251 ARQGPPEGLGHXXXXXXXXXXYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGR 303
             +   +G             Y +PE +Q      G+   + D WS GV +YE++ G 
Sbjct: 238 CLKMNDDGTVQ-SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 294

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G F  V R +   +  ++           A K +N +      H++   E     ++
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEY-----------AAKIINTKKLSARDHQKLEREARICRLL 60
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPN+V+L    +E+   G    LV++L+    L + +++R               DA+ 
Sbjct: 61  KHPNIVRLHDSISEE---GFH-YLVFDLVTGGELFEDIVAR---------EYYSEADASH 107
Query: 213 GLAYLHEEMDF----QLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXX 265
            +  + E ++      ++ RD K  N+LL    K    KL+DFGLA +   +G       
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFG 165
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                 Y +PE ++        D+W+ GV+LY L+ G
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 63/171 (36%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 274 APEYVQTGRLTAKS-----------DVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++    + ++           DVWS G +LY +  G+   ++              
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 269
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 270 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+               ++    A K +  +  +  +++I E+  L    H
Sbjct: 27  LGDGAFGKVYKA-----------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH 75
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P +VKL+G    D     +  ++ E     ++ D ++  +   L       + +     L
Sbjct: 76  PYIVKLLGAYYHDG----KLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEAL 130
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            +LH +   ++I RD K  N+L+  +   +L+DFG++ +                  + A
Sbjct: 131 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMA 185
Query: 275 PEYV--QTGRLTA---KSDVWSFGVVLYEL 299
           PE V  +T + T    K+D+WS G+ L E+
Sbjct: 186 PEVVMCETMKDTPYDYKADIWSLGITLIEM 215

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 121 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 179
Query: 274 APEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++             +++ KSDVWS G +LY +  G+   ++              
Sbjct: 180 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 225
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 226 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 275

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 117 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 175
Query: 274 APEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++             +++ KSDVWS G +LY +  G+   ++              
Sbjct: 176 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 221
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 222 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 271

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 195
Query: 274 APEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++             +++ KSDVWS G +LY +  G+   ++              
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 241
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 242 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/210 (22%), Positives = 90/210 (42%), Gaps = 26/210 (12%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+               ++    A K +  +  +  +++I E+  L    H
Sbjct: 19  LGDGAFGKVYKA-----------KNKETGALAAAKVIETKSEEELEDYIVEIEILATCDH 67
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P +VKL+G    D     +  ++ E     ++ D ++  +   L       + +     L
Sbjct: 68  PYIVKLLGAYYHDG----KLWIMIEFCPGGAV-DAIMLELDRGLTEPQIQVVCRQMLEAL 122
Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAA 274
            +LH +   ++I RD K  N+L+  +   +L+DFG++ +                  + A
Sbjct: 123 NFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKN--LKTLQKRDSFIGTPYWMA 177
Query: 275 PEYV--QTGRLTA---KSDVWSFGVVLYEL 299
           PE V  +T + T    K+D+WS G+ L E+
Sbjct: 178 PEVVMCETMKDTPYDYKADIWSLGITLIEM 207

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 98/233 (42%), Gaps = 45/233 (19%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLGV 151
           +G+G +G V++ + R + +            VA+K++    FQ   +      E+  L  
Sbjct: 17  LGKGAYGIVWKSIDRRTGEV-----------VAVKKI-FDAFQNSTDAQRTFREIMILTE 64
Query: 152 VK-HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           +  H N+V L+     D++R +   LV++ M     + H + R    L  + +  +    
Sbjct: 65  LSGHENIVNLLNVLRADNDRDV--YLVFDYMET---DLHAVIRANI-LEPVHKQYVVYQL 118
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR---------QGPPEGLGH 261
            + + YLH      L+ RD K SNILL+ +   K++DFGL+R            P  +  
Sbjct: 119 IKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175
Query: 262 XXXX----------XXXXXXYAAPEY-VQTGRLTAKSDVWSFGVVLYELITGR 303
                               Y APE  + + + T   D+WS G +L E++ G+
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGK 228

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 223
Query: 274 APEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++             +++ KSDVWS G +LY +  G+   ++              
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 269
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 270 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 52/217 (23%), Positives = 93/217 (42%), Gaps = 35/217 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G F  V R +   +  ++           A K +N +      H++   E     ++
Sbjct: 12  LGKGAFSVVRRCMKIPTGQEY-----------AAKIINTKKLSARDHQKLEREARICRLL 60
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPN+V+L    +E+   G    LV++L+    L + +++R               DA+ 
Sbjct: 61  KHPNIVRLHDSISEE---GFH-YLVFDLVTGGELFEDIVAR---------EYYSEADASH 107
Query: 213 GLAYLHEEMDF----QLIFRDFKTSNILLDEDYKA---KLSDFGLARQGPPEGLGHXXXX 265
            +  + E ++      ++ RD K  N+LL    K    KL+DFGLA +   +G       
Sbjct: 108 CIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIE--VQGDQQAWFG 165
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                 Y +PE ++        D+W+ GV+LY L+ G
Sbjct: 166 FAGTPGYLSPEVLRKDPYGKPVDMWACGVILYILLVG 202

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 71/162 (43%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  V HPN++ L        E     +L+ EL+    L D L  +    L+     
Sbjct: 65  EVSILRQVLHPNIITLHDVY----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
              +    G+ YLH +   ++   D K  NI LLD++      KL DFGLA +      G
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---G 172
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 118 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYM 176
Query: 274 APEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++             +++ KSDVWS G +LY +  G+   ++              
Sbjct: 177 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 222
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 223 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 272

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 56/241 (23%), Positives = 95/241 (39%), Gaps = 52/241 (21%)
Query: 89  FSRALLIGEGGFGCV----------YRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-Q 137
           F    ++G+G FG V          Y  + ++   + + S   S++ + +  LN Q   +
Sbjct: 8   FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXL-LASLNHQYVVR 66
Query: 138 GHKEWINEVNFL----GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR 193
            +  W+   NF+     V K   L     YC        +   +Y+L+H+++L       
Sbjct: 67  YYAAWLERRNFVKPXTAVKKKSTLFIQXEYC--------ENRTLYDLIHSENLNQQ---- 114
Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR- 252
                 W    ++ +     L+Y+H +    +I R+ K  NI +DE    K+ DFGLA+ 
Sbjct: 115 --RDEYW----RLFRQILEALSYIHSQ---GIIHRNLKPXNIFIDESRNVKIGDFGLAKN 165
Query: 253 ------------QGPPEGLGHXXXXXXXXXXYAAPEYVQ-TGRLTAKSDVWSFGVVLYEL 299
                       Q  P G             Y A E +  TG    K D +S G++ +E 
Sbjct: 166 VHRSLDILKLDSQNLP-GSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFEX 224
Query: 300 I 300
           I
Sbjct: 225 I 225

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/171 (23%), Positives = 65/171 (38%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 165 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYM 223
Query: 274 APEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++             +++ KSDVWS G +LY +  G+   ++              
Sbjct: 224 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 269
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 270 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 319

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 90  SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL 149
           +  L +G G FG V+R       +D QT         A+K++  + F+       E+   
Sbjct: 96  THQLRLGRGSFGEVHR------MEDKQTG-----FQCAVKKVRLEVFRA-----EELMAC 139
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             +  P +V L G   E    G    +  EL+   SL    L +    L     L     
Sbjct: 140 AGLTSPRIVPLYGAVRE----GPWVNIFMELLEGGSLGQ--LVKEQGCLPEDRALYYLGQ 193
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHXXXXX-- 266
           A  GL YLH     +++  D K  N+LL  D   A L DFG A    P+GLG        
Sbjct: 194 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 267 -XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                 + APE V      AK DVWS   ++  ++ G
Sbjct: 251 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 287

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 23/158 (14%)
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK---IAQD 209
           +HPN++ L      DD  G    LV ELM    L D +L +      + +  +   +   
Sbjct: 79  QHPNIITLKD--VYDD--GKHVYLVTELMRGGELLDKILRQ-----KFFSEREASFVLHT 129
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNIL-LDEDYKA---KLSDFGLARQGPPE-GLGHXXX 264
             + + YLH +    ++ RD K SNIL +DE       ++ DFG A+Q   E GL     
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL---LM 183
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  + APE ++        D+WS G++LY ++ G
Sbjct: 184 TPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 71/158 (44%), Gaps = 23/158 (14%)
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK---IAQD 209
           +HPN++ L      DD  G    LV ELM    L D +L +      + +  +   +   
Sbjct: 79  QHPNIITLKD--VYDD--GKHVYLVTELMRGGELLDKILRQ-----KFFSEREASFVLHT 129
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNIL-LDEDYKA---KLSDFGLARQGPPE-GLGHXXX 264
             + + YLH +    ++ RD K SNIL +DE       ++ DFG A+Q   E GL     
Sbjct: 130 IGKTVEYLHSQ---GVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGL---LM 183
Query: 265 XXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                  + APE ++        D+WS G++LY ++ G
Sbjct: 184 TPCYTANFVAPEVLKRQGYDEGCDIWSLGILLYTMLAG 221

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 64/221 (28%), Positives = 93/221 (42%), Gaps = 41/221 (18%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F R   +G G +G V++  VR        S  D +L    + ++   F+G K+   ++  
Sbjct: 59  FQRLSRLGHGSYGEVFK--VR--------SKEDGRLYAVKRSMSP--FRGPKDRARKLAE 106
Query: 149 LG----VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           +G    V +HP  V+L     +  E G    L  EL    SL+ H         AW A L
Sbjct: 107 VGSHEKVGQHPCCVRL----EQAWEEGGILYLQTELC-GPSLQQHCE-------AWGASL 154
Query: 205 KIAQ------DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
             AQ      D    LA+LH +    L+  D K +NI L    + KL DFGL  +    G
Sbjct: 155 PEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG 211
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
            G           Y APE +Q G     +DV+S G+ + E+
Sbjct: 212 AGE---VQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEV 248

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 57/234 (24%), Positives = 94/234 (40%), Gaps = 38/234 (16%)
Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL---NRQGFQGHKEWINE 145
           F     +G GGFG V+    +V  DD          + AIK++   NR+     ++ + E
Sbjct: 7   FEPIQCLGRGGFGVVFEAKNKV--DD---------CNYAIKRIRLPNRE--LAREKVMRE 53
Query: 146 VNFLGVVKHPNLVK-----LVGYCAEDDERGMQRLLVY---ELMHNKSLEDHLLSRVPTP 197
           V  L  ++HP +V+     L     E  +    ++ +Y   +L   ++L+D +  R    
Sbjct: 54  VKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE 113
Query: 198 -LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG-- 254
                  L I    A  + +LH +    L+ RD K SNI    D   K+ DFGL      
Sbjct: 114 ERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQ 170
Query: 255 --------PPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELI 300
                    P               Y +PE +     + K D++S G++L+EL+
Sbjct: 171 DEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/171 (22%), Positives = 63/171 (36%), Gaps = 27/171 (15%)
Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYA 273
           L  +H      ++  D K +N L+  D   KL DFG+A Q  P+              Y 
Sbjct: 137 LEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQVGTVNYM 195
Query: 274 APEYVQTGRLTAKS-----------DVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            PE ++    + ++           DVWS G +LY +  G+   ++              
Sbjct: 196 PPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ-------------- 241
Query: 323 PYVSDSKKFHLIIDPRLEGNYCIXXXXXXXXXXXXCLTKQPKSRPKMSEVV 373
             ++   K H IIDP  E  +              CL + PK R  + E++
Sbjct: 242 -IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELL 291

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 90/213 (42%), Gaps = 31/213 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           +G+G FG VY  + R   +    +     L V  K QL ++G +   +   E+     ++
Sbjct: 23  LGKGKFGNVY--LAREKQNKFIMA-----LKVLFKSQLEKEGVE--HQLRREIEIQSHLR 73
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVY----ELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           HPN++++  Y    D + +  +L +    EL   K L+ H          ++  L     
Sbjct: 74  HPNILRMYNYF--HDRKRIYLMLEFAPRGELY--KELQKHGRFDEQRSATFMEEL----- 124
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A  L Y HE    ++I RD K  N+L+    + K++DFG +   P              
Sbjct: 125 -ADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGT 176
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y  PE ++      K D+W  GV+ YE + G
Sbjct: 177 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 209

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 46.2 bits (108), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 54/213 (25%), Positives = 91/213 (42%), Gaps = 31/213 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           +G+G FG VY  + R   +    +     L V  K QL ++G +   +   E+     ++
Sbjct: 22  LGKGKFGNVY--LAREKQNKFIMA-----LKVLFKSQLEKEGVE--HQLRREIEIQSHLR 72
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVY----ELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           HPN++++  Y    D + +  +L +    EL   K L+ H   R     +        ++
Sbjct: 73  HPNILRMYNYF--HDRKRIYLMLEFAPRGELY--KELQKH--GRFDEQRSAT----FMEE 122
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXX 269
            A  L Y HE    ++I RD K  N+L+    + K++DFG +   P              
Sbjct: 123 LADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAP----SLRRRXMCGT 175
Query: 270 XXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
             Y  PE ++      K D+W  GV+ YE + G
Sbjct: 176 LDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVG 208

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 60/217 (27%), Positives = 85/217 (39%), Gaps = 29/217 (13%)
Query: 90  SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL 149
           +  L +G G FG V+R       +D QT         A+K++  + F+       E+   
Sbjct: 77  THQLRLGRGSFGEVHR------MEDKQTG-----FQCAVKKVRLEVFRA-----EELMAC 120
Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
             +  P +V L G   E    G    +  EL+   SL    L +    L     L     
Sbjct: 121 AGLTSPRIVPLYGAVRE----GPWVNIFMELLEGGSLGQ--LVKEQGCLPEDRALYYLGQ 174
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHXXXXX-- 266
           A  GL YLH     +++  D K  N+LL  D   A L DFG A    P+GLG        
Sbjct: 175 ALEGLEYLHSR---RILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDY 231
Query: 267 -XXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                 + APE V      AK DVWS   ++  ++ G
Sbjct: 232 IPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNG 268

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 56/222 (25%), Positives = 90/222 (40%), Gaps = 39/222 (17%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-QLNRQGFQGHKEWINEVNFLGVVK 153
           +G+G FG VY           + S     L V  K Q+ ++G +   +   E+     + 
Sbjct: 31  LGKGKFGNVYLA-------REKKSHFIVALKVLFKSQIEKEGVE--HQLRREIEIQAHLH 81
Query: 154 HPNLVKLVGYCAEDDERGMQRLLVY--------ELMHNKSLEDHLLSRVPTPLAWIARLK 205
           HPN+++L  Y    D R +  +L Y        EL  + + ++    R  T         
Sbjct: 82  HPNILRLYNYFY--DRRRIYLILEYAPRGELYKELQKSCTFDE---QRTAT--------- 127
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           I ++ A  L Y H +   ++I RD K  N+LL    + K++DFG +   P          
Sbjct: 128 IMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELKIADFGWSVHAP----SLRRKT 180
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE 307
                 Y  PE ++      K D+W  GV+ YEL+ G    E
Sbjct: 181 MCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPFE 222

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HP ++K+  +   +D       +V ELM    L D ++       A   +
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEA-TCK 242
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLG 260
           L   Q     + YLHE     +I RD K  N+LL   +ED   K++DFG ++     G  
Sbjct: 243 LYFYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGET 295
Query: 261 HXXXXXXXXXXYAAPEY---VQTGRLTAKSDVWSFGVVLYELITG 302
                      Y APE    V T       D WS GV+L+  ++G
Sbjct: 296 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/184 (24%), Positives = 75/184 (40%), Gaps = 25/184 (13%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           E+  L  ++H N+++LV     ++++ M  ++ Y +   + + D +  +         R 
Sbjct: 56  EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEK---------RF 106
Query: 205 KIAQDAAR------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
            + Q          GL YLH +    ++ +D K  N+LL      K+S  G+A    P  
Sbjct: 107 PVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFA 163
Query: 259 LGHXXXXXXXXXXYAAPEYVQTGRLTA---KSDVWSFGVVLYELITGRRAVERNLPRNEQ 315
                        +  PE +  G  T    K D+WS GV LY + TG    E +   N  
Sbjct: 164 ADDTCRTSQGSPAFQPPE-IANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD---NIY 219
Query: 316 KLLE 319
           KL E
Sbjct: 220 KLFE 223

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 69/165 (41%), Gaps = 19/165 (11%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HP ++K+  +   +D       +V ELM    L D ++       A   +
Sbjct: 203 TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGNKRLKEA-TCK 256
Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLG 260
           L   Q     + YLHE     +I RD K  N+LL   +ED   K++DFG ++     G  
Sbjct: 257 LYFYQ-MLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI---LGET 309
Query: 261 HXXXXXXXXXXYAAPEY---VQTGRLTAKSDVWSFGVVLYELITG 302
                      Y APE    V T       D WS GV+L+  ++G
Sbjct: 310 SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 354

>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317

Iteration: 1
 Score = 45.8 bits (107), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 55/220 (25%), Positives = 84/220 (38%), Gaps = 26/220 (11%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEGGF   Y  +V    D H           A+K++     Q  +E   E +   +  H
Sbjct: 37  LGEGGFS--YVDLVEGLHDGH---------FYALKRILCHEQQDREEAQREADMHRLFNH 85
Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAAR 212
           PN+++LV YC  +     +  L+       +L + +  L      L     L +     R
Sbjct: 86  PNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXX---- 268
           GL  +H +       RD K +NILL ++ +  L D G   Q      G            
Sbjct: 146 GLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAA 202
Query: 269 ---XXXYAAPEYVQTGR---LTAKSDVWSFGVVLYELITG 302
                 Y APE         +  ++DVWS G VLY ++ G
Sbjct: 203 QRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFG 242

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 69/171 (40%), Gaps = 31/171 (18%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HP ++K+  +   +D       +V ELM    L D ++           R
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGN--------KR 110
Query: 204 LKIAQ------DAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQG 254
           LK A            + YLHE     +I RD K  N+LL   +ED   K++DFG ++  
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 255 PPEGLGHXXXXXXXXXXYAAPEY---VQTGRLTAKSDVWSFGVVLYELITG 302
              G             Y APE    V T       D WS GV+L+  ++G
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 69/171 (40%), Gaps = 31/171 (18%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HP ++K+  +   +D       +V ELM    L D ++           R
Sbjct: 63  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGN--------KR 109
Query: 204 LKIAQ------DAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQG 254
           LK A            + YLHE     +I RD K  N+LL   +ED   K++DFG ++  
Sbjct: 110 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 166
Query: 255 PPEGLGHXXXXXXXXXXYAAPEY---VQTGRLTAKSDVWSFGVVLYELITG 302
              G             Y APE    V T       D WS GV+L+  ++G
Sbjct: 167 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 214

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 69/171 (40%), Gaps = 31/171 (18%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HP ++K+  +   +D       +V ELM    L D ++           R
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGN--------KR 110
Query: 204 LKIAQ------DAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQG 254
           LK A            + YLHE     +I RD K  N+LL   +ED   K++DFG ++  
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 255 PPEGLGHXXXXXXXXXXYAAPEY---VQTGRLTAKSDVWSFGVVLYELITG 302
              G             Y APE    V T       D WS GV+L+  ++G
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 69/171 (40%), Gaps = 31/171 (18%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HP ++K+  +   +D       +V ELM    L D ++           R
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGN--------KR 110
Query: 204 LKIAQ------DAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQG 254
           LK A            + YLHE     +I RD K  N+LL   +ED   K++DFG ++  
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL 167
Query: 255 PPEGLGHXXXXXXXXXXYAAPEY---VQTGRLTAKSDVWSFGVVLYELITG 302
              G             Y APE    V T       D WS GV+L+  ++G
Sbjct: 168 ---GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 69/171 (40%), Gaps = 31/171 (18%)
Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
            E+  L  + HP ++K+  +   +D       +V ELM    L D ++           R
Sbjct: 70  TEIEILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGN--------KR 116
Query: 204 LKIAQ------DAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQG 254
           LK A            + YLHE     +I RD K  N+LL   +ED   K++DFG ++  
Sbjct: 117 LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 172
Query: 255 PPEGLGHXXXXXXXXXXYAAPEY---VQTGRLTAKSDVWSFGVVLYELITG 302
              G             Y APE    V T       D WS GV+L+  ++G
Sbjct: 173 --LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 221

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 45.4 bits (106), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 56/236 (23%), Positives = 87/236 (36%), Gaps = 44/236 (18%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGV 151
           LIG G +G V     ++            K  VAIK++ R  +     K  + E+  L  
Sbjct: 60  LIGTGSYGHVCEAYDKLE-----------KRVVAIKKILRVFEDLIDCKRILREIAILNR 108
Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H ++VK++      D      L V   + +   +   L R P  L  +    +  +  
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKK--LFRTPVYLTELHIKTLLYNLL 166
Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-------------GPPE- 257
            G+ Y+H      ++ RD K +N L+++D   K+ DFGLAR               P E 
Sbjct: 167 VGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 258 -----------GLGHXXXXXXXXXXYAAPEYVQTGR-LTAKSDVWSFGVVLYELIT 301
                       L            Y APE +      T   DVWS G +  EL+ 
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 21/109 (19%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           KIA    + L +LH ++   +I RD K SN+L++   + K+ DFG++        G+   
Sbjct: 157 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS--------GYLVD 206
Query: 265 XXXXX-----XXYAAPEYV-----QTGRLTAKSDVWSFGVVLYELITGR 303
                       Y APE +     Q G  + KSD+WS G+ + EL   R
Sbjct: 207 SVAKTIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILR 254

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 49/97 (50%), Gaps = 11/97 (11%)
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNIL-LDEDYKA---KLSDFGLARQGPPE-GLGHXXXX 265
            + + YLH +    ++ RD K SNIL +DE       ++ DFG A+Q   E GL      
Sbjct: 126 TKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGL---LXT 179
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                 + APE ++     A  D+WS GV+LY  +TG
Sbjct: 180 PCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTG 216

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 77/187 (41%), Gaps = 34/187 (18%)
Query: 142 WINEVNFLGVV--KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLA 199
           W  E      V  +H N++  +    +      Q  L+ +   N SL D+L S   T L 
Sbjct: 76  WFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS---TTLD 132
Query: 200 WIARLKIAQDAARGLAYLHEEM-----DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
             + LK+A  +  GL +LH E+        +  RD K+ NIL+ ++    ++D GLA + 
Sbjct: 133 AKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKF 192
Query: 255 ---------PPEGLGHXXXXXXXXXXYAAPEYVQTG------RLTAKSDVWSFGVVLYEL 299
                    PP               Y  PE +         +    +D++SFG++L+E+
Sbjct: 193 ISDTNEVDIPPN-------TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245
Query: 300 ITGRRAV 306
              RR V
Sbjct: 246 --ARRCV 250

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 45.1 bits (105), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 40/141 (28%), Positives = 59/141 (41%), Gaps = 15/141 (10%)
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           Q    G++Y H     Q+  RD K  N LLD     + K+ DFG ++      L      
Sbjct: 123 QQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKS 176
Query: 266 XXXXXXYAAPEYVQTGRLTAK-SDVWSFGVVLYELITGRRAVE-RNLPRNEQKLLEWVRP 323
                 Y APE +       K +DVWS GV LY ++ G    E    PR+ +K ++ +  
Sbjct: 177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRIL- 235
Query: 324 YVSDSKKFHLIIDPRLEGNYC 344
               S K+ +  D R+    C
Sbjct: 236 ----SVKYSIPDDIRISPECC 252

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 45.1 bits (105), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 69/154 (44%), Gaps = 16/154 (10%)
Query: 147 NFLGVVKHPNLVKLVGYCAEDDERG-MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
            FL  V HP++V++  +    D  G     +V E +  +SL+     ++P   A    L+
Sbjct: 131 QFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEAIAYLLE 190
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXX 265
           I       L+YLH      L++ D K  NI+L E+ + KL D G   +      G+    
Sbjct: 191 ILP----ALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY---- 236
Query: 266 XXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYEL 299
                 + APE V+TG  T  +D+++ G  L  L
Sbjct: 237 LYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAAL 269

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 56/218 (25%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL----NRQGFQGHKEWINEVNFLG 150
           IGEG +G V++   R   + H+         VA+K++    + +G       + E+  L 
Sbjct: 10  IGEGTYGTVFKAKNR---ETHEI--------VALKRVRLDDDDEGVPSSA--LREICLLK 56
Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            +KH N+V+L      D     +  LV+E   ++ L+ +  S        I +  + Q  
Sbjct: 57  ELKHKNIVRLHDVLHSDK----KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ-L 110
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXX 269
            +GL + H      ++ RD K  N+L++ + + KL+DFGLAR  G P             
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPV---RCYSAEVVT 164
Query: 270 XXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
             Y  P+ +   +L + S D+WS G +  EL    R +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPL 202

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 44.3 bits (103), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 42/145 (28%), Positives = 59/145 (40%), Gaps = 28/145 (19%)
Query: 176 LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI 235
           LV+E M   S+  H+  R       +    + QD A  L +LH +    +  RD K  NI
Sbjct: 88  LVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENI 142
Query: 236 LLDEDYKA---KLSDFGLARQ----------GPPEGLGHXXXXXXXXXXYAAPEYVQTGR 282
           L +   +    K+ DFGL               PE L            Y APE V+   
Sbjct: 143 LCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELL-----TPCGSAEYMAPEVVEAFS 197
Query: 283 LTA-----KSDVWSFGVVLYELITG 302
             A     + D+WS GV+LY L++G
Sbjct: 198 EEASIYDKRCDLWSLGVILYILLSG 222

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/109 (30%), Positives = 51/109 (46%), Gaps = 21/109 (19%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXX 264
           KIA    + L +LH ++   +I RD K SN+L++   + K+ DFG++        G+   
Sbjct: 113 KIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGIS--------GYLVD 162
Query: 265 XXXX-----XXXYAAPEYV-----QTGRLTAKSDVWSFGVVLYELITGR 303
                       Y APE +     Q G  + KSD+WS G+ + EL   R
Sbjct: 163 DVAKDIDAGCKPYMAPERINPELNQKG-YSVKSDIWSLGITMIELAILR 210

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 43.5 bits (101), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/246 (21%), Positives = 99/246 (40%), Gaps = 40/246 (16%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI--NEVNFLGVV 152
           +G G FG V+R V        +TS   + +   +K       +G  + +   E++ L + 
Sbjct: 13  LGRGEFGIVHRCV--------ETSSKKTYMAKFVK------VKGTDQVLVKKEISILNIA 58
Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA---QD 209
           +H N++ L     E  E   + ++++E +    +      R+ T    +   +I      
Sbjct: 59  RHRNILHL----HESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQ 110
Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHXXXXXX 267
               L +LH      +   D +  NI+         K+ +FG ARQ  P   G       
Sbjct: 111 VCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLF 164
Query: 268 XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR--PYV 325
               Y APE  Q   ++  +D+WS G ++Y L++G   +   L    Q+++E +    Y 
Sbjct: 165 TAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSG---INPFLAETNQQIIENIMNAEYT 221
Query: 326 SDSKKF 331
            D + F
Sbjct: 222 FDEEAF 227

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 27/75 (36%), Positives = 35/75 (46%), Gaps = 1/75 (1%)
Query: 228 RDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHXXXXXXXXXXYAAPEYVQTGRLTAKS 287
           RD K  NIL+  D  A L DFG+A     E L            Y APE       T ++
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLY-YXAPERFSESHATYRA 216
Query: 288 DVWSFGVVLYELITG 302
           D+++   VLYE +TG
Sbjct: 217 DIYALTCVLYECLTG 231

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 165 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 217
Query: 262 XXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                     Y  APE +   +     D+WS GV++Y L+ G
Sbjct: 218 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 259

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 126 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 178
Query: 262 XXXXXX-XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      Y APE +   +     D+WS GV++Y L+ G
Sbjct: 179 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 220

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 173
Query: 262 XXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                     Y  APE +   +     D+WS GV++Y L+ G
Sbjct: 174 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 120 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 172
Query: 262 XXXXXXXXX-XYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      Y APE +   +     D+WS GV++Y L+ G
Sbjct: 173 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 214

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 171
Query: 262 XXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                     Y  APE +   +     D+WS GV++Y L+ G
Sbjct: 172 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 171 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 223
Query: 262 XXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                     Y  APE +   +     D+WS GV++Y L+ G
Sbjct: 224 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 265

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 125 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 177
Query: 262 XXXXXX-XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      Y APE +   +     D+WS GV++Y L+ G
Sbjct: 178 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 219

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 121 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 173
Query: 262 XXXXXXXXX-XYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      Y APE +   +     D+WS GV++Y L+ G
Sbjct: 174 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 215

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           Q    G++Y H     Q+  RD K  N LLD     + K+ DFG ++      L      
Sbjct: 122 QQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKS 175
Query: 266 XXXXXXYAAPEYVQTGRLTAK-SDVWSFGVVLYELITGRRAVE-RNLPRNEQKLLEWV 321
                 Y APE +       K +DVWS GV LY ++ G    E    P+N +K +  +
Sbjct: 176 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 127 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 179
Query: 262 XXXXXX-XXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      Y APE +   +     D+WS GV++Y L+ G
Sbjct: 180 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 221

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 119 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 171
Query: 262 XXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                     Y  APE +   +     D+WS GV++Y L+ G
Sbjct: 172 NSLTEPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 213

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/102 (28%), Positives = 43/102 (42%), Gaps = 11/102 (10%)
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKAKLSDFGLARQGPPEGLGH 261
           +I +     + YLH      +  RD K  N+L      +   KL+DFG A+    E   H
Sbjct: 135 EIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK----ETTSH 187
Query: 262 XXXXXXXXXXY-AAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                     Y  APE +   +     D+WS GV++Y L+ G
Sbjct: 188 NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 229

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 50/118 (42%), Gaps = 10/118 (8%)
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           Q    G++Y H     Q+  RD K  N LLD     + K+ DFG ++      L      
Sbjct: 121 QQLISGVSYCHA---MQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSS---VLHSQPKS 174
Query: 266 XXXXXXYAAPEYVQTGRLTAK-SDVWSFGVVLYELITGRRAVE-RNLPRNEQKLLEWV 321
                 Y APE +       K +DVWS GV LY ++ G    E    P+N +K +  +
Sbjct: 175 TVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 232

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  V H N++ L        E     +L+ EL+    L D L  +    L+     
Sbjct: 65  EVSILRQVLHHNVITLHDVY----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
              +    G+ YLH +   ++   D K  NI LLD++      KL DFGLA +      G
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---G 172
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  V H N++ L        E     +L+ EL+    L D L  +    L+     
Sbjct: 65  EVSILRQVLHHNVITLHDVY----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
              +    G+ YLH +   ++   D K  NI LLD++      KL DFGLA +      G
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---G 172
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  V H N++ L        E     +L+ EL+    L D L  +    L+     
Sbjct: 65  EVSILRQVLHHNVITLHDVY----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
              +    G+ YLH +   ++   D K  NI LLD++      KL DFGLA +      G
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---G 172
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  V H N++ L        E     +L+ EL+    L D L  +    L+     
Sbjct: 65  EVSILRQVLHHNVITLHDVY----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
              +    G+ YLH +   ++   D K  NI LLD++      KL DFGLA +      G
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---G 172
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 47/162 (29%), Positives = 70/162 (43%), Gaps = 16/162 (9%)
Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           EV+ L  V H N++ L        E     +L+ EL+    L D L  +    L+     
Sbjct: 65  EVSILRQVLHHNVITLHDVY----ENRTDVVLILELVSGGELFDFLAQK--ESLSEEEAT 118
Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNI-LLDEDY---KAKLSDFGLARQGPPEGLG 260
              +    G+ YLH +   ++   D K  NI LLD++      KL DFGLA +      G
Sbjct: 119 SFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---G 172
Query: 261 HXXXXXXXXXXYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
                      + APE V    L  ++D+WS GV+ Y L++G
Sbjct: 173 VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 214

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 42.4 bits (98), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 35/118 (29%), Positives = 51/118 (43%), Gaps = 10/118 (8%)
Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHXXXX 265
           Q    G++Y H     Q+  RD K  N LLD     + K++DFG ++      L      
Sbjct: 122 QQLISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRLKIADFGYSKAS---VLHSQPKS 175
Query: 266 XXXXXXYAAPEYVQTGRLTAK-SDVWSFGVVLYELITGRRAVE-RNLPRNEQKLLEWV 321
                 Y APE +       K +DVWS GV LY ++ G    E    P+N +K +  +
Sbjct: 176 AVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRI 233

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 96/218 (44%), Gaps = 31/218 (14%)
Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL----NRQGFQGHKEWINEVNFLG 150
           IGEG +G V++   R   + H+         VA+K++    + +G       + E+  L 
Sbjct: 10  IGEGTYGTVFKAKNR---ETHEI--------VALKRVRLDDDDEGVPSSA--LREICLLK 56
Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            +KH N+V+L      D     +  LV+E   ++ L+ +  S        I +  + Q  
Sbjct: 57  ELKHKNIVRLHDVLHSDK----KLTLVFEFC-DQDLKKYFDSCNGDLDPEIVKSFLFQ-L 110
Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHXXXXXXXX 269
            +GL + H      ++ RD K  N+L++ + + KL++FGLAR  G P             
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV---RCYSAEVVT 164
Query: 270 XXYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAV 306
             Y  P+ +   +L + S D+WS G +  EL    R +
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPL 202

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 78/174 (44%), Gaps = 37/174 (21%)
Query: 154 HPNLVKLVGYCAEDDERGMQ------RLLVYELMHNKSLEDH--LLSRVPTPLAWIARLK 205
           HPN+++   YC+E  +R +        L + +L+ +K++ D    L +   P++ + ++ 
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI- 142
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-------------EDYKAKLSDFGLAR 252
                A G+A+LH     ++I RD K  NIL+              E+ +  +SDFGL +
Sbjct: 143 -----ASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 253 Q--GPPEGLGHXXXXXXXXXXYAAPEYVQTG---RLTAKSDVWSFGVVLYELIT 301
           +                    + APE ++     RLT   D++S G V Y +++
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 42.4 bits (98), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 78/174 (44%), Gaps = 37/174 (21%)
Query: 154 HPNLVKLVGYCAEDDERGMQ------RLLVYELMHNKSLEDH--LLSRVPTPLAWIARLK 205
           HPN+++   YC+E  +R +        L + +L+ +K++ D    L +   P++ + ++ 
Sbjct: 86  HPNVIRY--YCSETTDRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI- 142
Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-------------EDYKAKLSDFGLAR 252
                A G+A+LH     ++I RD K  NIL+              E+ +  +SDFGL +
Sbjct: 143 -----ASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 194
Query: 253 Q--GPPEGLGHXXXXXXXXXXYAAPEYVQTG---RLTAKSDVWSFGVVLYELIT 301
           +                    + APE ++     RLT   D++S G V Y +++
Sbjct: 195 KLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFSMGCVFYYILS 248

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 41.6 bits (96), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 95/228 (41%), Gaps = 44/228 (19%)
Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           L+GEG +  V +G V + +            + A+K + +Q          EV  L   +
Sbjct: 20  LLGEGAYAKV-QGAVSLQNGK----------EYAVKIIEKQAGHSRSRVFREVETLYQCQ 68
Query: 154 -HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            + N+++L+ +  EDD R     LV+E +   S+  H+  +        +R  + +D A 
Sbjct: 69  GNKNILELIEF-FEDDTR---FYLVFEKLQGGSILAHIQKQKHFNEREASR--VVRDVAA 122
Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA---KLSDFGLARQ----------GPPEGL 259
            L +LH +    +  RD K  NIL +   K    K+ DF L               PE  
Sbjct: 123 ALDFLHTK---GIAHRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPE-- 177
Query: 260 GHXXXXXXXXXXYAAPEYVQ--TGRLT---AKSDVWSFGVVLYELITG 302
                       Y APE V+  T + T    + D+WS GVVLY +++G
Sbjct: 178 ---LTTPCGSAEYMAPEVVEVFTDQATFYDKRCDLWSLGVVLYIMLSG 222

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	453
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	1e-162
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-153
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-136
3soc_A	322	Activin receptor type-2A; structural genomics cons	4e-81
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-62
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-62
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	7e-61
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-60
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-58
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-57
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	2e-57
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-57
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	5e-57
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-56
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	1e-55
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-55
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	6e-55
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	2e-53
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	9e-44
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	1e-43
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	1e-43
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	3e-43
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	5e-43
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-42
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-42
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	5e-42
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-42
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-41
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-41
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-41
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-41
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-41
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	4e-41
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-41
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-40
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	1e-40
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-40
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	3e-40
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-40
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-40
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	8e-40
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-39
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-39
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-39
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	2e-39
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-39
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-39
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	5e-39
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	5e-39
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-39
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-39
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	9e-39
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	1e-38
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-38
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-38
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-38
4aoj_A	329	High affinity nerve growth factor receptor; transf	3e-38
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	4e-38
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	4e-38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	9e-38
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-37
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-37
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-37
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-37
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	2e-37
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-37
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-37
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-37
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-36
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-36
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-36
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	4e-36
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-36
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-36
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-36
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	8e-36
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	8e-36
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-35
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	4e-35
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	6e-35
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-34
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	4e-34
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-34
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-33
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-33
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-33
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	3e-33
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-33
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-33
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	8e-33
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	1e-32
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	2e-32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	3e-32
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	4e-32
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	9e-32
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-31
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-31
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-31
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-31
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-31
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	7e-31
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-30
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-30
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	4e-30
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	7e-30
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-29
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	3e-29
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	3e-29
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	3e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	5e-29
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	8e-29
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	1e-28
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	1e-28
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	2e-28
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	3e-28
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-28
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	6e-28
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	6e-28
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	7e-28
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-27
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	1e-27
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-27
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	2e-27
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-27
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	3e-27
2dyl_A	318	Dual specificity mitogen-activated protein kinase	5e-27
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-26
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-26
3an0_A	340	Dual specificity mitogen-activated protein kinase;	5e-26
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	1e-25
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-25
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	1e-25
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-25
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	2e-25
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	2e-25
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-25
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	2e-25
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-25
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	3e-25
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	4e-25
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	6e-25
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	6e-25
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	9e-25
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-24
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-24
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-24
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-24
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	4e-24
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	4e-24
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-24
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	8e-24
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-23
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	3e-23
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	8e-23
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-22
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-22
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-22
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	2e-22
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-22
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	4e-22
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	8e-22
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-21
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-21
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	1e-21
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-21
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	3e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-21
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	8e-21
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	9e-21
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-20
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-20
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	1e-20
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-20
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-20
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-20
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-20
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-20
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-20
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	9e-20
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-19
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-19
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-19
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	3e-19
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	8e-19
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-18
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-18
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-18
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	2e-18
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-18
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-18
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-18
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-18
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-18
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-18
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-18
3niz_A	311	Rhodanese family protein; structural genomics, str	8e-18
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	1e-17
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-17
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	2e-17
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-17
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-17
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-17
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-16
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	3e-16
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-16
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	7e-16
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	1e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	2e-15
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	2e-15
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	3e-15
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	5e-15
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	5e-15
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-14
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	3e-14
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-12
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	8e-12
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	2e-10
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	8e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	1e-09
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-09
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-08
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	2e-08
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-08
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	9e-08
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-07
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-07
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	5e-07
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	6e-07

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  458 bits (1180), Expect = e-162
 Identities = 113/325 (34%), Positives = 169/325 (52%), Gaps = 35/325 (10%)

Query: 68  QRRANDLRVFSFAELKSATRGFSRAL------LIGEGGFGCVYRGVVRVSSDDHQTSGHD 121
           +        FSF ELK+ T  F           +GEGGFG VY+G V    ++       
Sbjct: 6   EVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV----NNTT----- 56

Query: 122 SKLDVAIKQL----NRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLV 177
               VA+K+L    +    +  +++  E+  +   +H NLV+L+G+ ++ D       LV
Sbjct: 57  ----VAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGD----DLCLV 108

Query: 178 YELMHNKSLEDHLLSRVPT-PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL 236
           Y  M N SL D L     T PL+W  R KIAQ AA G+ +LHE      I RD K++NIL
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165

Query: 237 LDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL 296
           LDE + AK+SDFGLAR         +++ +VGT  Y APE +  G +T KSD++SFGVVL
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPKSDIYSFGVVL 224

Query: 297 YELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALAS 356
            E+ITG  AV+ +  R  Q LL+       + K     ID ++  +    S + + ++AS
Sbjct: 225 LEIITGLPAVDEH--REPQLLLDIKEEIEDEEKTIEDYIDKKM-NDADSTSVEAMYSVAS 281

Query: 357 KCLTKQPKSRPKMSEVVDILGNIIS 381
           +CL ++   RP + +V  +L  + +
Sbjct: 282 QCLHEKKNKRPDIKKVQQLLQEMTA 306

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  437 bits (1126), Expect = e-153
 Identities = 117/328 (35%), Positives = 173/328 (52%), Gaps = 22/328 (6%)

Query: 51  SDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRV 110
           S     ++S+      S     +       +L+ AT  F    LIG G FG VY+GV+  
Sbjct: 3   SKYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVL-- 60

Query: 111 SSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDER 170
              D           VA+K+   +  QG +E+  E+  L   +HP+LV L+G+C E +  
Sbjct: 61  --RDGAK--------VALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN-- 108

Query: 171 GMQRLLVYELMHNKSLEDHLL--SRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR 228
             + +L+Y+ M N +L+ HL         ++W  RL+I   AARGL YLH      +I R
Sbjct: 109 --EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHR 163

Query: 229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSD 288
           D K+ NILLDE++  K++DFG++++G      H+ST V GT+GY  PEY   GRLT KSD
Sbjct: 164 DVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSD 223

Query: 289 VWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSA 348
           V+SFGVVL+E++  R A+ ++LPR    L EW      ++ +   I+DP L      +S 
Sbjct: 224 VYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH-NNGQLEQIVDPNLADKIRPESL 282

Query: 349 QKLAALASKCLTKQPKSRPKMSEVVDIL 376
           +K    A KCL    + RP M +V+  L
Sbjct: 283 RKFGDTAVKCLALSSEDRPSMGDVLWKL 310

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  395 bits (1016), Expect = e-136
 Identities = 126/315 (40%), Positives = 186/315 (59%), Gaps = 24/315 (7%)

Query: 74  LRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR 133
           L+ FS  EL+ A+  FS   ++G GGFG VY+G +            D  L VA+K+L  
Sbjct: 17  LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLA-----------DGTL-VAVKRLKE 64

Query: 134 QGFQGHK-EWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS 192
           +  QG + ++  EV  + +  H NL++L G+C        +RLLVY  M N S+   L  
Sbjct: 65  ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPT----ERLLVYPYMANGSVASCLRE 120

Query: 193 RVP--TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
           R     PL W  R +IA  +ARGLAYLH+  D ++I RD K +NILLDE+++A + DFGL
Sbjct: 121 RPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGL 180

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL 310
           A+        HV+T+V GT+G+ APEY+ TG+ + K+DV+ +GV+L ELITG+RA +   
Sbjct: 181 AKLM-DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239

Query: 311 PRNEQK--LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
             N+    LL+WV+  + + KK   ++D  L+GNY  +  ++L  +A  C    P  RPK
Sbjct: 240 LANDDDVMLLDWVKGLLKE-KKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPK 298

Query: 369 MSEVVDIL-GNIISE 382
           MSEVV +L G+ ++E
Sbjct: 299 MSEVVRMLEGDGLAE 313

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  252 bits (646), Expect = 4e-81
 Identities = 71/324 (21%), Positives = 120/324 (37%), Gaps = 38/324 (11%)

Query: 77  FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF 136
                L   +       +   G FGCV++  +                 VA+K    Q  
Sbjct: 14  LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNE-------------YVAVKIFPIQDK 60

Query: 137 QGHKEWINE--VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV 194
           Q    W NE  V  L  +KH N+++ +G         +   L+       SL D L +  
Sbjct: 61  Q---SWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN- 116

Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQL-------IFRDFKTSNILLDEDYKAKLSD 247
              ++W     IA+  ARGLAYLHE++             RD K+ N+LL  +  A ++D
Sbjct: 117 --VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIAD 174

Query: 248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-----RLTAKSDVWSFGVVLYELITG 302
           FGLA +         +   VGT  Y APE ++           + D+++ G+VL+EL + 
Sbjct: 175 FGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASR 234

Query: 303 RRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI----IDPRLEGNYCIKSA-QKLAALASK 357
             A +  +        E +  + S      ++      P L   +   +    L     +
Sbjct: 235 CTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294

Query: 358 CLTKQPKSRPKMSEVVDILGNIIS 381
           C     ++R     V + +  +  
Sbjct: 295 CWDHDAEARLSAGCVGERITQMQR 318

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  204 bits (521), Expect = 2e-62
 Identities = 71/347 (20%), Positives = 129/347 (37%), Gaps = 55/347 (15%)

Query: 77  FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF 136
            + +E            LIG G +G VY+G +                 VA+K  +    
Sbjct: 3   AAASEPSLDLDNLKLLELIGRGRYGAVYKGSLDER-------------PVAVKVFSFANR 49

Query: 137 QGHKEWINEVN--FLGVVKHPNLVKLVGYCAEDDERG-MQRLLVYELMHNKSLEDHLLSR 193
           Q    +INE N   + +++H N+ + +         G M+ LLV E   N SL  +L   
Sbjct: 50  Q---NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH 106

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDF------QLIFRDFKTSNILLDEDYKAKLSD 247
                 W++  ++A    RGLAYLH E+         +  RD  + N+L+  D    +SD
Sbjct: 107 ---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISD 163

Query: 248 FGLAR------QGPPEGLGHVSTSVVGTVGYAAPEYVQ-------TGRLTAKSDVWSFGV 294
           FGL+          P    + + S VGT+ Y APE ++             + D+++ G+
Sbjct: 164 FGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGL 223

Query: 295 VLYELITGRRAVERNLPRNEQKL-----------LEWVRPYVSDSKKFHLIIDPRLEGNY 343
           + +E+      +       E ++            E ++  VS  +K         + N 
Sbjct: 224 IYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSR-EKQRPKFPEAWKENS 282

Query: 344 CIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVT 390
              + + L      C  +  ++R       + +  ++        V+
Sbjct: 283 --LAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNKSVS 327

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  203 bits (518), Expect = 3e-62
 Identities = 85/319 (26%), Positives = 129/319 (40%), Gaps = 43/319 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V +   R               DVAIKQ+  +  +  K +I E+  L  V H
Sbjct: 16  VGRGAFGVVCKAKWR-------------AKDVAIKQIESESER--KAFIVELRQLSRVNH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-LAWIARLKIAQDAARG 213
           PN+VKL G C           LV E     SL + L    P P       +      ++G
Sbjct: 61  PNIVKLYGACLNP------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG 114

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYK-AKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           +AYLH      LI RD K  N+LL       K+ DFG A       +    T+  G+  +
Sbjct: 115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD-----IQTHMTNNKGSAAW 169

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFH 332
            APE  +    + K DV+S+G++L+E+IT R       P +E     +   +        
Sbjct: 170 MAPEVFEGSNYSEKCDVFSWGIILWEVITRR------KPFDEIGGPAFRIMWAV-HNGTR 222

Query: 333 LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTLQ 392
             +   L         + + +L ++C +K P  RP M E+V I+ +++      DE    
Sbjct: 223 PPLIKNLP--------KPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGADEPLQY 274

Query: 393 PVAEIEDVKEEPEAEAVVE 411
           P        E+   E  V+
Sbjct: 275 PCQHSLPPGEDGRVEPYVD 293

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  199 bits (509), Expect = 7e-61
 Identities = 70/314 (22%), Positives = 124/314 (39%), Gaps = 52/314 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG   +   R + +            + +K+L R   +  + ++ EV  +  ++H
Sbjct: 18  LGKGCFGQAIKVTHRETGEV-----------MVMKELIRFDEETQRTFLKEVKVMRCLEH 66

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PN++K +G       +  +   + E +   +L   + S   +   W  R+  A+D A G+
Sbjct: 67  PNVLKFIGVL----YKDKRLNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGM 121

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR------------QGPPEGLGHV 262
           AYLH  M+   I RD  + N L+ E+    ++DFGLAR            +   +     
Sbjct: 122 AYLHS-MNI--IHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKK 178

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL---E 319
             +VVG   + APE +       K DV+SFG+VL E+I    A    LPR     L    
Sbjct: 179 RYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRG 238

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI 379
           ++  Y   +        P                +  +C    P+ RP   ++   L  +
Sbjct: 239 FLDRYCPPN------CPP------------SFFPITVRCCDLDPEKRPSFVKLEHWLETL 280

Query: 380 ISEISSQDEVTLQP 393
              ++    +  Q 
Sbjct: 281 RMHLAGHLPLGPQL 294

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  197 bits (503), Expect = 5e-60
 Identities = 81/308 (26%), Positives = 128/308 (41%), Gaps = 65/308 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           IG G FG V+R                   DVA+K L  Q F      E++ EV  +  +
Sbjct: 45  IGAGSFGTVHRAEWH-------------GSDVAVKILMEQDFHAERVNEFLREVAIMKRL 91

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAA 211
           +HPN+V  +G       +     +V E +   SL   L        L    RL +A D A
Sbjct: 92  RHPNIVLFMGAVT----QPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVA 147

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           +G+ YLH   +  ++ R+ K+ N+L+D+ Y  K+ DFGL+R      L   S S  GT  
Sbjct: 148 KGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLS--SKSAAGTPE 204

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR-------------AVERNLPRNEQKLL 318
           + APE ++      KSDV+SFGV+L+EL T ++                +          
Sbjct: 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK-------- 256

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN 378
              R  +  +      ++P            ++AA+   C T +P  RP  + ++D+L  
Sbjct: 257 ---RLEIPRN------LNP------------QVAAIIEGCWTNEPWKRPSFATIMDLLRP 295

Query: 379 IISEISSQ 386
           +I      
Sbjct: 296 LIKSAVPP 303

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  192 bits (491), Expect = 1e-58
 Identities = 61/298 (20%), Positives = 113/298 (37%), Gaps = 60/298 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           + E   G +++G  +               D+ +K L  + +     +++  E   L + 
Sbjct: 18  LNENHSGELWKGRWQ-------------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIF 64

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ ++G C           L+   M   SL + L       +     +K A D AR
Sbjct: 65  SHPNVLPVLGACQSPPAPHP--TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMAR 122

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           G+A+LH  ++  +      + ++++DED  A++S   +            S   +    +
Sbjct: 123 GMAFLH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFS-------FQSPGRMYAPAW 174

Query: 273 AAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV-------- 321
            APE +Q          +D+WSF V+L+EL+T        +P  +   +E          
Sbjct: 175 VAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE------VPFADLSNMEIGMKVALEGL 228

Query: 322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI 379
           RP +         I P             ++ L   C+ + P  RPK   +V IL  +
Sbjct: 229 RPTIPPG------ISP------------HVSKLMKICMNEDPAKRPKFDMIVPILEKM 268

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  190 bits (484), Expect = 2e-57
 Identities = 76/304 (25%), Positives = 126/304 (41%), Gaps = 62/304 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-------KEWINEVN 147
           IG+GGFG V++G +              K  VAIK L     +G        +E+  EV 
Sbjct: 27  IGKGGFGLVHKGRLV-----------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVF 75

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +  + HPN+VKL G             +V E +    L   LL +   P+ W  +L++ 
Sbjct: 76  IMSNLNHPNIVKLYGLMHN------PPRMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLM 128

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-----DYKAKLSDFGLARQGPPEGLGHV 262
            D A G+ Y+    +  ++ RD ++ NI L          AK++DFGL++Q       H 
Sbjct: 129 LDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHS 182

Query: 263 STSVVGTVGYAAPE--YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW 320
            + ++G   + APE    +    T K+D +SF ++LY ++TG    +      + K +  
Sbjct: 183 VSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD-EYSYGKIKFINM 241

Query: 321 V-----RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
           +     RP + +         P            +L  +   C +  PK RP  S +V  
Sbjct: 242 IREEGLRPTIPED------CPP------------RLRNVIELCWSGDPKKRPHFSYIVKE 283

Query: 376 LGNI 379
           L  +
Sbjct: 284 LSEL 287

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  190 bits (485), Expect = 2e-57
 Identities = 70/309 (22%), Positives = 118/309 (38%), Gaps = 46/309 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINE--VNFLGV 151
            +G+G +G V+RG  +               +VA+K  + +  +    W  E  +    +
Sbjct: 15  CVGKGRYGEVWRGSWQGE-------------NVAVKIFSSRDEK---SWFRETELYNTVM 58

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           ++H N++  +           Q  L+       SL D+L       L  ++ L+I    A
Sbjct: 59  LRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT---TLDTVSCLRIVLSIA 115

Query: 212 RGLAYLHEEMDFQL-----IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG--LGHVST 264
            GLA+LH E+           RD K+ NIL+ ++ +  ++D GLA         L   + 
Sbjct: 116 SGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNN 175

Query: 265 SVVGTVGYAAPE------YVQTGRLTAKSDVWSFGVVLYELITG----RRAVERNLPRNE 314
             VGT  Y APE       V       + D+W+FG+VL+E+           +   P  +
Sbjct: 176 PRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYD 235

Query: 315 ----QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
                   E +R  V    +    I  R   +  + S   LA L  +C  + P +R    
Sbjct: 236 VVPNDPSFEDMRKVVCV-DQQRPNIPNRWFSDPTLTS---LAKLMKECWYQNPSARLTAL 291

Query: 371 EVVDILGNI 379
            +   L  I
Sbjct: 292 RIKKTLTKI 300

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  190 bits (485), Expect = 5e-57
 Identities = 64/313 (20%), Positives = 115/313 (36%), Gaps = 40/313 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINE--VNFLGV 151
            IG+G +G V+ G  R                VA+K            W  E  +    +
Sbjct: 44  QIGKGRYGEVWMGKWRGE-------------KVAVKVFFTTEEA---SWFRETEIYQTVL 87

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           ++H N++  +    +      Q  L+ +   N SL D+L S     L   + LK+A  + 
Sbjct: 88  MRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSV 144

Query: 212 RGLAYLHEEMDFQL-----IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG--LGHVST 264
            GL +LH E+           RD K+ NIL+ ++    ++D GLA +   +   +     
Sbjct: 145 SGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPN 204

Query: 265 SVVGTVGYAAPE------YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL 318
           + VGT  Y  PE           +    +D++SFG++L+E+   R      +   +    
Sbjct: 205 TRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVAR-RCVSGGIVEEYQLPYH 263

Query: 319 EWVRPYVSDSKKFHLIID----PRLEGNYCIKSA-QKLAALASKCLTKQPKSRPKMSEVV 373
           + V    S      ++      P     +      +++  L ++C    P SR     V 
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

Query: 374 DILGNIISEISSQ 386
             L  +      +
Sbjct: 324 KTLAKMSESQDIK 336

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  188 bits (479), Expect = 1e-56
 Identities = 84/297 (28%), Positives = 130/297 (43%), Gaps = 48/297 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           IG G FG VY+G                  DVA+K LN         + + NEV  L   
Sbjct: 32  IGSGSFGTVYKGKWHG--------------DVAVKMLNVTAPTPQQLQAFKNEVGVLRKT 77

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++  +GY         Q  +V +     SL  HL +   T       + IA+  AR
Sbjct: 78  RHVNILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTAR 131

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           G+ YLH +    +I RD K++NI L ED   K+ DFGLA +       H    + G++ +
Sbjct: 132 GMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILW 188

Query: 273 AAPE---YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQKLLEWVRPYV 325
            APE      +   + +SDV++FG+VLYEL+TG+      LP     N  +++E V    
Sbjct: 189 MAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ------LPYSNINNRDQIIEMV---G 239

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
             S    L        + C    +++  L ++CL K+   RP    ++  +  +  E
Sbjct: 240 RGSLSPDLSKVR----SNC---PKRMKRLMAECLKKKRDERPSFPRILAEIEELARE 289

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  187 bits (476), Expect = 1e-55
 Identities = 64/316 (20%), Positives = 122/316 (38%), Gaps = 46/316 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINE--VNFLGV 151
            IG+G FG V+RG  R               +VA+K  + +  +    W  E  +    +
Sbjct: 49  SIGKGRFGEVWRGKWRGE-------------EVAVKIFSSREER---SWFREAEIYQTVM 92

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           ++H N++  +    +D+    Q  LV +   + SL D+L       +     +K+A   A
Sbjct: 93  LRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTA 149

Query: 212 RGLAYLHEEMDFQL-----IFRDFKTSNILLDEDYKAKLSDFGLAR--QGPPEGLGHVST 264
            GLA+LH E+           RD K+ NIL+ ++    ++D GLA       + +     
Sbjct: 150 SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPN 209

Query: 265 SVVGTVGYAAPE------YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP------- 311
             VGT  Y APE       ++      ++D+++ G+V +E+         +         
Sbjct: 210 HRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYD 269

Query: 312 -RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
                  +E +R  V + +K    I  R +    ++    +A +  +C      +R    
Sbjct: 270 LVPSDPSVEEMRKVVCE-QKLRPNIPNRWQSCEALR---VMAKIMRECWYANGAARLTAL 325

Query: 371 EVVDILGNIISEISSQ 386
            +   L  +  +   +
Sbjct: 326 RIKKTLSQLSQQEGIK 341

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  184 bits (468), Expect = 3e-55
 Identities = 85/297 (28%), Positives = 120/297 (40%), Gaps = 52/297 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH----KEWINEVNFLG 150
           IG GGFG VYR             G +    VA+K       +      +    E     
Sbjct: 15  IGIGGFGKVYRAFWI---------GDE----VAVKAARHDPDEDISQTIENVRQEAKLFA 61

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           ++KHPN++ L G C ++        LV E      L   L  +    +     +  A   
Sbjct: 62  MLKHPNIIALRGVCLKEP----NLCLVMEFARGGPLNRVLSGK---RIPPDILVNWAVQI 114

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK--------AKLSDFGLARQGPPEGLGHV 262
           ARG+ YLH+E    +I RD K+SNIL+ +  +         K++DFGLAR    E     
Sbjct: 115 ARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTT 170

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
             S  G   + APE ++    +  SDVWS+GV+L+EL+TG       +P      L    
Sbjct: 171 KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE------VPFRGIDGLAVA- 223

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI 379
            Y     K  L I P      C    +  A L   C    P SRP  + ++D L  I
Sbjct: 224 -YGVAMNKLALPI-PS----TC---PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  180 bits (459), Expect = 2e-53
 Identities = 59/320 (18%), Positives = 109/320 (34%), Gaps = 77/320 (24%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           IG+G FG VY G            G     +VAI+ ++ +       K +  EV      
Sbjct: 41  IGKGRFGQVYHGRWH---------G-----EVAIRLIDIERDNEDQLKAFKREVMAYRQT 86

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N+V  +G C       +    +  L   ++L   +       L      +IAQ+  +
Sbjct: 87  RHENVVLFMGACMSPPHLAI----ITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVK 141

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS---TSVVGT 269
           G+ YLH +    ++ +D K+ N+  D   K  ++DFGL         G          G 
Sbjct: 142 GMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNGW 197

Query: 270 VGYAAPEYVQTGRL---------TAKSDVWSFGVVLYELITGRR------------AVER 308
           + + APE ++             +  SDV++ G + YEL                  +  
Sbjct: 198 LCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGT 257

Query: 309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
            +           +P +S                   K    ++ +   C   + + RP 
Sbjct: 258 GM-----------KPNLSQIG--------------MGKE---ISDILLFCWAFEQEERPT 289

Query: 369 MSEVVDILGNIISEISSQDE 388
            ++++D+L  +         
Sbjct: 290 FTKLMDMLEKLPKRNRRLSH 309

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  154 bits (391), Expect = 9e-44
 Identities = 71/299 (23%), Positives = 122/299 (40%), Gaps = 31/299 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V         D+           VA+K+L     +  +++  E+  L  ++H
Sbjct: 18  LGKGNFGSVEMCRYDPLQDNTGEV-------VAVKKLQHSTEEHLRDFEREIEILKSLQH 70

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+VK  G C     R ++  L+ E +   SL D+L       +  I  L+      +G+
Sbjct: 71  DNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGM 127

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL     +  I RD  T NIL++ + + K+ DFGL +  P +               + 
Sbjct: 128 EYL-GTKRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE--PGESPIF 182

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY--VSDSK 329
           + APE +   + +  SDVWSFGVVLYEL T     +   P  E   +        +    
Sbjct: 183 WYAPESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMIVFH 240

Query: 330 KFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
              L+ +    PR +G  C     ++  + ++C       RP   ++   +  I   ++
Sbjct: 241 LIELLKNNGRLPRPDG--C---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMA 294

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  155 bits (393), Expect = 1e-43
 Identities = 71/299 (23%), Positives = 124/299 (41%), Gaps = 31/299 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V         D+           VA+K+L     +  +++  E+  L  ++H
Sbjct: 49  LGKGNFGSVEMCRYDPLQDNTGEV-------VAVKKLQHSTEEHLRDFEREIEILKSLQH 101

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N+VK  G C     R ++  L+ E +   SL D+L       +  I  L+      +G+
Sbjct: 102 DNIVKYKGVCYSAGRRNLK--LIMEYLPYGSLRDYLQKHKER-IDHIKLLQYTSQICKGM 158

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL     +  I RD  T NIL++ + + K+ DFGL +  P +   +           + 
Sbjct: 159 EYL-GTKRY--IHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKE--PGESPIF 213

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY--VSDSK 329
           + APE +   + +  SDVWSFGVVLYEL T     +   P  E   +        +    
Sbjct: 214 WYAPESLTESKFSVASDVWSFGVVLYELFT--YIEKSKSPPAEFMRMIGNDKQGQMIVFH 271

Query: 330 KFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
              L+ +    PR +G  C     ++  + ++C       RP   ++   +  I  +++
Sbjct: 272 LIELLKNNGRLPRPDG--C---PDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQMA 325

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  154 bits (392), Expect = 1e-43
 Identities = 72/310 (23%), Positives = 119/310 (38%), Gaps = 30/310 (9%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V         D+           VA+KQL   G    +++  E+  L  +  
Sbjct: 31  LGKGNFGSVELCRYDPLGDNTGA-------LVAVKQLQHSGPDQQRDFQREIQILKALHS 83

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             +VK  G       + ++  LV E + +  L D L       L     L  +    +G+
Sbjct: 84  DFIVKYRGVSYGPGRQSLR--LVMEYLPSGCLRDFLQRHRAR-LDASRLLLYSSQICKGM 140

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL        + RD    NIL++ +   K++DFGLA+  P +   +V          + 
Sbjct: 141 EYL-GSRRC--VHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE--PGQSPIF 195

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
           + APE +     + +SDVWSFGVVLYEL T   +    +      +++   R   + S+ 
Sbjct: 196 WYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDK--SCSPSAEFLRMMGCERDVPALSRL 253

Query: 331 FHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ 386
             L+ +    P      C     ++  L   C    P+ RP  S +   L  + S     
Sbjct: 254 LELLEEGQRLPAPPA--C---PAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRGC 308

Query: 387 DEVTLQPVAE 396
           +        E
Sbjct: 309 ETHAFTAHPE 318

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  153 bits (388), Expect = 3e-43
 Identities = 69/293 (23%), Positives = 124/293 (42%), Gaps = 27/293 (9%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVVK 153
           +GEG FG V         D+           VA+K L    G     +   E+  L  + 
Sbjct: 29  LGEGHFGKVELCRYDPEGDNTGEQ-------VAVKSLKPESGGNHIADLKKEIEILRNLY 81

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N+VK  G C ED   G++  L+ E + + SL+++L       +    +LK A    +G
Sbjct: 82  HENIVKYKGICTEDGGNGIK--LIMEFLPSGSLKEYLPKNKNK-INLKQQLKYAVQICKG 138

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---V 270
           + YL     +  + RD    N+L++ +++ K+ DFGL +    +   +           V
Sbjct: 139 MDYL-GSRQY--VHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKD--DRDSPV 193

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSK 329
            + APE +   +    SDVWSFGV L+EL+T      + +      K++      ++ ++
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDS--DSSPMALFLKMIGPTHGQMTVTR 251

Query: 330 KFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
             + + +  RL     C     ++  L  KC   QP +R     +++    ++
Sbjct: 252 LVNTLKEGKRLPCPPNC---PDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL 301

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  153 bits (388), Expect = 5e-43
 Identities = 79/301 (26%), Positives = 118/301 (39%), Gaps = 33/301 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GEG FG V       ++D            VA+K L    G Q    W  E++ L  + 
Sbjct: 39  LGEGHFGKVSLYCYDPTNDGTGEM-------VAVKALKADAGPQHRSGWKQEIDILRTLY 91

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H +++K  G C +     +Q  LV E +   SL D+L             L  AQ    G
Sbjct: 92  HEHIIKYKGCCEDAGAASLQ--LVMEYVPLGSLRDYLPRHSIGL---AQLLLFAQQICEG 146

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---V 270
           +AYL     +  I RD    N+LLD D   K+ DFGLA+  P     +           V
Sbjct: 147 MAYL-HAQHY--IHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVRE--DGDSPV 201

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSD 327
            + APE ++  +    SDVWSFGV LYEL+T    +        E   +        ++ 
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGI----AQGQMTV 257

Query: 328 SKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS 385
            +   L+    RL   + C     ++  L   C   +   RP    ++ IL  +  +   
Sbjct: 258 LRLTELLERGERLPRPDKC---PAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG 314

Query: 386 Q 386
           Q
Sbjct: 315 Q 315

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  151 bits (384), Expect = 1e-42
 Identities = 84/305 (27%), Positives = 135/305 (44%), Gaps = 56/305 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +              L VA+K L ++     +E++ E   +  +KH
Sbjct: 21  LGGGQYGEVYEGVWK-----------KYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKH 68

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C  +        ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 69  PNLVQLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 124

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL E+ +F  I RD    N L+ E++  K++DFGL+R       G   T+  G    + 
Sbjct: 125 EYL-EKKNF--IHRDLAARNCLVGENHLVKVADFGLSR----LMTGDTYTAHAGAKFPIK 177

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + APE +   + + KSDVW+FGV+L+E+ T G                    PY  +  S
Sbjct: 178 WTAPESLAYNKFSIKSDVWAFGVLLWEIATYGM------------------SPYPGIDLS 219

Query: 329 KKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
           + + L+       R EG  C    +K+  L   C    P  RP  +E+      +  E S
Sbjct: 220 QVYELLEKDYRMERPEG--C---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESS 274

Query: 385 SQDEV 389
             DEV
Sbjct: 275 ISDEV 279

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  151 bits (384), Expect = 2e-42
 Identities = 62/295 (21%), Positives = 106/295 (35%), Gaps = 49/295 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +GEGGF  V   +V    D H           A+K++     Q  +E   E +   +  
Sbjct: 36  KLGEGGFSYVD--LVEGLHDGHF---------YALKRILCHEQQDREEAQREADMHRLFN 84

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL------LSRVPTPLAWIARLKIA 207
           HPN+++LV YC  +     +  L+       +L + +       + +           + 
Sbjct: 85  HPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQIL----WLL 140

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS---- 263
               RGL  +H +       RD K +NILL ++ +  L D G   Q      G       
Sbjct: 141 LGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTL 197

Query: 264 ---TSVVGTVGYAAPEYVQTGR---LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
               +   T+ Y APE         +  ++DVWS G VLY ++ G    +    + +   
Sbjct: 198 QDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVA 257

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           L       +   +  +   PR         +  L  L +  +T  P  RP +  +
Sbjct: 258 L-------AVQNQLSIPQSPRH--------SSALWQLLNSMMTVDPHQRPHIPLL 297

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  154 bits (391), Expect = 5e-42
 Identities = 77/295 (26%), Positives = 131/295 (44%), Gaps = 36/295 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY GV +              L VA+K L ++     +E++ E   +  +KH
Sbjct: 228 LGGGQYGEVYEGVWK-----------KYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKH 275

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PNLV+L+G C  +        ++ E M   +L D+L       ++ +  L +A   +  +
Sbjct: 276 PNLVQLLGVCTREP----PFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM 331

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
            YL E+ +F  I R+    N L+ E++  K++DFGL+R                 + + A
Sbjct: 332 EYL-EKKNF--IHRNLAARNCLVGENHLVKVADFGLSRL-MTGDTYTAHAGAKFPIKWTA 387

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE +   + + KSDVW+FGV+L+E+ T   +    +  ++      V   +   K + + 
Sbjct: 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ------VYELL--EKDYRM- 438

Query: 335 IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
              R EG  C    +K+  L   C    P  RP  +E+      +  E S  DEV
Sbjct: 439 --ERPEG--C---PEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 486

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  153 bits (388), Expect = 7e-42
 Identities = 81/299 (27%), Positives = 126/299 (42%), Gaps = 44/299 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G                   VAIK L + G    + ++ E   +  ++H
Sbjct: 192 LGQGCFGEVWMGTWN------------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 238

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 239 EKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 293

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR        +  T+  G    + 
Sbjct: 294 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARLIE----DNEYTARQGAKFPIK 346

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           + APE    GR T KSDVWSFG++L EL T  R     +   E      V   V   + +
Sbjct: 347 WTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQV--ERGY 398

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVT 390
            +   P      C    + L  L  +C  K+P+ RP    +   L +  +    Q +  
Sbjct: 399 RM---PCPPE--C---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 449

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  148 bits (376), Expect = 1e-41
 Identities = 83/301 (27%), Positives = 123/301 (40%), Gaps = 44/301 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           IG G FGCVY G +              K+  A+K LNR        +++ E   +    
Sbjct: 33  IGRGHFGCVYHGTLL--------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 84

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+G
Sbjct: 85  HPNVLSLLGICLRSE---GSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKG 140

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--VG 271
           + YL     F  + RD    N +LDE +  K++DFGLAR    +    V         V 
Sbjct: 141 MKYL-ASKKF--VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVK 197

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + A E +QT + T KSDVWSFGV+L+EL+T G                    PY  V+  
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGA------------------PPYPDVNTF 239

Query: 329 KKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ 386
                ++   RL    YC      L  +  KC   + + RP  SE+V  +  I S    +
Sbjct: 240 DITVYLLQGRRLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 296

Query: 387 D 387
            
Sbjct: 297 H 297

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  148 bits (375), Expect = 1e-41
 Identities = 75/309 (24%), Positives = 133/309 (43%), Gaps = 52/309 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           +G G FG V +GV R             ++DVAIK L +QG +    +E + E   +  +
Sbjct: 18  LGCGNFGSVRQGVYR---------MRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 67

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            +P +V+L+G C  +       +LV E+     L   L+ +    +      ++    + 
Sbjct: 68  DNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSM 121

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--- 269
           G+ YL EE +F  + RD    N+LL   + AK+SDFGL++    +   + + S       
Sbjct: 122 GMKYL-EEKNF--VHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWP 176

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VS 326
           + + APE +   + +++SDVWS+GV ++E ++ G+                  +PY  + 
Sbjct: 177 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ------------------KPYKKMK 218

Query: 327 DSKKFHLIIDP-RLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
             +    I    R+E    C     +L AL S C   + + RP    V   +      ++
Sbjct: 219 GPEVMAFIEQGKRMECPPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275

Query: 385 SQDEVTLQP 393
           S+ E     
Sbjct: 276 SKVEGHHHH 284

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  150 bits (381), Expect = 2e-41
 Identities = 81/298 (27%), Positives = 119/298 (39%), Gaps = 54/298 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           IG G FG V+ G +R                VA+K            +++ E   L    
Sbjct: 122 IGRGNFGEVFSGRLR-----------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS 170

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN+V+L+G C +         +V EL+        L +     L     L++  DAA G
Sbjct: 171 HPNIVRLIGVCTQKQPI----YIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAG 225

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---- 269
           + YL  +     I RD    N L+ E    K+SDFG++R    E    V  +  G     
Sbjct: 226 MEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSR----EEADGVYAASGGLRQVP 278

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLP----RNEQKLLEWVRPY 324
           V + APE +  GR +++SDVWSFG++L+E  + G        P     N+Q      R +
Sbjct: 279 VKWTAPEALNYGRYSSESDVWSFGILLWETFSLGAS------PYPNLSNQQ-----TREF 327

Query: 325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
           V   K   L   P  E   C      +  L  +C   +P  RP  S +   L +I   
Sbjct: 328 V--EKGGRL---PCPEL--C---PDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  153 bits (388), Expect = 2e-41
 Identities = 79/296 (26%), Positives = 123/296 (41%), Gaps = 38/296 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G                   VAIK L + G    + ++ E   +  ++H
Sbjct: 275 LGQGCFGEVWMGTWN------------GTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 321

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 322 EKLVQLYAVVSEE-----PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 376

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
           AY+ E M++  + RD + +NIL+ E+   K++DFGLAR    +            + + A
Sbjct: 377 AYV-ERMNY--VHRDLRAANILVGENLVCKVADFGLARL-IEDNEYTARQGAKFPIKWTA 432

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE    GR T KSDVWSFG++L EL T  R     +   E      V   V   + + + 
Sbjct: 433 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE------VLDQV--ERGYRM- 483

Query: 335 IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVT 390
             P      C    + L  L  +C  K+P+ RP    +   L +  +    Q +  
Sbjct: 484 --PCPPE--C---PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQPG 532

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  151 bits (383), Expect = 3e-41
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 62/298 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V  G  R +              VA+K +        + ++ E + +  ++H
Sbjct: 201 IGKGEFGDVMLGDYRGN-------------KVAVKCIKNDATA--QAFLAEASVMTQLRH 245

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G   E+        +V E M   SL D+L SR  + L     LK + D    +
Sbjct: 246 SNLVQLLGVIVEEKGGLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 302

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL E  +F  + RD    N+L+ ED  AK+SDFGL +          S++       V 
Sbjct: 303 EYL-EGNNF--VHRDLAARNVLVSEDNVAKVSDFGLTK--------EASSTQDTGKLPVK 351

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + APE ++  + + KSDVWSFG++L+E+ + GR                   PY  +   
Sbjct: 352 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR------------------VPYPRIPLK 393

Query: 329 KKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
                +         +G  C      +  +   C      +RP   ++ + L +I + 
Sbjct: 394 DVVPRVEKGYKMDAPDG--C---PPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRTH 446

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  148 bits (376), Expect = 4e-41
 Identities = 72/297 (24%), Positives = 120/297 (40%), Gaps = 49/297 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY+G+           G   K+ VAIK+L      + +KE ++E   +  V 
Sbjct: 23  LGSGAFGTVYKGLWI-------PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           +P++ +L+G C           L+ +LM    L D++       +     L      A+G
Sbjct: 76  NPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKG 129

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---V 270
           + YL E+     + RD    N+L+      K++DFGLA+    E          G    +
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAE---EKEYHAEGGKVPI 183

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSD 327
            + A E +     T +SDVWS+GV ++EL+T G                   +PY  +  
Sbjct: 184 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGS------------------KPYDGIPA 225

Query: 328 SKKFHLIIDP-RLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
           S+   ++    RL     C      +  +  KC      SRPK  E++     +  +
Sbjct: 226 SEISSILEKGERLPQPPIC---TIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  148 bits (376), Expect = 8e-41
 Identities = 83/307 (27%), Positives = 125/307 (40%), Gaps = 44/307 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           IG G FGCVY G +              K+  A+K LNR        +++ E   +    
Sbjct: 97  IGRGHFGCVYHGTLL--------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS 148

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+G
Sbjct: 149 HPNVLSLLGICLRSE---GSPLVVLPYMKHGDLRNFIRNETHNPTV-KDLIGFGLQVAKG 204

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--VG 271
           + +L     F  + RD    N +LDE +  K++DFGLAR    +    V         V 
Sbjct: 205 MKFL-ASKKF--VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVK 261

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + A E +QT + T KSDVWSFGV+L+EL+T G                    PY  V+  
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELMTRGA------------------PPYPDVNTF 303

Query: 329 KKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ 386
                ++   RL    YC      L  +  KC   + + RP  SE+V  +  I S    +
Sbjct: 304 DITVYLLQGRRLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE 360

Query: 387 DEVTLQP 393
             V +  
Sbjct: 361 HYVHVNA 367

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  146 bits (370), Expect = 1e-40
 Identities = 70/312 (22%), Positives = 126/312 (40%), Gaps = 60/312 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G G FG V +G  +                VA+K L +          E + E N +  
Sbjct: 25  LGSGNFGTVKKGYYQ---------MKKVVKTVAVKIL-KNEANDPALKDELLAEANVMQQ 74

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + +P +V+++G C  +       +LV E+     L  +L          I  +++    +
Sbjct: 75  LDNPYIVRMIGICEAE-----SWMLVMEMAELGPLNKYLQQNRHVKDKNI--IELVHQVS 127

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT-- 269
            G+ YL EE +F  + RD    N+LL   + AK+SDFGL++    +   + + +      
Sbjct: 128 MGMKYL-EESNF--VHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQT--HGKW 182

Query: 270 -VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSD 327
            V + APE +   + ++KSDVWSFGV+++E  + G+                  +PY   
Sbjct: 183 PVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ------------------KPY--R 222

Query: 328 SKKFHLIIDPRLEGNY-------CIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
             K   +    LE          C    +++  L + C T   ++RP  + V   L N  
Sbjct: 223 GMKGSEVTA-MLEKGERMGCPAGC---PREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 278

Query: 381 SEISSQDEVTLQ 392
            ++ ++      
Sbjct: 279 YDVVNEGHHHHH 290

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  146 bits (371), Expect = 1e-40
 Identities = 74/322 (22%), Positives = 127/322 (39%), Gaps = 55/322 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           +G+G FG V    ++            S + VA+K L          +E++ E   +   
Sbjct: 31  LGKGEFGSVREAQLK--------QEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF 82

Query: 153 KHPNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHLLSRVP----TPLAWIARLKI 206
            HP++ KLVG       +G     +++   M +  L   LL+         L     ++ 
Sbjct: 83  DHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRF 142

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
             D A G+ YL    +F  I RD    N +L ED    ++DFGL+R+     +       
Sbjct: 143 MVDIACGMEYL-SSRNF--IHRDLAARNCMLAEDMTVCVADFGLSRK-----IYSGDYYR 194

Query: 267 VGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEW 320
            G        + A E +     T  SDVW+FGV ++E++T G+                 
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQ----------------- 237

Query: 321 VRPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
             PY  + +++ ++ +I   RL+    C    +++  L  +C +  PK RP  + +   L
Sbjct: 238 -TPYAGIENAEIYNYLIGGNRLKQPPEC---MEEVYDLMYQCWSADPKQRPSFTCLRMEL 293

Query: 377 GNIISEISSQDEVTLQPVAEIE 398
            NI+  +S            IE
Sbjct: 294 ENILGHLSVLSTSQDPLYINIE 315

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  149 bits (377), Expect = 2e-40
 Identities = 75/302 (24%), Positives = 127/302 (42%), Gaps = 58/302 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+                     VA+K + + G    + ++ E N +  ++H
Sbjct: 196 LGAGQFGEVWMATYN------------KHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQH 242

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LVKL     ++        ++ E M   SL D L S   +       +  +   A G+
Sbjct: 243 DKLVKLHAVVTKE-----PIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM 297

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           A++ E+ ++  I RD + +NIL+      K++DFGLAR        +  T+  G    + 
Sbjct: 298 AFI-EQRNY--IHRDLRAANILVSASLVCKIADFGLAR----VIEDNEYTAREGAKFPIK 350

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + APE +  G  T KSDVWSFG++L E++T GR                   PY  +S+ 
Sbjct: 351 WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR------------------IPYPGMSNP 392

Query: 329 KKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
           +    +      PR E   C    ++L  +  +C   +P+ RP    +  +L +  +   
Sbjct: 393 EVIRALERGYRMPRPEN--C---PEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE 447

Query: 385 SQ 386
           SQ
Sbjct: 448 SQ 449

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  145 bits (369), Expect = 3e-40
 Identities = 71/307 (23%), Positives = 124/307 (40%), Gaps = 54/307 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           +GEG FG V  G ++            + L VA+K +       +  +E+++E   +   
Sbjct: 42  LGEGEFGSVMEGNLK--------QEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLV-YELMHNKSLEDHLLSRVPT----PLAWIARLKIA 207
            HPN+++L+G C E   +G+ + +V    M    L  +LL          +     LK  
Sbjct: 94  SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
            D A G+ YL    +F  + RD    N +L +D    ++DFGL+++     +        
Sbjct: 154 VDIALGMEYL-SNRNF--LHRDLAARNCMLRDDMTVCVADFGLSKK-----IYSGDYYRQ 205

Query: 268 GTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWV 321
           G +      + A E +     T+KSDVW+FGV ++E+ T G                   
Sbjct: 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM------------------ 247

Query: 322 RPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG 377
            PY  V + + +  ++   RL+    C     +L  +   C    P  RP  S +   L 
Sbjct: 248 TPYPGVQNHEMYDYLLHGHRLKQPEDC---LDELYEIMYSCWRTDPLDRPTFSVLRLQLE 304

Query: 378 NIISEIS 384
            ++  + 
Sbjct: 305 KLLESLP 311

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  143 bits (364), Expect = 6e-40
 Identities = 78/302 (25%), Positives = 129/302 (42%), Gaps = 58/302 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+ G                   VA+K L +QG      ++ E N +  ++H
Sbjct: 21  LGAGQFGEVWMGYYN------------GHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQH 67

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L     ++        ++ E M N SL D L +     L     L +A   A G+
Sbjct: 68  QRLVRLYAVVTQE-----PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM 122

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           A++ EE ++  I RD + +NIL+ +    K++DFGLAR        +  T+  G    + 
Sbjct: 123 AFI-EERNY--IHRDLRAANILVSDTLSCKIADFGLAR----LIEDNEYTAREGAKFPIK 175

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + APE +  G  T KSDVWSFG++L E++T GR                   PY  +++ 
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR------------------IPYPGMTNP 217

Query: 329 KKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
           +    +       R +   C    ++L  L   C  ++P+ RP    +  +L +  +   
Sbjct: 218 EVIQNLERGYRMVRPDN--C---PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATE 272

Query: 385 SQ 386
            Q
Sbjct: 273 GQ 274

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  144 bits (365), Expect = 6e-40
 Identities = 83/305 (27%), Positives = 121/305 (39%), Gaps = 44/305 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           IG+G FG VY G               +++  AIK L+R    Q  + ++ E   +  + 
Sbjct: 29  IGKGHFGVVYHGEYI--------DQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN 80

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPN++ L+G     +       ++   M +  L   + S    P      +      ARG
Sbjct: 81  HPNVLALIGIMLPPEGLPH---VLLPYMCHGDLLQFIRSPQRNPTV-KDLISFGLQVARG 136

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--VG 271
           + YL  E  F  + RD    N +LDE +  K++DFGLAR         V         V 
Sbjct: 137 MEYL-AEQKF--VHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVK 193

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + A E +QT R T KSDVWSFGV+L+EL+T G                    PY  +   
Sbjct: 194 WTALESLQTYRFTTKSDVWSFGVLLWELLTRGA------------------PPYRHIDPF 235

Query: 329 KKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ 386
              H +    RL    YC      L  +  +C    P  RP    +V  +  I+S +   
Sbjct: 236 DLTHFLAQGRRLPQPEYC---PDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD 292

Query: 387 DEVTL 391
             V L
Sbjct: 293 HYVQL 297

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  143 bits (363), Expect = 8e-40
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 62/298 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V  G  R                VA+K + +      + ++ E + +  ++H
Sbjct: 29  IGKGEFGDVMLGDYR-------------GNKVAVKCI-KNDAT-AQAFLAEASVMTQLRH 73

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            NLV+L+G   E+        +V E M   SL D+L SR  + L     LK + D    +
Sbjct: 74  SNLVQLLGVIVEEKGGLY---IVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM 130

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL E  +F  + RD    N+L+ ED  AK+SDFGL ++         S++       V 
Sbjct: 131 EYL-EGNNF--VHRDLAARNVLVSEDNVAKVSDFGLTKE--------ASSTQDTGKLPVK 179

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           + APE ++  + + KSDVWSFG++L+E+ + GR                   PY  +   
Sbjct: 180 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGR------------------VPYPRIPLK 221

Query: 329 KKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
                +         +G  C      +  +   C       RP   ++ + L +I + 
Sbjct: 222 DVVPRVEKGYKMDAPDG--C---PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 274

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  143 bits (362), Expect = 1e-39
 Identities = 68/291 (23%), Positives = 113/291 (38%), Gaps = 55/291 (18%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           LIG GGFG V++   +   D              IK++       +++   EV  L  + 
Sbjct: 18  LIGSGGFGQVFK--AKHRIDGKT---------YVIKRVKYN----NEKAEREVKALAKLD 62

Query: 154 HPNLVKLVGYCAEDDERGMQRL------------LVYELMHNKSLEDHLLSRVPTPLAWI 201
           H N+V   G     D                   +  E     +LE  +  R    L  +
Sbjct: 63  HVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKV 122

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L++ +   +G+ Y+H +   +LI RD K SNI L +  + K+ DFGL      +G   
Sbjct: 123 LALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGK-- 177

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
             T   GT+ Y +PE + +     + D+++ G++L EL+                     
Sbjct: 178 -RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVC------------------ 218

Query: 322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                 SK F  + D  +   +     +K   L  K L+K+P+ RP  SE+
Sbjct: 219 DTAFETSKFFTDLRDGIISDIF----DKKEKTLLQKLLSKKPEDRPNTSEI 265

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  144 bits (364), Expect = 1e-39
 Identities = 76/339 (22%), Positives = 132/339 (38%), Gaps = 49/339 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +G G FG V++GV           G   K+ V IK +  + G Q  +   + +  +G + 
Sbjct: 21  LGSGVFGTVHKGVWI-------PEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD 73

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H ++V+L+G C           LV + +   SL DH+       L     L      A+G
Sbjct: 74  HAHIVRLLGLCPGS-----SLQLVTQYLPLGSLLDHVRQHRGA-LGPQLLLNWGVQIAKG 127

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL EE     + R+    N+LL    + +++DFG+A   PP+    + +     + + 
Sbjct: 128 MYYL-EEHGM--VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWM 184

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDSKK 330
           A E +  G+ T +SDVWS+GV ++EL+T G                    PY  +  ++ 
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMTFGA------------------EPYAGLRLAEV 226

Query: 331 FHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS------E 382
             L+    RL     C      +  +  KC       RP   E+ +    +         
Sbjct: 227 PDLLEKGERLAQPQIC---TIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDPPRYLV 283

Query: 383 ISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQGNSYLK 421
           I  +    + P  E   +  +   E  +E     +  L+
Sbjct: 284 IKRESGPGIAPGPEPHGLTNKKLEEVELEPELDLDLDLE 322

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  142 bits (361), Expect = 1e-39
 Identities = 72/300 (24%), Positives = 126/300 (42%), Gaps = 58/300 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  R             + DVAIK + ++G     E+I E   +  + H
Sbjct: 32  LGTGQFGVVKYGKWR------------GQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSH 78

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L G C +         ++ E M N  L ++L             L++ +D    +
Sbjct: 79  EKLVQLYGVCTKQRPI----FIITEYMANGCLLNYLREMRHR-FQTQQLLEMCKDVCEAM 133

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
            YL E   F  + RD    N L+++    K+SDFGL+R      L    TS VG+   V 
Sbjct: 134 EYL-ESKQF--LHRDLAARNCLVNDQGVVKVSDFGLSR----YVLDDEYTSSVGSKFPVR 186

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           ++ PE +   + ++KSD+W+FGV+++E+ + G+                   PY   ++S
Sbjct: 187 WSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK------------------MPYERFTNS 228

Query: 329 KKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
           +    I       R         ++K+  +   C  ++   RP    ++  + +++ E S
Sbjct: 229 ETAEHIAQGLRLYRPHL--A---SEKVYTIMYSCWHEKADERPTFKILLSNILDVMDEES 283

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  142 bits (360), Expect = 2e-39
 Identities = 66/305 (21%), Positives = 122/305 (40%), Gaps = 55/305 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +GEG FG VY GV      +        K++VA+K   +       +++++E   +  + 
Sbjct: 20  LGEGFFGEVYEGVYTNHKGE--------KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP++VKL+G   E+        ++ EL     L  +L     +    +  +  +    + 
Sbjct: 72  HPHIVKLIGIIEEE-----PTWIIMELYPYGELGHYLERNKNSLKV-LTLVLYSLQICKA 125

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---V 270
           +AYL E ++   + RD    NIL+      KL DFGL+R                T   +
Sbjct: 126 MAYL-ESINC--VHRDIAVRNILVASPECVKLGDFGLSR----YIEDEDYYKASVTRLPI 178

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSD 327
            + +PE +   R T  SDVW F V ++E+++ G+                  +P+  + +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCMWEILSFGK------------------QPFFWLEN 220

Query: 328 SKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI 383
                ++      P+ +   C      L  L ++C    P  RP+ +E+V  L ++    
Sbjct: 221 KDVIGVLEKGDRLPKPDL--C---PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQME 275

Query: 384 SSQDE 388
                
Sbjct: 276 KDIAM 280

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  142 bits (360), Expect = 2e-39
 Identities = 64/319 (20%), Positives = 116/319 (36%), Gaps = 73/319 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G F  +++GV R   D     G   + +V +K L++      + +    + +  + H
Sbjct: 16  LGQGTFTKIFKGVRREVGDY----GQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSH 71

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT-PLAWIARLKIAQDAARG 213
            +LV   G C   DE     +LV E +   SL+ +L        + W   L++A+  A  
Sbjct: 72  KHLVLNYGVCVCGDEN----ILVQEFVKFGSLDTYLKKNKNCINILWK--LEVAKQLAAA 125

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYK--------AKLSDFGLARQGPPEGLGHVSTS 265
           + +L EE     I  +    NILL  +           KLSD G++             +
Sbjct: 126 MHFL-EENTL--IHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI------------T 170

Query: 266 VVGTVGY------AAPEYVQTGRL-TAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKL 317
           V+             PE ++  +     +D WSFG  L+E+ + G               
Sbjct: 171 VLPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGD-------------- 216

Query: 318 LEWVRPY--VSDSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
               +P   +   +K     D    P  +         +LA L + C+  +P  RP    
Sbjct: 217 ----KPLSALDSQRKLQFYEDRHQLPAPKA--A-----ELANLINNCMDYEPDHRPSFRA 265

Query: 372 VVDILGNIISEISSQDEVT 390
           ++  L ++ +         
Sbjct: 266 IIRDLNSLFTPDLVPRGSH 284

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  144 bits (366), Expect = 3e-39
 Identities = 67/356 (18%), Positives = 121/356 (33%), Gaps = 53/356 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
           ++G+G    V+RG        H+ +G       AIK  N   F    +  + E   L  +
Sbjct: 16  ILGQGATANVFRGR-------HKKTGDL----FAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-VPTPLAWIARLKIAQDAA 211
            H N+VKL  +  E++     ++L+ E     SL   L        L     L + +D  
Sbjct: 65  NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
            G+ +L E     ++ R+ K  NI+     D     KL+DFG AR+           S+ 
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLY 176

Query: 268 GTVGYAAPEYVQTGRL--------TAKSDVWSFGVVLYELITGRRA-VERNLPRNEQKLL 318
           GT  Y  P+  +   L         A  D+WS GV  Y   TG         PR  ++++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 319 EWVR----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
             +              +++       D  +  +        L  + +  L    +    
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 369 MSEVVDILGNIISEI---------SSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQ 415
             +      +I+  +          +  ++ +          E    +  + S+ Q
Sbjct: 297 FDQFFAETSDILHRMVIHVFSLQQMTAHKIYIHSYNTATIFHELVYKQTKIISSNQ 352

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  142 bits (361), Expect = 3e-39
 Identities = 63/304 (20%), Positives = 107/304 (35%), Gaps = 44/304 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
           ++G+G    V+RG        H+ +G       AIK  N   F    +  + E   L  +
Sbjct: 16  ILGQGATANVFRGR-------HKKTGDL----FAIKVFNNISFLRPVDVQMREFEVLKKL 64

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-VPTPLAWIARLKIAQDAA 211
            H N+VKL  +  E++     ++L+ E     SL   L        L     L + +D  
Sbjct: 65  NHKNIVKL--FAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVV 122

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
            G+ +L E     ++ R+ K  NI+     D     KL+DFG AR+           S+ 
Sbjct: 123 GGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED---DEQFVSLY 176

Query: 268 GTVGYAAPEYVQTGRL--------TAKSDVWSFGVVLYELITGRRA-VERNLPRNEQKLL 318
           GT  Y  P+  +   L         A  D+WS GV  Y   TG         PR  ++++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236

Query: 319 EWVR----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
             +              +++       D  +  +        L  + +  L    +    
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296

Query: 369 MSEV 372
             + 
Sbjct: 297 FDQF 300

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  141 bits (358), Expect = 4e-39
 Identities = 77/307 (25%), Positives = 123/307 (40%), Gaps = 63/307 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           IGEG FG V++G+          S  +  L VAIK   +        ++++ E   +   
Sbjct: 23  IGEGQFGDVHQGIYM--------SPENPALAVAIKTC-KNCTSDSVREKFLQEALTMRQF 73

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   + 
Sbjct: 74  DHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKYS-LDLASLILYAYQLST 127

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG- 271
            LAYL E   F  + RD    N+L+  +   KL DFGL+R           ++       
Sbjct: 128 ALAYL-ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSRY-------MEDSTYYKASKG 177

Query: 272 -----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY- 324
                + APE +   R T+ SDVW FGV ++E++  G                   +P+ 
Sbjct: 178 KLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV------------------KPFQ 219

Query: 325 -VSDSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI 379
            V ++     I +    P      C      L +L +KC    P  RP+ +E+   L  I
Sbjct: 220 GVKNNDVIGRIENGERLPMPPN--C---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 274

Query: 380 ISEISSQ 386
           + E  +Q
Sbjct: 275 LEEEKAQ 281

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  141 bits (357), Expect = 5e-39
 Identities = 73/214 (34%), Positives = 103/214 (48%), Gaps = 29/214 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + R+G    +++I E   +  + H
Sbjct: 16  IGSGQFGLVHLGYWL------------NKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 62

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV E M +  L D+L ++     A    L +  D   G+
Sbjct: 63  PKLVQLYGVCLEQAPI----CLVTEFMEHGCLSDYLRTQRGL-FAAETLLGMCLDVCEGM 117

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           AYL EE     I RD    N L+ E+   K+SDFG+ R      L    TS  GT   V 
Sbjct: 118 AYL-EEACV--IHRDLAARNCLVGENQVIKVSDFGMTR----FVLDDQYTSSTGTKFPVK 170

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRR 304
           +A+PE     R ++KSDVWSFGV+++E+ + G+ 
Sbjct: 171 WASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKI 204

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  142 bits (360), Expect = 5e-39
 Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 57/296 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGV 151
            IG GG   V++ +            ++ K   AIK +N +         + NE+ +L  
Sbjct: 35  QIGSGGSSKVFQVL------------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 82

Query: 152 VKHPNL--VKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLKIA 207
           ++  +   ++L  Y   D         +Y +M   N  L   L  +              
Sbjct: 83  LQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWLKKKKSIDPWERKS--YW 133

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           ++    +  +H+     ++  D K +N L+ +    KL DFG+A Q  P+    V  S V
Sbjct: 134 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 189

Query: 268 GTVGYAAPEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
           GTV Y  PE ++             +++ KSDVWS G +LY +  G+       P  +  
Sbjct: 190 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQ-- 241

Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                   ++   K H IIDP  E  +     + L  +   CL + PK R  + E+
Sbjct: 242 -------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 290

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  140 bits (356), Expect = 7e-39
 Identities = 73/298 (24%), Positives = 125/298 (41%), Gaps = 58/298 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G  +             + DVA+K + ++G     E+  E   +  + H
Sbjct: 16  LGSGQFGVVKLGKWK------------GQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSH 62

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LVK  G C+++        +V E + N  L ++L S     L     L++  D   G+
Sbjct: 63  PKLVKFYGVCSKEY----PIYIVTEYISNGCLLNYLRSHGKG-LEPSQLLEMCYDVCEGM 117

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT---VG 271
           A+L E   F  I RD    N L+D D   K+SDFG+ R      L     S VGT   V 
Sbjct: 118 AFL-ESHQF--IHRDLAARNCLVDRDLCVKVSDFGMTR----YVLDDQYVSSVGTKFPVK 170

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDS 328
           ++APE     + ++KSDVW+FG++++E+ + G+                   PY   ++S
Sbjct: 171 WSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGK------------------MPYDLYTNS 212

Query: 329 KKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
           +    +       R         +  +  +   C  + P+ RP   +++  +  +  +
Sbjct: 213 EVVLKVSQGHRLYRPHL--A---SDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK 265

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  142 bits (359), Expect = 9e-39
 Identities = 81/317 (25%), Positives = 148/317 (46%), Gaps = 58/317 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           IG G FG VY+G+++       TS    ++ VAIK L + G+  +   +++ E   +G  
Sbjct: 52  IGAGEFGEVYKGMLK-------TSSGKKEVPVAIKTL-KAGYTEKQRVDFLGEAGIMGQF 103

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            H N+++L G  +    +    +++ E M N +L+  L  +     + +  + + +  A 
Sbjct: 104 SHHNIIRLEGVIS----KYKPMMIITEYMENGALDKFLREKDGE-FSVLQLVGMLRGIAA 158

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--- 269
           G+ YL   M++  + RD    NIL++ +   K+SDFGL+R    +     +TS  G    
Sbjct: 159 GMKYL-ANMNY--VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTS--GGKIP 213

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VS 326
           + + APE +   + T+ SDVWSFG+V++E++T G                   RPY  +S
Sbjct: 214 IRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGE------------------RPYWELS 255

Query: 327 DSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
           + +    I D    P      C      +  L  +C  ++   RPK +++V IL  +I  
Sbjct: 256 NHEVMKAINDGFRLPTPMD--C---PSAIYQLMMQCWQQERARRPKFADIVSILDKLI-- 308

Query: 383 ISSQDEVTLQPVAEIED 399
              +   +L+ +A+ + 
Sbjct: 309 ---RAPDSLKTLADFDP 322

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  142 bits (359), Expect = 9e-39
 Identities = 72/325 (22%), Positives = 128/325 (39%), Gaps = 43/325 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-QGFQGHKEWINEVNFLGVVK 153
           +G G FG VY+G+           G   K+ VAIK+L      + +KE ++E   +  V 
Sbjct: 23  LGSGAFGTVYKGLWI-------PEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD 75

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           +P++ +L+G C           L+ +LM    L D++       +     L      A+G
Sbjct: 76  NPHVCRLLGICLTS-----TVQLITQLMPFGCLLDYVREHKDN-IGSQYLLNWCVQIAKG 129

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL E+     + RD    N+L+      K++DFGLA+    E   + +      + + 
Sbjct: 130 MNYL-EDRRL--VHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VSDSKK 330
           A E +     T +SDVWS+GV ++EL+T G                   +PY  +  S+ 
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMTFGS------------------KPYDGIPASEI 228

Query: 331 FHLIIDP-RLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDE 388
             ++    RL     C      +  +  KC      SRPK  E++     +  +      
Sbjct: 229 SSILEKGERLPQPPIC---TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARDPQRYLV 285

Query: 389 VTLQPVAEIEDVKEEPEAEAVVESA 413
           +       +    +     A+++  
Sbjct: 286 IQGDERMHLPSPTDSNFYRALMDEE 310

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  141 bits (358), Expect = 1e-38
 Identities = 80/329 (24%), Positives = 125/329 (37%), Gaps = 65/329 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V             S L VA+K L      Q   +++ E   +    
Sbjct: 38  LGHGAFGEVYEGQVS------GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 91

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT-----PLAWIARLKIAQ 208
           H N+V+ +G       + + R ++ ELM    L+  L    P       LA +  L +A+
Sbjct: 92  HQNIVRCIGVSL----QSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 147

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHVSTS 265
           D A G  YL EE  F  I RD    N LL        AK+ DFG+AR      +   S  
Sbjct: 148 DIACGCQYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRASYY 199

Query: 266 VVGTVGY-----AAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE 319
             G           PE    G  T+K+D WSFGV+L+E+ + G                 
Sbjct: 200 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---------------- 243

Query: 320 WVRPY--VSDSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
              PY   S+ +    +         +   C      +  + ++C   QP+ RP  + ++
Sbjct: 244 --MPYPSKSNQEVLEFVTSGGRMDPPKN--C---PGPVYRIMTQCWQHQPEDRPNFAIIL 296

Query: 374 DILGNIISEISSQD---EVTLQPVAEIED 399
           + +     +    +    +   P+ E E+
Sbjct: 297 ERIEYCTQDPDVINTALPIEYGPLVEEEE 325

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  141 bits (357), Expect = 1e-38
 Identities = 76/307 (24%), Positives = 128/307 (41%), Gaps = 58/307 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +G+G FG VY GV +           + +  VAIK +N     +   E++NE + +    
Sbjct: 33  LGQGSFGMVYEGVAK------GVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 86

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  ++        L++ ELM    L+ +L S  P         P +    ++
Sbjct: 87  CHHVVRLLGVVSQGQ----PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 142

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           +A + A G+AYL     F  + RD    N ++ ED+  K+ DFG+ R      +      
Sbjct: 143 MAGEIADGMAYL-NANKF--VHRDLAARNCMVAEDFTVKIGDFGMTRD-----IYETDYY 194

Query: 266 VVGTVGY-----AAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE 319
             G  G       +PE ++ G  T  SDVWSFGVVL+E+ T                   
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE---------------- 238

Query: 320 WVRPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
             +PY  +S+ +    +++   L+  + C      L  L   C    PK RP   E++  
Sbjct: 239 --QPYQGLSNEQVLRFVMEGGLLDKPDNC---PDMLFELMRMCWQYNPKMRPSFLEIISS 293

Query: 376 LGNIISE 382
           +   +  
Sbjct: 294 IKEEMEP 300

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  141 bits (358), Expect = 2e-38
 Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 57/296 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGV 151
            IG GG   V++ +            ++ K   AIK +N +         + NE+ +L  
Sbjct: 16  QIGSGGSSKVFQVL------------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 63

Query: 152 VKHPNL--VKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLKIA 207
           ++  +   ++L  Y   D         +Y +M   N  L   L  +              
Sbjct: 64  LQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWLKKKKSIDPWERKS--YW 114

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           ++    +  +H+     ++  D K +N L+ +    KL DFG+A Q  P+    V  S V
Sbjct: 115 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 170

Query: 268 GTVGYAAPEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
           GTV Y  PE ++             +++ KSDVWS G +LY +  G+       P  +  
Sbjct: 171 GTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQ-- 222

Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                   ++   K H IIDP  E  +     + L  +   CL + PK R  + E+
Sbjct: 223 -------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 271

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  140 bits (356), Expect = 2e-38
 Identities = 79/315 (25%), Positives = 138/315 (43%), Gaps = 59/315 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           IG G  G V  G +RV             + VAIK L + G+  +  +++++E + +G  
Sbjct: 57  IGSGDSGEVCYGRLRVPGQR--------DVPVAIKAL-KAGYTERQRRDFLSEASIMGQF 107

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN+++L G       RG   ++V E M N SL+  L +        +  + + +    
Sbjct: 108 DHPNIIRLEGVVT----RGRLAMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGA 162

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--- 269
           G+ YL  ++ +  + RD    N+L+D +   K+SDFGL+R    +     +T+  G    
Sbjct: 163 GMRYL-SDLGY--VHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTT--GGKIP 217

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VS 326
           + + APE +     ++ SDVWSFGVV++E++  G                   RPY  ++
Sbjct: 218 IRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE------------------RPYWNMT 259

Query: 327 DSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
           +      + +    P   G  C      L  L   C  K    RP+ S++V +L  +I  
Sbjct: 260 NRDVISSVEEGYRLPAPMG--C---PHALHQLMLDCWHKDRAQRPRFSQIVSVLDALI-- 312

Query: 383 ISSQDEVTLQPVAEI 397
              +   +L+  A +
Sbjct: 313 ---RSPESLRATATV 324

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  140 bits (355), Expect = 3e-38
 Identities = 73/313 (23%), Positives = 123/313 (39%), Gaps = 52/313 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+                  K+ VA+K L        +++  E   L +++H
Sbjct: 49  LGEGAFGKVFLAECH------NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQH 102

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR----------- 203
            ++V+  G C E        L+V+E M +  L   L S  P                   
Sbjct: 103 QHIVRFFGVCTEGR----PLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLG 158

Query: 204 --LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
             L +A   A G+ YL   + F  + RD  T N L+ +    K+ DFG++R         
Sbjct: 159 QLLAVASQVAAGMVYL-AGLHF--VHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYR 215

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEW 320
           V    +  + +  PE +   + T +SDVWSFGVVL+E+ T G+                 
Sbjct: 216 VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGK----------------- 258

Query: 321 VRPY--VSDSKKFHLIIDP-RLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
            +P+  +S+++    I     LE    C     ++ A+   C  ++P+ R  + +V   L
Sbjct: 259 -QPWYQLSNTEAIDCITQGRELERPRAC---PPEVYAIMRGCWQREPQQRHSIKDVHARL 314

Query: 377 GNIISEISSQDEV 389
             +        +V
Sbjct: 315 QALAQAPPVYLDV 327

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  145 bits (367), Expect = 4e-38
 Identities = 74/304 (24%), Positives = 132/304 (43%), Gaps = 52/304 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           +G G FG V +GV R             ++DVAIK L +QG      +E + E   +  +
Sbjct: 344 LGCGNFGSVRQGVYR---------MRKKQIDVAIKVL-KQGTEKADTEEMMREAQIMHQL 393

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            +P +V+L+G C  +       +LV E+     L   L+ +    +      ++    + 
Sbjct: 394 DNPYIVRLIGVCQAE-----ALMLVMEMAGGGPLHKFLVGKREE-IPVSNVAELLHQVSM 447

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--- 269
           G+ YL EE +F  + R+    N+LL   + AK+SDFGL++    +   + + S       
Sbjct: 448 GMKYL-EEKNF--VHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARS--AGKWP 502

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VS 326
           + + APE +   + +++SDVWS+GV ++E ++ G+                  +PY  + 
Sbjct: 503 LKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ------------------KPYKKMK 544

Query: 327 DSKKFHLIIDP-RLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS 384
             +    I    R+E    C     +L AL S C   + + RP    V   +      ++
Sbjct: 545 GPEVMAFIEQGKRMECPPEC---PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 601

Query: 385 SQDE 388
           S+ E
Sbjct: 602 SKVE 605

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  139 bits (352), Expect = 4e-38
 Identities = 73/312 (23%), Positives = 124/312 (39%), Gaps = 67/312 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +GEG FG V+          +  S    K+ VA+K L        K++  E   L  ++H
Sbjct: 23  LGEGAFGKVFLAEC------YNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQH 76

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR----------- 203
            ++VK  G C + D      ++V+E M +  L   L +  P  +  +             
Sbjct: 77  EHIVKFYGVCGDGD----PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGL 132

Query: 204 ---LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
              L IA   A G+ YL     F  + RD  T N L+  +   K+ DFG++R      + 
Sbjct: 133 SQMLHIASQIASGMVYL-ASQHF--VHRDLATRNCLVGANLLVKIGDFGMSRD-----VY 184

Query: 261 HVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNE 314
                 VG        +  PE +   + T +SDVWSFGV+L+E+ T G+           
Sbjct: 185 STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK----------- 233

Query: 315 QKLLEWVRPY--VSDSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
                  +P+  +S+++    I       R     C    +++  +   C  ++P+ R  
Sbjct: 234 -------QPWFQLSNTEVIECITQGRVLERPRV--C---PKEVYDVMLGCWQREPQQRLN 281

Query: 369 MSEVVDILGNII 380
           + E+  IL  + 
Sbjct: 282 IKEIYKILHALG 293

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  138 bits (349), Expect = 9e-38
 Identities = 63/217 (29%), Positives = 87/217 (40%), Gaps = 26/217 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR---QGFQGHKEWINEVNFLGV 151
           +G+G FG V RG     S           + VA+K L        +   ++I EVN +  
Sbjct: 26  LGDGSFGVVRRGEWDAPSGK--------TVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G             +V EL    SL D L              + A   A
Sbjct: 78  LDHRNLIRLYGVVLTP-----PMKMVTELAPLGSLLDRLRKHQGH-FLLGTLSRYAVQVA 131

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT-- 269
            G+ YL E   F  I RD    N+LL      K+ DFGL R  P     +V         
Sbjct: 132 EGMGYL-ESKRF--IHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQE--HRKV 186

Query: 270 -VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRR 304
              + APE ++T   +  SD W FGV L+E+ T G+ 
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQE 223

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  144 bits (364), Expect = 1e-37
 Identities = 75/293 (25%), Positives = 110/293 (37%), Gaps = 34/293 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVVK 153
           +G GGFG V R +       HQ +G      VAIKQ  ++    ++E W  E+  +  + 
Sbjct: 22  LGTGGFGYVLRWI-------HQDTGEQ----VAIKQCRQELSPKNRERWCLEIQIMKKLN 70

Query: 154 HPNLVKLVGYCAEDDERGMQR----LLVYELMHNKSLEDHLLSR-VPTPLAWIARLKIAQ 208
           HPN+V        D  + +      LL  E      L  +L        L       +  
Sbjct: 71  HPNVVSA--REVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLS 128

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHVSTS 265
           D +  L YLHE     +I RD K  NI+L    +    K+ D G A++      G + T 
Sbjct: 129 DISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ---GELCTE 182

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE-RNLPRN-----EQKLLE 319
            VGT+ Y APE ++  + T   D WSFG + +E ITG R       P        +K  E
Sbjct: 183 FVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNE 242

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
            +  Y   +             +     A KL       L    + R    + 
Sbjct: 243 HIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQN 295

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  139 bits (353), Expect = 2e-37
 Identities = 79/329 (24%), Positives = 124/329 (37%), Gaps = 65/329 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWINEVNFLGVVK 153
           +G G FG VY G V             S L VA+K L      Q   +++ E   +    
Sbjct: 79  LGHGAFGEVYEGQVS------GMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN 132

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPT-----PLAWIARLKIAQ 208
           H N+V+ +G       + + R ++ ELM    L+  L    P       LA +  L +A+
Sbjct: 133 HQNIVRCIGVSL----QSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVAR 188

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHVSTS 265
           D A G  YL EE  F  I RD    N LL        AK+ DFG+AR      +      
Sbjct: 189 DIACGCQYL-EENHF--IHRDIAARNCLLTCPGPGRVAKIGDFGMARD-----IYRAGYY 240

Query: 266 VVGTVGY-----AAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE 319
             G           PE    G  T+K+D WSFGV+L+E+ + G                 
Sbjct: 241 RKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGY---------------- 284

Query: 320 WVRPY--VSDSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
              PY   S+ +    +         +   C      +  + ++C   QP+ RP  + ++
Sbjct: 285 --MPYPSKSNQEVLEFVTSGGRMDPPKN--C---PGPVYRIMTQCWQHQPEDRPNFAIIL 337

Query: 374 DILGNIISEISSQD---EVTLQPVAEIED 399
           + +     +    +    +   P+ E E+
Sbjct: 338 ERIEYCTQDPDVINTALPIEYGPLVEEEE 366

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  137 bits (348), Expect = 2e-37
 Identities = 70/293 (23%), Positives = 109/293 (37%), Gaps = 51/293 (17%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLG 150
            IG G F  VYR       D            VA+K++        K     I E++ L 
Sbjct: 39  KIGRGQFSEVYR--AACLLDGVP---------VALKKVQIFDLMDAKARADCIKEIDLLK 87

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHL----LSRVPTPLAWIARLK 205
            + HPN++K      ED+E     L +  EL     L   +      +   P   +   K
Sbjct: 88  QLNHPNVIKYYASFIEDNE-----LNIVLELADAGDLSRMIKHFKKQKRLIPERTV--WK 140

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH---V 262
                   L ++H     +++ RD K +N+ +      KL D GL R             
Sbjct: 141 YFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRF-----FSSKTTA 192

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
           + S+VGT  Y +PE +       KSD+WS G +LYE+   +     +   N   L     
Sbjct: 193 AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD-KMNLYSLC---- 247

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
                 K       P    +Y   S ++L  L + C+   P+ RP ++ V D+
Sbjct: 248 -----KKIEQCDYPPLPSDHY---S-EELRQLVNMCINPDPEKRPDVTYVYDV 291

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  138 bits (350), Expect = 2e-37
 Identities = 70/284 (24%), Positives = 116/284 (40%), Gaps = 45/284 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
            IGEG FG      V+ + D  Q           IK++N       KE      EV  L 
Sbjct: 31  KIGEGSFGKAIL--VKSTEDGRQ---------YVIKEINISR-MSSKEREESRREVAVLA 78

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
            +KHPN+V+      E+       L +V +      L   + ++          L     
Sbjct: 79  NMKHPNIVQYRESFEENGS-----LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQ 133

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
               L ++H+    +++ RD K+ NI L +D   +L DFG+AR         ++ + +GT
Sbjct: 134 ICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVL--NSTVELARACIGT 188

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE-RNLPRNEQKLLEWVRPYVSDS 328
             Y +PE  +      KSD+W+ G VLYEL T + A E  ++     K++     +    
Sbjct: 189 PYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS--GSF---- 242

Query: 329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                   P +  +Y   S   L +L S+   + P+ RP ++ +
Sbjct: 243 --------PPVSLHY---S-YDLRSLVSQLFKRNPRDRPSVNSI 274

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  139 bits (352), Expect = 2e-37
 Identities = 68/296 (22%), Positives = 115/296 (38%), Gaps = 57/296 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
            IG GG   V++ +            ++ K   AIK +N +    Q    + NE+ +L  
Sbjct: 63  QIGSGGSSKVFQVL------------NEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNK 110

Query: 152 VKHPNL--VKLVGYCAEDDERGMQRLLVYELM--HNKSLEDHLLSRVPTPLAWIARLKIA 207
           ++  +   ++L  Y   D         +Y +M   N  L   L  +              
Sbjct: 111 LQQHSDKIIRLYDYEITDQY-------IYMVMECGNIDLNSWLKKKKSIDPWERKS--YW 161

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           ++    +  +H+     ++  D K +N L+ +    KL DFG+A Q  P+    V  S V
Sbjct: 162 KNMLEAVHTIHQHG---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQV 217

Query: 268 GTVGYAAPEYVQ-----------TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK 316
           G V Y  PE ++             +++ KSDVWS G +LY +  G+       P  +  
Sbjct: 218 GAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK------TPFQQ-- 269

Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                   ++   K H IIDP  E  +     + L  +   CL + PK R  + E+
Sbjct: 270 -------IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPEL 318

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  143 bits (362), Expect = 2e-37
 Identities = 78/306 (25%), Positives = 123/306 (40%), Gaps = 61/306 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           IGEG FG V++G+     +          + VAIK   +        ++++ E   +   
Sbjct: 398 IGEGQFGDVHQGIYMSPENP--------AMAVAIKTC-KNCTSDSVREKFLQEALTMRQF 448

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HP++VKL+G   E+        ++ EL     L   L  R  + L   + +  A   + 
Sbjct: 449 DHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVRKFS-LDLASLILYAYQLST 502

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG- 271
            LAYL E   F  + RD    N+L+  +   KL DFGL+R          ST    + G 
Sbjct: 503 ALAYL-ESKRF--VHRDIAARNVLVSSNDCVKLGDFGLSR------YMEDSTYYKASKGK 553

Query: 272 ----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY-- 324
               + APE +   R T+ SDVW FGV ++E++  G                   +P+  
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGV------------------KPFQG 595

Query: 325 VSDSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
           V ++     I +    P      C      L +L +KC    P  RP+ +E+   L  I+
Sbjct: 596 VKNNDVIGRIENGERLPMPPN--C---PPTLYSLMTKCWAYDPSRRPRFTELKAQLSTIL 650

Query: 381 SEISSQ 386
            E   Q
Sbjct: 651 EEEKLQ 656

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  135 bits (342), Expect = 8e-37
 Identities = 65/290 (22%), Positives = 105/290 (36%), Gaps = 48/290 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN--RQGFQGHKEWINEVNFLGV 151
            IG G +G   +  +R  SD            +  K+L+         +  ++EVN L  
Sbjct: 13  TIGTGSYGRCQK--IRRKSDGKI---------LVWKELDYGSMTEAEKQMLVSEVNLLRE 61

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR------VPTPLAWIARLK 205
           +KHPN+V+   Y    D       +V E      L   +         +          +
Sbjct: 62  LKHPNIVRY--YDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL----R 115

Query: 206 IAQDAARGLAYLHE--EMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
           +       L   H   +    ++ RD K +N+ LD     KL DFGLAR    +     +
Sbjct: 116 VMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFA 173

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE-RNLPRNEQKLLEWVR 322
            + VGT  Y +PE +       KSD+WS G +LYEL          +      K+ E   
Sbjct: 174 KTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIRE--G 231

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
            +             R+   Y   S  +L  + ++ L  +   RP + E+
Sbjct: 232 KF------------RRIPYRY---S-DELNEIITRMLNLKDYHRPSVEEI 265

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  135 bits (343), Expect = 9e-37
 Identities = 63/309 (20%), Positives = 109/309 (35%), Gaps = 73/309 (23%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLGVV 152
            +G GGFG V+    +   DD            AIK++     +  +E +  EV  L  +
Sbjct: 12  CLGRGGFGVVFE--AKNKVDDCN---------YAIKRIRLPNRELAREKVMREVKALAKL 60

Query: 153 KHPNLVKLVGYCAEDDERGMQ-----RLLVY---ELMHNKSLEDHL-----LSRVPTPLA 199
           +HP +V+      E +          ++ +Y   +L   ++L+D +     +      + 
Sbjct: 61  EHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC 120

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ------ 253
                 I    A  + +LH +    L+ RD K SNI    D   K+ DFGL         
Sbjct: 121 L----HIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEE 173

Query: 254 ----GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN 309
                 P       T  VGT  Y +PE +     + K D++S G++L+EL+         
Sbjct: 174 EQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY-------- 225

Query: 310 LPRNEQKLLEWVRPYVSDSKKFHLIID------PRLEGNYCIKSAQKLAALASKCLTKQP 363
                        P+ +  ++   + D      P L              +    L+  P
Sbjct: 226 -------------PFSTQMERVRTLTDVRNLKFPPLFTQKY----PCEYVMVQDMLSPSP 268

Query: 364 KSRPKMSEV 372
             RP+   +
Sbjct: 269 MERPEAINI 277

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  135 bits (342), Expect = 1e-36
 Identities = 62/304 (20%), Positives = 106/304 (34%), Gaps = 60/304 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G FG V +         +           AIK++     +     ++EV  L  + 
Sbjct: 13  VLGQGAFGQVVKAR-------NALDSRY----YAIKKIRHTEEK-LSTILSEVMLLASLN 60

Query: 154 HPNLVKLVGYCAEDDERGMQRL---------LVYELMHNKSLEDHLLSR---VPTPLAWI 201
           H  +V+      E                  +  E   N +L D + S          W 
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW- 119

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-------- 253
              ++ +     L+Y+H +    +I RD K  NI +DE    K+ DFGLA+         
Sbjct: 120 ---RLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDIL 173

Query: 254 ----GPPEGLGHVSTSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGRRAVER 308
                   G     TS +GT  Y A E +  TG    K D++S G++ +E+I        
Sbjct: 174 KLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFST--- 230

Query: 309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
                   +L+ +R          +   P  + N  +K  +K   +    +   P  RP 
Sbjct: 231 --GMERVNILKKLR-------SVSIEFPPDFDDNK-MKVEKK---IIRLLIDHDPNKRPG 277

Query: 369 MSEV 372
              +
Sbjct: 278 ARTL 281

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  137 bits (346), Expect = 1e-36
 Identities = 79/308 (25%), Positives = 135/308 (43%), Gaps = 54/308 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           +G G FG V  G +++ S          ++ VAIK L + G+  +  ++++ E + +G  
Sbjct: 53  VGAGEFGEVCSGRLKLPSKK--------EISVAIKTL-KVGYTEKQRRDFLGEASIMGQF 103

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN+++L G       +    ++V E M N SL+  L          I  + + +  A 
Sbjct: 104 DHPNIIRLEGVVT----KSKPVMIVTEYMENGSLDSFLRKHDAQ-FTVIQLVGMLRGIAS 158

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT--- 269
           G+ YL  +M +  + RD    NIL++ +   K+SDFGL R    +     +T   G    
Sbjct: 159 GMKYL-SDMGY--VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTR--GGKIP 213

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--VS 326
           + + +PE +   + T+ SDVWS+G+VL+E+++ G                   RPY  +S
Sbjct: 214 IRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGE------------------RPYWEMS 255

Query: 327 DSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
           +      + +    P      C      L  L   C  K   +RPK  ++V IL  +I  
Sbjct: 256 NQDVIKAVDEGYRLPPPMD--C---PAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN 310

Query: 383 ISSQDEVT 390
             S   +T
Sbjct: 311 PGSLKIIT 318

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  133 bits (338), Expect = 4e-36
 Identities = 68/309 (22%), Positives = 119/309 (38%), Gaps = 68/309 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GE  FG VY+G +   +   QT        VAIK L  +      +E+ +E      ++
Sbjct: 17  LGEDRFGKVYKGHLFGPAPGEQT------QAVAIKTLKDKAEGPLREEFRHEAMLRARLQ 70

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR---------- 203
           HPN+V L+G   +D        +++    +  L + L+ R P                  
Sbjct: 71  HPNVVCLLGVVTKDQ----PLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALE 126

Query: 204 ----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
               + +    A G+ YL        + +D  T N+L+ +    K+SD GL R+     +
Sbjct: 127 PPDFVHLVAQIAAGMEYL-SSHHV--VHKDLATRNVLVYDKLNVKISDLGLFRE-----V 178

Query: 260 GHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRN 313
                  +         + APE +  G+ +  SD+WS+GVVL+E+ + G           
Sbjct: 179 YAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGL---------- 228

Query: 314 EQKLLEWVRPY--VSDSKKFHLIID----PRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
                   +PY   S+     +I +    P  +   C      + AL  +C  + P  RP
Sbjct: 229 --------QPYCGYSNQDVVEMIRNRQVLPCPDD--C---PAWVYALMIECWNEFPSRRP 275

Query: 368 KMSEVVDIL 376
           +  ++   L
Sbjct: 276 RFKDIHSRL 284

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  134 bits (339), Expect = 4e-36
 Identities = 71/322 (22%), Positives = 119/322 (36%), Gaps = 69/322 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFL-GVV 152
           +G G FG V                  +   VA+K L        H+  ++E+  L  + 
Sbjct: 35  LGRGAFGQVIEADAF------GIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 88

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
            H N+V L+G C +        +++ E     +L  +L S+    + +            
Sbjct: 89  HHLNVVNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFL 145

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  +   A+G+ +L        I RD    NILL E    K+ DFGLAR      
Sbjct: 146 TLEHLICYSFQVAKGMEFL-ASRKC--IHRDLAARNILLSEKNVVKICDFGLARD----- 197

Query: 259 LGHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-------GRRAV 306
           +      V          + APE +     T +SDVWSFGV+L+E+ +       G    
Sbjct: 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG---- 253

Query: 307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEG-NYCIKSAQKLAALASKCLTKQPKS 365
              +  +E+         + +          R+   +Y      ++      C   +P  
Sbjct: 254 ---VKIDEE-----FCRRLKEGT--------RMRAPDYT---TPEMYQTMLDCWHGEPSQ 294

Query: 366 RPKMSEVVDILGNIISEISSQD 387
           RP  SE+V+ LGN++   + QD
Sbjct: 295 RPTFSELVEHLGNLLQANAQQD 316

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  134 bits (340), Expect = 5e-36
 Identities = 73/323 (22%), Positives = 130/323 (40%), Gaps = 63/323 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFL-GVV 152
           +GEG FG V                    + VA+K L      +   + ++E+  +  + 
Sbjct: 43  LGEGAFGQVVMAEAV----GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 98

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  + +            
Sbjct: 99  KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +      ARG+ YL        I RD    N+L+ E+   K++DFGLAR      
Sbjct: 155 TFKDLVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARD----- 206

Query: 259 LGHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPR 312
           + ++      T G     + APE +     T +SDVWSFGV+++E+ T G          
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--------- 257

Query: 313 NEQKLLEWVRPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPK 368
                     PY  +   + F L+ +  R++    C     +L  +   C    P  RP 
Sbjct: 258 ---------SPYPGIPVEELFKLLKEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPT 305

Query: 369 MSEVVDILGNIISEISSQDEVTL 391
             ++V+ L  I++  ++++ + L
Sbjct: 306 FKQLVEDLDRILTLTTNEEYLDL 328

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  135 bits (341), Expect = 5e-36
 Identities = 78/328 (23%), Positives = 122/328 (37%), Gaps = 72/328 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           IGEG FG V++              ++    VA+K L  +       ++  E   +    
Sbjct: 55  IGEGAFGRVFQARAP------GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 108

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR---------- 203
           +PN+VKL+G CA          L++E M    L + L S  P  +  ++           
Sbjct: 109 NPNIVKLLGVCAVGK----PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 164

Query: 204 ------------LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA 251
                       L IA+  A G+AYL  E  F  + RD  T N L+ E+   K++DFGL+
Sbjct: 165 SPGPPPLSCAEQLCIARQVAAGMAYL-SERKF--VHRDLATRNCLVGENMVVKIADFGLS 221

Query: 252 RQGPPEGLGHVSTSVVGTVGY-----AAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRA 305
           R      +                    PE +   R T +SDVW++GVVL+E+ + G   
Sbjct: 222 RN-----IYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGL-- 274

Query: 306 VERNLPRNEQKLLEWVRPY--VSDSKKFHLIIDP-RLEG-NYCIKSAQKLAALASKCLTK 361
                           +PY  ++  +  + + D   L     C     +L  L   C +K
Sbjct: 275 ----------------QPYYGMAHEEVIYYVRDGNILACPENC---PLELYNLMRLCWSK 315

Query: 362 QPKSRPKMSEVVDILGNIISEISSQDEV 389
            P  RP    +  IL  +         V
Sbjct: 316 LPADRPSFCSIHRILQRMCERAEGTVGV 343

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  135 bits (341), Expect = 8e-36
 Identities = 72/319 (22%), Positives = 128/319 (40%), Gaps = 63/319 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFL-GVV 152
           +GEG FG V                    + VA+K L      +   + ++E+  +  + 
Sbjct: 89  LGEGCFGQVVMAEAV----GIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIG 144

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  + +            
Sbjct: 145 KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +      ARG+ YL        I RD    N+L+ E+   K++DFGLAR      
Sbjct: 201 TFKDLVSCTYQLARGMEYL-ASQKC--IHRDLAARNVLVTENNVMKIADFGLARD----- 252

Query: 259 LGHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPR 312
           + ++      T G     + APE +     T +SDVWSFGV+++E+ T G          
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGG--------- 303

Query: 313 NEQKLLEWVRPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPK 368
                     PY  +   + F L+ +  R++    C     +L  +   C    P  RP 
Sbjct: 304 ---------SPYPGIPVEELFKLLKEGHRMDKPANC---TNELYMMMRDCWHAVPSQRPT 351

Query: 369 MSEVVDILGNIISEISSQD 387
             ++V+ L  I++  ++++
Sbjct: 352 FKQLVEDLDRILTLTTNEE 370

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  134 bits (338), Expect = 8e-36
 Identities = 71/325 (21%), Positives = 116/325 (35%), Gaps = 58/325 (17%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++ EGGF  VY    +      +          A+K+L     + ++  I EV F+  + 
Sbjct: 35  VLAEGGFAFVY--EAQDVGSGRE---------YALKRLLSNEEEKNRAIIQEVCFMKKLS 83

Query: 154 -HPNLVKLVGYCA---EDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQ 208
            HPN+V+     +   E+ + G    L+   +    L + L       PL+    LKI  
Sbjct: 84  GHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFY 143

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA---RQGPPEGLGHVSTS 265
              R + ++H +    +I RD K  N+LL      KL DFG A      P         +
Sbjct: 144 QTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRA 202

Query: 266 VV-------GTVGYAAPEYVQTGR---LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ 315
           +V        T  Y  PE +       +  K D+W+ G +LY L   +       P  + 
Sbjct: 203 LVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQ------HPFEDG 256

Query: 316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSA----QKLAALASKCLTKQPKSRPKMSE 371
             L               I    + G Y I           +L    L   P+ R  ++E
Sbjct: 257 AKLR--------------I----VNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAE 298

Query: 372 VVDILGNIISEISSQDEVTLQPVAE 396
           VV  L  I +  +   +  +  + E
Sbjct: 299 VVHQLQEIAAARNVNPKSPITELLE 323

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  133 bits (337), Expect = 8e-36
 Identities = 67/289 (23%), Positives = 102/289 (35%), Gaps = 60/289 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFL-G 150
            +G G +G V++   +           D +L  A+K+     +G +     + EV     
Sbjct: 64  RLGHGSYGEVFKVRSK----------EDGRL-YAVKRSMSPFRGPKDRARKLAEVGSHEK 112

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLL---SRVPTPLAWIARLKI 206
           V +HP  V+L     E        L L  EL    SL+ H     + +P    W      
Sbjct: 113 VGQHPCCVRLEQAWEEGG-----ILYLQTELC-GPSLQQHCEAWGASLPEAQVW----GY 162

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
            +D    LA+LH      L+  D K +NI L    + KL DFGL  +    G G      
Sbjct: 163 LRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE---VQ 216

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVRP 323
            G   Y APE +Q       +DV+S G+ + E+          LP      Q+L      
Sbjct: 217 EGDPRYMAPELLQGSY-GTAADVFSLGLTILEVACNME-----LPHGGEGWQQL------ 264

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                      + P         S++ L ++    L   PK R     +
Sbjct: 265 -------RQGYLPPEFTAGL---SSE-LRSVLVMMLEPDPKLRATAEAL 302

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  137 bits (347), Expect = 3e-35
 Identities = 64/308 (20%), Positives = 108/308 (35%), Gaps = 58/308 (18%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD---VAIKQLNRQGFQGHKE-WINEVNFL 149
            I  GG G +Y                D  ++   V +K L   G    +   + E  FL
Sbjct: 87  CIAHGGLGWIYLA-------------LDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFL 133

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             V HP++V++  +    D  G     +V E +  +SL+     ++P   A    +    
Sbjct: 134 AEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAEA----IAYLL 189

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
           +    L+YLH      L++ D K  NI+L E+ + KL D G         +      + G
Sbjct: 190 EILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVS-----RINSFG-YLYG 239

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
           T G+ APE V     T  +D+++ G  L  L                             
Sbjct: 240 TPGFQAPEIV-RTGPTVATDIYTVGRTLAALTLDL------------------PTRNGRY 280

Query: 329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-MSEVVDILGNIISEISSQD 387
               L  D  +     +K+      L  + +   P+ R     E+   L  ++ E+ +QD
Sbjct: 281 VD-GLPEDDPV-----LKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLREVVAQD 334

Query: 388 EVTLQPVA 395
               +P  
Sbjct: 335 TGVPRPGL 342

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  133 bits (336), Expect = 4e-35
 Identities = 81/319 (25%), Positives = 130/319 (40%), Gaps = 63/319 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFL-GVV 152
           +GEG FG V                 +    VA+K L      +   + I+E+  +  + 
Sbjct: 77  LGEGAFGQVVLAEAI----GLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 132

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           KH N++ L+G C +D        ++ E     +L ++L +R P  L +            
Sbjct: 133 KHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188

Query: 204 -----LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                +  A   ARG+ YL        I RD    N+L+ ED   K++DFGLAR      
Sbjct: 189 SSKDLVSCAYQVARGMEYL-ASKKC--IHRDLAARNVLVTEDNVMKIADFGLAR-----D 240

Query: 259 LGHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPR 312
           + H+      T G     + APE +     T +SDVWSFGV+L+E+ T G          
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG--------- 291

Query: 313 NEQKLLEWVRPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPK 368
                     PY  V   + F L+ +  R++  + C     +L  +   C    P  RP 
Sbjct: 292 ---------SPYPGVPVEELFKLLKEGHRMDKPSNC---TNELYMMMRDCWHAVPSQRPT 339

Query: 369 MSEVVDILGNIISEISSQD 387
             ++V+ L  I++  S+Q+
Sbjct: 340 FKQLVEDLDRIVALTSNQE 358

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  131 bits (332), Expect = 6e-35
 Identities = 81/341 (23%), Positives = 137/341 (40%), Gaps = 75/341 (21%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLG- 150
           +IGEG FG V +  ++             ++D AIK++ ++      H+++  E+  L  
Sbjct: 32  VIGEGNFGQVLKARIK---------KDGLRMDAAIKRM-KEYASKDDHRDFAGELEVLCK 81

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR------- 203
           +  HPN++ L+G C           L  E   + +L D L                    
Sbjct: 82  LGHHPNIINLLGACEHRG----YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAS 137

Query: 204 -------LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
                  L  A D ARG+ YL  +  F  I RD    NIL+ E+Y AK++DFGL+R    
Sbjct: 138 TLSSQQLLHFAADVARGMDYL-SQKQF--IHRDLAARNILVGENYVAKIADFGLSRGQ-- 192

Query: 257 EGLGHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNL 310
                    V  T+G     + A E +     T  SDVWS+GV+L+E+++ G        
Sbjct: 193 ------EVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG------- 239

Query: 311 PRNEQKLLEWVRPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSR 366
                       PY  ++ ++ +  +    RLE    C     ++  L  +C  ++P  R
Sbjct: 240 -----------TPYCGMTCAELYEKLPQGYRLEKPLNC---DDEVYDLMRQCWREKPYER 285

Query: 367 PKMSEVVDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAE 407
           P  ++++  L  ++ E   +  V      +      +  AE
Sbjct: 286 PSFAQILVSLNRMLEE--RKTYVNTTLYEKFTYAGIDCSAE 324

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  130 bits (328), Expect = 2e-34
 Identities = 69/288 (23%), Positives = 114/288 (39%), Gaps = 52/288 (18%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGHKEWI----NEVN 147
           ++G GG   V+                D +    VA+K L R        +      E  
Sbjct: 19  ILGFGGMSEVHLA-------------RDLRDHRDVAVKVL-RADLARDPSFYLRFRREAQ 64

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
               + HP +V +      +   G    +V E +   +L D + +    P+     +++ 
Sbjct: 65  NAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVI 122

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVST-SV 266
            DA + L + H+     +I RD K +NI++      K+ DFG+AR     G     T +V
Sbjct: 123 ADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAV 179

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
           +GT  Y +PE  +   + A+SDV+S G VLYE++TG                    P+  
Sbjct: 180 IGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE------------------PPFTG 221

Query: 327 DS------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
           DS      +  H+  DP          +  L A+  K L K P++R +
Sbjct: 222 DSPVSVAYQ--HVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ 267

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  129 bits (326), Expect = 4e-34
 Identities = 78/321 (24%), Positives = 130/321 (40%), Gaps = 72/321 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVK 153
           +GEG FG V +             G      VA+K L         ++ ++E N L  V 
Sbjct: 31  LGEGEFGKVVKATAF------HLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN 84

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR---------- 203
           HP+++KL G C++D       LL+ E     SL   L         ++            
Sbjct: 85  HPHVIKLYGACSQDGPL----LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLD 140

Query: 204 ------------LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA 251
                       +  A   ++G+ YL  EM    + RD    NIL+ E  K K+SDFGL+
Sbjct: 141 HPDERALTMGDLISFAWQISQGMQYL-AEMKL--VHRDLAARNILVAEGRKMKISDFGLS 197

Query: 252 RQGPPEGLGHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRA 305
           R      +    + V  + G     + A E +     T +SDVWSFGV+L+E++T G   
Sbjct: 198 RD-----VYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGG-- 250

Query: 306 VERNLPRNEQKLLEWVRPY--VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTK 361
                            PY  +   + F+L+    R+E  + C   ++++  L  +C  +
Sbjct: 251 ----------------NPYPGIPPERLFNLLKTGHRMERPDNC---SEEMYRLMLQCWKQ 291

Query: 362 QPKSRPKMSEVVDILGNIISE 382
           +P  RP  +++   L  ++ +
Sbjct: 292 EPDKRPVFADISKDLEKMMVK 312

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  130 bits (328), Expect = 4e-34
 Identities = 47/341 (13%), Positives = 80/341 (23%), Gaps = 69/341 (20%)

Query: 69  RRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAI 128
            +  +  V S   L    R       +  G    V+                D     A+
Sbjct: 46  PQNAETTVDS--LLSQGERKLKLVEPLRVGDRSVVFLVR-------DVERLED----FAL 92

Query: 129 KQLNRQGFQGHKEW---INEVNFLGVVKHPNLVKLVGYC--------------------- 164
           K           E             +   +  +                          
Sbjct: 93  KVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLS 152

Query: 165 -AEDDERGMQRLLVYELMHNKSLED-----HLLSRVPTPLAWIARLKIAQDAARGLAYLH 218
             +DD      LL+        LE        +         +A   +     R  A L 
Sbjct: 153 PGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQ 211

Query: 219 EEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV 278
            +    L+   F   N+ +  D +  L D     +     +G    +    V YA  E++
Sbjct: 212 SK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWK-----VGTRGPASSVPVTYAPREFL 263

Query: 279 Q--TGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVRPYVSDSKKFHL 333
              T   T   + W  G+ +Y +          LP           W RP +        
Sbjct: 264 NASTATFTHALNAWQLGLSIYRVWCLF------LPFGLVTPGIKGSWKRPSLRVPGT--- 314

Query: 334 IIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
                L    C      +  L  + L    + R    E ++
Sbjct: 315 ---DSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAME 352

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  128 bits (323), Expect = 1e-33
 Identities = 69/314 (21%), Positives = 120/314 (38%), Gaps = 54/314 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFL-GVV 152
           +G G FG V                 D+ L VA+K L         +  ++E+  +  + 
Sbjct: 54  LGAGAFGKVVEATA------FGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLG 107

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
           +H N+V L+G C          L++ E      L + L  +        A          
Sbjct: 108 QHENIVNLLGACTHGGPV----LVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTAST 163

Query: 204 ---LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
              L  +   A+G+A+L    +   I RD    N+LL   + AK+ DFGLAR    +   
Sbjct: 164 RDLLHFSSQVAQGMAFL-ASKNC--IHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNY 220

Query: 261 HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLE 319
            V  +    V + APE +     T +SDVWS+G++L+E+ + G                 
Sbjct: 221 IVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGL---------------- 264

Query: 320 WVRPY---VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
              PY   + +SK + L+ D  ++    +     + + ++   C   +P  RP   ++  
Sbjct: 265 --NPYPGILVNSKFYKLVKDGYQMAQPAFA---PKNIYSIMQACWALEPTHRPTFQQICS 319

Query: 375 ILGNIISEISSQDE 388
            L     E   + +
Sbjct: 320 FLQEQAQEDRRERD 333

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  127 bits (321), Expect = 2e-33
 Identities = 73/321 (22%), Positives = 119/321 (37%), Gaps = 68/321 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFL-GVV 152
           +G G FG V                 D+ + VA+K L         +  ++E+  L  + 
Sbjct: 31  LGAGAFGKVVEATAY------GLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLG 84

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
            H N+V L+G C          L++ E      L + L  +  + +              
Sbjct: 85  NHMNIVNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDEL 140

Query: 204 -------LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPP 256
                  L  +   A+G+A+L    +   I RD    NILL      K+ DFGLAR    
Sbjct: 141 ALDLEDLLSFSYQVAKGMAFL-ASKNC--IHRDLAARNILLTHGRITKICDFGLARD--- 194

Query: 257 EGLGHVSTSVVGTVG-----YAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNL 310
             + + S  VV         + APE +     T +SDVWS+G+ L+EL + G        
Sbjct: 195 --IKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGS------- 245

Query: 311 PRNEQKLLEWVRPY---VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKS 365
                       PY     DSK + +I +  R+    +      ++  +   C    P  
Sbjct: 246 -----------SPYPGMPVDSKFYKMIKEGFRMLSPEHA---PAEMYDIMKTCWDADPLK 291

Query: 366 RPKMSEVVDILGNIISEISSQ 386
           RP   ++V ++   ISE ++ 
Sbjct: 292 RPTFKQIVQLIEKQISESTNH 312

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  126 bits (318), Expect = 2e-33
 Identities = 49/213 (23%), Positives = 86/213 (40%), Gaps = 22/213 (10%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQ--LNRQGFQGHKEWINEVNFLGV 151
            IG G F  VY+G+          +     ++VA  +    +      + +  E   L  
Sbjct: 33  EIGRGSFKTVYKGL-------DTETT----VEVAWCELQDRKLTKSERQRFKEEAEMLKG 81

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           ++HPN+V+         +     +LV ELM + +L+ +L       +  +      +   
Sbjct: 82  LQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRS--WCRQIL 139

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
           +GL +LH      +I RD K  NI +       K+ D GLA           + +V+GT 
Sbjct: 140 KGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTP 194

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            + APE  +        DV++FG+ + E+ T  
Sbjct: 195 EFMAPEMYEEK-YDESVDVYAFGMCMLEMATSE 226

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 2e-33
 Identities = 66/292 (22%), Positives = 110/292 (37%), Gaps = 54/292 (18%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL-GVV 152
           ++G G  G +               G     DVA+K++  + F        EV  L    
Sbjct: 31  VLGHGAEGTIVYR------------GMFDNRDVAVKRILPECFSFAD---REVQLLRESD 75

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+++   +C E D +   + +  EL    +L++++  +    L       + Q    
Sbjct: 76  EHPNVIRY--FCTEKDRQ--FQYIAIELC-AATLQEYVEQKDFAHLGLEPI-TLLQQTTS 129

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDE-----DYKAKLSDFGLARQ-GPPEGLGHVSTSV 266
           GLA+LH      ++ RD K  NIL+         KA +SDFGL ++           + V
Sbjct: 130 GLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGV 186

Query: 267 VGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
            GT G+ APE +        T   D++S G V Y +I+                     P
Sbjct: 187 PGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGS-----------------HP 229

Query: 324 Y--VSDSKKFHLIIDPRLEGNYCIKSAQKLAA-LASKCLTKQPKSRPKMSEV 372
           +      +   L+    L+  +  K    +A  L  K +   P+ RP    V
Sbjct: 230 FGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHV 281

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  127 bits (320), Expect = 3e-33
 Identities = 66/280 (23%), Positives = 107/280 (38%), Gaps = 39/280 (13%)

Query: 38  ASSSVDTRRSE-FDSDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSA-------TRGF 89
            S SV + ++    S ++ WS   A  + L     ++  V    +LK             
Sbjct: 1   GSGSVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWM 60

Query: 90  SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL 149
           +    +G G FG V+R          + +G       A+K++  + F+     + E+   
Sbjct: 61  THQPRVGRGSFGEVHRMK-------DKQTGFQ----CAVKKVRLEVFR-----VEELVAC 104

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             +  P +V L G   E        + ++ EL+   SL   +      P           
Sbjct: 105 AGLSSPRIVPLYGAVREGPW-----VNIFMELLEGGSLGQLIKQMGCLPEDRAL--YYLG 157

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHVST--- 264
            A  GL YLH     +++  D K  N+LL  D  +A L DFG A    P+GLG       
Sbjct: 158 QALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD 214

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
            + GT  + APE V      AK D+WS   ++  ++ G  
Sbjct: 215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCH 254

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  128 bits (322), Expect = 3e-33
 Identities = 59/378 (15%), Positives = 109/378 (28%), Gaps = 78/378 (20%)

Query: 36  SVASSSVDTRRSEFDSDSRDWSDSLAFYELLSQRRANDLRVFSFA-ELKSATRGFSRALL 94
            V    +  R  + +  +       A   L+S    N  + F    EL    R   R  +
Sbjct: 21  DVVIEELFNRIPQANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTV 80

Query: 95  IGEGGFGCVYRG------------VVRVSSDDHQTSGHDSKLDVAIKQLNRQG-----FQ 137
           +G+                     V   +      +    K +V   +L R        +
Sbjct: 81  LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140

Query: 138 GHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE--DHLLSRVP 195
            H  +I   + +   +   ++++     E D   + R  +Y  M +      + LLS   
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLD--ERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 196 T--PLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
           T   L   ARL++     R LA LH      L+    +  +I+LD+     L+ F    +
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQT-----------GRLTAKSDVWSFGVVLYELITG 302
                          + G+  PE                 +T   D W+ G+V+Y +   
Sbjct: 256 ------DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309

Query: 303 RRAVERNLP---RNEQKLLEWV---RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALAS 356
                  LP          EW+      +    +  L+                      
Sbjct: 310 D------LPITKDAALGGSEWIFRSCKNIPQPVR-ALL---------------------E 341

Query: 357 KCLTKQPKSRPKMSEVVD 374
             L    + R    + ++
Sbjct: 342 GFLRYPKEDRLLPLQAME 359

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  126 bits (318), Expect = 3e-33
 Identities = 65/289 (22%), Positives = 116/289 (40%), Gaps = 59/289 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGHKEWI----NEVN 147
            +G GG   VY                D+ L+  VAIK +     +  +E +     EV+
Sbjct: 18  KLGGGGMSTVYLA-------------EDTILNIKVAIKAI-FIPPREKEETLKRFEREVH 63

Query: 148 FLGVVKHPNLVKL--VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
               + H N+V +  V    E+D+      LV E +   +L +++ S    PL+    + 
Sbjct: 64  NSSQLSHQNIVSMIDVD---EEDD---CYYLVMEYIEGPTLSEYIESH--GPLSVDTAIN 115

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
                  G+ + H+    +++ RD K  NIL+D +   K+ DFG+A+      L   +  
Sbjct: 116 FTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-TNH 171

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
           V+GTV Y +PE  +       +D++S G+VLYE++ G                    P+ 
Sbjct: 172 VLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGE------------------PPFN 213

Query: 326 SDS------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
            ++      K     + P +  +      Q L+ +  +   K   +R K
Sbjct: 214 GETAVSIAIKHIQDSV-PNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  124 bits (314), Expect = 8e-33
 Identities = 79/298 (26%), Positives = 117/298 (39%), Gaps = 70/298 (23%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK---EWINEVNFLG 150
           L+G+G F  VYR            +G +    VAIK ++++            NEV    
Sbjct: 18  LLGKGSFAGVYRAE-------SIHTGLE----VAIKMIDKKAMYKAGMVQRVQNEVKIHC 66

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---ELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +KHP++++L  Y  ED         VY   E+ HN  +  +L +RV       AR  + 
Sbjct: 67  QLKHPSILELYNY-FEDSNY------VYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMH 119

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA-RQGPPEGLGHVSTSV 266
           Q    G+ YLH      ++ RD   SN+LL  +   K++DFGLA +   P    +  T  
Sbjct: 120 Q-IITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHY--TL- 172

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR- 322
            GT  Y +PE         +SDVWS G + Y L+ GR       P      +  L  V  
Sbjct: 173 CGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGR------PPFDTDTVKNTLNKVVL 226

Query: 323 ------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
                  ++S   K  LI                      + L + P  R  +S V+D
Sbjct: 227 ADYEMPSFLSIEAK-DLI---------------------HQLLRRNPADRLSLSSVLD 262

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  125 bits (315), Expect = 1e-32
 Identities = 56/219 (25%), Positives = 83/219 (37%), Gaps = 34/219 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQGHKEWI----NEVN 147
           L+G GG G VY                D+  +  VA+K +  +       +      E  
Sbjct: 41  LVGRGGMGDVYEA-------------EDTVRERIVALKLM-SETLSSDPVFRTRMQREAR 86

Query: 148 FLGVVKHPNLVKL--VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
             G ++ P++V +   G   E D    Q  +   L++   L   L  + P          
Sbjct: 87  TAGRLQEPHVVPIHDFG---EIDG---QLYVDMRLINGVDLAAMLRRQGPLAPPRAVA-- 138

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           I +     L   H         RD K  NIL+  D  A L DFG+A     E L  +   
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGN- 194

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR 304
            VGT+ Y APE       T ++D+++   VLYE +TG  
Sbjct: 195 TVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSP 233

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  125 bits (315), Expect = 2e-32
 Identities = 65/339 (19%), Positives = 114/339 (33%), Gaps = 89/339 (26%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFL-GVV 152
           +G G FG V              S     + VA+K L  +      +  ++E+  +  + 
Sbjct: 53  LGSGAFGKVMNATAY------GISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLG 106

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR--------- 203
            H N+V L+G C           L++E      L ++L S+                   
Sbjct: 107 SHENIVNLLGACTLSGPI----YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEE 162

Query: 204 ------------LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA 251
                       L  A   A+G+ +L E      + RD    N+L+      K+ DFGLA
Sbjct: 163 EEDLNVLTFEDLLCFAYQVAKGMEFL-EFKSC--VHRDLAARNVLVTHGKVVKICDFGLA 219

Query: 252 RQGPPEGLGHVSTSVVGTVGY-------------AAPEYVQTGRLTAKSDVWSFGVVLYE 298
           R              + +                 APE +  G  T KSDVWS+G++L+E
Sbjct: 220 RD-------------IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWE 266

Query: 299 LIT-GRRAVERNLPRNEQKLLEWVRPY---VSDSKKFHLIID-PRLEG-NYCIKSAQKLA 352
           + + G                    PY     D+  + LI +  +++   Y     +++ 
Sbjct: 267 IFSLGV------------------NPYPGIPVDANFYKLIQNGFKMDQPFYA---TEEIY 305

Query: 353 ALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVTL 391
            +   C     + RP    +   LG  +++        +
Sbjct: 306 IIMQSCWAFDSRKRPSFPNLTSFLGCQLADAEEAMYQNV 344

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  123 bits (310), Expect = 3e-32
 Identities = 64/299 (21%), Positives = 111/299 (37%), Gaps = 73/299 (24%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK---EWINEVNFLG 150
            +G+GGF   +             +        A K + +          +   E++   
Sbjct: 22  FLGKGGFAKCFEIS-------DADTKEV----FAGKIVPKSLLLKPHQREKMSMEISIHR 70

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---ELMHNKSLEDHLLS--RVPTPLAWIARLK 205
            + H ++V   G+  ED++       V+   EL   +SL +       +  P A   R  
Sbjct: 71  SLAHQHVVGFHGF-FEDNDF------VFVVLELCRRRSLLELHKRRKALTEPEA---RYY 120

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           + Q    G  YLH      +I RD K  N+ L+ED + K+ DFGLA +   E  G     
Sbjct: 121 LRQ-IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKV 174

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR 322
           + GT  Y APE +     + + DVWS G ++Y L+ G+       P      ++    ++
Sbjct: 175 LCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRIK 228

Query: 323 -------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
                   +++      LI                      K L   P +RP ++E+++
Sbjct: 229 KNEYSIPKHINPVAA-SLI---------------------QKMLQTDPTARPTINELLN 265

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  123 bits (310), Expect = 4e-32
 Identities = 78/285 (27%), Positives = 124/285 (43%), Gaps = 50/285 (17%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           ++R   IG+G  G VY  +          +G +    VAI+Q+N Q     +  INE+  
Sbjct: 22  YTRFEKIGQGASGTVYTAM-------DVATGQE----VAIRQMNLQQQPKKELIINEILV 70

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
           +   K+PN+V  +      DE     L +V E +   SL D +++        IA   + 
Sbjct: 71  MRENKNPNIVNYLDSYLVGDE-----LWVVMEYLAGGSLTD-VVTETCMDEGQIAA--VC 122

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           ++  + L +LH     Q+I RD K+ NILL  D   KL+DFG   Q  PE      +++V
Sbjct: 123 RECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMV 177

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
           GT  + APE V       K D+WS G++  E+I G        P           PY+++
Sbjct: 178 GTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE-------P-----------PYLNE 219

Query: 328 S--KKFHLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           +  +  +LI     P L+     K +       ++CL    + R 
Sbjct: 220 NPLRALYLIATNGTPELQNPE--KLSAIFRDFLNRCLEMDVEKRG 262

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  123 bits (310), Expect = 9e-32
 Identities = 65/300 (21%), Positives = 113/300 (37%), Gaps = 75/300 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK---EWINEVNFLG 150
            +G+GGF   +             +        A K + +          +   E++   
Sbjct: 48  FLGKGGFAKCFEIS-------DADTKEV----FAGKIVPKSLLLKPHQREKMSMEISIHR 96

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---ELMHNKSLEDHLLS--RVPTPLAWIARLK 205
            + H ++V   G+  ED++       V+   EL   +SL +       +  P A   R  
Sbjct: 97  SLAHQHVVGFHGF-FEDNDF------VFVVLELCRRRSLLELHKRRKALTEPEA---RYY 146

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           + Q    G  YLH      +I RD K  N+ L+ED + K+ DFGLA +   E  G     
Sbjct: 147 LRQ-IVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATK--VEYDGERKKV 200

Query: 266 VVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWV 321
           + GT  Y APE V + +  + + DVWS G ++Y L+ G+       P      ++    +
Sbjct: 201 LCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGK------PPFETSCLKETYLRI 253

Query: 322 R-------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
           +        +++      LI                      K L   P +RP ++E+++
Sbjct: 254 KKNEYSIPKHINPVAA-SLI---------------------QKMLQTDPTARPTINELLN 291

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  122 bits (308), Expect = 1e-31
 Identities = 86/330 (26%), Positives = 127/330 (38%), Gaps = 75/330 (22%)

Query: 67  SQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDV 126
           S   A  L     + L+     F    L+G G +G VY+G        H  +G       
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGR-------HVKTGQL----A 52

Query: 127 AIKQLNRQGFQGHKEWINEVNFLG-VVKHPNLVKLVG-YCAEDDERGMQRL-LVYELMHN 183
           AIK ++  G    +E   E+N L     H N+    G +  ++      +L LV E    
Sbjct: 53  AIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGA 111

Query: 184 KSLEDHLLSRVPTPL--AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY 241
            S+ D + +     L   WIA   I ++  RGL++LH+    ++I RD K  N+LL E+ 
Sbjct: 112 GSVTDLIKNTKGNTLKEEWIA--YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENA 166

Query: 242 KAKLSDFGLARQGPPEGLGHVS---TSVVGTVGYAAPEYVQTGRLT-----AKSDVWSFG 293
           + KL DFG++ Q     L        + +GT  + APE +            KSD+WS G
Sbjct: 167 EVKLVDFGVSAQ-----LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLG 221

Query: 294 VVLYELITGR---------RAVERNLPRNEQKLLE---WVRPYVSDSKKFHLIIDPRLEG 341
           +   E+  G          RA+   +PRN    L+   W       SKKF   I      
Sbjct: 222 ITAIEMAEGAPPLCDMHPMRAL-FLIPRNPAPRLKSKKW-------SKKFQSFI------ 267

Query: 342 NYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
                           CL K    RP   +
Sbjct: 268 --------------ESCLVKNHSQRPATEQ 283

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  121 bits (306), Expect = 2e-31
 Identities = 80/284 (28%), Positives = 120/284 (42%), Gaps = 61/284 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLGVVK 153
           IG+G FG V++G+          +       VAIK ++ +  +   E I  E+  L    
Sbjct: 30  IGKGSFGEVFKGI-------DNRTQKV----VAIKIIDLEEAEDEIEDIQQEITVLSQCD 78

Query: 154 HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            P + K  G   +D +     L ++ E +   S  D LL   P     IA   I ++  +
Sbjct: 79  SPYVTKYYGSYLKDTK-----LWIIMEYLGGGSALD-LLEPGPLDETQIA--TILREILK 130

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           GL YLH E   + I RD K +N+LL E  + KL+DFG+A Q     +     + VGT  +
Sbjct: 131 GLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR--NTFVGTPFW 185

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR---------RAVERNLPRNEQKLLEWVRP 323
            APE ++     +K+D+WS G+   EL  G          + +   +P+N         P
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL-FLIPKNN--------P 236

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
                        P LEGNY     + L      CL K+P  RP
Sbjct: 237 -------------PTLEGNYS----KPLKEFVEACLNKEPSFRP 263

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  120 bits (304), Expect = 2e-31
 Identities = 57/303 (18%), Positives = 95/303 (31%), Gaps = 77/303 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGV 151
            IG G FG V++ V      D            AIK+  +   G    +  + EV    V
Sbjct: 18  KIGSGEFGSVFKCV---KRLDGCI--------YAIKRSKKPLAGSVDEQNALREVYAHAV 66

Query: 152 V-KHPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHLL--SRVPTPLAWIARLKIA 207
           + +H ++V+     AEDD      +L+  E  +  SL D +    R+ +         + 
Sbjct: 67  LGQHSHVVRYFSAWAEDD-----HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLL 121

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-------------------YKAKLSDF 248
               RGL Y+H      L+  D K SNI +                         K+ D 
Sbjct: 122 LQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDL 178

Query: 249 GLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGRRAVE 307
           G   +              G   + A E +Q       K+D+++  + +           
Sbjct: 179 GHVTRISS------PQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA----- 227

Query: 308 RNLPRNEQKLLEWVRPYVSDSKKFHLIID---PRLEGNYCIKSAQKLAALASKCLTKQPK 364
                          P   +  ++H I     PR+       S +    L    +   P+
Sbjct: 228 --------------EPLPRNGDQWHEIRQGRLPRIPQVL---SQE-FTELLKVMIHPDPE 269

Query: 365 SRP 367
            RP
Sbjct: 270 RRP 272

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  123 bits (310), Expect = 2e-31
 Identities = 65/408 (15%), Positives = 113/408 (27%), Gaps = 88/408 (21%)

Query: 5   HFSNGERERRDGGDDGGVVSRTSKVSWARSLSVASSSVDTRRSEFDSDSRDWSDSLAFYE 64
           H S+G       G  G              +  A+    +   +    + D   S + + 
Sbjct: 6   HHSSGRENLYFQGFRGTDPGDVVIEELFNRIPQANVRTTSEYMQ---SAADSLVSTSLW- 61

Query: 65  LLSQRRANDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKL 124
                     RV S  EL    R   R  ++G+                  Q +G     
Sbjct: 62  ----NTGQPFRVES--ELGERPRTLVRGTVLGQEDPYAYLEAT-------DQETGES--- 105

Query: 125 DVAIKQLNR----------------------QGFQGHKEWINEVNFLG---VVKHPNLVK 159
              +                           +G +  K+    + F+    +VK P   K
Sbjct: 106 -FEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKK 164

Query: 160 LV-GYCAEDDERGMQRLLVYELMH--NKSLEDHLLSRVPT--PLAWIARLKIAQDAARGL 214
           ++     E D   + R  +Y  M    ++  + LLS   T   L   ARL++     R L
Sbjct: 165 MIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL 224

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
           A LH      L+    +  +I+LD+     L+ F    +     +              A
Sbjct: 225 ASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVS-PIGRGFAPPETTA 280

Query: 275 PEYV-----QTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVRPYVS 326
              +         +T   D W+ G+ +Y +          LP          EW+     
Sbjct: 281 ERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD------LPNTDDAALGGSEWIFR--- 331

Query: 327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
                            C    Q + AL    L    + R    + ++
Sbjct: 332 ----------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAME 363

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  121 bits (306), Expect = 2e-31
 Identities = 74/285 (25%), Positives = 123/285 (43%), Gaps = 50/285 (17%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
               + IGEG  G V            + SG      VA+K ++ +  Q  +   NEV  
Sbjct: 47  LDSYVKIGEGSTGIVCLAR-------EKHSGRQ----VAVKMMDLRKQQRRELLFNEVVI 95

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
           +   +H N+V++       +E     L ++ E +   +L D ++S+V      IA   + 
Sbjct: 96  MRDYQHFNVVEMYKSYLVGEE-----LWVLMEFLQGGALTD-IVSQVRLNEEQIAT--VC 147

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           +   + LAYLH +    +I RD K+ +ILL  D + KLSDFG   Q   +       S+V
Sbjct: 148 EAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR--KSLV 202

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
           GT  + APE +       + D+WS G+++ E++ G        P           PY SD
Sbjct: 203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE-------P-----------PYFSD 244

Query: 328 S--KKFHLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           S  +    + D   P+L+ ++  K +  L     + L + P+ R 
Sbjct: 245 SPVQAMKRLRDSPPPKLKNSH--KVSPVLRDFLERMLVRDPQERA 287

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  119 bits (300), Expect = 7e-31
 Identities = 67/295 (22%), Positives = 112/295 (37%), Gaps = 71/295 (24%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK---EWINEVNFLG 150
            +G+G FG VY    +            SK  +A+K L +   +      +   EV    
Sbjct: 16  PLGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLS--RVPTPLAWIARLKIA 207
            ++HPN+++L GY  +       R+ L+ E     ++   L    +            I 
Sbjct: 65  HLRHPNILRLYGYFHDAT-----RVYLILEYAPLGTVYRELQKLSKFDEQRT---ATYIT 116

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
           +  A  L+Y H +    +I RD K  N+LL    + K++DFG +   P        T + 
Sbjct: 117 E-LANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTDLC 168

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR-- 322
           GT+ Y  PE ++      K D+WS GV+ YE + G+       P      Q+  + +   
Sbjct: 169 GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK------PPFEANTYQETYKRISRV 222

Query: 323 -----PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                 +V++  +  LI                     S+ L   P  RP + EV
Sbjct: 223 EFTFPDFVTEGAR-DLI---------------------SRLLKHNPSQRPMLREV 255

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  120 bits (302), Expect = 1e-30
 Identities = 55/315 (17%), Positives = 100/315 (31%), Gaps = 70/315 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI----------- 143
           + +G F  +                 D+K   A+K+  +   +  +++            
Sbjct: 39  LNQGKFNKIILCE------------KDNKF-YALKKYEKSLLEKKRDFTKSNNDKISIKS 85

Query: 144 ------NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPT 196
                 NE+  +  +K+   +   G     D      + ++YE M N S+          
Sbjct: 86  KYDDFKNELQIITDIKNEYCLTCEGIITNYD-----EVYIIYEYMENDSILKFDEYFFVL 140

Query: 197 PLAWIARL------KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
              +   +       I +      +Y+H E +  +  RD K SNIL+D++ + KLSDFG 
Sbjct: 141 DKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGE 198

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT--AKSDVWSFGVVLYELITGRRAVER 308
           +          +  S  GT  +  PE+         AK D+WS G+ LY +         
Sbjct: 199 SEYMVD---KKIKGS-RGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV----- 249

Query: 309 NLP----RNEQKLLEWVR-------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASK 357
            +P     +  +L   +R          +               N+              
Sbjct: 250 -VPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDID---FLKL 305

Query: 358 CLTKQPKSRPKMSEV 372
            L K P  R    + 
Sbjct: 306 FLRKNPAERITSEDA 320

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  118 bits (299), Expect = 1e-30
 Identities = 79/299 (26%), Positives = 110/299 (36%), Gaps = 67/299 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLGVVK 153
           IG G    V                      VAIK++N +  Q   + +  E+  +    
Sbjct: 23  IGSGATAVVQAAY-------CAPKKEK----VAIKRINLEKCQTSMDELLKEIQAMSQCH 71

Query: 154 HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLK------I 206
           HPN+V         DE     L LV +L+   S+ D +   V         L       I
Sbjct: 72  HPNIVSYYTSFVVKDE-----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATI 126

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ---GPPEGLGHVS 263
            ++   GL YLH+      I RD K  NILL ED   +++DFG++     G       V 
Sbjct: 127 LREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVR 183

Query: 264 TSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            + VGT  + APE ++  R    K+D+WSFG+   EL TG                    
Sbjct: 184 KTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGA-------A----------- 225

Query: 323 PYVSDSKKFH------LIID---PRLEGNYCIKSAQK-----LAALASKCLTKQPKSRP 367
           PY     K+       L +    P LE     K   K        + S CL K P+ RP
Sbjct: 226 PYH----KYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP 280

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  118 bits (297), Expect = 4e-30
 Identities = 76/291 (26%), Positives = 118/291 (40%), Gaps = 62/291 (21%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           F     +GEG +G VY+ +       H+ +G      VAIKQ+  +     +E I E++ 
Sbjct: 31  FDVLEKLGEGSYGSVYKAI-------HKETGQI----VAIKQVPVE--SDLQEIIKEISI 77

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPL--AWIARLK 205
           +     P++VK  G   ++ +     L +V E     S+ D ++      L    IA   
Sbjct: 78  MQQCDSPHVVKYYGSYFKNTD-----LWIVMEYCGAGSVSD-IIRLRNKTLTEDEIAT-- 129

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           I Q   +GL YLH     + I RD K  NILL+ +  AKL+DFG+A Q           +
Sbjct: 130 ILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKR--NT 184

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR---------RAVERNLPRNEQK 316
           V+GT  + APE +Q       +D+WS G+   E+  G+         RA+   +P N   
Sbjct: 185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFM-IPTNPPP 243

Query: 317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
                  +   S  F   +                     +CL K P+ R 
Sbjct: 244 TFRKPELW---SDNFTDFV--------------------KQCLVKSPEQRA 271

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  117 bits (294), Expect = 7e-30
 Identities = 54/217 (24%), Positives = 99/217 (45%), Gaps = 28/217 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G+G +G VY G          ++       +AIK++  +  +  +    E+     +K
Sbjct: 29  VLGKGTYGIVYAGR-------DLSNQVR----IAIKEIPERDSRYSQPLHEEIALHKHLK 77

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVY-ELMHNKSLEDHLLSRVPTPLAWIARL--KIAQDA 210
           H N+V+ +G  +E+       + ++ E +   SL   LL     PL    +      +  
Sbjct: 78  HKNIVQYLGSFSENG-----FIKIFMEQVPGGSLSA-LLRSKWGPLKDNEQTIGFYTKQI 131

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
             GL YLH+    Q++ RD K  N+L++      K+SDFG +++    G+   + +  GT
Sbjct: 132 LEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR--LAGINPCTETFTGT 186

Query: 270 VGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGRR 304
           + Y APE +  G       +D+WS G  + E+ TG+ 
Sbjct: 187 LQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  119 bits (300), Expect = 2e-29
 Identities = 69/297 (23%), Positives = 110/297 (37%), Gaps = 71/297 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G G +G V            + +  +     AIK + +       + + + EV  L ++
Sbjct: 45  LGSGAYGEVLLCR-------DKVTHVE----RAIKIIRKTSVSTSSNSKLLEEVAVLKLL 93

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++KL  +  ED        LV E      L D ++ R+       A   I +    
Sbjct: 94  DHPNIMKLYDFF-EDKR---NYYLVMECYKGGELFDEIIHRMKFNEVDAA--VIIKQVLS 147

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
           G+ YLH+     ++ RD K  N+LL   ++D   K+ DFGL+               +GT
Sbjct: 148 GVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN---QKKMKERLGT 201

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR---- 322
             Y APE V   +   K DVWS GV+L+ L+ G        P   + +Q++L  V     
Sbjct: 202 AYYIAPE-VLRKKYDEKCDVWSIGVILFILLAGYP------PFGGQTDQEILRKVEKGKY 254

Query: 323 -------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                    VS+  K  LI                      + L    + R    + 
Sbjct: 255 TFDSPEWKNVSEGAK-DLI---------------------KQMLQFDSQRRISAQQA 289

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  118 bits (298), Expect = 3e-29
 Identities = 76/298 (25%), Positives = 117/298 (39%), Gaps = 72/298 (24%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLGV 151
           +G+G FG V            + +G +     A+K ++++  +   +    + EV  L  
Sbjct: 34  LGKGSFGEVILCK-------DKITGQE----CAVKVISKRQVKQKTDKESLLREVQLLKQ 82

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + HPN++KL  +  ED        LV E+     L D ++SR        A  +I +   
Sbjct: 83  LDHPNIMKLYEFF-EDKG---YFYLVGEVYTGGELFDEIISRKRFSEVDAA--RIIRQVL 136

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
            G+ Y+H+    +++ RD K  N+LL    +D   ++ DFGL+               +G
Sbjct: 137 SGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA---SKKMKDKIG 190

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR--- 322
           T  Y APE V  G    K DVWS GV+LY L++G        P    NE  +L+ V    
Sbjct: 191 TAYYIAPE-VLHGTYDEKCDVWSTGVILYILLSGCP------PFNGANEYDILKKVEKGK 243

Query: 323 --------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                     VS+S K  LI                      K LT  P  R    + 
Sbjct: 244 YTFELPQWKKVSESAK-DLI---------------------RKMLTYVPSMRISARDA 279

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  118 bits (298), Expect = 3e-29
 Identities = 76/297 (25%), Positives = 114/297 (38%), Gaps = 71/297 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G FG V +          + +  +     A+K +N+   +       + EV  L  +
Sbjct: 30  LGKGSFGEVLKCK-------DRITQQE----YAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++KL     ED        +V EL     L D ++ R        A  +I +    
Sbjct: 79  DHPNIMKLFEIL-EDSS---SFYIVGELYTGGELFDEIIKRKRFSEHDAA--RIIKQVFS 132

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
           G+ Y+H+     ++ RD K  NILL   ++D   K+ DFGL+               +GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGT 186

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR---- 322
             Y APE V  G    K DVWS GV+LY L++G        P   +NE  +L+ V     
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP------PFYGKNEYDILKRVETGKY 239

Query: 323 -------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                    +SD  K  LI                      K LT  P  R   ++ 
Sbjct: 240 AFDLPQWRTISDDAK-DLI---------------------RKMLTFHPSLRITATQC 274

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  117 bits (296), Expect = 3e-29
 Identities = 67/317 (21%), Positives = 113/317 (35%), Gaps = 83/317 (26%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VV 152
           ++G G  G V               G      VA+K++             E+  L    
Sbjct: 22  ILGYGSSGTVVFQ--------GSFQGRP----VAVKRMLIDFCDIAL---MEIKLLTESD 66

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR-----LKIA 207
            HPN+++   YC+E  +R     +  EL  N +L+D + S+  +      +     + + 
Sbjct: 67  DHPNVIRY--YCSETTDR--FLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLL 121

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLD-------------EDYKAKLSDFGLARQG 254
           +  A G+A+LH      +I RD K  NIL+              E+ +  +SDFGL ++ 
Sbjct: 122 RQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL 178

Query: 255 PPEGLGHVST--SVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITG--- 302
                   +   +  GT G+ APE            RLT   D++S G V Y +++    
Sbjct: 179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKH 238

Query: 303 ----RRAVERNLPRNEQKLLEWVRPY---VSDSKKFHLIIDPRLEGNYCIKSAQKLAALA 355
               + + E N+ R    L E    +   +       LI                     
Sbjct: 239 PFGDKYSRESNIIRGIFSLDEMKCLHDRSLIAEAT-DLI--------------------- 276

Query: 356 SKCLTKQPKSRPKMSEV 372
           S+ +   P  RP   +V
Sbjct: 277 SQMIDHDPLKRPTAMKV 293

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  114 bits (287), Expect = 5e-29
 Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 37/218 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK-----QLNRQGFQGHKEWINEVNF 148
            +G+G FG VY    +            +K  +A+K     QL ++G +       E+  
Sbjct: 21  PLGKGKFGNVYLAREK-----------QNKFIMALKVLFKSQLEKEGVEHQLR--REIEI 67

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLS--RVPTPLAWIARLK 205
              ++HPN++++  Y  +       R+ L+ E      L   L    R     +      
Sbjct: 68  QSHLRHPNILRMYNYFHDRK-----RIYLMLEFAPRGELYKELQKHGRFDEQRS---ATF 119

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           + +  A  L Y HE     +I RD K  N+L+    + K++DFG +   P         +
Sbjct: 120 MEE-LADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR----RT 171

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           + GT+ Y  PE ++      K D+W  GV+ YE + G 
Sbjct: 172 MCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  113 bits (286), Expect = 8e-29
 Identities = 59/290 (20%), Positives = 114/290 (39%), Gaps = 65/290 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+         ++ +G       A K +  +  +  +++I E+  L    H
Sbjct: 27  LGDGAFGKVYKAK-------NKETGAL----AAAKVIETKSEEELEDYIVEIEILATCDH 75

Query: 155 PNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPL--AWIARLKIAQDAA 211
           P +VKL+G    D +     L ++ E     +++  ++  +   L    I    + +   
Sbjct: 76  PYIVKLLGAYYHDGK-----LWIMIEFCPGGAVDA-IMLELDRGLTEPQIQV--VCRQML 127

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
             L +LH +   ++I RD K  N+L+  +   +L+DFG++ +           S +GT  
Sbjct: 128 EALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKR--DSFIGTPY 182

Query: 272 YAAPEYV-----QTGRLTAKSDVWSFGVVLYELITGR---------RAVERNLPRNEQKL 317
           + APE V     +      K+D+WS G+ L E+             R +   + +++   
Sbjct: 183 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVL-LKIAKSDPPT 241

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           L     +   S +F   +                       L K P++RP
Sbjct: 242 LLTPSKW---SVEFRDFL--------------------KIALDKNPETRP 268

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  115 bits (290), Expect = 1e-28
 Identities = 56/315 (17%), Positives = 95/315 (30%), Gaps = 63/315 (20%)

Query: 95  IGEG--GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN--RQGFQGHKEWINEVNFLG 150
           IG+G      V           ++ +G      V ++++N      +       E++   
Sbjct: 33  IGKGFEDLMTVNLAR-------YKPTGEY----VTVRRINLEACSNEMVTFLQGELHVSK 81

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPL--AWIARLKIA 207
           +  HPN+V        D+E     L +V   M   S +D + +     +    IA   I 
Sbjct: 82  LFNHPNIVPYRATFIADNE-----LWVVTSFMAYGSAKDLICTHFMDGMNELAIA--YIL 134

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG-----LGHV 262
           Q   + L Y+H       + R  K S+IL+  D K  LS           G     +   
Sbjct: 135 QGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDF 191

Query: 263 STSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGR----------------- 303
               V  + + +PE +Q       AKSD++S G+   EL  G                  
Sbjct: 192 PKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLN 251

Query: 304 -----------RAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLA 352
                         E       + +          +              Y    +    
Sbjct: 252 GTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFH 311

Query: 353 ALASKCLTKQPKSRP 367
               +CL + P +RP
Sbjct: 312 HFVEQCLQRNPDARP 326

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  114 bits (288), Expect = 1e-28
 Identities = 73/308 (23%), Positives = 117/308 (37%), Gaps = 58/308 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVK 153
           +G G  G V++         H+ SG      +A K ++ +       + I E+  L    
Sbjct: 41  LGAGNGGVVFKVS-------HKPSGLV----MARKLIHLEIKPAIRNQIIRELQVLHECN 89

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
            P +V   G    D E  +      E M   SL+  L      P   +   K++    +G
Sbjct: 90  SPYIVGFYGAFYSDGEISI----CMEHMDGGSLDQVLKKAGRIPEQILG--KVSIAVIKG 143

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH-VSTSVVGTVGY 272
           L YL E+   +++ RD K SNIL++   + KL DFG++ Q     L   ++ S VGT  Y
Sbjct: 144 LTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQ-----LIDSMANSFVGTRSY 196

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGR-------------------RAVERNLPRN 313
            +PE +Q    + +SD+WS G+ L E+  GR                          P  
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256

Query: 314 EQKLLEWVRPYVSDSKKFHLIID----------PRLEGNYCIKSAQKLAALASKCLTKQP 363
            +     +  +  DS+    I +          P+L         Q      +KCL K P
Sbjct: 257 PRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQD---FVNKCLIKNP 313

Query: 364 KSRPKMSE 371
             R  + +
Sbjct: 314 AERADLKQ 321

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  116 bits (292), Expect = 2e-28
 Identities = 68/293 (23%), Positives = 108/293 (36%), Gaps = 52/293 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHD--------SKLDVAIKQLNRQGFQGHKEWI-NE 145
           +G G +G V            +    +        S+ D      + +  +   E I NE
Sbjct: 44  LGSGAYGEVLLCK-------EKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNE 96

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           ++ L  + HPN++KL     ED +      LV E      L + +++R        A   
Sbjct: 97  ISLLKSLDHPNIIKLFDVF-EDKK---YFYLVTEFYEGGELFEQIINRHKFDECDAA--N 150

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHV 262
           I +    G+ YLH+     ++ RD K  NILL   +     K+ DFGL+         + 
Sbjct: 151 IMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK---DYK 204

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLE 319
               +GT  Y APE V   +   K DVWS GV++Y L+ G        P   +N+Q +++
Sbjct: 205 LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCGVIMYILLCGYP------PFGGQNDQDIIK 257

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
            V                  + N     + +   L    LT     R    E 
Sbjct: 258 KV-----------EKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEA 299

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  113 bits (284), Expect = 3e-28
 Identities = 72/350 (20%), Positives = 115/350 (32%), Gaps = 100/350 (28%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVN 147
           F     +G GGFG V+    +   DD            AIK++     +  +E +  EV 
Sbjct: 8   FEPIQCMGRGGFGVVFE--AKNKVDDCN---------YAIKRIRLPNRELAREKVMREVK 56

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLA-------- 199
            L  ++HP +V+      E      Q  +    + ++S +  L S  P            
Sbjct: 57  ALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMD 116

Query: 200 ----------------------------------WIAR------------LKIAQDAARG 213
                                             W+ R            L I    A  
Sbjct: 117 PFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEA 176

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ----------GPPEGLGHVS 263
           + +LH +    L+ RD K SNI    D   K+ DFGL               P       
Sbjct: 177 VEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATH 233

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV-ERNLPRNEQKLLEWVR 322
           T  VGT  Y +PE +     + K D++S G++L+EL+       ER       +++  VR
Sbjct: 234 TGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERV------RIITDVR 287

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                + KF     P L          +   +    L+  P  RP+ +++
Sbjct: 288 -----NLKF-----PLLFTQKY----PQEHMMVQDMLSPSPTERPEATDI 323

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  113 bits (284), Expect = 4e-28
 Identities = 38/225 (16%), Positives = 69/225 (30%), Gaps = 29/225 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           L+GEG F  VY       +D        +K    +K                +  L    
Sbjct: 72  LLGEGAFAQVYEATQGDLNDAK------NKQKFVLKVQKPANPWEFYIGTQLMERLKPSM 125

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA---RLKIAQDA 210
               +K        +      +LV EL    +L + +     TP   +     +  A   
Sbjct: 126 QHMFMKFYSAHLFQNGS----VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRM 181

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILL-----------DEDYKAKLSDFGLARQGPPEGL 259
              +  +H+    ++I  D K  N +L           D      L D G +        
Sbjct: 182 LYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK 238

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGR 303
           G + T+   T G+   E + + +    + D +     +Y ++ G 
Sbjct: 239 GTIFTAKCETSGFQCVE-MLSNKPWNYQIDYFGVAATVYCMLFGT 282

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  112 bits (283), Expect = 6e-28
 Identities = 95/325 (29%), Positives = 128/325 (39%), Gaps = 81/325 (24%)

Query: 67  SQRRANDLRVFSFAELKSA---TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSK 123
           +  RA  L+    AEL       + FS    IG G FG VY      +S+          
Sbjct: 31  AGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEV--------- 81

Query: 124 LDVAIKQLNRQGFQGHKEW---INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYE 179
             VAIK+++  G Q +++W   I EV FL  ++HPN ++  G    +         LV E
Sbjct: 82  --VAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHT-----AWLVME 134

Query: 180 LMHNKSLEDHLLSRVPTPL--AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL 237
                S  D LL     PL    IA   +   A +GLAYLH      +I RD K  NILL
Sbjct: 135 YCLG-SASD-LLEVHKKPLQEVEIAA--VTHGALQGLAYLHSH---NMIHRDVKAGNILL 187

Query: 238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV---QTGRLTAKSDVWSFGV 294
            E    KL DFG A    P      + S VGT  + APE +     G+   K DVWS G+
Sbjct: 188 SEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGI 241

Query: 295 VLYELITGR---------RAVERNLPRNEQKLLE---WVRPYVSDSKKFHLIIDPRLEGN 342
              EL   +          A+  ++ +NE   L+   W       S+ F   +       
Sbjct: 242 TCIELAERKPPLFNMNAMSAL-YHIAQNESPALQSGHW-------SEYFRNFV------- 286

Query: 343 YCIKSAQKLAALASKCLTKQPKSRP 367
                          CL K P+ RP
Sbjct: 287 -------------DSCLQKIPQDRP 298

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  111 bits (280), Expect = 6e-28
 Identities = 73/327 (22%), Positives = 115/327 (35%), Gaps = 88/327 (26%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
           ++G G F  V+           + +G       A+K + +          NE+  L  +K
Sbjct: 16  VLGSGAFSEVFLVK-------QRLTGKL----FALKCIKKSPAFRDSSLENEIAVLKKIK 64

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA-QDAAR 212
           H N+V L               LV +L+    L D +          + R     +DA+ 
Sbjct: 65  HENIVTLEDIYESTTH----YYLVMQLVSGGELFDRI----------LERGVYTEKDASL 110

Query: 213 -------GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHV 262
                   + YLHE     ++ RD K  N+L    +E+ K  ++DFGL++      +   
Sbjct: 111 VIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM--- 164

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLE 319
            ++  GT GY APE +     +   D WS GV+ Y L+ G        P     E KL E
Sbjct: 165 -STACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCG------YPPFYEETESKLFE 217

Query: 320 WVR--------PY---VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
            ++        P+   +S+S K   I                        L K P  R  
Sbjct: 218 KIKEGYYEFESPFWDDISESAK-DFI---------------------CHLLEKDPNERYT 255

Query: 369 MSEVVD---ILGNIISEISSQDEVTLQ 392
             + +    I GN          V+LQ
Sbjct: 256 CEKALSHPWIDGNTALHRDIYPSVSLQ 282

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  111 bits (279), Expect = 7e-28
 Identities = 73/298 (24%), Positives = 112/298 (37%), Gaps = 71/298 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLGVVK 153
           +G G FG V+    R            S L+  IK +N+   Q   E I  E+  L  + 
Sbjct: 30  LGSGAFGDVHLVEER-----------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD 78

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAW---IARLKIAQDA 210
           HPN++K+     ED        +V E      L + ++S      A        ++ +  
Sbjct: 79  HPNIIKIFEVF-EDYH---NMYIVMETCEGGELLERIVSAQARGKALSEGYVA-ELMKQM 133

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
              LAY H +    ++ +D K  NIL          K+ DFGLA           ST+  
Sbjct: 134 MNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKS---DEHSTNAA 187

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVRP- 323
           GT  Y APE V    +T K D+WS GVV+Y L+TG       LP    + +++ +     
Sbjct: 188 GTALYMAPE-VFKRDVTFKCDIWSAGVVMYFLLTGC------LPFTGTSLEEVQQKATYK 240

Query: 324 ---------YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                     ++      L+                      + LTK P+ RP  ++V
Sbjct: 241 EPNYAVECRPLTPQAV-DLL---------------------KQMLTKDPERRPSAAQV 276

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  110 bits (277), Expect = 1e-27
 Identities = 69/295 (23%), Positives = 110/295 (37%), Gaps = 69/295 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G +G V   V        + +        A K++ +   +    +  E+  +  + H
Sbjct: 17  IGRGSWGEVKIAV-------QKGTRIR----RAAKKIPKYFVEDVDRFKQEIEIMKSLDH 65

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PN+++L     ED+       LV EL     L + ++ +     +  AR  I +D    +
Sbjct: 66  PNIIRLYETF-EDNT---DIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAV 119

Query: 215 AYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           AY H+     +  RD K  N L      D   KL DFGLA +  P   G +  + VGT  
Sbjct: 120 AYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP---GKMMRTKVGTPY 173

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR------ 322
           Y +P+ V  G    + D WS GV++Y L+ G        P     + +++  +R      
Sbjct: 174 YVSPQ-VLEGLYGPECDEWSAGVMMYVLLCGYP------PFSAPTDSEVMLKIREGTFTF 226

Query: 323 -----PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                  VS   +  LI                      + LTK PK R    + 
Sbjct: 227 PEKDWLNVSPQAE-SLI---------------------RRLLTKSPKQRITSLQA 259

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  111 bits (280), Expect = 1e-27
 Identities = 73/370 (19%), Positives = 122/370 (32%), Gaps = 102/370 (27%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVV 152
            +GEG +G V   V       ++ +       VA+K ++ +      E I  E+    ++
Sbjct: 14  TLGEGAYGEVQLAV-------NRVTEEA----VAVKIVDMKRAVDCPENIKKEICINKML 62

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS-----LE--------DHLLSRVPTPLA 199
            H N+VK                  Y      +     LE        D +   +     
Sbjct: 63  NHENVVKF-----------------YGHRREGNIQYLFLEYCSGGELFDRIEPDI----- 100

Query: 200 WIARLKIAQDAAR--------GLAYLHEEMDFQLIF-RDFKTSNILLDEDYKAKLSDFGL 250
               +   +  A+        G+ YLH       I  RD K  N+LLDE    K+SDFGL
Sbjct: 101 ---GMP--EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGL 151

Query: 251 A---RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGRRA 305
           A   R    E L +      GT+ Y APE +   R       DVWS G+VL  ++ G   
Sbjct: 152 ATVFRYNNRERLLN--KM-CGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE-- 205

Query: 306 VERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSA---QKLAALASKCLTKQ 362
               LP ++              +++        +  Y            AL  K L + 
Sbjct: 206 ----LPWDQPS---------DSCQEYSDWK---EKKTYLNPWKKIDSAPLALLHKILVEN 249

Query: 363 PKSRPKMSEV-------VDILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQ 415
           P +R  + ++         +         +   V+  P    + ++   +   V  +++ 
Sbjct: 250 PSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRT 309

Query: 416 GNSYLKKVFD 425
             S   K   
Sbjct: 310 PGSGWSKEHH 319

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  110 bits (276), Expect = 2e-27
 Identities = 68/296 (22%), Positives = 110/296 (37%), Gaps = 66/296 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNF-LGVV 152
           +G G +G V +         H  SG      +A+K++      Q  K  + +++  +  V
Sbjct: 15  LGRGAYGVVEKMR-------HVPSGQI----MAVKRIRATVNSQEQKRLLMDLDISMRTV 63

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV-----PTPLAWIARLKIA 207
             P  V   G    + +  +      ELM + SL+     +V       P   +   KIA
Sbjct: 64  DCPFTVTFYGALFREGDVWI----CMELM-DTSLDK-FYKQVIDKGQTIPEDILG--KIA 115

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH--VSTS 265
               + L +LH ++   +I RD K SN+L++   + K+ DFG++       L        
Sbjct: 116 VSIVKALEHLHSKL--SVIHRDVKPSNVLINALGQVKMCDFGISGY-----LVDDVAKDI 168

Query: 266 VVGTVGYAAPE----YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
             G   Y APE     +     + KSD+WS G+ + EL   R                  
Sbjct: 169 DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILR-------F---------- 211

Query: 322 RPYVSDSKKF---HLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
            PY S    F     +++   P+L  +             S+CL K  K RP   E
Sbjct: 212 -PYDSWGTPFQQLKQVVEEPSPQLPADKFSAEFV---DFTSQCLKKNSKERPTYPE 263

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  111 bits (278), Expect = 2e-27
 Identities = 66/341 (19%), Positives = 103/341 (30%), Gaps = 109/341 (31%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-----INEVNFL 149
           IG+G +G V   +          +        AIK +N+   +            EV  +
Sbjct: 34  IGQGSYGVVRVAI-------ENQTRAI----RAIKIMNKNKIRQINPKDVERIKTEVRLM 82

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ- 208
             + HPN+ +L     ED++      LV EL H   L D L   +       A   +   
Sbjct: 83  KKLHHPNIARLYEVY-EDEQY---ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQ 138

Query: 209 ------------------------------DAAR-------GLAYLHEEMDFQLIFRDFK 231
                                           +         L YLH      +  RD K
Sbjct: 139 ICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIK 195

Query: 232 TSNILL--DEDYKAKLSDFGLAR--QGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL--TA 285
             N L   ++ ++ KL DFGL++       G  +  T+  GT  + APE + T       
Sbjct: 196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGP 255

Query: 286 KSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR-----------PYVSDSKKF 331
           K D WS GV+L+ L+ G       +P    N+   +  V              +S   + 
Sbjct: 256 KCDAWSAGVLLHLLLMGA------VPFPGVNDADTISQVLNKKLCFENPNYNVLSPLAR- 308

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
            L+                     S  L +    R      
Sbjct: 309 DLL---------------------SNLLNRNVDERFDAMRA 328

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  110 bits (276), Expect = 3e-27
 Identities = 62/298 (20%), Positives = 99/298 (33%), Gaps = 67/298 (22%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN----EVNFL 149
           L+GEG +G V   +          +        A+K L ++  +           E+  L
Sbjct: 12  LLGEGSYGKVKEVL-------DSETLCR----RAVKILKKKKLRRIPNGEANVKKEIQLL 60

Query: 150 GVVKHPNLVKL--VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
             ++H N+++L  V Y  E  +  M    V E       E  +L         +   +  
Sbjct: 61  RRLRHKNVIQLVDVLYNEEKQKMYM----VMEYCVCGMQE--MLDS-------VPEKRFP 107

Query: 208 QDAAR--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              A         GL YLH +    ++ +D K  N+LL      K+S  G+A    P   
Sbjct: 108 VCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGRRAVERNLP---RNE 314
                +  G+  +  PE           K D+WS GV LY + TG        P    N 
Sbjct: 165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGL------YPFEGDNI 218

Query: 315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
            KL E +         + +   P      C         L    L  +P  R  + ++
Sbjct: 219 YKLFENIG-----KGSYAI---PG----DCGPPLSD---LLKGMLEYEPAKRFSIRQI 261

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  109 bits (274), Expect = 3e-27
 Identities = 59/238 (24%), Positives = 87/238 (36%), Gaps = 74/238 (31%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVV 152
            +GEG +G V   V       ++ +       VA+K ++ +      E I  E+    ++
Sbjct: 14  TLGEGAYGEVQLAV-------NRVTEEA----VAVKIVDMKRAVDCPENIKKEICINKML 62

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS-----LE--------DHLLSRVPTPLA 199
            H N+VK                  Y      +     LE        D +   +     
Sbjct: 63  NHENVVKF-----------------YGHRREGNIQYLFLEYCSGGELFDRIEPDI----- 100

Query: 200 WIARLKIAQDAAR--------GLAYLHEEMDFQLIF-RDFKTSNILLDEDYKAKLSDFGL 250
               +   +  A+        G+ YLH       I  RD K  N+LLDE    K+SDFGL
Sbjct: 101 ---GMP--EPDAQRFFHQLMAGVVYLHGIG----ITHRDIKPENLLLDERDNLKISDFGL 151

Query: 251 A---RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGR 303
           A   R    E L +      GT+ Y APE +   R       DVWS G+VL  ++ G 
Sbjct: 152 ATVFRYNNRERLLN--KM-CGTLPYVAPE-LLKRREFHAEPVDVWSCGIVLTAMLAGE 205

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  109 bits (274), Expect = 5e-27
 Identities = 70/292 (23%), Positives = 118/292 (40%), Gaps = 59/292 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFL-GVV 152
           +G G  G V++          + +GH     +A+KQ+ R G  + +K  + +++ +    
Sbjct: 33  MGSGTCGQVWKMR-------FRKTGHV----IAVKQMRRSGNKEENKRILMDLDVVLKSH 81

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
             P +V+  G    + +  +      ELM   + +     + P P   +   K+     +
Sbjct: 82  DCPYIVQCFGTFITNTDVFI----AMELMGTCAEKLKKRMQGPIPERILG--KMTVAIVK 135

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH--VSTSVVGTV 270
            L YL E+    +I RD K SNILLDE  + KL DFG++ +     L          G  
Sbjct: 136 ALYYLKEKH--GVIHRDVKPSNILLDERGQIKLCDFGISGR-----LVDDKAKDRSAGCA 188

Query: 271 GYAAPEYVQTGRL-----TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            Y APE +            ++DVWS G+ L EL TG+                   PY 
Sbjct: 189 AYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ------------------FPYK 230

Query: 326 SDSKKFHL---IID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
           +    F +   ++    P L G+  +  +    +    CLTK  + RPK ++
Sbjct: 231 NCKTDFEVLTKVLQEEPPLLPGH--MGFSGDFQSFVKDCLTKDHRKRPKYNK 280

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  109 bits (274), Expect = 7e-27
 Identities = 75/300 (25%), Positives = 116/300 (38%), Gaps = 70/300 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNF-LGVV 152
           IG G +G V + V       H+ SG      +A+K++      +  K+ + +++  +   
Sbjct: 30  IGRGAYGSVNKMV-------HKPSGQI----MAVKRIRSTVDEKEQKQLLMDLDVVMRSS 78

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV------PTPLAWIARLKI 206
             P +V+  G    + +  +      ELM + S  D     V        P   +   KI
Sbjct: 79  DCPYIVQFYGALFREGDCWI----CMELM-STSF-DKFYKYVYSVLDDVIPEEILG--KI 130

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
                + L +L E +  ++I RD K SNILLD     KL DFG++        G +  S+
Sbjct: 131 TLATVKALNHLKENL--KIIHRDIKPSNILLDRSGNIKLCDFGIS--------GQLVDSI 180

Query: 267 -----VGTVGYAAPEYVQTGRL----TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                 G   Y APE +           +SDVWS G+ LYEL TGR              
Sbjct: 181 AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGR-------F------ 227

Query: 318 LEWVRPYVSDSKKFHL---IID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
                PY   +  F     ++    P+L  +   + +       + CLTK    RPK  E
Sbjct: 228 -----PYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  108 bits (273), Expect = 1e-26
 Identities = 74/289 (25%), Positives = 118/289 (40%), Gaps = 60/289 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH--KEWINEVNFLGVV 152
           IG+G F  V           H  +G +    VAIK +++        ++   EV  + ++
Sbjct: 23  IGKGNFAKVKLAR-------HILTGRE----VAIKIIDKTQLNPTSLQKLFREVRIMKIL 71

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDA 210
            HPN+VKL  +  E  E      L+ E      + D+L++  R+    A        +  
Sbjct: 72  NHPNIVKL--F--EVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEA----RSKFRQI 123

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
              + Y H++    ++ RD K  N+LLD D   K++DFG + +    G   +     G  
Sbjct: 124 VSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK--LDAF-CGAP 177

Query: 271 GYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVRPYV 325
            YAAPE  Q G+     + DVWS GV+LY L++G       LP   +N ++L E V    
Sbjct: 178 PYAAPELFQ-GKKYDGPEVDVWSLGVILYTLVSGS------LPFDGQNLKELRERV---- 226

Query: 326 SDSKKFHLIIDPRLEGNYCIKS--AQKLAALASKCLTKQPKSRPKMSEV 372
                        L G Y I    +     L  + L   P  R  + ++
Sbjct: 227 -------------LRGKYRIPFYMSTDCENLLKRFLVLNPIKRGTLEQI 262

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  107 bits (270), Expect = 1e-26
 Identities = 76/297 (25%), Positives = 114/297 (38%), Gaps = 71/297 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G FG V +          + +  +     A+K +N+   +       + EV  L  +
Sbjct: 30  LGKGSFGEVLKCK-------DRITQQE----YAVKVINKASAKNKDTSTILREVELLKKL 78

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++KL     ED        +V EL     L D ++ R        A  +I +    
Sbjct: 79  DHPNIMKLFEIL-EDSS---SFYIVGELYTGGELFDEIIKRKRFSEHDAA--RIIKQVFS 132

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
           G+ Y+H+     ++ RD K  NILL   ++D   K+ DFGL+               +GT
Sbjct: 133 GITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ---NTKMKDRIGT 186

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR---- 322
             Y APE V  G    K DVWS GV+LY L++G        P   +NE  +L+ V     
Sbjct: 187 AYYIAPE-VLRGTYDEKCDVWSAGVILYILLSGTP------PFYGKNEYDILKRVETGKY 239

Query: 323 -------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                    +SD  K  LI                      K LT  P  R   ++ 
Sbjct: 240 AFDLPQWRTISDDAK-DLI---------------------RKMLTFHPSLRITATQC 274

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  105 bits (265), Expect = 1e-25
 Identities = 66/302 (21%), Positives = 111/302 (36%), Gaps = 83/302 (27%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN------EVN 147
           L+G GGFG VY G+         +        VAIK + +       E  N      EV 
Sbjct: 50  LLGSGGFGSVYSGI-------RVSDNLP----VAIKHVEKDRISDWGELPNGTRVPMEVV 98

Query: 148 FLGVVKH--PNLVKLVGYCAEDDE--------RGMQRLLVYELMHNKSLEDHLLSRVPTP 197
            L  V      +++L+ +    D           +Q L  + +    +L++ L       
Sbjct: 99  LLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF-ITERGALQEEL------- 150

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIF-RDFKTSNILLDEDY-KAKLSDFGLARQGP 255
               AR          + + H       +  RD K  NIL+D +  + KL DFG      
Sbjct: 151 ----AR-SFFWQVLEAVRHCHNCG----VLHRDIKDENILIDLNRGELKLIDFGSGAL-L 200

Query: 256 PEGLGHVSTSVVGTVGYAAPEYVQTGRLTA-KSDVWSFGVVLYELITGRRAVERNLP-RN 313
            + +        GT  Y+ PE+++  R     + VWS G++LY+++ G       +P  +
Sbjct: 201 KDTVYTDF---DGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------IPFEH 251

Query: 314 EQKLLE---WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
           +++++    + R  VS   + HLI                       CL  +P  RP   
Sbjct: 252 DEEIIRGQVFFRQRVSSECQ-HLI---------------------RWCLALRPSDRPTFE 289

Query: 371 EV 372
           E+
Sbjct: 290 EI 291

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  107 bits (269), Expect = 1e-25
 Identities = 65/315 (20%), Positives = 110/315 (34%), Gaps = 97/315 (30%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI--------NEV 146
           +G G  G V            + +       VAI+ ++++ F                E+
Sbjct: 143 LGSGACGEVKLAF-------ERKTCKK----VAIRIISKRKFAIGSAREADPALNVETEI 191

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             L  + HP ++K+  +   +D       +V ELM  +  E  L  +V      +   ++
Sbjct: 192 EILKKLNHPCIIKIKNFFDAED-----YYIVLELM--EGGE--LFDKV------VGNKRL 236

Query: 207 AQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGP 255
            +   +         + YLHE     +I RD K  N+LL   +ED   K++DFG ++   
Sbjct: 237 KEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 293

Query: 256 PEGLGHVSTSVVGTVGYAAPE---YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP- 311
                 +  ++ GT  Y APE    V T       D WS GV+L+  ++G        P 
Sbjct: 294 E---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY------PPF 344

Query: 312 ---RNEQKLLE--------WVRPY---VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASK 357
              R +  L +        ++      VS+     L+                      K
Sbjct: 345 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL-DLV---------------------KK 382

Query: 358 CLTKQPKSRPKMSEV 372
            L   PK+R    E 
Sbjct: 383 LLVVDPKARFTTEEA 397

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (264), Expect = 1e-25
 Identities = 68/299 (22%), Positives = 109/299 (36%), Gaps = 75/299 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN------EVN 147
           L+G+GGFG V+ G          T        VAIK + R    G     +      EV 
Sbjct: 38  LLGKGGFGTVFAGH-------RLTDRLQ----VAIKVIPRNRVLGWSPLSDSVTCPLEVA 86

Query: 148 FL----GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHN-KSLEDHLLS--RVPTPLAW 200
            L        HP +++L+ +    +      +LV E     + L D++     +    + 
Sbjct: 87  LLWKVGAGGGHPGVIRLLDWFETQEGF----MLVLERPLPAQDLFDYITEKGPLGEGPS- 141

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIF-RDFKTSNILLDEDY-KAKLSDFGLARQGPPEG 258
             R          + + H       +  RD K  NIL+D     AKL DFG       + 
Sbjct: 142 --R-CFFGQVVAAIQHCHSRG----VVHRDIKDENILIDLRRGCAKLIDFGSGAL-LHDE 193

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLT-AKSDVWSFGVVLYELITGRRAVERNLP-RNEQK 316
                    GT  Y+ PE++   +     + VWS G++LY+++ G       +P   +Q+
Sbjct: 194 PYTDF---DGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGD------IPFERDQE 244

Query: 317 LLE---WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           +LE       +VS      LI                      +CL  +P SRP + E+
Sbjct: 245 ILEAELHFPAHVSPDCC-ALI---------------------RRCLAPKPSSRPSLEEI 281

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  106 bits (266), Expect = 1e-25
 Identities = 71/313 (22%), Positives = 113/313 (36%), Gaps = 92/313 (29%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI--------NEV 146
           IG G    V R V       H+ +GH+     A+K +     +   E +         E 
Sbjct: 102 IGRGVSSVVRRCV-------HRATGHE----FAVKIMEVTAERLSPEQLEEVREATRRET 150

Query: 147 NFL-GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL- 204
           + L  V  HP+++ L+    E         LV++LM    L D+L  +V         L 
Sbjct: 151 HILRQVAGHPHIITLIDSY-ESSS---FMFLVFDLMRKGELFDYLTEKV--------ALS 198

Query: 205 -----KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
                 I +     +++LH      ++ RD K  NILLD++ + +LSDFG +    P   
Sbjct: 199 EKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLEP--- 252

Query: 260 GHVSTSVVGTVGYAAPE------YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP-- 311
           G     + GT GY APE               + D+W+ GV+L+ L+ G        P  
Sbjct: 253 GEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP------PFW 306

Query: 312 -RNEQKLLEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCL 359
            R +  +L  +               S + K  LI                     S+ L
Sbjct: 307 HRRQILMLRMIMEGQYQFSSPEWDDRSSTVK-DLI---------------------SRLL 344

Query: 360 TKQPKSRPKMSEV 372
              P++R    + 
Sbjct: 345 QVDPEARLTAEQA 357

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  105 bits (264), Expect = 2e-25
 Identities = 59/297 (19%), Positives = 97/297 (32%), Gaps = 65/297 (21%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VV 152
           ++G G  G V           H+ +G       A+K L         +   EV+      
Sbjct: 36  VLGLGVNGKVLECF-------HRRTGQK----CALKLLYDS-----PKARQEVDHHWQAS 79

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
             P++V ++             L++ E M    L   +  R           +I +D   
Sbjct: 80  GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
            + +LH      +  RD K  N+L    ++D   KL+DFG A++     L     +   T
Sbjct: 140 AIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNAL----QTPCYT 192

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL----------- 318
             Y APE +   +     D+WS GV++Y L+ G      N  +     +           
Sbjct: 193 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGF 252

Query: 319 ---EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
              EW    VS+  K  LI                        L   P  R  +++ 
Sbjct: 253 PNPEW--SEVSEDAK-QLI---------------------RLLLKTDPTERLTITQF 285

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  104 bits (262), Expect = 2e-25
 Identities = 74/314 (23%), Positives = 112/314 (35%), Gaps = 93/314 (29%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---------INE 145
           +G G    V R +       H+ +  +     A+K ++  G                + E
Sbjct: 25  LGRGVSSVVRRCI-------HKPTCKE----YAVKIIDVTGGGSFSAEEVQELREATLKE 73

Query: 146 VNFL-GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           V+ L  V  HPN+++L      +        LV++LM    L D+L  +V         L
Sbjct: 74  VDILRKVSGHPNIIQLKDTY--ETNTFF--FLVFDLMKKGELFDYLTEKV--------TL 121

Query: 205 ------KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
                 KI +     +  LH+     ++ RD K  NILLD+D   KL+DFG + Q  P  
Sbjct: 122 SEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQLDP-- 176

Query: 259 LGHVSTSVVGTVGYAAPE------YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP- 311
            G     V GT  Y APE               + D+WS GV++Y L+ G        P 
Sbjct: 177 -GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP------PF 229

Query: 312 --RNEQKLLEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKC 358
             R +  +L  +               SD+ K  L+                     S+ 
Sbjct: 230 WHRKQMLMLRMIMSGNYQFGSPEWDDYSDTVK-DLV---------------------SRF 267

Query: 359 LTKQPKSRPKMSEV 372
           L  QP+ R    E 
Sbjct: 268 LVVQPQKRYTAEEA 281

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  104 bits (262), Expect = 2e-25
 Identities = 66/305 (21%), Positives = 111/305 (36%), Gaps = 86/305 (28%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G F  V R V       H+T+G +     A K +N +       ++   E      +
Sbjct: 14  LGKGAFSVVRRCV-------HKTTGLE----FAAKIINTKKLSARDFQKLEREARICRKL 62

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+V+L     E+        LV++L+    L + +          +AR   ++  A 
Sbjct: 63  QHPNIVRLHDSIQEESF----HYLVFDLVTGGELFEDI----------VAREFYSEADAS 108

Query: 213 --------GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGH 261
                    +AY H      ++ R+ K  N+LL    +    KL+DFGLA +        
Sbjct: 109 HCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SE 162

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLL 318
                 GT GY +PE ++    +   D+W+ GV+LY L+ G        P    ++ +L 
Sbjct: 163 AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYP------PFWDEDQHRLY 216

Query: 319 EWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             ++             V+   K  LI                        LT  PK R 
Sbjct: 217 AQIKAGAYDYPSPEWDTVTPEAK-SLI---------------------DSMLTVNPKKRI 254

Query: 368 KMSEV 372
              + 
Sbjct: 255 TADQA 259

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  104 bits (261), Expect = 2e-25
 Identities = 70/312 (22%), Positives = 117/312 (37%), Gaps = 74/312 (23%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN--------- 144
            IG+G +G V           ++          A+K L+++       +           
Sbjct: 20  EIGKGSYGVVKLAY-------NENDNTY----YAMKVLSKKKLIRQAGFPRRPPPRGTRP 68

Query: 145 -----------------EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE 187
                            E+  L  + HPN+VKL      DD       +V+EL++   + 
Sbjct: 69  APGGCIQPRGPIEQVYQEIAILKKLDHPNVVKL--VEVLDDPNEDHLYMVFELVNQGPVM 126

Query: 188 DHLLS-RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS 246
           +      +    A        QD  +G+ YLH     ++I RD K SN+L+ ED   K++
Sbjct: 127 EVPTLKPLSEDQAR----FYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIA 179

Query: 247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT---AKSDVWSFGVVLYELITGR 303
           DFG++ +        +S + VGT  + APE +   R        DVW+ GV LY  + G+
Sbjct: 180 DFGVSNEFKGSD-ALLSNT-VGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237

Query: 304 RAVERNLP---RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLT 360
                  P        L   ++     S+       P +        A+ L  L ++ L 
Sbjct: 238 ------CPFMDERIMCLHSKIK-----SQALEFPDQPDI--------AEDLKDLITRMLD 278

Query: 361 KQPKSRPKMSEV 372
           K P+SR  + E+
Sbjct: 279 KNPESRIVVPEI 290

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  105 bits (263), Expect = 2e-25
 Identities = 58/224 (25%), Positives = 91/224 (40%), Gaps = 43/224 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN---------E 145
           +G G FG V+  V        +    +    V +K + ++       WI          E
Sbjct: 32  LGSGAFGFVWTAV-------DKEKNKE----VVVKFIKKEKVLEDC-WIEDPKLGKVTLE 79

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLE--DHLLS--RVPTPLAWI 201
           +  L  V+H N++K+      +++   Q  LV E  H   L+    +    R+  PLA  
Sbjct: 80  IAILSRVEHANIIKV--LDIFENQGFFQ--LVMEK-HGSGLDLFAFIDRHPRLDEPLA-- 132

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
               I +     + YL  +    +I RD K  NI++ ED+  KL DFG A       L +
Sbjct: 133 -S-YIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFY 187

Query: 262 VSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGR 303
                 GT+ Y APE +  G      + ++WS GV LY L+   
Sbjct: 188 TF---CGTIEYCAPEVLM-GNPYRGPELEMWSLGVTLYTLVFEE 227

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  105 bits (263), Expect = 3e-25
 Identities = 70/356 (19%), Positives = 121/356 (33%), Gaps = 98/356 (27%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVV 152
            IG G FG              + +       VA+K + R       E +  E+     +
Sbjct: 27  DIGSGNFGVARLMR-------DKLTKEL----VAVKYIERG--AAIDENVQREIINHRSL 73

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS-----LE--------DHLLSRVPTPLA 199
           +HPN+V+                   E++   +     +E        + + +       
Sbjct: 74  RHPNIVRF-----------------KEVILTPTHLAIIMEYASGGELYERICNA------ 110

Query: 200 WIARLKIAQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKA--KLSDFG 249
              R    +D AR        G++Y H     Q+  RD K  N LLD       K+ DFG
Sbjct: 111 --GRFS--EDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFG 163

Query: 250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGRRAVE 307
            ++            S VGT  Y APE V   +      +DVWS GV LY ++ G    E
Sbjct: 164 YSKSSVLHSQPK---STVGTPAYIAPE-VLLRQEYDGKIADVWSCGVTLYVMLVGAYPFE 219

Query: 308 -RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA----LASKCLTKQ 362
               PR+ +K ++ +                 L   Y I    +++     L S+     
Sbjct: 220 DPEEPRDYRKTIQRI-----------------LSVKYSIPDDIRISPECCHLISRIFVAD 262

Query: 363 PKSRPKMSEVVD---ILGNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQ 415
           P +R  + E+      L N+ +++ ++     Q     + ++       ++  A  
Sbjct: 263 PATRISIPEIKTHSWFLKNLPADLMNESNTGSQFQEPEQPMQSLDTIMQIISEATI 318

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  104 bits (261), Expect = 4e-25
 Identities = 65/315 (20%), Positives = 107/315 (33%), Gaps = 97/315 (30%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI--------NEV 146
           +G G  G V            + +       VAIK ++++ F                E+
Sbjct: 18  LGSGACGEVKLAF-------ERKTCKK----VAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
             L  + HP ++K+  +   +D       +V ELM    L D +          +   ++
Sbjct: 67  EILKKLNHPCIIKIKNFFDAED-----YYIVLELMEGGELFDKV----------VGNKRL 111

Query: 207 AQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGP 255
            +   +         + YLHE     +I RD K  N+LL   +ED   K++DFG ++   
Sbjct: 112 KEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILG 168

Query: 256 PEGLGHVSTSVVGTVGYAAPE---YVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP- 311
                 +  ++ GT  Y APE    V T       D WS GV+L+  ++G        P 
Sbjct: 169 E---TSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY------PPF 219

Query: 312 ---RNEQKLLEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASK 357
              R +  L + +              VS+     L+                      K
Sbjct: 220 SEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL-DLV---------------------KK 257

Query: 358 CLTKQPKSRPKMSEV 372
            L   PK+R    E 
Sbjct: 258 LLVVDPKARFTTEEA 272

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (258), Expect = 4e-25
 Identities = 65/236 (27%), Positives = 98/236 (41%), Gaps = 71/236 (30%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN---EVNFLG 150
            +G G FG V  G        HQ +GH     VA+K LNRQ  +          E+  L 
Sbjct: 18  TLGVGTFGKVKIGE-------HQLTGHK----VAVKILNRQKIRSLDVVGKIKREIQNLK 66

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS-----LE--------DHLLSRVPTP 197
           + +HP+++KL                 Y+++   +     +E        D++       
Sbjct: 67  LFRHPHIIKL-----------------YQVISTPTDFFMVMEYVSGGELFDYICKH---- 105

Query: 198 LAWIARLKIAQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG 249
                R++  +  AR         + Y H  M   ++ RD K  N+LLD    AK++DFG
Sbjct: 106 ----GRVE--EMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 156

Query: 250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGR 303
           L+            TS  G+  YAAPE +  GRL    + D+WS GV+LY L+ G 
Sbjct: 157 LSNMMSDGEFLR--TS-CGSPNYAAPEVIS-GRLYAGPEVDIWSCGVILYALLCGT 208

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  103 bits (259), Expect = 6e-25
 Identities = 58/221 (26%), Positives = 90/221 (40%), Gaps = 29/221 (13%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INE 145
           F    ++GEG F  V   + R        +  +     AIK L ++      +      E
Sbjct: 32  FKFGKILGEGSFSTVV--LAR-----ELATSRE----YAIKILEKRHIIKENKVPYVTRE 80

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHL--LSRVPTPLAWIA 202
            + +  + HP  VKL  Y    D+    +L        N  L  ++  +           
Sbjct: 81  RDVMSRLDHPFFVKL--YFTFQDDE---KLYFGLSYAKNGELLKYIRKIGSFDETCT--- 132

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHV 262
           R   A+     L YLH      +I RD K  NILL+ED   +++DFG A+   PE     
Sbjct: 133 RFYTAE-IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQAR 188

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           + S VGT  Y +PE +        SD+W+ G ++Y+L+ G 
Sbjct: 189 ANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  103 bits (260), Expect = 9e-25
 Identities = 67/297 (22%), Positives = 111/297 (37%), Gaps = 70/297 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G F  V R V       H+T+G +     A K +N +       ++   E      +
Sbjct: 37  LGKGAFSVVRRCV-------HKTTGLE----FAAKIINTKKLSARDFQKLEREARICRKL 85

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+V+L     E+        LV++L+    L + +++R     A  A     Q    
Sbjct: 86  QHPNIVRLHDSIQEESF----HYLVFDLVTGGELFEDIVAREFYSEA-DAS-HCIQQILE 139

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
            +AY H      ++ R+ K  N+LL    +    KL+DFGLA +              GT
Sbjct: 140 SIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND---SEAWHGFAGT 193

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR---- 322
            GY +PE ++    +   D+W+ GV+LY L+ G        P    ++ +L   ++    
Sbjct: 194 PGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY------PPFWDEDQHRLYAQIKAGAY 247

Query: 323 -------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                    V+   K  LI                        LT  PK R    + 
Sbjct: 248 DYPSPEWDTVTPEAK-SLI---------------------DSMLTVNPKKRITADQA 282

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  103 bits (258), Expect = 1e-24
 Identities = 65/298 (21%), Positives = 116/298 (38%), Gaps = 68/298 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK- 153
           +GEG F    + V       H+ S        A+K ++++     +    E+  L + + 
Sbjct: 19  LGEGSFSICRKCV-------HKKSNQA----FAVKIISKRMEANTQ---KEITALKLCEG 64

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAAR 212
           HPN+VKL      D        LV EL++   L + +  +   +     A   I +    
Sbjct: 65  HPNIVKLHEVF-HDQLH---TFLVMELLNGGELFERIKKKKHFSETE--AS-YIMRKLVS 117

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
            ++++H+     ++ RD K  N+L    +++ + K+ DFG AR  PP+       +   T
Sbjct: 118 AVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD--NQPLKTPCFT 172

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG----RRAVERNLPRNEQKLLEWVR--- 322
           + YAAPE +         D+WS GV+LY +++G    +         +  ++++ ++   
Sbjct: 173 LHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD 232

Query: 323 --------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                     VS   K  LI                        LT  P  R KMS +
Sbjct: 233 FSFEGEAWKNVSQEAK-DLI---------------------QGLLTVDPNKRLKMSGL 268

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  103 bits (259), Expect = 1e-24
 Identities = 66/306 (21%), Positives = 111/306 (36%), Gaps = 81/306 (26%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-----INEVNFL 149
           IG+G F  V R +       ++ +G       A+K ++   F             E +  
Sbjct: 32  IGKGPFSVVRRCI-------NRETGQQ----FAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
            ++KHP++V+L+   + D        +V+E M    L   ++ R      +         
Sbjct: 81  HMLKHPHIVELLETYSSDGML----YMVFEFMDGADLCFEIVKRADAGFVYSEA-----V 131

Query: 210 AAR-------GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGL 259
           A+         L Y H+  +  +I RD K   +LL   +     KL  FG+A Q    G 
Sbjct: 132 ASHYMRQILEALRYCHD-NN--IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG- 187

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP--RNEQKL 317
             V+   VGT  + APE V+        DVW  GV+L+ L++G        P    +++L
Sbjct: 188 -LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCL------PFYGTKERL 240

Query: 318 LEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
            E +             ++S+S K  L+                      + L   P  R
Sbjct: 241 FEGIIKGKYKMNPRQWSHISESAK-DLV---------------------RRMLMLDPAER 278

Query: 367 PKMSEV 372
             + E 
Sbjct: 279 ITVYEA 284

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  103 bits (258), Expect = 1e-24
 Identities = 58/235 (24%), Positives = 101/235 (42%), Gaps = 70/235 (29%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN---EVNFLG 150
            +GEG FG V           H  +       VA+K ++RQ  +     +    E+++L 
Sbjct: 16  TLGEGSFGKVKLAT-------HYKTQQK----VALKFISRQLLKKSDMHMRVEREISYLK 64

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS-----LE-------DHLLSRVPTPL 198
           +++HP+++KL                 Y+++   +     +E       D+++ +     
Sbjct: 65  LLRHPHIIKL-----------------YDVITTPTDIVMVIEYAGGELFDYIVEK----- 102

Query: 199 AWIARLKIAQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
               R+   +D  R         + Y H      ++ RD K  N+LLD++   K++DFGL
Sbjct: 103 ---KRMT--EDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGL 154

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGR 303
           +            TS  G+  YAAPE +  G+L    + DVWS G+VLY ++ GR
Sbjct: 155 SNIMTDGNFLK--TS-CGSPNYAAPEVIN-GKLYAGPEVDVWSCGIVLYVMLVGR 205

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  102 bits (256), Expect = 1e-24
 Identities = 70/317 (22%), Positives = 114/317 (35%), Gaps = 81/317 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VV 152
           ++GEG    V   +       +  +  +     A+K + +Q          EV  L    
Sbjct: 20  VLGEGAHARVQTCI-------NLITSQE----YAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAA 211
            H N+++L+ +  E+++R     LV+E M   S+  H+  R     L   A   + QD A
Sbjct: 69  GHRNVLELIEFF-EEEDR---FYLVFEKMRGGSILSHIHKRRHFNELE--AS-VVVQDVA 121

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTS--- 265
             L +LH +    +  RD K  NIL    ++    K+ DF L       G     ++   
Sbjct: 122 SALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178

Query: 266 --VVGTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITG------------RRAV 306
               G+  Y APE V+     A       D+WS GV+LY L++G                
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDR 238

Query: 307 ERNLPRNEQKLLEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALA 355
               P  +  L E ++            ++S + K  LI                     
Sbjct: 239 GEACPACQNMLFESIQEGKYEFPDKDWAHISCAAK-DLI--------------------- 276

Query: 356 SKCLTKQPKSRPKMSEV 372
           SK L +  K R   ++V
Sbjct: 277 SKLLVRDAKQRLSAAQV 293

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  102 bits (257), Expect = 3e-24
 Identities = 67/237 (28%), Positives = 102/237 (43%), Gaps = 39/237 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
            IG+G FG V   +V+          +D+K   A+K +N+Q      E      E+  + 
Sbjct: 22  AIGKGSFGKVC--IVQ---------KNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ 70

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHL--LSRVPTPLA--WIARLK 205
            ++HP LV L  Y  +D+E     + +V +L+    L  HL             +I  L 
Sbjct: 71  GLEHPFLVNLW-YSFQDEED----MFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELV 125

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           +A      L YL      ++I RD K  NILLDE     ++DF +A   P        T+
Sbjct: 126 MA------LDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITT 173

Query: 266 VVGTVGYAAPEYVQTGRLTAKS---DVWSFGVVLYELITGRRAVERNLPRNEQKLLE 319
           + GT  Y APE   + +    S   D WS GV  YEL+ GRR        + ++++ 
Sbjct: 174 MAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH 230

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  103 bits (258), Expect = 4e-24
 Identities = 66/320 (20%), Positives = 118/320 (36%), Gaps = 72/320 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G+G F  V R V          +G +     A   +N +      H++   E     ++
Sbjct: 19  LGKGAFSVVRRCV-------KVLAGQE----YAAMIINTKKLSARDHQKLEREARICRLL 67

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPN+V+L    +E+        L+++L+    L + +++R     A  +     Q    
Sbjct: 68  KHPNIVRLHDSISEEGHH----YLIFDLVTGGELFEDIVAREYYSEADAS--HCIQQILE 121

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
            + + H+     ++ R+ K  N+LL    +    KL+DFGLA +   E          GT
Sbjct: 122 AVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ--QAWFGFAGT 176

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLEWVR---- 322
            GY +PE ++        D+W+ GV+LY L+ G        P    ++ +L + ++    
Sbjct: 177 PGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYP------PFWDEDQHRLYQQIKAGAY 230

Query: 323 -------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD- 374
                    V+   K  LI                     +K LT  P  R   +E +  
Sbjct: 231 DFPSPEWDTVTPEAK-DLI---------------------NKMLTINPSKRITAAEALKH 268

Query: 375 --ILGNIISEISSQDEVTLQ 392
             I            + T+ 
Sbjct: 269 PWISHRSTVASCMHRQETVD 288

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  102 bits (255), Expect = 4e-24
 Identities = 69/301 (22%), Positives = 118/301 (39%), Gaps = 68/301 (22%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
            S+  ++G G FG V++            +G    L +A K +  +G +  +E  NE++ 
Sbjct: 91  VSKTEILGGGRFGQVHKCE-------ETATG----LKLAAKIIKTRGMKDKEEVKNEISV 139

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           +  + H NL++L  Y A + +  +  +LV E +    L D ++            L + Q
Sbjct: 140 MNQLDHANLIQL--YDAFESKNDI--VLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILL--DEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
               G+ ++H+     ++  D K  NIL    +  + K+ DFGLAR+  P          
Sbjct: 196 -ICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP---REKLKVN 248

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQKLLEWVR 322
            GT  + APE V    ++  +D+WS GV+ Y L++G       L      N+ + L  + 
Sbjct: 249 FGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSG-------LSPFLGDNDAETLNNIL 301

Query: 323 -----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
                        +S+  K   I                     SK L K+   R   SE
Sbjct: 302 ACRWDLEDEEFQDISEEAK-EFI---------------------SKLLIKEKSWRISASE 339

Query: 372 V 372
            
Sbjct: 340 A 340

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  102 bits (257), Expect = 6e-24
 Identities = 66/236 (27%), Positives = 98/236 (41%), Gaps = 71/236 (30%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN---EVNFLG 150
            +G G FG V  G        H+ +GH     VA+K LNRQ  +          E+  L 
Sbjct: 23  TLGVGTFGKVKVGK-------HELTGHK----VAVKILNRQKIRSLDVVGKIRREIQNLK 71

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKS-----LE--------DHLLSRVPTP 197
           + +HP+++KL                 Y+++   S     +E        D++       
Sbjct: 72  LFRHPHIIKL-----------------YQVISTPSDIFMVMEYVSGGELFDYICKN---- 110

Query: 198 LAWIARLKIAQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG 249
                RL   +  +R        G+ Y H  M   ++ RD K  N+LLD    AK++DFG
Sbjct: 111 ----GRLD--EKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFG 161

Query: 250 LARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGR 303
           L+            TS  G+  YAAPE +  GRL    + D+WS GV+LY L+ G 
Sbjct: 162 LSNMMSDGEFLR--TS-CGSPNYAAPEVIS-GRLYAGPEVDIWSSGVILYALLCGT 213

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  101 bits (254), Expect = 8e-24
 Identities = 58/295 (19%), Positives = 99/295 (33%), Gaps = 62/295 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VVK 153
           +G G  G V +         ++ +        A+K L         +   EV       +
Sbjct: 70  LGLGINGKVLQIF-------NKRTQEK----FALKMLQDC-----PKARREVELHWRASQ 113

Query: 154 HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            P++V++V    E+   G + L +V E +    L   +  R           +I +    
Sbjct: 114 CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
            + YLH      +  RD K  N+L      +   KL+DFG A++       +  T+   T
Sbjct: 173 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS---HNSLTTPCYT 226

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRA-VERNLPRNEQKLLEWVR------ 322
             Y APE +   +     D+WS GV++Y L+ G       +       +   +R      
Sbjct: 227 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEF 286

Query: 323 -----PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                  VS+  K  LI                        L  +P  R  ++E 
Sbjct: 287 PNPEWSEVSEEVK-MLI---------------------RNLLKTEPTQRMTITEF 319

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  100 bits (252), Expect = 1e-23
 Identities = 62/308 (20%), Positives = 105/308 (34%), Gaps = 94/308 (30%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R V +            +      K +N           NE++ +  + H
Sbjct: 59  LGSGAFGVVHRCVEK-----------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHH 107

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSL------EDHLLSRVPTPLAWIARLKIAQ 208
           P L+ L     ED     + +L+ E +    L      ED+ +S                
Sbjct: 108 PKLINLHDAF-EDKY---EMVLILEFLSGGELFDRIAAEDYKMSE--------------A 149

Query: 209 DAAR-------GLAYLHEEMDFQLIFRDFKTSNILL--DEDYKAKLSDFGLARQGPPEGL 259
           +          GL ++HE     ++  D K  NI+    +    K+ DFGLA +  P   
Sbjct: 150 EVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP--- 203

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQ 315
             +      T  +AAPE V    +   +D+W+ GV+ Y L++G       L      ++ 
Sbjct: 204 DEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG-------LSPFAGEDDL 256

Query: 316 KLLEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPK 364
           + L+ V+             VS   K   I                        L K+P+
Sbjct: 257 ETLQNVKRCDWEFDEDAFSSVSPEAK-DFI---------------------KNLLQKEPR 294

Query: 365 SRPKMSEV 372
            R  + + 
Sbjct: 295 KRLTVHDA 302

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 99.3 bits (248), Expect = 3e-23
 Identities = 65/295 (22%), Positives = 112/295 (37%), Gaps = 66/295 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VVK 153
           IG G +    R +       H+ +  +     A+K +++       E   E+  L    +
Sbjct: 30  IGVGSYSVCKRCI-------HKATNME----FAVKIIDKSKRDP-TE---EIEILLRYGQ 74

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAAR 212
           HPN++ L     +D +      +V ELM    L D +L +   +     A   +     +
Sbjct: 75  HPNIITLKDVY-DDGKY---VYVVTELMKGGELLDKILRQKFFSERE--AS-AVLFTITK 127

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKA-KLSDFGLARQGPPEGLGHVSTSVVG 268
            + YLH +    ++ RD K SNIL      + ++ ++ DFG A+Q   E    +  +   
Sbjct: 128 TVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN--GLLMTPCY 182

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR------ 322
           T  + APE ++     A  D+WS GV+LY ++TG            +++L  +       
Sbjct: 183 TANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSL 242

Query: 323 -----PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                  VSD+ K  L+                     SK L   P  R   + V
Sbjct: 243 SGGYWNSVSDTAK-DLV---------------------SKMLHVDPHQRLTAALV 275

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 98.2 bits (245), Expect = 8e-23
 Identities = 68/305 (22%), Positives = 108/305 (35%), Gaps = 87/305 (28%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +G G    VYR   +            ++   A+K L +      K    E+  L  + 
Sbjct: 60  ELGRGATSIVYRCKQK-----------GTQKPYALKVLKKT--VDKKIVRTEIGVLLRLS 106

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA-QDAAR 212
           HPN++KL        E      LV EL+    L D +          + +   + +DAA 
Sbjct: 107 HPNIIKLKEIFETPTEI----SLVLELVTGGELFDRI----------VEKGYYSERDAAD 152

Query: 213 -------GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHV 262
                   +AYLHE     ++ RD K  N+L      D   K++DFGL++         +
Sbjct: 153 AVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---QVL 206

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQKLL 318
             +V GT GY APE ++      + D+WS G++ Y L+ G        P    R +Q + 
Sbjct: 207 MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFE------PFYDERGDQFMF 260

Query: 319 EWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
             +              VS + K  L+                      K +   PK R 
Sbjct: 261 RRILNCEYYFISPWWDEVSLNAK-DLV---------------------RKLIVLDPKKRL 298

Query: 368 KMSEV 372
              + 
Sbjct: 299 TTFQA 303

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 96.9 bits (242), Expect = 1e-22
 Identities = 58/306 (18%), Positives = 104/306 (33%), Gaps = 85/306 (27%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWI-NEVNFLGVV 152
           +G G F  V + +        +++G     + A K L  R+  Q  +  I +E+  L + 
Sbjct: 37  LGRGKFAVVRQCI-------SKSTG----QEYAAKFLKKRRRGQDCRAEILHEIAVLELA 85

Query: 153 KH-PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           K  P ++ L  +   ++   +  +L+ E      +    L  +   ++         D  
Sbjct: 86  KSCPRVINL--HEVYENTSEI--ILILEYAAGGEIFSLCLPELAEMVS-------ENDVI 134

Query: 212 R-------GLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGH 261
           R       G+ YLH+     ++  D K  NILL         K+ DFG++R+        
Sbjct: 135 RLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGH---AC 188

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQKL 317
               ++GT  Y APE +    +T  +D+W+ G++ Y L+T               + Q+ 
Sbjct: 189 ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH-------TSPFVGEDNQET 241

Query: 318 LEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
              +              VS       I                        L K P+ R
Sbjct: 242 YLNISQVNVDYSEETFSSVSQLAT-DFI---------------------QSLLVKNPEKR 279

Query: 367 PKMSEV 372
           P     
Sbjct: 280 PTAEIC 285

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 96.1 bits (240), Expect = 1e-22
 Identities = 63/311 (20%), Positives = 114/311 (36%), Gaps = 93/311 (29%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI------NEVNF 148
           +G G F  V +          + +G     + A K + ++     +  +       EVN 
Sbjct: 13  LGSGQFAIVRKCR-------QKGTG----KEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA- 207
           L  ++HPN++ L      +++  +   L+ EL+    L D L            +  +  
Sbjct: 62  LREIRHPNIITLHDIF--ENKTDVV--LILELVSGGELFDFL----------AEKESLTE 107

Query: 208 QDAAR-------GLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLARQGPP 256
            +A +       G+ YLH +   ++   D K  NI+L      + + KL DFG+A +   
Sbjct: 108 DEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164

Query: 257 EGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----R 312
              G+   ++ GT  + APE V    L  ++D+WS GV+ Y L++G              
Sbjct: 165 ---GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------ASPFLGE 214

Query: 313 NEQKLLEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTK 361
            +Q+ L  +               S+  K   I                      + L K
Sbjct: 215 TKQETLTNISAVNYDFDEEYFSNTSELAK-DFI---------------------RRLLVK 252

Query: 362 QPKSRPKMSEV 372
            PK R  +++ 
Sbjct: 253 DPKRRMTIAQS 263

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 98.2 bits (245), Expect = 2e-22
 Identities = 65/223 (29%), Positives = 102/223 (45%), Gaps = 44/223 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           IG G FG VY+  +  S +            VAIK++  Q     K + N E+  +  + 
Sbjct: 62  IGNGSFGVVYQAKLCDSGEL-----------VAIKKV-LQ----DKRFKNRELQIMRKLD 105

Query: 154 HPNLVKLVGY-CAEDDERGMQRL-LVYELMH---NKSLEDHLLSRVPTPLAWIARLKIAQ 208
           H N+V+L  +  +  +++    L LV + +     +    +  ++   P+ ++ +L + Q
Sbjct: 106 HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYV-KLYMYQ 164

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHVSTSVV 267
              R LAY+H    F +  RD K  N+LLD D    KL DFG A+Q      G  + S +
Sbjct: 165 -LFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR---GEPNVSYI 217

Query: 268 GTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
            +  Y APE       Y      T+  DVWS G VL EL+ G+
Sbjct: 218 CSRYYRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 54/304 (17%), Positives = 100/304 (32%), Gaps = 87/304 (28%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R V              SK     K +  +G         E++ L + +H
Sbjct: 13  LGRGEFGIVHRCVET-----------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARH 60

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA---QDAA 211
            N++ L      +    +  ++++E +    + + + +                  ++  
Sbjct: 61  RNILHLHESF--ESMEEL--VMIFEFISGLDIFERINTS-----------AFELNEREIV 105

Query: 212 R-------GLAYLHEEMDFQLIFRDFKTSNILL--DEDYKAKLSDFGLARQGPPEGLGHV 262
                    L +LH      +   D +  NI+         K+ +FG ARQ  P   G  
Sbjct: 106 SYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDN 159

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLE 319
              +     Y APE  Q   ++  +D+WS G ++Y L++G        P      Q+++E
Sbjct: 160 FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN------PFLAETNQQIIE 213

Query: 320 WVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
            +              +S       +                      + L K+ KSR  
Sbjct: 214 NIMNAEYTFDEEAFKEISIEAM-DFV---------------------DRLLVKERKSRMT 251

Query: 369 MSEV 372
            SE 
Sbjct: 252 ASEA 255

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 63/303 (20%), Positives = 108/303 (35%), Gaps = 77/303 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI------NEVNF 148
           +G G F  V +          +++G    L+ A K + ++  +  +  +       EV+ 
Sbjct: 20  LGSGQFAIVKKCR-------EKSTG----LEYAAKFIKKRQSRASRRGVSREEIEREVSI 68

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           L  V H N++ L      ++   +   L+ EL+    L D L  +              +
Sbjct: 69  LRQVLHHNVITLHDVY--ENRTDVV--LILELVSGGELFDFLAQKESLSEEEATSF--IK 122

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLARQGPPEGLGHVST 264
               G+ YLH +   ++   D K  NI+L          KL DFGLA +      G    
Sbjct: 123 QILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED---GVEFK 176

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQKLLEW 320
           ++ GT  + APE V    L  ++D+WS GV+ Y L++G               +Q+ L  
Sbjct: 177 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------ASPFLGDTKQETLAN 229

Query: 321 VR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM 369
           +             + S+  K   I                      K L K+ + R  +
Sbjct: 230 ITSVSYDFDEEFFSHTSELAK-DFI---------------------RKLLVKETRKRLTI 267

Query: 370 SEV 372
            E 
Sbjct: 268 QEA 270

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 96.3 bits (240), Expect = 4e-22
 Identities = 65/311 (20%), Positives = 112/311 (36%), Gaps = 93/311 (29%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI------NEVNF 148
           +G G F  V +          +++G    L+ A K + ++  +  +  +       EV+ 
Sbjct: 20  LGSGQFAIVKKCR-------EKSTG----LEYAAKFIKKRQSRASRRGVCREEIEREVSI 68

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA- 207
           L  V HPN++ L      ++   +   L+ EL+    L D L            +  ++ 
Sbjct: 69  LRQVLHPNIITLHDVY--ENRTDVV--LILELVSGGELFDFL----------AQKESLSE 114

Query: 208 QDAAR-------GLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLARQGPP 256
           ++A         G+ YLH +   ++   D K  NI+L          KL DFGLA +   
Sbjct: 115 EEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

Query: 257 EGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----R 312
              G    ++ GT  + APE V    L  ++D+WS GV+ Y L++G              
Sbjct: 172 ---GVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------ASPFLGD 221

Query: 313 NEQKLLEWVR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTK 361
            +Q+ L  +               S+  K   I                      K L K
Sbjct: 222 TKQETLANITAVSYDFDEEFFSQTSELAK-DFI---------------------RKLLVK 259

Query: 362 QPKSRPKMSEV 372
           + + R  + E 
Sbjct: 260 ETRKRLTIQEA 270

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 64/303 (21%), Positives = 109/303 (35%), Gaps = 77/303 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI------NEVNF 148
           +G G F  V +          +++G    L  A K + ++  +  +  +       EV+ 
Sbjct: 19  LGSGQFAVVKKCR-------EKSTG----LQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           L  ++HPN++ L      +++  +   L+ EL+    L D L  +              +
Sbjct: 68  LKEIQHPNVITLHEVY--ENKTDVI--LILELVAGGELFDFLAEKESLTEEEATEF--LK 121

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILL----DEDYKAKLSDFGLARQGPPEGLGHVST 264
               G+ YLH     Q+   D K  NI+L        + K+ DFGLA +      G+   
Sbjct: 122 QILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEFK 175

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQKLLEW 320
           ++ GT  + APE V    L  ++D+WS GV+ Y L++G               +Q+ L  
Sbjct: 176 NIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG-------ASPFLGDTKQETLAN 228

Query: 321 VR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM 369
           V               S   K   I                      + L K PK R  +
Sbjct: 229 VSAVNYEFEDEYFSNTSALAK-DFI---------------------RRLLVKDPKKRMTI 266

Query: 370 SEV 372
            + 
Sbjct: 267 QDS 269

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 96.8 bits (241), Expect = 1e-21
 Identities = 64/303 (21%), Positives = 106/303 (34%), Gaps = 84/303 (27%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V+R          + +G     + A K +        +    E+  + V++H
Sbjct: 165 LGTGAFGVVHRVT-------ERATG----NNFAAKFVMTPHESDKETVRKEIQTMSVLRH 213

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA-QDAAR- 212
           P LV L      +D+  M  +++YE M    L + +              K++  +A   
Sbjct: 214 PTLVNLHDAF--EDDNEM--VMIYEFMSGGELFEKVADE---------HNKMSEDEAVEY 260

Query: 213 ------GLAYLHEEMDFQLIFRDFKTSNILL--DEDYKAKLSDFGLARQGPPEGLGHVST 264
                 GL ++HE      +  D K  NI+       + KL DFGL     P        
Sbjct: 261 MRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP---KQSVK 314

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----RNEQKLLEW 320
              GT  +AAPE  +   +   +D+WS GV+ Y L++G       L      N+ + L  
Sbjct: 315 VTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG-------LSPFGGENDDETLRN 367

Query: 321 VR-----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM 369
           V+             +S+  K   I                      K L   P +R  +
Sbjct: 368 VKSCDWNMDDSAFSGISEDGK-DFI---------------------RKLLLADPNTRMTI 405

Query: 370 SEV 372
            + 
Sbjct: 406 HQA 408

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 95.5 bits (238), Expect = 1e-21
 Identities = 62/217 (28%), Positives = 98/217 (45%), Gaps = 33/217 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           IG G FG V++  +  S +            VAIK++  Q     K + N E+  + +VK
Sbjct: 48  IGNGSFGVVFQAKLVESDE------------VAIKKV-LQ----DKRFKNRELQIMRIVK 90

Query: 154 HPNLVKLVGYCAEDDERGMQRL--LVYELMH---NKSLEDHLLSRVPTPLAWIARLKIAQ 208
           HPN+V L  +   + ++  +    LV E +     ++   +   +   P+  I +L + Q
Sbjct: 91  HPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLI-KLYMYQ 149

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHVSTSVV 267
              R LAY+H      +  RD K  N+LLD      KL DFG A+       G  + S +
Sbjct: 150 -LLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA---GEPNVSYI 202

Query: 268 GTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGR 303
            +  Y APE +      T   D+WS G V+ EL+ G+
Sbjct: 203 CSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQ 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 96.4 bits (240), Expect = 1e-21
 Identities = 68/214 (31%), Positives = 97/214 (45%), Gaps = 26/214 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
           ++G+GGFG V     +V           +    A K+L ++  +  K     +NE   L 
Sbjct: 191 VLGKGGFGEVC--ACQV---------RATGKMYACKKLEKKRIKKRKGEAMALNEKQILE 239

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI-AQD 209
            V    +V L  Y  E  +      LV  LM+   L+ H+   +       AR    A +
Sbjct: 240 KVNSRFVVSLA-YAYETKDA---LCLVLTLMNGGDLKFHI-YHMGQAGFPEARAVFYAAE 294

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
              GL  LH E   ++++RD K  NILLD+    ++SD GLA   P    G      VGT
Sbjct: 295 ICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPE---GQTIKGRVGT 348

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           VGY APE V+  R T   D W+ G +LYE+I G+
Sbjct: 349 VGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQ 382

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 96.4 bits (240), Expect = 2e-21
 Identities = 58/217 (26%), Positives = 92/217 (42%), Gaps = 29/217 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
           ++G GGFG V+    ++           +    A K+LN++  +  K +   + E   L 
Sbjct: 192 VLGRGGFGEVF--ACQM---------KATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA 240

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWI---ARLKI 206
            V    +V L  Y  E        L LV  +M+   +  H+ +       +    A    
Sbjct: 241 KVHSRFIVSLA-YAFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYT 295

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           AQ    GL +LH+     +I+RD K  N+LLD+D   ++SD GLA +         +   
Sbjct: 296 AQ-IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ--TKTKGY 349

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            GT G+ APE +         D ++ GV LYE+I  R
Sbjct: 350 AGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 93.0 bits (232), Expect = 3e-21
 Identities = 60/221 (27%), Positives = 89/221 (40%), Gaps = 43/221 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           IGEG +G V++         ++ +G      VAIK+   +        I      E+  L
Sbjct: 11  IGEGSYGVVFKCR-------NRDTGQI----VAIKKF-LESED--DPVIKKIALREIRML 56

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             +KHPNLV L+     +  R  +RL LV+E     ++  H L R    +       I  
Sbjct: 57  KQLKHPNLVNLL-----EVFRRKRRLHLVFEYCD-HTVL-HELDRYQRGVPEHLVKSITW 109

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVV 267
              + + + H+      I RD K  NIL+ +    KL DFG AR    P          V
Sbjct: 110 QTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGP---SDYYDDEV 163

Query: 268 GTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITGR 303
            T  Y +PE +    +         DVW+ G V  EL++G 
Sbjct: 164 ATRWYRSPELL----VGDTQYGPPVDVWAIGCVFAELLSGV 200

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 96.1 bits (239), Expect = 3e-21
 Identities = 63/218 (28%), Positives = 98/218 (44%), Gaps = 33/218 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
           +IG GGFG VY    R           D+    A+K L+++  +  +     +NE   L 
Sbjct: 196 IIGRGGFGEVY--GCRK---------ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 244

Query: 151 VVK---HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
           +V     P +V +  Y     ++    L  + +LM+   L  HL S+         R   
Sbjct: 245 LVSTGDCPFIVCMS-YAFHTPDK----LSFILDLMNGGDLHYHL-SQHGVFSEADMRFYA 298

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV 266
           A+    GL ++H      +++RD K +NILLDE    ++SD GLA     +       + 
Sbjct: 299 AE-IILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHAS 350

Query: 267 VGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGR 303
           VGT GY APE +Q G     S D +S G +L++L+ G 
Sbjct: 351 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 92.4 bits (230), Expect = 8e-21
 Identities = 56/227 (24%), Positives = 93/227 (40%), Gaps = 46/227 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN----EVNFLG 150
            G+G FG V  G  + +              VAIK++     Q    + N     +  L 
Sbjct: 31  AGQGTFGTVQLGKEKSTGMS-----------VAIKKV----IQ-DPRFRNRELQIMQDLA 74

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRL---LVYELMH---NKSLEDHLLSRVPTPLAWIARL 204
           V+ HPN+V+L  Y     ER  + +   +V E +    ++   ++   +V  P   I ++
Sbjct: 75  VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILI-KV 133

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEGLGHVS 263
            + Q   R +  LH      +  RD K  N+L++  D   KL DFG A++  P      +
Sbjct: 134 FLFQ-LIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSP---SEPN 188

Query: 264 TSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
            + + +  Y APE       Y      T   D+WS G +  E++ G 
Sbjct: 189 VAYICSRYYRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 92.9 bits (231), Expect = 9e-21
 Identities = 54/231 (23%), Positives = 89/231 (38%), Gaps = 48/231 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G +G VY+   +    D +        D A+KQ+   G         E+  L  +KH
Sbjct: 29  VGRGTYGHVYKAKRK----DGKDDK-----DYALKQIEGTGI--SMSACREIALLRELKH 77

Query: 155 PNLVKLVGYCAEDDERGMQRL-LVYE--------LMHNKSLEDHLLSRVPTPLAWIARLK 205
           PN++ L        +R   ++ L+++        ++            V  P   +    
Sbjct: 78  PNVISLQKVFLSHADR---KVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK--S 132

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA----KLSDFGLAR--QGPPEGL 259
           +      G+ YLH      ++ RD K +NIL+  +       K++D G AR    P + L
Sbjct: 133 LLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 189

Query: 260 GHVSTSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
             +   VV T  Y APE       Y      T   D+W+ G +  EL+T  
Sbjct: 190 ADLDPVVV-TFWYRAPELLLGARHY------TKAIDIWAIGCIFAELLTSE 233

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 92.1 bits (229), Expect = 1e-20
 Identities = 58/231 (25%), Positives = 92/231 (39%), Gaps = 44/231 (19%)

Query: 86  TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEW 142
            + +     IG G  G V       ++ D     +     VAIK+L+R  FQ     K  
Sbjct: 24  LKRYQNLKPIGSGAQGIV------CAAYDAILERN-----VAIKKLSRP-FQNQTHAKRA 71

Query: 143 INEVNFLGVVKHPNLVKLVG-YCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAW 200
             E+  +  V H N++ L+  +  +      Q + +V ELM                L  
Sbjct: 72  YRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-------------DANLCQ 118

Query: 201 IARLKIAQDAA--------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
           + ++++  +           G+ +LH      +I RD K SNI++  D   K+ DFGLAR
Sbjct: 119 VIQMELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 175

Query: 253 QGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                    + T  V T  Y APE +         D+WS G ++ E+I G 
Sbjct: 176 TAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 91.5 bits (228), Expect = 1e-20
 Identities = 57/217 (26%), Positives = 89/217 (41%), Gaps = 35/217 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           +GEG +G V +         ++ +G      VAIK+   +      + +      E+  L
Sbjct: 33  VGEGSYGMVMKCR-------NKDTGRI----VAIKKF-LESDD--DKMVKKIAMREIKLL 78

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             ++H NLV L+     +  +  +R  LV+E +   ++    L   P  L +    K   
Sbjct: 79  KQLRHENLVNLL-----EVCKKKKRWYLVFEFVD-HTIL-DDLELFPNGLDYQVVQKYLF 131

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVV 267
               G+ + H      +I RD K  NIL+ +    KL DFG AR    P   G V    V
Sbjct: 132 QIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP---GEVYDDEV 185

Query: 268 GTVGYAAPEY-VQTGRLTAKSDVWSFGVVLYELITGR 303
            T  Y APE  V   +     DVW+ G ++ E+  G 
Sbjct: 186 ATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGE 222

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 93.0 bits (231), Expect = 1e-20
 Identities = 57/222 (25%), Positives = 90/222 (40%), Gaps = 44/222 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           IG G  G V       ++ D     +     VAIK+L+R  FQ     K    E+  +  
Sbjct: 70  IGSGAQGIVC------AAYDAVLDRN-----VAIKKLSRP-FQNQTHAKRAYRELVLMKC 117

Query: 152 VKHPNLVKLVG-YCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           V H N++ L+  +  +      Q + LV ELM                L  + ++++  +
Sbjct: 118 VNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-------------DANLCQVIQMELDHE 164

Query: 210 AA--------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                      G+ +LH      +I RD K SNI++  D   K+ DFGLAR         
Sbjct: 165 RMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS---F 218

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           + T  V T  Y APE +         D+WS G ++ E++  +
Sbjct: 219 MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 90.7 bits (226), Expect = 2e-20
 Identities = 62/226 (27%), Positives = 102/226 (45%), Gaps = 49/226 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           +G G +  VY+G+      +  T  +     VA+K++        +E        E++ +
Sbjct: 13  LGNGTYATVYKGL------NKTTGVY-----VALKEVKLD----SEEGTPSTAIREISLM 57

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHN---KSLEDHLLSRVPTPLAWIARLK 205
             +KH N+V+L      D      +L LV+E M N   K ++   +   P  L       
Sbjct: 58  KELKHENIVRLY-----DVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKY 112

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVST 264
                 +GLA+ HE    +++ RD K  N+L+++  + KL DFGLAR  G P    +  +
Sbjct: 113 FQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP---VNTFS 166

Query: 265 SVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
           S V T+ Y AP+       Y      +   D+WS G +L E+ITG+
Sbjct: 167 SEVVTLWYRAPDVLMGSRTY------STSIDIWSCGCILAEMITGK 206

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 71/364 (19%), Positives = 110/364 (30%), Gaps = 106/364 (29%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR-----------------QGFQ 137
           +G G FG V                  +   VA+K L                       
Sbjct: 30  LGRGAFGQVIEADA------FGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIG 83

Query: 138 GHKEWINEVNFLGVV--------------KHPNLVKLV---------------------G 162
            H    N VN LG                K  NL   +                      
Sbjct: 84  HHL---NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKD 140

Query: 163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQ 208
           Y         +RL       + +    +  +                  L     +  + 
Sbjct: 141 YVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSF 200

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
             A+G+ +L      + I RD    NILL E    K+ DFGLAR    +           
Sbjct: 201 QVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 257

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY--- 324
            + + APE +     T +SDVWSFGV+L+E+ + G                    PY   
Sbjct: 258 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA------------------SPYPGV 299

Query: 325 VSDSKKFHLIID-PRLEG-NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
             D +    + +  R+   +Y      ++      C   +P  RP  SE+V+ LGN++  
Sbjct: 300 KIDEEFCRRLKEGTRMRAPDYT---TPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA 356

Query: 383 ISSQ 386
            ++Q
Sbjct: 357 -NAQ 359

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 62/224 (27%), Positives = 91/224 (40%), Gaps = 39/224 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           IG G +G VY+        D  +        VA+K +      G    +      EV  L
Sbjct: 17  IGVGAYGTVYKAR------DPHSGHF-----VALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 150 ---GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDH----LLSRVPTPLAWI 201
                 +HPN+V+L+  CA        ++ LV+E +      D      L + P P    
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV------DQDLRTYLDKAPPPGLPA 119

Query: 202 ARLK-IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGL 259
             +K + +   RGL +LH      ++ RD K  NIL+      KL+DFGLAR       L
Sbjct: 120 ETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
               T VV T+ Y APE +         D+WS G +  E+   +
Sbjct: 177 ----TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 89.9 bits (224), Expect = 4e-20
 Identities = 67/240 (27%), Positives = 109/240 (45%), Gaps = 48/240 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW--INEVNFLGV 151
           ++G+G FG V+  +V+      + SG D++   A+K L +   +         E + L  
Sbjct: 31  VLGQGSFGKVF--LVK------KISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVE 82

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSRVPTPLAWIA 202
           V HP +VKL  Y  + + +      +Y         +L         L   V        
Sbjct: 83  VNHPFIVKLH-YAFQTEGK------LYLILDFLRGGDLFT------RLSKEVMFTEED-V 128

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHV 262
           +  +A+ A   L +LH      +I+RD K  NILLDE+   KL+DFGL+++         
Sbjct: 129 KFYLAELAL-ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDH--EKK 182

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLLE 319
           + S  GTV Y APE V     T  +D WSFGV+++E++TG       LP   ++ ++ + 
Sbjct: 183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGT------LPFQGKDRKETMT 236

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 90.9 bits (226), Expect = 5e-20
 Identities = 62/226 (27%), Positives = 96/226 (42%), Gaps = 47/226 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLG 150
           +IG G FG V   +VR            ++   A+K L++       +   +  E + + 
Sbjct: 76  VIGRGAFGEVQ--LVR---------HKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA 124

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSRVPTPLAWI 201
               P +V+L  Y  +DD        +Y         +L++       L+S    P  W 
Sbjct: 125 FANSPWVVQLF-YAFQDDRY------LYMVMEYMPGGDLVN-------LMSNYDVPEKW- 169

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
           AR   A+     L  +H  M F  I RD K  N+LLD+    KL+DFG   +   EG+  
Sbjct: 170 ARFYTAEVVL-ALDAIHS-MGF--IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR 225

Query: 262 VSTSVVGTVGYAAPEYVQT----GRLTAKSDVWSFGVVLYELITGR 303
              + VGT  Y +PE +++    G    + D WS GV LYE++ G 
Sbjct: 226 -CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 89.6 bits (223), Expect = 5e-20
 Identities = 66/224 (29%), Positives = 97/224 (43%), Gaps = 41/224 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           IGEG +G V++        D +  G      VA+K++     Q  +E +      EV  L
Sbjct: 19  IGEGAYGKVFKAR------DLKNGGRF----VALKRVR---VQTGEEGMPLSTIREVAVL 65

Query: 150 ---GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDH----LLSRVPTPLAWI 201
                 +HPN+V+L   C         +L LV+E +      D      L +VP P    
Sbjct: 66  RHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV------DQDLTTYLDKVPEPGVPT 119

Query: 202 ARLK-IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGL 259
             +K +     RGL +LH     +++ RD K  NIL+    + KL+DFGLAR       L
Sbjct: 120 ETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL 176

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
               TSVV T+ Y APE +         D+WS G +  E+   +
Sbjct: 177 ----TSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 90.2 bits (224), Expect = 9e-20
 Identities = 55/235 (23%), Positives = 91/235 (38%), Gaps = 62/235 (26%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLG 150
           +IG G FG V   VV+           ++    A+K LN+       E   +  E + L 
Sbjct: 81  VIGRGAFGEVA--VVK---------LKNADKVFAMKILNKWEMLKRAETACFREERDVLV 129

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSRVPTPLAWI 201
                 +  L  Y  +DD        +Y         +L+        LLS+        
Sbjct: 130 NGDSKWITTLH-YAFQDDNN------LYLVMDYYVGGDLLT-------LLSKF------- 168

Query: 202 ARLKIAQDAAR--------GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
              ++ ++ AR         +  +H+ + +  + RD K  NIL+D +   +L+DFG   +
Sbjct: 169 -EDRLPEEMARFYLAEMVIAIDSVHQ-LHY--VHRDIKPDNILMDMNGHIRLADFGSCLK 224

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITGR 303
              +G    S+  VGT  Y +PE +Q             D WS GV +YE++ G 
Sbjct: 225 LMEDGTVQ-SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 87.9 bits (218), Expect = 1e-19
 Identities = 40/279 (14%), Positives = 78/279 (27%), Gaps = 69/279 (24%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGF---QGHKEWINEVNF 148
             G       ++               D+ LD  VA+  ++ QG       +E ++    
Sbjct: 38  FHGGVPPLQFWQA-------------LDTALDRQVALTFVDPQGVLPDDVLQETLSRTLR 84

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           L  +  P + + V         G   L+V E +   SL++ +    P+P   +  ++  Q
Sbjct: 85  LSRIDKPGVAR-VLDVVHTRAGG---LVVAEWIRGGSLQE-VADTSPSP---VGAIRAMQ 136

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
             A      H      +       S + +  D                   G V   V+ 
Sbjct: 137 SLAAAADAAHRA---GVALSIDHPSRVRVSID-------------------GDV---VLA 171

Query: 269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
                            + D+   G  LY L+  R  +     R+     E         
Sbjct: 172 YPATMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--------- 215

Query: 329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
                   P    +       +++A+A++ +      R 
Sbjct: 216 --RDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIRS 252

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 88.4 bits (220), Expect = 2e-19
 Identities = 60/232 (25%), Positives = 97/232 (41%), Gaps = 53/232 (22%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           IG+G FG V++         H+ +G      VA+K++     +  KE        E+  L
Sbjct: 25  IGQGTFGEVFKAR-------HRKTGQK----VALKKVL---MENEKEGFPITALREIKIL 70

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL----LVYELMHNKSLEDH----LLSRVPTPLAWI 201
            ++KH N+V L+  C        +      LV++        +H    LLS V      +
Sbjct: 71  QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC------EHDLAGLLSNVLVKFT-L 123

Query: 202 ARLK-IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ--GPPEG 258
           + +K + Q    GL Y+H     +++ RD K +N+L+  D   KL+DFGLAR        
Sbjct: 124 SEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNS 180

Query: 259 LGHVSTSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
             +  T+ V T+ Y  PE       Y          D+W  G ++ E+ T  
Sbjct: 181 QPNRYTNRVVTLWYRPPELLLGERDY------GPPIDLWGAGCIMAEMWTRS 226

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 88.2 bits (219), Expect = 3e-19
 Identities = 53/231 (22%), Positives = 88/231 (38%), Gaps = 52/231 (22%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLG 150
           +IG G F  V   VV++           +    A+K +N+       E   +  E + L 
Sbjct: 68  VIGRGAFSEVA--VVKM---------KQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV 116

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSRVPT--PLA 199
                 + +L  +  +D+        +Y         +L+        LLS+     P  
Sbjct: 117 NGDRRWITQLH-FAFQDENY------LYLVMEYYVGGDLLT-------LLSKFGERIPAE 162

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
             AR  +A+     +  +H  + +  + RD K  NILLD     +L+DFG   +   +G 
Sbjct: 163 M-ARFYLAEIVM-AIDSVHR-LGY--VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT 217

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRLTAKS-------DVWSFGVVLYELITGR 303
              S   VGT  Y +PE +Q       +       D W+ GV  YE+  G+
Sbjct: 218 VR-SLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 87.2 bits (217), Expect = 3e-19
 Identities = 62/249 (24%), Positives = 103/249 (41%), Gaps = 64/249 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI----NEV--- 146
           ++G+GG+G V+   VR      + +G ++    A+K L        K  I     +    
Sbjct: 24  VLGKGGYGKVF--QVR------KVTGANTGKIFAMKVLK-------KAMIVRNAKDTAHT 68

Query: 147 ----NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
               N L  VKHP +V L+ Y  +   +      +Y         EL         L   
Sbjct: 69  KAERNILEEVKHPFIVDLI-YAFQTGGK------LYLILEYLSGGELFM------QLERE 115

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                   A   +A+  +  L +LH+     +I+RD K  NI+L+     KL+DFGL ++
Sbjct: 116 GIFMEDT-ACFYLAE-ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE 170

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP-- 311
              +  G V+ +  GT+ Y APE +         D WS G ++Y+++TG        P  
Sbjct: 171 SIHD--GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGA------PPFT 222

Query: 312 -RNEQKLLE 319
             N +K ++
Sbjct: 223 GENRKKTID 231

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 86.6 bits (215), Expect = 8e-19
 Identities = 61/223 (27%), Positives = 94/223 (42%), Gaps = 47/223 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +G G +G V       S+ D ++        VAIK+L+R  FQ     K    E+  L  
Sbjct: 32  VGSGAYGSVC------SAIDKRSGEK-----VAIKKLSRP-FQSEIFAKRAYRELLLLKH 79

Query: 152 VKHPNLVKLVG-YCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           ++H N++ L+  +      R      LV   M              T L  I  LK +++
Sbjct: 80  MQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-------------QTDLQKIMGLKFSEE 126

Query: 210 --------AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     +GL Y+H      ++ RD K  N+ ++ED + K+ DFGLAR    E    
Sbjct: 127 KIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE---- 179

Query: 262 VSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
             T  V T  Y APE +          D+WS G ++ E++TG+
Sbjct: 180 -MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 85.3 bits (212), Expect = 1e-18
 Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 45/224 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           IGEG +G V++        + +T        VA+K++         E +      E+  L
Sbjct: 10  IGEGTYGTVFKAK------NRETHEI-----VALKRVR---LDDDDEGVPSSALREICLL 55

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLK-IA 207
             +KH N+V+L      D     ++L LV+E    + L+          L     +K   
Sbjct: 56  KELKHKNIVRLH-----DVLHSDKKLTLVFEFCD-QDLK-KYFDSCNGDLD-PEIVKSFL 107

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSV 266
               +GL + H      ++ RD K  N+L++ + + KL++FGLAR  G P       ++ 
Sbjct: 108 FQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIP---VRCYSAE 161

Query: 267 VGTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITGRRA 305
           V T+ Y  P+ +      AK      D+WS G +  EL    R 
Sbjct: 162 VVTLWYRPPDVL----FGAKLYSTSIDMWSAGCIFAELANAGRP 201

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 85.8 bits (213), Expect = 1e-18
 Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 44/224 (19%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           IGEG +G V       S+ D+          VAIK+++   F+     +  + E+  L  
Sbjct: 35  IGEGAYGMVC------SAYDNLNKVR-----VAIKKISP--FEHQTYCQRTLREIKILLR 81

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            +H N++ +           M+ + +V +LM              T L  + + +   + 
Sbjct: 82  FRHENIIGINDIIRAPTIEQMKDVYIVQDLM-------------ETDLYKLLKTQHLSND 128

Query: 211 ---------ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR-QGPPEGLG 260
                     RGL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P     
Sbjct: 129 HICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHT 185

Query: 261 HVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              T  V T  Y APE +  +   T   D+WS G +L E+++ R
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNR 229

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 65/268 (24%), Positives = 109/268 (40%), Gaps = 51/268 (19%)

Query: 51  SDSRDWSDSLAFYELLSQRRANDLRVFSFAELKSAT-RGFSRALLIGEGGFGCVYRGVVR 109
           + ++  S+  +  E L++ + + L+ +      +A    F R   +G G FG V      
Sbjct: 4   AAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRV------ 57

Query: 110 VSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLGVVKHPNLVKLVGYCAE 166
                      +S    A+K L++Q     K+    +NE   L  V  P LVKL  +  +
Sbjct: 58  -----MLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE-FSFK 111

Query: 167 DDERGMQRLLVY---------ELMHNKSLEDHL--LSRVPTPLAWIARLKIAQDAARGLA 215
           D+        +Y         E+        HL  + R   P A   R   AQ       
Sbjct: 112 DNSN------LYMVMEYVAGGEMFS------HLRRIGRFSEPHA---RFYAAQ-IVLTFE 155

Query: 216 YLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAP 275
           YLH      LI+RD K  N+L+D+    +++DFG A++     +   + ++ GT    AP
Sbjct: 156 YLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKR-----VKGRTWTLCGTPEALAP 207

Query: 276 EYVQTGRLTAKSDVWSFGVVLYELITGR 303
           E + +       D W+ GV++YE+  G 
Sbjct: 208 EIILSKGYNKAVDWWALGVLIYEMAAGY 235

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 63/224 (28%), Positives = 95/224 (42%), Gaps = 46/224 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           +GEG F  VY+   + ++             VAIK++        K+ IN     E+  L
Sbjct: 18  LGEGQFATVYKARDKNTNQI-----------VAIKKIKLGHRSEAKDGINRTALREIKLL 66

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLK-IA 207
             + HPN++ L      D       + LV++ M    LE  ++      L   + +K   
Sbjct: 67  QELSHPNIIGL-----LDAFGHKSNISLVFDFME-TDLE-VIIKDNSLVLT-PSHIKAYM 118

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSV 266
               +GL YLH+     ++ RD K +N+LLDE+   KL+DFGLA+  G P       T  
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP---NRAYTHQ 172

Query: 267 VGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
           V T  Y APE       Y          D+W+ G +L EL+   
Sbjct: 173 VVTRWYRAPELLFGARMY------GVGVDMWAVGCILAELLLRV 210

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 85.9 bits (213), Expect = 3e-18
 Identities = 75/288 (26%), Positives = 113/288 (39%), Gaps = 66/288 (22%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
           L+G+G FG V                  +    A+K L ++      E    + E   L 
Sbjct: 155 LLGKGTFGKVI-----------LVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ 203

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSRVPTPLAWI 201
             +HP L  L  Y  +  +R      +          EL        HL SR        
Sbjct: 204 NSRHPFLTALK-YSFQTHDR------LCFVMEYANGGELFF------HL-SRERVFSEDR 249

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
           AR   A+     L YLH E +  +++RD K  N++LD+D   K++DFGL ++G  +  G 
Sbjct: 250 ARFYGAE-IVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD--GA 304

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLL 318
              +  GT  Y APE ++        D W  GVV+YE++ GR      LP   ++ +KL 
Sbjct: 305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHEKL- 357

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
                       F LI+   +   +      +  +L S  L K PK R
Sbjct: 358 ------------FELILMEEI--RFPRTLGPEAKSLLSGLLKKDPKQR 391

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 59/226 (26%), Positives = 97/226 (42%), Gaps = 43/226 (19%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI----NEVNFL 149
           ++G G +G V+  +VR      + SGHD+    A+K L +       +       E   L
Sbjct: 61  VLGTGAYGKVF--LVR------KISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 112

Query: 150 GVVKH-PNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSRVPTPLA 199
             ++  P LV L  Y  + + +      ++         EL        HL  R      
Sbjct: 113 EHIRQSPFLVTLH-YAFQTETK------LHLILDYINGGELFT------HLSQRERFTEH 159

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGL 259
              ++ + +     L +LH+     +I+RD K  NILLD +    L+DFGL+++   +  
Sbjct: 160 E-VQIYVGE-IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE- 213

Query: 260 GHVSTSVVGTVGYAAPEYVQTGRL--TAKSDVWSFGVVLYELITGR 303
              +    GT+ Y AP+ V+ G        D WS GV++YEL+TG 
Sbjct: 214 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 84.7 bits (210), Expect = 3e-18
 Identities = 65/224 (29%), Positives = 98/224 (43%), Gaps = 48/224 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +G G +G V       S+ D +T        VAIK+L R  FQ     K    E+  L  
Sbjct: 33  VGSGAYGAV------CSAVDGRTGAK-----VAIKKLYRP-FQSELFAKRAYRELRLLKH 80

Query: 152 VKHPNLVKLVG-YCAEDDERGMQRL-LVYELM--------HNKSL-EDHLLSRVPTPLAW 200
           ++H N++ L+  +  ++         LV   M         ++ L ED +          
Sbjct: 81  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRI---------- 130

Query: 201 IARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
             +  + Q   +GL Y+H      +I RD K  N+ ++ED + K+ DFGLARQ   E   
Sbjct: 131 --QFLVYQ-MLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE--- 181

Query: 261 HVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              T  V T  Y APE +    R T   D+WS G ++ E+ITG+
Sbjct: 182 --MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 223

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 84.3 bits (209), Expect = 4e-18
 Identities = 58/235 (24%), Positives = 83/235 (35%), Gaps = 59/235 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI----------- 143
           I  G +G V       +  D +         VAIK++      G    I           
Sbjct: 30  ISSGSYGAV------CAGVDSEGI------PVAIKRVFNTVSDGRTVNILSDSFLCKRVL 77

Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIA 202
            E+  L    HPN++ L       +E  M +L LV ELM         L++V        
Sbjct: 78  REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM------RTDLAQV-------- 123

Query: 203 RLKIAQDAA-------------RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFG 249
            +   +                 GL  LHE     ++ RD    NILL ++    + DF 
Sbjct: 124 -IHDQRIVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFN 179

Query: 250 LARQGPPEGLGHVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
           LAR+   +      T  V    Y APE V Q    T   D+WS G V+ E+   +
Sbjct: 180 LAREDTADA---NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK 231

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 61/223 (27%), Positives = 98/223 (43%), Gaps = 48/223 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           +GEG +  VY+G  +++ +            VA+K++  +    H+E        EV+ L
Sbjct: 10  LGEGTYATVYKGKSKLTDNL-----------VALKEIRLE----HEEGAPCTAIREVSLL 54

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             +KH N+V L      D     + L LV+E +  K L+   L      +          
Sbjct: 55  KDLKHANIVTL-----HDIIHTEKSLTLVFEYLD-KDLK-QYLDDCGNIINMHNVKLFLF 107

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVV 267
              RGLAY H +   +++ RD K  N+L++E  + KL+DFGLAR    P        + V
Sbjct: 108 QLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIP---TKTYDNEV 161

Query: 268 GTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
            T+ Y  P+       Y      + + D+W  G + YE+ TGR
Sbjct: 162 VTLWYRPPDILLGSTDY------STQIDMWGVGCIFYEMATGR 198

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 84.0 bits (208), Expect = 7e-18
 Identities = 57/255 (22%), Positives = 94/255 (36%), Gaps = 76/255 (29%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-EVNFLGVVK 153
           +G G FG V       S               A+K++ +        + N E++ + V+ 
Sbjct: 15  LGTGSFGIVCEVFDIESGKR-----------FALKKVLQ-----DPRYKNRELDIMKVLD 58

Query: 154 HPNLVKL--VGYCAEDDERGMQRL--------------------------------LVYE 179
           H N++KL    Y   D+E    +                                 ++ E
Sbjct: 59  HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118

Query: 180 LMH---NKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL 236
            +    +K L+  + S    P+  I  + I Q   R + ++H      +  RD K  N+L
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLI-SIYIYQ-LFRAVGFIHS---LGICHRDIKPQNLL 173

Query: 237 LD-EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPE-------YVQTGRLTAKSD 288
           ++ +D   KL DFG A++  P      S + + +  Y APE       Y      T   D
Sbjct: 174 VNSKDNTLKLCDFGSAKKLIP---SEPSVAYICSRFYRAPELMLGATEY------TPSID 224

Query: 289 VWSFGVVLYELITGR 303
           +WS G V  ELI G+
Sbjct: 225 LWSIGCVFGELILGK 239

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 83.0 bits (206), Expect = 8e-18
 Identities = 66/222 (29%), Positives = 104/222 (46%), Gaps = 46/222 (20%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           +GEG +G VY+           + G      VA+K++         E I      E++ L
Sbjct: 29  VGEGTYGVVYKA--------KDSQGRI----VALKRIR---LDAEDEGIPSTAIREISLL 73

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLK-IA 207
             + HPN+V L+     D     + L LV+E M  K L+  +L    T L   +++K   
Sbjct: 74  KELHHPNIVSLI-----DVIHSERCLTLVFEFME-KDLK-KVLDENKTGLQ-DSQIKIYL 125

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSV 266
               RG+A+ H+    +++ RD K  N+L++ D   KL+DFGLAR  G P       T  
Sbjct: 126 YQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIP---VRSYTHE 179

Query: 267 VGTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITGR 303
           V T+ Y AP+ +    + +K      D+WS G +  E+ITG+
Sbjct: 180 VVTLWYRAPDVL----MGSKKYSTSVDIWSIGCIFAEMITGK 217

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 57/237 (24%), Positives = 83/237 (35%), Gaps = 63/237 (26%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +GEG +G V       S+    T        VAIK++    F         + E+  L  
Sbjct: 19  LGEGAYGVV------CSATHKPTGEI-----VAIKKIEP--FDKPLFALRTLREIKILKH 65

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            KH N++ +      D       + ++ ELM              T L  +   ++  D 
Sbjct: 66  FKHENIITIFNIQRPDSFENFNEVYIIQELM-------------QTDLHRVISTQMLSDD 112

Query: 211 ---------ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     R +  LH      +I RD K SN+L++ +   K+ DFGLAR        +
Sbjct: 113 HIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 262 VS--------TSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
                        V T  Y APE       Y      +   DVWS G +L EL   R
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKY------SRAMDVWSCGCILAELFLRR 220

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 82.8 bits (205), Expect = 2e-17
 Identities = 64/224 (28%), Positives = 93/224 (41%), Gaps = 48/224 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +G G +G V       ++ D +T        VA+K+L+R  FQ     K    E+  L  
Sbjct: 37  VGSGAYGSVC------AAFDTKTGLR-----VAVKKLSRP-FQSIIHAKRTYRELRLLKH 84

Query: 152 VKHPNLVKLVG-YCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           +KH N++ L+  +           + LV  LM                L  I + +   D
Sbjct: 85  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-------------GADLNNIVKCQKLTD 131

Query: 210 A---------ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG 260
                      RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR    E   
Sbjct: 132 DHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE--- 185

Query: 261 HVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELITGR 303
              T  V T  Y APE +          D+WS G ++ EL+TGR
Sbjct: 186 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 81.4 bits (202), Expect = 2e-17
 Identities = 60/225 (26%), Positives = 101/225 (44%), Gaps = 52/225 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           IGEG +G VY+             G       A+K++     +   E I      E++ L
Sbjct: 10  IGEGTYGVVYKA--------QNNYGET----FALKKIR---LEKEDEGIPSTTIREISIL 54

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHN--KSLEDHLLSRVPTPL--AWIARL 204
             +KH N+VKL      D     +RL LV+E +    K L D     + +    +++ +L
Sbjct: 55  KELKHSNIVKLY-----DVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQL 109

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVS 263
                   G+AY H+    +++ RD K  N+L++ + + K++DFGLAR  G P       
Sbjct: 110 ------LNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIP---VRKY 157

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKS-----DVWSFGVVLYELITGR 303
           T  + T+ Y AP+ +    + +K      D+WS G +  E++ G 
Sbjct: 158 THEIVTLWYRAPDVL----MGSKKYSTTIDIWSVGCIFAEMVNGT 198

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 82.3 bits (204), Expect = 2e-17
 Identities = 53/228 (23%), Positives = 91/228 (39%), Gaps = 53/228 (23%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN-----EVNFL 149
           +GEG +G VY+ +      D  T+       VAIK++     +  +E +      EV+ L
Sbjct: 42  LGEGTYGEVYKAI------DTVTNET-----VAIKRIR---LEHEEEGVPGTAIREVSLL 87

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             ++H N+++L     +       RL L++E      L+ ++       +  I    + Q
Sbjct: 88  KELQHRNIIEL-----KSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSF-LYQ 140

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-----KLSDFGLARQ-GPPEGLGHV 262
               G+ + H     + + RD K  N+LL     +     K+ DFGLAR  G P      
Sbjct: 141 -LINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP---IRQ 193

Query: 263 STSVVGTVGYAAPE-------YVQTGRLTAKSDVWSFGVVLYELITGR 303
            T  + T+ Y  PE       Y      +   D+WS   +  E++   
Sbjct: 194 FTHEIITLWYRPPEILLGSRHY------STSVDIWSIACIWAEMLMKT 235

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 81.4 bits (202), Expect = 3e-17
 Identities = 61/229 (26%), Positives = 97/229 (42%), Gaps = 50/229 (21%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INE 145
           F     +G G FG       RV    H      +    A+K L ++     K+     +E
Sbjct: 8   FQILRTLGTGSFG-------RV----HLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDE 56

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHL--LSRV 194
              L +V HP ++++     +D ++      ++         EL         L    R 
Sbjct: 57  RLMLSIVTHPFIIRMW-GTFQDAQQ------IFMIMDYIEGGELFS------LLRKSQRF 103

Query: 195 PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG 254
           P P+A   +   A+     L YLH      +I+RD K  NILLD++   K++DFG A+  
Sbjct: 104 PNPVA---KFYAAE-VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKY- 155

Query: 255 PPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
               +  V+ ++ GT  Y APE V T       D WSFG+++YE++ G 
Sbjct: 156 ----VPDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGY 200

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 79.6 bits (197), Expect = 8e-17
 Identities = 56/300 (18%), Positives = 92/300 (30%), Gaps = 93/300 (31%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VVK 153
           +G G  G V +         ++ +        A+K L         +   EV       +
Sbjct: 26  LGLGINGKVLQIF-------NKRTQEK----FALKMLQD-----CPKARREVELHWRASQ 69

Query: 154 HPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLEDHLLSRVPTPL-----AWIARLKIA 207
            P++V++V    E+   G + L +V E +    L   +  R          + I +  I 
Sbjct: 70  CPHIVRIVDVY-ENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMK-SIG 127

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYKAKLSDFGLARQGPPEGLGHVST 264
           +     + YLH      +  RD K  N+L      +   KL+DFG A     E  G    
Sbjct: 128 E----AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFA----KETTGE--- 173

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRA-VERNLPRNEQKLLEWVR- 322
                  Y               D+WS GV++Y L+ G       +       +   +R 
Sbjct: 174 ------KY-----------DKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM 216

Query: 323 ----------PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                       VS+  K  LI                        L  +P  R  ++E 
Sbjct: 217 GQYEFPNPEWSEVSEEVK-MLI---------------------RNLLKTEPTQRMTITEF 254

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 56/231 (24%), Positives = 89/231 (38%), Gaps = 49/231 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G GG G V       S+ D+          VAIK++     Q  K  + E+  +  + H
Sbjct: 19  LGCGGNGLV------FSAVDNDCDKR-----VAIKKIVLTDPQSVKHALREIKIIRRLDH 67

Query: 155 PNLVKLVG-YCAEDDERGMQRL---------LVYELM---------HNKSLEDHLLSRVP 195
            N+VK+         +               +V E M             LE+H      
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEEHA----- 122

Query: 196 TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLAR-Q 253
                  RL + Q   RGL Y+H      ++ RD K +N+ ++ ED   K+ DFGLAR  
Sbjct: 123 -------RLFMYQ-LLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

Query: 254 GPPEGLGHVSTSVVGTVGYAAPE-YVQTGRLTAKSDVWSFGVVLYELITGR 303
            P        +  + T  Y +P   +     T   D+W+ G +  E++TG+
Sbjct: 172 DPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 67/332 (20%), Positives = 108/332 (32%), Gaps = 98/332 (29%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           IG G +G V        + D  T  +     VAIK++NR  F+     K  + E+  L  
Sbjct: 34  IGRGSYGYV------YLAYDKNTEKN-----VAIKKVNRM-FEDLIDCKRILREITILNR 81

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELM---------HNKSL-EDH-------LLSR 193
           +K   +++L      DD      L +V E+              L E+H       LL  
Sbjct: 82  LKSDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIKTILYNLL-- 139

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                              G  ++HE     +I RD K +N LL++D   K+ DFGLAR 
Sbjct: 140 ------------------LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLART 178

Query: 254 GPPEGLGHVSTSVVGTVGYAAP---------EYVQT------------GRLTAKSDVWSF 292
              E   ++   +                   +V T               T   D+WS 
Sbjct: 179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWST 238

Query: 293 GVVLYELITGRRAVERNL-------PRNEQKLLEWVRPYVSDSKKFH-----LIID---- 336
           G +  EL+   ++   +        P +    L   R      +K +     +I +    
Sbjct: 239 GCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGT 298

Query: 337 PRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
           P  +    I   +       K +   P  +P 
Sbjct: 299 PTEDDLKNINKPE-----VIKYIKLFPHRKPI 325

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 78.4 bits (194), Expect = 4e-16
 Identities = 70/288 (24%), Positives = 110/288 (38%), Gaps = 67/288 (23%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
           L+G+G FG V                  +    A+K L ++      E    + E   L 
Sbjct: 12  LLGKGTFGKVI-----------LVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSRVPTPLAWI 201
             +HP L  L  Y  +  +R      +          EL        HL           
Sbjct: 61  NTRHPFLTALK-YAFQTHDR------LCFVMEYANGGELFF------HLSRERVFTEER- 106

Query: 202 ARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
           AR   A+     L YLH      +++RD K  N++LD+D   K++DFGL ++G  +  G 
Sbjct: 107 ARFYGAE-IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GA 160

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP---RNEQKLL 318
              +  GT  Y APE ++        D W  GVV+YE++ GR      LP   ++ ++L 
Sbjct: 161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERL- 213

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR 366
                       F LI+   +   +    + +  +L +  L K PK R
Sbjct: 214 ------------FELILMEEIR--FPRTLSPEAKSLLAGLLKKDPKQR 247

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 77.6 bits (192), Expect = 7e-16
 Identities = 55/230 (23%), Positives = 92/230 (40%), Gaps = 58/230 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI---NEVN--- 147
           ++G+G FG V+                 +    AIK L        K+ +   ++V    
Sbjct: 24  MLGKGSFGKVF-----------LAEFKKTNQFFAIKALK-------KDVVLMDDDVECTM 65

Query: 148 -----FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
                     +HP L  +     +  E       ++         +LM+      H+ S 
Sbjct: 66  VEKRVLSLAWEHPFLTHMF-CTFQTKEN------LFFVMEYLNGGDLMY------HIQSC 112

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
               L+  A    A+    GL +LH      +++RD K  NILLD+D   K++DFG+ ++
Sbjct: 113 HKFDLSR-ATFYAAE-IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE 167

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                    + +  GT  Y APE +   +     D WSFGV+LYE++ G+
Sbjct: 168 NMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 78.5 bits (193), Expect = 1e-15
 Identities = 52/230 (22%), Positives = 90/230 (39%), Gaps = 58/230 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI---NEVN--- 147
           ++G+G FG V             +    +    A+K L        K+ +   ++V    
Sbjct: 348 VLGKGSFGKVM-----------LSERKGTDELYAVKIL-------KKDVVIQDDDVECTM 389

Query: 148 -----FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
                     K P L +L   C +  +R      +Y         +LM++          
Sbjct: 390 VEKRVLALPGKPPFLTQLH-SCFQTMDR------LYFVMEYVNGGDLMYHIQQVGRFKEP 442

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                   A    A+  A GL +L       +I+RD K  N++LD +   K++DFG+ ++
Sbjct: 443 H-------AVFYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 491

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
              +  G  + +  GT  Y APE +         D W+FGV+LYE++ G+
Sbjct: 492 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 63/249 (25%), Positives = 91/249 (36%), Gaps = 67/249 (26%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI---NEVN--- 147
           +IG+G FG V                   ++  A+K L        K+ I    E     
Sbjct: 45  VIGKGSFGKVL-----------LARHKAEEVFYAVKVLQ-------KKAILKKKEEKHIM 86

Query: 148 -----FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
                 L  VKHP LV L  +  +  ++      +Y         EL +      HL   
Sbjct: 87  SERNVLLKNVKHPFLVGLH-FSFQTADK------LYFVLDYINGGELFY------HLQRE 133

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                   AR   A+  A  L YLH      +++RD K  NILLD      L+DFGL ++
Sbjct: 134 RCFLEPR-ARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE 188

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP-- 311
                    +++  GT  Y APE +         D W  G VLYE++ G        P  
Sbjct: 189 NIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL------PPFY 240

Query: 312 -RNEQKLLE 319
            RN  ++ +
Sbjct: 241 SRNTAEMYD 249

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 76.5 bits (189), Expect = 2e-15
 Identities = 53/230 (23%), Positives = 91/230 (39%), Gaps = 58/230 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI---NEVN--- 147
           ++G+G FG V             +    +    A+K L        K+ +   ++V    
Sbjct: 27  VLGKGSFGKVM-----------LSERKGTDELYAVKILK-------KDVVIQDDDVECTM 68

Query: 148 -----FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
                     K P L +L   C +  +R      +Y         +LM+      H+   
Sbjct: 69  VEKRVLALPGKPPFLTQLH-SCFQTMDR------LYFVMEYVNGGDLMY------HIQQV 115

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                   A    A+  A GL +L       +I+RD K  N++LD +   K++DFG+ ++
Sbjct: 116 GRFKEPH-AVFYAAE-IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE 170

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
              +  G  + +  GT  Y APE +         D W+FGV+LYE++ G+
Sbjct: 171 NIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 76.1 bits (188), Expect = 2e-15
 Identities = 57/230 (24%), Positives = 92/230 (40%), Gaps = 58/230 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI---NEVN--- 147
           ++G+G FG V                 ++    A+K L        K+ I   ++V    
Sbjct: 30  VLGKGSFGKVM-----------LARVKETGDLYAVKVLK-------KDVILQDDDVECTM 71

Query: 148 -----FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
                      HP L +L   C +  +R      ++         +LM       H+   
Sbjct: 72  TEKRILSLARNHPFLTQLF-CCFQTPDR------LFFVMEFVNGGDLMF------HIQKS 118

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
                A  AR   A+     L +LH++    +I+RD K  N+LLD +   KL+DFG+ ++
Sbjct: 119 RRFDEAR-ARFYAAE-IISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKE 173

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           G     G  + +  GT  Y APE +Q        D W+ GV+LYE++ G 
Sbjct: 174 GICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 75.7 bits (187), Expect = 3e-15
 Identities = 55/230 (23%), Positives = 93/230 (40%), Gaps = 58/230 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI---NEVN--- 147
           +IG G +  V                  +    A+K +        KE +    +++   
Sbjct: 16  VIGRGSYAKVL-----------LVRLKKTDRIYAMKVVK-------KELVNDDEDIDWVQ 57

Query: 148 -----FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
                F     HP LV L   C + + R      ++         +LM       H+  +
Sbjct: 58  TEKHVFEQASNHPFLVGLH-SCFQTESR------LFFVIEYVNGGDLMF------HMQRQ 104

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
              P    AR   A+  +  L YLHE     +I+RD K  N+LLD +   KL+D+G+ ++
Sbjct: 105 RKLPEEH-ARFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 159

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           G     G  +++  GT  Y APE ++        D W+ GV+++E++ GR
Sbjct: 160 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 207

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 74.6 bits (184), Expect = 5e-15
 Identities = 45/227 (19%), Positives = 83/227 (36%), Gaps = 58/227 (25%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK- 153
           +G G +  V+  +       + T+       V +K L        K+   E+  L  ++ 
Sbjct: 44  LGRGKYSEVFEAI-------NITNNEK----VVVKILKPVK---KKKIKREIKILENLRG 89

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHN------KSLEDH--------LLSRVPTPLA 199
            PN++ L     +D       L+   + +       ++L D+        +L        
Sbjct: 90  GPNIITLAD-IVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYDIRFYMYEIL-------- 140

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEG 258
                       + L Y H      ++ RD K  N+++D E  K +L D+GLA    P  
Sbjct: 141 ------------KALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 183

Query: 259 LGHVSTSVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRR 304
            G      V +  +  PE +   ++   S D+WS G +L  +I  + 
Sbjct: 184 -GQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 75.5 bits (186), Expect = 5e-15
 Identities = 54/230 (23%), Positives = 93/230 (40%), Gaps = 58/230 (25%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI---NEVN--- 147
           +IG G +  V                  +    A++ +        KE +    +++   
Sbjct: 59  VIGRGSYAKVL-----------LVRLKKTDRIYAMRVVK-------KELVNDDEDIDWVQ 100

Query: 148 -----FLGVVKHPNLVKLVGYCAEDDERGMQRLLVY---------ELMHNKSLEDHLLSR 193
                F     HP LV L   C + + R      ++         +LM       H+  +
Sbjct: 101 TEKHVFEQASNHPFLVGLH-SCFQTESR------LFFVIEYVNGGDLMF------HMQRQ 147

Query: 194 VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ 253
              P    AR   A+  +  L YLHE     +I+RD K  N+LLD +   KL+D+G+ ++
Sbjct: 148 RKLPEEH-ARFYSAE-ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE 202

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           G     G  +++  GT  Y APE ++        D W+ GV+++E++ GR
Sbjct: 203 GLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 250

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 74.1 bits (182), Expect = 2e-14
 Identities = 54/238 (22%), Positives = 86/238 (36%), Gaps = 50/238 (21%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           IG G +G V        + D           VAIK++ R  F+     K  + E+  L  
Sbjct: 61  IGTGSYGHVC------EAYDKLEKRV-----VAIKKILRV-FEDLIDCKRILREIAILNR 108

Query: 152 VKHPNLVKLVGYCAEDDERGMQRL-LVYELMHNKSLED-HLLSRVPTPLAWIARLKIAQD 209
           + H ++VK++      D      L +V E+  +    D   L R P  L  +    +  +
Sbjct: 109 LNHDHVVKVLDIVIPKDVEKFDELYVVLEIADS----DFKKLFRTPVYLTELHIKTLLYN 164

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
              G+ Y+H      ++ RD K +N L+++D   K+ DFGLAR       G+    +   
Sbjct: 165 LLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPR 221

Query: 270 VGYAAP--------------EYVQT------------GRLTAKSDVWSFGVVLYELIT 301
                                +V T               T   DVWS G +  EL+ 
Sbjct: 222 EDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 56/242 (23%), Positives = 92/242 (38%), Gaps = 63/242 (26%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH---KEWINEVNFLGV 151
           +G+G +G V        S D +T        VA+K++    FQ     +    E+  L  
Sbjct: 17  LGKGAYGIV------WKSIDRRTGEV-----VAVKKIFD-AFQNSTDAQRTFREIMILTE 64

Query: 152 VK-HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           +  H N+V L+     D++R +   LV++ M              T L  + R  I +  
Sbjct: 65  LSGHENIVNLLNVLRADNDRDV--YLVFDYM-------------ETDLHAVIRANILEPV 109

Query: 211 ---------ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGH 261
                     + + YLH      L+ RD K SNILL+ +   K++DFGL+R         
Sbjct: 110 HKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166

Query: 262 VSTSVVGTVGYAAP--------EYVQT------------GRLTAKSDVWSFGVVLYELIT 301
            +  +                 +YV T             + T   D+WS G +L E++ 
Sbjct: 167 NNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC 226

Query: 302 GR 303
           G+
Sbjct: 227 GK 228

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 47/230 (20%), Positives = 92/230 (40%), Gaps = 43/230 (18%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVV 152
            +G G F  V+         D   + H     VA+K +   + +   +   +E+  L  V
Sbjct: 26  KLGWGHFSTVWLAK------DMVNNTH-----VAMKIVRGDKVY--TEAAEDEIKLLQRV 72

Query: 153 K-----------HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLA 199
                         +++KL+ +       G+  ++V+E++  ++L   +        PL 
Sbjct: 73  NDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLG-ENLLALIKKYEHRGIPLI 131

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA------KLSDFGLARQ 253
           ++   +I++    GL Y+H      +I  D K  N+L++           K++D G A  
Sbjct: 132 YVK--QISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187

Query: 254 GPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                     T+ + T  Y +PE +        +D+WS   +++ELITG 
Sbjct: 188 Y-----DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGD 232

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 65.5 bits (160), Expect = 8e-12
 Identities = 57/228 (25%), Positives = 87/228 (38%), Gaps = 51/228 (22%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVV 152
           LIG+G FG V +        D        +  VAIK + N++ F    +   EV  L ++
Sbjct: 61  LIGKGSFGQVVKAY------DRVE-----QEWVAIKIIKNKKAF--LNQAQIEVRLLELM 107

Query: 153 KHP------NLVKLVGY-------CAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTP 197
                     +V L  +       C           LV+E++   +L D L   +     
Sbjct: 108 NKHDTEMKYYIVHLKRHFMFRNHLC-----------LVFEMLS-YNLYDLLRNTNFRGVS 155

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA--KLSDFGLARQGP 255
           L      K AQ     L +L    +  +I  D K  NILL    ++  K+ DFG + Q  
Sbjct: 156 LNLTR--KFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQ-- 210

Query: 256 PEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
              LG      + +  Y +PE +         D+WS G +L E+ TG 
Sbjct: 211 ---LGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGE 255

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 64.0 bits (156), Expect = 3e-11
 Identities = 51/226 (22%), Positives = 89/226 (39%), Gaps = 49/226 (21%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVV 152
           +IG+G FG V +        DH+         VA+K + N + F  H++   E+  L   
Sbjct: 104 VIGKGSFGQVVKAY------DHKV-----HQHVALKMVRNEKRF--HRQAAEEIRIL--- 147

Query: 153 KHPNLVKLVGYCAEDDERGMQRL-----------LVYELMHNKSLEDHLLSR--VPTPLA 199
                 + +    +D+   +  +           + +EL+   +L + +         L 
Sbjct: 148 ------EHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLP 200

Query: 200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA--KLSDFGLARQGPPE 257
            +   K A    + L  LH     ++I  D K  NILL +  ++  K+ DFG +      
Sbjct: 201 LVR--KFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY---- 251

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                  + + +  Y APE +   R     D+WS G +L EL+TG 
Sbjct: 252 -EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 62.2 bits (150), Expect = 2e-10
 Identities = 61/455 (13%), Positives = 121/455 (26%), Gaps = 138/455 (30%)

Query: 47  SEFDSDSRDWSDSLAFYELLSQRRANDLRVFS---------FAELKSATRGFSRALLI-- 95
           S   ++ R  S     Y     R  ND +VF+         + +L+ A      A  +  
Sbjct: 96  SPIKTEQRQPSMMTRMYIEQRDRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLI 155

Query: 96  -GEGGFG--CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV 152
            G  G G   V    + V                  K   +  F+    W+N        
Sbjct: 156 DGVLGSGKTWV---ALDVCLSY--------------KVQCKMDFKIF--WLN-------- 188

Query: 153 KHPNLVKLVGYCAEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA----RLKIA 207
                   +  C   +    M + L+Y++  N +      S +   +  I     RL  +
Sbjct: 189 --------LKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKS 240

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL----SDFGLARQGPPEGLGHVS 263
           +     L          L+  + + +      +   K+        +          H+S
Sbjct: 241 KPYENCL----------LVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDFLSAATTTHIS 290

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP----------RN 313
                ++     E      L  K   +       +L    R V    P          R+
Sbjct: 291 -LDHHSMTLTPDE---VKSLLLK---Y-LDCRPQDL---PREVLTTNPRRLSIIAESIRD 339

Query: 314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSA------QKLAALASKCLTKQPKSRP 367
                +  +    +  K   II+  L     ++ A       +L+          P S  
Sbjct: 340 GLATWDNWKHV--NCDKLTTIIESSLN---VLEPAEYRKMFDRLSVF--------PPSAH 386

Query: 368 KMSEVVDIL-GNIISEISSQDEVTLQPVAEIEDVKEEPEAEAVVESAKQGNSYLKKVFDI 426
             + ++ ++  ++I               ++  V  +    ++VE  KQ       +  I
Sbjct: 387 IPTILLSLIWFDVIKS-------------DVMVVVNKLHKYSLVE--KQPKESTISIPSI 431

Query: 427 --------RDLVNLRNKSIG------KLDWRNWTP 447
                    +   L    +         D  +  P
Sbjct: 432 YLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 7e-05
 Identities = 41/286 (14%), Positives = 92/286 (32%), Gaps = 78/286 (27%)

Query: 218 HEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHV-STSVVGTVGYAA 274
           H  MDF+     ++  +IL    + +     D     +   +    + S   +  +  + 
Sbjct: 4   HHHMDFETGEHQYQYKDILSVFEDAFVDNF-DC----KDVQDMPKSILSKEEIDHIIMSK 58

Query: 275 PEYVQTGRL------TAKSDVWSF-GVVL---YELITGRRAVERNLP-RNEQKLLEWVRP 323
                T RL        +  V  F   VL   Y+ +      E+  P    +  +E    
Sbjct: 59  DAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINYKFLMSPIKTEQRQPSMMTRMYIEQRDR 118

Query: 324 YVSDSKKF---HLIIDPRLEGNYCIKSA--------------------QKLAALASKCLT 360
             +D++ F   ++    RL+    ++ A                      +A     CL+
Sbjct: 119 LYNDNQVFAKYNV---SRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDV--CLS 173

Query: 361 KQPKSRP-------------KMSEVVDILGNIISEI----SSQDEVTLQPVAEIEDVKEE 403
            + + +                  V+++L  ++ +I    +S+ + +      I  ++ E
Sbjct: 174 YKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAE 233

Query: 404 PEAEAVVESAKQGNSYL-------KKV---FDI--RDLVNLRNKSI 437
                +++S    N  L        K    F++  + L+  R K +
Sbjct: 234 L--RRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQV 277

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 59.4 bits (144), Expect = 8e-10
 Identities = 45/231 (19%), Positives = 78/231 (33%), Gaps = 35/231 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----------GHKEW 142
            IG+GGFGC+Y   +  S          S     +K                      E 
Sbjct: 42  PIGQGGFGCIYLADMNSSESVG------SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQ 95

Query: 143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
           I +      +K+  + K  G    D      R ++ +      L+  +        +   
Sbjct: 96  IQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQK-IYEANAKRFSRKT 153

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK--LSDFGLARQ-GPPEGL 259
            L+++      L Y+HE    + +  D K SN+LL+     +  L D+GLA +  P    
Sbjct: 154 VLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVH 210

Query: 260 GHVS----TSVVGTVGYA---APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
              +        GT+ +    A   V   R   + D+   G  + + +TG 
Sbjct: 211 KAYAADPKRCHDGTIEFTSIDAHNGVAPSR---RGDLEILGYCMIQWLTGH 258

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.0 bits (143), Expect = 1e-09
 Identities = 39/230 (16%), Positives = 76/230 (33%), Gaps = 35/230 (15%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSG----------HDSKLDVAIKQLNRQGFQGHKEWIN 144
                 G +Y      +                   D +L        R         +N
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQR---AAKPLQVN 106

Query: 145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARL 204
           +   L       +   +G+    D+    R LV   +  +SL+  L       L+  + L
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVL 162

Query: 205 KIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK--LSDFGLARQGPPEGLGHV 262
           ++A      L +LHE    + +  +    NI +D + +++  L+ +G A +  P G  HV
Sbjct: 163 QVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG-KHV 218

Query: 263 ------STSVVGTVGYA---APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                  +   G + +      +     R   +SD+ S G  + + + G 
Sbjct: 219 AYVEGSRSPHEGDLEFISMDLHKGCGPSR---RSDLQSLGYCMLKWLYGF 265

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 58.7 bits (141), Expect = 1e-09
 Identities = 27/214 (12%), Positives = 57/214 (26%), Gaps = 48/214 (22%)

Query: 75  RVFSFAELKSATRGFSRALLIGEGGFGCVYRG----------VVRVSSDDHQTSGHDSKL 124
               F+      +   R   IGEG FG V++           ++ +   D     H    
Sbjct: 9   GPVPFSHCLPTEK-LQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTF 67

Query: 125 DVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVG---------------------- 162
           +  + ++         + ++ ++     +    + L                        
Sbjct: 68  EEILPEIIIS------KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST 121

Query: 163 ----YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLH 218
                   D  +  Q  +V E        + + +++ +         I       LA   
Sbjct: 122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRTKLSS---LATAKSILHQLTASLAVAE 178

Query: 219 EEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR 252
             + F    RD    N+LL +    KL      +
Sbjct: 179 ASLRF--EHRDLHWGNVLLKKTSLKKLHYTLNGK 210

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 57.0 bits (138), Expect = 3e-09
 Identities = 43/227 (18%), Positives = 76/227 (33%), Gaps = 30/227 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQT------SGHDSKLDVAIKQLNR-QGFQGHKEWINEV 146
            IG GGFG +Y        +             +  L   +K   R       K+WI   
Sbjct: 44  KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103

Query: 147 NFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKI 206
                  +  +    G    + +    R +V E +    L+           + +  L++
Sbjct: 104 QL----DYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTV--LQL 156

Query: 207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK--LSDFGLARQ-GPPEGLGHVS 263
                  L Y+HE    + +  D K +N+LL      +  L+D+GL+ +  P        
Sbjct: 157 GIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQ 213

Query: 264 ----TSVVGTVGYA---APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
                   GT+ +    A + V   R   +SDV   G  +   + G+
Sbjct: 214 ENPRKGHNGTIEFTSLDAHKGVALSR---RSDVEILGYCMLRWLCGK 257

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 37/182 (20%), Positives = 57/182 (31%), Gaps = 65/182 (35%)

Query: 176 LVYELMHNKSLEDHLLS----RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK 231
           +V+E++    L   ++      +P P       KI Q   +GL YLH +   ++I  D K
Sbjct: 122 MVFEVLG-HHLLKWIIKSNYQGLPLPCVK----KIIQQVLQGLDYLHTKC--RIIHTDIK 174

Query: 232 TSNILL-------------------------------------------------DEDYK 242
             NILL                                                  E  K
Sbjct: 175 PENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLK 234

Query: 243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG 302
            K++D G A            T  + T  Y + E +        +D+WS   + +EL TG
Sbjct: 235 VKIADLGNACWV-----HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATG 289

Query: 303 RR 304
             
Sbjct: 290 DY 291

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 54.7 bits (132), Expect = 2e-08
 Identities = 53/221 (23%), Positives = 84/221 (38%), Gaps = 37/221 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG +Y G           +G     +VAIK    +    H +   E     +++ 
Sbjct: 17  IGSGSFGDIYLGT-------DIAAGE----EVAIKLECVK--TKHPQLHIESKIYKMMQG 63

Query: 155 -PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
              +  +    AE D      ++V EL+   SLED L +      +    L +A      
Sbjct: 64  GVGIPTIRWCGAEGD----YNVMVMELL-GPSLED-LFNFCSRKFSLKTVLLLADQMISR 117

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAK---LSDFGLARQ-GPPEGLGHV----STS 265
           + Y+H +     I RD K  N L+    K     + DFGLA++        H+    + +
Sbjct: 118 IEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 174

Query: 266 VVGTVGYA---APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           + GT  YA       ++  R   + D+ S G VL     G 
Sbjct: 175 LTGTARYASINTHLGIEQSR---RDDLESLGYVLMYFNLGS 212

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 53.1 bits (128), Expect = 7e-08
 Identities = 52/245 (21%), Positives = 82/245 (33%), Gaps = 67/245 (27%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVV 152
            +G+G FG     V+           +      A+K + N + +   +    E + L  +
Sbjct: 42  KMGDGTFG----RVLLCQ--HIDNKKY-----YAVKVVRNIKKY--TRSAKIEADILKKI 88

Query: 153 KH-----PNLVKLVGY-------CAEDDERGMQRLLVYELMHNKSLEDHLL--SRVPTPL 198
           ++      N+VK  G        C           L++E +   SL + +   +     +
Sbjct: 89  QNDDINNNNIVKYHGKFMYYDHMC-----------LIFEPLG-PSLYEIITRNNYNGFHI 136

Query: 199 AWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG 258
             I       +  + L YL       L   D K  NILLD+ Y  K            + 
Sbjct: 137 EDIK--LYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKI 191

Query: 259 LGHVS--------------------TSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLY 297
             + +                     S++ T  Y APE V         SD+WSFG VL 
Sbjct: 192 QIYRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPE-VILNLGWDVSSDMWSFGCVLA 250

Query: 298 ELITG 302
           EL TG
Sbjct: 251 ELYTG 255

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 53.1 bits (127), Expect = 9e-08
 Identities = 53/221 (23%), Positives = 90/221 (40%), Gaps = 37/221 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK- 153
           IG G FG +Y G       + QT       +VAIK  N +    H + + E     +++ 
Sbjct: 15  IGSGSFGEIYLGT------NIQT-----NEEVAIKLENVK--TKHPQLLYESKIYRILQG 61

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
              +  +  +  E D      +LV +L+   SLED L +     L+    L +A      
Sbjct: 62  GTGIPNVRWFGVEGD----YNVLVMDLL-GPSLED-LFNFCSRKLSLKTVLMLADQMINR 115

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAK---LSDFGLARQ-GPPEGLGHV----STS 265
           + ++H +     + RD K  N L+    +A    + DFGLA++        H+    + +
Sbjct: 116 VEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKN 172

Query: 266 VVGTVGYA---APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           + GT  YA       ++  R   + D+ S G VL   + G 
Sbjct: 173 LTGTARYASVNTHLGIEQSR---RDDLESLGYVLMYFLRGS 210

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 52.3 bits (126), Expect = 1e-07
 Identities = 56/244 (22%), Positives = 83/244 (34%), Gaps = 69/244 (28%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVV 152
            +GEG FG     VV     DH       K  VA+K + N   +   +    E+N L  +
Sbjct: 26  NLGEGTFG----KVVECL--DHARG----KSQVALKIIRNVGKY--REAARLEINVLKKI 73

Query: 153 KHP------NLVKLVGY-------CAEDDERGMQRLLVYELMHNKSLEDHLL--SRVPTP 197
           K          V +  +       C           + +EL+  K+  + L   +  P P
Sbjct: 74  KEKDKENKFLCVLMSDWFNFHGHMC-----------IAFELLG-KNTFEFLKENNFQPYP 121

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA-------------- 243
           L  +    +A      L +LH   + QL   D K  NIL                     
Sbjct: 122 LPHVR--HMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176

Query: 244 -----KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYE 298
                +++DFG A            T++V T  Y  PE +         DVWS G +L+E
Sbjct: 177 KNTSIRVADFGSATF-----DHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFE 231

Query: 299 LITG 302
              G
Sbjct: 232 YYRG 235

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 51.1 bits (123), Expect = 3e-07
 Identities = 56/250 (22%), Positives = 87/250 (34%), Gaps = 81/250 (32%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQL-NRQGFQGHKEWINEVNFLGVV 152
            +GEG FG V   +      DH+  G      VA+K + N   +   +   +E+  L  +
Sbjct: 21  TLGEGAFGKVVECI------DHKAGGRH----VAVKIVKNVDRY--CEAARSEIQVLEHL 68

Query: 153 KHP------NLVKLVGY-------CAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTP 197
                      V+++ +       C           +V+EL+   S  D +     +P  
Sbjct: 69  NTTDPNSTFRCVQMLEWFEHHGHIC-----------IVFELLG-LSTYDFIKENGFLPFR 116

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL-DEDYKA------------- 243
           L  I   K+A    + + +LH     +L   D K  NIL    DY               
Sbjct: 117 LDHIR--KMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171

Query: 244 -----KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPE------YVQTGRLTAKSDVWSF 292
                K+ DFG A            +++V T  Y APE      +      +   DVWS 
Sbjct: 172 INPDIKVVDFGSATY-----DDEHHSTLVSTRHYRAPEVILALGW------SQPCDVWSI 220

Query: 293 GVVLYELITG 302
           G +L E   G
Sbjct: 221 GCILIEYYLG 230

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 50.4 bits (121), Expect = 5e-07
 Identities = 45/223 (20%), Positives = 78/223 (34%), Gaps = 39/223 (17%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IGEG FG ++ G       +           VAIK   R+      +  +E     ++  
Sbjct: 18  IGEGSFGVIFEGT------NLLN-----NQQVAIKFEPRR--SDAPQLRDEYRTYKLLAG 64

Query: 155 -PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
              +  +  +  E        +LV +L+   SLED LL       +       A+     
Sbjct: 65  CTGIPNVYYFGQEGL----HNVLVIDLL-GPSLED-LLDLCGRKFSVKTVAMAAKQMLAR 118

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAK-----LSDFGLARQ-GPPEGLGHV----S 263
           +  +HE+    L++RD K  N L+            + DFG+ +    P    H+     
Sbjct: 119 VQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 175

Query: 264 TSVVGTVGYA---APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
            ++ GT  Y         +  R   + D+ + G V    + G 
Sbjct: 176 KNLSGTARYMSINTHLGREQSR---RDDLEALGHVFMYFLRGS 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 50.1 bits (120), Expect = 6e-07
 Identities = 48/224 (21%), Positives = 77/224 (34%), Gaps = 41/224 (18%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIK--QLNRQGFQGHKEWINEVNFLGVV 152
           IG G FG +  G        +  +       VAIK   +  +  Q H E+          
Sbjct: 17  IGCGNFGELRLGK-------NLYTNE----YVAIKLEPMKSRAPQLHLEYRFYKQLGSG- 64

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
               + ++  +            +V EL+   SLED L        +    L IA     
Sbjct: 65  --DGIPQVYYFGPCGK----YNAMVLELL-GPSLED-LFDLCDRTFSLKTVLMIAIQLIS 116

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK-----LSDFGLARQ-GPPEGLGHV---- 262
            + Y+H +    LI+RD K  N L+            + DF LA++   PE   H+    
Sbjct: 117 RMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYRE 173

Query: 263 STSVVGTVGYA---APEYVQTGRLTAKSDVWSFGVVLYELITGR 303
             S+ GT  Y         +  R   + D+ + G +    + G 
Sbjct: 174 HKSLTGTARYMSINTHLGKEQSR---RDDLEALGHMFMYFLRGS 214

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	453
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.92
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.84
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.73
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.44
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.28
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.22
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.16
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.73
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.66
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.53
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.48
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.47
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.46
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.37
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.09
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.08
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.03
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.95
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	97.65
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.64
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	97.58
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.54
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.5
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.44
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.43
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.34
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.21
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	96.81
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	96.58
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.32
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.69
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	89.43
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	89.04
3cxl_A	463	N-chimerin; SH2, RHO-GAP, structural genomics cons	87.93

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=1e-59  Score=451.35  Aligned_cols=266  Identities=27%  Similarity=0.453  Sum_probs=217.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||+||+|++....      ...++..||||+++.......++|.+|+.+|++++|||||+++|+|.+
T Consensus        13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~------~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~   86 (299)
T 4asz_A           13 HNIVLKRELGEGAFGKVFLAECYNLC------PEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVE   86 (299)
T ss_dssp             GGEEEEEEEEC--CCCEEEEEECSCC----------CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HHeEEeeEEeeCCCcEEEEEEECCcc------cCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            56788899999999999999975321      124578899999987666667889999999999999999999999988


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV-----------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      .+.    ++||||||++|+|.++|....           ...++|..++.|+.|||.||.|||++   +||||||||+||
T Consensus        87 ~~~----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NI  159 (299)
T 4asz_A           87 GDP----LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNC  159 (299)
T ss_dssp             SSS----EEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGE
T ss_pred             CCE----EEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhE
Confidence            665    799999999999999997642           35799999999999999999999998   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhh
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNE  314 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~  314 (453)
                      ||+.++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||++|||+| |+.||......  
T Consensus       160 Ll~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~--  237 (299)
T 4asz_A          160 LVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN--  237 (299)
T ss_dssp             EECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH--
T ss_pred             EECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH--
Confidence            999999999999999986543333333445679999999999999999999999999999999999 89999765332  


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                       .+...+..    +..          ...+..+++++.+|+.+||+.||++|||+.+|++.|+++...
T Consensus       238 -~~~~~i~~----~~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          238 -EVIECITQ----GRV----------LQRPRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             -HHHHHHHH----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -HHHHHHHc----CCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence             22222211    110          112334577899999999999999999999999999987754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=6.1e-59  Score=452.00  Aligned_cols=266  Identities=26%  Similarity=0.446  Sum_probs=211.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...++||+|+||+||+|+++..      ....++..||||+++.......++|.+|+.+|++++|||||+++|+|.+
T Consensus        41 ~d~~l~~~LG~G~fG~Vy~a~~~~~------~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~  114 (329)
T 4aoj_A           41 RDIVLKWELGEGAFGKVFLAECHNL------LPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTE  114 (329)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEESSS------CC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             HHeEEEEEEccCCCcEEEEEEECCc------ccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            5677788999999999999997531      1124578899999987666667889999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV-------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      ...    ++||||||++|+|.++|....             ..+++|..++.|+.|||.||.|||+.   +||||||||+
T Consensus       115 ~~~----~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~  187 (329)
T 4aoj_A          115 GRP----LLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATR  187 (329)
T ss_dssp             SSS----EEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGG
T ss_pred             CCE----EEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHh
Confidence            664    799999999999999997643             24699999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCCh
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPR  312 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~  312 (453)
                      ||||+.++.+||+|||+|+...............||+.|||||++.+..++.++|||||||+||||+| |+.||......
T Consensus       188 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~  267 (329)
T 4aoj_A          188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNT  267 (329)
T ss_dssp             GEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHH
T ss_pred             hEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHH
Confidence            99999999999999999987654443344456789999999999999999999999999999999999 89999765332


Q ss_pred             hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         .++..+..    +..          ...+..+++++.+|+.+||+.||++||||.+|++.|+.+.+.
T Consensus       268 ---~~~~~i~~----g~~----------~~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          268 ---EAIDCITQ----GRE----------LERPRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             ---HHHHHHHH----TCC----------CCCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             ---HHHHHHHc----CCC----------CCCcccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence               22222211    110          112334577899999999999999999999999999988753

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2e-58  Score=442.75  Aligned_cols=263  Identities=29%  Similarity=0.470  Sum_probs=207.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|+++              ..||||+++...  ....+.|.+|+.+|++++|||||+++|+
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~--------------~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~  100 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWH--------------GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGY  100 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESS--------------SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEEC--------------CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            356788889999999999999864              259999987543  2345779999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      |..+.     ++||||||++|+|.++|... ..++++..++.|+.|||.||.|||++   +||||||||+||||++++.+
T Consensus       101 ~~~~~-----~~iVmEy~~gGsL~~~l~~~-~~~l~~~~~~~i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~  171 (307)
T 3omv_A          101 MTKDN-----LAIVTQWCEGSSLYKHLHVQ-ETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTV  171 (307)
T ss_dssp             ECSSS-----CEEEEECCSSCBHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEE
T ss_pred             EECCe-----EEEEEEcCCCCCHHHHHhhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcE
Confidence            86543     69999999999999999765 35799999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      ||+|||+|+...............||+.|||||++.+   ++|+.++|||||||+||||+||+.||........  +...
T Consensus       172 Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~--~~~~  249 (307)
T 3omv_A          172 KIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQ--IIFM  249 (307)
T ss_dssp             EECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH--HHHH
T ss_pred             EEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHH--HHHH
Confidence            9999999987654333334456789999999999864   4689999999999999999999999976443221  1111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      +....         ..+.+ ...+..++.++.+|+.+||+.||++||||.+|++.|+.+.+.+
T Consensus       250 ~~~~~---------~~p~~-~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          250 VGRGY---------ASPDL-SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             HHTTC---------CCCCS-TTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             HhcCC---------CCCCc-ccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            11100         11111 1223456788999999999999999999999999998876543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=4.7e-59  Score=448.72  Aligned_cols=263  Identities=24%  Similarity=0.389  Sum_probs=212.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++...+.||+|+||+||+|++....      ....++.||||+++... ....++|.+|+.+|++++|||||+++|+|.
T Consensus        26 ~~~~~~~~lG~G~fG~Vykg~~~~~~------~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~   99 (308)
T 4gt4_A           26 SAVRFMEELGEDRFGKVYKGHLFGPA------PGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT   99 (308)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEEC-------------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHCeEeeEeccCCCcEEEEEEEcCCc------cCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEE
Confidence            34566778999999999999975321      12456789999997543 334578999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      +...    ++||||||++|+|.++|..+.              ...++|..++.|+.|||.||.|||++   +|||||||
T Consensus       100 ~~~~----~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK  172 (308)
T 4gt4_A          100 KDQP----LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLA  172 (308)
T ss_dssp             SSSS----CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCS
T ss_pred             ECCE----EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCcc
Confidence            8665    699999999999999997543              24689999999999999999999998   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCC
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNL  310 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~  310 (453)
                      |+||||++++.+||+|||+|+...............||+.|||||++.++.|+.++|||||||+||||+| |..||....
T Consensus       173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999986543333333456689999999999999999999999999999999998 899997653


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .   ..+...+..    +.          ....+..++..+.+|+.+||+.||++||||.+|++.|+++
T Consensus       253 ~---~~~~~~i~~----~~----------~~~~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 N---QDVVEMIRN----RQ----------VLPCPDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             H---HHHHHHHHT----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             H---HHHHHHHHc----CC----------CCCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            2   223332221    11          0112345678899999999999999999999999999764

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.3e-57  Score=439.70  Aligned_cols=252  Identities=26%  Similarity=0.401  Sum_probs=205.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|+++           .+++.||||++.....  ...+.|.+|+.+|++|+|||||+++++
T Consensus        23 me~Y~~~~~lG~G~fg~V~~a~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~   91 (350)
T 4b9d_A           23 MEKYVRLQKIGEGSFGKAILVKST-----------EDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRES   91 (350)
T ss_dssp             CCCEEEEEEC------CEEEEEET-----------TTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceEEeEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEE
Confidence            368999999999999999999986           5578999999976543  235678999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    +|||||||+||+|.++|..+....+++..++.++.||+.||.|||++   +||||||||+||||+.++.+
T Consensus        92 ~~~~~~----~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~v  164 (350)
T 4b9d_A           92 FEENGS----LYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTV  164 (350)
T ss_dssp             EEETTE----EEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCE
T ss_pred             EEECCE----EEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCE
Confidence            987664    79999999999999999877667789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+.....  .......+||+.|||||++.+..|+.++|||||||+||||++|+.||......   .+...+..
T Consensus       165 Kl~DFGla~~~~~~--~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~---~~~~~i~~  239 (350)
T 4b9d_A          165 QLGDFGIARVLNST--VELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMK---NLVLKIIS  239 (350)
T ss_dssp             EECSTTEESCCCHH--HHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHHHHH
T ss_pred             EEcccccceeecCC--cccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH---HHHHHHHc
Confidence            99999999875421  12234568999999999999999999999999999999999999999765322   22211111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .     ..     +    ..+...+.++.+||.+||+.||++|||+.|+++
T Consensus       240 ~-----~~-----~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  276 (350)
T 4b9d_A          240 G-----SF-----P----PVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILE  276 (350)
T ss_dssp             T-----CC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             C-----CC-----C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0     00     0    112335678999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-56  Score=435.12  Aligned_cols=263  Identities=24%  Similarity=0.305  Sum_probs=212.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+.|...++||+|+||+||+|+++           .++..||||+++....     +.+|+.+|+.++|||||++++++.
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~-----------~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~  120 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDK-----------QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVR  120 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEE
T ss_pred             hhheEeCcEeccCCCeEEEEEEEC-----------CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEE
Confidence            356888889999999999999986           5678999999975432     247999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-cEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-KAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~k  244 (453)
                      +.+.    ++||||||+||+|.++|...  .++++..+..++.||+.||.|||++   +||||||||+||||+.++ .+|
T Consensus       121 ~~~~----~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vK  191 (336)
T 4g3f_A          121 EGPW----VNIFMELLEGGSLGQLIKQM--GCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAA  191 (336)
T ss_dssp             ETTE----EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEE
T ss_pred             ECCE----EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEE
Confidence            7664    79999999999999999875  5799999999999999999999998   999999999999999987 699


Q ss_pred             EeccccccCCCCCCCCc---cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          245 LSDFGLARQGPPEGLGH---VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      |+|||+|+.........   .....+||+.|||||++.+..|+.++|||||||++|||++|+.||...........+.. 
T Consensus       192 l~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~-  270 (336)
T 4g3f_A          192 LCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS-  270 (336)
T ss_dssp             ECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHH-
T ss_pred             EeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHc-
Confidence            99999998765432211   12346799999999999999999999999999999999999999976543322111110 


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcccCc
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDE  388 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~~~  388 (453)
                           ...         .....+..++..+.+||.+||+.||.+|||+.|+++.|...+........
T Consensus       271 -----~~~---------~~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~h  323 (336)
T 4g3f_A          271 -----EPP---------PIREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKS  323 (336)
T ss_dssp             -----SCC---------GGGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCS
T ss_pred             -----CCC---------CchhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccC
Confidence                 000         00112334577899999999999999999999999999988877654333

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=3.8e-57  Score=442.97  Aligned_cols=272  Identities=24%  Similarity=0.339  Sum_probs=220.2

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCC-CceeeEe
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKH-PNLVKLV  161 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h-~nIv~l~  161 (453)
                      ...++|...+.||+|+||+||+|.+....      .....+.||||.+..... ...+.|.+|+.+|.++.| ||||+++
T Consensus        61 i~~~~~~l~~~LG~G~fG~Vy~a~~~~~~------~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~  134 (353)
T 4ase_A           61 FPRDRLKLGKPLGRGAFGQVIEADAFGID------KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL  134 (353)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEETSS------STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             ecHHHeEEeeEEecCCCeEEEEEEEcCCC------cccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEE
Confidence            34578999999999999999999987422      124457899999976543 335679999999999965 9999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIF  227 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH  227 (453)
                      |+|...+..   ++||||||++|+|.++|+...              ...+++..++.++.|||.||.|||++   +|||
T Consensus       135 g~~~~~~~~---~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiH  208 (353)
T 4ase_A          135 GACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIH  208 (353)
T ss_dssp             EEECCTTSC---CEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EEEEecCCE---EEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhC---Ceec
Confidence            999775432   699999999999999997542              24589999999999999999999999   9999


Q ss_pred             eccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccc
Q 043568          228 RDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV  306 (453)
Q Consensus       228 ~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~  306 (453)
                      |||||+|||+++++.+||+|||+|+...............||+.|||||++.+..|+.++|||||||+||||+| |+.||
T Consensus       209 RDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf  288 (353)
T 4ase_A          209 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  288 (353)
T ss_dssp             SCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSS
T ss_pred             CccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCC
Confidence            99999999999999999999999997654443334556789999999999999999999999999999999998 89999


Q ss_pred             cCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .......  .+...+..    +.          ....+..+++++.+|+.+||+.||++|||+.+|++.|+.+++..
T Consensus       289 ~~~~~~~--~~~~~i~~----g~----------~~~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~~  349 (353)
T 4ase_A          289 PGVKIDE--EFCRRLKE----GT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQAN  349 (353)
T ss_dssp             TTCCCSH--HHHHHHHH----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCCCHHH--HHHHHHHc----CC----------CCCCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHHh
Confidence            7643322  12111111    11          11122345678999999999999999999999999999988653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-56  Score=435.68  Aligned_cols=250  Identities=27%  Similarity=0.392  Sum_probs=211.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ..|...+.||+|+||+||+|+++           .+++.||||++........+.+.+|+.+|+.++|||||++++++.+
T Consensus        74 ~~y~~~~~iG~G~fG~V~~a~~~-----------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  142 (346)
T 4fih_A           74 SYLDNFIKIGEGSTGIVCIATVR-----------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV  142 (346)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HhcEEeEEeecCcCeEEEEEEEC-----------CCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEE
Confidence            56999999999999999999986           5678999999986665666778999999999999999999999988


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    +|||||||+||+|.+++..   ..+++..+..++.||+.||.|||++   +||||||||+||||+.++.+||+
T Consensus       143 ~~~----~~ivmEy~~gg~L~~~l~~---~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~  212 (346)
T 4fih_A          143 GDE----LWVVMEFLEGGALTDIVTH---TRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS  212 (346)
T ss_dssp             TTE----EEEEECCCTTEEHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             CCE----EEEEEeCCCCCcHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEe
Confidence            764    7999999999999999876   3689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+|+......  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....+..   +...+.... 
T Consensus       213 DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~---~~~~i~~~~-  286 (346)
T 4fih_A          213 DFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLK---AMKMIRDNL-  286 (346)
T ss_dssp             CCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH---HHHHHHHSS-
T ss_pred             cCcCceecCCCC--CcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHH---HHHHHHcCC-
Confidence            999998754322  23456789999999999999999999999999999999999999997654322   222221110 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               .+.  .......+.++.+||.+||..||++|||+.|+++
T Consensus       287 ---------~~~--~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~  323 (346)
T 4fih_A          287 ---------PPR--LKNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  323 (346)
T ss_dssp             ---------CCC--CSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------CCC--CCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     011  1122345678999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=1.7e-56  Score=426.38  Aligned_cols=251  Identities=22%  Similarity=0.373  Sum_probs=201.0

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      ...+.||+|+||+||+|.++           .++..||||++.....  ...+.|.+|+.+|++|+|||||++++++...
T Consensus        29 ~~~~~iG~G~fg~Vy~a~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~   97 (290)
T 3fpq_A           29 KFDIEIGRGSFKTVYKGLDT-----------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   97 (290)
T ss_dssp             EEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC-----------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeec
Confidence            55668999999999999986           5578899999975432  3346799999999999999999999999764


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-CCcEEEe
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKAKLS  246 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~kL~  246 (453)
                      ......++||||||+||+|.++|.+.  ..+++..+..++.||+.||.|||++ .++||||||||+||||+. ++.+||+
T Consensus        98 ~~~~~~~~lvmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~  174 (290)
T 3fpq_A           98 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG  174 (290)
T ss_dssp             ETTEEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEEC
T ss_pred             cCCCcEEEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEE
Confidence            33333479999999999999999875  5789999999999999999999998 123999999999999984 8999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+|+....    ......+||+.|||||++.+ .|+.++|||||||++|||+||+.||......  ..+...+.... 
T Consensus       175 DFGla~~~~~----~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~--~~~~~~i~~~~-  246 (290)
T 3fpq_A          175 DLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNA--AQIYRRVTSGV-  246 (290)
T ss_dssp             CTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSH--HHHHHHHTTTC-
T ss_pred             eCcCCEeCCC----CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcH--HHHHHHHHcCC-
Confidence            9999986432    22456789999999999865 6999999999999999999999999754322  12222221100 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                  .....+...++++.+||.+||..||++|||+.++++
T Consensus       247 ------------~~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~  282 (290)
T 3fpq_A          247 ------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             ------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------------CCCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                        011122233567999999999999999999999875

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.2e-56  Score=429.56  Aligned_cols=249  Identities=24%  Similarity=0.330  Sum_probs=210.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...++||+|+||+||+|+++           .+++.||||++.+..   ....+.+.+|+.+|++++|||||+++++
T Consensus        32 ~dy~i~~~lG~G~fg~V~~a~~~-----------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~  100 (311)
T 4aw0_A           32 EDFKFGKILGEGSFSTVVLAREL-----------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT  100 (311)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccEEEEEEecccCeEEEEEEEC-----------CCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            57999999999999999999986           567899999997542   3445779999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    +|||||||+||+|.++|...  ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+
T Consensus       101 ~~~~~~----~yivmEy~~gG~L~~~i~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~v  171 (311)
T 4aw0_A          101 FQDDEK----LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHI  171 (311)
T ss_dssp             EECSSE----EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred             EEeCCE----EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCE
Confidence            987664    79999999999999999875  5789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+..............+||+.|||||++.+..|+.++|||||||++|||++|+.||......   .+...+..
T Consensus       172 Kl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~---~~~~~i~~  248 (311)
T 4aw0_A          172 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEG---LIFAKIIK  248 (311)
T ss_dssp             EECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHHH
T ss_pred             EEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHc
Confidence            999999999765444344456778999999999999999999999999999999999999999764322   22222111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                         ..        .    .++...+.++.+||.+||..||++|||+.|++
T Consensus       249 ---~~--------~----~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~  283 (311)
T 4aw0_A          249 ---LE--------Y----DFPEKFFPKARDLVEKLLVLDATKRLGCEEME  283 (311)
T ss_dssp             ---TC--------C----CCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGT
T ss_pred             ---CC--------C----CCCcccCHHHHHHHHHHccCCHhHCcChHHHc
Confidence               00        0    11223467799999999999999999999864

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.4e-55  Score=437.07  Aligned_cols=250  Identities=27%  Similarity=0.401  Sum_probs=211.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +.|...+.||+|+||+||+|+++           .+++.||||++........+.+.+|+.+|+.++|||||++++++.+
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~-----------~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~  219 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVR-----------SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV  219 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEEC-----------CCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEE
Confidence            56999999999999999999986           5678999999987666667789999999999999999999999988


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    +|||||||+||+|.+++...   .+++..+..++.||+.||.|||++   +||||||||+||||+.+|.+||+
T Consensus       220 ~~~----~~iVmEy~~gG~L~~~i~~~---~l~e~~~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~  289 (423)
T 4fie_A          220 GDE----LWVVMEFLEGGALTDIVTHT---RMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLS  289 (423)
T ss_dssp             TTE----EEEEEECCTTEEHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEEC
T ss_pred             CCE----EEEEEeCCCCCcHHHHHhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEe
Confidence            764    79999999999999998753   689999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+|+......  ......+||+.|||||++.+..|+.++|||||||++|||++|+.||....+...   +..+.... 
T Consensus       290 DFGla~~~~~~~--~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~---~~~i~~~~-  363 (423)
T 4fie_A          290 DFGFCAQVSKEV--PRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKA---MKMIRDNL-  363 (423)
T ss_dssp             CCTTCEECCSSC--CCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH---HHHHHHSC-
T ss_pred             cCccceECCCCC--ccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHcCC-
Confidence            999998754332  234567899999999999999999999999999999999999999976543322   22221110 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               .+.+  ......+.++.+||.+||..||++|||+.|+++
T Consensus       364 ---------~~~~--~~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~  400 (423)
T 4fie_A          364 ---------PPRL--KNLHKVSPSLKGFLDRLLVRDPAQRATAAELLK  400 (423)
T ss_dssp             ---------CCCC--SCTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             ---------CCCC--cccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                     0011  112234678999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=7.1e-56  Score=426.92  Aligned_cols=270  Identities=22%  Similarity=0.289  Sum_probs=204.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||+||+|+++             ++.||||+++.... ....+..|+..+.+++|||||+++|+|..
T Consensus         3 r~i~L~~~iG~G~fG~Vy~~~~~-------------g~~VAvK~l~~~~~-~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~   68 (303)
T 3hmm_A            3 RTIVLQESIGKGRFGEVWRGKWR-------------GEEVAVKIFSSREE-RSWFREAEIYQTVMLRHENILGFIAADNK   68 (303)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEET-------------TEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-------------CEEEEEEEECccch-hhHHHHHHHHHHhcCCCCCCCcEEEEEEe
Confidence            45777889999999999999864             57899999965421 12223456667788999999999999998


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeeccccccEEEcCCC
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM-----DFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~Dlkp~NILl~~~~  241 (453)
                      .+.....++||||||++|+|.++|...   +++|..+++++.|++.||+|||+++     .++||||||||+||||+.++
T Consensus        69 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~---~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~  145 (303)
T 3hmm_A           69 DNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNG  145 (303)
T ss_dssp             ECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTS
T ss_pred             cCCCceEEEEEecCCCCCcHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCC
Confidence            765444589999999999999999864   6899999999999999999999752     45899999999999999999


Q ss_pred             cEEEeccccccCCCCCCCC--ccccccccCcCCCCccccccC------CCCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          242 KAKLSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTG------RLTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                      ++||+|||+|+........  .......||+.|||||++.+.      .++.++|||||||+||||+||..|+.......
T Consensus       146 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~  225 (303)
T 3hmm_A          146 TCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQ  225 (303)
T ss_dssp             CEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCC
T ss_pred             CEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCcccccc
Confidence            9999999999865432211  122346799999999999754      36789999999999999999988775322110


Q ss_pred             ------------hHHHHHhhhhcccCccccccccCCcCCCc-cchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          314 ------------EQKLLEWVRPYVSDSKKFHLIIDPRLEGN-YCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       314 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                                  ...+...+         .....+|.+... ...+.+..+.+|+.+||+.||++||||.+|++.|+++.
T Consensus       226 ~p~~~~~~~~~~~~~~~~~~---------~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~  296 (303)
T 3hmm_A          226 LPYYDLVPSDPSVEEMRKVV---------CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLS  296 (303)
T ss_dssp             CTTTTTSCSSCCHHHHHHHH---------TTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHH
T ss_pred             ccchhcccccchHHHHHHHH---------hcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHH
Confidence                        00111000         001112222221 12356678999999999999999999999999999887


Q ss_pred             hh
Q 043568          381 SE  382 (453)
Q Consensus       381 ~~  382 (453)
                      ++
T Consensus       297 ~~  298 (303)
T 3hmm_A          297 QQ  298 (303)
T ss_dssp             HC
T ss_pred             HH
Confidence            53

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=5.9e-55  Score=412.23  Aligned_cols=246  Identities=25%  Similarity=0.392  Sum_probs=192.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|+++           .+++.||||++.+..   ......+.+|+.+|++++|||||+++++
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~   81 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHT-----------TTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV   81 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECT-----------TTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEEC-----------CCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEE
Confidence            68999999999999999999975           557899999997543   2335678999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    ++|||||| +|+|.+++..+  .++++..+..++.||+.||+|||++   +|+||||||+|||++.++++
T Consensus        82 ~~~~~~----~~ivmEy~-~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~v  151 (275)
T 3hyh_A           82 IKSKDE----IIMVIEYA-GNELFDYIVQR--DKMSEQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNV  151 (275)
T ss_dssp             EECSSE----EEEEEECC-CEEHHHHHHHS--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCE
T ss_pred             EEECCE----EEEEEeCC-CCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCE
Confidence            987654    79999999 78999999876  5799999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||+|+.....   .......||+.|||||++.+..+ +.++|||||||++|||++|+.||......   .+...+.
T Consensus       152 kl~DFGla~~~~~~---~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~---~~~~~i~  225 (275)
T 3hyh_A          152 KIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIP---VLFKNIS  225 (275)
T ss_dssp             EECCSSCC------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred             EEeecCCCeecCCC---CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH
Confidence            99999999875432   23446789999999999988776 58999999999999999999999764322   2222221


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..   .        .    .++...++++.+|+.+||+.||++|||+.|+++
T Consensus       226 ~~---~--------~----~~p~~~s~~~~~li~~~L~~dP~~R~s~~eil~  262 (275)
T 3hyh_A          226 NG---V--------Y----TLPKFLSPGAAGLIKRMLIVNPLNRISIHEIMQ  262 (275)
T ss_dssp             HT---C--------C----CCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cC---C--------C----CCCCCCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            10   0        0    112234677999999999999999999999876

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.4e-55  Score=417.51  Aligned_cols=246  Identities=26%  Similarity=0.346  Sum_probs=196.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||+||+|++...        ...++.||||++++...  .....+.+|+.+|++++|||||++++++
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~--------~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~   95 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISG--------SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAF   95 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSS--------TTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccC--------CCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEE
Confidence            5799999999999999999987421        24567899999975432  2334688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    ++||||||+||+|.++|...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus        96 ~~~~~----~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vK  166 (304)
T 3ubd_A           96 QTEGK----LYLILDFLRGGDLFTRLSKE--VMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIK  166 (304)
T ss_dssp             EETTE----EEEEECCCTTCEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEE
T ss_pred             EECCE----EEEEEEcCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEE
Confidence            88664    79999999999999999875  5789999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||+|+......  .......||+.|||||++.+..|+.++|||||||++|||++|+.||.......   +...+.. 
T Consensus       167 l~DFGla~~~~~~~--~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~~-  240 (304)
T 3ubd_A          167 LTDFGLSKESIDHE--KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKE---TMTMILK-  240 (304)
T ss_dssp             EESSEEEEC-------CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH-
T ss_pred             ecccccceeccCCC--ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHH---HHHHHHc-
Confidence            99999998643321  23456789999999999999999999999999999999999999997653322   2221111 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                        ..            ..++...++++.+||.+||+.||++|||+
T Consensus       241 --~~------------~~~p~~~s~~~~~li~~~L~~dP~~R~ta  271 (304)
T 3ubd_A          241 --AK------------LGMPQFLSPEAQSLLRMLFKRNPANRLGA  271 (304)
T ss_dssp             --CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTC
T ss_pred             --CC------------CCCCCcCCHHHHHHHHHHcccCHHHCCCC
Confidence              00            01123356789999999999999999995

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.6e-53  Score=407.46  Aligned_cols=255  Identities=24%  Similarity=0.379  Sum_probs=190.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||+||+|+++           .++..||||++..... ...+.+.+|+.+|++|+|||||++++++.
T Consensus         5 ~dy~~~~~lG~G~fg~V~~a~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~   73 (299)
T 4g31_A            5 TDFEPIQCLGRGGFGVVFEAKNK-----------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWL   73 (299)
T ss_dssp             HHEEEEEEEEECC--EEEEEEET-----------TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hhCEEeeEEecCCCeEEEEEEEC-----------CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            46899999999999999999976           4578899999975543 23467899999999999999999999997


Q ss_pred             ecccc--------cceEEEEEEecCCCChHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEE
Q 043568          166 EDDER--------GMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL  236 (453)
Q Consensus       166 ~~~~~--------~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NIL  236 (453)
                      +.+..        ...++||||||++|+|.+++..+.. ...++..++.++.||+.||+|||++   +|+||||||+|||
T Consensus        74 ~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NIL  150 (299)
T 4g31_A           74 EKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIF  150 (299)
T ss_dssp             EEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEE
T ss_pred             ecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeE
Confidence            65531        1236899999999999999987643 2356677889999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeccccccCCCCCCCC----------ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccc
Q 043568          237 LDEDYKAKLSDFGLARQGPPEGLG----------HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV  306 (453)
Q Consensus       237 l~~~~~~kL~DFGla~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~  306 (453)
                      |+.++.+||+|||+|+........          ...+..+||+.|||||++.+..|+.++|||||||++|||++   ||
T Consensus       151 l~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf  227 (299)
T 4g31_A          151 FTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PF  227 (299)
T ss_dssp             ECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CC
T ss_pred             ECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CC
Confidence            999999999999999875432211          11234579999999999999999999999999999999996   66


Q ss_pred             cCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...  .........+..             ... .......++.+.+|+.+||+.||++|||+.++++
T Consensus       228 ~~~--~~~~~~~~~~~~-------------~~~-p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  279 (299)
T 4g31_A          228 STQ--MERVRTLTDVRN-------------LKF-PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIE  279 (299)
T ss_dssp             SSH--HHHHHHHHHHHT-------------TCC-CHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             CCc--cHHHHHHHHHhc-------------CCC-CCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            432  111111111110             000 0112233456788999999999999999999875

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.9e-51  Score=405.24  Aligned_cols=271  Identities=24%  Similarity=0.305  Sum_probs=205.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|+++           .+++.||||++.....  ...+.+.+|+.+|+.|+|||||+++++
T Consensus        53 ~~~Y~~~~~lG~G~fG~V~~a~~~-----------~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~  121 (398)
T 4b99_A           53 GDEYEIIETIGNGAYGVVSSARRR-----------LTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDI  121 (398)
T ss_dssp             CSSEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCeEEEEEEecccCeEEEEEEEC-----------CCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeee
Confidence            367999999999999999999986           5678999999975432  234678899999999999999999999


Q ss_pred             eeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.....  ....+|||||||+ |+|.+++...  .++++..+..++.||+.||.|||++   +||||||||+|||++.++
T Consensus       122 ~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~--~~l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~  195 (398)
T 4b99_A          122 LRPTVPYGEFKSVYVVLDLME-SDLHQIIHSS--QPLTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENC  195 (398)
T ss_dssp             CCCSSCTTTCCCEEEEEECCS-EEHHHHHTSS--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTC
T ss_pred             eecccccccCCEEEEEEeCCC-CCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCC
Confidence            875432  1234799999995 7899999765  5799999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCC--CCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          242 KAKLSDFGLARQGPPEG--LGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      .+||+|||+|+......  ........+||+.|+|||++.+. .++.++||||+|||+|||++|+.||...........+
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I  275 (398)
T 4b99_A          196 ELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLI  275 (398)
T ss_dssp             CEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHH
T ss_pred             CEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            99999999998754321  12234567899999999998774 5799999999999999999999999865443332222


Q ss_pred             HhhhhcccCccccc--------c---ccCCcCCCc---cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPYVSDSKKFH--------L---IIDPRLEGN---YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~--------~---~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ........ .....        .   .+.+.....   .....+.++.+||.+||..||.+|||+.|+++
T Consensus       276 ~~~~g~p~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  344 (398)
T 4b99_A          276 MMVLGTPS-PAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALR  344 (398)
T ss_dssp             HHHHCCCC-GGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             HHhcCCCC-hHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            11110000 00000        0   000000000   11234567899999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=6.7e-50  Score=388.93  Aligned_cols=287  Identities=40%  Similarity=0.702  Sum_probs=238.8

Q ss_pred             cccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCC
Q 043568           76 VFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHP  155 (453)
Q Consensus        76 ~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~  155 (453)
                      .+++.++..++++|...+.||+|+||+||+|++.            ++..||||++........+.+.+|+.+++.++||
T Consensus        28 ~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~   95 (321)
T 2qkw_B           28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLR------------DGAKVALKRRTPESSQGIEEFETEIETLSFCRHP   95 (321)
T ss_dssp             --CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECT------------TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCT
T ss_pred             eecHHHHHHHHhccCccceeecCCCeeEEEEEEC------------CCCEEEEEEecccChHHHHHHHHHHHHHHhCCCC
Confidence            3445556668899999999999999999999853            3678999998776666678899999999999999


Q ss_pred             ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      ||+++++++...+.    .++||||+++|+|.+++....  ...+++..++.++.|++.||.|||+.   +|+||||||+
T Consensus        96 ~iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~  168 (321)
T 2qkw_B           96 HLVSLIGFCDERNE----MILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSI  168 (321)
T ss_dssp             TBCCEEEECCCTTC----CEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCST
T ss_pred             CEeeEEEEEcCCCe----EEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCC---CeecCCCCHH
Confidence            99999999987654    699999999999999997653  23589999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                      |||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||....+..
T Consensus       169 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~  248 (321)
T 2qkw_B          169 NILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE  248 (321)
T ss_dssp             TEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSS
T ss_pred             HEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHH
Confidence            99999999999999999986543322333445679999999999999999999999999999999999999998766554


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ......|...... ...+...+++.+........+..+.+++.+||+.||++|||+.++++.|+.+++.
T Consensus       249 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          249 MVNLAEWAVESHN-NGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             CCCHHHHTHHHHT-TTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             HHHHHHHhhhccc-cccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            4444444332221 2334445566666667788899999999999999999999999999999998864

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=1.3e-49  Score=391.84  Aligned_cols=205  Identities=24%  Similarity=0.358  Sum_probs=171.5

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEee
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVG  162 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~  162 (453)
                      ...++|...++||+|+||+||+|+++..        ...+..||||.+....  ....+.+|+.+|+.+ +||||+++++
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~--------~~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~   87 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQ--------VGPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKY   87 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBT--------TSCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEccc--------CCCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEE
Confidence            3467899999999999999999987521        1346789999986543  446688999999998 6999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-C
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-Y  241 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-~  241 (453)
                      ++.+.+.    .+||||||++|+|.+++.     .+++..+..++.||+.||.|||++   +|+||||||+|||++.+ +
T Consensus        88 ~~~~~~~----~~lvmE~~~g~~L~~~~~-----~l~~~~~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~  155 (361)
T 4f9c_A           88 CFRKNDH----VVIAMPYLEHESFLDILN-----SLSFQEVREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLK  155 (361)
T ss_dssp             EEEETTE----EEEEEECCCCCCHHHHHT-----TCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred             EEEECCE----EEEEEeCCCcccHHHHHc-----CCCHHHHHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCC
Confidence            9987664    799999999999999883     478999999999999999999999   99999999999999876 7


Q ss_pred             cEEEeccccccCCCCCCCC--------------------------ccccccccCcCCCCccccccC-CCCCchhHHHHHH
Q 043568          242 KAKLSDFGLARQGPPEGLG--------------------------HVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGV  294 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~--------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGv  294 (453)
                      .+||+|||+|+........                          ......+||+.|+|||++.+. .|+.++||||+||
T Consensus       156 ~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~  235 (361)
T 4f9c_A          156 KYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGV  235 (361)
T ss_dssp             EEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred             eEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHH
Confidence            9999999999764432110                          112345799999999998775 5899999999999


Q ss_pred             HHHHHHhCCccccCCC
Q 043568          295 VLYELITGRRAVERNL  310 (453)
Q Consensus       295 il~elltg~~p~~~~~  310 (453)
                      |+|||++|+.||....
T Consensus       236 il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          236 IFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             HHHHHHHTCSSSSCCS
T ss_pred             HHHHHHHCCCCCCCCC
Confidence            9999999999996544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=2.7e-49  Score=412.15  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=210.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|.+.+.||+|+||+||+|+++           .++..||||.+........+.+.+|+.+|+.|+|||||++++++.
T Consensus       156 l~~Y~i~~~lG~G~fg~V~~~~~~-----------~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~  224 (573)
T 3uto_A          156 LDHYDIHEELGTGAFGVVHRVTER-----------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE  224 (573)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             ccccEEEEEEeeccCeEEEEEEEC-----------CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            468999999999999999999986           567889999997766556677899999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC--CcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED--YKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~--~~~  243 (453)
                      +...    ++||||||+||+|.++|... ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+  +.+
T Consensus       225 ~~~~----~~iv~E~~~gg~L~~~i~~~-~~~l~e~~~~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~v  296 (573)
T 3uto_A          225 DDNE----MVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL  296 (573)
T ss_dssp             CSSE----EEEEEECCCCCBHHHHHTCT-TSCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCE
T ss_pred             ECCE----EEEEEeecCCCcHHHHHHHh-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCE
Confidence            7664    79999999999999998754 34789999999999999999999999   99999999999999854  899


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+.....   ......+||+.|||||++.+..|+.++|||||||++|||++|..||........   ...+..
T Consensus       297 Kl~DFG~a~~~~~~---~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~---~~~i~~  370 (573)
T 3uto_A          297 KLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET---LRNVKS  370 (573)
T ss_dssp             EECCCSSCEECCTT---SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHH---HHHHHT
T ss_pred             EEeeccceeEccCC---CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHH---HHHHHh
Confidence            99999999986543   234566899999999999999999999999999999999999999976543222   111111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .           +...........+.++.+||.+||..||.+|||+.|+++
T Consensus       371 ~-----------~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~  410 (573)
T 3uto_A          371 C-----------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  410 (573)
T ss_dssp             T-----------CCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C-----------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0           001111122345678999999999999999999999876

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=3.3e-49  Score=410.13  Aligned_cols=250  Identities=25%  Similarity=0.341  Sum_probs=203.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHH---HHHHHHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEW---INEVNFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~---~~E~~~l~~l~h~nIv~  159 (453)
                      .++|...++||+|+||+||+|+++           .++..||||++.+..   ......+   ..++.+++.++|||||+
T Consensus       188 lddf~i~k~LG~G~fG~V~la~~~-----------~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~  256 (689)
T 3v5w_A          188 MNDFSVHRIIGRGGFGEVYGCRKA-----------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC  256 (689)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCC
T ss_pred             hHHeEEEEEEecccCeEEEEEEEC-----------CCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeE
Confidence            367999999999999999999986           567899999996532   1222233   34577888899999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++.+.+.    +|||||||+||+|.++|...  ..+++..+..++.||+.||.|||++   +||||||||+||||+.
T Consensus       257 l~~~f~~~~~----lylVmEy~~GGdL~~~l~~~--~~l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~  327 (689)
T 3v5w_A          257 MSYAFHTPDK----LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE  327 (689)
T ss_dssp             EEEEEECSSE----EEEEECCCCSCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECT
T ss_pred             EEEEEEECCE----EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeC
Confidence            9999988764    79999999999999999875  5789999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      +|++||+|||+|+.....    .....+||+.|||||++.. ..|+.++||||||||+|||++|+.||..........+.
T Consensus       328 ~G~vKL~DFGlA~~~~~~----~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~  403 (689)
T 3v5w_A          328 HGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  403 (689)
T ss_dssp             TSCEEECCCTTCEECSSC----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHH
T ss_pred             CCCEEecccceeeecCCC----CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence            999999999999875432    2345689999999999974 57999999999999999999999999764433332332


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      ......               ...++...+.++.+||.+||..||.+|++     +.+|++
T Consensus       404 ~~i~~~---------------~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~  449 (689)
T 3v5w_A          404 RMTLTM---------------AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  449 (689)
T ss_dssp             HHHHHC---------------CCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTT
T ss_pred             HhhcCC---------------CCCCCccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhc
Confidence            222110               01122345678999999999999999998     677764

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=2e-48  Score=379.13  Aligned_cols=289  Identities=42%  Similarity=0.713  Sum_probs=238.5

Q ss_pred             CCCccccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhc
Q 043568           72 NDLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLG  150 (453)
Q Consensus        72 ~~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~  150 (453)
                      .....|++.++..++++|...+.||+|+||+||+|.+            .++..||||++..... .....+.+|+.+++
T Consensus        15 ~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~------------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~   82 (326)
T 3uim_A           15 GQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRL------------ADGTLVAVKRLKEERTQGGELQFQTEVEMIS   82 (326)
T ss_dssp             CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECC------------SSSCCEEEEECCC-----CCCHHHHHHHGGG
T ss_pred             CccceecHHHHHHHhhccccceeEecCCCcEEEEEEe------------cCCCEEEEEEeccccCchHHHHHHHHHHHHH
Confidence            4677899999999999999999999999999999974            2367899999875432 22346899999999


Q ss_pred             cCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 043568          151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR  228 (453)
Q Consensus       151 ~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~  228 (453)
                      .++||||+++++++.....    .++||||+++|+|.+++....  ..++++..++.++.|++.||.|||+.+.++|+||
T Consensus        83 ~l~h~~iv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~  158 (326)
T 3uim_A           83 MAVHRNLLRLRGFCMTPTE----RLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHR  158 (326)
T ss_dssp             TCCCTTBCCCCEEECCSSC----CEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECC
T ss_pred             hccCCCccceEEEEecCCc----eEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Confidence            9999999999999987664    689999999999999998754  3459999999999999999999999866699999


Q ss_pred             ccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       229 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ||||+|||++.++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       159 Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  237 (326)
T 3uim_A          159 DVKAANILLDEEFEAVVGDFGLAKLMDYKD-THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDL  237 (326)
T ss_dssp             CCSGGGEEECTTCCEEECCCSSCEECCSSS-SCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCH
T ss_pred             CCchhhEEECCCCCEEeccCccccccCccc-ccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccc
Confidence            999999999999999999999998754332 2234455699999999999988999999999999999999999999952


Q ss_pred             CC--ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          309 NL--PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       309 ~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                      ..  .........|...... ......+.+..+........+..+.+++.+||+.||.+|||+.+|++.|+.
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~  308 (326)
T 3uim_A          238 ARLANDDDVMLLDWVKGLLK-EKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG  308 (326)
T ss_dssp             HHHTTTSCSBHHHHHTTTTS-SCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHT
T ss_pred             cccccccchhHHHHHHHHhh-chhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcC
Confidence            11  1112223344443333 334555666777777788889999999999999999999999999999975

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.3e-48  Score=371.89  Aligned_cols=265  Identities=26%  Similarity=0.427  Sum_probs=214.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...++||+|+||+||+|.+.           .++..||+|.+........+.|.+|+.++++++||||+++++++.
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~-----------~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   77 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHR-----------ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLY   77 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEET-----------TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEEC-----------CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEe
Confidence            467889999999999999999976           457789999987666566778999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        78 ~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl  149 (310)
T 3s95_A           78 KDKR----LNFITEYIKGGTLRGIIKSM-DSQYPWSQRVSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVV  149 (310)
T ss_dssp             ETTE----EEEEEECCTTCBHHHHHHHC-CTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEE
T ss_pred             cCCe----eEEEEEecCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEE
Confidence            7654    79999999999999999874 35789999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCc------------cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          246 SDFGLARQGPPEGLGH------------VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~------------~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                      +|||+++.........            ......||+.|+|||++.+..++.++|||||||++|||++|..|+....+..
T Consensus       150 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~  229 (310)
T 3s95_A          150 ADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRT  229 (310)
T ss_dssp             CCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBC
T ss_pred             eecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhH
Confidence            9999998654322111            1114579999999999999999999999999999999999999886543221


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      ...           ........+    ...+..++..+.+|+.+||+.||++|||+.++++.|+.+.....
T Consensus       230 ~~~-----------~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~  285 (310)
T 3s95_A          230 MDF-----------GLNVRGFLD----RYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLA  285 (310)
T ss_dssp             TTS-----------SBCHHHHHH----HTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHH-----------hhhhhcccc----ccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhcc
Confidence            100           000000000    01122345679999999999999999999999999999887654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=1.9e-47  Score=379.07  Aligned_cols=271  Identities=24%  Similarity=0.405  Sum_probs=218.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.....    .....+..||||++..... .....+.+|+.+|+.+ +||||++++++
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  155 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDK----DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  155 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCST----TCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccC----cCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEE
Confidence            4678999999999999999999753211    1124567899999975532 3346789999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      |...+.    +++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||++   +|+|||
T Consensus       156 ~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrD  228 (370)
T 2psq_A          156 CTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD  228 (370)
T ss_dssp             ECSSSS----CEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             EccCCC----EEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---Ceeccc
Confidence            987664    6999999999999999986532              3588999999999999999999999   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       229 lkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~  308 (370)
T 2psq_A          229 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  308 (370)
T ss_dssp             CCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             cchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            999999999999999999999986554333233345567889999999999999999999999999999999 9999876


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      ......   ...+..    .          .....+..++..+.+|+.+||+.||.+|||+.++++.|+.++....
T Consensus       309 ~~~~~~---~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          309 IPVEEL---FKLLKE----G----------HRMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             CCGGGH---HHHHHT----T----------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CCHHHH---HHHHhc----C----------CCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            433222   111111    0          0111223456789999999999999999999999999999987553

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=7.1e-48  Score=375.00  Aligned_cols=280  Identities=24%  Similarity=0.316  Sum_probs=212.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...++||+|+||+||+|++.             +..||||++.... .....+.+|+.++++++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~-------------~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL-------------NEYVAVKIFPIQD-KQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET-------------TEEEEEEEECGGG-HHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC-------------CCEEEEEEeecCc-hHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            478999999999999999999863             5789999986543 23345667999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------CCceEeeccccccEEEc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM-------DFQLIFRDFKTSNILLD  238 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-------~~~iiH~Dlkp~NILl~  238 (453)
                      ........+++||||+++|+|.+++...   .+++..++.++.|++.||.|||+..       .++|+||||||+|||++
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~  165 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKAN---VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLK  165 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEEC
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhc---CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEEC
Confidence            8765444579999999999999999764   5899999999999999999999751       23899999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-----CCCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-----RLTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                      .++.+||+|||+++...............||+.|+|||++.+.     .++.++|||||||++|||++|+.||.......
T Consensus       166 ~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~  245 (322)
T 3soc_A          166 NNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY  245 (322)
T ss_dssp             TTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred             CCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence            9999999999999765443332334456799999999999763     45678899999999999999999997543221


Q ss_pred             hHHHHHhhhhcccCcc----ccccccCCcCCCc-cchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          314 EQKLLEWVRPYVSDSK----KFHLIIDPRLEGN-YCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ................    .......+.+... .....+.++.+|+.+||+.||++|||+.+|++.|+.+.+.
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          246 MLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1111000000000000    0000011111111 1234567799999999999999999999999999998764

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.4e-47  Score=364.57  Aligned_cols=251  Identities=28%  Similarity=0.398  Sum_probs=210.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++........+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   87 (297)
T 3fxz_A           19 KKKYTRFEKIGQGASGTVYTAMDV-----------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL   87 (297)
T ss_dssp             GGTBCCCEEEEEETTEEEEEEEBT-----------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hhceeeeeeeccCCCeEEEEEEEC-----------CCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEE
Confidence            478999999999999999999865           457889999997666666778999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+++|+|.+++...   .+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        88 ~~~~----~~lv~e~~~~~~L~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl  157 (297)
T 3fxz_A           88 VGDE----LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL  157 (297)
T ss_dssp             ETTE----EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEE
T ss_pred             ECCE----EEEEEECCCCCCHHHHHhhc---CCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEE
Confidence            7664    79999999999999999764   689999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||++.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+........  ..  
T Consensus       158 ~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~--~~--  231 (297)
T 3fxz_A          158 TDFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIA--TN--  231 (297)
T ss_dssp             CCCTTCEECCSTT--CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH--HH--
T ss_pred             eeCCCceecCCcc--cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH--hC--
Confidence            9999998754332  22345679999999999999999999999999999999999999997654322211111  00  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                 .......+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       232 -----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  269 (297)
T 3fxz_A          232 -----------GTPELQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQ  269 (297)
T ss_dssp             -----------CSCCCSCGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----------CCCCCCCccccCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence                       00011123345678999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=1.6e-46  Score=362.50  Aligned_cols=283  Identities=38%  Similarity=0.614  Sum_probs=227.2

Q ss_pred             CCccccHHHHHHHhcCCCcc------ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHH
Q 043568           73 DLRVFSFAELKSATRGFSRA------LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEW  142 (453)
Q Consensus        73 ~~~~~~~~~~~~~~~~f~~~------~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~  142 (453)
                      +...|++.++..++++|...      +.||+|+||+||+|.+             .+..||||++....    ....+.+
T Consensus        11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~   77 (307)
T 2nru_A           11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-------------NNTTVAVKKLAAMVDITTEELKQQF   77 (307)
T ss_dssp             CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-------------SSCEEEEEEECCCTTSCTTTHHHHH
T ss_pred             CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-------------CCceEEEEEEecccCcchHHHHHHH
Confidence            56789999999999999988      8999999999999984             35689999986532    2235678


Q ss_pred             HHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 043568          143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEM  221 (453)
Q Consensus       143 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~  221 (453)
                      .+|+.+++.++||||+++++++.....    .++||||+++++|.+++.... ..++++..++.++.|++.||.|||+. 
T Consensus        78 ~~E~~~l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~-  152 (307)
T 2nru_A           78 DQEIKVMAKCQHENLVELLGFSSDGDD----LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN-  152 (307)
T ss_dssp             HHHHHHHHHCCCTTBCCEEEEECSSSS----CEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             HHHHHHHHhcCCCCeEEEEEEEecCCc----eEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcC-
Confidence            999999999999999999999987654    699999999999999987532 35689999999999999999999998 


Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT  301 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt  301 (453)
                        +|+||||||+|||++.++.+||+|||++................||+.|+|||.+.+ .++.++||||||+++|+|++
T Consensus       153 --~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~  229 (307)
T 2nru_A          153 --HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIIT  229 (307)
T ss_dssp             --TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHH
T ss_pred             --CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHH
Confidence              999999999999999999999999999986544332223345679999999998864 58899999999999999999


Q ss_pred             CCccccCCCChhh-HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          302 GRRAVERNLPRNE-QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       302 g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      |..||........ ..+....   ......+...+++.+ ...+...+..+.+++.+||+.||.+|||+.+|++.|+.+.
T Consensus       230 g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          230 GLPAVDEHREPQLLLDIKEEI---EDEEKTIEDYIDKKM-NDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             CCCSBCTTBSSSBTTHHHHHH---HTTSCCHHHHSCSSC-SCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             CCCCcccCcchHHHHHHHHHh---hhhhhhhhhhccccc-cccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            9999975432221 1111111   111122222333332 2345667889999999999999999999999999998864

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=2.3e-47  Score=376.52  Aligned_cols=278  Identities=24%  Similarity=0.340  Sum_probs=221.3

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CC
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KH  154 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h  154 (453)
                      +...+.....++|...+.||+|+||.||+|.+....      ...++..||||++..... ...+.+.+|+.++.++ +|
T Consensus        12 ~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h   85 (359)
T 3vhe_A           12 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID------KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHH   85 (359)
T ss_dssp             CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS------STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCC
T ss_pred             CCcccccccccceeeceeecCCCCceEEEEEecccc------ccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCC
Confidence            444455556789999999999999999999975321      225678999999975432 3346799999999999 89


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCC---------------------------------------
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP---------------------------------------  195 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------------------------  195 (453)
                      |||+++++++...+.   ..++||||+++|+|.+++.....                                       
T Consensus        86 pniv~~~~~~~~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (359)
T 3vhe_A           86 LNVVNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSS  162 (359)
T ss_dssp             TTBCCEEEEECSTTS---CCEEEEECCTTEEHHHHHHTTTTSBCSCC---------------------------------
T ss_pred             cceeeeeeeeecCCC---ceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccc
Confidence            999999999987554   26899999999999999986532                                       


Q ss_pred             -------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          196 -------------------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       196 -------------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                                               ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+|||+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~  239 (359)
T 3vhe_A          163 ASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGL  239 (359)
T ss_dssp             ---------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGG
T ss_pred             cccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCcEEEEeccc
Confidence                                     1288999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCcc
Q 043568          251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSK  329 (453)
Q Consensus       251 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~  329 (453)
                      ++...............||+.|+|||++.+..++.++|||||||++|||++ |..||........  +.......     
T Consensus       240 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~--~~~~~~~~-----  312 (359)
T 3vhe_A          240 ARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE--FCRRLKEG-----  312 (359)
T ss_dssp             GSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH--HHHHHHHT-----
T ss_pred             eeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHH--HHHHHHcC-----
Confidence            987654433334456778999999999999999999999999999999998 9999976543221  11111100     


Q ss_pred             ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       330 ~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                               .....+...+.++.+++.+||+.||.+|||+.+|++.|+.++..
T Consensus       313 ---------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          313 ---------TRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             ---------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---------CCCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHH
Confidence                     00111223456799999999999999999999999999998864

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.5e-46  Score=362.89  Aligned_cols=262  Identities=27%  Similarity=0.399  Sum_probs=216.3

Q ss_pred             ccccHHHHHHHhcC----------CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHH
Q 043568           75 RVFSFAELKSATRG----------FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWIN  144 (453)
Q Consensus        75 ~~~~~~~~~~~~~~----------f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~  144 (453)
                      ..|++++++.+++.          |...+.||+|+||.||+|++.           .++..||||++........+.+.+
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~-----------~~g~~vavK~~~~~~~~~~~~~~~   91 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREK-----------HSGRQVAVKMMDLRKQQRRELLFN   91 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEETTTCCSHHHHHH
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEEC-----------CCCcEEEEEEEeccchhHHHHHHH
Confidence            46889999988875          667779999999999999975           457889999998766667788999


Q ss_pred             HHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          145 EVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       145 E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      |+.+++.++||||+++++++.....    .++||||+++++|.+++..   ..+++..+..++.|++.||.|||+.   +
T Consensus        92 E~~~l~~l~h~niv~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~---~~l~~~~~~~i~~qi~~~L~~LH~~---~  161 (321)
T 2c30_A           92 EVVIMRDYQHFNVVEMYKSYLVGEE----LWVLMEFLQGGALTDIVSQ---VRLNEEQIATVCEAVLQALAYLHAQ---G  161 (321)
T ss_dssp             HHHHHTTCCCTTBCCEEEEEEETTE----EEEEECCCCSCBHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHHHHhCCCCCcceEEEEEEECCE----EEEEEecCCCCCHHHHHHh---cCCCHHHHHHHHHHHHHHHHHHHHC---C
Confidence            9999999999999999999987664    7999999999999998865   3689999999999999999999998   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCc
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR  304 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~  304 (453)
                      |+||||||+|||++.++.+||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus       162 ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~  239 (321)
T 2c30_A          162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV--PKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP  239 (321)
T ss_dssp             EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred             eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc--cccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999999999999999999999998654321  12345679999999999999999999999999999999999999


Q ss_pred             cccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          305 AVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ||.......   ....+....          .+.+  ......+..+.+++.+||..||++|||+.++++
T Consensus       240 pf~~~~~~~---~~~~~~~~~----------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  294 (321)
T 2c30_A          240 PYFSDSPVQ---AMKRLRDSP----------PPKL--KNSHKVSPVLRDFLERMLVRDPQERATAQELLD  294 (321)
T ss_dssp             TTTTSCHHH---HHHHHHHSS----------CCCC--TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             CCCCCCHHH---HHHHHhcCC----------CCCc--CccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            997653322   111111100          0111  112234677999999999999999999999875

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.2e-47  Score=368.41  Aligned_cols=265  Identities=26%  Similarity=0.442  Sum_probs=212.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+...+        ..+..||||.+.... ....+.|.+|+.++++++||||+++++++
T Consensus        48 ~~~y~i~~~lG~G~~g~V~~~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  119 (325)
T 3kul_A           48 ASRIHIEKIIGSGDSGEVCYGRLRVPG--------QRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVV  119 (325)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECCTT--------SCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhHeEEeeEEEeCCCcEEEEEEEecCC--------CCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            356888899999999999999986321        345679999997543 23456799999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       120 ~~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~k  191 (325)
T 3kul_A          120 TRGRL----AMIVTEYMENGSLDTFLRTH-DGQFTIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCK  191 (325)
T ss_dssp             CGGGC----CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EeCCc----cEEEeeCCCCCcHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEE
Confidence            77654    69999999999999999654 35789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCC-CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||+++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   +...+.
T Consensus       192 l~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~---~~~~~~  268 (325)
T 3kul_A          192 VSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRD---VISSVE  268 (325)
T ss_dssp             ECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHH
T ss_pred             ECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHH---HHHHHH
Confidence            999999987543221 112233456788999999998999999999999999999999 999997643322   211111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ..              .....+..++..+.+|+.+||..||.+|||+.+|++.|+.+....
T Consensus       269 ~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~  315 (325)
T 3kul_A          269 EG--------------YRLPAPMGCPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSP  315 (325)
T ss_dssp             TT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSC
T ss_pred             cC--------------CCCCCCCCcCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCc
Confidence            10              011122345678999999999999999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=1.5e-46  Score=363.59  Aligned_cols=260  Identities=30%  Similarity=0.450  Sum_probs=203.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+.             +..||||++......  ....|.+|+.++++++||||++++++
T Consensus        36 ~~~y~i~~~lG~G~~g~V~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  102 (309)
T 3p86_A           36 WCDLNIKEKIGAGSFGTVHRAEWH-------------GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGA  102 (309)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------------TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhHceeeeEeecCCCeEEEEEEEC-------------CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            578999999999999999999853             568999998765432  34678999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeeccccccEEEcCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQ--LIFRDFKTSNILLDED  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~NILl~~~  240 (453)
                      +.....    .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+.   +  |+||||||+|||++.+
T Consensus       103 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~  175 (309)
T 3p86_A          103 VTQPPN----LSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKK  175 (309)
T ss_dssp             ECSTTC----CEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTT
T ss_pred             EEECCc----eEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCC
Confidence            987664    6999999999999999986531 2489999999999999999999998   8  9999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||..............
T Consensus       176 ~~~kL~Dfg~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~  253 (309)
T 3p86_A          176 YTVKVCDFGLSRLKAST--FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGF  253 (309)
T ss_dssp             CCEEECCCC-------------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHH
T ss_pred             CcEEECCCCCCcccccc--ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence            99999999999864322  1223456799999999999999999999999999999999999999976543222111110


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ..                .....+...+..+.+|+.+||..||.+|||+.+|++.|+.++...
T Consensus       254 ~~----------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          254 KC----------------KRLEIPRNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             SC----------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             cC----------------CCCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            00                011122345678999999999999999999999999999988653

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=7e-47  Score=368.76  Aligned_cols=264  Identities=26%  Similarity=0.403  Sum_probs=208.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||+||+|++...       +......||+|.+.... ....+.|.+|+.++++++||||++++++|
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   86 (327)
T 3poz_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE-------GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECC-----------CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEE
T ss_pred             HHHcccceEEeeCCCeEEEEEEEcCC-------CceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            46789999999999999999997532       12234567999886433 34567899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++|+||+.+|+|.+++.... ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~-----~~~v~e~~~~g~L~~~l~~~~-~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~k  157 (327)
T 3poz_A           87 LTST-----VQLITQLMPFGCLLDYVREHK-DNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK  157 (327)
T ss_dssp             ESSS-----EEEEEECCTTCBHHHHHHHST-TSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEE
T ss_pred             ecCC-----eEEEEEecCCCcHHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEE
Confidence            8754     589999999999999998753 5789999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |+.||...........+...  
T Consensus       158 l~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~--  235 (327)
T 3poz_A          158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--  235 (327)
T ss_dssp             ECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--
T ss_pred             EccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcC--
Confidence            999999986544333333345567889999999999999999999999999999999 99999765433322222111  


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                                     .....+..++..+.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       236 ---------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          236 ---------------ERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---------------CCCCCCTTBCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---------------CCCCCCccCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence                           01112233466799999999999999999999999999988764

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=2.3e-47  Score=378.12  Aligned_cols=269  Identities=28%  Similarity=0.434  Sum_probs=212.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+....      ....+..||||++.... ......+.+|+.++++++||||+++++++
T Consensus        70 ~~~~~~~~~LG~G~fg~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~  143 (367)
T 3l9p_A           70 RKNITLIRGLGHGAFGEVYEGQVSGMP------NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS  143 (367)
T ss_dssp             GGGEEEEEECCCCSSSCEEEEEECC-----------CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HhHeEEeeEeeeCCCEEEEEEEEccCC------CCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            467889999999999999999965311      12456789999986442 33445788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC-----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV-----PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      .....    .++||||+++|+|.+++....     ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       144 ~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~  216 (367)
T 3l9p_A          144 LQSLP----RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTC  216 (367)
T ss_dssp             CSSSS----CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESC
T ss_pred             ecCCC----CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEec
Confidence            87654    599999999999999998643     24589999999999999999999999   9999999999999995


Q ss_pred             CC---cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhH
Q 043568          240 DY---KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQ  315 (453)
Q Consensus       240 ~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~  315 (453)
                      ++   .+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||++ |..||......   
T Consensus       217 ~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~---  293 (367)
T 3l9p_A          217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---  293 (367)
T ss_dssp             SSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             CCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH---
Confidence            55   599999999975322222223345678999999999999999999999999999999998 99999764322   


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      .+...+...    .          ....+..++..+.+|+.+||+.||.+|||+.+|++.|+.+.....
T Consensus       294 ~~~~~i~~~----~----------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~~~  348 (367)
T 3l9p_A          294 EVLEFVTSG----G----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPD  348 (367)
T ss_dssp             HHHHHHHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCHH
T ss_pred             HHHHHHHcC----C----------CCCCCccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhChh
Confidence            222222110    0          011123346779999999999999999999999999998876543

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.1e-47  Score=363.99  Aligned_cols=281  Identities=23%  Similarity=0.361  Sum_probs=212.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|++..       ....++..||||++........+.|.+|+.++++++||||+++++++.
T Consensus         9 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   81 (295)
T 3ugc_A            9 ERHLKFLQQLGKGNFGSVEMCRYDP-------LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY   81 (295)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT-------TCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHhhhhheeeccCCEEEEEEEEec-------ccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4678899999999999999998641       112467899999998666556678999999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+..  ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        82 ~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl  155 (295)
T 3ugc_A           82 SAGRR--NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI  155 (295)
T ss_dssp             HHHHT--SCEEEEECCTTCBHHHHHHHC-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred             cCCCC--ceEEEEEeCCCCCHHHHHHhc-ccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEE
Confidence            65432  268999999999999999775 24589999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|..|+......    ........
T Consensus       156 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~----~~~~~~~~  231 (295)
T 3ugc_A          156 GDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE----FMRMIGND  231 (295)
T ss_dssp             CCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHH----HHHHHCTT
T ss_pred             ccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHH----HHhhhcCc
Confidence            999999875432211 1223445778899999999999999999999999999999999887542110    00000000


Q ss_pred             ccCc---cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          325 VSDS---KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       325 ~~~~---~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ....   ......+........+..++.++.+|+.+||+.||++|||+.++++.|+.+.+.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          232 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             cccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            0000   0000000111111223455788999999999999999999999999999988754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=2e-46  Score=365.51  Aligned_cols=248  Identities=24%  Similarity=0.378  Sum_probs=205.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++.....  ...+.+.+|+.+|+.++||||++++++
T Consensus        14 ~~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~   82 (328)
T 3fe3_A           14 IGNYRLLKTIGKGNFAKVKLARHI-----------LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV   82 (328)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCEEEEEEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            578999999999999999999975           4578899999975432  335678899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        83 ~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~l~~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~  153 (328)
T 3fe3_A           83 IETEKT----LYLIMEYASGGEVFDYLVAH--GRMKEKEARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNI  153 (328)
T ss_dssp             EECSSE----EEEEECCCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCE
T ss_pred             EEECCE----EEEEEECCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCE
Confidence            987654    79999999999999999775  5689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCC-CchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT-AKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||++......   .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.......   +...+.
T Consensus       154 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~  227 (328)
T 3fe3_A          154 KIADFGFSNEFTVG---GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKE---LRERVL  227 (328)
T ss_dssp             EECSTTCCGGGSSS---CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EEeeccCceecCCC---CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            99999999865432   234566899999999999887765 79999999999999999999997653322   111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..     .          ...+...+..+.+|+.+||..||.+|||+.++++
T Consensus       228 ~~-----~----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~eil~  264 (328)
T 3fe3_A          228 RG-----K----------YRIPFYMSTDCENLLKRFLVLNPIKRGTLEQIMK  264 (328)
T ss_dssp             HC-----C----------CCCCTTSCHHHHHHHHHHCCSSTTTSCCHHHHTT
T ss_pred             hC-----C----------CCCCCCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            10     0          0112234567899999999999999999999875

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=3e-47  Score=378.73  Aligned_cols=261  Identities=27%  Similarity=0.422  Sum_probs=210.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||.+..... .....|.+|+.+|++++||||+++++++
T Consensus       113 ~~~~~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~  181 (377)
T 3cbl_A          113 HEDLVLGEQIGRGNFGEVFSGRLR-----------ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC  181 (377)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hHHeEEeeEeccCCCCeEEEEEEe-----------cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE
Confidence            467888999999999999999975           3567899999875422 2235688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus       182 ~~~~~----~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~k  253 (377)
T 3cbl_A          182 TQKQP----IYIVMELVQGGDFLTFLRTE-GARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLK  253 (377)
T ss_dssp             CSSSS----CEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             ecCCC----cEEEEEcCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEE
Confidence            87654    69999999999999999764 24688999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...............+++.|+|||++.+..++.++|||||||++|||++ |..||........   ...+..
T Consensus       254 l~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~---~~~~~~  330 (377)
T 3cbl_A          254 ISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQT---REFVEK  330 (377)
T ss_dssp             ECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHH---HHHHHT
T ss_pred             ECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHH---HHHHHc
Confidence            999999986433211111122345778999999998899999999999999999998 9999876533222   111111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                          ..          ....+..++..+.+|+.+||+.||.+|||+.+|++.|+.+...
T Consensus       331 ----~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          331 ----GG----------RLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             ----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CC----------CCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence                10          0112233567899999999999999999999999999988754

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-46  Score=371.00  Aligned_cols=273  Identities=27%  Similarity=0.408  Sum_probs=220.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+.....    .....+..||||++..... .....+.+|+.+++++ +||||++++++
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~  143 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDK----DKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA  143 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSST----TCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccc----cccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheee
Confidence            5789999999999999999999763221    1123456899999975532 3346789999999999 99999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      +...+.    .++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.   +|+|||
T Consensus       144 ~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  216 (382)
T 3tt0_A          144 CTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD  216 (382)
T ss_dssp             ECSSSS----CEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             eccCCc----eEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCC
Confidence            987664    6999999999999999987542              4589999999999999999999999   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       217 lkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~  296 (382)
T 3tt0_A          217 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  296 (382)
T ss_dssp             CCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            999999999999999999999987654333333445567899999999999999999999999999999999 9999875


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhccc
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ  386 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~  386 (453)
                      ....   .+...+....              ....+..++.++.+|+.+||+.||.+|||+.+|++.|+.+......+
T Consensus       297 ~~~~---~~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~~  357 (382)
T 3tt0_A          297 VPVE---ELFKLLKEGH--------------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSNQ  357 (382)
T ss_dssp             CCHH---HHHHHHHTTC--------------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCSC
T ss_pred             CCHH---HHHHHHHcCC--------------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhcC
Confidence            4322   2222221110              01112234678999999999999999999999999999998765443

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=1.9e-46  Score=360.17  Aligned_cols=263  Identities=24%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           ..+..||+|.+.....   ...+.|.+|+.++++++||||+++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~   78 (294)
T 4eqm_A           10 NERYKIVDKLGGGGMSTVYLAEDT-----------ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMID   78 (294)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET-----------TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEE
T ss_pred             hccEEEEEEEccCCCEEEEEEEEC-----------CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEE
Confidence            467999999999999999999875           4577899999865432   23467899999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...+.    .++||||+++++|.+++...  .++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        79 ~~~~~~~----~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~  149 (294)
T 4eqm_A           79 VDEEDDC----YYLVMEYIEGPTLSEYIESH--GPLSVDTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKT  149 (294)
T ss_dssp             EEECSSE----EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSC
T ss_pred             eeeeCCe----EEEEEeCCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCC
Confidence            9877654    79999999999999999875  4789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++...... ........||+.|+|||++.+..++.++||||||+++|+|++|+.||........  ......
T Consensus       150 ~kl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~~  226 (294)
T 4eqm_A          150 LKIFDFGIAKALSETS-LTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQ  226 (294)
T ss_dssp             EEECCCSSSTTC--------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHH--HHHHHS
T ss_pred             EEEEeCCCcccccccc-ccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHhh
Confidence            9999999998754322 1223456799999999999999999999999999999999999999976532211  111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhHhh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-KMSEVVDILGNIISE  382 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ei~~~L~~~~~~  382 (453)
                      ...           +..........+..+.+++.+||+.||.+|| ++.++.+.|..++..
T Consensus       227 ~~~-----------~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          227 DSV-----------PNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             SCC-----------CCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             ccC-----------CCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            000           0001112234567899999999999999998 899999998887654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=5.9e-46  Score=367.64  Aligned_cols=288  Identities=20%  Similarity=0.262  Sum_probs=217.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-----------HHHHHHHHHHhccCCC
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-----------HKEWINEVNFLGVVKH  154 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-----------~~~~~~E~~~l~~l~h  154 (453)
                      .++|...++||+|+||+||+|.+..+.      ....+..||||++.......           ...+..|+..++.++|
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (364)
T 3op5_A           34 AAAWKVGLPIGQGGFGCIYLADMNSSE------SVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKY  107 (364)
T ss_dssp             CCEEEEEEECCCC-CCEEEEEEECCSS------CCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSC
T ss_pred             CCeEEEEEEEecCCCeEEEEeeecCcc------ccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccC
Confidence            568999999999999999999886321      11235789999986543211           1234566777888899


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      |||+++++++..........+|||||+ +++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus       108 ~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~-~~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~N  182 (364)
T 3op5_A          108 LGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEAN-AKRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASN  182 (364)
T ss_dssp             CCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGG
T ss_pred             CCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHH
Confidence            999999999988654344579999999 99999999764 45799999999999999999999999   99999999999


Q ss_pred             EEEc--CCCcEEEeccccccCCCCCCCCc-----cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          235 ILLD--EDYKAKLSDFGLARQGPPEGLGH-----VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       235 ILl~--~~~~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      ||++  .++.+||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       183 ill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~  262 (364)
T 3op5_A          183 LLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWE  262 (364)
T ss_dssp             EEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTG
T ss_pred             EEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999  89999999999997654321111     1134469999999999999999999999999999999999999998


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcccC
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQD  387 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~~  387 (453)
                      .........  ........  ..+..+.++.+.   ....+.++.+++..||..+|.+||++.+|++.|+.++.......
T Consensus       263 ~~~~~~~~~--~~~~~~~~--~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~  335 (364)
T 3op5_A          263 DNLKDPKYV--RDSKIRYR--ENIASLMDKCFP---AANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKD  335 (364)
T ss_dssp             GGTTCHHHH--HHHHHHHH--HCHHHHHHHHSC---TTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             ccccCHHHH--HHHHHHhh--hhHHHHHHHhcc---cccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCc
Confidence            543322111  11110000  011111111111   12346789999999999999999999999999999998876554


Q ss_pred             cccC
Q 043568          388 EVTL  391 (453)
Q Consensus       388 ~~~~  391 (453)
                      ....
T Consensus       336 ~~~~  339 (364)
T 3op5_A          336 DGKL  339 (364)
T ss_dssp             CCCC
T ss_pred             CCcc
Confidence            4433

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3e-46  Score=361.47  Aligned_cols=267  Identities=28%  Similarity=0.414  Sum_probs=216.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+...      .+..++..||||.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   95 (314)
T 2ivs_A           22 RKNLVLGKTLGEGEFGKVVKATAFHL------KGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGAC   95 (314)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEETG------GGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             hhheeeeeeecccCCeeEEEEEEecc------CcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEE
Confidence            57899999999999999999987521      112456789999987543 23346789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP----------------------TPLAWIARLKIAQDAARGLAYLHEEMD  222 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~  222 (453)
                      ...+.    .++||||+++++|.+++.....                      ..+++..++.++.||+.||.|||++  
T Consensus        96 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~--  169 (314)
T 2ivs_A           96 SQDGP----LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM--  169 (314)
T ss_dssp             CSSSS----CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             ecCCc----eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC--
Confidence            87654    6999999999999999986532                      3488999999999999999999999  


Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-  301 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-  301 (453)
                       +|+||||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ 
T Consensus       170 -~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  248 (314)
T 2ivs_A          170 -KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL  248 (314)
T ss_dssp             -TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             -CCcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence             999999999999999999999999999986544332223344567889999999999899999999999999999999 


Q ss_pred             CCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          302 GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      |..||...........+.   .    .          .....+...+..+.+|+.+||+.||.+|||+.+|++.|+.++.
T Consensus       249 g~~p~~~~~~~~~~~~~~---~----~----------~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  311 (314)
T 2ivs_A          249 GGNPYPGIPPERLFNLLK---T----G----------HRMERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMV  311 (314)
T ss_dssp             SCCSSTTCCGGGHHHHHH---T----T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCCCCHHHHHHHhh---c----C----------CcCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999997654332222111   1    0          0111223456789999999999999999999999999999876


Q ss_pred             h
Q 043568          382 E  382 (453)
Q Consensus       382 ~  382 (453)
                      .
T Consensus       312 ~  312 (314)
T 2ivs_A          312 K  312 (314)
T ss_dssp             T
T ss_pred             h
Confidence            4

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.4e-46  Score=360.12  Aligned_cols=269  Identities=25%  Similarity=0.376  Sum_probs=217.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|++...      .....+..||||.+..... ...+.+.+|+.+++++ +||||++++++
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   95 (313)
T 1t46_A           22 RNRLSFGKTLGAGAFGKVVEATAYGL------IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (313)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESS------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhHHHhhCccCCcceEEEEEeec------cccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEE
Confidence            46789999999999999999987421      1225578899999975533 3356789999999999 99999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCC----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVP----------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIF  227 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~----------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH  227 (453)
                      +...+.    .++||||+++|+|.+++.....                ..+++..++.++.|++.||.|||++   +|+|
T Consensus        96 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H  168 (313)
T 1t46_A           96 CTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIH  168 (313)
T ss_dssp             ECSSSS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EecCCC----cEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHC---Ceec
Confidence            987664    6999999999999999987542                2589999999999999999999999   9999


Q ss_pred             eccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccc
Q 043568          228 RDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV  306 (453)
Q Consensus       228 ~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~  306 (453)
                      |||||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++||||||+++|||++ |..||
T Consensus       169 ~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~  248 (313)
T 1t46_A          169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (313)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCCccceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCC
Confidence            99999999999999999999999987654433333445668889999999999999999999999999999999 99998


Q ss_pred             cCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ........  .........              ....+...+..+.+|+.+||+.||.+|||+.++++.|++++...
T Consensus       249 ~~~~~~~~--~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          249 PGMPVDSK--FYKMIKEGF--------------RMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             TTCCSSHH--HHHHHHHTC--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CcccchhH--HHHHhccCC--------------CCCCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            76533221  111111100              01112234678999999999999999999999999999988754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.9e-46  Score=370.96  Aligned_cols=265  Identities=26%  Similarity=0.457  Sum_probs=202.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||.||+|++...        ...+..||||.+.... ....+.|.+|+.++++++||||+++++++
T Consensus        44 ~~~~~~~~~lG~G~fg~Vy~~~~~~~--------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~  115 (373)
T 2qol_A           44 ATNISIDKVVGAGEFGEVCSGRLKLP--------SKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVV  115 (373)
T ss_dssp             GGGCCCCEEEEECSSSEEEEC-CBCT--------TSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             HhhceeeeEEeeCCCeEEEEEEEecC--------CCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            46799999999999999999986521        1346679999987543 23356799999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus       116 ~~~~~----~~lv~e~~~~~sL~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~k  187 (373)
T 2qol_A          116 TKSKP----VMIVTEYMENGSLDSFLRKH-DAQFTVIQLVGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCK  187 (373)
T ss_dssp             CSSSS----CEEEEECCTTCBHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEE
T ss_pred             eeCCc----eEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEE
Confidence            87654    69999999999999999764 35789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||+++......... ......+++.|+|||++.+..++.++|||||||++|||++ |+.||......   .+...+.
T Consensus       188 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~---~~~~~i~  264 (373)
T 2qol_A          188 VSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQ---DVIKAVD  264 (373)
T ss_dssp             ECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHH---HHHHHHH
T ss_pred             ECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHH---HHHHHHH
Confidence            99999998754322111 1122345778999999999999999999999999999998 99999754322   2222221


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ...              ....+..++..+.+|+.+||+.||.+||++.+|++.|+.+....
T Consensus       265 ~~~--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~~  311 (373)
T 2qol_A          265 EGY--------------RLPPPMDCPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRNP  311 (373)
T ss_dssp             TTE--------------ECCCCTTCBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCG
T ss_pred             cCC--------------CCCCCccccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhCc
Confidence            110              01112245678999999999999999999999999999998754

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.7e-46  Score=365.91  Aligned_cols=269  Identities=23%  Similarity=0.384  Sum_probs=212.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+....      ....+..||||.+.... ......+.+|+.+++++ +||||++++++
T Consensus        44 ~~~y~~~~~lG~G~~g~V~~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  117 (344)
T 1rjb_A           44 RENLEFGKVLGSGAFGKVMNATAYGIS------KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGA  117 (344)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCS------SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHceeeeeecCCCCceeEEeeeeccc------cCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            578999999999999999999975321      12456789999997543 23456789999999999 99999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVP---------------------TPLAWIARLKIAQDAARGLAYLHEEMD  222 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~  222 (453)
                      +...+.    .++||||+++|+|.+++.....                     ..+++..++.++.||+.||.|||+.  
T Consensus       118 ~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~--  191 (344)
T 1rjb_A          118 CTLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK--  191 (344)
T ss_dssp             ECSSSS----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT--
T ss_pred             EeeCCc----cEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC--
Confidence            987654    6999999999999999986532                     2478999999999999999999998  


Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-  301 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-  301 (453)
                       +|+||||||+|||++.++.+||+|||++................||+.|+|||++.+..++.++|||||||++|||++ 
T Consensus       192 -~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  270 (344)
T 1rjb_A          192 -SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL  270 (344)
T ss_dssp             -TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTT
T ss_pred             -CcccCCCChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcC
Confidence             999999999999999999999999999986543332333445678899999999999999999999999999999998 


Q ss_pred             CCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          302 GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      |..||........  +.......              .....+...+..+.+|+.+||..||.+|||+.+|++.|..+..
T Consensus       271 g~~p~~~~~~~~~--~~~~~~~~--------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~  334 (344)
T 1rjb_A          271 GVNPYPGIPVDAN--FYKLIQNG--------------FKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLA  334 (344)
T ss_dssp             SCCSSTTCCCSHH--HHHHHHTT--------------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             CCCCcccCCcHHH--HHHHHhcC--------------CCCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHH
Confidence            9999976533221  11111110              0111222346789999999999999999999999999998876


Q ss_pred             hh
Q 043568          382 EI  383 (453)
Q Consensus       382 ~~  383 (453)
                      ..
T Consensus       335 ~~  336 (344)
T 1rjb_A          335 DA  336 (344)
T ss_dssp             --
T ss_pred             HH
Confidence            53

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=6.1e-46  Score=357.07  Aligned_cols=263  Identities=25%  Similarity=0.402  Sum_probs=203.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhcc--CCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV--VKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++.             +..||||++...   ....+.+|.+++..  ++||||++++++
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~   70 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQ-------------GENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIAS   70 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEET-------------TEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEEC-------------CEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEe
Confidence            578999999999999999999853             578999998643   34556666666665  799999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeeccccccE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLH--------EEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiH~Dlkp~NI  235 (453)
                      +..........++||||+++|+|.+++..   ..+++..++.++.|++.||.|||        +.   +|+||||||+||
T Consensus        71 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Ni  144 (301)
T 3q4u_A           71 DMTSRHSSTQLWLITHYHEMGSLYDYLQL---TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNI  144 (301)
T ss_dssp             EEEEETTEEEEEEEECCCTTCBHHHHHTT---CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGE
T ss_pred             eccccCCCceeEEehhhccCCCHHHHHhh---cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhE
Confidence            87765544558999999999999999954   47899999999999999999999        76   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCc--cccccccCcCCCCccccccC------CCCCchhHHHHHHHHHHHHhC-----
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGH--VSTSVVGTVGYAAPEYVQTG------RLTAKSDVWSFGVVLYELITG-----  302 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DV~SlGvil~elltg-----  302 (453)
                      |++.++.+||+|||+++.........  ......||+.|+|||++.+.      .++.++|||||||++|||++|     
T Consensus       145 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~  224 (301)
T 3q4u_A          145 LVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG  224 (301)
T ss_dssp             EECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcc
Confidence            99999999999999997543322111  12334799999999999876      455799999999999999999     


Q ss_pred             -----CccccCCCChhh--HHHHHhhhhcccCccccccccCCcCC-CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          303 -----RRAVERNLPRNE--QKLLEWVRPYVSDSKKFHLIIDPRLE-GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       303 -----~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           ..||....+...  ..+......    .     ...+.+. .......+..+.+|+.+||+.||.+|||+.+|++
T Consensus       225 ~~~~~~~pf~~~~~~~~~~~~~~~~~~~----~-----~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          225 IVEDYKPPFYDVVPNDPSFEDMRKVVCV----D-----QQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTT----S-----CCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ccccccccccccCCCCcchhhhhHHHhc----c-----CCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                 777755332211  111111100    0     0011111 1123456789999999999999999999999999


Q ss_pred             HHHHh
Q 043568          375 ILGNI  379 (453)
Q Consensus       375 ~L~~~  379 (453)
                      .|+++
T Consensus       296 ~L~~i  300 (301)
T 3q4u_A          296 TLTKI  300 (301)
T ss_dssp             HHHHH
T ss_pred             HHhcc
Confidence            99875

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=7.2e-46  Score=377.16  Aligned_cols=253  Identities=28%  Similarity=0.431  Sum_probs=209.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.             +..||||.++...  ..+.|.+|+.+|++++||||+++++++.
T Consensus       192 ~~~~~~~~~lG~G~fg~V~~~~~~-------------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~  256 (450)
T 1k9a_A          192 MKELKLLQTIGKGEFGDVMLGDYR-------------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV  256 (450)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-------------TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hHHeEEEeeecCcCCeeEEEEEec-------------CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEE
Confidence            467888999999999999999864             5689999997543  4578999999999999999999999988


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....   ..++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus       257 ~~~~---~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl  330 (450)
T 1k9a_A          257 EEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV  330 (450)
T ss_dssp             CTTS---CEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEE
T ss_pred             cCCC---ceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEE
Confidence            7653   279999999999999999877555689999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++.....     .....+++.|+|||++.+..++.++|||||||++|||++ |+.||...........   +.. 
T Consensus       331 ~DfG~a~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~---i~~-  401 (450)
T 1k9a_A          331 SDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR---VEK-  401 (450)
T ss_dssp             CCCTTCEECC-----------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHH---HHT-
T ss_pred             eeCCCccccccc-----ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH---HHc-
Confidence            999999864321     223367889999999999999999999999999999998 9999976543322111   110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                         +          .....+..++..+.+||.+||..||.+|||+.+|++.|+.+..
T Consensus       402 ---~----------~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~~~l~~~L~~i~~  445 (450)
T 1k9a_A          402 ---G----------YKMDAPDGCPPAVYDVMKNCWHLDAATRPTFLQLREQLEHIRT  445 (450)
T ss_dssp             ---T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             ---C----------CCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHH
Confidence               0          0111233457789999999999999999999999999998875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-46  Score=367.02  Aligned_cols=269  Identities=28%  Similarity=0.440  Sum_probs=214.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..++|...+.||+|+||.||+|.+....      ...++..||||.+..... .....|.+|+.++++++||||++++++
T Consensus        45 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~  118 (343)
T 1luf_A           45 PRNNIEYVRDIGEGAFGRVFQARAPGLL------PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV  118 (343)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSS------TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             cHHHCeeeeeeeecCCeeEEEEEecCcC------CCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            4688999999999999999999986321      113457899999975432 335678999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV----------------------PTPLAWIARLKIAQDAARGLAYLHEEM  221 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~  221 (453)
                      +.....    .++||||+++|+|.+++....                      ...+++..++.++.||+.||.|||++ 
T Consensus       119 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~-  193 (343)
T 1luf_A          119 CAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-  193 (343)
T ss_dssp             ECSSSS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             EccCCc----eEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC-
Confidence            987654    699999999999999998643                      25789999999999999999999999 


Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT  301 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt  301 (453)
                        +|+||||||+|||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++
T Consensus       194 --~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t  271 (343)
T 1luf_A          194 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  271 (343)
T ss_dssp             --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --CeecCCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHh
Confidence              999999999999999999999999999976433222222345578899999999999999999999999999999999


Q ss_pred             -CCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          302 -GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       302 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                       |..||.......   +...+..    ...          ...+..++..+.+|+.+||+.||.+|||+.+|++.|+++.
T Consensus       272 ~g~~p~~~~~~~~---~~~~~~~----~~~----------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~  334 (343)
T 1luf_A          272 YGLQPYYGMAHEE---VIYYVRD----GNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  334 (343)
T ss_dssp             TTCCTTTTSCHHH---HHHHHHT----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCCCcCCCCChHH---HHHHHhC----CCc----------CCCCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHH
Confidence             999997543221   2111111    000          0112345678999999999999999999999999999987


Q ss_pred             hhh
Q 043568          381 SEI  383 (453)
Q Consensus       381 ~~~  383 (453)
                      ...
T Consensus       335 ~~~  337 (343)
T 1luf_A          335 ERA  337 (343)
T ss_dssp             C--
T ss_pred             hhh
Confidence            654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.4e-45  Score=364.00  Aligned_cols=252  Identities=24%  Similarity=0.371  Sum_probs=206.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc------cHHHHHHHHHHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------GHKEWINEVNFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~nIv~  159 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||.+......      ..+.+.+|+.+|+.++||||++
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~-----------~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~   79 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREK-----------STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIIT   79 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCC
T ss_pred             hhceEEeeEEeeCcCEEEEEEEEC-----------CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCc
Confidence            567999999999999999999976           45788999999765322      3467899999999999999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++.....    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.
T Consensus        80 l~~~~~~~~~----~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~  150 (361)
T 2yab_A           80 LHDVYENRTD----VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLD  150 (361)
T ss_dssp             EEEEEECSSE----EEEEEECCCSCBHHHHHTTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESC
T ss_pred             EEEEEEeCCE----EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeC
Confidence            9999987654    79999999999999999764  5789999999999999999999998   9999999999999988


Q ss_pred             CC----cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          240 DY----KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       240 ~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      ++    .+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  
T Consensus       151 ~~~~~~~vkl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~--  225 (361)
T 2yab_A          151 KNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--  225 (361)
T ss_dssp             TTSSSCCEEECCCSSCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--
T ss_pred             CCCCccCEEEEecCCceEcCCCC---ccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHH--
Confidence            77    79999999998754321   2345679999999999999899999999999999999999999997643222  


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ....+...   ..        ..........+..+.+||.+||..||.+|||+.++++
T Consensus       226 -~~~~i~~~---~~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~  272 (361)
T 2yab_A          226 -TLANITAV---SY--------DFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALR  272 (361)
T ss_dssp             -HHHHHHTT---CC--------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             -HHHHHHhc---CC--------CCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence             21111110   00        0001112234677999999999999999999999875

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.5e-46  Score=382.72  Aligned_cols=264  Identities=24%  Similarity=0.399  Sum_probs=213.8

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEee
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ....++|...+.||+|+||+||+|.+.            .+..||||.+.... ...+.|.+|+.+|++++||||+++++
T Consensus       184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~  250 (454)
T 1qcf_A          184 EIPRESLKLEKKLGAGQFGEVWMATYN------------KHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHA  250 (454)
T ss_dssp             BCCGGGEEEEEEEECCSSEEEEEEEET------------TTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             eechHHeEEEEEcccCCceEEEEEEEC------------CccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEE
Confidence            344677888999999999999999874            35679999997543 45688999999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++....     .++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       251 ~~~~~~-----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~  322 (454)
T 1qcf_A          251 VVTKEP-----IYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLV  322 (454)
T ss_dssp             EECSSS-----CEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCC
T ss_pred             EEeCCc-----cEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCc
Confidence            986332     69999999999999999865445688899999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||+++...... ........+++.|+|||++....++.++|||||||++|||++ |+.||.......   +...+
T Consensus       323 ~kl~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i  398 (454)
T 1qcf_A          323 CKIADFGLARVIEDNE-YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPE---VIRAL  398 (454)
T ss_dssp             EEECSTTGGGGBCCHH-HHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHH---HHHHH
T ss_pred             EEEeeCCCceEcCCCc-eeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHH
Confidence            9999999998753211 111233456788999999999999999999999999999999 999997643222   22211


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      ....              ....+..++..+.+|+.+||..||++|||+.+|++.|+.+......
T Consensus       399 ~~~~--------------~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~~  448 (454)
T 1qcf_A          399 ERGY--------------RMPRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATES  448 (454)
T ss_dssp             HHTC--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSCC
T ss_pred             HcCC--------------CCCCCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhcccc
Confidence            1100              0111234567899999999999999999999999999988765433

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=1.2e-45  Score=359.65  Aligned_cols=265  Identities=25%  Similarity=0.390  Sum_probs=210.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||+||+|++...       +......||+|.+.... ......+.+|+.+++.++||||+++++++
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   84 (325)
T 3kex_A           12 ETELRKLKVLGSGVFGTVHKGVWIPE-------GESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC   84 (325)
T ss_dssp             TTTEEEEEEEECCSSCEEEEEEECCT-------TCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEE
T ss_pred             HhHceeeeeeeecCCceEEEEEEcCC-------CceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEE
Confidence            35788999999999999999997632       12234558999886443 23345678899999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        85 ~~~~-----~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~k  155 (325)
T 3kex_A           85 PGSS-----LQLVTQYLPLGSLLDHVRQH-RGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQ  155 (325)
T ss_dssp             CBSS-----EEEEEECCTTCBSHHHHHSS-GGGSCTTHHHHHHHHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEE
T ss_pred             cCCc-----cEEEEEeCCCCCHHHHHHHc-cccCCHHHHHHHHHHHHHHHHHHHhC---CCCCCccchheEEECCCCeEE
Confidence            6433     68999999999999999764 34688889999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...............||..|+|||++.+..++.++|||||||++|||++ |..||...........+.....
T Consensus       156 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~  235 (325)
T 3kex_A          156 VADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGER  235 (325)
T ss_dssp             ECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCB
T ss_pred             ECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCC
Confidence            999999987655443344456678889999999999999999999999999999999 9999976544333222221100


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                                       ...+..++..+.+|+.+||..||.+|||+.++++.|..+....
T Consensus       236 -----------------~~~~~~~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~~  278 (325)
T 3kex_A          236 -----------------LAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARDP  278 (325)
T ss_dssp             -----------------CCCCTTBCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTSH
T ss_pred             -----------------CCCCCcCcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcc
Confidence                             0111123445889999999999999999999999999887643

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.5e-45  Score=360.52  Aligned_cols=249  Identities=26%  Similarity=0.387  Sum_probs=206.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||++.+.   .......+.+|+.+|+.++||||+++++
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~   72 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREK-----------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY   72 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEE
Confidence            467999999999999999999975           45788999999754   2344567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...+.    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        73 ~~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~  143 (337)
T 1o6l_A           73 AFQTHDR----LCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGH  143 (337)
T ss_dssp             EEECSSE----EEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             EEEeCCE----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCC
Confidence            9987664    79999999999999999765  5789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+.
T Consensus       144 vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~i~  218 (337)
T 1o6l_A          144 IKITDFGLCKEGISD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE---RLFELIL  218 (337)
T ss_dssp             EEECCCTTCBCSCCT--TCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHHH
T ss_pred             EEEeeccchhhcccC--CCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHH---HHHHHHH
Confidence            999999999864322  12245668999999999999999999999999999999999999999754322   1221111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      .   ..            ..++...+.++.+||.+||..||.+||     ++.+|++
T Consensus       219 ~---~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~  260 (337)
T 1o6l_A          219 M---EE------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             H---CC------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             c---CC------------CCCCCCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHc
Confidence            0   00            011223467899999999999999999     8888875

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=3.5e-46  Score=363.27  Aligned_cols=254  Identities=25%  Similarity=0.356  Sum_probs=203.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++..... ...+.+.+|+.+++.++||||+++++++
T Consensus         6 ~~~y~i~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   74 (323)
T 3tki_A            6 VEDWDLVQTLGEGAYGEVQLAVNR-----------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR   74 (323)
T ss_dssp             TTCEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhhceeeeEEecCCCEEEEEEEEC-----------CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            478999999999999999999975           4577899999865432 2345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        75 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~k  145 (323)
T 3tki_A           75 REGNI----QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLK  145 (323)
T ss_dssp             ECSSE----EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             ecCCe----EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEE
Confidence            87654    79999999999999998765  5689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...............||+.|+|||++.+..+ +.++|||||||++|+|++|+.||........ ....+...
T Consensus       146 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~-~~~~~~~~  224 (323)
T 3tki_A          146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK  224 (323)
T ss_dssp             ECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSH-HHHHHHTT
T ss_pred             EEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHHhcc
Confidence            999999986543322233446689999999999987765 7899999999999999999999976543221 11111111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                    ..........+..+.+|+.+||..||.+|||+.++++
T Consensus       225 --------------~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eil~  261 (323)
T 3tki_A          225 --------------KTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (323)
T ss_dssp             --------------CTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             --------------cccCCccccCCHHHHHHHHHHccCChhhCcCHHHHhh
Confidence                          0000112234677899999999999999999999875

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-46  Score=365.11  Aligned_cols=271  Identities=25%  Similarity=0.394  Sum_probs=199.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||+||+|.+...+        .....||||++....  ....+.+.+|+.++++++||||+++++
T Consensus        21 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~   92 (323)
T 3qup_A           21 PEQQFTLGRMLGKGEFGSVREAQLKQED--------GSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVG   92 (323)
T ss_dssp             C---CEEEEEEEEETTEEEEEEEC---------------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCE
T ss_pred             ChhHeEEeceecccCCeEEEEEEEcccC--------CcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhc
Confidence            3578999999999999999999875321        112379999987542  334577999999999999999999999


Q ss_pred             eeeeccccc--ceEEEEEEecCCCChHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEE
Q 043568          163 YCAEDDERG--MQRLLVYELMHNKSLEDHLLSRV----PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL  236 (453)
Q Consensus       163 ~~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NIL  236 (453)
                      ++......+  ...++||||+++|+|.+++....    ...+++..++.++.|++.||.|||+.   +|+||||||+|||
T Consensus        93 ~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIl  169 (323)
T 3qup_A           93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCM  169 (323)
T ss_dssp             EEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEE
T ss_pred             eeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEE
Confidence            998765422  12489999999999999986432    23689999999999999999999999   9999999999999


Q ss_pred             EcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhH
Q 043568          237 LDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQ  315 (453)
Q Consensus       237 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~  315 (453)
                      ++.++.+||+|||+++...............+++.|+|||.+.+..++.++|||||||++|||++ |..||.........
T Consensus       170 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~  249 (323)
T 3qup_A          170 LAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIY  249 (323)
T ss_dssp             ECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH
T ss_pred             EcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHH
Confidence            99999999999999987554333333445567889999999999999999999999999999999 89998765433221


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ...   ..    ..          ....+...+..+.+|+.+||+.||.+|||+.++++.|++++...
T Consensus       250 ~~~---~~----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~  300 (323)
T 3qup_A          250 NYL---IG----GN----------RLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHL  300 (323)
T ss_dssp             HHH---HT----TC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHH---hc----CC----------CCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHh
Confidence            111   10    00          01112344678999999999999999999999999999998754

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=7.2e-45  Score=353.11  Aligned_cols=276  Identities=21%  Similarity=0.262  Sum_probs=214.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||+||+|.+.           .++..||||++.... ....+.+.+|+.++++++||||+++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   76 (319)
T 4euu_A            8 NHLWLLSDILGQGATANVFRGRHK-----------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE   76 (319)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCCEEEEEEecCCCCeEEEEEEEC-----------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEe
Confidence            367899999999999999999976           456789999997543 34467788999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE----cC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL----DE  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl----~~  239 (453)
                      ......  ..++||||+++++|.+++..... ..+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.
T Consensus        77 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~  151 (319)
T 4euu_A           77 EETTTR--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDG  151 (319)
T ss_dssp             ECTTTC--CEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTS
T ss_pred             ecCCCc--eEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCC
Confidence            766532  36999999999999999986532 3489999999999999999999999   99999999999999    78


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccc--------cCCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ--------TGRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      ++.+||+|||+++......   ......||+.|+|||++.        +..++.++|||||||++|||++|+.||.....
T Consensus       152 ~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~  228 (319)
T 4euu_A          152 QSVYKLTDFGAARELEDDE---QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG  228 (319)
T ss_dssp             CEEEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred             CceEEEccCCCceecCCCC---ceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence            8889999999998754332   234567999999999986        56789999999999999999999999975432


Q ss_pred             hh-hHHHHHhhhhcccCc----------cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          312 RN-EQKLLEWVRPYVSDS----------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       312 ~~-~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      .. ...+...+.......          ..+................+..+.+|+.+||+.||++|||+.|+++...+..
T Consensus       229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~~  308 (319)
T 4euu_A          229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (319)
T ss_dssp             GGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHT
T ss_pred             cchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHHh
Confidence            21 122221111110000          0000000111222445677889999999999999999999999998876543

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.7e-45  Score=357.96  Aligned_cols=268  Identities=17%  Similarity=0.179  Sum_probs=214.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++....  ....+.+|+.+++.+ +||||+++++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~   74 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNL-----------YTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFG   74 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEET-----------TTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEEC-----------CCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEE
Confidence            467999999999999999999975           457899999986543  234588999999999 999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc--
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK--  242 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~--  242 (453)
                      .....    .++||||+ +++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.  
T Consensus        75 ~~~~~----~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~  145 (330)
T 2izr_A           75 PCGKY----NAMVLELL-GPSLEDLFDLC-DRTFSLKTVLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKT  145 (330)
T ss_dssp             EETTE----EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTC
T ss_pred             ecCCc----cEEEEEeC-CCCHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCC
Confidence            87653    79999999 99999999864 45799999999999999999999999   9999999999999998887  


Q ss_pred             ---EEEeccccccCCCCCCCCc-----cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          243 ---AKLSDFGLARQGPPEGLGH-----VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       243 ---~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                         +||+|||+++.........     ......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       146 ~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~  225 (330)
T 2izr_A          146 QQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTL  225 (330)
T ss_dssp             TTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSH
T ss_pred             CceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccH
Confidence               9999999998653322111     12456899999999999999999999999999999999999999987544333


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhccc
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ  386 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~  386 (453)
                      ......+.......          .....+...+ ++.+++..||+.||.+||++.+|++.|+.+.......
T Consensus       226 ~~~~~~i~~~~~~~----------~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~~  286 (330)
T 2izr_A          226 KERYQKIGDTKRAT----------PIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGYM  286 (330)
T ss_dssp             HHHHHHHHHHHHHS----------CHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             HHHHHHHHhhhccC----------CHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCCC
Confidence            33222221100000          0000111234 8999999999999999999999999999998876543

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.7e-45  Score=348.58  Aligned_cols=257  Identities=30%  Similarity=0.448  Sum_probs=210.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+.            .+..||||++.... ...+.+.+|+.++++++||||+++++++.
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   75 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL------------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL   75 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET------------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEec------------CCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            367888999999999999999874            35679999997543 34577999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +...    .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        76 ~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  147 (269)
T 4hcu_A           76 EQAP----ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV  147 (269)
T ss_dssp             SSSS----EEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEE
T ss_pred             cCCc----eEEEEEeCCCCcHHHHHHhc-CcccCHHHHHHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEe
Confidence            7654    79999999999999999764 35689999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.......   ....+...
T Consensus       148 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~---~~~~~~~~  223 (269)
T 4hcu_A          148 SDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG  223 (269)
T ss_dssp             CCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT
T ss_pred             ccccccccccccc-cccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHH---HHHHHhcC
Confidence            9999998643221 112234566788999999999999999999999999999999 899987643322   11111110


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .              ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       224 ~--------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          224 F--------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             C--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             c--------------cCCCCCcCCHHHHHHHHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            0              011122235679999999999999999999999999998875

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=4.4e-45  Score=350.59  Aligned_cols=270  Identities=16%  Similarity=0.226  Sum_probs=215.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++....  ....+.+|+.+++.+ +|+||+++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~   75 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNL-----------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG   75 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET-----------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC-----------CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeec
Confidence            467999999999999999999975           457899999986443  234578899999999 899999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc--
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK--  242 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~--  242 (453)
                      .....    .++||||+ +++|.+++... ..++++..++.++.||+.||.|||+.   +|+||||||+|||++.++.  
T Consensus        76 ~~~~~----~~lv~e~~-~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~  146 (298)
T 1csn_A           76 QEGLH----NVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKN  146 (298)
T ss_dssp             EETTE----EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTT
T ss_pred             CCCce----eEEEEEec-CCCHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCC
Confidence            76654    79999999 99999999865 34689999999999999999999998   9999999999999987776  


Q ss_pred             ---EEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          243 ---AKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       243 ---~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                         +||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||........
T Consensus       147 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~  226 (298)
T 1csn_A          147 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN  226 (298)
T ss_dssp             TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred             CCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhcccc
Confidence               999999999865433211     123456799999999999999999999999999999999999999987544333


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcccC
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQD  387 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~~  387 (453)
                      ......+....... .         ....+...+..+.+|+.+||+.||.+|||+.+|++.|+++........
T Consensus       227 ~~~~~~~~~~~~~~-~---------~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~~  289 (298)
T 1csn_A          227 KQKYERIGEKKQST-P---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE  289 (298)
T ss_dssp             HHHHHHHHHHHHHS-C---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             HHHHHHHHhhccCc-c---------HHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCCC
Confidence            33222211100000 0         001112346789999999999999999999999999999998765443

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.6e-46  Score=383.73  Aligned_cols=259  Identities=25%  Similarity=0.425  Sum_probs=214.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...+.||+|+||.||+|++.           ..+..||||.+.... ...+.|.+|+.+|++++||||++++++|.
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~-----------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~l~~~~~  286 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWK-----------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT  286 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEG-----------GGTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHceeeeEecCCCCeEEEEEEEc-----------CCCeEEEEEEecCcc-cchHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence            466888899999999999999986           346789999997543 34678999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .+|||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus       287 ~~~~----~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl  359 (495)
T 1opk_A          287 REPP----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKV  359 (495)
T ss_dssp             SSSS----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEE
T ss_pred             cCCc----EEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEE
Confidence            7654    69999999999999999876667799999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++...... ........++..|+|||++....++.++|||||||++|||++ |..||.........   ..+.. 
T Consensus       360 ~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~---~~~~~-  434 (495)
T 1opk_A          360 ADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY---ELLEK-  434 (495)
T ss_dssp             CCTTCEECCTTCC-EECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH---HHHHT-
T ss_pred             eecccceeccCCc-eeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH---HHHHc-
Confidence            9999998754322 122234456789999999999999999999999999999999 89998765432221   11111 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                                   ......+..++..+.+||.+||+.||.+|||+.+|++.|+.+..
T Consensus       435 -------------~~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~el~~~L~~~~~  478 (495)
T 1opk_A          435 -------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  478 (495)
T ss_dssp             -------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSCS
T ss_pred             -------------CCCCCCCCCCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHh
Confidence                         11112233456789999999999999999999999999987753

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=3.6e-45  Score=349.57  Aligned_cols=254  Identities=28%  Similarity=0.488  Sum_probs=205.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-------HHHHHHHHHHhccCCCCcee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-------HKEWINEVNFLGVVKHPNLV  158 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-------~~~~~~E~~~l~~l~h~nIv  158 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++.......       .+.+.+|+.++++++||||+
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~   86 (287)
T 4f0f_A           18 DNEIEYEKQIGKGGFGLVHKGRLV-----------KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIV   86 (287)
T ss_dssp             STTEEEEEECCCCSSSCEEEEEET-----------TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBC
T ss_pred             hccceehhccccCCceeEEEEEEc-----------CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCch
Confidence            478999999999999999999975           457789999986543221       26789999999999999999


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeeccccccEE
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ--LIFRDFKTSNIL  236 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~NIL  236 (453)
                      ++++++....      ++||||+++|+|.+++... ..++++..++.++.|++.||.|||++   +  |+||||||+|||
T Consensus        87 ~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil  156 (287)
T 4f0f_A           87 KLYGLMHNPP------RMVMEFVPCGDLYHRLLDK-AHPIKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIF  156 (287)
T ss_dssp             CEEEEETTTT------EEEEECCTTCBHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEE
T ss_pred             hhheeecCCC------eEEEEecCCCCHHHHHhcc-cCCccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEE
Confidence            9999986543      7999999999999988765 35789999999999999999999998   8  999999999999


Q ss_pred             EcCCCc-----EEEeccccccCCCCCCCCccccccccCcCCCCccccc--cCCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          237 LDEDYK-----AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ--TGRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       237 l~~~~~-----~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                      ++.++.     +||+|||+++....     ......||+.|+|||++.  ...++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~kl~Dfg~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  231 (287)
T 4f0f_A          157 LQSLDENAPVCAKVADFGLSQQSVH-----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEY  231 (287)
T ss_dssp             ESCCCTTCSCCEEECCCTTCBCCSS-----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             EeccCCCCceeEEeCCCCccccccc-----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            988776     99999999985432     244567999999999984  456789999999999999999999999765


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      .............              .......+..++..+.+|+.+||+.||.+|||+.++++.|+++
T Consensus       232 ~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          232 SYGKIKFINMIRE--------------EGLRPTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCHHHHHHHHHH--------------SCCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             cccHHHHHHHHhc--------------cCCCCCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            4332211111111              0111122334567899999999999999999999999998763

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.4e-45  Score=359.61  Aligned_cols=264  Identities=26%  Similarity=0.407  Sum_probs=207.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-CcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||+||+|.+...       +......||+|.+... .......+.+|+.++++++||||+++++++
T Consensus        14 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-------~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   86 (327)
T 3lzb_A           14 ETEFKKIKVLGSGAFGTVYKGLWIPE-------GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGIC   86 (327)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEECCT-------TCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEE
T ss_pred             HhHceEEEEeeeCCCeEEEEEEEcCC-------CceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEE
Confidence            46799999999999999999997632       1223446788888644 334567899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++|++|+.+|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        87 ~~~~-----~~~v~~~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~k  157 (327)
T 3lzb_A           87 LTST-----VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVK  157 (327)
T ss_dssp             ESSS-----EEEEECCCSSCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEE
T ss_pred             ecCC-----ceEEEEecCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEE
Confidence            8754     58999999999999999875 35689999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...............+|+.|+|||++.+..++.++|||||||++|||++ |..||...........+...  
T Consensus       158 L~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~--  235 (327)
T 3lzb_A          158 ITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKG--  235 (327)
T ss_dssp             ECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT--
T ss_pred             EccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcC--
Confidence            999999987654333333344567889999999999999999999999999999999 99999765433322222110  


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                                     .....+...+..+.+|+.+||..||.+|||+.++++.|..+...
T Consensus       236 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          236 ---------------ERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             ---------------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             ---------------CCCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence                           01111233466799999999999999999999999999998864

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=357.47  Aligned_cols=252  Identities=24%  Similarity=0.380  Sum_probs=205.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc------cHHHHHHHHHHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------GHKEWINEVNFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~nIv~  159 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||.+......      ....+.+|+.+|+.++||||++
T Consensus        10 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~   78 (326)
T 2y0a_A           10 DDYYDTGEELGSGQFAVVKKCREK-----------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT   78 (326)
T ss_dssp             HHHEEEEEEEECCSSEEEEEEEET-----------TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccceEeceEEeeCCCeEEEEEEEC-----------CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCc
Confidence            356889999999999999999975           45778999998754322      3577999999999999999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++.....    .++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.
T Consensus        79 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~  149 (326)
T 2y0a_A           79 LHEVYENKTD----VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLD  149 (326)
T ss_dssp             EEEEEECSSE----EEEEEECCCSCBHHHHHTTS--SCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESC
T ss_pred             EEEEEEeCCE----EEEEEEcCCCCCHHHHHHhc--CCcCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEec
Confidence            9999987654    79999999999999999764  5789999999999999999999998   9999999999999998


Q ss_pred             CC----cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          240 DY----KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       240 ~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      ++    .+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.........
T Consensus       150 ~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~  226 (326)
T 2y0a_A          150 RNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL  226 (326)
T ss_dssp             SSSSSCCEEECCCTTCEECCTTS---CCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred             CCCCCCCEEEEECCCCeECCCCC---ccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence            87    79999999998754321   234567999999999999899999999999999999999999999764322211


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..+...              ............+..+.+|+.+||..||.+|||+.++++
T Consensus       227 ~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  271 (326)
T 2y0a_A          227 ANVSAV--------------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  271 (326)
T ss_dssp             HHHHHT--------------CCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHHHhc--------------CCCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            111100              000111112234577999999999999999999999886

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=9.7e-46  Score=353.57  Aligned_cols=262  Identities=27%  Similarity=0.431  Sum_probs=218.8

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...+.||+|+||+||+|.+.           ..+..||||.+... ....+.+.+|+.++++++||||+++++++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   78 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWK-----------KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVC   78 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEG-----------GGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEec-----------CCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3578999999999999999999986           34678999998643 34457799999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        79 ~~~~~----~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~  151 (288)
T 3kfa_A           79 TREPP----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVK  151 (288)
T ss_dssp             CSSSS----EEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEE
T ss_pred             ccCCC----EEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEE
Confidence            77654    79999999999999999887667899999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||..............   
T Consensus       152 l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~---  227 (288)
T 3kfa_A          152 VADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---  227 (288)
T ss_dssp             ECCCCGGGTSCSSS-SEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHT---
T ss_pred             EccCccceeccCCc-cccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc---
Confidence            99999998755332 223445567889999999999999999999999999999999 9999876543322221111   


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                                    ......+...+..+.+|+.+||..||.+|||+.++++.|+.+....
T Consensus       228 --------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~  273 (288)
T 3kfa_A          228 --------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQES  273 (288)
T ss_dssp             --------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             --------------cCCCCCCCCCCHHHHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhc
Confidence                          0111122344678999999999999999999999999999988754

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.6e-46  Score=359.37  Aligned_cols=278  Identities=24%  Similarity=0.333  Sum_probs=220.7

Q ss_pred             cHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCC
Q 043568           78 SFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHP  155 (453)
Q Consensus        78 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~  155 (453)
                      .........++|...+.||+|+||+||+|.+....      ...++..||||.+..... .....+.+|+.++.++ +||
T Consensus        18 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp   91 (316)
T 2xir_A           18 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGID------KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL   91 (316)
T ss_dssp             CHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSS------STTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             cccceecchhheeeeeEEcCCCceeEEEEEEecCC------ccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCC
Confidence            34444445688999999999999999999875321      124578899999975433 2346789999999999 799


Q ss_pred             ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPLAWIARLKIAQDAARGLAYLHEEM  221 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~  221 (453)
                      ||+++++++...+.   ..++||||+++|+|.+++.....              ..+++..++.++.|++.||.|||+. 
T Consensus        92 ~iv~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~-  167 (316)
T 2xir_A           92 NVVNLLGACTKPGG---PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR-  167 (316)
T ss_dssp             TBCCEEEEECCTTS---CCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             CeeeEEEEEecCCC---ceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhC-
Confidence            99999999876543   26999999999999999987542              2278999999999999999999999 


Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT  301 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt  301 (453)
                        +|+||||||+|||++.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|+|++
T Consensus       168 --~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t  245 (316)
T 2xir_A          168 --KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS  245 (316)
T ss_dssp             --TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHh
Confidence              999999999999999999999999999987654333333445678999999999999999999999999999999998


Q ss_pred             -CCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          302 -GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       302 -g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                       |..||........  +.......    .          ....+...+..+.+++.+||+.||.+|||+.+|++.|+.++
T Consensus       246 ~g~~p~~~~~~~~~--~~~~~~~~----~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~  309 (316)
T 2xir_A          246 LGASPYPGVKIDEE--FCRRLKEG----T----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLL  309 (316)
T ss_dssp             TSCCSSTTCCCSHH--HHHHHHHT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             CCCCCCcccchhHH--HHHHhccC----c----------cCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHH
Confidence             9999976433221  11111110    0          00112234567999999999999999999999999999998


Q ss_pred             hhh
Q 043568          381 SEI  383 (453)
Q Consensus       381 ~~~  383 (453)
                      ...
T Consensus       310 ~~~  312 (316)
T 2xir_A          310 QAN  312 (316)
T ss_dssp             HHH
T ss_pred             hhh
Confidence            754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=9.4e-46  Score=352.74  Aligned_cols=262  Identities=26%  Similarity=0.400  Sum_probs=200.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+...        ...+..||||.+..... ...+.+.+|+.++++++||||+++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   85 (281)
T 1mp8_A           14 RERIELGRCIGEGQFGDVHQGIYMSP--------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI   85 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC----------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hHHeEEEeEeeecCCeeEEEEEEecC--------CCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE
Confidence            46788999999999999999997532        13356799999865432 3346789999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+..     .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        86 ~~~~-----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  156 (281)
T 1mp8_A           86 TENP-----VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK  156 (281)
T ss_dssp             CSSS-----CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             ccCc-----cEEEEecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEE
Confidence            5432     68999999999999999765 34689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.........   ..+..
T Consensus       157 l~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~---~~i~~  232 (281)
T 1mp8_A          157 LGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVI---GRIEN  232 (281)
T ss_dssp             ECC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHH---HHHHT
T ss_pred             ECccccccccCccc-ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHH---HHHHc
Confidence            99999998754322 112334467789999999999999999999999999999997 89999765433221   11110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                          ..          ....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       233 ----~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          233 ----GE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             ----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence                00          0112234567899999999999999999999999999998865

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=4e-45  Score=353.21  Aligned_cols=261  Identities=30%  Similarity=0.458  Sum_probs=203.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+.             +..||||.+...  ...+.|.+|+.++++++||||+++++++.
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~-------------~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~   71 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR-------------AKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL   71 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET-------------TEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC-------------CeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc
Confidence            357888999999999999999863             567999998643  34577999999999999999999999887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc-E
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK-A  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~-~  243 (453)
                      +.      .++||||+++|+|.+++..... ..+++..++.++.|++.||.|||+....+|+||||||+|||++.++. +
T Consensus        72 ~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~  145 (307)
T 2eva_A           72 NP------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVL  145 (307)
T ss_dssp             TT------TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEE
T ss_pred             CC------cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEE
Confidence            42      4899999999999999987543 24788899999999999999999932229999999999999998886 7


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||......... +......
T Consensus       146 kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~-~~~~~~~  219 (307)
T 2eva_A          146 KICDFGTACDIQTH-----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR-IMWAVHN  219 (307)
T ss_dssp             EECCCCC-----------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHH-HHHHHHT
T ss_pred             EEcccccccccccc-----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHH-HHHHHhc
Confidence            99999999764321     23456999999999999999999999999999999999999999754322211 1111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcccC
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQD  387 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~~  387 (453)
                          ..          ........+..+.+|+.+||+.||.+|||+.++++.|+.+.......+
T Consensus       220 ----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~~~~  269 (307)
T 2eva_A          220 ----GT----------RPPLIKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFPGAD  269 (307)
T ss_dssp             ----TC----------CCCCBTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCCCTT
T ss_pred             ----CC----------CCCcccccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhccCCC
Confidence                00          011122346779999999999999999999999999999887665433

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=2.4e-45  Score=347.27  Aligned_cols=258  Identities=24%  Similarity=0.398  Sum_probs=209.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.            ++..||||++.... ....++.+|+.++++++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   73 (268)
T 3sxs_A            7 REEITLLKELGSGQFGVVKLGKWK------------GQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCS   73 (268)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET------------TTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheeeeeeeccCCCceEEEEEec------------CceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            467889999999999999999864            35679999997543 34577999999999999999999999997


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        74 ~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l  145 (268)
T 3sxs_A           74 KEYP----IYIVTEYISNGCLLNYLRSH-GKGLEPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKV  145 (268)
T ss_dssp             SSSS----EEEEEECCTTCBHHHHHHHH-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEE
T ss_pred             cCCc----eEEEEEccCCCcHHHHHHHc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEE
Confidence            6654    79999999999999999764 34689999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |..||............   .. 
T Consensus       146 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~---~~-  220 (268)
T 3sxs_A          146 SDFGMTRYVLDDQ-YVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKV---SQ-  220 (268)
T ss_dssp             CCTTCEEECCTTC-EEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHH---HT-
T ss_pred             ccCccceecchhh-hhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHH---Hc-
Confidence            9999998654332 122334456778999999998899999999999999999999 99998754332211111   10 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         ..          ....+...+..+.+++.+||+.||.+|||+.++++.|+.+.++
T Consensus       221 ---~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~~  265 (268)
T 3sxs_A          221 ---GH----------RLYRPHLASDTIYQIMYSCWHELPEKRPTFQQLLSSIEPLREK  265 (268)
T ss_dssp             ---TC----------CCCCCTTSCHHHHHHHHHTTCSSGGGSCCHHHHHHHHGGGCC-
T ss_pred             ---CC----------CCCCCCcChHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhhc
Confidence               00          0011122356799999999999999999999999999887643

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=3e-45  Score=350.77  Aligned_cols=261  Identities=30%  Similarity=0.505  Sum_probs=197.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++.              ..||||++.....  ...+.|.+|+.++++++||||++++++
T Consensus        23 ~~~y~~~~~lG~G~~g~Vy~~~~~--------------~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (289)
T 3og7_A           23 DGQITVGQRIGSGSFGTVYKGKWH--------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   88 (289)
T ss_dssp             TTSCEEEEEEEECSSEEEEEEESS--------------SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             ccceeeeeEecCCCCeEEEEEEEc--------------CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEee
Confidence            567999999999999999999853              2599999875432  334678999999999999999999997


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +....     .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        89 ~~~~~-----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~  159 (289)
T 3og7_A           89 STAPQ-----LAIVTQWCEGSSLYHHLHAS-ETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTV  159 (289)
T ss_dssp             ECSSS-----CEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEE
T ss_pred             ccCCc-----cEEEEEecCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCE
Confidence            65433     58999999999999998654 35789999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      ||+|||++................||+.|+|||++.   +..++.++||||||+++|+|++|+.||.......  .+...
T Consensus       160 kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~--~~~~~  237 (289)
T 3og7_A          160 KIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD--QIIEM  237 (289)
T ss_dssp             EECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH--HHHHH
T ss_pred             EEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH--HHHHH
Confidence            999999998654322223344567999999999986   5678899999999999999999999997654322  22221


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .....         ..+. .......++..+.+|+.+||+.||.+|||+.++++.|+++..
T Consensus       238 ~~~~~---------~~~~-~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~~  288 (289)
T 3og7_A          238 VGRGS---------LSPD-LSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELAR  288 (289)
T ss_dssp             HHHTS---------CCCC-TTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred             hcccc---------cCcc-hhhccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHhh
Confidence            11100         0000 011223456789999999999999999999999999988754

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=1.2e-45  Score=349.31  Aligned_cols=255  Identities=22%  Similarity=0.338  Sum_probs=207.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++.             +..||||++.....  ...+.|.+|+.++++++||||++++++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   75 (271)
T 3kmu_A            9 FKQLNFLTKLNENHSGELWKGRWQ-------------GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGA   75 (271)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEET-------------TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEE
T ss_pred             HHHhHHHHHhcCCCcceEEEEEEC-------------CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEE
Confidence            467899999999999999999963             57899999976532  334679999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeeccccccEEEcCCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ--LIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~NILl~~~~  241 (453)
                      +......  ..++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +  |+||||||+|||++.++
T Consensus        76 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~  150 (271)
T 3kmu_A           76 CQSPPAP--HPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDM  150 (271)
T ss_dssp             ECTTTSS--SCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTS
T ss_pred             EccCCCC--CeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCc
Confidence            9876322  369999999999999999887656799999999999999999999998   7  99999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCC---chhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTA---KSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      .++|+|||++....       .....||+.|+|||++.+..++.   ++|||||||++|||++|+.||.........  .
T Consensus       151 ~~~l~~~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~--~  221 (271)
T 3kmu_A          151 TARISMADVKFSFQ-------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIG--M  221 (271)
T ss_dssp             CEEEEGGGSCCTTS-------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHH--H
T ss_pred             ceeEEeccceeeec-------ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHH--H
Confidence            99999998876532       23457899999999998765444   899999999999999999999754322211  1


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .....              ......+...+..+.+++.+||+.||.+|||+.++++.|+.+.+
T Consensus       222 ~~~~~--------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~L~~l~~  270 (271)
T 3kmu_A          222 KVALE--------------GLRPTIPPGISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD  270 (271)
T ss_dssp             HHHHS--------------CCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHCC
T ss_pred             HHHhc--------------CCCCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            11100              01111223456789999999999999999999999999988753

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-45  Score=356.20  Aligned_cols=252  Identities=21%  Similarity=0.318  Sum_probs=206.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|++.           .++..||+|.+.... .....+.+|+.+++.++||||+++++++.
T Consensus         4 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~hpnIv~~~~~~~   71 (321)
T 1tki_A            4 YEKYMIAEDLGRGEFGIVHRCVET-----------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             hhceEeeeEEecCCCeEEEEEEEC-----------CCCcEEEEEEEecCc-ccHHHHHHHHHHHHhCCCCCCCeEeEEEe
Confidence            478999999999999999999975           457889999986442 34456889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC--CCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE--DYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~--~~~~  243 (453)
                      ..+.    .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.  ++.+
T Consensus        72 ~~~~----~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~  143 (321)
T 1tki_A           72 SMEE----LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTI  143 (321)
T ss_dssp             ETTE----EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCE
T ss_pred             cCCE----EEEEEEeCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCE
Confidence            7654    79999999999999999764 34689999999999999999999999   9999999999999987  7899


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|+|++|..||.......   ....+..
T Consensus       144 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~i~~  217 (321)
T 1tki_A          144 KIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMN  217 (321)
T ss_dssp             EECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHH
T ss_pred             EEEECCCCeECCCC---CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHH---HHHHHHc
Confidence            99999999876432   22445679999999999998889999999999999999999999997643221   2111111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .   ..        ..........+.++.+|+.+||..||.+|||+.++++
T Consensus       218 ~---~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~  257 (321)
T 1tki_A          218 A---EY--------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             T---CC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             C---CC--------CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            0   00        0000111234678999999999999999999999986

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=7.6e-46  Score=362.01  Aligned_cols=269  Identities=24%  Similarity=0.377  Sum_probs=214.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+...+      .......||+|.+..... ...+.+.+|+.+++.+ +||||++++++
T Consensus        45 ~~~~~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~  118 (333)
T 2i1m_A           45 RNNLQFGKTLGAGAFGKVVEATAFGLG------KEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGA  118 (333)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTCS------SSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHceeeeEeccCCCcceEEEEecCCC------cccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEE
Confidence            478999999999999999999975321      113346799999975532 3456789999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      +...+.    .++||||+++|+|.+++....            ...+++..++.++.||+.||.|||+.   +|+|||||
T Consensus       119 ~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlk  191 (333)
T 2i1m_A          119 CTHGGP----VLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVA  191 (333)
T ss_dssp             ECSSSS----CEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             EecCCc----eEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcc
Confidence            987654    699999999999999987532            34689999999999999999999998   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCC
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNL  310 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~  310 (453)
                      |+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||....
T Consensus       192 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          192 ARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            9999999999999999999986543322223345667889999999999999999999999999999999 889987643


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ....  +........              ....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+....
T Consensus       272 ~~~~--~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          272 VNSK--FYKLVKDGY--------------QMAQPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             SSHH--HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhHH--HHHHHhcCC--------------CCCCCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            3221  111111100              01112233567999999999999999999999999999887653

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2e-45  Score=349.89  Aligned_cols=261  Identities=26%  Similarity=0.426  Sum_probs=211.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.            ++..||||.+.... ...+.+.+|+.+++.++||||+++++++.
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   78 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYN------------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET------------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHhhhheeeecCCCCeEEEEEEEc------------CCcEEEEEEecCCc-ccHHHHHHHHHHHHhCCCcCcceEEEEEc
Confidence            467889999999999999999863            35679999986543 34678999999999999999999999986


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ...     .++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        79 ~~~-----~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl  150 (279)
T 1qpc_A           79 QEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKI  150 (279)
T ss_dssp             SSS-----CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             CCC-----cEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEE
Confidence            443     58999999999999999765334789999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........++..|+|||++.+..++.++||||||+++|||++ |+.||.......   +...+...
T Consensus       151 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~---~~~~~~~~  226 (279)
T 1qpc_A          151 ADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPE---VIQNLERG  226 (279)
T ss_dssp             CCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHTT
T ss_pred             CCCcccccccCcc-cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHH---HHHHHhcc
Confidence            9999998754322 112234467889999999998899999999999999999999 899987543221   22111110


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      .              ....+...+..+.+|+.+||..||++|||+.++++.|+.+......
T Consensus       227 ~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          227 Y--------------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             C--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             c--------------CCCCcccccHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            0              0111223467899999999999999999999999999999876544

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=1.2e-45  Score=359.92  Aligned_cols=284  Identities=24%  Similarity=0.312  Sum_probs=215.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|++..       .....+..||||++........+.+.+|+.++++++||||+++++++.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   94 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDP-------LGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSY   94 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECT-------TSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEecc-------CCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEe
Confidence            4679999999999999999998642       122567899999998766556677999999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+..  ..++||||+++++|.+++.... ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        95 ~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl  168 (327)
T 3lxl_A           95 GPGRQ--SLRLVMEYLPSGCLRDFLQRHR-ARLDASRLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKI  168 (327)
T ss_dssp             CSSSC--EEEEEEECCTTCBHHHHHHHHG-GGCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEE
T ss_pred             cCCCc--eEEEEEeecCCCCHHHHHHhcc-cCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEE
Confidence            54332  3789999999999999997642 3689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh-h
Q 043568          246 SDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR-P  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~-~  323 (453)
                      +|||++......... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......   ...... .
T Consensus       169 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~---~~~~~~~~  245 (327)
T 3lxl_A          169 ADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEF---LRMMGCER  245 (327)
T ss_dssp             CCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH---HHHCC---
T ss_pred             cccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchh---hhhccccc
Confidence            999999875433211 12334568888999999999889999999999999999999999986432110   000000 0


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      ....................+..++..+.+|+.+||+.||.+|||+.++++.|+.+......
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  307 (327)
T 3lxl_A          246 DVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSGSRG  307 (327)
T ss_dssp             -CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC------
T ss_pred             ccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhhhcC
Confidence            00000000011111112223445678899999999999999999999999999998875543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=8.1e-45  Score=349.26  Aligned_cols=252  Identities=27%  Similarity=0.386  Sum_probs=198.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--------------------------cH
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--------------------------GH  139 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--------------------------~~  139 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||++......                          ..
T Consensus        12 ~~~y~~~~~lG~G~~g~Vy~a~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   80 (298)
T 2zv2_A           12 LNQYTLKDEIGKGSYGVVKLAYNE-----------NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI   80 (298)
T ss_dssp             ETTEEEEEEEEC--CCEEEEEEET-----------TTTEEEEEEEEECC-------------------------------
T ss_pred             ecceEEEeEEeecCCEEEEEEEEC-----------CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchH
Confidence            468999999999999999999875           45788999998654311                          13


Q ss_pred             HHHHHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh
Q 043568          140 KEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE  219 (453)
Q Consensus       140 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~  219 (453)
                      +.+.+|+.+|++++||||+++++++.....  ...++||||+++++|.+++..   .++++..++.++.||+.||.|||+
T Consensus        81 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~lv~e~~~~~~l~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~  155 (298)
T 2zv2_A           81 EQVYQEIAILKKLDHPNVVKLVEVLDDPNE--DHLYMVFELVNQGPVMEVPTL---KPLSEDQARFYFQDLIKGIEYLHY  155 (298)
T ss_dssp             CHHHHHHHHHHTCCCTTBCCEEEEEECSSS--SEEEEEEECCTTCBSCCSSCS---SCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcCCC--CEEEEEEecCCCCcHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHH
Confidence            568899999999999999999999986432  237999999999999886543   478999999999999999999999


Q ss_pred             CCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC---CCCchhHHHHHHHH
Q 043568          220 EMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR---LTAKSDVWSFGVVL  296 (453)
Q Consensus       220 ~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SlGvil  296 (453)
                      .   +|+||||||+|||++.++.+||+|||+++......  .......||+.|+|||++.+..   ++.++|||||||++
T Consensus       156 ~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l  230 (298)
T 2zv2_A          156 Q---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD--ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL  230 (298)
T ss_dssp             T---TEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS--CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHH
T ss_pred             C---CeeccCCCHHHEEECCCCCEEEecCCCcccccccc--ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHH
Confidence            9   99999999999999999999999999998754321  2234567999999999997655   37889999999999


Q ss_pred             HHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          297 YELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       297 ~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      |+|++|+.||.......   +...+...   .          .........+..+.+|+.+||+.||++|||+.++++
T Consensus       231 ~~l~~g~~pf~~~~~~~---~~~~~~~~---~----------~~~~~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~  292 (298)
T 2zv2_A          231 YCFVFGQCPFMDERIMC---LHSKIKSQ---A----------LEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEIKL  292 (298)
T ss_dssp             HHHHHSSCSSCCSSHHH---HHHHHHHC---C----------CCCCSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHHCCCCCCCccHHH---HHHHHhcc---c----------CCCCCccccCHHHHHHHHHHhhcChhhCCCHHHHhc
Confidence            99999999997543221   11111100   0          000111234577999999999999999999999874

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2.9e-45  Score=355.85  Aligned_cols=281  Identities=27%  Similarity=0.387  Sum_probs=214.3

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      |...+.||+|+||+||++.+..       ....++..||||++..... .....+.+|+.++++++||||+++++++...
T Consensus        33 ~~~~~~lG~G~~g~V~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           33 LKKIRDLGEGHFGKVSLYCYDP-------TNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDA  105 (318)
T ss_dssp             EEEEEEEEECSSEEEEEEEECS-------CC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET
T ss_pred             HhhhheecCCCCeEEEEEEEcc-------CCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecC
Confidence            4888999999999999997642       1224678999999976532 3356789999999999999999999999875


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEec
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSD  247 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~D  247 (453)
                      +..  ..++||||+++|+|.+++...   .+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+|
T Consensus       106 ~~~--~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~D  177 (318)
T 3lxp_A          106 GAA--SLQLVMEYVPLGSLRDYLPRH---SIGLAQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGD  177 (318)
T ss_dssp             TTT--EEEEEECCCTTCBHHHHGGGS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECC
T ss_pred             CCc--eEEEEEecccCCcHHHHHhhC---CCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECC
Confidence            432  378999999999999999765   489999999999999999999999   999999999999999999999999


Q ss_pred             cccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          248 FGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       248 FGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      ||++......... .......+|..|+|||++.+..++.++||||||+++|+|++|..||....... .....+..... 
T Consensus       178 fg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~-~~~~~~~~~~~-  255 (318)
T 3lxp_A          178 FGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKF-LELIGIAQGQM-  255 (318)
T ss_dssp             GGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHH-HHHHCSCCHHH-
T ss_pred             ccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhh-hhhhcccccch-
Confidence            9999876543211 12344568889999999999899999999999999999999999986431110 00000000000 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhccc
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ  386 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~  386 (453)
                      .................+..++..+.+|+.+||+.||.+|||+.++++.|+.+.+....+
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~~  315 (318)
T 3lxp_A          256 TVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQGQ  315 (318)
T ss_dssp             HHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC-
T ss_pred             hHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhccC
Confidence            000001111111122233455778999999999999999999999999999998877543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-44  Score=347.00  Aligned_cols=266  Identities=22%  Similarity=0.298  Sum_probs=201.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||+||+|.+.           .++..||||++.....  .....+.+|+.++++++||||+++++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   70 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNR-----------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL   70 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEEC-----------CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEE
Confidence            57889999999999999999975           4577899999975533  2346788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++ +|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        71 ~~~~~----~~lv~e~~~~-~l~~~~~~~-~~~l~~~~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~k  141 (292)
T 3o0g_A           71 HSDKK----LTLVFEFCDQ-DLKKYFDSC-NGDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             EETTE----EEEEEECCSE-EHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             EeCCE----EEEEEecCCC-CHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEE
Confidence            87654    7999999965 666656543 35789999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCC-CCCchhHHHHHHHHHHHHhCCccccCCCChhhH--HHHHhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ--KLLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~--~~~~~~  321 (453)
                      |+|||+++.....  ........||+.|+|||++.+.. ++.++|||||||++|||++|..||.........  .+....
T Consensus       142 l~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~  219 (292)
T 3o0g_A          142 LANFGLARAFGIP--VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_dssp             ECCCTTCEECCSC--CSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred             EeecccceecCCc--cccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHh
Confidence            9999999865422  12234567899999999997765 899999999999999999998886544332211  111111


Q ss_pred             hhccc-CccccccccC---------CcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVS-DSKKFHLIID---------PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~-~~~~~~~~~~---------~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..... .-.......+         ...........+..+.+|+.+||+.||++|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  282 (292)
T 3o0g_A          220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhc
Confidence            00000 0000000000         00011122345678999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=5.7e-45  Score=347.49  Aligned_cols=258  Identities=24%  Similarity=0.415  Sum_probs=207.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+.            ++..||||++.... ...+++.+|+.++++++||||+++++++.
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   89 (283)
T 3gen_A           23 PKDLTFLKELGTGQFGVVKYGKWR------------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCT   89 (283)
T ss_dssp             GGGEEEEEECC---CEEEEEEEET------------TTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHHHhHhhcCCCCCceEEEEEEc------------CCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEe
Confidence            567888999999999999999864            35679999997543 34577999999999999999999999997


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        90 ~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl  161 (283)
T 3gen_A           90 KQRP----IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV  161 (283)
T ss_dssp             SSSS----EEEEECCCTTCBHHHHHHCG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEE
T ss_pred             cCCC----eEEEEeccCCCcHHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEE
Confidence            7654    79999999999999999763 24689999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........   +...
T Consensus       162 ~Dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~---~~~~  237 (283)
T 3gen_A          162 SDFGLSRYVLDDE-YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEH---IAQG  237 (283)
T ss_dssp             CSTTGGGGBCCHH-HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHH---HHTT
T ss_pred             ccccccccccccc-cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHH---Hhcc
Confidence            9999998643221 111234456788999999999999999999999999999998 9999976543222111   1110


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                                    .....+...+..+.+|+.+||+.+|.+|||+.++++.|..+..+
T Consensus       238 --------------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          238 --------------LRLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             --------------CCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --------------cCCCCCCcCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence                          00111222356799999999999999999999999999998864

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=9.6e-46  Score=376.46  Aligned_cols=260  Identities=28%  Similarity=0.438  Sum_probs=207.2

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...+.||+|+||.||+|.+.            ....||||.+.... ...+.|.+|+.+|++++||||+++++++
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~  248 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWN------------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  248 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEET------------TTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             ChhHceeeeeecCCCCeEEEEEEEC------------CCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3567888899999999999999874            24579999997543 3457899999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++||||+++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus       249 ~~~~-----~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~k  320 (452)
T 1fmk_A          249 SEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK  320 (452)
T ss_dssp             CSSS-----CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             cCCc-----eEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEE
Confidence            7632     69999999999999999865445689999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...... ........++..|+|||++.+..++.++|||||||++|||++ |+.||.......   +...+..
T Consensus       321 l~DfG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~---~~~~i~~  396 (452)
T 1fmk_A          321 VADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER  396 (452)
T ss_dssp             ECCCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT
T ss_pred             ECCCccceecCCCc-eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc
Confidence            99999998754321 112234457889999999999999999999999999999999 899987543222   2221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                          ..          ....+..++..+.+|+.+||+.||++|||+.+|++.|+.+....
T Consensus       397 ----~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~  442 (452)
T 1fmk_A          397 ----GY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  442 (452)
T ss_dssp             ----TC----------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ----CC----------CCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhccC
Confidence                00          11122345678999999999999999999999999999887654

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=5.9e-45  Score=361.93  Aligned_cols=251  Identities=28%  Similarity=0.398  Sum_probs=206.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||+|++....   ......+.+|+.+|+.++||||+++++
T Consensus        14 ~~~y~i~~~LG~G~fG~V~~~~~~-----------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~   82 (384)
T 4fr4_A           14 FDHFEILRAIGKGSFGKVCIVQKN-----------DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY   82 (384)
T ss_dssp             GGGEEEEEEEECCTTCCEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hHHeEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            367999999999999999999976           457789999986532   234577889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        83 ~~~~~~~----~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~  153 (384)
T 4fr4_A           83 SFQDEED----MFMVVDLLLGGDLRYHLQQN--VHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGH  153 (384)
T ss_dssp             EEECSSE----EEEEECCCTTEEHHHHHHTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             EEEeCCE----EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCC
Confidence            9987664    79999999999999999865  5789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      +||+|||+++.....   .......||+.|+|||++..   ..++.++|||||||++|||++|+.||..........+..
T Consensus       154 vkL~DFG~a~~~~~~---~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~  230 (384)
T 4fr4_A          154 VHITDFNIAAMLPRE---TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVH  230 (384)
T ss_dssp             EEECCCTTCEECCTT---CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHH
T ss_pred             EEEeccceeeeccCC---CceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHH
Confidence            999999999875432   23456789999999999864   458999999999999999999999997654433333332


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-HHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-MSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ei~~  374 (453)
                      ......               ..++...+..+.+||.+||..||.+||+ +.+|.+
T Consensus       231 ~~~~~~---------------~~~p~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~  271 (384)
T 4fr4_A          231 TFETTV---------------VTYPSAWSQEMVSLLKKLLEPNPDQRFSQLSDVQN  271 (384)
T ss_dssp             HHHHCC---------------CCCCTTSCHHHHHHHHHHSCSSGGGSCCSHHHHHT
T ss_pred             HHhhcc---------------cCCCCcCCHHHHHHHHHHhcCCHhHhcccHHHHHc
Confidence            221110               1122334678999999999999999999 666653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.4e-45  Score=358.84  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=203.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++....   ......+.+|+.+++.++||||+++++
T Consensus         8 i~~Y~i~~~lG~G~~g~V~~a~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~   76 (336)
T 3h4j_B            8 IGPYIIRETLGEGSFGKVKLATHY-----------KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYD   76 (336)
T ss_dssp             ETTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCCEEEEEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            468999999999999999999975           457789999986432   223457889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+ +|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        77 ~~~~~~~----~~lv~E~~-~g~l~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~  146 (336)
T 3h4j_B           77 VITTPTD----IVMVIEYA-GGELFDYIVEK--KRMTEDEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLN  146 (336)
T ss_dssp             EEECSSE----EEEEECCC-CEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCC
T ss_pred             EEEeCCE----EEEEEECC-CCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCC
Confidence            9987664    79999999 78999988765  5689999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||++......   .......||+.|+|||++.+..+ ++++|||||||++|+|++|+.||........       
T Consensus       147 ~kl~DFG~s~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~-------  216 (336)
T 3h4j_B          147 VKIADFGLSNIMTDG---NFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNL-------  216 (336)
T ss_dssp             EEECCSSCTBTTTTS---BTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTC-------
T ss_pred             EEEEEeccceeccCC---cccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHH-------
Confidence            999999999875432   22345679999999999987775 7899999999999999999999975422110       


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               ...+...  ....+...+..+.+|+.+||..||.+|||+.++++
T Consensus       217 ---------~~~i~~~--~~~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~  258 (336)
T 3h4j_B          217 ---------FKKVNSC--VYVMPDFLSPGAQSLIRRMIVADPMQRITIQEIRR  258 (336)
T ss_dssp             ---------BCCCCSS--CCCCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTT
T ss_pred             ---------HHHHHcC--CCCCcccCCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence                     0000000  11123345678999999999999999999999985

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=5e-45  Score=353.05  Aligned_cols=265  Identities=25%  Similarity=0.364  Sum_probs=202.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++.......   ...+.+|+.++++++||||+++++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~   79 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDL-----------RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD   79 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEEC-----------CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEE
Confidence            468999999999999999999975           457899999997653332   356889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++......+...++||||+++++|.+++...  .++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        80 ~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~  154 (311)
T 3ork_A           80 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA  154 (311)
T ss_dssp             EEEEEETTEEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSC
T ss_pred             eeeccCCCCcccEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCC
Confidence            9987765544569999999999999999865  4789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||+++........ .......||+.|+|||++.+..++.++|||||||++|||++|+.||....+...  .....
T Consensus       155 ~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~--~~~~~  232 (311)
T 3ork_A          155 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHV  232 (311)
T ss_dssp             EEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH
T ss_pred             EEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHh
Confidence            999999999865432211 123345799999999999999999999999999999999999999976533221  11111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH-HHHHHhH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV-DILGNII  380 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~-~~L~~~~  380 (453)
                      ..    ..        ..........+..+.+|+.+||+.||.+||+..+++ ..|..+.
T Consensus       233 ~~----~~--------~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~  280 (311)
T 3ork_A          233 RE----DP--------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  280 (311)
T ss_dssp             HC----CC--------CCHHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             cC----CC--------CCcccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHh
Confidence            10    00        000011123467899999999999999999766655 4444443

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=3.5e-45  Score=349.90  Aligned_cols=261  Identities=24%  Similarity=0.411  Sum_probs=207.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+...+..    ....+..||+|.+........+.+.+|+.++++++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~----~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   82 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDY----GQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCV   82 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGG----GCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEEC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEeccccc----ccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEE
Confidence            46788999999999999999998743210    00113579999997766666788999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc---
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK---  242 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~---  242 (453)
                      ..+.    .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.   
T Consensus        83 ~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~  154 (289)
T 4fvq_A           83 CGDE----NILVQEFVKFGSLDTYLKKN-KNCINILWKLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKT  154 (289)
T ss_dssp             CTTC----CEEEEECCTTCBHHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGG
T ss_pred             eCCC----CEEEEECCCCCCHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccc
Confidence            7664    58999999999999999875 33489999999999999999999999   9999999999999998887   


Q ss_pred             -----EEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          243 -----AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       243 -----~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                           +||+|||++.....      .....||+.|+|||++.+ ..++.++|||||||++|||++|..|+..........
T Consensus       155 ~~~~~~kl~Dfg~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~  228 (289)
T 4fvq_A          155 GNPPFIKLSDPGISITVLP------KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKL  228 (289)
T ss_dssp             TBCCEEEECCCCSCTTTSC------HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHH
T ss_pred             cccceeeeccCcccccccC------ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHH
Confidence                 99999999976432      234568999999999987 779999999999999999999765554433222111


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                        .....    ...            .+...+.++.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       229 --~~~~~----~~~------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p  276 (289)
T 4fvq_A          229 --QFYED----RHQ------------LPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTP  276 (289)
T ss_dssp             --HHHHT----TCC------------CCCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC--
T ss_pred             --HHhhc----cCC------------CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence              11110    000            0111234588999999999999999999999999988763

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=3.7e-45  Score=351.94  Aligned_cols=278  Identities=25%  Similarity=0.369  Sum_probs=210.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .+.|...+.||+|+||.||+|++..       .....+..||||++.... ......+.+|+.+++.++||||+++++++
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   92 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDP-------EGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGIC   92 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECT-------TSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhhhhhhhccCCCCceEEEEEEEcc-------ccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEE
Confidence            3558888999999999999998532       122567899999997543 34457899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+..  ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        93 ~~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k  166 (302)
T 4e5w_A           93 TEDGGN--GIKLIMEFLPSGSLKEYLPKN-KNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVK  166 (302)
T ss_dssp             EC---C--CEEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEE
T ss_pred             ecCCCc--eEEEEEEeCCCCcHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEE
Confidence            876432  368999999999999999654 25689999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||++......... .......||..|+|||++.+..++.++||||||+++|+|++|..|+.....    .......+
T Consensus       167 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~----~~~~~~~~  242 (302)
T 4e5w_A          167 IGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMA----LFLKMIGP  242 (302)
T ss_dssp             ECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH----HHHHHHCS
T ss_pred             ECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhh----HHhhccCC
Confidence            9999999875543211 223455788899999999999999999999999999999999988643210    00000000


Q ss_pred             cccCc--cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          324 YVSDS--KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       324 ~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      .....  ...............+...+..+.+|+.+||+.||.+|||+.++++.|++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          243 THGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             CCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             cccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            00000  0000001111112223455678999999999999999999999999999876

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=2.5e-45  Score=347.60  Aligned_cols=254  Identities=30%  Similarity=0.454  Sum_probs=195.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc----ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF----QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~----~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .++|...+.||+|+||+||+|.+.             +..||||++.....    ...+.+.+|+.+++.++||||++++
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~   72 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI-------------GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALR   72 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET-------------TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc-------------CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEE
Confidence            467889999999999999999863             56899999865432    2346789999999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC--
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE--  239 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~--  239 (453)
                      +++.....    .++||||+++++|.+++..   ..+++..++.++.|++.||.|||++...+|+||||||+|||++.  
T Consensus        73 ~~~~~~~~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~  145 (271)
T 3dtc_A           73 GVCLKEPN----LCLVMEFARGGPLNRVLSG---KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV  145 (271)
T ss_dssp             EEECCC------CEEEEECCTTEEHHHHHTS---SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCC
T ss_pred             EEEecCCc----eEEEEEcCCCCCHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEeccc
Confidence            99987654    6999999999999998864   47899999999999999999999982222999999999999986  


Q ss_pred             ------CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          240 ------DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       240 ------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                            ++.+||+|||++......    ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.......
T Consensus       146 ~~~~~~~~~~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~  221 (271)
T 3dtc_A          146 ENGDLSNKILKITDFGLAREWHRT----TKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLA  221 (271)
T ss_dssp             SSSCCSSCCEEECCCCC-----------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHH
T ss_pred             ccccccCcceEEccCCcccccccc----cccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence                  778999999999865432    1234579999999999999999999999999999999999999997643221


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ....  ...              .......+...+..+.+++.+||+.||.+|||+.++++.|+++
T Consensus       222 ~~~~--~~~--------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          222 VAYG--VAM--------------NKLALPIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             HHHH--HHT--------------SCCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             HHHh--hhc--------------CCCCCCCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            1111  000              0111122334567899999999999999999999999999754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.4e-45  Score=352.89  Aligned_cols=272  Identities=24%  Similarity=0.391  Sum_probs=204.8

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||+||+|.+...        ...+..||||.+.....  .....+.+|+.++++++||||+++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~  103 (313)
T 3brb_A           32 DRNLLILGKILGEGEFGSVMEGNLKQE--------DGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLG  103 (313)
T ss_dssp             CGGGEEEEEEEEC-CCCCEEEEEEECT--------TSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCE
T ss_pred             CHHHeeeccceeecCCeEEEEEEEecc--------CCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeE
Confidence            367899999999999999999987531        13456899999875432  33467899999999999999999999


Q ss_pred             eeeeccccc-ceEEEEEEecCCCChHHhhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          163 YCAEDDERG-MQRLLVYELMHNKSLEDHLLSR----VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       163 ~~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~----~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      ++......+ ...++||||+++|+|.+++...    ....+++..++.++.||+.||.|||+.   +|+||||||+|||+
T Consensus       104 ~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli  180 (313)
T 3brb_A          104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCML  180 (313)
T ss_dssp             EEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEE
T ss_pred             EEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEE
Confidence            998765422 1368999999999999998532    245799999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHH
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQK  316 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~  316 (453)
                      +.++.+||+|||++................+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus       181 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  260 (313)
T 3brb_A          181 RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYD  260 (313)
T ss_dssp             CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHH
T ss_pred             cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence            9999999999999987544332233345567889999999999999999999999999999999 888887543322211


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      .   ...    ..          ....+...+..+.+|+.+||..||.+|||+.++++.|+.+...+.
T Consensus       261 ~---~~~----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          261 Y---LLH----GH----------RLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             H---HHT----TC----------CCCCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             H---HHc----CC----------CCCCCccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            1   110    00          011223456789999999999999999999999999999987653

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=7.6e-45  Score=359.31  Aligned_cols=253  Identities=23%  Similarity=0.372  Sum_probs=206.0

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||.||+|.++           .++..||+|++.....  .....+.+|+.+++.++||||+++++
T Consensus        27 ~~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~   95 (362)
T 2bdw_A           27 FSDNYDVKEELGKGAFSVVRRCVHK-----------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHD   95 (362)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             cccCeEEeeEEecCCCeEEEEEEEC-----------CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3578999999999999999999975           4577899999975533  23467889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC--
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED--  240 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~--  240 (453)
                      ++.+...    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.+  
T Consensus        96 ~~~~~~~----~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~  166 (362)
T 2bdw_A           96 SIQEESF----HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAK  166 (362)
T ss_dssp             EEECSSE----EEEEECCCCSCBHHHHHTTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSST
T ss_pred             EEEeCCE----EEEEEecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCC
Confidence            9987654    79999999999999998765  5789999999999999999999999   99999999999999865  


Q ss_pred             -CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          241 -YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 -~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                       +.+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+..
T Consensus       167 ~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~---~~~~  240 (362)
T 2bdw_A          167 GAAVKLADFGLAIEVNDSE---AWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---RLYA  240 (362)
T ss_dssp             TCCEEECCCTTCBCCTTCC---SCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHH
T ss_pred             CCCEEEeecCcceEecCCc---ccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHH
Confidence             459999999998754322   234567999999999999989999999999999999999999999764322   2222


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+....           ...........+.++.+|+.+||..||.+|||+.++++
T Consensus       241 ~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  284 (362)
T 2bdw_A          241 QIKAGA-----------YDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  284 (362)
T ss_dssp             HHHHTC-----------CCCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhCC-----------CCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            111100           00001112234678999999999999999999999875

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.4e-45  Score=361.44  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=200.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      .++|...++||+|+||+||+|+++           .++..||||++....   ......+.+|..++..+ +||||++++
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~-----------~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~   90 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVK-----------ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLF   90 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEc-----------CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEE
Confidence            578999999999999999999976           457789999997542   23456688999999988 799999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    +++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        91 ~~~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g  161 (353)
T 3txo_A           91 CCFQTPDR----LFFVMEFVNGGDLMFHIQKS--RRFDEARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEG  161 (353)
T ss_dssp             EEEECSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred             EEEEeCCE----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCC
Confidence            99987664    79999999999999999875  5689999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+
T Consensus       162 ~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~---~~~~i  236 (353)
T 3txo_A          162 HCKLADFGMCKEGICN--GVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDD---LFEAI  236 (353)
T ss_dssp             CEEECCCTTCBCSCC-----------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred             CEEEccccceeecccC--CccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            9999999999864322  223455689999999999998899999999999999999999999997653322   22211


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH------HHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM------SEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~------~ei~~  374 (453)
                      ..   ..            ..++...+..+.+|+.+||..||.+||++      .+|++
T Consensus       237 ~~---~~------------~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~  280 (353)
T 3txo_A          237 LN---DE------------VVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILR  280 (353)
T ss_dssp             HH---CC------------CCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHT
T ss_pred             Hc---CC------------CCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhh
Confidence            11   00            01122345679999999999999999998      66654

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=9.1e-45  Score=367.54  Aligned_cols=254  Identities=23%  Similarity=0.347  Sum_probs=205.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||+||+|.+.           .++..||+|++.....  .....+.+|+.+++.++||||+++++
T Consensus         9 ~~~~Y~i~~~LG~G~fg~V~~~~~~-----------~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~   77 (444)
T 3soa_A            9 FTEEYQLFEELGKGAFSVVRRCVKV-----------LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHD   77 (444)
T ss_dssp             HHHHEEEEEEEEEC--CEEEEEEET-----------TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEE
T ss_pred             ccCCeEEEEEeccCCCeEEEEEEEC-----------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEE
Confidence            4578999999999999999999976           5678999999876543  23456889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc---C
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---E  239 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~---~  239 (453)
                      ++.+...    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++   .
T Consensus        78 ~~~~~~~----~~lv~E~~~gg~L~~~i~~~--~~~~e~~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~  148 (444)
T 3soa_A           78 SISEEGH----HYLIFDLVTGGELFEDIVAR--EYYSEADASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLK  148 (444)
T ss_dssp             EEECSSE----EEEEECCCBCCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSST
T ss_pred             EEEECCE----EEEEEEeCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCC
Confidence            9987654    79999999999999999876  5689999999999999999999999   999999999999998   5


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      ++.+||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+..
T Consensus       149 ~~~vkL~DFG~a~~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~---~~~~  223 (444)
T 3soa_A          149 GAAVKLADFGLAIEVEGEQ--QAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQH---RLYQ  223 (444)
T ss_dssp             TCCEEECCCSSCBCCCTTC--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHH
T ss_pred             CCcEEEccCceeEEecCCC--ceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHH---HHHH
Confidence            6789999999998754322  2234568999999999999989999999999999999999999999764322   2222


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+....   .        ..........+.++.+|+.+||..||.+|||+.++++
T Consensus       224 ~i~~~~---~--------~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~  267 (444)
T 3soa_A          224 QIKAGA---Y--------DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALK  267 (444)
T ss_dssp             HHHHTC---C--------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHhCC---C--------CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            111100   0        0001111234678999999999999999999999986

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-44  Score=349.72  Aligned_cols=266  Identities=24%  Similarity=0.322  Sum_probs=201.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++.            .+..||||++.....  .....+.+|+.++++++||||++++++
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~   87 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDS------------QGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDV   87 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEET------------TSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEEC------------CCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeE
Confidence            478999999999999999999863            367899999875432  224678899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||++ ++|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        88 ~~~~~~----~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~  158 (311)
T 3niz_A           88 IHSERC----LTLVFEFME-KDLKKVLDEN-KTGLQDSQIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGAL  158 (311)
T ss_dssp             ECCSSC----EEEEEECCS-EEHHHHHHTC-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCE
T ss_pred             EccCCE----EEEEEcCCC-CCHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCE
Confidence            987654    799999996 5888887764 35689999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-HHhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-LEWV  321 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-~~~~  321 (453)
                      ||+|||+++.....  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........... ....
T Consensus       159 kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~  236 (311)
T 3niz_A          159 KLADFGLARAFGIP--VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSIL  236 (311)
T ss_dssp             EECCCTTCEETTSC--CC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHH
T ss_pred             EEccCcCceecCCC--cccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHH
Confidence            99999999875422  122345678999999999876 5689999999999999999999999976554433222 1111


Q ss_pred             hhcccC----ccccc-------cccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSD----SKKFH-------LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~----~~~~~-------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......    .....       ...............+.++.+|+.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  300 (311)
T 3niz_A          237 GTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMN  300 (311)
T ss_dssp             CCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             CCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            100000    00000       000000000112234568899999999999999999999885

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=358.05  Aligned_cols=245  Identities=24%  Similarity=0.285  Sum_probs=194.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      ++|...++||+|+||+||+|++.           .++..||||++.....  .....+..|+..+..+ +||||++++++
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~  125 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSK-----------EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA  125 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEET-----------TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEEC-----------CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEE
Confidence            67999999999999999999975           4578899999865432  2234456666666655 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      |.....    .++||||+ +++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+
T Consensus       126 ~~~~~~----~~lv~e~~-~~~L~~~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~  196 (311)
T 3p1a_A          126 WEEGGI----LYLQTELC-GPSLQQHCEAW-GASLPEAQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRC  196 (311)
T ss_dssp             EEETTE----EEEEEECC-CCBHHHHHHHH-CSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCE
T ss_pred             EEeCCE----EEEEEecc-CCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCE
Confidence            987654    79999999 78999988765 35799999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||++......   .......||+.|+|||++.+ .++.++|||||||++|||++|..|+....     .... +. 
T Consensus       197 kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~-----~~~~-~~-  265 (311)
T 3p1a_A          197 KLGDFGLLVELGTA---GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE-----GWQQ-LR-  265 (311)
T ss_dssp             EECCCTTCEECC---------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH-----HHHH-HT-
T ss_pred             EEccceeeeecccC---CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc-----HHHH-Hh-
Confidence            99999999875432   22345579999999999875 78999999999999999999977664321     1100 00 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                  ............+.++.+|+.+||+.||++|||+.++++
T Consensus       266 ------------~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  304 (311)
T 3p1a_A          266 ------------QGYLPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLA  304 (311)
T ss_dssp             ------------TTCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ------------ccCCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence                        011111222344678999999999999999999999885

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9.2e-45  Score=361.38  Aligned_cols=253  Identities=22%  Similarity=0.342  Sum_probs=207.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||+|.+..........+.+|+.+|+.++||||+++++++.
T Consensus        50 ~~~y~i~~~LG~G~~g~Vy~~~~~-----------~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~  118 (387)
T 1kob_A           50 YDYYDILEELGSGAFGVVHRCVEK-----------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE  118 (387)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCEEEEEEEEC-----------CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEE
Confidence            468999999999999999999975           456789999997655445567899999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC--CCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE--DYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~--~~~~  243 (453)
                      ....    .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.  ++.+
T Consensus       119 ~~~~----~~lv~E~~~gg~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~v  190 (387)
T 1kob_A          119 DKYE----MVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV  190 (387)
T ss_dssp             CSSE----EEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCE
T ss_pred             eCCE----EEEEEEcCCCCcHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCce
Confidence            7654    79999999999999998764 34689999999999999999999998   9999999999999974  5779


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|..||.......   ....+..
T Consensus       191 kL~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~---~~~~i~~  264 (387)
T 1kob_A          191 KIIDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKR  264 (387)
T ss_dssp             EECCCTTCEECCTTS---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH
T ss_pred             EEEecccceecCCCc---ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHH---HHHHHHh
Confidence            999999998754322   2345579999999999999999999999999999999999999997643221   1111111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .   .        ...........+.++.+||.+||..||.+|||+.++++
T Consensus       265 ~---~--------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  304 (387)
T 1kob_A          265 C---D--------WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  304 (387)
T ss_dssp             C---C--------CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C---C--------CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0   0        00011112234678999999999999999999999875

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=5.8e-45  Score=354.86  Aligned_cols=257  Identities=23%  Similarity=0.368  Sum_probs=200.6

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..++|...+.||+|+||.||+|+++           .++..||||++..... ...+.+.+|+.+|++++||||++++++
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   72 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNK-----------VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNA   72 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEET-----------TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEE
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEc-----------CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3567999999999999999999975           4577899999975433 345779999999999999999999999


Q ss_pred             eeecccc-----------------------------------------------------cceEEEEEEecCCCChHHhh
Q 043568          164 CAEDDER-----------------------------------------------------GMQRLLVYELMHNKSLEDHL  190 (453)
Q Consensus       164 ~~~~~~~-----------------------------------------------------~~~~~lv~e~~~~gsL~~~l  190 (453)
                      +.+....                                                     ....++|||||++++|.+++
T Consensus        73 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~  152 (332)
T 3qd2_B           73 WLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWM  152 (332)
T ss_dssp             EEECCSCHHHHHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHH
T ss_pred             EEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHH
Confidence            8765421                                                     11379999999999999999


Q ss_pred             hcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCC---------
Q 043568          191 LSRVP-TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG---------  260 (453)
Q Consensus       191 ~~~~~-~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~---------  260 (453)
                      ..... ...++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++........         
T Consensus       153 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~  229 (332)
T 3qd2_B          153 NRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA  229 (332)
T ss_dssp             HTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECSCC------------
T ss_pred             hcccCccchhhHHHHHHHHHHHHHHHHHHhC---CeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccc
Confidence            87543 3456777899999999999999998   9999999999999999999999999999875543211         


Q ss_pred             -ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcC
Q 043568          261 -HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRL  339 (453)
Q Consensus       261 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  339 (453)
                       .......||+.|+|||++.+..++.++|||||||++|||++|..|+..     ..........             .. 
T Consensus       230 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~-------------~~-  290 (332)
T 3qd2_B          230 YATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRN-------------LK-  290 (332)
T ss_dssp             --CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHT-------------TC-
T ss_pred             cccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhc-------------cC-
Confidence             122345799999999999999999999999999999999998766431     1111111110             00 


Q ss_pred             CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          340 EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       340 ~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       291 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~  325 (332)
T 3qd2_B          291 FPLLFTQKYPQEHMMVQDMLSPSPTERPEATDIIE  325 (332)
T ss_dssp             CCHHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHH
T ss_pred             CCcccccCChhHHHHHHHHccCCCCcCCCHHHHhh
Confidence            01112334567899999999999999999999885

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=4.1e-45  Score=357.26  Aligned_cols=272  Identities=25%  Similarity=0.411  Sum_probs=215.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.....    .....+..||||++..... .....+.+|+.+++++ +||||++++++
T Consensus        34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~  109 (334)
T 2pvf_A           34 RDKLTLGKPLGEGAFGQVVMAEAVGIDK----DKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGA  109 (334)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTCST----TCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HhHeEEeeEEeecCceeEEEeEeccccc----cccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEE
Confidence            4789999999999999999999753211    1123567899999875432 3356789999999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCC--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~--------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      +.....    .++||||+++|+|.+++.....              ..+++..++.++.||+.||.|||+.   +|+|||
T Consensus       110 ~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~D  182 (334)
T 2pvf_A          110 CTQDGP----LYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRD  182 (334)
T ss_dssp             ECSSSC----CEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSC
T ss_pred             EccCCc----eEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCC
Confidence            987654    6999999999999999986532              3489999999999999999999999   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||++................+|+.|+|||++.+..++.++|||||||++|||++ |..||..
T Consensus       183 lkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~  262 (334)
T 2pvf_A          183 LAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG  262 (334)
T ss_dssp             CSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCc
Confidence            999999999999999999999987554332222344567889999999998889999999999999999999 9999875


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      .....   +...+....              ....+..++..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       263 ~~~~~---~~~~~~~~~--------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~~  322 (334)
T 2pvf_A          263 IPVEE---LFKLLKEGH--------------RMDKPANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTTN  322 (334)
T ss_dssp             CCHHH---HHHHHHHTC--------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC-
T ss_pred             CCHHH---HHHHHhcCC--------------CCCCCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcccc
Confidence            43222   221111100              0111223467899999999999999999999999999999876543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=350.11  Aligned_cols=272  Identities=26%  Similarity=0.340  Sum_probs=205.5

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-----ccHHHHHHHHHHhccCC---CCc
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-----QGHKEWINEVNFLGVVK---HPN  156 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-----~~~~~~~~E~~~l~~l~---h~n  156 (453)
                      .+++|...+.||+|+||+||+|++.           .++..||||++.....     .....+.+|+.+++.+.   |||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~n   75 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDP-----------HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPN   75 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECT-----------TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTT
T ss_pred             cccceEEEEEEecCCCeEEEEEEEC-----------CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCC
Confidence            3679999999999999999999865           4578899999864321     12346778888877764   999


Q ss_pred             eeeEeeeeeecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          157 LVKLVGYCAEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       157 Iv~l~~~~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      |+++++++...... ....++||||+. ++|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus        76 iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Ni  151 (308)
T 3g33_A           76 VVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENI  151 (308)
T ss_dssp             BCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTE
T ss_pred             eEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHE
Confidence            99999999875532 234789999995 6999999887666799999999999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      |++.++.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.........
T Consensus       152 l~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~  228 (308)
T 3g33_A          152 LVTSGGTVKLADFGLARIYSYQ---MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL  228 (308)
T ss_dssp             EECTTSCEEECSCSCTTTSTTC---CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHH
T ss_pred             EEcCCCCEEEeeCccccccCCC---cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            9999999999999999875432   2235568999999999999999999999999999999999999999765433222


Q ss_pred             HH-HHhhhhcccC----cccc-ccccCCcCC---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KL-LEWVRPYVSD----SKKF-HLIIDPRLE---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~-~~~~~~~~~~----~~~~-~~~~~~~~~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .. ..........    .... ...+.+...   .......+..+.+|+.+||+.||.+|||+.++++
T Consensus       229 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  296 (308)
T 3g33_A          229 GKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ  296 (308)
T ss_dssp             HHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhc
Confidence            11 1111100000    0000 000000000   0112234678999999999999999999999875

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.6e-45  Score=359.86  Aligned_cols=266  Identities=28%  Similarity=0.446  Sum_probs=201.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .|...++||+|+||+||+|++....        .....||||.+.... ....+.|.+|+.++++++||||++++++|..
T Consensus        90 ~~~~~~~LG~G~fg~Vy~~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~  161 (373)
T 3c1x_A           90 IVHFNEVIGRGHFGCVYHGTLLDND--------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR  161 (373)
T ss_dssp             EEEEEEEEECCSSSEEEEEEEEETT--------TEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECC
T ss_pred             eeecCcEeeeCCCeEEEEEEEECCC--------CcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEc
Confidence            4667789999999999999976321        224579999986543 3345789999999999999999999999866


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...   ..++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus       162 ~~~---~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~  234 (373)
T 3c1x_A          162 SEG---SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVA  234 (373)
T ss_dssp             CSS---CCEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCC---CeEEEEECCCCCCHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEe
Confidence            543   268999999999999999764 35688999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCCC--ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          247 DFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       247 DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |||+++........  .......+|+.|+|||++.+..++.++|||||||++|||++ |.+||..............   
T Consensus       235 DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~---  311 (373)
T 3c1x_A          235 DFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ---  311 (373)
T ss_dssp             CC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHT---
T ss_pred             eccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHc---
Confidence            99999865432211  11234567889999999999999999999999999999999 6667755433222111110   


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                          ...          ...+..++..+.+++.+||+.||.+|||+.++++.|+.+......
T Consensus       312 ----~~~----------~~~p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~  359 (373)
T 3c1x_A          312 ----GRR----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  359 (373)
T ss_dssp             ----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             ----CCC----------CCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccc
Confidence                000          011223467799999999999999999999999999999987654

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.7e-44  Score=346.84  Aligned_cols=267  Identities=28%  Similarity=0.416  Sum_probs=207.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..+|...++||+|+||+||+|++...        ......||+|.+..... ...+.+.+|+.++++++||||+++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   95 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDN--------DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC   95 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-------------CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             ceehhhcceeeecCCceEEEEEEecC--------CCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEE
Confidence            45688889999999999999987532        12345699999875432 3456789999999999999999999997


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....   ..++||||+++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        96 ~~~~~---~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~k  168 (298)
T 3f66_A           96 LRSEG---SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVK  168 (298)
T ss_dssp             CCSSS---CCEEEEECCTTCBHHHHHHCT-TCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEE
T ss_pred             EcCCC---ceEEEEeCCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEE
Confidence            76543   268999999999999999764 35689999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCC--CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhC-CccccCCCChhhHHHHHhh
Q 043568          245 LSDFGLARQGPPEGL--GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITG-RRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg-~~p~~~~~~~~~~~~~~~~  321 (453)
                      |+|||+++.......  ........+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...............
T Consensus       169 l~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~  248 (298)
T 3f66_A          169 VADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG  248 (298)
T ss_dssp             ECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTT
T ss_pred             ECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcC
Confidence            999999986543221  1123345678899999999999999999999999999999995 5555443322211111100


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                             .          ....+...+..+.+++.+||+.||.+|||+.++++.|+++.....
T Consensus       249 -------~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          249 -------R----------RLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             -------C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             -------C----------CCCCCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence                   0          001122345679999999999999999999999999999988654

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=347.04  Aligned_cols=266  Identities=28%  Similarity=0.407  Sum_probs=210.7

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      .|...++||+|+||+||+|.+...        ...+..||+|.+..... ...+.+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~--------~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   93 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQ--------AQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLP   93 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECS--------SSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECC
T ss_pred             EEccCceeccCCCceEEEEEEecC--------CCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEec
Confidence            456678999999999999997532        13355799999875433 345678999999999999999999999986


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+..   .++||||+.+|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        94 ~~~~---~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~  166 (298)
T 3pls_A           94 PEGL---PHVLLPYMCHGDLLQFIRSP-QRNPTVKDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVA  166 (298)
T ss_dssp             SSSC---CEEEECCCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEEC
T ss_pred             CCCC---cEEEEecccCCCHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeC
Confidence            6542   48999999999999999764 35789999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCC--CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCC-ChhhHHHHHhhhh
Q 043568          247 DFGLARQGPPEGL--GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL-PRNEQKLLEWVRP  323 (453)
Q Consensus       247 DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~-~~~~~~~~~~~~~  323 (453)
                      |||+++.......  ........+|+.|+|||.+.+..++.++||||||+++|+|++|..|+.... ............ 
T Consensus       167 Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~-  245 (298)
T 3pls_A          167 DFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGR-  245 (298)
T ss_dssp             CTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTC-
T ss_pred             cCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCC-
Confidence            9999986543211  112234567899999999999999999999999999999999666654332 222111111100 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                                      ....+...+..+.+|+.+||+.||.+|||+.++++.|+++...+..
T Consensus       246 ----------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~  291 (298)
T 3pls_A          246 ----------------RLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLG  291 (298)
T ss_dssp             ----------------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCS
T ss_pred             ----------------CCCCCccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhc
Confidence                            0111223457799999999999999999999999999999987644

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.2e-44  Score=345.06  Aligned_cols=262  Identities=25%  Similarity=0.401  Sum_probs=209.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|++...        ...+..||||.+.... ....+.|.+|+.+++.++||||+++++++
T Consensus        11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   82 (281)
T 3cc6_A           11 REDVVLNRILGEGFFGEVYEGVYTNH--------KGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII   82 (281)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEECT--------TCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEE
T ss_pred             ccceEEEEEEEecCCeeEEEeEEcCC--------CCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEE
Confidence            57899999999999999999997632        1335679999987553 23457789999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        83 ~~~~-----~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  153 (281)
T 3cc6_A           83 EEEP-----TWIIMELYPYGELGHYLERN-KNSLKVLTLVLYSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVK  153 (281)
T ss_dssp             CSSS-----CEEEEECCTTCBHHHHHHHH-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEE
T ss_pred             cCCC-----CEEEEecCCCCCHHHHHHhc-cccCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEE
Confidence            6543     58999999999999999764 35689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||...........+...  
T Consensus       154 l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~--  230 (281)
T 3cc6_A          154 LGDFGLSRYIEDEDY-YKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKG--  230 (281)
T ss_dssp             ECCCCGGGCC----------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHT--
T ss_pred             eCccCCCcccccccc-cccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcC--
Confidence            999999987543221 12334567889999999998999999999999999999998 99999754433222211110  


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                           .          ....+...+..+.+++.+||..||.+|||+.++++.|+.+...
T Consensus       231 -----~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          231 -----D----------RLPKPDLCPPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             -----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -----C----------CCCCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence                 0          0011223457799999999999999999999999999988764

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-44  Score=351.40  Aligned_cols=246  Identities=25%  Similarity=0.380  Sum_probs=204.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|++.           .++..||+|++....   ....+.+.+|+.+++.++||||+++++
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~   73 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSR-----------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG   73 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeE
Confidence            467899999999999999999975           457889999997542   234567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.+...    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        74 ~~~~~~~----~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~  144 (318)
T 1fot_A           74 TFQDAQQ----IFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGH  144 (318)
T ss_dssp             EEECSSE----EEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSC
T ss_pred             EEEeCCE----EEEEEeCCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCC
Confidence            9987654    79999999999999999875  5689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+.
T Consensus       145 ~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~---~~~~i~  216 (318)
T 1fot_A          145 IKITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEKIL  216 (318)
T ss_dssp             EEECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHH
T ss_pred             EEEeecCcceecCC-----ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            99999999987432     2345679999999999999999999999999999999999999997643221   111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      .   ..            ..++...+.++.+|+.+||..||.+||     ++++|++
T Consensus       217 ~---~~------------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~  258 (318)
T 1fot_A          217 N---AE------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  258 (318)
T ss_dssp             H---CC------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             h---CC------------CCCCCCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhc
Confidence            0   00            011223457799999999999999999     8888874

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=5.6e-45  Score=358.83  Aligned_cols=254  Identities=24%  Similarity=0.351  Sum_probs=204.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-----cccHHHHHHHHHHhccCCCCceeeE
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-----FQGHKEWINEVNFLGVVKHPNLVKL  160 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-----~~~~~~~~~E~~~l~~l~h~nIv~l  160 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||++....     ....+.+.+|+.+++.++||||+++
T Consensus        23 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~   91 (351)
T 3c0i_A           23 EDVYELCEVIGKGPFSVVRRCINR-----------ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVEL   91 (351)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccceEEeeEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcE
Confidence            357899999999999999999976           457889999986421     2245779999999999999999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ++++.....    .++|||||++++|.+++...  ....+++..+..++.||+.||.|||++   +|+||||||+|||++
T Consensus        92 ~~~~~~~~~----~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~  164 (351)
T 3c0i_A           92 LETYSSDGM----LYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLA  164 (351)
T ss_dssp             EEEEEETTE----EEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC
T ss_pred             EEEEEeCCE----EEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEe
Confidence            999987654    79999999999999888653  234689999999999999999999999   999999999999998


Q ss_pred             CCCc---EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          239 EDYK---AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       239 ~~~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      .++.   +||+|||++.......  .......||+.|+|||++.+..++.++|||||||++|+|++|..||....    .
T Consensus       165 ~~~~~~~vkl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~----~  238 (351)
T 3c0i_A          165 SKENSAPVKLGGFGVAIQLGESG--LVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK----E  238 (351)
T ss_dssp             SSSTTCCEEECCCTTCEECCTTS--CBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH----H
T ss_pred             cCCCCCcEEEecCcceeEecCCC--eeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH----H
Confidence            7655   9999999998754322  22345679999999999999999999999999999999999999997632    1


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+...+...   ...        .........+..+.+|+.+||..||.+|||+.++++
T Consensus       239 ~~~~~i~~~---~~~--------~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~  286 (351)
T 3c0i_A          239 RLFEGIIKG---KYK--------MNPRQWSHISESAKDLVRRMLMLDPAERITVYEALN  286 (351)
T ss_dssp             HHHHHHHHT---CCC--------CCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHHHHcC---CCC--------CCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            121111100   000        000011234678999999999999999999999985

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.7e-44  Score=350.43  Aligned_cols=268  Identities=25%  Similarity=0.381  Sum_probs=190.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||.+..... .....+.+|+.++++++||||+++++++
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   72 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNK-----------TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVI   72 (317)
T ss_dssp             ---------------CEEEEEECS-----------SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEEC-----------CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEE
Confidence            467899999999999999999865           4577899999875432 3346788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV----PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ...+.    .++||||++ |+|.+++....    ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus        73 ~~~~~----~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~  144 (317)
T 2pmi_A           73 HTENK----LTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKR  144 (317)
T ss_dssp             CCTTE----EEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred             EECCe----EEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCC
Confidence            87654    799999997 69999886532    34689999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH-
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL-  318 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~-  318 (453)
                      +.+||+|||+++......  .......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ 
T Consensus       145 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~  222 (317)
T 2pmi_A          145 GQLKLGDFGLARAFGIPV--NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIF  222 (317)
T ss_dssp             CCEEECCCSSCEETTSCC--CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCEEECcCccceecCCCc--ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence            999999999998654221  12345578999999999876 46899999999999999999999999765433222211 


Q ss_pred             Hhhhhc-------ccCccccccccCCcC--------CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPY-------VSDSKKFHLIIDPRL--------EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~-------~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......       ..........+....        ........+..+.+|+.+||+.||++|||+.++++
T Consensus       223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~  293 (317)
T 2pmi_A          223 DIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALH  293 (317)
T ss_dssp             HHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhC
Confidence            111000       000000000000000        00011134568999999999999999999999875

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.2e-44  Score=360.84  Aligned_cols=247  Identities=23%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      .++|...++||+|+||+||+|+++           .++..||||++.+...   .....+.+|..++.++ +||||++++
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~-----------~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~  119 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLK-----------KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH  119 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeE
Confidence            467999999999999999999976           4578899999975432   2335578899999887 899999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    ++|||||+++|+|..++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++
T Consensus       120 ~~~~~~~~----~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g  190 (396)
T 4dc2_A          120 SCFQTESR----LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEG  190 (396)
T ss_dssp             EEEECSSE----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred             EEEEECCE----EEEEEEcCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCC
Confidence            99987654    79999999999999999875  5789999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh------hH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN------EQ  315 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~------~~  315 (453)
                      .+||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ..
T Consensus       191 ~ikL~DFGla~~~~~~--~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~  268 (396)
T 4dc2_A          191 HIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  268 (396)
T ss_dssp             CEEECCCTTCBCCCCT--TCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHH
T ss_pred             CEEEeecceeeecccC--CCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHH
Confidence            9999999999863322  223456789999999999999999999999999999999999999996432111      11


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                      .+.+.+..             ..  ..++...+.++.+||.+||+.||.+||++
T Consensus       269 ~~~~~i~~-------------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  307 (396)
T 4dc2_A          269 YLFQVILE-------------KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  307 (396)
T ss_dssp             HHHHHHHH-------------CC--CCCCTTSCHHHHHHHHHHTCSCTTTSTTC
T ss_pred             HHHHHHhc-------------cc--cCCCCcCCHHHHHHHHHHhcCCHhHcCCC
Confidence            11111110             00  11223356789999999999999999996

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-44  Score=353.23  Aligned_cols=267  Identities=25%  Similarity=0.459  Sum_probs=205.9

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+|...++||+|+||+||+|.+...       ....+..||||.+..... .....+.+|+.++++++||||+++++++.
T Consensus        44 ~~~~~~~~lG~G~~g~Vy~~~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  116 (333)
T 1mqb_A           44 SCVTRQKVIGAGEFGEVYKGMLKTS-------SGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS  116 (333)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC----------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHhhcccEEecCCCeEEEEEEEecC-------CCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            4677788999999999999997632       112356799999975432 23457889999999999999999999997


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++|+|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       117 ~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl  188 (333)
T 1mqb_A          117 KYKP----MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKV  188 (333)
T ss_dssp             SSSS----EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             cCCC----cEEEEeCCCCCcHHHHHHhC-CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEE
Confidence            7554    79999999999999999764 35789999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          246 SDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      +|||+++........ .......+|+.|+|||++.+..++.++|||||||++|||++ |+.||......   .+...+..
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~---~~~~~~~~  265 (333)
T 1mqb_A          189 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH---EVMKAIND  265 (333)
T ss_dssp             CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHHT
T ss_pred             CCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHH---HHHHHHHC
Confidence            999999875432211 11223456788999999999999999999999999999999 99999654322   22221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                          ..          ....+...+..+.+|+.+||+.||.+||++.+|++.|+.+......
T Consensus       266 ----~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~~  313 (333)
T 1mqb_A          266 ----GF----------RLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPDS  313 (333)
T ss_dssp             ----TC----------CCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGGG
T ss_pred             ----CC----------cCCCcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcchh
Confidence                00          0111223467899999999999999999999999999998875443

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.2e-45  Score=354.14  Aligned_cols=267  Identities=23%  Similarity=0.325  Sum_probs=208.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++........+.+.+|+.+++.++||||+++++++.
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   96 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGL-----------HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL   96 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEET-----------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEec-----------CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEE
Confidence            468999999999999999999975           457889999987665556678999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      .........++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        97 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~  173 (317)
T 2buj_A           97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQP  173 (317)
T ss_dssp             EEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCE
T ss_pred             eccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCE
Confidence            5443334579999999999999998753  346789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCc-------cccccccCcCCCCccccccCC---CCCchhHHHHHHHHHHHHhCCccccCCCChh
Q 043568          244 KLSDFGLARQGPPEGLGH-------VSTSVVGTVGYAAPEYVQTGR---LTAKSDVWSFGVVLYELITGRRAVERNLPRN  313 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~~---~~~~~DV~SlGvil~elltg~~p~~~~~~~~  313 (453)
                      ||+|||++..........       ......||+.|+|||++.+..   ++.++|||||||++|||++|+.||.......
T Consensus       174 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~  253 (317)
T 2buj_A          174 VLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKG  253 (317)
T ss_dssp             EECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTT
T ss_pred             EEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhccc
Confidence            999999987643211000       012346799999999987544   6899999999999999999999985311000


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      . .+......              ..........+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       254 ~-~~~~~~~~--------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  306 (317)
T 2buj_A          254 D-SVALAVQN--------------QLSIPQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQP  306 (317)
T ss_dssp             S-CHHHHHHC--------------C--CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCC
T ss_pred             c-hhhHHhhc--------------cCCCCccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCC
Confidence            0 00000000              00111122346789999999999999999999999999988654

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.3e-44  Score=355.86  Aligned_cols=246  Identities=24%  Similarity=0.343  Sum_probs=205.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||++....   ......+.+|+.+|+.++||||+++++
T Consensus        40 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~  108 (350)
T 1rdq_E           40 LDQFDRIKTLGTGSFGRVMLVKHK-----------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEF  108 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             HHHCEEEEEeecCcCcEEEEEEEC-----------CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            468999999999999999999975           457789999986542   234567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.+...    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       109 ~~~~~~~----~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~  179 (350)
T 1rdq_E          109 SFKDNSN----LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGY  179 (350)
T ss_dssp             EEECSSE----EEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSC
T ss_pred             EEEcCCE----EEEEEcCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCC
Confidence            9987654    79999999999999999875  4689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|..||.......   +...+.
T Consensus       180 ~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i~  251 (350)
T 1rdq_E          180 IQVTDFGFAKRVKGR-----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIV  251 (350)
T ss_dssp             EEECCCTTCEECSSC-----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EEEcccccceeccCC-----cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHH---HHHHHH
Confidence            999999999875422     345679999999999999999999999999999999999999997643221   211111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      .   .  .          ..++...+..+.+||.+||..||.+||+     +.+|++
T Consensus       252 ~---~--~----------~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~  293 (350)
T 1rdq_E          252 S---G--K----------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             H---C--C----------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             c---C--C----------CCCCCCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHh
Confidence            1   0  0          0112234677999999999999999998     777764

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=3.8e-45  Score=369.14  Aligned_cols=264  Identities=20%  Similarity=0.252  Sum_probs=210.3

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCC
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVK  153 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~  153 (453)
                      +.+.++...+++|...++||+|+||+||+|+++           .++..||||++.+..   ......+.+|+.++..++
T Consensus        64 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----------~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~  132 (437)
T 4aw2_A           64 SKVKQMRLHREDFEILKVIGRGAFGEVAVVKLK-----------NADKVFAMKILNKWEMLKRAETACFREERDVLVNGD  132 (437)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC
T ss_pred             chhhcccCChhheEEEEEEEeCCCEEEEEEEEc-----------CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC
Confidence            345566667889999999999999999999986           457889999986532   122344889999999999


Q ss_pred             CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       154 h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      ||||++++++|.+...    ++||||||++|+|.+++... ...+++..+..++.||+.||.|||+.   +|+||||||+
T Consensus       133 hp~Iv~l~~~~~~~~~----~~lV~Ey~~gg~L~~~l~~~-~~~l~e~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~  204 (437)
T 4aw2_A          133 SKWITTLHYAFQDDNN----LYLVMDYYVGGDLLTLLSKF-EDRLPEEMARFYLAEMVIAIDSVHQL---HYVHRDIKPD  204 (437)
T ss_dssp             TTTBCCEEEEEECSSE----EEEEECCCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred             CCCEEEEEEEEeeCCE----EEEEEecCCCCcHHHHHHHc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeEecccCHH
Confidence            9999999999987664    79999999999999999764 35789999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ||||+.++.+||+|||+++...... ........||+.|+|||++.     ...++.++|||||||++|||++|+.||..
T Consensus       205 NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~  283 (437)
T 4aw2_A          205 NILMDMNGHIRLADFGSCLKLMEDG-TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYA  283 (437)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTS-CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCC
T ss_pred             HeeEcCCCCEEEcchhhhhhcccCC-CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999997654322 22234568999999999987     46789999999999999999999999976


Q ss_pred             CCChhhHHHH-HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 043568          309 NLPRNEQKLL-EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS--RPKMSEVVD  374 (453)
Q Consensus       309 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ei~~  374 (453)
                      .........+ .+... .         .-+.    .....+.++.+||.+||..+|++  ||+++++++
T Consensus       284 ~~~~~~~~~i~~~~~~-~---------~~p~----~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~  338 (437)
T 4aw2_A          284 ESLVETYGKIMNHKER-F---------QFPT----QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKK  338 (437)
T ss_dssp             SSHHHHHHHHHTHHHH-C---------CCCS----SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHT
T ss_pred             CChhHHHHhhhhcccc-c---------cCCc----ccccCCHHHHHHHHHHhcccccccCCCCHHHHhC
Confidence            5432221111 11000 0         0000    01124677999999999888888  999999875

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.4e-45  Score=358.32  Aligned_cols=249  Identities=25%  Similarity=0.410  Sum_probs=204.8

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeE
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKL  160 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l  160 (453)
                      ..++|...++||+|+||.||+|+++           .+++.||||++....   ......+..|..++..+ +||||+++
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l   83 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFK-----------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM   83 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEET-----------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcE
Confidence            4688999999999999999999976           457899999997542   23456788899999877 99999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++++.....    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.+
T Consensus        84 ~~~~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~  154 (345)
T 1xjd_A           84 FCTFQTKEN----LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKD  154 (345)
T ss_dssp             EEEEECSSE----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTT
T ss_pred             EEEEEeCCE----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCC
Confidence            999987654    79999999999999999865  4689999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...
T Consensus       155 g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~---~~~~~  229 (345)
T 1xjd_A          155 GHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE---ELFHS  229 (345)
T ss_dssp             SCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred             CCEEEeEChhhhhcccCC--CcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHH---HHHHH
Confidence            999999999998643221  2245668999999999999999999999999999999999999999764322   22221


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH-HHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS-EVV  373 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ei~  373 (453)
                      +...           .+    .++...+.++.+|+.+||..||.+||++. +|+
T Consensus       230 i~~~-----------~~----~~p~~~s~~~~~li~~lL~~dp~~R~~~~~~i~  268 (345)
T 1xjd_A          230 IRMD-----------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIR  268 (345)
T ss_dssp             HHHC-----------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGG
T ss_pred             HHhC-----------CC----CCCcccCHHHHHHHHHHhcCCHhHcCCChHHHH
Confidence            1110           00    11223457799999999999999999997 554

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=2.5e-45  Score=356.57  Aligned_cols=268  Identities=26%  Similarity=0.436  Sum_probs=212.9

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ...++|...+.||+|+||.||+|++....      ....+..||||.+..... .....+.+|+.+++.++||||+++++
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   95 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVV------KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLG   95 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEE------TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEE
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCcc------CCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEE
Confidence            34678999999999999999999876311      113457899999875432 33456889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      ++.....    .++||||+++|+|.+++....        ..++++..++.++.||+.||.|||++   +|+||||||+|
T Consensus        96 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~N  168 (322)
T 1p4o_A           96 VVSQGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARN  168 (322)
T ss_dssp             EECSSSS----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGG
T ss_pred             EEccCCc----cEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccce
Confidence            9977654    699999999999999987532        24678999999999999999999999   99999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChh
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRN  313 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~  313 (453)
                      ||++.++.+||+|||+++...............+|+.|+|||++.+..++.++|||||||++|+|++ |..||.......
T Consensus       169 Ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~  248 (322)
T 1p4o_A          169 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ  248 (322)
T ss_dssp             EEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHH
T ss_pred             EEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHH
Confidence            9999999999999999986433222222344567899999999999999999999999999999999 888886543221


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                         +...+..    ...          ...+...+..+.+|+.+||+.||.+|||+.++++.|+.+..
T Consensus       249 ---~~~~~~~----~~~----------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~  299 (322)
T 1p4o_A          249 ---VLRFVME----GGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  299 (322)
T ss_dssp             ---HHHHHHT----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             ---HHHHHHc----CCc----------CCCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhc
Confidence               1111110    000          01122456779999999999999999999999999987654

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=3.1e-45  Score=361.68  Aligned_cols=277  Identities=24%  Similarity=0.288  Sum_probs=213.0

Q ss_pred             CCccccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC
Q 043568           73 DLRVFSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV  152 (453)
Q Consensus        73 ~~~~~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l  152 (453)
                      ....|++.+.....++|...++||+|+||+||+|++.           .++..||||++... ......+..|+.+++.+
T Consensus        21 ~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l   88 (360)
T 3llt_A           21 EIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHI-----------DNKKYYAVKVVRNI-KKYTRSAKIEADILKKI   88 (360)
T ss_dssp             GGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHT
T ss_pred             cceeeeeecceEecCEEEEEEEEcccCCeEEEEEEEC-----------CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHh
Confidence            4455666666666899999999999999999999975           45678999998642 23345677899999988


Q ss_pred             C-----CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 043568          153 K-----HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIF  227 (453)
Q Consensus       153 ~-----h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH  227 (453)
                      .     ||||+++++++...+.    .++||||+ +++|.+++.......+++..+..++.||+.||.|||+.   +|+|
T Consensus        89 ~~~~~~h~~iv~~~~~~~~~~~----~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH  160 (360)
T 3llt_A           89 QNDDINNNNIVKYHGKFMYYDH----MCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTH  160 (360)
T ss_dssp             CCCSTTGGGBCCEEEEEEETTE----EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             cccCCCCCCeecccceeeECCe----eEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---Ceee
Confidence            6     9999999999987664    79999999 99999999887666799999999999999999999998   9999


Q ss_pred             eccccccEEEcC-------------------------CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC
Q 043568          228 RDFKTSNILLDE-------------------------DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR  282 (453)
Q Consensus       228 ~Dlkp~NILl~~-------------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  282 (453)
                      |||||+|||++.                         ++.+||+|||+++....     ......||+.|+|||++.+..
T Consensus       161 rDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~-----~~~~~~gt~~y~aPE~~~~~~  235 (360)
T 3llt_A          161 TDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD-----YHGSIINTRQYRAPEVILNLG  235 (360)
T ss_dssp             SCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS-----CCCSCCSCGGGCCHHHHTTCC
T ss_pred             CCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCC-----CCcCccCcccccCcHHHcCCC
Confidence            999999999975                         78899999999986432     234567899999999999999


Q ss_pred             CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc-------cccccccC--------CcCC-------
Q 043568          283 LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS-------KKFHLIID--------PRLE-------  340 (453)
Q Consensus       283 ~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~~~--------~~~~-------  340 (453)
                      ++.++|||||||++|+|++|+.||...........+..........       .......+        +...       
T Consensus       236 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~  315 (360)
T 3llt_A          236 WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIK  315 (360)
T ss_dssp             CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHH
T ss_pred             CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhh
Confidence            9999999999999999999999997654333222222111100000       00000000        0000       


Q ss_pred             ------CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          341 ------GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       341 ------~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                            ..+.......+.+|+.+||+.||.+|||+.++++
T Consensus       316 ~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~  355 (360)
T 3llt_A          316 HVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLK  355 (360)
T ss_dssp             HHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             hhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence                  0001111267889999999999999999999874

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.4e-44  Score=378.86  Aligned_cols=257  Identities=25%  Similarity=0.445  Sum_probs=206.3

Q ss_pred             eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeeecccccc
Q 043568           94 LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGM  172 (453)
Q Consensus        94 ~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~  172 (453)
                      .||+|+||.||+|.++..         ..+..||||+++... ....+.|.+|+.+|++++||||++++++|....    
T Consensus       343 ~LG~G~fG~Vy~~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~----  409 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMR---------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA----  409 (613)
T ss_dssp             EEEECSSSEEEEEEEECS---------SCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSS----
T ss_pred             EEecCCCcEEEEEEEecC---------CCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCC----
Confidence            799999999999987632         345679999997653 335678999999999999999999999997532    


Q ss_pred             eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccccc
Q 043568          173 QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLAR  252 (453)
Q Consensus       173 ~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~  252 (453)
                       .+|||||+++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+++
T Consensus       410 -~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~  484 (613)
T 2ozo_A          410 -LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSK  484 (613)
T ss_dssp             -EEEEEECCTTCBHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTT
T ss_pred             -eEEEEEeCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcc
Confidence             79999999999999999764 45789999999999999999999999   99999999999999999999999999998


Q ss_pred             CCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCccc
Q 043568          253 QGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKK  330 (453)
Q Consensus       253 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  330 (453)
                      ........ .......+++.|+|||++.+..++.++|||||||++|||++ |+.||........   ...+..    +. 
T Consensus       485 ~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~---~~~i~~----~~-  556 (613)
T 2ozo_A          485 ALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIEQ----GK-  556 (613)
T ss_dssp             TCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHH---HHHHHT----TC-
T ss_pred             cccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHH---HHHHHc----CC-
Confidence            75432211 11223346789999999999999999999999999999998 9999976544322   221111    11 


Q ss_pred             cccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       331 ~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                               ....+..++.++.+||.+||..||.+|||+.+|++.|+.+......
T Consensus       557 ---------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          557 ---------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             ---------CCCCCTTCCHHHHHHHHHTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             ---------CCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence                     1112334577899999999999999999999999999999877654

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=4.8e-45  Score=365.68  Aligned_cols=260  Identities=22%  Similarity=0.269  Sum_probs=207.6

Q ss_pred             HHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCC
Q 043568           79 FAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHP  155 (453)
Q Consensus        79 ~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~  155 (453)
                      +.++....++|...++||+|+||+||+|+++           .++..||+|++.+..   ......+.+|+.+++.++||
T Consensus        61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----------~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp  129 (410)
T 3v8s_A           61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHK-----------STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSP  129 (410)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCT
T ss_pred             HHhcccCccccEEEEEEEcCCCEEEEEEEEC-----------CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCC
Confidence            3445556789999999999999999999976           457789999986521   12334578999999999999


Q ss_pred             ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      ||+++++++.+...    ++|||||+++|+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+||
T Consensus       130 ~Iv~l~~~~~~~~~----~~lV~E~~~gg~L~~~l~~~---~~~e~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NI  199 (410)
T 3v8s_A          130 WVVQLFYAFQDDRY----LYMVMEYMPGGDLVNLMSNY---DVPEKWARFYTAEVVLALDAIHSM---GFIHRDVKPDNM  199 (410)
T ss_dssp             TBCCEEEEEECSSE----EEEEECCCTTEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGE
T ss_pred             CCCeEEEEEEECCE----EEEEEeCCCCCcHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHe
Confidence            99999999987654    79999999999999999764   588999999999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC----CCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR----LTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      |++.++.+||+|||+++...... ........||+.|+|||++.+..    ++.++|||||||++|||++|+.||.....
T Consensus       200 Ll~~~g~ikL~DFG~a~~~~~~~-~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~  278 (410)
T 3v8s_A          200 LLDKSGHLKLADFGTCMKMNKEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL  278 (410)
T ss_dssp             EECTTSCEEECCCTTCEECCTTS-EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred             eECCCCCEEEeccceeEeeccCC-cccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCCh
Confidence            99999999999999998754332 11234668999999999998655    78999999999999999999999976543


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCC--CCCHHHHHH
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKS--RPKMSEVVD  374 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~--RPs~~ei~~  374 (453)
                      ......+.....      .        +........+.++.+||.+||..+|.+  ||++.+|++
T Consensus       279 ~~~~~~i~~~~~------~--------~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~  329 (410)
T 3v8s_A          279 VGTYSKIMNHKN------S--------LTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKR  329 (410)
T ss_dssp             HHHHHHHHTHHH------H--------CCCCTTCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHT
T ss_pred             hhHHHHHHhccc------c--------ccCCCcccccHHHHHHHHHHccChhhhCCCCCHHHHhc
Confidence            222111110000      0        000011124577999999999999988  999999886

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=1.7e-44  Score=351.77  Aligned_cols=261  Identities=29%  Similarity=0.458  Sum_probs=208.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCe--eEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKL--DVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~--~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      .++|...+.||+|+||.||+|++..           ++.  .+|||.+.... ....+.+.+|+.+++++ +||||++++
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~-----------~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~   92 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKK-----------DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL   92 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEE-----------TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEE
T ss_pred             HHHccceeeeecCCCceEEEEEEcc-----------CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhc
Confidence            3689999999999999999999863           234  45999986432 33456789999999999 999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIF  227 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH  227 (453)
                      +++...+.    .++||||+++|+|.+++....              ...+++..++.++.||+.||.|||+.   +|+|
T Consensus        93 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH  165 (327)
T 1fvr_A           93 GACEHRGY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIH  165 (327)
T ss_dssp             EEEEETTE----EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEEC
T ss_pred             eeeeeCCc----eEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccC
Confidence            99987654    799999999999999997653              34789999999999999999999998   9999


Q ss_pred             eccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccc
Q 043568          228 RDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAV  306 (453)
Q Consensus       228 ~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~  306 (453)
                      |||||+|||++.++.+||+|||+++.....   .......+++.|+|||++.+..++.++|||||||++|||++ |+.||
T Consensus       166 ~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf  242 (327)
T 1fvr_A          166 RDLAARNILVGENYVAKIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPY  242 (327)
T ss_dssp             SCCSGGGEEECGGGCEEECCTTCEESSCEE---CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             CCCccceEEEcCCCeEEEcccCcCcccccc---ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCC
Confidence            999999999999999999999999753321   12234467889999999998889999999999999999998 99999


Q ss_pred             cCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          307 ERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       307 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      ......   .+...+..    .          .....+...+..+.+|+.+||..||.+|||+.++++.|..+.....
T Consensus       243 ~~~~~~---~~~~~~~~----~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  303 (327)
T 1fvr_A          243 CGMTCA---ELYEKLPQ----G----------YRLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEERK  303 (327)
T ss_dssp             TTCCHH---HHHHHGGG----T----------CCCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSSS
T ss_pred             CCCcHH---HHHHHhhc----C----------CCCCCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhhc
Confidence            754322   12211111    0          0111223446789999999999999999999999999999987654

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=1.2e-44  Score=346.86  Aligned_cols=263  Identities=24%  Similarity=0.386  Sum_probs=208.7

Q ss_pred             hcCCCccc-eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRAL-LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|.... .||+|+||+||+|.+...         ..+..||||++......  ..+.+.+|+.+++.++||||+++++
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   85 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMK---------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIG   85 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECS---------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             chhhhhccCccccccCeeeEeeeecCC---------CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEE
Confidence            46677777 999999999999976421         44678999999755322  2567999999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...     ..++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        86 ~~~~~-----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~  155 (291)
T 1xbb_A           86 ICEAE-----SWMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHY  155 (291)
T ss_dssp             EEESS-----SEEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTE
T ss_pred             EECCC-----CcEEEEEeCCCCCHHHHHHhC--cCCCHHHHHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCc
Confidence            99432     269999999999999999875  4689999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHh
Q 043568          243 AKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  320 (453)
                      +||+|||++......... .......+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......   +...
T Consensus       156 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~  232 (291)
T 1xbb_A          156 AKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAM  232 (291)
T ss_dssp             EEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHH
T ss_pred             EEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHH---HHHH
Confidence            999999999875433211 11233456789999999998889999999999999999999 999997643322   2221


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      +..    ..          ....+...+..+.+++.+||+.||.+|||+.+|++.|+++.....
T Consensus       233 ~~~----~~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          233 LEK----GE----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             HHT----TC----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             HHc----CC----------CCCCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            111    00          011223456789999999999999999999999999999987643

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=4.9e-45  Score=347.13  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=201.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+.             +..||||.+....  ..+.+.+|+.++++++||||+++++++.
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~   84 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR-------------GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIV   84 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-------------TEEEEEEECCCCC----HHHHHTHHHHTTCCCTTBCCEEEEEC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc-------------CCEEEEEEecchh--HHHHHHHHHHHHHhCCCCCEeeEEEEEE
Confidence            467899999999999999999853             5789999986543  4577899999999999999999999986


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....   ..++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        85 ~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l  158 (278)
T 1byg_A           85 EEKG---GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKV  158 (278)
T ss_dssp             CC-----CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEE
T ss_pred             cCCC---ceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEE
Confidence            6543   269999999999999999865434488899999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++......     .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||.......   +...+.. 
T Consensus       159 ~Dfg~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~---~~~~~~~-  229 (278)
T 1byg_A          159 SDFGLTKEASST-----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD---VVPRVEK-  229 (278)
T ss_dssp             CCCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGG---HHHHHTT-
T ss_pred             eecccccccccc-----ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHhc-
Confidence            999999764321     233467889999999999999999999999999999998 999987543222   1111110 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         .          .....+...+..+.+++.+||+.||.+|||+.++++.|+.+...
T Consensus       230 ---~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          230 ---G----------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             ---T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---C----------CCCCCcccCCHHHHHHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence               0          01112234567899999999999999999999999999988753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=345.71  Aligned_cols=264  Identities=25%  Similarity=0.431  Sum_probs=211.3

Q ss_pred             cCCCccc-eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRAL-LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|.... .||+|+||.||+|+++..         ..+..||||.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~---------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   79 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMR---------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC   79 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC------------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccC---------CCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe
Confidence            4566665 899999999999986521         346789999997643 23456789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        80 ~~~~-----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~k  150 (287)
T 1u59_A           80 QAEA-----LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK  150 (287)
T ss_dssp             ESSS-----EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred             cCCC-----cEEEEEeCCCCCHHHHHHhC-CccCCHHHHHHHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEE
Confidence            4332     69999999999999998754 35689999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||++......... .......+|+.|+|||++.+..++.++||||||+++|||++ |+.||........   ...+.
T Consensus       151 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~---~~~i~  227 (287)
T 1u59_A          151 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEV---MAFIE  227 (287)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHH---HHHHH
T ss_pred             ECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHH---HHHHh
Confidence            9999999875432211 11233456899999999998889999999999999999998 9999976543322   11111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      .    ..          ....+...+..+.+++.+||..||.+|||+.++++.|..+......
T Consensus       228 ~----~~----------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  276 (287)
T 1u59_A          228 Q----GK----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLAS  276 (287)
T ss_dssp             T----TC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHT
T ss_pred             c----CC----------cCCCCCCcCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCC
Confidence            1    00          0112234567899999999999999999999999999999876543

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.5e-44  Score=358.51  Aligned_cols=249  Identities=25%  Similarity=0.374  Sum_probs=198.2

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeeccc
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDE  169 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~  169 (453)
                      ...++||+|+||.||+|.+.           .++..||+|++........+.+.+|+.+|++++||||+++++++.....
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~-----------~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  160 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEET-----------ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKND  160 (373)
T ss_dssp             EEEEECC-----CEEEEEET-----------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             ecceEEecCcCEEEEEEEEc-----------CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCE
Confidence            33568999999999999975           4578899999987665666789999999999999999999999987654


Q ss_pred             ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE--cCCCcEEEec
Q 043568          170 RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL--DEDYKAKLSD  247 (453)
Q Consensus       170 ~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl--~~~~~~kL~D  247 (453)
                          .+|||||+++++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||+  +.++.+||+|
T Consensus       161 ----~~lv~E~~~~~~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~D  232 (373)
T 2x4f_A          161 ----IVLVMEYVDGGELFDRIIDE-SYNLTELDTILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIID  232 (373)
T ss_dssp             ----EEEEEECCTTCEEHHHHHHT-GGGCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECC
T ss_pred             ----EEEEEeCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEe
Confidence                79999999999999988764 24689999999999999999999998   99999999999999  6678999999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccC
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD  327 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~  327 (453)
                      ||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||........  +........  
T Consensus       233 FG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~--~~~i~~~~~--  305 (373)
T 2x4f_A          233 FGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET--LNNILACRW--  305 (373)
T ss_dssp             CSSCEECCTTC---BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--HHHHHHTCC--
T ss_pred             CCCceecCCcc---ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHH--HHHHHhccC--
Confidence            99998754332   23345799999999999988999999999999999999999999976532221  111111000  


Q ss_pred             ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       328 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                ..........+.++.+|+.+||..||.+|||+.++++
T Consensus       306 ----------~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~  342 (373)
T 2x4f_A          306 ----------DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK  342 (373)
T ss_dssp             ----------CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ----------CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence                      0011111234678999999999999999999999986

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.1e-44  Score=343.61  Aligned_cols=265  Identities=23%  Similarity=0.323  Sum_probs=197.8

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||+||+|.+.            .+..||||++.....  .....+.+|+.+++.++||||+++++++
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~------------~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   69 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQNN------------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI   69 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEcC------------CCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEE
Confidence            57889999999999999999862            357899999865432  2346788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ...+.    .++||||+++ +|.+++... ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus        70 ~~~~~----~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~k  140 (288)
T 1ob3_A           70 HTKKR----LVLVFEHLDQ-DLKKLLDVC-EGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELK  140 (288)
T ss_dssp             ECSSC----EEEEEECCSE-EHHHHHHTS-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccCCe----EEEEEEecCC-CHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEE
Confidence            87654    7999999964 999988764 35689999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~  322 (453)
                      |+|||+++.....  ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.......... +.....
T Consensus       141 l~Dfg~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~  218 (288)
T 1ob3_A          141 IADFGLARAFGIP--VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG  218 (288)
T ss_dssp             ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             EeECccccccCcc--ccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHC
Confidence            9999999764321  112344578999999999876 458999999999999999999999997643322111 111110


Q ss_pred             hcccC-cccccc--ccCCcC-------CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSD-SKKFHL--IIDPRL-------EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~-~~~~~~--~~~~~~-------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..... -.....  ..++..       ........+.++.+|+.+||..||++|||+.++++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  280 (288)
T 1ob3_A          219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (288)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            00000 000000  000000       01112335678999999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.6e-44  Score=359.93  Aligned_cols=279  Identities=22%  Similarity=0.271  Sum_probs=216.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||+||+|.+.           .++..||||++.... ......+.+|+.++++++||||+++++++
T Consensus         8 ~~~y~i~~~LG~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~   76 (396)
T 4eut_A            8 NHLWLLSDILGQGATANVFRGRHK-----------KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIE   76 (396)
T ss_dssp             SEEEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             CCceEEEEEEEcCCCeEEEEEEEC-----------CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEee
Confidence            367899999999999999999976           457789999997543 23457788999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE----cC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL----DE  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl----~~  239 (453)
                      ......  ..++||||+++|+|.+++.... ...+++..++.++.||+.||.|||+.   +|+||||||+|||+    +.
T Consensus        77 ~~~~~~--~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~  151 (396)
T 4eut_A           77 EETTTR--HKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDG  151 (396)
T ss_dssp             ECTTTC--CEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTS
T ss_pred             ccCCCC--eeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCC
Confidence            866532  3699999999999999997653 23489999999999999999999999   99999999999999    77


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc--------CCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT--------GRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      ++.+||+|||+++.....   .......||+.|+|||++.+        ..++.++|||||||++|||++|+.||.....
T Consensus       152 ~~~~kL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~  228 (396)
T 4eut_A          152 QSVYKLTDFGAARELEDD---EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEG  228 (396)
T ss_dssp             CEEEEECCGGGCEECCCG---GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTC
T ss_pred             ceeEEEecCCCceEccCC---CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCc
Confidence            888999999999875432   22345679999999999865        4677899999999999999999999975332


Q ss_pred             -hhhHHHHHhhhhcccCc----------cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          312 -RNEQKLLEWVRPYVSDS----------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       312 -~~~~~~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                       .........+.......          ..+....+...........+..+.+++.+||..||++|||+.++++.+..++
T Consensus       229 ~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il  308 (396)
T 4eut_A          229 PRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDIL  308 (396)
T ss_dssp             TTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHH
T ss_pred             ccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHh
Confidence             11122221111100000          0000000111122345677889999999999999999999999999999988


Q ss_pred             hhh
Q 043568          381 SEI  383 (453)
Q Consensus       381 ~~~  383 (453)
                      ...
T Consensus       309 ~~~  311 (396)
T 4eut_A          309 HRM  311 (396)
T ss_dssp             TCE
T ss_pred             hce
Confidence            753

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=9.9e-45  Score=355.91  Aligned_cols=252  Identities=28%  Similarity=0.429  Sum_probs=195.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCC--CceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKH--PNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h--~nIv~l~  161 (453)
                      .++|...+.||+|+||+||+|.+.            ++..||||++.....  .....+.+|+.+|+.++|  |||++++
T Consensus         8 ~~~y~i~~~lG~G~~g~Vy~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~   75 (343)
T 3dbq_A            8 GRIYSILKQIGSGGSSKVFQVLNE------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY   75 (343)
T ss_dssp             SCEEEEEEEESCCSSEEEEEEECT------------TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             cCEEEEEEEEecCCCeEEEEEEeC------------CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEe
Confidence            467999999999999999999852            367899999875432  234678999999999976  9999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    .++|||+ .+++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++
T Consensus        76 ~~~~~~~~----~~lv~e~-~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~  144 (343)
T 3dbq_A           76 DYEITDQY----IYMVMEC-GNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DG  144 (343)
T ss_dssp             EEEECSSE----EEEEECC-CSEEHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TT
T ss_pred             eeEeeCCE----EEEEEeC-CCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CC
Confidence            99987654    7999995 589999999875  5789999999999999999999999   999999999999997 67


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----------GRLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      .+||+|||+++...............||+.|+|||++.+           ..++.++|||||||++|||++|+.||....
T Consensus       145 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~  224 (343)
T 3dbq_A          145 MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  224 (343)
T ss_dssp             EEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhh
Confidence            899999999987654433333456689999999999865           678999999999999999999999997543


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ... ..+...              .++......+...+..+.+|+.+||..||.+|||+.++++.
T Consensus       225 ~~~-~~~~~~--------------~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~h  274 (343)
T 3dbq_A          225 NQI-SKLHAI--------------IDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  274 (343)
T ss_dssp             SHH-HHHHHH--------------HCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hHH-HHHHHH--------------hcCCcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhC
Confidence            221 111111              11111122222335678999999999999999999999863

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=3.9e-44  Score=343.47  Aligned_cols=269  Identities=20%  Similarity=0.275  Sum_probs=208.9

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...+.||+|+||+||+|++.           .++..||||++.....  ...+.+|+.+++.++|+|++..++++
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~   73 (296)
T 4hgt_A            7 VGNRYRLGRKIGSGSFGDIYLGTDI-----------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWC   73 (296)
T ss_dssp             ----CEEEEEEEECSSSEEEEEEET-----------TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEE
T ss_pred             cCCceEEeeeecCCCCeEEEEEEEc-----------CCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeee
Confidence            4678999999999999999999975           4578899998754432  23578899999999999888888777


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE---cCCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDY  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl---~~~~  241 (453)
                      .....   ..++||||+ +++|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||+   +.++
T Consensus        74 ~~~~~---~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~  145 (296)
T 4hgt_A           74 GAEGD---YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGN  145 (296)
T ss_dssp             EEETT---EEEEEEECC-CCBHHHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTT
T ss_pred             cCCCC---ceEEEEEcc-CCCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCC
Confidence            65443   379999999 99999998754 34689999999999999999999999   99999999999999   7899


Q ss_pred             cEEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          242 KAKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus       146 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~  225 (296)
T 4hgt_A          146 LVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ  225 (296)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSS
T ss_pred             eEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhh
Confidence            9999999999865433211     12235679999999999999999999999999999999999999997643322211


Q ss_pred             HHHhhh-hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          317 LLEWVR-PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       317 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      ...... ......           ....+...+..+.+|+.+||+.||++|||+.+|++.|+++......
T Consensus       226 ~~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~  284 (296)
T 4hgt_A          226 KYERISEKKMSTP-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF  284 (296)
T ss_dssp             HHHHHHHHHHHSC-----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTC
T ss_pred             hhhhhhcccccch-----------hhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCC
Confidence            111110 000000           0001122357899999999999999999999999999999987654

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=1.1e-44  Score=358.06  Aligned_cols=253  Identities=23%  Similarity=0.308  Sum_probs=194.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++.... ...+.+.+|+.+++.++||||+++++++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~   86 (361)
T 3uc3_A           19 SDRYDFVKDIGSGNFGVARLMRDK-----------LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVIL   86 (361)
T ss_dssp             TTTEEEEEEESSSTTSSEEEEEET-----------TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             CCcEEEEEEeccCCCEEEEEEEEC-----------CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEe
Confidence            568999999999999999999975           457789999997543 33467889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc--E
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK--A  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~--~  243 (453)
                      ....    .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.  +
T Consensus        87 ~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~  157 (361)
T 3uc3_A           87 TPTH----LAIIMEYASGGELYERICNA--GRFSEDEARFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRL  157 (361)
T ss_dssp             CSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCE
T ss_pred             eCCE----EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceE
Confidence            7654    79999999999999999765  4689999999999999999999998   9999999999999987765  9


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCc-hhHHHHHHHHHHHHhCCccccCCCChh-hHHHHHhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAK-SDVWSFGVVLYELITGRRAVERNLPRN-EQKLLEWV  321 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DV~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~  321 (453)
                      ||+|||+++.....   .......||+.|+|||++.+..++.+ +|||||||++|+|++|+.||....... ........
T Consensus       158 kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~  234 (361)
T 3uc3_A          158 KICDFGYSKSSVLH---SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRI  234 (361)
T ss_dssp             EECCCCCC------------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHH
T ss_pred             EEeecCcccccccc---CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHH
Confidence            99999999753321   22345679999999999988777655 899999999999999999997643221 11121111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ..             ...........+..+.+|+.+||..||.+|||+.++++.
T Consensus       235 ~~-------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rps~~ell~h  275 (361)
T 3uc3_A          235 LS-------------VKYSIPDDIRISPECCHLISRIFVADPATRISIPEIKTH  275 (361)
T ss_dssp             HT-------------TCCCCCTTSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hc-------------CCCCCCCcCCCCHHHHHHHHHHccCChhHCcCHHHHHhC
Confidence            10             000111111245779999999999999999999999863

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.1e-44  Score=356.39  Aligned_cols=252  Identities=24%  Similarity=0.342  Sum_probs=190.2

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...+.||+|+||+||+|++.           .++..||||++....  ..+.+.+|+.+|++++||||+++++++
T Consensus        51 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~  117 (349)
T 2w4o_A           51 LSDFFEVESELGRGATSIVYRCKQK-----------GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIF  117 (349)
T ss_dssp             GGGTEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEE
T ss_pred             ccCcEEEeeEEeeCCCEEEEEEEEC-----------CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeE
Confidence            3578999999999999999999975           456789999987543  345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---CC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DY  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~~  241 (453)
                      .....    .++||||+++|+|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++
T Consensus       118 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~  188 (349)
T 2w4o_A          118 ETPTE----ISLVLELVTGGELFDRIVEK--GYYSERDAADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDA  188 (349)
T ss_dssp             ECSSE----EEEEECCCCSCBHHHHHTTC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTC
T ss_pred             ecCCe----EEEEEEeCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCC
Confidence            87654    79999999999999999765  5689999999999999999999998   9999999999999975   88


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|..||.......  .+...+
T Consensus       189 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~i  263 (349)
T 2w4o_A          189 PLKIADFGLSKIVEHQ---VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQ--FMFRRI  263 (349)
T ss_dssp             CEEECCCC-------------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHH--HHHHHH
T ss_pred             CEEEccCccccccCcc---cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccH--HHHHHH
Confidence            9999999999865432   12345679999999999999999999999999999999999999997544322  111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..   ...        ..........+..+.+|+.+||..||++|||+.++++
T Consensus       264 ~~---~~~--------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  305 (349)
T 2w4o_A          264 LN---CEY--------YFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQ  305 (349)
T ss_dssp             HT---TCC--------CCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             Hh---CCC--------ccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            10   000        0011112234678999999999999999999999875

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.8e-44  Score=342.48  Aligned_cols=269  Identities=20%  Similarity=0.275  Sum_probs=212.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||++.....  ...+.+|+.+++.++|++++..++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~   74 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDI-----------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCG   74 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-----------TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEc-----------CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCcccccc
Confidence            578999999999999999999975           4578999999865432  346889999999999988887777776


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE---cCCCc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYK  242 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl---~~~~~  242 (453)
                      ....   ..++||||+ +++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||+   +.++.
T Consensus        75 ~~~~---~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~  146 (296)
T 3uzp_A           75 AEGD---YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNL  146 (296)
T ss_dssp             EETT---EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTC
T ss_pred             CCCC---ceEEEEEec-CCCHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCe
Confidence            5443   379999999 99999999754 35789999999999999999999999   99999999999999   48899


Q ss_pred             EEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          243 AKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      +||+|||++.........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........
T Consensus       147 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~  226 (296)
T 3uzp_A          147 VYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK  226 (296)
T ss_dssp             EEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSH
T ss_pred             EEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhh
Confidence            999999999865433211     112456799999999999999999999999999999999999999976433221111


Q ss_pred             HHhhhh-cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhccc
Q 043568          318 LEWVRP-YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ  386 (453)
Q Consensus       318 ~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~~  386 (453)
                      ...+.. .....           ....+...+..+.+|+.+||+.||.+|||+.+|++.|+.+.......
T Consensus       227 ~~~~~~~~~~~~-----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          227 YERISEKKMSTP-----------IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHHHHHHHHSC-----------HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hhhhcccccCCc-----------hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            111100 00000           00011234577999999999999999999999999999998876543

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.3e-44  Score=359.34  Aligned_cols=269  Identities=21%  Similarity=0.287  Sum_probs=205.3

Q ss_pred             hcCCCccceecCC--CceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEe
Q 043568           86 TRGFSRALLIGEG--GFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G--~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .++|...++||+|  +||+||+|++.           .++..||||++.....  .....+.+|+.+++.++||||++++
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~   92 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYK-----------PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYR   92 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEET-----------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEc-----------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEe
Confidence            5789999999999  99999999976           4578899999975432  2346688899999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    .++|||||++|+|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        93 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~  165 (389)
T 3gni_B           93 ATFIADNE----LWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDG  165 (389)
T ss_dssp             EEEEETTE----EEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTC
T ss_pred             EEEEECCE----EEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCC
Confidence            99987664    79999999999999999887667799999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCC-----CCccccccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          242 KAKLSDFGLARQGPPEG-----LGHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~-----~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      .+||+|||++.......     .........||+.|+|||++.+  ..++.++|||||||++|||++|+.||........
T Consensus       166 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~  245 (389)
T 3gni_B          166 KVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQM  245 (389)
T ss_dssp             CEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTH
T ss_pred             CEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHH
Confidence            99999999886432111     0111233578999999999987  5789999999999999999999999976433221


Q ss_pred             HHHHHhhhhccc---Cc-----ccc-------------cccc---------CCcCCCccchHHHHHHHHHHHHhhccCCC
Q 043568          315 QKLLEWVRPYVS---DS-----KKF-------------HLII---------DPRLEGNYCIKSAQKLAALASKCLTKQPK  364 (453)
Q Consensus       315 ~~~~~~~~~~~~---~~-----~~~-------------~~~~---------~~~~~~~~~~~~~~~l~~li~~cl~~dp~  364 (453)
                      .  .........   +.     ...             ....         ............+..+.+|+.+||+.||.
T Consensus       246 ~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  323 (389)
T 3gni_B          246 L--LEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPD  323 (389)
T ss_dssp             H--HHC--------------------------------------------------------CCHHHHHHHHHHTCSCTT
T ss_pred             H--HHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcc
Confidence            1  110000000   00     000             0000         00000112334567899999999999999


Q ss_pred             CCCCHHHHHH
Q 043568          365 SRPKMSEVVD  374 (453)
Q Consensus       365 ~RPs~~ei~~  374 (453)
                      +|||+.++++
T Consensus       324 ~Rpta~ell~  333 (389)
T 3gni_B          324 ARPSASTLLN  333 (389)
T ss_dssp             TSCCHHHHTT
T ss_pred             cCCCHHHHhc
Confidence            9999999885

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.5e-44  Score=340.94  Aligned_cols=251  Identities=23%  Similarity=0.358  Sum_probs=205.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||+|++........+.+.+|+.++++++||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~   76 (277)
T 3f3z_A            8 NQYYTLENTIGRGSWGEVKIAVQK-----------GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE   76 (277)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             hhhEEeeeEEeecCCEEEEEEEeC-----------CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            467999999999999999999976           456789999998766666788999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE---cCCCc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYK  242 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl---~~~~~  242 (453)
                      ....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.++.
T Consensus        77 ~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~  147 (277)
T 3f3z_A           77 DNTD----IYLVMELCTGGELFERVVHK--RVFRESDAARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSP  147 (277)
T ss_dssp             CSSE----EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCC
T ss_pred             cCCe----EEEEEeccCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCc
Confidence            7654    79999999999999998765  5689999999999999999999999   99999999999999   78899


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++|+.||...........  ...
T Consensus       148 ~~l~Dfg~~~~~~~~~---~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~--~~~  221 (277)
T 3f3z_A          148 LKLIDFGLAARFKPGK---MMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLK--IRE  221 (277)
T ss_dssp             EEECCCTTCEECCTTS---CBCCCCSCTTTCCHHHHTT-CBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH--HHH
T ss_pred             EEEEecccceeccCcc---chhccCCCCCccChHHhcc-cCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHH--HHh
Confidence            9999999998654322   2345679999999999865 489999999999999999999999976432221111  111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...            ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       222 ~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~  261 (277)
T 3f3z_A          222 GTF------------TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALE  261 (277)
T ss_dssp             CCC------------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             CCC------------CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            000            0000011134678999999999999999999999885

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=9.5e-45  Score=368.67  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=196.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...++||+|+||.||+|.+.           .++..||||++...   .......+.+|+.+++.++||||+++++
T Consensus       147 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~  215 (446)
T 4ejn_A          147 MNEFEYLKLLGKGTFGKVILVKEK-----------ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY  215 (446)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEE
T ss_pred             hHHcEEeEEEeeCcCEEEEEEEEc-----------CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEE
Confidence            467999999999999999999975           45788999998753   2334466789999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccccccEEEcCCC
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      ++...+.    .+|||||+++|+|.+++...  ..+++..+..++.||+.||.|||+ .   +|+||||||+||||+.++
T Consensus       216 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~  286 (446)
T 4ejn_A          216 SFQTHDR----LCFVMEYANGGELFFHLSRE--RVFSEDRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDG  286 (446)
T ss_dssp             EEEETTE----EEEEECCCSSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSS
T ss_pred             EEeeCCE----EEEEEeeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCC
Confidence            9987764    79999999999999999765  578999999999999999999998 7   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+
T Consensus       287 ~~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~---~~~~i  361 (446)
T 4ejn_A          287 HIKITDFGLCKEGIKD--GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK---LFELI  361 (446)
T ss_dssp             CEEECCCCCCCTTCC-------CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHH
T ss_pred             CEEEccCCCceeccCC--CcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHH---HHHHH
Confidence            9999999999864322  122445789999999999999999999999999999999999999997643322   21111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      ..   ..            ..++...+.++.+||.+||+.||.+||     |+.++++
T Consensus       362 ~~---~~------------~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~  404 (446)
T 4ejn_A          362 LM---EE------------IRFPRTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQ  404 (446)
T ss_dssp             HH---CC------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             Hh---CC------------CCCCccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHh
Confidence            10   00            011223457799999999999999999     9999875

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=2.4e-44  Score=354.10  Aligned_cols=249  Identities=24%  Similarity=0.377  Sum_probs=204.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      .++|...++||+|+||.||+|+++           .++..||||++....   ......+..|..+|..+ +||||++++
T Consensus        19 ~~~y~~~~~lG~G~fg~V~~~~~~-----------~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~   87 (353)
T 2i0e_A           19 LTDFNFLMVLGKGSFGKVMLSERK-----------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH   87 (353)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET-----------TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEE
Confidence            578999999999999999999975           456789999997542   23456788999999988 899999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++...+.    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        88 ~~~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g  158 (353)
T 2i0e_A           88 SCFQTMDR----LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEG  158 (353)
T ss_dssp             EEEECSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred             EEEEcCCE----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCC
Confidence            99987654    79999999999999999865  4689999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...+
T Consensus       159 ~vkL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i  233 (353)
T 2i0e_A          159 HIKIADFGMCKENIWD--GVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQSI  233 (353)
T ss_dssp             CEEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             cEEEEeCCcccccccC--CcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHH---HHHHHH
Confidence            9999999999864322  12244568999999999999999999999999999999999999999764322   222211


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH-----HHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM-----SEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~-----~ei~~  374 (453)
                      ..   ..            ..++...+.++.+|+.+||..||.+||++     .+|++
T Consensus       234 ~~---~~------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~  276 (353)
T 2i0e_A          234 ME---HN------------VAYPKSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKE  276 (353)
T ss_dssp             HH---CC------------CCCCTTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHT
T ss_pred             Hh---CC------------CCCCCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence            11   00            01122346789999999999999999964     56553

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=3.1e-44  Score=341.82  Aligned_cols=248  Identities=27%  Similarity=0.428  Sum_probs=202.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++....   ......+.+|+.++++++||||+++++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   76 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG   76 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEc-----------cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhh
Confidence            578999999999999999999976           456789999986432   233567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        77 ~~~~~~~----~~lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~  147 (279)
T 3fdn_A           77 YFHDATR----VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGE  147 (279)
T ss_dssp             EEECSSE----EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSC
T ss_pred             eEecCCE----EEEEEecCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCC
Confidence            9987654    79999999999999999765  4689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++......    ......||+.|+|||++.+..++.++||||||+++|+|++|..||...........+....
T Consensus       148 ~~l~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  223 (279)
T 3fdn_A          148 LKIADFGWSVHAPSS----RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVE  223 (279)
T ss_dssp             EEECSCCEESCC------------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTC
T ss_pred             EEEEeccccccCCcc----cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCC
Confidence            999999998764322    2345678999999999999999999999999999999999999997643322211111100


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                                        ...+...+..+.+|+.+||+.||.+|||+.++++.
T Consensus       224 ------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h  258 (279)
T 3fdn_A          224 ------------------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEH  258 (279)
T ss_dssp             ------------------CCCCTTSCHHHHHHHHHHCCSSGGGSCCHHHHHHC
T ss_pred             ------------------CCCCCcCCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence                              01122345678999999999999999999999863

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=354.38  Aligned_cols=272  Identities=17%  Similarity=0.183  Sum_probs=202.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-----------cHHHHHHHHHHhccCCC
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----------GHKEWINEVNFLGVVKH  154 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E~~~l~~l~h  154 (453)
                      .++|...+.||+|+||+||+|.+...        ...+..||||++......           ....+.+|+.+++.++|
T Consensus        36 ~~~y~~~~~lg~G~~g~Vy~~~~~~~--------~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h  107 (345)
T 2v62_A           36 GNQWVLGKKIGSGGFGLIYLAFPTNK--------PEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDY  107 (345)
T ss_dssp             SCEEEEEEEC------CEEEEEESSS--------CGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSC
T ss_pred             CceEEEEeeEeecCCeEEEEEEecCC--------CCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccc
Confidence            46799999999999999999998521        124678999998754321           12346788999999999


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      |||+++++++..........++||||+ +++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus       108 ~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~N  181 (345)
T 2v62_A          108 LGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQN--GTFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAAN  181 (345)
T ss_dssp             CCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGG--GBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             cCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHH
Confidence            999999999988433333589999999 99999999875  3789999999999999999999999   99999999999


Q ss_pred             EEEcCCC--cEEEeccccccCCCCCCC-----CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          235 ILLDEDY--KAKLSDFGLARQGPPEGL-----GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       235 ILl~~~~--~~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      ||++.++  .+||+|||+++.......     ........||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       182 Ill~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~  261 (345)
T 2v62_A          182 LLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWE  261 (345)
T ss_dssp             EEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTG
T ss_pred             EEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcc
Confidence            9999887  999999999976532211     111245689999999999999999999999999999999999999996


Q ss_pred             CCCChhhHH--HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          308 RNLPRNEQK--LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       308 ~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      .........  ......+...  .....    ..   .....+.++.+++.+||..||.+|||+.+|++.|+.+.
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~--~~~~~----~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          262 QNLKDPVAVQTAKTNLLDELP--QSVLK----WA---PSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             GGTTCHHHHHHHHHHHHHTTT--HHHHH----HS---CTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             ccccccHHHHHHHHhhccccc--HHHHh----hc---cccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            532222111  1111111000  00000    00   00134568999999999999999999999999997654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=6.9e-45  Score=354.50  Aligned_cols=268  Identities=27%  Similarity=0.431  Sum_probs=206.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|++....      ...++..||||.+.... ......+.+|+.++++++||||+++++++
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  102 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMP------NDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVS  102 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCC------CCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEE
Confidence            468999999999999999999854211      12456789999986442 23456789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP-----TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      .....    .++||||+++++|.+++.....     ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.
T Consensus       103 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~  175 (327)
T 2yfx_A          103 LQSLP----RFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTC  175 (327)
T ss_dssp             CSSSS----CEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESC
T ss_pred             cCCCC----cEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEec
Confidence            87654    6999999999999999987542     4589999999999999999999999   9999999999999984


Q ss_pred             ---CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhH
Q 043568          240 ---DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQ  315 (453)
Q Consensus       240 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~  315 (453)
                         +..+||+|||++................||+.|+|||++.+..++.++||||||+++|+|++ |..||......   
T Consensus       176 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~---  252 (327)
T 2yfx_A          176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ---  252 (327)
T ss_dssp             SSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH---
T ss_pred             CCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHH---
Confidence               45699999999875332222222345578999999999999999999999999999999998 88998754322   


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .+...+...    .          ....+..++..+.+|+.+||+.||.+|||+.+|++.|..+....
T Consensus       253 ~~~~~~~~~----~----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~~  306 (327)
T 2yfx_A          253 EVLEFVTSG----G----------RMDPPKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDP  306 (327)
T ss_dssp             HHHHHHHTT----C----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHCH
T ss_pred             HHHHHHhcC----C----------CCCCCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcCH
Confidence            222222110    0          00112234677999999999999999999999999999887654

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.8e-44  Score=339.41  Aligned_cols=257  Identities=30%  Similarity=0.439  Sum_probs=209.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.            ++..||+|.+.... ...+.+.+|+.+++.++||||+++++++.
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   73 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL------------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCL   73 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET------------TTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             hhheeeeeEecCCCceeEEEEEec------------CCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEc
Confidence            357888999999999999999873            35679999997543 34577999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        74 ~~~~----~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl  145 (267)
T 3t9t_A           74 EQAP----ICLVTEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKV  145 (267)
T ss_dssp             SSSS----CEEEECCCTTCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEE
T ss_pred             cCCC----eEEEEeCCCCCcHHHHHhhC-cccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEE
Confidence            7654    69999999999999999765 35689999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++....... ........++..|+|||++.+..++.++||||||+++|+|++ |+.||.......   ....+...
T Consensus       146 ~dfg~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~---~~~~i~~~  221 (267)
T 3t9t_A          146 SDFGMTRFVLDDQ-YTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE---VVEDISTG  221 (267)
T ss_dssp             CCTTGGGGBCCHH-HHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHTT
T ss_pred             ccccccccccccc-ccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHH---HHHHHhcC
Confidence            9999998643211 111234467788999999998999999999999999999999 899987543221   21111110


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .              ....+...+..+.+++.+||+.||.+|||+.++++.|..+.+
T Consensus       222 ~--------------~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          222 F--------------RLYKPRLASTHVYQIMNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             C--------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             C--------------cCCCCccCcHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            0              001112235679999999999999999999999999998875

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.8e-44  Score=359.91  Aligned_cols=257  Identities=21%  Similarity=0.287  Sum_probs=194.3

Q ss_pred             hcCCCcc-ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhc-cCCCCceeeEeee
Q 043568           86 TRGFSRA-LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~  163 (453)
                      .++|... ++||+|+||+||+|.+.           .++..||||++..     ...+.+|+.++. ..+||||++++++
T Consensus        60 ~~~y~~~~~~LG~G~~g~V~~~~~~-----------~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~  123 (400)
T 1nxk_A           60 IDDYKVTSQVLGLGINGKVLQIFNK-----------RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV  123 (400)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             cccceeccceeeeccCeEEEEEEEC-----------CCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEE
Confidence            4566665 68999999999999975           4578899999853     245778998874 4589999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---C
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---D  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~  240 (453)
                      +.........++||||||++|+|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+|||++.   +
T Consensus       124 ~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~  200 (400)
T 1nxk_A          124 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN  200 (400)
T ss_dssp             EEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTT
T ss_pred             EeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCC
Confidence            876332223479999999999999999887666799999999999999999999998   9999999999999997   7


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh-HHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE-QKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~-~~~~~  319 (453)
                      +.+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||........ .....
T Consensus       201 ~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~  277 (400)
T 1nxk_A          201 AILKLTDFGFAKETTSH---NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKT  277 (400)
T ss_dssp             CCEEECCCTTCEECC--------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHH
T ss_pred             ccEEEEecccccccCCC---CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHH
Confidence            89999999999865422   223456789999999999999999999999999999999999999975432210 00111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .+..     ..      ...........+.++.+||.+||..||++|||+.++++.
T Consensus       278 ~i~~-----~~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~h  322 (400)
T 1nxk_A          278 RIRM-----GQ------YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  322 (400)
T ss_dssp             HHHH-----TC------CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHc-----Cc------ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            0100     00      000001112346789999999999999999999999863

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-44  Score=352.88  Aligned_cols=260  Identities=23%  Similarity=0.268  Sum_probs=199.8

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-----CcccHHHHHHHHHHhccCCCCce
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-----GFQGHKEWINEVNFLGVVKHPNL  157 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-----~~~~~~~~~~E~~~l~~l~h~nI  157 (453)
                      ....++|...+.||+|+||+||+|.+.           .++..||+|++...     .....+.+.+|+.++++++||||
T Consensus        22 ~~~~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpni   90 (345)
T 3hko_A           22 LELQKKYHLKGAIGQGSYGVVRVAIEN-----------QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNI   90 (345)
T ss_dssp             HHHHHHEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTB
T ss_pred             hhhhhheeecceeeecCCeEEEEEEEC-----------CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCc
Confidence            445688999999999999999999875           45778999998643     23445779999999999999999


Q ss_pred             eeEeeeeeecccccceEEEEEEecCCCChHHhhhcCC--------------------------------------CCCCC
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------------------------------PTPLA  199 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------------------------------~~~l~  199 (453)
                      +++++++.+...    .++||||+++|+|.+++....                                      ...++
T Consensus        91 v~~~~~~~~~~~----~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (345)
T 3hko_A           91 ARLYEVYEDEQY----ICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQR  166 (345)
T ss_dssp             CCEEEEEECSSE----EEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHH
T ss_pred             ceeehhhccCCe----EEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999987654    799999999999999985210                                      11235


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC--cEEEeccccccCCCCCC--CCccccccccCcCCCCc
Q 043568          200 WIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY--KAKLSDFGLARQGPPEG--LGHVSTSVVGTVGYAAP  275 (453)
Q Consensus       200 ~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~--~~kL~DFGla~~~~~~~--~~~~~~~~~gt~~y~aP  275 (453)
                      +..++.++.||+.||.|||+.   +|+||||||+|||++.++  .+||+|||+++......  .........||+.|+||
T Consensus       167 ~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  243 (345)
T 3hko_A          167 EKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAP  243 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCH
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCc
Confidence            667788999999999999999   999999999999998776  89999999997543211  11123456799999999


Q ss_pred             ccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHH
Q 043568          276 EYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA  353 (453)
Q Consensus       276 E~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  353 (453)
                      |++.+  ..++.++|||||||++|||++|+.||........  ........            ...........+..+.+
T Consensus       244 E~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~--~~~~~~~~------------~~~~~~~~~~~~~~~~~  309 (345)
T 3hko_A          244 EVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT--ISQVLNKK------------LCFENPNYNVLSPLARD  309 (345)
T ss_dssp             HHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH--HHHHHHCC------------CCTTSGGGGGSCHHHHH
T ss_pred             hhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHH--HHHHHhcc------------cccCCcccccCCHHHHH
Confidence            99875  6789999999999999999999999976533221  11111100            00011112234678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 043568          354 LASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       354 li~~cl~~dp~~RPs~~ei~~  374 (453)
                      |+.+||+.||.+|||+.++++
T Consensus       310 li~~~l~~~p~~Rps~~~~l~  330 (345)
T 3hko_A          310 LLSNLLNRNVDERFDAMRALQ  330 (345)
T ss_dssp             HHHHHSCSCTTTSCCHHHHHH
T ss_pred             HHHHHcCCChhHCCCHHHHhc
Confidence            999999999999999999986

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=5.1e-44  Score=347.52  Aligned_cols=252  Identities=23%  Similarity=0.355  Sum_probs=205.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc------cHHHHHHHHHHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------GHKEWINEVNFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~h~nIv~  159 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||.+......      ..+.+.+|+.+++.++||||++
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   79 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREK-----------STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT   79 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred             hccEEEeeEeeecCCEEEEEEEEC-----------CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcce
Confidence            467899999999999999999975           45778999998754322      3577999999999999999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++.....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.
T Consensus        80 ~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~  150 (321)
T 2a2a_A           80 LHDVYENRTD----VVLILELVSGGELFDFLAQK--ESLSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLD  150 (321)
T ss_dssp             EEEEEECSSE----EEEEECCCCSCBHHHHHHTC--SCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESC
T ss_pred             EEEEEecCCE----EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEec
Confidence            9999987654    79999999999999999764  5789999999999999999999999   9999999999999998


Q ss_pred             CC----cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          240 DY----KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       240 ~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      ++    .+||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||.......  
T Consensus       151 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--  225 (321)
T 2a2a_A          151 KNIPIPHIKLIDFGLAHEIEDGV---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--  225 (321)
T ss_dssp             TTSSSCCEEECCCTTCEECCTTC---CCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHH--
T ss_pred             CCCCcCCEEEccCccceecCccc---cccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHH--
Confidence            88    79999999998754321   2345579999999999999999999999999999999999999997643222  


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ....+....           ...........+..+.+|+.+||..||.+|||+.++++
T Consensus       226 -~~~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~  272 (321)
T 2a2a_A          226 -TLANITSVS-----------YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALR  272 (321)
T ss_dssp             -HHHHHHTTC-----------CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHH
T ss_pred             -HHHHHHhcc-----------cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence             111111000           00001111234567999999999999999999999875

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=5.7e-44  Score=345.23  Aligned_cols=267  Identities=25%  Similarity=0.315  Sum_probs=200.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++......  ..+.+.+|+.++++++||||++++++
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~   70 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNR-----------DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV   70 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeC-----------CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhhe
Confidence            367999999999999999999975           45778999998654332  24668899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        71 ~~~~~~----~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  141 (311)
T 4agu_A           71 FRRKRR----LHLVFEYCDHTVLHELDRYQ--RGVPEHLVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVI  141 (311)
T ss_dssp             EEETTE----EEEEEECCSEEHHHHHHHTS--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             eecCCe----EEEEEEeCCCchHHHHHhhh--cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCE
Confidence            987654    79999999999999987754  5689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      ||+|||++.......  .......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+....
T Consensus       142 kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~  219 (311)
T 4agu_A          142 KLCDFGFARLLTGPS--DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTL  219 (311)
T ss_dssp             EECCCTTCEECC--------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEeeCCCchhccCcc--cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999998754321  22345678999999999876 678999999999999999999999997654433322221110


Q ss_pred             -hc-------ccCcccccc--ccCCcCCCc---cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 -PY-------VSDSKKFHL--IIDPRLEGN---YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 -~~-------~~~~~~~~~--~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ..       .........  ..++.....   .....+..+.+|+.+||+.||.+|||+.++++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  284 (311)
T 4agu_A          220 GDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH  284 (311)
T ss_dssp             CSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHT
T ss_pred             cccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhc
Confidence             00       000000000  000000000   01235677999999999999999999999885

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.2e-44  Score=344.90  Aligned_cols=256  Identities=27%  Similarity=0.389  Sum_probs=208.1

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...+.||+|+||.||+|.+.           .++..||||.+....    ..+.+|+.++++++||||+++++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~   73 (284)
T 2a19_B            9 FGMDFKEIELIGSGGFGQVFKAKHR-----------IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCW   73 (284)
T ss_dssp             HHHHEEEEEEEECSSSCCEEEEEET-----------TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hccccceeeeeccCCceEEEEEEEc-----------CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeE
Confidence            3567999999999999999999975           457789999987543    4567899999999999999999988


Q ss_pred             eeccc------------ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          165 AEDDE------------RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       165 ~~~~~------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      .....            .....++||||+++++|.+++.......+++..++.++.|++.||.|||+.   +|+||||||
T Consensus        74 ~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp  150 (284)
T 2a19_B           74 DGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINRDLKP  150 (284)
T ss_dssp             EEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             eccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCH
Confidence            65211            122379999999999999999876556899999999999999999999998   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      +|||++.++.+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..|+...   
T Consensus       151 ~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---  224 (284)
T 2a19_B          151 SNIFLVDTKQVKIGDFGLVTSLKNDG---KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET---  224 (284)
T ss_dssp             GGEEEEETTEEEECCCTTCEESSCCS---CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH---
T ss_pred             HHEEEcCCCCEEECcchhheeccccc---cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH---
Confidence            99999999999999999998754322   234457999999999999999999999999999999999999887421   


Q ss_pred             hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                        ........             ...+    +...+..+.+|+.+||..||.+|||+.++++.|..+....
T Consensus       225 --~~~~~~~~-------------~~~~----~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          225 --SKFFTDLR-------------DGII----SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             --HHHHHHHH-------------TTCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             --HHHHHHhh-------------cccc----cccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence              11111111             0011    1123567899999999999999999999999998876543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=2.1e-44  Score=354.78  Aligned_cols=278  Identities=18%  Similarity=0.281  Sum_probs=210.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceee------
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVK------  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~------  159 (453)
                      .++|...+.||+|+||.||+|++..+...   .....+..||||.+...     ..+.+|+.++++++||||++      
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~---~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~  112 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTC---DSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLY  112 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC--------------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHT
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccc---cccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhc
Confidence            36899999999999999999998632100   00013678999998644     46789999999999999988      


Q ss_pred             ---------EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          160 ---------LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       160 ---------l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                               +++++...+.   ..++||||+ +++|.+++.......+++..++.++.||+.||.|||++   +|+||||
T Consensus       113 ~~~~~~i~~~~~~~~~~~~---~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Di  185 (352)
T 2jii_A          113 STPLLAIPTCMGFGVHQDK---YRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHEN---EYVHGNV  185 (352)
T ss_dssp             TCTTCSCCCCCEEEEETTT---EEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCC
T ss_pred             cCCccCccchhhccccCCc---EEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCC
Confidence                     5666665332   379999999 99999999876556799999999999999999999999   9999999


Q ss_pred             ccccEEEcCCC--cEEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCC
Q 043568          231 KTSNILLDEDY--KAKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR  303 (453)
Q Consensus       231 kp~NILl~~~~--~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~  303 (453)
                      ||+|||++.++  .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||++|||++|+
T Consensus       186 kp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~  265 (352)
T 2jii_A          186 TAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGF  265 (352)
T ss_dssp             CGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSC
T ss_pred             CHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence            99999999998  8999999999865432111     1123458999999999999999999999999999999999999


Q ss_pred             ccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          304 RAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       304 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .||....+... .+............   .+....   ......+..+.+|+.+||..||.+|||+.+|++.|+.+....
T Consensus       266 ~pf~~~~~~~~-~~~~~~~~~~~~~~---~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~  338 (352)
T 2jii_A          266 LPWTNCLPNTE-DIMKQKQKFVDKPG---PFVGPC---GHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDL  338 (352)
T ss_dssp             CTTGGGTTCHH-HHHHHHHHHHHSCC---CEECTT---SCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred             CCcccCCcCHH-HHHHHHHhccCChh---hhhhhc---cccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhc
Confidence            99986542221 12221111111111   011110   001123578999999999999999999999999999999876


Q ss_pred             cc
Q 043568          384 SS  385 (453)
Q Consensus       384 ~~  385 (453)
                      ..
T Consensus       339 ~~  340 (352)
T 2jii_A          339 RV  340 (352)
T ss_dssp             TC
T ss_pred             CC
Confidence            54

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=5.4e-44  Score=342.06  Aligned_cols=252  Identities=22%  Similarity=0.372  Sum_probs=202.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +.|...+.||+|+||+||+|.+.           .++..||+|.+....  ....+.+.+|+.+++.++||||+++++++
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   94 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDT-----------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSW   94 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEec-----------CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeee
Confidence            34777789999999999999875           457789999987543  23356789999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeeccccccEEEc-CCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ--LIFRDFKTSNILLD-EDY  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~NILl~-~~~  241 (453)
                      ..........++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +  |+||||||+|||++ .++
T Consensus        95 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~  169 (290)
T 1t4h_A           95 ESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTG  169 (290)
T ss_dssp             EEESSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTS
T ss_pred             ccccCCCceEEEEEEecCCCCHHHHHHHc--cCCCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCC
Confidence            77544444579999999999999999875  5688999999999999999999998   7  99999999999997 789


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||++......    ......||+.|+|||++. +.++.++|||||||++|+|++|+.||.......  ......
T Consensus       170 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~--~~~~~~  242 (290)
T 1t4h_A          170 SVKIGDLGLATLKRAS----FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRV  242 (290)
T ss_dssp             CEEECCTTGGGGCCTT----SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHH
T ss_pred             CEEEeeCCCccccccc----ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHH--HHHHHH
Confidence            9999999999764422    234567999999999886 468999999999999999999999997543322  111111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....             .....+...+.++.+|+.+||..||.+|||+.++++
T Consensus       243 ~~~~-------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  282 (290)
T 1t4h_A          243 TSGV-------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  282 (290)
T ss_dssp             TTTC-------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             hccC-------------CccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence            1100             001112223467999999999999999999999875

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=4.1e-45  Score=379.24  Aligned_cols=261  Identities=28%  Similarity=0.437  Sum_probs=211.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...++||+|+||.||+|.+.            ....||||++.... ...+.|.+|+.+|++++||||+++++++
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~------------~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~  331 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWN------------GTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVV  331 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET------------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             chhhhhhheecccCCCeEEEEEEEC------------CCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEE
Confidence            3567888899999999999999874            24579999997543 3457899999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ....     .+|||||+++|+|.++|.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus       332 ~~~~-----~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~k  403 (535)
T 2h8h_A          332 SEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCK  403 (535)
T ss_dssp             CSSS-----CEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEE
T ss_pred             eecc-----ceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEE
Confidence            7632     69999999999999999865445689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...... ........++..|+|||++....++.++|||||||+||||++ |+.||.......   +...+..
T Consensus       404 l~DFG~a~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~---~~~~i~~  479 (535)
T 2h8h_A          404 VADFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE---VLDQVER  479 (535)
T ss_dssp             ECCTTSTTTCCCHH-HHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHH---HHHHHHT
T ss_pred             EcccccceecCCCc-eecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc
Confidence            99999998754211 111223456788999999999999999999999999999999 899987543222   2221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                          ..          ....+..++..+.+||.+||..||++|||+.+|++.|+.+.....
T Consensus       480 ----~~----------~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          480 ----GY----------RMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             ----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             ----CC----------CCCCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence                00          011223456789999999999999999999999999998876443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.6e-44  Score=351.31  Aligned_cols=247  Identities=24%  Similarity=0.368  Sum_probs=200.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccC-CCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      .++|...+.||+|+||.||+|+++           .++..||||++......   ....+.+|..++.++ +||||++++
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~   76 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLK-----------KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH   76 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEEC-----------CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEE
Confidence            367899999999999999999976           45789999999765322   345678899999988 899999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        77 ~~~~~~~~----~~lv~e~~~gg~L~~~l~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g  147 (345)
T 3a8x_A           77 SCFQTESR----LFFVIEYVNGGDLMFHMQRQ--RKLPEEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEG  147 (345)
T ss_dssp             EEEECSSE----EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTS
T ss_pred             EEEEeCCE----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCC
Confidence            99987654    79999999999999999865  4689999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh------hH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN------EQ  315 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~------~~  315 (453)
                      .+||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||.......      ..
T Consensus       148 ~~kL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~  225 (345)
T 3a8x_A          148 HIKLTDYGMCKEGLRP--GDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTED  225 (345)
T ss_dssp             CEEECCGGGCBCSCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHH
T ss_pred             CEEEEeccccccccCC--CCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHH
Confidence            9999999999863322  123455689999999999999999999999999999999999999996432111      11


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                      .+...+..             ..  ..++...+..+.+|+.+||..||.+||++
T Consensus       226 ~~~~~i~~-------------~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  264 (345)
T 3a8x_A          226 YLFQVILE-------------KQ--IRIPRSLSVKAASVLKSFLNKDPKERLGC  264 (345)
T ss_dssp             HHHHHHHH-------------CC--CCCCTTSCHHHHHHHHHHTCSSTTTSTTC
T ss_pred             HHHHHHHc-------------CC--CCCCCCCCHHHHHHHHHHhcCCHhHCCCC
Confidence            11111110             00  01223346779999999999999999996

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-44  Score=380.24  Aligned_cols=255  Identities=24%  Similarity=0.401  Sum_probs=203.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeecccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDER  170 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  170 (453)
                      +.||+|+||+||+|.+...         ..+..||||+++....  ...++|.+|+.+|++++||||+++++++....  
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~--  443 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMK---------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES--  443 (635)
T ss_dssp             EEEEECSSEEEEEEEEECS---------SCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSS--
T ss_pred             CEeccCCCEEEEEEEEcCC---------CcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC--
Confidence            4799999999999976532         3467899999975432  33578999999999999999999999996433  


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                         .+|||||+++|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||+|||+
T Consensus       444 ---~~lv~E~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGl  515 (635)
T 4fl3_A          444 ---WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL  515 (635)
T ss_dssp             ---EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTH
T ss_pred             ---EEEEEEccCCCCHHHHHhhC--CCCCHHHHHHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCC
Confidence               68999999999999999765  5789999999999999999999999   999999999999999999999999999


Q ss_pred             ccCCCCCCC-CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCc
Q 043568          251 ARQGPPEGL-GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       251 a~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      ++....... ........+|+.|+|||++.+..++.++|||||||++|||++ |+.||.......   +...+..    .
T Consensus       516 a~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~---~~~~i~~----~  588 (635)
T 4fl3_A          516 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSE---VTAMLEK----G  588 (635)
T ss_dssp             HHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH---HHHHHHT----T
T ss_pred             ccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHH---HHHHHHc----C
Confidence            986543221 122334467889999999999999999999999999999998 999997654322   2211111    0


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .          ....+..++.++.+||.+||+.||++|||+.+|++.|+++...+
T Consensus       589 ~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          589 E----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             C----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            0          11123345678999999999999999999999999999988654

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=4.7e-44  Score=348.55  Aligned_cols=281  Identities=23%  Similarity=0.363  Sum_probs=214.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+..       ....++..||||++........+.+.+|+.++++++||||+++++++.
T Consensus        40 ~~~y~~~~~lg~G~~g~V~~~~~~~-------~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~  112 (326)
T 2w1i_A           40 ERHLKFLQQLGKGNFGSVEMCRYDP-------LQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCY  112 (326)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEECT-------TSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHHceeeeeeccCCCeEEEEEEecc-------ccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEE
Confidence            4668889999999999999998631       112467899999998765556678999999999999999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+..  ..++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus       113 ~~~~~--~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL  186 (326)
T 2w1i_A          113 SAGRR--NLKLIMEYLPYGSLRDYLQKH-KERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKI  186 (326)
T ss_dssp             C------CCEEEECCCTTCBHHHHHHHS-TTSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEE
T ss_pred             ecCCC--ceEEEEECCCCCCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEE
Confidence            65422  268999999999999999875 34689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++......... .......++..|+|||.+.+..++.++||||||+++|||++|..|+.....    .........
T Consensus       187 ~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~----~~~~~~~~~  262 (326)
T 2w1i_A          187 GDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPA----EFMRMIGND  262 (326)
T ss_dssp             CCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHH----HHHHHHCTT
T ss_pred             ecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHH----HHHHhhccc
Confidence            999999875433211 112334677889999999988899999999999999999999998763210    000000000


Q ss_pred             ccC---ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          325 VSD---SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       325 ~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ...   ...+...+........+..++.++.+|+.+||+.||.+|||+.+|++.|+.+.+.+
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          263 KQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             CCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             cchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            000   00000001111111123345678999999999999999999999999999988764

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.1e-44  Score=364.00  Aligned_cols=248  Identities=25%  Similarity=0.366  Sum_probs=205.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||++....   ......+.+|+.+|+.++||||+++++
T Consensus        15 ~~~Y~l~~~LG~G~fg~V~~a~~~-----------~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~   83 (476)
T 2y94_A           15 IGHYILGDTLGVGTFGKVKVGKHE-----------LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ   83 (476)
T ss_dssp             ETTEEEEEEEECCSSSCEEEEEET-----------TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             ecCEEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            467999999999999999999975           457889999996542   234567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        84 ~~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~  154 (476)
T 2y94_A           84 VISTPSD----IFMVMEYVSGGELFDYICKN--GRLDEKESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMN  154 (476)
T ss_dssp             EEECSSE----EEEEEECCSSEEHHHHTTSS--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCC
T ss_pred             EEEECCE----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCC
Confidence            9987654    79999999999999999765  5689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||++......   .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.......   +...+
T Consensus       155 vkL~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~---~~~~i  228 (476)
T 2y94_A          155 AKIADFGLSNMMSDG---EFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPT---LFKKI  228 (476)
T ss_dssp             EEECCCSSCEECCTT---CCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHH---HHHHH
T ss_pred             eEEEeccchhhcccc---ccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHH---HHHHH
Confidence            999999999875432   22345679999999999988765 689999999999999999999997654322   11111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...     .        .  ..+...+..+.+|+.+||..||.+|||+.+|++
T Consensus       229 ~~~-----~--------~--~~p~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~  266 (476)
T 2y94_A          229 CDG-----I--------F--YTPQYLNPSVISLLKHMLQVDPMKRATIKDIRE  266 (476)
T ss_dssp             HTT-----C--------C--CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             hcC-----C--------c--CCCccCCHHHHHHHHHHcCCCchhCcCHHHHHh
Confidence            110     0        0  011223567999999999999999999999986

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=3.3e-44  Score=340.64  Aligned_cols=254  Identities=25%  Similarity=0.360  Sum_probs=205.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||.+.... ....+.+.+|+.+++.++||||+++++++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   74 (276)
T 2yex_A            6 VEDWDLVQTLGEGAYGEVQLAVNR-----------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR   74 (276)
T ss_dssp             HHHEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ecceEEEEEeecCCCcEEEEEEEC-----------CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEE
Confidence            467999999999999999999975           456789999987543 23457789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        75 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k  145 (276)
T 2yex_A           75 REGNI----QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLK  145 (276)
T ss_dssp             EETTE----EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEE
T ss_pred             EcCCE----EEEEEEecCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEE
Confidence            87654    69999999999999998754  5689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||++................||+.|+|||++.+..+ +.++||||||+++|+|++|+.||........ ....+...
T Consensus       146 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~~~~~~  224 (276)
T 2yex_A          146 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEK  224 (276)
T ss_dssp             ECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSH-HHHHHHTT
T ss_pred             EeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHH-HHHHhhhc
Confidence            999999976543222222345678999999999987665 7899999999999999999999976443211 11111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           .         .........+..+.+|+.+||+.||.+|||+.++++
T Consensus       225 -----~---------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~  261 (276)
T 2yex_A          225 -----K---------TYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  261 (276)
T ss_dssp             -----C---------TTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -----c---------cccCchhhcCHHHHHHHHHHCCCCchhCCCHHHHhc
Confidence                 0         000112234677999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.5e-43  Score=344.29  Aligned_cols=273  Identities=24%  Similarity=0.357  Sum_probs=205.7

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC--CCCceeeE
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV--KHPNLVKL  160 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l--~h~nIv~l  160 (453)
                      ....++|...+.||+|+||.||+|+++             +..||||++...   ....+.+|.+++..+  +||||+++
T Consensus        33 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-------------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~   96 (337)
T 3mdy_A           33 RTIAKQIQMVKQIGKGRYGEVWMGKWR-------------GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGF   96 (337)
T ss_dssp             TTHHHHCEEEEEEEEETTEEEEEEEET-------------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCE
T ss_pred             cccccceEEEeEeecCCCeEEEEEEEC-------------CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeE
Confidence            344678999999999999999999863             578999998543   234455666666554  99999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeeccccccE
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM-----DFQLIFRDFKTSNI  235 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~Dlkp~NI  235 (453)
                      ++++..........++||||+++|+|.+++...   .+++..++.++.|++.||.|||+.+     .++|+||||||+||
T Consensus        97 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Ni  173 (337)
T 3mdy_A           97 IAADIKGTGSWTQLYLITDYHENGSLYDYLKST---TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNI  173 (337)
T ss_dssp             EEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGE
T ss_pred             EEEEccCCCCCCceEEEEeccCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHE
Confidence            999988754334589999999999999999764   6899999999999999999999751     23899999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCc--cccccccCcCCCCccccccCCCCCc------hhHHHHHHHHHHHHhC-----
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGH--VSTSVVGTVGYAAPEYVQTGRLTAK------SDVWSFGVVLYELITG-----  302 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~------~DV~SlGvil~elltg-----  302 (453)
                      |++.++.+||+|||++..........  ......||+.|+|||++.+...+..      +|||||||++|||++|     
T Consensus       174 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~  253 (337)
T 3mdy_A          174 LVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG  253 (337)
T ss_dssp             EECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTT
T ss_pred             EECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCccc
Confidence            99999999999999997654322111  1234579999999999987766655      9999999999999999     


Q ss_pred             -----CccccCCCChhh--HHHHHhhhhcccCccccccccCCcCCCc-cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          303 -----RRAVERNLPRNE--QKLLEWVRPYVSDSKKFHLIIDPRLEGN-YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       303 -----~~p~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                           ..||....+...  .........         ....+..... ....++.++.+|+.+||+.||.+|||+.+|++
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  324 (337)
T 3mdy_A          254 IVEEYQLPYHDLVPSDPSYEDMREIVCI---------KKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKK  324 (337)
T ss_dssp             BCCCCCCTTTTTSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccccccccHhhhcCCCCchhhhHHHHhh---------hccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHH
Confidence                 555543222111  111111100         0011111111 12367888999999999999999999999999


Q ss_pred             HHHHhHhhh
Q 043568          375 ILGNIISEI  383 (453)
Q Consensus       375 ~L~~~~~~~  383 (453)
                      .|+.+.+..
T Consensus       325 ~L~~l~~~~  333 (337)
T 3mdy_A          325 TLAKMSESQ  333 (337)
T ss_dssp             HHHHHHHTT
T ss_pred             HHHHHHhhc
Confidence            999988753

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=4.3e-44  Score=346.24  Aligned_cols=262  Identities=22%  Similarity=0.292  Sum_probs=201.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++.......   .+.+.+|+.++++++||||+++++
T Consensus        33 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~  101 (309)
T 2h34_A           33 FGPYRLRRLVGRGGMGDVYEAEDT-----------VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHD  101 (309)
T ss_dssp             -CCEEEEEEEEECSSSEEEEEEET-----------TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             eccEEEEEEEcCCCCeeEEEEEEc-----------CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEE
Confidence            578999999999999999999975           457889999987543322   367889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++...  .++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       102 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~  172 (309)
T 2h34_A          102 FGEIDGQ----LYVDMRLINGVDLAAMLRRQ--GPLAPPRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDF  172 (309)
T ss_dssp             EEEETTE----EEEEEECCCCEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSC
T ss_pred             EEeeCCe----EEEEEEecCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCC
Confidence            9987654    79999999999999999865  4689999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++........ .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......   .+.....
T Consensus       173 ~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~~~  248 (309)
T 2h34_A          173 AYLVDFGIASATTDEKL-TQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLS---VMGAHIN  248 (309)
T ss_dssp             EEECSCCC-----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHH---HHHHHHH
T ss_pred             EEEecCccCcccccccc-ccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHH---HHHHHhc
Confidence            99999999986543221 1233557999999999999989999999999999999999999999754221   1111111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhHhhh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-KMSEVVDILGNIISEI  383 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ei~~~L~~~~~~~  383 (453)
                      ....            .........+..+.+|+.+||+.||++|| |+.++++.|+.++...
T Consensus       249 ~~~~------------~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          249 QAIP------------RPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             SCCC------------CGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             cCCC------------CccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            1000            00111234466799999999999999999 9999999998877543

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=6.9e-44  Score=345.45  Aligned_cols=258  Identities=24%  Similarity=0.350  Sum_probs=198.4

Q ss_pred             hcCCCcc-ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRA-LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .+.|... ++||+|+||+||+|.+.           .++..||||++..........+.+|+.++.++ +||||++++++
T Consensus        11 ~~~y~i~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~   79 (316)
T 2ac3_A           11 EDVYQLQEDVLGEGAHARVQTCINL-----------ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEF   79 (316)
T ss_dssp             TTSCEECCCCCCCCSSEEEEEEECS-----------SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ceeEEecCceecCCceEEEEEEEEc-----------CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            3567774 68999999999999865           45678999999876656678899999999985 79999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc-
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK-  242 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~-  242 (453)
                      +...+.    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++. 
T Consensus        80 ~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~  150 (316)
T 2ac3_A           80 FEEEDR----FYLVFEKMRGGSILSHIHKR--RHFNELEASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQV  150 (316)
T ss_dssp             EEETTE----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSS
T ss_pred             EeeCCE----EEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCc
Confidence            987654    79999999999999999875  5689999999999999999999999   9999999999999998776 


Q ss_pred             --EEEeccccccCCCCCCC-----CccccccccCcCCCCcccccc-----CCCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          243 --AKLSDFGLARQGPPEGL-----GHVSTSVVGTVGYAAPEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       243 --~kL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                        +||+|||++........     ........||+.|+|||++..     ..++.++|||||||++|||++|+.||....
T Consensus       151 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  230 (316)
T 2ac3_A          151 SPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRC  230 (316)
T ss_dssp             CSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCC
T ss_pred             CceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccc
Confidence              99999999876432211     111224569999999999875     568899999999999999999999997643


Q ss_pred             Chh------------hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          311 PRN------------EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       311 ~~~------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...            ...+...+....           ...........+..+.+|+.+||..||.+|||+.++++
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  295 (316)
T 2ac3_A          231 GSDCGWDRGEACPACQNMLFESIQEGK-----------YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQ  295 (316)
T ss_dssp             CSCSCC----CCHHHHHHHHHHHHHCC-----------CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cccccccccccchhHHHHHHHHHhccC-----------cccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhc
Confidence            221            111111111000           00000001224577999999999999999999999876

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.8e-44  Score=338.96  Aligned_cols=252  Identities=23%  Similarity=0.368  Sum_probs=204.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||+|++.....  .....+.+|+.++++++||||++++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHK-----------TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS   73 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEc-----------CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEE
Confidence            578999999999999999999976           4577899999875432  334678899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc-
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK-  242 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~-  242 (453)
                      +.....    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++. 
T Consensus        74 ~~~~~~----~~~v~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~  144 (284)
T 3kk8_A           74 IQEESF----HYLVFDLVTGGELFEDIVAR--EFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKG  144 (284)
T ss_dssp             EECSSE----EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTT
T ss_pred             EEcCCE----EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCC
Confidence            977654    69999999999999988775  5689999999999999999999999   9999999999999986655 


Q ss_pred             --EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          243 --AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       243 --~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                        +||+|||++......   .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+. 
T Consensus       145 ~~~kl~Dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~-  220 (284)
T 3kk8_A          145 AAVKLADFGLAIEVNDS---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK-  220 (284)
T ss_dssp             CCEEECCCTTCEECCSS---CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-
T ss_pred             CcEEEeeceeeEEcccC---ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH-
Confidence              999999999765432   22345679999999999999999999999999999999999999997643322111111 


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ....            ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       221 -~~~~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (284)
T 3kk8_A          221 -AGAY------------DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALK  261 (284)
T ss_dssp             -HTCC------------CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -hccc------------cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence             0000            0000111234577999999999999999999999986

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=1.5e-43  Score=342.18  Aligned_cols=264  Identities=24%  Similarity=0.372  Sum_probs=200.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++.....   .....+.+|+.+++.++||||+++++
T Consensus        31 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~   99 (310)
T 2wqm_A           31 LANFRIEKKIGRGQFSEVYRAACL-----------LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA   99 (310)
T ss_dssp             GGGEEEEEEEECC--CEEEEEEET-----------TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccceEEEEeecCCCCceEEEEEEc-----------CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            467999999999999999999975           4567899999875332   23467889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.....    .++||||+++++|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus       100 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~  172 (310)
T 2wqm_A          100 SFIEDNE----LNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITAT  172 (310)
T ss_dssp             EEEETTE----EEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             EEEcCCc----EEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCC
Confidence            9987654    79999999999999998642  245789999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||++.......  .......|++.|+|||++.+..++.++||||||+++|+|++|+.||....... ..+...
T Consensus       173 ~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~~~  249 (310)
T 2wqm_A          173 GVVKLGDLGLGRFFSSKT--TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNL-YSLCKK  249 (310)
T ss_dssp             SCEEECCC--------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCH-HHHHHH
T ss_pred             CCEEEEeccceeeecCCC--ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhH-HHHHHH
Confidence            999999999998654321  12334578999999999999999999999999999999999999997543221 111111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      +...     ..     +.   ......+.++.+|+.+||..||.+|||+.+|++.|+.+....
T Consensus       250 ~~~~-----~~-----~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          250 IEQC-----DY-----PP---LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             HHTT-----CS-----CC---CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             hhcc-----cC-----CC---CcccccCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            1100     00     00   011234677999999999999999999999999999988654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=3.1e-44  Score=358.50  Aligned_cols=252  Identities=27%  Similarity=0.424  Sum_probs=196.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCC--CCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVK--HPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~--h~nIv~l~  161 (453)
                      .++|...+.||+|+||+||+|.+.            .+..||||++.....  .....+.+|+.+|+++.  ||||++++
T Consensus        55 ~~~y~~~~~LG~G~fg~Vy~~~~~------------~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~  122 (390)
T 2zmd_A           55 GRIYSILKQIGSGGSSKVFQVLNE------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLY  122 (390)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEECT------------TCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             CCceEEEEEEccCCCeEEEEEEcC------------CCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEE
Confidence            356999999999999999999853            367899999875432  33567899999999996  59999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++...+.    .++||| +.+++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++ ++
T Consensus       123 ~~~~~~~~----~~lv~E-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~  191 (390)
T 2zmd_A          123 DYEITDQY----IYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DG  191 (390)
T ss_dssp             EEEECSSE----EEEEEE-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SS
T ss_pred             EEEecCCE----EEEEEe-cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CC
Confidence            99987664    799999 5689999999876  4788889999999999999999998   999999999999995 58


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----------GRLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      .+||+|||+++...............||+.|+|||++.+           ..++.++||||||||+|||++|+.||....
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  271 (390)
T 2zmd_A          192 MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQII  271 (390)
T ss_dssp             CEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             eEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhh
Confidence            899999999987654332223445689999999999865           468899999999999999999999997543


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ... ..+....              ++......+...+..+.+|+.+||..||.+|||+.++++.
T Consensus       272 ~~~-~~~~~~~--------------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  321 (390)
T 2zmd_A          272 NQI-SKLHAII--------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH  321 (390)
T ss_dssp             CHH-HHHHHHH--------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             HHH-HHHHHHh--------------CccccCCCCccchHHHHHHHHHHcccChhhCCCHHHHhhC
Confidence            221 1111111              1111111222235679999999999999999999999863

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=2.7e-44  Score=350.27  Aligned_cols=247  Identities=25%  Similarity=0.418  Sum_probs=179.6

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  170 (453)
                      .++||+|+||+||+|.+.           .++..||||++...   ....+.+|+.+++.+. ||||+++++++.+... 
T Consensus        16 ~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~-   80 (325)
T 3kn6_A           16 DKPLGEGSFSICRKCVHK-----------KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLH-   80 (325)
T ss_dssp             SCCSEEETTEEEEEEEET-----------TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE-
T ss_pred             CCccccCCCeEEEEEEEC-----------CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCE-
Confidence            468999999999999976           45788999998643   3466789999999996 9999999999987654 


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC---cEEEec
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY---KAKLSD  247 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~---~~kL~D  247 (453)
                         .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++   .+||+|
T Consensus        81 ---~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~D  152 (325)
T 3kn6_A           81 ---TFLVMELLNGGELFERIKKK--KHFSETEASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIID  152 (325)
T ss_dssp             ---EEEEECCCCSCBHHHHHHHC--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECC
T ss_pred             ---EEEEEEccCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEec
Confidence               79999999999999999875  5789999999999999999999998   999999999999997665   899999


Q ss_pred             cccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh----hHHHHHhhhh
Q 043568          248 FGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN----EQKLLEWVRP  323 (453)
Q Consensus       248 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~----~~~~~~~~~~  323 (453)
                      ||+++......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    ...+...+..
T Consensus       153 fg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~  230 (325)
T 3kn6_A          153 FGFARLKPPDN--QPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKK  230 (325)
T ss_dssp             CTTCEECCC------------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTT
T ss_pred             cccceecCCCC--CcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHc
Confidence            99998654322  22345678999999999999999999999999999999999999997543211    1111111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          .       ............+.++.+|+.+||..||.+|||+.++++
T Consensus       231 ----~-------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  270 (325)
T 3kn6_A          231 ----G-------DFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRY  270 (325)
T ss_dssp             ----T-------CCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTT
T ss_pred             ----C-------CCCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhc
Confidence                0       001111112345678999999999999999999998864

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=5.1e-44  Score=364.53  Aligned_cols=200  Identities=27%  Similarity=0.382  Sum_probs=157.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|++.           .++..||||++....  ....+.+.+|+.+|+.++||||++++++
T Consensus        52 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~  120 (458)
T 3rp9_A           52 PDRYEIRHLIGTGSYGHVCEAYDK-----------LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDI  120 (458)
T ss_dssp             CTTEEECCC-------CEEEEEEC-----------C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCeEEeeEeeecCCeEEEEEEEC-----------CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEE
Confidence            478999999999999999999976           457789999986542  2334678999999999999999999999


Q ss_pred             eeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          164 CAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       164 ~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +..... .....++||||+ +++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.++.
T Consensus       121 ~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~  194 (458)
T 3rp9_A          121 VIPKDVEKFDELYVVLEIA-DSDFKKLFRTP--VYLTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCS  194 (458)
T ss_dssp             CCCSCTTTCCCEEEEECCC-SEEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCC
T ss_pred             EecCCcccCceEEEEEecc-ccchhhhcccC--CCCCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCC
Confidence            966542 223479999998 68999988765  5789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCC-------------------------ccccccccCcCCCCcccc-ccCCCCCchhHHHHHHHH
Q 043568          243 AKLSDFGLARQGPPEGLG-------------------------HVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVL  296 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~-------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~SlGvil  296 (453)
                      +||+|||+++........                         ...+..+||+.|+|||++ ....++.++||||||||+
T Consensus       195 ~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il  274 (458)
T 3rp9_A          195 VKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF  274 (458)
T ss_dssp             EEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHH
T ss_pred             EeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHH
Confidence            999999999875422110                         123456789999999976 466799999999999999


Q ss_pred             HHHHhC
Q 043568          297 YELITG  302 (453)
Q Consensus       297 ~elltg  302 (453)
                      |||++|
T Consensus       275 ~elltg  280 (458)
T 3rp9_A          275 AELLNM  280 (458)
T ss_dssp             HHHHTT
T ss_pred             HHHHHh
Confidence            999993

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.2e-44  Score=347.95  Aligned_cols=252  Identities=25%  Similarity=0.356  Sum_probs=194.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHHHHHHHHhccCCCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .++|...+.||+|+||.||+|++..        ...++..||||++....    ......+.+|+.+|+.++||||++++
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~--------~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~   87 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVT--------GANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLI   87 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECS--------STTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEE
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEec--------cCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCcccee
Confidence            4679999999999999999998742        12457889999997543    22345678899999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.....    .++||||+++++|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        88 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~  158 (327)
T 3a62_A           88 YAFQTGGK----LYLILEYLSGGELFMQLERE--GIFMEDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQG  158 (327)
T ss_dssp             EEEECSSC----EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTS
T ss_pred             EEEEcCCE----EEEEEeCCCCCcHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCC
Confidence            99987654    79999999999999999765  4688899999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   ....+
T Consensus       159 ~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~---~~~~i  233 (327)
T 3a62_A          159 HVKLTDFGLCKESIHDG--TVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKK---TIDKI  233 (327)
T ss_dssp             CEEECCCSCC------------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH
T ss_pred             cEEEEeCCcccccccCC--ccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHH---HHHHH
Confidence            99999999997643221  22345679999999999999899999999999999999999999997643221   11111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      ..   ..            ...+...+..+.+|+.+||..||.+||     ++.++++
T Consensus       234 ~~---~~------------~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~  276 (327)
T 3a62_A          234 LK---CK------------LNLPPYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQA  276 (327)
T ss_dssp             HH---TC------------CCCCTTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHH
T ss_pred             Hh---CC------------CCCCCCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHc
Confidence            10   00            011223467799999999999999999     6667664

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=9.2e-44  Score=339.84  Aligned_cols=252  Identities=27%  Similarity=0.390  Sum_probs=198.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||+|.+.... ....+.+.+|+.++++++||||+++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~   89 (285)
T 3is5_A           21 DDLFIFKRKLGSGAFGDVHLVEER-----------SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVF   89 (285)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             hhheeecceeccCCCeEEEEEEEc-----------cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHhe
Confidence            357888999999999999999975           457789999987553 33467899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE---cC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DE  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl---~~  239 (453)
                      .....    .++||||+++|+|.+++...  ....+++..++.++.|++.||.|||+.   +|+||||||+|||+   +.
T Consensus        90 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~  162 (285)
T 3is5_A           90 EDYHN----MYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSP  162 (285)
T ss_dssp             ECSSE----EEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSST
T ss_pred             ecCCe----EEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCC
Confidence            87654    79999999999999988643  236789999999999999999999998   99999999999999   45


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      ++.+||+|||++......   .......||+.|+|||++. ..++.++||||||+++|||++|+.||.............
T Consensus       163 ~~~~kl~Dfg~a~~~~~~---~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~  238 (285)
T 3is5_A          163 HSPIKIIDFGLAELFKSD---EHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKAT  238 (285)
T ss_dssp             TCCEEECCCCCCCC-------------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred             CCCEEEEeeecceecCCc---ccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhc
Confidence            688999999999865432   2234567999999999985 578999999999999999999999997654322211111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...+..              . ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       239 ~~~~~~--------------~-~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  278 (285)
T 3is5_A          239 YKEPNY--------------A-VECRPLTPQAVDLLKQMLTKDPERRPSAAQVLH  278 (285)
T ss_dssp             HCCCCC--------------C-C--CCCCHHHHHHHHHHTCSCTTTSCCHHHHHT
T ss_pred             cCCccc--------------c-cccCcCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence            111000              0 001123567899999999999999999999875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=2.6e-44  Score=352.70  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=202.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.++           .++..||||++......    +.+|+.++.++ +||||+++++++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~   85 (342)
T 2qr7_A           21 TDGYEVKEDIGVGSYSVCKRCIHK-----------ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVY   85 (342)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cccEEEEEEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEE
Confidence            567999999999999999999976           45789999999765432    34688888888 799999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC----
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED----  240 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~----  240 (453)
                      .+...    .++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||+..+    
T Consensus        86 ~~~~~----~~lv~E~~~gg~L~~~i~~~--~~~~~~~~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~  156 (342)
T 2qr7_A           86 DDGKY----VYVVTELMKGGELLDKILRQ--KFFSEREASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNP  156 (342)
T ss_dssp             ECSSE----EEEEECCCCSCBHHHHHHTC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSG
T ss_pred             EcCCE----EEEEEeCCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCc
Confidence            77653    79999999999999999765  5689999999999999999999999   99999999999998543    


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|..||..........+...
T Consensus       157 ~~~kl~Dfg~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~  234 (342)
T 2qr7_A          157 ESIRICDFGFAKQLRAEN--GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILAR  234 (342)
T ss_dssp             GGEEECCCTTCEECBCTT--CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHH
T ss_pred             CeEEEEECCCcccCcCCC--CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHH
Confidence            359999999998654322  223456789999999999888889999999999999999999999976433333333332


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +...     .      ...........+.++.+|+.+||..||++|||+.++++
T Consensus       235 i~~~-----~------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~  277 (342)
T 2qr7_A          235 IGSG-----K------FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLR  277 (342)
T ss_dssp             HHHC-----C------CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             HccC-----C------cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            2210     0      01111222345678999999999999999999999875

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=3.9e-44  Score=350.58  Aligned_cols=243  Identities=23%  Similarity=0.348  Sum_probs=201.5

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--------cHHHHHHHHHHhccCCCCc
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--------GHKEWINEVNFLGVVKHPN  156 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l~~l~h~n  156 (453)
                      ..++|...+.||+|+||+||+|++.           .++..||||.+......        ....+.+|+.++++++|||
T Consensus        22 ~~~~y~~~~~lG~G~~g~Vy~a~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   90 (335)
T 3dls_A           22 YSQKYSTMSPLGSGAFGFVWTAVDK-----------EKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHAN   90 (335)
T ss_dssp             HHHHEEEEEECSSSSSCSEEEEEET-----------TTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTT
T ss_pred             cccceEEEeEEEecCCEEEEEEEEC-----------CCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCC
Confidence            3578999999999999999999975           55789999998755321        2345778999999999999


Q ss_pred             eeeEeeeeeecccccceEEEEEEecCCC-ChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          157 LVKLVGYCAEDDERGMQRLLVYELMHNK-SLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       157 Iv~l~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      |+++++++.....    .++||||+.+| +|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+||
T Consensus        91 Iv~~~~~~~~~~~----~~lv~e~~~~g~~l~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NI  161 (335)
T 3dls_A           91 IIKVLDIFENQGF----FQLVMEKHGSGLDLFAFIDRH--PRLDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENI  161 (335)
T ss_dssp             BCCEEEEEECSSE----EEEEEECCTTSCBHHHHHHTC--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGE
T ss_pred             EeeEEEEEeeCCE----EEEEEEeCCCCccHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHE
Confidence            9999999987654    79999999776 999998765  4689999999999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      |++.++.+||+|||++.......   ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||......  
T Consensus       162 ll~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--  236 (335)
T 3dls_A          162 VIAEDFTIKLIDFGSAAYLERGK---LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET--  236 (335)
T ss_dssp             EECTTSCEEECCCTTCEECCTTC---CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG--
T ss_pred             EEcCCCcEEEeecccceECCCCC---ceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH--
Confidence            99999999999999998754322   2345679999999999988776 88999999999999999999999642100  


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                      .    ....  ..+...+.++.+|+.+||+.||.+|||+.++++
T Consensus       237 ----------------~----~~~~--~~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~  274 (335)
T 3dls_A          237 ----------------V----EAAI--HPPYLVSKELMSLVSGLLQPVPERRTTLEKLVT  274 (335)
T ss_dssp             ----------------T----TTCC--CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ----------------H----hhcc--CCCcccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                            0    0000  011124567999999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=1.8e-44  Score=354.75  Aligned_cols=248  Identities=32%  Similarity=0.463  Sum_probs=200.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .+.|...+.||+|+||+||+|++.           .++..||||++......   ....+.+|+.++++++||||+++++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~a~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~  121 (348)
T 1u5q_A           53 EKLFSDLREIGHGSFGAVYFARDV-----------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRG  121 (348)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhheeeeeEEccCCCEEEEEEEEc-----------cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEE
Confidence            355888999999999999999975           45789999998754322   2356889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+. |+|.+++... ..++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus       122 ~~~~~~~----~~lv~e~~~-g~l~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~  192 (348)
T 1u5q_A          122 CYLREHT----AWLVMEYCL-GSASDLLEVH-KKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGL  192 (348)
T ss_dssp             EEEETTE----EEEEEECCS-EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTE
T ss_pred             EEEECCe----EEEEEecCC-CCHHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCC
Confidence            9987654    799999996 6888877643 35789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      +||+|||++.....      .....||+.|+|||++.   ...++.++|||||||++|||++|+.||........  +..
T Consensus       193 ~kL~DfG~a~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~--~~~  264 (348)
T 1u5q_A          193 VKLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYH  264 (348)
T ss_dssp             EEECCCTTCBSSSS------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHH
T ss_pred             EEEeeccCceecCC------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHH--HHH
Confidence            99999999987542      23457999999999985   56789999999999999999999999975432211  111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      ....    .       .+..   .....+..+.+|+.+||+.||.+|||+.++++.
T Consensus       265 ~~~~----~-------~~~~---~~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h  306 (348)
T 1u5q_A          265 IAQN----E-------SPAL---QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH  306 (348)
T ss_dssp             HHHS----C-------CCCC---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHhc----C-------CCCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHhhC
Confidence            1110    0       0000   112345679999999999999999999998763

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.8e-44  Score=361.76  Aligned_cols=263  Identities=20%  Similarity=0.236  Sum_probs=207.7

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCC
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVK  153 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~  153 (453)
                      +.+.+.....++|...++||+|+||.||+|+++           .+++.||||++.+..   ......+.+|..++..++
T Consensus        51 ~~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~-----------~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~  119 (412)
T 2vd5_A           51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMK-----------QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD  119 (412)
T ss_dssp             HHHHHHSCCGGGEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC
T ss_pred             hhhhhccCChhhEEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC
Confidence            445556666889999999999999999999975           457889999996532   122345789999999999


Q ss_pred             CCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       154 h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      ||||+++++++.+...    ++|||||+++|+|.+++... +..+++..+..++.||+.||.|||+.   +|+||||||+
T Consensus       120 hp~Iv~l~~~~~~~~~----~~lVmE~~~gg~L~~~l~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~  191 (412)
T 2vd5_A          120 RRWITQLHFAFQDENY----LYLVMEYYVGGDLLTLLSKF-GERIPAEMARFYLAEIVMAIDSVHRL---GYVHRDIKPD  191 (412)
T ss_dssp             TTTBCCEEEEEECSSE----EEEEECCCCSCBHHHHHHHH-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGG
T ss_pred             CCCeeeEEEEEeeCCE----EEEEEcCCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccCHH
Confidence            9999999999987654    79999999999999999764 24789999999999999999999998   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccc-------cCCCCCchhHHHHHHHHHHHHhCCccc
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-------TGRLTAKSDVWSFGVVLYELITGRRAV  306 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DV~SlGvil~elltg~~p~  306 (453)
                      |||++.++++||+|||+++....... .......||+.|+|||++.       ...++.++|||||||++|||++|+.||
T Consensus       192 NILld~~g~vkL~DFGla~~~~~~~~-~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf  270 (412)
T 2vd5_A          192 NILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPF  270 (412)
T ss_dssp             GEEECTTSCEEECCCTTCEECCTTSC-EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTT
T ss_pred             HeeecCCCCEEEeechhheeccCCCc-cccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCC
Confidence            99999999999999999987543221 1233468999999999987       356899999999999999999999999


Q ss_pred             cCCCChhhHH-HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCC---CCHHHHHH
Q 043568          307 ERNLPRNEQK-LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR---PKMSEVVD  374 (453)
Q Consensus       307 ~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R---Ps~~ei~~  374 (453)
                      .......... +..+... .         ..+    ..+...+.++.+||.+||. +|.+|   |++++|++
T Consensus       271 ~~~~~~~~~~~i~~~~~~-~---------~~p----~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~  327 (412)
T 2vd5_A          271 YADSTAETYGKIVHYKEH-L---------SLP----LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRT  327 (412)
T ss_dssp             CCSSHHHHHHHHHTHHHH-C---------CCC--------CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHT
T ss_pred             CCCCHHHHHHHHHhcccC-c---------CCC----ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhc
Confidence            7654322211 1111000 0         000    0112346789999999999 99998   58888864

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=4.8e-44  Score=370.15  Aligned_cols=253  Identities=30%  Similarity=0.443  Sum_probs=208.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...++||+|+||.||+|.++           .++..||||++....   ......+.+|+.+|+.++||||+++++
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~-----------~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~  251 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVR-----------ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAY  251 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEEC-----------CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEE
Confidence            467999999999999999999975           457889999996532   234567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.+...    +++||||++||+|.+++.......+++..+..++.||+.||.|||++   +|+||||||+||||+.++.
T Consensus       252 ~~~~~~~----l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~  324 (576)
T 2acx_A          252 AYETKDA----LCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGH  324 (576)
T ss_dssp             EEECSSE----EEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSC
T ss_pred             EEeeCCE----EEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCC
Confidence            9987654    79999999999999999877666799999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh-hHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN-EQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~-~~~~~~~~  321 (453)
                      +||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ...+...+
T Consensus       325 vKL~DFGla~~~~~~~---~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i  401 (576)
T 2acx_A          325 IRISDLGLAVHVPEGQ---TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV  401 (576)
T ss_dssp             EEECCCTTCEECCTTC---CEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHH
T ss_pred             eEEEecccceecccCc---cccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHh
Confidence            9999999998754322   2345689999999999999899999999999999999999999997653221 11222211


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      ...               ...++...+.++.+||.+||..||.+||     ++.+|++
T Consensus       402 ~~~---------------~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~  444 (576)
T 2acx_A          402 KEV---------------PEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKE  444 (576)
T ss_dssp             HHC---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHT
T ss_pred             hcc---------------cccCCccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHh
Confidence            110               0112233467899999999999999999     6788764

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=4.1e-44  Score=349.57  Aligned_cols=263  Identities=25%  Similarity=0.325  Sum_probs=192.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~  164 (453)
                      ..+|...++||+|+||.||+|.+.           .++..||||++..........+.+|+.++.++. ||||+++++++
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~   95 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDV-----------GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAA   95 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEET-----------TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             CceEEEEEEEccCCceEEEEEEEC-----------CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccc
Confidence            457999999999999999999975           457789999987665556678899999999995 99999999999


Q ss_pred             eecc----cccceEEEEEEecCCCChHHhhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc--eEeeccccccEEE
Q 043568          165 AEDD----ERGMQRLLVYELMHNKSLEDHLLSR-VPTPLAWIARLKIAQDAARGLAYLHEEMDFQ--LIFRDFKTSNILL  237 (453)
Q Consensus       165 ~~~~----~~~~~~~lv~e~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~--iiH~Dlkp~NILl  237 (453)
                      ....    ......++||||+ +|+|.+++... ...++++..++.++.||+.||.|||+.   +  |+||||||+|||+
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~-~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~  171 (337)
T 3ll6_A           96 SIGKEESDTGQAEFLLLTELC-KGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLL  171 (337)
T ss_dssp             EECTTTSTTSSEEEEEEEECC-SEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEE
T ss_pred             cccccccccCCceEEEEEEec-CCCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEE
Confidence            5432    1223479999999 57999988652 235699999999999999999999998   7  9999999999999


Q ss_pred             cCCCcEEEeccccccCCCCCCCCc----------cccccccCcCCCCcccc---ccCCCCCchhHHHHHHHHHHHHhCCc
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGH----------VSTSVVGTVGYAAPEYV---QTGRLTAKSDVWSFGVVLYELITGRR  304 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~----------~~~~~~gt~~y~aPE~~---~~~~~~~~~DV~SlGvil~elltg~~  304 (453)
                      +.++.+||+|||+++.........          ......||+.|+|||++   .+..++.++|||||||++|+|++|+.
T Consensus       172 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~  251 (337)
T 3ll6_A          172 SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQH  251 (337)
T ss_dssp             CTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSC
T ss_pred             CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCC
Confidence            999999999999998754322111          11245689999999998   56678999999999999999999999


Q ss_pred             cccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          305 AVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       305 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ||......   .+..                 ...........+..+.+|+.+||+.||.+|||+.++++.|..+....
T Consensus       252 p~~~~~~~---~~~~-----------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~  310 (337)
T 3ll6_A          252 PFEDGAKL---RIVN-----------------GKYSIPPHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAAR  310 (337)
T ss_dssp             CC--------------------------------CCCCTTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             CCcchhHH---Hhhc-----------------CcccCCcccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhcc
Confidence            99643211   0100                 00000111122345889999999999999999999999999988653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.2e-44  Score=351.96  Aligned_cols=260  Identities=15%  Similarity=0.149  Sum_probs=206.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC---CCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK---HPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~  161 (453)
                      ..++|...++||+|+||+||+|++....      ....+..||||++...   ...++..|+.+++.++   |+||++++
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~------~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~  133 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLN------DAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFY  133 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCc------ccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhh
Confidence            3577999999999999999999643211      1245778999998653   3456778888887776   99999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSR---VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~---~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      +++...+.    .+|||||+++|+|.+++...   ....+++..++.++.||+.||.|||+.   +|+||||||+|||++
T Consensus       134 ~~~~~~~~----~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~  206 (365)
T 3e7e_A          134 SAHLFQNG----SVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILG  206 (365)
T ss_dssp             EEEECSSC----EEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEEC
T ss_pred             eeeecCCC----cEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEec
Confidence            99988765    69999999999999999742   245799999999999999999999998   999999999999999


Q ss_pred             C-----------CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          239 E-----------DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       239 ~-----------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      .           ++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||.
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            8           89999999999975432222334456789999999999999999999999999999999999999986


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCC-CCHHHHHHHHHHhHhh
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSR-PKMSEVVDILGNIISE  382 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R-Ps~~ei~~~L~~~~~~  382 (453)
                      ......               ..    ........   ..++.+.+++..|++.+|.+| |++.++.+.|+.++..
T Consensus       287 ~~~~~~---------------~~----~~~~~~~~---~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~  340 (365)
T 3e7e_A          287 KNEGGE---------------CK----PEGLFRRL---PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQ  340 (365)
T ss_dssp             EEETTE---------------EE----ECSCCTTC---SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHH
T ss_pred             cCCCCc---------------ee----echhcccc---CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHH
Confidence            432110               00    01111111   135678899999999999998 6788889999888865

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.5e-43  Score=361.07  Aligned_cols=267  Identities=25%  Similarity=0.319  Sum_probs=198.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC--CcccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ--GFQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|.+.           .++..||||++...  .....+.+.+|+.+|+.++||||++++++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~  129 (464)
T 3ttj_A           61 LKRYQNLKPIGSGAQGIVCAAYDA-----------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV  129 (464)
T ss_dssp             ETTEEEEEEEEECSSCEEEEEEET-----------TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             cCCeEEEEEeecCCCeEEEEEEEC-----------CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            578999999999999999999976           45788999999754  22335678899999999999999999999


Q ss_pred             eeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.....  .....+|||||+++ +|.+.+..    .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus       130 ~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~  201 (464)
T 3ttj_A          130 FTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC  201 (464)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred             EccCCccccCCeEEEEEeCCCC-CHHHHHhh----cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCC
Confidence            976542  12347999999965 56666643    488999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~  320 (453)
                      .+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......... ++..
T Consensus       202 ~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~  278 (464)
T 3ttj_A          202 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  278 (464)
T ss_dssp             CEEECCCCCC-----C---CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             CEEEEEEEeeeecCCC---cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999999875432   22455789999999999999999999999999999999999999997654322211 1111


Q ss_pred             hh---------------hcccCcc-----ccccccCCcC---CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VR---------------PYVSDSK-----KFHLIIDPRL---EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~---------------~~~~~~~-----~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..               .+.....     .+...+...+   ........+.++.+|+.+||..||++|||+.|+++
T Consensus       279 lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  355 (464)
T 3ttj_A          279 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  355 (464)
T ss_dssp             HCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            00               0000000     0000000000   00111223678999999999999999999999886

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=6e-44  Score=348.86  Aligned_cols=284  Identities=23%  Similarity=0.380  Sum_probs=202.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHH--hccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF--LGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~--l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++.             +..||||++...   ....+..|.++  +..++||||++++++
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~-------------~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~   75 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLD-------------ERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVG   75 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEET-------------TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEE
T ss_pred             hHHhheeeecccCCCeEEEEEEEC-------------CeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheec
Confidence            478999999999999999999753             578999998643   23444445444  556899999999987


Q ss_pred             eeecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEeeccccccEE
Q 043568          164 CAEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM------DFQLIFRDFKTSNIL  236 (453)
Q Consensus       164 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------~~~iiH~Dlkp~NIL  236 (453)
                      +...... ...+++||||+++|+|.+++...   ..++..++.++.||+.||.|||+..      .++|+||||||+|||
T Consensus        76 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nil  152 (336)
T 3g2f_A           76 DERVTADGRMEYLLVMEYYPNGSLXKYLSLH---TSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL  152 (336)
T ss_dssp             EEEECTTSCEEEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEE
T ss_pred             ccccccCCCceEEEEEecCCCCcHHHHHhhc---ccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEE
Confidence            6543222 23468999999999999999765   4588899999999999999999762      238999999999999


Q ss_pred             EcCCCcEEEeccccccCCCCCCC------CccccccccCcCCCCcccccc-------CCCCCchhHHHHHHHHHHHHhCC
Q 043568          237 LDEDYKAKLSDFGLARQGPPEGL------GHVSTSVVGTVGYAAPEYVQT-------GRLTAKSDVWSFGVVLYELITGR  303 (453)
Q Consensus       237 l~~~~~~kL~DFGla~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~SlGvil~elltg~  303 (453)
                      ++.++.+||+|||+++.......      ........||+.|+|||++.+       ..++.++|||||||++|||++|.
T Consensus       153 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~  232 (336)
T 3g2f_A          153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRC  232 (336)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTB
T ss_pred             EcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcC
Confidence            99999999999999986543211      112234579999999999976       35667899999999999999998


Q ss_pred             ccccCCCChhhH--HHHHhh--hhcccCcc--ccccccCCcCCC--ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          304 RAVERNLPRNEQ--KLLEWV--RPYVSDSK--KFHLIIDPRLEG--NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       304 ~p~~~~~~~~~~--~~~~~~--~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .||.........  .+....  .+......  .......+.+..  ......+..+.+||.+||+.||++|||+.++++.
T Consensus       233 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~  312 (336)
T 3g2f_A          233 TDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEER  312 (336)
T ss_dssp             GGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHH
Confidence            877543221110  000000  00000000  000000111111  1123467789999999999999999999999999


Q ss_pred             HHHhHhhhcccCc
Q 043568          376 LGNIISEISSQDE  388 (453)
Q Consensus       376 L~~~~~~~~~~~~  388 (453)
                      |+.++........
T Consensus       313 L~~ll~~~~~~~~  325 (336)
T 3g2f_A          313 MAELMMIWERNKS  325 (336)
T ss_dssp             HHHHHHCCCC---
T ss_pred             HHHHHHHHHhccc
Confidence            9999987655433

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3e-44  Score=358.41  Aligned_cols=269  Identities=23%  Similarity=0.353  Sum_probs=193.7

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCC-CCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVK-HPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~-h~nIv~l~  161 (453)
                      ..++|...+.||+|+||+||+|.+.           .++..||||++....  ......+.+|+.+|+.+. ||||++++
T Consensus         7 ~~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~   75 (388)
T 3oz6_A            7 VLRKYELVKKLGKGAYGIVWKSIDR-----------RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLL   75 (388)
T ss_dssp             HHTTEEEEEC-------CEEEEEET-----------TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEE
T ss_pred             ccCceEEEEEeeeCCCeEEEEEEEC-----------CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeee
Confidence            4678999999999999999999976           457889999986432  233466889999999997 99999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++...+..  ..++|||||+ ++|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        76 ~~~~~~~~~--~~~lv~e~~~-~~L~~~~~~~---~~~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~  146 (388)
T 3oz6_A           76 NVLRADNDR--DVYLVFDYME-TDLHAVIRAN---ILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAEC  146 (388)
T ss_dssp             EEEECTTSS--CEEEEEECCS-EEHHHHHHHT---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             eEEecCCCC--EEEEEecccC-cCHHHHHHcC---CCCHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCC
Confidence            999765432  3799999996 6899988763   688999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCC-------------------CCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEG-------------------LGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELIT  301 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~-------------------~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~ellt  301 (453)
                      .+||+|||+++......                   .........||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus       147 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~  226 (388)
T 3oz6_A          147 HVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILC  226 (388)
T ss_dssp             CEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHH
T ss_pred             CEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHh
Confidence            99999999997643210                   0112344689999999999876 678999999999999999999


Q ss_pred             CCccccCCCChhhHHHHHhhhhcccCcccccccc------------------CCcCCCcc------------chHHHHHH
Q 043568          302 GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLII------------------DPRLEGNY------------CIKSAQKL  351 (453)
Q Consensus       302 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~------------~~~~~~~l  351 (453)
                      |+.||...........+....... ....+..+.                  .......+            ....+.++
T Consensus       227 g~~pf~~~~~~~~~~~i~~~~~~p-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  305 (388)
T 3oz6_A          227 GKPIFPGSSTMNQLERIIGVIDFP-SNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEA  305 (388)
T ss_dssp             SSCSCCCSSHHHHHHHHHHHHCCC-CHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHH
T ss_pred             CCCCCCCCCHHHHHHHHHHhcCCC-CHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHH
Confidence            999997654332222111100000 000000000                  00000000            01335679


Q ss_pred             HHHHHHhhccCCCCCCCHHHHHH
Q 043568          352 AALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       352 ~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+|+.+||..||.+|||+.++++
T Consensus       306 ~dll~~~L~~dP~~R~t~~e~l~  328 (388)
T 3oz6_A          306 LDLLDKLLQFNPNKRISANDALK  328 (388)
T ss_dssp             HHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHhhccCcccCCCHHHHhC
Confidence            99999999999999999999876

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.5e-44  Score=338.12  Aligned_cols=250  Identities=28%  Similarity=0.445  Sum_probs=183.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||.+....   ......+.+|+.++++++||||+++++
T Consensus        10 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   78 (278)
T 3cok_A           10 IEDFKVGNLLGKGSFAGVYRAESI-----------HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN   78 (278)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEE
T ss_pred             cccceeeeeecCCCceEEEEEEEc-----------cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEE
Confidence            467999999999999999999875           456789999986432   223467899999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++... ..++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        79 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~  150 (278)
T 3cok_A           79 YFEDSNY----VYLVLEMCHNGEMNRYLKNR-VKPFSENEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMN  150 (278)
T ss_dssp             EEECSSE----EEEEEECCTTEEHHHHHHTC-SSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCC
T ss_pred             EEccCCe----EEEEEecCCCCcHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCC
Confidence            9987653    79999999999999998764 35789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........       
T Consensus       151 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~-------  221 (278)
T 3cok_A          151 IKIADFGLATQLKMPH--EKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTL-------  221 (278)
T ss_dssp             EEECCCTTCEECC------------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC----------
T ss_pred             EEEEeecceeeccCCC--CcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHH-------
Confidence            9999999998654321  1223457899999999999888999999999999999999999999754321110       


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                               .......  ...+...+.++.+|+.+||..||.+|||+.++++
T Consensus       222 ---------~~~~~~~--~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  262 (278)
T 3cok_A          222 ---------NKVVLAD--YEMPSFLSIEAKDLIHQLLRRNPADRLSLSSVLD  262 (278)
T ss_dssp             -----------CCSSC--CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             ---------HHHhhcc--cCCccccCHHHHHHHHHHcccCHhhCCCHHHHhc
Confidence                     0000000  0112234678999999999999999999999875

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=5.4e-44  Score=354.12  Aligned_cols=248  Identities=26%  Similarity=0.357  Sum_probs=194.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHH-hccCCCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNF-LGVVKHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~-l~~l~h~nIv~l~  161 (453)
                      .++|...++||+|+||.||+|+++           .++..||||++.+...   .....+.+|..+ ++.++||||++++
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~-----------~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~  105 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHK-----------AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH  105 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEET-----------TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEc-----------CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEE
Confidence            467999999999999999999976           4577899999976532   233456777777 5778999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++...+.    +++||||+++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++
T Consensus       106 ~~~~~~~~----~~lv~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g  176 (373)
T 2r5t_A          106 FSFQTADK----LYFVLDYINGGELFYHLQRE--RCFLEPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQG  176 (373)
T ss_dssp             EEEECSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred             EEEEeCCE----EEEEEeCCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCC
Confidence            99987664    79999999999999999865  4688889999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      ++||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|..||......   .+...+
T Consensus       177 ~ikL~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~---~~~~~i  251 (373)
T 2r5t_A          177 HIVLTDFGLCKENIEH--NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA---EMYDNI  251 (373)
T ss_dssp             CEEECCCCBCGGGBCC--CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHH---HHHHHH
T ss_pred             CEEEeeCccccccccC--CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHH---HHHHHH
Confidence            9999999999853221  12245668999999999999999999999999999999999999999754322   121111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                      ..   ..          +  .++...+..+.+|+.+||..||.+||++.+.+
T Consensus       252 ~~---~~----------~--~~~~~~~~~~~~li~~lL~~dp~~R~~~~~~~  288 (373)
T 2r5t_A          252 LN---KP----------L--QLKPNITNSARHLLEGLLQKDRTKRLGAKDDF  288 (373)
T ss_dssp             HH---SC----------C--CCCSSSCHHHHHHHHHHTCSSGGGSTTTTTTH
T ss_pred             Hh---cc----------c--CCCCCCCHHHHHHHHHHcccCHHhCCCCCCCH
Confidence            10   00          0  11223456799999999999999999986433

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=7.6e-44  Score=347.61  Aligned_cols=266  Identities=20%  Similarity=0.261  Sum_probs=194.5

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||+||+|++.           .++..||||++......  ....+.+|+.++++++||||+++++
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  100 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDT-----------VTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS  100 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEET-----------TTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEEC-----------CCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEE
Confidence            3578999999999999999999875           55789999998754322  2456789999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE-----
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL-----  237 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl-----  237 (453)
                      ++.....    .++||||++ |+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||+     
T Consensus       101 ~~~~~~~----~~lv~e~~~-~~L~~~~~~~--~~~~~~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~  170 (329)
T 3gbz_A          101 VIHHNHR----LHLIFEYAE-NDLKKYMDKN--PDVSMRVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDA  170 (329)
T ss_dssp             EEEETTE----EEEEEECCS-EEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC---
T ss_pred             EEecCCE----EEEEEecCC-CCHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCC
Confidence            9987664    799999996 5999999876  4689999999999999999999999   99999999999999     


Q ss_pred             cCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      +.++.+||+|||+++.....  ........||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus       171 ~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  248 (329)
T 3gbz_A          171 SETPVLKIGDFGLARAFGIP--IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLF  248 (329)
T ss_dssp             --CCEEEECCTTHHHHHC-------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CccceEEECcCCCccccCCc--ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHH
Confidence            45556999999999764322  1223455789999999999874 58999999999999999999999997654332211


Q ss_pred             HHHhhhhcccCccccc-------------cccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFH-------------LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~-------------~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+....... ......             ......+........+.++.+|+.+||..||.+|||+.++++
T Consensus       249 ~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  318 (329)
T 3gbz_A          249 KIFEVLGLP-DDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE  318 (329)
T ss_dssp             HHHHHHCCC-CTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCC-chhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhC
Confidence            111100000 000000             000000000111224578899999999999999999999875

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=1.5e-43  Score=337.59  Aligned_cols=251  Identities=24%  Similarity=0.403  Sum_probs=202.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc------ccHHHHHHHHHHhccCCCCceeeE
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF------QGHKEWINEVNFLGVVKHPNLVKL  160 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~nIv~l  160 (453)
                      ++|...+.||+|+||+||+|.+.           .++..||+|.+.....      ...+.+.+|+.++++++||||+++
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~   73 (283)
T 3bhy_A            5 DHYEMGEELGSGQFAIVRKCRQK-----------GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITL   73 (283)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             hhhhhHHhhcccCceEEEEEEEc-----------CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeeh
Confidence            56889999999999999999975           4567899999875432      135789999999999999999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++++.....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.+
T Consensus        74 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~  144 (283)
T 3bhy_A           74 HDIFENKTD----VVLILELVSGGELFDFLAEK--ESLTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDK  144 (283)
T ss_dssp             EEEEECSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCS
T ss_pred             hheecCCCe----EEEEEeecCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecC
Confidence            999987654    79999999999999999764  5789999999999999999999998   99999999999999887


Q ss_pred             C----cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          241 Y----KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       241 ~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      +    .+||+|||++.......   ......||+.|+|||++.+..++.++||||||+++|+|++|..||........  
T Consensus       145 ~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--  219 (283)
T 3bhy_A          145 NVPNPRIKLIDFGIAHKIEAGN---EFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQET--  219 (283)
T ss_dssp             SSSSCCEEECCCTTCEECC-----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHH--
T ss_pred             CCCCCceEEEecccceeccCCC---cccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHH--
Confidence            7    89999999998654321   23455799999999999999999999999999999999999999976432221  


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ...+...           ............+..+.+|+.+||..||.+|||+.++++
T Consensus       220 -~~~~~~~-----------~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  265 (283)
T 3bhy_A          220 -LTNISAV-----------NYDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLE  265 (283)
T ss_dssp             -HHHHHTT-----------CCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHhHhc-----------ccCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHh
Confidence             1111100           000011112234577999999999999999999999986

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=1.4e-43  Score=341.58  Aligned_cols=251  Identities=25%  Similarity=0.377  Sum_probs=203.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||.+..........+.+|+.+++.++||||+++++++.
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   76 (304)
T 2jam_A            8 RKTFIFMEVLGSGAFSEVFLVKQR-----------LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYE   76 (304)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             hccceeeeeccCCCCceEEEEEEC-----------CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcc
Confidence            467899999999999999999975           457789999997655445567889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE---cCCCc
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDYK  242 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl---~~~~~  242 (453)
                      ....    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||+   +.++.
T Consensus        77 ~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~  147 (304)
T 2jam_A           77 STTH----YYLVMQLVSGGELFDRILER--GVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSK  147 (304)
T ss_dssp             CSSE----EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCC
T ss_pred             cCCE----EEEEEEcCCCccHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCC
Confidence            7654    79999999999999998765  4689999999999999999999999   99999999999999   78899


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||......   .+...+.
T Consensus       148 ~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~---~~~~~i~  220 (304)
T 2jam_A          148 IMITDFGLSKMEQNG----IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES---KLFEKIK  220 (304)
T ss_dssp             EEBCSCSTTCCCCCB----TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHH---HHHHHHH
T ss_pred             EEEccCCcceecCCC----ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHH---HHHHHHH
Confidence            999999999764321    234457999999999999999999999999999999999999999764322   1221111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...   .        ..........+..+.+|+.+||..||.+|||+.++++
T Consensus       221 ~~~---~--------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~  261 (304)
T 2jam_A          221 EGY---Y--------EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALS  261 (304)
T ss_dssp             HCC---C--------CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCC---C--------CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            100   0        0011122334678999999999999999999999885

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-43  Score=357.83  Aligned_cols=254  Identities=24%  Similarity=0.374  Sum_probs=193.9

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--------ccHHHHHHHHHHhccCCCC
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--------QGHKEWINEVNFLGVVKHP  155 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~  155 (453)
                      ...++|...+.||+|+||+||+|.+.           .++..||||++.....        .....+.+|+.+|++++||
T Consensus       132 ~~~~~y~~~~~LG~G~~g~V~~a~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  200 (419)
T 3i6u_A          132 ALRDEYIMSKTLGSGACGEVKLAFER-----------KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHP  200 (419)
T ss_dssp             HHHTTEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCT
T ss_pred             hhhccEEEEeEEeeCCCeEEEEEEEC-----------CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCC
Confidence            44688999999999999999999976           4577899999875321        1223578999999999999


Q ss_pred             ceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      ||+++++++....     .++||||+++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+||
T Consensus       201 niv~l~~~~~~~~-----~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NI  270 (419)
T 3i6u_A          201 CIIKIKNFFDAED-----YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENV  270 (419)
T ss_dssp             TBCCCCEEEESSE-----EEEEEECCTTCBGGGGTSSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             CEeeEEEEEecCc-----eEEEEEcCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhE
Confidence            9999999985433     68999999999999988765  5789999999999999999999998   999999999999


Q ss_pred             EEcCC---CcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          236 LLDED---YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       236 Ll~~~---~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                      |++.+   +.+||+|||+++.....   .......||+.|+|||++.+   ..++.++|||||||++|+|++|..||...
T Consensus       271 ll~~~~~~~~~kl~DFG~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~  347 (419)
T 3i6u_A          271 LLSSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEH  347 (419)
T ss_dssp             EESSSSSSCCEEECCSSTTTSCC--------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCC
T ss_pred             EEecCCCcceEEEeecccceecCCC---ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            99754   45999999999875432   22345679999999999853   67888999999999999999999999754


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....  +...+..     ...      ..........+..+.+|+.+||+.||.+|||+.++++
T Consensus       348 ~~~~~--~~~~i~~-----~~~------~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~  399 (419)
T 3i6u_A          348 RTQVS--LKDQITS-----GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  399 (419)
T ss_dssp             SSSCC--HHHHHHT-----TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             cchHH--HHHHHhc-----CCC------CCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            32211  1111100     000      0000111234678999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=2.1e-43  Score=345.73  Aligned_cols=270  Identities=23%  Similarity=0.356  Sum_probs=210.1

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhcc--CCCCceeeE
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGV--VKHPNLVKL  160 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~--l~h~nIv~l  160 (453)
                      ....++|...+.||+|+||.||+|++.             +..||||.+...   ....+.+|++++..  ++||||+++
T Consensus        38 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-------------~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~  101 (342)
T 1b6c_B           38 RTIARTIVLQESIGKGRFGEVWRGKWR-------------GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGF  101 (342)
T ss_dssp             HHHHHHCEEEEEEEEETTEEEEEEEET-------------TEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCE
T ss_pred             ccccccEEEEeeecCCCCcEEEEEEEc-------------CccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEE
Confidence            445678999999999999999999863             578999998643   34667888888887  799999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEeecccc
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLH--------EEMDFQLIFRDFKT  232 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------~~~~~~iiH~Dlkp  232 (453)
                      ++++..........++||||+++|+|.+++...   .+++..++.++.|++.||.|||        +.   +|+||||||
T Consensus       102 ~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~---~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp  175 (342)
T 1b6c_B          102 IAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKS  175 (342)
T ss_dssp             EEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSG
T ss_pred             EeeecccCCccceeEEEEeecCCCcHHHHHhcc---CccHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCH
Confidence            999988764333479999999999999999764   6899999999999999999999        66   999999999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCc--cccccccCcCCCCccccccCC------CCCchhHHHHHHHHHHHHhC--
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGH--VSTSVVGTVGYAAPEYVQTGR------LTAKSDVWSFGVVLYELITG--  302 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~SlGvil~elltg--  302 (453)
                      +|||++.++.+||+|||++..........  ......||+.|+|||++.+..      ++.++|||||||++|||++|  
T Consensus       176 ~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~  255 (342)
T 1b6c_B          176 KNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS  255 (342)
T ss_dssp             GGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBC
T ss_pred             HHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccC
Confidence            99999999999999999997644322111  224457999999999987652      33689999999999999999  


Q ss_pred             --------CccccCCCChh--hHHHHHhhhhcccCccccccccCCcCCCc-cchHHHHHHHHHHHHhhccCCCCCCCHHH
Q 043568          303 --------RRAVERNLPRN--EQKLLEWVRPYVSDSKKFHLIIDPRLEGN-YCIKSAQKLAALASKCLTKQPKSRPKMSE  371 (453)
Q Consensus       303 --------~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~li~~cl~~dp~~RPs~~e  371 (453)
                              ..||....+..  ...+...+..         ....+.+... .....+..+.+|+.+||+.||.+|||+.+
T Consensus       256 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~  326 (342)
T 1b6c_B          256 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCE---------QKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALR  326 (342)
T ss_dssp             BTTBCCCCCCTTTTTSCSSCCHHHHHHHHTT---------SCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHH
T ss_pred             cCCcccccccCccccCcCcccHHHHHHHHHH---------HHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHH
Confidence                    66775543211  1111111100         0011111111 13356788999999999999999999999


Q ss_pred             HHHHHHHhHhhh
Q 043568          372 VVDILGNIISEI  383 (453)
Q Consensus       372 i~~~L~~~~~~~  383 (453)
                      |++.|+.+..+.
T Consensus       327 i~~~L~~i~~~~  338 (342)
T 1b6c_B          327 IKKTLSQLSQQE  338 (342)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHHHHh
Confidence            999999988653

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.4e-43  Score=336.17  Aligned_cols=253  Identities=23%  Similarity=0.359  Sum_probs=200.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|....+||+|+||.||+|.+.           .++..||||.+........+.+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   90 (295)
T 2clq_A           22 DENGDRVVLGKGTYGIVYAGRDL-----------SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSE   90 (295)
T ss_dssp             CTTSSBCEEEECSSSEEEEEEET-----------TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEE
T ss_pred             cCCCCcEEEeecCcEEEEEEEEC-----------CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEe
Confidence            45666679999999999999975           4567899999987665566789999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-CCcEE
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-DYKAK  244 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-~~~~k  244 (453)
                      .+.    .++||||+++++|.+++.... ...+++..+..++.|++.||.|||+.   +|+||||||+|||++. ++.+|
T Consensus        91 ~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~k  163 (295)
T 2clq_A           91 NGF----IKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLK  163 (295)
T ss_dssp             TTE----EEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEE
T ss_pred             CCc----EEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEE
Confidence            654    799999999999999998653 34567888999999999999999998   9999999999999987 89999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCC--CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||++.......  .......||+.|+|||++.+..  ++.++||||||+++|+|++|+.||........... ....
T Consensus       164 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~-~~~~  240 (295)
T 2clq_A          164 ISDFGTSKRLAGIN--PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF-KVGM  240 (295)
T ss_dssp             ECCTTTCEESCC-------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHH-HHHH
T ss_pred             EeecccccccCCCC--CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHH-hhcc
Confidence            99999998654321  1234557899999999987643  88999999999999999999999975432221111 1000


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        .            ......+...+.++.+|+.+||..||++|||+.++++
T Consensus       241 --~------------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  278 (295)
T 2clq_A          241 --F------------KVHPEIPESMSAEAKAFILKCFEPDPDKRACANDLLV  278 (295)
T ss_dssp             --H------------CCCCCCCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHT
T ss_pred             --c------------cccccccccCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence              0            0011122334678999999999999999999999874

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=4.1e-43  Score=338.17  Aligned_cols=255  Identities=22%  Similarity=0.300  Sum_probs=203.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHHHHHHHHhccCCCCceeeEe
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++....    ......+.+|+.+++.++||||++++
T Consensus         4 ~~~y~i~~~lg~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~   72 (305)
T 2wtk_C            4 IGKYLMGDLLGEGSYGKVKEVLDS-----------ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV   72 (305)
T ss_dssp             -CCBCCCCEEEECSSCEEEEEEBT-----------TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEE
T ss_pred             ccceeEeeEEecCCCeEEEEEEEC-----------CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEE
Confidence            478999999999999999999865           456789999987542    23456789999999999999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++......  ..++||||++++ |.+++.......+++..++.++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        73 ~~~~~~~~~--~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~  146 (305)
T 2wtk_C           73 DVLYNEEKQ--KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGG  146 (305)
T ss_dssp             EEEECC-----CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTC
T ss_pred             EEEEcCCCC--eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCC
Confidence            998643321  379999999766 88888776667899999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCC--CCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      .+||+|||++................||+.|+|||++.+..  ++.++||||||+++|||++|+.||.......   ...
T Consensus       147 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~---~~~  223 (305)
T 2wtk_C          147 TLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK---LFE  223 (305)
T ss_dssp             CEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHH
T ss_pred             cEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH---HHH
Confidence            99999999998765433333345667999999999987644  3789999999999999999999997643221   111


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                      .+...     .      .    ..+...+..+.+|+.+||..||.+|||+.++++.
T Consensus       224 ~i~~~-----~------~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          224 NIGKG-----S------Y----AIPGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             HHHHC-----C------C----CCCSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             HHhcC-----C------C----CCCCccCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            11110     0      0    1122345678999999999999999999999863

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7.9e-44  Score=347.69  Aligned_cols=267  Identities=26%  Similarity=0.404  Sum_probs=200.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||++......  ..+.+.+|+.++++++||||++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   92 (331)
T 4aaa_A           24 MEKYENLGLVGEGSYGMVMKCRNK-----------DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEV   92 (331)
T ss_dssp             GGGEEEEEEGGGGTTSSEEEEEET-----------TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhhheeeeEEeecCCEEEEEEEEC-----------CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEE
Confidence            467999999999999999999975           45778999998654332  24567899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        93 ~~~~~~----~~lv~e~~~~~~l~~~~~~~--~~~~~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~  163 (331)
T 4aaa_A           93 CKKKKR----WYLVFEFVDHTILDDLELFP--NGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVV  163 (331)
T ss_dssp             EEETTE----EEEEEECCSEEHHHHHHHST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             eecCCE----EEEEEecCCcchHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcE
Confidence            987654    79999999999998876654  5689999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-HHhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-LEWV  321 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-~~~~  321 (453)
                      ||+|||++.......  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||........... ....
T Consensus       164 kl~Dfg~~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  241 (331)
T 4aaa_A          164 KLCDFGFARTLAAPG--EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCL  241 (331)
T ss_dssp             EECCCTTC--------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EEEeCCCceeecCCc--cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHh
Confidence            999999997654321  223456789999999999875 789999999999999999999999976543322111 1100


Q ss_pred             hhc-------ccCccccccccCCcCCC-----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPY-------VSDSKKFHLIIDPRLEG-----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~-------~~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...       +...........+....     ......+..+.+|+.+||..||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~  306 (331)
T 4aaa_A          242 GNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLH  306 (331)
T ss_dssp             CSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             CCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhc
Confidence            000       00000000011111111     112245678999999999999999999999885

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=6.2e-44  Score=347.47  Aligned_cols=265  Identities=24%  Similarity=0.346  Sum_probs=195.8

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-HHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||+||+|.+.           .++..||||++....... ...+.+|+.+++.++||||+++++++.
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~   70 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSK-----------LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIH   70 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEEC-----------CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEe
Confidence            57889999999999999999975           456789999986543221 224567999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        71 ~~~~----~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl  141 (324)
T 3mtl_A           71 TEKS----LTLVFEYLD-KDLKQYLDDC-GNIINMHNVKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKL  141 (324)
T ss_dssp             CSSC----EEEEEECCS-EEHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEE
T ss_pred             eCCE----EEEEecccc-cCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEE
Confidence            7654    799999996 6999988765 35689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||++......  ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+......
T Consensus       142 ~Dfg~a~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  219 (324)
T 3mtl_A          142 ADFGLARAKSIP--TKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGT  219 (324)
T ss_dssp             CSSSEEECC--------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             ccCcccccccCC--ccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCC
Confidence            999999864422  122345578999999999876 56899999999999999999999999765433322222111000


Q ss_pred             ccCcccccc---------ccCCcCCC----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHL---------IIDPRLEG----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~---------~~~~~~~~----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .. ...+..         ...+....    ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       220 ~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  281 (324)
T 3mtl_A          220 PT-EETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMK  281 (324)
T ss_dssp             CC-TTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CC-hHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhc
Confidence            00 000000         00000000    011234567899999999999999999999986

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=4.4e-44  Score=353.48  Aligned_cols=266  Identities=24%  Similarity=0.338  Sum_probs=203.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||+|++.... ......+.+|+.+++.++||||+++++++
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  100 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHK-----------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF  100 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEEC-----------CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEE
Confidence            467999999999999999999975           457889999987653 23346789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|.+++...  ..+++..+..++.+++.||.|||+..  +|+||||||+|||++.++.+|
T Consensus       101 ~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~k  172 (360)
T 3eqc_A          101 YSDGE----ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIK  172 (360)
T ss_dssp             EETTE----EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEE
T ss_pred             EECCE----EEEEEECCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEE
Confidence            87654    79999999999999999875  46889999999999999999999831  799999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh-
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP-  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~-  323 (453)
                      |+|||++.....    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||................. 
T Consensus       173 l~Dfg~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  248 (360)
T 3eqc_A          173 LCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG  248 (360)
T ss_dssp             ECCCCCCHHHHH----HC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC-----
T ss_pred             EEECCCCccccc----ccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccc
Confidence            999999864321    123345799999999999999999999999999999999999999976433222111100000 


Q ss_pred             ----cc--------------c---Ccc----ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 ----YV--------------S---DSK----KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ----~~--------------~---~~~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          ..              .   ...    ....+.............+.++.+|+.+||..||.+|||+.++++
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  324 (360)
T 3eqc_A          249 DAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  324 (360)
T ss_dssp             -------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             cCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence                00              0   000    000000000011111224668999999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=1.2e-43  Score=345.84  Aligned_cols=256  Identities=20%  Similarity=0.317  Sum_probs=203.3

Q ss_pred             HHhcCCCcc-ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccC-CCCceee
Q 043568           84 SATRGFSRA-LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVV-KHPNLVK  159 (453)
Q Consensus        84 ~~~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~  159 (453)
                      ...+.|... +.||+|+||+||+|.+.           .++..||||++....  ......+.+|+.++..+ +||||++
T Consensus        25 ~~~~~y~~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~   93 (327)
T 3lm5_A           25 NFNNFYILTSKELGRGKFAVVRQCISK-----------STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVIN   93 (327)
T ss_dssp             HHHHHEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCC
T ss_pred             hhhhEEeeccceeCCCCCeEEEEEEEC-----------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEE
Confidence            334567776 78999999999999975           457889999987543  33467889999999999 5699999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++.....    .++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.
T Consensus        94 ~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~  166 (327)
T 3lm5_A           94 LHEVYENTSE----IILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSS  166 (327)
T ss_dssp             EEEEEECSSE----EEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESC
T ss_pred             EEEEEEeCCe----EEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEec
Confidence            9999987654    79999999999999999776667899999999999999999999999   9999999999999987


Q ss_pred             ---CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          240 ---DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       240 ---~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                         ++.+||+|||+++......   ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..........
T Consensus       167 ~~~~~~~kL~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~  243 (327)
T 3lm5_A          167 IYPLGDIKIVDFGMSRKIGHAC---ELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYL  243 (327)
T ss_dssp             BTTBCCEEECCGGGCEEC------------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             CCCCCcEEEeeCccccccCCcc---ccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHH
Confidence               7899999999998754321   2345679999999999999999999999999999999999999997643322211


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+....              ...........+..+.+|+.+||..||.+|||+.++++
T Consensus       244 ~i~~~~--------------~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~  287 (327)
T 3lm5_A          244 NISQVN--------------VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLS  287 (327)
T ss_dssp             HHHHTC--------------CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             HHHhcc--------------cccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhC
Confidence            111100              00111112234677999999999999999999999875

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=2.9e-43  Score=335.95  Aligned_cols=247  Identities=23%  Similarity=0.371  Sum_probs=204.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||.+....   ......+.+|+.+++.++||||+++++
T Consensus        13 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   81 (284)
T 2vgo_A           13 IDDFDIGRPLGKGKFGNVYLAREK-----------QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN   81 (284)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             hhhceeeheecCCCCeEEEEEEEc-----------CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEE
Confidence            467999999999999999999975           457789999986432   233467889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        82 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~  152 (284)
T 2vgo_A           82 YFHDRKR----IYLMLEFAPRGELYKELQKH--GRFDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGE  152 (284)
T ss_dssp             EEECSSE----EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCC
T ss_pred             EEEcCCE----EEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCC
Confidence            9987653    79999999999999999875  4689999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++......    ......|++.|+|||++.+..++.++||||||+++|+|++|..||........   ...+.
T Consensus       153 ~kl~Dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~---~~~~~  225 (284)
T 2vgo_A          153 LKIADFGWSVHAPSL----RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTET---HRRIV  225 (284)
T ss_dssp             EEECCCTTCEECSSS----CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHH---HHHHH
T ss_pred             EEEecccccccCccc----ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHH---HHHHh
Confidence            999999998764321    23456789999999999998999999999999999999999999975432221   11111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .   .        +    ...+...+..+.+++.+||..||.+|||+.++++
T Consensus       226 ~---~--------~----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  262 (284)
T 2vgo_A          226 N---V--------D----LKFPPFLSDGSKDLISKLLRYHPPQRLPLKGVME  262 (284)
T ss_dssp             T---T--------C----CCCCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             c---c--------c----cCCCCcCCHHHHHHHHHHhhcCHhhCCCHHHHhh
Confidence            0   0        0    0112234577999999999999999999999986

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.1e-43  Score=338.70  Aligned_cols=246  Identities=22%  Similarity=0.279  Sum_probs=198.0

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccC-CCCceeeEe
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVV-KHPNLVKLV  161 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l-~h~nIv~l~  161 (453)
                      ..++|...+.||+|+||+||+|.+.           .++..||||.+....  ......+.+|+..+..+ +||||++++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~   77 (289)
T 1x8b_A            9 YTTEFHELEKIGSGEFGSVFKCVKR-----------LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYF   77 (289)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEE
T ss_pred             ccchhhhhhhhcCCCceEEEEEEEc-----------CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeee
Confidence            3577999999999999999999975           457889999987543  23456788999999999 999999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++...+.    .++||||+++++|.+++....  ...+++..++.++.||+.||.|||++   +|+||||||+|||++.
T Consensus        78 ~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~  150 (289)
T 1x8b_A           78 SAWAEDDH----MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISR  150 (289)
T ss_dssp             EEEEETTE----EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC-
T ss_pred             eeeecCCe----EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcC
Confidence            99987664    799999999999999997642  25689999999999999999999999   9999999999999984


Q ss_pred             C-------------------CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHH
Q 043568          240 D-------------------YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYEL  299 (453)
Q Consensus       240 ~-------------------~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~el  299 (453)
                      +                   ..+||+|||++......      ....||+.|+|||++.+. .++.++|||||||++|+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l  224 (289)
T 1x8b_A          151 TSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCA  224 (289)
T ss_dssp             -------------------CCCEEECCCTTCEETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHH
T ss_pred             CCCCcccccccccccccCCceEEEEcccccccccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHH
Confidence            4                   47999999999875432      234599999999999765 567899999999999999


Q ss_pred             HhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          300 ITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       300 ltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ++|.+++....     .......      ..     .+    ..+...+..+.+|+.+||..||.+|||+.++++
T Consensus       225 ~~~~~~~~~~~-----~~~~~~~------~~-----~~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  279 (289)
T 1x8b_A          225 AGAEPLPRNGD-----QWHEIRQ------GR-----LP----RIPQVLSQEFTELLKVMIHPDPERRPSAMALVK  279 (289)
T ss_dssp             TTCCCCCSSSH-----HHHHHHT------TC-----CC----CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hcCCCCCcchh-----HHHHHHc------CC-----CC----CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhh
Confidence            99988764321     1111000      00     01    112234678999999999999999999999875

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.9e-43  Score=360.57  Aligned_cols=251  Identities=24%  Similarity=0.407  Sum_probs=199.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||++....  ......+.+|+.+++.++||||++++++
T Consensus        36 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  104 (494)
T 3lij_A           36 SEMYQRVKKLGSGAYGEVLLCRDK-----------VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF  104 (494)
T ss_dssp             HHHEEEEEEEECC---EEEEEEET-----------TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             hcCeEEeeEEecCCCEEEEEEEEC-----------CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            456999999999999999999975           457789999987543  2345678999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---C
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---D  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~  240 (453)
                      +.....    .++|||||++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.   +
T Consensus       105 ~~~~~~----~~lv~e~~~~g~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~  175 (494)
T 3lij_A          105 FEDKRN----YYLVMECYKGGELFDEIIHR--MKFNEVDAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKD  175 (494)
T ss_dssp             EECSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTT
T ss_pred             EEeCCE----EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCC
Confidence            987654    79999999999999988765  5689999999999999999999999   9999999999999976   4


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||++......   .......||+.|+|||++. ..++.++|||||||++|+|++|..||.......   +...
T Consensus       176 ~~~kl~DfG~a~~~~~~---~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~  248 (494)
T 3lij_A          176 ALIKIVDFGLSAVFENQ---KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE---ILRK  248 (494)
T ss_dssp             CCEEECCCTTCEECBTT---BCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             CcEEEEECCCCeECCCC---ccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence            55999999999875432   2234567999999999986 568999999999999999999999997654322   2211


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +....   .        ..........+..+.+|+.+||..||.+|||+.++++
T Consensus       249 i~~~~---~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  291 (494)
T 3lij_A          249 VEKGK---Y--------TFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALE  291 (494)
T ss_dssp             HHHTC---C--------CCCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCC---C--------CCCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhc
Confidence            11100   0        0001111234677999999999999999999999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-43  Score=345.08  Aligned_cols=270  Identities=23%  Similarity=0.320  Sum_probs=196.8

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-----cHHHHHHHHHHhccCCCCce
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----GHKEWINEVNFLGVVKHPNL  157 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~nI  157 (453)
                      ....++|...+.||+|+||.||+|++.           .++..||||++......     ....+.+|+.+++.++||||
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   74 (346)
T 1ua2_A            6 KSRAKRYEKLDFLGEGQFATVYKARDK-----------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNI   74 (346)
T ss_dssp             -------CEEEEEEEETTEEEEEEECS-----------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTB
T ss_pred             HHHhcccEEEeEEeecCCEEEEEEEEC-----------CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCC
Confidence            344678999999999999999999975           45678999998643221     12468899999999999999


Q ss_pred             eeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      +++++++.....    .++||||+++ +|.+++... ...+++..+..++.|++.||.|||+.   +|+||||||+|||+
T Consensus        75 v~~~~~~~~~~~----~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~  145 (346)
T 1ua2_A           75 IGLLDAFGHKSN----ISLVFDFMET-DLEVIIKDN-SLVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLL  145 (346)
T ss_dssp             CCEEEEECCTTC----CEEEEECCSE-EHHHHHTTC-CSSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEE
T ss_pred             CeEEEEEeeCCc----eEEEEEcCCC-CHHHHHHhc-CcCCCHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEE
Confidence            999999987654    6999999965 898888764 34678888999999999999999999   99999999999999


Q ss_pred             cCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      +.++.+||+|||+++......  .......||+.|+|||++.+. .++.++|||||||++|||++|.+||..........
T Consensus       146 ~~~~~~kl~Dfg~a~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~  223 (346)
T 1ua2_A          146 DENGVLKLADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLT  223 (346)
T ss_dssp             CTTCCEEECCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred             cCCCCEEEEecccceeccCCc--ccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence            999999999999998754322  223456789999999998754 58999999999999999999999987654322211


Q ss_pred             -HHHhhhhcc----cCccccccccCCcCCC-----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 -LLEWVRPYV----SDSKKFHLIIDPRLEG-----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 -~~~~~~~~~----~~~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       +........    ................     ......+..+.+|+.+||..||.+|||+.++++
T Consensus       224 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  291 (346)
T 1ua2_A          224 RIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  291 (346)
T ss_dssp             HHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             HHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence             111110000    0000000000000000     011334578999999999999999999999886

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.1e-43  Score=341.42  Aligned_cols=263  Identities=28%  Similarity=0.407  Sum_probs=186.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||.+.... ......+.+|+.++++++||||+++++++
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   82 (303)
T 2vwi_A           14 RDDYELQEVIGSGATAVVQAAYCA-----------PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSF   82 (303)
T ss_dssp             CCCCEEEEECC---CCCEEEEEC---------------CEEEEECCC----------------CCCCCCCTTBCCEEEEE
T ss_pred             hhhhhhhheeccccceEEEEEEEC-----------CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEE
Confidence            578999999999999999999865           346789999986543 23456788999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLS------RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      ...+.    .++||||+++++|.+++..      .....+++..++.++.||+.||.|||+.   +|+||||||+|||++
T Consensus        83 ~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~  155 (303)
T 2vwi_A           83 VVKDE----LWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLG  155 (303)
T ss_dssp             ESSSC----EEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEC
T ss_pred             eecCC----cEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEc
Confidence            87664    7999999999999999874      1235689999999999999999999998   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCC---CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          239 EDYKAKLSDFGLARQGPPEGL---GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      .++.+||+|||++........   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||........
T Consensus       156 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  235 (303)
T 2vwi_A          156 EDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKV  235 (303)
T ss_dssp             TTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH
T ss_pred             CCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhH
Confidence            999999999999876443211   112234579999999999875 5689999999999999999999999976543322


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...  ....   ......   ............+..+.+|+.+||+.||.+|||+.++++
T Consensus       236 ~~~--~~~~---~~~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  287 (303)
T 2vwi_A          236 LML--TLQN---DPPSLE---TGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLR  287 (303)
T ss_dssp             HHH--HHTS---SCCCTT---C-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHH--Hhcc---CCCccc---cccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhh
Confidence            111  1110   000000   000001112234567999999999999999999999885

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4.8e-43  Score=359.95  Aligned_cols=251  Identities=26%  Similarity=0.413  Sum_probs=202.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|++.           .++..||||++....  ......+.+|+.+|++++||||++++++
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   89 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDR-----------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEI   89 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEET-----------TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEEC-----------CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEE
Confidence            467999999999999999999975           457889999986432  3346778999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc---CC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---ED  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~---~~  240 (453)
                      +.....    .++|||||++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++   .+
T Consensus        90 ~~~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~  160 (486)
T 3mwu_A           90 LEDSSS----FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD  160 (486)
T ss_dssp             EECSSE----EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTT
T ss_pred             EEcCCE----EEEEEEcCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCC
Confidence            987654    79999999999999988765  5789999999999999999999999   999999999999995   46


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||+++.....   .......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......   +...
T Consensus       161 ~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~~  233 (486)
T 3mwu_A          161 CDIKIIDFGLSTCFQQN---TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILKR  233 (486)
T ss_dssp             CCEEECSCSCTTTBCCC-------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHH
T ss_pred             CCEEEEECCcCeECCCC---CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH---HHHH
Confidence            67999999999865432   22345679999999999875 58999999999999999999999997653322   2211


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +....           ...........+..+.+||.+||..||.+|||+.++++
T Consensus       234 i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~  276 (486)
T 3mwu_A          234 VETGK-----------YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (486)
T ss_dssp             HHHTC-----------CCSCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHhCC-----------CCCCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence            11100           00011112345678999999999999999999999986

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.6e-43  Score=336.62  Aligned_cols=250  Identities=28%  Similarity=0.426  Sum_probs=206.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .+.|...+.||+|+||.||+|++.           .++..||||++.... ....+.+.+|+.+++.++||||+++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~   89 (303)
T 3a7i_A           21 EELFTKLEKIGKGSFGEVFKGIDN-----------RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSY   89 (303)
T ss_dssp             GGTEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHHHHHhhhhcccCCeEEEEEEEC-----------CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEE
Confidence            466889999999999999999875           457789999997554 34467899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|.+++..   .++++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+|
T Consensus        90 ~~~~~----~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k  159 (303)
T 3a7i_A           90 LKDTK----LWIIMEYLGGGSALDLLEP---GPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVK  159 (303)
T ss_dssp             EETTE----EEEEEECCTTEEHHHHHTT---SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEE
T ss_pred             ecCCe----EEEEEEeCCCCcHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEE
Confidence            87654    7999999999999999865   4789999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.........   ..+...
T Consensus       160 l~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~---~~~~~~  234 (303)
T 3a7i_A          160 LADFGVAGQLTDTQ--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVL---FLIPKN  234 (303)
T ss_dssp             ECCCTTCEECBTTB--CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHH---HHHHHS
T ss_pred             EeecccceecCccc--cccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHH---HHhhcC
Confidence            99999997654321  1234567899999999999999999999999999999999999999754332211   111100


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI  375 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~  375 (453)
                          .      .+    ......+..+.+|+.+||..||.+|||+.++++.
T Consensus       235 ----~------~~----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  271 (303)
T 3a7i_A          235 ----N------PP----TLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH  271 (303)
T ss_dssp             ----C------CC----CCCSSCCHHHHHHHHHHCCSSGGGSCCHHHHTTC
T ss_pred             ----C------CC----CCccccCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                0      01    1122345679999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=3.5e-43  Score=337.04  Aligned_cols=249  Identities=26%  Similarity=0.414  Sum_probs=204.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||+|.+.....   ...+.+.+|+.+++.++||||+++++
T Consensus        14 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   82 (294)
T 2rku_A           14 RRRYVRGRFLGKGGFAKCFEISDA-----------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG   82 (294)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEEC-----------CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            467899999999999999999975           4567899999865432   23467889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...+.    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.
T Consensus        83 ~~~~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~  153 (294)
T 2rku_A           83 FFEDNDF----VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE  153 (294)
T ss_dssp             EEECSSE----EEEEEECCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred             eeccCCE----EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCC
Confidence            9987653    79999999999999988765  5789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||..........  ....
T Consensus       154 ~kl~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~--~~~~  229 (294)
T 2rku_A          154 VKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYL--RIKK  229 (294)
T ss_dssp             EEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH--HHHT
T ss_pred             EEEEeccCceecccCc--cccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH--HHhh
Confidence            9999999998654322  22345679999999999998889999999999999999999999997643222111  1100


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .    .            ...+...+..+.+|+.+||+.||++|||+.++++
T Consensus       230 ~----~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~  265 (294)
T 2rku_A          230 N----E------------YSIPKHINPVAASLIQKMLQTDPTARPTINELLN  265 (294)
T ss_dssp             T----C------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             c----c------------CCCccccCHHHHHHHHHHcccChhhCcCHHHHhh
Confidence            0    0            0112234567899999999999999999999886

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=6.2e-44  Score=341.42  Aligned_cols=263  Identities=26%  Similarity=0.376  Sum_probs=200.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||+||+|++....        .....||||.+....   ....+.+.+|+.++++++||||+++++
T Consensus        17 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (291)
T 1u46_A           17 EKDLRLLEKLGDGSFGVVRRGEWDAPS--------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG   88 (291)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTT--------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhHeeeeeeecCCCceeEEEEEeccCC--------CceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEE
Confidence            467999999999999999999875211        223469999987542   234567899999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++....     .++||||+++++|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.
T Consensus        89 ~~~~~~-----~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~  159 (291)
T 1u46_A           89 VVLTPP-----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDL  159 (291)
T ss_dssp             EECSSS-----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTE
T ss_pred             EEccCC-----ceeeEecccCCCHHHHHHhc-cCCcCHHHHHHHHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCC
Confidence            998654     58999999999999999764 24688999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHh
Q 043568          243 AKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~  320 (453)
                      +||+|||++......... .......+|..|+|||++.+..++.++||||||+++|+|++ |+.||......   .+...
T Consensus       160 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~---~~~~~  236 (291)
T 1u46_A          160 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHK  236 (291)
T ss_dssp             EEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHH
T ss_pred             EEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH---HHHHH
Confidence            999999999875433221 12234567889999999998889999999999999999999 99999754322   12111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      +..   ..          .....+...+..+.+++.+||..||.+|||+.++++.|.++..
T Consensus       237 ~~~---~~----------~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          237 IDK---EG----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             HHT---SC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             HHc---cC----------CCCCCCcCcCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            110   00          0011123456789999999999999999999999999987654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=3.5e-43  Score=362.65  Aligned_cols=249  Identities=24%  Similarity=0.348  Sum_probs=203.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...++||+|+||.||+|+++           .+++.||||++....   ......+.+|+.+|++++||||+++++
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~-----------~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~  252 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMK-----------ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAY  252 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEC-----------CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence            367888999999999999999975           457889999996542   234567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++.....    +++||||++||+|.+++....  ...+++..+..++.||+.||.|||++   +|+||||||+|||++.+
T Consensus       253 ~~~~~~~----l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~  325 (543)
T 3c4z_A          253 AFETKTD----LCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDD  325 (543)
T ss_dssp             EEECSSE----EEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTT
T ss_pred             EEeeCCE----EEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCC
Confidence            9887654    799999999999999997653  45699999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCCh-hhHHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPR-NEQKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~-~~~~~~~  319 (453)
                      +.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||...... ....+..
T Consensus       326 g~vkL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~  403 (543)
T 3c4z_A          326 GNVRISDLGLAVELKAGQ--TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQ  403 (543)
T ss_dssp             SCEEECCCTTCEECCTTC--CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHH
T ss_pred             CCEEEeecceeeeccCCC--cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHH
Confidence            999999999998754322  1233458999999999999999999999999999999999999999764321 1122222


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                      .+..   .          .  ..++...+..+.+|+.+||..||.+||++
T Consensus       404 ~i~~---~----------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  438 (543)
T 3c4z_A          404 RVLE---Q----------A--VTYPDKFSPASKDFCEALLQKDPEKRLGF  438 (543)
T ss_dssp             HHHH---C----------C--CCCCTTSCHHHHHHHHHHSCSSGGGSCCC
T ss_pred             HHhh---c----------c--cCCCcccCHHHHHHHHHhccCCHhHCCCC
Confidence            1111   0          0  01223456789999999999999999975

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=7.5e-43  Score=345.47  Aligned_cols=260  Identities=24%  Similarity=0.375  Sum_probs=206.8

Q ss_pred             cHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--------cHHHHHHHHHHh
Q 043568           78 SFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--------GHKEWINEVNFL  149 (453)
Q Consensus        78 ~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--------~~~~~~~E~~~l  149 (453)
                      .........++|...+.||+|+||.||+|++.           .++..||||++......        ..+.+.+|+.++
T Consensus        85 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~-----------~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l  153 (365)
T 2y7j_A           85 DWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHR-----------ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL  153 (365)
T ss_dssp             HHHHHHHHHHHEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             cchhhhhhhhhcccceEEecCCCEEEEEEEEC-----------CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHH
Confidence            34445566788999999999999999999975           45778999998654321        134678999999


Q ss_pred             ccC-CCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEee
Q 043568          150 GVV-KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFR  228 (453)
Q Consensus       150 ~~l-~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~  228 (453)
                      +++ +||||+++++++.....    .++||||+++++|.+++...  ..+++..+..++.||+.||.|||+.   +|+|+
T Consensus       154 ~~l~~hp~iv~~~~~~~~~~~----~~lv~e~~~g~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~  224 (365)
T 2y7j_A          154 RQVAGHPHIITLIDSYESSSF----MFLVFDLMRKGELFDYLTEK--VALSEKETRSIMRSLLEAVSFLHAN---NIVHR  224 (365)
T ss_dssp             HHHTTCTTBCCEEEEEEBSSE----EEEEECCCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECS
T ss_pred             HHhcCCCCEeEEEEEEeeCCE----EEEEEEeCCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecC
Confidence            999 89999999999877553    79999999999999999865  5689999999999999999999998   99999


Q ss_pred             ccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc------CCCCCchhHHHHHHHHHHHHhC
Q 043568          229 DFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT------GRLTAKSDVWSFGVVLYELITG  302 (453)
Q Consensus       229 Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~SlGvil~elltg  302 (453)
                      ||||+|||++.++.+||+|||++.......   ......||+.|+|||++.+      ..++.++|||||||++|+|++|
T Consensus       225 Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g  301 (365)
T 2y7j_A          225 DLKPENILLDDNMQIRLSDFGFSCHLEPGE---KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAG  301 (365)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred             CCCHHHEEECCCCCEEEEecCcccccCCCc---ccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHC
Confidence            999999999999999999999998754322   2345679999999999864      3588999999999999999999


Q ss_pred             CccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          303 RRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..||.......   ....+....   ..        .........+..+.+|+.+||..||++|||+.++++
T Consensus       302 ~~pf~~~~~~~---~~~~i~~~~---~~--------~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~  359 (365)
T 2y7j_A          302 SPPFWHRRQIL---MLRMIMEGQ---YQ--------FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQ  359 (365)
T ss_dssp             SCSSCCSSHHH---HHHHHHHTC---CC--------CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             CCCCCCCCHHH---HHHHHHhCC---CC--------CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence            99997543221   111111100   00        000001123567999999999999999999999885

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=5.2e-44  Score=339.97  Aligned_cols=256  Identities=24%  Similarity=0.354  Sum_probs=204.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||+|.+.....  ...+.+.+|+.++++++||||++++++
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~   73 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRK-----------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDR   73 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEEC-----------CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence            468999999999999999999975           4577899999975432  234678899999999999999999998


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCc-----eEeeccccccEE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV--PTPLAWIARLKIAQDAARGLAYLHEEMDFQ-----LIFRDFKTSNIL  236 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~-----iiH~Dlkp~NIL  236 (453)
                      +......  ..++||||+++++|.+++....  ...+++..++.++.|++.||.|||+.   +     |+||||||+|||
T Consensus        74 ~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl  148 (279)
T 2w5a_A           74 IIDRTNT--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVF  148 (279)
T ss_dssp             EEEGGGT--EEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEE
T ss_pred             EecCCCc--eEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEE
Confidence            8754322  3799999999999999997532  34589999999999999999999998   7     999999999999


Q ss_pred             EcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          237 LDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       237 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      ++.++.+||+|||++......  ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......   .
T Consensus       149 ~~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~---~  223 (279)
T 2w5a_A          149 LDGKQNVKLGDFGLARILNHD--TSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---E  223 (279)
T ss_dssp             ECSSSCEEECCCCHHHHC-----CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHH---H
T ss_pred             EcCCCCEEEecCchheeeccc--cccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHH---H
Confidence            999999999999999865432  12233457899999999999989999999999999999999999999765322   2


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL  376 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L  376 (453)
                      +...+...     ..         ...+...+.++.+++.+||+.||.+|||+.+|++.+
T Consensus       224 ~~~~i~~~-----~~---------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~  269 (279)
T 2w5a_A          224 LAGKIREG-----KF---------RRIPYRYSDELNEIITRMLNLKDYHRPSVEEILENP  269 (279)
T ss_dssp             HHHHHHHT-----CC---------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTST
T ss_pred             HHHHHhhc-----cc---------ccCCcccCHHHHHHHHHHcCCCcccCCCHHHHHhCh
Confidence            22111110     00         011223467899999999999999999999998744

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=2.7e-43  Score=361.64  Aligned_cols=251  Identities=26%  Similarity=0.414  Sum_probs=205.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...++||+|+||+||+|++.           .++..||||++....   ......+.+|+.++++++||||+++++
T Consensus        25 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~   93 (484)
T 3nyv_A           25 SDRYKGQRVLGKGSFGEVILCKDK-----------ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYE   93 (484)
T ss_dssp             HHHEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEE
T ss_pred             cCceEEeeEEecCCCEEEEEEEEC-----------CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEE
Confidence            467999999999999999999975           457889999986543   234678999999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE---cC
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DE  239 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl---~~  239 (453)
                      ++.....    .++||||+.+|+|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||+   +.
T Consensus        94 ~~~~~~~----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~  164 (484)
T 3nyv_A           94 FFEDKGY----FYLVGEVYTGGELFDEIISR--KRFSEVDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSK  164 (484)
T ss_dssp             EEECSSE----EEEEECCCCSCBHHHHHHTC--SCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSST
T ss_pred             EEEeCCE----EEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCC
Confidence            9987654    79999999999999999765  5789999999999999999999999   99999999999999   56


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      ++.+||+|||+++......   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.......   +..
T Consensus       165 ~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~---~~~  237 (484)
T 3nyv_A          165 DANIRIIDFGLSTHFEASK---KMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYD---ILK  237 (484)
T ss_dssp             TCCEEECCTTHHHHBCCCC---SHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred             CCcEEEEeeeeeEEccccc---ccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHH---HHH
Confidence            7899999999998654322   2345679999999999865 68999999999999999999999997653322   222


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+....           ...........+..+.+|+.+||..||.+|||+.++++
T Consensus       238 ~i~~~~-----------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~  281 (484)
T 3nyv_A          238 KVEKGK-----------YTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALD  281 (484)
T ss_dssp             HHHHCC-----------CCCCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHHcCC-----------CCCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhh
Confidence            111100           00011112345678999999999999999999999985

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=2.4e-43  Score=344.88  Aligned_cols=249  Identities=26%  Similarity=0.418  Sum_probs=205.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||++.+.           .++..||+|++.....   ...+.+.+|+.+++.++||||+++++
T Consensus        40 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  108 (335)
T 2owb_A           40 RRRYVRGRFLGKGGFAKCFEISDA-----------DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG  108 (335)
T ss_dssp             TEEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            467999999999999999999975           4567899999875432   23467889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...+.    .++||||+++++|.+++...  ..+++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus       109 ~~~~~~~----~~lv~e~~~~~~L~~~~~~~--~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~  179 (335)
T 2owb_A          109 FFEDNDF----VFVVLELCRRRSLLELHKRR--KALTEPEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLE  179 (335)
T ss_dssp             EEECSSE----EEEEECCCTTCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCC
T ss_pred             EEecCCe----EEEEEecCCCCCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCC
Confidence            9987653    79999999999999988765  5789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+  ..
T Consensus       180 ~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~--~~  255 (335)
T 2owb_A          180 VKIGDFGLATKVEYDG--ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRI--KK  255 (335)
T ss_dssp             EEECCCTTCEECCSTT--CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHH--HH
T ss_pred             EEEeeccCceecccCc--ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHH--hc
Confidence            9999999998654322  2234567999999999999989999999999999999999999999764322211111  00


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .    .        .    ..+...+..+.+|+.+||+.||++|||+.++++
T Consensus       256 ~----~--------~----~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  291 (335)
T 2owb_A          256 N----E--------Y----SIPKHINPVAASLIQKMLQTDPTARPTINELLN  291 (335)
T ss_dssp             T----C--------C----CCCTTSCHHHHHHHHHHTCSSGGGSCCGGGGGG
T ss_pred             C----C--------C----CCCccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0    0        0    011233567899999999999999999999886

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=6.2e-43  Score=349.12  Aligned_cols=269  Identities=21%  Similarity=0.282  Sum_probs=206.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC--------CCce
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK--------HPNL  157 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--------h~nI  157 (453)
                      .++|...++||+|+||+||+|++.           .++..||||++... ....+.+.+|+.+++.++        |+||
T Consensus        36 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~i  103 (397)
T 1wak_A           36 NGRYHVIRKLGWGHFSTVWLSWDI-----------QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMV  103 (397)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGB
T ss_pred             CCeEEEEEEeeecCCeeEEEEEec-----------CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCccee
Confidence            478999999999999999999875           45788999998643 234567889999999985        7889


Q ss_pred             eeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      +++++++......+...++||||+ +++|.+++.......+++..++.++.||+.||.|||+++  +|+||||||+|||+
T Consensus       104 v~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll  180 (397)
T 1wak_A          104 VQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILL  180 (397)
T ss_dssp             CCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEE
T ss_pred             eeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeE
Confidence            999999985543344589999999 777877777665567999999999999999999999863  89999999999999


Q ss_pred             cCCC-------------------------------------------------cEEEeccccccCCCCCCCCcccccccc
Q 043568          238 DEDY-------------------------------------------------KAKLSDFGLARQGPPEGLGHVSTSVVG  268 (453)
Q Consensus       238 ~~~~-------------------------------------------------~~kL~DFGla~~~~~~~~~~~~~~~~g  268 (453)
                      +.++                                                 .+||+|||++......     .....|
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~g  255 (397)
T 1wak_A          181 SVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQ  255 (397)
T ss_dssp             CCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCS
T ss_pred             eccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCC
Confidence            9775                                                 7999999999875422     344578


Q ss_pred             CcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChh---hHHHHHhhhh------------------cccC
Q 043568          269 TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRN---EQKLLEWVRP------------------YVSD  327 (453)
Q Consensus       269 t~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~---~~~~~~~~~~------------------~~~~  327 (453)
                      |+.|+|||++.+..++.++|||||||++|||++|+.||.......   ..........                  ++..
T Consensus       256 t~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~  335 (397)
T 1wak_A          256 TRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTK  335 (397)
T ss_dssp             CGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCT
T ss_pred             CCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCC
Confidence            999999999999999999999999999999999999997543221   1111111100                  0000


Q ss_pred             ccccccccCCcC---------CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          328 SKKFHLIIDPRL---------EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       328 ~~~~~~~~~~~~---------~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......+.+...         ....+...+..+.+|+.+||+.||++|||+.++++
T Consensus       336 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  391 (397)
T 1wak_A          336 KGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLR  391 (397)
T ss_dssp             TSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHT
T ss_pred             ccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhh
Confidence            000000000000         01234567788999999999999999999999885

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.4e-43  Score=349.43  Aligned_cols=270  Identities=22%  Similarity=0.297  Sum_probs=199.1

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEee
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ....++|...+.||+|+||+||+|++.           .++..||||++.....    ...+|+.+|+.++||||+++++
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~-----------~~~~~vAiK~~~~~~~----~~~~E~~il~~l~hpnIv~l~~   67 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDI-----------ESGKRFALKKVLQDPR----YKNRELDIMKVLDHVNIIKLVD   67 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEET-----------TTCCEEEEEEEECCTT----SCCHHHHHHTTCCCTTBCCEEE
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEEC-----------CCCCEEEEEEEecCcc----hHHHHHHHHHHcCCCCccchhh
Confidence            345788999999999999999999975           4578899999865432    2237999999999999999999


Q ss_pred             eeeeccc----------------------------------ccceEEEEEEecCCCChHHhhhc--CCCCCCCHHHHHHH
Q 043568          163 YCAEDDE----------------------------------RGMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKI  206 (453)
Q Consensus       163 ~~~~~~~----------------------------------~~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i  206 (453)
                      ++.....                                  .....++||||++ |+|.+.+..  .....+++..+..+
T Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i  146 (383)
T 3eb0_A           68 YFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIY  146 (383)
T ss_dssp             EEEEC-------------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHH
T ss_pred             eeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHH
Confidence            9866432                                  1224789999996 688877764  23467899999999


Q ss_pred             HHHHHHHHHHHHhCCCCceEeeccccccEEEc-CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCC
Q 043568          207 AQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLT  284 (453)
Q Consensus       207 ~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~  284 (453)
                      +.||+.||.|||+.   +|+||||||+|||++ .++.+||+|||+++......   ......||+.|+|||++.+. .++
T Consensus       147 ~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~  220 (383)
T 3eb0_A          147 IYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE---PSVAYICSRFYRAPELMLGATEYT  220 (383)
T ss_dssp             HHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS---CCCCCCCCSSCCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC---CCcCcccCCCccCHHHhcCCCCCC
Confidence            99999999999998   999999999999997 68999999999998654322   23455789999999998764 589


Q ss_pred             CchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhhhcc-----cCccccccccCCcC-----CCccchHHHHHHHH
Q 043568          285 AKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVRPYV-----SDSKKFHLIIDPRL-----EGNYCIKSAQKLAA  353 (453)
Q Consensus       285 ~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~~~~-----~~~~~~~~~~~~~~-----~~~~~~~~~~~l~~  353 (453)
                      .++|||||||++|||++|+.||......+... ++.......     ..........-+..     ....+...+..+.+
T Consensus       221 ~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  300 (383)
T 3eb0_A          221 PSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAID  300 (383)
T ss_dssp             THHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHH
T ss_pred             cchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHH
Confidence            99999999999999999999997654332211 111100000     00000000000111     11123345678999


Q ss_pred             HHHHhhccCCCCCCCHHHHHH
Q 043568          354 LASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       354 li~~cl~~dp~~RPs~~ei~~  374 (453)
                      |+.+||..||.+|||+.++++
T Consensus       301 li~~~L~~dP~~R~t~~e~l~  321 (383)
T 3eb0_A          301 LLEQILRYEPDLRINPYEAMA  321 (383)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHT
T ss_pred             HHHHHccCChhhCCCHHHHhc
Confidence            999999999999999999985

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=9.1e-43  Score=342.87  Aligned_cols=273  Identities=22%  Similarity=0.323  Sum_probs=203.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++.....  .....+.+|+.+++.++||||++++++
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   84 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHR-----------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI   84 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEET-----------TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             ccceeEEEEEecCCCcEEEEEEEC-----------CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhhe
Confidence            468999999999999999999975           4577899999865432  234578899999999999999999999


Q ss_pred             eeecccc----cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          164 CAEDDER----GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       164 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +......    ....++||||++ ++|.+.+... ...+++..+..++.||+.||.|||+.   +|+||||||+|||++.
T Consensus        85 ~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~  159 (351)
T 3mi9_A           85 CRTKASPYNRCKGSIYLVFDFCE-HDLAGLLSNV-LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITR  159 (351)
T ss_dssp             EEEC--------CEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECT
T ss_pred             eeccccccccCCceEEEEEeccC-CCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcC
Confidence            9875421    224799999996 5787777654 34689999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCC--CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          240 DYKAKLSDFGLARQGPPEGL--GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      ++.+||+|||+++.......  ........||+.|+|||++.+ ..++.++|||||||++|||++|..||..........
T Consensus       160 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~  239 (351)
T 3mi9_A          160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA  239 (351)
T ss_dssp             TSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence            99999999999986542211  122345678999999999876 568999999999999999999999998754433322


Q ss_pred             HHHhhhhcccCc-----cccccccCCcC----CCccch-----HHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDS-----KKFHLIIDPRL----EGNYCI-----KSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~-----~~~~~~~~~~~----~~~~~~-----~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+..........     ...........    ......     ..+..+.+|+.+||..||.+|||+.++++
T Consensus       240 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  311 (351)
T 3mi9_A          240 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  311 (351)
T ss_dssp             HHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhC
Confidence            222111110000     00000000000    000000     11456889999999999999999999886

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=7.2e-43  Score=360.24  Aligned_cols=251  Identities=25%  Similarity=0.415  Sum_probs=201.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-------------ccHHHHHHHHHHhccC
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-------------QGHKEWINEVNFLGVV  152 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-------------~~~~~~~~E~~~l~~l  152 (453)
                      .++|...++||+|+||+||+|.++           .++..||||++.....             ...+.+.+|+.+|+++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  103 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEK-----------NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL  103 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEET-----------TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTC
T ss_pred             ccceEEEeEecccCCeEEEEEEEC-----------CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhC
Confidence            678999999999999999999976           4567899999875432             2346788999999999


Q ss_pred             CCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      +||||+++++++.....    .++|||||++|+|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||
T Consensus       104 ~hpniv~~~~~~~~~~~----~~lv~e~~~gg~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp  174 (504)
T 3q5i_A          104 DHPNIIKLFDVFEDKKY----FYLVTEFYEGGELFEQIINR--HKFDECDAANIMKQILSGICYLHKH---NIVHRDIKP  174 (504)
T ss_dssp             CCTTBCCEEEEEECSSE----EEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSG
T ss_pred             CCCCCCeEEEEEEcCCE----EEEEEecCCCCcHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcH
Confidence            99999999999987654    79999999999999999775  5689999999999999999999999   999999999


Q ss_pred             ccEEEcCCC---cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          233 SNILLDEDY---KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       233 ~NILl~~~~---~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                      +|||++.++   .+||+|||++......   .......||+.|+|||++. +.++.++|||||||++|+|++|..||...
T Consensus       175 ~Nil~~~~~~~~~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~  250 (504)
T 3q5i_A          175 ENILLENKNSLLNIKIVDFGLSSFFSKD---YKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQ  250 (504)
T ss_dssp             GGEEESSTTCCSSEEECCCTTCEECCTT---SCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             HHEEEecCCCCccEEEEECCCCEEcCCC---CccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence            999998776   6999999999875432   2234567999999999986 56899999999999999999999999765


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....   +...+...     ..      ..........+.++.+|+.+||..||.+|||+.++++
T Consensus       251 ~~~~---~~~~i~~~-----~~------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~  301 (504)
T 3q5i_A          251 NDQD---IIKKVEKG-----KY------YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALN  301 (504)
T ss_dssp             SHHH---HHHHHHHC-----CC------CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CHHH---HHHHHHcC-----CC------CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhc
Confidence            3322   22211110     00      0000011234678999999999999999999999985

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.7e-43  Score=356.40  Aligned_cols=204  Identities=29%  Similarity=0.384  Sum_probs=168.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|++.           .++..||||++....  ....+.+.+|+.+|++++||||++++++
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~   93 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDK-----------NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDL   93 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEET-----------TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCEEEEEEEeecCCEEEEEEEEC-----------CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEE
Confidence            578999999999999999999976           557889999997542  2334678999999999999999999999


Q ss_pred             eeecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          164 CAEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       164 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +...... ....++||||++ ++|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++.
T Consensus        94 ~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~--~~l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~  167 (432)
T 3n9x_A           94 IIPDDLLKFDELYIVLEIAD-SDLKKLFKTP--IFLTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCS  167 (432)
T ss_dssp             CCCSCTTTCCCEEEEEECCS-EEHHHHHHSS--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCC
T ss_pred             EecCCCCcCCeEEEEEecCC-cCHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCC
Confidence            9765421 124799999995 6999999765  5789999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCC--------------------ccccccccCcCCCCcccc-ccCCCCCchhHHHHHHHHHHHHh
Q 043568          243 AKLSDFGLARQGPPEGLG--------------------HVSTSVVGTVGYAAPEYV-QTGRLTAKSDVWSFGVVLYELIT  301 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~--------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DV~SlGvil~ellt  301 (453)
                      +||+|||+++........                    ...+...||+.|+|||++ ....++.++||||||||+|||++
T Consensus       168 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~  247 (432)
T 3n9x_A          168 VKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN  247 (432)
T ss_dssp             EEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHT
T ss_pred             EEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHh
Confidence            999999999875432211                    123567899999999986 56679999999999999999998


Q ss_pred             CCccc
Q 043568          302 GRRAV  306 (453)
Q Consensus       302 g~~p~  306 (453)
                      |..||
T Consensus       248 g~~p~  252 (432)
T 3n9x_A          248 MLQSH  252 (432)
T ss_dssp             TCTTT
T ss_pred             ccccc
Confidence            54444

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=4e-43  Score=346.82  Aligned_cols=278  Identities=24%  Similarity=0.287  Sum_probs=203.1

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-----------cHHHHHHH
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----------GHKEWINE  145 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-----------~~~~~~~E  145 (453)
                      ....++....++|...+.||+|+||.||+|.+.            .+..||||++......           ..+.+.+|
T Consensus        12 ~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E   79 (362)
T 3pg1_A           12 DLIAELHAMQSPYTVQRFISSGSYGAVCAGVDS------------EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLRE   79 (362)
T ss_dssp             HHHHHHHHTTCSCEEEEEEEEETTEEEEEEECT------------TSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHH
T ss_pred             HHHHHHHHhccceEEeEEeccCCCEEEEEEECC------------CCCeEEEEeccccCCccchhhhhhhhhHHHHHHHH
Confidence            346778888999999999999999999999853            3678999998643221           12678999


Q ss_pred             HHHhccCCCCceeeEeeeeeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          146 VNFLGVVKHPNLVKLVGYCAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       146 ~~~l~~l~h~nIv~l~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      +.++++++||||+++++++..... .....++||||++ |+|.+++... ...+++..+..++.||+.||.|||+.   +
T Consensus        80 ~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~  154 (362)
T 3pg1_A           80 IRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQ-RIVISPQHIQYFMYHILLGLHVLHEA---G  154 (362)
T ss_dssp             HHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCT-TSCCCHHHHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHC---c
Confidence            999999999999999999876442 2335799999996 6888888754 35789999999999999999999999   9


Q ss_pred             eEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCC
Q 043568          225 LIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGR  303 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~  303 (453)
                      |+||||||+|||++.++.+||+|||++......   .......||+.|+|||++.+ ..++.++|||||||++|+|++|+
T Consensus       155 ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~  231 (362)
T 3pg1_A          155 VVHRDLHPGNILLADNNDITICDFNLAREDTAD---ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRK  231 (362)
T ss_dssp             CCCCCCCGGGEEECTTCCEEECCTTC------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSS
T ss_pred             CEecCCChHHEEEcCCCCEEEEecCcccccccc---cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCC
Confidence            999999999999999999999999999754322   22345678999999999876 67899999999999999999999


Q ss_pred             ccccCCCChhhHH-HHHhhhhccc------Ccccccccc-------CCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          304 RAVERNLPRNEQK-LLEWVRPYVS------DSKKFHLII-------DPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       304 ~p~~~~~~~~~~~-~~~~~~~~~~------~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                      .||.......... +.........      .........       ............+..+.+|+.+||+.||.+|||+
T Consensus       232 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~  311 (362)
T 3pg1_A          232 ALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRIST  311 (362)
T ss_dssp             CSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCH
T ss_pred             CCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCH
Confidence            9997654322211 1111100000      000000000       0000011122345679999999999999999999


Q ss_pred             HHHHH
Q 043568          370 SEVVD  374 (453)
Q Consensus       370 ~ei~~  374 (453)
                      .++++
T Consensus       312 ~ell~  316 (362)
T 3pg1_A          312 EQALR  316 (362)
T ss_dssp             HHHHT
T ss_pred             HHHHc
Confidence            99885

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-43  Score=344.61  Aligned_cols=265  Identities=27%  Similarity=0.392  Sum_probs=202.5

Q ss_pred             ccHHHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCC
Q 043568           77 FSFAELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHP  155 (453)
Q Consensus        77 ~~~~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~  155 (453)
                      +++.++....++|...+.||+|+||.||+|.+.           .++..||||++.... .....+.+|+.+++++ +||
T Consensus        14 ~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~   81 (326)
T 2x7f_A           14 IDLSALRDPAGIFELVELVGNGTYGQVYKGRHV-----------KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHR   81 (326)
T ss_dssp             --CCCCCCCTTTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCST
T ss_pred             ccchhccCCCCcEEEEEEeccCCCEEEEEEEEC-----------CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCC
Confidence            334444456789999999999999999999975           456789999986543 3456788999999999 899


Q ss_pred             ceeeEeeeeeecccc--cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccc
Q 043568          156 NLVKLVGYCAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTS  233 (453)
Q Consensus       156 nIv~l~~~~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~  233 (453)
                      ||+++++++......  ....++||||+++++|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+
T Consensus        82 ~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~  158 (326)
T 2x7f_A           82 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQ  158 (326)
T ss_dssp             TBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGG
T ss_pred             CeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHH
Confidence            999999999875321  22479999999999999999876556789999999999999999999999   9999999999


Q ss_pred             cEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          234 NILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       234 NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      |||++.++.+||+|||++.......  .......||+.|+|||++.     +..++.++|||||||++|+|++|..||..
T Consensus       159 NIl~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  236 (326)
T 2x7f_A          159 NVLLTENAEVKLVDFGVSAQLDRTV--GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  236 (326)
T ss_dssp             GEEECTTCCEEECCCTTTC---------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             HEEEcCCCCEEEeeCcCceecCcCc--cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence            9999999999999999998654221  1234457999999999987     56789999999999999999999999965


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ........  .....    .       .+..   .....+..+.+|+.+||..||.+|||+.++++
T Consensus       237 ~~~~~~~~--~~~~~----~-------~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  286 (326)
T 2x7f_A          237 MHPMRALF--LIPRN----P-------APRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMK  286 (326)
T ss_dssp             SCHHHHHH--HHHHS----C-------CCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             CcHHHHHH--HhhcC----c-------cccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhh
Confidence            43222111  11100    0       0000   11223567999999999999999999999986

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.8e-44  Score=357.32  Aligned_cols=252  Identities=19%  Similarity=0.247  Sum_probs=192.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHH---HHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEV---NFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~---~~l~~l~h~nIv~  159 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++...   .....+.|.+|+   .+|+.++||||++
T Consensus        72 ~~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~  140 (377)
T 3byv_A           72 PRTLVRGTVLGQEDPYAYLEATDQ-----------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK  140 (377)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEC------------CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHH
T ss_pred             CceEEEcceeecCCCEEEEEEEEC-----------CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHH
Confidence            467888999999999999999975           45778999999743   233457788999   5566668999999


Q ss_pred             Ee-------eeeeeccc----------cc---ceEEEEEEecCCCChHHhhhcCCC-----CCCCHHHHHHHHHHHHHHH
Q 043568          160 LV-------GYCAEDDE----------RG---MQRLLVYELMHNKSLEDHLLSRVP-----TPLAWIARLKIAQDAARGL  214 (453)
Q Consensus       160 l~-------~~~~~~~~----------~~---~~~~lv~e~~~~gsL~~~l~~~~~-----~~l~~~~~~~i~~~ia~~L  214 (453)
                      ++       +++...+.          ..   ...+|||||+ +|+|.+++.....     ..+++..++.++.||+.||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL  219 (377)
T 3byv_A          141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLL  219 (377)
T ss_dssp             HHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHH
T ss_pred             HHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHH
Confidence            98       44443321          00   1268999999 7899999986421     1234578889999999999


Q ss_pred             HHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-----------CC
Q 043568          215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-----------RL  283 (453)
Q Consensus       215 ~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~  283 (453)
                      .|||++   +|+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++.+.           .+
T Consensus       220 ~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~  290 (377)
T 3byv_A          220 ASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLM  290 (377)
T ss_dssp             HHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEEC
T ss_pred             HHHHhC---CeecCCCCHHHEEEcCCCCEEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccC
Confidence            999999   999999999999999999999999999986322     2345567 999999999887           89


Q ss_pred             CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCC
Q 043568          284 TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQP  363 (453)
Q Consensus       284 ~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  363 (453)
                      +.++|||||||++|||++|+.||.......                ....+..      .....+..+.+|+.+||+.||
T Consensus       291 ~~~~DvwSlG~il~elltg~~Pf~~~~~~~----------------~~~~~~~------~~~~~~~~~~~li~~~L~~dp  348 (377)
T 3byv_A          291 TFSFDAWALGLVIYWIWCADLPITKDAALG----------------GSEWIFR------SCKNIPQPVRALLEGFLRYPK  348 (377)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCC------C----------------CSGGGGS------SCCCCCHHHHHHHHHHTCSSG
T ss_pred             ChhhhHHHHHHHHHHHHHCCCCCccccccc----------------chhhhhh------hccCCCHHHHHHHHHHcCCCc
Confidence            999999999999999999999996532111                0011111      012345779999999999999


Q ss_pred             CCCCCHHHHHH--HHHHhH
Q 043568          364 KSRPKMSEVVD--ILGNII  380 (453)
Q Consensus       364 ~~RPs~~ei~~--~L~~~~  380 (453)
                      .+|||+.++++  .+..+.
T Consensus       349 ~~Rpt~~e~l~hp~f~~~~  367 (377)
T 3byv_A          349 EDRLLPLQAMETPEYEQLR  367 (377)
T ss_dssp             GGCCCHHHHHTSHHHHHHH
T ss_pred             hhCCCHHHHhhChHHHHHH
Confidence            99999999985  444443

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.7e-43  Score=347.18  Aligned_cols=265  Identities=25%  Similarity=0.321  Sum_probs=198.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++.....  ...+.+.+|+.+|+.++||||++++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~   92 (367)
T 1cm8_A           24 RAVYRDLQPVGSGAYGAVCSAVDG-----------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV   92 (367)
T ss_dssp             BSSEEEEEEC------CEEEEEET-----------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred             cceEEEeEEeeecCCeEEEEEEEC-----------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceee
Confidence            468999999999999999999975           4578899999865422  234678899999999999999999999


Q ss_pred             eeecccc--cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +......  ....++||||+ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~  165 (367)
T 1cm8_A           93 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDC  165 (367)
T ss_dssp             ECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             EecCCccccCceEEEEEecC-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCC
Confidence            9765421  12369999999 8999999876   3688999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .+||+|||+++.....     .....+|+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+..
T Consensus       166 ~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  240 (367)
T 1cm8_A          166 ELKILDFGLARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  240 (367)
T ss_dssp             CEEECCCTTCEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             CEEEEeeecccccccc-----cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            9999999999875422     345678999999999887 6899999999999999999999999976543222111110


Q ss_pred             hhhc--------ccCcc------ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPY--------VSDSK------KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~--------~~~~~------~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....        +....      .+....... -.......+..+.+|+.+||..||.+|||+.++++
T Consensus       241 ~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~  307 (367)
T 1cm8_A          241 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKD-FASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  307 (367)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCC-GGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             hcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCC-HHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhc
Confidence            0000        00000      000000000 00112234678999999999999999999999886

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=7.5e-43  Score=331.44  Aligned_cols=248  Identities=25%  Similarity=0.370  Sum_probs=195.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||.+....   ......+.+|+.+++.++||||+++++
T Consensus        10 ~~~y~i~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   78 (276)
T 2h6d_A           10 IGHYVLGDTLGVGTFGKVKIGEHQ-----------LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ   78 (276)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             eccEEEEeeecCCCCeEEEEEEEC-----------CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEE
Confidence            468999999999999999999975           456789999986432   234567889999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.....    .++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.
T Consensus        79 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~  149 (276)
T 2h6d_A           79 VISTPTD----FFMVMEYVSGGELFDYICKH--GRVEEMEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMN  149 (276)
T ss_dssp             EEECSSE----EEEEEECCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSC
T ss_pred             EEecCCe----EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCC
Confidence            9987654    79999999999999999765  4688999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +||+|||++.......   ......||+.|+|||.+.+..+ +.++||||||+++|+|++|+.||......   .+...+
T Consensus       150 ~~l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~---~~~~~~  223 (276)
T 2h6d_A          150 AKIADFGLSNMMSDGE---FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVP---TLFKKI  223 (276)
T ss_dssp             EEECCCCGGGCCCC----------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHHH
T ss_pred             EEEeecccccccCCCc---ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHH---HHHHHh
Confidence            9999999998754321   2345578999999999987665 68999999999999999999999754322   122111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....               ...+...+..+.+++.+||+.||.+|||+.++++
T Consensus       224 ~~~~---------------~~~~~~~~~~l~~li~~~l~~~p~~Rps~~~~l~  261 (276)
T 2h6d_A          224 RGGV---------------FYIPEYLNRSVATLLMHMLQVDPLKRATIKDIRE  261 (276)
T ss_dssp             HHCC---------------CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCc---------------ccCchhcCHHHHHHHHHHccCChhhCCCHHHHHh
Confidence            1100               0011223567999999999999999999999986

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=4.5e-43  Score=354.37  Aligned_cols=201  Identities=23%  Similarity=0.334  Sum_probs=173.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC------CCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV------KHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l------~h~nIv~  159 (453)
                      ..+|...++||+|+||+||+|.+.           .++..||||++... ......+.+|+.+++.+      +|+||++
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~-----------~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~  163 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDH-----------KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIH  163 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEET-----------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCC
T ss_pred             cCcEEEEEEcccCccEEEEEEEEC-----------CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEE
Confidence            467999999999999999999875           45789999998643 23345677888888776      5779999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++.....    .++||||+ +++|.+++.......+++..+..++.||+.||.|||+.   +|+||||||+|||++.
T Consensus       164 ~~~~~~~~~~----~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~  235 (429)
T 3kvw_A          164 MLENFTFRNH----ICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQ  235 (429)
T ss_dssp             EEEEEEETTE----EEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESS
T ss_pred             EEeecccCCe----EEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcc
Confidence            9999987654    79999999 57999999887666799999999999999999999999   9999999999999999


Q ss_pred             CCc--EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          240 DYK--AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       240 ~~~--~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      ++.  +||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|..||.....
T Consensus       236 ~~~~~vkL~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~  304 (429)
T 3kvw_A          236 QGRSGIKVIDFGSSCYEHQR-----VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDE  304 (429)
T ss_dssp             TTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             CCCcceEEeecccceecCCc-----ccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCH
Confidence            887  999999999764322     3346789999999999999999999999999999999999999976543

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.4e-42  Score=354.48  Aligned_cols=267  Identities=20%  Similarity=0.293  Sum_probs=209.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCc-eeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPN-LVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~  164 (453)
                      .++|...++||+|+||.||+|++.           .++..||||++.....  ...+.+|+.+++.+.|++ |..+..++
T Consensus         6 ~~~y~i~~~LG~G~fG~Vy~a~~~-----------~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~   72 (483)
T 3sv0_A            6 GNKFRLGRKIGSGSFGEIYLGTNI-----------QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFG   72 (483)
T ss_dssp             TTTEECCCCCEECSSCEEEEEEET-----------TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEE
T ss_pred             CCcEEEEEEEeeCCCEEEEEEEEC-----------CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEE
Confidence            478999999999999999999975           4577899998765432  245789999999998754 55554444


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE---cCCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL---DEDY  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl---~~~~  241 (453)
                      ....    ..+|||||+ +++|.+++... ...+++..++.|+.||+.||.|||++   +|+||||||+||||   +.++
T Consensus        73 ~~~~----~~~lvme~~-g~sL~~ll~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~  143 (483)
T 3sv0_A           73 VEGD----YNVLVMDLL-GPSLEDLFNFC-SRKLSLKTVLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRAN  143 (483)
T ss_dssp             EETT----EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTT
T ss_pred             eeCC----EEEEEEECC-CCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCC
Confidence            4433    369999999 99999998753 35799999999999999999999999   99999999999999   6889


Q ss_pred             cEEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          242 KAKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      .+||+|||+++........     .......||+.|+|||++.+..++.++|||||||+||||++|+.||..........
T Consensus       144 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~  223 (483)
T 3sv0_A          144 QVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQ  223 (483)
T ss_dssp             CEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHH
T ss_pred             eEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHH
Confidence            9999999999865433221     11235689999999999999999999999999999999999999998755433333


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhc
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEIS  384 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~  384 (453)
                      .+..+...... ...         ...+..++.++.+|+.+||..+|++||++.+|++.|+.++....
T Consensus       224 ~~~~i~~~~~~-~~~---------~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~  281 (483)
T 3sv0_A          224 KYEKISEKKVA-TSI---------EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREG  281 (483)
T ss_dssp             HHHHHHHHHHH-SCH---------HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHhhcccc-ccH---------HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcC
Confidence            32222110000 000         01122346789999999999999999999999999999987654

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=335.78  Aligned_cols=252  Identities=27%  Similarity=0.403  Sum_probs=200.2

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...+.||+|+||.||+|.+.           .++..||||.+....  ....+.+|+.+++.++||||+++++++
T Consensus        27 ~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~   93 (314)
T 3com_A           27 PEEVFDVLEKLGEGSYGSVYKAIHK-----------ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSY   93 (314)
T ss_dssp             ---CEEEEEECC----CEEEEEEET-----------TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             chhhhhhheeeccCCCeEEEEEEEC-----------CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEE
Confidence            3578999999999999999999975           456789999987543  446789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+|+||||+|||++.++.+|
T Consensus        94 ~~~~~----~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~k  165 (314)
T 3com_A           94 FKNTD----LWIVMEYCGAGSVSDIIRLR-NKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAK  165 (314)
T ss_dssp             EETTE----EEEEEECCTTEEHHHHHHHH-TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             EeCCE----EEEEeecCCCCCHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEE
Confidence            87654    79999999999999998743 35789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      |+|||++.......  .......||+.|+|||++.+..++.++||||||+++|+|++|..||............   ...
T Consensus       166 l~dfg~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~---~~~  240 (314)
T 3com_A          166 LADFGVAGQLTDTM--AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMI---PTN  240 (314)
T ss_dssp             ECCCTTCEECBTTB--SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHH---HHS
T ss_pred             Eeecccchhhhhhc--cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHH---hcC
Confidence            99999997654321  1234557899999999999989999999999999999999999999754322211111   000


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                  .......+...+..+.+|+.+||..||.+|||+.++++
T Consensus       241 ------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~  278 (314)
T 3com_A          241 ------------PPPTFRKPELWSDNFTDFVKQCLVKSPEQRATATQLLQ  278 (314)
T ss_dssp             ------------CCCCCSSGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             ------------CCcccCCcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence                        00000112234678999999999999999999999976

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=2.4e-43  Score=348.90  Aligned_cols=272  Identities=24%  Similarity=0.313  Sum_probs=205.6

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEee
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ...++|...+.||+|+||.||+|.+.           .++..||||++..... .....+.+|+.++++++||||+++++
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~   92 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDN-----------LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGIND   92 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCE
T ss_pred             cccccEEEEEEeecCCCeEEEEEEEC-----------CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCcccee
Confidence            34678999999999999999999975           4578899999975432 23467889999999999999999999


Q ss_pred             eeeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          163 YCAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       163 ~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      ++..... .....++||||++ |+|.+++...   .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~  165 (364)
T 3qyz_A           93 IIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTC  165 (364)
T ss_dssp             EECCSSTTTCCCEEEEEECCS-EEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             EEecCCccccceEEEEEcccC-cCHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCC
Confidence            9976542 1224799999995 6999988763   689999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCC-CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          242 KAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      .+||+|||++........ ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.
T Consensus       166 ~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~  245 (364)
T 3qyz_A          166 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL  245 (364)
T ss_dssp             CEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHH
T ss_pred             CEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHH
Confidence            999999999986543211 111245589999999998754 558999999999999999999999997654433322211


Q ss_pred             hhhhcccCcccccc------------ccCCc-C-CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHL------------IIDPR-L-EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~------------~~~~~-~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....... ...+..            ..... . ........+.++.+|+.+||..||.+|||+.++++
T Consensus       246 ~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  313 (364)
T 3qyz_A          246 GILGSPS-QEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  313 (364)
T ss_dssp             HHHCSCC-HHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHhCCCC-HHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence            1000000 000000            00000 0 00011234577999999999999999999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=2.1e-43  Score=350.27  Aligned_cols=258  Identities=14%  Similarity=0.104  Sum_probs=184.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHH---HHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEV---NFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~---~~l~~l~h~nIv~  159 (453)
                      ..+|...+.||+|+||+||+|++.           .++..||||++.....   .....+.+|+   .+|+. +||||++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~  128 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDV-----------ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEAR  128 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC--------
T ss_pred             ceeeeeeeeccCCCCEEEEEEEEC-----------CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhh
Confidence            345889999999999999999975           4578999999986543   2245567785   45555 7999888


Q ss_pred             Ee-------eeeeecccc-------------cceEEEEEEecCCCChHHhhhcCCCCCCCHHHH------HHHHHHHHHH
Q 043568          160 LV-------GYCAEDDER-------------GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR------LKIAQDAARG  213 (453)
Q Consensus       160 l~-------~~~~~~~~~-------------~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~------~~i~~~ia~~  213 (453)
                      ++       +++......             ....+|||||++ |+|.+++.... ..+.+..+      +.++.||+.|
T Consensus       129 ~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-~~~~~~~~~~~~vk~~i~~qi~~a  206 (371)
T 3q60_A          129 DRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLD-FVYVFRGDEGILALHILTAQLIRL  206 (371)
T ss_dssp             ---CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHH-HSCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhc-cccchhhhhhhhhHHHHHHHHHHH
Confidence            65       333332210             023799999998 89999998642 23355555      7888999999


Q ss_pred             HHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc--CCCCCchhHHH
Q 043568          214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWS  291 (453)
Q Consensus       214 L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~S  291 (453)
                      |+|||++   +|+||||||+|||++.++.+||+|||+++....     ......+|+.|+|||++.+  ..++.++||||
T Consensus       207 L~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwS  278 (371)
T 3q60_A          207 AANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT-----RGPASSVPVTYAPREFLNASTATFTHALNAWQ  278 (371)
T ss_dssp             HHHHHHT---TEEETTCSGGGEEECTTSCEEECCGGGEEETTC-----EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHH
T ss_pred             HHHHHHC---CCccCcCCHHHEEECCCCCEEEEecceeeecCC-----CccCccCCcCCcChhhccCCCCCcCccccHHH
Confidence            9999999   999999999999999999999999999987532     1224567799999999987  67999999999


Q ss_pred             HHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHH
Q 043568          292 FGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE  371 (453)
Q Consensus       292 lGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e  371 (453)
                      |||++|||++|+.||....+.....        .. ................+...+..+.+|+.+||+.||++|||+.+
T Consensus       279 lG~il~elltg~~Pf~~~~~~~~~~--------~~-~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e  349 (371)
T 3q60_A          279 LGLSIYRVWCLFLPFGLVTPGIKGS--------WK-RPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLE  349 (371)
T ss_dssp             HHHHHHHHHHSSCSTTBCCTTCTTC--------CC-BCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHH
T ss_pred             HHHHHHHHHhCCCCCCCcCcccccc--------hh-hhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence            9999999999999997653321100        00 00000011111111222355788999999999999999999999


Q ss_pred             HHH
Q 043568          372 VVD  374 (453)
Q Consensus       372 i~~  374 (453)
                      +++
T Consensus       350 ~l~  352 (371)
T 3q60_A          350 AME  352 (371)
T ss_dssp             HTT
T ss_pred             Hhc
Confidence            974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=3e-43  Score=338.58  Aligned_cols=253  Identities=23%  Similarity=0.364  Sum_probs=199.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||+|.+..........+.+|+.+++.++||||+++++++.
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~-----------~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~   86 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNK-----------ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY   86 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEET-----------TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEc-----------CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeee
Confidence            578999999999999999999975           456789999998766667788999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ....    .++||||+++++|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++.+||
T Consensus        87 ~~~~----~~lv~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl  158 (302)
T 2j7t_A           87 HDGK----LWIMIEFCPGGAVDAIMLEL-DRGLTEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRL  158 (302)
T ss_dssp             CC-C----EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEE
T ss_pred             eCCe----EEEEEEeCCCCcHHHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEE
Confidence            7654    79999999999999988753 35689999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +|||++......  ........||+.|+|||++.     ...++.++||||||+++|+|++|..||........  ....
T Consensus       159 ~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~--~~~~  234 (302)
T 2j7t_A          159 ADFGVSAKNLKT--LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV--LLKI  234 (302)
T ss_dssp             CCCHHHHHHHHH--HHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH
T ss_pred             EECCCCcccccc--ccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHH--HHHH
Confidence            999987532110  01123457899999999983     56789999999999999999999999976432211  1111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...    .         ......+...+..+.+|+.+||..||.+|||+.++++
T Consensus       235 ~~~----~---------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  275 (302)
T 2j7t_A          235 AKS----D---------PPTLLTPSKWSVEFRDFLKIALDKNPETRPSAAQLLE  275 (302)
T ss_dssp             HHS----C---------CCCCSSGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTT
T ss_pred             hcc----C---------CcccCCccccCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence            110    0         0000112344678999999999999999999999875

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.4e-42  Score=338.28  Aligned_cols=262  Identities=19%  Similarity=0.290  Sum_probs=201.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++..   ...+.+.+|+.++++++ ||||+++++++
T Consensus        35 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~  100 (330)
T 3nsz_A           35 QDDYQLVRKLGRGKYSEVFEAINI-----------TNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIV  100 (330)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             CCceEEEEEecccCCeEEEEEEEC-----------CCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeee
Confidence            477999999999999999999875           4577899999864   33567899999999997 99999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-cE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-KA  243 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~  243 (453)
                      ......  ..++||||+++++|.+++..     ++...+..++.||+.||.|||+.   +|+||||||+|||++.++ .+
T Consensus       101 ~~~~~~--~~~lv~e~~~~~~l~~~~~~-----~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~  170 (330)
T 3nsz_A          101 KDPVSR--TPALVFEHVNNTDFKQLYQT-----LTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKL  170 (330)
T ss_dssp             ECTTTC--CEEEEEECCCCCCHHHHGGG-----CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEE
T ss_pred             ccCCCC--ceEEEEeccCchhHHHHHHh-----CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEE
Confidence            874322  36999999999999998853     78889999999999999999999   999999999999999776 89


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-----
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-----  317 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-----  317 (453)
                      ||+|||+++......   ......||..|+|||++.+ ..++.++|||||||++|+|++|+.||...........     
T Consensus       171 kl~Dfg~a~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~  247 (330)
T 3nsz_A          171 RLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKV  247 (330)
T ss_dssp             EECCCTTCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHH
T ss_pred             EEEeCCCceEcCCCC---ccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHh
Confidence            999999998654322   2345578999999999877 6789999999999999999999999965433221110     


Q ss_pred             ------HHhhhhcc-cCcccccc--------ccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 ------LEWVRPYV-SDSKKFHL--------IIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ------~~~~~~~~-~~~~~~~~--------~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                            ..+..... ........        ..............+.++.+|+.+||+.||.+|||+.++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~  319 (330)
T 3nsz_A          248 LGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  319 (330)
T ss_dssp             HCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             cCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence                  00000000 00000000        00011111222335778999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.9e-43  Score=338.83  Aligned_cols=252  Identities=25%  Similarity=0.380  Sum_probs=197.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--------ccHHHHHHHHHHhccCCCCce
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--------QGHKEWINEVNFLGVVKHPNL  157 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~h~nI  157 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||.+.....        .....+.+|+.++++++||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i   77 (322)
T 2ycf_A            9 RDEYIMSKTLGSGACGEVKLAFER-----------KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCI   77 (322)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTB
T ss_pred             hhceeEeeEEecCCCEEEEEEEEc-----------CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCC
Confidence            467999999999999999999975           4578899999865421        123457899999999999999


Q ss_pred             eeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      +++++++....     .++||||+++++|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||+
T Consensus        78 ~~~~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~  147 (322)
T 2ycf_A           78 IKIKNFFDAED-----YYIVLELMEGGELFDKVVGN--KRLKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLL  147 (322)
T ss_dssp             CCEEEEEESSS-----EEEEEECCTTEETHHHHSTT--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEE
T ss_pred             ceEeeEEcCCc-----eEEEEecCCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEE
Confidence            99999986543     69999999999999988764  5789999999999999999999998   99999999999999


Q ss_pred             cCCCc---EEEeccccccCCCCCCCCccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          238 DEDYK---AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       238 ~~~~~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      +.++.   +||+|||++......   .......||+.|+|||++.   ...++.++|||||||++|+|++|..||.....
T Consensus       148 ~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          148 SSQEEDCLIKITDFGHSKILGET---SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             SSSSSSCCEEECCCTTCEECCCC---HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             ecCCCCCeEEEccCccceecccc---cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            87664   999999999875422   2234567999999999974   46789999999999999999999999975432


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...  +...+..     ...      ..........+..+.+|+.+||..||.+|||+.++++
T Consensus       225 ~~~--~~~~~~~-----~~~------~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~  274 (322)
T 2ycf_A          225 QVS--LKDQITS-----GKY------NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALR  274 (322)
T ss_dssp             SSC--HHHHHHH-----TCC------CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHH--HHHHHHh-----Ccc------ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhh
Confidence            211  1111100     000      0000111234678999999999999999999999984

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.1e-43  Score=346.91  Aligned_cols=257  Identities=25%  Similarity=0.357  Sum_probs=202.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHHHHHHHHhccC-CCCceeeE
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEWINEVNFLGVV-KHPNLVKL  160 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l-~h~nIv~l  160 (453)
                      .++|...++||+|+||+||+|++..        +..++..||||++....    ......+.+|+.+|+.+ +||||+++
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~--------~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~  124 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKIS--------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL  124 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECS--------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCE
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcc--------cCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEE
Confidence            4689999999999999999998742        12457899999986532    23345677899999999 79999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++++.....    .+|||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus       125 ~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~  195 (355)
T 1vzo_A          125 HYAFQTETK----LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSN  195 (355)
T ss_dssp             EEEEEETTE----EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTT
T ss_pred             EEEEeeCce----EEEEeecCCCCCHHHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCC
Confidence            999987654    79999999999999999875  4689999999999999999999998   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCccccCCCChh-hHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAVERNLPRN-EQKL  317 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~-~~~~  317 (453)
                      +.+||+|||+++...... ........||+.|+|||++.+  ..++.++|||||||++|||++|+.||....... ...+
T Consensus       196 ~~~kl~DfG~a~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~  274 (355)
T 1vzo_A          196 GHVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI  274 (355)
T ss_dssp             SCEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHH
T ss_pred             CcEEEeeCCCCeecccCC-CCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHH
Confidence            999999999998653221 122345679999999999985  347899999999999999999999997543222 1112


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVDI  375 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~~  375 (453)
                      .......               ...++...+..+.+||.+||..||.+||     |+.++++.
T Consensus       275 ~~~~~~~---------------~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h  322 (355)
T 1vzo_A          275 SRRILKS---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  322 (355)
T ss_dssp             HHHHHHC---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHhcc---------------CCCCCcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcC
Confidence            1111100               0112233467789999999999999999     88888753

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.8e-42  Score=332.49  Aligned_cols=253  Identities=26%  Similarity=0.379  Sum_probs=203.8

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---------ccHHHHHHHHHHhccCC-C
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---------QGHKEWINEVNFLGVVK-H  154 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---------~~~~~~~~E~~~l~~l~-h  154 (453)
                      ..++|...+.||+|+||.||+|.+.           .++..||||.+.....         ...+.+.+|+.+++++. |
T Consensus        15 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h   83 (298)
T 1phk_A           15 FYENYEPKEILGRGVSSVVRRCIHK-----------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH   83 (298)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred             hhhccceeeeecCCCceEEEEEEEc-----------CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCC
Confidence            3578999999999999999999975           4578899999875431         12356789999999995 9


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      |||+++++++.....    .++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus        84 ~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~N  154 (298)
T 1phk_A           84 PNIIQLKDTYETNTF----FFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPEN  154 (298)
T ss_dssp             TTBCCEEEEEECSSE----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGG
T ss_pred             CCEeeeeeeeccCCe----EEEEEeccCCCcHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcce
Confidence            999999999976553    79999999999999999865  5789999999999999999999998   99999999999


Q ss_pred             EEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccc------cCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          235 ILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ------TGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       235 ILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ||++.++.+||+|||++.......   ......||+.|+|||++.      ...++.++||||||+++|+|++|..||..
T Consensus       155 il~~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  231 (298)
T 1phk_A          155 ILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWH  231 (298)
T ss_dssp             EEECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred             EEEcCCCcEEEecccchhhcCCCc---ccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcC
Confidence            999999999999999998754322   234567899999999985      45688999999999999999999999975


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....   ....+...   .        ...........+..+.+|+.+||+.||.+|||+.++++
T Consensus       232 ~~~~~---~~~~~~~~---~--------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (298)
T 1phk_A          232 RKQML---MLRMIMSG---N--------YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  283 (298)
T ss_dssp             SSHHH---HHHHHHHT---C--------CCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             ccHHH---HHHHHhcC---C--------cccCcccccccCHHHHHHHHHHccCCcccCCCHHHHHh
Confidence            43221   11111100   0        00011112345678999999999999999999999875

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=5e-43  Score=344.01  Aligned_cols=263  Identities=19%  Similarity=0.281  Sum_probs=204.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc-----------------HHHHHHHHHH
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-----------------HKEWINEVNF  148 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~-----------------~~~~~~E~~~  148 (453)
                      .++|...+.||+|+||.||+|.+             ++..||||.+.......                 ...+.+|+.+
T Consensus        30 ~~~y~~~~~lg~G~~g~V~~~~~-------------~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~   96 (348)
T 2pml_X           30 INDYRIIRTLNQGKFNKIILCEK-------------DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQI   96 (348)
T ss_dssp             ETTEEEEEEEECCSSCCEEEEEE-------------TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHH
T ss_pred             cCceEEEEEEcCCCCeEEEEEEc-------------CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHH
Confidence            47899999999999999999985             36789999986432211                 1789999999


Q ss_pred             hccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHh------hhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 043568          149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDH------LLSRVPTPLAWIARLKIAQDAARGLAYLHE-EM  221 (453)
Q Consensus       149 l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~------l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~  221 (453)
                      +++++||||+++++++...+.    .++||||+++++|.++      +.......+++..++.++.|++.||.|||+ . 
T Consensus        97 l~~l~h~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-  171 (348)
T 2pml_X           97 ITDIKNEYCLTCEGIITNYDE----VYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEK-  171 (348)
T ss_dssp             HTTCCCTTBCCCSEEEESSSE----EEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTS-
T ss_pred             HHhCCCCCcceEEEEEeeCCe----EEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccC-
Confidence            999999999999999987654    7999999999999998      665446789999999999999999999998 7 


Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCC-chhHHHHHHHHHHH
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTA-KSDVWSFGVVLYEL  299 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DV~SlGvil~el  299 (453)
                        +|+||||||+|||++.++.+||+|||++......    ......||+.|+|||++.+. .++. ++|||||||++|||
T Consensus       172 --~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l  245 (348)
T 2pml_X          172 --NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM  245 (348)
T ss_dssp             --CEECCCCCGGGEEECTTSCEEECCCTTCEECBTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHH
T ss_pred             --CEeecCCChHhEEEcCCCcEEEeccccccccccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHH
Confidence              9999999999999999999999999999875332    24456799999999999876 5666 99999999999999


Q ss_pred             HhCCccccCCCChhhHHHHHhhhhc-ccCccccccccCCcC---CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          300 ITGRRAVERNLPRNEQKLLEWVRPY-VSDSKKFHLIIDPRL---EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       300 ltg~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ++|..||......  ..+...+... ............+..   ........+..+.+|+.+||+.||.+|||+.++++
T Consensus       246 ~~g~~pf~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~  322 (348)
T 2pml_X          246 FYNVVPFSLKISL--VELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK  322 (348)
T ss_dssp             HHSSCSSCCSSCS--HHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhCCCCCCCCCcH--HHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence            9999999765431  1222222111 000000000000000   00111345678999999999999999999999885

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=9.4e-43  Score=370.16  Aligned_cols=245  Identities=24%  Similarity=0.376  Sum_probs=202.9

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHHHHhccC-CCCceeeE
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEVNFLGVV-KHPNLVKL  160 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l-~h~nIv~l  160 (453)
                      ..++|...++||+|+||.||+|.++           .++..||||++...   .......+..|..+|..+ +||||+++
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~-----------~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l  407 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERK-----------GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQL  407 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEES-----------SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCE
T ss_pred             cccceEEEEEEccCCCEEEEEEEEC-----------CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEE
Confidence            3578999999999999999999986           45678999999753   223456788999999988 79999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++++.+.+.    ++|||||+++|+|.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+||||+.+
T Consensus       408 ~~~~~~~~~----~~lV~E~~~gg~L~~~l~~~--~~~~~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~  478 (674)
T 3pfq_A          408 HSCFQTMDR----LYFVMEYVNGGDLMYHIQQV--GRFKEPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSE  478 (674)
T ss_dssp             EEECBCSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSS
T ss_pred             EEEEEeCCE----EEEEEeCcCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCC
Confidence            999877654    79999999999999999875  4689999999999999999999999   99999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||+++......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...
T Consensus       479 g~ikL~DFGla~~~~~~~--~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~---~~~~~  553 (674)
T 3pfq_A          479 GHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED---ELFQS  553 (674)
T ss_dssp             SCEEECCCTTCEECCCTT--CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH---HHHHH
T ss_pred             CcEEEeecceeeccccCC--cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH---HHHHH
Confidence            999999999998643222  2345678999999999999999999999999999999999999999764322   22221


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM  369 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~  369 (453)
                      +..   .          .  ..++...+.++.+||.+||..||.+||++
T Consensus       554 i~~---~----------~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~  587 (674)
T 3pfq_A          554 IME---H----------N--VAYPKSMSKEAVAICKGLMTKHPGKRLGC  587 (674)
T ss_dssp             HHS---S----------C--CCCCTTSCHHHHHHHHHHSCSSSTTCTTC
T ss_pred             HHh---C----------C--CCCCccCCHHHHHHHHHHccCCHHHCCCC
Confidence            111   0          0  11223456789999999999999999997

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.5e-42  Score=341.49  Aligned_cols=267  Identities=25%  Similarity=0.301  Sum_probs=194.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++....  ......+.+|+.+++.++||||++++++
T Consensus        24 ~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~   92 (371)
T 2xrw_A           24 LKRYQNLKPIGSGAQGIVCAAYDA-----------ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNV   92 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             hhheeEeeeeEecCCEEEEEEEEC-----------CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEe
Confidence            478999999999999999999875           457889999987543  2234678899999999999999999999


Q ss_pred             eeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.....  .....++||||++ ++|.+++..    .+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~  164 (371)
T 2xrw_A           93 FTPQKSLEEFQDVYIVMELMD-ANLCQVIQM----ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC  164 (371)
T ss_dssp             ECSCCSTTTCCEEEEEEECCS-EEHHHHHHS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTS
T ss_pred             eccccccccccceEEEEEcCC-CCHHHHHhh----ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCC
Confidence            976542  1224799999996 578888753    478999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH-Hh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL-EW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~-~~  320 (453)
                      .+||+|||+++.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||...........+ ..
T Consensus       165 ~~kl~Dfg~a~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~  241 (371)
T 2xrw_A          165 TLKILDFGLARTAGTS---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQ  241 (371)
T ss_dssp             CEEECCCCC-------------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-
T ss_pred             CEEEEEeecccccccc---cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence            9999999999865422   2234567999999999999999999999999999999999999999765332211110 00


Q ss_pred             hh---------------hcccCcc-----ccccccCCc---CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VR---------------PYVSDSK-----KFHLIIDPR---LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~---------------~~~~~~~-----~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..               .......     .+.......   .........+..+.+|+.+||..||.+|||+.++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~  318 (371)
T 2xrw_A          242 LGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQ  318 (371)
T ss_dssp             CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhC
Confidence            00               0000000     000000000   000112234678999999999999999999999986

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=7.7e-43  Score=369.74  Aligned_cols=262  Identities=26%  Similarity=0.409  Sum_probs=208.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+...        ...+..||||.+..... ...+.|.+|+.++++++||||+++++++
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~--------~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~  460 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSP--------ENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI  460 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCS--------SSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecC--------CCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            46788899999999999999997532        13456899999865432 3346789999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+..     .++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+|||++.++.+|
T Consensus       461 ~~~~-----~~lv~E~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vk  531 (656)
T 2j0j_A          461 TENP-----VWIIMELCTLGELRSFLQVR-KFSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVK  531 (656)
T ss_dssp             CSSS-----CEEEEECCTTCBHHHHHHHT-TTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEE
T ss_pred             ecCc-----eEEEEEcCCCCcHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEE
Confidence            5432     68999999999999999765 34689999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+++...... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.......   +...+..
T Consensus       532 L~DFG~a~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~---~~~~i~~  607 (656)
T 2j0j_A          532 LGDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN  607 (656)
T ss_dssp             ECCCCCCCSCCC-----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH---HHHHHHH
T ss_pred             EEecCCCeecCCCc-ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH---HHHHHHc
Confidence            99999998754332 122334567889999999999999999999999999999997 899987543222   2221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                          ..          ....+..++..+.+|+.+||..||.+|||+.+|++.|..++..
T Consensus       608 ----~~----------~~~~~~~~~~~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          608 ----GE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             ----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ----CC----------CCCCCccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence                00          0112234567899999999999999999999999999998764

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=7.7e-43  Score=338.05  Aligned_cols=271  Identities=23%  Similarity=0.321  Sum_probs=197.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++........+.+.+|+.++++++||||+++++++.
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~   78 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDN-----------DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILG   78 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEET-----------TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             CCceeEEEEeccCCCeEEEEEEEC-----------CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecc
Confidence            468999999999999999999975           457899999997665556678999999999999999999999885


Q ss_pred             ecc----------cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          166 EDD----------ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       166 ~~~----------~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      ...          ......++||||++ |+|.+++..   .++++..++.++.|++.||.|||+.   +|+||||||+||
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Ni  151 (320)
T 2i6l_A           79 PSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLEQ---GPLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANL  151 (320)
T ss_dssp             TTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGE
T ss_pred             ccccccccccccccccCceeEEeeccC-CCHHHHhhc---CCccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHE
Confidence            432          11234799999996 699998865   4688999999999999999999999   999999999999


Q ss_pred             EEc-CCCcEEEeccccccCCCCCCC-CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          236 LLD-EDYKAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       236 Ll~-~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      |++ .++.+||+|||+++....... ........+|..|+|||.+.+ ..++.++|||||||++|||++|+.||......
T Consensus       152 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  231 (320)
T 2i6l_A          152 FINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHEL  231 (320)
T ss_dssp             EEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred             EEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHH
Confidence            997 577999999999987543211 112234567999999998865 67899999999999999999999999765432


Q ss_pred             hhHHHHHhhhhcccCcc--c----cc-----cccCCcC-CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          313 NEQKLLEWVRPYVSDSK--K----FH-----LIIDPRL-EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~--~----~~-----~~~~~~~-~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....+....+......  .    ..     ....+.. ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (320)
T 2i6l_A          232 EQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALS  305 (320)
T ss_dssp             HHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhC
Confidence            22111111100000000  0    00     0000000 00112235678999999999999999999999985

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=4e-42  Score=334.35  Aligned_cols=273  Identities=25%  Similarity=0.323  Sum_probs=205.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccC---CCCceee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV---KHPNLVK  159 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l---~h~nIv~  159 (453)
                      +.++|...+.||+|+||.||+|.+..          .++..||||++.....  .....+.+|+.+++.+   +||||++
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~   78 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLK----------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR   78 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETT----------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCC
T ss_pred             chhceeeeeeecccccEEEEEEEecC----------CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEe
Confidence            46889999999999999999998731          3467899999864322  2234566788777766   8999999


Q ss_pred             Eeeeeeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc
Q 043568          160 LVGYCAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD  238 (453)
Q Consensus       160 l~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~  238 (453)
                      +++++..... .....++||||++ |+|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++
T Consensus        79 ~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~  154 (326)
T 1blx_A           79 LFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVT  154 (326)
T ss_dssp             EEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             eeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEc
Confidence            9999873211 1234799999996 6999999887666799999999999999999999999   999999999999999


Q ss_pred             CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-H
Q 043568          239 EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-L  317 (453)
Q Consensus       239 ~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~  317 (453)
                      .++.+||+|||++.....   ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.......... +
T Consensus       155 ~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i  231 (326)
T 1blx_A          155 SSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKI  231 (326)
T ss_dssp             TTCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             CCCCEEEecCcccccccC---CCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence            999999999999986542   122345678999999999999999999999999999999999999997654322211 1


Q ss_pred             HHhhhhc----ccCcccc-ccccC---CcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 LEWVRPY----VSDSKKF-HLIID---PRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~~~~~~~----~~~~~~~-~~~~~---~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .......    +...... ...+.   ...........+..+.+|+.+||..||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  296 (326)
T 1blx_A          232 LDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  296 (326)
T ss_dssp             HHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            1111000    0000000 00000   00011122345678999999999999999999999874

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=4.1e-42  Score=339.08  Aligned_cols=275  Identities=23%  Similarity=0.313  Sum_probs=192.5

Q ss_pred             HHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeE
Q 043568           81 ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKL  160 (453)
Q Consensus        81 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l  160 (453)
                      ......++|...+.||+|+||+||+|++.           .++..||||++.... .....+.+|+..++.++||||+++
T Consensus        17 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~-~~~~~~~~~~~~l~~l~h~niv~~   84 (360)
T 3e3p_A           17 RSRKEMDRFQVERMAGQGTFGTVQLGKEK-----------STGMSVAIKKVIQDP-RFRNRELQIMQDLAVLHHPNIVQL   84 (360)
T ss_dssp             HHHHHHTTEEEC----------CEEEEET-----------TTCCEEEEEEEECCT-TCCCHHHHHHHHHHHHCCTTBCCE
T ss_pred             hchhhccceEEEEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEecCc-cccHHHHHHHHHHHhcCCCCcccH
Confidence            34456789999999999999999999975           456789999986543 233456788888999999999999


Q ss_pred             eeeeeecccc---cceEEEEEEecCCCChHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEeeccccc
Q 043568          161 VGYCAEDDER---GMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDAARGLAYLH--EEMDFQLIFRDFKTS  233 (453)
Q Consensus       161 ~~~~~~~~~~---~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH--~~~~~~iiH~Dlkp~  233 (453)
                      ++++......   ....++||||+++ +|.+.+..  .....+++..+..++.|++.||.|||  +.   +|+||||||+
T Consensus        85 ~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~  160 (360)
T 3e3p_A           85 QSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPH  160 (360)
T ss_dssp             EEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGG
T ss_pred             HHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHH
Confidence            9999764431   2236899999965 55554432  23467889999999999999999999  77   9999999999


Q ss_pred             cEEEcC-CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          234 NILLDE-DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       234 NILl~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      |||++. ++.+||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus       161 NIll~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~  237 (360)
T 3e3p_A          161 NVLVNEADGTLKLCDFGSAKKLSPSE---PNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNS  237 (360)
T ss_dssp             GEEEETTTTEEEECCCTTCBCCCTTS---CCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             HEEEeCCCCcEEEeeCCCceecCCCC---CcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCCh
Confidence            999996 8999999999998755322   23455789999999998654 489999999999999999999999976543


Q ss_pred             hhhHHH-HHhhh--------hcccCccccccccCCc-----CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          312 RNEQKL-LEWVR--------PYVSDSKKFHLIIDPR-----LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       312 ~~~~~~-~~~~~--------~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...... .....        ................     .........+.++.+|+.+||+.||.+|||+.++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~  314 (360)
T 3e3p_A          238 AGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALC  314 (360)
T ss_dssp             HHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhc
Confidence            322111 11100        0000000000000000     001112235778999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.5e-42  Score=337.05  Aligned_cols=265  Identities=22%  Similarity=0.280  Sum_probs=204.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCC------ceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHP------NLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~------nIv~  159 (453)
                      .++|...+.||+|+||+||+|.+..          .++..||||++... ......+.+|+.+++.++|+      +|++
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~   81 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHK----------AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQ   81 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT----------TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCC
T ss_pred             cCceEEEEEEecCCCeEEEEEEecC----------CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEe
Confidence            4689999999999999999998631          35688999998643 23346688899999988765      4999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++...+.    .++||||+ +++|.+++......++++..+..++.||+.||.|||++   +|+||||||+|||++.
T Consensus        82 ~~~~~~~~~~----~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~  153 (339)
T 1z57_A           82 MLEWFEHHGH----ICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQ  153 (339)
T ss_dssp             EEEEEEETTE----EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESC
T ss_pred             eecccccCCc----EEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEec
Confidence            9999987664    79999999 99999999887666899999999999999999999999   9999999999999987


Q ss_pred             -------------------CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHH
Q 043568          240 -------------------DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELI  300 (453)
Q Consensus       240 -------------------~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ell  300 (453)
                                         ++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       154 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  228 (339)
T 1z57_A          154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY  228 (339)
T ss_dssp             CCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHH
T ss_pred             cccccccCCccccccccccCCCceEeeCcccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHH
Confidence                               678999999999864322     33557899999999999999999999999999999999


Q ss_pred             hCCccccCCCChhhHHHHHhhhhcccCc-----ccccc--------------------ccCCc-CCCccchHHHHHHHHH
Q 043568          301 TGRRAVERNLPRNEQKLLEWVRPYVSDS-----KKFHL--------------------IIDPR-LEGNYCIKSAQKLAAL  354 (453)
Q Consensus       301 tg~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~--------------------~~~~~-~~~~~~~~~~~~l~~l  354 (453)
                      +|..||...........+..........     .....                    ...+. .........+..+.+|
T Consensus       229 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  308 (339)
T 1z57_A          229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL  308 (339)
T ss_dssp             HSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred             hCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHH
Confidence            9999997654333222222111100000     00000                    00000 0001123457889999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 043568          355 ASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       355 i~~cl~~dp~~RPs~~ei~~  374 (453)
                      +.+||..||.+|||+.++++
T Consensus       309 i~~~L~~dP~~Rpt~~ell~  328 (339)
T 1z57_A          309 IQKMLEYDPAKRITLREALK  328 (339)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHhCcCcccccCHHHHhc
Confidence            99999999999999999875

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=2.5e-42  Score=347.96  Aligned_cols=265  Identities=26%  Similarity=0.346  Sum_probs=197.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...++||+|+||+||+|++.           .++..||||++....    ..+.+|+.+|+.++||||+++++++.
T Consensus        53 ~~~y~~~~~lG~G~fg~Vy~~~~~-----------~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~  117 (420)
T 1j1b_A           53 EVSYTDTKVIGNGSFGVVYQAKLC-----------DSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFY  117 (420)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceEEeeeEEeeCCCEEEEEEEEC-----------CCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEe
Confidence            346889999999999999999985           456789999986432    22347999999999999999999987


Q ss_pred             ecccc--cceEEEEEEecCCCChHHhhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC-
Q 043568          166 EDDER--GMQRLLVYELMHNKSLEDHLLS--RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-  240 (453)
Q Consensus       166 ~~~~~--~~~~~lv~e~~~~gsL~~~l~~--~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~-  240 (453)
                      .....  ...+++||||+++ +|.+.+..  .....+++..+..++.||+.||.|||+.   +|+||||||+|||++.+ 
T Consensus       118 ~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~  193 (420)
T 1j1b_A          118 SSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDT  193 (420)
T ss_dssp             EEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTT
T ss_pred             ccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCC
Confidence            64332  2336799999965 67666543  2346789999999999999999999998   99999999999999965 


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                      +.+||+|||+++......   ......||+.|+|||++.+. .++.++||||||||+|||++|+.||.......  .+..
T Consensus       194 ~~~kl~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~--~l~~  268 (420)
T 1j1b_A          194 AVLKLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD--QLVE  268 (420)
T ss_dssp             TEEEECCCTTCEECCTTC---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHH
T ss_pred             CeEEeccchhhhhcccCC---CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHH
Confidence            678999999998654321   23456789999999998764 79999999999999999999999997653322  1211


Q ss_pred             hhhhcccC--------ccccccccCCcCCC-----ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSD--------SKKFHLIIDPRLEG-----NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~--------~~~~~~~~~~~~~~-----~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+......        .........+.+..     .+....+.++.+|+.+||..||.+|||+.++++
T Consensus       269 i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~  336 (420)
T 1j1b_A          269 IIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  336 (420)
T ss_dssp             HHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhC
Confidence            11100000        00001111111111     122334678999999999999999999999885

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-42  Score=332.45  Aligned_cols=253  Identities=23%  Similarity=0.293  Sum_probs=186.7

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cH-HHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GH-KEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++...... .. ..+..+...++.++||||++++++
T Consensus         6 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~   74 (290)
T 3fme_A            6 ADDLEPIMELGRGAYGVVEKMRHV-----------PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA   74 (290)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HHhhhhHHhcCCCCCeEEEEEEec-----------CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeee
Confidence            468999999999999999999975           45789999998754322 22 334455556888999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.....    .++||||++ |+|.+++...  ....+++..++.++.|++.||.|||++.  +|+||||||+|||++.++
T Consensus        75 ~~~~~~----~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~--~i~H~dlkp~Nil~~~~~  147 (290)
T 3fme_A           75 LFREGD----VWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKL--SVIHRDVKPSNVLINALG  147 (290)
T ss_dssp             EECSSS----EEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHS--CCCCCCCSGGGCEECTTC
T ss_pred             eeccCC----EEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCC
Confidence            987654    799999996 5888877542  3467999999999999999999999852  899999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccc----ccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV----QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      .+||+|||++......   .......||+.|+|||++    .+..++.++|||||||++|+|++|+.||....... ..+
T Consensus       148 ~~kl~Dfg~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~  223 (290)
T 3fme_A          148 QVKMCDFGISGYLVDD---VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPF-QQL  223 (290)
T ss_dssp             CEEBCCC------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHH-HHH
T ss_pred             CEEEeecCCccccccc---ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchH-HHH
Confidence            9999999999865432   123345799999999996    45678999999999999999999999997533221 111


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .......              .........+..+.+|+.+||+.||++|||+.++++
T Consensus       224 ~~~~~~~--------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~  266 (290)
T 3fme_A          224 KQVVEEP--------------SPQLPADKFSAEFVDFTSQCLKKNSKERPTYPELMQ  266 (290)
T ss_dssp             HHHHHSC--------------CCCCCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HHHhccC--------------CCCcccccCCHHHHHHHHHHhhcChhhCcCHHHHHh
Confidence            1111110              000111234577999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-42  Score=338.74  Aligned_cols=257  Identities=20%  Similarity=0.277  Sum_probs=177.6

Q ss_pred             hcCCCccc-eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRAL-LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+ +||+|+||+||+|.++           .++..||||++...    ..........++.+.||||+++++++
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~-----------~~~~~vavK~~~~~----~~~~~e~~~~~~~~~h~~i~~~~~~~   91 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHR-----------RTGQKCALKLLYDS----PKARQEVDHHWQASGGPHIVCILDVY   91 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEESS----HHHHHHHHHHHHHTTSTTBCCEEEEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEEC-----------CCCCEEEEEEecCc----HHHHHHHHHHHHhcCCCChHHHHHHH
Confidence            67888854 6999999999999976           45788999998642    12222223345667999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---CC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DY  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~~  241 (453)
                      ..........++||||+++|+|.+++.......+++..++.++.||+.||.|||+.   +|+||||||+|||++.   ++
T Consensus        92 ~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~  168 (336)
T 3fhr_A           92 ENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDA  168 (336)
T ss_dssp             EEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTC
T ss_pred             hhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCc
Confidence            87544334579999999999999999887667899999999999999999999999   9999999999999976   45


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||++......    ......||+.|+|||++.+..++.++|||||||++|+|++|..||............   
T Consensus       169 ~~kl~Dfg~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~---  241 (336)
T 3fhr_A          169 VLKLTDFGFAKETTQN----ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGM---  241 (336)
T ss_dssp             CEEECCCTTCEEC--------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------
T ss_pred             eEEEeccccceecccc----ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhH---
Confidence            5999999999865422    234567899999999998888999999999999999999999999654322110000   


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....       ..............+..+.+|+.+||..||.+|||+.++++
T Consensus       242 ~~~~~-------~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  287 (336)
T 3fhr_A          242 KRRIR-------LGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMN  287 (336)
T ss_dssp             ----------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             HHhhh-------ccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhc
Confidence            00000       00000111112245678999999999999999999999986

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=7.6e-43  Score=345.54  Aligned_cols=265  Identities=26%  Similarity=0.348  Sum_probs=185.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++....  ....+.+.+|+.+|+.++||||++++++
T Consensus        28 ~~~y~~~~~lG~G~~g~V~~a~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~   96 (367)
T 2fst_X           28 PERYQNLSPVGSGAYGSVCAAFDT-----------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   96 (367)
T ss_dssp             ETTEEEEEECC----CCEEEEEET-----------TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CCceEEeeEEeecCCeEEEEEEEC-----------CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEE
Confidence            478999999999999999999875           567899999986542  2334678899999999999999999999


Q ss_pred             eeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.....  .....++|+||+ +++|.+++..   ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~---~~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~  169 (367)
T 2fst_X           97 FTPARSLEEFNDVYLVTHLM-GADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDC  169 (367)
T ss_dssp             ECSCSSGGGCCCCEEEEECC-CEECC--------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTC
T ss_pred             EecCCccccCCeEEEEeccc-CCCHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCC
Confidence            876421  112369999999 8899998865   4689999999999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH-H
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL-E  319 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~-~  319 (453)
                      .+||+|||+++....     ......||+.|+|||++.+ ..++.++|||||||++|||++|+.||...........+ .
T Consensus       170 ~~kL~DFG~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~  244 (367)
T 2fst_X          170 ELKILDFGLARHTAD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILR  244 (367)
T ss_dssp             CEEECC--------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CEEEeeccccccccc-----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999987432     2345679999999999876 67899999999999999999999999765433222111 1


Q ss_pred             hhhh-------cccCccccccccC---CcCCCc---cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRP-------YVSDSKKFHLIID---PRLEGN---YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~-------~~~~~~~~~~~~~---~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....       .+.. ......+.   ......   .....+..+.+|+.+||..||.+|||+.++++
T Consensus       245 ~~g~p~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~  311 (367)
T 2fst_X          245 LVGTPGAELLKKISS-ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  311 (367)
T ss_dssp             HHCSCCHHHHTTCCC-HHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHHhhh-HHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhc
Confidence            1000       0000 00000000   000000   11233567899999999999999999999875

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=3.6e-42  Score=341.05  Aligned_cols=269  Identities=20%  Similarity=0.312  Sum_probs=205.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-----------C
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-----------H  154 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h  154 (453)
                      .++|...+.||+|+||+||+|++.           .++..||||++... ......+.+|+.++++++           |
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~   85 (373)
T 1q8y_A           18 DARYILVRKLGWGHFSTVWLAKDM-----------VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGA   85 (373)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHH
T ss_pred             CCeEEEEEeeeecCCeEEEEEEec-----------CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhcccc
Confidence            468999999999999999999975           45789999998643 233466889999999886           8


Q ss_pred             CceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       155 ~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      |||+++++++......+...++||||+ +++|.+++.......+++..++.++.||+.||.|||+++  +|+||||||+|
T Consensus        86 ~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~N  162 (373)
T 1q8y_A           86 NHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPEN  162 (373)
T ss_dssp             TTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGG
T ss_pred             chHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHH
Confidence            999999999987665455689999999 999999998866667999999999999999999999853  89999999999


Q ss_pred             EEEc------CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccC
Q 043568          235 ILLD------EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVER  308 (453)
Q Consensus       235 ILl~------~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~  308 (453)
                      ||++      ..+.+||+|||++......     .....||+.|+|||++.+..++.++|||||||++|||++|+.||..
T Consensus       163 Ill~~~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~  237 (373)
T 1q8y_A          163 VLMEIVDSPENLIQIKIADLGNACWYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP  237 (373)
T ss_dssp             EEEEEEETTTTEEEEEECCCTTCEETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             eEEeccCCCcCcceEEEcccccccccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCC
Confidence            9994      4457999999999865422     3345789999999999999999999999999999999999999975


Q ss_pred             CCChh----hHHH---HHhhhh--------------cccCccccccccCCc---------CCCccchHHHHHHHHHHHHh
Q 043568          309 NLPRN----EQKL---LEWVRP--------------YVSDSKKFHLIIDPR---------LEGNYCIKSAQKLAALASKC  358 (453)
Q Consensus       309 ~~~~~----~~~~---~~~~~~--------------~~~~~~~~~~~~~~~---------~~~~~~~~~~~~l~~li~~c  358 (453)
                      .....    ...+   .....+              ++........+....         .....+...+.++.+||.+|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  317 (373)
T 1q8y_A          238 DEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPM  317 (373)
T ss_dssp             -------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGG
T ss_pred             CcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHH
Confidence            43211    1111   111100              000000000000000         01123456788999999999


Q ss_pred             hccCCCCCCCHHHHHH
Q 043568          359 LTKQPKSRPKMSEVVD  374 (453)
Q Consensus       359 l~~dp~~RPs~~ei~~  374 (453)
                      |+.||.+|||+.++++
T Consensus       318 L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          318 LQLDPRKRADAGGLVN  333 (373)
T ss_dssp             GCSSTTTCBCHHHHHT
T ss_pred             hccCccccCCHHHHhh
Confidence            9999999999999875

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.8e-42  Score=340.81  Aligned_cols=271  Identities=24%  Similarity=0.284  Sum_probs=201.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||.+..... .....+.+|+.+++.++||||+++++++
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   78 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHK-----------PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQ   78 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEEC-----------CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeee
Confidence            578999999999999999999975           4578899999964432 2345688999999999999999999998


Q ss_pred             eeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          165 AEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       165 ~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      ..... .....++||||+. ++|.+++..   ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+
T Consensus        79 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~---~~~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~  151 (353)
T 2b9h_A           79 RPDSFENFNEVYIIQELMQ-TDLHRVIST---QMLSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDL  151 (353)
T ss_dssp             CCSCSTTCCCEEEEECCCS-EEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCE
T ss_pred             cccccCccceEEEEEeccC-ccHHHHHhh---cCCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcE
Confidence            76421 1234799999995 699998876   3689999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCc--------cccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          244 KLSDFGLARQGPPEGLGH--------VSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~--------~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      ||+|||++..........        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||........
T Consensus       152 kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~  231 (353)
T 2b9h_A          152 KVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQ  231 (353)
T ss_dssp             EECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred             EEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHH
Confidence            999999998654321111        1223578999999998764 7789999999999999999999999976543222


Q ss_pred             HHHHHhhhhcccCcccccc--------ccCC--cC-C---CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHL--------IIDP--RL-E---GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~--------~~~~--~~-~---~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...+...............        ....  .. .   .......+.++.+|+.+||..||.+|||+.++++
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  305 (353)
T 2b9h_A          232 LLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE  305 (353)
T ss_dssp             HHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence            1111111000000000000        0000  00 0   0011245678999999999999999999999886

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=2.8e-43  Score=341.53  Aligned_cols=259  Identities=22%  Similarity=0.343  Sum_probs=199.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.              ..+|+|++....  ....+.+.+|+.++++++||||++++++
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~--------------~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~   97 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWH--------------GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGA   97 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEES--------------SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEE
T ss_pred             HHHeEEeeEeccCCceEEEEEEEc--------------CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEE
Confidence            578999999999999999999864              249999986542  2334567789999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+++++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+|||++ ++.+
T Consensus        98 ~~~~~~----~~iv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~  168 (319)
T 2y4i_B           98 CMSPPH----LAIITSLCKGRTLYSVVRDA-KIVLDVNKTRQIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKV  168 (319)
T ss_dssp             EECSSC----EEEECBCCCSEEHHHHTTSS-CCCCCSHHHHHHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CC
T ss_pred             EecCCc----eEEEeecccCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCE
Confidence            987654    79999999999999999764 35688999999999999999999999   999999999999998 6799


Q ss_pred             EEeccccccCCCCCC---CCccccccccCcCCCCcccccc---------CCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          244 KLSDFGLARQGPPEG---LGHVSTSVVGTVGYAAPEYVQT---------GRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       244 kL~DFGla~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      ||+|||++.......   .........||+.|+|||++..         ..++.++|||||||++|||++|+.||.....
T Consensus       169 ~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~  248 (319)
T 2y4i_B          169 VITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA  248 (319)
T ss_dssp             EECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred             EEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence            999999987543211   1112234568999999999864         4578999999999999999999999976432


Q ss_pred             hhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       312 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      ...   .......          ..+..   .....+..+.+|+.+||..||.+|||+.++++.|+.+....
T Consensus       249 ~~~---~~~~~~~----------~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~~  304 (319)
T 2y4i_B          249 EAI---IWQMGTG----------MKPNL---SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKRN  304 (319)
T ss_dssp             HHH---HHHHHTT----------CCCCC---CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC----
T ss_pred             HHH---HHHhccC----------CCCCC---CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhh
Confidence            221   1111100          00000   01123456899999999999999999999999999887654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1e-41  Score=327.39  Aligned_cols=258  Identities=21%  Similarity=0.338  Sum_probs=195.5

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ..++|...+.||+|+||.||+|++.           .++..||||.+... ......+.+|+.++++++||||+++++++
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~   71 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNA-----------LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAW   71 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             ccccchhhheeccCCcEEEEEEEEc-----------CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHH
Confidence            3567999999999999999999975           45778999998643 23456788999999999999999999998


Q ss_pred             eeccc---------ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccE
Q 043568          165 AEDDE---------RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNI  235 (453)
Q Consensus       165 ~~~~~---------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NI  235 (453)
                      .....         .....++||||+++|+|.+++... ...+++..++.++.|++.||.|||++   +|+||||||+||
T Consensus        72 ~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Ni  147 (303)
T 1zy4_A           72 LERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSE-NLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNI  147 (303)
T ss_dssp             EECCCCCC------CEEEEEEEEECCCSCBHHHHHHHS-CGGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGE
T ss_pred             HhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhcc-ccccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhE
Confidence            76421         123479999999999999999864 34678889999999999999999999   999999999999


Q ss_pred             EEcCCCcEEEeccccccCCCCCC------------CCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhC
Q 043568          236 LLDEDYKAKLSDFGLARQGPPEG------------LGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITG  302 (453)
Q Consensus       236 Ll~~~~~~kL~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg  302 (453)
                      |++.++.+||+|||++.......            .........||+.|+|||++.+. .++.++|||||||++|+|++ 
T Consensus       148 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~-  226 (303)
T 1zy4_A          148 FIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-  226 (303)
T ss_dssp             EECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS-
T ss_pred             EEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh-
Confidence            99999999999999998654211            01122455789999999999764 78999999999999999998 


Q ss_pred             CccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          303 RRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        ||...  ............           .........+...+..+.+|+.+||+.||.+|||+.++++
T Consensus       227 --p~~~~--~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  283 (303)
T 1zy4_A          227 --PFSTG--MERVNILKKLRS-----------VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLN  283 (303)
T ss_dssp             --CCSSH--HHHHHHHHHHHS-----------TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             --ccCCc--hhHHHHHHhccc-----------cccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhC
Confidence              44321  111122221111           0111122233445677999999999999999999999885

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.8e-42  Score=333.93  Aligned_cols=252  Identities=28%  Similarity=0.429  Sum_probs=194.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCC--CCceeeE
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVK--HPNLVKL  160 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~--h~nIv~l  160 (453)
                      ..++|...+.||+|+||.||+|.+.            ++..||||++.....  .....+.+|+.++++++  ||||+++
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~------------~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~   93 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE------------KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL   93 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT------------TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC------------CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEE
Confidence            4678999999999999999999853            367899999875432  34567899999999997  5999999


Q ss_pred             eeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          161 VGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       161 ~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ++++.....    .++||| +.+++|.+++...  ..+++..++.++.|++.||.|||+.   +|+||||||+|||++ +
T Consensus        94 ~~~~~~~~~----~~lv~e-~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~-~  162 (313)
T 3cek_A           94 YDYEITDQY----IYMVME-CGNIDLNSWLKKK--KSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-D  162 (313)
T ss_dssp             EEEEECSSE----EEEEEC-CCSEEHHHHHHHC--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-T
T ss_pred             EEEeecCCE----EEEEEe-cCCCcHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEE-C
Confidence            999987654    799999 5589999999875  5789999999999999999999999   999999999999996 4


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-----------CCCCCchhHHHHHHHHHHHHhCCccccCC
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-----------GRLTAKSDVWSFGVVLYELITGRRAVERN  309 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DV~SlGvil~elltg~~p~~~~  309 (453)
                      +.+||+|||++................||+.|+|||++.+           ..++.++|||||||++|||++|+.||...
T Consensus       163 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          163 GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             TEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence            8999999999987554332223345679999999999875           46888999999999999999999999754


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..... .+....              ++......+...+..+.+|+.+||..||.+|||+.++++
T Consensus       243 ~~~~~-~~~~~~--------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  292 (313)
T 3cek_A          243 INQIS-KLHAII--------------DPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLA  292 (313)
T ss_dssp             CSHHH-HHHHHH--------------CTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             HHHHH-HHHHHH--------------hcccccCCcccchHHHHHHHHHHccCCcccCcCHHHHhc
Confidence            32211 111111              111111122223567999999999999999999999986

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.1e-42  Score=339.25  Aligned_cols=263  Identities=22%  Similarity=0.322  Sum_probs=198.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++......  ..+.+.+|+.+++.++||||++++++
T Consensus        41 ~~~y~~~~~lG~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~  109 (371)
T 4exu_A           41 PKTYVSPTHVGSGAYGSVCSAIDK-----------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV  109 (371)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             cccEEEEeEEecCCCeEEEEEEEC-----------CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhh
Confidence            478999999999999999999976           56789999999754322  24678899999999999999999999


Q ss_pred             eeeccccc--ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDERG--MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +.......  ...++||||+. ++|.+++.    ..+++..+..++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus       110 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~  181 (371)
T 4exu_A          110 FTPASSLRNFYDFYLVMPFMQ-TDLQKIMG----MEFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDC  181 (371)
T ss_dssp             ECSCSSSTTCCCCEEEEECCC-EEHHHHTT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred             eeccCCcccceeEEEEEcccc-ccHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCC
Confidence            98765421  12489999995 78888774    3489999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .+||+|||+++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus       182 ~~kL~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~  256 (371)
T 4exu_A          182 ELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  256 (371)
T ss_dssp             CEEECSTTCC-------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred             CEEEEecCccccccc-----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence            999999999986432     2345678999999999887 6899999999999999999999999976543222111100


Q ss_pred             hhhcccCcccc---------ccc---cCCcCCC---ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKF---------HLI---IDPRLEG---NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~---------~~~---~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...  ......         ...   .......   ......+..+.+|+.+||+.||.+|||+.++++
T Consensus       257 ~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  323 (371)
T 4exu_A          257 VTG--VPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  323 (371)
T ss_dssp             HHC--CCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhC--CCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhc
Confidence            000  000000         000   0000000   011234678999999999999999999999875

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.5e-41  Score=324.77  Aligned_cols=252  Identities=26%  Similarity=0.418  Sum_probs=202.1

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..++|...+.||+|+||.||+|.+.           .++..||||++....  ......+.+|+.++++++||||+++++
T Consensus        20 ~~~~y~i~~~lg~G~~g~V~~~~~~-----------~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~   88 (287)
T 2wei_A           20 FAERYNIVCMLGKGSFGEVLKCKDR-----------ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFE   88 (287)
T ss_dssp             HHHHEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             HhhcceeeEEEcCCCCEEEEEEEEc-----------CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEE
Confidence            3578999999999999999999975           456789999986543  345678999999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC--
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED--  240 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~--  240 (453)
                      ++.....    .++||||+++++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|||++.+  
T Consensus        89 ~~~~~~~----~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~  159 (287)
T 2wei_A           89 ILEDSSS----FYIVGELYTGGELFDEIIKR--KRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEK  159 (287)
T ss_dssp             EEECSSE----EEEEECCCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSST
T ss_pred             EEeCCCe----EEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCC
Confidence            9987653    79999999999999988765  4689999999999999999999999   99999999999999754  


Q ss_pred             -CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHH
Q 043568          241 -YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLE  319 (453)
Q Consensus       241 -~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~  319 (453)
                       +.+||+|||++.......   ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||.......   +..
T Consensus       160 ~~~~kL~Dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~---~~~  232 (287)
T 2wei_A          160 DCDIKIIDFGLSTCFQQNT---KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYD---ILK  232 (287)
T ss_dssp             TCCEEECSTTGGGTBCCCS---SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHH
T ss_pred             cccEEEeccCcceeecCCC---ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHH---HHH
Confidence             469999999998654321   1234568999999999865 58999999999999999999999997643222   211


Q ss_pred             hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+...    . .      ..........+..+.+++.+||..||.+|||+.++++
T Consensus       233 ~~~~~----~-~------~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~  276 (287)
T 2wei_A          233 RVETG----K-Y------AFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLE  276 (287)
T ss_dssp             HHHHC----C-C------CCCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHcC----C-C------CCCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhc
Confidence            11110    0 0      0000111234677999999999999999999999986

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=5.6e-42  Score=342.62  Aligned_cols=266  Identities=24%  Similarity=0.342  Sum_probs=194.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..+|...++||+|+||+||+|++.           . ...||+|++......    ..+|+.+|+.++||||+++++++.
T Consensus        39 ~~~Y~~~~~lG~G~~g~V~~a~~~-----------~-~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~  102 (394)
T 4e7w_A           39 EIAYTNCKVIGNGSFGVVFQAKLV-----------E-SDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFY  102 (394)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEET-----------T-TEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEE
T ss_pred             cceEEEeEEEeeCCCeEEEEEEEC-----------C-CCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEE
Confidence            356899999999999999999974           2 345899887543221    237999999999999999999997


Q ss_pred             eccc--ccceEEEEEEecCCCChHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc-CCC
Q 043568          166 EDDE--RGMQRLLVYELMHNKSLEDHLL-SRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDY  241 (453)
Q Consensus       166 ~~~~--~~~~~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~-~~~  241 (453)
                      ....  .....++||||++++.+..... ......+++..+..++.||+.||.|||+.   +|+||||||+|||++ .++
T Consensus       103 ~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~  179 (394)
T 4e7w_A          103 SNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSG  179 (394)
T ss_dssp             EESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTT
T ss_pred             ecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCC
Confidence            6543  2233689999997654433222 12245789999999999999999999999   999999999999999 799


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLE  319 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~  319 (453)
                      .+||+|||+++......   ......||+.|+|||++.+. .++.++|||||||++|||++|+.||.......... +..
T Consensus       180 ~~kL~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~  256 (394)
T 4e7w_A          180 VLKLIDFGSAKILIAGE---PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIK  256 (394)
T ss_dssp             EEEECCCTTCEECCTTC---CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             cEEEeeCCCcccccCCC---CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            99999999998754322   23456789999999998764 58999999999999999999999997654322211 111


Q ss_pred             hh-----------hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 WV-----------RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 ~~-----------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..           .+.... ..+...........+....+.++.+|+.+||..||.+|||+.++++
T Consensus       257 ~~g~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~  321 (394)
T 4e7w_A          257 VLGTPSREQIKTMNPNYME-HKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALC  321 (394)
T ss_dssp             HHCCCCHHHHHHHCGGGSS-SCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred             HhCCCCHHHHHhhChhhhh-hccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhc
Confidence            10           000000 0000000000001122235678999999999999999999999885

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.2e-41  Score=341.64  Aligned_cols=271  Identities=24%  Similarity=0.311  Sum_probs=183.0

Q ss_pred             cCCCc-cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSR-ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~-~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      +.|.. +++||+|+||+||+|++++.         ..+..||||++....  ....+.+|+.+|+.++||||+++++++.
T Consensus        20 ~~y~~~g~~lG~G~~g~Vy~~~~~~~---------~~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (405)
T 3rgf_A           20 DLFEYEGCKVGRGTYGHVYKAKRKDG---------KDDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFL   88 (405)
T ss_dssp             HHEECSSCCCC-----EEEEEEESSS---------SCCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEE
T ss_pred             hhhhhcCcEeeecCCeEEEEEEEccC---------CCCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEe
Confidence            33554 45899999999999997532         346789999986543  2356889999999999999999999997


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE-
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSR-------VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL-  237 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~-------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl-  237 (453)
                      .....  ..++||||++ ++|.+++...       ....+++..++.++.||+.||.|||+.   +|+||||||+|||+ 
T Consensus        89 ~~~~~--~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~  162 (405)
T 3rgf_A           89 SHADR--KVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVM  162 (405)
T ss_dssp             ETTTT--EEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEC
T ss_pred             cCCCC--eEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEe
Confidence            64332  3799999995 6888877532       123589999999999999999999999   99999999999999 


Q ss_pred             ---cCCCcEEEeccccccCCCCCCC-CccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          238 ---DEDYKAKLSDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       238 ---~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                         +.++.+||+|||+++....... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||......
T Consensus       163 ~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~  242 (405)
T 3rgf_A          163 GEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED  242 (405)
T ss_dssp             CSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred             cCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCcccc
Confidence               6788999999999987543211 122345689999999999887 45899999999999999999999999654321


Q ss_pred             -------hhHHHHHhhhhcc-cCcccccccc-------------CCcCCC--------ccchHHHHHHHHHHHHhhccCC
Q 043568          313 -------NEQKLLEWVRPYV-SDSKKFHLII-------------DPRLEG--------NYCIKSAQKLAALASKCLTKQP  363 (453)
Q Consensus       313 -------~~~~~~~~~~~~~-~~~~~~~~~~-------------~~~~~~--------~~~~~~~~~l~~li~~cl~~dp  363 (453)
                             ....+........ .....+..+.             ......        ......+..+.+||.+||..||
T Consensus       243 ~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP  322 (405)
T 3rgf_A          243 IKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDP  322 (405)
T ss_dssp             ----CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSG
T ss_pred             ccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCc
Confidence                   0111111110000 0000000000             000000        0000114578899999999999


Q ss_pred             CCCCCHHHHHH
Q 043568          364 KSRPKMSEVVD  374 (453)
Q Consensus       364 ~~RPs~~ei~~  374 (453)
                      .+|||+.++++
T Consensus       323 ~~R~ta~e~L~  333 (405)
T 3rgf_A          323 IKRITSEQAMQ  333 (405)
T ss_dssp             GGSCCHHHHHT
T ss_pred             ccCCCHHHHhc
Confidence            99999999886

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=2.3e-41  Score=336.87  Aligned_cols=205  Identities=25%  Similarity=0.285  Sum_probs=173.0

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CC-----ce
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HP-----NL  157 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~-----nI  157 (453)
                      ...++|...+.||+|+||+||+|++.           .++..||||++... ......+..|+.+++.++ |+     +|
T Consensus        51 ~~~~~y~~~~~lG~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i  118 (382)
T 2vx3_A           51 KWMDRYEIDSLIGKGSFGQVVKAYDR-----------VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYI  118 (382)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEET-----------TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGB
T ss_pred             EeeeeEEEEEEEeecCCEEEEEEEEc-----------CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeE
Confidence            34688999999999999999999975           45788999998643 233456778898888884 55     49


Q ss_pred             eeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      +++++++.....    .+|||||++ ++|.+++.......+++..+..++.|++.||.|||++ ..+|+||||||+|||+
T Consensus       119 v~~~~~~~~~~~----~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll  192 (382)
T 2vx3_A          119 VHLKRHFMFRNH----LCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILL  192 (382)
T ss_dssp             CCEEEEEEETTE----EEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEE
T ss_pred             EEeeeeeccCCc----eEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEE
Confidence            999999987654    799999995 6999999887666799999999999999999999953 2399999999999999


Q ss_pred             c--CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          238 D--EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       238 ~--~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      +  .++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus       193 ~~~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~  263 (382)
T 2vx3_A          193 CNPKRSAIKIVDFGSSCQLGQR-----IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE  263 (382)
T ss_dssp             SSTTSCCEEECCCTTCEETTCC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred             ecCCCCcEEEEeccCceecccc-----cccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence            4  5788999999999875422     3456789999999999999999999999999999999999999986543

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.5e-41  Score=333.74  Aligned_cols=265  Identities=23%  Similarity=0.294  Sum_probs=202.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCc------eee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPN------LVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n------Iv~  159 (453)
                      .++|...+.||+|+||+||+|.+..          ..+..||||++... ......+.+|+.+++.++|+|      ++.
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~----------~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~   86 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHA----------RGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVL   86 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETT----------TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCC
T ss_pred             cccEEEEEEeeccCCeEEEEEEecC----------CCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEE
Confidence            4789999999999999999998752          22468999998643 233466888999999987665      899


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE--
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL--  237 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl--  237 (453)
                      +++++.....    .++||||+ +++|.+++......++++..++.++.||+.||.|||+.   +|+||||||+|||+  
T Consensus        87 ~~~~~~~~~~----~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~  158 (355)
T 2eu9_A           87 MSDWFNFHGH----MCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVN  158 (355)
T ss_dssp             EEEEEEETTE----EEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESC
T ss_pred             eeeeeeeCCe----EEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEec
Confidence            9998877654    79999999 77888888776666899999999999999999999998   99999999999999  


Q ss_pred             -----------------cCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHH
Q 043568          238 -----------------DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELI  300 (453)
Q Consensus       238 -----------------~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ell  300 (453)
                                       +.++.+||+|||+++.....     .....||+.|+|||++.+..++.++|||||||++|||+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~  233 (355)
T 2eu9_A          159 SEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY  233 (355)
T ss_dssp             CCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccCCCcEEEeecCcccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHH
Confidence                             56789999999999864322     34567999999999999999999999999999999999


Q ss_pred             hCCccccCCCChhhHHHHHhhhhcccC-----ccccccccC--------------------C-cCCCccchHHHHHHHHH
Q 043568          301 TGRRAVERNLPRNEQKLLEWVRPYVSD-----SKKFHLIID--------------------P-RLEGNYCIKSAQKLAAL  354 (453)
Q Consensus       301 tg~~p~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~--------------------~-~~~~~~~~~~~~~l~~l  354 (453)
                      +|..||...........+.........     .........                    + ..........+.++.+|
T Consensus       234 ~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  313 (355)
T 2eu9_A          234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDL  313 (355)
T ss_dssp             HSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHH
T ss_pred             hCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHH
Confidence            999999765433222222111100000     000000000                    0 00001123446789999


Q ss_pred             HHHhhccCCCCCCCHHHHHH
Q 043568          355 ASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       355 i~~cl~~dp~~RPs~~ei~~  374 (453)
                      +.+||..||.+|||+.++++
T Consensus       314 i~~~L~~dP~~Rpt~~e~l~  333 (355)
T 2eu9_A          314 MRRMLEFDPAQRITLAEALL  333 (355)
T ss_dssp             HHHHTCSSTTTSCCHHHHTT
T ss_pred             HHHHhcCChhhCcCHHHHhc
Confidence            99999999999999999874

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2e-41  Score=333.68  Aligned_cols=264  Identities=22%  Similarity=0.311  Sum_probs=198.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|++.           .++..||||++.....  .....+.+|+.+++.++||||++++++
T Consensus        23 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   91 (353)
T 3coi_A           23 PKTYVSPTHVGSGAYGSVCSAIDK-----------RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV   91 (353)
T ss_dssp             ETTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CceEEEeeeEecCCCeEEEEEEEC-----------CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhhe
Confidence            467999999999999999999975           4578999999975432  224678899999999999999999999


Q ss_pred             eeecccc--cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +......  ....++||||+. ++|.+++..    .+++..+..++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        92 ~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~  163 (353)
T 3coi_A           92 FTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDC  163 (353)
T ss_dssp             ECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTC
T ss_pred             EecccccccceeEEEEecccc-CCHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCC
Confidence            9875432  123599999996 688887643    589999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .+||+|||+++....     ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+..
T Consensus       164 ~~kl~Dfg~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~  238 (353)
T 3coi_A          164 ELKILDFGLARHADA-----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILK  238 (353)
T ss_dssp             CEEECSTTCTTC-------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHH
T ss_pred             cEEEeecccccCCCC-----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            999999999986432     1344578999999999876 6789999999999999999999999976543222111100


Q ss_pred             hhhc--------ccCc------cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPY--------VSDS------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~--------~~~~------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....        ..+.      ..+........ .......+..+.+|+.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~  305 (353)
T 3coi_A          239 VTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALT  305 (353)
T ss_dssp             HHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCT-TTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHT
T ss_pred             HhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccH-HHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence            0000        0000      00000000000 1112345678999999999999999999999875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=1.3e-41  Score=331.33  Aligned_cols=256  Identities=27%  Similarity=0.366  Sum_probs=179.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHH-HhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVN-FLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~-~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++..... .....+..|+. +++.++||||++++++
T Consensus        21 ~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~   89 (327)
T 3aln_A           21 AEDLKDLGEIGRGAYGSVNKMVHK-----------PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA   89 (327)
T ss_dssp             SCSEEC-CEEEECSSEEEEEEEET-----------TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEE
T ss_pred             HHHhhehheeccCCCEEEEEEEEc-----------CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeE
Confidence            467888999999999999999975           4578999999975432 23345666666 7788899999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhc---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLS---RVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~---~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      +...+.    .++||||++ ++|.+++..   .....+++..+..++.|++.||.|||+.  .+|+||||||+|||++.+
T Consensus        90 ~~~~~~----~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~  162 (327)
T 3aln_A           90 LFREGD----CWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRS  162 (327)
T ss_dssp             EECSSE----EEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETT
T ss_pred             EEeCCc----eEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCC
Confidence            987654    799999996 488877653   2346789999999999999999999985  289999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCcccc----ccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV----QTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      +.+||+|||+++......   ......||+.|+|||++    .+..++.++|||||||++|+|++|+.||.......   
T Consensus       163 ~~~kl~Dfg~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~---  236 (327)
T 3aln_A          163 GNIKLCDFGISGQLVDSI---AKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF---  236 (327)
T ss_dssp             TEEEECCCSSSCC---------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------
T ss_pred             CCEEEccCCCceeccccc---ccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHH---
Confidence            999999999998754321   22344799999999998    45678999999999999999999999997532110   


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                        +.......       ...+.+........+..+.+|+.+||..||.+|||+.+|++
T Consensus       237 --~~~~~~~~-------~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~  285 (327)
T 3aln_A          237 --DQLTQVVK-------GDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLK  285 (327)
T ss_dssp             -----CCCCC-------SCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             --HHHHHHhc-------CCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHh
Confidence              00000000       00111111122345678999999999999999999999976

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=330.55  Aligned_cols=243  Identities=29%  Similarity=0.461  Sum_probs=192.2

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc------cHHHHHHHHHHhccC----C
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------GHKEWINEVNFLGVV----K  153 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l----~  153 (453)
                      ...++|...+.||+|+||.||+|.+.           .++..||||++......      ....+.+|+.++.++    +
T Consensus        28 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~   96 (312)
T 2iwi_A           28 AFEAEYRLGPLLGKGGFGTVFAGHRL-----------TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGG   96 (312)
T ss_dssp             -----CEEEEEEEEETTEEEEEEECT-----------TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCC
T ss_pred             hhhhceEEeeEEEcCCCEEEEEEEEc-----------cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCC
Confidence            34678999999999999999999865           45678999998654322      223456799999888    8


Q ss_pred             CCceeeEeeeeeecccccceEEEEEEe-cCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          154 HPNLVKLVGYCAEDDERGMQRLLVYEL-MHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       154 h~nIv~l~~~~~~~~~~~~~~~lv~e~-~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      ||||+++++++...+.    .++|||| +.+++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||
T Consensus        97 h~~i~~~~~~~~~~~~----~~~v~e~~~~~~~L~~~l~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp  167 (312)
T 2iwi_A           97 HPGVIRLLDWFETQEG----FMLVLERPLPAQDLFDYITEK--GPLGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKD  167 (312)
T ss_dssp             CSSBCCEEEEC---------CEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSG
T ss_pred             CCCeeeEEEEEecCCe----EEEEEEecCCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCh
Confidence            9999999999987654    6899999 7899999999875  4689999999999999999999999   999999999


Q ss_pred             ccEEEc-CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCC-CchhHHHHHHHHHHHHhCCccccCCC
Q 043568          233 SNILLD-EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLT-AKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       233 ~NILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      +|||++ .++.+||+|||++......    ......||..|+|||++.+..+. .++|||||||++|+|++|+.||... 
T Consensus       168 ~Nil~~~~~~~~kl~dfg~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~-  242 (312)
T 2iwi_A          168 ENILIDLRRGCAKLIDFGSGALLHDE----PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD-  242 (312)
T ss_dssp             GGEEEETTTTEEEECCCSSCEECCSS----CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-
T ss_pred             hhEEEeCCCCeEEEEEcchhhhcccC----cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh-
Confidence            999999 8999999999999875432    23455799999999998876654 5899999999999999999998642 


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                          ......       .            ...+...+..+.+|+.+||..||++|||+.++++
T Consensus       243 ----~~~~~~-------~------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~  283 (312)
T 2iwi_A          243 ----QEILEA-------E------------LHFPAHVSPDCCALIRRCLAPKPSSRPSLEEILL  283 (312)
T ss_dssp             ----HHHHHT-------C------------CCCCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             ----HHHhhh-------c------------cCCcccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence                111110       0            0112234567999999999999999999999985

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=5e-42  Score=333.45  Aligned_cols=243  Identities=26%  Similarity=0.423  Sum_probs=199.0

Q ss_pred             HHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc------cHHHHHHHHHHhccCC--CC
Q 043568           84 SATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------GHKEWINEVNFLGVVK--HP  155 (453)
Q Consensus        84 ~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~  155 (453)
                      ...++|...+.||+|+||.||+|++.           .++..||||.+......      ....+.+|+.++++++  ||
T Consensus        40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~  108 (320)
T 3a99_A           40 PLESQYQVGPLLGSGGFGSVYSGIRV-----------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFS  108 (320)
T ss_dssp             CCTTTEEEEEECSSSSSCEEEEEEET-----------TTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSC
T ss_pred             CccCceEEEEEEeeCCCeEEEEEEEC-----------CCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCC
Confidence            34678999999999999999999875           45789999998754322      2245678999999996  59


Q ss_pred             ceeeEeeeeeecccccceEEEEEEecCC-CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccccc
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELMHN-KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSN  234 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~N  234 (453)
                      ||+++++++...+.    .++||||+.+ ++|.+++...  ..+++..++.++.||+.||.|||+.   +|+||||||+|
T Consensus       109 ~i~~~~~~~~~~~~----~~lv~e~~~~~~~L~~~l~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~N  179 (320)
T 3a99_A          109 GVIRLLDWFERPDS----FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDEN  179 (320)
T ss_dssp             SBCCEEEEEECSSE----EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGG
T ss_pred             CceEEEEEEecCCc----EEEEEEcCCCCccHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHH
Confidence            99999999987654    7999999976 8999999875  5789999999999999999999998   99999999999


Q ss_pred             EEEc-CCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCCh
Q 043568          235 ILLD-EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPR  312 (453)
Q Consensus       235 ILl~-~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~  312 (453)
                      ||++ .++.+||+|||++......    ......||+.|+|||++.+..+ +.++|||||||++|||++|+.||....  
T Consensus       180 Ill~~~~~~~kL~Dfg~~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~--  253 (320)
T 3a99_A          180 ILIDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE--  253 (320)
T ss_dssp             EEEETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH--
T ss_pred             EEEeCCCCCEEEeeCccccccccc----cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh--
Confidence            9999 7899999999999875432    2344579999999999987665 688999999999999999999986421  


Q ss_pred             hhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         ....   .    ..            ......+.++.+|+.+||+.||.+|||+.+|++
T Consensus       254 ---~~~~---~----~~------------~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~  293 (320)
T 3a99_A          254 ---EIIR---G----QV------------FFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  293 (320)
T ss_dssp             ---HHHH---C----CC------------CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---hhhc---c----cc------------cccccCCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence               1110   0    00            011224567999999999999999999999875

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=1.1e-40  Score=337.34  Aligned_cols=252  Identities=23%  Similarity=0.312  Sum_probs=184.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~  165 (453)
                      +.|...++||+|+||+||.+..            .++..||||++...   ..+.+.+|+.+|+++ +||||+++++++.
T Consensus        15 ~~~~~~~~LG~G~~g~V~~~~~------------~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~   79 (434)
T 2rio_A           15 NLVVSEKILGYGSSGTVVFQGS------------FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSET   79 (434)
T ss_dssp             SCEEEEEEEEECSTTCEEEEEE------------SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             heeeccCeEeeCCCeEEEEEEE------------ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEe
Confidence            3445567899999999976532            34678999998643   345678999999876 8999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCC
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-----LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~-----l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~  240 (453)
                      ....    .+||||||. |+|.+++.......     ..+..++.++.||+.||.|||+.   +|+||||||+|||++.+
T Consensus        80 ~~~~----~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~  151 (434)
T 2rio_A           80 TDRF----LYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTS  151 (434)
T ss_dssp             CSSE----EEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECC
T ss_pred             cCCe----EEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecC
Confidence            6553    799999994 79999998653221     12334578999999999999998   99999999999999754


Q ss_pred             -------------CcEEEeccccccCCCCCCCCc--cccccccCcCCCCcccccc-------CCCCCchhHHHHHHHHHH
Q 043568          241 -------------YKAKLSDFGLARQGPPEGLGH--VSTSVVGTVGYAAPEYVQT-------GRLTAKSDVWSFGVVLYE  298 (453)
Q Consensus       241 -------------~~~kL~DFGla~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-------~~~~~~~DV~SlGvil~e  298 (453)
                                   +.+||+|||+++.........  ......||+.|+|||++.+       ..++.++|||||||++||
T Consensus       152 ~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~e  231 (434)
T 2rio_A          152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYY  231 (434)
T ss_dssp             HHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHH
T ss_pred             cccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHH
Confidence                         489999999998755332111  1235679999999999875       678999999999999999


Q ss_pred             HHh-CCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          299 LIT-GRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       299 llt-g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      |++ |..||....... ..+.....   .         .+..........+.++.+|+.+||+.||.+|||+.+|++
T Consensus       232 llt~g~~Pf~~~~~~~-~~i~~~~~---~---------~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~  295 (434)
T 2rio_A          232 ILSKGKHPFGDKYSRE-SNIIRGIF---S---------LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLR  295 (434)
T ss_dssp             HHTTSCCTTCSTTTHH-HHHHHTCC---C---------CCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHhCCCCCCCCchhhH-HHHhcCCC---C---------cccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHh
Confidence            999 899997543322 12211110   0         011111223456788999999999999999999999985

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.5e-40  Score=322.08  Aligned_cols=252  Identities=26%  Similarity=0.390  Sum_probs=179.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cH-HHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GH-KEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~-~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++...... .. ..+..+..+++.++||||++++++
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~   92 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFR-----------KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT   92 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEET-----------TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEe-----------cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEE
Confidence            467888999999999999999975           45678999999755322 22 334455567888899999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccccccEEEcCCCc
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +...+.    .++||||+ ++.+..+... ....+++..++.++.|++.||.|||+ .   +|+||||||+|||++.++.
T Consensus        93 ~~~~~~----~~lv~e~~-~~~~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~  163 (318)
T 2dyl_A           93 FITNTD----VFIAMELM-GTCAEKLKKR-MQGPIPERILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQ  163 (318)
T ss_dssp             EECSSE----EEEEECCC-SEEHHHHHHH-HTSCCCHHHHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSC
T ss_pred             EecCCc----EEEEEecc-CCcHHHHHHH-hccCCCHHHHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCC
Confidence            987654    79999999 5555554433 24578999999999999999999998 5   8999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL  317 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~  317 (453)
                      +||+|||++......   .......||+.|+|||++.     ...++.++|||||||++|||++|+.||.......  ..
T Consensus       164 ~kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~--~~  238 (318)
T 2dyl_A          164 IKLCDFGISGRLVDD---KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDF--EV  238 (318)
T ss_dssp             EEECCCTTC-----------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHH--HH
T ss_pred             EEEEECCCchhccCC---ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccH--HH
Confidence            999999999765432   1234457999999999984     4568899999999999999999999997543221  11


Q ss_pred             HHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       318 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .......   .       .+.+  ......+..+.+|+.+||..||.+|||+.++++
T Consensus       239 ~~~~~~~---~-------~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  283 (318)
T 2dyl_A          239 LTKVLQE---E-------PPLL--PGHMGFSGDFQSFVKDCLTKDHRKRPKYNKLLE  283 (318)
T ss_dssp             HHHHHHS---C-------CCCC--CSSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTT
T ss_pred             HHHHhcc---C-------CCCC--CccCCCCHHHHHHHHHHccCChhHCcCHHHHhh
Confidence            1111100   0       0000  001124567999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=8.1e-41  Score=349.63  Aligned_cols=275  Identities=26%  Similarity=0.336  Sum_probs=205.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+.           .++..||||++.... ......+.+|+.++++++||||+++++++
T Consensus        13 ~grY~i~~~LG~G~fG~Vyla~~~-----------~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~   81 (676)
T 3qa8_A           13 CGPWEMKERLGTGGFGYVLRWIHQ-----------DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVP   81 (676)
T ss_dssp             ----CCCCCCCBCSSSBCCCCCCT-----------TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECC
T ss_pred             CCCeEEEEEEeeCCCeEEEEEEEC-----------CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeee
Confidence            478999999999999999999864           456789999986542 23356789999999999999999999987


Q ss_pred             eeccc--ccceEEEEEEecCCCChHHhhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          165 AEDDE--RGMQRLLVYELMHNKSLEDHLLSRV-PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       165 ~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~-~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      .....  .....++||||+++|+|.+++.... ...+++..++.++.|++.||.|||+.   +|+||||||+|||++.++
T Consensus        82 ~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g  158 (676)
T 3qa8_A           82 DGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGP  158 (676)
T ss_dssp             TTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCS
T ss_pred             cccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCC
Confidence            65221  1223689999999999999998753 23688889999999999999999998   999999999999999766


Q ss_pred             c---EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          242 K---AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       242 ~---~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      .   +||+|||++.......   ......||+.|+|||++.+..++.++|||||||++|+|++|..||......     .
T Consensus       159 ~~~~vKL~DFG~a~~~~~~~---~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~-----~  230 (676)
T 3qa8_A          159 QRLIHKIIDLGYAKELDQGE---LCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQP-----V  230 (676)
T ss_dssp             SSCEEEECSCCCCCBTTSCC---CCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHH-----H
T ss_pred             CceeEEEccccccccccccc---ccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccch-----h
Confidence            5   9999999998754322   234568999999999999999999999999999999999999999653211     1


Q ss_pred             HhhhhcccCc-----------cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHH-----HHHHHHHhHhh
Q 043568          319 EWVRPYVSDS-----------KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE-----VVDILGNIISE  382 (453)
Q Consensus       319 ~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~e-----i~~~L~~~~~~  382 (453)
                      .|........           ...................+..+.+|+.+||..||++|||+.+     +.+.+..++..
T Consensus       231 ~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~l~~iL~~  310 (676)
T 3qa8_A          231 QWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSL  310 (676)
T ss_dssp             HSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHHHHHHHCC
T ss_pred             hhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHHHHHHHhc
Confidence            1111100000           0000000011122344567889999999999999999999988     45666666653

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.2e-40  Score=352.28  Aligned_cols=248  Identities=25%  Similarity=0.369  Sum_probs=197.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|.+..          .++..||||++..... .....+.+|+.++++++||||+++++++
T Consensus        79 ~~~y~i~~~lg~G~~g~Vy~a~~~~----------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~  148 (681)
T 2pzi_A           79 AGQYEVKGCIAHGGLGWIYLALDRN----------VNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFV  148 (681)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEEGG----------GTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEE
T ss_pred             CCceEEEEEEeeCCCeEEEEEEEcC----------CCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeE
Confidence            4789999999999999999999752          1467899999865432 3345788999999999999999999999


Q ss_pred             eecccccc-eEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          165 AEDDERGM-QRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       165 ~~~~~~~~-~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      ...+..+. ..+|||||+++++|.+++..    .+++..++.++.||+.||.|||++   +|+||||||+|||++.+ .+
T Consensus       149 ~~~~~~~~~~~~lv~E~~~g~~L~~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~  220 (681)
T 2pzi_A          149 EHTDRHGDPVGYIVMEYVGGQSLKRSKGQ----KLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QL  220 (681)
T ss_dssp             EEECTTSCEEEEEEEECCCCEECC----C----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CE
T ss_pred             eecCCCCCceeEEEEEeCCCCcHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cE
Confidence            87664322 25999999999999987654    689999999999999999999999   99999999999999986 89


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+++.....      ....||+.|+|||++.+.. +.++|||||||++|+|++|..||......           
T Consensus       221 kl~DFG~a~~~~~~------~~~~gt~~y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~~~-----------  282 (681)
T 2pzi_A          221 KLIDLGAVSRINSF------GYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRYVD-----------  282 (681)
T ss_dssp             EECCCTTCEETTCC------SCCCCCTTTSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEECS-----------
T ss_pred             EEEecccchhcccC------CccCCCccccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccccc-----------
Confidence            99999999875432      4457999999999987754 89999999999999999998887532100           


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-HHHHHHHHHHhHhh
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-MSEVVDILGNIISE  382 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-~~ei~~~L~~~~~~  382 (453)
                                   ...........+..+.+||.+||+.||.+||+ ++++...|..+...
T Consensus       283 -------------~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~~  329 (681)
T 2pzi_A          283 -------------GLPEDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLRE  329 (681)
T ss_dssp             -------------SCCTTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHHH
T ss_pred             -------------cccccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHHHHH
Confidence                         00011112234567999999999999999995 66677777766544

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.2e-40  Score=334.69  Aligned_cols=249  Identities=26%  Similarity=0.373  Sum_probs=183.8

Q ss_pred             hcCCCccceecCCCceEEE-EEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVY-RGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy-~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      ..+|...++||+|+||+|| ++.             .+++.||||++.....   ..+.+|+.+|+.+ +||||++++++
T Consensus        23 ~~~y~~~~~LG~G~~G~V~~~~~-------------~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~   86 (432)
T 3p23_A           23 KISFCPKDVLGHGAEGTIVYRGM-------------FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCT   86 (432)
T ss_dssp             TEEEEEEEEEEECGGGCEEEEEE-------------SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEE
T ss_pred             cEEEecCCeeecCcCEEEEEEEE-------------eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEE
Confidence            4568889999999999965 333             3467899999865432   2356899999999 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC----
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE----  239 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~----  239 (453)
                      +.....    .+||||||. |+|.+++.... ..+....++.++.||+.||.|||+.   +|+||||||+|||++.    
T Consensus        87 ~~~~~~----~~lv~E~~~-g~L~~~l~~~~-~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~  157 (432)
T 3p23_A           87 EKDRQF----QYIAIELCA-ATLQEYVEQKD-FAHLGLEPITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAH  157 (432)
T ss_dssp             EEETTE----EEEEEECCS-EEHHHHHHSSS-CCCCSSCHHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTT
T ss_pred             EecCCE----EEEEEECCC-CCHHHHHHhcC-CCccchhHHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCC
Confidence            887654    799999995 69999998653 2344445678999999999999999   9999999999999953    


Q ss_pred             -CCcEEEeccccccCCCCCCCC-ccccccccCcCCCCccccc---cCCCCCchhHHHHHHHHHHHHh-CCccccCCCChh
Q 043568          240 -DYKAKLSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQ---TGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRN  313 (453)
Q Consensus       240 -~~~~kL~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~---~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~  313 (453)
                       ...+||+|||+++........ .......||+.|+|||++.   ...++.++|||||||++|||++ |..||.......
T Consensus       158 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~  237 (432)
T 3p23_A          158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ  237 (432)
T ss_dssp             TBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHH
T ss_pred             CceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHH
Confidence             335889999999875432211 2234567999999999997   4567889999999999999999 888886543322


Q ss_pred             hHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....   .     .....     .  .......+..+.+|+.+||+.||.+|||+.+|++
T Consensus       238 ~~~~~---~-----~~~~~-----~--~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~  283 (432)
T 3p23_A          238 ANILL---G-----ACSLD-----C--LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLK  283 (432)
T ss_dssp             HHHHT---T-----CCCCT-----T--SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             HHHHh---c-----cCCcc-----c--cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHh
Confidence            11110   0     00000     0  0112234567889999999999999999999984

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.5e-39  Score=312.71  Aligned_cols=234  Identities=20%  Similarity=0.286  Sum_probs=182.3

Q ss_pred             hcCCCcc-ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHh-ccCCCCceeeEeee
Q 043568           86 TRGFSRA-LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFL-GVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~-~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l-~~l~h~nIv~l~~~  163 (453)
                      .++|... ++||+|+||.||+|.+.           .++..||||++..     ...+.+|+.++ +.++||||++++++
T Consensus        16 ~~~y~~~~~~lg~G~~g~V~~~~~~-----------~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~   79 (299)
T 3m2w_A           16 IDDYKVTSQVLGLGINGKVLQIFNK-----------RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV   79 (299)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             ccchhhcCcccccCCCeEEEEEEEc-----------CCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhh
Confidence            4567776 78999999999999975           4577899999853     24677899988 56699999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---C
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---D  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~  240 (453)
                      +..........++||||+++|+|.+++.......+++..++.++.|++.||.|||+.   +|+||||||+|||++.   +
T Consensus        80 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~  156 (299)
T 3m2w_A           80 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN  156 (299)
T ss_dssp             EEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTT
T ss_pred             hhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCC
Confidence            876332233479999999999999999987667899999999999999999999999   9999999999999998   7


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||++....                        +..++.++|||||||++|||++|+.||.......   ... 
T Consensus       157 ~~~kl~Dfg~a~~~~------------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~---~~~-  208 (299)
T 3m2w_A          157 AILKLTDFGFAKETT------------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA---ISP-  208 (299)
T ss_dssp             CCEEECCCTTCEECT------------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC----------C-
T ss_pred             CcEEEeccccccccc------------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchh---hhH-
Confidence            889999999986532                        2346789999999999999999999996542211   000 


Q ss_pred             hhhcccCccccccccCCcC--CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRL--EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                              .....+.....  ........+.++.+|+.+||+.||.+|||+.++++
T Consensus       209 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~  256 (299)
T 3m2w_A          209 --------GMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  256 (299)
T ss_dssp             --------CSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             --------HHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhc
Confidence                    00000000000  00011235678999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.1e-39  Score=309.87  Aligned_cols=232  Identities=13%  Similarity=0.127  Sum_probs=184.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc---HHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~---~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||.||+|.+.           .++..||||++.......   ...|.+|+.++.+++||||+++++
T Consensus        30 ~~~y~i~~~lg~G~~g~Vy~a~~~-----------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~   98 (286)
T 3uqc_A           30 NGRYRLLIFHGGVPPLQFWQALDT-----------ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLD   98 (286)
T ss_dssp             TTTEEEEEEEEBSTTCEEEEEEET-----------TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCcEEEEEEEcccCCeEEEEEEec-----------CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeE
Confidence            367999999999999999999975           457899999997654322   367899999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...+.    .++||||+++++|.+++...    .....+..++.|++.||.|||++   +|+||||||+|||++.++.
T Consensus        99 ~~~~~~~----~~lv~e~~~g~~L~~~l~~~----~~~~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~  167 (286)
T 3uqc_A           99 VVHTRAG----GLVVAEWIRGGSLQEVADTS----PSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGD  167 (286)
T ss_dssp             EEEETTE----EEEEEECCCEEEHHHHHTTC----CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSC
T ss_pred             EEEECCc----EEEEEEecCCCCHHHHHhcC----CChHHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCC
Confidence            9987654    79999999999999998542    34557889999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+++|                      |++       .++.++|||||||++|||++|+.||.........       
T Consensus       168 ~kl~~~~----------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~-------  211 (286)
T 3uqc_A          168 VVLAYPA----------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGL-------  211 (286)
T ss_dssp             EEECSCC----------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCS-------
T ss_pred             EEEEecc----------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhh-------
Confidence            9998543                      333       3688999999999999999999999764321100       


Q ss_pred             hcccCccccccccCCcC--CCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          323 PYVSDSKKFHLIIDPRL--EGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                            ...........  ........+..+.+|+.+||+.||.+| |+.++++.|..+...
T Consensus       212 ------~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          212 ------APAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             ------EECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             ------HHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence                  00000000000  011223456789999999999999999 999999999987753

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=8.5e-40  Score=328.81  Aligned_cols=247  Identities=19%  Similarity=0.233  Sum_probs=184.1

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHHHHHHHhccCCC-CceeeE
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGVVKH-PNLVKL  160 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~~E~~~l~~l~h-~nIv~l  160 (453)
                      .+++|...++||+|+||+||+|++.           .++..||||++.....   ...+.|.+|+.+++.+.| +|+...
T Consensus        76 ~~~~~~~~~~LG~G~fG~Vy~a~~~-----------~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~  144 (413)
T 3dzo_A           76 RPRTLVRGTVLGQEDPYAYLEATDQ-----------ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQA  144 (413)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHH
T ss_pred             CceeEEEecccccCCCEEEEEEEec-----------CCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHH
Confidence            3456888899999999999999976           4577999999874332   235779999999999987 322111


Q ss_pred             ---------eeee------------eecc-cccceEEEEEEecCCCChHHhhh-----cCCCCCCCHHHHHHHHHHHHHH
Q 043568          161 ---------VGYC------------AEDD-ERGMQRLLVYELMHNKSLEDHLL-----SRVPTPLAWIARLKIAQDAARG  213 (453)
Q Consensus       161 ---------~~~~------------~~~~-~~~~~~~lv~e~~~~gsL~~~l~-----~~~~~~l~~~~~~~i~~~ia~~  213 (453)
                               +..+            .... .....++++|+++ +++|.+++.     ......+++..++.++.||+.|
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~a  223 (413)
T 3dzo_A          145 KVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRL  223 (413)
T ss_dssp             HHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHH
T ss_pred             HHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHH
Confidence                     1111            1111 0012357777776 789999885     2234567888999999999999


Q ss_pred             HHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccc----------ccCCC
Q 043568          214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYV----------QTGRL  283 (453)
Q Consensus       214 L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~  283 (453)
                      |.|||++   +|+||||||+|||++.++.+||+|||+++....     ......| +.|+|||++          ....+
T Consensus       224 L~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~  294 (413)
T 3dzo_A          224 LASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-----SAVSPIG-RGFAPPETTAERMLPFGQHHPTLM  294 (413)
T ss_dssp             HHHHHHT---TEECSCCCGGGEEECTTCCEEECCGGGCEETTE-----EECCCCC-TTTCCHHHHHHHTSTTGGGCCEEE
T ss_pred             HHHHHhC---CcccCCcccceEEEecCCeEEEEeccceeecCC-----ccccCCC-CceeCchhhhccccccccccCcCC
Confidence            9999998   999999999999999999999999999886432     2345567 999999999          55568


Q ss_pred             CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCC
Q 043568          284 TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQP  363 (453)
Q Consensus       284 ~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp  363 (453)
                      +.++|||||||++|||++|+.||.......                ....++..      ....+..+.+|+.+||..||
T Consensus       295 ~~~~DvwSlGvil~elltg~~Pf~~~~~~~----------------~~~~~~~~------~~~~~~~~~~li~~~l~~dP  352 (413)
T 3dzo_A          295 TFAFDTWTLGLAIYWIWCADLPNTDDAALG----------------GSEWIFRS------CKNIPQPVRALLEGFLRYPK  352 (413)
T ss_dssp             CHHHHHHHHHHHHHHHHHSSCCCCTTGGGS----------------CSGGGGSS------CCCCCHHHHHHHHHHTCSSG
T ss_pred             CchhhHHHHHHHHHHHHHCCCCCCCcchhh----------------hHHHHHhh------cccCCHHHHHHHHHHccCCh
Confidence            889999999999999999999997542111                01111110      11235779999999999999


Q ss_pred             CCCCCHHHHHH
Q 043568          364 KSRPKMSEVVD  374 (453)
Q Consensus       364 ~~RPs~~ei~~  374 (453)
                      ++|||+.++++
T Consensus       353 ~~Rpt~~~~l~  363 (413)
T 3dzo_A          353 EDRLLPLQAME  363 (413)
T ss_dssp             GGSCCHHHHTT
T ss_pred             hhCcCHHHHHh
Confidence            99999888754

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=4.8e-39  Score=314.42  Aligned_cols=246  Identities=15%  Similarity=0.144  Sum_probs=184.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--------ccHHHHHHHHHHhccCC----
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--------QGHKEWINEVNFLGVVK----  153 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--------~~~~~~~~E~~~l~~l~----  153 (453)
                      .++|...+.||+|+||+||+|++.             +..||||++.....        ...+.+.+|+.+|+.++    
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~-------------~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~   85 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIAD-------------HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSG   85 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEET-------------TEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGG
T ss_pred             cccchheeeecccCceEEEEEEeC-------------CceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhc
Confidence            466888999999999999999852             57899999976532        23477889999998886    


Q ss_pred             -----CCceeeEeeeeeeccc--------------------------ccceEEEEEEecCCCChHHhhhcCCCCCCCHHH
Q 043568          154 -----HPNLVKLVGYCAEDDE--------------------------RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA  202 (453)
Q Consensus       154 -----h~nIv~l~~~~~~~~~--------------------------~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~  202 (453)
                           ||||+++.+++.....                          .....+|||||+++|++.+.+.+   ..+++..
T Consensus        86 ~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~---~~~~~~~  162 (336)
T 2vuw_A           86 EVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT---KLSSLAT  162 (336)
T ss_dssp             CSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT---TCCCHHH
T ss_pred             cccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh---cCCCHHH
Confidence                 7777777766532110                          02348999999999987776744   4689999


Q ss_pred             HHHHHHHHHHHHHHHH-hCCCCceEeeccccccEEEcCCC--------------------cEEEeccccccCCCCCCCCc
Q 043568          203 RLKIAQDAARGLAYLH-EEMDFQLIFRDFKTSNILLDEDY--------------------KAKLSDFGLARQGPPEGLGH  261 (453)
Q Consensus       203 ~~~i~~~ia~~L~~LH-~~~~~~iiH~Dlkp~NILl~~~~--------------------~~kL~DFGla~~~~~~~~~~  261 (453)
                      +..++.||+.||.||| +.   +|+||||||+|||++.++                    .+||+|||+|+....     
T Consensus       163 ~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~-----  234 (336)
T 2vuw_A          163 AKSILHQLTASLAVAEASL---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD-----  234 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET-----
T ss_pred             HHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC-----
Confidence            9999999999999999 88   999999999999999887                    899999999986432     


Q ss_pred             cccccccCcCCCCccccccCCCCCchhHHHHHHH-HHHHHhCCccccCCCChhhHHHHHhhhhcccCccccccccCCcCC
Q 043568          262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVV-LYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLE  340 (453)
Q Consensus       262 ~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvi-l~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  340 (453)
                        ....||+.|+|||++.+.. +.++||||||++ .+++++|..||.....  ...+.+......        .......
T Consensus       235 --~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~--~~~~~~~~~~~~--------~~~~~~~  301 (336)
T 2vuw_A          235 --GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLW--LHYLTDKMLKQM--------TFKTKCN  301 (336)
T ss_dssp             --TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHH--HHHHHHHHHHTC--------CCSSCCC
T ss_pred             --CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhh--hhHHHHhhhhhh--------ccCcccc
Confidence              2457999999999998766 899999998776 7888889988843100  001111111000        0111112


Q ss_pred             CccchHHHHHHHHHHHHhhccCCCCCCCHHHHH
Q 043568          341 GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV  373 (453)
Q Consensus       341 ~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~  373 (453)
                      .......+.++.+||.+||..|     |+.+++
T Consensus       302 ~~~~~~~s~~~~dli~~~L~~d-----sa~e~l  329 (336)
T 2vuw_A          302 TPAMKQIKRKIQEFHRTMLNFS-----SATDLL  329 (336)
T ss_dssp             SHHHHHHHHHHHHHHHHGGGSS-----SHHHHH
T ss_pred             hhhhhhcCHHHHHHHHHHhccC-----CHHHHH
Confidence            2234567889999999999976     888877

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=1e-32  Score=287.21  Aligned_cols=170  Identities=20%  Similarity=0.147  Sum_probs=127.4

Q ss_pred             CCeeEEEEEeccCCc----------ccHHHHHHHHHHhccC-CCCceeeEeeeeeecccccceEEEEEEecCCCChHHhh
Q 043568          122 SKLDVAIKQLNRQGF----------QGHKEWINEVNFLGVV-KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL  190 (453)
Q Consensus       122 ~~~~vavK~l~~~~~----------~~~~~~~~E~~~l~~l-~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l  190 (453)
                      .+..+|+|.+.....          ...++|.+|+++|+++ .|+||+++++++.+...    .||||||++|++|.++|
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~----~yLVMEyv~G~~L~d~i  333 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQS----GWLVMEKLPGRLLSDML  333 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSE----EEEEEECCCSEEHHHHH
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCE----EEEEEecCCCCcHHHHH
Confidence            467799999975421          2235699999999999 79999999999987765    79999999999999999


Q ss_pred             hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCc
Q 043568          191 LSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV  270 (453)
Q Consensus       191 ~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~  270 (453)
                      ...  .+++..   +|+.||+.||+|||++   |||||||||+||||+.++.+||+|||+|+......  ......+||+
T Consensus       334 ~~~--~~l~~~---~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~--~~~~t~vGTp  403 (569)
T 4azs_A          334 AAG--EEIDRE---KILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC--SWPTNLVQSF  403 (569)
T ss_dssp             HTT--CCCCHH---HHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC-----CCSHHHHHHH
T ss_pred             HhC--CCCCHH---HHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCC--ccccCceech
Confidence            876  456643   5889999999999999   99999999999999999999999999998754332  2345678999


Q ss_pred             CCCCccccccCCCCCchhHHHHHHHHHHHHhCCccc
Q 043568          271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAV  306 (453)
Q Consensus       271 ~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~  306 (453)
                      .|||||++.+ .+..++|+||+|+++++|.++..++
T Consensus       404 ~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~  438 (569)
T 4azs_A          404 FVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW  438 (569)
T ss_dssp             HHHHHHHC------------------CCCCTTHHHH
T ss_pred             hhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence            9999999975 4677899999999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=4.5e-29  Score=258.30  Aligned_cols=185  Identities=21%  Similarity=0.284  Sum_probs=142.5

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCccc--------HHHHHHHHHHhccCCCCceeeEe
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--------HKEWINEVNFLGVVKHPNLVKLV  161 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~--------~~~~~~E~~~l~~l~h~nIv~l~  161 (453)
                      ...++||+|+||+||+|..             .+..+|+|+........        .+.|.+|+.+|++++||||+++.
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~-------------~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~  405 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY-------------LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPY  405 (540)
T ss_dssp             ---------CCEEEEEEEC-------------SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCC
T ss_pred             CCCCEEeeCCCEEEEEEEE-------------CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceE
Confidence            4456899999999999963             35679999865432211        24588999999999999999665


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      .++...+.    .+|||||+++++|.+++..          ++.++.|++.||.|||++   +|+||||||+|||++.  
T Consensus       406 ~~~~~~~~----~~lVmE~~~ggsL~~~l~~----------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--  466 (540)
T 3en9_A          406 IFDVDLDN----KRIMMSYINGKLAKDVIED----------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--  466 (540)
T ss_dssp             EEEEETTT----TEEEEECCCSEEHHHHSTT----------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--
T ss_pred             EEEEeCCc----cEEEEECCCCCCHHHHHHH----------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--
Confidence            55555443    5999999999999999876          468899999999999998   9999999999999998  


Q ss_pred             cEEEeccccccCCCCCCCCc-----cccccccCcCCCCcccccc--CCCCCchhHHHHHHHHHHHHhCCccc
Q 043568          242 KAKLSDFGLARQGPPEGLGH-----VSTSVVGTVGYAAPEYVQT--GRLTAKSDVWSFGVVLYELITGRRAV  306 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DV~SlGvil~elltg~~p~  306 (453)
                      .+||+|||+++.........     ......||+.|||||++..  ..|+..+|+||..+-.++.+.++.+|
T Consensus       467 ~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY  538 (540)
T 3en9_A          467 DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARY  538 (540)
T ss_dssp             SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCC
T ss_pred             eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhcccc
Confidence            99999999999764321111     1246689999999999986  56788899999999888888877655

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.92  E-value=4.2e-25  Score=210.05  Aligned_cols=151  Identities=15%  Similarity=0.114  Sum_probs=118.0

Q ss_pred             HHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc------------------ccHHHH
Q 043568           81 ELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF------------------QGHKEW  142 (453)
Q Consensus        81 ~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~------------------~~~~~~  142 (453)
                      .+......|...+.||+|+||.||+|.+            .++..||||.+.....                  .....+
T Consensus        84 ~~~~~~~~~~~~~~iG~G~~g~Vy~~~~------------~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~  151 (282)
T 1zar_A           84 RLVRSGKVDAIGKLMGEGKESAVFNCYS------------EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSA  151 (282)
T ss_dssp             HHHHTTSCSEEEEEEEECSSEEEEEEEE------------TTTEEEEEEEECC------CCCC-------CHHHHHHHHH
T ss_pred             HHHhCCeEEEecCEeccCCCceEEEEEe------------CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHH
Confidence            3344455677779999999999999986            2467899999864321                  123568


Q ss_pred             HHHHHHhccCCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 043568          143 INEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMD  222 (453)
Q Consensus       143 ~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~  222 (453)
                      .+|+.+|++++  | +++++++....     .++||||++|++|.+ +...        ....++.|++.||.|||+.  
T Consensus       152 ~~E~~~l~~l~--~-~~v~~~~~~~~-----~~lvmE~~~g~~L~~-l~~~--------~~~~i~~qi~~~l~~lH~~--  212 (282)
T 1zar_A          152 RNEFRALQKLQ--G-LAVPKVYAWEG-----NAVLMELIDAKELYR-VRVE--------NPDEVLDMILEEVAKFYHR--  212 (282)
T ss_dssp             HHHHHHHHHTT--T-SSSCCEEEEET-----TEEEEECCCCEEGGG-CCCS--------CHHHHHHHHHHHHHHHHHT--
T ss_pred             HHHHHHHHhcc--C-CCcCeEEeccc-----eEEEEEecCCCcHHH-cchh--------hHHHHHHHHHHHHHHHHHC--
Confidence            89999999998  4 56666554322     599999999999998 5221        2346899999999999998  


Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccc
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ  279 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~  279 (453)
                       +|+||||||+|||++ ++.+||+|||+|+.               +..|+|||++.
T Consensus       213 -giiHrDlkp~NILl~-~~~vkl~DFG~a~~---------------~~~~~a~e~l~  252 (282)
T 1zar_A          213 -GIVHGDLSQYNVLVS-EEGIWIIDFPQSVE---------------VGEEGWREILE  252 (282)
T ss_dssp             -TEECSCCSTTSEEEE-TTEEEECCCTTCEE---------------TTSTTHHHHHH
T ss_pred             -CCEeCCCCHHHEEEE-CCcEEEEECCCCeE---------------CCCCCHHHHHH
Confidence             999999999999999 99999999999864               33478899875

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.84  E-value=3.3e-21  Score=180.84  Aligned_cols=137  Identities=18%  Similarity=0.096  Sum_probs=103.8

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCee--EEEEEeccCCccc------------------------HHHH
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLD--VAIKQLNRQGFQG------------------------HKEW  142 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~--vavK~l~~~~~~~------------------------~~~~  142 (453)
                      |...+.||+|+||.||+|.+.           .++..  ||||++.......                        ...+
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~-----------~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  117 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGV-----------FDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWT  117 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEE-----------ETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEc-----------CCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHH
Confidence            567789999999999999974           24677  9999875431110                        1257


Q ss_pred             HHHHHHhccCCCCce--eeEeeeeeecccccceEEEEEEecCC-C----ChHHhhhcCCCCCCCHHHHHHHHHHHHHHHH
Q 043568          143 INEVNFLGVVKHPNL--VKLVGYCAEDDERGMQRLLVYELMHN-K----SLEDHLLSRVPTPLAWIARLKIAQDAARGLA  215 (453)
Q Consensus       143 ~~E~~~l~~l~h~nI--v~l~~~~~~~~~~~~~~~lv~e~~~~-g----sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~  215 (453)
                      .+|+.+|.++.|++|  ..++++  .  .    .+|||||+.+ |    +|.++....     ++.....++.|++.||.
T Consensus       118 ~~E~~~l~~l~~~~i~~p~~~~~--~--~----~~lVmE~~g~~g~~~~~L~~~~~~~-----~~~~~~~i~~qi~~~l~  184 (258)
T 1zth_A          118 EKEFRNLERAKEAGVSVPQPYTY--M--K----NVLLMEFIGEDELPAPTLVELGREL-----KELDVEGIFNDVVENVK  184 (258)
T ss_dssp             HHHHHHHHHHHHTTCCCCCEEEE--E--T----TEEEEECCEETTEECCBHHHHGGGG-----GGSCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCeEEEc--C--C----CEEEEEecCCCCCccccHHHHhhcc-----ChHHHHHHHHHHHHHHH
Confidence            899999999988764  444432  1  1    4899999942 4    677665431     23356788999999999


Q ss_pred             HHH-hCCCCceEeeccccccEEEcCCCcEEEeccccccCC
Q 043568          216 YLH-EEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQG  254 (453)
Q Consensus       216 ~LH-~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~  254 (453)
                      ||| +.   +|+||||||+|||++.  .++|+|||+|...
T Consensus       185 ~lH~~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          185 RLYQEA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHTS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            999 87   9999999999999998  9999999999763

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.73  E-value=2.7e-18  Score=167.98  Aligned_cols=134  Identities=16%  Similarity=0.192  Sum_probs=95.9

Q ss_pred             CCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--------------ccHHHH--------HHHH
Q 043568           89 FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--------------QGHKEW--------INEV  146 (453)
Q Consensus        89 f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--------------~~~~~~--------~~E~  146 (453)
                      |.+...||+|+||.||+|.+            .++..||||+++....              ......        .+|.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d------------~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~  164 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVAD------------EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEF  164 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEEC------------TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHH
T ss_pred             EEecCEeeeCCceEEEEEEC------------CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHH
Confidence            88999999999999999985            3467899998753210              011112        2456


Q ss_pred             HHhccCCCCcee--eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 043568          147 NFLGVVKHPNLV--KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQ  224 (453)
Q Consensus       147 ~~l~~l~h~nIv--~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~  224 (453)
                      ..|.++.+.++.  ..+++  . .     .+|||||++|++|.++...      +  ....++.|++.+|.+||+.   |
T Consensus       165 ~nL~rL~~~gv~vp~p~~~--~-~-----~~LVME~i~G~~L~~l~~~------~--~~~~l~~qll~~l~~lH~~---g  225 (397)
T 4gyi_A          165 AFMKALYEEGFPVPEPIAQ--S-R-----HTIVMSLVDALPMRQVSSV------P--DPASLYADLIALILRLAKH---G  225 (397)
T ss_dssp             HHHHHHHHTTCSCCCEEEE--E-T-----TEEEEECCSCEEGGGCCCC------S--CHHHHHHHHHHHHHHHHHT---T
T ss_pred             HHHHHHHhcCCCCCeeeec--c-C-----ceEEEEecCCccHhhhccc------H--HHHHHHHHHHHHHHHHHHC---C
Confidence            666666443332  22211  1 1     2799999999988764322      1  2346789999999999998   9


Q ss_pred             eEeeccccccEEEcCCC----------cEEEeccccccC
Q 043568          225 LIFRDFKTSNILLDEDY----------KAKLSDFGLARQ  253 (453)
Q Consensus       225 iiH~Dlkp~NILl~~~~----------~~kL~DFGla~~  253 (453)
                      ||||||||.|||+++++          .+.|+||+-+..
T Consensus       226 IVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          226 LIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             EECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            99999999999998776          389999997764

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.44  E-value=5.3e-13  Score=124.81  Aligned_cols=147  Identities=13%  Similarity=0.076  Sum_probs=110.9

Q ss_pred             HHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEe
Q 043568           83 KSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLV  161 (453)
Q Consensus        83 ~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~  161 (453)
                      .....+|.....+|.|+.+.||+...             .+..+++|............+.+|+.+++.+. +.++.+++
T Consensus        10 ~~~l~~~~~~~~~~g~s~~~v~~~~~-------------~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~   76 (263)
T 3tm0_A           10 KKLIEKYRCVKDTEGMSPAKVYKLVG-------------ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVL   76 (263)
T ss_dssp             HHHHTTSEEEECCSCCSSSEEEEEEC-------------SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEE
T ss_pred             HHHhccceeEeeccCCCCCeEEEEEC-------------CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEE
Confidence            34456788888899999999999863             24679999986432223345889999999884 67788899


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC---------------------
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEE---------------------  220 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~---------------------  220 (453)
                      +++...+.    .++||||++|.+|.+.+...       .....++.+++++|..||+.                     
T Consensus        77 ~~~~~~~~----~~lv~e~i~G~~l~~~~~~~-------~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~  145 (263)
T 3tm0_A           77 HFERHDGW----SNLLMSEADGVLCSEEYEDE-------QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYL  145 (263)
T ss_dssp             EEEEETTE----EEEEEECCSSEEHHHHCCTT-------TCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHH
T ss_pred             EEEecCCc----eEEEEEecCCeehhhccCCc-------ccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHH
Confidence            88876543    69999999999998763211       12346788999999999981                     


Q ss_pred             -----------------------------------CCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          221 -----------------------------------MDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       221 -----------------------------------~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                                                         ..+.++|||++|.|||++++..+.|+||+.+..
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          146 LNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                                               013699999999999998766667999987654

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.28  E-value=6.1e-12  Score=117.04  Aligned_cols=139  Identities=16%  Similarity=0.091  Sum_probs=96.9

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCc--eeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPN--LVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n--Iv~l~~~  163 (453)
                      ..++....+.+.|..+.||+...            .++..+++|.....   ....+.+|+.+++.+.+.+  +.+++++
T Consensus        19 ~~~~~~~~~~~gg~~~~v~~~~~------------~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~   83 (264)
T 1nd4_A           19 LFGYDWAQQTIGCSDAAVFRLSA------------QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDV   83 (264)
T ss_dssp             TTTCEEEECSCTTSSCEEEEEEC------------TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEE
T ss_pred             cCCCceEecccCCCCceEEEEec------------CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEe
Confidence            34455443334666699999863            23456999997543   2245778999999885444  5568877


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM----------------------  221 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~----------------------  221 (453)
                      ....+.    .++||||++|.+|.  ...     ..   ...++.+++..|..||+..                      
T Consensus        84 ~~~~~~----~~~v~e~i~G~~l~--~~~-----~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~  149 (264)
T 1nd4_A           84 VTEAGR----DWLLLGEVPGQDLL--SSH-----LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME  149 (264)
T ss_dssp             EECSSC----EEEEEECCSSEETT--TSC-----CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred             ccCCCC----CEEEEEecCCcccC--cCc-----CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence            665432    69999999998884  211     11   2356778888888888742                      


Q ss_pred             ---------------------------------CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 ---------------------------------DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 ---------------------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                                                       ...++|+|++|.|||++.+..+.|+|||.+..
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                                             12399999999999998776677999998754

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.22  E-value=6e-11  Score=116.16  Aligned_cols=145  Identities=12%  Similarity=0.200  Sum_probs=105.9

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEec--cCC-cccHHHHHHHHHHhccCC--CCceeeEeeeee
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN--RQG-FQGHKEWINEVNFLGVVK--HPNLVKLVGYCA  165 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~--~~~-~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~  165 (453)
                      ..+.|+.|.++.||+....             +..+++|+..  ... ......+.+|+.+++.|.  +.++.++++++.
T Consensus        42 ~~~~l~~G~sn~~y~v~~~-------------~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~  108 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP-------------GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCE  108 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS-------------SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEEC
T ss_pred             eEEEcCCcccceEEEEEEC-------------CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECC
Confidence            4567999999999998732             3568898865  222 122346778999999886  456888998887


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM------------------------  221 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------  221 (453)
                      +....+ ..++||||++|.++.+..    ...++...+..++.+++..|..||+..                        
T Consensus       109 ~~~~~g-~~~~vme~v~G~~l~~~~----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (359)
T 3dxp_A          109 DESVIG-RAFYIMEFVSGRVLWDQS----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWT  183 (359)
T ss_dssp             CTTTTS-SCEEEEECCCCBCCCCTT----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHH
T ss_pred             CCCccC-CeEEEEEecCCeecCCCc----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHH
Confidence            653222 268999999998875422    124677788889999999999999731                        


Q ss_pred             -------------------------------CCceEeeccccccEEEcCCCc--EEEeccccccC
Q 043568          222 -------------------------------DFQLIFRDFKTSNILLDEDYK--AKLSDFGLARQ  253 (453)
Q Consensus       222 -------------------------------~~~iiH~Dlkp~NILl~~~~~--~kL~DFGla~~  253 (453)
                                                     .+.++|||+++.|||++.++.  +.|+||+.+..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          184 KQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                                           247999999999999997753  68999998875

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.16  E-value=7.3e-11  Score=112.79  Aligned_cols=187  Identities=24%  Similarity=0.268  Sum_probs=121.9

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCc--eeeEeeeeeecc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPN--LVKLVGYCAEDD  168 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~n--Iv~l~~~~~~~~  168 (453)
                      .+.++.|....||+..                ..+++|.....  .....+.+|+.+|+.+ .+..  +.+++.......
T Consensus        25 i~~~~~G~~n~v~~v~----------------~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~   86 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN----------------RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE   86 (304)
T ss_dssp             CCEEEECSSEEEEEST----------------TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS
T ss_pred             eEecCCCCcceEEEEC----------------CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCC
Confidence            4468999999999742                35899986432  3346788999999887 3332  445554443322


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEE----------------------------  220 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------  220 (453)
                      .. ...++||++++|.+|.+....    .++..++..++.+++..|..||+.                            
T Consensus        87 ~~-~~~~~vm~~i~G~~l~~~~~~----~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (304)
T 3sg8_A           87 TY-QMSFAGFTKIKGVPLTPLLLN----NLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLL  161 (304)
T ss_dssp             SC-SCSCEEEECCCCEECCHHHHH----TSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHH
T ss_pred             CC-CcceEEEcccCCeECCccccc----cCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHh
Confidence            11 124789999999888754332    356667778888888888888861                            


Q ss_pred             ---------------------------CCCceEeeccccccEEEcC--CCcEEEeccccccCCCCCCCCccccccccCcC
Q 043568          221 ---------------------------MDFQLIFRDFKTSNILLDE--DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG  271 (453)
Q Consensus       221 ---------------------------~~~~iiH~Dlkp~NILl~~--~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~  271 (453)
                                                 ..+.++|+|++|.||+++.  +..+.|+||+.+....+.      ........
T Consensus       162 ~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~------~Dl~~~~~  235 (304)
T 3sg8_A          162 SRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPD------NDFISLME  235 (304)
T ss_dssp             TTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTT------HHHHTTCC
T ss_pred             cccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChH------HHHHHHHh
Confidence                                       1246899999999999998  456789999988753321      00001111


Q ss_pred             C---CCcccccc-----CCC---------CCchhHHHHHHHHHHHHhCCcccc
Q 043568          272 Y---AAPEYVQT-----GRL---------TAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       272 y---~aPE~~~~-----~~~---------~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      +   ..|+....     +..         ....+.|++|.++|.+.+|..+|.
T Consensus       236 ~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~  288 (304)
T 3sg8_A          236 DDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY  288 (304)
T ss_dssp             TTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred             hccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence            1   22332110     011         123689999999999999987763

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.53  E-value=7.5e-07  Score=84.91  Aligned_cols=137  Identities=20%  Similarity=0.158  Sum_probs=91.3

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCC---ceeeEeeeeeecc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHP---NLVKLVGYCAEDD  168 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~---nIv~l~~~~~~~~  168 (453)
                      ...++.|....||+.                +..+++|+...  ......+.+|+.+|+.|.+.   .+.+.+.++....
T Consensus        24 v~~l~~G~~n~v~~v----------------g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~   85 (306)
T 3tdw_A           24 VESLGEGFRNYAILV----------------NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSD   85 (306)
T ss_dssp             EEEEEECSSEEEEEE----------------TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTT
T ss_pred             eeecCCCcceeEEEE----------------CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCC
Confidence            346888999999975                13588998432  22346788999999999642   3566666664222


Q ss_pred             cccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC----------------------------
Q 043568          169 ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEE----------------------------  220 (453)
Q Consensus       169 ~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~----------------------------  220 (453)
                      .   ..++||||++|.+|.+....    .++...+..++.+++..|..||+.                            
T Consensus        86 g---~~~~v~e~i~G~~l~~~~~~----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~  158 (306)
T 3tdw_A           86 G---NPFVGYRKVQGQILGEDGMA----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVED  158 (306)
T ss_dssp             S---CEEEEEECCCSEECHHHHHT----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHH
T ss_pred             C---ceEEEEeccCCeECchhhhh----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHH
Confidence            1   25899999999888763221    123334444455555555555532                            


Q ss_pred             -----------------------------CCCceEeeccccccEEEcC---CCc-EEEeccccccC
Q 043568          221 -----------------------------MDFQLIFRDFKTSNILLDE---DYK-AKLSDFGLARQ  253 (453)
Q Consensus       221 -----------------------------~~~~iiH~Dlkp~NILl~~---~~~-~kL~DFGla~~  253 (453)
                                                   ..+.++|+|++|.|||++.   ++. +.|+||+.+..
T Consensus       159 ~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          159 QVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             hcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                                         2336799999999999987   455 48999998765

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.47  E-value=1.2e-06  Score=81.67  Aligned_cols=136  Identities=18%  Similarity=0.128  Sum_probs=92.7

Q ss_pred             eecCCCce-EEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeeeeeccccc
Q 043568           94 LIGEGGFG-CVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        94 ~lG~G~~g-~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  171 (453)
                      .+..|..| .||+....           .++..+++|.-...   ....+.+|..+|+.+. +-.+.++++++...+.  
T Consensus        31 ~~~~G~S~~~v~rl~~~-----------~~~~~~~lk~~~~~---~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~--   94 (272)
T 4gkh_A           31 RDNVGQSGATIYRLYGK-----------PNAPELFLKHGKGS---VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDD--   94 (272)
T ss_dssp             EEECSSSSCEEEEEECC-----------TTCCCEEEEEEETH---HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTE--
T ss_pred             EccCCCcCCeEEEEEec-----------CCCeEEEEEECCCC---CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCe--
Confidence            35556555 68986543           33556899985432   3456788999998883 4447778888876543  


Q ss_pred             ceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------
Q 043568          172 MQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM------------------------------  221 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~------------------------------  221 (453)
                        .++|||+++|.++.+......      .....++.+++..|.-||+..                              
T Consensus        95 --~~lvme~l~G~~~~~~~~~~~------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (272)
T 4gkh_A           95 --AWLLTTAIPGKTAFQVLEEYP------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASD  166 (272)
T ss_dssp             --EEEEEECCCSEEHHHHHHHCG------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGG
T ss_pred             --EEEEEEeeCCccccccccCCH------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhh
Confidence              699999999988876543321      122345556666666666421                              


Q ss_pred             -------------------------CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 -------------------------DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 -------------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                                               .+.++|+|+.+.|||++.++.+-|+||+.+..
T Consensus       167 ~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          167 FDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             ccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                                     12479999999999999877778999998764

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.46  E-value=4.8e-07  Score=88.04  Aligned_cols=90  Identities=9%  Similarity=0.023  Sum_probs=55.1

Q ss_pred             cee-cCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCC-C--CceeeEeeeee
Q 043568           93 LLI-GEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVK-H--PNLVKLVGYCA  165 (453)
Q Consensus        93 ~~l-G~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~-h--~nIv~l~~~~~  165 (453)
                      +.| +.|..+.+|+.......+     +...+..+++|......   ......+.+|+.+|+.|. +  ..+.++++++.
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~-----~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~  100 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQD-----GRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIET  100 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEET-----TEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEEC
T ss_pred             EECCCCCccceEEEEEEecccC-----CCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEcc
Confidence            467 889999999876420000     00014568899764322   111245678888888883 2  35777887776


Q ss_pred             ecccccceEEEEEEecCCCChHH
Q 043568          166 EDDERGMQRLLVYELMHNKSLED  188 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~  188 (453)
                      .....+ ..++||||++|.++.+
T Consensus       101 ~~~~~g-~~~~v~e~l~G~~l~~  122 (357)
T 3ats_A          101 TGDVLG-TPFFLMDYVEGVVPPD  122 (357)
T ss_dssp             SSTTTS-SCEEEEECCCCBCCCB
T ss_pred             CCCccC-CceEEEEecCCCChhh
Confidence            543211 2589999998877653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.37  E-value=1.4e-06  Score=86.22  Aligned_cols=76  Identities=16%  Similarity=0.055  Sum_probs=48.0

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-------ccHHHHHHHHHHhccCCC--C-ceeeEe
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-------QGHKEWINEVNFLGVVKH--P-NLVKLV  161 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-------~~~~~~~~E~~~l~~l~h--~-nIv~l~  161 (453)
                      .+.||.|.++.||++.+.           ..+..++||.......       .....+..|.++|+.+..  + .+.+++
T Consensus        35 ~~~lg~G~~n~vyrv~~~-----------~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~  103 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQ-----------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF  103 (397)
T ss_dssp             EEECCSSSSEEEEEEEC---------------CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEE
T ss_pred             EEECCCCceEEEEEEEEC-----------CCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEE
Confidence            457999999999999753           2346799998643211       123456789998887732  3 344565


Q ss_pred             eeeeecccccceEEEEEEecCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNK  184 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~g  184 (453)
                      .+.  .+.    .++||||+++.
T Consensus       104 ~~d--~~~----~~lvmE~l~g~  120 (397)
T 2olc_A          104 YSD--TEM----AVTVMEDLSHL  120 (397)
T ss_dssp             EEE--TTT----TEEEECCCTTS
T ss_pred             EEc--CCc----cEEEEEeCCCc
Confidence            442  222    38999999764

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.09  E-value=1.5e-05  Score=76.67  Aligned_cols=32  Identities=25%  Similarity=0.290  Sum_probs=28.3

Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ...+||||+++.|||++.++.+.|+||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            35899999999999998888899999997754

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.08  E-value=2.7e-05  Score=74.12  Aligned_cols=138  Identities=12%  Similarity=0.108  Sum_probs=88.8

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC---CCceeeEeeeeeec
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK---HPNLVKLVGYCAED  167 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~---h~nIv~l~~~~~~~  167 (453)
                      ....|+.|....+|+...             ++..+++|.....   ....|..|+..|+.|.   ...+.++++++...
T Consensus        40 ~~~~l~gG~~n~~y~v~~-------------~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~  103 (312)
T 3jr1_A           40 HKEKLYSGEMNEIWLIND-------------EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ  103 (312)
T ss_dssp             EEEEECCSSSSEEEEEES-------------SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS
T ss_pred             eeEEeCCccceeeeEEEE-------------CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC
Confidence            345799999999998762             2457899986532   3566888999998883   35688888877654


Q ss_pred             ccccceEEEEEEecCCCChHH-----------hhhcCCC-C-------------------CCCHHHHH---HHH------
Q 043568          168 DERGMQRLLVYELMHNKSLED-----------HLLSRVP-T-------------------PLAWIARL---KIA------  207 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~-----------~l~~~~~-~-------------------~l~~~~~~---~i~------  207 (453)
                      +    ..++||||+++..+..           .|+.... .                   .-+|...+   ++.      
T Consensus       104 g----~~~lvme~l~G~~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a  179 (312)
T 3jr1_A          104 G----HSFLLLEALNKSKNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQIC  179 (312)
T ss_dssp             S----EEEEEEECCCCCCCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHH
T ss_pred             C----ceEEEEEeccCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHH
Confidence            3    2699999999876521           1222211 0                   12454322   111      


Q ss_pred             ----------HHHHHHH-HHHHh-CCCCceEeeccccccEEEcCCCcEEEeccc
Q 043568          208 ----------QDAARGL-AYLHE-EMDFQLIFRDFKTSNILLDEDYKAKLSDFG  249 (453)
Q Consensus       208 ----------~~ia~~L-~~LH~-~~~~~iiH~Dlkp~NILl~~~~~~kL~DFG  249 (453)
                                ..++..+ ..|.. ...+.++|+|+.+.||+++.++ +.|.||.
T Consensus       180 ~~~g~~~~~~~~l~~~l~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          180 KEKGLIFGNIDLIVQIVADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             HHHTCCCSCHHHHHHHHHHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             HHcCCChHHHHHHHHHHHHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence                      1122122 23421 2246899999999999999887 8899974

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=98.03  E-value=1.7e-05  Score=74.55  Aligned_cols=79  Identities=15%  Similarity=0.108  Sum_probs=55.2

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC---CceeeEeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH---PNLVKLVGYC  164 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h---~nIv~l~~~~  164 (453)
                      .......+|.|..+.||+.+.            .+++.|++|+...........|..|+..|+.|.-   -.+.+++++.
T Consensus        16 ~v~~v~~~g~G~~~~vyrv~l------------~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~   83 (288)
T 3f7w_A           16 EVAAVAERGHSHRWHLYRVEL------------ADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGWD   83 (288)
T ss_dssp             CEEEEEEEEEETTEEEEEEEE------------TTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEEE
T ss_pred             CeEEEEecCCCCCeEEEEEEE------------CCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEecc
Confidence            345566899999999999886            3467899998654443444567889999888742   2345555432


Q ss_pred             eecccccceEEEEEEecCCCCh
Q 043568          165 AEDDERGMQRLLVYELMHNKSL  186 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL  186 (453)
                         .     .++||||++++..
T Consensus        84 ---~-----~~lv~e~l~~~~~   97 (288)
T 3f7w_A           84 ---D-----RTLAMEWVDERPP   97 (288)
T ss_dssp             ---T-----TEEEEECCCCCCC
T ss_pred             ---C-----ceEEEEeecccCC
Confidence               2     2789999987654

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.95  E-value=4.7e-05  Score=75.72  Aligned_cols=78  Identities=17%  Similarity=0.149  Sum_probs=45.6

Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCcccccc-ccCcCCCCccccccC---CCCCchhHHHHHHHHH
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSV-VGTVGYAAPEYVQTG---RLTAKSDVWSFGVVLY  297 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~---~~~~~~DV~SlGvil~  297 (453)
                      ...++|||++|.|||++.++ ++|+||+.+...++.  ....... .-...|++|+.....   ......++.+....+|
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~--~Dla~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  307 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMG--FDIGAYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW  307 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHH--HHHHHHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchH--HHHHHHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence            34899999999999998876 999999988763211  0000000 001235555544311   1112345557777777


Q ss_pred             HHHhC
Q 043568          298 ELITG  302 (453)
Q Consensus       298 elltg  302 (453)
                      +.+++
T Consensus       308 ~~y~~  312 (420)
T 2pyw_A          308 NLFNK  312 (420)
T ss_dssp             HHHHH
T ss_pred             HHHHH
Confidence            76654

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=97.65  E-value=0.00025  Score=67.48  Aligned_cols=163  Identities=12%  Similarity=0.078  Sum_probs=86.2

Q ss_pred             cccHHHHHHHhcCCCc-----cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhc
Q 043568           76 VFSFAELKSATRGFSR-----ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG  150 (453)
Q Consensus        76 ~~~~~~~~~~~~~f~~-----~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~  150 (453)
                      .++.+++......|..     .+.|+.|....+|+....             +..+++|......  ....+..|+.+++
T Consensus         6 ~~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~-------------~g~~vlk~~~~~~--~~~~l~~e~~~l~   70 (322)
T 2ppq_A            6 DITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTT-------------KDPLILTLYEKRV--EKNDLPFFLGLMQ   70 (322)
T ss_dssp             CCCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEES-------------SCCEEEEEECC-----CCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeC-------------CccEEEEEeCCCC--CHHHHHHHHHHHH
Confidence            4556666666666654     235677888999987642             2258899876521  2234556777777


Q ss_pred             cCCCCc--eeeEeeeeeecc--cccceEEEEEEecCCCChHH--------------hhhcC---CCCC----C---CHHH
Q 043568          151 VVKHPN--LVKLVGYCAEDD--ERGMQRLLVYELMHNKSLED--------------HLLSR---VPTP----L---AWIA  202 (453)
Q Consensus       151 ~l~h~n--Iv~l~~~~~~~~--~~~~~~~lv~e~~~~gsL~~--------------~l~~~---~~~~----l---~~~~  202 (453)
                      .|...+  +.+++.......  ......+++|+|++|.++..              .++..   ...+    .   .|..
T Consensus        71 ~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~  150 (322)
T 2ppq_A           71 HLAAKGLSCPLPLPRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKV  150 (322)
T ss_dssp             HHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHH
T ss_pred             HHHHCCCCCCcccCCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHH
Confidence            663212  333332110000  00112589999998865421              11111   0111    1   1222


Q ss_pred             HHHH------------HHHHHHHHHHHHhC----CCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          203 RLKI------------AQDAARGLAYLHEE----MDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       203 ~~~i------------~~~ia~~L~~LH~~----~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      .+.-            ...+...+..++..    ...++||+|+++.|||++.+..+.|+||+.+..
T Consensus       151 ~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          151 LWDKSEERADEVEKGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             HHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence            1110            01134455555532    234799999999999999876668999987654

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.64  E-value=0.0004  Score=61.55  Aligned_cols=101  Identities=15%  Similarity=0.095  Sum_probs=66.2

Q ss_pred             CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccc
Q 043568          184 KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS  263 (453)
Q Consensus       184 gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~  263 (453)
                      -||.+.|... +.++++.++|.++.|.+.+|.-+-.... + ..+=+.|..|+|..+|.+.+.+ +.+.           
T Consensus        33 vSL~eIL~~~-~~PlsEEqaWALc~Qc~~~L~~~~~~~~-~-~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------   97 (229)
T 2yle_A           33 LSLEEILRLY-NQPINEEQAWAVCYQCCGSLRAAARRRQ-P-RHRVRSAAQIRVWRDGAVTLAP-AADD-----------   97 (229)
T ss_dssp             EEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHTTC-C-CCCCCSGGGEEEETTSCEEECC-C--------------
T ss_pred             ccHHHHHHHc-CCCcCHHHHHHHHHHHHHHHHhhhhccc-C-CceecCCcceEEecCCceeccc-cccc-----------
Confidence            4788888765 5799999999999999999877621100 1 1233457999999999998764 1110           


Q ss_pred             cccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCC
Q 043568          264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR  303 (453)
Q Consensus       264 ~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~  303 (453)
                         .....+.|||... ...+.+.=|||||++||.-+--.
T Consensus        98 ---~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDyg  133 (229)
T 2yle_A           98 ---AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYG  133 (229)
T ss_dssp             ------------CCSS-SSSCHHHHHHHHHHHHHHHHTTT
T ss_pred             ---ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcC
Confidence               1223456888763 34567889999999999987643

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=97.58  E-value=0.00023  Score=67.25  Aligned_cols=30  Identities=17%  Similarity=0.151  Sum_probs=25.8

Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            46899999999999 5667789999988765

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.54  E-value=0.00028  Score=70.31  Aligned_cols=81  Identities=12%  Similarity=0.097  Sum_probs=49.8

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCce-eeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNL-VKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~  170 (453)
                      ...|+.|....||+........    .....+..+++|+....  .....+.+|+.+++.|...++ .++++.+.  +  
T Consensus        78 v~~l~gG~tN~~y~v~~~~~~~----~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--  147 (429)
T 1nw1_A           78 ISRIKGGMSNMLFLCRLSEVYP----PIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--  147 (429)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC----CSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--
T ss_pred             EEEeCCCcccceEEEEeCCCcc----ccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--
Confidence            4568888889999987532100    00012457899987432  122556689999988843333 56666542  1  


Q ss_pred             cceEEEEEEecCCCCh
Q 043568          171 GMQRLLVYELMHNKSL  186 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL  186 (453)
                          .+|+||++|.+|
T Consensus       148 ----g~v~e~l~G~~l  159 (429)
T 1nw1_A          148 ----GRLEEYIPSRPL  159 (429)
T ss_dssp             ----EEEECCCCEEEC
T ss_pred             ----CEEEEEeCCccc
Confidence                379999986444

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.50  E-value=0.00075  Score=67.69  Aligned_cols=75  Identities=12%  Similarity=0.054  Sum_probs=46.0

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCce-eeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNL-VKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nI-v~l~~~~~~~~~~  170 (453)
                      ...|+.|-...+|+....           ..+..+++|+........ -.-.+|+.+++.|...++ .++++++.  +  
T Consensus       113 i~~lsgG~tN~~y~v~~~-----------~~~~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~~--~--  176 (458)
T 2qg7_A          113 FQIINGGITNILIKVKDM-----------SKQAKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFFT--N--  176 (458)
T ss_dssp             EEEECC--CEEEEEEEET-----------TTTEEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEET--T--
T ss_pred             EEEcCCCeEeEEEEEEEC-----------CCCceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--
Confidence            456888888999998753           123678899874322111 112478888888865444 56666652  1  


Q ss_pred             cceEEEEEEecCCCCh
Q 043568          171 GMQRLLVYELMHNKSL  186 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL  186 (453)
                          .+||||++|.+|
T Consensus       177 ----G~v~e~I~G~~l  188 (458)
T 2qg7_A          177 ----GRIEEFMDGYAL  188 (458)
T ss_dssp             ----EEEEECCCSEEC
T ss_pred             ----eEEEEeeCCccC
Confidence                359999987554

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.44  E-value=0.00075  Score=64.59  Aligned_cols=33  Identities=30%  Similarity=0.526  Sum_probs=28.4

Q ss_pred             CCceEeeccccccEEEcCC----CcEEEeccccccCC
Q 043568          222 DFQLIFRDFKTSNILLDED----YKAKLSDFGLARQG  254 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~~  254 (453)
                      ...++|||+.+.|||++.+    +.+.|+||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            3489999999999999875    67999999988763

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.43  E-value=0.00055  Score=66.83  Aligned_cols=148  Identities=14%  Similarity=0.133  Sum_probs=81.8

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeeeeeccccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYCAEDDERG  171 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~~  171 (453)
                      +.|..|-...+|+.......    ......+..+++|+... .......+.+|..+++.|. +.-..++++++..     
T Consensus        56 ~~lsGG~TN~~y~v~~~~~~----~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~-----  125 (379)
T 3feg_A           56 YPVSGGLSNLLFRCSLPDHL----PSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE-----  125 (379)
T ss_dssp             EEC-----CCEEEEECCTTS----CCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT-----
T ss_pred             EEcCCcccccEEEEEeCCCc----cccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC-----
Confidence            46777888999998753100    00012346799998532 2234556678999998884 3223566655432     


Q ss_pred             ceEEEEEEecCCCChHHh-----------------hhcCC---CCCCC--HHHHHHHHHHHH------------------
Q 043568          172 MQRLLVYELMHNKSLEDH-----------------LLSRV---PTPLA--WIARLKIAQDAA------------------  211 (453)
Q Consensus       172 ~~~~lv~e~~~~gsL~~~-----------------l~~~~---~~~l~--~~~~~~i~~~ia------------------  211 (453)
                         .+||||++|.+|...                 |+...   ..+..  |.+..++..++.                  
T Consensus       126 ---g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l  202 (379)
T 3feg_A          126 ---GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSL  202 (379)
T ss_dssp             ---EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTH
T ss_pred             ---ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHH
Confidence               289999988665321                 11110   12222  333344443321                  


Q ss_pred             -HHHHHHH----hC-CCCceEeeccccccEEEcCC----CcEEEeccccccC
Q 043568          212 -RGLAYLH----EE-MDFQLIFRDFKTSNILLDED----YKAKLSDFGLARQ  253 (453)
Q Consensus       212 -~~L~~LH----~~-~~~~iiH~Dlkp~NILl~~~----~~~kL~DFGla~~  253 (453)
                       ..+..|.    .. ....++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       203 ~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          203 KDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence             1222332    21 23479999999999999876    7899999987754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.34  E-value=0.0039  Score=59.25  Aligned_cols=143  Identities=13%  Similarity=0.131  Sum_probs=78.2

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC--CceeeEeeeeeeccc-
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH--PNLVKLVGYCAEDDE-  169 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h--~nIv~l~~~~~~~~~-  169 (453)
                      ..|+ |....||+...            .++..+++|...... .....+..|..+++.+..  -.+++++..  +... 
T Consensus        32 ~~l~-g~~n~~y~v~~------------~~g~~~vlK~~~~~~-~~~~~~~~E~~~~~~L~~~g~~vp~~~~~--~g~~~   95 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQD------------EDRRRFVVKFYRPER-WTADQILEEHQFALQLVNDEVPVAAPVAF--NGQTL   95 (328)
T ss_dssp             EEEC-CSSSEEEEECC------------TTCCCEEEEEECTTT-SCHHHHHHHHHHHHHHHHTTCSBCCCCCB--TTBSC
T ss_pred             Eeec-CcccceEEEEc------------CCCCEEEEEEcCCCC-CCHHHHHHHHHHHHHHHHcCCeecceeec--CCcEE
Confidence            3577 88889997652            224469999986332 234566778888887742  224445443  1110 


Q ss_pred             --ccceEEEEEEecCCCChHH----h----------hhc----CC---CCCCCHHHH----HHHH---------------
Q 043568          170 --RGMQRLLVYELMHNKSLED----H----------LLS----RV---PTPLAWIAR----LKIA---------------  207 (453)
Q Consensus       170 --~~~~~~lv~e~~~~gsL~~----~----------l~~----~~---~~~l~~~~~----~~i~---------------  207 (453)
                        .....+++|+|++|.++..    .          ++.    ..   ....++...    ..++               
T Consensus        96 ~~~~g~~~~l~~~i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  175 (328)
T 1zyl_A           96 LNHQGFYFAVFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFL  175 (328)
T ss_dssp             EEETTEEEEEEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHH
T ss_pred             EEECCEEEEEEEecCCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHH
Confidence              0113578999998754320    0          111    00   011222111    0010               


Q ss_pred             HHHHHHHHHHHhC----CCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          208 QDAARGLAYLHEE----MDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       208 ~~ia~~L~~LH~~----~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..+...+..+...    ....++|||+++.|||++ + .+.|+||+.+..
T Consensus       176 ~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          176 KATDELIAAVTAHWREDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             HHHHHHHHHHHHHCCSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             HHHHHHHHHHHHHhhhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            0111122233221    234789999999999999 4 899999988765

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.21  E-value=0.0008  Score=65.46  Aligned_cols=83  Identities=10%  Similarity=0.054  Sum_probs=43.1

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCc-eeeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPN-LVKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~n-Iv~l~~~~~~~~~~  170 (453)
                      ...|+.|....+|+.........   .....+..+++|+..... ........|..+++.+...+ ..++++..  .+  
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~---~~~~~~~~~vlRi~~~~~-~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--  109 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETAN---NYNSIRTRVLFRIYGKHV-DELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--  109 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHT---TCTTSCCEEEEEECCTTG-GGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEeCCcccceEEEEEeCCCCcc---cccCCCceEEEEecCCCc-cceecHHHHHHHHHHHHhcCCCCceEEec--CC--
Confidence            34678888899999875321000   000012468888864321 11112357888888774333 34666443  11  


Q ss_pred             cceEEEEEEecCCCCh
Q 043568          171 GMQRLLVYELMHNKSL  186 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL  186 (453)
                          ++||||++|.++
T Consensus       110 ----~~v~e~i~G~~l  121 (369)
T 3c5i_A          110 ----GRIEEWLYGDPL  121 (369)
T ss_dssp             ----EEEEECCCSEEC
T ss_pred             ----cEEEEEecCCcC
Confidence                689999987544

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=96.81  E-value=0.0063  Score=58.39  Aligned_cols=31  Identities=16%  Similarity=0.303  Sum_probs=27.9

Q ss_pred             CceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          223 FQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       223 ~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4799999999999999888899999987765

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.32  E-value=0.0093  Score=58.99  Aligned_cols=82  Identities=7%  Similarity=-0.029  Sum_probs=46.7

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  170 (453)
                      ...|..|--..+|+.........    ....+..+++++..... ...-...+|..+++.+. +.-..++++.+  .+  
T Consensus        75 v~~lsGG~TN~~y~v~~~~~~~~----~~~~~~~~vlRi~g~~t-~~~idR~~E~~~l~~L~~~gi~P~l~~~~--~~--  145 (424)
T 3mes_A           75 VKQIFSGLTNQLFVVSIVNESMS----LSLKHPRILFRIYGKHV-GKFYDSKVELDVFRYLSNINIAPNIIADF--PE--  145 (424)
T ss_dssp             EEEECCCSSSEEEEEEECCC---------CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--TT--
T ss_pred             EEEcCCCcccceEEEEeCCCccc----ccCCCCeEEEEECCCCc-chhcCHHHHHHHHHHHHhcCCCCCEEEEc--CC--
Confidence            34677888899999875311000    00114678998864322 11112347888888774 32234555432  11  


Q ss_pred             cceEEEEEEecCCCCh
Q 043568          171 GMQRLLVYELMHNKSL  186 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL  186 (453)
                          ++||||++|.+|
T Consensus       146 ----~~I~efI~G~~l  157 (424)
T 3mes_A          146 ----GRIEEFIDGEPL  157 (424)
T ss_dssp             ----EEEEECCCSEEC
T ss_pred             ----CEEEEEeCCccC
Confidence                689999998664

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=94.69  E-value=0.17  Score=49.47  Aligned_cols=30  Identities=33%  Similarity=0.411  Sum_probs=25.4

Q ss_pred             ceEeeccccccEEE------cCCCcEEEeccccccC
Q 043568          224 QLIFRDFKTSNILL------DEDYKAKLSDFGLARQ  253 (453)
Q Consensus       224 ~iiH~Dlkp~NILl------~~~~~~kL~DFGla~~  253 (453)
                      .++|+|+.+.|||+      +++..+.++||.+|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            46899999999999      4567799999988764

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=89.43  E-value=0.75  Score=40.49  Aligned_cols=116  Identities=9%  Similarity=0.081  Sum_probs=75.7

Q ss_pred             CCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecccc
Q 043568          153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKT  232 (453)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp  232 (453)
                      .||+++.. .+-...+.    +.+.|+.-+.+.=...+.     .++...+++++..|+....+++.     -+|--|.|
T Consensus        43 ~~~~Fl~~-~I~e~eD~----v~~~y~~~~~~~~f~~ik-----~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P  107 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDS----FQIHYDINDNHTPFDNIK-----SFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAP  107 (215)
T ss_dssp             CCTTBCCE-EEEECSSE----EEEEECCCTTSEEGGGGG-----GSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSG
T ss_pred             cCCcccce-EEEEcccE----EEEEEEcCcccCCHHHHH-----hcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEec
Confidence            68888866 34444432    344444432221122232     45788899999999988866664     37888999


Q ss_pred             ccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          233 SNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       233 ~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      +||+++.++.+++.--|+-....+                   .     ..+...=.-.+=+++..+++++..|+
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l~P-------------------~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVVDP-------------------L-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTBSC-------------------C-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             ceEEEcCCCCEEEEEccCccCCCC-------------------C-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999998776543222                   1     11222233457788899999988775

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=89.04  E-value=1.2  Score=39.23  Aligned_cols=115  Identities=10%  Similarity=0.110  Sum_probs=73.0

Q ss_pred             CCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHH-HHHhCCCCceEeeccc
Q 043568          153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLA-YLHEEMDFQLIFRDFK  231 (453)
Q Consensus       153 ~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~-~LH~~~~~~iiH~Dlk  231 (453)
                      .||++ . ..+-.+.+.    +.+.++.-+++.=...+.     .++...+++++.+|+.... +++     .-+|--|.
T Consensus        48 ~~~~f-~-~~I~~~eD~----~~i~y~~~~~~~~f~~i~-----~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~  111 (219)
T 4ano_A           48 VDPCI-V-RDIDVSEDE----VKVVIKPPSSFLTFAAIR-----KTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVC  111 (219)
T ss_dssp             SCSSS-E-EEEEECSSE----EEEEEECCTTCEEHHHHH-----TSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCC
T ss_pred             cCCCC-C-eEEEEeCCE----EEEEEEcCcccCcHHHHH-----hcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEe
Confidence            57887 2 223333332    345555443333233343     4578889999998888766 555     45788899


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      |+||+++.++.++|.-.|+-...+                   |.-     .+..-=.-.+=+++..++.++..|+
T Consensus       112 P~NL~f~~~~~p~i~hRGi~~~lp-------------------P~e-----~~ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          112 PENLMFNRALEPFFLHVGVKESLP-------------------PDE-----WDDERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             GGGEEECTTCCEEESCCEETTTBS-------------------SCS-----CCHHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             CceEEEeCCCcEEEEEcCCcccCC-------------------CCC-----CCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            999999999999999887654422                   211     1112223357788888999887764

>3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A

Probab=87.93  E-value=0.065  Score=53.59  Aligned_cols=63  Identities=10%  Similarity=0.115  Sum_probs=18.5

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEE------EEeccCC--cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAI------KQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vav------K~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      ..+.||   ||.||+|.+..           ...+|||      |......  ......|.+|..+++.++|||+++.++
T Consensus       146 l~~~lG---fG~v~~g~~~~-----------~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~  211 (463)
T 3cxl_A          146 IYEHVG---YTTLNREPAYK-----------KHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHN  211 (463)
T ss_dssp             STTTSS---BCCC--------------------CCBGGGC-----------------------------------CBCCC
T ss_pred             ccccCC---chhhhcccccc-----------cCCchhhhhccCccccccccccccccccccccccccccccccccCCCcc
Confidence            345666   99999999752           2346888      6654322  223356889999999999999999988


Q ss_pred             eeeec
Q 043568          163 YCAED  167 (453)
Q Consensus       163 ~~~~~  167 (453)
                      +....
T Consensus       212 f~~~~  216 (463)
T 3cxl_A          212 FKVHT  216 (463)
T ss_dssp             EEEEC
T ss_pred             eEEee
Confidence            77654

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	453
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-68
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-63
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	8e-63
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	2e-62
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	9e-62
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-61
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	5e-61
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-61
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-60
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-60
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-60
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	5e-60
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	9e-60
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-59
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-59
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-58
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-58
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-58
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-57
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	3e-56
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	6e-56
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	7e-56
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	9e-56
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	2e-55
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-55
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-54
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	1e-53
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-53
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-53
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	4e-51
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	2e-50
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	5e-50
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	2e-49
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	7e-49
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-48
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	9e-46
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	9e-45
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-44
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-44
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-44
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-43
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-43
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-43
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-42
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-42
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-42
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-41
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	9e-41
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-40
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-40
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	5e-40
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-39
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	8e-38
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-36
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-35
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-33
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	9e-33
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	2e-32
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	4e-32
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-32
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-26
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	1e-14

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  216 bits (551), Expect = 4e-68
 Identities = 80/295 (27%), Positives = 127/295 (43%), Gaps = 40/295 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
            IG G FG VY+G                  DVA+K LN      Q  + + NEV  L  
Sbjct: 15  RIGSGSFGTVYKGK--------------WHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRK 60

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
            +H N++  +GY         Q  +V +     SL  HL     T    I  + IA+  A
Sbjct: 61  TRHVNILLFMGYSTAP-----QLAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTA 114

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           +G+ YLH +    +I RD K++NI L ED   K+ DFGLA         H    + G++ 
Sbjct: 115 QGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSIL 171

Query: 272 YAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS 328
           + APE ++       + +SDV++FG+VLYEL+TG+       P +     + +   V   
Sbjct: 172 WMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL------PYSNINNRDQIIFMVGRG 225

Query: 329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI 383
                 + P L         + +  L ++CL K+   RP   +++  +  +   +
Sbjct: 226 -----YLSPDLS-KVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  205 bits (523), Expect = 1e-63
 Identities = 80/322 (24%), Positives = 138/322 (42%), Gaps = 45/322 (13%)

Query: 77  FSFAELKSATRGFSRAL---------LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVA 127
           F+F +   A R F++ +         +IG G FG V  G +++               VA
Sbjct: 7   FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIF--------VA 58

Query: 128 IKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSL 186
           IK L      +  +++++E + +G   HPN++ L G   +        +++ E M N SL
Sbjct: 59  IKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV----MIITEFMENGSL 114

Query: 187 EDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS 246
            D  L +       I  + + +  A G+ YL    D   + RD    NIL++ +   K+S
Sbjct: 115 -DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVS 170

Query: 247 DFGLARQGPPEGLGHVSTSVVG---TVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR 303
           DFGL+R    +      TS +G    + + APE +Q  + T+ SDVWS+G+V++E+++  
Sbjct: 171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYG 230

Query: 304 RAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQP 363
                ++    Q ++  +              D RL           L  L   C  K  
Sbjct: 231 ERPYWDM--TNQDVINAIEQ------------DYRLPPPMDC--PSALHQLMLDCWQKDR 274

Query: 364 KSRPKMSEVVDILGNIISEISS 385
             RPK  ++V+ L  +I   +S
Sbjct: 275 NHRPKFGQIVNTLDKMIRNPNS 296

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 8e-63
 Identities = 69/288 (23%), Positives = 122/288 (42%), Gaps = 38/288 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +G G FG V+ G             ++    VA+K L +QG      ++ E N +  ++
Sbjct: 20  RLGAGQFGEVWMGY------------YNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQ 66

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H  LV+L     ++        ++ E M N SL D L +     L     L +A   A G
Sbjct: 67  HQRLVRLYAVVTQEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEG 121

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           +A++ E      I RD + +NIL+ +    K++DFGLAR                 + + 
Sbjct: 122 MAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWT 177

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHL 333
           APE +  G  T KSDVWSFG++L E++T  R     +     ++++ +       + + +
Sbjct: 178 APEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGM--TNPEVIQNLE------RGYRM 229

Query: 334 IIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS 381
           +              ++L  L   C  ++P+ RP    +  +L +  +
Sbjct: 230 VRPDNC--------PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT 269

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 2e-62
 Identities = 80/303 (26%), Positives = 126/303 (41%), Gaps = 34/303 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
           +IG G FGCVY G +              K+  A+K LNR    G   +++ E   +   
Sbjct: 34  VIGRGHFGCVYHGTLL--------DNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF 85

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HPN++ L+G C   +      L+V   M +  L + + +    P      +      A+
Sbjct: 86  SHPNVLSLLGICLRSEGS---PLVVLPYMKHGDLRNFIRNETHNPT-VKDLIGFGLQVAK 141

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG--HVSTSVVGTV 270
           G+ +L  +   + + RD    N +LDE +  K++DFGLAR    +     H  T     V
Sbjct: 142 GMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            + A E +QT + T KSDVWSFGV+L+EL+T         P  +    +     +     
Sbjct: 199 KWMALESLQTQKFTTKSDVWSFGVLLWELMTRGA-----PPYPDVNTFDITVYLLQG--- 250

Query: 331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEVT 390
                   L+  YC      L  +  KC   + + RP  SE+V  +  I S    +  V 
Sbjct: 251 -----RRLLQPEYC---PDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302

Query: 391 LQP 393
           +  
Sbjct: 303 VNA 305

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  200 bits (509), Expect = 9e-62
 Identities = 65/296 (21%), Positives = 129/296 (43%), Gaps = 36/296 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVVK 153
           +G G FG V +GV R+            ++DVAIK L +   +   +E + E   +  + 
Sbjct: 17  LGCGNFGSVRQGVYRMR---------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 67

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           +P +V+L+G C     +    +LV E+     L   L+ +    +      ++    + G
Sbjct: 68  NPYIVRLIGVC-----QAEALMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMG 121

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVGTVGY 272
           + YL E+     + RD    N+LL   + AK+SDFGL++  G  +      ++    + +
Sbjct: 122 MKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFH 332
            APE +   + +++SDVWS+GV ++E ++  +   + +     +++ ++       +   
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKM--KGPEVMAFIE------QGKR 230

Query: 333 LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDE 388
           +   P            +L AL S C   + + RP    V   +      ++S+ E
Sbjct: 231 MECPPEC--------PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASKVE 278

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  199 bits (506), Expect = 2e-61
 Identities = 70/296 (23%), Positives = 123/296 (41%), Gaps = 36/296 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +G G +G VY GV +              L VA+K L     +  +E++ E   +  +K
Sbjct: 24  KLGGGQYGEVYEGVWK-----------KYSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIK 71

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HPNLV+L+G C  +    +      E M   +L D+L       ++ +  L +A   +  
Sbjct: 72  HPNLVQLLGVCTREPPFYII----TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSA 127

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL ++     I RD    N L+ E++  K++DFGL+R    +            + + 
Sbjct: 128 MEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWT 183

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHL 333
           APE +   + + KSDVW+FGV+L+E+ T   +    +  ++                 + 
Sbjct: 184 APESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ----------------VYE 227

Query: 334 IIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDEV 389
           +++            +K+  L   C    P  RP  +E+      +  E S  DEV
Sbjct: 228 LLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEV 283

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 5e-61
 Identities = 70/286 (24%), Positives = 117/286 (40%), Gaps = 42/286 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            IG+G FG V  G  R                VA+K +        + ++ E + +  ++
Sbjct: 14  TIGKGEFGDVMLGDYR-------------GNKVAVKCIKNDATA--QAFLAEASVMTQLR 58

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H NLV+L+G   E+        +V E M   SL D+L SR  + L     LK + D    
Sbjct: 59  HSNLVQLLGVIVEEKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA 115

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           + YL        + RD    N+L+ ED  AK+SDFGL ++           +    V + 
Sbjct: 116 MEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKE-----ASSTQDTGKLPVKWT 167

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHL 333
           APE ++  + + KSDVWSFG++L+E+ +  R     +P  +  ++  V       K + +
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPRVE------KGYKM 219

Query: 334 IIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI 379
                            +  +   C       RP   ++ + L +I
Sbjct: 220 DAPDGC--------PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHI 257

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (501), Expect = 7e-61
 Identities = 81/286 (28%), Positives = 129/286 (45%), Gaps = 38/286 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG G FG V+ G               +K  VAIK + R+G    +++I E   +  + H
Sbjct: 13  IGSGQFGLVHLGY------------WLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSH 59

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           P LV+L G C E         LV+E M +  L D+L ++     A    L +  D   G+
Sbjct: 60  PKLVQLYGVCLEQAPI----CLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGM 114

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
           AYL E     +I RD    N L+ E+   K+SDFG+ R    +     ST     V +A+
Sbjct: 115 AYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWAS 170

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE     R ++KSDVWSFGV+++E+ +  +    N  R+  +++E +            +
Sbjct: 171 PEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDIS-------TGFRL 221

Query: 335 IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
             PRL   +  +       + + C  ++P+ RP  S ++  L  I 
Sbjct: 222 YKPRLASTHVYQ-------IMNHCWKERPEDRPAFSRLLRQLAEIA 260

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (503), Expect = 1e-60
 Identities = 62/305 (20%), Positives = 118/305 (38%), Gaps = 34/305 (11%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           IG+G FG V+RG                  +VA+K  + +  +       E+    +++H
Sbjct: 11  IGKGRFGEVWRGK-------------WRGEEVAVKIFSSREER-SWFREAEIYQTVMLRH 56

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
            N++  +    +D+    Q  LV +   + SL D+L       +     +K+A   A GL
Sbjct: 57  ENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGL 113

Query: 215 AYLHEEMDFQL-----IFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG--LGHVSTSVV 267
           A+LH E+           RD K+ NIL+ ++    ++D GLA +       +       V
Sbjct: 114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRV 173

Query: 268 GTVGYAAPEYVQT------GRLTAKSDVWSFGVVLYELITGRRAVERNLP-RNEQKLLEW 320
           GT  Y APE +             ++D+++ G+V +E+         +   +     L  
Sbjct: 174 GTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVP 233

Query: 321 VRPYVSDSKKFHL--IIDPRLEGNYCIKSA-QKLAALASKCLTKQPKSRPKMSEVVDILG 377
             P V + +K      + P +   +    A + +A +  +C      +R     +   L 
Sbjct: 234 SDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLS 293

Query: 378 NIISE 382
            +  +
Sbjct: 294 QLSQQ 298

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  198 bits (504), Expect = 2e-60
 Identities = 64/307 (20%), Positives = 115/307 (37%), Gaps = 51/307 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLG-V 151
           ++G G FG V           +  S     + VA+K L  +     +E  ++E+  +  +
Sbjct: 44  VLGSGAFGKVMNAT------AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQL 97

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR------------------ 193
             H N+V L+G C           L++E      L ++L S+                  
Sbjct: 98  GSHENIVNLLGACTLSG----PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLE 153

Query: 194 ---VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL 250
                  L +   L  A   A+G+ +L  +     + RD    N+L+      K+ DFGL
Sbjct: 154 EEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGL 210

Query: 251 ARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNL 310
           AR    +    V  +    V + APE +  G  T KSDVWS+G++L+E+ +        +
Sbjct: 211 ARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270

Query: 311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS 370
           P +                 F+ +I    + +    + +++  +   C     + RP   
Sbjct: 271 PVDAN---------------FYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFP 315

Query: 371 EVVDILG 377
            +   LG
Sbjct: 316 NLTSFLG 322

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (498), Expect = 2e-60
 Identities = 63/287 (21%), Positives = 117/287 (40%), Gaps = 42/287 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G G FG V  G                + DVAIK +   G     E+I E   +  + H
Sbjct: 12  LGTGQFGVVKYGK------------WRGQYDVAIKMIKE-GSMSEDEFIEEAKVMMNLSH 58

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L G C +         ++ E M N  L ++L             L++ +D    +
Sbjct: 59  EKLVQLYGVCTKQRPI----FIITEYMANGCLLNYLREMRH-RFQTQQLLEMCKDVCEAM 113

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
            YL  +   Q + RD    N L+++    K+SDFGL+R    +     S      V ++ 
Sbjct: 114 EYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSP 169

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE--QKLLEWVRPYVSDSKKFH 332
           PE +   + ++KSD+W+FGV+++E+ +  +        +E  + + + +R Y        
Sbjct: 170 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY-------- 221

Query: 333 LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI 379
               P L        ++K+  +   C  ++   RP    ++  + ++
Sbjct: 222 ---RPHLA-------SEKVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  195 bits (497), Expect = 5e-60
 Identities = 75/294 (25%), Positives = 120/294 (40%), Gaps = 38/294 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG V+ G              +    VAIK L + G    + ++ E   +  ++H
Sbjct: 25  LGQGCFGEVWMGT------------WNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRH 71

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
             LV+L    +E+        +V E M   SL D L       L     + +A   A G+
Sbjct: 72  EKLVQLYAVVSEEP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM 126

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
           AY+        + RD + +NIL+ E+   K++DFGLAR                 + + A
Sbjct: 127 AYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTA 182

Query: 275 PEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHLI 334
           PE    GR T KSDVWSFG++L EL T  R          +++L+ V       + + + 
Sbjct: 183 PEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG--MVNREVLDQVE------RGYRMP 234

Query: 335 IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDE 388
             P           + L  L  +C  K+P+ RP    +   L +  +    Q +
Sbjct: 235 CPPEC--------PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  196 bits (499), Expect = 9e-60
 Identities = 69/311 (22%), Positives = 115/311 (36%), Gaps = 50/311 (16%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVN 147
           F +   +G G  G V++   +            S L +A K ++ +       + I E+ 
Sbjct: 8   FEKISELGAGNGGVVFKVSHK-----------PSGLVMARKLIHLEIKPAIRNQIIRELQ 56

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L     P +V   G    D E      +  E M   SL+  L       +      K++
Sbjct: 57  VLHECNSPYIVGFYGAFYSDGEI----SICMEHMDGGSLDQVLKKA--GRIPEQILGKVS 110

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
               +GL YL E+    ++ RD K SNIL++   + KL DFG++ Q        ++ S V
Sbjct: 111 IAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID----SMANSFV 164

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR----------------------- 304
           GT  Y +PE +Q    + +SD+WS G+ L E+  GR                        
Sbjct: 165 GTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAA 224

Query: 305 ---AVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTK 361
                 R   R         RP ++  +    I++           + +     +KCL K
Sbjct: 225 ETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIK 284

Query: 362 QPKSRPKMSEV 372
            P  R  + ++
Sbjct: 285 NPAERADLKQL 295

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  194 bits (493), Expect = 4e-59
 Identities = 69/310 (22%), Positives = 115/310 (37%), Gaps = 46/310 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLG-V 151
            +G G FG V                 D+ + VA+K L        +E + +E+  L  +
Sbjct: 30  TLGAGAFGKVVEATAYGLIKS------DAAMTVAVKMLKPSAHLTEREALMSELKVLSYL 83

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL----------------LSRVP 195
             H N+V L+G C          L++ E      L + L                +    
Sbjct: 84  GNHMNIVNLLGACTIGGPT----LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDE 139

Query: 196 TPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGP 255
             L     L  +   A+G+A+L  +     I RD    NILL      K+ DFGLAR   
Sbjct: 140 LALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIK 196

Query: 256 PEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ 315
            +    V  +    V + APE +     T +SDVWS+G+ L+EL +   +    +P + +
Sbjct: 197 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256

Query: 316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDI 375
                          F+ +I           +  ++  +   C    P  RP   ++V +
Sbjct: 257 ---------------FYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL 301

Query: 376 LGNIISEISS 385
           +   ISE ++
Sbjct: 302 IEKQISESTN 311

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (488), Expect = 9e-59
 Identities = 52/283 (18%), Positives = 106/283 (37%), Gaps = 37/283 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           IG G F  VY+G+             ++ ++VA  +L  +       + +  E   L  +
Sbjct: 17  IGRGSFKTVYKGLDT-----------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGL 65

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +HPN+V+         +     +LV ELM + +L+ +L       +         +   +
Sbjct: 66  QHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILK 123

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILL-DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           GL +LH      +I RD K  NI +       K+ D GLA           + +V+GT  
Sbjct: 124 GLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR----ASFAKAVIGTPE 178

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           + APE  +  +     DV++FG+ + E+ T            +                +
Sbjct: 179 FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI---------------Y 222

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
             +       ++   +  ++  +   C+ +    R  + ++++
Sbjct: 223 RRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (487), Expect = 1e-58
 Identities = 63/298 (21%), Positives = 120/298 (40%), Gaps = 40/298 (13%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           +G G FG V +G  ++               VA+K L  +        E + E N +  +
Sbjct: 15  LGSGNFGTVKKGYYQMKKVVKT---------VAVKILKNEANDPALKDELLAEANVMQQL 65

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            +P +V+++G C  +       +LV E+     L  +L       +     +++    + 
Sbjct: 66  DNPYIVRMIGICEAES-----WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSM 118

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE-GLGHVSTSVVGTVG 271
           G+ YL E      + RD    N+LL   + AK+SDFGL++    +       T     V 
Sbjct: 119 GMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS-KK 330
           + APE +   + ++KSDVWSFGV+++E  +  +                 +PY      +
Sbjct: 176 WYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ-----------------KPYRGMKGSE 218

Query: 331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQDE 388
              +++            +++  L + C T   ++RP  + V   L N   ++ ++  
Sbjct: 219 VTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 276

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-58
 Identities = 69/294 (23%), Positives = 130/294 (44%), Gaps = 33/294 (11%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVN 147
            +R  +IG G FG VY+G+        +TS    ++ VAIK L     +  + +++ E  
Sbjct: 9   VTRQKVIGAGEFGEVYKGM-------LKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAG 61

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +G   H N+++L G  ++        +++ E M N +L+  L  +     + +  + + 
Sbjct: 62  IMGQFSHHNIIRLEGVISKYKPM----MIITEYMENGALDKFLREK-DGEFSVLQLVGML 116

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLG-HVSTSV 266
           +  A G+ YL        + RD    NIL++ +   K+SDFGL+R    +    + ++  
Sbjct: 117 RGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 173

Query: 267 VGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
              + + APE +   + T+ SDVWSFG+V++E++T        L  +E            
Sbjct: 174 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE------------ 221

Query: 327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
                   I+        +     +  L  +C  ++   RPK +++V IL  +I
Sbjct: 222 ----VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLI 271

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  191 bits (486), Expect = 3e-58
 Identities = 75/308 (24%), Positives = 121/308 (39%), Gaps = 52/308 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLGVVK 153
           IGEG FG V++              ++    VA+K L  +       ++  E   +    
Sbjct: 21  IGEGAFGRVFQAR------APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD 74

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR-------------------- 193
           +PN+VKL+G CA          L++E M    L + L S                     
Sbjct: 75  NPNIVKLLGVCAVGKPM----CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVS 130

Query: 194 --VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLA 251
              P PL+   +L IA+  A G+AYL E    + + RD  T N L+ E+   K++DFGL+
Sbjct: 131 SPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLS 187

Query: 252 RQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLP 311
           R            +    + +  PE +   R T +SDVW++GVVL+E+ +        + 
Sbjct: 188 RNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGM- 246

Query: 312 RNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSE 371
              ++++ +VR          L                +L  L   C +K P  RP    
Sbjct: 247 -AHEEVIYYVR------DGNILACPENC--------PLELYNLMRLCWSKLPADRPSFCS 291

Query: 372 VVDILGNI 379
           +  IL  +
Sbjct: 292 IHRILQRM 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (482), Expect = 2e-57
 Identities = 68/296 (22%), Positives = 121/296 (40%), Gaps = 35/296 (11%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVN 147
           F +  ++G G FG VY+G+           G   K+ VAIK+L      + +KE ++E  
Sbjct: 11  FKKIKVLGSGAFGTVYKGL-------WIPEGEKVKIPVAIKELREATSPKANKEILDEAY 63

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            +  V +P++ +L+G C     +     L+ +LM    L D++       +     L   
Sbjct: 64  VMASVDNPHVCRLLGICLTSTVQ-----LITQLMPFGCLLDYVREH-KDNIGSQYLLNWC 117

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
              A+G+ YL +    +L+ RD    N+L+      K++DFGLA+    E   + +    
Sbjct: 118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
             + + A E +     T +SDVWS+GV ++EL+T                    +PY   
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS-----------------KPYDGI 217

Query: 328 S-KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE 382
              +   I++              +  +  KC      SRPK  E++     +  +
Sbjct: 218 PASEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 3e-56
 Identities = 67/281 (23%), Positives = 112/281 (39%), Gaps = 37/281 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN-RQGFQGHKEWINEVNFLGVV 152
            +GEG +G V   V R            ++  VA+K ++ ++     +    E+    ++
Sbjct: 12  TLGEGAYGEVQLAVNR-----------VTEEAVAVKIVDMKRAVDCPENIKKEICINKML 60

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            H N+VK  G+  E + +     L  E      L D +   +  P     R         
Sbjct: 61  NHENVVKFYGHRREGNIQ----YLFLEYCSGGELFDRIEPDIGMPEPDAQR--FFHQLMA 114

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           G+ YLH      +  RD K  N+LLDE    K+SDFGLA          +   + GT+ Y
Sbjct: 115 GVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPY 171

Query: 273 AAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
            APE ++         DVWS G+VL  ++ G    ++    + Q+  +W        KK 
Sbjct: 172 VAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD-SCQEYSDWKE------KKT 224

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           +L    +++            AL  K L + P +R  + ++
Sbjct: 225 YLNPWKKID--------SAPLALLHKILVENPSARITIPDI 257

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 6e-56
 Identities = 64/287 (22%), Positives = 111/287 (38%), Gaps = 38/287 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
            IG G +G   +   +                +  K+L+         +  ++EVN L  
Sbjct: 11  TIGTGSYGRCQKIRRK-----------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRE 59

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHL--LSRVPTPLAWIARLKIAQD 209
           +KHPN+V+      +     +   +V E      L   +   ++    L     L++   
Sbjct: 60  LKHPNIVRYYDRIIDRTNTTL--YIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQ 117

Query: 210 AARGLAYLHEEMD--FQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
               L   H   D    ++ RD K +N+ LD     KL DFGLAR    +     + + V
Sbjct: 118 LTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT--SFAKAFV 175

Query: 268 GTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSD 327
           GT  Y +PE +       KSD+WS G +LYEL             ++++L   +R     
Sbjct: 176 GTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAF---SQKELAGKIR----- 227

Query: 328 SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
             KF      R+   Y    + +L  + ++ L  +   RP + E+++
Sbjct: 228 EGKF-----RRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILE 265

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  185 bits (471), Expect = 7e-56
 Identities = 78/291 (26%), Positives = 114/291 (39%), Gaps = 48/291 (16%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INE 145
           FS    IG G FG VY                 +   VAIK+++  G Q +++W   I E
Sbjct: 17  FSDLREIGHGSFGAVYFARDV-----------RNSEVVAIKKMSYSGKQSNEKWQDIIKE 65

Query: 146 VNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
           V FL  ++HPN ++  G    +        LV E     + +   + +   PL  +    
Sbjct: 66  VRFLQKLRHPNTIQYRGCYLREHTA----WLVMEYCLGSASDLLEVHK--KPLQEVEIAA 119

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           +   A +GLAYLH      +I RD K  NILL E    KL DFG A    P      + S
Sbjct: 120 VTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANS 170

Query: 266 VVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR 322
            VGT  + APE +     G+   K DVWS G+   EL   +       P      +  + 
Sbjct: 171 FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP------PLFNMNAMSALY 224

Query: 323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVV 373
               +         P L+  +  +  +        CL K P+ RP    ++
Sbjct: 225 HIAQNE-------SPALQSGHWSEYFRN---FVDSCLQKIPQDRPTSEVLL 265

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 9e-56
 Identities = 71/286 (24%), Positives = 109/286 (38%), Gaps = 36/286 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLGV 151
           +G+G FG V RG     S    +        VA+K L        +   ++I EVN +  
Sbjct: 16  LGDGSFGVVRRGEWDAPSGKTVS--------VAVKCLKPDVLSQPEAMDDFIREVNAMHS 67

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + H NL++L G       +     +V EL    SL D L              + A   A
Sbjct: 68  LDHRNLIRLYGVVLTPPMK-----MVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVA 121

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHV-STSVVGTV 270
            G+ YL  +   + I RD    N+LL      K+ DFGL R  P     +V         
Sbjct: 122 EGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPF 178

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            + APE ++T   +  SD W FGV L+E+ T  +      P       + +     + ++
Sbjct: 179 AWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ-----EPWIGLNGSQILHKIDKEGER 233

Query: 331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDIL 376
                 PR E        Q +  +  +C   +P+ RP    + D L
Sbjct: 234 L-----PRPED-----CPQDIYNVMVQCWAHKPEDRPTFVALRDFL 269

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 2e-55
 Identities = 63/283 (22%), Positives = 114/283 (40%), Gaps = 41/283 (14%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH 154
           +G+G FG VY+   +           ++ +  A K ++ +  +  ++++ E++ L    H
Sbjct: 20  LGDGAFGKVYKAQNK-----------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68

Query: 155 PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGL 214
           PN+VKL+     ++       ++ E     +++  +L     PL       + +     L
Sbjct: 69  PNIVKLLDAFYYENNL----WILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDAL 123

Query: 215 AYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAA 274
            YLH+    ++I RD K  NIL   D   KL+DFG++ +           S +GT  + A
Sbjct: 124 NYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT--IQRRDSFIGTPYWMA 178

Query: 275 PEYVQT-----GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
           PE V            K+DVWS G+ L E+           P +E   +  +   ++ S+
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP------PHHELNPMRVLL-KIAKSE 231

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
              L    R         +        KCL K   +R   S++
Sbjct: 232 PPTLAQPSRW--------SSNFKDFLKKCLEKNVDARWTTSQL 266

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-55
 Identities = 79/316 (25%), Positives = 128/316 (40%), Gaps = 51/316 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLG-V 151
           +IGEG FG V +  ++             ++D AIK++        H+++  E+  L  +
Sbjct: 17  VIGEGNFGQVLKARIKKD---------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKL 67

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------------TP 197
             HPN++ L+G C           L  E   + +L D L                   + 
Sbjct: 68  GHHPNIINLLGACEHRGYL----YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST 123

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
           L+    L  A D ARG+ YL ++   Q I RD    NIL+ E+Y AK++DFGL+R     
Sbjct: 124 LSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 180

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                 T     V + A E +     T  SDVWS+GV+L+E+++         P      
Sbjct: 181 ---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG-----TPYCGMTC 232

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG 377
            E             L    RLE    +    ++  L  +C  ++P  RP  ++++  L 
Sbjct: 233 AELYE---------KLPQGYRLE--KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLN 281

Query: 378 NIISEISSQDEVTLQP 393
            ++ E  +    TL  
Sbjct: 282 RMLEERKTYVNTTLYE 297

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-54
 Identities = 72/294 (24%), Positives = 120/294 (40%), Gaps = 35/294 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-WINEVNFLGVV 152
            IGEG FG V++G+          S  +  L VAIK          +E ++ E   +   
Sbjct: 14  CIGEGQFGDVHQGIYM--------SPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQF 65

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
            HP++VKL+G   E+        ++ EL     L   L  R    L   + +  A   + 
Sbjct: 66  DHPHIVKLIGVITEN-----PVWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLST 119

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            LAYL  +   + + RD    N+L+  +   KL DFGL+R        + ++     + +
Sbjct: 120 ALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY-YKASKGKLPIKW 175

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFH 332
            APE +   R T+ SDVW FGV ++E++       + +      ++  +           
Sbjct: 176 MAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGV--KNNDVIGRIE------NGER 227

Query: 333 LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISSQ 386
           L + P             L +L +KC    P  RP+ +E+   L  I+ E  +Q
Sbjct: 228 LPMPPNCP--------PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEEKAQ 273

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 1e-53
 Identities = 66/284 (23%), Positives = 113/284 (39%), Gaps = 45/284 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLG 150
            +G+G FG VY    +            SK  +A+K L +          +   EV    
Sbjct: 13  PLGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 61

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            ++HPN+++L GY  +         L+ E     ++   L  +  +            + 
Sbjct: 62  HLRHPNILRLYGYFHDATRV----YLILEYAPLGTVYREL--QKLSKFDEQRTATYITEL 115

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
           A  L+Y H +   ++I RD K  N+LL    + K++DFG +   P        T++ GT+
Sbjct: 116 ANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAP----SSRRTTLCGTL 168

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            Y  PE ++      K D+WS GV+ YE + G+   E N     Q+  + +         
Sbjct: 169 DYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEAN---TYQETYKRIS-------- 217

Query: 331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD 374
                  R+E  +     +    L S+ L   P  RP + EV++
Sbjct: 218 -------RVEFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (454), Expect = 1e-53
 Identities = 70/279 (25%), Positives = 111/279 (39%), Gaps = 38/279 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            IG+G  G VY  +              +  +VAI+Q+N Q     +  INE+  +   K
Sbjct: 27  KIGQGASGTVYTAMDV-----------ATGQEVAIRQMNLQQQPKKELIINEILVMRENK 75

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           +PN+V  +      DE      +V E +   SL D +               + ++  + 
Sbjct: 76  NPNIVNYLDSYLVGDEL----WVVMEYLAGGSLTDVVTETCMD---EGQIAAVCRECLQA 128

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYA 273
           L +LH     Q+I RD K+ NILL  D   KL+DFG   Q  PE      +++VGT  + 
Sbjct: 129 LEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ--SKRSTMVGTPYWM 183

Query: 274 APEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFHL 333
           APE V       K D+WS G++  E+I G          N  + L      ++ +    L
Sbjct: 184 APEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLN---ENPLRALY----LIATNGTPEL 236

Query: 334 IIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
               +L        +       ++CL    + R    E+
Sbjct: 237 QNPEKL--------SAIFRDFLNRCLDMDVEKRGSAKEL 267

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 3e-53
 Identities = 68/303 (22%), Positives = 113/303 (37%), Gaps = 43/303 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG-HKEWINEVNFLG-V 151
            +G G FG V                  +   VA+K L        H+  ++E+  L  +
Sbjct: 20  PLGRGAFGQVIEAD------AFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHI 73

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSR--------------VPTP 197
             H N+V L+G C +        +++ E     +L  +L S+                  
Sbjct: 74  GHHLNVVNLLGACTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDF 130

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
           L     +  +   A+G+ +L      + I RD    NILL E    K+ DFGLAR    +
Sbjct: 131 LTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 187

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                       + + APE +     T +SDVWSFGV+L+E+ +         P    K+
Sbjct: 188 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA-----SPYPGVKI 242

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG 377
            E     + +  +                +  ++      C   +P  RP  SE+V+ LG
Sbjct: 243 DEEFCRRLKEGTRMRAPDY----------TTPEMYQTMLDCWHGEPSQRPTFSELVEHLG 292

Query: 378 NII 380
           N++
Sbjct: 293 NLL 295

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 4e-51
 Identities = 71/295 (24%), Positives = 122/295 (41%), Gaps = 38/295 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHK-EWINEVNFLGVVK 153
           +G+G FG VY GV             + +  VAIK +N       + E++NE + +    
Sbjct: 28  LGQGSFGMVYEGV------AKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN 81

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVP--------TPLAWIARLK 205
             ++V+L+G  ++        L++ ELM    L+ +L S  P         P +    ++
Sbjct: 82  CHHVVRLLGVVSQGQPT----LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQ 137

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTS 265
           +A + A G+AYL+     + + RD    N ++ ED+  K+ DFG+ R             
Sbjct: 138 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 194

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
            +  V + +PE ++ G  T  SDVWSFGVVL+E+ T      + L   +           
Sbjct: 195 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQV---------- 244

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII 380
                   +++  L  +        L  L   C    PK RP   E++  +   +
Sbjct: 245 -----LRFVMEGGLL-DKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEM 293

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 2e-50
 Identities = 74/304 (24%), Positives = 123/304 (40%), Gaps = 43/304 (14%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLG-V 151
            +GEG FG V          D           VA+K L     +    + I+E+  +  +
Sbjct: 20  PLGEGAFGQVVLAEAIGLDKDKPNRV----TKVAVKMLKSDATEKDLSDLISEMEMMKMI 75

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTP-------------- 197
            KH N++ L+G C +D        ++ E     +L ++L +R P                
Sbjct: 76  GKHKNIINLLGACTQDGPL----YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQ 131

Query: 198 LAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPE 257
           L+    +  A   ARG+ YL  +   + I RD    N+L+ ED   K++DFGLAR     
Sbjct: 132 LSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 188

Query: 258 GLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
                +T+    V + APE +     T +SDVWSFGV+L+E+ T   +    +P  E  L
Sbjct: 189 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEE--L 246

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG 377
            + ++      +   +                +L  +   C    P  RP   ++V+ L 
Sbjct: 247 FKLLK------EGHRMDKPSNC--------TNELYMMMRDCWHAVPSQRPTFKQLVEDLD 292

Query: 378 NIIS 381
            I++
Sbjct: 293 RIVA 296

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  169 bits (430), Expect = 5e-50
 Identities = 62/286 (21%), Positives = 101/286 (35%), Gaps = 45/286 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLG 150
           ++GEG F  V                  +  + AIK L ++             E + + 
Sbjct: 15  ILGEGSFSTVVLAREL-----------ATSREYAIKILEKRHIIKENKVPYVTRERDVMS 63

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            + HP  VKL     +D++             N  L  ++                  + 
Sbjct: 64  RLDHPFFVKLYFTFQDDEKL----YFGLSYAKNGELLKYIRKIGSFDETCTRF--YTAEI 117

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
              L YLH +    +I RD K  NILL+ED   +++DFG A+   PE     + S VGT 
Sbjct: 118 VSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 174

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            Y +PE +        SD+W+ G ++Y+L+ G                    P+ + ++ 
Sbjct: 175 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGL------------------PPFRAGNE- 215

Query: 331 FHLIIDPRLEGNYCIKSA--QKLAALASKCLTKQPKSRPKMSEVVD 374
            +LI    ++  Y        K   L  K L      R    E+  
Sbjct: 216 -YLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  167 bits (424), Expect = 2e-49
 Identities = 66/288 (22%), Positives = 114/288 (39%), Gaps = 35/288 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG---HKEWINEVNFLG 150
           ++G GG   V+                    DVA+K L     +    +  +  E     
Sbjct: 14  ILGFGGMSEVHLARDL-----------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
            + HP +V +      +   G    +V E +   +L D +      P+     +++  DA
Sbjct: 63  ALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV--HTEGPMTPKRAIEVIADA 120

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEG-LGHVSTSVVGT 269
            + L + H+     +I RD K +NI++      K+ DFG+AR     G     + +V+GT
Sbjct: 121 CQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
             Y +PE  +   + A+SDV+S G VLYE++TG        P      +     +V +  
Sbjct: 178 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP------PFTGDSPVSVAYQHVREDP 231

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-MSEVVDIL 376
                    L        +  L A+  K L K P++R +  +E+   L
Sbjct: 232 IPPSARHEGL--------SADLDAVVLKALAKNPENRYQTAAEMRADL 271

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  168 bits (427), Expect = 7e-49
 Identities = 59/281 (20%), Positives = 107/281 (38%), Gaps = 38/281 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +G G FG V+R   R            +  + A K +        +    E+  + V++
Sbjct: 33  ELGTGAFGVVHRVTER-----------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR 81

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP LV L     +D+E     +++YE M    L + +       ++    ++  +   +G
Sbjct: 82  HPTLVNLHDAFEDDNEM----VMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKG 136

Query: 214 LAYLHEEMDFQLIFRDFKTSNILL--DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           L ++HE      +  D K  NI+       + KL DFGL     P+          GT  
Sbjct: 137 LCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK---QSVKVTTGTAE 190

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           +AAPE  +   +   +D+WS GV+ Y L++G          N+ + L  V+         
Sbjct: 191 FAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFG---GENDDETLRNVKS-------- 239

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
               D  ++ +     ++       K L   P +R  + + 
Sbjct: 240 ---CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 277

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  166 bits (421), Expect = 5e-48
 Identities = 57/281 (20%), Positives = 105/281 (37%), Gaps = 38/281 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +G G FG V+R V +            +      K +N           NE++ +  + 
Sbjct: 36  ELGSGAFGVVHRCVEK-----------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH 84

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           HP L+ L     +  E     +L+ E +    L D + +     ++    +   + A  G
Sbjct: 85  HPKLINLHDAFEDKYEM----VLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEG 139

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           L ++HE     ++  D K  NI+ +  +    K+ DFGLA +  P     +      T  
Sbjct: 140 LKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP---DEIVKVTTATAE 193

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           +AAPE V    +   +D+W+ GV+ Y L++G        P   +  LE ++       +F
Sbjct: 194 FAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS------PFAGEDDLETLQNVKRCDWEF 247

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                  +          +        L K+P+ R  + + 
Sbjct: 248 DEDAFSSVS--------PEAKDFIKNLLQKEPRKRLTVHDA 280

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  163 bits (413), Expect = 3e-47
 Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 35/280 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI-NEVNFLGVV 152
           ++G G F  V     +            ++  VAIK + ++  +G +  + NE+  L  +
Sbjct: 16  VLGTGAFSEVILAEDK-----------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKI 64

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KHPN+V L               L+ +L+    L D ++ +        +R  +      
Sbjct: 65  KHPNIVALDDIYESGGHL----YLIMQLVSGGELFDRIVEKGFYTERDASR--LIFQVLD 118

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            + YLH+        +        LDED K  +SDFGL++   P   G V ++  GT GY
Sbjct: 119 AVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDP---GSVLSTACGTPGY 175

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFH 332
            APE +     +   D WS GV+ Y L+ G        P  ++   +     +    +F 
Sbjct: 176 VAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP------PFYDENDAKLFEQILKAEYEFD 229

Query: 333 LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                 +        +          + K P+ R    + 
Sbjct: 230 SPYWDDI--------SDSAKDFIRHLMEKDPEKRFTCEQA 261

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (401), Expect = 9e-46
 Identities = 67/293 (22%), Positives = 110/293 (37%), Gaps = 32/293 (10%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW-----INEVNFL 149
           IGEG +G V++        D +  G      VA+K++  Q  +          +  +  L
Sbjct: 15  IGEGAYGKVFKAR------DLKNGGRF----VALKRVRVQTGEEGMPLSTIREVAVLRHL 64

Query: 150 GVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +HPN+V+L   C         +L +     ++ L  +L       +       +   
Sbjct: 65  ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
             RGL +LH     +++ RD K  NIL+    + KL+DFGLAR    +      TSVV T
Sbjct: 125 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVT 178

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL----------E 319
           + Y APE +         D+WS G +  E+   +     +   ++   +          +
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED 238

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           W R      + FH      +E  +     +    L  KCLT  P  R      
Sbjct: 239 WPRDVALPRQAFHSKSAQPIE-KFVTDIDELGKDLLLKCLTFNPAKRISAYSA 290

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  156 bits (396), Expect = 9e-45
 Identities = 55/281 (19%), Positives = 102/281 (36%), Gaps = 39/281 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +G G FG V+R V              SK     K +  +G         E++ L + +
Sbjct: 12  DLGRGEFGIVHRCVET-----------SSKKTYMAKFVKVKGTD-QVLVKKEISILNIAR 59

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
           H N++ L       +E     ++++E +    + + + +     L     +         
Sbjct: 60  HRNILHLHESFESMEEL----VMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEA 114

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLD--EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           L +LH      +   D +  NI+         K+ +FG ARQ  P   G     +     
Sbjct: 115 LQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP---GDNFRLLFTAPE 168

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
           Y APE  Q   ++  +D+WS G ++Y L++G            Q+++E +   ++    F
Sbjct: 169 YYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFL---AETNQQIIENI---MNAEYTF 222

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                  +        + +      + L K+ KSR   SE 
Sbjct: 223 DEEAFKEI--------SIEAMDFVDRLLVKERKSRMTASEA 255

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  155 bits (392), Expect = 1e-44
 Identities = 73/295 (24%), Positives = 119/295 (40%), Gaps = 53/295 (17%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---------QGHKEWIN 144
           ++G G    V R + +            +  + A+K ++  G          +  +  + 
Sbjct: 10  ILGRGVSSVVRRCIHK-----------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLK 58

Query: 145 EVNFLGVVK-HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
           EV+ L  V  HPN+++L        E      LV++LM    L D+L  +V   L+    
Sbjct: 59  EVDILRKVSGHPNIIQLKDTY----ETNTFFFLVFDLMKKGELFDYLTEKVT--LSEKET 112

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS 263
            KI +     +  LH+     ++ RD K  NILLD+D   KL+DFG + Q  P   G   
Sbjct: 113 RKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDP---GEKL 166

Query: 264 TSVVGTVGYAAPEYVQTGRL------TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL 317
             V GT  Y APE ++            + D+WS GV++Y L+ G        P   +K 
Sbjct: 167 REVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS------PPFWHRKQ 220

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           +  +R  +S + +F                +  +  L S+ L  QP+ R    E 
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDY--------SDTVKDLVSRFLVVQPQKRYTAEEA 267

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  154 bits (389), Expect = 5e-44
 Identities = 44/305 (14%), Positives = 95/305 (31%), Gaps = 41/305 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            IGEG FG ++ G        +  +       VAIK   R+      +  +E     ++ 
Sbjct: 12  RIGEGSFGVIFEGT-------NLLNNQQ----VAIKFEPRR--SDAPQLRDEYRTYKLLA 58

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
               +  V Y  ++       +LV +L+      + LL       +       A+     
Sbjct: 59  GCTGIPNVYYFGQEGLH---NVLVIDLLGP--SLEDLLDLCGRKFSVKTVAMAAKQMLAR 113

Query: 214 LAYLHEEMDFQLIFRDFKTSNILLDEDYK-----AKLSDFGLARQGPPEGLG-----HVS 263
           +  +HE+    L++RD K  N L+            + DFG+ +                
Sbjct: 114 VQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREK 170

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
            ++ GT  Y +         + + D+ + G V    + G    +       ++  E +  
Sbjct: 171 KNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI-- 228

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI 383
                        P  E   C    ++              + P    +  +   ++  +
Sbjct: 229 ------GEKKQSTPLRE--LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280

Query: 384 SSQDE 388
           ++ ++
Sbjct: 281 NTTED 285

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 6e-44
 Identities = 62/295 (21%), Positives = 108/295 (36%), Gaps = 38/295 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE-----WINEVNF 148
            +GEG F  VY+   +           ++   VAIK++        K+      + E+  
Sbjct: 5   FLGEGQFATVYKARDK-----------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKL 53

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           L  + HPN++ L+              LV++ M          + +    + I       
Sbjct: 54  LQELSHPNIIGLLDAFGHKSNI----SLVFDFMETDLEVIIKDNSLVLTPSHIKA--YML 107

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
              +GL YLH+     ++ RD K +N+LLDE+   KL+DFGLA+           T  V 
Sbjct: 108 MTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP--NRAYTHQVV 162

Query: 269 TVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL--------- 318
           T  Y APE +   R+     D+W+ G +L EL+     +  +   ++   +         
Sbjct: 163 TRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTE 222

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA-LASKCLTKQPKSRPKMSEV 372
           E      S          P +  ++   +A      L        P +R   ++ 
Sbjct: 223 EQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQA 277

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 1e-43
 Identities = 68/295 (23%), Positives = 113/295 (38%), Gaps = 33/295 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGH-KEWINEVNFLGVV 152
            IGEG +G V                  +K+ VAIK+++    Q + +  + E+  L   
Sbjct: 15  YIGEGAYGMVCSAYDN-----------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRF 63

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           +H N++ +           M+ + +   +    L   L ++    L+            R
Sbjct: 64  RHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILR 120

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHVSTSVVGTVG 271
           GL Y+H      ++ RD K SN+LL+     K+ DFGLAR   P        T  V T  
Sbjct: 121 GLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 177

Query: 272 YAAPEYVQTGRL-TAKSDVWSFGVVLYELITGR------------RAVERNLPRNEQKLL 318
           Y APE +   +  T   D+WS G +L E+++ R              +   L    Q+ L
Sbjct: 178 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDL 237

Query: 319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA-LASKCLTKQPKSRPKMSEV 372
             +    + +    L    ++  N    +A   A  L  K LT  P  R ++ + 
Sbjct: 238 NCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQA 292

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 61/278 (21%), Positives = 110/278 (39%), Gaps = 44/278 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
           ++G+G FG V+    +            +    AIK L +       +    + E   L 
Sbjct: 9   MLGKGSFGKVFLAEFK-----------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLS 57

Query: 151 -VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
              +HP L  +       +          E ++   L  H+ S     L+       A +
Sbjct: 58  LAWEHPFLTHMFCTFQTKENLFFV----MEYLNGGDLMYHIQSCHKFDLSRATF--YAAE 111

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
              GL +LH +    +++RD K  NILLD+D   K++DFG+ ++         + +  GT
Sbjct: 112 IILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGT 166

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
             Y APE +   +     D WSFGV+LYE++ G+        ++E++L   +R    D+ 
Sbjct: 167 PDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFH---GQDEEELFHSIR---MDNP 220

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
            +   ++   +             L  K   ++P+ R 
Sbjct: 221 FYPRWLEKEAK------------DLLVKLFVREPEKRL 246

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  152 bits (386), Expect = 7e-43
 Identities = 67/281 (23%), Positives = 113/281 (40%), Gaps = 46/281 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWINEVNFLG 150
           +IG GGFG VY                D+    A+K L+++     QG    +NE   L 
Sbjct: 11  IIGRGGFGEVYGCRKA-----------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLS 59

Query: 151 VVK---HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
           +V     P +V +       D+       + +LM+   L  HL        A +     A
Sbjct: 60  LVSTGDCPFIVCMSYAFHTPDKL----SFILDLMNGGDLHYHLSQHGVFSEADMRF--YA 113

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVV 267
            +   GL ++H      +++RD K +NILLDE    ++SD GLA     +         V
Sbjct: 114 AEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SV 166

Query: 268 GTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
           GT GY APE +Q G    + +D +S G +L++L+ G     ++  +++ ++         
Sbjct: 167 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM------ 220

Query: 327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
                 L +   L  ++      +L +L    L +    R 
Sbjct: 221 -----TLTMAVELPDSFS----PELRSLLEGLLQRDVNRRL 252

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (376), Expect = 4e-42
 Identities = 62/289 (21%), Positives = 111/289 (38%), Gaps = 47/289 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWI------NEVN 147
            +G G F  V +   +            + L  A K + ++  +  +  +       EV+
Sbjct: 17  ELGSGQFAVVKKCREK-----------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVS 65

Query: 148 FLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIA 207
            L  ++HPN++ L        +     +L+ EL+    L D L  +    L      +  
Sbjct: 66  ILKEIQHPNVITLHEVYENKTDV----ILILELVAGGELFDFLAEK--ESLTEEEATEFL 119

Query: 208 QDAARGLAYLHEEMDFQLIFRDFKTSNILLDED----YKAKLSDFGLARQGPPEGLGHVS 263
           +    G+ YLH      +   D K  NI+L +      + K+ DFGLA +      G+  
Sbjct: 120 KQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF---GNEF 173

Query: 264 TSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
            ++ GT  + APE V    L  ++D+WS GV+ Y L++G      +    +Q+ L  V  
Sbjct: 174 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD---TKQETLANV-- 228

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
                      ++   E  Y   ++        + L K PK R  + + 
Sbjct: 229 ---------SAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDS 268

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  149 bits (376), Expect = 4e-42
 Identities = 53/303 (17%), Positives = 101/303 (33%), Gaps = 39/303 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            IG G FG +Y G           +G +    VAIK    +    H +   E     +++
Sbjct: 14  KIGSGSFGDIYLGT-------DIAAGEE----VAIKLECVK--TKHPQLHIESKIYKMMQ 60

Query: 154 HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARG 213
               +  + +C  + +     ++V EL+     +           +    L +A      
Sbjct: 61  GGVGIPTIRWCGAEGDY---NVMVMELLGPSLEDLFN--FCSRKFSLKTVLLLADQMISR 115

Query: 214 LAYLHEEMDFQLIFRDFKTSNIL---LDEDYKAKLSDFGLARQGPPEGLG-----HVSTS 265
           + Y+H +     I RD K  N L     +     + DFGLA++              + +
Sbjct: 116 IEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKN 172

Query: 266 VVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV 325
           + GT  YA+         + + D+ S G VL     G    +      +++  E +    
Sbjct: 173 LTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISE-- 230

Query: 326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS 385
              KK    I+       C     + A   + C + +   +P  S +  +  N+      
Sbjct: 231 ---KKMSTPIEV-----LCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGF 282

Query: 386 QDE 388
             +
Sbjct: 283 SYD 285

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (378), Expect = 5e-42
 Identities = 52/283 (18%), Positives = 94/283 (33%), Gaps = 36/283 (12%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VV 152
           ++G G  G V +   +            ++   A+K L         +   EV       
Sbjct: 19  VLGLGINGKVLQIFNK-----------RTQEKFALKMLQD-----CPKARREVELHWRAS 62

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           + P++V++V             L+V E +    L   +  R           +I +    
Sbjct: 63  QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 122

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLD---EDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
            + YLH      +  RD K  N+L      +   KL+DFG A++           +   T
Sbjct: 123 AIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLT---TPCYT 176

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSK 329
             Y APE +   +     D+WS GV++Y L+ G      N        +          K
Sbjct: 177 PYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM----------K 226

Query: 330 KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
               +           + ++++  L    L  +P  R  ++E 
Sbjct: 227 TRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 269

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  148 bits (374), Expect = 1e-41
 Identities = 62/277 (22%), Positives = 109/277 (39%), Gaps = 46/277 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE---WINEVNFLG 150
            +G G FG V+    R            +    A+K L ++     K+     +E   L 
Sbjct: 11  TLGTGSFGRVHLIRSR-----------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 59

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
           +V HP ++++ G   +  +  M    + + +    L   L      P         A + 
Sbjct: 60  IVTHPFIIRMWGTFQDAQQIFM----IMDYIEGGELFSLLRKSQRFPNPVAKF--YAAEV 113

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
              L YLH +    +I+RD K  NILLD++   K++DFG A+      +  V+ ++ GT 
Sbjct: 114 CLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKY-----VPDVTYTLCGTP 165

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            Y APE V T       D WSFG+++YE++ G        P  +   ++     ++   +
Sbjct: 166 DYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYT------PFYDSNTMKTYEKILNAELR 219

Query: 331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP 367
           F    +              +  L S+ +T+    R 
Sbjct: 220 FPPFFNE------------DVKDLLSRLITRDLSQRL 244

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 9e-41
 Identities = 66/301 (21%), Positives = 118/301 (39%), Gaps = 39/301 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQG--HKEWINEVNFLGVV 152
           IG+G FG V++         H+ +G      VA+K++  +  +       + E+  L ++
Sbjct: 18  IGQGTFGEVFKAR-------HRKTGQK----VALKKVLMENEKEGFPITALREIKILQLL 66

Query: 153 KHPNLVKLVGYCAEDDERGMQR----LLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
           KH N+V L+  C        +      LV++   +          V   L+ I R  + Q
Sbjct: 67  KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKR--VMQ 124

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVS--TSV 266
               GL Y+H     +++ RD K +N+L+  D   KL+DFGLAR          +  T+ 
Sbjct: 125 MLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181

Query: 267 VGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL------- 318
           V T+ Y  PE +   R      D+W  G ++ E+ T    ++ N  +++  L+       
Sbjct: 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSI 241

Query: 319 -EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA------LASKCLTKQPKSRPKMSE 371
              V P V + + +  +   + +        +          L  K L   P  R    +
Sbjct: 242 TPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDD 301

Query: 372 V 372
            
Sbjct: 302 A 302

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (368), Expect = 2e-40
 Identities = 69/300 (23%), Positives = 109/300 (36%), Gaps = 37/300 (12%)

Query: 89  FSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNF 148
           ++   +IG G FG VY+  +            DS   VAIK++     Q  +    E+  
Sbjct: 22  YTDTKVIGNGSFGVVYQAKLC-----------DSGELVAIKKVL----QDKRFKNRELQI 66

Query: 149 LGVVKHPNLVKLVGYCAEDDERGMQR--LLVYELMHNKSLEDHL-LSRVPTPLAWIARLK 205
           +  + H N+V+L  +     E+  +    LV + +           SR    L  I    
Sbjct: 67  MRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKL 126

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHVST 264
                 R LAY+H      +  RD K  N+LLD D    KL DFG A+Q          +
Sbjct: 127 YMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV--S 181

Query: 265 SVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR------------RAVERNLPR 312
            +      A          T+  DVWS G VL EL+ G+              + + L  
Sbjct: 182 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGT 241

Query: 313 NEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
             ++ +  + P  ++ K   +   P  +        +   AL S+ L   P +R    E 
Sbjct: 242 PTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTPTARLTPLEA 300

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (360), Expect = 4e-40
 Identities = 63/291 (21%), Positives = 102/291 (35%), Gaps = 61/291 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKE------WINEVN 147
           L+G GGFG VY G+                L VAIK + +       E         EV 
Sbjct: 11  LLGSGGFGSVYSGIRV-----------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVV 59

Query: 148 FLGVVK--HPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLK 205
            L  V      +++L+ +    D      +L+ E           ++     L       
Sbjct: 60  LLKKVSSGFSGVIRLLDWFERPD----SFVLILERPEPVQDLFDFITE-RGALQEELARS 114

Query: 206 IAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDED-YKAKLSDFGLARQGPPEGLGHVST 264
                   + + H      ++ RD K  NIL+D +  + KL DFG            V T
Sbjct: 115 FFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKD----TVYT 167

Query: 265 SVVGTVGYAAPEYVQTGRLTAKS-DVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP 323
              GT  Y+ PE+++  R   +S  VWS G++LY+++ G                    P
Sbjct: 168 DFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD------------------IP 209

Query: 324 YVSDSK--KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           +  D +  +  +    R+        + +   L   CL  +P  RP   E+
Sbjct: 210 FEHDEEIIRGQVFFRQRV--------SSECQHLIRWCLALRPSDRPTFEEI 252

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  143 bits (361), Expect = 5e-40
 Identities = 63/292 (21%), Positives = 108/292 (36%), Gaps = 33/292 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
            IGEG +G VY+         ++ +G      VA+K++             I E++ L  
Sbjct: 9   KIGEGTYGVVYKAR-------NKLTGEV----VALKKIRLDTETEGVPSTAIREISLLKE 57

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           + HPN+VKL+     +++      LV+E +H   L+  + +   T +             
Sbjct: 58  LNHPNIVKLLDVIHTENKL----YLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLL 112

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           +GLA+ H      ++ RD K  N+L++ +   KL+DFGLAR          +  VV    
Sbjct: 113 QGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWY 168

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR--------AVERNLPRNEQKLLEWVRP 323
            A    +     +   D+WS G +  E++T R              + R      E V P
Sbjct: 169 RAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWP 228

Query: 324 YVSDSKKFHLII---DPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
            V+    +         +          +   +L S+ L   P  R      
Sbjct: 229 GVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAA 280

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  141 bits (356), Expect = 2e-39
 Identities = 54/291 (18%), Positives = 108/291 (37%), Gaps = 35/291 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           IGEG +G VY+              ++     A+K++  +          I E++ L  +
Sbjct: 10  IGEGTYGVVYKAQ------------NNYGETFALKKIRLEKEDEGIPSTTIREISILKEL 57

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KH N+VKL            + +LV+E +     +   +      L  +           
Sbjct: 58  KHSNIVKLYDVIHTK----KRLVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLN 111

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
           G+AY H+    +++ RD K  N+L++ + + K++DFGLAR          +  +V     
Sbjct: 112 GIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTLWYR 167

Query: 273 AAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKFH 332
           A    + + + +   D+WS G +  E++ G          ++   +  +    +     +
Sbjct: 168 APDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPN 227

Query: 333 LIIDPRLEGNYCIKSAQKLAA-----------LASKCLTKQPKSRPKMSEV 372
           +   P+ + N+ +       +           L SK L   P  R    + 
Sbjct: 228 VTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (349), Expect = 8e-38
 Identities = 64/296 (21%), Positives = 108/296 (36%), Gaps = 39/296 (13%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGV 151
            +G G +G V   V              +   VAIK+L R        K    E+  L  
Sbjct: 25  PVGSGAYGAVCSAVDG-----------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKH 73

Query: 152 VKHPNLVKLVGYCAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           ++H N++ L+     D+         LV   M        L+      L       +   
Sbjct: 74  MRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGT--DLGKLMKH--EKLGEDRIQFLVYQ 129

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
             +GL Y+H      +I RD K  N+ ++ED + K+ DFGLARQ        ++  VV  
Sbjct: 130 MLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMTGYVVTR 182

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR------------RAVERNLPRNEQKL 317
              A    +   R T   D+WS G ++ E+ITG+            + + +       + 
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEF 242

Query: 318 LEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA-LASKCLTKQPKSRPKMSEV 372
           ++ ++   + +    L    + +    + +A  LA  L  K L    + R    E 
Sbjct: 243 VQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEA 298

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 1e-36
 Identities = 63/279 (22%), Positives = 99/279 (35%), Gaps = 43/279 (15%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLG 150
           L+G+G FG V     +            +    A+K L ++      E    + E   L 
Sbjct: 12  LLGKGTFGKVILVREK-----------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60

Query: 151 VVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDA 210
             +HP L  L       D          E  +   L  HL                    
Sbjct: 61  NTRHPFLTALKYAFQTHDRLCFV----MEYANGGELFFHLSRERVFTEERARFY-----G 111

Query: 211 ARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTV 270
           A  ++ L       +++RD K  N++LD+D   K++DFGL ++G  +  G    +  GT 
Sbjct: 112 AEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTP 169

Query: 271 GYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKK 330
            Y APE ++        D W  GVV+YE++ GR      LP   Q         + +  +
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR------LPFYNQDHERLFELILMEEIR 223

Query: 331 FHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKM 369
           F   + P            +  +L +  L K PK R   
Sbjct: 224 FPRTLSP------------EAKSLLAGLLKKDPKQRLGG 250

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (329), Expect = 2e-35
 Identities = 58/293 (19%), Positives = 98/293 (33%), Gaps = 37/293 (12%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVV 152
           IGEG +G V++   R           ++   VA+K++             + E+  L  +
Sbjct: 10  IGEGTYGTVFKAKNR-----------ETHEIVALKRVRLDDDDEGVPSSALREICLLKEL 58

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
           KH N+V+L      D     +  LV+E       +             +          +
Sbjct: 59  KHKNIVRLHDVLHSD----KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSF-----LFQ 109

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGY 272
            L  L       ++ RD K  N+L++ + + KL++FGLAR           ++ V T+ Y
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP--VRCYSAEVVTLWY 167

Query: 273 AAPE-YVQTGRLTAKSDVWSFGVVLYELITGRR---------AVERNLPRNEQKLLEWVR 322
             P+        +   D+WS G +  EL    R            + + R      E   
Sbjct: 168 RPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQW 227

Query: 323 PYVS---DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEV 372
           P ++   D K + +        N   K       L    L   P  R    E 
Sbjct: 228 PSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (314), Expect = 7e-33
 Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 35/294 (11%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGV 151
            +G G +G V                  + L VA+K+L+R  Q     K    E+  L  
Sbjct: 25  PVGSGAYGSVCAAFDT-----------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKH 73

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           +KH N++ L+              +        +  ++++      L       +     
Sbjct: 74  MKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQIL 131

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
           RGL Y+H      +I RD K SN+ ++ED + K+ DFGLAR         ++  V     
Sbjct: 132 RGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWY 184

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGR------------RAVERNLPRNEQKLLE 319
            A    +         D+WS G ++ EL+TGR            + + R +     +LL+
Sbjct: 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLK 244

Query: 320 WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAA-LASKCLTKQPKSRPKMSEV 372
            +    + +    L   P++        A  LA  L  K L      R   ++ 
Sbjct: 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  124 bits (312), Expect = 9e-33
 Identities = 54/302 (17%), Positives = 97/302 (32%), Gaps = 50/302 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLG-VV 152
            +G G +  V+  +              +   V +K L        K+   E+  L  + 
Sbjct: 42  KLGRGKYSEVFEAINI-----------TNNEKVVVKILKPVK---KKKIKREIKILENLR 87

Query: 153 KHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAAR 212
             PN++ L     +   R     LV+E ++N   +          L          +  +
Sbjct: 88  GGPNIITLADIVKDPVSRTPA--LVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILK 140

Query: 213 GLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
            L Y H      ++ RD K  N+++D E  K +L D+GLA    P   G      V +  
Sbjct: 141 ALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQEYNVRVASRY 194

Query: 272 YAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL-------EWVRP 323
           +  PE +   ++     D+WS G +L  +I  +          +Q +        E +  
Sbjct: 195 FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYD 254

Query: 324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAA-------------LASKCLTKQPKSRPKMS 370
           Y+             + G +  K  ++                   K L    +SR    
Sbjct: 255 YIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAR 314

Query: 371 EV 372
           E 
Sbjct: 315 EA 316

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 2e-32
 Identities = 64/285 (22%), Positives = 103/285 (36%), Gaps = 47/285 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF----QGHKEWINEVNFL 149
           ++G G +G V+           + SGHD+    A+K L +       +  +    E   L
Sbjct: 31  VLGTGAYGKVFLV--------RKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVL 82

Query: 150 GVVKH-PNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQ 208
             ++  P LV L      + +  +      + ++   L  HL  R       +       
Sbjct: 83  EHIRQSPFLVTLHYAFQTETKLHLI----LDYINGGELFTHLSQRERFTEHEVQI----- 133

Query: 209 DAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVG 268
                +  L       +I+RD K  NILLD +    L+DFGL+++   +     +    G
Sbjct: 134 YVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE-TERAYDFCG 192

Query: 269 TVGYAAPEYVQTGR--LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS 326
           T+ Y AP+ V+ G        D WS GV++YEL+TG                    P+  
Sbjct: 193 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA------------------SPFTV 234

Query: 327 DSKK--FHLIIDPRLEGNYCIKSA--QKLAALASKCLTKQPKSRP 367
           D +K     I    L+               L  + L K PK R 
Sbjct: 235 DGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRL 279

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (309), Expect = 4e-32
 Identities = 69/307 (22%), Positives = 109/307 (35%), Gaps = 50/307 (16%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNR--QGFQGHKEWINEVNFLGV 151
            IG G  G V                 +    VAIK+L+R  Q     K    E+  +  
Sbjct: 24  PIGSGAQGIVCAAY-------DAVLDRN----VAIKKLSRPFQNQTHAKRAYRELVLMKC 72

Query: 152 VKHPNLVKLVGYCAEDD--ERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQD 209
           V H N++ L+         E      LV ELM     +   +      ++++        
Sbjct: 73  VNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLY-----Q 127

Query: 210 AARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGT 269
              G+ +LH      +I RD K SNI++  D   K+ DFGLAR         + T  V T
Sbjct: 128 MLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGT---SFMMTPYVVT 181

Query: 270 VGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR----------------RAVERNLPRN 313
             Y APE +         D+WS G ++ E++  +                  +    P  
Sbjct: 182 RYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEF 241

Query: 314 EQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALAS--------KCLTKQPKS 365
            +KL   VR YV +  K+  +  P+L  +    +  +   L +        K L   P  
Sbjct: 242 MKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAK 301

Query: 366 RPKMSEV 372
           R  + + 
Sbjct: 302 RISVDDA 308

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  122 bits (308), Expect = 5e-32
 Identities = 59/277 (21%), Positives = 95/277 (34%), Gaps = 46/277 (16%)

Query: 95  IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW---INEVNFLGV 151
           +G G FG V     +           +S    A+K L++Q     K+    +NE   L  
Sbjct: 49  LGTGSFGRVMLVKHK-----------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 97

Query: 152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAA 211
           V  P LVKL     ++    M    V E +    +  HL        +       A    
Sbjct: 98  VNFPFLVKLEFSFKDNSNLYM----VMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIV 151

Query: 212 RGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVG 271
               YLH      LI+RD K  N+L+D+    +++DFG A++         + ++ GT  
Sbjct: 152 LTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-----GRTWTLCGTPE 203

Query: 272 YAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDSKKF 331
             APE + +       D W+ GV++YE+  G                    P+ +D    
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAGY------------------PPFFADQPIQ 245

Query: 332 HLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK 368
                   +  +    +  L  L    L      R  
Sbjct: 246 IYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFG 282

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  107 bits (266), Expect = 3e-26
 Identities = 54/321 (16%), Positives = 105/321 (32%), Gaps = 57/321 (17%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK 153
            +G G F  V+                 +   VA+K + R      +   +E+  L  V 
Sbjct: 20  KLGWGHFSTVWLAKDM-----------VNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVN 67

Query: 154 HPNL-----------VKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIA 202
             +            +KL+ +       G+  ++V+E++    L                
Sbjct: 68  DADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYV 127

Query: 203 RLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLSDFGLARQGPPEGLGH 261
           + +I++    GL Y+H      +I  D K  N+L++  D    L    +A  G       
Sbjct: 128 K-QISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE 184

Query: 262 VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV 321
             T+ + T  Y +PE +        +D+WS   +++ELITG    E +   +  K  + +
Sbjct: 185 HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHI 244

Query: 322 ------------------------------RPYVSDSKKFHLIIDPRLEGNYCIKSAQKL 351
                                            +S  K + L      +  +    A+++
Sbjct: 245 AQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEI 304

Query: 352 AALASKCLTKQPKSRPKMSEV 372
           +   S  L   P+ R     +
Sbjct: 305 SDFLSPMLQLDPRKRADAGGL 325

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 70.2 bits (171), Expect = 1e-14
 Identities = 27/209 (12%), Positives = 55/209 (26%), Gaps = 42/209 (20%)

Query: 94  LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLN----------RQGFQGHKEWI 143
           L+GEG    V+                +   +  +K              +   G   + 
Sbjct: 7   LMGEGKESAVFNCY------------SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFS 54

Query: 144 NEVNFLGVVKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIAR 203
                    +   L KL G             ++ EL+  K L                 
Sbjct: 55  VLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDAKELYRV---------RVENP 105

Query: 204 LKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ-GPPEGLGHV 262
            ++       +A  +      ++  D    N+L+  +    + DF  + + G       +
Sbjct: 106 DEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSVEVGEEGWREIL 161

Query: 263 STSVVGTVGYAAPEYVQTGRLTAKSDVWS 291
              V   + Y +  Y        + D+ S
Sbjct: 162 ERDVRNIITYFSRTY------RTEKDINS 184

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	453
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.91
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.7
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.08
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.01
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.31
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.98
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.79

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-56  Score=422.26  Aligned_cols=263  Identities=30%  Similarity=0.467  Sum_probs=207.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|+++              ..||||+++...  ....+.|.+|+.+|++++|||||+++|+
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~--------------~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~   72 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH--------------GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGY   72 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS--------------SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC--------------CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEE
Confidence            467899999999999999999853              259999987543  3445789999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +....     ++||||||++|+|.+++... ...+++..++.++.|||.||+|||++   +||||||||+||||+.++.+
T Consensus        73 ~~~~~-----~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~  143 (276)
T d1uwha_          73 STAPQ-----LAIVTQWCEGSSLYHHLHII-ETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTV  143 (276)
T ss_dssp             ECSSS-----CEEEEECCCEEEHHHHHHTS-CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSE
T ss_pred             EeccE-----EEEEEecCCCCCHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCE
Confidence            86543     69999999999999999765 35699999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      ||+|||+|+...............||+.|||||++.+   ..++.++|||||||++|||+||+.||....+....  ...
T Consensus       144 Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~--~~~  221 (276)
T d1uwha_         144 KIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQI--IFM  221 (276)
T ss_dssp             EECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHH--HHH
T ss_pred             EEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHH--HHH
Confidence            9999999987654433334456789999999999864   45899999999999999999999999765433221  111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      +.....         .+. ....+..+++++.+|+.+||+.||++|||+.+|++.|+.+.+.+
T Consensus       222 ~~~~~~---------~p~-~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~~  274 (276)
T d1uwha_         222 VGRGYL---------SPD-LSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL  274 (276)
T ss_dssp             HHHTSC---------CCC-GGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTC
T ss_pred             HhcCCC---------CCc-chhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHcC
Confidence            111000         010 01123345678999999999999999999999999999887643

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.8e-56  Score=426.64  Aligned_cols=262  Identities=26%  Similarity=0.458  Sum_probs=201.3

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +|...++||+|+||+||+|+++..+        .....||||.+.... ....+.|.+|+.+|++++|||||+++|+|..
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~   98 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPG--------KREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTK   98 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC-----------CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCC--------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEee
Confidence            4555689999999999999986321        223569999986543 2345679999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    .++|||||++|+|.+++... ...+++..++.++.|||.||.|||++   +|+||||||+||||+.++++||+
T Consensus        99 ~~~----~~iv~Ey~~~g~L~~~~~~~-~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~  170 (299)
T d1jpaa_          99 STP----VMIITEFMENGSLDSFLRQN-DGQFTVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVS  170 (299)
T ss_dssp             SSS----CEEEEECCTTEEHHHHHHTT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEEC
T ss_pred             CCE----EEEEEEecCCCcceeeeccc-cCCCCHHHHHHHHHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEEC
Confidence            664    69999999999999988764 35689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCcc---ccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          247 DFGLARQGPPEGLGHV---STSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       247 DFGla~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |||+|+..........   .....||+.|+|||.+.++.++.++|||||||++|||+| |+.||......   .+...+.
T Consensus       171 DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~---~~~~~i~  247 (299)
T d1jpaa_         171 DFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ---DVINAIE  247 (299)
T ss_dssp             CC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHHH
T ss_pred             CcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH---HHHHHHH
Confidence            9999987543322111   123467899999999999999999999999999999998 89998764332   2222221


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      .    +          .....+..++..+.+|+.+||+.||++|||+.+|++.|+++++.
T Consensus       248 ~----~----------~~~~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         248 Q----D----------YRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             T----T----------CCCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             c----C----------CCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            1    0          01112334577899999999999999999999999999998764

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.9e-56  Score=423.18  Aligned_cols=260  Identities=25%  Similarity=0.431  Sum_probs=217.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|+++           .+++.||||+++... ...++|.+|+.+|++++|||||+++|+|.
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~-----------~~~~~vAvK~i~~~~-~~~~~~~~E~~il~~l~HpnIv~~~~~~~   83 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWK-----------KYSLTVAVKTLKEDT-MEVEEFLKEAAVMKEIKHPNLVQLLGVCT   83 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEG-----------GGTEEEEEEECCTTC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEC-----------CCCeEEEEEEECCcc-chHHHHHHHHHHHHhCCCCCEecCCccEe
Confidence            457888899999999999999986           346789999986543 45678999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +.+.    .+||||||++|+|.+++.......+++..++.++.||+.||.|||++   +|+||||||+||||+.++.+||
T Consensus        84 ~~~~----~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl  156 (287)
T d1opja_          84 REPP----FYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKV  156 (287)
T ss_dssp             SSSS----CEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEE
T ss_pred             eCCe----eEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEE
Confidence            7664    69999999999999999887778899999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||++|..|+.......  .+.+.+..  
T Consensus       157 ~DFG~a~~~~~~~-~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~--~~~~~i~~--  231 (287)
T d1opja_         157 ADFGLSRLMTGDT-YTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEK--  231 (287)
T ss_dssp             CCCCCTTTCCSSS-SEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHHHHHHT--
T ss_pred             ccccceeecCCCC-ceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHH--HHHHHHhc--
Confidence            9999998765432 233445678999999999999999999999999999999999877765443322  22222211  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                                  ......+..++.++.+|+.+||+.||++|||+.+|++.|+.+..
T Consensus       232 ------------~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~  275 (287)
T d1opja_         232 ------------DYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ  275 (287)
T ss_dssp             ------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred             ------------CCCCCCCccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence                        11112233456789999999999999999999999999987654

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-56  Score=418.61  Aligned_cols=254  Identities=25%  Similarity=0.357  Sum_probs=205.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...+.||+|+||+||+|+++           .+++.||||++..... ...+.+.+|+.+|++++||||+++++++
T Consensus         4 ~~dy~~~~~lG~G~fg~V~~~~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~   72 (271)
T d1nvra_           4 VEDWDLVQTLGEGAYGEVQLAVNR-----------VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR   72 (271)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CcceEEEEEEecCcCeEEEEEEEC-----------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeee
Confidence            467999999999999999999986           4578899999975532 3345689999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    .+||||||++|+|.++|...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus        73 ~~~~~----~~ivmEy~~gg~L~~~l~~~--~~l~e~~~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~K  143 (271)
T d1nvra_          73 REGNI----QYLFLEYCSGGELFDRIEPD--IGMPEPDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLK  143 (271)
T ss_dssp             EETTE----EEEEEECCTTEEGGGGSBTT--TBCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEE
T ss_pred             ccCce----eEEEEeccCCCcHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEE
Confidence            88764    79999999999999999764  5799999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      |+|||+|+...............||+.|+|||++.+..+ +.++|||||||++|||++|+.||......... ...... 
T Consensus       144 L~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~-~~~~~~-  221 (271)
T d1nvra_         144 ISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE-YSDWKE-  221 (271)
T ss_dssp             ECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHH-HHHHHT-
T ss_pred             EccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHH-HHHHhc-
Confidence            999999987654333333456789999999999988775 67899999999999999999999764332211 111110 


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                   ...........+.++.+|+.+||+.||++|||+.|+++
T Consensus       222 -------------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  259 (271)
T d1nvra_         222 -------------KKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIKK  259 (271)
T ss_dssp             -------------TCTTSTTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             -------------CCCCCCccccCCHHHHHHHHHHcCCChhHCcCHHHHhc
Confidence                         00011112234677899999999999999999999864

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-56  Score=418.97  Aligned_cols=259  Identities=26%  Similarity=0.432  Sum_probs=212.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|+++            ++..||||+++... ...+.|.+|+.+|++++|||||+++|++.
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~------------~~~~vAvK~~~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~   78 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN------------GHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLVRLYAVVT   78 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET------------TTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC------------CCCEEEEEEEccCc-CCHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            357888899999999999999974            35689999997543 45678999999999999999999999886


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +..     .+||||||++|+|.+++......++++..++.|+.||+.||.|||++   +|+||||||+||||++++.+||
T Consensus        79 ~~~-----~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl  150 (272)
T d1qpca_          79 QEP-----IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKI  150 (272)
T ss_dssp             SSS-----CEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEE
T ss_pred             cCC-----eEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceee
Confidence            543     58999999999999988766556799999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      +|||+|+...... ........||+.|+|||++.++.++.++|||||||++|||+||..|+......  ..+...+..  
T Consensus       151 ~DFGla~~~~~~~-~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~--~~~~~~i~~--  225 (272)
T d1qpca_         151 ADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN--PEVIQNLER--  225 (272)
T ss_dssp             CCCTTCEECSSSC-EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHT--
T ss_pred             ccccceEEccCCc-cccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCH--HHHHHHHHh--
Confidence            9999998765332 22344567999999999999999999999999999999999976665443322  122222211  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                        ..          ....+..+++++.+|+.+||+.||++|||+.+|++.|+.+...
T Consensus       226 --~~----------~~~~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         226 --GY----------RMVRPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             --TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --cC----------CCCCcccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence              00          1111234567899999999999999999999999999988753

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-55  Score=413.40  Aligned_cols=257  Identities=29%  Similarity=0.443  Sum_probs=200.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||+||+|++.            ++..||||+++... ...++|.+|+.++++++|||||+++|+|..
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~------------~~~~vAvK~i~~~~-~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   71 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL------------NKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLE   71 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET------------TTEEEEEEECCSSS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC------------CCCEEEEEEECCCc-CcHHHHHHHHHHHHhcCCCCcccccceecc
Confidence            46888899999999999999874            35679999997543 455789999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    .++|||||++|+|.+++... ...+++..++.++.|||.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        72 ~~~----~~lv~E~~~~g~L~~~l~~~-~~~~~~~~~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~  143 (263)
T d1sm2a_          72 QAP----ICLVFEFMEHGCLSDYLRTQ-RGLFAAETLLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVS  143 (263)
T ss_dssp             SSS----CEEEEECCTTCBHHHHHHTT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEEC
T ss_pred             CCc----eEEEEEecCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEec
Confidence            665    69999999999999998765 35789999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+++....... .......||+.|+|||++.+..++.++|||||||++|||+|+..|+......  ..+...+.... 
T Consensus       144 DFGla~~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~~-  219 (263)
T d1sm2a_         144 DFGMTRFVLDDQY-TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN--SEVVEDISTGF-  219 (263)
T ss_dssp             SCC-------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH--HHHHHHHHHTC-
T ss_pred             ccchheeccCCCc-eeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCH--HHHHHHHHhcC-
Confidence            9999987543322 2233467899999999999999999999999999999999965554433222  22222222110 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                                   ....+..++.++.+|+.+||+.||++|||+++|++.|+++.+
T Consensus       220 -------------~~~~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~e  261 (263)
T d1sm2a_         220 -------------RLYKPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAE  261 (263)
T ss_dssp             -------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             -------------CCCCccccCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHh
Confidence                         001122345789999999999999999999999999998865

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-55  Score=414.42  Aligned_cols=250  Identities=28%  Similarity=0.395  Sum_probs=210.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||+||+|+++           .+++.||||++........+.+.+|+.+|++++|||||++++++..
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~-----------~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~   88 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDV-----------ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLV   88 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBT-----------TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEEC-----------CCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEE
Confidence            57999999999999999999975           4578899999987666667889999999999999999999999988


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    .+||||||++|+|.+++...   .+++..+..++.||+.||.|||++   +|+||||||+|||++.++++||+
T Consensus        89 ~~~----~~ivmEy~~gg~L~~~~~~~---~l~~~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~  158 (293)
T d1yhwa1          89 GDE----LWVVMEYLAGGSLTDVVTET---CMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLT  158 (293)
T ss_dssp             TTE----EEEEEECCTTCBHHHHHHHS---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEEC
T ss_pred             CCE----EEEEEEecCCCcHHHHhhcc---CCCHHHHHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeec
Confidence            764    79999999999999988763   689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+|+......  .......||+.|+|||++.+..++.++|||||||++|||++|+.||........  +......   
T Consensus       159 DFG~a~~~~~~~--~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~--~~~~~~~---  231 (293)
T d1yhwa1         159 DFGFCAQITPEQ--SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA--LYLIATN---  231 (293)
T ss_dssp             CCTTCEECCSTT--CCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHHHHH---
T ss_pred             cchhheeecccc--ccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHH--HHHHHhC---
Confidence            999998764332  234566899999999999999999999999999999999999999976433221  1111110   


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                .......+...+.++.+||.+||+.||++|||+.|+++
T Consensus       232 ----------~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  269 (293)
T d1yhwa1         232 ----------GTPELQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ  269 (293)
T ss_dssp             ----------CSCCCSSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred             ----------CCCCCCCcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                      00011123345678999999999999999999999864

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-55  Score=409.57  Aligned_cols=246  Identities=26%  Similarity=0.433  Sum_probs=207.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|+++           .++..||||++.+..   ......+.+|+.+|++++||||++++++
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~   74 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREK-----------QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY   74 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEEC-----------CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence            57899999999999999999986           457889999986432   2345678999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    .+||||||++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+
T Consensus        75 ~~~~~~----~~ivmEy~~~g~L~~~l~~~--~~l~e~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~  145 (263)
T d2j4za1          75 FHDATR----VYLILEYAPLGTVYRELQKL--SKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGEL  145 (263)
T ss_dssp             EECSSE----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCE
T ss_pred             EEECCE----EEEEEeecCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCE
Confidence            987664    79999999999999999875  5789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+.....    ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+..
T Consensus       146 kl~DFG~a~~~~~~----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~  218 (263)
T d2j4za1         146 KIADFGWSVHAPSS----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE---TYKRISR  218 (263)
T ss_dssp             EECCCCSCSCCCCC----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHT
T ss_pred             eecccceeeecCCC----cccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHH---HHHHHHc
Confidence            99999999875432    2345679999999999999999999999999999999999999997643322   2221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         .            ....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       219 ---~------------~~~~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~  254 (263)
T d2j4za1         219 ---V------------EFTFPDFVTEGARDLISRLLKHNPSQRPMLREVLE  254 (263)
T ss_dssp             ---T------------CCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             ---C------------CCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHHc
Confidence               0            00112234678999999999999999999999985

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-55  Score=414.33  Aligned_cols=262  Identities=24%  Similarity=0.441  Sum_probs=211.6

Q ss_pred             cCCCccce-ecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALL-IGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~-lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+. ||+|+||+||+|+++..         ..+..||||+++.... ...+.|.+|+.+|++++|||||+++|+|
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~---------~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~   78 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMR---------KKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC   78 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC------------CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecC---------CCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeee
Confidence            45666664 99999999999987532         3456799999975533 3457899999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ..+.     ++||||||++|+|.+++... ...+++..++.++.||+.||.|||++   +|+||||||+|||++.++.+|
T Consensus        79 ~~~~-----~~lvmE~~~~g~L~~~l~~~-~~~l~~~~~~~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~K  149 (285)
T d1u59a_          79 QAEA-----LMLVMEMAGGGPLHKFLVGK-REEIPVSNVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAK  149 (285)
T ss_dssp             ESSS-----EEEEEECCTTEEHHHHHTTC-TTTSCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEE
T ss_pred             ccCe-----EEEEEEeCCCCcHHHHhhcc-ccCCCHHHHHHHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCcee
Confidence            6543     69999999999999987654 35789999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||+|+........ .......||+.|+|||++.++.++.++|||||||++|||+| |+.||......+   +...+.
T Consensus       150 l~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~---~~~~i~  226 (285)
T d1u59a_         150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE---VMAFIE  226 (285)
T ss_dssp             ECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH---HHHHHH
T ss_pred             eccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH---HHHHHH
Confidence            9999999876543221 22334578999999999999999999999999999999998 899997654332   222221


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .    +.          ....+..++.++.+||.+||+.||++|||+.+|++.|+.+...+
T Consensus       227 ~----~~----------~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~  273 (285)
T d1u59a_         227 Q----GK----------RMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL  273 (285)
T ss_dssp             T----TC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             c----CC----------CCCCCCcCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            1    11          11123345778999999999999999999999999998877654

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=411.19  Aligned_cols=254  Identities=24%  Similarity=0.399  Sum_probs=204.2

Q ss_pred             ceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeeeeecccc
Q 043568           93 LLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDER  170 (453)
Q Consensus        93 ~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  170 (453)
                      ++||+|+||+||+|.++..         ..++.||||+++....  ...+.|.+|+.+|++++|||||+++|+|....  
T Consensus        13 k~iG~G~fG~Vy~~~~~~~---------~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~--   81 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMK---------KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAES--   81 (277)
T ss_dssp             EEEEECSSEEEEEEEEECS---------SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSS--
T ss_pred             CCcccCCCeEEEEEEEccC---------CcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCC--
Confidence            4799999999999997632         3457899999965432  23467999999999999999999999986433  


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                         .+||||||++|+|.+++...  .++++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||+|||+
T Consensus        82 ---~~lvmE~~~~g~L~~~l~~~--~~l~~~~~~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGl  153 (277)
T d1xbba_          82 ---WMLVMEMAELGPLNKYLQQN--RHVKDKNIIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGL  153 (277)
T ss_dssp             ---EEEEEECCTTEEHHHHHHHC--TTCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTT
T ss_pred             ---EEEEEEcCCCCcHHHHHhhc--cCCCHHHHHHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhh
Confidence               68999999999999999875  5789999999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCCC-ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcccCc
Q 043568          251 ARQGPPEGLG-HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       251 a~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      ++........ .......||+.|+|||++.+..++.++|||||||++|||+| |+.||......   .+...+..    +
T Consensus       154 a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~---~~~~~i~~----~  226 (277)
T d1xbba_         154 SKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS---EVTAMLEK----G  226 (277)
T ss_dssp             CEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH---HHHHHHHT----T
T ss_pred             hhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHH---HHHHHHHc----C
Confidence            9875433222 22334678999999999999999999999999999999998 89999764322   22222211    1


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      .          ....+..++.++.+|+.+||+.||++|||+.+|++.|+.....
T Consensus       227 ~----------~~~~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         227 E----------RMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             C----------CCCCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             C----------CCCCCcccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            1          1112334567899999999999999999999999999887654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-54  Score=421.02  Aligned_cols=262  Identities=23%  Similarity=0.395  Sum_probs=210.4

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      ++|...++||+|+||+||+|++...+      .......||||.+.... ......|.+|+.+|.++ +|||||++++++
T Consensus        37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~  110 (325)
T d1rjba_          37 ENLEFGKVLGSGAFGKVMNATAYGIS------KTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC  110 (325)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEEESCS------SSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             HHeEEeeEEeeCCCeEEEEEEEcCCC------cccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEE
Confidence            57889999999999999999986422      11335679999986543 33446789999999998 899999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCC---------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVP---------------------TPLAWIARLKIAQDAARGLAYLHEEMDF  223 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~---------------------~~l~~~~~~~i~~~ia~~L~~LH~~~~~  223 (453)
                      .+.+.    .++|||||++|+|.++|..+..                     ..+++..++.++.||+.||.|||++   
T Consensus       111 ~~~~~----~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---  183 (325)
T d1rjba_         111 TLSGP----IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---  183 (325)
T ss_dssp             CSSSS----CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHT---
T ss_pred             eeCCe----EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---
Confidence            87765    6999999999999999976532                     3589999999999999999999998   


Q ss_pred             ceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-C
Q 043568          224 QLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-G  302 (453)
Q Consensus       224 ~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g  302 (453)
                      +||||||||+|||++.++.+||+|||+|+...............||+.|||||++.++.++.++|||||||++|||+| |
T Consensus       184 ~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         184 SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             CeeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence            999999999999999999999999999987554433333456678999999999999999999999999999999998 8


Q ss_pred             CccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHH
Q 043568          303 RRAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILG  377 (453)
Q Consensus       303 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~  377 (453)
                      +.||........  +...+..              ......+..+++++.+||.+||+.||++|||++||++.|.
T Consensus       264 ~~Pf~~~~~~~~--~~~~~~~--------------~~~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         264 VNPYPGIPVDAN--FYKLIQN--------------GFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSSTTCCCSHH--HHHHHHT--------------TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHH--HHHHHhc--------------CCCCCCCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            999976433221  1111111              1111223345678999999999999999999999999885

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-54  Score=406.70  Aligned_cols=251  Identities=22%  Similarity=0.366  Sum_probs=200.9

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      .....||+|+||+||+|+++           .++..||+|.+....  ....+.|.+|+++|++++|||||++++++...
T Consensus        12 ~~~~~iG~G~fg~Vy~~~~~-----------~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~   80 (270)
T d1t4ha_          12 KFDIEIGRGSFKTVYKGLDT-----------ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWEST   80 (270)
T ss_dssp             EEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEE
T ss_pred             EeeeEEecCcCcEEEEEEEC-----------CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeec
Confidence            45568999999999999976           456789999987543  23346789999999999999999999999765


Q ss_pred             ccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc-CCCcEEEe
Q 043568          168 DERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD-EDYKAKLS  246 (453)
Q Consensus       168 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~-~~~~~kL~  246 (453)
                      ......+++|||||++|+|.+++...  ..+++..+..++.||+.||.|||++ .++|+||||||+|||++ +++.+||+
T Consensus        81 ~~~~~~~~ivmE~~~~g~L~~~l~~~--~~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~  157 (270)
T d1t4ha_          81 VKGKKCIVLVTELMTSGTLKTYLKRF--KVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIG  157 (270)
T ss_dssp             SSSCEEEEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEEC
T ss_pred             cccCCEEEEEEeCCCCCcHHHHHhcc--ccccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEe
Confidence            44344579999999999999999875  5789999999999999999999998 12399999999999996 58899999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+|+....    .......||+.|+|||++.+ .++.++|||||||++|||++|+.||.......  .+...+.... 
T Consensus       158 DFGla~~~~~----~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~--~~~~~i~~~~-  229 (270)
T d1t4ha_         158 DLGLATLKRA----SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA--QIYRRVTSGV-  229 (270)
T ss_dssp             CTTGGGGCCT----TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH--HHHHHHTTTC-
T ss_pred             ecCcceeccC----CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHH--HHHHHHHcCC-
Confidence            9999986432    22346689999999999865 69999999999999999999999997543222  2222221100 


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                                  .....+...++++.+|+.+||+.||++|||+.|+++
T Consensus       230 ------------~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~  265 (270)
T d1t4ha_         230 ------------KPASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLN  265 (270)
T ss_dssp             ------------CCGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             ------------CCcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhC
Confidence                        011122234567999999999999999999999875

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=410.46  Aligned_cols=265  Identities=25%  Similarity=0.456  Sum_probs=206.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ..|...++||+|+||+||+|.++..+       ......||||++..... ....+|.+|+.+|++++|||||+++|++.
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~-------~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~   79 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSS-------GKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVIS   79 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC----------CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCC-------CEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEe
Confidence            46888899999999999999987321       13346799999965433 23457999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +...    .++|||||.+++|.+++... ...+++..++.++.||+.||.|||+.   +|+||||||+||||+.++.+||
T Consensus        80 ~~~~----~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl  151 (283)
T d1mqba_          80 KYKP----MMIITEYMENGALDKFLREK-DGEFSVLQLVGMLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKV  151 (283)
T ss_dssp             SSSS----EEEEEECCTTEEHHHHHHHT-TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEE
T ss_pred             cCCc----eEEEEEecccCcchhhhhcc-cccccHHHHHHHHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEE
Confidence            7665    79999999999999987765 35799999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCC-CccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGL-GHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|..|+......  ..+...+...
T Consensus       152 ~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~--~~~~~~i~~~  229 (283)
T d1mqba_         152 SDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN--HEVMKAINDG  229 (283)
T ss_dssp             CCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH--HHHHHHHHTT
T ss_pred             cccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCH--HHHHHHHhcc
Confidence            99999987543221 12233457899999999999999999999999999999999977666543322  2222222211


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                                    .....+..++..+.+|+.+||+.||++||||.+|++.|+.+.+.
T Consensus       230 --------------~~~~~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         230 --------------FRLPTPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             --------------CCCCCCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --------------CCCCCchhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence                          11122334567899999999999999999999999999988864

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-55  Score=411.02  Aligned_cols=256  Identities=24%  Similarity=0.361  Sum_probs=195.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc--cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ--GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||+||+|+++           .+++.||||.+......  ..+.|.+|+.+|++++|||||++++++
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~   72 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRK-----------SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRI   72 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEE
Confidence            67999999999999999999976           45778999999765432  346688999999999999999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcC--CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEeeccccccEEEcCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSR--VPTPLAWIARLKIAQDAARGLAYLHEEM--DFQLIFRDFKTSNILLDED  240 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--~~~~l~~~~~~~i~~~ia~~L~~LH~~~--~~~iiH~Dlkp~NILl~~~  240 (453)
                      .+....  .+++|||||++|+|.+++...  ....+++..++.++.||+.||.|||+.+  ..+|+||||||+||||+.+
T Consensus        73 ~~~~~~--~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~  150 (269)
T d2java1          73 IDRTNT--TLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGK  150 (269)
T ss_dssp             EC------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTT
T ss_pred             EeCCCC--EEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCC
Confidence            754322  368999999999999998643  2467999999999999999999999862  1249999999999999999


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||+|+.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||......   .+...
T Consensus       151 ~~vkl~DFG~a~~~~~~--~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~---~~~~~  225 (269)
T d2java1         151 QNVKLGDFGLARILNHD--TSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK---ELAGK  225 (269)
T ss_dssp             SCEEECCHHHHHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH---HHHHH
T ss_pred             CcEEEeeccceeecccC--CCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH---HHHHH
Confidence            99999999999875432  12345678999999999999999999999999999999999999999754322   22222


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +..    . ..     +    ..+...++++.+|+.+||+.||.+|||+.|+++
T Consensus       226 i~~----~-~~-----~----~~~~~~s~~l~~li~~~L~~dp~~Rps~~ell~  265 (269)
T d2java1         226 IRE----G-KF-----R----RIPYRYSDELNEIITRMLNLKDYHRPSVEEILE  265 (269)
T ss_dssp             HHH----T-CC-----C----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             HHc----C-CC-----C----CCCcccCHHHHHHHHHHcCCChhHCcCHHHHHh
Confidence            211    0 00     0    112234678999999999999999999999874

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-54  Score=410.75  Aligned_cols=252  Identities=23%  Similarity=0.366  Sum_probs=207.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      +.|+..+.||+|+||+||+|+++           .++..||||++........+.|.+|+.+|++++|||||++++++.+
T Consensus        12 d~Y~i~~~iG~G~fg~Vy~~~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~   80 (288)
T d2jfla1          12 DFWEIIGELGDGAFGKVYKAQNK-----------ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY   80 (288)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEE
T ss_pred             cCeEEeEEEeeCCCcEEEEEEEC-----------CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEee
Confidence            46888999999999999999976           4577899999987766667889999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      .+.    .+||||||++|+|.+++... ..++++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||+
T Consensus        81 ~~~----~~lvmEy~~~g~L~~~~~~~-~~~l~e~~~~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~  152 (288)
T d2jfla1          81 ENN----LWILIEFCAGGAVDAVMLEL-ERPLTESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLA  152 (288)
T ss_dssp             TTE----EEEEEECCTTEEHHHHHHHH-TSCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEEC
T ss_pred             CCe----EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEE
Confidence            664    79999999999999987654 35799999999999999999999999   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccc-----cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQ-----TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      |||+|+.....  ........||+.|+|||++.     ...|+.++|||||||++|||++|+.||....+.....  ...
T Consensus       153 DFG~a~~~~~~--~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~--~i~  228 (288)
T d2jfla1         153 DFGVSAKNTRT--IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLL--KIA  228 (288)
T ss_dssp             CCTTCEECHHH--HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHH--HHH
T ss_pred             echhhhccCCC--cccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHH--HHH
Confidence            99999764321  11234578999999999984     4568999999999999999999999997654332211  111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..             .......+...+.++.+|+.+||+.||++|||+.|+++
T Consensus       229 ~~-------------~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~  268 (288)
T d2jfla1         229 KS-------------EPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ  268 (288)
T ss_dssp             HS-------------CCCCCSSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred             cC-------------CCCCCCccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10             00011123345678999999999999999999999865

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-54  Score=400.14  Aligned_cols=253  Identities=25%  Similarity=0.415  Sum_probs=210.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...++||+|+||+||+|+++            ++..||||+++... ...++|.+|+.++++++||||++++|+|.+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~------------~~~~vAvK~l~~~~-~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~   70 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR------------GQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTK   70 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET------------TTEEEEEEEEESSS-SCHHHHHHHHHHHHTCCCTTBCCEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC------------CCCEEEEEEECcCc-CCHHHHHHHHHHHHhcCCCceeeEEEEEee
Confidence            68999999999999999999974            46789999997654 345789999999999999999999999987


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ...    .++||||+++|+|.+++... ...+++..+++++.|+++||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        71 ~~~----~~iv~Ey~~~g~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~  142 (258)
T d1k2pa_          71 QRP----IFIITEYMANGCLLNYLREM-RHRFQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVS  142 (258)
T ss_dssp             SSS----EEEEEECCTTEEHHHHHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEEC
T ss_pred             CCc----eEEEEEccCCCcHHHhhhcc-ccCCcHHHHHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEEC
Confidence            654    79999999999999987664 35688999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||+++....... .......||+.|+|||.+.+..++.++|||||||++|||+| |+.||......+   +...+..  
T Consensus       143 DfG~a~~~~~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~---~~~~i~~--  216 (258)
T d1k2pa_         143 DFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE---TAEHIAQ--  216 (258)
T ss_dssp             CCSSCCBCSSSSC-CCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH---HHHHHHT--
T ss_pred             cchhheeccCCCc-eeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHH---HHHHHHh--
Confidence            9999986554322 23345679999999999999999999999999999999998 788987654322   2222211  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHH
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGN  378 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~  378 (453)
                        ..          ....+...+.++.+|+.+||+.||++|||+.+|++.|.+
T Consensus       217 --~~----------~~~~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         217 --GL----------RLYRPHLASEKVYTIMYSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             --TC----------CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             --CC----------CCCCcccccHHHHHHHHHHccCCHhHCcCHHHHHHHhhC
Confidence              10          011123345789999999999999999999999998854

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-54  Score=417.19  Aligned_cols=266  Identities=25%  Similarity=0.357  Sum_probs=205.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .++|...++||+|+||+||+|+++           .++..||||+++.... .....+.+|+.+|++++|||||+++++|
T Consensus         5 ~d~y~~~~~iG~G~fg~V~~~~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~   73 (322)
T d1s9ja_           5 DDDFEKISELGAGNGGVVFKVSHK-----------PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAF   73 (322)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEET-----------TTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEE
T ss_pred             ccCCEEEEEEecCCCeEEEEEEEC-----------CCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            578999999999999999999976           5678999999976533 3346789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    .+||||||++|+|.+++.+.  ..+++..+..++.|++.||.|||+++  +|+||||||+||||+.++.+|
T Consensus        74 ~~~~~----~~iVmEy~~gg~L~~~l~~~--~~l~~~~~~~~~~qil~aL~yLH~~~--~IiHRDiKP~NILl~~~~~vk  145 (322)
T d1s9ja_          74 YSDGE----ISICMEHMDGGSLDQVLKKA--GRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIK  145 (322)
T ss_dssp             ECSSE----EEEEEECCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEE
T ss_pred             EECCE----EEEEEEcCCCCcHHHHHhhc--CCCCHHHHHHHHHHHHHHHHHHHHhC--CEEccccCHHHeeECCCCCEE
Confidence            87764    79999999999999999875  46899999999999999999999731  899999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh-hhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW-VRP  323 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~-~~~  323 (453)
                      |+|||+|+....    ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.............. ...
T Consensus       146 l~DFGla~~~~~----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~  221 (322)
T d1s9ja_         146 LCDFGVSGQLID----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEG  221 (322)
T ss_dssp             ECCCCCCHHHHH----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------
T ss_pred             EeeCCCccccCC----CccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcC
Confidence            999999986432    123456899999999999999999999999999999999999999976443221111000 000


Q ss_pred             cccC------------------c---c----ccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSD------------------S---K----KFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~------------------~---~----~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ....                  .   .    ..................+.++.+|+.+||..||++|||++|+++
T Consensus       222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~  297 (322)
T d1s9ja_         222 DAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV  297 (322)
T ss_dssp             ------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhh
Confidence            0000                  0   0    000000000000011123567999999999999999999999986

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-54  Score=409.82  Aligned_cols=250  Identities=24%  Similarity=0.329  Sum_probs=204.8

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|+++           .++..||||++....   ....+.+.+|+.+|++++||||++++++
T Consensus         8 ~dy~i~~~lG~G~fg~Vy~a~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~   76 (288)
T d1uu3a_           8 EDFKFGKILGEGSFSTVVLAREL-----------ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFT   76 (288)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEE
T ss_pred             CCCEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEE
Confidence            57999999999999999999986           457789999986432   2345779999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    .++|||||++|+|.+++...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||+++++.+
T Consensus        77 ~~~~~~----~~ivmEy~~gg~L~~~~~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~v  147 (288)
T d1uu3a_          77 FQDDEK----LYFGLSYAKNGELLKYIRKI--GSFDETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHI  147 (288)
T ss_dssp             EECSSE----EEEEECCCTTEEHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCE
T ss_pred             EEECCE----EEEEEEccCCCCHHHhhhcc--CCCCHHHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceE
Confidence            987654    79999999999999998875  5789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+..
T Consensus       148 kl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i~~  224 (288)
T d1uu3a_         148 QITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYL---IFQKIIK  224 (288)
T ss_dssp             EECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHT
T ss_pred             EecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHH---HHHHHHc
Confidence            9999999987654433334456789999999999999999999999999999999999999997643222   2211110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         .  .          ..++...++++.+||.+||+.||++|||++|+++
T Consensus       225 ---~--~----------~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~  260 (288)
T d1uu3a_         225 ---L--E----------YDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEG  260 (288)
T ss_dssp             ---T--C----------CCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred             ---C--C----------CCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcC
Confidence               0  0          0112234677999999999999999999998754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-54  Score=407.40  Aligned_cols=259  Identities=28%  Similarity=0.423  Sum_probs=207.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|+..+.||+|+||+||+|+++            ++..||||++... ....+.|.+|+.+|++++|||||+++|+|.+
T Consensus        17 ~~~~i~~~iG~G~fg~Vy~~~~~------------~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3          17 ESLRLEVKLGQGCFGEVWMGTWN------------GTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET------------TTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             HHEEEeeEEeeCCCeEEEEEEEC------------CCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            57999999999999999999974            3457999999654 3456789999999999999999999999865


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ..     .++|||||++|+|..++.......++|..++.++.||+.||+|||+.   +|+||||||+||||+.++++||+
T Consensus        84 ~~-----~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~  155 (285)
T d1fmka3          84 EP-----IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVA  155 (285)
T ss_dssp             SS-----CEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEEC
T ss_pred             CC-----eEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEc
Confidence            33     58999999999999998876556799999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhccc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVS  326 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~  326 (453)
                      |||+++...... ........||+.|+|||++..+.++.++|||||||++|||++|..|+......  ..+...+...  
T Consensus       156 DfGla~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~--~~~~~~i~~~--  230 (285)
T d1fmka3         156 DFGLARLIEDNE-YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN--REVLDQVERG--  230 (285)
T ss_dssp             CCCTTC---------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH--HHHHHHHHTT--
T ss_pred             ccchhhhccCCC-ceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCH--HHHHHHHHhc--
Confidence            999998754332 22334567999999999999999999999999999999999987776554332  2222222210  


Q ss_pred             CccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          327 DSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       327 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                                  .....+..++.++.+||.+||+.||++|||+.+|++.|+......
T Consensus       231 ------------~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         231 ------------YRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             ------------CCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ------------CCCCCCcccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCC
Confidence                        011123345678999999999999999999999999998877543

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=410.36  Aligned_cols=263  Identities=25%  Similarity=0.417  Sum_probs=209.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-CcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+|+..++||+|+||+||+|.+...       +...+..||||.+... .....++|.+|+.+|++++|||||+++|+|.
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~-------~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~   81 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPE-------GEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL   81 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC-----------CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCC-------CCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            4699999999999999999997632       2233457999998654 3345678999999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +..     .++++||+.+|+|.+++... ...+++..++.++.|||.||.|||++   +|+||||||+|||++.++.+||
T Consensus        82 ~~~-----~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~i~~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl  152 (317)
T d1xkka_          82 TST-----VQLITQLMPFGCLLDYVREH-KDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKI  152 (317)
T ss_dssp             SSS-----EEEEEECCTTCBHHHHHHHT-SSSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEE
T ss_pred             cCC-----eeEEEEeccCCccccccccc-ccCCCHHHHHHHHHHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEe
Confidence            754     58899999999999988765 46789999999999999999999998   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+|+...............||+.|+|||++.++.++.++|||||||++|||+| |..||...........+   .. 
T Consensus       153 ~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i---~~-  228 (317)
T d1xkka_         153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL---EK-  228 (317)
T ss_dssp             CCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHH---HH-
T ss_pred             eccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHH---Hc-
Confidence            99999987654443333455678999999999999999999999999999999999 78887654433222221   11 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         +.          ....+..++..+.+|+.+||+.||.+|||+.+|++.|..+...
T Consensus       229 ---~~----------~~~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~~  273 (317)
T d1xkka_         229 ---GE----------RLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  273 (317)
T ss_dssp             ---TC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ---CC----------CCCCCcccCHHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHhC
Confidence               00          1112234567899999999999999999999999999887654

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.5e-53  Score=406.21  Aligned_cols=252  Identities=24%  Similarity=0.379  Sum_probs=191.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      .+.|...+.||+|+||+||+|+++           .+++.||||++...... ....+.+|+.+|++++|||||++++++
T Consensus         8 ~d~Y~~~~~lG~G~fg~Vy~~~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~   76 (307)
T d1a06a_           8 RDIYDFRDVLGTGAFSEVILAEDK-----------RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIY   76 (307)
T ss_dssp             GGTEEEEEESBSGGGGGEEEEEET-----------TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEE
T ss_pred             ccceEEEEEEeeccCeEEEEEEEC-----------CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEE
Confidence            466999999999999999999976           45778999999765432 345688999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc---CCC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD---EDY  241 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~---~~~  241 (453)
                      .+.+.    ++||||||+||+|.++|...  ..+++..+..++.||+.||.|||++   +|+||||||+|||+.   +++
T Consensus        77 ~~~~~----~~lvmE~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~  147 (307)
T d1a06a_          77 ESGGH----LYLIMQLVSGGELFDRIVEK--GFYTERDASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDS  147 (307)
T ss_dssp             ECSSE----EEEEECCCCSCBHHHHHHTC--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTC
T ss_pred             EECCE----EEEEEeccCCCcHHHhhhcc--cCCCHHHHHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCc
Confidence            87654    79999999999999999765  5799999999999999999999998   999999999999994   578


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      .+||+|||+|+.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+
T Consensus       148 ~vkl~DFG~a~~~~~~---~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~---~~~~i  221 (307)
T d1a06a_         148 KIMISDFGLSKMEDPG---SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK---LFEQI  221 (307)
T ss_dssp             CEEECCC---------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH---HHHHH
T ss_pred             eEEEeccceeEEccCC---CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHH
Confidence            9999999999875432   22345689999999999999999999999999999999999999997643222   22111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..   .        ............++++.+|+.+||+.||++|||+.|+++
T Consensus       222 ~~---~--------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  263 (307)
T d1a06a_         222 LK---A--------EYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ  263 (307)
T ss_dssp             HT---T--------CCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hc---c--------CCCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            11   0        011111222345678999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.1e-53  Score=407.98  Aligned_cols=246  Identities=31%  Similarity=0.455  Sum_probs=202.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..|+..+.||+|+||+||+|++.           .++..||||++......   ..+.+.+|+.+|++++|||||+++++
T Consensus        15 ~~y~~l~~lG~G~fg~Vy~a~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~   83 (309)
T d1u5ra_          15 KLFSDLREIGHGSFGAVYFARDV-----------RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC   83 (309)
T ss_dssp             HHEEEEEEEEECSSSEEEEEEET-----------TTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             HhcEeeEEEecCCCeEEEEEEEC-----------CCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEE
Confidence            35889999999999999999976           55788999999765432   23568899999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    .++|||||++|+|..++..+  .++++..+..++.||+.||.|||++   +|+||||||+||||+.++.+
T Consensus        84 ~~~~~~----~~iv~E~~~~g~l~~~~~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~  154 (309)
T d1u5ra_          84 YLREHT----AWLVMEYCLGSASDLLEVHK--KPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLV  154 (309)
T ss_dssp             EEETTE----EEEEEECCSEEHHHHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEE
T ss_pred             EEECCE----EEEEEEecCCCchHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCE
Confidence            987654    79999999999998776654  5799999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc---CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT---GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      ||+|||+|+....      .....||+.|+|||++.+   +.|+.++|||||||++|||++|..||........  +...
T Consensus       155 Kl~DFG~a~~~~~------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~--~~~i  226 (309)
T d1u5ra_         155 KLGDFGSASIMAP------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHI  226 (309)
T ss_dssp             EECCCTTCBSSSS------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHH--HHHH
T ss_pred             EEeecccccccCC------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHH--HHHH
Confidence            9999999987432      335679999999999864   4689999999999999999999999976433221  1111


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ...     .      .+.   ..+...++++.+|+.+||+.||.+|||+.++++
T Consensus       227 ~~~-----~------~~~---~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~  266 (309)
T d1u5ra_         227 AQN-----E------SPA---LQSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK  266 (309)
T ss_dssp             HHS-----C------CCC---CSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred             HhC-----C------CCC---CCCCCCCHHHHHHHHHHCcCChhHCcCHHHHHh
Confidence            110     0      000   112234678999999999999999999999875

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-52  Score=409.80  Aligned_cols=253  Identities=23%  Similarity=0.371  Sum_probs=210.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||++........+.+.+|+.+|++++|||||++++++.
T Consensus        25 l~~Y~i~~~lG~G~fg~Vy~~~~~-----------~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~   93 (350)
T d1koaa2          25 LDHYDIHEELGTGAFGVVHRVTER-----------ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE   93 (350)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-----------TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEE
T ss_pred             ccCeEEEEEEecCcCeEEEEEEEC-----------CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            468999999999999999999976           557899999997766556678899999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc--CCCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~--~~~~~  243 (453)
                      +.+.    ++||||||++|+|.+++... ...+++..+..++.||+.||.|||++   +||||||||+|||++  .++.+
T Consensus        94 ~~~~----~~ivmE~~~gg~L~~~l~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~v  165 (350)
T d1koaa2          94 DDNE----MVMIYEFMSGGELFEKVADE-HNKMSEDEAVEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNEL  165 (350)
T ss_dssp             ETTE----EEEEECCCCSCBHHHHHTCT-TSCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCE
T ss_pred             ECCE----EEEEEEcCCCCCHHHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeE
Confidence            7654    79999999999999998654 34699999999999999999999999   999999999999996  46789


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+..
T Consensus       166 kL~DFG~a~~~~~~---~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~---~~~~i~~  239 (350)
T d1koaa2         166 KLIDFGLTAHLDPK---QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDE---TLRNVKS  239 (350)
T ss_dssp             EECCCTTCEECCTT---SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             EEeecchheecccc---cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHHh
Confidence            99999999876532   23456789999999999999999999999999999999999999997543222   2211111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .           +...........++++.+||.+||..||++|||+.|+++
T Consensus       240 ~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~  279 (350)
T d1koaa2         240 C-----------DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALE  279 (350)
T ss_dssp             T-----------CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             C-----------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0           011111222345678999999999999999999999876

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-53  Score=398.57  Aligned_cols=252  Identities=28%  Similarity=0.437  Sum_probs=201.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|...+.||+|+||.||+|+++             +..||||+++..  ...+.|.+|+.++++++||||++++|+|.+
T Consensus         7 ~~~~~~~~lG~G~fg~Vy~~~~~-------------~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~   71 (262)
T d1byga_           7 KELKLLQTIGKGEFGDVMLGDYR-------------GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVE   71 (262)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-------------TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECC
T ss_pred             HHeEEeEEEecCCCeEEEEEEEC-------------CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEe
Confidence            56788899999999999999964             467999999654  345779999999999999999999999976


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEe
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLS  246 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~  246 (453)
                      ....   +++||||+++|+|.++|..+....+++..+++++.||+.||.|||+.   +|+||||||+|||++.++.+||+
T Consensus        72 ~~~~---~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~  145 (262)
T d1byga_          72 EKGG---LYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVS  145 (262)
T ss_dssp             C--C---CEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEEC
T ss_pred             cCCc---EEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeec
Confidence            5432   68999999999999999876545689999999999999999999998   99999999999999999999999


Q ss_pred             ccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhcc
Q 043568          247 DFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPYV  325 (453)
Q Consensus       247 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~~  325 (453)
                      |||+++....     ......+|..|+|||++.++.++.++|||||||++|||+| |+.||......   .+...+..  
T Consensus       146 dfg~s~~~~~-----~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~---~~~~~i~~--  215 (262)
T d1byga_         146 DFGLTKEASS-----TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK---DVVPRVEK--  215 (262)
T ss_dssp             CCCC-----------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG---GHHHHHTT--
T ss_pred             ccccceecCC-----CCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH---HHHHHHHc--
Confidence            9999987442     2334568999999999999999999999999999999998 67777654322   22222211  


Q ss_pred             cCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          326 SDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                        .          .....+...++++.+|+.+||+.||.+|||+.+|++.|+.+..
T Consensus       216 --~----------~~~~~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~  259 (262)
T d1byga_         216 --G----------YKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT  259 (262)
T ss_dssp             --T----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             --C----------CCCCCCccCCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHh
Confidence              0          1112233456789999999999999999999999999988754

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.5e-53  Score=407.03  Aligned_cols=266  Identities=28%  Similarity=0.433  Sum_probs=213.3

Q ss_pred             HhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeee
Q 043568           85 ATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        85 ~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ..++|...+.||+|+||+||+|+++...      ...++..||||+++..... ..++|.+|+.+|++++||||++++++
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~------~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~   84 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLL------PYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGV   84 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSS------TTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCc------cCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceee
Confidence            4678999999999999999999986321      2245678999999755433 35679999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC----------------------CCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV----------------------PTPLAWIARLKIAQDAARGLAYLHEEM  221 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------------~~~l~~~~~~~i~~~ia~~L~~LH~~~  221 (453)
                      |.....    .++||||+++|+|.++|....                      ...+++..++.++.|++.||+|||+. 
T Consensus        85 ~~~~~~----~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~-  159 (301)
T d1lufa_          85 CAVGKP----MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-  159 (301)
T ss_dssp             ECSSSS----CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHT-
T ss_pred             eccCCc----eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC-
Confidence            987664    699999999999999997532                      23588999999999999999999998 


Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT  301 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt  301 (453)
                        +||||||||+||||+.++.+||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||++
T Consensus       160 --~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~  237 (301)
T d1lufa_         160 --KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS  237 (301)
T ss_dssp             --TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred             --CeEeeEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHc
Confidence              999999999999999999999999999986543333334456778999999999999999999999999999999999


Q ss_pred             CC-ccccCCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhH
Q 043568          302 GR-RAVERNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNII  380 (453)
Q Consensus       302 g~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~  380 (453)
                      |. +||......   .+...+..    ...          ...+..++.++.+|+.+||+.+|++||||.+|++.|+++.
T Consensus       238 ~~~~p~~~~~~~---e~~~~v~~----~~~----------~~~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         238 YGLQPYYGMAHE---EVIYYVRD----GNI----------LACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             TTCCTTTTSCHH---HHHHHHHT----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             cCCCCCCCCCHH---HHHHHHHc----CCC----------CCCCccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            96 456544322   22222221    110          1122345678999999999999999999999999998874

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-53  Score=398.92  Aligned_cols=261  Identities=26%  Similarity=0.414  Sum_probs=201.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||+||+|++...        ......||||.+...... ..+.|.+|+.+|++++||||++++|++.
T Consensus         7 ~~~~l~~~iG~G~fg~Vy~a~~~~~--------~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~   78 (273)
T d1mp8a_           7 ERIELGRCIGEGQFGDVHQGIYMSP--------ENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT   78 (273)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEECCC----------CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             HHeEEEEEEeeCCCcEEEEEEEecC--------CceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe
Confidence            5788899999999999999997532        133567999998654333 3467999999999999999999999996


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      +..     .++||||+++|+|.+++... ..++++..++.++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        79 ~~~-----~~iv~E~~~~g~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl  149 (273)
T d1mp8a_          79 ENP-----VWIIMELCTLGELRSFLQVR-KYSLDLASLILYAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKL  149 (273)
T ss_dssp             SSS-----CEEEEECCTTEEHHHHHHHT-TTTSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEE
T ss_pred             cCe-----EEEEEEeccCCcHHhhhhcc-CCCCCHHHHHHHHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEE
Confidence            432     69999999999999987764 35789999999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhhhhc
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWVRPY  324 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~~~~  324 (453)
                      +|||+|+...... ........||+.|+|||++.+..++.++|||||||++|||++ |.+||.......   +...+.. 
T Consensus       150 ~DfG~a~~~~~~~-~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~---~~~~i~~-  224 (273)
T d1mp8a_         150 GDFGLSRYMEDST-YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND---VIGRIEN-  224 (273)
T ss_dssp             CC--------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG---HHHHHHT-
T ss_pred             ccchhheeccCCc-ceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHH---HHHHHHc-
Confidence            9999998754332 223445678999999999999999999999999999999998 888887654332   2221111 


Q ss_pred             ccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          325 VSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       325 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                         ..          ....+..+++.+.+||.+||+.||++|||+.+|++.|++++++
T Consensus       225 ---~~----------~~~~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         225 ---GE----------RLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             ---TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             ---CC----------CCCCCCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence               11          0112334577899999999999999999999999999988765

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-53  Score=404.04  Aligned_cols=268  Identities=24%  Similarity=0.338  Sum_probs=205.5

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||.||+|++....      ...+++.||||+++.... ...+.+.+|..++.++ +|+||+.++++
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~------~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~   85 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGID------KTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGA   85 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTT------SSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCC------cccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeee
Confidence            367899999999999999999986421      224567899999875432 3356788888888877 78999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      +...+..   +++|||||++|+|.++|....              ...+++..++.++.||+.||.|||++   +|+|||
T Consensus        86 ~~~~~~~---~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrD  159 (299)
T d1ywna1          86 CTKPGGP---LMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRD  159 (299)
T ss_dssp             ECSTTSC---CEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             eccCCCe---EEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCc
Confidence            8776542   699999999999999997542              23588999999999999999999998   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCC-ccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR-RAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~-~p~~~  308 (453)
                      |||+||||+.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||++|. .||..
T Consensus       160 lKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~  239 (299)
T d1ywna1         160 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  239 (299)
T ss_dssp             CCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             CCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999998765444334455678999999999999999999999999999999999975 46654


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      .....  .+...+..    +.          ....+...++++.+|+.+||+.||++|||+.+|++.|+++++
T Consensus       240 ~~~~~--~~~~~~~~----~~----------~~~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         240 VKIDE--EFCRRLKE----GT----------RMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             CCCSH--HHHHHHHH----TC----------CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCHHH--HHHHHHhc----CC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            33221  11111111    00          011223346789999999999999999999999999999875

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.9e-52  Score=408.26  Aligned_cols=253  Identities=22%  Similarity=0.351  Sum_probs=210.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||++..........+.+|+.+|++++|||||++++++.
T Consensus        28 ~d~Y~i~~~lG~G~fg~V~~a~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   96 (352)
T d1koba_          28 YDYYDILEELGSGAFGVVHRCVEK-----------ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE   96 (352)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC-----------CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEE
Confidence            357999999999999999999976           457889999998765555677889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEc--CCCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLD--EDYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~--~~~~~  243 (453)
                      +.+.    ++||||||++|+|.+++... ..++++..+..++.||+.||.|||++   +|+||||||+||||+  .++.+
T Consensus        97 ~~~~----~~ivmE~~~gg~L~~~~~~~-~~~l~e~~~~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~v  168 (352)
T d1koba_          97 DKYE----MVLILEFLSGGELFDRIAAE-DYKMSEAEVINYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSV  168 (352)
T ss_dssp             CSSE----EEEEEECCCCCBHHHHTTCT-TCCBCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCE
T ss_pred             ECCE----EEEEEEcCCCChHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeE
Confidence            7654    79999999999999987654 35799999999999999999999998   999999999999998  67899


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+..
T Consensus       169 kL~DFGla~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~---~~~~i~~  242 (352)
T d1koba_         169 KIIDFGLATKLNPD---EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE---TLQNVKR  242 (352)
T ss_dssp             EECCCTTCEECCTT---SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH---HHHHHHH
T ss_pred             EEeecccceecCCC---CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh
Confidence            99999999876543   23456789999999999999999999999999999999999999997653322   2111111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .           +...........+.++.+||.+||..||.+|||+.|+++
T Consensus       243 ~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  282 (352)
T d1koba_         243 C-----------DWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE  282 (352)
T ss_dssp             C-----------CCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred             C-----------CCCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0           011111222345678999999999999999999999875

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-52  Score=397.74  Aligned_cols=252  Identities=24%  Similarity=0.383  Sum_probs=207.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc------ccHHHHHHHHHHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF------QGHKEWINEVNFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~------~~~~~~~~E~~~l~~l~h~nIv~  159 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||++.+...      ...+.|.+|+.+|++++|||||+
T Consensus         9 ~d~Y~~~~~lG~G~fg~Vy~~~~~-----------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~   77 (293)
T d1jksa_           9 DDYYDTGEELGSGQFAVVKKCREK-----------STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT   77 (293)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCC
T ss_pred             ccCEEEeEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCc
Confidence            367999999999999999999986           4578899999875422      23577999999999999999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++.+...    .+||||||++|+|.++|...  ..+++..+..++.|++.||.|||+.   +|+||||||+|||++.
T Consensus        78 ~~~~~~~~~~----~~iv~E~~~gg~L~~~i~~~--~~l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~  148 (293)
T d1jksa_          78 LHEVYENKTD----VILILELVAGGELFDFLAEK--ESLTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLD  148 (293)
T ss_dssp             EEEEEECSSE----EEEEEECCCSCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESC
T ss_pred             EEEEEEECCE----EEEEEEcCCCccccchhccc--cccchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEec
Confidence            9999987664    79999999999999999875  5799999999999999999999999   9999999999999987


Q ss_pred             CC----cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhH
Q 043568          240 DY----KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ  315 (453)
Q Consensus       240 ~~----~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~  315 (453)
                      ++    .+||+|||+|+.....   .......||+.|+|||++.+..++.++|||||||++|||++|+.||.......  
T Consensus       149 ~~~~~~~vkl~DfG~a~~~~~~---~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--  223 (293)
T d1jksa_         149 RNVPKPRIKIIDFGLAHKIDFG---NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--  223 (293)
T ss_dssp             SSSSSCCEEECCCTTCEECTTS---CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--
T ss_pred             CCCcccceEecchhhhhhcCCC---ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHH--
Confidence            76    4999999999875432   23445689999999999999999999999999999999999999997643222  


Q ss_pred             HHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          316 KLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       316 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       ....+...           ............+..+.+||.+||+.||.+|||++++++
T Consensus       224 -~~~~i~~~-----------~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  270 (293)
T d1jksa_         224 -TLANVSAV-----------NYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ  270 (293)
T ss_dssp             -HHHHHHTT-----------CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             -HHHHHHhc-----------CCCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence             21111110           001111122345678999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.4e-52  Score=392.15  Aligned_cols=265  Identities=25%  Similarity=0.357  Sum_probs=208.6

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---cHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---GHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||+||+|++.           .+++.||||++......   ....|.+|+.+|+.++||||+++++
T Consensus         6 ~drY~i~~~lG~G~fg~Vy~a~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~   74 (277)
T d1o6ya_           6 SDRYELGEILGFGGMSEVHLARDL-----------RLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYD   74 (277)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cceeEEeEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccc
Confidence            467999999999999999999976           56789999999765433   2456899999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++...+..+..++||||||+|++|.+++...  .++++..++.++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        75 ~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~--~~l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~  149 (277)
T d1o6ya_          75 TGEAETPAGPLPYIVMEYVDGVTLRDIVHTE--GPMTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNA  149 (277)
T ss_dssp             EEEEECSSSEEEEEEEECCCEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSC
T ss_pred             eeeeccCCCceEEEEEECCCCCEehhhhccc--CCCCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCcccc
Confidence            9988766555679999999999999988775  5789999999999999999999998   9999999999999999999


Q ss_pred             EEEeccccccCCCCCC-CCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEG-LGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      ++|+|||.+....... .........||+.|+|||++.+..++.++|||||||++|||+||+.||....+...  +....
T Consensus       150 ~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~--~~~~~  227 (277)
T d1o6ya_         150 VKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHV  227 (277)
T ss_dssp             EEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH--HHHHH
T ss_pred             ceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHH--HHHHH
Confidence            9999999987543322 12234556899999999999999999999999999999999999999976433221  11111


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-CHHHHHHHHHHhH
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-KMSEVVDILGNII  380 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-s~~ei~~~L~~~~  380 (453)
                      .    ...        ..........++++.+||.+||+.||.+|| |++++++.|.++.
T Consensus       228 ~----~~~--------~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         228 R----EDP--------IPPSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             H----CCC--------CCGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             h----cCC--------CCCchhccCCCHHHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            1    000        011111223567899999999999999999 8999998887764

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=396.40  Aligned_cols=263  Identities=28%  Similarity=0.468  Sum_probs=207.7

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC-CcccHHHHHHHHHHhccCCCCceeeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ-GFQGHKEWINEVNFLGVVKHPNLVKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~  170 (453)
                      .++||+|+||+||+|++...+        .....||||+++.. .....++|.+|+++|++++||||++++|+|...+. 
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~--------~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~-  102 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDND--------GKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEG-  102 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC------------CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTT-
T ss_pred             ceEEeecCCeEEEEEEEECCC--------CEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCC-
Confidence            468999999999999986321        22457999999753 33445789999999999999999999999886543 


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEEecccc
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGL  250 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGl  250 (453)
                        ..++|||||++|+|.+++... ...+++..++.++.|++.||.|||+.   +|+||||||+||||++++.+||+|||+
T Consensus       103 --~~~lv~E~~~~g~l~~~~~~~-~~~~~~~~~~~i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~  176 (311)
T d1r0pa_         103 --SPLVVLPYMKHGDLRNFIRNE-THNPTVKDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGL  176 (311)
T ss_dssp             --EEEEEEECCTTCBHHHHHHCT-TCCCBHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGG
T ss_pred             --ceEEEEEEeecCchhhhhccc-cccchHHHHHHHHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccc
Confidence              279999999999999988765 45678889999999999999999998   999999999999999999999999999


Q ss_pred             ccCCCCCCCC--ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhhcccCc
Q 043568          251 ARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRPYVSDS  328 (453)
Q Consensus       251 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~  328 (453)
                      ++........  .......||+.|+|||.+.+..++.++||||||+++|||++|+.||......  ..+...+..    +
T Consensus       177 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~--~~~~~~i~~----g  250 (311)
T d1r0pa_         177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT--FDITVYLLQ----G  250 (311)
T ss_dssp             GCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--------CHHHHHT----T
T ss_pred             hhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCH--HHHHHHHHc----C
Confidence            9875433221  1233467899999999999999999999999999999999988887653221  111111111    1


Q ss_pred             cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          329 KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       329 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      ..          ...+..+++.+.+||.+||+.||++||||.||++.|+++.+....
T Consensus       251 ~~----------~~~p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~  297 (311)
T d1r0pa_         251 RR----------LLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIG  297 (311)
T ss_dssp             CC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCS
T ss_pred             CC----------CCCcccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhh
Confidence            10          011223467899999999999999999999999999999876433

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-52  Score=396.31  Aligned_cols=260  Identities=26%  Similarity=0.382  Sum_probs=200.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|+..+.||+|+||+||+|++....        .....||||++....   ....+.|.+|+.+|++++||||++++|+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~--------~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~   79 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPS--------GKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGV   79 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTT--------SCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCC--------CcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEE
Confidence            56888999999999999999875321        234579999987543   2334679999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      |.+..     .++|||||++|+|.+++..+ ..++++..++.++.|||.||.|||++   +|+||||||+|||++.++.+
T Consensus        80 ~~~~~-----~~lv~e~~~~~~l~~~~~~~-~~~l~~~~~~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~v  150 (273)
T d1u46a_          80 VLTPP-----MKMVTELAPLGSLLDRLRKH-QGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLV  150 (273)
T ss_dssp             ECSSS-----CEEEEECCTTCBHHHHHHHH-GGGSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEE
T ss_pred             Eeecc-----hheeeeeecCcchhhhhhcc-cCCCCHHHHHHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccce
Confidence            97643     58999999999999988765 34699999999999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCc-cccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccCCCChhhHHHHHhh
Q 043568          244 KLSDFGLARQGPPEGLGH-VSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~~~~~~~~~~~~~~  321 (453)
                      ||+|||+++......... ......|+..|+|||++.+..++.++|||||||++|||+| |+.||......   .+...+
T Consensus       151 kl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~---~~~~~i  227 (273)
T d1u46a_         151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS---QILHKI  227 (273)
T ss_dssp             EECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH---HHHHHH
T ss_pred             eeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH---HHHHHH
Confidence            999999999765433222 2334568889999999999999999999999999999998 89998754322   222222


Q ss_pred             hhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHh
Q 043568          322 RPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNI  379 (453)
Q Consensus       322 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~  379 (453)
                      ..   ..          .....+..++..+.+|+.+||+.||++|||+.+|.+.|.+.
T Consensus       228 ~~---~~----------~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         228 DK---EG----------ERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HT---SC----------CCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             Hh---CC----------CCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            11   11          11112234567899999999999999999999999988763

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.6e-52  Score=397.64  Aligned_cols=261  Identities=28%  Similarity=0.447  Sum_probs=208.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccC-CCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVV-KHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l-~h~nIv~l~~~~  164 (453)
                      ++|...++||+|+||+||+|+++.+         .....||||.+.... ....+.|.+|+++|+++ +|||||+++|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~---------~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~   80 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKD---------GLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGAC   80 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEET---------TEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCC---------CeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEE
Confidence            6788899999999999999998742         112358889886443 33456799999999999 799999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeecc
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSR--------------VPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDF  230 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~--------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dl  230 (453)
                      ...+.    +++||||+++|+|.++|...              ....+++..++.++.|||.||.|||+.   +|+||||
T Consensus        81 ~~~~~----~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDl  153 (309)
T d1fvra_          81 EHRGY----LYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDL  153 (309)
T ss_dssp             EETTE----EEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCC
T ss_pred             ecCCe----eEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcC---Ccccccc
Confidence            87664    79999999999999999754              236799999999999999999999998   9999999


Q ss_pred             ccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCc-cccCC
Q 043568          231 KTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRR-AVERN  309 (453)
Q Consensus       231 kp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~-p~~~~  309 (453)
                      ||+|||++.++.+||+|||+++......   ......||..|+|||.+.++.++.++|||||||++|||++|.. ||...
T Consensus       154 kp~NIL~~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~  230 (309)
T d1fvra_         154 AARNILVGENYVAKIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  230 (309)
T ss_dssp             SGGGEEECGGGCEEECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccceEEEcCCCceEEccccccccccccc---cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCC
Confidence            9999999999999999999998644321   2234578999999999999999999999999999999999765 45433


Q ss_pred             CChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          310 LPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       310 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      .   ...+...+..    +.          ....+..+++++.+||.+||+.||++||||.+|++.|++++++.
T Consensus       231 ~---~~~~~~~i~~----~~----------~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~~  287 (309)
T d1fvra_         231 T---CAELYEKLPQ----GY----------RLEKPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  287 (309)
T ss_dssp             C---HHHHHHHGGG----TC----------CCCCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             C---HHHHHHHHHh----cC----------CCCCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhcC
Confidence            2   2223322221    10          11223345678999999999999999999999999999988653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-52  Score=398.06  Aligned_cols=269  Identities=25%  Similarity=0.391  Sum_probs=216.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||.||+|++...      .....+..||||+++.... .....|.+|+.+++++ +|||||+++|+
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~------~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~   95 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGL------IKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGA   95 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESS------SSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEecc------ccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEE
Confidence            36788899999999999999998632      1225678999999976543 3345789999999999 79999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV----------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIF  227 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~----------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH  227 (453)
                      |.+...    .++|||||++|+|.+++....                ...+++..++.++.||+.||+|||++   +|+|
T Consensus        96 ~~~~~~----~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivH  168 (311)
T d1t46a_          96 CTIGGP----TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIH  168 (311)
T ss_dssp             ECSSSS----CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCC
T ss_pred             EeeCCE----EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---Ceee
Confidence            987765    699999999999999997643                23689999999999999999999999   9999


Q ss_pred             eccccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          228 RDFKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       228 ~Dlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      |||||+|||++.++.+||+|||+++...............||+.|+|||++.++.++.++|||||||++|||+|++.|+.
T Consensus       169 rDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~  248 (311)
T d1t46a_         169 RDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY  248 (311)
T ss_dssp             SCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCC
Confidence            99999999999999999999999997665444444566789999999999999999999999999999999999555544


Q ss_pred             CCCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          308 RNLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       308 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ....... .+...+..              ......+...+..+.+||.+||+.||++|||+.+|+++|++++.+
T Consensus       249 ~~~~~~~-~~~~~i~~--------------~~~~~~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~~  308 (311)
T d1t46a_         249 PGMPVDS-KFYKMIKE--------------GFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISE  308 (311)
T ss_dssp             TTCCSSH-HHHHHHHH--------------TCCCCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCHHH-HHHHHHhc--------------CCCCCCcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhcc
Confidence            3322211 11111111              011112223467899999999999999999999999999988765

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-51  Score=398.72  Aligned_cols=249  Identities=26%  Similarity=0.376  Sum_probs=208.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVG  162 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~  162 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||++.+..   ....+.+.+|+.+|++++||||+++++
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~-----------~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~   72 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREK-----------ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY   72 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEEC-----------CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEe
Confidence            467999999999999999999976           567899999997542   334677899999999999999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.+.+.    +++|||||++|+|.+++...  ..+++..+..++.||+.||+|||++   +|+||||||+|||++.+|.
T Consensus        73 ~~~~~~~----~~iv~ey~~gg~L~~~~~~~--~~~~e~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~  143 (337)
T d1o6la_          73 AFQTHDR----LCFVMEYANGGELFFHLSRE--RVFTEERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGH  143 (337)
T ss_dssp             EEECSSE----EEEEEECCTTCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             eeccccc----cccceeccCCCchhhhhhcc--cCCcHHHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCC
Confidence            9988764    79999999999999999876  5788889999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+|+......  ......+||+.|+|||++.+..|+.++|||||||++|||++|+.||.......   +.....
T Consensus       144 vkl~DFG~a~~~~~~~--~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~---~~~~i~  218 (337)
T d1o6la_         144 IKITDFGLCKEGISDG--ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER---LFELIL  218 (337)
T ss_dssp             EEECCCTTCBCSCCTT--CCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             EEEeecccccccccCC--cccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHH---HHHHHh
Confidence            9999999998654322  23456789999999999999999999999999999999999999997654322   222111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      .   ..            ..++...+.++.+||.+||+.||.+||+     ++++++
T Consensus       219 ~---~~------------~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~  260 (337)
T d1o6la_         219 M---EE------------IRFPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME  260 (337)
T ss_dssp             H---CC------------CCCCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred             c---CC------------CCCCccCCHHHHHHHHhhccCCchhhcccccccHHHHHc
Confidence            1   00            0122335677899999999999999995     777765

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2.3e-51  Score=395.10  Aligned_cols=245  Identities=25%  Similarity=0.388  Sum_probs=205.3

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC---CcccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ---GFQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~---~~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|+++           .++..||||++...   .....+.+.+|+.+|++++||||++++++
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~-----------~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~   72 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSR-----------HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGT   72 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEEC-----------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeee
Confidence            57999999999999999999976           45788999998643   23446789999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.+.+.    +++|||||+||+|..++...  ..+++..+..++.||+.||.|||++   +|+||||||+||||+.++.+
T Consensus        73 ~~~~~~----~~ivmE~~~gg~l~~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~v  143 (316)
T d1fota_          73 FQDAQQ----IFMIMDYIEGGELFSLLRKS--QRFPNPVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHI  143 (316)
T ss_dssp             EECSSE----EEEEECCCCSCBHHHHHHHT--SSCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCE
T ss_pred             EeeCCe----eeeEeeecCCcccccccccc--ccccccHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCE
Confidence            987664    79999999999999988876  5678888889999999999999998   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+....     ......||+.|+|||++.+..++.++|||||||++|||++|+.||.......   +...+..
T Consensus       144 kL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~  215 (316)
T d1fota_         144 KITDFGFAKYVPD-----VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK---TYEKILN  215 (316)
T ss_dssp             EECCCSSCEECSS-----CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHH
T ss_pred             EEecCccceEecc-----ccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHH---HHHHHHc
Confidence            9999999987543     2345689999999999999999999999999999999999999997643322   1111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                         ..            ...+...+.++.+++.+||..||.+||     |++++++
T Consensus       216 ---~~------------~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~  256 (316)
T d1fota_         216 ---AE------------LRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN  256 (316)
T ss_dssp             ---CC------------CCCCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred             ---CC------------CCCCCCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHc
Confidence               00            011223457799999999999999996     8888875

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-51  Score=394.80  Aligned_cols=269  Identities=27%  Similarity=0.411  Sum_probs=211.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||.||+|++......    .......||||+++.... ....++.+|+..+.++ +|||||+++++
T Consensus        12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~----~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~   87 (299)
T d1fgka_          12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKD----KPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGA   87 (299)
T ss_dssp             GGGEEEEEECC-----CEEEEEEECC--------CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             HHHeEEeeEEeecCCcEEEEEEEcCCCcc----cccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence            35788889999999999999997643211    113456899999976543 3357788999999888 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeec
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRV--------------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRD  229 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~D  229 (453)
                      |.+...    .++|||||++|+|.++|..+.              ...+++..++.++.||+.||.|||+.   +|||||
T Consensus        88 ~~~~~~----~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrD  160 (299)
T d1fgka_          88 CTQDGP----LYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRD  160 (299)
T ss_dssp             ECSSSS----CEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSC
T ss_pred             cccCCe----EEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeee
Confidence            987654    699999999999999997653              24589999999999999999999999   999999


Q ss_pred             cccccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHh-CCccccC
Q 043568          230 FKTSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELIT-GRRAVER  308 (453)
Q Consensus       230 lkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~ellt-g~~p~~~  308 (453)
                      |||+|||++.++.+||+|||+++...............||+.|+|||.+.++.++.++|||||||++|||++ |..||..
T Consensus       161 iKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             CSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             ecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            999999999999999999999987654444444556789999999999999999999999999999999998 6777765


Q ss_pred             CCChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          309 NLPRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       309 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      ....   .+...+..    +.          ....+...++++.+||.+||+.||.+|||+.||++.|++++..
T Consensus       241 ~~~~---~~~~~i~~----~~----------~~~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a~  297 (299)
T d1fgka_         241 VPVE---ELFKLLKE----GH----------RMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVAL  297 (299)
T ss_dssp             CCHH---HHHHHHHT----TC----------CCCCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHH---HHHHHHHc----CC----------CCCCCccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhhc
Confidence            4322   22222211    11          1112233567899999999999999999999999999988753

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-51  Score=396.13  Aligned_cols=257  Identities=20%  Similarity=0.284  Sum_probs=204.1

Q ss_pred             hcCCCccc-eecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccC-CCCceeeEeee
Q 043568           86 TRGFSRAL-LIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVV-KHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~-~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l-~h~nIv~l~~~  163 (453)
                      .++|.+.. +||+|+||+||+|++.           .+++.||||+++.     ...+.+|+.++.++ +|||||+++++
T Consensus        10 ~~~y~i~~~~lG~G~fg~Vy~a~~~-----------~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~   73 (335)
T d2ozaa1          10 IDDYKVTSQVLGLGINGKVLQIFNK-----------RTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDV   73 (335)
T ss_dssp             GGTEEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEE
T ss_pred             ccCEEEeeEEeeeccCeEEEEEEEC-----------CCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEE
Confidence            46788764 6999999999999976           4578899999853     25677899987655 89999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---C
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---D  240 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~  240 (453)
                      +.+.......++||||||+||+|.++|..+....+++..+..++.||+.||+|||+.   +|+||||||+|||++.   +
T Consensus        74 ~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~  150 (335)
T d2ozaa1          74 YENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPN  150 (335)
T ss_dssp             EEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTT
T ss_pred             EeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHc---CCcccccccccccccccccc
Confidence            876433334589999999999999999887667899999999999999999999999   9999999999999985   5


Q ss_pred             CcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          241 YKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       241 ~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      +.+||+|||+|+......   ......||+.|+|||++.+..|+.++|||||||++|+|+||+.||...........+  
T Consensus       151 ~~~Kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~--  225 (335)
T d2ozaa1         151 AILKLTDFGFAKETTSHN---SLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGM--  225 (335)
T ss_dssp             CCEEECCCTTCEECCCCC---CCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------
T ss_pred             ccccccccceeeeccCCC---ccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHH--
Confidence            679999999998755432   245568999999999999999999999999999999999999999764322211100  


Q ss_pred             hhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                       .....       ..............++++.+||.+||..||++|||+.|+++
T Consensus       226 -~~~i~-------~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~  271 (335)
T d2ozaa1         226 -KTRIR-------MGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMN  271 (335)
T ss_dssp             ---CCC-------SCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             -HHHHh-------cCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence             00000       00111111223356788999999999999999999999876

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-51  Score=393.40  Aligned_cols=273  Identities=23%  Similarity=0.323  Sum_probs=204.8

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHH--HHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEW--INEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~--~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||+||+|+++             +..||||++....   ...+  ..|+..+.+++||||++++|+|
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~-------------g~~vAvK~~~~~~---~~~~~~e~ei~~~~~~~HpnIv~~~~~~   66 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWR-------------GEEVAVKIFSSRE---ERSWFREAEIYQTVMLRHENILGFIAAD   66 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEET-------------TEEEEEEEECGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEEC-------------CEEEEEEEECccc---hhHHHHHHHHHHHhhCCCCcCcceEEEE
Confidence            56777889999999999999863             5789999986432   2333  3455566788999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEeeccccccEEEcC
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM-----DFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----~~~iiH~Dlkp~NILl~~  239 (453)
                      ...+.....+++|||||++|+|.++|.+.   +++|..++.++.|+|.||.|||+..     ..+|+||||||+||||+.
T Consensus        67 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~---~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~  143 (303)
T d1vjya_          67 NKDNGTWTQLWLVSDYHEHGSLFDYLNRY---TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKK  143 (303)
T ss_dssp             EEECSSSEEEEEEEECCTTCBHHHHHHHC---CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECT
T ss_pred             EeCCCcceEEEEEEecccCCCHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcC
Confidence            98776555689999999999999999874   6899999999999999999999731     249999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCC--ccccccccCcCCCCccccccCC------CCCchhHHHHHHHHHHHHhCCccccCCCC
Q 043568          240 DYKAKLSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTGR------LTAKSDVWSFGVVLYELITGRRAVERNLP  311 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~------~~~~~DV~SlGvil~elltg~~p~~~~~~  311 (453)
                      ++.+||+|||+++........  .......||+.|+|||++.+..      ++.++|||||||+||||+||..|+.....
T Consensus       144 ~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~  223 (303)
T d1vjya_         144 NGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED  223 (303)
T ss_dssp             TSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred             CCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence            999999999999865432211  1234568999999999987542      56789999999999999999888754321


Q ss_pred             hhhHH--------HHHhhhhcccCccccccccCCcCCCcc-chHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhh
Q 043568          312 RNEQK--------LLEWVRPYVSDSKKFHLIIDPRLEGNY-CIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISE  382 (453)
Q Consensus       312 ~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~  382 (453)
                      .....        .........     .....++.+.... ....+..+.+|+.+||+.||++|||+.||++.|+++.++
T Consensus       224 ~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         224 YQLPYYDLVPSDPSVEEMRKVV-----CEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCCTTTTTSCSSCCHHHHHHHH-----TTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cccchhhcccccchHHHHHHHH-----hccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence            11000        000000000     0001122222221 334567799999999999999999999999999988765


Q ss_pred             h
Q 043568          383 I  383 (453)
Q Consensus       383 ~  383 (453)
                      -
T Consensus       299 ~  299 (303)
T d1vjya_         299 E  299 (303)
T ss_dssp             H
T ss_pred             c
Confidence            3

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.1e-50  Score=383.14  Aligned_cols=251  Identities=26%  Similarity=0.385  Sum_probs=206.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc---------cHHHHHHHHHHhccCC-CCc
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ---------GHKEWINEVNFLGVVK-HPN  156 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~---------~~~~~~~E~~~l~~l~-h~n  156 (453)
                      ++|...+.||+|+||+||+|++.           .+++.||||++......         ..+.+.+|+.+|++++ |||
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~-----------~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpn   71 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHK-----------PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPN   71 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTT
T ss_pred             ccCEEceEEecCcCeEEEEEEEC-----------CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            68999999999999999999975           46789999999765322         1235889999999996 999


Q ss_pred             eeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEE
Q 043568          157 LVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL  236 (453)
Q Consensus       157 Iv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NIL  236 (453)
                      |+++++++.+.+.    .+||||||++|+|.++|..+  .++++..+..++.||+.||+|||++   +|+||||||+|||
T Consensus        72 Iv~~~~~~~~~~~----~~ivmE~~~~g~L~~~l~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nil  142 (277)
T d1phka_          72 IIQLKDTYETNTF----FFLVFDLMKKGELFDYLTEK--VTLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENIL  142 (277)
T ss_dssp             BCCEEEEEECSSE----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             eEEEEeecccCcc----eEEEEEcCCCchHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEE
Confidence            9999999987664    79999999999999999875  5789999999999999999999998   9999999999999


Q ss_pred             EcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc------CCCCCchhHHHHHHHHHHHHhCCccccCCC
Q 043568          237 LDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT------GRLTAKSDVWSFGVVLYELITGRRAVERNL  310 (453)
Q Consensus       237 l~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DV~SlGvil~elltg~~p~~~~~  310 (453)
                      ++.++.+||+|||+++......   ......||+.|+|||++.+      ..++.++||||+||++|||++|+.||....
T Consensus       143 l~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         143 LDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             ECTTCCEEECCCTTCEECCTTC---CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EcCCCCeEEccchheeEccCCC---ceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            9999999999999998765422   2455689999999999863      346889999999999999999999998654


Q ss_pred             ChhhHHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          311 PRNEQKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       311 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      +......   +..   .        ............++++.+|+.+||+.||++|||+.||++
T Consensus       220 ~~~~~~~---i~~---~--------~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~  269 (277)
T d1phka_         220 QMLMLRM---IMS---G--------NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA  269 (277)
T ss_dssp             HHHHHHH---HHH---T--------CCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTT
T ss_pred             HHHHHHH---HHh---C--------CCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHc
Confidence            3222111   110   0        001111223356788999999999999999999999864

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.1e-50  Score=395.77  Aligned_cols=245  Identities=24%  Similarity=0.333  Sum_probs=206.1

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      ++|...+.||+|+||+||+|+++           .+++.||||++....   ....+.+.+|+.+|+.++||||++++++
T Consensus        41 d~y~i~~~lG~G~fg~Vy~a~~~-----------~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~  109 (350)
T d1rdqe_          41 DQFDRIKTLGTGSFGRVMLVKHK-----------ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFS  109 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEE
T ss_pred             cCeEEEEEeecCcCcEEEEEEEC-----------CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccc
Confidence            68999999999999999999986           457889999986432   2445678999999999999999999999


Q ss_pred             eeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcE
Q 043568          164 CAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKA  243 (453)
Q Consensus       164 ~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~  243 (453)
                      +.....    .++||||+.+|+|.+++...  ..+++..+..++.||+.||.|||++   +||||||||+||||+.++.+
T Consensus       110 ~~~~~~----~~~v~e~~~~g~l~~~l~~~--~~l~e~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~i  180 (350)
T d1rdqe_         110 FKDNSN----LYMVMEYVAGGEMFSHLRRI--GRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYI  180 (350)
T ss_dssp             EECSSE----EEEEEECCTTCBHHHHHHHH--CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCE
T ss_pred             cccccc----cccccccccccchhhhHhhc--CCCCHHHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCE
Confidence            987664    79999999999999999876  4789999999999999999999999   99999999999999999999


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+|+....     ......||+.|||||++.+..++.++|||||||++|||++|+.||....+..   +...+..
T Consensus       181 kL~DFG~a~~~~~-----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~---~~~~i~~  252 (350)
T d1rdqe_         181 QVTDFGFAKRVKG-----RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ---IYEKIVS  252 (350)
T ss_dssp             EECCCTTCEECSS-----CBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHHH
T ss_pred             Eeeeceeeeeccc-----ccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHH---HHHHHhc
Confidence            9999999987542     2345689999999999999999999999999999999999999997653222   2221111


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCC-----CHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRP-----KMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP-----s~~ei~~  374 (453)
                      .   .            ...+...+.++.+||.+||..||.+|+     |++++++
T Consensus       253 ~---~------------~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~  293 (350)
T d1rdqe_         253 G---K------------VRFPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN  293 (350)
T ss_dssp             C---C------------CCCCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred             C---C------------CCCCccCCHHHHHHHHHHhhhCHHhccccccccHHHHHc
Confidence            0   0            011223467899999999999999994     8898875

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-50  Score=396.52  Aligned_cols=250  Identities=25%  Similarity=0.357  Sum_probs=202.2

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc---ccHHHHH---HHHHHhccCCCCceee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF---QGHKEWI---NEVNFLGVVKHPNLVK  159 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~---~~~~~~~---~E~~~l~~l~h~nIv~  159 (453)
                      .++|...++||+|+||+||+|+++           .++..||||++.+...   .....+.   .|+.+++.++|||||+
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~-----------~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~   71 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKA-----------DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVC   71 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEET-----------TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCC
T ss_pred             HHhCeeeeEEecCCCeEEEEEEEC-----------CCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEE
Confidence            368999999999999999999976           4578899999864321   2223333   4577888889999999


Q ss_pred             EeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          160 LVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       160 l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++++...+.    ++||||||++|+|.++|...  ..+++..+..++.||+.||.|||++   +||||||||+|||++.
T Consensus        72 l~~~~~~~~~----~~ivmE~~~gg~L~~~l~~~--~~~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~  142 (364)
T d1omwa3          72 MSYAFHTPDK----LSFILDLMNGGDLHYHLSQH--GVFSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDE  142 (364)
T ss_dssp             EEEEEECSSE----EEEEECCCCSCBHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECS
T ss_pred             EEEEEEECCE----EEEEEEecCCCcHHHHHHhc--ccccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcC
Confidence            9999987664    79999999999999999875  5688899999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      ++.+||+|||+|+.....    ......||+.|+|||++.. ..++.++|||||||++|||++|+.||..........+.
T Consensus       143 ~g~iKl~DFGla~~~~~~----~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~  218 (364)
T d1omwa3         143 HGHVRISDLGLACDFSKK----KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID  218 (364)
T ss_dssp             SSCEEECCCTTCEECSSS----CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred             CCcEEEeeeceeeecCCC----cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence            999999999999875432    2345679999999999875 56899999999999999999999999865443333332


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      .....               .....+...++++.+||.+||..||++|||     ++++++
T Consensus       219 ~~~~~---------------~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~  264 (364)
T d1omwa3         219 RMTLT---------------MAVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE  264 (364)
T ss_dssp             HHSSS---------------CCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred             Hhccc---------------CCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHc
Confidence            21110               001112234678999999999999999999     577764

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-51  Score=392.63  Aligned_cols=265  Identities=26%  Similarity=0.439  Sum_probs=211.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC-cccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG-FQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~-~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      ++|...+.||+|+||+||+|.++...      ....+..||||+++... ......|.+|+.++++++||||++++|+|.
T Consensus        20 ~~~~l~~~lG~G~fG~Vy~a~~~~~~------~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~   93 (308)
T d1p4oa_          20 EKITMSRELGQGSFGMVYEGVAKGVV------KDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVS   93 (308)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEEEEEE------TTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEEC
T ss_pred             HHeEEeeEEeeCCCeEEEEEEECCcc------cCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEe
Confidence            67888899999999999999986421      11335789999997543 233456899999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRV--------PTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILL  237 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~--------~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl  237 (453)
                      ....    .++|||||++|+|.+++....        ...+++..+++++.|+|.||.|||++   +|+||||||+|||+
T Consensus        94 ~~~~----~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLl  166 (308)
T d1p4oa_          94 QGQP----TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMV  166 (308)
T ss_dssp             SSSS----CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEE
T ss_pred             cCCc----eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceee
Confidence            7665    699999999999999886431        24578999999999999999999998   99999999999999


Q ss_pred             cCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCC-ccccCCCChhhHH
Q 043568          238 DEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGR-RAVERNLPRNEQK  316 (453)
Q Consensus       238 ~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~-~p~~~~~~~~~~~  316 (453)
                      +.++++||+|||+|+...............||+.|+|||.+.+..++.++|||||||++|||+||. .||......   .
T Consensus       167 d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~---~  243 (308)
T d1p4oa_         167 AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE---Q  243 (308)
T ss_dssp             CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH---H
T ss_pred             cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHH---H
Confidence            999999999999998654433333345567999999999999999999999999999999999985 556443221   2


Q ss_pred             HHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHh
Q 043568          317 LLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIIS  381 (453)
Q Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~  381 (453)
                      ....+..    +..          ...+..++..+.+|+.+||+.+|.+|||+.+|++.|++.++
T Consensus       244 ~~~~i~~----~~~----------~~~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         244 VLRFVME----GGL----------LDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHHHT----TCC----------CCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHHHh----CCC----------CCCcccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            2221111    110          11122346789999999999999999999999999876544

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.4e-50  Score=387.92  Aligned_cols=252  Identities=21%  Similarity=0.320  Sum_probs=206.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .++|...+.||+|+||+||+|+++           .++..||||+++... .....+.+|+.+|+.++|||||++++++.
T Consensus         4 ~~rY~i~~~lG~G~fg~Vy~~~~~-----------~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~   71 (321)
T d1tkia_           4 YEKYMIAEDLGRGEFGIVHRCVET-----------SSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFE   71 (321)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEE
T ss_pred             ccceEEEEEEecCCCeEEEEEEEC-----------CCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEE
Confidence            467999999999999999999976           567899999997654 23456889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC--CCcE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE--DYKA  243 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~--~~~~  243 (453)
                      +.+.    ++||||||+||+|.++|... +..+++..+..++.||+.||.|||++   +|+||||||+|||++.  .+.+
T Consensus        72 ~~~~----~~lvmE~~~gg~L~~~i~~~-~~~l~e~~~~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~i  143 (321)
T d1tkia_          72 SMEE----LVMIFEFISGLDIFERINTS-AFELNEREIVSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTI  143 (321)
T ss_dssp             ETTE----EEEEECCCCCCBHHHHHTSS-SCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCE
T ss_pred             ECCE----EEEEEecCCCCcHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEE
Confidence            7664    79999999999999999765 34789999999999999999999998   9999999999999985  4579


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhhh
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVRP  323 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~~  323 (453)
                      ||+|||+++.....   .......||+.|+|||.+.+..++.++|||||||++|+|++|..||.......   +...+..
T Consensus       144 kl~DFG~~~~~~~~---~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~---~~~~i~~  217 (321)
T d1tkia_         144 KIIEFGQARQLKPG---DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ---IIENIMN  217 (321)
T ss_dssp             EECCCTTCEECCTT---CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH---HHHHHHH
T ss_pred             EEcccchhhccccC---CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHH---HHHHHHh
Confidence            99999999875432   23455689999999999999999999999999999999999999997654322   2111110


Q ss_pred             cccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                         ...        ..........+.++.+|+.+||..||.+|||+.|+++
T Consensus       218 ---~~~--------~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  257 (321)
T d1tkia_         218 ---AEY--------TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ  257 (321)
T ss_dssp             ---TCC--------CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred             ---CCC--------CCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence               000        0011111234677999999999999999999999986

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-50  Score=390.02  Aligned_cols=248  Identities=25%  Similarity=0.418  Sum_probs=204.5

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC---cccHHHHHHHHHHhc-cCCCCceeeEee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG---FQGHKEWINEVNFLG-VVKHPNLVKLVG  162 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~---~~~~~~~~~E~~~l~-~l~h~nIv~l~~  162 (453)
                      ++|...+.||+|+||+||+|+++           .+++.||||++.+..   ....+.+..|..++. .++||||+++++
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~-----------~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~   70 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFK-----------KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFC   70 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-----------TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEEC-----------CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEE
Confidence            57899999999999999999986           567899999996432   234566777877765 689999999999


Q ss_pred             eeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          163 YCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       163 ~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      ++.+.+.    .++|||||++|+|.+++...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.
T Consensus        71 ~~~~~~~----~yivmEy~~~g~L~~~i~~~--~~~~e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~  141 (320)
T d1xjda_          71 TFQTKEN----LFFVMEYLNGGDLMYHIQSC--HKFDLSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGH  141 (320)
T ss_dssp             EEECSSE----EEEEEECCTTCBHHHHHHHH--SSCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSC
T ss_pred             EEccCCc----eeEEEeecCCCcHHHHhhcc--CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCc
Confidence            9988764    79999999999999999875  5688899999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      +||+|||+++.....  ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+..   +...+.
T Consensus       142 ~kl~DFG~a~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~---~~~~i~  216 (320)
T d1xjda_         142 IKIADFGMCKENMLG--DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEE---LFHSIR  216 (320)
T ss_dssp             EEECCCTTCBCCCCT--TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH---HHHHHH
T ss_pred             eeccccchhhhcccc--cccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHH---HHHHHH
Confidence            999999999865432  223455689999999999999999999999999999999999999997654322   222111


Q ss_pred             hcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHH-HHHH
Q 043568          323 PYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMS-EVVD  374 (453)
Q Consensus       323 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~-ei~~  374 (453)
                      .   .        .+    .++...+.++.+||.+||..||.+|||+. ++++
T Consensus       217 ~---~--------~~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~  254 (320)
T d1xjda_         217 M---D--------NP----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ  254 (320)
T ss_dssp             H---C--------CC----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred             c---C--------CC----CCCccCCHHHHHHHHHhcccCCCCCcCHHHHHHh
Confidence            0   0        01    11223467799999999999999999985 6653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-50  Score=381.45  Aligned_cols=267  Identities=23%  Similarity=0.324  Sum_probs=202.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...+.||+|+||+||+|++.           .+++.||||++.....  .....+.+|+.+|++++|||||++++++
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~   70 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNK-----------LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVI   70 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEEC-----------CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEecccc
Confidence            58999999999999999999986           4578899999965432  2357899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .+.+.    .++||||+. +.+.+++.......+++..+..++.||+.||.|||+.   +||||||||+|||++.++.+|
T Consensus        71 ~~~~~----~~iv~e~~~-~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~k  142 (298)
T d1gz8a_          71 HTENK----LYLVFEFLH-QDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIK  142 (298)
T ss_dssp             EETTE----EEEEEECCS-EEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccccc----eeEEEeecC-CchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcce
Confidence            88764    799999995 5566666655567899999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCC-CCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~~~  322 (453)
                      |+|||+|+.....  ........||+.|+|||.+.... ++.++|||||||++|+|++|+.||.......... +.....
T Consensus       143 l~DFG~a~~~~~~--~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~  220 (298)
T d1gz8a_         143 LADFGLARAFGVP--VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLG  220 (298)
T ss_dssp             ECSTTHHHHHCCC--SBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             eccCCcceeccCC--cccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcC
Confidence            9999999865432  22345568999999999877655 5889999999999999999999997643222111 111100


Q ss_pred             hcc-cCccccccc------cCCcCCC---ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYV-SDSKKFHLI------IDPRLEG---NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~-~~~~~~~~~------~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ... .........      .......   ......+.++.+|+.+||..||++|||+.|+++
T Consensus       221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~  282 (298)
T d1gz8a_         221 TPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALA  282 (298)
T ss_dssp             CCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhC
Confidence            000 000000000      0000000   011234578899999999999999999999976

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-49  Score=381.50  Aligned_cols=262  Identities=23%  Similarity=0.287  Sum_probs=195.3

Q ss_pred             ccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc-----cHHHHHHHHHHhccCCCCceeeEeeeee
Q 043568           91 RALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ-----GHKEWINEVNFLGVVKHPNLVKLVGYCA  165 (453)
Q Consensus        91 ~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~-----~~~~~~~E~~~l~~l~h~nIv~l~~~~~  165 (453)
                      .+++||+|+||+||+|+++           .+++.||||+++.....     ..+.+.+|+.+|++++|||||++++++.
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~   70 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDK-----------NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFG   70 (299)
T ss_dssp             EEEEEEEETTEEEEEEECS-----------SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cceEeccCcCeEEEEEEEC-----------CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeec
Confidence            3578999999999999975           45788999998654322     1356889999999999999999999998


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAKL  245 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~kL  245 (453)
                      ..+.    .+|||||+.++++...+...  ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++.+||
T Consensus        71 ~~~~----~~ivmE~~~~~~~~~~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL  141 (299)
T d1ua2a_          71 HKSN----ISLVFDFMETDLEVIIKDNS--LVLTPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKL  141 (299)
T ss_dssp             CTTC----CEEEEECCSEEHHHHHTTCC--SSCCSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEE
T ss_pred             cCCc----eeehhhhhcchHHhhhhhcc--cCCCHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCcccc
Confidence            8765    69999999888777665443  5678888999999999999999999   9999999999999999999999


Q ss_pred             eccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-HHhhhh
Q 043568          246 SDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-LEWVRP  323 (453)
Q Consensus       246 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-~~~~~~  323 (453)
                      +|||+|+......  .......||+.|+|||++.. ..++.++|||||||++|||++|..||......+.... .+....
T Consensus       142 ~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~  219 (299)
T d1ua2a_         142 ADFGLAKSFGSPN--RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGT  219 (299)
T ss_dssp             CCCGGGSTTTSCC--CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCC
T ss_pred             ccCccccccCCCc--ccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCC
Confidence            9999998754432  22345679999999999865 4689999999999999999999999976543332211 111100


Q ss_pred             cc----cCccccccccC-CcCC----CccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          324 YV----SDSKKFHLIID-PRLE----GNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       324 ~~----~~~~~~~~~~~-~~~~----~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..    ........... ....    .......++++.+|+.+||..||++|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~  279 (299)
T d1ua2a_         220 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK  279 (299)
T ss_dssp             CCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred             CChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhC
Confidence            00    00000000000 0000    0011234578999999999999999999999875

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-50  Score=377.54  Aligned_cols=241  Identities=26%  Similarity=0.423  Sum_probs=196.8

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc------cHHHHHHHHHHhccCC--CCce
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------GHKEWINEVNFLGVVK--HPNL  157 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------~~~~~~~E~~~l~~l~--h~nI  157 (453)
                      .++|.+.++||+|+||+||+|++.           .++..||||++......      ....+.+|+.+|++++  ||||
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nI   71 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRV-----------SDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV   71 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSB
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCc
Confidence            357999999999999999999976           45788999998754221      1234678999999996  8999


Q ss_pred             eeEeeeeeecccccceEEEEEEecCC-CChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEE
Q 043568          158 VKLVGYCAEDDERGMQRLLVYELMHN-KSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNIL  236 (453)
Q Consensus       158 v~l~~~~~~~~~~~~~~~lv~e~~~~-gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NIL  236 (453)
                      |++++++.+.+.    .++||||+.+ +++.+++...  ..+++..+..++.||+.||.|||+.   +|+||||||+|||
T Consensus        72 v~~~~~~~~~~~----~~lv~e~~~~~~~l~~~~~~~--~~l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIl  142 (273)
T d1xwsa_          72 IRLLDWFERPDS----FVLILERPEPVQDLFDFITER--GALQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENIL  142 (273)
T ss_dssp             CCEEEEEECSSE----EEEEEECCSSEEEHHHHHHHH--CSCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEE
T ss_pred             cEEEEEEeeCCe----EEEEEEeccCcchHHHHHhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceE
Confidence            999999987664    7999999976 6788887765  5789999999999999999999998   9999999999999


Q ss_pred             EcC-CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCC-CCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          237 LDE-DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRL-TAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       237 l~~-~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      ++. ++.+||+|||+|+.....    ..+...||+.|+|||++.+..+ +.++|||||||++|||++|+.||...     
T Consensus       143 l~~~~~~vkl~DFG~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~-----  213 (273)
T d1xwsa_         143 IDLNRGELKLIDFGSGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD-----  213 (273)
T ss_dssp             EETTTTEEEECCCTTCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH-----
T ss_pred             EecCCCeEEECccccceecccc----cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc-----
Confidence            985 479999999999875432    2445689999999999987665 67899999999999999999999642     


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..+...       .            ..++...+.++.+|+.+||..||++|||++|+++
T Consensus       214 ~~i~~~-------~------------~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~  254 (273)
T d1xwsa_         214 EEIIRG-------Q------------VFFRQRVSSECQHLIRWCLALRPSDRPTFEEIQN  254 (273)
T ss_dssp             HHHHHC-------C------------CCCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred             hHHhhc-------c------------cCCCCCCCHHHHHHHHHHccCCHhHCcCHHHHhc
Confidence            111110       0            0111234678999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-48  Score=373.45  Aligned_cols=272  Identities=24%  Similarity=0.287  Sum_probs=203.0

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccC---CCCceeeE
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVV---KHPNLVKL  160 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l---~h~nIv~l  160 (453)
                      .++|...+.||+|+||+||+|++..          .+++.||||++....  ......+.+|+.+|+.|   +||||+++
T Consensus         6 ~~~Y~i~~~LG~G~fg~V~~a~~~~----------~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~   75 (305)
T d1blxa_           6 DQQYECVAEIGEGAYGKVFKARDLK----------NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRL   75 (305)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETT----------TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCE
T ss_pred             cCCEEEEEEEecccCeEEEEEEEEC----------CCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCccee
Confidence            5789999999999999999999741          235679999986432  22234566788877766   79999999


Q ss_pred             eeeeeeccc-ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          161 VGYCAEDDE-RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       161 ~~~~~~~~~-~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +++|..... .....+++|||++++++.... ......+++..+..++.|++.||+|||++   +|+||||||+|||++.
T Consensus        76 ~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~-~~~~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~  151 (305)
T d1blxa_          76 FDVCTVSRTDRETKLTLVFEHVDQDLTTYLD-KVPEPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTS  151 (305)
T ss_dssp             EEEEEEEECSSEEEEEEEEECCSCBHHHHHH-HSCTTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECT
T ss_pred             eeeecccccccCceEEEEEEeccCCchhhhh-hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcC
Confidence            999875432 223579999999877665443 33456789999999999999999999999   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH-
Q 043568          240 DYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL-  318 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~-  318 (453)
                      ++.+||+|||+++....   ........||+.|+|||++.+..++.++|||||||++|||++|+.||....+......+ 
T Consensus       152 ~~~~kl~dfg~~~~~~~---~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~  228 (305)
T d1blxa_         152 SGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL  228 (305)
T ss_dssp             TCCEEECSCCSCCCCCG---GGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred             CCCeeecchhhhhhhcc---cccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence            99999999999986442   23445678999999999999999999999999999999999999999765433322211 


Q ss_pred             Hhhhhc----ccCccc-cccc---cCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          319 EWVRPY----VSDSKK-FHLI---IDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       319 ~~~~~~----~~~~~~-~~~~---~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......    +..... ....   .............++.+.+|+.+||..||++|||+.|+++
T Consensus       229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~  292 (305)
T d1blxa_         229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS  292 (305)
T ss_dssp             HHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             HhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            111000    000000 0000   0001111123345678899999999999999999999875

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=3.1e-48  Score=368.97  Aligned_cols=265  Identities=21%  Similarity=0.314  Sum_probs=198.7

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|...++||+|+||+||+|+++            +++.||||++.....  ...+.+.+|+.+|++++||||+++++++
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~------------~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~   69 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN------------YGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI   69 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET------------TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC------------CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeec
Confidence            57999999999999999999863            357899999975432  3357899999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .+++|||+.++.+..+....  ..++...+..++.||+.||+|||+.   +||||||||+|||++.++.+|
T Consensus        70 ~~~~~----~~i~~e~~~~~~~~~~~~~~--~~l~~~~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~k  140 (286)
T d1ob3a_          70 HTKKR----LVLVFEHLDQDLKKLLDVCE--GGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELK  140 (286)
T ss_dssp             ECSSC----EEEEEECCSEEHHHHHHTST--TCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEE
T ss_pred             ccCCc----eeEEEEeehhhhHHHHHhhc--CCcchhhhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEE
Confidence            88765    69999999777666655443  6799999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-HHhhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-LEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-~~~~~  322 (453)
                      |+|||++.......  .......|++.|+|||.+.+ ..++.++|||||||++|||++|+.||......+...- .....
T Consensus       141 l~DfG~a~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~  218 (286)
T d1ob3a_         141 IADFGLARAFGIPV--RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILG  218 (286)
T ss_dssp             ECCTTHHHHHCC-----------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHC
T ss_pred             ecccccceecccCc--cccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhC
Confidence            99999998654322  22345578999999999875 4579999999999999999999999976433222111 11000


Q ss_pred             h-c---ccCccc---cc---cccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 P-Y---VSDSKK---FH---LIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~-~---~~~~~~---~~---~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      . .   ......   ..   ....+..........++.+.+|+.+||..||++|||++|+++
T Consensus       219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~  280 (286)
T d1ob3a_         219 TPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE  280 (286)
T ss_dssp             CCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred             CCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0 0   000000   00   000111111122334678999999999999999999999874

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-47  Score=374.74  Aligned_cols=272  Identities=23%  Similarity=0.306  Sum_probs=201.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc-ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF-QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~-~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      +.+|...++||+|+||+||+|+++           .+++.||||++..... ...+.+++|+.+|++++||||+++++++
T Consensus         7 ~~rY~~~~~LG~G~fg~Vy~~~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~   75 (345)
T d1pmea_           7 GPRYTNLSYIGEGAYGMVCSAYDN-----------VNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII   75 (345)
T ss_dssp             CTTEEEEEECC---CCCEEEEEET-----------TTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEE
T ss_pred             CCCeEEEEEEeeccCeEEEEEEEC-----------CCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEE
Confidence            467999999999999999999975           4578899999975432 3356789999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      ..........+++++|+.+|+|.+++..+   .+++..+..++.|++.||+|||++   +||||||||+|||++.++.+|
T Consensus        76 ~~~~~~~~~~~~l~~~~~~g~L~~~l~~~---~l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~k  149 (345)
T d1pmea_          76 RAPTIEQMKDVYLVTHLMGADLYKLLKTQ---HLSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLK  149 (345)
T ss_dssp             CCSSTTTCCCEEEEEECCCEEHHHHHHHC---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEE
T ss_pred             eeccccccceEEEEEeecCCchhhhhhcC---CCCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEE
Confidence            77654333345556677799999999764   689999999999999999999999   999999999999999999999


Q ss_pred             EeccccccCCCCCCCC-ccccccccCcCCCCccccc-cCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhhh
Q 043568          245 LSDFGLARQGPPEGLG-HVSTSVVGTVGYAAPEYVQ-TGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWVR  322 (453)
Q Consensus       245 L~DFGla~~~~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~~  322 (453)
                      |+|||+++........ .......||+.|+|||++. ...++.++||||+||++|||++|+.||................
T Consensus       150 l~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~  229 (345)
T d1pmea_         150 ICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGIL  229 (345)
T ss_dssp             ECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHH
T ss_pred             EcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhc
Confidence            9999999865433221 1234567999999999985 4567899999999999999999999997654332222111111


Q ss_pred             hcccCcc--------cccc-ccCCc-CCC---ccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          323 PYVSDSK--------KFHL-IIDPR-LEG---NYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       323 ~~~~~~~--------~~~~-~~~~~-~~~---~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .......        .... ...+. ...   ......+.++.+|+.+||..||.+|||+.++++
T Consensus       230 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~  294 (345)
T d1pmea_         230 GSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALA  294 (345)
T ss_dssp             CSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             cCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            0000000        0000 00000 000   011233467899999999999999999999986

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.4e-47  Score=365.14  Aligned_cols=265  Identities=20%  Similarity=0.270  Sum_probs=202.6

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAE  166 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~  166 (453)
                      ++|+..+.||+|+||+||+|++.           .+++.||||++.....  ..++..|+++++.++|+|++..++.+..
T Consensus         7 ~rY~l~~~iG~G~fG~Vy~a~~~-----------~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~   73 (299)
T d1ckia_           7 NRYRLGRKIGSGSFGDIYLGTDI-----------AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGA   73 (299)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEET-----------TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEE
T ss_pred             CEEEEeEEEeeCCCcEEEEEEEC-----------CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEe
Confidence            57999999999999999999976           4578999999865432  2457899999999988776666665554


Q ss_pred             cccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC---CCcE
Q 043568          167 DDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE---DYKA  243 (453)
Q Consensus       167 ~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~---~~~~  243 (453)
                      ...   ..++||||+ +++|.+.+... ...+++..++.++.|++.||+|||++   +|+||||||+|||++.   +..+
T Consensus        74 ~~~---~~~ivme~~-~~~l~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~v  145 (299)
T d1ckia_          74 EGD---YNVMVMELL-GPSLEDLFNFC-SRKFSLKTVLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLV  145 (299)
T ss_dssp             ETT---EEEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCE
T ss_pred             cCC---EEEEEEEEc-CCchhhhhhhc-cCCCcHHHHHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCcee
Confidence            443   378999999 66777766543 35789999999999999999999999   9999999999999864   5579


Q ss_pred             EEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHH
Q 043568          244 KLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLL  318 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~  318 (453)
                      ||+|||+|+........     .......||+.|+|||++.+..++.++|||||||++|||++|+.||............
T Consensus       146 kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~  225 (299)
T d1ckia_         146 YIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY  225 (299)
T ss_dssp             EECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------H
T ss_pred             eeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHH
Confidence            99999999875433221     1234568999999999999999999999999999999999999999765433222211


Q ss_pred             H-hhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhh
Q 043568          319 E-WVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEI  383 (453)
Q Consensus       319 ~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~  383 (453)
                      . ........           .....+..++.++.+++.+||+.+|++||++.++.+.|+.+....
T Consensus       226 ~~~~~~~~~~-----------~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         226 ERISEKKMST-----------PIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHHHHHHHHS-----------CHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHhhcccCCC-----------ChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            1 11100000           000112234678999999999999999999999999999887643

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.1e-47  Score=361.43  Aligned_cols=268  Identities=17%  Similarity=0.224  Sum_probs=211.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCC-CceeeEeeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKH-PNLVKLVGYC  164 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h-~nIv~l~~~~  164 (453)
                      .++|.+.+.||+|+||+||+|++.           .+++.||||++....  ....+.+|+++++.+.| +||+.+++++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~-----------~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~   70 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNL-----------LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFG   70 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEET-----------TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEe
Confidence            368999999999999999999976           457899999986543  23456788999998865 8999999998


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC-----
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE-----  239 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~-----  239 (453)
                      .....    .++||||+ +++|.+++... ...++...++.++.|++.||.|||+.   +|+||||||+|||++.     
T Consensus        71 ~~~~~----~~~vme~~-~~~l~~~~~~~-~~~~~~~~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~  141 (293)
T d1csna_          71 QEGLH----NVLVIDLL-GPSLEDLLDLC-GRKFSVKTVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKN  141 (293)
T ss_dssp             EETTE----EEEEEECC-CCBHHHHHHHT-TTCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTT
T ss_pred             ecCCc----cEEEEEec-CCCHHHHHHhh-ccchhhHHHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCccccc
Confidence            77654    69999999 79999988664 35789999999999999999999998   9999999999999974     


Q ss_pred             CCcEEEeccccccCCCCCCCC-----ccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhh
Q 043568          240 DYKAKLSDFGLARQGPPEGLG-----HVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNE  314 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~  314 (453)
                      ++.+||+|||+|+........     .......||+.|||||++.+..++.++|||||||++|||++|+.||........
T Consensus       142 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~  221 (293)
T d1csna_         142 ANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATN  221 (293)
T ss_dssp             TTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCH
T ss_pred             CCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhH
Confidence            578999999999875432211     123456899999999999999999999999999999999999999976544433


Q ss_pred             HHHHHhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHHHHHHhHhhhcc
Q 043568          315 QKLLEWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVDILGNIISEISS  385 (453)
Q Consensus       315 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~~L~~~~~~~~~  385 (453)
                      ......+..... ...         ....+..+++++.+++..|+..+|++||+++.+.+.|++++.....
T Consensus       222 ~~~~~~i~~~~~-~~~---------~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~  282 (293)
T d1csna_         222 KQKYERIGEKKQ-STP---------LRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNT  282 (293)
T ss_dssp             HHHHHHHHHHHH-HSC---------HHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             HHHHHHHHhccC-CCC---------hHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCC
Confidence            222221111000 000         0111223467899999999999999999999999999998876543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-47  Score=370.51  Aligned_cols=266  Identities=27%  Similarity=0.312  Sum_probs=195.5

Q ss_pred             CCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCceeeEeeeeeec
Q 043568           88 GFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNLVKLVGYCAED  167 (453)
Q Consensus        88 ~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~  167 (453)
                      +|...++||+|+||+||+|++.           .+++.||||++.....    .+.+|+.+|++++||||+++++++...
T Consensus        21 ~Y~~~k~LG~G~fg~Vy~a~~~-----------~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~   85 (350)
T d1q5ka_          21 SYTDTKVIGNGSFGVVYQAKLC-----------DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSS   85 (350)
T ss_dssp             EEEEEEEEEEETTEEEEEEEET-----------TTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC
T ss_pred             CcEeeeEEeeCcCeEEEEEEEC-----------CCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEec
Confidence            5788889999999999999986           4578899999975432    234799999999999999999999765


Q ss_pred             cc--ccceEEEEEEecCCCChHHhhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-cE
Q 043568          168 DE--RGMQRLLVYELMHNKSLEDHLL-SRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-KA  243 (453)
Q Consensus       168 ~~--~~~~~~lv~e~~~~gsL~~~l~-~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~  243 (453)
                      ..  .....+||||||+++.+..... ......+++..+..++.||+.||+|||++   +|+||||||+|||++.++ .+
T Consensus        86 ~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~  162 (350)
T d1q5ka_          86 GEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVL  162 (350)
T ss_dssp             --CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCE
T ss_pred             CccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCce
Confidence            42  2234789999997664443332 12346799999999999999999999998   999999999999999775 89


Q ss_pred             EEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHH-HHh-
Q 043568          244 KLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKL-LEW-  320 (453)
Q Consensus       244 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~-~~~-  320 (453)
                      ||+|||+++......   ......||..|+|||.+.+ ..++.++|||||||++|||++|+.||......+.... ... 
T Consensus       163 kl~DFG~a~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~  239 (350)
T d1q5ka_         163 KLCDFGSAKQLVRGE---PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVL  239 (350)
T ss_dssp             EECCCTTCEECCTTS---CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHH
T ss_pred             eEecccchhhccCCc---ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHh
Confidence            999999998754322   2345689999999998765 5789999999999999999999999976543222111 110 


Q ss_pred             -------hhhcccCc--cccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 -------VRPYVSDS--KKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 -------~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             ........  ..+................++++.+|+.+||..||++|||+.|+++
T Consensus       240 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~  302 (350)
T d1q5ka_         240 GTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACA  302 (350)
T ss_dssp             CCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   00000000  0000000000001112234677999999999999999999999875

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-47  Score=364.54  Aligned_cols=273  Identities=21%  Similarity=0.285  Sum_probs=198.3

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC--cccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG--FQGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...+.||+|+||+||+|+++           .+++.||||++....  ......+.+|+.+|++++||||++++++
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~   77 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHR-----------KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEI   77 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             cCCEEEEEEEecCcCeEEEEEEEC-----------CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEee
Confidence            478999999999999999999976           457899999986542  2345678999999999999999999999


Q ss_pred             eeecccc----cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcC
Q 043568          164 CAEDDER----GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDE  239 (453)
Q Consensus       164 ~~~~~~~----~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~  239 (453)
                      +......    ....++||||+.++++..+...  ...++...+..++.||+.||.|||+.   +|+||||||+|||++.
T Consensus        78 ~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~--~~~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~  152 (318)
T d3blha1          78 CRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITR  152 (318)
T ss_dssp             EEC----------CEEEEEECCCEEHHHHHTCT--TCCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECT
T ss_pred             eecccccccccCceEEEEEeccCCCccchhhhc--ccccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecC
Confidence            8664321    1247899999987776654433  35788889999999999999999998   9999999999999999


Q ss_pred             CCcEEEeccccccCCCCCCCC--ccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH
Q 043568          240 DYKAKLSDFGLARQGPPEGLG--HVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK  316 (453)
Q Consensus       240 ~~~~kL~DFGla~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~  316 (453)
                      ++.+||+|||+++........  .......||+.|+|||++.+. .++.++|||||||++|||++|+.||..........
T Consensus       153 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~  232 (318)
T d3blha1         153 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA  232 (318)
T ss_dssp             TSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred             CCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHH
Confidence            999999999999765432211  123345799999999998764 68999999999999999999999997654433322


Q ss_pred             HHHhhhhcccCcc--------ccccccCCcCCCc-cc-----hHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          317 LLEWVRPYVSDSK--------KFHLIIDPRLEGN-YC-----IKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       317 ~~~~~~~~~~~~~--------~~~~~~~~~~~~~-~~-----~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+...........        ............. ..     ......+.+|+.+||..||++|||++|+++
T Consensus       233 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~  304 (318)
T d3blha1         233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN  304 (318)
T ss_dssp             HHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             HHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHc
Confidence            2222111111000        0000000000000 00     112356789999999999999999999884

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-47  Score=369.75  Aligned_cols=266  Identities=25%  Similarity=0.317  Sum_probs=197.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|+++           .+++.||||++.....  ...+.+.+|+.+|+.++|||||+++++
T Consensus        17 ~~~Y~~i~~lG~G~fg~V~~~~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~   85 (346)
T d1cm8a_          17 RAVYRDLQPVGSGAYGAVCSAVDG-----------RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV   85 (346)
T ss_dssp             BSSEEEEEEC------CEEEEEET-----------TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEE
T ss_pred             CCcEEEEEEEecCCCeEEEEEEEC-----------CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            468999999999999999999976           4578899999975432  234678899999999999999999999


Q ss_pred             eeecccc--cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDER--GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~~--~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      |...+..  ...+++||||+ +.+|..++..   ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++
T Consensus        86 ~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~---~~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~  158 (346)
T d1cm8a_          86 FTPDETLDDFTDFYLVMPFM-GTDLGKLMKH---EKLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDC  158 (346)
T ss_dssp             ECSCSSTTTCCCCEEEEECC-SEEHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTC
T ss_pred             eccCccccccceEEEEEecc-cccHHHHHHh---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhccccc
Confidence            9876532  23469999999 6778877654   4699999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCcccccc-CCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQT-GRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~  320 (453)
                      .+||+|||+|+....     ..+...||+.|+|||.+.+ ..++.++|||||||++|||++|+.||..............
T Consensus       159 ~~kl~Dfg~a~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~  233 (346)
T d1cm8a_         159 ELKILDFGLARQADS-----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMK  233 (346)
T ss_dssp             CEEECCCTTCEECCS-----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred             ccccccccceeccCC-----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHh
Confidence            999999999987543     2355689999999999876 4578999999999999999999999976533222111111


Q ss_pred             hhhcc--------cCc--ccccccc---CCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VRPYV--------SDS--KKFHLII---DPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~~~~--------~~~--~~~~~~~---~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .....        ...  .......   ............++.+.+|+.+||..||.+|||+.|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~  300 (346)
T d1cm8a_         234 VTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALA  300 (346)
T ss_dssp             HHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHH
T ss_pred             ccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00000        000  0000000   000000112234567899999999999999999999986

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-46  Score=355.52  Aligned_cols=266  Identities=22%  Similarity=0.288  Sum_probs=205.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGYC  164 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~~  164 (453)
                      ++|+..+.||+|+||+||+|++.           .++..||||+++....  .....+.+|+.+|+.++||||+++++++
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~-----------~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~   70 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNR-----------ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL   70 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEET-----------TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEEC-----------CCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeecccc
Confidence            57999999999999999999986           4578899999965432  3357889999999999999999999999


Q ss_pred             eecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCcEE
Q 043568          165 AEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYKAK  244 (453)
Q Consensus       165 ~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~~k  244 (453)
                      .....    .++|++++.+++|..++...  ..+++..+..++.|++.||+|||++   +|+||||||+|||++.++.+|
T Consensus        71 ~~~~~----~~iv~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~k  141 (292)
T d1unla_          71 HSDKK----LTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELK  141 (292)
T ss_dssp             ECSSE----EEEEEECCSEEHHHHHHHTT--TCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEE
T ss_pred             ccccc----eeEEeeeccccccccccccc--cccchhHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCcee
Confidence            88775    68999999999988877654  5788999999999999999999998   999999999999999999999


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccCC-CCCchhHHHHHHHHHHHHhCCccccCCCChhhH-H-HHHhh
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGR-LTAKSDVWSFGVVLYELITGRRAVERNLPRNEQ-K-LLEWV  321 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~-~-~~~~~  321 (453)
                      |+|||.++......  .......++..|+|||.+.... ++.++|||||||++|||++|+.||.......+. . +....
T Consensus       142 l~DFG~a~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~  219 (292)
T d1unla_         142 LANFGLARAFGIPV--RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL  219 (292)
T ss_dssp             ECCCTTCEECCSCC--SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHH
T ss_pred             eeecchhhcccCCC--ccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhc
Confidence            99999998765432  2234456788999999987654 689999999999999999999998654332221 1 11111


Q ss_pred             hhccc-C---------ccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVS-D---------SKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~-~---------~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      .+... .         ....................+..+.+|+.+||+.||.+|||++|+++
T Consensus       220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~  282 (292)
T d1unla_         220 GTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ  282 (292)
T ss_dssp             CCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred             CCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence            10000 0         00000000001111223345678999999999999999999999875

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.1e-45  Score=358.30  Aligned_cols=261  Identities=20%  Similarity=0.306  Sum_probs=200.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeeee
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYCA  165 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~  165 (453)
                      ++|.+.++||+|+||+||+|+++           .+++.||||+++..   ..+.+.+|+.+|+.++ ||||+++++++.
T Consensus        35 d~y~i~~~LG~G~fg~V~~a~~~-----------~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~  100 (328)
T d3bqca1          35 DDYQLVRKLGRGKYSEVFEAINI-----------TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVK  100 (328)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cCeEEEEEEecCcCeEEEEEEEC-----------CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEE
Confidence            68999999999999999999976           56789999998643   3567889999999995 999999999987


Q ss_pred             ecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC-cEE
Q 043568          166 EDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY-KAK  244 (453)
Q Consensus       166 ~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~-~~k  244 (453)
                      .....  ..++|||||.+++|..+.     ..+++..+..++.||+.||.|||++   +|+||||||+|||++.++ .+|
T Consensus       101 ~~~~~--~~~~v~e~~~~~~L~~~~-----~~l~e~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vk  170 (328)
T d3bqca1         101 DPVSR--TPALVFEHVNNTDFKQLY-----QTLTDYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLR  170 (328)
T ss_dssp             CTTTC--SEEEEEECCCSCBGGGTT-----TSCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEE
T ss_pred             ecCCC--ceeEEEeecCCCcHHHHh-----cCCCHHHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeee
Confidence            64432  379999999999997753     3588999999999999999999999   999999999999998655 699


Q ss_pred             EeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH--HHH--
Q 043568          245 LSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK--LLE--  319 (453)
Q Consensus       245 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~--~~~--  319 (453)
                      |+|||+|+......   ......+|+.|+|||.+.+. .++.++||||+||++|||++|+.||..........  +..  
T Consensus       171 l~DFG~a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~  247 (328)
T d3bqca1         171 LIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVL  247 (328)
T ss_dssp             ECCGGGCEECCTTC---CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHH
T ss_pred             ecccccceeccCCC---cccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHH
Confidence            99999998754322   24566799999999998765 47999999999999999999999997654432211  110  


Q ss_pred             -------hhhhc-ccCcccccccc--------CCcCCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          320 -------WVRPY-VSDSKKFHLII--------DPRLEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       320 -------~~~~~-~~~~~~~~~~~--------~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                             +.... ...........        ............+.++.+||.+||..||++|||++|+++
T Consensus       248 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~  318 (328)
T d3bqca1         248 GTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME  318 (328)
T ss_dssp             CHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             CCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhc
Confidence                   00000 00000000000        001111122335678999999999999999999999875

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-46  Score=361.45  Aligned_cols=255  Identities=26%  Similarity=0.372  Sum_probs=202.0

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCC----cccHHHHHHHHHHhccCCC-CceeeEe
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQG----FQGHKEWINEVNFLGVVKH-PNLVKLV  161 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~----~~~~~~~~~E~~~l~~l~h-~nIv~l~  161 (453)
                      ++|...+.||+|+||+||+|++..        ...+++.||||.+++..    ....+.+.+|+.+|++++| |||++++
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~--------~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~   95 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKIS--------GHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH   95 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECS--------STTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEE
T ss_pred             hceEEEEEEecCCCeEEEEEEECc--------cCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEee
Confidence            669999999999999999998742        12457899999986542    2334668899999999966 8999999


Q ss_pred             eeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +++.+...    .++||||+.+|+|.+++...  ..++......++.||+.||.|||+.   +|+||||||+|||++.++
T Consensus        96 ~~~~~~~~----~~~v~e~~~~~~L~~~i~~~--~~~~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~  166 (322)
T d1vzoa_          96 YAFQTETK----LHLILDYINGGELFTHLSQR--ERFTEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNG  166 (322)
T ss_dssp             EEEEETTE----EEEEECCCCSCBHHHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTS
T ss_pred             eeeccCCc----eeeeeecccccHHHHHHHhc--ccccHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCC
Confidence            99887764    79999999999999999876  4567888899999999999999998   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccC--CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HH
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG--RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LL  318 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~  318 (453)
                      .+||+|||+++...... ........|++.|+|||.+.+.  .++.++|||||||+||||++|+.||.......... +.
T Consensus       167 ~vkL~DFG~a~~~~~~~-~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~  245 (322)
T d1vzoa_         167 HVVLTDFGLSKEFVADE-TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEIS  245 (322)
T ss_dssp             CEEESCSSEEEECCGGG-GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHH
T ss_pred             CEEEeeccchhhhcccc-cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence            99999999998654322 2234456899999999998754  47889999999999999999999997654333211 11


Q ss_pred             HhhhhcccCccccccccCCcCCCccchHHHHHHHHHHHHhhccCCCCCCC-----HHHHHH
Q 043568          319 EWVRPYVSDSKKFHLIIDPRLEGNYCIKSAQKLAALASKCLTKQPKSRPK-----MSEVVD  374 (453)
Q Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPs-----~~ei~~  374 (453)
                      ......               ....+...+.++.+|+.+||..||.+|||     ++|+++
T Consensus       246 ~~~~~~---------------~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~  291 (322)
T d1vzoa_         246 RRILKS---------------EPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE  291 (322)
T ss_dssp             HHHHHC---------------CCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred             HhcccC---------------CCCCcccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHc
Confidence            111100               01122345678999999999999999995     677764

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-45  Score=360.36  Aligned_cols=267  Identities=24%  Similarity=0.301  Sum_probs=193.1

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|+++           .++..||||++.....  .....+.+|+.+|++++||||++++++
T Consensus        16 ~~~Y~i~~~LG~G~fg~V~~~~d~-----------~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~   84 (355)
T d2b1pa1          16 LKRYQNLKPIGSGAQGIVCAAYDA-----------VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNV   84 (355)
T ss_dssp             ETTEEEEEECSCC--CEEEEEEET-----------TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             cCCeEEEEEeecCcCeEEEEEEEC-----------CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEE
Confidence            367999999999999999999976           4578999999975532  234568899999999999999999999


Q ss_pred             eeeccc--ccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCC
Q 043568          164 CAEDDE--RGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDY  241 (453)
Q Consensus       164 ~~~~~~--~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~  241 (453)
                      +...+.  ....+++|||||.++.+ +.+.    ..+++..+..++.||+.||.|||+.   ||+||||||+|||++.++
T Consensus        85 f~~~~~~~~~~~~~iv~Ey~~~~l~-~~~~----~~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~  156 (355)
T d2b1pa1          85 FTPQKTLEEFQDVYLVMELMDANLC-QVIQ----MELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDC  156 (355)
T ss_dssp             ECSCCSTTTCCEEEEEEECCSEEHH-HHHT----SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTC
T ss_pred             EecccccccCceeEEEEeccchHHH-Hhhh----cCCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCcccccccccc
Confidence            976542  23468999999966544 4443    3578999999999999999999999   999999999999999999


Q ss_pred             cEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCccccCCCChhhHH-HHHh
Q 043568          242 KAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQK-LLEW  320 (453)
Q Consensus       242 ~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~-~~~~  320 (453)
                      .+|++|||+++....   ........||+.|+|||++.+..+++++||||+||+++||++|+.||.......... +...
T Consensus       157 ~~kl~df~~~~~~~~---~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~  233 (355)
T d2b1pa1         157 TLKILDFGLARTAGT---SFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQ  233 (355)
T ss_dssp             CEEECCCCC------------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHH
T ss_pred             ceeeechhhhhcccc---ccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHh
Confidence            999999999887543   223456689999999999999999999999999999999999999997543222111 1100


Q ss_pred             hh--------h-------cccC-----ccccccccCCc---CCCccchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          321 VR--------P-------YVSD-----SKKFHLIIDPR---LEGNYCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       321 ~~--------~-------~~~~-----~~~~~~~~~~~---~~~~~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ..        .       ....     ...........   .........+.++.+|+.+||..||++|||++|+++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~  310 (355)
T d2b1pa1         234 LGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ  310 (355)
T ss_dssp             HCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHT
T ss_pred             ccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhc
Confidence            00        0       0000     00000000000   011123345778999999999999999999999975

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-45  Score=358.65  Aligned_cols=267  Identities=24%  Similarity=0.317  Sum_probs=198.4

Q ss_pred             hcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCc--ccHHHHHHHHHHhccCCCCceeeEeee
Q 043568           86 TRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGF--QGHKEWINEVNFLGVVKHPNLVKLVGY  163 (453)
Q Consensus        86 ~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~--~~~~~~~~E~~~l~~l~h~nIv~l~~~  163 (453)
                      .++|...++||+|+||+||+|++.           .+++.||||++.....  ...+.+.+|+.+|++++|||||+++++
T Consensus        17 ~~rY~i~~~LG~G~fg~Vy~a~~~-----------~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~   85 (348)
T d2gfsa1          17 PERYQNLSPVGSGAYGSVCAAFDT-----------KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDV   85 (348)
T ss_dssp             ETTEEEEEECGGGTTSSEEEEEET-----------TTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEE
T ss_pred             CCCeEEEEEEecCCCeEEEEEEEC-----------CCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEE
Confidence            568999999999999999999976           5678999999975532  234578899999999999999999999


Q ss_pred             eeecccc-cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccccccEEEcCCCc
Q 043568          164 CAEDDER-GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFKTSNILLDEDYK  242 (453)
Q Consensus       164 ~~~~~~~-~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlkp~NILl~~~~~  242 (453)
                      +...... ....+++|+|+.+|+|.+++..   ..+++..+..++.||+.||+|||++   +|+||||||+|||++.++.
T Consensus        86 ~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~---~~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~  159 (348)
T d2gfsa1          86 FTPARSLEEFNDVYLVTHLMGADLNNIVKC---QKLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCE  159 (348)
T ss_dssp             ECSCSSTTTCCCCEEEEECCSEEHHHHHTT---CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCC
T ss_pred             EeeccccccCceEEEEEeecCCchhhhccc---ccccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCcccccccccc
Confidence            8754321 1124667778889999998865   3699999999999999999999999   9999999999999999999


Q ss_pred             EEEeccccccCCCCCCCCccccccccCcCCCCccccccC-CCCCchhHHHHHHHHHHHHhCCccccCCCChhhHHHHHhh
Q 043568          243 AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTG-RLTAKSDVWSFGVVLYELITGRRAVERNLPRNEQKLLEWV  321 (453)
Q Consensus       243 ~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DV~SlGvil~elltg~~p~~~~~~~~~~~~~~~~  321 (453)
                      +|++|||++....     .......||+.|+|||.+.+. .++.++|||||||++|+|++|+.||...........+...
T Consensus       160 ~kl~dfg~a~~~~-----~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~  234 (348)
T d2gfsa1         160 LKILDFGLARHTD-----DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRL  234 (348)
T ss_dssp             EEECCC----CCT-----GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred             ccccccchhcccC-----cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHh
Confidence            9999999997643     234566899999999987664 5689999999999999999999999765432222211111


Q ss_pred             hhcccC-------cccccccc---CCcCCCc---cchHHHHHHHHHHHHhhccCCCCCCCHHHHHH
Q 043568          322 RPYVSD-------SKKFHLII---DPRLEGN---YCIKSAQKLAALASKCLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       322 ~~~~~~-------~~~~~~~~---~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RPs~~ei~~  374 (453)
                      ......       ........   .......   .....+.++.+||.+||..||.+|||+.|+++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~  300 (348)
T d2gfsa1         235 VGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA  300 (348)
T ss_dssp             HCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred             cCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhc
Confidence            000000       00000000   0000000   01234567899999999999999999999885

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=7.3e-41  Score=328.44  Aligned_cols=266  Identities=19%  Similarity=0.255  Sum_probs=192.2

Q ss_pred             cCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-----------CC
Q 043568           87 RGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-----------HP  155 (453)
Q Consensus        87 ~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-----------h~  155 (453)
                      ++|.++++||+|+||+||+|++.           .+++.||||+++... ...+.+.+|+.+++.++           |+
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~-----------~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~   80 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDM-----------VNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGAN   80 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEET-----------TTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHT
T ss_pred             CcEEEEEEEeeCCCeEEEEEEEC-----------CCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcC
Confidence            35999999999999999999976           567899999997543 23456788999988875           57


Q ss_pred             ceeeEeeeeeecccccceEEEEEEecCCC-ChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEeeccccc
Q 043568          156 NLVKLVGYCAEDDERGMQRLLVYELMHNK-SLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHE-EMDFQLIFRDFKTS  233 (453)
Q Consensus       156 nIv~l~~~~~~~~~~~~~~~lv~e~~~~g-sL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~~~~iiH~Dlkp~  233 (453)
                      ||+++++++.......  .+++|+++..+ .............+++..+..++.||+.||.|||+ .   +|+||||||+
T Consensus        81 ~iv~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~  155 (362)
T d1q8ya_          81 HILKLLDHFNHKGPNG--VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPE  155 (362)
T ss_dssp             TBCCCCEEEEEEETTE--EEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGG
T ss_pred             ceEEEEEEeeeccccc--eeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChh
Confidence            8999999987655432  45666655444 34444445555678899999999999999999998 5   9999999999


Q ss_pred             cEEEcCCCc------EEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHHHHHHhCCcccc
Q 043568          234 NILLDEDYK------AKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVLYELITGRRAVE  307 (453)
Q Consensus       234 NILl~~~~~------~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil~elltg~~p~~  307 (453)
                      ||||+.++.      ++|+|||.+.....     ......||+.|+|||++....++.++||||+||++++|++|+.||.
T Consensus       156 NIll~~~~~~~~~~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~  230 (362)
T d1q8ya_         156 NVLMEIVDSPENLIQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFE  230 (362)
T ss_dssp             GEEEEEEETTTTEEEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             HeeeeccCcccccceeeEeeccccccccc-----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCC
Confidence            999986553      99999999986432     2345679999999999999999999999999999999999999986


Q ss_pred             CCCChh----hHHHHHhhhh-----------------cccCccccccccCC---------cCCCccchHHHHHHHHHHHH
Q 043568          308 RNLPRN----EQKLLEWVRP-----------------YVSDSKKFHLIIDP---------RLEGNYCIKSAQKLAALASK  357 (453)
Q Consensus       308 ~~~~~~----~~~~~~~~~~-----------------~~~~~~~~~~~~~~---------~~~~~~~~~~~~~l~~li~~  357 (453)
                      ......    ...+......                 ..........+...         ..........+.++.+|+.+
T Consensus       231 ~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~  310 (362)
T d1q8ya_         231 PDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSP  310 (362)
T ss_dssp             --------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGG
T ss_pred             CCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHH
Confidence            432211    1111111100                 00000000000000         00122345667899999999


Q ss_pred             hhccCCCCCCCHHHHHH
Q 043568          358 CLTKQPKSRPKMSEVVD  374 (453)
Q Consensus       358 cl~~dp~~RPs~~ei~~  374 (453)
                      ||..||.+|||++|+++
T Consensus       311 mL~~dP~~Rpta~e~L~  327 (362)
T d1q8ya_         311 MLQLDPRKRADAGGLVN  327 (362)
T ss_dssp             GGCSSTTTCBCHHHHHT
T ss_pred             HCCCChhHCcCHHHHhc
Confidence            99999999999999875

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.91  E-value=5.9e-25  Score=194.70  Aligned_cols=169  Identities=16%  Similarity=0.133  Sum_probs=117.1

Q ss_pred             CccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcc------------------cHHHHHHHHHHhcc
Q 043568           90 SRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQ------------------GHKEWINEVNFLGV  151 (453)
Q Consensus        90 ~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~------------------~~~~~~~E~~~l~~  151 (453)
                      .++++||+|+||+||+|++.            ++..||||+++.....                  ....+.+|+..+.+
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~------------~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~   70 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSE------------KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK   70 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEET------------TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH
T ss_pred             hhCCEeeeCcceEEEEEECC------------CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHH
Confidence            45789999999999999863            4678999987532100                  01234568899999


Q ss_pred             CCCCceeeEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEeeccc
Q 043568          152 VKHPNLVKLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEMDFQLIFRDFK  231 (453)
Q Consensus       152 l~h~nIv~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~~~~iiH~Dlk  231 (453)
                      +.|++++..+++..        .+++|||+++..+.++         +......++.|++.+|.|||++   +|+|||||
T Consensus        71 l~~~~v~~~~~~~~--------~~lvme~~~~~~~~~l---------~~~~~~~i~~ql~~~l~~lH~~---giiHrDiK  130 (191)
T d1zara2          71 LQGLAVPKVYAWEG--------NAVLMELIDAKELYRV---------RVENPDEVLDMILEEVAKFYHR---GIVHGDLS  130 (191)
T ss_dssp             TTTSSSCCEEEEET--------TEEEEECCCCEEGGGC---------CCSCHHHHHHHHHHHHHHHHHT---TEECSCCS
T ss_pred             ccCCCcceEEEecC--------CEEEEEeeccccccch---------hhHHHHHHHHHHHHHHHHHhhC---CEEEccCC
Confidence            99999998876531        2799999987665442         2223467899999999999998   99999999


Q ss_pred             cccEEEcCCCcEEEeccccccCCCCCCCCccccccccCcCCCCccccccCCCCCchhHHHHHHHH
Q 043568          232 TSNILLDEDYKAKLSDFGLARQGPPEGLGHVSTSVVGTVGYAAPEYVQTGRLTAKSDVWSFGVVL  296 (453)
Q Consensus       232 p~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DV~SlGvil  296 (453)
                      |+|||++++ .++|+|||+|...............+..    -.+.+ ...|+.++|+||+.--+
T Consensus       131 P~NILv~~~-~~~liDFG~a~~~~~~~~~~~l~rd~~~----~~~~f-~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         131 QYNVLVSEE-GIWIIDFPQSVEVGEEGWREILERDVRN----IITYF-SRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TTSEEEETT-EEEECCCTTCEETTSTTHHHHHHHHHHH----HHHHH-HHHHCCCCCHHHHHHHH
T ss_pred             hhheeeeCC-CEEEEECCCcccCCCCCcHHHHHHHHHH----HHHHH-cCCCCCcccHHHHHHHH
Confidence            999999965 4899999999765422110000000000    01122 35678899999975433

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.70  E-value=3.1e-08  Score=89.81  Aligned_cols=150  Identities=14%  Similarity=0.098  Sum_probs=99.1

Q ss_pred             HHHHHHhcCCCccceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCcee
Q 043568           80 AELKSATRGFSRALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLV  158 (453)
Q Consensus        80 ~~~~~~~~~f~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv  158 (453)
                      .++++....|+..+..+.++.+.||+..             .++..+++|............+.+|...++.+. +--+.
T Consensus         7 ~~l~~~~~~~~~~~~~~G~s~~~v~rv~-------------~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP   73 (263)
T d1j7la_           7 PELKKLIEKYRCVKDTEGMSPAKVYKLV-------------GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVP   73 (263)
T ss_dssp             HHHHHHHTTSEEEECSCCCSSSEEEEEE-------------CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCC
T ss_pred             HHHHHhhhceEEEEcCCCCCCCcEEEEE-------------eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCC
Confidence            3556666777776655555567899875             234568899876544334445678888887763 44466


Q ss_pred             eEeeeeeecccccceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------
Q 043568          159 KLVGYCAEDDERGMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLHEEM-----------------  221 (453)
Q Consensus       159 ~l~~~~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----------------  221 (453)
                      +++.++...+.    .++||++++|.++.+.....    ..   ...++.+++..|..||+..                 
T Consensus        74 ~vl~~~~~~~~----~~lv~~~l~G~~~~~~~~~~----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~  142 (263)
T d1j7la_          74 KVLHFERHDGW----SNLLMSEADGVLCSEEYEDE----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAEL  142 (263)
T ss_dssp             CEEEEEEETTE----EEEEEECCSSEEHHHHTTTC----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHH
T ss_pred             cEEEEEecCCc----eEEEEEeccccccccccccc----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhH
Confidence            77776655442    68999999998886644321    11   1233455555555665321                 


Q ss_pred             ---------------------------------------CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 ---------------------------------------DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 ---------------------------------------~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                                                             .+.++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         143 DYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                                                   12479999999999999877677999987754

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.08  E-value=1.6e-05  Score=70.90  Aligned_cols=131  Identities=17%  Similarity=0.122  Sum_probs=79.2

Q ss_pred             eecCCCc-eEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC--CCceeeEeeeeeecccc
Q 043568           94 LIGEGGF-GCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK--HPNLVKLVGYCAEDDER  170 (453)
Q Consensus        94 ~lG~G~~-g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~--h~nIv~l~~~~~~~~~~  170 (453)
                      .+..|.. +.||+...            .++..+++|.......   ..+..|+..|+.+.  .-.+.++++++.+.+. 
T Consensus        17 ~~~~G~s~~~v~r~~~------------~~~~~~vlK~~~~~~~---~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~-   80 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSA------------QGRPVLFVKTDLSGAL---NELQDEAARLSWLATTGVPCAAVLDVVTEAGR-   80 (255)
T ss_dssp             ECSCTTSSCEEEEEEC------------TTSCCEEEEEECSCTT---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSC-
T ss_pred             EcCCcccCCeEEEEEe------------CCCCEEEEEeCCccCH---hHHHHHHHHHHHHHhcCCCCCceeeecccccc-
Confidence            3455553 67898763            2345688887654332   23567788777663  3335667776655433 


Q ss_pred             cceEEEEEEecCCCChHHhhhcCCCCCCCHHHHHHHHHHHHHHHHHHH--------------------------------
Q 043568          171 GMQRLLVYELMHNKSLEDHLLSRVPTPLAWIARLKIAQDAARGLAYLH--------------------------------  218 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~~ia~~L~~LH--------------------------------  218 (453)
                         .++||++++|.++.+..       ...   ..++.+++..|.-||                                
T Consensus        81 ---~~~v~~~i~G~~~~~~~-------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  147 (255)
T d1nd4a_          81 ---DWLLLGEVPGQDLLSSH-------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQD  147 (255)
T ss_dssp             ---EEEEEECCSSEETTTSC-------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTT
T ss_pred             ---eEEEEEeeecccccccc-------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccc
Confidence               68999999887764311       000   011122222222332                                


Q ss_pred             -------------------hCC----CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          219 -------------------EEM----DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       219 -------------------~~~----~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                                         ...    .+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus       148 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         148 DLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             SCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cccchhhhhHHHHHHHHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence                               211    13489999999999999876678999987654

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.01  E-value=1.3e-05  Score=76.60  Aligned_cols=78  Identities=17%  Similarity=0.098  Sum_probs=47.8

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccC------Cc-ccHHHHHHHHHHhccC-CC--CceeeEe
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQ------GF-QGHKEWINEVNFLGVV-KH--PNLVKLV  161 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~------~~-~~~~~~~~E~~~l~~l-~h--~nIv~l~  161 (453)
                      .+.||.|....||+....           .++..|+||.-...      .. ....+...|...|+.+ .+  ..+.+++
T Consensus        31 ~~eig~G~~N~vfrV~~~-----------~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~   99 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQ-----------EHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVF   99 (392)
T ss_dssp             EEECCSSSSEEEEEEEC---------------CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEE
T ss_pred             EEEeCCCceEeEEEEEeC-----------CCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEE
Confidence            346899999999998753           33567999975321      11 1233455688888766 22  3466666


Q ss_pred             eeeeecccccceEEEEEEecCCCCh
Q 043568          162 GYCAEDDERGMQRLLVYELMHNKSL  186 (453)
Q Consensus       162 ~~~~~~~~~~~~~~lv~e~~~~gsL  186 (453)
                      .+..+  .    .++|||++++..+
T Consensus       100 ~~d~~--~----~~lvmE~L~~~~~  118 (392)
T d2pula1         100 YSDTE--M----AVTVMEDLSHLKI  118 (392)
T ss_dssp             EEETT--T----TEEEECCCTTSEE
T ss_pred             EEcCC--C----CEEEEeccCCccc
Confidence            55332  2    3899999976543

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.31  E-value=0.00058  Score=64.80  Aligned_cols=81  Identities=11%  Similarity=0.027  Sum_probs=50.7

Q ss_pred             cceecCCCceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCC-CCceeeEeeeeeecccc
Q 043568           92 ALLIGEGGFGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVK-HPNLVKLVGYCAEDDER  170 (453)
Q Consensus        92 ~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~~  170 (453)
                      .+.|+.|---.+|+........    ........|.+++...  ....-...+|..+++.+. +.-..++++++..    
T Consensus        47 v~~l~GGltN~~y~v~~~~~~~----~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----  116 (395)
T d1nw1a_          47 ISRIKGGMSNMLFLCRLSEVYP----PIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----  116 (395)
T ss_dssp             EEEECCCTTEEEEEEEECTTSC----CSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred             EEEcCCccccceEEEEeCCCCc----cccCCCCcEEEEecCC--cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----
Confidence            3468889999999987653211    1112345577777642  223334568999998884 4334577776632    


Q ss_pred             cceEEEEEEecCCCCh
Q 043568          171 GMQRLLVYELMHNKSL  186 (453)
Q Consensus       171 ~~~~~lv~e~~~~gsL  186 (453)
                          .+|+||++|.+|
T Consensus       117 ----g~I~efi~g~~l  128 (395)
T d1nw1a_         117 ----GRLEEYIPSRPL  128 (395)
T ss_dssp             ----EEEECCCCEEEC
T ss_pred             ----ceEEEEeccccC
Confidence                579999987554

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.98  E-value=0.0012  Score=60.84  Aligned_cols=139  Identities=14%  Similarity=0.158  Sum_probs=73.7

Q ss_pred             ceEEEEEEEeecCCCCCcCCCCCCeeEEEEEeccCCcccHHHHHHHHHHhccCCCCce--eeEeeeeeec-ccccceEEE
Q 043568          100 FGCVYRGVVRVSSDDHQTSGHDSKLDVAIKQLNRQGFQGHKEWINEVNFLGVVKHPNL--VKLVGYCAED-DERGMQRLL  176 (453)
Q Consensus       100 ~g~Vy~~~~~~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~E~~~l~~l~h~nI--v~l~~~~~~~-~~~~~~~~l  176 (453)
                      --.||+...            .++..|++|+.... ....+++..|+..+..|....|  +..+...... .......+.
T Consensus        35 EN~vy~v~~------------~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~  101 (325)
T d1zyla1          35 ENRVYQFQD------------EDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFA  101 (325)
T ss_dssp             SSEEEEECC------------TTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEE
T ss_pred             cceeEEEEc------------CCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEE
Confidence            468998875            34667999987543 3355678888888887742222  2221110000 001123688


Q ss_pred             EEEecCCCChHH----hh----------h----cCC---CCCCCHH----------------------HHHHHHHHHHHH
Q 043568          177 VYELMHNKSLED----HL----------L----SRV---PTPLAWI----------------------ARLKIAQDAARG  213 (453)
Q Consensus       177 v~e~~~~gsL~~----~l----------~----~~~---~~~l~~~----------------------~~~~i~~~ia~~  213 (453)
                      ++++++|..+..    .+          +    ...   ....++.                      ....++..+...
T Consensus       102 l~~~~~G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  181 (325)
T d1zyla1         102 VFPSVGGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAA  181 (325)
T ss_dssp             EEECCCCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHH
T ss_pred             EEeecCCcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHH
Confidence            999997644310    00          0    000   0111111                      111222233332


Q ss_pred             HHHH-HhCCCCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          214 LAYL-HEEMDFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       214 L~~L-H~~~~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      +.-+ ......++||+|+.+.|||++++  ..++||+-+..
T Consensus       182 l~~~~~~~~p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         182 VTAHWREDFTVLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             HHHHCCSCSCCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             HHHhccccCCceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            2222 12224589999999999999743  45899998765

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.79  E-value=0.0022  Score=58.41  Aligned_cols=32  Identities=25%  Similarity=0.250  Sum_probs=28.0

Q ss_pred             CCceEeeccccccEEEcCCCcEEEeccccccC
Q 043568          222 DFQLIFRDFKTSNILLDEDYKAKLSDFGLARQ  253 (453)
Q Consensus       222 ~~~iiH~Dlkp~NILl~~~~~~kL~DFGla~~  253 (453)
                      ..++||+|+.+.||+++.+...-|.||+.+..
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccCCcchhhhhcccccceeEeccccccc
Confidence            45899999999999999888778999998754